Citrus Sinensis ID: 011154
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LJL9 | 599 | CDPK-related kinase 2 OS= | yes | no | 0.975 | 0.801 | 0.681 | 0.0 | |
| P53681 | 602 | CDPK-related protein kina | N/A | no | 0.985 | 0.805 | 0.689 | 0.0 | |
| Q9SCS2 | 601 | CDPK-related kinase 5 OS= | no | no | 0.979 | 0.801 | 0.678 | 0.0 | |
| Q9FX86 | 606 | CDPK-related kinase 8 OS= | no | no | 0.979 | 0.795 | 0.667 | 0.0 | |
| O80673 | 576 | CDPK-related kinase 1 OS= | no | no | 0.951 | 0.812 | 0.623 | 1e-171 | |
| Q9LET1 | 577 | CDPK-related kinase 7 OS= | no | no | 0.914 | 0.779 | 0.660 | 1e-170 | |
| Q10KY3 | 600 | Calcium/calmodulin-depend | no | no | 0.867 | 0.711 | 0.674 | 1e-165 | |
| Q9ZUZ2 | 595 | CDPK-related kinase 3 OS= | no | no | 0.800 | 0.662 | 0.675 | 1e-152 | |
| Q9FIM9 | 594 | CDPK-related kinase 4 OS= | no | no | 0.912 | 0.755 | 0.553 | 1e-142 | |
| Q9SG12 | 594 | CDPK-related kinase 6 OS= | no | no | 0.792 | 0.656 | 0.630 | 1e-141 |
| >sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 684 bits (1766), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/512 (68%), Positives = 398/512 (77%), Gaps = 32/512 (6%)
Query: 1 MGGCTSKPQ---KPNPYAPRNT--QNDLSIPPTPNTTTNKNNDAVNDDKQSHSAALSPFF 55
MGGCTSKP KPNPYAP++ QND S P P + +++ AV SPFF
Sbjct: 1 MGGCTSKPSSSVKPNPYAPKDAVLQNDDSTPAHPGKSPVRSSPAVK---------ASPFF 51
Query: 56 PLYTPSPAYIFKKSLSGSKKGG-------NLTPMRVFR---MPPSPAKHIKAVLRRRKST 105
P YTPSPA + + S+ GG TP+R PPSPA+HI+ VLRRRK
Sbjct: 52 PFYTPSPA---RHRRNKSRDGGGGESKSVTSTPLRQLARAFHPPSPARHIRDVLRRRKEK 108
Query: 106 KKSSAEEGAPEEAAPE-----LDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEH 160
K+++ ++ E LDKRFGFSKE+ SR+E+GEE+GRGHFGYTC+A++KKGE
Sbjct: 109 KEAALPAARQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIGRGHFGYTCSAKFKKGEL 168
Query: 161 KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELC 220
KDQ+VA+KVIPKSKMT+AI++EDVRREVKILRALSGH NLV+FYDAFED NVYIVMELC
Sbjct: 169 KDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGHQNLVQFYDAFEDNANVYIVMELC 228
Query: 221 EGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ 280
GGELLDRIL+R GKYSED+AKAVL+QILNVVAFCHL GVVHRDLKPENFLYTSK+E+S
Sbjct: 229 GGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHRDLKPENFLYTSKEENSM 288
Query: 281 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPF 340
LK IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYILLCGSRPF
Sbjct: 289 LKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPF 348
Query: 341 WARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
WARTESGIFRAVLKADPSFD+ WPSLS +AKDFVK LL KDPRKRMTA+QAL HPWI
Sbjct: 349 WARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDPRKRMTASQALMHPWIAG 408
Query: 401 YNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCI 460
Y + +P DI I K +KAY++SSSLR+AAL ALSKTLT DE YLK QFA L PNKNG I
Sbjct: 409 YKKIDIPFDILIFKQIKAYLRSSSLRKAALMALSKTLTTDELLYLKAQFAHLAPNKNGLI 468
Query: 461 AFENIKTVLMKNATDAMKESRISDLLAPSDGF 492
++I+ L NAT+AMKESRI D LA +G
Sbjct: 469 TLDSIRLALATNATEAMKESRIPDFLALLNGL 500
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 678 bits (1749), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/499 (68%), Positives = 389/499 (77%), Gaps = 14/499 (2%)
Query: 1 MGGCTSKPQKPNPYAPRNTQ---NDLSIPPTPNTTTNKNNDAVNDDKQSHSAALSPFFPL 57
MG C SKP +T ND S+PP N+ K+ D SPF P
Sbjct: 1 MGICVSKPSPEPDLHNHHTSIPVNDTSLPPQDNSIPPKDIAIPAQDNNKPPGKKSPFLPF 60
Query: 58 YTPSPAYIF---KKSLSGSKKGG--NLTPMRVFRMPP-SPAKHIKAVLRRRKSTKKSSAE 111
Y+PSPA+ K GS G N TP R+F PP SPAKHIKA RR + K + E
Sbjct: 61 YSPSPAHFLFSKKSPAVGSPAAGSSNSTPKRLFPFPPPSPAKHIKAAWARRHGSVKPN-E 119
Query: 112 EGAPE----EAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAI 167
PE + LDK FGFSK+ S+ EVGEEVGRGHFGYTC A++KKGE K Q VA+
Sbjct: 120 AAIPENNEVDGGAGLDKSFGFSKKFGSKFEVGEEVGRGHFGYTCRAKFKKGEFKGQDVAV 179
Query: 168 KVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD 227
KVIPK+KMTTAIA+EDVRREVKILRAL+GH+NLV+FYDAFED NVY+VMELCEGGELLD
Sbjct: 180 KVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVQFYDAFEDHTNVYVVMELCEGGELLD 239
Query: 228 RILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287
RILSR GKY+ED+AKAV++QILNVVAFCHL GVVHRDLKPENFL+ SKDE SQLKAIDFG
Sbjct: 240 RILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFKSKDEDSQLKAIDFG 299
Query: 288 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESG 347
LSD+V+PDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVI+YILLCGSRPFWARTESG
Sbjct: 300 LSDYVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVISYILLCGSRPFWARTESG 359
Query: 348 IFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVP 407
IFRAVLKA+ SFD+ WPS+SS+AKDFVK LLNKDPRKRMTAAQAL H WI+N N++K P
Sbjct: 360 IFRAVLKANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTAAQALCHSWIKNSNDIKFP 419
Query: 408 LDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKT 467
LDI + KLMK YM+SS LR+AAL+ALSKTLTVDE FYLKEQF LLEP KNG I+ ENIK
Sbjct: 420 LDILVFKLMKVYMRSSPLRKAALRALSKTLTVDELFYLKEQFVLLEPTKNGTISLENIKQ 479
Query: 468 VLMKNATDAMKESRISDLL 486
LM+N+TDAMK+SR+ DLL
Sbjct: 480 ALMRNSTDAMKDSRVLDLL 498
|
Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 675 bits (1742), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/504 (67%), Positives = 403/504 (79%), Gaps = 22/504 (4%)
Query: 1 MGGCTSKPQKPNPYAPRNTQNDLSIPPTP-NTTTNKNNDAVNDDKQ-----SHSAALSPF 54
MG CTSKP N + Q P P + + ++ +VN + Q ++ SPF
Sbjct: 1 MGLCTSKPNSSN-----SDQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNNEGKKSPF 55
Query: 55 FPLYTPSPA-YIFKK---SLSGSKKGGNLTPMRVFRMP---PSPAKHIKAVLRRRKSTKK 107
FP Y+PSPA Y F K + S + N TP R F+ P PSPAKHI+AVL RR + K
Sbjct: 56 FPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVLARRHGSVK 115
Query: 108 ---SSAEEGAPEEAAP-ELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQ 163
S+ EG+ E LDK FGFSK S+ E+G+EVGRGHFGYTC A++KKG++K Q
Sbjct: 116 PNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKFKKGDNKGQ 175
Query: 164 KVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGG 223
+VA+KVIPK+KMTTAIA+EDVRREVKILRALSGH+NL FYDA+ED DNVYIVMELCEGG
Sbjct: 176 QVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYIVMELCEGG 235
Query: 224 ELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283
ELLDRILSR GKY+E++AK V++QILNVVAFCHL GVVHRDLKPENFL+TSK+++SQLKA
Sbjct: 236 ELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSKEDTSQLKA 295
Query: 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWAR 343
IDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSY TEAD+WS+GVI YILLCGSRPFWAR
Sbjct: 296 IDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLCGSRPFWAR 355
Query: 344 TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
TESGIFRAVLKADPSFDD WP LSS+A+DFVK LLNKDPRKR+TAAQALSHPWI++ N+
Sbjct: 356 TESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKDSND 415
Query: 404 VKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFE 463
KVP+DI + KLM+AY++SSSLR+AAL+ALSKTLTVDE FYL+EQFALLEP+KNG I+ E
Sbjct: 416 AKVPMDILVFKLMRAYLRSSSLRKAALRALSKTLTVDELFYLREQFALLEPSKNGTISLE 475
Query: 464 NIKTVLMKNATDAMKESRISDLLA 487
NIK+ LMK ATDAMK+SRI + L
Sbjct: 476 NIKSALMKMATDAMKDSRIPEFLG 499
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 662 bits (1709), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/517 (66%), Positives = 395/517 (76%), Gaps = 35/517 (6%)
Query: 1 MGGCTSKPQ----KPNPYAPRNT--QNDLSIPPTPNTTTNKNNDAVNDDKQSHSAALSPF 54
MGGCTSKP +PNP+AP N Q D P P + A A SPF
Sbjct: 1 MGGCTSKPSTSSGRPNPFAPGNDYPQIDDFAPDHPGKSPIPTPSA---------AKASPF 51
Query: 55 FPLYTPSPAYIFK---KSLSGSKKGGNLT--PMRVFR---MPPSPAKHIKAVLRRRKSTK 106
FP YTPSPA + + + G + +LT P+R R PPSPAKHI+A LRRRK K
Sbjct: 52 FPFYTPSPARHRRNKSRDVGGGGESKSLTSTPLRQLRRAFHPPSPAKHIRAALRRRKG-K 110
Query: 107 KSSAEEGAPE--EAAPE--------LDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYK 156
K +A G + P+ LDKRFGFSKE SR+E+GEE+GRGHFGYTC+A++K
Sbjct: 111 KEAALSGVTQLTTEVPQREEEEEVGLDKRFGFSKEFHSRVELGEEIGRGHFGYTCSAKFK 170
Query: 157 KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIV 216
KGE K Q VA+K+IPKSKMTTAIA+EDVRREVKIL+ALSGH NLV+FYDAFED NVYI
Sbjct: 171 KGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQALSGHKNLVQFYDAFEDNANVYIA 230
Query: 217 MELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276
MELCEGGELLDRIL+R GKYSE++AK V++QILNVVAFCH GVVHRDLKPENFLYTSK+
Sbjct: 231 MELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVVHRDLKPENFLYTSKE 290
Query: 277 ESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCG 336
E+SQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYILLCG
Sbjct: 291 ENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSIGVIAYILLCG 350
Query: 337 SRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396
SRPFWARTESGIFRAVLKADPSFD+ WP LSSDAKDFVK LL KDPR+RM+A+QAL HP
Sbjct: 351 SRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFKDPRRRMSASQALMHP 410
Query: 397 WIRNYN-NVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPN 455
WIR YN ++ +P DI I + MKAY++SSSLR+AAL+ALSKTL DE YLK QF+LL PN
Sbjct: 411 WIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALRALSKTLIKDEILYLKTQFSLLAPN 470
Query: 456 KNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492
K+G I + I+ L NAT+AMKESRI + LA +G
Sbjct: 471 KDGLITMDTIRMALASNATEAMKESRIPEFLALLNGL 507
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 602 bits (1552), Expect = e-171, Method: Compositional matrix adjust.
Identities = 306/491 (62%), Positives = 371/491 (75%), Gaps = 23/491 (4%)
Query: 1 MGGCTSKPQKPNPYAPRNTQNDLSIPPTPNTTTNKNNDAVNDDKQSHSAALSPFFPLYTP 60
MG C KP + Q S+P + T N S A S FP Y+P
Sbjct: 1 MGICHGKPVE---------QQSKSLPVSGETNEAPTN--------SQPPAKSSGFPFYSP 43
Query: 61 SPAYIFKKSLSGSKKGGNLTPMRVFRMP---PSPAKHIKAVLRRRKSTKKSSAEEGAPE- 116
SP KS + TP+R+F+ P PSPAKHI+A L RR + K + E PE
Sbjct: 44 SPVPSLFKSSPSVSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARRYGSVKPN-EVSIPEG 102
Query: 117 -EAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM 175
E LDK FGFSK+ S E+ EVGRGHFGYTC+A+ KKG K Q+VA+KVIPKSKM
Sbjct: 103 KECEIGLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIPKSKM 162
Query: 176 TTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK 235
TTAIA+EDV REVK+LRAL+GH NLV+FYDAFED +NVYIVMELC+GGELLD+IL R GK
Sbjct: 163 TTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKILQRGGK 222
Query: 236 YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295
YSED+AK V+VQIL+VVA+CHL GVVHRDLKPENFL+++KDE+S LKAIDFGLSD+V+PD
Sbjct: 223 YSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSDYVKPD 282
Query: 296 ERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 355
ERLNDIVGSAYYVAPEVLHR+YGTEAD+WSIGVIAYILLCGSRPFWARTESGIFRAVLKA
Sbjct: 283 ERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 342
Query: 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKL 415
+P+F++ WPSLS +A DFVK LLNKD RKR+TAAQAL HPW+ + +K+P D+ I KL
Sbjct: 343 EPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYKL 402
Query: 416 MKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATD 475
+K Y+ S+SLR++AL AL+KTLTV + YL+EQF LL P+KNG I+ +N KT ++K++TD
Sbjct: 403 VKVYIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGYISMQNYKTAILKSSTD 462
Query: 476 AMKESRISDLL 486
AMK+SR+ D +
Sbjct: 463 AMKDSRVFDFV 473
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LET1|CAMK7_ARATH CDPK-related kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 599 bits (1545), Expect = e-170, Method: Compositional matrix adjust.
Identities = 302/457 (66%), Positives = 367/457 (80%), Gaps = 7/457 (1%)
Query: 36 NNDAVNDDKQSHSAALSPFFPLYTPSPA-YIFKKSLSGSKKGGNLTPMRVFRMP---PSP 91
+N+ K S A S FP Y+PSP +FK S + S + TP+R+F+ P PSP
Sbjct: 19 SNEIEETPKNSSQKAKSSGFPFYSPSPLPSLFKTSPAVSSSSVSSTPLRIFKRPFPPPSP 78
Query: 92 AKHIKAVLRRRKSTKKSSAEEGAPEEAAPE--LDKRFGFSKEVTSRLEVGEEVGRGHFGY 149
AKHI+A+L RR + K + E PE + E LDK+FGFSK+ S E+ EVGRGHFGY
Sbjct: 79 AKHIRALLARRHGSVKPN-EASIPEGSECEVGLDKKFGFSKQFASHYEIDGEVGRGHFGY 137
Query: 150 TCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209
TC+A+ KKG K Q VA+KVIPKSKMTTAIA+EDVRREVKILRAL+GH NLV+FYDAFED
Sbjct: 138 TCSAKGKKGSLKGQDVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFED 197
Query: 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPEN 269
+NVYIVMELC+GGELLD+IL R GKYSE +AK V++QIL+VVA+CHL GVVHRDLKPEN
Sbjct: 198 DENVYIVMELCQGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPEN 257
Query: 270 FLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVI 329
FL+T+KDESS LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHR+YGTEAD+WSIGVI
Sbjct: 258 FLFTTKDESSPLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVI 317
Query: 330 AYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTA 389
AYILLCGSRPFWAR+ESGIFRAVLKA+P+F++ WPSLS DA DFVK LLNKD RKR+TA
Sbjct: 318 AYILLCGSRPFWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTA 377
Query: 390 AQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQF 449
AQAL HPW+ + +K+P D+ I KL+K Y+ SSSLR++AL AL+KTLTV + YL+EQF
Sbjct: 378 AQALCHPWLVGSHELKIPSDMIIYKLVKVYIMSSSLRKSALAALAKTLTVPQLTYLQEQF 437
Query: 450 ALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLL 486
LL P+KNG I+ +N KT ++K++T+A K+SR+ D +
Sbjct: 438 NLLGPSKNGYISMQNYKTAILKSSTEATKDSRVLDFV 474
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 583 bits (1502), Expect = e-165, Method: Compositional matrix adjust.
Identities = 298/442 (67%), Positives = 356/442 (80%), Gaps = 15/442 (3%)
Query: 55 FPLYTPSP--AYIFKKSLSGSK------KGGNLTPMRVFRMPPSPAKHIKAVLRRRKSTK 106
FP Y PSP A +K S + S +GG P PPSPAKHI+A+L RR +
Sbjct: 61 FPFYLPSPLPASSYKGSPANSSVASTPARGGFKRPFP----PPSPAKHIRALLARRHGSV 116
Query: 107 KSSAEEGAPEEAAP--ELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQK 164
K + E PE P LDK FGFS+ ++ E+G EVGRGHFGYTC A KKGE K
Sbjct: 117 KPN-EASIPESGEPGVALDKGFGFSRHFAAKYELGREVGRGHFGYTCAATCKKGELKGDD 175
Query: 165 VAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGE 224
VA+KVIPK+KMTTAIA+EDVRREV+IL +L+GHSNLV+FYDA+ED +NVYIVMELC+GGE
Sbjct: 176 VAVKVIPKAKMTTAIAIEDVRREVRILSSLAGHSNLVQFYDAYEDEENVYIVMELCKGGE 235
Query: 225 LLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284
LLDRIL+R GKYSE++AK V+ QIL+V +FCHL GVVHRDLKPENFL++SKDE+S +K I
Sbjct: 236 LLDRILARGGKYSEEDAKVVMRQILSVASFCHLQGVVHRDLKPENFLFSSKDENSAMKVI 295
Query: 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWART 344
DFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSYGTEAD+WSIGVI YILLCGSRPFWART
Sbjct: 296 DFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIVYILLCGSRPFWART 355
Query: 345 ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV 404
ESGIFRAVLKADPSF++ WP+LS++AKDFV+ LLNKD RKRMTAAQAL HPWIR V
Sbjct: 356 ESGIFRAVLKADPSFEEAPWPTLSAEAKDFVRRLLNKDYRKRMTAAQALCHPWIRGTEEV 415
Query: 405 KVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFEN 464
K+PLD+ I +LM+AY+ SSSLRRAAL+AL+KTLT D+ +YL+EQF L+ PNK+ I +N
Sbjct: 416 KLPLDMIIYRLMRAYISSSSLRRAALRALAKTLTTDQIYYLREQFELIGPNKSDLITLQN 475
Query: 465 IKTVLMKNATDAMKESRISDLL 486
+KT LMKN+T+AMK+SR+ D +
Sbjct: 476 LKTALMKNSTNAMKDSRVVDFV 497
|
Possesses kinase activity in vitro. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|Q9ZUZ2|CAMK3_ARATH CDPK-related kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 538 bits (1386), Expect = e-152, Method: Compositional matrix adjust.
Identities = 271/401 (67%), Positives = 326/401 (81%), Gaps = 7/401 (1%)
Query: 90 SPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPE----LDKRFGFSKEVTSRLEVGEEVGRG 145
SPAKHIKA L +R K E PEE E LDK FG+ K ++ E+G+EVGRG
Sbjct: 95 SPAKHIKASLIKRLGVKPK--EGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRG 152
Query: 146 HFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYD 205
HFG+TC+ R KKG+ KD +A+K+I K+KMTTAIA+EDVRREVK+L++LSGH L+K+YD
Sbjct: 153 HFGHTCSGRGKKGDIKDHPIAVKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYD 212
Query: 206 AFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDL 265
A ED +NVYIVMELC+GGELLDRIL+R GKY ED+AKA++VQIL VV+FCHL GVVHRDL
Sbjct: 213 ACEDANNVYIVMELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDL 272
Query: 266 KPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWS 325
KPENFL+TS E S LK IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSY EAD+WS
Sbjct: 273 KPENFLFTSSREDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWS 332
Query: 326 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRK 385
IGVI YILLCGSRPFWARTESGIFR VL+ +P++DD WPS SS+ KDFVK LLNKD RK
Sbjct: 333 IGVITYILLCGSRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRK 392
Query: 386 RMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYL 445
RM+A QAL+HPW+R+ + V +PLDI I KL+KAY+ ++ LRRAALKAL+K LT +E YL
Sbjct: 393 RMSAVQALTHPWLRDDSRV-IPLDILIYKLVKAYLHATPLRRAALKALAKALTENELVYL 451
Query: 446 KEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLL 486
+ QF LL PNK+G ++ EN KT LM+NATDAM+ESR+ ++L
Sbjct: 452 RAQFMLLGPNKDGSVSLENFKTALMQNATDAMRESRVPEIL 492
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3 an GLN1-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIM9|CAMK4_ARATH CDPK-related kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 505 bits (1300), Expect = e-142, Method: Compositional matrix adjust.
Identities = 262/473 (55%), Positives = 336/473 (71%), Gaps = 24/473 (5%)
Query: 36 NNDAVNDDKQSHSAALSPFFPLYTPSPAY------IFKKSL-SGSKKGGNLTPMRVFRMP 88
N + N Q+H A P P+ + +P F+ L +G TP R F+ P
Sbjct: 21 NGEVSNQPSQNHRHASIPQSPVASGTPEVNSYNISPFQSPLPAGVAPSPARTPGRKFKWP 80
Query: 89 PSPAKH---IKAVLRRRKSTKKSSAEEGAPEEA------------APELDKRFGFSKEVT 133
P I A LRRR+ +E PE++ LDK FGF K
Sbjct: 81 FPPPSPAKPIMAALRRRRGAPPQPRDEPIPEDSEDVVDHGGDSGGGERLDKNFGFGKNFE 140
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ E+G+EVGRGHFG+TC A+ KKG+ K+Q VA+K+I K+KMT+ +++EDVRREVK+L+A
Sbjct: 141 GKYELGKEVGRGHFGHTCWAKAKKGKMKNQTVAVKIISKAKMTSTLSIEDVRREVKLLKA 200
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
LSGH ++VKFYD +ED DNV++VMELCEGGELLDRIL+R G+Y E +AK +LVQIL+ A
Sbjct: 201 LSGHRHMVKFYDVYEDADNVFVVMELCEGGELLDRILARGGRYPEVDAKRILVQILSATA 260
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 313
F HL GVVHRDLKPENFL+TS++E + LK IDFGLSDF+R D+RLND+VGSAYYVAPEVL
Sbjct: 261 FFHLQGVVHRDLKPENFLFTSRNEDAILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVL 320
Query: 314 HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKD 373
HRSY TEAD+WSIGVI+YILLCGSRPF+ RTES IFR VL+A+P+F+D WPS+S AKD
Sbjct: 321 HRSYSTEADMWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFEDMPWPSISPTAKD 380
Query: 374 FVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKAL 433
FVK LLNKD RKRMTAAQAL+HPW+R+ N + LD S+ KL+K+Y+++S RR+ALKAL
Sbjct: 381 FVKRLLNKDHRKRMTAAQALAHPWLRD-ENPGLLLDFSVYKLVKSYIRASPFRRSALKAL 439
Query: 434 SKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLL 486
SK + +E +LK QF LL+P K+G ++ L + ATDAM ESR+ D+L
Sbjct: 440 SKAIPDEELVFLKAQFMLLDP-KDGGLSLNCFTMALTRYATDAMMESRLPDIL 491
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SG12|CAMK6_ARATH CDPK-related kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 501 bits (1289), Expect = e-141, Method: Compositional matrix adjust.
Identities = 253/401 (63%), Positives = 311/401 (77%), Gaps = 11/401 (2%)
Query: 95 IKAVLRRRKSTKKSSAEEGAPEEA---------APELDKRFGFSKEVTSRLEVGEEVGRG 145
I A LRRR+ T + PE++ LDK FGF+K + E+G EVGRG
Sbjct: 92 IMAALRRRRGTAPHPRDGPIPEDSEAGGSGGGIGERLDKNFGFAKNFEGKYELGREVGRG 151
Query: 146 HFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYD 205
HFG+TC A+ KKG+ K Q VA+K+I KSKMT+A+++EDVRREVK+L+ALSGHS++VKFYD
Sbjct: 152 HFGHTCWAKAKKGKIKGQTVAVKIISKSKMTSALSIEDVRREVKLLKALSGHSHMVKFYD 211
Query: 206 AFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDL 265
FED DNV++VMELCEGGELLD IL+R G+Y E EAK +LVQIL+ AF HL GVVHRDL
Sbjct: 212 VFEDSDNVFVVMELCEGGELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVHRDL 271
Query: 266 KPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWS 325
KPENFL+TSK+E + LK IDFGLSD+ R D+RLND+VGSAYYVAPEVLHRSY TEAD+WS
Sbjct: 272 KPENFLFTSKNEDAVLKVIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWS 331
Query: 326 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRK 385
IGVI+YILLCGSRPF+ RTES IFR VL+A+P+FDD WPS+S AKDFVK LLNKD RK
Sbjct: 332 IGVISYILLCGSRPFYGRTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKDHRK 391
Query: 386 RMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYL 445
RMTAAQAL+HPW+R+ N + LD SI KL+K+Y+++S RRAALK+LSK + +E +L
Sbjct: 392 RMTAAQALAHPWLRD-ENPGLLLDFSIYKLVKSYIRASPFRRAALKSLSKAIPEEELVFL 450
Query: 446 KEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLL 486
K QF LLEP ++G + N T L + ATDAM ESR+ D+L
Sbjct: 451 KAQFMLLEP-EDGGLHLHNFTTALTRYATDAMIESRLPDIL 490
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | ||||||
| 357475475 | 592 | Calcium/calmodulin-dependent protein kin | 0.971 | 0.807 | 0.760 | 0.0 | |
| 224123300 | 596 | predicted protein [Populus trichocarpa] | 0.971 | 0.802 | 0.741 | 0.0 | |
| 356519687 | 598 | PREDICTED: CDPK-related protein kinase-l | 0.971 | 0.799 | 0.734 | 0.0 | |
| 356502732 | 598 | PREDICTED: CDPK-related protein kinase-l | 0.973 | 0.801 | 0.733 | 0.0 | |
| 147852275 | 584 | hypothetical protein VITISV_007568 [Viti | 0.963 | 0.811 | 0.742 | 0.0 | |
| 359475215 | 584 | PREDICTED: CDPK-related protein kinase-l | 0.963 | 0.811 | 0.742 | 0.0 | |
| 379048251 | 594 | calcium-dependent protein kinase 6 [Heve | 0.971 | 0.804 | 0.748 | 0.0 | |
| 255561689 | 598 | calcium-dependent protein kinase, putati | 0.951 | 0.782 | 0.728 | 0.0 | |
| 16904226 | 602 | calcium/calmodulin-dependent protein kin | 0.975 | 0.797 | 0.695 | 0.0 | |
| 73761697 | 617 | CDPK-related protein kinase [Gossypium h | 0.985 | 0.786 | 0.711 | 0.0 |
| >gi|357475475|ref|XP_003608023.1| Calcium/calmodulin-dependent protein kinase CaMK3 [Medicago truncatula] gi|355509078|gb|AES90220.1| Calcium/calmodulin-dependent protein kinase CaMK3 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1914), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/497 (76%), Positives = 421/497 (84%), Gaps = 19/497 (3%)
Query: 1 MGGCTSKPQKPNPYAPRNTQND-LSIPPTPNT--TTNKNNDAVNDDKQSHSAALSPFFPL 57
MGGCTSKPQKPNPYA R T+ D IP TP + T N+ +D + K SPFFP
Sbjct: 1 MGGCTSKPQKPNPYALRETETDPTQIPQTPQSPYTGNRKDDVIAGKK-------SPFFPF 53
Query: 58 YTPSPAYIFKKSLS--GSKKGGNLTPMRVFRMPP---SPAKHIKAVLRRRKSTKKSSA-- 110
Y+PSPA KKS S S++ N TP R FR P SPAKHI+AVL RR+ K+++A
Sbjct: 54 YSPSPARFLKKSPSTPASERSRNSTPRRFFRRPFPPPSPAKHIRAVLARRQGKKEAAAIP 113
Query: 111 EEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI 170
EEG EE A +LDKRFGFSK+ S+LEVGEEVGRGHFGYT A++KKGE K Q+VA+KVI
Sbjct: 114 EEG--EEGAGDLDKRFGFSKDFASKLEVGEEVGRGHFGYTSAAKFKKGEFKGQQVAVKVI 171
Query: 171 PKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRIL 230
PK+KMTTAIA+EDVRREVKILRAL+GHSNLVKFYDAFED +NVYIVMELCEGGELLD IL
Sbjct: 172 PKAKMTTAIAIEDVRREVKILRALNGHSNLVKFYDAFEDQENVYIVMELCEGGELLDMIL 231
Query: 231 SRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290
SR GKYSED+AKAV+VQILNVVAFCHL GVVHRDLKPENFLYT+KDESS+LKAIDFGLSD
Sbjct: 232 SRGGKYSEDDAKAVMVQILNVVAFCHLQGVVHRDLKPENFLYTTKDESSELKAIDFGLSD 291
Query: 291 FVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFR 350
FVRPDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYILLCGSRPFWARTESGIFR
Sbjct: 292 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 351
Query: 351 AVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDI 410
AVLKADP FD+G WPSLSS+AKDFVK LLNKDPRKR++AAQALSHPWIRNYN+VKVPLDI
Sbjct: 352 AVLKADPGFDEGPWPSLSSEAKDFVKRLLNKDPRKRISAAQALSHPWIRNYNDVKVPLDI 411
Query: 411 SILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLM 470
I KLMK YM+SSSLR+AAL+ALSKTLT DE +YL+EQFALLEP+KNG I+ ENI L
Sbjct: 412 LIFKLMKTYMRSSSLRKAALRALSKTLTADELYYLREQFALLEPSKNGSISLENINKALK 471
Query: 471 KNATDAMKESRISDLLA 487
K+ATDAMKESRI+D L+
Sbjct: 472 KHATDAMKESRITDFLS 488
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123300|ref|XP_002330282.1| predicted protein [Populus trichocarpa] gi|222871317|gb|EEF08448.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1890), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/502 (74%), Positives = 413/502 (82%), Gaps = 24/502 (4%)
Query: 1 MGGCTSKPQKPNPYAPRNTQNDLSIP---PT----PNTTTNKNNDAVNDDKQSHSAALSP 53
MG CTSKP KPNPYAP +T +P P+ P T T V S + SP
Sbjct: 1 MGTCTSKPPKPNPYAPSDTDPPPQLPFQTPSQHDLPATQTQTPKSPVTPFPTSKA---SP 57
Query: 54 FFPLYTPSPAYIFKKSLSGSKKGGNLTPMRVFR---MPPSPAKHIKAVLRRR-KSTKKSS 109
FFP YTPSP FKK+ K TP+R F+ PPSPAKHIKAVLRR+ K KKS
Sbjct: 58 FFPFYTPSP---FKKT---PFKSTTSTPLRFFKKSFAPPSPAKHIKAVLRRQNKKKKKSG 111
Query: 110 AEEGAPE----EAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKV 165
AE A E E A ELDKRFGFSKE TSRLEVGEEVGRGHFGYTC+A++KKGE K Q+V
Sbjct: 112 AEPNAEEDDDNEEAVELDKRFGFSKEFTSRLEVGEEVGRGHFGYTCSAKFKKGERKGQQV 171
Query: 166 AIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGEL 225
A+KVIPKSKMTTAIAVEDVRREV+IL+ L+GH+NLV FYDAFEDLDNVYIVMELCEGGEL
Sbjct: 172 AVKVIPKSKMTTAIAVEDVRREVRILKDLTGHNNLVHFYDAFEDLDNVYIVMELCEGGEL 231
Query: 226 LDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285
LDRILSR GKYSED+AKAV+VQILNVVAFCHL GVVHRDLKPENFLYTSK+E++QLK ID
Sbjct: 232 LDRILSRGGKYSEDDAKAVMVQILNVVAFCHLQGVVHRDLKPENFLYTSKEENAQLKVID 291
Query: 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTE 345
FGLSDF RPDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIA+ILLCGSRPFWARTE
Sbjct: 292 FGLSDFARPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAFILLCGSRPFWARTE 351
Query: 346 SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVK 405
SGIF+AVLKADPSFD+ WP+LS ++KDFVK LLNKDPRKR+TAAQALSHPWIRNYN+VK
Sbjct: 352 SGIFQAVLKADPSFDEAPWPTLSLESKDFVKRLLNKDPRKRITAAQALSHPWIRNYNDVK 411
Query: 406 VPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENI 465
VPLDI I + MKAYM+SSSLR+AAL+ALSKTLT DE+F+LKEQFALLEP K+G I EN+
Sbjct: 412 VPLDIMIFRHMKAYMRSSSLRKAALRALSKTLTADEQFFLKEQFALLEPKKSGSITLENL 471
Query: 466 KTVLMKNATDAMKESRISDLLA 487
+ LMKNAT+AMK+SRI D LA
Sbjct: 472 RMALMKNATNAMKDSRIPDFLA 493
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519687|ref|XP_003528501.1| PREDICTED: CDPK-related protein kinase-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 727 bits (1876), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/504 (73%), Positives = 412/504 (81%), Gaps = 26/504 (5%)
Query: 1 MGGCTSKPQKPNPYAPRNTQNDL---SIPPTPNT-----TTNKNNDAVNDDKQSHSAALS 52
MG CTSKPQKP+PYA R + + IP TP + T + +DA+ + S
Sbjct: 1 MGVCTSKPQKPSPYALREAEAEADPSQIPKTPLSPAAADTPRRKDDAITGKR-------S 53
Query: 53 PFFPLYTPSPAYIFKKS---LSGSKKGGN--LTPMRVFRMPPSPAKHIKAVLRRRKSTKK 107
PF+P Y+PSPA KKS GS+ + R PPSPAKHI+AVL RR+ K
Sbjct: 54 PFYPFYSPSPARFLKKSPAPAGGSRSASSTPRRFFRRPFPPPSPAKHIRAVLARRQGKKA 113
Query: 108 SSA----EEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQ 163
S+ EEG EE A +LDKRFGFSKE TSRLEVGEEVGRGHFGYTC+A++KKGE K Q
Sbjct: 114 SATAAIPEEG--EEGAADLDKRFGFSKEFTSRLEVGEEVGRGHFGYTCSAKFKKGELKGQ 171
Query: 164 KVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGG 223
+VA+KVIPK+KMTTAIA+EDVRREVKILRAL+GHSNL++FYDAFED DNVYIVMELCEGG
Sbjct: 172 QVAVKVIPKAKMTTAIAIEDVRREVKILRALNGHSNLIQFYDAFEDQDNVYIVMELCEGG 231
Query: 224 ELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283
ELLD ILSR GKYSED+AKAV+VQILNVVAFCHL GVVHRDLKPENFLY KDESS+LKA
Sbjct: 232 ELLDMILSRGGKYSEDDAKAVMVQILNVVAFCHLQGVVHRDLKPENFLYAKKDESSELKA 291
Query: 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWAR 343
IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYILLCGSRPFWAR
Sbjct: 292 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWAR 351
Query: 344 TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
TESGIFRAVLKADPSFD+ WPSLS +AKDFVK LLNKDPRKR++AAQALSHPWIRNYNN
Sbjct: 352 TESGIFRAVLKADPSFDETPWPSLSLEAKDFVKRLLNKDPRKRISAAQALSHPWIRNYNN 411
Query: 404 VKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFE 463
VKVPLDI I KLMK YM+SSSLR+AAL+ALSKTLT DE +YL+EQFALLEP+KNG I+ E
Sbjct: 412 VKVPLDILIFKLMKTYMRSSSLRKAALRALSKTLTADELYYLREQFALLEPSKNGSISLE 471
Query: 464 NIKTVLMKNATDAMKESRISDLLA 487
N+ LMK ATDAMKESRI D L+
Sbjct: 472 NVNKALMKYATDAMKESRILDFLS 495
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502732|ref|XP_003520170.1| PREDICTED: CDPK-related protein kinase-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1869), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/503 (73%), Positives = 408/503 (81%), Gaps = 24/503 (4%)
Query: 1 MGGCTSKPQKPNPYAPRNTQNDLSIPPTPNTT-------TNKNNDAVNDDKQSHSAALSP 53
MG CTSKPQKPNPYA R + + P TT T + D V+ K+S P
Sbjct: 1 MGVCTSKPQKPNPYALREAEAEADPSQNPKTTLSPAGADTPRRKDDVSTGKRS------P 54
Query: 54 FFPLYTPSPAYIFKKS---LSGSKKGGNLTPMRVFRMPP--SPAKHIKAVLRRRKSTKKS 108
FFP Y+PSPA KKS GS+ + R P SPAKHI+AVL RR+ K S
Sbjct: 55 FFPFYSPSPARFLKKSPAPAGGSRSASSTPRRFFRRPFPPPSPAKHIRAVLARRQGKKAS 114
Query: 109 SA----EEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQK 164
+ EEG EE A +LDKRFGFSKE TSRLEVGEEVGRGHFGYTC+AR+KKGE K Q+
Sbjct: 115 ATAAIPEEG--EEGAADLDKRFGFSKEFTSRLEVGEEVGRGHFGYTCSARFKKGELKGQQ 172
Query: 165 VAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGE 224
VA+KVIPK+KMTTAIA+EDVRREVKILRAL+GH+NL++FYDAFED DNVYIVMELCEGGE
Sbjct: 173 VAVKVIPKAKMTTAIAIEDVRREVKILRALNGHNNLIQFYDAFEDQDNVYIVMELCEGGE 232
Query: 225 LLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284
LLD ILSR GKYSED+AKAV+VQILNVVAFCHL GVVHRDLKPENFLY KDESS+LKAI
Sbjct: 233 LLDMILSRGGKYSEDDAKAVMVQILNVVAFCHLQGVVHRDLKPENFLYAKKDESSELKAI 292
Query: 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWART 344
DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWART
Sbjct: 293 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWART 352
Query: 345 ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV 404
ESGIFRAVLKADPSFD+ WPSLS +AKDFVK +LNKDPRKR++AAQALSHPWIRN NNV
Sbjct: 353 ESGIFRAVLKADPSFDETPWPSLSLEAKDFVKRILNKDPRKRISAAQALSHPWIRNCNNV 412
Query: 405 KVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFEN 464
KVPLDI I KLMK YM+SSSLR+AAL+ALSKTLT DE +YL+ QFALLEP+KNG I+ EN
Sbjct: 413 KVPLDILIFKLMKTYMRSSSLRKAALRALSKTLTADELYYLRGQFALLEPSKNGSISLEN 472
Query: 465 IKTVLMKNATDAMKESRISDLLA 487
+ LMK ATDAMKESRI D L+
Sbjct: 473 VNKALMKYATDAMKESRIPDFLS 495
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852275|emb|CAN82235.1| hypothetical protein VITISV_007568 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 720 bits (1858), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/494 (74%), Positives = 408/494 (82%), Gaps = 20/494 (4%)
Query: 1 MGGCTSKPQKPNPYAPRNTQNDLSIPPTPNTTTNKNNDAVNDDKQSHSAALSPFFPLYTP 60
MG C SKP K NPYAP + + P+ T AV+ D+ SPFFP Y+P
Sbjct: 1 MGICASKPPKQNPYAPESLE--------PSATPG----AVSKDEAEGPGKRSPFFPFYSP 48
Query: 61 SPA-YIFKKSLSGSKKGGNLTPMRVFRMP---PSPAKHIKAVLRRRKSTKKSS---AEEG 113
SPA Y+F K S + + + TP R F+ P PSPAKHIKAVL RR+ K ++ E
Sbjct: 49 SPAHYLFSKK-SPAVRSASSTPRRFFKRPFPPPSPAKHIKAVLARRQGKKAAAIPEGEGE 107
Query: 114 APEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKS 173
E AA LDK FGFSK+ TS+ EVGEEVGRGHFGYTC+AR+KKGE K Q+VA+KVIPK+
Sbjct: 108 EEEAAAGGLDKSFGFSKQFTSKYEVGEEVGRGHFGYTCSARFKKGERKGQQVAVKVIPKA 167
Query: 174 KMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC 233
KMTTAIA+EDVRREVKILRAL+GH NLV+FYDAFED DNVYIVMELCEGGELLDRILSR
Sbjct: 168 KMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDHDNVYIVMELCEGGELLDRILSRG 227
Query: 234 GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293
GKYSED+A+AV+VQILNVV+F HL GVVHRDLKPENFL+TSKDE+S+LKAIDFGLSDFV+
Sbjct: 228 GKYSEDDARAVMVQILNVVSFFHLQGVVHRDLKPENFLFTSKDENSELKAIDFGLSDFVK 287
Query: 294 PDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 353
PDERLNDIVGSAYYV+PEVLHRSY TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL
Sbjct: 288 PDERLNDIVGSAYYVSPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 347
Query: 354 KADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISIL 413
KADPSFD+ WPSLSS+AKDFVK LLNKDPRKR+TAAQALSHPWIR YN VKVPLDI I
Sbjct: 348 KADPSFDEVPWPSLSSEAKDFVKCLLNKDPRKRITAAQALSHPWIRGYNGVKVPLDILIF 407
Query: 414 KLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473
KLMKAYM+SSSLR+AAL+ALSKTLT+DE FYLKEQFA LEPNKNG I ENI+T LMKNA
Sbjct: 408 KLMKAYMRSSSLRKAALRALSKTLTMDELFYLKEQFAHLEPNKNGTITLENIRTALMKNA 467
Query: 474 TDAMKESRISDLLA 487
TDAMKESRI D LA
Sbjct: 468 TDAMKESRIPDFLA 481
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475215|ref|XP_002281956.2| PREDICTED: CDPK-related protein kinase-like [Vitis vinifera] gi|297741321|emb|CBI32452.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/494 (74%), Positives = 407/494 (82%), Gaps = 20/494 (4%)
Query: 1 MGGCTSKPQKPNPYAPRNTQNDLSIPPTPNTTTNKNNDAVNDDKQSHSAALSPFFPLYTP 60
MG C SKP K NPYAP + + P+ T AV+ D+ SPFFP Y+P
Sbjct: 1 MGICASKPPKQNPYAPESLE--------PSATPG----AVSKDEAEGPGKRSPFFPFYSP 48
Query: 61 SPA-YIFKKSLSGSKKGGNLTPMRVFRMP---PSPAKHIKAVLRRRKSTKKSS---AEEG 113
SPA Y+F K S + + + TP R F+ P PSPAKHIKAVL RR+ K ++ E
Sbjct: 49 SPAHYLFSKK-SPAVRSASSTPRRFFKRPFPPPSPAKHIKAVLARRQGKKAAAIPEGEGE 107
Query: 114 APEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKS 173
E AA LDK FGFSK+ TS+ EVGEEVGRGHFGYTC+AR+KKGE K Q+VA+KVIPK+
Sbjct: 108 EEEAAAGGLDKSFGFSKQFTSKYEVGEEVGRGHFGYTCSARFKKGERKGQQVAVKVIPKA 167
Query: 174 KMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC 233
KMTTAIA+EDVRREVKILRAL+GH NLV+FYDAFED DNVYIVMELCEGGELLDRILSR
Sbjct: 168 KMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDHDNVYIVMELCEGGELLDRILSRG 227
Query: 234 GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293
GKYSED+A+AV+VQILNVV+F HL GVVHRDLKPENFL+TSKDE+S+LKAIDFGLSDFV+
Sbjct: 228 GKYSEDDARAVMVQILNVVSFFHLQGVVHRDLKPENFLFTSKDENSELKAIDFGLSDFVK 287
Query: 294 PDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 353
PDERLNDIVGSAYYV+PEVLHRSY TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL
Sbjct: 288 PDERLNDIVGSAYYVSPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 347
Query: 354 KADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISIL 413
KADPSFD+ WPSLSS+AKDFVK LLNKDPRKR+TAAQALSHPWIR YN VKVPLDI I
Sbjct: 348 KADPSFDEVPWPSLSSEAKDFVKCLLNKDPRKRITAAQALSHPWIRGYNGVKVPLDILIF 407
Query: 414 KLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473
KLMKAYM+SSSLR+AAL+ALSKTLTVDE YLKEQFA LEPNKNG I ENI+T LMKNA
Sbjct: 408 KLMKAYMRSSSLRKAALRALSKTLTVDELLYLKEQFAHLEPNKNGTITLENIRTALMKNA 467
Query: 474 TDAMKESRISDLLA 487
TDAMKESRI D LA
Sbjct: 468 TDAMKESRIPDFLA 481
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|379048251|gb|AFC88293.1| calcium-dependent protein kinase 6 [Hevea brasiliensis] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1852), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/500 (74%), Positives = 407/500 (81%), Gaps = 22/500 (4%)
Query: 1 MGGCTSKPQKPNPYAPRNTQ-NDLSIPPTPNTTTNKNNDAVNDDKQSHSAALSPFFPLYT 59
MG CTSKP K NPYA +N ND S PN T + + KQS PFFP YT
Sbjct: 1 MGTCTSKPPKANPYASQNEPVNDQS---NPNQTPISPLAPLPNPKQS------PFFPFYT 51
Query: 60 PSPAYIFKKSLSGSKKGGNLTPMRV-----FRMPPSPAKHIKAVLRRRKSTKKSSAE--- 111
PSPAY FKKS S N TP + PPSPAKHI+AVLRRR+ KK
Sbjct: 52 PSPAYPFKKSPSAEFTPANSTPTPLRFFKKPFPPPSPAKHIRAVLRRREQGKKKKKAAIP 111
Query: 112 ---EGAPEEAAP-ELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAI 167
EG E+A +LDKRFGFSKE TSRLEVGEEVGRGHFGYTC+A++KKG+ K Q+VA+
Sbjct: 112 EEGEGDSEDATGIDLDKRFGFSKEFTSRLEVGEEVGRGHFGYTCSAKFKKGDRKGQQVAV 171
Query: 168 KVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD 227
KVIPKSKMTTAIA+EDVRREVKILRAL+GHSNLV+F+DAFED DNVYIVMELCEGGELLD
Sbjct: 172 KVIPKSKMTTAIAIEDVRREVKILRALTGHSNLVQFHDAFEDFDNVYIVMELCEGGELLD 231
Query: 228 RILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287
RILSR GKYSED+AK VLVQILNVVAFCHL GVVHRDLKPENFLYTSKDE+SQLK IDFG
Sbjct: 232 RILSRGGKYSEDDAKGVLVQILNVVAFCHLQGVVHRDLKPENFLYTSKDENSQLKVIDFG 291
Query: 288 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESG 347
LSDFVRPDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYILLCGSRPFWAR ESG
Sbjct: 292 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARNESG 351
Query: 348 IFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVP 407
IFRAVLKADPSFD+ WPSLS +AKDFVK LLNKDPRKRMTAAQAL HPWIRN+N+VKVP
Sbjct: 352 IFRAVLKADPSFDEAPWPSLSPEAKDFVKRLLNKDPRKRMTAAQALGHPWIRNHNDVKVP 411
Query: 408 LDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKT 467
DI I +LMKAYM+SSSLR+AAL+ALS+TLTVDE +YLKEQFALLEPNKNG I EN +
Sbjct: 412 HDILIFRLMKAYMRSSSLRKAALRALSETLTVDELYYLKEQFALLEPNKNGSITLENFRK 471
Query: 468 VLMKNATDAMKESRISDLLA 487
LMKNATDAMK+S I D L+
Sbjct: 472 ALMKNATDAMKDSHIPDFLS 491
|
Source: Hevea brasiliensis Species: Hevea brasiliensis Genus: Hevea Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561689|ref|XP_002521854.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223538892|gb|EEF40490.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/512 (72%), Positives = 413/512 (80%), Gaps = 44/512 (8%)
Query: 1 MGGCTSKPQKPNPYAPRN-----------TQNDLS-IPPTPNTTTNKNNDAVNDDKQSHS 48
MG CTSKP KPNPYAP+N TQN S + P PN KQS
Sbjct: 1 MGTCTSKPPKPNPYAPQNQNQHQNVQSNQTQNPKSPLTPLPNP------------KQS-- 46
Query: 49 AALSPFFPLYTPSPAYIFKKS-LSGSKKGGN---LTPMRVFRMPPSP---AKHIKAVLRR 101
PFFP YTPSPAY+FKKS + S N TPMR+F+ P P AKHI+AVLRR
Sbjct: 47 ----PFFPFYTPSPAYLFKKSPFTESTPVNNNSTPTPMRIFKKPFPPPSPAKHIRAVLRR 102
Query: 102 RK-------STKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTAR 154
R+ ++ E + E +LDKRFGFSKE TSRLEVG+EVGRGHFGYTC+A+
Sbjct: 103 REQRKKKKKASIPEEGEGESESEDGVQLDKRFGFSKEFTSRLEVGDEVGRGHFGYTCSAK 162
Query: 155 YKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214
+KKG+ K Q+VA+KVIPKSKMTTAIAVEDVRREVKIL+AL+GH NL++FYDAFED+DNVY
Sbjct: 163 FKKGDRKGQQVAVKVIPKSKMTTAIAVEDVRREVKILKALAGHGNLIQFYDAFEDIDNVY 222
Query: 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS 274
IVMELCEGGELLDRILSR GKYSED+AKAVLVQILNVVAFCHL GVVHRDLKPENFLYTS
Sbjct: 223 IVMELCEGGELLDRILSRGGKYSEDDAKAVLVQILNVVAFCHLQGVVHRDLKPENFLYTS 282
Query: 275 KDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILL 334
K+E+SQLK IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY TEADVWS+GVIAYILL
Sbjct: 283 KEENSQLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSVGVIAYILL 342
Query: 335 CGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394
CGSRPFWAR+ESGIFRAVLKADPSFD+ WPSLS +AKDFVK LLNKDPRKRMTAAQALS
Sbjct: 343 CGSRPFWARSESGIFRAVLKADPSFDEAPWPSLSLEAKDFVKRLLNKDPRKRMTAAQALS 402
Query: 395 HPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEP 454
HPWIRN+N+VKVPLDI I +L+KAYM+SSSLR+AAL+ LSKTLTVDE YLKEQFALLEP
Sbjct: 403 HPWIRNHNDVKVPLDILIFRLLKAYMRSSSLRKAALRTLSKTLTVDELCYLKEQFALLEP 462
Query: 455 NKNGCIAFENIKTVLMKNATDAMKESRISDLL 486
NKNG I EN + LMKNATDAMK+SRI D L
Sbjct: 463 NKNGTITLENFRMALMKNATDAMKDSRIPDYL 494
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16904226|gb|AAL30820.1|AF435452_1 calcium/calmodulin-dependent protein kinase CaMK3 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1808), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/506 (69%), Positives = 404/506 (79%), Gaps = 26/506 (5%)
Query: 1 MGGCTSKPQKPNPYAPRNTQNDLSIPPTPNTTTNKNNDAVNDDKQSHS--------AALS 52
MG CTSKP + +D+++ K+ + +DD SH S
Sbjct: 1 MGACTSKPSN-------FSVDDITVAGDGAIFPVKSGPSNDDDVNSHQTKNDEPSVGKKS 53
Query: 53 PFFPLYTPSPA-YIFKKSLSGSKKGGNLTPMRVFRMP---PSPAKHIKAVLRRRKSTKK- 107
PFFP Y+PSPA Y+F K + N TPMR F+ P PSPAKHI+++L RR T K
Sbjct: 54 PFFPFYSPSPAHYLFSKKSPATNASSNSTPMRFFKRPFPPPSPAKHIRSLLARRHGTVKP 113
Query: 108 --SSAEEGAPEE----AAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHK 161
S+ EG E LDK FGFSK ++ E+GEEVGRGHFGYTC A++KKGE K
Sbjct: 114 NESAIPEGNESEVGDGGGAGLDKSFGFSKNFVNKYEMGEEVGRGHFGYTCKAKFKKGEVK 173
Query: 162 DQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221
Q+VA+KVIPKSKMTTAIA+EDVRREVKILRAL+GH+NLVKFYDA+ED +NVYIVMELCE
Sbjct: 174 GQEVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHNNLVKFYDAYEDPNNVYIVMELCE 233
Query: 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281
GGELLDRILSR GKY+ED+AK+V++QIL VVAFCHL GVVHRDLKPENFL+TSKDE++QL
Sbjct: 234 GGELLDRILSRGGKYTEDDAKSVMIQILKVVAFCHLQGVVHRDLKPENFLFTSKDENAQL 293
Query: 282 KAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFW 341
KAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYILLCGSRPFW
Sbjct: 294 KAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFW 353
Query: 342 ARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
ARTESGIFRAVLKADPSFD+ WP+LSS+AKDFVK LLNKDPRKRMTAAQAL HPWI+N
Sbjct: 354 ARTESGIFRAVLKADPSFDEQPWPTLSSEAKDFVKRLLNKDPRKRMTAAQALGHPWIKNS 413
Query: 402 NNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIA 461
+N++ PLDI I KLMKAYM+SS+LR+AAL+ALSKTLTVDE FYLKEQFALLEPNKNG I+
Sbjct: 414 HNMEEPLDILIFKLMKAYMRSSALRKAALRALSKTLTVDELFYLKEQFALLEPNKNGTIS 473
Query: 462 FENIKTVLMKNATDAMKESRISDLLA 487
F NIKT LMK+ATDAMKE+R+ D LA
Sbjct: 474 FNNIKTALMKHATDAMKEARMHDFLA 499
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|73761697|gb|AAZ83348.1| CDPK-related protein kinase [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/516 (71%), Positives = 418/516 (81%), Gaps = 31/516 (6%)
Query: 1 MGGCTSKPQKPNPY----APRNTQND--------LSIPPTPNTTTNKNNDAVNDDKQSHS 48
MG CTSKP PNP A NT+N+ +S P P+ +K + +++ S
Sbjct: 1 MGLCTSKPS-PNPSDSTNASINTRNNDIYRKPNSVSASPLPDGVNSKEDQGKQGEEEKES 59
Query: 49 A------ALSPFFPLYTPSPA-YIFKKSLSGSKKGGNLTPMRVFRMPPSP---AKHIKAV 98
+ SPFFP Y+PSPA Y+F K S ++ N TP R FR P P AKHI+AV
Sbjct: 60 SNPNNEGKKSPFFPFYSPSPAHYLFSKK-SPARSSTNSTPKRFFRRPFPPPSPAKHIRAV 118
Query: 99 LRRRKSTKK---SSAEEGAPEEAAPE----LDKRFGFSKEVTSRLEVGEEVGRGHFGYTC 151
L RR + K ++ EG+ EAA LDK FGFSK S+ E+G+EVGRGHFGYTC
Sbjct: 119 LARRHGSVKPNEAAIPEGSDAEAAGATGTGLDKSFGFSKHFGSKYELGDEVGRGHFGYTC 178
Query: 152 TARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211
TA++KKGE K Q+VA+KVIPK+KMTTAIA+EDVRREVKILRALSGHSNLV+FYDA+ED D
Sbjct: 179 TAKFKKGELKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHSNLVQFYDAYEDHD 238
Query: 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFL 271
NVYIVMELCEGGELLDRILSR GKY+ED+AKAV++QILNVVAFCHL GVVHRDLKPENFL
Sbjct: 239 NVYIVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFL 298
Query: 272 YTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAY 331
+TSKDE+SQLKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAY
Sbjct: 299 FTSKDENSQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAY 358
Query: 332 ILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQ 391
ILLCGSRPFWARTESGIFRAVLKADPSFD+ WPSLSS+A+DFVK LLNKDPRKR+TAAQ
Sbjct: 359 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 418
Query: 392 ALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFAL 451
ALSHPWI+ YN+VKVPLDI I KLMKAY++SSSLR+AAL+ALSKTLTVDE FYLKEQFAL
Sbjct: 419 ALSHPWIKKYNDVKVPLDILIFKLMKAYLRSSSLRKAALRALSKTLTVDELFYLKEQFAL 478
Query: 452 LEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLA 487
LEPNKNG I+ ENIK VLMKNATDAMK++RI + LA
Sbjct: 479 LEPNKNGTISLENIKAVLMKNATDAMKDARIPEFLA 514
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | ||||||
| TAIR|locus:2012232 | 606 | AT1G49580 [Arabidopsis thalian | 0.837 | 0.679 | 0.724 | 1.2e-173 | |
| TAIR|locus:2094053 | 599 | AT3G19100 [Arabidopsis thalian | 0.979 | 0.804 | 0.675 | 5.6e-171 | |
| TAIR|locus:2103655 | 577 | AT3G56760 [Arabidopsis thalian | 0.900 | 0.767 | 0.658 | 5.6e-155 | |
| TAIR|locus:2063197 | 576 | CRK1 "AT2G41140" [Arabidopsis | 0.896 | 0.765 | 0.653 | 1.3e-153 | |
| TAIR|locus:2062764 | 595 | CRK3 "AT2G46700" [Arabidopsis | 0.825 | 0.682 | 0.662 | 4e-145 | |
| TAIR|locus:2082931 | 594 | AT3G49370 [Arabidopsis thalian | 0.823 | 0.681 | 0.625 | 6.2e-133 | |
| TAIR|locus:2152876 | 594 | AT5G24430 [Arabidopsis thalian | 0.823 | 0.681 | 0.597 | 5.2e-129 | |
| TAIR|locus:2827826 | 571 | CPK16 "AT2G17890" [Arabidopsis | 0.739 | 0.637 | 0.549 | 9.5e-105 | |
| TAIR|locus:2156947 | 523 | CPK28 "calcium-dependent prote | 0.735 | 0.692 | 0.544 | 7.9e-101 | |
| TAIR|locus:2061290 | 582 | CPK24 "AT2G31500" [Arabidopsis | 0.672 | 0.568 | 0.470 | 3.2e-87 |
| TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1553 (551.7 bits), Expect = 1.2e-173, Sum P(2) = 1.2e-173
Identities = 308/425 (72%), Positives = 350/425 (82%)
Query: 80 TPMRVFRM---PPSPAKHIKAVLRRRKSTKKSSXXXXXXXXXXX---------XLDKRFG 127
TP+R R PPSPAKHI+A LRRRK K+++ LDKRFG
Sbjct: 82 TPLRQLRRAFHPPSPAKHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEVGLDKRFG 141
Query: 128 FSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRRE 187
FSKE SR+E+GEE+GRGHFGYTC+A++KKGE K Q VA+K+IPKSKMTTAIA+EDVRRE
Sbjct: 142 FSKEFHSRVELGEEIGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRRE 201
Query: 188 VKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQ 247
VKIL+ALSGH NLV+FYDAFED NVYI MELCEGGELLDRIL+R GKYSE++AK V++Q
Sbjct: 202 VKILQALSGHKNLVQFYDAFEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQ 261
Query: 248 ILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYY 307
ILNVVAFCH GVVHRDLKPENFLYTSK+E+SQLKAIDFGLSDFVRPDERLNDIVGSAYY
Sbjct: 262 ILNVVAFCHFQGVVHRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYY 321
Query: 308 VAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367
VAPEVLHRSY TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD+ WP L
Sbjct: 322 VAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFL 381
Query: 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN-NVKVPLDISILKLMKAYMQSSSLR 426
SSDAKDFVK LL KDPR+RM+A+QAL HPWIR YN ++ +P DI I + MKAY++SSSLR
Sbjct: 382 SSDAKDFVKRLLFKDPRRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLR 441
Query: 427 RAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLL 486
+AAL+ALSKTL DE YLK QF+LL PNK+G I + I+ L NAT+AMKESRI + L
Sbjct: 442 KAALRALSKTLIKDEILYLKTQFSLLAPNKDGLITMDTIRMALASNATEAMKESRIPEFL 501
Query: 487 APSDG 491
A +G
Sbjct: 502 ALLNG 506
|
|
| TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1662 (590.1 bits), Expect = 5.6e-171, P = 5.6e-171
Identities = 343/508 (67%), Positives = 383/508 (75%)
Query: 1 MGGCTSKPQ---KPNPYAPRNT--QNDLSIXXXXXXXXXXXXDAVNDDKQSHSAALSPFF 55
MGGCTSKP KPNPYAP++ QND S AV SPFF
Sbjct: 1 MGGCTSKPSSSVKPNPYAPKDAVLQNDDSTPAHPGKSPVRSSPAVK---------ASPFF 51
Query: 56 PLYTPSPAYIFXXXXXXX----XXXXNLTPMRVFRM---PPSPAKHIKAVLRRRKSTKKS 108
P YTPSPA TP+R PPSPA+HI+ VLRRRK K++
Sbjct: 52 PFYTPSPARHRRNKSRDGGGGESKSVTSTPLRQLARAFHPPSPARHIRDVLRRRKEKKEA 111
Query: 109 SXXXXXXXXXXXX-----LDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQ 163
+ LDKRFGFSKE+ SR+E+GEE+GRGHFGYTC+A++KKGE KDQ
Sbjct: 112 ALPAARQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIGRGHFGYTCSAKFKKGELKDQ 171
Query: 164 KVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGG 223
+VA+KVIPKSKMT+AI++EDVRREVKILRALSGH NLV+FYDAFED NVYIVMELC GG
Sbjct: 172 EVAVKVIPKSKMTSAISIEDVRREVKILRALSGHQNLVQFYDAFEDNANVYIVMELCGGG 231
Query: 224 ELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283
ELLDRIL+R GKYSED+AKAVL+QILNVVAFCHL GVVHRDLKPENFLYTSK+E+S LK
Sbjct: 232 ELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHRDLKPENFLYTSKEENSMLKV 291
Query: 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWAR 343
IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYILLCGSRPFWAR
Sbjct: 292 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWAR 351
Query: 344 TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
TESGIFRAVLKADPSFD+ WPSLS +AKDFVK LL KDPRKRMTA+QAL HPWI Y
Sbjct: 352 TESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDPRKRMTASQALMHPWIAGYKK 411
Query: 404 VKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFE 463
+ +P DI I K +KAY++SSSLR+AAL ALSKTLT DE YLK QFA L PNKNG I +
Sbjct: 412 IDIPFDILIFKQIKAYLRSSSLRKAALMALSKTLTTDELLYLKAQFAHLAPNKNGLITLD 471
Query: 464 NIKTVLMKNATDAMKESRISDLLAPSDG 491
+I+ L NAT+AMKESRI D LA +G
Sbjct: 472 SIRLALATNATEAMKESRIPDFLALLNG 499
|
|
| TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1511 (537.0 bits), Expect = 5.6e-155, P = 5.6e-155
Identities = 295/448 (65%), Positives = 355/448 (79%)
Query: 44 KQSHSAALSPFFPLYTPSPA-YIFXXXXXXXXXXXNLTPMRVFRMP---PSPAKHIKAVL 99
K S A S FP Y+PSP +F + TP+R+F+ P PSPAKHI+A+L
Sbjct: 27 KNSSQKAKSSGFPFYSPSPLPSLFKTSPAVSSSSVSSTPLRIFKRPFPPPSPAKHIRALL 86
Query: 100 RRRK-STKKSSXXXXXXXXXXXXLDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKG 158
RR S K + LDK+FGFSK+ S E+ EVGRGHFGYTC+A+ KKG
Sbjct: 87 ARRHGSVKPNEASIPEGSECEVGLDKKFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKG 146
Query: 159 EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVME 218
K Q VA+KVIPKSKMTTAIA+EDVRREVKILRAL+GH NLV+FYDAFED +NVYIVME
Sbjct: 147 SLKGQDVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVME 206
Query: 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES 278
LC+GGELLD+IL R GKYSE +AK V++QIL+VVA+CHL GVVHRDLKPENFL+T+KDES
Sbjct: 207 LCQGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDES 266
Query: 279 SQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSR 338
S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHR+YGTEAD+WSIGVIAYILLCGSR
Sbjct: 267 SPLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSR 326
Query: 339 PFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
PFWAR+ESGIFRAVLKA+P+F++ WPSLS DA DFVK LLNKD RKR+TAAQAL HPW+
Sbjct: 327 PFWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWL 386
Query: 399 RNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNG 458
+ +K+P D+ I KL+K Y+ SSSLR++AL AL+KTLTV + YL+EQF LL P+KNG
Sbjct: 387 VGSHELKIPSDMIIYKLVKVYIMSSSLRKSALAALAKTLTVPQLTYLQEQFNLLGPSKNG 446
Query: 459 CIAFENIKTVLMKNATDAMKESRISDLL 486
I+ +N KT ++K++T+A K+SR+ D +
Sbjct: 447 YISMQNYKTAILKSSTEATKDSRVLDFV 474
|
|
| TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1498 (532.4 bits), Expect = 1.3e-153, P = 1.3e-153
Identities = 291/445 (65%), Positives = 352/445 (79%)
Query: 46 SHSAALSPFFPLYTPSPAYIFXXXXXXXXXXXNLTPMRVFRMP---PSPAKHIKAVLRRR 102
S A S FP Y+PSP + TP+R+F+ P PSPAKHI+A L RR
Sbjct: 29 SQPPAKSSGFPFYSPSPVPSLFKSSPSVSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARR 88
Query: 103 K-STKKSSXXXXXXXXXXXXLDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHK 161
S K + LDK FGFSK+ S E+ EVGRGHFGYTC+A+ KKG K
Sbjct: 89 YGSVKPNEVSIPEGKECEIGLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLK 148
Query: 162 DQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221
Q+VA+KVIPKSKMTTAIA+EDV REVK+LRAL+GH NLV+FYDAFED +NVYIVMELC+
Sbjct: 149 GQEVAVKVIPKSKMTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCK 208
Query: 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281
GGELLD+IL R GKYSED+AK V+VQIL+VVA+CHL GVVHRDLKPENFL+++KDE+S L
Sbjct: 209 GGELLDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPL 268
Query: 282 KAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFW 341
KAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHR+YGTEAD+WSIGVIAYILLCGSRPFW
Sbjct: 269 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFW 328
Query: 342 ARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
ARTESGIFRAVLKA+P+F++ WPSLS +A DFVK LLNKD RKR+TAAQAL HPW+
Sbjct: 329 ARTESGIFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLVGS 388
Query: 402 NNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIA 461
+ +K+P D+ I KL+K Y+ S+SLR++AL AL+KTLTV + YL+EQF LL P+KNG I+
Sbjct: 389 HELKIPSDMIIYKLVKVYIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGYIS 448
Query: 462 FENIKTVLMKNATDAMKESRISDLL 486
+N KT ++K++TDAMK+SR+ D +
Sbjct: 449 MQNYKTAILKSSTDAMKDSRVFDFV 473
|
|
| TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1418 (504.2 bits), Expect = 4.0e-145, P = 4.0e-145
Identities = 273/412 (66%), Positives = 329/412 (79%)
Query: 80 TPMRVFRMP---PSPAKHIKAVLRRRKSTK--KSSXXXXXXXXXXXXLDKRFGFSKEVTS 134
TP R FR P PSPAKHIKA L +R K + LDK FG+ K +
Sbjct: 82 TPRRFFRRPFPPPSPAKHIKASLIKRLGVKPKEGPIPEERGTEPEQSLDKSFGYGKNFGA 141
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+ E+G+EVGRGHFG+TC+ R KKG+ KD +A+K+I K+KMTTAIA+EDVRREVK+L++L
Sbjct: 142 KYELGKEVGRGHFGHTCSGRGKKGDIKDHPIAVKIISKAKMTTAIAIEDVRREVKLLKSL 201
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
SGH L+K+YDA ED +NVYIVMELC+GGELLDRIL+R GKY ED+AKA++VQIL VV+F
Sbjct: 202 SGHKYLIKYYDACEDANNVYIVMELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSF 261
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 314
CHL GVVHRDLKPENFL+TS E S LK IDFGLSDF+RPDERLNDIVGSAYYVAPEVLH
Sbjct: 262 CHLQGVVHRDLKPENFLFTSSREDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 321
Query: 315 RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
RSY EAD+WSIGVI YILLCGSRPFWARTESGIFR VL+ +P++DD WPS SS+ KDF
Sbjct: 322 RSYSLEADIWSIGVITYILLCGSRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDF 381
Query: 375 VKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALS 434
VK LLNKD RKRM+A QAL+HPW+R+ + V +PLDI I KL+KAY+ ++ LRRAALKAL+
Sbjct: 382 VKRLLNKDYRKRMSAVQALTHPWLRDDSRV-IPLDILIYKLVKAYLHATPLRRAALKALA 440
Query: 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLL 486
K LT +E YL+ QF LL PNK+G ++ EN KT LM+NATDAM+ESR+ ++L
Sbjct: 441 KALTENELVYLRAQFMLLGPNKDGSVSLENFKTALMQNATDAMRESRVPEIL 492
|
|
| TAIR|locus:2082931 AT3G49370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1303 (463.7 bits), Expect = 6.2e-133, P = 6.2e-133
Identities = 262/419 (62%), Positives = 317/419 (75%)
Query: 80 TPMRVFRMP---PSPAKHIKAVLRRRKSTK---------KSSXXXXXXXXXXXXLDKRFG 127
TP R F+ P PSPAK I A LRRR+ T + S LDK FG
Sbjct: 74 TPGRKFKWPFPPPSPAKPIMAALRRRRGTAPHPRDGPIPEDSEAGGSGGGIGERLDKNFG 133
Query: 128 FSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRRE 187
F+K + E+G EVGRGHFG+TC A+ KKG+ K Q VA+K+I KSKMT+A+++EDVRRE
Sbjct: 134 FAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIKGQTVAVKIISKSKMTSALSIEDVRRE 193
Query: 188 VKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQ 247
VK+L+ALSGHS++VKFYD FED DNV++VMELCEGGELLD IL+R G+Y E EAK +LVQ
Sbjct: 194 VKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCEGGELLDSILARGGRYPEAEAKRILVQ 253
Query: 248 ILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYY 307
IL+ AF HL GVVHRDLKPENFL+TSK+E + LK IDFGLSD+ R D+RLND+VGSAYY
Sbjct: 254 ILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVLKVIDFGLSDYARFDQRLNDVVGSAYY 313
Query: 308 VAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367
VAPEVLHRSY TEAD+WSIGVI+YILLCGSRPF+ RTES IFR VL+A+P+FDD WPS+
Sbjct: 314 VAPEVLHRSYSTEADIWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFDDLPWPSI 373
Query: 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRR 427
S AKDFVK LLNKD RKRMTAAQAL+HPW+R+ N + LD SI KL+K+Y+++S RR
Sbjct: 374 SPIAKDFVKRLLNKDHRKRMTAAQALAHPWLRD-ENPGLLLDFSIYKLVKSYIRASPFRR 432
Query: 428 AALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLL 486
AALK+LSK + +E +LK QF LLEP G + N T L + ATDAM ESR+ D+L
Sbjct: 433 AALKSLSKAIPEEELVFLKAQFMLLEPEDGG-LHLHNFTTALTRYATDAMIESRLPDIL 490
|
|
| TAIR|locus:2152876 AT5G24430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1266 (450.7 bits), Expect = 5.2e-129, P = 5.2e-129
Identities = 252/422 (59%), Positives = 317/422 (75%)
Query: 80 TPMRVFRMP---PSPAKHIKAVLRRRKST------------KKSSXXXXXXXXXXXXLDK 124
TP R F+ P PSPAK I A LRRR+ + LDK
Sbjct: 72 TPGRKFKWPFPPPSPAKPIMAALRRRRGAPPQPRDEPIPEDSEDVVDHGGDSGGGERLDK 131
Query: 125 RFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDV 184
FGF K + E+G+EVGRGHFG+TC A+ KKG+ K+Q VA+K+I K+KMT+ +++EDV
Sbjct: 132 NFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKKGKMKNQTVAVKIISKAKMTSTLSIEDV 191
Query: 185 RREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
RREVK+L+ALSGH ++VKFYD +ED DNV++VMELCEGGELLDRIL+R G+Y E +AK +
Sbjct: 192 RREVKLLKALSGHRHMVKFYDVYEDADNVFVVMELCEGGELLDRILARGGRYPEVDAKRI 251
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
LVQIL+ AF HL GVVHRDLKPENFL+TS++E + LK IDFGLSDF+R D+RLND+VGS
Sbjct: 252 LVQILSATAFFHLQGVVHRDLKPENFLFTSRNEDAILKVIDFGLSDFIRYDQRLNDVVGS 311
Query: 305 AYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364
AYYVAPEVLHRSY TEAD+WSIGVI+YILLCGSRPF+ RTES IFR VL+A+P+F+D W
Sbjct: 312 AYYVAPEVLHRSYSTEADMWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFEDMPW 371
Query: 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSS 424
PS+S AKDFVK LLNKD RKRMTAAQAL+HPW+R+ N + LD S+ KL+K+Y+++S
Sbjct: 372 PSISPTAKDFVKRLLNKDHRKRMTAAQALAHPWLRD-ENPGLLLDFSVYKLVKSYIRASP 430
Query: 425 LRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISD 484
RR+ALKALSK + +E +LK QF LL+P K+G ++ L + ATDAM ESR+ D
Sbjct: 431 FRRSALKALSKAIPDEELVFLKAQFMLLDP-KDGGLSLNCFTMALTRYATDAMMESRLPD 489
Query: 485 LL 486
+L
Sbjct: 490 IL 491
|
|
| TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1037 (370.1 bits), Expect = 9.5e-105, P = 9.5e-105
Identities = 205/373 (54%), Positives = 277/373 (74%)
Query: 126 FGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVR 185
FG++K+ R +G+ +G G FGYT A KK +VA+K I K+KMT IAVEDV+
Sbjct: 98 FGYAKDFDHRYTIGKLLGHGQFGYTYVATDKK---TGDRVAVKKIDKAKMTIPIAVEDVK 154
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAV 244
REVKIL+AL+GH N+V+FY+AFED ++VYIVMELCEGGELLDRIL+R +YSE +A V
Sbjct: 155 REVKILQALTGHENVVRFYNAFEDKNSVYIVMELCEGGELLDRILARKDSRYSERDAAVV 214
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
+ Q+L V A CHL G+VHRD+KPENFL+ S +E S LKA DFGLSDF++P ++ +DIVGS
Sbjct: 215 VRQMLKVAAECHLRGLVHRDMKPENFLFKSTEEDSPLKATDFGLSDFIKPGKKFHDIVGS 274
Query: 305 AYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364
AYYVAPEVL R G E+DVWSIGVI+YILLCG RPFW +TE GIF+ VLK P F W
Sbjct: 275 AYYVAPEVLKRRSGPESDVWSIGVISYILLCGRRPFWDKTEDGIFKEVLKNKPDFRRKPW 334
Query: 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDISILKLMKAYMQSS 423
P++S+ AKDFVK LL KDPR R+TAAQALSHPW+R + ++P+DIS+L M+ +++ S
Sbjct: 335 PTISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKFS 394
Query: 424 SLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRIS 483
L++ AL+AL+ TL +E L++QF ++ +KNG I+ E ++ L K+ +K++R++
Sbjct: 395 RLKQFALRALATTLDEEELADLRDQFDAIDVDKNGVISLEEMRQALAKDHPWKLKDARVA 454
Query: 484 DLL----APSDGF 492
++L + +DGF
Sbjct: 455 EILQAIDSNTDGF 467
|
|
| TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1000 (357.1 bits), Expect = 7.9e-101, P = 7.9e-101
Identities = 200/367 (54%), Positives = 262/367 (71%)
Query: 126 FGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVR 185
FG+SK+ +G+ +G G FGYT A ++ +VA+K + KSKM IAVEDV+
Sbjct: 52 FGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPN---GDRVAVKRLDKSKMVLPIAVEDVK 108
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAV 244
REV+IL ALSGH N+V+F++AFED D VYIVMELCEGGELLDRILS+ G +YSE +A V
Sbjct: 109 REVQILIALSGHENVVQFHNAFEDDDYVYIVMELCEGGELLDRILSKKGNRYSEKDAAVV 168
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
+ Q+L V CHLHG+VHRD+KPENFL+ S S LKA DFGLSDF++P +R +DIVGS
Sbjct: 169 VRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSPLKATDFGLSDFIKPGKRFHDIVGS 228
Query: 305 AYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364
AYYVAPEVL R G E+DVWSIGVI YILLCG RPFW RTE GIF+ VL+ P F W
Sbjct: 229 AYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDRTEDGIFKEVLRNKPDFSRKPW 288
Query: 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVK-VPLDISILKLMKAYMQSS 423
++S AKDFVK LL KDPR R+TAAQALSH W+R N +P+DIS+L ++ +++ S
Sbjct: 289 ATISDSAKDFVKKLLVKDPRARLTAAQALSHAWVREGGNATDIPVDISVLNNLRQFVRYS 348
Query: 424 SLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRIS 483
L++ AL+AL+ TL E L++QF ++ +KNG I+ E ++ L K+ +K+SR++
Sbjct: 349 RLKQFALRALASTLDEAEISDLRDQFDAIDVDKNGVISLEEMRQALAKDLPWKLKDSRVA 408
Query: 484 DLLAPSD 490
++L D
Sbjct: 409 EILEAID 415
|
|
| TAIR|locus:2061290 CPK24 "AT2G31500" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 3.2e-87, Sum P(3) = 3.2e-87
Identities = 160/340 (47%), Positives = 223/340 (65%)
Query: 135 RLEVGEEVGRGHFGYT--CTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
+ ++G+E+GRG FG T C + ++ A K I K K+ T I VEDVRREV+I+R
Sbjct: 65 KYDLGKELGRGEFGVTHECIEISTR-----ERFACKRISKEKLRTEIDVEDVRREVEIMR 119
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
L H N+V F +AFED D VY+VME+CEGGEL DRI+SR G Y+E A +V IL VV
Sbjct: 120 CLPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSR-GHYTERAAASVAKTILEVV 178
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 312
CH HGV+HRDLKPENFL+++ E++QLKAIDFGLS F +P +R N+IVGS YY+APEV
Sbjct: 179 KVCHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEV 238
Query: 313 LHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372
L R+YG E DVWS GVI YILLCG PFWA TE GI A+++ + F+ WP +S +AK
Sbjct: 239 LRRNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAK 298
Query: 373 DFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDISILKLMKAYMQSSSLRRAALK 431
+ VK +L+ +P R+T + L HPWIRN V L ++ ++ ++ + ++ L+
Sbjct: 299 ELVKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLR 358
Query: 432 ALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMK 471
++ L +E + + F ++ +KNG + FE ++ L K
Sbjct: 359 IVADNLPNEEIAAIVQMFQTMDTDKNGHLTFEELRDGLKK 398
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P53681 | CRK_DAUCA | 2, ., 7, ., 1, 1, ., 1 | 0.6893 | 0.9857 | 0.8056 | N/A | no |
| Q9LJL9 | CAMK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6816 | 0.9756 | 0.8013 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 492 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-101 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-86 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-65 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-64 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-59 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-57 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-55 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-54 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-53 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-52 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-50 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-50 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-49 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-46 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-44 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-44 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-44 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-43 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-42 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-41 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-41 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-40 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-40 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-40 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-40 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-40 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-39 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-39 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-38 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-38 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-37 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-37 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-36 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-36 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-35 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-34 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-34 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-34 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-34 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-33 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-33 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-32 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-31 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-31 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-31 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-30 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-30 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-30 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-30 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-30 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-30 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-30 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-30 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-30 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-30 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-29 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-29 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-29 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-29 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-29 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-28 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-28 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-28 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-28 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-28 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-28 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-28 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-27 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-27 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-27 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-27 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-26 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-26 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-26 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-26 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-26 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-26 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-25 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-25 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-25 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-25 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-25 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-25 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-24 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-24 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-24 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-24 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-24 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-24 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-23 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-23 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-23 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-23 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-22 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-22 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-22 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-22 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-22 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-22 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-21 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-20 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-20 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-19 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-19 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-19 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-18 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-18 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-08 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 5e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.004 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 304 bits (781), Expect = e-101
Identities = 121/264 (45%), Positives = 161/264 (60%), Gaps = 13/264 (4%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E+ E++G G FG AR KK + VAIKVI K K+ E + RE+KIL+ L
Sbjct: 2 EILEKLGEGSFGKVYLARDKK---TGKLVAIKVIKKKKIKKD--RERILREIKILKKL-K 55
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H N+V+ YD FED D +Y+VME CEGG+L D + R G+ SEDEA+ L QIL+ + + H
Sbjct: 56 HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLH 114
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HR 315
G+VHRDLKPEN L DE +K DFGL+ + P E+L VG+ Y+APEVL +
Sbjct: 115 SKGIVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 316 SYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
YG D+WS+GVI Y LL G PF + +F+ + K P F W +S +AKD
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDL 230
Query: 375 VKLLLNKDPRKRMTAAQALSHPWI 398
++ LL KDP KR+TA +AL HP+
Sbjct: 231 IRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 265 bits (679), Expect = 3e-86
Identities = 114/269 (42%), Positives = 156/269 (57%), Gaps = 15/269 (5%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
E+ ++G G FG A++K + VA+K++ K + RRE++ILR LS
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTG---KIVAVKILKKRSEKSKKDQTA-RREIRILRRLS 56
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255
H N+V+ DAFED D++Y+VME CEGG+L D + G SEDEAK + +QIL + +
Sbjct: 57 -HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG-GPLSEDEAKKIALQILRGLEYL 114
Query: 256 HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 313
H +G++HRDLKPEN L DE+ +K DFGL+ ++ L VG+ +Y+APEVL
Sbjct: 115 HSNGIIHRDLKPENILL---DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 314 -HRSYGTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDDGSWPSLSS 369
YG + DVWS+GVI Y LL G PF + R +L FD+ W S S
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
+AKD +K LNKDP KR TA + L HPW
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 2e-65
Identities = 98/258 (37%), Positives = 140/258 (54%), Gaps = 46/258 (17%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G G FG AR KK +KVAIK+I K ++ +E++ RE++IL+ L+ H N+V
Sbjct: 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSSL--LEELLREIEILKKLN-HPNIV 54
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
K Y FED +++Y+VME CEGG L D + GK SEDE +L+QIL + + H +G++
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLH--RSYG 318
HRDLKPEN L S + ++K DFGLS + D+ L IVG+ Y+APEVL Y
Sbjct: 115 HRDLKPENILLDSDN--GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
++D+WS+GVI Y L + KD ++ +
Sbjct: 173 EKSDIWSLGVILYEL-----------------------------------PELKDLIRKM 197
Query: 379 LNKDPRKRMTAAQALSHP 396
L KDP KR +A + L H
Sbjct: 198 LQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 4e-64
Identities = 95/265 (35%), Positives = 140/265 (52%), Gaps = 25/265 (9%)
Query: 142 VGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+G+G FG R KD + A+KV+ K K+ VE E IL ++ H
Sbjct: 1 LGKGSFGKVLLVR-----KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPF 54
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH- 258
+VK + AF+ + +Y+V+E GGEL LS+ G++SE+ A+ +I V+A +LH
Sbjct: 55 IVKLHYAFQTEEKLYLVLEYAPGGELFSH-LSKEGRFSEERARFYAAEI--VLALEYLHS 111
Query: 259 -GVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS 316
G+++RDLKPEN L D +K DFGL+ + R N G+ Y+APEVL
Sbjct: 112 LGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 317 -YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFV 375
YG D WS+GV+ Y +L G PF+A I+ +LK F + LS +A+D +
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF----LSPEARDLI 224
Query: 376 KLLLNKDPRKRMTAAQA---LSHPW 397
LL KDP KR+ + A +HP+
Sbjct: 225 SGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 4e-59
Identities = 94/266 (35%), Positives = 144/266 (54%), Gaps = 20/266 (7%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E+ E++G+G FG AR+K+ ++VAIKVI E + E++IL+
Sbjct: 3 EILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESKE---KKEKIINEIQILKKCK- 55
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H N+VK+Y ++ D ++IVME C GG L D + S +E + V ++L + + H
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR- 315
+G++HRD+K N L TS E +K IDFGLS + + N +VG+ Y++APEV++
Sbjct: 116 SNGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 316 SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----PSFDDGSWPSLSSDA 371
Y +AD+WS+G+ A L G P+ +E +A+ K P + S
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDE--F 227
Query: 372 KDFVKLLLNKDPRKRMTAAQALSHPW 397
KDF+K L K+P KR TA Q L HP+
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 3e-57
Identities = 83/264 (31%), Positives = 135/264 (51%), Gaps = 16/264 (6%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+++G+G FG R K + +K I S M+ ED EVKIL+ L+ H N
Sbjct: 6 KQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLN-HPN 60
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSR--CGKY-SEDEAKAVLVQILNVVAFCH 256
++K+Y++FE+ + IVME +GG+L +I + GK E++ VQ+ + + H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL-NDIVGSAYYVAPEVL-H 314
++HRD+KP+N TS +K DFG+S + L +VG+ YY++PE+ +
Sbjct: 121 SRKILHRDIKPQNIFLTSNG---LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177
Query: 315 RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
+ Y ++D+WS+G + Y L PF + +LK SS+ ++
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELRNL 234
Query: 375 VKLLLNKDPRKRMTAAQALSHPWI 398
V LL KDP +R + AQ L P+I
Sbjct: 235 VSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 2e-55
Identities = 86/260 (33%), Positives = 126/260 (48%), Gaps = 21/260 (8%)
Query: 156 KKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215
KK D AIKVI K+ M V+ V E IL +VK Y +F+ N+Y+
Sbjct: 13 KKKSTGD-IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY-VVKLYYSFQGKKNLYL 70
Query: 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK 275
VME GG+L +L G ED A+ + +I+ + + H +G++HRDLKP+N L S
Sbjct: 71 VMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS- 128
Query: 276 DESSQLKAIDFGLSDF---------VRPDERLNDIVGSAYYVAPEV-LHRSYGTEADVWS 325
+ LK DFGLS ++ IVG+ Y+APEV L + + D WS
Sbjct: 129 --NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS 186
Query: 326 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRK 385
+G I Y L G PF T IF+ +L + + +S +A D + LL DP K
Sbjct: 187 LGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLISKLLVPDPEK 244
Query: 386 RMTAA---QALSHPWIRNYN 402
R+ A + +HP+ + +
Sbjct: 245 RLGAKSIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 186 bits (471), Expect = 5e-54
Identities = 97/312 (31%), Positives = 149/312 (47%), Gaps = 30/312 (9%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+ ++G G FG AR +K VA+KV+ K + + VE RE++IL +L+
Sbjct: 3 RILRKLGEGSFGEVYLARDRK------LVALKVLAKKLESKSKEVERFLREIQILASLNH 56
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRI--LSRCGKYSEDEAKAVLVQILNVVAF 254
N+VK YD F+D ++Y+VME +GG L D + + R G SE EA +L QIL+ + +
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-------PDERLNDIVGSAYY 307
H G++HRD+KPEN L +K IDFGL+ + + VG+ Y
Sbjct: 117 LHSKGIIHRDIKPENILLDRDG--RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 308 VAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK--------- 354
+APEVL + +D+WS+G+ Y LL G PF S LK
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 355 ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILK 414
+ +S A D +K LL KDP+ R++++ LSH + + + L +
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294
Query: 415 LMKAYMQSSSLR 426
A ++ S
Sbjct: 295 DDSAPLRLSLPP 306
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-53
Identities = 91/268 (33%), Positives = 144/268 (53%), Gaps = 24/268 (8%)
Query: 138 VGEEVGRGHFG--YTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+G+ +GRG FG Y KG + + VAIK I K+ A++ + +E+ +L+
Sbjct: 4 LGDLIGRGAFGVVY-------KGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKN 55
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H N+VK+ + E D++YI++E E G L +I+ + G + E + Q+L +A
Sbjct: 56 LK-HPNIVKYIGSIETSDSLYIILEYAENGSLR-QIIKKFGPFPESLVAVYVYQVLQGLA 113
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEV 312
+ H GV+HRD+K N L T+KD +L DFG++ + + +VG+ Y++APEV
Sbjct: 114 YLHEQGVIHRDIKAANIL-TTKDGVVKLA--DFGVATKLNDVSKDDASVVGTPYWMAPEV 170
Query: 313 LHRSYGTEA-DVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGSWPSLSSD 370
+ S + A D+WS+G LL G+ P++ + +FR V P +G +S +
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEG----ISPE 226
Query: 371 AKDFVKLLLNKDPRKRMTAAQALSHPWI 398
KDF+ KDP R TA Q L HPWI
Sbjct: 227 LKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-52
Identities = 87/287 (30%), Positives = 139/287 (48%), Gaps = 37/287 (12%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+ G+ +G G F A+ K +++ AIK++ K ++ V+ V+ E ++L L+G
Sbjct: 4 KFGKIIGEGSFSTVVLAKEK---ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H ++K Y F+D +N+Y V+E GELL I G E + +IL + + H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH 119
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-------------------- 296
G++HRDLKPEN L +K DFG + + P+
Sbjct: 120 SKGIIHRDLKPENILLDKD---MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 297 -RLNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 354
R VG+A YV+PE+L + G +D+W++G I Y +L G PF E F+ +LK
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236
Query: 355 ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTA----AQALSHPW 397
+ SF P+ DAKD ++ LL DP+ R+ + +HP+
Sbjct: 237 LEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 84/275 (30%), Positives = 135/275 (49%), Gaps = 26/275 (9%)
Query: 135 RLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
GE +GRG FG Y + GE +A+K + S + +E + RE++IL
Sbjct: 1 EWTRGELLGRGSFGSVYLALDK-DTGE----LMAVKSVELSGDSEE-ELEALEREIRILS 54
Query: 193 ALSGHSNLVKFYDAF--EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
+L H N+V++Y + E+ + + I +E GG L +L + GK E + QIL
Sbjct: 55 SLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILE 112
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS---DFVRPDERLNDIVGSAYY 307
+A+ H +G+VHRD+K N L D +K DFG + + E + G+ Y+
Sbjct: 113 GLAYLHSNGIVHRDIKGANIL---VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 308 VAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESG--IFR-AVLKADPSFDDGS 363
+APEV+ YG AD+WS+G + G P+ +++ P +
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH- 228
Query: 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
LS +AKDF++ L +DP+KR TA + L HP++
Sbjct: 229 ---LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-50
Identities = 84/264 (31%), Positives = 138/264 (52%), Gaps = 20/264 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG C + + + + A+K + K K +V +V E +IL+ L+ H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTK---KMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLV 63
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRI-LSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
+ +F+D +N+Y+V++L GG+L R LS+ K+SE++ K + +I+ + + H G+
Sbjct: 64 NLWYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYGT 319
+HRD+KP+N L DE + DF ++ V PD G+ Y+APEVL + Y
Sbjct: 122 IHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSV 178
Query: 320 EADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
D WS+GV AY L G RP+ + I AD + + S++A D +
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWSTEAIDAIN 234
Query: 377 LLLNKDPRKRM--TAAQALSHPWI 398
LL +DP+KR+ +HP+
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 4e-50
Identities = 91/278 (32%), Positives = 138/278 (49%), Gaps = 30/278 (10%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
E + +G G FG R+K + A+K++ K+K+ VE V E +IL+++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255
H LV Y +F+D N+Y+VME GGEL L + G++ E A+ Q+ V+A
Sbjct: 60 -HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFYAAQV--VLALE 115
Query: 256 HLH--GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV- 312
+LH +V+RDLKPEN L D +K DFG + V R + G+ Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRV--KGRTYTLCGTPEYLAPEII 170
Query: 313 LHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDDGSWPSLSS 369
L + YG D W++G++ Y +L G PF+ I+ +L+ PSF S
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF-------FSP 223
Query: 370 DAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
DAKD ++ LL D KR+ +HPW +
Sbjct: 224 DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 86/280 (30%), Positives = 133/280 (47%), Gaps = 26/280 (9%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIP---KSKMTTAIAVEDVRREVKI 190
S LE + +G+G G R+K + A+K I + + RE+K
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDEEFRKQLL-----RELKT 52
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
LR+ +VK Y AF + IV+E +GG L +L + GK E + QIL
Sbjct: 53 LRS-CESPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILK 110
Query: 251 VVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERLNDIVGSAYYV 308
+ + H ++HRD+KP N L SK E +K DFG+S + ++ N VG+ Y+
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYM 167
Query: 309 APEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIF---RAVLK-ADPSFDDGS 363
+PE + SY AD+WS+G+ G PF + F +A+ PS
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEE 227
Query: 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
+ S + +DF+ L KDP+KR +AA+ L HP+I+ +N
Sbjct: 228 F---SPEFRDFISACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 7e-46
Identities = 102/300 (34%), Positives = 144/300 (48%), Gaps = 58/300 (19%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIA-VEDVR--REVKILRA 193
+V +++G G FG AR K + VAIK KM E+ REVK LR
Sbjct: 2 KVIKQLGDGTFGSVYLARNK---ETGELVAIK-----KMKKKFYSWEECMNLREVKSLRK 53
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY-SEDEAKAVLVQILNVV 252
L+ H N+VK + F + D +Y V E EG L + R GK SE ++++ QIL +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 312
A H HG HRDLKPEN L + + +K DFGL+ +R D V + +Y APE+
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169
Query: 313 L--HRSYGTEADVWSIGVIA---YILLCGSRP-FWARTESG-IFR--AVLKADPSFDDGS 363
L SY + D+W++G I Y L RP F +E +++ +VL P+ D
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTL----RPLFPGSSEIDQLYKICSVL-GTPTKQD-- 222
Query: 364 W--------------------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
W P+ S +A D +K +L DP+KR TA+QAL HP+
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 88/299 (29%), Positives = 135/299 (45%), Gaps = 55/299 (18%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-----TAIAVEDVRREVKIL 191
E E++G G +G AR KK + VA+K I TA+ RE+ +L
Sbjct: 2 EKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNEEEGIPSTAL------REISLL 52
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILN 250
+ L H N+VK D +Y+V E C+ L + L + G S + K+++ Q+L
Sbjct: 53 KELK-HPNIVKLLDVIHTERKLYLVFEYCD--MDLKKYLDKRPGPLSPNLIKSIMYQLLR 109
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 309
+A+CH H ++HRDLKP+N L LK DFGL+ F P V + +Y A
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLRTYTHEVVTLWYRA 166
Query: 310 PEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVL---------- 353
PE+L + Y T D+WS+G I ++ G F +E IF+ +L
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWPG 225
Query: 354 -----KADPSFDDGSW---------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
P+F + P L + D + +L +P KR++A +AL HP+
Sbjct: 226 VTKLPDYKPTFP--KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-44
Identities = 80/270 (29%), Positives = 133/270 (49%), Gaps = 20/270 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G G FG + K K++ A+K + K + E + E +IL + H +V
Sbjct: 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIV 56
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
K Y F+D +Y++ME C GGEL IL G + E A+ + ++ + H G++
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYGTE 320
+RDLKPEN L D + +K +DFG + ++ ++ G+ YVAPE+ L++ Y
Sbjct: 116 YRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 321 ADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDDGSWPS-LSSDAKDFVKL 377
D WS+G++ Y LL G PF E I+ +LK + +P+ + AKD +K
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---GKLEFPNYIDKAAKDLIKQ 229
Query: 378 LLNKDPRKRMTAAQA-----LSHPWIRNYN 402
LL ++P +R+ + H W ++
Sbjct: 230 LLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 5e-44
Identities = 83/268 (30%), Positives = 130/268 (48%), Gaps = 16/268 (5%)
Query: 140 EEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
+ + +G FG A+ + G++ AIKV+ KS M V +V+ E I+
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDY----FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP 57
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258
+ K Y +F+ D +Y+VME GG+ ++ G ED AK + +++ V H
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYG 318
G++HRD+KPEN L D++ LK DFGLS R VG+ Y+APE +
Sbjct: 117 GIIHRDIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGD 170
Query: 319 TEA-DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377
+ D WS+G + + L G PF A T +F +L ++ + S +A D +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230
Query: 378 LLNKDPRKRMTA---AQALSHPWIRNYN 402
LL DP KR+ A + SHP+ ++ N
Sbjct: 231 LLCMDPAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 77/271 (28%), Positives = 132/271 (48%), Gaps = 26/271 (9%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIP--KSKMTTAIAVEDVRREVKILRA 193
+ E++G G G A + ++VAIK + K I E+ I++
Sbjct: 21 YKNLEKIGEGASGEVYKATDR---ATGKEVAIKKMRLRKQNKELII------NEILIMKD 71
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY-SEDEAKAVLVQILNVV 252
H N+V +YD++ D +++VME +GG L D I+++ +E + V ++L +
Sbjct: 72 CK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGL 129
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPE 311
+ H V+HRD+K +N L + +K DFG + + + N +VG+ Y++APE
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186
Query: 312 VLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDDGSWPSL 367
V+ R YG + D+WS+G++ + G P+ E +F K P +
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL--REPPLRALFLITTKGIPPLKNPE--KW 242
Query: 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
S + KDF+ L KDP KR +A + L HP++
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-42
Identities = 92/289 (31%), Positives = 130/289 (44%), Gaps = 40/289 (13%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
++G G +G AR K + VAIK I + I +R E+K+L+ L+ H N
Sbjct: 5 GKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELN-HPN 59
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
++K D F ++Y+V E + +L I R E K+ L Q+L +AFCH HG
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLHRS-- 316
++HRDLKPEN L + LK DFGL+ R V + +Y APE+L
Sbjct: 119 ILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTE-----SGIFRA----------VLKADPSFDD 361
Y T D+WS+G I LL RP + IFR +
Sbjct: 176 YSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 362 GSWPS------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
S+P S A D + +L+ DP KR+TA QAL+HP+
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 89/280 (31%), Positives = 136/280 (48%), Gaps = 32/280 (11%)
Query: 135 RLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
R + G ++G G FG YT GE +A+K I ++++ E+K+L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVN-LDTGE----LMAVKEIRIQDNDPKT-IKEIADEMKVLE 54
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEA--KAVLVQILN 250
L H NLVK+Y + VYI ME C GG L + L G+ DE + +Q+L
Sbjct: 55 LLK-HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE--LLEHGRI-LDEHVIRVYTLQLLE 110
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV-----RPDERLNDIVGSA 305
+A+ H HG+VHRD+KP N D + +K DFG + + E + + G+
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 306 YYVAPEVLHRS----YGTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPS 358
Y+APEV+ +G AD+WS+G + + G RP W+ ++ +F P
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPP 226
Query: 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
D LS + KDF+ L DP+KR TA++ L HP++
Sbjct: 227 IPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 9e-42
Identities = 91/304 (29%), Positives = 138/304 (45%), Gaps = 53/304 (17%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT--------TAIAVEDVRR 186
R E G+++G G + AR K+ + VAIK I + TA+ R
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTAL------R 51
Query: 187 EVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV 246
E+K+L+ L H N++ D F N+ +V E E +L I + + + K+ ++
Sbjct: 52 EIKLLQELK-HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYML 109
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSA 305
L + + H + ++HRDLKP N L S LK DFGL+ F P+ ++ V +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASD---GVLKLADFGLARSFGSPNRKMTHQVVTR 166
Query: 306 YYVAPEVLH--RSYGTEADVWSIGVI-AYILLCGSRPFWARTE-----SGIFRA------ 351
+Y APE+L R YG D+WS+G I A +LL PF IF A
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLL--RVPFLPGDSDIDQLGKIFEALGTPTE 224
Query: 352 ----VLKADPSFD----------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
+ + P + +P+ S DA D ++ LL +P KR+TA QAL HP+
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
Query: 398 IRNY 401
N
Sbjct: 285 FSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-41
Identities = 89/277 (32%), Positives = 137/277 (49%), Gaps = 29/277 (10%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ E +G+G FG A K+ +Q VAIKVI + I ED+++E++ L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQ 55
Query: 194 LSGHS-NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
S + K+Y +F ++I+ME C GG LD L + GK E +L ++L +
Sbjct: 56 C--RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD--LLKPGKLDETYIAFILREVLLGL 111
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPE 311
+ H G +HRD+K N L + E +K DFG+S + N VG+ +++APE
Sbjct: 112 EYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168
Query: 312 VLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGI------FRAVLKADPSFDDGSW 364
V+ +S Y +AD+WS+G+ A L G P S + F PS + +
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPL-----SDLHPMRVLFLIPKNNPPSLEGNKF 223
Query: 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
S KDFV L LNKDP++R +A + L H +I+
Sbjct: 224 ---SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 8e-41
Identities = 86/280 (30%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E+ E +G G A ++KVAIK I K T+ V+++R+EV+ + +
Sbjct: 4 ELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQTS--VDELRKEVQAM-SQCN 57
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR--CGKYSEDEAKAVLVQILNVVAF 254
H N+VK+Y +F D +++VM GG LLD + S G E VL ++L + +
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV-----RPDERLNDIVGSAYYVA 309
H +G +HRD+K N L E +K DFG+S + R + VG+ ++A
Sbjct: 118 LHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 310 PEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367
PEV+ Y +AD+WS G+ A L G+ P+ + L+ DP PSL
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-------PSL 227
Query: 368 SSDA---------KDFVKLLLNKDPRKRMTAAQALSHPWI 398
+ A + + L L KDP KR TA + L H +
Sbjct: 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 97/302 (32%), Positives = 141/302 (46%), Gaps = 55/302 (18%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVR----REV 188
+ EV VG G +G R +K + VAIK K + EDV+ REV
Sbjct: 2 KYEVLGVVGEGAYGVVLKCR-----NKATGEIVAIK-----KFKESEDDEDVKKTALREV 51
Query: 189 KILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI 248
K+LR L H N+V +AF +Y+V E E LL+ + + G D ++ + Q+
Sbjct: 52 KVLRQLR-HENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL 109
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV--RPDERLNDIVGSAY 306
L +A+CH H ++HRD+KPEN L ES LK DFG + + RP L D V + +
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRW 166
Query: 307 YVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTES-----GIFRA-------- 351
Y APE+L +YG DVW+IG I LL G P + I +
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPSH 225
Query: 352 --VLKADPSFDDGSWPS--------------LSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
+ ++P F ++P +SS A DF+K L DP++R+T + L H
Sbjct: 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285
Query: 396 PW 397
P+
Sbjct: 286 PY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 89/293 (30%), Positives = 142/293 (48%), Gaps = 43/293 (14%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK 189
+ T E+ E +G G +G AR+KK Q VAIK++ E+++ E
Sbjct: 2 PDPTGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMD----IIEDEEEEIKEEYN 54
Query: 190 ILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGG---ELLDRILSRCGKYSEDE 240
ILR S H N+ FY AF + D +++VMELC GG +L+ + + + E+
Sbjct: 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLN 299
+L + L +A+ H + V+HRD+K +N L T +++++K +DFG+S R N
Sbjct: 115 IAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 300 DIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 353
+G+ Y++APEV+ SY +DVWS+G+ A L G P + RA+
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALF 228
Query: 354 K--ADPSFDDGSWPSLSSDAK------DFVKLLLNKDPRKRMTAAQALSHPWI 398
K +P P+L S DF+ L K+ +R + L HP+I
Sbjct: 229 KIPRNPP------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 90/291 (30%), Positives = 158/291 (54%), Gaps = 36/291 (12%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQK--VAIKVIPKSKMTTAIAVEDVRREVKILR 192
RLE+ +GRG +G A Y+ G+H VA+K+I T V D++REV +L
Sbjct: 5 RLEL---IGRGAYG----AVYR-GKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLS 54
Query: 193 AL--SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
L S N+ K+Y ++ ++I+ME EGG + R L + G +E ++ ++L
Sbjct: 55 QLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLV 112
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 309
+ + H GV+HRD+K N L T+ + +K DFG++ + + + VG+ Y++A
Sbjct: 113 ALKYIHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMA 169
Query: 310 PEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDDGS 363
PEV+ + Y T+AD+WS+G+ Y + G+ P+ ++ FRA++ P +D
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNG 226
Query: 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILK 414
+ S ++FV L+++P++R++A + L WI+ ++ K P+ SILK
Sbjct: 227 Y---SKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS--KTPV--SILK 270
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 6e-40
Identities = 100/290 (34%), Positives = 141/290 (48%), Gaps = 55/290 (18%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKV-AIKVIPKSKMTTA-----IAVEDVRREVKI 190
EV E +G+G FG R K D K+ K I MT ++ EV I
Sbjct: 3 EVLETIGKGSFGTVRKVRRKS----DGKILVWKEIDYGNMTEKEKQQLVS------EVNI 52
Query: 191 LRALSGHSNLVKFYDAFEDLDN--VYIVMELCEGGELLDRILSRCGK----YSEDEAKAV 244
LR L H N+V++YD D N +YIVME CEGG+L +++ +C K E+ +
Sbjct: 53 LRELK-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRI 110
Query: 245 LVQILNVVAFCHL-----HGVVHRDLKPEN-FLYTSKDESSQLKAIDFGLSDFVRPDERL 298
L Q+L + CH + V+HRDLKP N FL D ++ +K DFGL+ + D
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLGDFGLAKILGHDSSF 166
Query: 299 -NDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWART--------ESGI 348
VG+ YY++PE L H SY ++D+WS+G + Y L S PF AR + G
Sbjct: 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK 226
Query: 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
FR + P SS+ + +K +LN DP KR + + L P I
Sbjct: 227 FRRI----PYR-------YSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 8e-40
Identities = 81/269 (30%), Positives = 134/269 (49%), Gaps = 20/269 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG A K D+ A+KV+ K + VE E ++L H L
Sbjct: 3 LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ + F+ D ++ VME GG+L+ I R G++ E A+ +I+ + F H G++
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL-HRSYGT 319
+RDLK +N L D +K DFG+ + + + G+ Y+APE+L ++ YG
Sbjct: 119 YRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP-SLSSDAKDFVKLL 378
D W++GV+ Y +L G PF E +F+++L+ + + P LS +AK +K
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY-----PRWLSKEAKSILKSF 230
Query: 379 LNKDPRKRM----TAAQAL-SHPWIRNYN 402
L K+P KR+ T Q + HP+ R +
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFREID 259
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 96/314 (30%), Positives = 146/314 (46%), Gaps = 62/314 (19%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDV----R--REV 188
R E+ + +G G +G C+A K+ +KVAIK I +D+ R RE+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISN-------VFDDLIDAKRILREI 50
Query: 189 KILRALSGHSNLVKFYDAF-----EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKA 243
K+LR L H N++ D ED ++VYIV EL E L +++ ++D +
Sbjct: 51 KLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQY 107
Query: 244 VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER----LN 299
L QIL + + H V+HRDLKP N L + + LK DFGL+ V PDE L
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 300 DIVGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWA--------------- 342
+ V + +Y APE+L Y D+WS+G I LL +P +
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGRDYIDQLNLIVEVL 223
Query: 343 --RTESGI-------FRAVLKADPSFDDGSW----PSLSSDAKDFVKLLLNKDPRKRMTA 389
+E + R LK+ P P S +A D ++ +L DP+KR+TA
Sbjct: 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283
Query: 390 AQALSHPWIRNYNN 403
+AL+HP++ ++
Sbjct: 284 DEALAHPYLAQLHD 297
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 84/275 (30%), Positives = 141/275 (51%), Gaps = 37/275 (13%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
++ E++G G +G A +K+ Q VAIKV+P + + +++ +E+ IL+
Sbjct: 6 DILEKLGEGSYGSVYKAIHKET---GQVVAIKVVP---VEEDL--QEIIKEISILKQ-CD 56
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
+VK+Y ++ +++IVME C G + D + +E+E A+L Q L + + H
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND-------IVGSAYYVA 309
+ +HRD+K N L +E Q K DFG+S +L D ++G+ +++A
Sbjct: 117 SNKKIHRDIKAGNILL---NEEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWMA 167
Query: 310 PEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDD-GS 363
PEV+ Y +AD+WS+G+ A I + +P ++ RA+ K P+ D
Sbjct: 168 PEVIQEIGYNNKADIWSLGITA-IEMAEGKPPYSDIHP--MRAIFMIPNKPPPTLSDPEK 224
Query: 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
W S + DFVK L KDP +R +A Q L HP+I
Sbjct: 225 W---SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 7e-39
Identities = 84/293 (28%), Positives = 135/293 (46%), Gaps = 39/293 (13%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
R ++ +G G G A+ ++ + VA+K + ++ I RE+K L+A
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIP-NQALREIKALQAC 56
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H +VK D F +VME +L + + E + K+ + +L VA+
Sbjct: 57 Q-HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD-FVRPDERL-NDIVGSAYYVAPEV 312
H +G++HRDLKP N L ++ LK DFGL+ F + RL + V + +Y APE+
Sbjct: 115 MHANGIMHRDLKPANLLISADG---VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 313 LH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS- 369
L+ R Y D+W++G I LL GS F + V + + ++ +WP L+S
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 370 -------------------------DAKDFVKLLLNKDPRKRMTAAQALSHPW 397
+A D +K LL DP KR++AA+AL HP+
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 90/270 (33%), Positives = 132/270 (48%), Gaps = 19/270 (7%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+VG+G +G A+ KK + VA+K + KS + V V E IL +
Sbjct: 7 TQVGQGGYGQVFLAK-KKDTG--EIVALKRMKKSLLFKLNEVRHVLTERDIL-TTTKSEW 62
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
LVK AF+D + +Y+ ME GG+ +L+ G SED A+ + ++ V H G
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH-RSY 317
+HRDLKPENFL D S +K DFGLS V N +VGS Y+APEVL + Y
Sbjct: 122 YIHRDLKPENFLI---DASGHIKLTDFGLSKGIV---TYANSVVGSPDYMAPEVLRGKGY 175
Query: 318 GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-----ADPSFDDGSWPSLSSDAK 372
D WS+G + Y LCG PF T + + + P +DD + +LS +A
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF-NLSDEAW 234
Query: 373 DFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402
D + L+N R+ + +HP+ + +
Sbjct: 235 DLITKLINDPSRRFGSLEDIKNHPFFKEVD 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 89/302 (29%), Positives = 137/302 (45%), Gaps = 47/302 (15%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
EV + +GRG FG R K Q A+KV+ KS M + VR E IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-- 55
Query: 194 LSGHSN---LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
++ +VK Y +F+D +++Y+VME GG+L+ +L R + E+ A+ + +++
Sbjct: 56 --ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARFYIAELVL 112
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS--------DFVRPDERLND-- 300
+ H G +HRD+KP+N L D +K DFGL ++ N
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 301 --------------------IVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRP 339
VG+ Y+APEVL YG E D WS+GVI Y +L G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 340 FWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAA-QALSHPWI 398
F++ T + ++ S P +S +A D + LL DP R+ + + SHP+
Sbjct: 230 FYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFF 288
Query: 399 RN 400
+
Sbjct: 289 KG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 8e-38
Identities = 85/269 (31%), Positives = 132/269 (49%), Gaps = 24/269 (8%)
Query: 139 GEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIP--KSKMTTAIAVEDVRREVKILRAL 194
GE +G G FG Y G+ A+K + T AV+ + +E+ +L L
Sbjct: 5 GELLGSGSFGSVYEGLNL-DDGDF----FAVKEVSLADDGQTGQEAVKQLEQEIALLSKL 59
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H N+V++ + DN+YI +EL GG L ++L + G + E + QIL + +
Sbjct: 60 Q-HPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILLGLEY 117
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 314
H VHRD+K N L D + +K DFG++ V GS Y++APEV+
Sbjct: 118 LHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 315 R--SYGTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAV-LKADPSFDDGSWPSLSS 369
+ YG AD+WS+G + + +P W++ E + +F+ K P D LS
Sbjct: 175 QQGGYGLAADIWSLGCTV-LEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD----HLSD 229
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
+AKDF+ L +DP R TAA+ L HP++
Sbjct: 230 EAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 94/305 (30%), Positives = 141/305 (46%), Gaps = 45/305 (14%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ + +G+G G R K A+KV+ K +M V+ V E +IL
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKL---FALKVLDKKEMIKRNKVKRVLTEQEILAT 57
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY-SEDEAKAVLVQILNVV 252
L H L Y +F+ + +VM+ C GGEL + + GK SE+ A+ ++L +
Sbjct: 58 LD-HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS----------------------- 289
+ HL G+V+RDLKPEN L ES + DF LS
Sbjct: 117 EYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 290 -----DFVR--PDERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFW 341
+ P R N VG+ Y+APEV+ +G+ D W++G++ Y +L G+ PF
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233
Query: 342 ARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRM----TAAQALSHPW 397
F +LK + +F GS P +SS A+D ++ LL KDP KR+ AA+ HP+
Sbjct: 234 GSNRDETFSNILKKEVTF-PGSPP-VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291
Query: 398 IRNYN 402
R N
Sbjct: 292 FRGVN 296
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 88/276 (31%), Positives = 143/276 (51%), Gaps = 27/276 (9%)
Query: 143 GRGHFGYTCTARYKKGEHKDQKV-AIKVIPKSKMTT-AIAVEDVRREVKILRALSGHSNL 200
G G +G R K G H K+ A+KV+ K+ + A E R E ++L A+ L
Sbjct: 9 GTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-- 258
V + AF+ ++++++ GGEL + R ++E E + + +I V+A HLH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEI--VLALDHLHQL 124
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLHR- 315
G+++RD+K EN L D + DFGLS +E R G+ Y+APEV+
Sbjct: 125 GIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 316 --SYGTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDDGSWPSLSS 369
+ D WS+GV+ + LL G+ PF ++S I R +LK+ P F ++S+
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP----KTMSA 237
Query: 370 DAKDFVKLLLNKDPRKRMTAAQA---LSHPWIRNYN 402
+A+DF++ LL KDP+KR+ A A +HP+ + +
Sbjct: 238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 91/305 (29%), Positives = 139/305 (45%), Gaps = 64/305 (20%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIK--VIPKSK----MTTAIAVEDVRREVKI 190
E E+G G +G AR + + VA+K +P S+ ++T RE+ +
Sbjct: 2 EELAEIGEGAYGTVYKARDL---NTGRFVALKKVRVPLSEEGIPLSTL-------REIAL 51
Query: 191 LRAL--SGHSNLVKFYD--AFEDLDN---VYIVMELCEGGELLDRILSRCGK--YSEDEA 241
L+ L H N+V+ D D + +V E + + L LS+C K +
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD--QDLATYLSKCPKPGLPPETI 109
Query: 242 KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI 301
K ++ Q+L V F H H +VHRDLKP+N L TS Q+K DFGL+ + L +
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS---DGQVKIADFGLARIYSFEMALTSV 166
Query: 302 VGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRP-FWARTESG----IFRAVLKA 355
V + +Y APEVL +S Y T D+WS+G I L RP F +E+ IF +
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDKIFDVI--G 223
Query: 356 DPSFDDGSWP-----------------------SLSSDAKDFVKLLLNKDPRKRMTAAQA 392
PS ++ WP + + D +K +L +P KR++A +A
Sbjct: 224 LPSEEE--WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281
Query: 393 LSHPW 397
L HP+
Sbjct: 282 LQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 82/269 (30%), Positives = 140/269 (52%), Gaps = 15/269 (5%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
S L+ ++G G G C A K ++VA+K K + E + EV I+R
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDK---STGRQVAVK---KMDLRKQQRRELLFNEVVIMRD 72
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
H N+V+ Y ++ D +++VME EGG L D I++ + +E++ V + +L ++
Sbjct: 73 YQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTH-TRMNEEQIATVCLAVLKALS 129
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEV 312
F H GV+HRD+K ++ L TS ++K DFG V + R +VG+ Y++APEV
Sbjct: 130 FLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEV 186
Query: 313 LHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371
+ R YGTE D+WS+G++ ++ G P++ + + P +S
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSPRL 245
Query: 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
+ F+ +L +DP +R TAA+ L+HP++
Sbjct: 246 RSFLDRMLVRDPAQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 86/288 (29%), Positives = 135/288 (46%), Gaps = 45/288 (15%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIP---KSKMTTAIAVEDVRREVKILR 192
LE E+G G+ G ++ + +A+K I + I RE+ IL
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINEAIQKQIL-----RELDILH 54
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNV 251
+V FY AF + ++ I ME +GG L D+IL G+ E + V +L
Sbjct: 55 K-CNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKG 112
Query: 252 VAFCH-LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI----VGSAY 306
+ + H H ++HRD+KP N L S+ Q+K DFG+S + +N + VG++
Sbjct: 113 LTYLHEKHKIIHRDVKPSNILVNSR---GQIKLCDFGVSG-----QLVNSLAKTFVGTSS 164
Query: 307 YVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPF--WARTESGIF---RAVLKADPSFD 360
Y+APE + Y ++D+WS+G+ L G P+ GIF + ++ P
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--- 221
Query: 361 DGSWPSL-----SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
P L S D +DFV L L KDPR+R + + L HP+I+ Y +
Sbjct: 222 ----PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-35
Identities = 83/273 (30%), Positives = 126/273 (46%), Gaps = 24/273 (8%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
E+ + +G G +G AR + VAIKVI K+ E +++E+ +L+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDI---ATGELVAIKVI---KLEPGDDFEIIQQEISMLKE 56
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
H N+V ++ ++ D ++IVME C GG L D G SE + V + L +A
Sbjct: 57 CR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 312
+ H G +HRD+K N L T E +K DFG+S + +G+ Y++APEV
Sbjct: 116 YLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 313 L----HRSYGTEADVWSIGVIAYILLCGSRPFW----ARTESGIFRAVLKADPSFDDGS- 363
Y + D+W++G+ A L P + R I ++ P D
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-PKLKDKEK 231
Query: 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396
W S DF+K L KDP+KR TA + L HP
Sbjct: 232 W---SPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 21/270 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG AR K+ + A+KV+ K + VE E +IL H L
Sbjct: 3 LGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ Y F+ D ++ VME GG+L+ I + ++ E A+ +I + + F H G++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YGT 319
+RDLK +N L D K DFG+ + + + + G+ Y+APE+L YG
Sbjct: 119 YRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSDAKDFVKLL 378
D W++GV+ Y +LCG PF A E +F A+L D+ +P+ LS DA D +K
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTWLSQDAVDILKAF 230
Query: 379 LNKDPRKRMTA------AQALSHPWIRNYN 402
+ K+P R+ + L HP+ + +
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELD 260
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 86/304 (28%), Positives = 130/304 (42%), Gaps = 60/304 (19%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-----TAIAVEDVRREVKIL 191
E ++G G +G AR KK + VA+K I TAI RE+K+L
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTG---ELVALKKIRMENEKEGFPITAI------REIKLL 52
Query: 192 RALSGHSNLVKFYDAF--EDLDNVYIVMELCE----GGELLDRILSRCGKYSEDEAKAVL 245
+ L H N+V+ + + ++Y+V E + G LLD S K++E + K +
Sbjct: 53 QKLR-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLD---SPEVKFTESQIKCYM 106
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV--RPDERLNDIVG 303
Q+L + + H +G++HRD+K N L + LK DFGL+ R + V
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVI 163
Query: 304 SAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD 361
+ +Y PE+L YG E D+WS+G I L G F TE + + S D
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223
Query: 362 GSWPSL---------------------------SSDAKDFVKLLLNKDPRKRMTAAQALS 394
+WP + A D + LL DP+KR++A QAL
Sbjct: 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283
Query: 395 HPWI 398
H +
Sbjct: 284 HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-34
Identities = 86/257 (33%), Positives = 131/257 (50%), Gaps = 19/257 (7%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
S E+GE +G G FG A++K + AIK + K ++ V+ V +E IL
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTG---EYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
LS H +V +F+D + VY ++E GGEL L + G++ D AK ++ V+A
Sbjct: 75 LS-HPFIVNMMCSFQDENRVYFLLEFVVGGELFTH-LRKAGRFPNDVAKFYHAEL--VLA 130
Query: 254 FCHLH--GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 311
F +LH +++RDLKPEN L D +K DFG + V +R + G+ Y+APE
Sbjct: 131 FEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPE 185
Query: 312 VLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370
V+ + +G D W++GV+ Y + G PF+ T I+ +L F +W
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP--NW--FDGR 241
Query: 371 AKDFVKLLLNKDPRKRM 387
A+D VK LL D KR+
Sbjct: 242 ARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 98/309 (31%), Positives = 149/309 (48%), Gaps = 45/309 (14%)
Query: 126 FGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVR 185
FG E+T+R + VG G FG C+AR + Q VAIK I K T +A +
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSAR---DQLTGQNVAIKKIMKPFSTPVLA-KRTY 57
Query: 186 REVKILRALSGHSNLVKFYDAF-EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
RE+K+L+ L H N++ D F L+++Y V EL G L R+L+ + +
Sbjct: 58 RELKLLKHLR-HENIISLSDIFISPLEDIYFVTELL--GTDLHRLLT-SRPLEKQFIQYF 113
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERLNDIVG 303
L QIL + + H GVVHRDLKP N L +E+ LK DFGL+ R D ++ V
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA---RIQDPQMTGYVS 167
Query: 304 SAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIF------------ 349
+ YY APE++ + Y E D+WS G I +L G F + F
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 350 ---------------RAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394
+++ K +P + + A D ++ +L DP+KR++AA+AL+
Sbjct: 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287
Query: 395 HPWIRNYNN 403
HP++ Y++
Sbjct: 288 HPYLAPYHD 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 86/276 (31%), Positives = 139/276 (50%), Gaps = 24/276 (8%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
E+G G FG A++K+ A K+I ++ + +ED E+ IL H N+
Sbjct: 12 ELGDGAFGKVYKAQHKE---TGLFAAAKII---QIESEEELEDFMVEIDILSECK-HPNI 64
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAFCHLHG 259
V Y+A+ + ++I++E C+GG L D I+ + +E + + V Q+L + F H H
Sbjct: 65 VGLYEAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL----- 313
V+HRDLK N L T +K DFG+S ++ + +G+ Y++APEV+
Sbjct: 124 VIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 314 -HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-PSFDDGS-WPSLSSD 370
Y +AD+WS+G+ L P + +LK++ P+ D S W SS
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW---SSS 237
Query: 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKV 406
DF+K L KDP R TAA+ L HP++ + ++ K
Sbjct: 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKA 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 92/314 (29%), Positives = 150/314 (47%), Gaps = 60/314 (19%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT----TAIAVEDVRR 186
EV R + VG G +G C+A K +KVAIK K++ +AI + R
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTG---RKVAIK-----KLSRPFQSAIHAKRTYR 63
Query: 187 EVKILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDE 240
E+++L+ + H N++ D F ED +VY+V L G L+ I+ +C K S+D
Sbjct: 64 ELRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIV-KCQKLSDDH 119
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERLN 299
+ ++ QIL + + H G++HRDLKP N + +E +LK +DFGL+ R D+ +
Sbjct: 120 IQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLA---RHTDDEMT 173
Query: 300 DIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCG--------------------- 336
V + +Y APE++ Y D+WS+G I LL G
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233
Query: 337 --SRPFWARTESGIFRAVLKADP-----SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTA 389
+ S R +++ P F + + + A D ++ +L DP KR+TA
Sbjct: 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITA 292
Query: 390 AQALSHPWIRNYNN 403
A+AL+HP++ Y++
Sbjct: 293 AEALAHPYLAEYHD 306
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 136 LEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
L +G+++G G FG + K KG K +VA+K + + I E+ RE +I+R L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKL 58
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H N+VK + + +YIVME EGG+LL + K S + + +QI + +
Sbjct: 59 D-HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 308
+HRDL N L +K DFGLS + D+ YY
Sbjct: 118 LESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDD---------YYRKRGGKL 165
Query: 309 -----APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFW 341
APE L + +++DVWS GV+ + I G +P+
Sbjct: 166 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP 205
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 91/281 (32%), Positives = 141/281 (50%), Gaps = 21/281 (7%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+V VGRGHFG R K A+KV+ KS + V E IL ++S
Sbjct: 4 DVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDIL-SISN 59
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFC 255
+ + AF+D DN+Y+VME GG+LL +L+R ++ ED A+ L +++ +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 256 HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI--VGSAYYVAPEVL 313
H G VHRD+KPEN L D + +K DFG + + ++ +N VG+ Y+APEVL
Sbjct: 119 HQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 314 HR-------SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366
+YG E D WS+GVIAY ++ G PF T + + ++ P
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235
Query: 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR--NYNNVK 405
+SSD D ++ LL ++R+ HP+ ++NN++
Sbjct: 236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIR 275
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 24/268 (8%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKV-AIKVIPKSKMTTAIAVEDVRREVKILRALS 195
E+ ++G+G FG +K D++V A+K I SKM E + E ++L L
Sbjct: 3 EILNKIGKGSFG----VVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLD 57
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAF 254
S ++++Y++F D + IVME E G+L + + G+ ED+ +QIL +A
Sbjct: 58 -SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL-NDIVGSAYYVAPEVL 313
H ++HRD+K N D +K D G++ + + N IVG+ YY++PE+
Sbjct: 117 LHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173
Query: 314 H-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL----S 368
+ Y ++DVW++GV+ Y G PF A + + +++ G +P + S
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-------GVFPPVSQMYS 226
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHP 396
+ L KD R+R Q L +P
Sbjct: 227 QQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 80/263 (30%), Positives = 124/263 (47%), Gaps = 24/263 (9%)
Query: 142 VGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR----EVKILRALS 195
VGRG FG + C + + + V IK IP +MT +D R E ++L+ LS
Sbjct: 8 VGRGAFGIVHLC-----RRKADQKLVIIKQIPVEQMT-----KDERLAAQNECQVLKLLS 57
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY-SEDEAKAVLVQILNVVAF 254
H N++++Y+ F + + IVME GG L + I RC ED VQIL +
Sbjct: 58 -HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 314
H ++HRDLK +N L +K DFG+S + + +VG+ Y++PE+
Sbjct: 117 VHTKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE 174
Query: 315 -RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKD 373
+ Y ++D+W++G + Y L R F A + VLK S D +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIMSGTFAPISDRYSPDLRQ 231
Query: 374 FVKLLLNKDPRKRMTAAQALSHP 396
+ +LN DP KR +Q ++ P
Sbjct: 232 LILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 136 LEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
L +G+++G G FG K KG+ K+ +VA+K + + I E+ RE +I+R L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKL 58
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY-SEDEAKAVLVQILNVVA 253
H N+VK + + + IVME GG+LLD + K S + + +QI +
Sbjct: 59 D-HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 308
+ +HRDL N L +K DFGLS + D+ YY
Sbjct: 118 YLESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDD---------YYKVKGGK 165
Query: 309 ------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFW 341
APE L + +++DVWS GV+ + I G P+
Sbjct: 166 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP 206
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 91/313 (29%), Positives = 140/313 (44%), Gaps = 50/313 (15%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
+V SR + E +G G +G C+A + +KVAIK IP + +A +R E+KI
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAFDVPTLAKRTLR-ELKI 57
Query: 191 LRALSGHSNLVKFYDAF----EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV 246
LR H N++ D D +VY+VM+L E L I+ +E+ + L
Sbjct: 58 LRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHIIHSDQPLTEEHIRYFLY 114
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV--RPDER---LNDI 301
Q+L + + H V+HRDLKP N L +E +L+ DFG++ + P E + +
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 302 VGSAYYVAPE---VLHRSYGTEADVWSIG-----------------------VIAYILLC 335
V + +Y APE L Y T D+WS+G +I +L
Sbjct: 172 VATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230
Query: 336 GSRPFWARTESGIFRAVLKADPSFDDGSW----PSLSSDAKDFVKLLLNKDPRKRMTAAQ 391
S R S R ++ P W P S +A D + +L DP +R+T Q
Sbjct: 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290
Query: 392 ALSHPWIRNYNNV 404
AL HP++ Y++
Sbjct: 291 ALQHPFLAQYHDP 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 75/258 (29%), Positives = 133/258 (51%), Gaps = 14/258 (5%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG Y++ E D V K + ++++ D E+ IL L H N++
Sbjct: 8 LGKGAFGEATL--YRRTE-DDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQ-HPNII 62
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAFCHLHGV 260
+Y+ F D + + I ME GG L D+I+ + G+ + E+ L QI++ V++ H G+
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND-IVGSAYYVAPEVLH-RSYG 318
+HRD+K N T ++ +K DFG+S + + + + +VG+ YY++PE+ Y
Sbjct: 123 LHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN 179
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
++D+W++G + Y LL R F A + +++ + + + SS+ V L
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISLVHSL 236
Query: 379 LNKDPRKRMTAAQALSHP 396
L +DP KR TA + L P
Sbjct: 237 LQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 93/314 (29%), Positives = 137/314 (43%), Gaps = 60/314 (19%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI-PKSKMTTAIAVEDVR--RE 187
+V R + +G G +G C+A +K KVAIK I P T R RE
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFCQ-----RTLRE 53
Query: 188 VKILRALSGHSNLVKFYD-----AFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAK 242
+KILR H N++ D +FE ++VYIV EL E L +++ + S D +
Sbjct: 54 IKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLI-KTQHLSNDHIQ 109
Query: 243 AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER----L 298
L QIL + + H V+HRDLKP N L + + LK DFGL+ P+ L
Sbjct: 110 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTGFL 166
Query: 299 NDIVGSAYYVAPEVL--HRSYGTEADVWSIGVI-AYILLCGSRPFW-------------- 341
+ V + +Y APE++ + Y D+WS+G I A +L RP +
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN--RPLFPGKDYLHQLNLILG 224
Query: 342 ----------ARTESGIFRAVLKADPSFDDGSWPSL----SSDAKDFVKLLLNKDPRKRM 387
S R +K+ P W L A D + +L +P KR+
Sbjct: 225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284
Query: 388 TAAQALSHPWIRNY 401
T +AL+HP++ Y
Sbjct: 285 TVEEALAHPYLEQY 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 87/271 (32%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM-TTAIAVEDVRREVKILRALSGHSNL 200
+G+G +G R G + A+KV+ K+ + + E IL A+ H +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFI 62
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-- 258
V AF+ +Y+++E GGEL L R G + ED A L +I +A HLH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMH-LEREGIFMEDTACFYLSEI--SLALEHLHQQ 119
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS- 316
G+++RDLKPEN L D +K DFGL + + + G+ Y+APE+L RS
Sbjct: 120 GIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
+G D WS+G + Y +L G+ PF A +LK + P L+ +A+D +K
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLK 232
Query: 377 LLLNKDPRKRM-----TAAQALSHPWIRNYN 402
LL ++P R+ AA+ SHP+ R+ N
Sbjct: 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 79/284 (27%), Positives = 134/284 (47%), Gaps = 26/284 (9%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
LE + VG G FG R + EH A+KV+ ++ + V E ++L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHY---YALKVMAIPEVIRLKQEQHVHNEKRVLKE 57
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
+S H +++ + D +Y++ME GGEL + + G++S +I+ +
Sbjct: 58 VS-HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALE 115
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 313
+ H +V+RDLKPEN L D+ +K DFG + +R +R + G+ Y+APEV+
Sbjct: 116 YLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVI 170
Query: 314 HRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL--KADPSFDDGSWP-SLSS 369
+ D W++G++ Y +L G PF+ GI+ +L K + +P L
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE-------FPRHLDL 223
Query: 370 DAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNYNNVKVPL 408
AKD +K LL D +R+ A +H W ++ + VP
Sbjct: 224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ 267
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-30
Identities = 77/260 (29%), Positives = 144/260 (55%), Gaps = 15/260 (5%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
++G G G C AR K H ++VA+K++ K E + EV I+R H N+
Sbjct: 28 KIGEGSTGIVCIAREK---HSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HQNV 80
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
V+ Y ++ + ++++ME +GG L D I+S+ + +E++ V +L + + H GV
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQT-RLNEEQIATVCESVLQALCYLHSQGV 138
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHRS-YG 318
+HRD+K ++ L T ++K DFG + D + +VG+ Y++APEV+ R+ YG
Sbjct: 139 IHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
TE D+WS+G++ ++ G P+++ + + L+ P + +S +DF++ +
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNAHKISPVLRDFLERM 254
Query: 379 LNKDPRKRMTAAQALSHPWI 398
L ++P++R TA + L HP++
Sbjct: 255 LTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 80/261 (30%), Positives = 138/261 (52%), Gaps = 15/261 (5%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
++G G G C A K H ++VA+K + K E + EV I+R H N+
Sbjct: 29 KIGEGSTGIVCIATEK---HTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYH-HENV 81
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
V Y+++ D +++VME EGG L D + + +E++ V + +L +++ H GV
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGV 139
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR-SYG 318
+HRD+K ++ L TS ++K DFG V + + +VG+ Y++APEV+ R YG
Sbjct: 140 IHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
TE D+WS+G++ ++ G P++ R + P S +SS + F+ L+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS-HKVSSVLRGFLDLM 255
Query: 379 LNKDPRKRMTAAQALSHPWIR 399
L ++P +R TA + L HP+++
Sbjct: 256 LVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 80/264 (30%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG A K +Q AIK + K + VE E ++L H L
Sbjct: 3 LGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
Y F+ +N++ VME GG+L+ I S C K+ A +I+ + F H G+V
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVL-HRSYGT 319
+RDLK +N L D +K DFG+ + + D + G+ Y+APE+L + Y T
Sbjct: 119 YRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D WS GV+ Y +L G PF E +F+++ +P + W L+ +AKD + L
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP--RW--LTREAKDILVKLF 231
Query: 380 NKDPRKRM-TAAQALSHPWIRNYN 402
++P +R+ HP+ R +
Sbjct: 232 VREPERRLGVKGDIRQHPFFREID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 91/282 (32%), Positives = 133/282 (47%), Gaps = 32/282 (11%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G G FG A YK + VAIK KSK+ V+ V E KIL ++ H V
Sbjct: 38 LGTGSFGRVILATYKNEDFP--PVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCV 94
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
Y +F+D +Y+V+E GGE L R ++ D QI+ + + +V
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYGTE 320
+RDLKPEN L D+ +K DFG + V D R + G+ Y+APE+L + +G
Sbjct: 154 YRDLKPENLLL---DKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLNVGHGKA 208
Query: 321 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDDGSWPSLSSDAKDFVKL 377
AD W++G+ Y +L G PF+A I++ +L+ P F L ++ K +K
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF-------LDNNCKHLMKK 261
Query: 378 LLNKDPRKRM-----TAAQALSHPWIRN-------YNNVKVP 407
LL+ D KR A HPW N + NV+VP
Sbjct: 262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVP 303
|
Length = 340 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 82/271 (30%), Positives = 130/271 (47%), Gaps = 22/271 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG A KG D+ AIKV+ K + V+ E +IL + H L
Sbjct: 3 LGKGSFGKVMLAE-LKG--TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ F+ D ++ VME GG+L+ +I R K+ E ++ ++ + F H HGV+
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHR-SYGT 319
+RDLK +N L D K DFG+ + + G+ Y+APE+L YG
Sbjct: 119 YRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSDAKDFVKLL 378
D W++GV+ Y ++ G PF A E +F ++L DD +P LS +A +K
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-----DDVLYPVWLSKEAVSILKAF 230
Query: 379 LNKDPRKRM--TAAQALS-----HPWIRNYN 402
+ K+P KR+ A+Q HP+ + +
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 27/266 (10%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIP-------KSKMTTAIAVEDVRREVK 189
V E +G G FG R K +A+K I K K ++ D+ EV
Sbjct: 3 AVLEHLGSGAFGCVYKVRKKNNGQN--LLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEG---GELLDRILSRCGKYSEDEAKAVLV 246
I++ H N+V++Y F + D +YIVM+L EG GE + + + +++E+ + V
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 247 QILNVVAFCHLHG---VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVG 303
Q+ V+A +LH +VHRDL P N + D ++ DFGL+ +P+ +L +VG
Sbjct: 121 QM--VLALRYLHKEKRIVHRDLTPNNIMLGEDD---KVTITDFGLAKQKQPESKLTSVVG 175
Query: 304 SAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--DPSFD 360
+ Y PE++ + YG +ADVW+ G I Y + PF++ + +++A +P
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-LP 234
Query: 361 DGSWPSLSSDAKDFVKLLLNKDPRKR 386
+G + S D D + L D R
Sbjct: 235 EGMY---SEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 75/246 (30%), Positives = 116/246 (47%), Gaps = 35/246 (14%)
Query: 186 REVKILRALSGHSNLVKFYDAF--EDLDNVYIVMELCEGGEL---LDRILSRCGKYSEDE 240
RE++I ++ +VK+Y AF E ++ I ME CEGG L ++ R G+ E
Sbjct: 48 RELEINKSCK-SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND 300
+ +L +++ H ++HRD+KP N L T K Q+K DFG+S E +N
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK---GQVKLCDFGVSG-----ELVNS 158
Query: 301 I----VGSAYYVAPE-VLHRSYGTEADVWSIGVIAYILLCGSRPFWARTE---------- 345
+ G+++Y+APE + + Y +DVWS+G+ + PF E
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218
Query: 346 --SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
+ LK +P + W S + KDF+K L KDP +R T L HPWI+
Sbjct: 219 YIVNMPNPELKDEPG-NGIKW---SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274
Query: 404 VKVPLD 409
KV +
Sbjct: 275 KKVNMA 280
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 84/306 (27%), Positives = 142/306 (46%), Gaps = 53/306 (17%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK---SKMTTAIAVEDVRREVKIL 191
R E+ +E+G+G +G C+AR +++ VAIK I K+ A+ RE+K+L
Sbjct: 1 RYELIKELGQGAYGIVCSARNA-ETSEEETVAIKKITNVFSKKILAKRAL----RELKLL 55
Query: 192 RALSGHSNLVKFYDA----FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQ 247
R GH N+ YD + + +Y+ EL E L +I+ ++ ++ + Q
Sbjct: 56 RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQ 113
Query: 248 ILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-----DFVRPDERLNDIV 302
IL + + H V+HRDLKP N L + +LK DFGL+ + + + V
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 303 GSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFW------------------- 341
+ +Y APE++ +SY DVWS+G I LL G +P +
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLGTP 229
Query: 342 -----ARTESGIFRAVLKADPSFDDGSWPSL----SSDAKDFVKLLLNKDPRKRMTAAQA 392
+R S + +++ P+ + S+ + A D ++ LL DP KR++ +A
Sbjct: 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA 289
Query: 393 LSHPWI 398
L HP++
Sbjct: 290 LEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 83/271 (30%), Positives = 132/271 (48%), Gaps = 25/271 (9%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL--SGHSN 199
+G+G FG R K + A+K++ K + IA ++V + R L + H
Sbjct: 3 LGKGTFGKVILVREKATG---KYYAMKILKKEVI---IAKDEVAHTLTESRVLQNTRHPF 56
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
L +F+ D + VME GGEL LSR +SED A+ +I++ + + H
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-Y 317
VV+RDLK EN + D+ +K DFGL + + + G+ Y+APEVL + Y
Sbjct: 116 VVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 318 GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSDAKDFVK 376
G D W +GV+ Y ++CG PF+ + +F +L + F P LS +AK +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF-----PRTLSPEAKSLLA 227
Query: 377 LLLNKDPRKRM-----TAAQALSHPWIRNYN 402
LL KDP++R+ A + + H + + N
Sbjct: 228 GLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 8e-30
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 32/222 (14%)
Query: 136 LEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
LE+G+++G G FG Y T + + KVA+K + + + E+ E I++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGT-ETKVAVKTLKEG--ASEEEREEFLEEASIMKK 57
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
LS H N+V+ + +YIV E GG+LLD + K + + + +QI +
Sbjct: 58 LS-HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 308
+ VHRDL N L E+ +K DFGLS + D+ YY
Sbjct: 117 YLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDD---------YYRKRGGG 164
Query: 309 -------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFW 341
APE L + +++DVWS GV+ + I G +P+
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 19/270 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR--ALSGHSN 199
+G+G FG R K + A+KV+ K ++ V E IL L
Sbjct: 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
+V +F+ ++Y+V + GGEL L + G++SED AK + +++ + H +
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWH-LQKEGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVL--HRS 316
+V+RDLKPEN L D + + DFGLS + ++ N G+ Y+APEVL +
Sbjct: 117 IVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
Y D WS+GV+ + + CG PF+A ++R + F LS + + FVK
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVK 230
Query: 377 LLLNKDPRKRM----TAAQALSHPWIRNYN 402
LLN++P+ R+ A + HP+ + +
Sbjct: 231 GLLNRNPQHRLGAHRDAVELKEHPFFADID 260
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 87/299 (29%), Positives = 136/299 (45%), Gaps = 66/299 (22%)
Query: 145 GHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--------TTAIAVEDVRREVKILRALSG 196
G +G AR KK + VA+K K KM T++ RE+ IL L
Sbjct: 16 GTYGVVYRARDKK---TGEIVALK---KLKMEKEKEGFPITSL------REINILLKLQ- 62
Query: 197 HSNLVKFYDAF--EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H N+V + +LD +Y+VME E +L + + + + E K +++Q+L+ VA
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 313
H + ++HRDLK N L ++ LK DFGL+ ++ P + +V + +Y APE+L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNR---GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL 178
Query: 314 --HRSYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSWP-- 365
+ Y T D+WS+G I LL F ++E + IF+ + P+ + WP
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL--GTPT--EKIWPGF 234
Query: 366 --------------------------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
SLS + D + LL DP KR++A AL HP+
Sbjct: 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 77/266 (28%), Positives = 138/266 (51%), Gaps = 22/266 (8%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+++G G FG + K+ ++ IK I SKM+ E+ R+EV +L + H N
Sbjct: 6 KKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSPK-EREESRKEVAVLSNMK-HPN 60
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLH 258
+V++ ++FE+ N+YIVM+ CEGG+L +I ++ G + ED+ VQI + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL-NDIVGSAYYVAPEVL-HRS 316
++HRD+K +N T KD + +L DFG++ + L +G+ YY++PE+ +R
Sbjct: 121 KILHRDIKSQNIFLT-KDGTIKLG--DFGIARVLNSTVELARTCIGTPYYLSPEICENRP 177
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL----SSDAK 372
Y ++D+W++G + Y + F A + +++ GS+P + S D +
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-------GSYPPVSSHYSYDLR 230
Query: 373 DFVKLLLNKDPRKRMTAAQALSHPWI 398
+ V L ++PR R + L +I
Sbjct: 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 83/291 (28%), Positives = 127/291 (43%), Gaps = 49/291 (16%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVI---PKSKMTTAIAVEDVRREVKILRALSGHS 198
VG G +G ++K+ Q VAIK KM IA+ RE+++L+ L H
Sbjct: 9 VGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDKMVKKIAM----REIRMLKQLR-HE 60
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258
NLV + F +Y+V E + +LD + E + L QIL + FCH H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVL--HR 315
++HRD+KPEN L + +S +K DFG + + P E D V + +Y APE+L
Sbjct: 120 NIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 316 SYGTEADVWSIGVIAYILLCGSRPFWARTESGI----------------FRAVLKADPSF 359
YG D+W++G + +L G F +S I + + + +P F
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLF--PGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234
Query: 360 D-------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
+ +P LS D K L DP R +++Q L H +
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 84/277 (30%), Positives = 138/277 (49%), Gaps = 26/277 (9%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT-AIAVEDVRREVKILRALSGHSNL 200
+G G +G R G + A+KV+ K+ + A VE R E +L + L
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-- 258
V + AF+ ++++++ GGE+ + R +SEDE + +I ++A HLH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEI--ILALEHLHKL 124
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPD-ERLNDIVGSAYYVAPEVLH-- 314
G+V+RD+K EN L D + DFGLS +F+ + ER G+ Y+APE++
Sbjct: 125 GIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 315 RSYGTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLKADPSFDDGSWPSLSSD 370
+G D WS+G++ + LL G+ PF T+S + R +LK DP F + +
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SFIGPE 237
Query: 371 AKDFVKLLLNKDPRKRMTAA-----QALSHPWIRNYN 402
A+D + LL KDP+KR+ A + HP+ + +
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 6e-29
Identities = 83/284 (29%), Positives = 142/284 (50%), Gaps = 27/284 (9%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-TAIAVEDVRREVKILRAL 194
E+ + +G G +G R G + A+KV+ K+ + A E R E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
LV + AF+ ++++++ GGEL + R ++ E E + +I V+A
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEI--VLAL 118
Query: 255 CHLH--GVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPD-ERLNDIVGSAYYVAP 310
HLH G+++RD+K EN L D + + DFGLS +F + ER G+ Y+AP
Sbjct: 119 EHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 311 EVLH---RSYGTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDDGS 363
+++ + D WS+GV+ Y LL G+ PF +++ I R +LK++P +
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ-- 233
Query: 364 WPSLSSDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
+S+ AKD ++ LL KDP+KR+ A + HP+ + N
Sbjct: 234 --EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 84/259 (32%), Positives = 133/259 (51%), Gaps = 28/259 (10%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR---EVKILRALSGHS 198
+G+G FG R G Q A+KV+ K+ + V D R E IL A H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA----TLKVRDRVRTKMERDIL-AEVNHP 58
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258
+VK + AF+ +Y++++ GG+L R LS+ ++E++ K L ++ +A HLH
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAEL--ALALDHLH 115
Query: 259 --GVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR 315
G+++RDLKPEN L DE +K DFGLS + + +++ G+ Y+APEV++R
Sbjct: 116 SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 316 -SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDDGSWPSLSSDA 371
+ AD WS GV+ + +L GS PF + +LKA P F LS +A
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-------LSPEA 225
Query: 372 KDFVKLLLNKDPRKRMTAA 390
+ ++ L ++P R+ A
Sbjct: 226 QSLLRALFKRNPANRLGAG 244
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 79/270 (29%), Positives = 128/270 (47%), Gaps = 23/270 (8%)
Query: 143 GRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS--GHSNL 200
GRGHFG A YK + AIK + K + VE + E +I + H L
Sbjct: 8 GRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
V + F+ D+V VME GG+L+ I + +SE A ++ + + H + +
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVL-HRSYG 318
V+RDLK +N L ++ +K DFGL + + +R + G+ ++APEVL SY
Sbjct: 123 VYRDLKLDNLLLDTE---GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP-SLSSDAKDFVKL 377
D W +GV+ Y +L G PF E +F +++ D+ +P LS +A ++
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREAISIMRR 234
Query: 378 LLNKDPRKRM-----TAAQALSHPWIRNYN 402
LL ++P +R+ A P+ R+ N
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 87/307 (28%), Positives = 138/307 (44%), Gaps = 67/307 (21%)
Query: 135 RLEVGEEVGRGHFG--YTCTARYKKGEHKD--QKVAIK---------VIPKSKMTTAIAV 181
+ E ++G G +G + C +++ Q VAIK VI K IA+
Sbjct: 2 KYEKLSKIGEGSYGVVFKC-------RNRETGQIVAIKKFVESEDDPVIKK------IAL 48
Query: 182 EDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEA 241
RE+++L+ L H NLV + F +++V E C+ +L+ + E
Sbjct: 49 ----REIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLI 102
Query: 242 KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV-RPDERLND 300
K ++ Q L V FCH H +HRD+KPEN L T + Q+K DFG + + P + D
Sbjct: 103 KKIIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTD 159
Query: 301 IVGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWA------------RT-- 344
V + +Y APE+L YG DVW+IG + LL G +P W +T
Sbjct: 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLG 218
Query: 345 -----------ESGIFRAVLKADPSFD---DGSWPSLSSDAKDFVKLLLNKDPRKRMTAA 390
+ F+ + +P + +P++SS A F+K L DP +R++
Sbjct: 219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCE 278
Query: 391 QALSHPW 397
+ L HP+
Sbjct: 279 ELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 75/248 (30%), Positives = 123/248 (49%), Gaps = 13/248 (5%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG A +KG D+ AIK++ K + VE E ++L L
Sbjct: 8 LGKGSFGKVMLAE-RKG--TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ + F+ +D +Y VME GG+L+ I + GK+ E A +I + F H G++
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPE-VLHRSYGT 319
+RDLK +N + D +K DFG+ + + + G+ Y+APE + ++ YG
Sbjct: 124 YRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D W+ GV+ Y +L G PF E +F+++++ + S+ SLS +A K LL
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLL 236
Query: 380 NKDPRKRM 387
K P KR+
Sbjct: 237 TKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 78/293 (26%), Positives = 128/293 (43%), Gaps = 50/293 (17%)
Query: 140 EEVGRGHFGYTCTARYK-KGEHKDQKVAIKVI----PKSKMTTAIAVEDVRREVKILRAL 194
E++G G T YK + + VA+K I + +TAI RE+ +++ L
Sbjct: 6 EKLGEG----TYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI------REISLMKEL 55
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGG--ELLDRILSRCGKYSEDEAKAVLVQILNVV 252
H N+V+ +D + + +V E + + +D R + K+ Q+L +
Sbjct: 56 K-HENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGI 113
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPE 311
AFCH + V+HRDLKP+N L + +LK DFGL+ F P ++ V + +Y AP+
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKR---GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPD 170
Query: 312 VL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369
VL R+Y T D+WS+G I ++ G F + + + + +WP +S
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 370 -------------------------DAKDFVKLLLNKDPRKRMTAAQALSHPW 397
D + LL +P R++A AL HPW
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 91/299 (30%), Positives = 134/299 (44%), Gaps = 62/299 (20%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVI---------PKSKMTTAIAVEDVRREVKI 190
E++G G +G AR K + VA+K I P +TAI RE+ +
Sbjct: 5 EKIGEGTYGVVYKARDKLT---GEIVALKKIRLETEDEGVP----STAI------REISL 51
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEA--KAVLVQI 248
L+ L+ H N+V+ D + +Y+V E + L + + D K+ L Q+
Sbjct: 52 LKELN-HPNIVRLLDVVHSENKLYLVFEFLDLD--LKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD-FVRPDERLNDIVGSAYY 307
L +A+CH H V+HRDLKP+N L D LK DFGL+ F P V + +Y
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLWY 165
Query: 308 VAPEVL--HRSYGTEADVWSIGVIAYILLCGSRP-FWARTE-SGIFRAVLKADPSFDDGS 363
APE+L R Y T D+WSIG I + + RP F +E +FR + + + D+
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFR-IFRTLGTPDEDV 223
Query: 364 WP-------------------------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
WP +L D D + +L DP KR++A AL HP+
Sbjct: 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-28
Identities = 91/294 (30%), Positives = 138/294 (46%), Gaps = 42/294 (14%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI----PKSKMTTAIAVEDVRREVK 189
+EV +E+G+G++G ++ +A+K I +SK I E+
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLELDESKFNQII------MELD 51
Query: 190 IL-RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI 248
IL +A+S + +V FY AF VY+ ME + G L D++ + G +E + VL +I
Sbjct: 52 ILHKAVSPY--IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAG-GVATEGIPEDVLRRI 107
Query: 249 LNVVA-----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIV 302
V H ++HRD+KP N L Q+K DFG+S + V + N +
Sbjct: 108 TYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN---GQVKLCDFGVSGNLVASLAKTN--I 162
Query: 303 GSAYYVAPEVLHR-------SYGTEADVWSIGVIAYILLCGSRPFWARTESGIF---RAV 352
G Y+APE + +Y ++DVWS+G+ + G P+ T + IF A+
Sbjct: 163 GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI 222
Query: 353 LKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKV 406
+ DP S DA+DFV LNK P +R T AQ L HPW+ Y N V
Sbjct: 223 VDGDPP---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 80/271 (29%), Positives = 141/271 (52%), Gaps = 18/271 (6%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
R + + +G+G FG + KK +++ +K IP ++ V+ +E ++L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKL 59
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRI--LSRCGK-YSEDEAKAVLVQILNV 251
H +VKF+ +F + D I+ E CEG +L ++ L GK SE++ +Q+L
Sbjct: 60 D-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 252 VAFCHLHGVVHRDLKPEN-FLYTSKDESSQLKAIDFGLSDFVRPDERL-NDIVGSAYYVA 309
V + H ++HRDLK +N FL +++ LK DFG+S + L G+ YY++
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL-----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 310 PEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-PSFDDGSWPSL 367
PE L H+ Y +++D+WS+G I Y + C + F + + +++ PS + +
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE----TY 229
Query: 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
S ++ +LNKDP R +AA+ L +P+I
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 81/282 (28%), Positives = 136/282 (48%), Gaps = 47/282 (16%)
Query: 139 GEEVGRGHFG--YTC----TARYKKGEHKDQKVAIKVIP--KSKMTTAIAVEDVRREVKI 190
G+ +G+G FG Y C T R ++A+K +P T V + E+++
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGR---------ELAVKQVPFDPDSPETKKEVNALECEIQL 57
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
L+ L H +V++Y D + + I ME GG + D++ + G +E + QIL
Sbjct: 58 LKNLQ-HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILE 115
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI--------- 301
V + H + +VHRD+K N L +D + +K DFG S +RL I
Sbjct: 116 GVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGAS------KRLQTICSSGTGMKS 166
Query: 302 -VGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE--SGIFR-AVLKAD 356
G+ Y+++PEV+ YG +ADVWS+G +L +P WA E + IF+ A +
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIATQPTN 225
Query: 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
P +S DA++F++ ++ +KR +A + L H ++
Sbjct: 226 PQLP----SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 89/267 (33%), Positives = 134/267 (50%), Gaps = 27/267 (10%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI--PKSKMTTAIAVEDVRREVKILRAL 194
V VG G FG ++ + DQK A+K I PKS + AVED R+E +L A
Sbjct: 3 NVLRVVGEGSFGRALLVQH---VNSDQKYAMKEIRLPKS----SSAVEDSRKEA-VLLAK 54
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVA 253
H N+V F ++FE ++YIVME C+GG+L+ +I + GK + ED VQ+ V
Sbjct: 55 MKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEV 312
H V+HRD+K +N T ++ ++K DFG + + P VG+ YYV PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 313 LHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL---- 367
Y ++D+WS+G I Y L PF A + + V + GS+ L
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-------GSYKPLPSHY 224
Query: 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394
S + + +K + ++PR R +A LS
Sbjct: 225 SYELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 83/288 (28%), Positives = 132/288 (45%), Gaps = 29/288 (10%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG A K ++ AIK + K + VE E ++L H L
Sbjct: 3 LGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ F+ ++++ VME GG+L+ I S G++ E A+ +I+ + F H G++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVLH-RSYGT 319
+RDLK +N L D+ +K DFG+ + + + + G+ Y+APE+L + Y
Sbjct: 119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D WS GV+ Y +L G PF E +F ++L P F W +S +AKD + L
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP--RW--ISKEAKDCLSKLF 231
Query: 380 NKDPRKRM-TAAQALSHPWIRNYN---------------NVKVPLDIS 411
+DP KR+ HP+ R + VK P D S
Sbjct: 232 ERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDAS 279
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 79/257 (30%), Positives = 123/257 (47%), Gaps = 33/257 (12%)
Query: 160 HKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVM 217
HK+ Q+ A+K I K + ++ V E IL + + +V + +FE ++ +VM
Sbjct: 22 HKETRQRFAMKKINKQNLILRNQIQQVFVERDIL-TFAENPFVVSMFCSFETKRHLCMVM 80
Query: 218 ELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277
E EGG+ +L G D A+ + + + + H +G+VHRDLKP+N L TS
Sbjct: 81 EYVEGGDCAT-LLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS--- 136
Query: 278 SSQLKAIDFGLSD-------------FVRPDERL---NDIVGSAYYVAPEV-LHRSYGTE 320
+K DFGLS + D R + G+ Y+APEV L + YG
Sbjct: 137 MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP 196
Query: 321 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP----SLSSDAKDFVK 376
D W++G+I Y L G PF+ T +F V+ DD WP +L +DA+D +
Sbjct: 197 VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-----DDIEWPEGDEALPADAQDLIS 251
Query: 377 LLLNKDPRKRMTAAQAL 393
LL ++P +R+ A
Sbjct: 252 RLLRQNPLERLGTGGAF 268
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 81/260 (31%), Positives = 130/260 (50%), Gaps = 30/260 (11%)
Query: 156 KKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR---------EVKILRALSGHSNLVKFYDA 206
K GE V I + S A+ D+R+ EV I+R H N+V+ Y++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNS 85
Query: 207 FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLK 266
+ D +++VME EGG L D + + +E++ AV + +L ++ H GV+HRD+K
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 267 PENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADVW 324
++ L T ++K DFG V + R +VG+ Y++APE++ R YG E D+W
Sbjct: 144 SDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 325 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL------SSDAKDFVKLL 378
S+G++ ++ G P++ LKA D P L S K F+ L
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL 253
Query: 379 LNKDPRKRMTAAQALSHPWI 398
L +DP +R TAA+ L HP++
Sbjct: 254 LVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 69/228 (30%), Positives = 115/228 (50%), Gaps = 17/228 (7%)
Query: 181 VEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY-IVMELCEGGELLDRILSRCGKYSED 239
V+ +R E++ L+ L H N+V+ Y FE + I +E GG + L G++ E
Sbjct: 52 VKALRSEIETLKDLD-HLNIVQ-YLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQ 108
Query: 240 EAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL---SDFVRPDE 296
+ Q+L +A+ H G++HRDLK +N L D K DFG+ SD + ++
Sbjct: 109 LVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKKSDDIYDND 165
Query: 297 RLNDIVGSAYYVAPEVLH---RSYGTEADVWSIGVIAYILLCGSRPFWARTES--GIFR- 350
+ + GS +++APEV+H + Y + D+WS+G + + G RP W+ E+ +F+
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKL 224
Query: 351 AVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
++ P +LS A DF+ +P R TA + L HP+I
Sbjct: 225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 93/288 (32%), Positives = 130/288 (45%), Gaps = 37/288 (12%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK-ILRAL 194
LE E+G G G R+KK H +A+K + ++ + E K IL L
Sbjct: 17 LENLGEIGSGTCGQVYKMRFKKTGHV---MAVKQMRRT---------GNKEENKRILMDL 64
Query: 195 S----GHS--NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQ 247
H +VK Y F +V+I MEL LD++L R G ED + V
Sbjct: 65 DVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA 122
Query: 248 ILNVVAFCHL---HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
I+ A +L HGV+HRD+KP N L D S +K DFG+S + + G
Sbjct: 123 IVK--ALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 305 AYYVAPEVL-----HRSYGTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPS 358
A Y+APE + + Y ADVWS+G+ L G P+ +TE + +L+ +P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
Query: 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKV 406
+ S D FV L L KD RKR + L HP+IR Y +V
Sbjct: 238 SLPPN-EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 81/281 (28%), Positives = 129/281 (45%), Gaps = 26/281 (9%)
Query: 128 FSKEVTSRLEVG-EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR 186
FSK+ +L E+G G FG AR + + VAIK + S + +D+ +
Sbjct: 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTN---EVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 187 EVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEG--GELLDRILSRCGKYSEDEAKAV 244
EV+ L+ L H N +++ + ++VME C G ++L+ + + E E A+
Sbjct: 65 EVRFLQQLR-HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE-VHKK--PLQEVEIAAI 120
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
L +A+ H H +HRD+K N L T E +K DFG + V P N VG+
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSP---ANSFVGT 174
Query: 305 AYYVAPEVL----HRSYGTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPS 358
Y++APEV+ Y + DVWS+G I I L +P F S ++ P+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPT 233
Query: 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
W S ++FV L K P+ R ++ + L H ++
Sbjct: 234 LSSNDW---SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 3e-27
Identities = 60/239 (25%), Positives = 105/239 (43%), Gaps = 41/239 (17%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+++G G FG + K + K +VA+K + + + +D +E ++++ L GH N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKL-GHPN 57
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC---- 255
+V+ + + +Y+V+E EGG+LLD + + E + ++ L ++F
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL--LSFAIQIA 115
Query: 256 ----HLH--GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV- 308
+L VHRDL N L +K DFGLS V D+ YY
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDL---VVKISDFGLSRDVYDDD---------YYRK 163
Query: 309 -----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
APE L + +++DVWS GV+ + I G+ P+ + + + K
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 78/248 (31%), Positives = 121/248 (48%), Gaps = 14/248 (5%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG R K + A+K++ K + V E ++L+ + H L
Sbjct: 3 LGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLT 58
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+F+ D + VME GGEL LSR +SED + +I++ + + H +V
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYGT 319
+RDLK EN + D+ +K DFGL + + + G+ Y+APEVL YG
Sbjct: 118 YRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D W +GV+ Y ++CG PF+ + +F +L D F +LS+DAK + LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLL 230
Query: 380 NKDPRKRM 387
KDP KR+
Sbjct: 231 IKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 3e-27
Identities = 87/282 (30%), Positives = 138/282 (48%), Gaps = 34/282 (12%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKV--AIKVIPKSKMTTAIAVEDVRREVKILRAL 194
E+ E+G G FG + K ++K+ V A KVI + +ED E+ IL A
Sbjct: 8 EIIGELGDGAFG-----KVYKAQNKETGVLAAAKVI---DTKSEEELEDYMVEIDIL-AS 58
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H N+VK DAF +N++I++E C GG + +L +E + + V Q L + +
Sbjct: 59 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNY 118
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 313
H + ++HRDLK N L+T + +K DFG+S R +R + +G+ Y++APEV+
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 314 ------HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367
R Y +ADVWS+G+ + P + + K++P P+L
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-------PTL 228
Query: 368 ------SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
SS+ KDF+K L K+ R T Q L HP++ +N
Sbjct: 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 86/294 (29%), Positives = 138/294 (46%), Gaps = 58/294 (19%)
Query: 162 DQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED------------ 209
D++VA+K K +T +V+ RE+KI+R L H N+VK Y+
Sbjct: 30 DKRVAVK---KIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSL 85
Query: 210 --LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKP 267
L++VYIV E E L +L + G SE+ A+ + Q+L + + H V+HRDLKP
Sbjct: 86 TELNSVYIVQEYMETD--LANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP 142
Query: 268 ENFLYTSKDESSQLKAIDFGLSDFVRPDER----LNDIVGSAYYVAPEVL--HRSYGTEA 321
N ++D LK DFGL+ V P L++ + + +Y +P +L +Y
Sbjct: 143 ANVFINTED--LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200
Query: 322 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA---------------DPSF--DDGSW 364
D+W+ G I +L G F E + +L++ PSF +DG
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGE 260
Query: 365 ---------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLD 409
P ++ +A DF++ +L +P R+TA +AL HP++ Y+ P D
Sbjct: 261 PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC---PFD 311
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 78/268 (29%), Positives = 129/268 (48%), Gaps = 19/268 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG R K + A+K++ K + V E ++L+ + H L
Sbjct: 3 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLT 58
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
AF+ D + VME GGEL LSR ++E+ A+ +I++ + + H VV
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYGT 319
+RD+K EN + D+ +K DFGL + + + G+ Y+APEVL YG
Sbjct: 118 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D W +GV+ Y ++CG PF+ + +F +L + F +LS +AK + LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 230
Query: 380 NKDPRKRM-----TAAQALSHPWIRNYN 402
KDP++R+ A + + H + + N
Sbjct: 231 KKDPKQRLGGGPSDAKEVMEHRFFLSIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 82/273 (30%), Positives = 135/273 (49%), Gaps = 25/273 (9%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
R E+ +++G G FG A K + + IK I +KM E ++EV IL A
Sbjct: 1 RYEIIKKIGEGSFGKIYLA---KAKSDSEHCVIKEIDLTKMPVK-EKEASKKEV-ILLAK 55
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVA 253
H N+V F+ +F++ ++IVME C+GG+L+ RI + G +SED+ + VQI +
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND-------IVGSAY 306
H ++HRD+K +N + ++L DFG++ +LND VG+ Y
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLG--DFGIA------RQLNDSMELAYTCVGTPY 167
Query: 307 YVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365
Y++PE+ +R Y + D+WS+G + Y L PF + + + VLK + P
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF---EGNNLHQLVLKICQGYFAPISP 224
Query: 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
+ S D + + L PR R + L P++
Sbjct: 225 NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 35/278 (12%)
Query: 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI---PKSKMTTAIAVEDVRREVKILRALS 195
GE +G+G +G +G Q +A+K + + + E ++ EV +L++L
Sbjct: 5 GEVLGKGAYGTVYCGLTNQG----QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255
H N+V++ D + + I ME GG + IL+R G E QIL+ VA+
Sbjct: 61 -HVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 256 HLHGVVHRDLKPENFLYTSKDESSQLKAIDFG-------LSDFVRPDERLNDIVGSAYYV 308
H + VVHRD+K N + + +K IDFG + L + G+ Y++
Sbjct: 119 HNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 309 APEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTE--SGIF-----RAVLKADPSFD 360
APEV++ S YG ++D+WSIG + + G +P A + + +F R ++ P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATG-KPPLASMDRLAAMFYIGAHRGLM---PRLP 231
Query: 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
D S S+ A DFV L +D +R +A Q L H ++
Sbjct: 232 D----SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 90/295 (30%), Positives = 132/295 (44%), Gaps = 54/295 (18%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-----TAIAVEDVRREVKILRAL 194
E++G G +G AR K + VA+K I T TAI RE+ +L+ L
Sbjct: 6 EKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAI------REISLLKEL 56
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC--GKYSEDEAKAVLVQILNVV 252
+ H N+VK D + +Y+V E + L + + K+ L Q+L +
Sbjct: 57 N-HPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD-FVRPDERLNDIVGSAYYVAPE 311
AFCH H V+HRDLKP+N L + +K DFGL+ F P V + +Y APE
Sbjct: 114 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170
Query: 312 VL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKAD--------- 356
+L + Y T D+WS+G I ++ F +E IFR + D
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230
Query: 357 -----PSFDDGSW---------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
PSF W P L D +D + +L+ DP KR++A AL+HP+
Sbjct: 231 LPDYKPSFP--KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 75/263 (28%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
E++G+G G TA Q+VAIK + + E + E+ ++R H N
Sbjct: 25 EKIGQGASGTVYTAIDVATG---QEVAIKQMNLQQQPKK---ELIINEILVMRENK-HPN 77
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
+V + D++ D +++VME GG L D + C E + AV + L + F H +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ 135
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLHR-SY 317
V+HRD+K +N L +K DFG + P++ + +VG+ Y++APEV+ R +Y
Sbjct: 136 VIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 318 GTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
G + D+WS+G++A ++ G P+ ++ P + LS+ +DF+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 250
Query: 377 LLLNKDPRKRMTAAQALSHPWIR 399
L D KR +A + L HP+++
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 84/290 (28%), Positives = 132/290 (45%), Gaps = 22/290 (7%)
Query: 128 FSKEVTSRLEVG-EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR 186
F K+ + VG E+G G FG + H ++ VA+K + S T +D+ +
Sbjct: 14 FYKDDPEEIFVGLHEIGHGSFG---AVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK 70
Query: 187 EVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV 246
EVK L+ L H N +++ + ++VME C G D + E E A+
Sbjct: 71 EVKFLQQLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITH 128
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY 306
L +A+ H H ++HRD+K N L T E Q+K DFG + P N VG+ Y
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSP---ANSFVGTPY 182
Query: 307 YVAPEVL----HRSYGTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFD 360
++APEV+ Y + DVWS+G I I L +P F S ++ P+
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ 241
Query: 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDI 410
W + + FV L K P++R +A+ L H ++R +V +D+
Sbjct: 242 SNEW---TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDL 288
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 88/314 (28%), Positives = 136/314 (43%), Gaps = 57/314 (18%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
S + +G G FG C R K + A+K + K+ + V+ E IL A
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVR-KVDTNA--LYAMKTLRKADVLMRNQAAHVKAERDIL-A 56
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
+ + +VK Y +F+D DN+Y VM+ GG+++ +L R G + ED A+ + ++ +
Sbjct: 57 EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDLARFYIAELTCAIE 115
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL--------------------SDFVR 293
H G +HRD+KP+N L D +K DFGL D +
Sbjct: 116 SVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 294 PDERLNDI------------------------VGSAYYVAPEVLHRS-YGTEADVWSIGV 328
P E ++I VG+ Y+APEVL R+ Y D WS+GV
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232
Query: 329 IAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRM- 387
I Y +L G PF A T + V+ + + S LS +A D + L L R+
Sbjct: 233 ILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLI-LRLCCGAEDRLG 291
Query: 388 --TAAQALSHPWIR 399
A + +HP+ +
Sbjct: 292 KNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 82/278 (29%), Positives = 136/278 (48%), Gaps = 28/278 (10%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
E+ E VG G +G R+ K Q AIKV+ T E++++E+ +L+ S
Sbjct: 8 FELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLKKYS 60
Query: 196 GHSNLVKFYDAFEDL------DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV-QI 248
H N+ +Y AF D +++VME C G + D I + G ++E A + +I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYY 307
L ++ H H V+HRD+K +N L T E++++K +DFG+S R R N +G+ Y+
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 177
Query: 308 VAPEVL------HRSYGTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFD 360
+APEV+ +Y ++D+WS+G+ A + G+ P +F P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237
Query: 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
W S + F++ L K+ +R T Q + HP+I
Sbjct: 238 SKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 69/273 (25%), Positives = 130/273 (47%), Gaps = 32/273 (11%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
++ +++G+G F A + VA+K + +M A A +D +E+ +L+ L
Sbjct: 5 KIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD- 60
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV--------LVQI 248
H N++K+ +F + + + IV+EL + G+L SR K+ + + + + VQ+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-----SRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYY 307
+ + H ++HRD+KP N T+ +K D GL F + +VG+ YY
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 308 VAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366
++PE +H + Y ++D+WS+G + Y + PF+ + ++ K + +P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKK----IEKCDYPP 227
Query: 367 LSSDA-----KDFVKLLLNKDPRKRMTAAQALS 394
L +D +D V +N DP KR + L
Sbjct: 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 79/269 (29%), Positives = 131/269 (48%), Gaps = 23/269 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKV-AIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
+G+G FG R + Q++ A+K I K+ + + V E +L A +
Sbjct: 1 IGKGSFGKVMQVRKRD----TQRIYALKTIRKAHIVSRSEVTHTLAERTVL-AQVNCPFI 55
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-- 258
V +F+ + +Y+V+ GGEL L R G++ A+ ++L A +LH
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHH-LQREGRFDLSRARFYTAELL--CALENLHKF 112
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVLH-RS 316
V++RDLKPEN L D + DFGL ++ D++ N G+ Y+APE+L
Sbjct: 113 NVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
Y D W++GV+ Y +L G PF+ + ++R +L+ F DG DAKD +
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLI 225
Query: 377 LLLNKDPRKRM---TAAQALSHPWIRNYN 402
LL++DP +R+ A + +HP+ +
Sbjct: 226 GLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 81/265 (30%), Positives = 132/265 (49%), Gaps = 18/265 (6%)
Query: 140 EEVGRGHFGYTCTARYKKGE-HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
E +G+G FG YK + + VAIK+I + I ED+++E+ +L
Sbjct: 10 ERIGKGSFGEV----YKGIDNRTKEVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDS-P 62
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258
+ ++Y ++ ++I+ME GG LD L + G E +L +IL + + H
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 316
+HRD+K N L + E +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 RKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
Y +AD+WS+G+ A L G P + + K P +G + S K+FV+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQY---SKPFKEFVE 234
Query: 377 LLLNKDPRKRMTAAQALSHPWIRNY 401
LNKDPR R TA + L H +I Y
Sbjct: 235 ACLNKDPRFRPTAKELLKHKFITRY 259
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKV-AIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
E++G+G FG +K +++ QKV AIK+I + I ED+++E+ +L
Sbjct: 10 EKIGKGSFGEV----FKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDS-P 62
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258
+ K+Y ++ ++I+ME GG LD L G E + +L +IL + + H
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 316
+HRD+K N L + E ++K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
Y ++AD+WS+G+ A L G P + + K +P +G++ S K+FV+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVE 234
Query: 377 LLLNKDPRKRMTAAQALSHPWI 398
LNK+P R TA + L H +I
Sbjct: 235 ACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 75/241 (31%), Positives = 121/241 (50%), Gaps = 33/241 (13%)
Query: 172 KSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILS 231
K M A+A RE+ +L+ L H N+V++ + D D++ I +E GG + +L+
Sbjct: 46 KRSMLDALA-----REIALLKELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLN 98
Query: 232 RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291
G + E + + QIL + + H G++HRD+K N L D +K DFG+S
Sbjct: 99 NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK 155
Query: 292 V------------RPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSR 338
+ RP + GS +++APEV+ + SY +AD+WS+G + +L G
Sbjct: 156 LEANSLSTKTNGARP-----SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210
Query: 339 PFWARTE-SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
PF T+ IF+ A P ++SS+A DF++ D KR TAA+ L HP+
Sbjct: 211 PFPDCTQLQAIFKIGENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
Query: 398 I 398
+
Sbjct: 267 L 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 84/279 (30%), Positives = 132/279 (47%), Gaps = 30/279 (10%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
E+ E VG G +G R+ K Q AIKV+ T E+++ E+ +L+ S
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTEDEEEEIKLEINMLKKYS 70
Query: 196 GHSNLVKFYDAF-------EDLDNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQ 247
H N+ +Y AF D D +++VME C G + D + + G ED + +
Sbjct: 71 HHRNIATYYGAFIKKSPPGHD-DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 248 ILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAY 306
IL +A H H V+HRD+K +N L T E++++K +DFG+S R R N +G+ Y
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186
Query: 307 YVAPEVL------HRSYGTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSF 359
++APEV+ +Y +D+WS+G+ A + G+ P +F P
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246
Query: 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
W S DF++ L K+ R + Q L HP+I
Sbjct: 247 KSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 87/283 (30%), Positives = 137/283 (48%), Gaps = 38/283 (13%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI-PKSKMTTAIAVEDVRREVKILRALS 195
E+ E +G+G +G KK K A+K++ P + E++ E IL+ALS
Sbjct: 21 EIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHDID-----EEIEAEYNILKALS 72
Query: 196 GHSNLVKFYDAF-----EDLDNVYIVMELCEGGELLDRI---LSRCGKYSEDEAKAVLVQ 247
H N+VKFY + ++ D +++V+ELC GG + D + L R + E +L +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 248 ILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAY 306
L + H++ +HRD+K N L T++ +K +DFG+S R N VG+ +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
Query: 307 YVAPEV------LHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK----AD 356
++APEV L +Y DVWS+G+ A L G P + RA+ K
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNPP 246
Query: 357 PSFDDGSWPSL-SSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
P+ P L S++ DF++ L KD KR T + L H +I
Sbjct: 247 PTLHQ---PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-26
Identities = 80/262 (30%), Positives = 135/262 (51%), Gaps = 18/262 (6%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKV-AIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
E +G+G FG +K +++ Q+V AIK+I + I ED+++E+ +L
Sbjct: 10 ERIGKGSFGEV----FKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDS-P 62
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258
+ K+Y ++ ++I+ME GG LD L R G + E + +L +IL + + H
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 316
+HRD+K N L + E +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 KKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
Y ++AD+WS+G+ A L G P + + K +P G + S K+F+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEF---SKPFKEFID 234
Query: 377 LLLNKDPRKRMTAAQALSHPWI 398
LNKDP R TA + L H +I
Sbjct: 235 ACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 84/297 (28%), Positives = 137/297 (46%), Gaps = 51/297 (17%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM-----TTAIAVEDVRREVKILRAL 194
E++G G +G AR + ++ +A+K I + +TAI RE+ +L+ +
Sbjct: 8 EKIGEGTYGVVYKARDR---VTNETIALKKIRLEQEDEGVPSTAI------REISLLKEM 58
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDE--AKAVLVQILNVV 252
H N+V+ D +Y+V E + L + + ++++ K L QIL +
Sbjct: 59 Q-HGNIVRLQDVVHSEKRLYLVFEYLDLD--LKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD-FVRPDERLNDIVGSAYYVAPE 311
A+CH H V+HRDLKP+N L + ++ LK DFGL+ F P V + +Y APE
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPE 173
Query: 312 VL--HRSYGTEADVWSIGVIAYILLCGSRP-FWARTE----SGIFRAV----------LK 354
+L R Y T D+WS+G I + + +P F +E IFR + +
Sbjct: 174 ILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 355 ADPSFDDG--SW---------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
+ P + W P+L D + +L DP KR+TA AL H + ++
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
|
Length = 294 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 76/278 (27%), Positives = 130/278 (46%), Gaps = 28/278 (10%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG + R KK ++ A+KV+ K + ++ V+ E + S H LV
Sbjct: 3 IGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ F+ ++ V+E GG+L+ + R K E+ A+ +I + + H G++
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYGT 319
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L YG
Sbjct: 119 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 320 EADVWSIGVIAYILLCGSRPF---------WARTESGIFRAVLKADPSFDDGSWPSLSSD 370
D W++GV+ + ++ G PF TE +F+ +L+ SLS
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231
Query: 371 AKDFVKLLLNKDPRKRMTA------AQALSHPWIRNYN 402
A +K LNKDP++R+ A HP+ RN +
Sbjct: 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 80/284 (28%), Positives = 137/284 (48%), Gaps = 34/284 (11%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKV--AIKVIPKSKMTTAIAVEDVRREVKILRAL 194
E+ E+G G FG + K ++K+ A KVI + + +ED E++IL A
Sbjct: 15 EIIGELGDGAFG-----KVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEIL-AT 65
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H +VK AF ++I++E C GG + +L +E + + + Q+L + +
Sbjct: 66 CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 313
H ++HRDLK N L T + +K DFG+S V+ +R + +G+ Y++APEV+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 314 ------HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367
Y +AD+WS+G+ + P + + K++P P+L
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-------PTL 235
Query: 368 SSDAK------DFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVK 405
S +K DF+K L+K P R +AAQ L HP++ + + +
Sbjct: 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 77/249 (30%), Positives = 122/249 (48%), Gaps = 15/249 (6%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG + K A+K++ K + V E ++L+ S H L
Sbjct: 3 LGKGTFGKVILVKEKATGRY---YAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLT 58
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-GV 260
+F+ D + VME GGEL LSR +SED A+ +I++ + + H V
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYG 318
V+RDLK EN + D+ +K DFGL + ++ + G+ Y+APEVL YG
Sbjct: 118 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
D W +GV+ Y ++CG PF+ + +F +L + F +LS +AK + L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGL 230
Query: 379 LNKDPRKRM 387
L KDP++R+
Sbjct: 231 LKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 44/291 (15%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G G +G AR + VA+K + I + +R E+ +L L H N+V
Sbjct: 15 IGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDGIPISSLR-EITLLLNLR-HPNIV 69
Query: 202 KFYDAF--EDLDNVYIVMELCEG--GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL 257
+ + + LD++++VME CE LLD + + +SE + K +++Q+L + + H
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126
Query: 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--H 314
+ ++HRDLK N L T K LK DFGL+ + P + + V + +Y APE+L
Sbjct: 127 NFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 315 RSYGTEADVWSIGVIAYILLCGSRPFWARTE-------------------------SGIF 349
+Y T D+W++G I LL ++E +
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243
Query: 350 RAVLKADP-SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
+ L P + +P LS + LL DP+KR TA +AL + +
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 78/263 (29%), Positives = 131/263 (49%), Gaps = 17/263 (6%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
E++G+G G TA Q+VAIK I K E + E+ +++ L + N
Sbjct: 25 EKIGQGASGTVFTA---IDVATGQEVAIKQINLQKQPKK---ELIINEILVMKELK-NPN 77
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
+V F D+F D +++VME GG L D + C E + AV + L + F H +
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHANQ 135
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SY 317
V+HRD+K +N L +K DFG + P++ + + +VG+ Y++APEV+ R +Y
Sbjct: 136 VIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 318 GTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
G + D+WS+G++A ++ G P+ ++ P + LS +DF+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSPIFRDFLN 250
Query: 377 LLLNKDPRKRMTAAQALSHPWIR 399
L D KR +A + L HP+++
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 86/287 (29%), Positives = 132/287 (45%), Gaps = 36/287 (12%)
Query: 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKD-QKVAIKVI-PKSKMTTAIAVEDVRREVKI 190
T E+ E +G+G +G YK KD A+K++ P S + E++ E I
Sbjct: 21 TDTWEIIETIGKGTYGKV----YKVTNKKDGSLAAVKILDPISDVD-----EEIEAEYNI 71
Query: 191 LRALSGHSNLVKFYDAFEDLDN-----VYIVMELCEGGELLDRI--LSRCGKYSEDEAKA 243
L++L H N+VKFY F D +++V+ELC GG + + + L CG+ DEA
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMI 130
Query: 244 VLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLND 300
+ ++ HLH ++HRD+K N L T++ +K +DFG+S R N
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNT 187
Query: 301 IVGSAYYVAPEVL------HRSYGTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVL 353
VG+ +++APEV+ SY DVWS+G+ A L G P F +F+
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247
Query: 354 KADPSF-DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
P+ W F+ L KD R + L HP+I+
Sbjct: 248 NPPPTLLHPEKW---CRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 87/325 (26%), Positives = 140/325 (43%), Gaps = 63/325 (19%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG FG + K H A+K + KS+M V VR E IL A + + +V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHI---YAMKKLRKSEMLEKEQVAHVRAERDIL-AEADNPWVV 64
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
K Y +F+D + +Y++ME GG+++ +L + ++E+E + + + + + H G +
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL---------SDFVR------PDERLNDI----- 301
HRD+KP+N L D +K DFGL ++F R P L+ I
Sbjct: 124 HRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 302 -------------------VGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFW 341
VG+ Y+APEV ++ Y E D WS+GVI Y +L G PF
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 342 ARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK-LLLNKDPR-KRMTAAQALSHPWIR 399
+ +R ++ + LS +AKD +K L + R + SHP+ +
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFK 300
Query: 400 NYN-------------NVKVPLDIS 411
+ +K D S
Sbjct: 301 GVDWEHIRERPAPIIPELKSITDTS 325
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 73/251 (29%), Positives = 123/251 (49%), Gaps = 15/251 (5%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG AR+K E + A+KV+ K + + + E +L H LV
Sbjct: 3 IGKGSFGKVLLARHKAEE---KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRIL-SRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
+ +F+ D +Y V++ GGEL + RC + E A+ +I + + + H +
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNI 117
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YG 318
V+RDLKPEN L D + DFGL + + + + G+ Y+APEVLH+ Y
Sbjct: 118 VYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
D W +G + Y +L G PF++R + ++ +L P++++ A+ ++ L
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGL 230
Query: 379 LNKDPRKRMTA 389
L KD KR+ A
Sbjct: 231 LQKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 92/332 (27%), Positives = 147/332 (44%), Gaps = 67/332 (20%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI--PKSKMTTAIAVEDVRRE 187
K + + E+ +++G+G +G A ++ + VA+K I T A + RE
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFRNATDA---QRTFRE 56
Query: 188 VKILRALSGHSNLVKFYD---AFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
+ L+ L H N+VK + A D D +Y+V E E L ++ R + + +
Sbjct: 57 IMFLQELGDHPNIVKLLNVIKAENDKD-IYLVFEYMETD--LHAVI-RANILEDVHKRYI 112
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER------L 298
+ Q+L + + H V+HRDLKP N L S ++K DFGL+ + E L
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVL 169
Query: 299 NDIVGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWART------------ 344
D V + +Y APE+L Y D+WS+G I +L G +P + T
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEKIIEV 228
Query: 345 ------------ESGIFRAVLKADPS-----FDDGSWPSLSSDAKDFVKLLLNKDPRKRM 387
+S +L + PS D+ P S DA D +K LL +P KR+
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL-LPKASDDALDLLKKLLVFNPNKRL 287
Query: 388 TAAQALSHPWIRNYNN----------VKVPLD 409
TA +AL HP++ ++N + +PLD
Sbjct: 288 TAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 85/297 (28%), Positives = 132/297 (44%), Gaps = 58/297 (19%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKV---------IPKSKMTTAIAVEDVRREVKI 190
E++G G +G A+ + + VA+K +P S + RE+ +
Sbjct: 6 EKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSAL----------REICL 52
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQIL 249
L+ L H N+V+ YD + +V E C+ + L + C G + K+ + Q+L
Sbjct: 53 LKELK-HKNIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLL 109
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYV 308
+AFCH H V+HRDLKP+N L E LK DFGL+ F P + V + +Y
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYR 166
Query: 309 APEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTE-----SGIFRAV--------- 352
P+VL + Y T D+WS G I L RP + + IFR +
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226
Query: 353 -------LKADPSFD-DGSW----PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
K P + S P L+S +D ++ LL +P +R++A +AL HP+
Sbjct: 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 87/304 (28%), Positives = 142/304 (46%), Gaps = 41/304 (13%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E+ + +GRG FG + K Q A+K++ K +M R E +L ++G
Sbjct: 4 EILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVL--VNG 58
Query: 197 HSNLV-KFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAF 254
+ + AF+D +N+Y+VM+ GG+LL +LS+ + ED A+ L +++ +
Sbjct: 59 DRRWITNLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVLAIDS 117
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEV 312
H G VHRD+KP+N L D++ ++ DFG + D + N VG+ Y++PE+
Sbjct: 118 VHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 313 LHR------SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366
L YG E D WS+GV Y +L G PF+A + + ++ F +P
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---FPP 231
Query: 367 ----LSSDAKDFV-KLLLNKDPRKRMTAAQAL-SHPW--------IRNYN-----NVKVP 407
+S +AKD + +L+ + + R Q HP+ IRN V P
Sbjct: 232 DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSP 291
Query: 408 LDIS 411
D S
Sbjct: 292 TDTS 295
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 78/254 (30%), Positives = 130/254 (51%), Gaps = 25/254 (9%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN-L 200
+G+G FG A +KG D+ AIK++ K + VE E ++L ALSG L
Sbjct: 8 LGKGSFGKVMLAE-RKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVL-ALSGKPPFL 63
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
+ + F+ +D +Y VME GG+L+ +I + G++ E A +I + F H G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV------GSAYYVAPEVL- 313
++RDLK +N + D +K DFG+ E + D V G+ Y+APE++
Sbjct: 123 IYRDLKLDNVML---DSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 314 HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKD 373
++ YG D W+ GV+ Y +L G PF E +F+++++ + ++ S+S +A
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVA 230
Query: 374 FVKLLLNKDPRKRM 387
K L+ K P KR+
Sbjct: 231 ICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 71/255 (27%), Positives = 122/255 (47%), Gaps = 20/255 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG + R KK DQ A+KV+ K + ++ V+ E + S + LV
Sbjct: 3 IGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ F+ +++V+E GG+L+ + R K E+ A+ +I + F H G++
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYGT 319
+RDLK +N L D +K D+G+ + + P + + G+ Y+APE+L YG
Sbjct: 119 YRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 320 EADVWSIGVIAYILLCGSRPF-------WARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372
D W++GV+ + ++ G PF TE +F+ +L+ LS A
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKAS 231
Query: 373 DFVKLLLNKDPRKRM 387
+K LNKDP++R+
Sbjct: 232 HVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 76/257 (29%), Positives = 124/257 (48%), Gaps = 23/257 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG A K D+ AIK++ K + VE E ++L L
Sbjct: 8 LGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ + F+ +D +Y VME GG+L+ I + GK+ E +A +I + F H G++
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV------GSAYYVAPEVL-H 314
+RDLK +N + D +K DFG+ E + D V G+ Y+APE++ +
Sbjct: 124 YRDLKLDNVML---DSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 315 RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
+ YG D W+ GV+ Y +L G PF E +F+++++ + S+ SLS +A
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSI 231
Query: 375 VKLLLNKDPRKRMTAAQ 391
K L+ K P KR+
Sbjct: 232 CKGLMTKHPSKRLGCGP 248
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 82/311 (26%), Positives = 141/311 (45%), Gaps = 54/311 (17%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKS---KMTTAIAVEDVRRE 187
EV R + VG G +G C A D K ++V K + I + RE
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAF-------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 66
Query: 188 VKILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEA 241
+++L+ + H N++ D F E+ ++VY+V L G L+ I+ +C K ++D
Sbjct: 67 LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV-KCQKLTDDHV 122
Query: 242 KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI 301
+ ++ QIL + + H ++HRDLKP N + +E +LK +DFGL+ D+ +
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHT--DDEMTGY 177
Query: 302 VGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPF------------------- 340
V + +Y APE++ Y D+WS+G I LL G F
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237
Query: 341 ----WARTESGIFRAVLKADPSFDDGSWPSL----SSDAKDFVKLLLNKDPRKRMTAAQA 392
+ S R +++ ++ ++ + A D ++ +L D KR+TAAQA
Sbjct: 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 297
Query: 393 LSHPWIRNYNN 403
L+H + Y++
Sbjct: 298 LAHAYFAQYHD 308
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 76/271 (28%), Positives = 131/271 (48%), Gaps = 26/271 (9%)
Query: 135 RLEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+V +++G+G +G YK K +Q A+K + M+ ED E++IL +
Sbjct: 1 DFKVLKKLGKGSYGSV----YKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILAS 55
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK---YSEDEAKAVLVQILN 250
++ H N++ + +AF D + + IVME G+L I R K E E + +Q+L
Sbjct: 56 VN-HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 310
+ H ++HRDLK N L + D +K D G+S V +G+ +Y+AP
Sbjct: 115 GLQALHEQKILHRDLKSANILLVAND---LVKIGDLGISK-VLKKNMAKTQIGTPHYMAP 170
Query: 311 EVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL-- 367
EV R Y ++D+WS+G + Y + + PF AR+ + V + G +P +
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-------GKYPPIPP 223
Query: 368 --SSDAKDFVKLLLNKDPRKRMTAAQALSHP 396
S D ++F++ +L P+ R + L+ P
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 92/323 (28%), Positives = 131/323 (40%), Gaps = 69/323 (21%)
Query: 126 FGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVR 185
F F EV S+ E ++G+G FG AR+KK Q VA+K + + +R
Sbjct: 5 FPFCDEV-SKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALR 60
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDN--------VYIVMELCEGGELLDRILSRCG-KY 236
E+KIL+ L H N+V + Y+V E CE L +LS K+
Sbjct: 61 -EIKILQLLK-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD--LAGLLSNKNVKF 116
Query: 237 SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPD 295
+ E K V+ +LN + + H + ++HRD+K N L T KD LK DFGL+ F
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT-KD--GILKLADFGLARAFSLSK 173
Query: 296 E----RLNDIVGSAYYVAPEVL--HRSYGTEADVWSIGVIA------------------- 330
R + V + +Y PE+L R YG D+W G I
Sbjct: 174 NSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233
Query: 331 --YILLCGS-----------RPFWARTE--SGIFRAVLKADPSFDDGSWPSLSS-DAKDF 374
LCGS + + E G R V + P + A D
Sbjct: 234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKV-------KERLKPYVKDPHALDL 286
Query: 375 VKLLLNKDPRKRMTAAQALSHPW 397
+ LL DP KR+ A AL+H +
Sbjct: 287 IDKLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 38/278 (13%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL---RALSGHS 198
+GRG FG R+K + Q A+K++ K +M R + R + H+
Sbjct: 51 IGRGAFGEVQLVRHKSSK---QVYAMKLLSKFEMIK-------RSDSAFFWEERDIMAHA 100
Query: 199 N---LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY--SEDEAKAVLVQILNVVA 253
N +V+ + AF+D +Y+VME GG+L+ + Y E A+ +++ +
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV----NLMSNYDIPEKWARFYTAEVVLALD 156
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE----RLNDIVGSAYYVA 309
H G +HRD+KP+N L D+S LK DFG ++ D R + VG+ Y++
Sbjct: 157 AIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYIS 211
Query: 310 PEVL-----HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364
PEVL YG E D WS+GV Y +L G PF+A + G + ++ S
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271
Query: 365 PSLSSDAKDFVKLLLNKDPRK--RMTAAQALSHPWIRN 400
+S AKD + L + R + SHP+ +N
Sbjct: 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 91/295 (30%), Positives = 133/295 (45%), Gaps = 53/295 (17%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVI-----PKSKMTTAIAVEDVRREVKILRAL 194
E++G G +G R KK Q VA+K I + +TAI RE+ +L+ L
Sbjct: 6 EKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEEGVPSTAI------REISLLKEL 56
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMEL--CEGGELLDRILSRCGKYSEDE-AKAVLVQILNV 251
H N+V D +Y++ E + + LD + G+Y + E K+ L QIL
Sbjct: 57 Q-HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYLYQILQG 113
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAP 310
+ FCH V+HRDLKP+N L D +K DFGL+ F P V + +Y AP
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAP 170
Query: 311 EVLHRS--YGTEADVWSIGVIAYILLCGSRP-FWARTESG----IFRAV----------- 352
EVL S Y T D+WSIG I + + +P F +E IFR +
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229
Query: 353 ----------LKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
K + +L D D ++ +L DP KR++A +AL+HP+
Sbjct: 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 8e-24
Identities = 81/308 (26%), Positives = 143/308 (46%), Gaps = 48/308 (15%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
EV R + VG G +G C+A + QKVA+K + + + I RE+++
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLR---QKVAVKKLSRP-FQSLIHARRTYRELRL 67
Query: 191 LRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
L+ + H N++ D F E+ + VY+V L G L+ I+ +C K S++ + +
Sbjct: 68 LKHMK-HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIV-KCQKLSDEHVQFL 123
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
+ Q+L + + H G++HRDLKP N + +E +L+ +DFGL+ + D+ + V +
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILDFGLAR--QADDEMTGYVAT 178
Query: 305 AYYVAPEVLHR--SYGTEADVWSIGVIAYILLCG-----------------------SRP 339
+Y APE++ Y D+WS+G I LL G S
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238
Query: 340 FWARTESGIFRAVLKADPSFDDGSWPSLSSDAK----DFVKLLLNKDPRKRMTAAQALSH 395
+ S R +++ P + A D ++ +L D KR++A++AL+H
Sbjct: 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298
Query: 396 PWIRNYNN 403
P+ Y++
Sbjct: 299 PYFSQYHD 306
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 72/263 (27%), Positives = 132/263 (50%), Gaps = 17/263 (6%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
E++G+G G TA Q+VAI+ + + E + E+ ++R + + N
Sbjct: 26 EKIGQGASGTVYTA---MDVATGQEVAIR---QMNLQQQPKKELIINEILVMRE-NKNPN 78
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
+V + D++ D +++VME GG L D + C E + AV + L + F H +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ 136
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SY 317
V+HRD+K +N L +K DFG + P++ + + +VG+ Y++APEV+ R +Y
Sbjct: 137 VIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 318 GTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
G + D+WS+G++A ++ G P+ ++ P + LS+ +DF+
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 251
Query: 377 LLLNKDPRKRMTAAQALSHPWIR 399
L+ D KR +A + L H +++
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 92/310 (29%), Positives = 142/310 (45%), Gaps = 59/310 (19%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
EV ++ + +GRG +G C+A K ++KVAIK I + I + RE+K+
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSA---KNSETNEKVAIKKIANA-FDNRIDAKRTLREIKL 57
Query: 191 LRALSGHSNLVKFYD--------AFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAK 242
LR L H N++ D AF D VYIV EL + L +I+ S+D +
Sbjct: 58 LRHLD-HENVIAIKDIMPPPHREAFND---VYIVYELMDTD--LHQIIRSSQTLSDDHCQ 111
Query: 243 AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP----DERL 298
L Q+L + + H V+HRDLKP N L + + LK DFGL+ R + +
Sbjct: 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA---RTTSEKGDFM 165
Query: 299 NDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWARTE----------- 345
+ V + +Y APE+L Y T DVWS+G I LL G +P + +
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITEL 224
Query: 346 -------------SGIFRAVLKADPSFDDGS----WPSLSSDAKDFVKLLLNKDPRKRMT 388
+ R +++ P S +P + A D ++ +L DP KR+T
Sbjct: 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT 284
Query: 389 AAQALSHPWI 398
+AL+HP++
Sbjct: 285 VEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 28/276 (10%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG + KK + A+KVI K + ++ V+ E + S H LV
Sbjct: 3 IGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ F+ ++ V+E GG+L+ + R K E+ A+ +I + F H G++
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFH-MQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYGT 319
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L YG
Sbjct: 119 YRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 320 EADVWSIGVIAYILLCGSRPF---------WARTESGIFRAVLKADPSFDDGSWPSLSSD 370
D W++GV+ + ++ G PF TE +F+ +L+ SLS
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231
Query: 371 AKDFVKLLLNKDPRKRMTA------AQALSHPWIRN 400
A +K LNKDP++R+ SHP+ RN
Sbjct: 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 75/265 (28%), Positives = 127/265 (47%), Gaps = 16/265 (6%)
Query: 142 VGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
+G+G FG A K KGE+ A+K + K + VE E ++L + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEY----FAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
Y F+ ++++ VME GG+L+ I + G++ A +I+ + F H G+
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYG 318
++RDLK +N + D +K DFG+ + V D R + G+ Y+APE+L Y
Sbjct: 118 IYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
D WS GV+ Y +L G PF E +F ++ P + W ++ ++KD ++ L
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP--RW--ITKESKDILEKL 230
Query: 379 LNKDPRKRMTAAQALS-HPWIRNYN 402
+DP +R+ + HP+ + N
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFKTIN 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 2e-23
Identities = 73/263 (27%), Positives = 132/263 (50%), Gaps = 17/263 (6%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
E++G+G G TA Q+VAIK + + E + E+ ++R + + N
Sbjct: 25 EKIGQGASGTVYTAI---DIATGQEVAIK---QMNLQQQPKKELIINEILVMRE-NKNPN 77
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
+V + D++ D +++VME GG L D + C E + AV + L + F H +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLHSNQ 135
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SY 317
V+HRD+K +N L +K DFG + P++ + + +VG+ Y++APEV+ R +Y
Sbjct: 136 VIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 318 GTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
G + D+WS+G++A ++ G P+ ++ P + LS+ +DF+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--RLSAVFRDFLN 250
Query: 377 LLLNKDPRKRMTAAQALSHPWIR 399
L D +R +A + L HP+++
Sbjct: 251 RCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 3e-23
Identities = 67/269 (24%), Positives = 118/269 (43%), Gaps = 13/269 (4%)
Query: 139 GEEVGRGHFGYTCTAR-YKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH 197
G+++G G F AR K G K + + + VE +R+E++++ L+ H
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVK-QVTYVRNTSSEQEEVVEALRKEIRLMARLN-H 62
Query: 198 SNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL 257
++++ A + + + +E GG + +LS+ G + E Q+L +++ H
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGL-----SDFVRPDERLNDIVGSAYYVAPEV 312
+ ++HRD+K N L S + +L+ DFG + E ++G+ ++APEV
Sbjct: 122 NQIIHRDVKGANLLIDSTGQ--RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 313 LH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSD 370
L YG DVWS+G + + P+ A S + K + S P LS
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
+D L P R + + L HP R
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 6e-23
Identities = 92/313 (29%), Positives = 137/313 (43%), Gaps = 65/313 (20%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKV--AIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+G G FG C AR D K A+K + K + V V+ E IL A + +
Sbjct: 9 LGIGAFGEVCLAR-----KVDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL-AEADNEW 62
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
+V+ Y +F+D DN+Y VM+ GG+++ +L R G + ED A+ + ++ V H G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDLARFYIAELTCAVESVHKMG 121
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGL---------------SDFVRPD--------- 295
+HRD+KP+N L D +K DFGL D VR D
Sbjct: 122 FIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 296 --------ERL----------------NDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIA 330
+RL + +VG+ Y+APEVL R+ Y D WS+GVI
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 331 YILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRM--- 387
Y +L G PF A+T V+ S LS +A D + + L + P R+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI-IKLCRGPEDRLGKN 297
Query: 388 TAAQALSHPWIRN 400
A + +HP+ +
Sbjct: 298 GADEIKAHPFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 83/352 (23%), Positives = 141/352 (40%), Gaps = 81/352 (23%)
Query: 121 ELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIA 180
+ +R+ G +G G +G A + VAIK + +++ +
Sbjct: 5 SISERYIQ---------KGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVT 52
Query: 181 VED-----------VRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRI 229
+ RE+KI+ + H N++ D + + D + +VM++ L ++
Sbjct: 53 KDRQLVGMCGIHFTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASD--LKKV 109
Query: 230 LSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289
+ R + +E + K +L+QILN + H +HRDL P N SK K DFGL+
Sbjct: 110 VDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLA 166
Query: 290 ---------------DFVRPDERLNDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYI 332
+ ++ E + V + +Y APE+L + Y D+WS+G I
Sbjct: 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226
Query: 333 LLCGSRPFWARTE----SGIFRAVLKADPSFDDGSWPSL--------------------- 367
LL G F E IF L P+ + +WP
Sbjct: 227 LLTGKPLFPGENEIDQLGRIFE--LLGTPN--EDNWPQAKKLPLYTEFTPRKPKDLKTIF 282
Query: 368 ---SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLM 416
S DA D ++ LL +P +R++A +AL H + ++ +P D S L
Sbjct: 283 PNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD---PLPCDPSQLPFN 331
|
Length = 335 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 9e-23
Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 24/273 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG C + + + A K + K ++ E +IL ++ +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF-VV 63
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL--VQILNVVAFCHLHG 259
A+E D + +V+ + GG+L I + G +E +A+ +IL + H
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYG 318
V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEVL ++ Y
Sbjct: 123 TVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
D W +G + Y ++ G PF R E + R VL+ + + S +AK
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS----AKFSEEAKSI 235
Query: 375 VKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
K+LL KDP++R+ A + HP+ RN N
Sbjct: 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 84/310 (27%), Positives = 145/310 (46%), Gaps = 48/310 (15%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
EV R ++VG G +G C+A ++ KVAIK + + + A + RE+++
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPFQSELFA-KRAYRELRL 67
Query: 191 LRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
L+ + H N++ D F + + Y+VM G L +++ + K SED + +
Sbjct: 68 LKHMK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLM-KHEKLSEDRIQFL 123
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
+ Q+L + + H G++HRDLKP N + +E +LK +DFGL+ + D + V +
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCELKILDFGLAR--QTDSEMTGYVVT 178
Query: 305 AYYVAPEVLHR--SYGTEADVWSIGVIAYILLCG-----------------------SRP 339
+Y APEV+ Y D+WS+G I +L G S+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238
Query: 340 FWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNK----DPRKRMTAAQALSH 395
F + +S + +K P F + SL +A +L K D R+TAA+AL+H
Sbjct: 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298
Query: 396 PWIRNYNNVK 405
P+ +++ +
Sbjct: 299 PYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 71/269 (26%), Positives = 133/269 (49%), Gaps = 34/269 (12%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKD-QKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
+ ++ +++GRG F + Y+ D + VA+K + +M A A +D +E+ +L+
Sbjct: 2 ANFQIEKKIGRGQF----SEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLK 57
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV-------- 244
L+ H N++K+ D+F + + + IV+EL + G+L I KY + + + +
Sbjct: 58 QLN-HPNVIKYLDSFIEDNELNIVLELADAGDLSQMI-----KYFKKQKRLIPERTVWKY 111
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER-LNDIVG 303
VQ+ + V H V+HRD+KP N T+ + +K D GL F + +VG
Sbjct: 112 FVQLCSAVEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 304 SAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362
+ YY++PE +H + Y ++D+WS+G + Y + PF+ + +F K +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQK----IEQC 223
Query: 363 SWPSL-----SSDAKDFVKLLLNKDPRKR 386
+P L S ++ V + + DP +R
Sbjct: 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 80/275 (29%), Positives = 133/275 (48%), Gaps = 22/275 (8%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
EV + +GRG FG R+K + A+K++ K +M E I+ A +
Sbjct: 46 EVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFAN 101
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
+V+ + AF+D +Y+VME GG+L++ L E A+ +++ + H
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTAEVVLALDAIH 159
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH 314
G +HRD+KP+N L D+S LK DFG + + R + VG+ Y++PEVL
Sbjct: 160 SMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 315 RS-----YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL--KADPSFDDGSWPSL 367
YG E D WS+GV Y +L G PF+A + G + ++ K +F D + +
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN--DI 274
Query: 368 SSDAKDFV-KLLLNKDPR-KRMTAAQALSHPWIRN 400
S +AK+ + L +++ R R + H + +N
Sbjct: 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 90/330 (27%), Positives = 145/330 (43%), Gaps = 63/330 (19%)
Query: 87 MPPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGH 146
+PP + S+ SS+ G+ AA L S LE +G G
Sbjct: 47 LPPPSSS---------SSSSSSSSASGSAPSAAKSL-----------SELERVNRIGSGA 86
Query: 147 FGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVR----REVKILRALSGHSNLVK 202
G ++ + A+KVI + + VR RE++ILR ++ H N+VK
Sbjct: 87 GGTVYKVIHRP---TGRLYALKVIYGNHE------DTVRRQICREIEILRDVN-HPNVVK 136
Query: 203 FYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVH 262
+D F+ + +++E +GG L ++ E V QIL+ +A+ H +VH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIA-----DEQFLADVARQILSGIAYLHRRHIVH 191
Query: 263 RDLKPENFLYTSKDESSQLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVL-----HRS 316
RD+KP N L S +K DFG+S + + + N VG+ Y++PE + H +
Sbjct: 192 RDIKPSNLLINSA---KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248
Query: 317 Y-GTEADVWSIGVIAYILLCGSRPF-------WARTESGIFRAVLKADPSFDDGSWPSLS 368
Y G D+WS+GV G PF WA + A+ + P + + S
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA----SLMCAICMSQPP---EAPATAS 301
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
+ + F+ L ++P KR +A Q L HP+I
Sbjct: 302 REFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 83/279 (29%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 137 EVGEEV--GRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
E GE V G+G +G AR + ++AIK IP+ V+ + E+ + L
Sbjct: 9 ENGERVVLGKGTYGIVYAARDLSTQ---VRIAIKEIPERDSRY---VQPLHEEIALHSYL 62
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG--KYSEDEAKAVLVQILNVV 252
H N+V++ + + I ME GG L + S+ G K +E QIL +
Sbjct: 63 K-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI-------VGSA 305
+ H + +VHRD+K +N L + S +K DFG S +RL I G+
Sbjct: 122 KYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTS------KRLAGINPCTETFTGTL 173
Query: 306 YYVAPEVLH---RSYGTEADVWSIGVIAYILLCGSRPFW--ARTESGIFR-AVLKADPSF 359
Y+APEV+ R YG AD+WS+G + G PF ++ +F+ + K P
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233
Query: 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
+ SLS++AK+F+ DP KR +A L P++
Sbjct: 234 PE----SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQ-KVAIKVIPKSKMTTAIAVEDVRREVKILR 192
S L +E+G G FG G+ + + VAIK+I + M + +D E K++
Sbjct: 4 SELTFLKELGSGQFG-----VVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMM 54
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
LS H NLV+ Y ++IV E G LL+ + R GK + + + +
Sbjct: 55 KLS-HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV---A 309
+ +G +HRDL N L E + +K DFGL+ +V D+ + G+ + V
Sbjct: 114 EYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAP 169
Query: 310 PEVLHRS-YGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVL 353
PEV S + +++DVWS GV+ + + G P+ + S + +V
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 24/263 (9%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
E+ + +GRG FG + K H ++ A+K++ K +M R E +L ++
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMK---HTERIYAMKILNKWEMLKRAETACFREERNVL--VN 57
Query: 196 GHSN-LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
G + + AF+D + +Y+VM+ GG+LL + + ED A+ + +++ +
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND--IVGSAYYVAPEV 312
H VHRD+KP+N L D + ++ DFG + D + VG+ Y++PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 313 LHR------SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366
L YG E D WS+GV Y +L G PF+A + + ++ + F +PS
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF---QFPS 231
Query: 367 ----LSSDAKDFVKLLLNKDPRK 385
+S +AKD ++ L+ R+
Sbjct: 232 HITDVSEEAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 80/298 (26%), Positives = 122/298 (40%), Gaps = 49/298 (16%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
++G G +G AR K + VA+K + + +R E+KILR L+ H N+
Sbjct: 14 QIGEGTYGQVYKARDK---DTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLN-HRNI 68
Query: 201 VKFYDAFEDLD----------NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
V + D Y+V E + +L+ + S +SED K+ + Q+L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER--LNDIVGSAYYV 308
+ +CH +HRD+K N L +K Q+K DFGL+ +E + V + +Y
Sbjct: 128 GLNYCHKKNFLHRDIKCSNILLNNK---GQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 309 APEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366
PE+L YG DVWS G I L F A E + + S WP
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244
Query: 367 --------------------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
+ + A D + +L DP KR TA +AL+ PW+
Sbjct: 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 82/276 (29%), Positives = 134/276 (48%), Gaps = 24/276 (8%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKV-AIKVIPKSKMTTAIAVEDVRREVKILRALS 195
+V + +GRG FG R+K QKV A+K++ K +M E I+ A +
Sbjct: 46 DVVKVIGRGAFGEVQLVRHKS----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFA 100
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255
+V+ + AF+D +Y+VME GG+L++ L E AK +++ +
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 256 HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE----RLNDIVGSAYYVAPE 311
H G++HRD+KP+N L D+ LK DFG ++ DE R + VG+ Y++PE
Sbjct: 159 HSMGLIHRDVKPDNMLL---DKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPE 213
Query: 312 VLHRS-----YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366
VL YG E D WS+GV + +L G PF+A + G + ++ S +
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273
Query: 367 LSSDAKDFV-KLLLNKDPR-KRMTAAQALSHPWIRN 400
+S AK+ + L +++ R R + HP+ +N
Sbjct: 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 6e-22
Identities = 72/254 (28%), Positives = 122/254 (48%), Gaps = 18/254 (7%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
E+ + +GRG FG + K D+ A+K++ K +M R E +L ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVL--VN 57
Query: 196 GHSN-LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
G + + + AF+D +N+Y+VM+ GG+LL + + ED A+ L +++ +
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND--IVGSAYYVAPEV 312
H VHRD+KP+N L D + ++ DFG + D + VG+ Y++PE+
Sbjct: 118 VHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 313 LHR------SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-DGSWP 365
L YG E D WS+GV Y +L G PF+A + + ++ F
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234
Query: 366 SLSSDAKDFVKLLL 379
+S DAKD ++ L+
Sbjct: 235 DVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 34/292 (11%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKV-AIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
+G+G FG A++K D K A+KV+ K + + + E +L H L
Sbjct: 3 IGKGSFGKVLLAKHKA----DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
V + +F+ D +Y V++ GGEL L R + E A+ +I + + + H +
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YG 318
++RDLKPEN L D + DFGL + + + + G+ Y+APEVL + Y
Sbjct: 118 IYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
D W +G + Y +L G PF++R + ++ +L P++S A+ ++ L
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGL 230
Query: 379 LNKDPRKRMTAAQAL----SHPWIRNYN---------------NVKVPLDIS 411
L KD KR+ A +H + + N NV P+D+
Sbjct: 231 LQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLK 282
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 9e-22
Identities = 71/250 (28%), Positives = 116/250 (46%), Gaps = 13/250 (5%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG A+ K A+KV+ K + + E +L H LV
Sbjct: 3 IGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ +F+ + +Y V++ GGEL L R + E A+ ++ + + + H ++
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YGT 319
+RDLKPEN L D + DFGL + V P+E + G+ Y+APEVL + Y
Sbjct: 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D W +G + Y +L G PF++R S ++ +L + A D + LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLL 231
Query: 380 NKDPRKRMTA 389
+KD R+R+ A
Sbjct: 232 HKDQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 9e-22
Identities = 82/276 (29%), Positives = 131/276 (47%), Gaps = 33/276 (11%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
E+ + +G G +G AR + + AIKVI K+ V++E+ +++
Sbjct: 11 FELIQRIGSGTYGDVYKAR---NVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCK 64
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255
HSN+V ++ ++ D ++I ME C GG L D I G SE + V + L + +
Sbjct: 65 -HSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYL 122
Query: 256 HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEV-- 312
H G +HRD+K N L T ++ +K DFG+S + + +G+ Y++APEV
Sbjct: 123 HSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179
Query: 313 LHRS--YGTEADVWSIGVIAYIL---------LCGSRPFWARTESGIFRAVLKADPSFDD 361
+ R Y D+W++G+ A L L R + T+S LK D
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK-----DK 234
Query: 362 GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
W S+ FVK+ L K+P+KR TA + L HP+
Sbjct: 235 MKW---SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 83/302 (27%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
E+ R ++VG G +G C+A K+ +KVAIK + + + I + RE+ +
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRP-FQSEIFAKRAYRELTL 67
Query: 191 LRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
L+ + H N++ D F ++ + Y+VM + L +I+ SED+ + +
Sbjct: 68 LKHMQ-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH--PLSEDKVQYL 122
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
+ Q+L + + H G++HRDLKP N + +E +LK +DFGL+ D + V +
Sbjct: 123 VYQMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVT 177
Query: 305 AYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----PS 358
+Y APEV+ Y D+WS+G I +L G F + +LK P
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237
Query: 359 F----DDGS-------------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
F +D + +P S A D ++ +L D KR+TA +AL H
Sbjct: 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297
Query: 396 PW 397
P+
Sbjct: 298 PY 299
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 79/276 (28%), Positives = 124/276 (44%), Gaps = 21/276 (7%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
E+G G FG AR + + VAIK + S + +D+ +EV+ L+ L H N
Sbjct: 22 EIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNT 77
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
+++ + ++VME C G D + E E AV L +A+ H H +
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 316
+HRD+K N L + E +K DFG + + P N VG+ Y++APEV+
Sbjct: 137 IHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQ 190
Query: 317 YGTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
Y + DVWS+G+ I L +P F S ++ P+ G W S ++F
Sbjct: 191 YDGKVDVWSLGITC-IELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNF 246
Query: 375 VKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDI 410
V L K P+ R T+ L H ++ V +D+
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 81/296 (27%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
++ EV VG G +G R+K+ + VAIK S+ + E RE+K+LR
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEENEEVK-ETTLRELKMLRT 56
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGG--ELLDRILSRCGKYSEDEAKAVLVQILNV 251
L N+V+ +AF +Y+V E E ELL+ + + ++ ++ + Q++
Sbjct: 57 LK-QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV---PPEKVRSYIYQLIKA 112
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP--DERLNDIVGSAYYVA 309
+ +CH + +VHRD+KPEN L + D LK DFG + + + + V + +Y +
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169
Query: 310 PEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-------------- 354
PE+L + YG D+WS+G I L G F +E + K
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229
Query: 355 ADPSFDDGSWPS--------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396
++P F +P+ LS D +K LL +P R Q L+HP
Sbjct: 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 85/299 (28%), Positives = 135/299 (45%), Gaps = 22/299 (7%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
E+G G FG AR + ++ VAIK + S + +D+ +EVK L+ + H N
Sbjct: 32 EIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNS 87
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
+++ + ++VME C G D + E E A+ L +A+ H H +
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 316
+HRD+K N L T E Q+K DFG + P N VG+ Y++APEV+
Sbjct: 147 IHRDIKAGNILLT---EPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQ 200
Query: 317 YGTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
Y + DVWS+G I I L +P F S ++ P+ W S ++F
Sbjct: 201 YDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNF 256
Query: 375 VKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKAL 433
V L K P+ R T+ + L H ++ V +D+ I + A + +L+ +K L
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDL-IQRTKDAVRELDNLQYRKMKKL 314
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 91/322 (28%), Positives = 135/322 (41%), Gaps = 78/322 (24%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVI--PKSKMT----TAIAVEDVRREVKILRAL 194
+GRG +G A+ K G+ ++ AIK K + T +A RE+ +LR L
Sbjct: 7 CIGRGTYGRVYKAKRKNGK-DGKEYAIKKFKGDKEQYTGISQSAC------REIALLREL 59
Query: 195 SGHSNLVKFYDAF-EDLD-NVYIVMELCEGGELLDRIL--SRCGKYSEDEA--KAVLVQI 248
H N+V + F E D +VY++ + E +L I + + S + K++L QI
Sbjct: 60 K-HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSK-DESSQLKAIDFGLSDFV----RPDERLNDIVG 303
LN V + H + V+HRDLKP N L + E +K D GL+ +P L+ +V
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 304 SAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTES-------------GI 348
+ +Y APE+L R Y D+W+IG I LL F R I
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237
Query: 349 FRAVLKADPSFDDGSWPSL---------------------------------SSDAKDFV 375
F + P+ D WP + S D +
Sbjct: 238 FE--VLGTPTEKD--WPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLL 293
Query: 376 KLLLNKDPRKRMTAAQALSHPW 397
+ LL DP KR+TA +AL HP+
Sbjct: 294 RKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 75/271 (27%), Positives = 130/271 (47%), Gaps = 35/271 (12%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVED--VRREVKILRALSGHSN 199
VG+G +G R++ D K VI K + A E +E ++L L H N
Sbjct: 8 VGKGSYGEVSLVRHRT----DGKQY--VIKKLNLRNASRRERKAAEQEAQLLSQLK-HPN 60
Query: 200 LVKFYDAFEDLDN-VYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAFCHL 257
+V + +++E D +YIVM CEGG+L ++ + GK E++ VQI + + H
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND----IVGSAYYVAPEVL 313
++HRDLK +N T ++ +K D G++ R E D ++G+ YY++PE+
Sbjct: 121 KHILHRDLKTQNVFLT---RTNIIKVGDLGIA---RVLENQCDMASTLIGTPYYMSPELF 174
Query: 314 -HRSYGTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDDGSWPSLSSDA 371
++ Y ++DVW++G Y + F A+ S ++R + +G P + D
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII--------EGKLPPMPKDY 226
Query: 372 K----DFVKLLLNKDPRKRMTAAQALSHPWI 398
+ + +L+K P KR + L P+I
Sbjct: 227 SPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 28/275 (10%)
Query: 142 VGRGHFGYTCTARYKK-GE-HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+G+G FG C + K G+ + +K+ K + K K E K +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNE------KKILEKVSSRF 54
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH- 258
+V AFE D++ +VM L GG+L I G+ EA+A+ + HLH
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHI-YNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 259 -GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS- 316
+V+RDLKPEN L D+ ++ D GL+ ++ +++ G+ Y+APEVL
Sbjct: 114 RRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTES----GIFRAVLKADPSFDDGSWPSLSSDAK 372
Y D +++G Y ++ G PF R E + R L+ + D S +AK
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD----KFSPEAK 226
Query: 373 DFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
D + LL KDP KR+ +A + HP ++ N
Sbjct: 227 DLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (238), Expect = 7e-21
Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 46/302 (15%)
Query: 134 SRL---EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREV 188
SRL EV +++G G FG ++K+ + + ++ + + + + + + +V RE+
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL 69
Query: 189 KILRALSGHSNLVKFYDAFEDLDN--VYIVMELCEGGELLDRILSRC----GKYSEDEAK 242
K H N+V++ D F + N +YI+ME C+ G+L R + +C GK E
Sbjct: 70 K-------HKNIVRYIDRFLNKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEHAIV 121
Query: 243 AVLVQILNVVAFCHL-------HGVVHRDLKPEN-FLYTSKDESSQLKAI---------- 284
+ Q+L+ +A+CH V+HRDLKP+N FL T ++ A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 285 ---DFGLSDFVRPDERLNDIVGSAYYVAPEVL---HRSYGTEADVWSIGVIAYILLCGSR 338
DFGLS + + + VG+ YY +PE+L +SY ++D+W++G I Y L G
Sbjct: 182 KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 339 PFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
PF + LK P D S + +K LLN ++R +A Q L + I
Sbjct: 242 PFHKANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298
Query: 399 RN 400
+N
Sbjct: 299 KN 300
|
Length = 1021 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-21
Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 39/283 (13%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
LE ++G G+ G ++ K + + KS + I RE++I+
Sbjct: 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQIL-----RELQIMHEC- 60
Query: 196 GHSN-LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
S +V FY AF + +N+ + ME + G L DRI + G + + V ++ + +
Sbjct: 61 -RSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 255 CH-LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI----VGSAYYVA 309
+ +H ++HRD+KP N L S+ Q+K DFG+S E +N I VG++ Y++
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSR---GQIKLCDFGVS-----GELINSIADTFVGTSTYMS 170
Query: 310 PEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES--------GIF----RAVLKAD 356
PE + Y ++DVWS+G+ L G PF GI + V +
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230
Query: 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQAL-SHPWI 398
P +P D +DFV L KDP +R T Q P+I
Sbjct: 231 PRLPSSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 81/284 (28%), Positives = 127/284 (44%), Gaps = 56/284 (19%)
Query: 155 YK-KGEHKDQKVAIKVI----PKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209
YK + + Q VA+K I + TAI RE +L+ L H+N+V +D
Sbjct: 22 YKGRSKLTGQLVALKEIRLEHEEGAPFTAI------REASLLKDLK-HANIVTLHDIIHT 74
Query: 210 LDNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPE 268
+ +V E + L + + CG S + L Q+L +A+CH V+HRDLKP+
Sbjct: 75 KKTLTLVFEYLDTD--LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQ 132
Query: 269 NFLYTSKDESSQLKAIDFGLSDFVR----PDERLNDIVGSAYYVAPEVLHRS--YGTEAD 322
N L + + E LK DFGL+ R P + ++ V + +Y P+VL S Y T D
Sbjct: 133 NLLISERGE---LKLADFGLA---RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLD 186
Query: 323 VWSIGVIAYILLCGSRPFWARTESG-----IFRAV----------LKADPSFDDGS---- 363
+W +G I Y + G F T+ IFR + + ++P F S
Sbjct: 187 MWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFY 246
Query: 364 --------WPSLS--SDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
P L ++ L +P+KR++AA+A+ HP+
Sbjct: 247 PPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 9e-21
Identities = 81/274 (29%), Positives = 124/274 (45%), Gaps = 44/274 (16%)
Query: 163 QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE--DLD---NVYIVM 217
++VA+K +P ++ + V RE+K+L H N++ D + +D +Y+V
Sbjct: 26 KRVALKKMPNV-FQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEIYVVT 83
Query: 218 ELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277
EL + L +I+ S D K L QIL + + H G++HRD+KP N L S
Sbjct: 84 ELMQSD--LHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS--- 138
Query: 278 SSQLKAIDFGLSDFVRPDERLNDI--VGSAYYVAPEVL--HRSYGTEADVWSIGVIAYIL 333
+ LK DFGL+ PDE + V + YY APE+L R Y + D+WS+G I L
Sbjct: 139 NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198
Query: 334 LCGSRPFWARTESGIFRAV--LKADPSFDDGSW----------------PSLSS------ 369
L F A++ + L PS + PSL
Sbjct: 199 LGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSS 258
Query: 370 ----DAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
+A + +L DP KR++AA AL+HP++
Sbjct: 259 QATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-20
Identities = 82/278 (29%), Positives = 136/278 (48%), Gaps = 38/278 (13%)
Query: 139 GEEVGRGHFG--YTC----TARYKKGEHKDQKVAIKVIP--KSKMTTAIAVEDVRREVKI 190
G+ +GRG FG Y C T R ++A+K +P T+ V + E+++
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGR---------ELAVKQVPFDPDSQETSKEVNALECEIQL 57
Query: 191 LRALSGHSNLVKFYDAFEDLDN--VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI 248
L+ L H +V++Y D + + I +E GG + D+ L G +E+ + QI
Sbjct: 58 LKNLR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ-LKAYGALTENVTRRYTRQI 115
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR----PDERLNDIVGS 304
L V++ H + +VHRD+K N L +D + +K DFG S ++ + + G+
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 305 AYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE--SGIFR-AVLKADPSFD 360
Y+++PEV+ YG +ADVWS+ +L +P WA E + IF+ A P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIFKIATQPTKPMLP 231
Query: 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
DG +S +DF+K + ++ R R TA L HP++
Sbjct: 232 DG----VSDACRDFLKQIFVEEKR-RPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 24/221 (10%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
S L + +E+G G FG + + +KVAIK I + M+ ED E +++
Sbjct: 4 SELTLVQEIGSGQFGLV----WLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMK 55
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNV-- 251
LS H LV+ Y + + +V E E G L D + ++ GK+S + +L L+V
Sbjct: 56 LS-HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFS---QETLLGMCLDVCE 111
Query: 252 -VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV-- 308
+A+ V+HRDL N L E+ +K DFG++ FV D++ G+ + V
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKW 167
Query: 309 -APEVLHRS-YGTEADVWSIGVIAYILLC-GSRPFWARTES 346
+PEV S Y +++DVWS GV+ + + G P+ R+ S
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-20
Identities = 69/243 (28%), Positives = 105/243 (43%), Gaps = 18/243 (7%)
Query: 163 QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN-VYIVMELCE 221
+VAIK++ RRE + L H N+V D+ E ++ V E
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281
G L + L+ G E +++Q+L+ +A H G+VHRDLKP+N + +
Sbjct: 63 GRTLREV-LAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 282 KAIDFG----LSDFVRPDE----RLNDIVGSAYYVAPEVLHRSYGT-EADVWSIGVIAYI 332
K +DFG L D R +++G+ Y APE L T +D+++ G+I
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 333 LLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL--SSDAKDFVKLLLNKDPRKRMTAA 390
L G R + + I L S D S P ++ LNKDPR+R +A
Sbjct: 182 CLTGQRVVQGASVAEILYQQL----SPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASA 237
Query: 391 QAL 393
AL
Sbjct: 238 PAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 83/295 (28%), Positives = 126/295 (42%), Gaps = 45/295 (15%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
E++G G +G AR K + VA+K + +M RE+ +L+ LS
Sbjct: 7 EKIGEGTYGKVYKARDKN---TGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 200 LVKFYDAFEDLDN------VYIVMELCEGGELLDRILSRCGKYS----EDEAKAVLVQIL 249
+V+ D E ++ +Y+V E + +L + S K+ + Q+L
Sbjct: 63 IVRLLDV-EHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYV 308
VA CH HGV+HRDLKP+N L + LK D GL F P + + + +Y
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR 178
Query: 309 APEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTES----GIFR-----------A 351
APEVL Y T D+WS+G I + F +E IF+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 352 VLKADPSFDDGSW---------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
V K + W P LS + D ++ +L DP KR++A AL+HP+
Sbjct: 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-20
Identities = 81/259 (31%), Positives = 122/259 (47%), Gaps = 25/259 (9%)
Query: 157 KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIV 216
+G +KV K + + A R E+ L A H +VK +D F+ D + ++
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYA---RSELHCLAACD-HFGIVKHFDDFKSDDKLLLI 143
Query: 217 MELCEGGELLDRILSRCGK---YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273
ME GG+L +I R + + E E + QI+ + H ++HRDLK N
Sbjct: 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM 203
Query: 274 SKDESSQLKAIDFGLS----DFVRPDERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGV 328
+ +K DFG S D V D + G+ YY+APE+ R Y +AD+WS+GV
Sbjct: 204 P---TGIIKLGDFGFSKQYSDSVSLDVA-SSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 329 IAYILLCGSRPFWARTESGIFRAVL--KADPSFDDGSWP-SLSSDAKDFVKLLLNKDPRK 385
I Y LL RPF ++ I + VL K DP +P +SS K + LL+K+P
Sbjct: 260 ILYELLTLHRPFKGPSQREIMQQVLYGKYDP------FPCPVSSGMKALLDPLLSKNPAL 313
Query: 386 RMTAAQALSHPWIRNYNNV 404
R T Q L +++ N+
Sbjct: 314 RPTTQQLLHTEFLKYVANL 332
|
Length = 478 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 19/268 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKV-AIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
+G+G FG A+ K D K A+KV+ K + + + E +L H L
Sbjct: 3 IGKGSFGKVLLAKRKL----DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL 58
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
V + +F+ + +Y V++ GGEL L R + E A+ +I + + + H +
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YG 318
V+RDLKPEN L D + DFGL + + + G+ Y+APEV+ + Y
Sbjct: 118 VYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
D W +G + Y +L G PF+ R + ++ +L P S A ++ L
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEEL 230
Query: 379 LNKDPRKRMTAAQAL----SHPWIRNYN 402
L KD ++R+ A + HP+ + +
Sbjct: 231 LEKDRQRRLGAKEDFLEIQEHPFFESLS 258
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-20
Identities = 70/265 (26%), Positives = 127/265 (47%), Gaps = 26/265 (9%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ + +++GRG F A VA+K + + A A D +E+ +L+
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 58
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV--------L 245
L+ H N++K+Y +F + + + IV+EL + G+ LSR K+ + + + +
Sbjct: 59 LN-HPNVIKYYASFIEDNELNIVLELADAGD-----LSRMIKHFKKQKRLIPEKTVWKYF 112
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER-LNDIVGS 304
VQ+ + + H V+HRD+KP N T+ + +K D GL F + +VG+
Sbjct: 113 VQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 305 AYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363
YY++PE +H + Y ++D+WS+G + Y + PF+ + ++ K D
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPP 227
Query: 364 WPS--LSSDAKDFVKLLLNKDPRKR 386
PS S + + V + +N DP KR
Sbjct: 228 LPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 81/296 (27%), Positives = 129/296 (43%), Gaps = 49/296 (16%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG FG + K H A+K++ K+ M V +R E IL G + +V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHI---YAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVV 64
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
K + +F+D N+Y++ME GG+++ ++ + SE+ + + + + + H G +
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFI 123
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL---------------------SDFV-------R 293
HRD+KP+N L +K +K DFGL SDF R
Sbjct: 124 HRDIKPDNLLLDAK---GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 294 PDERLN--------DIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWART 344
E VG+ Y+APEV ++ Y D WS+GVI Y +L G PF + T
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 345 ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAA---QALSHPW 397
+R V+ + +S AKD + L D R+ + + SHP+
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLI-LRFCTDSENRIGSNGVEEIKSHPF 295
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 78/269 (28%), Positives = 131/269 (48%), Gaps = 22/269 (8%)
Query: 139 GEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
G+ +G+G FG Y C E ++V P+S T+ V + E+++L+ L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFD--PESPETSK-EVSALECEIQLLKNLQ- 62
Query: 197 HSNLVKFYDAFEDL--DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H +V++Y D + I ME GG + D+ L G +E + QIL +++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ-LKAYGALTESVTRKYTRQILEGMSY 121
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR----PDERLNDIVGSAYYVAP 310
H + +VHRD+K N L +D + +K DFG S ++ + + G+ Y+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 311 EVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LS 368
EV+ YG +ADVWS+G +L +P WA E+ A+ K + PS +S
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEA--MAAIFKIATQPTNPQLPSHIS 235
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
A+DF+ + + R R +A + L HP+
Sbjct: 236 EHARDFLGCIF-VEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 83/310 (26%), Positives = 132/310 (42%), Gaps = 51/310 (16%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
R ++ E +G+G +G C+A H +KVAIK I + A + RE+K+LR L
Sbjct: 1 RYKIQEVIGKGSYGVVCSA---IDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLL 56
Query: 195 SGHSNLVKFYDAF-----EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL 249
H ++V+ + ++Y+V EL E L +++ + + + L Q+L
Sbjct: 57 R-HPDIVEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHHQFFLYQLL 113
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER----LNDIVGSA 305
+ + H V HRDLKP+N L + +LK DFGL+ D D V +
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 306 YYVAPEV---LHRSYGTEADVWSIGVIAYILLCGSRPFW--------------------- 341
+Y APE+ Y D+WSIG I +L G +P +
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 342 ---ARTESGIFRAVL----KADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394
+R + R L K P +P+ A ++ LL DP+ R TA +AL+
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289
Query: 395 HPWIRNYNNV 404
P+ + V
Sbjct: 290 DPYFKGLAKV 299
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 77/273 (28%), Positives = 130/273 (47%), Gaps = 33/273 (12%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E+ + VG G +G AR H + A+K+I K+ +++E+ +++
Sbjct: 12 ELIQRVGSGTYGDVYKAR---NLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECK- 64
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H N+V ++ ++ + ++I ME C GG L D I G SE + V + L +A+ H
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVL-- 313
G +HRD+K N L T ++ +K DFG++ + + +G+ Y++APEV
Sbjct: 124 SKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 314 --HRSYGTEADVWSIGVIAYIL---------LCGSRPFWARTESGIFRAVLKADPSFDDG 362
+ Y D+W++G+ A L L R + ++S LK D
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK-----DKT 235
Query: 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
W SS +FVK+ L K+P+KR TA + L+H
Sbjct: 236 KW---SSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 82/312 (26%), Positives = 135/312 (43%), Gaps = 59/312 (18%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG R + + + A+K + KS+M + V+ E +L A S +V
Sbjct: 9 IGKGAFG---EVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL-AESDSPWVV 64
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
Y +F+D +Y++ME GG+L+ +L + +SED + + + + + H G +
Sbjct: 65 SLYYSFQDAQYLYLIMEFLPGGDLMT-MLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLSD----------FVRP----------DERLNDI 301
HRD+KP+N L D +K DFGLS + + D R +
Sbjct: 124 HRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 302 VGS---------------------AY-------YVAPEV-LHRSYGTEADVWSIGVIAYI 332
V S AY Y+APE+ L + YG E D WS+G I +
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 333 LLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFV-KLLLNKDPR-KRMTAA 390
L G PF + +R ++ + LS +A+D + +L+ N + R R A
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAH 300
Query: 391 QALSHPWIRNYN 402
+ SHP+ R +
Sbjct: 301 EIKSHPFFRGVD 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 85/307 (27%), Positives = 130/307 (42%), Gaps = 59/307 (19%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G G FG C A K H A+K + K + V V+ E IL A + + +V
Sbjct: 9 LGIGAFGEVCLAC-KVDTHA--LYAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNEWVV 64
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
K Y +F+D DN+Y VM+ GG+++ +L R + E A+ + ++ + H G +
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL--------------------SDFVRPDERLNDI 301
HRD+KP+N L D +K DFGL D + P + +D+
Sbjct: 124 HRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 302 ----------------------------VGSAYYVAPEVLHRS-YGTEADVWSIGVIAYI 332
VG+ Y+APEVL R Y D WS+GVI +
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 333 LLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFV-KLLLNKDPR-KRMTAA 390
+L G PF A T + V+ + + LS +A D + KL + + R R A
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300
Query: 391 QALSHPW 397
+HP+
Sbjct: 301 DIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 69/229 (30%), Positives = 110/229 (48%), Gaps = 20/229 (8%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQ-KVAIKVIPKSKMTTAIAVEDVRREVKILR 192
S L +E+G G FG G+ + Q KVAIK I + M+ ED E K++
Sbjct: 4 SELTFMKELGSGQFGVV-----HLGKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMM 54
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
LS H LV+ Y +YIV E E G LL+ + R GK S+D ++ + +
Sbjct: 55 KLS-HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV---A 309
+ + +HRDL N L +S + +K DFG++ +V DE + G+ + V
Sbjct: 114 EYLERNSFIHRDLAARNCLVSS---TGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSP 169
Query: 310 PEVLHRS-YGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKAD 356
PEV + S Y +++DVWS GV+ + + G PF ++ + + +
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 57/273 (20%)
Query: 172 KSKMT-TAIAVEDVR------------REVKILRALSGHSNLVKFYDAFEDLDNVYIVME 218
+SK+T +A++++R REV +L+ L H+N+V +D + +V E
Sbjct: 25 RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLVFE 83
Query: 219 LCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277
+ L + L CG S K + Q+L +++CH ++HRDLKP+N L K E
Sbjct: 84 YLDSD--LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE 141
Query: 278 SSQLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILL 334
LK DFGL+ P + ++ V + +Y P+VL S Y T D+W +G I Y +
Sbjct: 142 ---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMA 198
Query: 335 CGSRPFWARTESG----IFRAVLKADPSFDDGSWPS------------------------ 366
G F T IFR L P+ + +WP
Sbjct: 199 TGRPMFPGSTVKEELHLIFR--LLGTPTEE--TWPGITSNEEFRSYLFPQYRAQPLINHA 254
Query: 367 --LSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
L +D D + LL + + R++A AL H +
Sbjct: 255 PRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 82/297 (27%), Positives = 120/297 (40%), Gaps = 42/297 (14%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+ E E+G G +G AR H VA+K + + + VR EV +L+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKAR---DPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRL 56
Query: 195 SG--HSNLVKFYDAFEDLDN-----VYIVMELCEGGELLDRILSRCGK--YSEDEAKAVL 245
H N+V+ D V +V E + + L L + + K ++
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD--QDLRTYLDKVPPPGLPAETIKDLM 114
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
Q L + F H + +VHRDLKPEN L TS Q+K DFGL+ L +V +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIYSCQMALTPVVVTL 171
Query: 306 YYVAPEVLHRS-YGTEADVWSIGVI------AYILLCG-----------------SRPFW 341
+Y APEVL +S Y T D+WS+G I L CG W
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231
Query: 342 ARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
R + A P P + + +L +P KR++A +AL HP+
Sbjct: 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 49/269 (18%)
Query: 172 KSKMT-TAIAVEDVR------------REVKILRALSGHSNLVKFYDAFEDLDNVYIVME 218
+SK+T +A++++R REV +L+ L H+N+V +D ++ +V E
Sbjct: 26 RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLVFE 84
Query: 219 LCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277
+ L + L CG + K L Q+L + +CH V+HRDLKP+N L + E
Sbjct: 85 YLDKD--LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE 142
Query: 278 SSQLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILL 334
LK DFGL+ P + ++ V + +Y P++L S Y T+ D+W +G I Y +
Sbjct: 143 ---LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199
Query: 335 CGSRPFWARTESGIFRAVLKADPSFDDGSWPS--------------------------LS 368
G F T + + + + +WP L
Sbjct: 200 TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLD 259
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
SD + + LL + RKR++A +A+ HP+
Sbjct: 260 SDGAELLSKLLQFEGRKRISAEEAMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 24/273 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG C + + + A K + K ++ E +IL ++ +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVV 63
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL--VQILNVVAFCHLHG 259
A+E D + +V+ + GG+L I + G DE +A+ ++ +
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRER 122
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYG 318
+V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEV+ + Y
Sbjct: 123 IVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
D W +G + Y ++ G PF R E + R V + + + S DAK
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE----KFSEDAKSI 235
Query: 375 VKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
++LL K+P++R+ AA HP +N N
Sbjct: 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 83/308 (26%), Positives = 130/308 (42%), Gaps = 66/308 (21%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVI--PKSKMTTAIAVEDVRREVKILRALSGHSN 199
+G G G C A Q VAIK + P +T A + RE+ +++ ++ H N
Sbjct: 24 IGSGAQGIVCAAYDTV---TGQNVAIKKLSRPFQNVTHA---KRAYRELVLMKLVN-HKN 76
Query: 200 LVKFYDAF------EDLDNVYIVMELCEGG--ELLDRILSRCGKYSEDEAKAVLVQILNV 251
++ + F E+ +VY+VMEL + +++ L + +L Q+L
Sbjct: 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD------HERMSYLLYQMLCG 130
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 311
+ H G++HRDLKP N + S LK +DFGL+ + V + YY APE
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 187
Query: 312 V-LHRSYGTEADVWSIGVIAYILLCGSRPF--------WAR------TESGIFRAVLKA- 355
V L Y D+WS+G I ++ G+ F W + T S F + L+
Sbjct: 188 VILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247
Query: 356 ----------------DPSFDDGSWPSLS--------SDAKDFVKLLLNKDPRKRMTAAQ 391
+ F D +P S S A+D + +L DP KR++
Sbjct: 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307
Query: 392 ALSHPWIR 399
AL HP+I
Sbjct: 308 ALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 77/274 (28%), Positives = 136/274 (49%), Gaps = 28/274 (10%)
Query: 138 VGEEVGRGHFG--YTCTARYKKGEHKDQKVA-IKVIPKSKMTTAIAVEDVRREVKILRAL 194
+G+ +G+G FG Y C Y ++ V ++ P+S T+ V + E+++L+ L
Sbjct: 6 LGKLLGQGAFGRVYLC---YDADTGRELAVKQVQFDPESPETSK-EVNALECEIQLLKNL 61
Query: 195 SGHSNLVKFYDAFEDL--DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
H +V++Y D + I ME GG + D++ S G +E+ + QIL V
Sbjct: 62 L-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGV 119
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR----PDERLNDIVGSAYYV 308
++ H + +VHRD+K N L +D +K DFG S ++ + + G+ Y++
Sbjct: 120 SYLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 309 APEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE--SGIFR-AVLKADPSFDDGSW 364
+PEV+ YG +AD+WS+G +L +P WA E + IF+ A +P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIATQPTNPVLP---- 231
Query: 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
P +S +DF+K + + + R +A + L H ++
Sbjct: 232 PHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 67/252 (26%), Positives = 117/252 (46%), Gaps = 30/252 (11%)
Query: 159 EHK-DQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVM 217
+HK QK+ ++ I K+K AI E + + + + N +K Y + L ++M
Sbjct: 36 KHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88
Query: 218 ELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277
+ + G+L D +L + GK SE E K ++ Q++ + H H ++H D+K EN LY
Sbjct: 89 DYIKDGDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA-- 145
Query: 278 SSQLKAIDFGLSDFVRPDERLNDIVG--SAY-----YVAPE-VLHRSYGTEADVWSIGVI 329
++ D+GL I+G S Y Y +PE + +Y D W++GV+
Sbjct: 146 KDRIYLCDYGLC----------KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVL 195
Query: 330 AYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTA 389
Y LL G PF + + L ++S +A DFV+ +L + R+T
Sbjct: 196 TYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTN 255
Query: 390 -AQALSHPWIRN 400
+ + HP+++
Sbjct: 256 YNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 86/335 (25%), Positives = 132/335 (39%), Gaps = 101/335 (30%)
Query: 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQK--VAIKVI----PKSKM-TTAIAVEDVR 185
E+ ++G G FG K VA+K I K TA+
Sbjct: 7 LRDYEILGKLGEGTFG-----EVYKARQIKTGRVVALKKILMHNEKDGFPITAL------ 55
Query: 186 REVKILRALSGHSNLVKFYD-AFEDLDN-------VYIVM-----ELCEGGELLD--RIL 230
RE+KIL+ L H N+V D A E D VY+V +L LL+ +
Sbjct: 56 REIKILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG---LLENPSV- 110
Query: 231 SRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290
K +E + K ++Q+L + + H + ++HRD+K N L D LK DFGL+
Sbjct: 111 ----KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA- 162
Query: 291 FVRP---------------DERLNDIVGSAYYVAPEVL--HRSYGTEADVWSIGVIAYIL 333
RP + ++V + +Y PE+L R Y T D+W IG + +
Sbjct: 163 --RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220
Query: 334 LCGSRP-FWARTE----SGIFRAVLKADPSFDDGSWP----------------------- 365
RP +++ IF+ P+ + +WP
Sbjct: 221 FTR-RPILQGKSDIDQLHLIFKLC--GTPT--EETWPGWRSLPGCEGVHSFTNYPRTLEE 275
Query: 366 ---SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
L + D + LL+ DP KR+TA+ AL HP+
Sbjct: 276 RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 24/273 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG C + + + A K + K ++ E +IL ++ +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF-VV 63
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG-- 259
A+E D + +V+ L GG+L I + G DE +AV LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLHRER 122
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYG 318
+V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEV+ + Y
Sbjct: 123 IVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYT 179
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
D W +G + Y ++ G PF R E + R V + + + S A+
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE----KFSEAARSI 235
Query: 375 VKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
+ LL KDP R+ A + +HP+ R N
Sbjct: 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 73/313 (23%), Positives = 124/313 (39%), Gaps = 71/313 (22%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGE--------HKDQKVAIKVIPKSKMTTAIAVEDVRRE 187
E E+G G+ G ++ H + K AI+ + RE
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIR-------------NQIIRE 49
Query: 188 VKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQ 247
+K+L + +V FY AF + I ME +GG L D++L + G+ E+ + +
Sbjct: 50 LKVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIA 107
Query: 248 ILNVVAFCHL---HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
+L +L H ++HRD+KP N L S+ E +K DFG+S + D N VG+
Sbjct: 108 VLR--GLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGT 161
Query: 305 AYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363
Y++PE L + Y ++D+WS+G+ + G P + + P + +
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL--EAMFGRPVSEGEA 219
Query: 364 WPSL------------------------------------SSDAKDFVKLLLNKDPRKRM 387
S S + +DFV L K+P++R
Sbjct: 220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA 279
Query: 388 TAAQALSHPWIRN 400
+ HP+I+
Sbjct: 280 DLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 59/293 (20%)
Query: 172 KSKMT-TAIAVEDVR------------REVKILRALSGHSNLVKFYDAFEDLDNVYIVME 218
+SK+T +A++++R REV +L+ L H+N+V +D ++ +V E
Sbjct: 26 RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLVFE 84
Query: 219 LCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277
+ L + + CG S K L QIL +A+CH V+HRDLKP+N L +E
Sbjct: 85 YLDKD--LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NE 139
Query: 278 SSQLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILL 334
+LK DFGL+ P + ++ V + +Y P+VL S Y T+ D+W +G I + +
Sbjct: 140 RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMA 199
Query: 335 CGSRPFWARTESG----IFRAVLKADPSFDDGSWPSLSSDAK----DFVKL----LLNKD 382
G F T IFR L P+ + +WP +SS+ + +F K L+N
Sbjct: 200 SGRPLFPGSTVEDELHLIFR--LLGTPTEE--TWPGISSNDEFKNYNFPKYKPQPLINHA 255
Query: 383 PR------------------KRMTAAQALSHPWIRNYNNV--KVPLDISILKL 415
PR KR++A +A+ H + R+ +P ISI L
Sbjct: 256 PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPESISIFSL 308
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 72/269 (26%), Positives = 119/269 (44%), Gaps = 16/269 (5%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG C + + + A K + K ++ E +IL ++ +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF-VV 63
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG-- 259
A+E D + +V+ L GG+L I G+ +E +AV LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYG 318
+V+RDLKPEN L D+ ++ D GL+ V + + VG+ Y+APEV+ + Y
Sbjct: 123 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
D W++G + Y ++ G PF R + V + + S DA+ K+L
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239
Query: 379 LNKDPRKRM-----TAAQALSHPWIRNYN 402
L KDP++R+ A + HP + N
Sbjct: 240 LCKDPKERLGCQGGGAREVKEHPLFKQIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 74/271 (27%), Positives = 119/271 (43%), Gaps = 45/271 (16%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG FG + K H A+K++ K+ M V +R E IL + +V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHV---YAMKILRKADMLEKEQVGHIRAERDIL-VEADSLWVV 64
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
K + +F+D N+Y++ME GG+++ ++ + +E+E + + + + + H G +
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFI 123
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGL---------------------SDFV-------- 292
HRD+KP+N L SK +K DFGL SDF
Sbjct: 124 HRDIKPDNLLLDSK---GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 293 ------RPDERLN-DIVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCGSRPFWART 344
R +L VG+ Y+APEV + Y D WS+GVI Y +L G PF + T
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 345 ESGIFRAVLKADPSFDDGSWPSLSSDAKDFV 375
++ V+ + +S AKD +
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 76/260 (29%), Positives = 115/260 (44%), Gaps = 57/260 (21%)
Query: 186 REVKILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSED 239
RE+ +L+ ++ H N++ + F E+ +VY+VMEL +D L + D
Sbjct: 69 RELVLLKCVN-HKNIISLLNVFTPQKSLEEFQDVYLVMEL------MDANLCQVIHMELD 121
Query: 240 EAKA--VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER 297
+ +L Q+L + H G++HRDLKP N + S LK +DFGL+ +
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFM 178
Query: 298 LNDIVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCGSRPF--------WAR----- 343
+ V + YY APEV L Y D+WS+G I L+ GS F W +
Sbjct: 179 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238
Query: 344 -TESGIFRAVLKA-----------------DPSFDDGSWPSLS-------SDAKDFVKLL 378
T S F L+ + F D +PS S S A+D + +
Sbjct: 239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKM 298
Query: 379 LNKDPRKRMTAAQALSHPWI 398
L DP KR++ +AL HP+I
Sbjct: 299 LVIDPDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 44/231 (19%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQK--VAIKVIPKSKMTTAIAVEDVRREVKILRALSGH 197
E+G G FG E ++ K VA+K + + + A +D RE ++L H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELLTNF-QH 67
Query: 198 SNLVKFYDAFEDLDNVYIVMELCEGGEL-------------LDRILSRCGKYSEDEAKAV 244
N+VKFY + D +V E E G+L L S G+ + + +
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
VQI + + + VHRDL N L +K DFG+S D+ +
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMS---------RDVYTT 175
Query: 305 AYY------------VAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPFW 341
YY + PE +++R + TE+DVWS GV+ + I G +P++
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 70/241 (29%), Positives = 111/241 (46%), Gaps = 34/241 (14%)
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDN--VYIVMELCEGGELLDRILSRCGKYSEDEAKA 243
RE++ LR LS H N+++ + D + +V EL + L + I R E K+
Sbjct: 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKS 104
Query: 244 VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVG 303
+ Q+L + H +G+ HRD+KPEN L KD+ LK DFG + + +
Sbjct: 105 YMYQLLKSLDHMHRNGIFHRDIKPENILI--KDDI--LKLADFGSCRGIYSKPPYTEYIS 160
Query: 304 SAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWARTE----SGI--------- 348
+ +Y APE L YG + D+W++G + + +L F E + I
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220
Query: 349 -----FRAVLKADPSF--DDGSW-----PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396
FR + +F G+ P+ S++ D +K LL DP +R+TA QAL HP
Sbjct: 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
Query: 397 W 397
+
Sbjct: 281 Y 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 21/273 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN-L 200
+G+G FG + + + A K + K ++ E E +IL + HS +
Sbjct: 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSRFI 55
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHL 257
V AF+ ++ +VM + GG+L I + + E A QI++ + H
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH-R 315
+++RDLKPEN L D ++ D GL+ + + G+ ++APE+L
Sbjct: 116 RRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 316 SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP-SLSSDAKDF 374
Y D +++GV Y ++ PF AR E + LK D ++P S +K F
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSVTYPDKFSPASKSF 231
Query: 375 VKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
+ LL KDP KR+ +HP R+ N
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 58/199 (29%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
L++G +G+G FG G+++ QKVA+K + K T A A E ++ L
Sbjct: 8 LKLGATIGKGEFG-----DVMLGDYRGQKVAVKCL-KDDSTAAQAFLA---EASVMTTLR 58
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255
H NLV+ + +YIV E G L+D + SR G+ A+ + +
Sbjct: 59 -HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGME 116
Query: 256 HLHG--VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS--AYYVAPE 311
+L VHRDL N L E K DFGL+ + G + APE
Sbjct: 117 YLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPE 169
Query: 312 VL-HRSYGTEADVWSIGVI 329
L + + T++DVWS G++
Sbjct: 170 ALREKKFSTKSDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-17
Identities = 59/188 (31%), Positives = 96/188 (51%), Gaps = 16/188 (8%)
Query: 206 AFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDL 265
AF D + +++L GG+L LS+ G +SE E + +I+ + H VV+RDL
Sbjct: 65 AFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDL 123
Query: 266 KPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEAD 322
KP N L DE ++ D GL+ DF + ++ + VG+ Y+APEVL + +Y + AD
Sbjct: 124 KPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSAD 178
Query: 323 VWSIGVIAYILLCGSRPF---WARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
+S+G + + LL G PF + + I R L D S S + + ++ LL
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLL 234
Query: 380 NKDPRKRM 387
+D +R+
Sbjct: 235 QRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 46/239 (19%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+++G G FG + K VA+K + K++ + +D +E I+ +L H N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLD-HEN 57
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRI---------LSRCGKYSEDEAKAVLVQILN 250
L++ Y + +V EL G LLDR+ +S Y+ VQI N
Sbjct: 58 LIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA--------VQIAN 108
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV-- 308
+ + +HRDL N L S D ++K DFGL L +YV
Sbjct: 109 GMRYLESKRFIHRDLAARNILLASDD---KVKIGDFGLM------RALPQ--NEDHYVME 157
Query: 309 ----------APEVL-HRSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 355
APE L R++ +DVW GV + + G P+ + S I + + K
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE 216
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 9e-17
Identities = 84/302 (27%), Positives = 133/302 (44%), Gaps = 42/302 (13%)
Query: 113 GAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK 172
E A E K++ S+ + S G T T K + A+KV+
Sbjct: 21 AKDEATAKEQAKKYWISRVLGS-------------GATGTVLCAKRVSDGEPFAVKVVDM 67
Query: 173 SKMTTAIAVEDVRR---EVKILRALSGHSNLVKFYDAF--------EDLDNVYIVMELCE 221
M+ A D R EV L S +VK ++ F E++ + +V++
Sbjct: 68 EGMSEA----DKNRAQAEVCCLLNCDFFS-IVKCHEDFAKKDPRNPENVLMIALVLDYAN 122
Query: 222 GGELLDRILSRCGK---YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES 278
G+L I SR + E EA + +Q+L V H ++HRD+K N L S +
Sbjct: 123 AGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---N 179
Query: 279 SQLKAIDFGLSDFVR---PDERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILL 334
+K DFG S D+ G+ YYVAPE+ R Y +AD++S+GV+ Y LL
Sbjct: 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239
Query: 335 CGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394
RPF + L +D PS+S + ++ V LL+ DP++R ++++ L+
Sbjct: 240 TLKRPFDGENMEEVMHKTLAG--RYDPLP-PSISPEMQEIVTALLSSDPKRRPSSSKLLN 296
Query: 395 HP 396
P
Sbjct: 297 MP 298
|
Length = 496 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 77/282 (27%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVR--REVKILRA 193
LEV EE+GRG +G R+ +A+K I + + E R ++ I
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTG---TIMAVKRIRATVNSQ----EQKRLLMDLDISMR 55
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI-LNVV 252
V FY A +V+I ME+ + LD+ + + +L +I +++V
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVMDTS--LDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 253 -AFCHLH---GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV 308
A +LH V+HRD+KP N L + + Q+K DFG+S ++ G Y+
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170
Query: 309 APEVL-----HRSYGTEADVWSIGVIAYILLCGSRPF--WARTESGIFRAVLKADPSFDD 361
APE + + Y ++DVWS+G+ L G P+ W +T + V++ +PS
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW-KTPFQQLKQVVE-EPS--- 225
Query: 362 GSWPSL-----SSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
P L S + +DFV L K+ ++R + L HP+
Sbjct: 226 ---PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+E+G G FG +++ G++ VAIK+I + M+ ++ E K++ LS H
Sbjct: 10 KELGTGQFGVVKYGKWR-GQYD---VAIKMIKEGSMSE----DEFIEEAKVMMKLS-HEK 60
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
LV+ Y +YIV E G LL+ + ++ + + + +A+
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVLHRS 316
+HRDL N L D+ +K DFGLS +V DE + VGS + V PEVL S
Sbjct: 121 FIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYS 176
Query: 317 -YGTEADVWSIGVIAY-ILLCGSRPF 340
+ +++DVW+ GV+ + + G P+
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 81/291 (27%), Positives = 126/291 (43%), Gaps = 54/291 (18%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVE----DVRREVKILRALS 195
E+GRG FG K HK + V K + E + ++ ++ S
Sbjct: 10 GEIGRGAFG-----TVNKMLHKPSGTIMAV----KRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 196 GHSNLVKFYDA-FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL-VQILNVVA 253
+VKFY A F + D +I MEL +D L + KY + K+V+ +IL +A
Sbjct: 61 DCPYIVKFYGALFREGD-CWICMEL------MDISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 254 FC------HL---HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI--- 301
+L ++HRD+KP N L D + +K DFG+S + ++ I
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQL-----VDSIAKT 165
Query: 302 --VGSAYYVAPEVLHRS----YGTEADVWSIGVIAYILLCGSRPFWARTESGIF---RAV 352
G Y+APE + S Y +DVWS+G+ Y + G P+ + +F V
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQV 223
Query: 353 LKAD-PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402
+K D P + S +F+ L L KD KR + L HP+I++Y
Sbjct: 224 VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 25/225 (11%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+ +G G FG C R K K+ VAIK + ++ D E I+ H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASIMGQFD-HPN 66
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV------- 252
+++ V I+ E E G L D+ L E++ K + Q++ ++
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSL-DKFLR------ENDGKFTVGQLVGMLRGIASGM 119
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVG---SAYYVA 309
+ VHRDL N L S + K DFGLS + E G + A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176
Query: 310 PEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
PE + +R + + +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 82/314 (26%), Positives = 132/314 (42%), Gaps = 61/314 (19%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
V R + + +G G G C A D+ VAIK + + A + RE+ ++
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAY---DAVLDRNVAIKKLSRPFQNQTHA-KRAYRELVLM 70
Query: 192 RALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKA-- 243
+ ++ H N++ + F E+ +VY+VMEL +D L + + D +
Sbjct: 71 KCVN-HKNIISLLNVFTPQKSLEEFQDVYLVMEL------MDANLCQVIQMELDHERMSY 123
Query: 244 VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVG 303
+L Q+L + H G++HRDLKP N + S LK +DFGL+ + V
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVV 180
Query: 304 SAYYVAPEV-LHRSYGTEADVWSIGVIA------YILLCGSR----------------PF 340
+ YY APEV L Y D+WS+G I IL G P
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 341 WARTESGIFRAVLKADPSFDDGSWPSL----------------SSDAKDFVKLLLNKDPR 384
+ + R ++ P + ++P L +S A+D + +L DP
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
Query: 385 KRMTAAQALSHPWI 398
KR++ +AL HP+I
Sbjct: 301 KRISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 3e-16
Identities = 88/319 (27%), Positives = 139/319 (43%), Gaps = 68/319 (21%)
Query: 139 GEEVGRGHFGYTCTARYKKGEHKDQK-VAIKVIPKSKMTTAIAVEDVRREVKILRALSGH 197
G +VGRG +G+ A+ K G KD+K A+K I + ++ + RE+ +LR L H
Sbjct: 6 GCKVGRGTYGHVYKAKRKDG--KDEKEYALKQIEGTGISMSAC-----REIALLRELK-H 57
Query: 198 SNLVKFYDAFEDLDN--VYIVMELCEGGELLDRILSRCGKYSEDE-------AKAVLVQI 248
N++ F + V+++ + E R K ++ K++L QI
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAIDFGLSDF----VRPDERLNDIVG 303
L+ + + H + V+HRDLKP N L + E ++K D G + ++P L+ +V
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 304 SAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTE-------------SGI 348
+ +Y APE+L R Y D+W+IG I LL F R E I
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237
Query: 349 FRAV-LKADPSFDD----GSWPSLSS-----------------------DAKDFVKL--L 378
F + AD ++D +P+L D+K F+ L L
Sbjct: 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKL 297
Query: 379 LNKDPRKRMTAAQALSHPW 397
L DP KR+T+ QAL P+
Sbjct: 298 LTMDPTKRITSEQALQDPY 316
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 141 EVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
++G GHFG RY G++ ++VA+K + S + D RE++ILR L H N
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRS--DFEREIEILRTLD-HEN 67
Query: 200 LVKFYDAFEDL--DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL--VQILNVVAFC 255
+VK+ E ++ ++ME G L R + + + + +L QI + +
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 256 HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE---RLNDIVGS-AYYVAPE 311
+HRDL N L S+D +K DFGL+ + D+ + + S ++ APE
Sbjct: 126 GSQRYIHRDLAARNILVESED---LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 312 VLH-RSYGTEADVWSIGVIAYILLCGSRPF 340
L + + +DVWS GV Y L P
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 17/221 (7%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+ ++G G+FG +K +VAIK++ K + +D ++EV+ L+ L
Sbjct: 9 TLERKLGSGYFGEVWEGLWKN----RVRVAIKIL---KSDDLLKQQDFQKEVQALKRLR- 60
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV--QILNVVAF 254
H +L+ + + VYI+ EL E G LL + S G+ A + + Q+ +A+
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAY 119
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY-YVAPEVL 313
+HRDL N L E K DFGL+ ++ D L+ Y + APE
Sbjct: 120 LEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 314 -HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
H ++ T++DVWS G++ Y + G P+ ++ +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ +G +G G FG Y E++ VA+K K+ + ++ E +E I+R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVR-EKFLQEAYIMRQ 63
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL--VQILNV 251
H ++VK + + V+IVMEL GEL R + KYS D A +L Q+
Sbjct: 64 FD-HPHIVKLIGVITE-NPVWIVMELAPLGEL--RSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS--AYYVA 309
+A+ VHRD+ N L +S D +K DFGLS ++ + G ++A
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 310 PEVLH-RSYGTEADVWSIGVIAY-ILLCGSRPF 340
PE ++ R + + +DVW GV + IL+ G +PF
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 68/252 (26%), Positives = 110/252 (43%), Gaps = 32/252 (12%)
Query: 165 VAIKVIPKSKMTTAIAVEDVRR---EVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221
+A+KVIP I VE ++ E++IL ++ FY AF + + I E +
Sbjct: 29 LAVKVIPLD-----ITVELQKQIMSELEILYKCDS-PYIIGFYGAFFVENRISICTEFMD 82
Query: 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281
GG L K E + V ++ + + ++HRD+KP N L ++ Q+
Sbjct: 83 GGSL-----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR---GQV 134
Query: 282 KAIDFGLSDFVRPDERLNDI----VGSAYYVAPE-VLHRSYGTEADVWSIGVIAYILLCG 336
K DFG+S + +N I VG+ Y+APE + YG +DVWS+G+ L G
Sbjct: 135 KLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189
Query: 337 SRPFWARTESGIFRAVLKADPSFDDGSWPSL-----SSDAKDFVKLLLNKDPRKRMTAAQ 391
P+ ++ L+ D P L S F+ + K P++R
Sbjct: 190 RFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPEN 249
Query: 392 ALSHPWIRNYNN 403
+ HP+I YN+
Sbjct: 250 LMDHPFIVQYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 84/318 (26%), Positives = 136/318 (42%), Gaps = 66/318 (20%)
Query: 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
G +VGRG +G+ A+ K G+ D+ A+K I + ++ + RE+ +LR L H
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGTGISMSAC-----REIALLRELK-HP 58
Query: 199 NLVKFYDAFEDLDN--VYIVMELCEGGELLDRILSRCGKYSEDEA-------KAVLVQIL 249
N++ F + V+++ + E R K ++ K++L QIL
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAIDFGLSDF----VRPDERLNDIVGS 304
+ + + H + V+HRDLKP N L + E ++K D G + ++P L+ +V +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 305 AYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTE-------------SGIF 349
+Y APE+L R Y D+W+IG I LL F R E IF
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 350 RAV-LKADPSFDD-GSWPSLSSDAKDF----------------------------VKLLL 379
+ AD ++D P S+ KDF ++ LL
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298
Query: 380 NKDPRKRMTAAQALSHPW 397
DP KR+T+ QA+ P+
Sbjct: 299 TMDPIKRITSEQAMQDPY 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 81/291 (27%), Positives = 126/291 (43%), Gaps = 43/291 (14%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG--HS 198
E+G G +G AR K + + VA+K + + + +R EV +LR L H
Sbjct: 8 EIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHP 64
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEA------KAVLVQILNVV 252
N+V+ +D + +L E +D+ L+ + K ++ Q+L +
Sbjct: 65 NVVRLFDVCT-VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 312
F H H VVHRDLKP+N L TS S Q+K DFGL+ L +V + +Y APEV
Sbjct: 124 DFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
Query: 313 -LHRSYGTEADVWSIGVIAYILLCGSRPF------------------------WARTESG 347
L SY T D+WS+G I + + +P W R +
Sbjct: 181 LLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR-DVA 238
Query: 348 IFRAVLKADPSFD-DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
+ R + + + + KD + L +P KR++A ALSHP+
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 128 FSKEVTSRLEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRR 186
F K R+ ++G GHFG RY +G++ ++VA+K + IA D+++
Sbjct: 1 FEKRFLKRIR---DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKK 55
Query: 187 EVKILRALSGHSNLVKFYD-AFEDLDN-VYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
E++ILR L H N+VK+ ED N + ++ME G L + + K + +
Sbjct: 56 EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL----ND 300
VQI + + VHRDL N L S+ Q+K DFGL+ + D+ +D
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKAIETDKEYYTVKDD 171
Query: 301 IVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILL 334
+ ++ APE L + +DVWS GV Y LL
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 83/314 (26%), Positives = 131/314 (41%), Gaps = 61/314 (19%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
V R + + +G G G C A E + VAIK + + A + RE+ ++
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHA-KRAYRELVLM 77
Query: 192 RALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKA-- 243
+ ++ H N++ + F E+ +VYIVMEL +D L + + D +
Sbjct: 78 KCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMEL------MDANLCQVIQMELDHERMSY 130
Query: 244 VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVG 303
+L Q+L + H G++HRDLKP N + S LK +DFGL+ + V
Sbjct: 131 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVV 187
Query: 304 SAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL--------- 353
+ YY APEV L Y D+WS+G I ++ G F + V+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247
Query: 354 ---KADPS-------------------FDDGSWPSLS-------SDAKDFVKLLLNKDPR 384
K P+ F D +P+ S S A+D + +L D
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 385 KRMTAAQALSHPWI 398
KR++ +AL HP+I
Sbjct: 308 KRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 64/262 (24%), Positives = 117/262 (44%), Gaps = 18/262 (6%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG C + K + + A K + K ++ + E +IL ++ +V
Sbjct: 1 LGKGGFGEVCAVQVK---NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIV 56
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH--G 259
AFE ++ +VM L GG+L I + G+ + + + HLH
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYG 318
+V+RD+KPEN L D+ + D GL+ ++ + + G+ Y+APE+L Y
Sbjct: 116 IVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
D +++G Y ++ G PF E + R L+ + F+ ++ + ++KD
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNF---TEESKDI 229
Query: 375 VKLLLNKDPRKRMTAAQALSHP 396
+L L K P R+ + + P
Sbjct: 230 CRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 78/259 (30%), Positives = 126/259 (48%), Gaps = 31/259 (11%)
Query: 142 VGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+GRG FG Y C + G+ K K K K +A+ + +I+ +L +
Sbjct: 2 IGRGGFGEVYGCR-KADTGKMYAMKCLDKKRIKMKQGETLALNE-----RIMLSLVSTGD 55
Query: 200 ---LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
+V AF D + +++L GG+L LS+ G +SE E + +I ++ H
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEI--ILGLEH 112
Query: 257 LHG--VVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 313
+H VV+RDLKP N L DE ++ D GL+ DF + ++ + VG+ Y+APEVL
Sbjct: 113 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVL 167
Query: 314 HR--SYGTEADVWSIGVIAYILLCGSRPFW---ARTESGIFRAVLKADPSFDDGSWPSLS 368
+ +Y + AD +S+G + + LL G PF + + I R L + D S S
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFS 223
Query: 369 SDAKDFVKLLLNKDPRKRM 387
+ K ++ LL +D KR+
Sbjct: 224 PELKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 32/210 (15%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L++ ++G G FG + + KVA+K + M+ E +E +I++
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTW----NGTTKVAVKTLKPGTMSP----EAFLQEAQIMKK 57
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV------- 246
L H LV+ Y + + +YIV E G LLD + E K + +
Sbjct: 58 LR-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL-------KSGEGKKLRLPQLVDMA 109
Query: 247 -QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
QI +A+ +HRDL N L E+ K DFGL+ + DE G+
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE-YTAREGAK 165
Query: 306 Y---YVAPE-VLHRSYGTEADVWSIGVIAY 331
+ + APE + + ++DVWS G++
Sbjct: 166 FPIKWTAPEAANYGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-15
Identities = 51/148 (34%), Positives = 78/148 (52%), Gaps = 8/148 (5%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+ RG FG R KK K A+KV+ K+ M V V+ E L ALS +V
Sbjct: 12 ISRGAFGKVYLGR-KKNNSK--LYAVKVVKKADMINKNMVHQVQAERDAL-ALSKSPFIV 67
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
Y + + +NVY+VME GG++ +L G + E+ A + ++ + + H HG++
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLHRHGII 126
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS 289
HRDLKP+N L +++ +K DFGLS
Sbjct: 127 HRDLKPDNMLISNE---GHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 66/259 (25%), Positives = 113/259 (43%), Gaps = 50/259 (19%)
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
RE+++L + +V FY AF + I ME +GG L D++L + G+ E V
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 109
Query: 246 VQILNVVAFC-HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
+ ++ + + H ++HRD+KP N L S+ E +K DFG+S + D N VG+
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGT 165
Query: 305 AYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFW---ARTESGIFRAVLKADPSFD 360
Y++PE L + Y ++D+WS+G+ + G P A+ +F ++ DP+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225
Query: 361 DGS-------------------------------------WPS--LSSDAKDFVKLLLNK 381
+ S PS ++ +DFV L K
Sbjct: 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIK 285
Query: 382 DPRKRMTAAQALSHPWIRN 400
+P +R Q + H +I+
Sbjct: 286 NPAERADLKQLMVHAFIKR 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 51/156 (32%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
RE+++L + +V FY AF + I ME +GG L D++L + E+ V
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVS 109
Query: 246 VQILNVVAFC-HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
+ +L +A+ H ++HRD+KP N L S+ E +K DFG+S + D N VG+
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGT 165
Query: 305 AYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRP 339
Y++PE L + Y ++D+WS+G+ L G P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 48/296 (16%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVI--PKSKMTTAIAVEDVRREVKILRALSGH 197
E++G G + T K + + VA+KVI + + T A+ RE +L+ L H
Sbjct: 11 EKLGEGSYA---TVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLKGLK-H 62
Query: 198 SNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL 257
+N+V +D + + +V E +L + G + K L Q+L +++ H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHRS 316
++HRDLKP+N L + ++ +LK DFGL+ P ++ V + +Y P+VL S
Sbjct: 122 RYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 317 --YGTEADVWSIGVIAYILLCG--SRPFWARTESGIFRAVLKADPSFDDGSWPSLSS--- 369
Y T D+W +G I ++ G + P + + R L +D +WP + S
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED-TWPGVHSLPH 237
Query: 370 -------------------------DAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
A+D LL P+ R++A ALSH + +
Sbjct: 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 71/272 (26%), Positives = 115/272 (42%), Gaps = 49/272 (18%)
Query: 163 QKVAIKVIPKSKMTTAIAVE-DVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221
Q VA+KVI M T V RE +L+ L H+N+V +D + + V E
Sbjct: 31 QLVALKVI---SMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFVFEYMH 86
Query: 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281
+L ++ G + + Q+L +A+ H ++HRDLKP+N L + E L
Sbjct: 87 T-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---L 142
Query: 282 KAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSR 338
K DFGL+ P + + V + +Y P+VL + Y + D+W G I +I + +
Sbjct: 143 KLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCI-FIEMLQGQ 201
Query: 339 PFWARTESGIFRAVLK-----ADPSFDDGSWPSLSS------------------------ 369
P + S +F + K P+ D +WP +S
Sbjct: 202 PAFPGV-SDVFEQLEKIWTVLGVPTED--TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRL 258
Query: 370 ----DAKDFVKLLLNKDPRKRMTAAQALSHPW 397
A+D +L P+ R++A AL HP+
Sbjct: 259 SRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+++G G FG Y + KVA+K + M+ V+ E +++ L H
Sbjct: 12 KKLGAGQFGEVWMGYY----NNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQ-HDK 62
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLH 258
LV+ Y + +YI+ E G LLD + S G K + QI +A+
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEVLHR 315
+HRDL+ N L + ES K DFGL+ + +E G+ + + APE ++
Sbjct: 123 NYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINF 178
Query: 316 -SYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
S+ ++DVWS G++ Y I+ G P+ + S + A+
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 24/231 (10%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
S +++ + +G G FG C+ R K ++ VAIK + T D E I+
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIMGQ 61
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
H N++ V IV E E G L + G+++ + +L I + +
Sbjct: 62 FD-HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY------- 306
+ G VHRDL N L S + K DFGLS + D +AY
Sbjct: 121 YLSDMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPE------AAYTTRGGKI 171
Query: 307 ---YVAPEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
+ APE + +R + + +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYK-----KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREV 188
+ LE + +G G FG YK +GE VAIKV+ + T+ A +++ E
Sbjct: 7 TELEKIKVLGSGAFG----TVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEA 60
Query: 189 KILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL--- 245
++ A H ++V+ V ++ +L G LLD + + ++ +L
Sbjct: 61 YVM-ASVDHPHVVRLL-GICLSSQVQLITQLMPLGCLLDYVRNHKDNIG---SQYLLNWC 115
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
VQI +++ +VHRDL N L + +K DFGL+ + DE+ G
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 306 Y---YVAPE-VLHRSYGTEADVWSIGVIAYILLC-GSRPF 340
++A E +LHR Y ++DVWS GV + L+ G++P+
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 29/202 (14%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+E+G G+FG Y K+ +VA+K + + + ++ RE ++ L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQLD-HPC 57
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
+V+ + + + +VMEL G LL + R + + K + Q+ +A+
Sbjct: 58 IVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKH 115
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYY------------ 307
VHRDL N L ++ Q K DFG+S + GS YY
Sbjct: 116 FVHRDLAARNVLLVNRH---QAKISDFGMSRALGA--------GSDYYRATTAGRWPLKW 164
Query: 308 VAPEVLH-RSYGTEADVWSIGV 328
APE ++ + +++DVWS GV
Sbjct: 165 YAPECINYGKFSSKSDVWSYGV 186
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 69/231 (29%), Positives = 97/231 (41%), Gaps = 43/231 (18%)
Query: 142 VGRGHFG--YTCTARYKKGE-HKDQKVAIKVIPKSKMTTAIAVEDVR--REVKILRALSG 196
+G G FG Y TA G +VA+K + K A E +E ++ +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFN- 57
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLD--RILSRCGKYSEDEAKAVLVQI-LNVVA 253
H N+VK + YI+MEL EGG+LL R L+ I L+V
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 254 FCH----LHGVVHRDLKPENFLYTSKDESSQ--LKAIDFGLSDFVRPDERLNDIVGSAYY 307
C +H +HRDL N L + K + +K DFGL+ DI S YY
Sbjct: 118 GCVYLEQMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSDYY 167
Query: 308 ------------VAPEVLHRS-YGTEADVWSIGVIAY-ILLCGSRPFWART 344
+APE L + T++DVWS GV+ + IL G +P+ A
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 32/286 (11%)
Query: 121 ELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIA 180
D ++ F + L G+ +G G FG A D +KV K TA +
Sbjct: 25 PYDLKWEFPRN---NLSFGKTLGAGAFGKVVEATAYGLSKSD--AVMKVAVKMLKPTAHS 79
Query: 181 VED--VRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSE 238
E + E+KI+ L H N+V A + ++ E C G+LL+ + + +
Sbjct: 80 SEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLT 139
Query: 239 -DEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER 297
++ + Q+ +AF +HRDL N L T +K DFGL+ + D
Sbjct: 140 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLARDIMNDS- 195
Query: 298 LNDIV-GSAY----YVAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFR 350
N +V G+A ++APE + + Y E+DVWS G++ + I GS P+ F
Sbjct: 196 -NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY 254
Query: 351 AVLK-----ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQ 391
++K A P ++ D +K + DP KR T Q
Sbjct: 255 KLIKEGYRMAQPEH-------APAEIYDIMKTCWDADPLKRPTFKQ 293
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR----EVKILRALS 195
E++G+G+FG K +VA+K +S + D++R E +IL+
Sbjct: 1 EKIGKGNFGDVYKGVLKGN----TEVAVKTC-RSTLP-----PDLKRKFLQEAEILKQYD 50
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255
H N+VK +YIVMEL GG LL + + + + + + + + +
Sbjct: 51 -HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 256 HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY------YVA 309
+HRDL N L E++ LK DFG+S R +E V + A
Sbjct: 110 ESKNCIHRDLAARNCLV---GENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTA 163
Query: 310 PEVLHRS-YGTEADVWSIGVIAY-ILLCGSRPF 340
PE L+ Y +E+DVWS G++ + G P+
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 22/231 (9%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
S +++ E +G G FG C R K ++ VAIK + KS T E RR+ +
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYT-----EKQRRDFLSEAS 57
Query: 194 LSG---HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
+ G H N++ V I+ E E G L + G+++ + +L I
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA 117
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY---- 306
+ + VHRDL N L S + K DFGLS F+ D+ + S+
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLE-DDTSDPTYTSSLGGKI 173
Query: 307 ---YVAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
+ APE + +R + + +DVWS G++ + ++ G RP+W + + A+
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 24/223 (10%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
L++ +++G G FG Y KVAIK + + M+ + E +++ L
Sbjct: 8 LKLVKKLGAGQFGEVWMGYYNG----HTKVAIKSLKQGSMSPEAFLA----EANLMKQLQ 59
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAF 254
H LV+ Y A + +YI+ E E G L+D + + G K + ++ + QI +AF
Sbjct: 60 -HPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE 311
+HRDL+ N L + E+ K DFGL+ + +E G+ + + APE
Sbjct: 118 IERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPE 173
Query: 312 VLHRSYGT---EADVWSIGV-IAYILLCGSRPFWARTESGIFR 350
+ +YGT ++DVWS G+ + I+ G P+ T + +
Sbjct: 174 AI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 15/182 (8%)
Query: 165 VAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGE 224
VA+K + M +D E +I++ L H L++ Y + +YIV EL + G
Sbjct: 33 VAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYGS 87
Query: 225 LLDRILSRCGKY-SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283
LL+ + G+ + + Q+ + +A+ +HRDL N L E++ K
Sbjct: 88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKV 144
Query: 284 IDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSR 338
DFGL+ ++ D G+ + + APE L+ + ++DVWS G++ I+ G
Sbjct: 145 ADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM 203
Query: 339 PF 340
P+
Sbjct: 204 PY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+L +GE +G G FG +GE+ QKVA+K I K +T +E+ K+
Sbjct: 6 QKLTLGEIIGEGEFGAVL-----QGEYTGQKVAVKNI-KCDVTAQAFLEETAVMTKL--- 56
Query: 194 LSGHSNLVKFYDAFEDLDN-VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
H NLV+ L N +YIVMEL G L++ + +R G+ + + +
Sbjct: 57 --HHKNLVRLLGVI--LHNGLYIVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAE 111
Query: 253 AFCHLHG--VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 310
+L +VHRDL N L + E K DFGL+ +++ + AP
Sbjct: 112 GMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS--MGVDNSKLPVKWTAP 166
Query: 311 EVL-HRSYGTEADVWSIGVIAY-ILLCGSRPF 340
E L H+ + +++DVWS GV+ + + G P+
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 20/223 (8%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
L++ +++G G FG A Y +K KVA+K + M+ VE E +++ L
Sbjct: 8 LKLEKKLGAGQFGEVWMATY----NKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQ 59
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAF 254
H LVK + A + +YI+ E G LLD + S G K + QI +AF
Sbjct: 60 -HDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE 311
+HRDL+ N L ++ S K DFGL+ + +E G+ + + APE
Sbjct: 118 IEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPE 173
Query: 312 VL-HRSYGTEADVWSIGV-IAYILLCGSRPFWARTESGIFRAV 352
+ S+ ++DVWS G+ + I+ G P+ + + RA+
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 50/233 (21%)
Query: 141 EVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
E+G G FG + E VA+K + K + A +D +RE ++L L H
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTVLQ-HQ 67
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRIL---------------SRCGKYSEDEAKA 243
++V+FY + + +V E G+L +R L G+ + + A
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 244 VLVQILN-VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV 302
+ QI + +V LH VHRDL N L + +K DFG+S DI
Sbjct: 127 IASQIASGMVYLASLH-FVHRDLATRNCLV---GQGLVVKIGDFGMS---------RDIY 173
Query: 303 GSAYY------------VAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPFW 341
+ YY + PE +L+R + TE+D+WS GV+ + I G +P++
Sbjct: 174 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 39/214 (18%)
Query: 140 EEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
+++G+G+FG RY ++ + VA+K K + +TA + D RE++IL++L H
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQ-HD 65
Query: 199 NLVKF----YDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV--QILNVV 252
N+VK+ Y A N+ +VME G L D + + D K +L QI +
Sbjct: 66 NIVKYKGVCYSAGRR--NLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGM 121
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV---- 308
+ VHRDL N L S+ +++K DFGL+ + D+ YY
Sbjct: 122 EYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKE--------YYKVREP 170
Query: 309 --------APEVLHRS-YGTEADVWSIGVIAYIL 333
APE L S + +DVWS GV+ Y L
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 66/246 (26%), Positives = 112/246 (45%), Gaps = 47/246 (19%)
Query: 141 EVGRGHFGYTCTAR-YKKGEHKDQK-VAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
E+G G FG A Y KD+ VA+K + K T A +D +RE ++L L H
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ-HE 67
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGEL--------LDRILSRCGKYSEDEAKAVLVQILN 250
++VKFY D D + +V E + G+L D ++ G+ + + + L Q+L+
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 251 V-------VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVG 303
+ + + VHRDL N L + + +K DFG+S D+
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS---------RDVYS 175
Query: 304 SAYY------------VAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 349
+ YY + PE +++R + TE+DVWS GVI + I G +P++ + + +
Sbjct: 176 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235
Query: 350 RAVLKA 355
+ +
Sbjct: 236 ECITQG 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVED-VRREVKILRALSGHS 198
E +GRG+FG + R + + VA+K + T ++ +E +IL+ S H
Sbjct: 1 ERIGRGNFGEVFSGRLRA---DNTPVAVK---SCRETLPPDLKAKFLQEARILKQYS-HP 53
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258
N+V+ +YIVMEL +GG+ L + + + E ++ + +
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK 113
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY---------YVA 309
+HRDL N L T K+ LK DFG+S R +E D V ++ + A
Sbjct: 114 HCIHRDLAARNCLVTEKN---VLKISDFGMS---REEE---DGVYASTGGMKQIPVKWTA 164
Query: 310 PEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPF 340
PE L + Y +E+DVWS G++ + G+ P+
Sbjct: 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 12/217 (5%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G G FG K K+ VAIK + T +D E I+ S H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFS-HHNII 69
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ I+ E E G L + G++S + +L I + + V
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLNDIVGSAY---YVAPEVL-HRS 316
HRDL N L S E K DFGLS + D E G + APE + +R
Sbjct: 130 HRDLAARNILVNSNLEC---KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 317 YGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
+ + +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 34/231 (14%)
Query: 136 LEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ + +G G FG Y R + G+ + +VA+K +P+ + D E I+
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLMEALIMSK 65
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGEL---LDRILSRCGKYSEDEAKAVLVQILN 250
+ H N+V+ + +I++EL GG+L L R + S K +L +
Sbjct: 66 FN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 251 VVAFCHL---HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYY 307
V C + +HRD+ N L T K K DFG++ DI ++YY
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYY 175
Query: 308 ------------VAPEV-LHRSYGTEADVWSIGVIAY-ILLCGSRPFWART 344
+ PE L + ++ DVWS GV+ + I G P+ RT
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
++G G +G +KK VA+K + + M VE+ +E +++ + H NL
Sbjct: 13 KLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNL 64
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL---VQILNVVAFCHL 257
V+ YI+ E G LLD L C + E A +L QI + + +
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNR-QEVNAVVLLYMATQISSAMEYLEK 122
Query: 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEVL- 313
+HRDL N L E+ +K DFGLS + + G+ + + APE L
Sbjct: 123 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 178
Query: 314 HRSYGTEADVWSIGVIAY-ILLCGSRPF 340
+ + ++DVW+ GV+ + I G P+
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 19/198 (9%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQK-VAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
E +G+G+FG KG KD+ VA+K K + + ++ + E +IL+ H
Sbjct: 1 ELLGKGNFG-----EVFKGTLKDKTPVAVKTC-KEDLPQELKIKFLS-EARILKQYD-HP 52
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258
N+VK +YIVMEL GG+ L + + + + + +A+
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLS----DFVRPDERLNDIVGSAYYVAPEVL- 313
+HRDL N L E++ LK DFG+S D + L I + APE L
Sbjct: 113 NCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALN 167
Query: 314 HRSYGTEADVWSIGVIAY 331
+ Y +E+DVWS G++ +
Sbjct: 168 YGRYSSESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 25/175 (14%)
Query: 188 VKILRALSGHSNLVKFYD---AFEDLDNVYIV--MELCEG------------GELLDRIL 230
+K ++ SG + D A LD+ YIV + +C G G LLD +
Sbjct: 41 IKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVR 100
Query: 231 SRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290
VQI + + H +VHR+L N L S S ++ DFG++D
Sbjct: 101 QHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS---DSIVQIADFGVAD 157
Query: 291 FVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPF 340
+ PD++ ++ ++A E + Y ++DVWS GV + ++ G+ P+
Sbjct: 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 142 VGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199
+GRG FG A+ K E + V +K + K+K + + RRE+ + R LS H N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLS-HKN 69
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-- 257
+V+ + + Y+++E + G+L + R K +++ K + VA C
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDL--KQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 258 --------HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYY 307
VHRDL N L +S+ ++K LS V E +L + + +
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQ---REVKVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 308 VAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPF 340
+APE V + T++DVWS GV+ + + G PF
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
RL+V ++G+G FG + + KVAIK + M E +E +I++ L
Sbjct: 9 RLDV--KLGQGCFGEVWMGTW----NGTTKVAIKTLKPGTMMP----EAFLQEAQIMKKL 58
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSE-DEAKAVLVQILNVVA 253
H LV Y + + +YIV E G LLD + GKY + + + QI + +A
Sbjct: 59 R-HDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY---YVAP 310
+ +HRDL+ N L ++ K DFGL+ + D G+ + + AP
Sbjct: 117 YIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAP 172
Query: 311 E-VLHRSYGTEADVWSIGVIAYILLCGSR 338
E L+ + ++DVWS G++ L+ R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 44/243 (18%)
Query: 141 EVGRGHFGYTCTAR-YKKGEHKDQ-KVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
E+G G FG A Y +D+ VA+K + K + A +D RE ++L L H
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQ-HE 67
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGEL--------LDRILSRCGKYSEDEAKAVLVQILN 250
++VKFY + D + +V E + G+L D +L G + ++ ++ I
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 251 VVA----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY 306
+A + VHRDL N L E+ +K DFG+S D+ + Y
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMS---------RDVYSTDY 175
Query: 307 Y------------VAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
Y + PE +++R + TE+DVWS+GV+ + I G +P++ + + + +
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235
Query: 353 LKA 355
+
Sbjct: 236 TQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 35/207 (16%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
L++ + +G+G FG G+++ KVA+K I A E ++ L
Sbjct: 8 LKLLQTIGKGEFGDVML-----GDYRGNKVAVKCIKNDATAQAFLAE-----ASVMTQLR 57
Query: 196 GHSNLVKFYDAF-EDLDNVYIVMELCEGGELLDRILSRCG---------KYSEDEAKAVL 245
HSNLV+ E+ +YIV E G L+D + SR K+S D +A+
Sbjct: 58 -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM- 115
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
+ + VHRDL N L + E + K DFGL+ + +
Sbjct: 116 -------EYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PV 163
Query: 306 YYVAPEVL-HRSYGTEADVWSIGVIAY 331
+ APE L + + T++DVWS G++ +
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
RLEV ++G+G FG + + +VAIK + M+ E +E ++++ L
Sbjct: 9 RLEV--KLGQGCFGEVWMGTW----NGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKL 58
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSE-DEAKAVLVQILNVVA 253
H LV+ Y + + +YIV E G LLD + GKY + + QI + +A
Sbjct: 59 R-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY---YVAP 310
+ VHRDL+ N L E+ K DFGL+ + D G+ + + AP
Sbjct: 117 YVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAP 172
Query: 311 E-VLHRSYGTEADVWSIGVI 329
E L+ + ++DVWS G++
Sbjct: 173 EAALYGRFTIKSDVWSFGIL 192
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 63/246 (25%), Positives = 98/246 (39%), Gaps = 39/246 (15%)
Query: 163 QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEG 222
Q +K + KS + + + V N+V + D+V++V++ EG
Sbjct: 19 QTFILKGLRKSSEYSRERLTIIPHCV---------PNMVCLHKYIVSEDSVFLVLQHAEG 69
Query: 223 GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLK 282
G+L I E+ K +++ + H G+V RDL P N L D+ ++
Sbjct: 70 GKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQ 125
Query: 283 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEA-DVWSIGVIAYILLCG----- 336
F V + V Y APEV S TEA D WS+G I + LL G
Sbjct: 126 LTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183
Query: 337 SRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQA---- 392
P SGI P + +S +A+ ++ LL +P +R+ A A
Sbjct: 184 CHP------SGINTHTTLNIPEW-------VSEEARSLLQQLLQFNPTERLGAGVAGVED 230
Query: 393 -LSHPW 397
SHP+
Sbjct: 231 IKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 29/242 (11%)
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY 306
Q+ +A+ H + HRDLKP+N L + LK DFG + + +R + S +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 307 YVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--------- 355
Y APE++ +Y T D+WS+G I ++ G F ++ +++
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 356 ---DPSFDDGSWPSLSS-------------DAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
+P++ D +P + DA +F+ L +P KR+ +AL+ P+
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355
Query: 400 NYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGC 459
+ + + L I KL + + + A + + + ++F + + N
Sbjct: 356 DLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCTYEAYKEFLMSDENDANI 415
Query: 460 IA 461
IA
Sbjct: 416 IA 417
|
Length = 440 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 48/236 (20%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIK-VIPKSKMTTAIAVEDVRREVKI 190
++ + E+G+G FG Y A+ + +VAIK V + M I E +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF---LNEASV 62
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL----- 245
++ + H ++V+ +VMEL G+L + SR E E L
Sbjct: 63 MKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTL 118
Query: 246 -------VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL 298
+I + +A+ VHRDL N + +K DFG++
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL---TVKIGDFGMT--------- 166
Query: 299 NDIVGSAYY------------VAPEVLHRS-YGTEADVWSIGVIAY-ILLCGSRPF 340
DI + YY +APE L + T++DVWS GV+ + + +P+
Sbjct: 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 41/236 (17%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVE----DVRREVK 189
RL +G+ +G G FG A ++ ++ + V KM A E D+ E++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAV----KMLKDDATEKDLSDLVSEME 67
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR--CGKYSEDEAKAVLVQ 247
+++ + H N++ +Y+V+E G L D + +R G+Y+ + +
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 248 IL---NVVAFCH--LHGV--------VHRDLKPENFLYTSKDESSQLKAIDFGLS----- 289
L ++V+F + G+ +HRDL N L T E +K DFGL+
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHH 184
Query: 290 -DFVRP--DERLNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPF 340
D+ R + RL ++APE L R Y ++DVWS GV+ + I G P+
Sbjct: 185 IDYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 70/332 (21%), Positives = 125/332 (37%), Gaps = 68/332 (20%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQK--VAIKVIPKSKMTTAIAVEDVRR---EVKIL 191
E+ +G+ K HK VA+K I + ED++ E+
Sbjct: 1 ELLTLIGKCFEDLMIVHLAK---HKPTNTLVAVKKINLDSCSK----EDLKLLQQEIITS 53
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGG---ELLDRILSRCGKYSEDEAKAVLVQI 248
R L H N++ + +F +Y+V L G +LL E +L +
Sbjct: 54 RQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDV 110
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA--- 305
LN + + H G +HR +K + L S D L + + +S ++ +R +
Sbjct: 111 LNALDYIHSKGFIHRSVKASHIL-LSGDGKVVLSGLRYSVS-MIKHGKRQRVVHDFPKSS 168
Query: 306 ----YYVAPEVLHRS---YGTEADVWSIGVIAYILLCGSRPFW----------------- 341
+++PEVL ++ Y ++D++S+G+ A L G PF
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP 228
Query: 342 ---------------ARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKR 386
+++ S + S D + S FV+L L +DP R
Sbjct: 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRD--SVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 387 MTAAQALSHPWIRNYNNVKVPLDISILKLMKA 418
+A+Q L+H + + + S+L L+K
Sbjct: 287 PSASQLLNHSFFKQCKRR----NTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 35/250 (14%)
Query: 116 EEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQ-----KVAIKVI 170
E PE D R+ FS++ +L +G+ +G G FG A G KD+ VA+K++
Sbjct: 1 EYELPE-DPRWEFSRD---KLTLGKPLGEGCFGQVVMAE-ALGIDKDKPKEAVTVAVKML 55
Query: 171 PKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRIL 230
T + D+ E+++++ + H N++ A +Y+++E G L + +
Sbjct: 56 KDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 113
Query: 231 SR---CGKYSEDEAK------------AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK 275
+R +YS D A+ + Q+ + + +HRDL N L T
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-- 171
Query: 276 DESSQLKAIDFGLSDFVRPDERLNDIVGS---AYYVAPEVL-HRSYGTEADVWSIGVIAY 331
E++ +K DFGL+ V + ++APE L R Y ++DVWS GV+ +
Sbjct: 172 -ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230
Query: 332 -ILLCGSRPF 340
I G P+
Sbjct: 231 EIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 37/135 (27%), Positives = 56/135 (41%), Gaps = 24/135 (17%)
Query: 161 KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV-KFYDAFEDLDNVYIVMEL 219
KD+ +K+ P D REV IL+ L+ V K + E Y++ME
Sbjct: 20 KDEDYVLKINPSR-----EKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74
Query: 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-----GVVHRDLKPENFLYTS 274
EG L + SE+E + + Q+ ++A LH + H DL P N L
Sbjct: 75 IEGETL--------DEVSEEEKEDIAEQLAELLA--KLHQLPLLVLCHGDLHPGNILV-- 122
Query: 275 KDESSQLKAIDFGLS 289
D+ L ID+ +
Sbjct: 123 -DDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 46/220 (20%)
Query: 163 QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEG 222
++VA+K I + + + RE KI L H +V Y D D VY M EG
Sbjct: 28 RRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYTMPYIEG 86
Query: 223 GELLDRILS---RCGKYSEDEAK--------AVLVQILNVVAFCHLHGVVHRDLKPENFL 271
L +L + S++ A+ ++ +I + + H GV+HRDLKP+N L
Sbjct: 87 -YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNIL 145
Query: 272 Y---------------TSKDESSQLKAIDFGL-----SDFVRPDERLNDIVGSAYYVAPE 311
K E L ID S P + IVG+ Y+APE
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGK----IVGTPDYMAPE 201
Query: 312 VLHRSYGTEA----DVWSIGVIAYILLCGSRPFWARTESG 347
R G A D++++GVI Y +L S P+ R + G
Sbjct: 202 ---RLLGVPASESTDIYALGVILYQMLTLSFPY--RRKKG 236
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 26/221 (11%)
Query: 115 PEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSK 174
++ A E+ G+ V L G E G A K G+ V +K+ K
Sbjct: 55 TKQKAREVVASLGY--TVIKTLTPGSE------GRVFVAT-KPGQ--PDPVVLKI--GQK 101
Query: 175 MTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG 234
TT I E +L+ ++ H ++++ D +V+ +L + R
Sbjct: 102 GTTLI-------EAMLLQNVN-HPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSR 152
Query: 235 KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294
D+A + QIL + + H ++HRD+K EN D Q+ D G + F
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVCIGDLGAAQFPVV 209
Query: 295 DERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILL 334
+ G+ APEVL R Y ++AD+WS G++ + +L
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 136 LEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
L+ +G GHFG Y + + VA+K + + ++E+ IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTL 63
Query: 195 SGHSNLVKFYDAFEDLDN--VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV--QILN 250
H N+VK+ + + ++ME G L D + K+ + A+ +L QI
Sbjct: 64 Y-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICE 118
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL----NDIVGSAY 306
+A+ H +HRDL N L D +K DFGL+ V D +
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 307 YVAPEVLHR-SYGTEADVWSIGVIAYILL 334
+ A E L + +DVWS GV Y LL
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 67/252 (26%), Positives = 114/252 (45%), Gaps = 33/252 (13%)
Query: 113 GAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARY----KKGEHKDQKVAIK 168
G E PE D R+ ++ RL +G+ +G G FG A K+ ++ KVA+K
Sbjct: 1 GVSEYELPE-DPRWEVPRD---RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK 56
Query: 169 VIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDR 228
++ KS T + D+ E+++++ + H N++ A +Y+++E G L +
Sbjct: 57 ML-KSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 114
Query: 229 ILSR-------CGKYSEDEAKAVLVQILNVVAFCHLHGV--------VHRDLKPENFLYT 273
+ +R C ++ + + + L A+ G+ +HRDL N L T
Sbjct: 115 LRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174
Query: 274 SKDESSQLKAIDFGLS-DFVRPDERLNDIVGS--AYYVAPEVL-HRSYGTEADVWSIGVI 329
E + +K DFGL+ D D G ++APE L R Y ++DVWS GV+
Sbjct: 175 ---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 231
Query: 330 AY-ILLCGSRPF 340
+ I G P+
Sbjct: 232 LWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 32/242 (13%)
Query: 123 DKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARY----KKGEHKDQKVAIKVIPKSKMTTA 178
D ++ S+ +RL +G+ +G G FG A K +K VA+K++ T
Sbjct: 4 DPKWELSR---TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATD 58
Query: 179 IAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR---CGK 235
+ D+ E+++++ + H N++ A +Y+++E G L + + +R
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 236 YSEDEAK------------AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283
YS D K + Q+ + + +HRDL N L T E + +K
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKI 175
Query: 284 IDFGLSDFVRPDERLNDIVGS---AYYVAPEVL-HRSYGTEADVWSIGVIAY-ILLCGSR 338
DFGL+ V + ++APE L R Y ++DVWS GV+ + I G
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235
Query: 339 PF 340
P+
Sbjct: 236 PY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR----EVKILRALSGH 197
+G G+FG AR KK +++ K A +D R E+++L L H
Sbjct: 3 IGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 55
Query: 198 SNLVKFYDAFEDLDNVYIVMELCEGGELLD-----RILSRCGKYSEDEAKAVLV---QIL 249
N++ A E +Y+ +E G LLD R+L ++ + A + Q+L
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 250 -------NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDI 301
+ + +HRDL N L E+ K DFGLS R E +
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQEVYVKKT 169
Query: 302 VGS--AYYVAPEVLHRS-YGTEADVWSIGVIAY-ILLCGSRPFWART 344
+G ++A E L+ S Y T +DVWS GV+ + I+ G P+ T
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
+ S L G E G + CT K G+ + +KV +K + K RE+ I
Sbjct: 95 NILSSLTPGSE---GEV-FVCT---KHGDEQRKKVIVKAVTGGK--------TPGREIDI 139
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMEL--CEGGELLDRILSRCGKYSEDEAKAVLVQI 248
L+ +S H ++ A+ V +VM C+ +DR G ++A + ++
Sbjct: 140 LKTIS-HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS----GPLPLEQAITIQRRL 194
Query: 249 LNVVAFCHLHGVVHRDLKPEN-FLYTSKDESSQLKAIDFGLSDFVRPDERLND-----IV 302
L +A+ H G++HRD+K EN FL DE DFG + + D +
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFL----DEPENAVLGDFGAA--CKLDAHPDTPQCYGWS 248
Query: 303 GSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKA 355
G+ +PE+L Y + D+WS G++ + + + + + + S R++++
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305
|
Length = 392 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQK----VAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E+G G+FG KKG +K +K VA+K++ A+ +++ RE +++ L
Sbjct: 2 ELGSGNFGTV-----KKGMYKMKKSEKTVAVKILKNDNNDPALK-DELLREANVMQQLD- 54
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
+ +V+ E ++ +VMEL E G L ++ L + +E ++ Q+ + +
Sbjct: 55 NPYIVRMIGICEA-ESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYY----VAPEV 312
VHRDL N L ++ + K DFGLS + DE + APE
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYA---KISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 313 L-HRSYGTEADVWSIGVIAY 331
+ + + +++DVWS GV+ +
Sbjct: 170 MNYYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 301 IVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359
I+G+ Y+APE+L + +G D W++GV + L G PF T +F+ +L D +
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599
Query: 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396
+G LS +A++ +++LL DP KR + HP
Sbjct: 600 PEGE-EKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 64/227 (28%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR----EVKILRALSGH 197
+G G+FG A KK K AIK M A E+ R E+++L L H
Sbjct: 10 IGEGNFGQVIRAMIKKDGLK-MNAAIK------MLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 198 SNLVKFYDAFEDLDNVYIVMELCEGGELLD-----RILSRCGKYSEDEAKA--------- 243
N++ A E+ +YI +E G LLD R+L ++++ A
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 244 -VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDI 301
+ + + +HRDL N L E+ K DFGLS R +E +
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLS---RGEEVYVKKT 176
Query: 302 VGS--AYYVAPEVLHRS-YGTEADVWSIGVIAY-ILLCGSRPFWART 344
+G ++A E L+ S Y T++DVWS GV+ + I+ G P+ T
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
L++ +++G G FG + + + KVA+K + M+ E E +I++ L
Sbjct: 8 LQLIKKLGNGQFGEVWMGTW----NGNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLR 59
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSE-DEAKAVLVQILNVVAF 254
H LV+ Y A + +YIV E G LLD + G+ + + Q+ +A+
Sbjct: 60 -HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE 311
+HRDL+ N L + K DFGL+ + D G+ + + APE
Sbjct: 118 IERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 312 V-LHRSYGTEADVWSIGVIAYILLCGSR 338
L+ + ++DVWS G++ L+ R
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 65/298 (21%), Positives = 124/298 (41%), Gaps = 59/298 (19%)
Query: 135 RLEVGEEVGRGHFGYTC--TARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
L +G+ +G G FG TA KG VA+K++ ++ ++ + D+ E +L+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLK 58
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGEL--------------LDRILSRCGKYSE 238
++ H +++K Y A + +++E + G L L +R Y +
Sbjct: 59 QVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 239 -DEAKAVLV--------QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289
+ +A+ + QI + + +VHRDL N L E ++K DFGLS
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFGLS 174
Query: 290 DFVRPDE----RLNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPF--- 340
V ++ R + ++A E L Y T++DVWS GV+ + I+ G P+
Sbjct: 175 RDVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233
Query: 341 -----WARTESG------------IFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNK 381
+ ++G ++ +L D P+ + +K+ K+++
Sbjct: 234 APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKR-PTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 61/251 (24%), Positives = 97/251 (38%), Gaps = 63/251 (25%)
Query: 133 TSRLEVGEEVGRGHFG--YTCTA---------RYKKGEHKDQK--VAIKVIPKSKMTTAI 179
L E++G G FG + C A + + ++ D VA+KV+ A
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 180 AVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSED 239
ED +EVKIL LS N+ + + ++ME E G+ L++ L +
Sbjct: 64 --EDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGD-LNQFLQKH----VA 115
Query: 240 EAKAVLVQILNVVAFCHLH---------------GVVHRDLKPENFLYTSKDESSQLKAI 284
E + ++ L+ VHRDL N L ++ +K
Sbjct: 116 ETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIA 172
Query: 285 DFGLSDFVRPDERLNDIVGSAYY------VAP-------EVLHRSYGTEADVWSIGVIAY 331
DFG+S ++ S YY P VL + T++DVW+ GV +
Sbjct: 173 DFGMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 332 -IL-LCGSRPF 340
IL LC +P+
Sbjct: 224 EILTLCREQPY 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 43/142 (30%), Positives = 64/142 (45%), Gaps = 23/142 (16%)
Query: 164 KVAIKV-IPKS----KMTTAIAVEDVRREVKIL-RALSGHSNLVKFYDAFEDLDNVYIVM 217
K IK IPK ++ I E RRE +I+ RA N+ Y F D +N IVM
Sbjct: 21 KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVY--FVDPENFIIVM 78
Query: 218 ELCEG---GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS 274
E EG +L++ + S + + LV L H G++H DL N + +
Sbjct: 79 EYIEGEPLKDLINSNGMEELELSREIGR--LVGKL------HSAGIIHGDLTTSNMILS- 129
Query: 275 KDESSQLKAIDFGLSDFVRPDE 296
++ IDFGL++F + E
Sbjct: 130 ---GGKIYLIDFGLAEFSKDLE 148
|
Length = 211 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 52/225 (23%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVED-VRREVKILRALSGHSN 199
E+G G+FG YK K VAIKV+ K +V D + RE +I+ L +
Sbjct: 2 ELGSGNFGCVKKGVYKM-RKKQIDVAIKVL---KNENEKSVRDEMMREAEIMHQLD-NPY 56
Query: 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH--- 256
+V+ E + + +VME+ GG L ++ LS GK E + + NVV H
Sbjct: 57 IVRMIGVCE-AEALMLVMEMASGGPL-NKFLS--GKKDE-------ITVSNVVELMHQVS 105
Query: 257 -----LHG--VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYY-- 307
L G VHRDL N L ++ + K DFGLS + D+ +YY
Sbjct: 106 MGMKYLEGKNFVHRDLAARNVLLVNQHYA---KISDFGLSKALGADD--------SYYKA 154
Query: 308 ----------VAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPF 340
APE ++ R + + +DVWS G+ + G +P+
Sbjct: 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 38/150 (25%), Positives = 53/150 (35%), Gaps = 20/150 (13%)
Query: 153 ARYKKGEHKDQKVAIKV-IPKSKMTTAIAV----EDVRREVKILRALSGHSNLVKFYDAF 207
A + +K IPK + E RRE +IL V +
Sbjct: 10 AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA--REAGVPVPIVY 67
Query: 208 E-DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLK 266
+ D DN IVME EG L D + + + V H G+VH DL
Sbjct: 68 DVDPDNGLIVMEYIEGELLKDALEEARPDLLREVGRLV--------GKLHKAGIVHGDLT 119
Query: 267 PENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
N + + ++ IDFGL +F E
Sbjct: 120 TSNIILS----GGRIYFIDFGLGEFSDEVE 145
|
Length = 204 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 57/240 (23%), Positives = 93/240 (38%), Gaps = 48/240 (20%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAV-EDVRREVKI 190
S + EE+G G FG Y VAIK + ++ V ++ R+E ++
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQEFRQEAEL 61
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR-------CGKYSEDEAKA 243
+ L H N+V ++ E G+L + ++ E +
Sbjct: 62 MSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 244 --------VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295
+ +QI + + H VHRDL N L E +K DFGLS
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLS------ 171
Query: 296 ERLNDIVGSAYY------------VAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPFW 341
DI + YY + PE +L+ + TE+D+WS GV+ + I G +P++
Sbjct: 172 ---RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 8/133 (6%)
Query: 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLY 272
V +V +L G LLD + + + VQI +++ +VHRDL N L
Sbjct: 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142
Query: 273 TSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA----YYVAPEVLHRSYGTEADVWSIGV 328
S + +K DFGL+ + DE G + +LHR + ++DVWS GV
Sbjct: 143 KS---PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGV 199
Query: 329 IAYILLC-GSRPF 340
+ L+ G++P+
Sbjct: 200 TVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 65/235 (27%), Positives = 99/235 (42%), Gaps = 37/235 (15%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRR---EVK 189
+ ++ + +G G+FG AR KK G D AIK +M + +D R E++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMD--AAIK-----RMKEYASKDDHRDFAGELE 59
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD-----RIL----------SRCG 234
+L L H N++ A E +Y+ +E G LLD R+L S
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 235 KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294
S + + + + +HRDL N L E+ K DFGLS R
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RG 173
Query: 295 DE-RLNDIVGS--AYYVAPEVLHRS-YGTEADVWSIGVIAY-ILLCGSRPFWART 344
E + +G ++A E L+ S Y T +DVWS GV+ + I+ G P+ T
Sbjct: 174 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 57/243 (23%), Positives = 104/243 (42%), Gaps = 32/243 (13%)
Query: 122 LDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARY----KKGEHKDQKVAIKVIPKSKMTT 177
LD ++ F ++ RL +G+ +G G FG A K + VA+K++ +
Sbjct: 3 LDPKWEFPRD---RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK 59
Query: 178 AIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR---CG 234
+A D+ E+++++ + H N++ +Y+++E G L + + +R
Sbjct: 60 DLA--DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGP 117
Query: 235 KYSEDEAK------------AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLK 282
Y+ D K + Q+ + + +HRDL N L T E + +K
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMK 174
Query: 283 AIDFGLSDFVRPDERLNDIVGS---AYYVAPEVL-HRSYGTEADVWSIGVIAY-ILLCGS 337
DFGL+ V + ++APE L R Y ++DVWS G++ + I G
Sbjct: 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234
Query: 338 RPF 340
P+
Sbjct: 235 SPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 43/152 (28%), Positives = 56/152 (36%), Gaps = 24/152 (15%)
Query: 153 ARYKKGEHKDQKVAIKV-IPKS----KMTTAIAVEDVRREVKILRALSGHSNLVK---FY 204
A G+ K IK +PKS ++ I E R E ++L V Y
Sbjct: 8 AIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA--RKAGVNTPVVY 65
Query: 205 DAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRD 264
D D DN IVME EG L D I + + + V H G+VH D
Sbjct: 66 DV--DPDNKTIVMEYIEGKPLKDVIEEGNDELLREIGRLV--------GKLHKAGIVHGD 115
Query: 265 LKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
L N + +L IDFGL + E
Sbjct: 116 LTTSNIIVR----DDKLYLIDFGLGKYSDEIE 143
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR---EVKILRALSG 196
+E+G G FG G Q V +K ++ + +V++ + E + R+L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQ-VVVK-----ELRVSASVQEQMKFLEEAQPYRSLQ- 53
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQ-----ILNV 251
HSNL++ ++ +VME C G+L L C K +Q I
Sbjct: 54 HSNLLQCLGQCTEVTPYLLVMEFCPLGDL-KGYLRSCRKAELMTPDPTTLQRMACEIALG 112
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD-------FVRPDERLNDIVGS 304
+ H + +H DL N L T+ +K D+GLS +V PD+ +
Sbjct: 113 LLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL--- 166
Query: 305 AYYVAPEVLHRSYGT--------EADVWSIGVIAYILL-CGSRPF 340
++APE++ +G E++VWS+GV + L GS+P+
Sbjct: 167 -RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
VQI + + +VHRDL N L + +K DFGL+ + DE+ G
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 306 Y---YVAPE-VLHRSYGTEADVWSIGVIAYILLC-GSRPF 340
++A E +LHR Y ++DVWS GV + L+ GS+P+
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 44/167 (26%), Positives = 67/167 (40%), Gaps = 22/167 (13%)
Query: 237 SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
+E+E AV +Q +HR K N L T LK G F
Sbjct: 15 NEEEIWAVCLQ------CLGALRELHRQAKSGNILLT---WDGLLKL--DGSVAFK---T 60
Query: 297 RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLK 354
Y++APEV+ SY +AD++S+G+ Y L P R S I +L
Sbjct: 61 PEQSRPDP-YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119
Query: 355 ADPSFDDGSWPSLSSD-----AKDFVKLLLNKDPRKRMTAAQALSHP 396
P+ D +L +DF++L ++ P++R A L+H
Sbjct: 120 GMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 53/286 (18%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQK---VAIKVIPKSKMTTAIAVEDVRREVKILRALSGH 197
++G+G FG AR G + VA+K++ + A D +RE ++ H
Sbjct: 12 DIGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMAEFD-H 67
Query: 198 SNLVKF---------------YDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSED--- 239
N+VK Y A+ DL+ ++ L S K +
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNE-FLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 240 ----EAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS------ 289
E + Q+ +A+ VHRDL N L E+ +K DFGLS
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYSA 183
Query: 290 DFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGI 348
D+ + E ND + + + + Y TE+DVW+ GV+ + I G +P++ +
Sbjct: 184 DYYKASE--NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 349 FRAVLKADPSFDDG---SWP-SLSSDAKDFVKLLLNKDPRKRMTAA 390
V DG S P + + + ++L +K P R + A
Sbjct: 242 IYYV-------RDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFA 280
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 55/246 (22%), Positives = 95/246 (38%), Gaps = 46/246 (18%)
Query: 140 EEVGRGHFGYTCTAR-YKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198
EE+G FG Y G Q VAIK + + + ++E ++ L H
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELH-HP 67
Query: 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR-------CGKYSEDEAKAVL------ 245
N+V V ++ E G+L + ++ R C + K+ L
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 246 ---VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV 302
+QI + + H VH+DL N L E +K D GLS +I
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLS---------REIY 175
Query: 303 GSAYY------------VAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGI 348
+ YY + PE +++ + +++D+WS GV+ + I G +P++ + +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235
Query: 349 FRAVLK 354
V K
Sbjct: 236 IEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 65/223 (29%)
Query: 244 VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR------PDER 297
++ QIL + H G+VHRD+KP+N +++ + S K ID G + +R P E
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEF 317
Query: 298 LNDIVGSAYYVAPEVLHRSYGT-EA----------------------DVWSIGVIAYILL 334
L D Y APE S T A D++S G+I ++ +
Sbjct: 318 LLD----PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI-FLQM 372
Query: 335 CGSRPFWARTESGI--FRAVLKADPSFDDGSW-----PSLSSDAK--------------D 373
R++S + F LK +D +W P S D + +
Sbjct: 373 AFPN---LRSDSNLIQFNRQLK-RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE 428
Query: 374 FVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLM 416
+K ++ R+R++A AL+HP+ L +S+++ +
Sbjct: 429 LLKSMMRFKGRQRISAKAALAHPYFDREG----LLGLSVMQNL 467
|
Length = 566 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 13/205 (6%)
Query: 142 VGRGHFGYTCTARY-KKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
+G G FG + +GE VAIK++ ++ T A + E I+ ++ H +L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMD-HPHL 71
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
V+ + +V +L G LLD + VQI + + +
Sbjct: 72 VRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEVLH-RS 316
VHRDL N L S + +K DFGL+ + DE+ + G ++A E +H R
Sbjct: 131 VHRDLAARNVLVKSPN---HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 317 YGTEADVWSIGVIAYILLC-GSRPF 340
+ ++DVWS GV + L+ G +P+
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 61/245 (24%), Positives = 108/245 (44%), Gaps = 37/245 (15%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
+G +G+G FG A+ K + QKVA+K++ K+ + ++ +E+ RE ++
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 196 GHSNLVKFYD------AFEDLDNVYIVMELCEGGELLDRIL-SRCGKYSEDEAKAVLVQI 248
H N++K A L +++ + G+L +L SR G+ LV+
Sbjct: 60 -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 249 LNVVA----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS------DFVRPDERL 298
+ +A + +HRDL N + +E+ + DFGLS D+ R
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQ---- 171
Query: 299 NDIVGSAY-----YVAPEVLHRS-YGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 351
G A ++A E L + Y T +DVW+ GV + I+ G P+ S I+
Sbjct: 172 ----GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY 227
Query: 352 VLKAD 356
++K +
Sbjct: 228 LIKGN 232
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 32/216 (14%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+GHFG + + A+K + +++T VE +E I++ S H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFS-HPNVL 59
Query: 202 KFYDAFEDLDNV-YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
+ +V+ + G+L + I S + + +Q+ + +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYY------------- 307
VHRDL N + DES +K DFGL+ DI YY
Sbjct: 120 VHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNHTGAKLPVK 167
Query: 308 -VAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPF 340
+A E L + + T++DVWS GV+ + L+ G+ P+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 32/226 (14%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR----EVKILRALSGH 197
+G G FG C K ++ VAI A + RR E L H
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIH------TLRAGCSDKQRRGFLAEALTLGQFD-H 65
Query: 198 SNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCH 256
SN+V+ + + IV E G LD L + G+ + +L + + + +
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDERLNDIVGS------AYYVA 309
G VH+ L L S + +S F R +++ I + + A
Sbjct: 125 EMGYVHKGLAAHKVLVNSD--------LVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAA 176
Query: 310 PEVL--HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
PE + H + + +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 177 PEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 54/238 (22%), Positives = 105/238 (44%), Gaps = 24/238 (10%)
Query: 135 RLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKS-KMTTAIAVEDVRREVKIL 191
++ + E+G+G FG Y A+ + + +VAIK + ++ M I + E ++
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 63
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV-----LV 246
+ + H ++V+ ++MEL G+L + S + + +A ++
Sbjct: 64 KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 247 Q----ILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDI 301
Q I + +A+ + + VHRDL N + E +K DFG++ D D
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 302 VG--SAYYVAPEVLHRS-YGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKA 355
G +++PE L + T +DVWS GV+ + I +P+ + + R V++
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 45/217 (20%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 157 KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVK----FYDAFEDLDN 212
KG +++V I+ K + ++ E+K LR + +N++K D +DL
Sbjct: 38 KGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPR 96
Query: 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL-----NVVAFCHLHGVVHRDLKP 267
+ +++E C G L + + +D + + + + +++L
Sbjct: 97 LSLILEYCTRGYLREVL-----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTS 151
Query: 268 ENFLYTSKDESSQLKAIDFGLSDF--VRPDERLNDIVGSAYYVAPEVLH---RSYGTEAD 322
+FL T E+ +LK I GL P + +N +V Y + ++L+ Y + D
Sbjct: 152 VSFLVT---ENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDD 204
Query: 323 VWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359
++S+GV+ + + G PF T I+ ++ + S
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL 241
|
Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 56/251 (22%), Positives = 100/251 (39%), Gaps = 29/251 (11%)
Query: 104 STKKSSAEEGAPEEAAPELD-------KRFGFSKEVTSRLEVGEEVGRGHFG--YTCTAR 154
+ S A +EA P+ + E + V +++ G FG + C R
Sbjct: 111 GAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALR 170
Query: 155 YKKGEHKDQK---VAIKVIPKSKMTTAIAVEDVRR-------EVKILRALSGHSNLVKFY 204
E + ++ + PK + A V+ R E+ L L+ H N++K
Sbjct: 171 ASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HENILKIE 229
Query: 205 DAFEDLDNVYIVMELCE---GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ N Y++ + + + D + + +A++ Q+L V + H ++
Sbjct: 230 EILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLI 289
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFG-LSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SYG 318
HRD+K EN ++ + D L DFG F + E VG+ +PE+L Y
Sbjct: 290 HRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC 346
Query: 319 TEADVWSIGVI 329
D+WS G+I
Sbjct: 347 EITDIWSCGLI 357
|
Length = 501 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 18/90 (20%)
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLS-------DFVRP-DERLNDIVGSAYYVAPE- 311
+HRDL N L + E++ +K DFGL+ D+VR D RL ++APE
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL-----PLKWMAPET 252
Query: 312 VLHRSYGTEADVWSIGVIAY-ILLCGSRPF 340
+ R Y ++DVWS GV+ + I G+ P+
Sbjct: 253 IFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 243 AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLN--- 299
AV Q+L+ + + H G++HRD+K EN L ++ + DFG + F R
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARGSWSTPFHY 320
Query: 300 DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAY 331
I G+ APEVL Y D+WS G++ +
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 11/89 (12%)
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
+QI +++ H GV+H+D+ N + DE Q+K D LS + P + +G
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDY--HCLGDN 178
Query: 306 YY-----VAPEVL-HRSYGTEADVWSIGV 328
+A E L ++ Y + +DVWS GV
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGV 207
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 18/90 (20%)
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLS-------DFVRP-DERLNDIVGSAYYVAPE- 311
+HRDL N L + E++ +K DFGL+ D+VR D RL ++APE
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL-----PLKWMAPES 246
Query: 312 VLHRSYGTEADVWSIGVIAY-ILLCGSRPF 340
+ + Y T++DVWS GV+ + I G+ P+
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 65/258 (25%), Positives = 111/258 (43%), Gaps = 33/258 (12%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
L +G+ +G G FG + + + KVA+K + K + T +ED E ++
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSI-LKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFD 58
Query: 196 GHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRIL-SRCGKYSEDEAKAVLVQI 248
H N+++ E + +++ + G+L +L SR G + +LV+
Sbjct: 59 -HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 249 LNVVA----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS------DFVRPDERL 298
+ +A + +HRDL N + +E+ + DFGLS D+ R R+
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYR-QGRI 173
Query: 299 NDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV---- 352
+ ++A E L R Y T++DVWS GV + I G P+ S I+ +
Sbjct: 174 AKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
Query: 353 -LKADPSFDDGSWPSLSS 369
LK P DG + +SS
Sbjct: 232 RLKQPPDCLDGLYSLMSS 249
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 24/93 (25%)
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLS-------DFVRPDERLNDIVGSAY----YVA 309
+HRDL N L + E++ +K DFGL+ D+VR GSA ++A
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK--------GSARLPLKWMA 244
Query: 310 PE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPF 340
PE + + Y T++DVWS GV+ + I G+ P+
Sbjct: 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSA 305
Q+ N + F VHRDL N L E +K DFGL+ D +R ++ GS
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISK--GST 301
Query: 306 Y----YVAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPF 340
+ ++APE + + Y T +DVWS G++ + I G P+
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 33/189 (17%)
Query: 228 RILSRCGKYSEDEAKAVLV-----------------QILNVVAFCHLHGVVHRDLKPENF 270
R R G Y + + + ++ Q+ ++F +HRDL N
Sbjct: 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245
Query: 271 LYTSKDESSQLKAIDFGLSDFVRPDERLNDIV-GSAY----YVAPE-VLHRSYGTEADVW 324
L T K DFGL+ +R D N +V G+A ++APE + + Y E+DVW
Sbjct: 246 LLT---HGRITKICDFGLARDIRNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300
Query: 325 SIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS-SDAKDFVKLLLNKD 382
S G++ + I GS P+ F ++K P + S+ D +K + D
Sbjct: 301 SYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS---PECAPSEMYDIMKSCWDAD 357
Query: 383 PRKRMTAAQ 391
P KR T Q
Sbjct: 358 PLKRPTFKQ 366
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 39/230 (16%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
L++G+ +G G FG + + + KVA+K + K + T +E+ E ++
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD 59
Query: 196 GHSNLVKFY------DAFEDLDNVYIVMELCEGGELLDRIL-SRCGKYSEDEAKAVLVQI 248
H N++K + + + +++ + G+L +L SR G E L++
Sbjct: 60 -HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 249 LNVVA----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
+ +A + +HRDL N + E + DFGLS I
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLS---------KKIYSG 166
Query: 305 AYY------------VAPEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPF 340
YY +A E L R Y +++DVW+ GV + I G P+
Sbjct: 167 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 22/46 (47%), Positives = 28/46 (60%), Gaps = 3/46 (6%)
Query: 242 KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287
K V+ Q+L + H G+VHRD+KPEN L T Q+K IDFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 31/135 (22%), Positives = 49/135 (36%), Gaps = 37/135 (27%)
Query: 183 DVRREVKILRALSGHSNLVKFYDAFEDLDNVYI-------------VMELCEGGELLDRI 229
D RRE N +F + F+D +VY+ ME +G ++ D
Sbjct: 207 DYRREAA---------NAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIA 257
Query: 230 LSR-----CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284
+ + +E +A L Q+L G H D P N L S ++ +
Sbjct: 258 ALKSAGIDRKELAELLVRAFLRQLLR-------DGFFHADPHPGNILVRSDG---RIVLL 307
Query: 285 DFGLSDFVRPDERLN 299
DFG+ + P R
Sbjct: 308 DFGIVGRLDPKFRRY 322
|
Length = 517 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 66/304 (21%), Positives = 117/304 (38%), Gaps = 68/304 (22%)
Query: 153 ARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211
ARYK GE+ V ++ I T + V ++ E+ + + L H N+V + F +
Sbjct: 19 ARYKPTGEY----VTVRRINLEACTNEM-VTFLQGELHVSK-LFNHPNIVPYRATFIADN 72
Query: 212 NVYIVMELCEGGELLDRILSRCGKY----SEDEAKAVLVQILNVVAFCHLHGVVHRDLKP 267
+++V G D I C + SE +L +L + + H G VHR +K
Sbjct: 73 ELWVVTSFMAYGSAKDLI---CTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKA 129
Query: 268 ENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI-------VGSAYYVAPEVLHRS---Y 317
+ L S D L + LS + +RL + V +++PEVL ++ Y
Sbjct: 130 SHIL-ISVDGKVYLSGLRSNLS-MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGY 187
Query: 318 GTEADVWSIGVIAYILLCGSRPF------------------------------------W 341
++D++S+G+ A L G PF
Sbjct: 188 DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSR 247
Query: 342 ARTESGIFRAVLKADPSFDDGSWP------SLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
+ SG+ + + P +G + S FV+ L ++P R +A+ L+H
Sbjct: 248 SGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307
Query: 396 PWIR 399
+ +
Sbjct: 308 SFFK 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 61/249 (24%), Positives = 98/249 (39%), Gaps = 53/249 (21%)
Query: 134 SRLEVGEEVGRGHFG--YTCTA-------------RYKKGEHKDQKVAIKVIPKSKMTTA 178
L E++G G FG + C +KG + VA+K++
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG--RPLLVAVKILRPD--ANK 60
Query: 179 IAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSE 238
A D +EVKIL L N+++ D D + ++ E E G+L + S E
Sbjct: 61 NARNDFLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119
Query: 239 DEAK------------------AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ 280
+ V +QI + + + VHRDL N L E+
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLT 176
Query: 281 LKAIDFGLS------DFVRPDERLNDIVGSAYYVAPE-VLHRSYGTEADVWSIGVIAY-- 331
+K DFG+S D+ R R V ++A E +L + T +DVW+ GV +
Sbjct: 177 IKIADFGMSRNLYAGDYYRIQGR---AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
Query: 332 ILLCGSRPF 340
++LC +P+
Sbjct: 234 LMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 56/238 (23%)
Query: 137 EVGEE----VGRGH-FGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
E+GE+ V +GH FG GE + Q VAIK + K K + E+ + E ++
Sbjct: 12 ELGEDRFGKVYKGHLFGTA------PGE-QTQAVAIKTL-KDKAEGPLR-EEFKHEA-MM 61
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY---SEDEAKAV---- 244
R+ H N+V + ++ C +L + ++ R S D+ K V
Sbjct: 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTL 121
Query: 245 --------LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
+ QI + F H VVH+DL N L K +K D GL
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK---LNVKISDLGL-------- 170
Query: 297 RLNDIVGSAYY------------VAPE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPF 340
++ + YY ++PE +++ + ++D+WS GV+ + + G +P+
Sbjct: 171 -FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 16/65 (24%), Positives = 30/65 (46%), Gaps = 3/65 (4%)
Query: 227 DRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDF 286
I R ++ K ++ +L + + H HG+ H D+KPEN + + ID+
Sbjct: 114 KEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY---IIDY 170
Query: 287 GLSDF 291
G++
Sbjct: 171 GIASH 175
|
Length = 294 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 58/233 (24%)
Query: 237 SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
SE +L L + + H +G +HR++K + L S D L + L VR +
Sbjct: 99 SEALIGNILFGALRGLNYLHQNGYIHRNIKASHIL-ISGDGLVSLSGLS-HLYSLVRNGQ 156
Query: 297 RLNDI-------VGSAYYVAPEVLHRS---YGTEADVWSIGVIAYILLCGSRPF--WART 344
+ + +++PE+L + Y ++D++S+G+ A L G PF RT
Sbjct: 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT 216
Query: 345 E----------------------------------SGIFRAVLKADPS-------FDDGS 363
+ SGI +V+ A + S
Sbjct: 217 QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS 276
Query: 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLM 416
+ S ++ V+L L +DP KR +A+ LSH + + VK SIL L+
Sbjct: 277 SKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF---FKQVKEQTQGSILSLL 326
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 27/105 (25%), Positives = 46/105 (43%), Gaps = 18/105 (17%)
Query: 248 ILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYY 307
+L + + H + ++HRD+K EN + + DFG + F DI + YY
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPV------DINANKYY 241
Query: 308 --------VAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWAR 343
APE+L R YG D+WS G++ + + + +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286
|
Length = 391 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.004
Identities = 40/148 (27%), Positives = 58/148 (39%), Gaps = 31/148 (20%)
Query: 153 ARYKKGEHKDQKVAIKV-IPKS----KMTTAIAVEDVRREVKILRALSGH---SNLVKFY 204
A KKGE+ + IK +PK ++ + E R E ++L + ++ Y
Sbjct: 347 ADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI--Y 404
Query: 205 DAFEDLDNVYIVMELCEG---GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
D D + IVME G ++L+ K E AK H G+V
Sbjct: 405 DV--DPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAK------------LHKAGIV 450
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS 289
H DL NF+ +L IDFGL
Sbjct: 451 HGDLTTSNFIVRDD----RLYLIDFGLG 474
|
Length = 535 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.42 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.38 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.37 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.32 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.29 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.27 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.23 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 98.21 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 98.15 | |
| PF00036 | 29 | EF-hand_1: EF hand; InterPro: IPR018248 Many calci | 98.15 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 98.14 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 98.1 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.07 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.01 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 97.98 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 97.95 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 97.92 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| PF13405 | 31 | EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J | 97.88 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 97.79 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.74 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 97.69 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.67 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 97.64 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 97.61 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 97.56 | |
| PF14658 | 66 | EF-hand_9: EF-hand domain | 97.55 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 97.53 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 97.53 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.53 | |
| PF13202 | 25 | EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ | 97.52 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.47 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.46 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 97.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.36 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.36 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-65 Score=486.15 Aligned_cols=270 Identities=36% Similarity=0.623 Sum_probs=246.2
Q ss_pred CCccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHH----HHHHHHHHHHHHHHccCCCCccE
Q 011154 127 GFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAI----AVEDVRREVKILRALSGHSNLVK 202 (492)
Q Consensus 127 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~----~~~~~~~Ev~~l~~l~~hpniv~ 202 (492)
...+.+.+.|.+.+.||+|+||.|-+|..+. +|+.||||++.+....... ....+.+|++||++|+ |||||+
T Consensus 165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~ 240 (475)
T KOG0615|consen 165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVR 240 (475)
T ss_pred CccchhcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEE
Confidence 4456678899999999999999999998776 8999999999886654311 2234679999999995 999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEE
Q 011154 203 FYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 203 l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~k 282 (492)
++++|+..+..|+||||++||+|++++..+ +.+.+...+.+++|++.||.|||++||+||||||+|||+..+.++..+|
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEE
Confidence 999999999999999999999999999876 6899999999999999999999999999999999999999887889999
Q ss_pred EEecccccccCCCCCccccccCccccccccccC----CCCCccchHHHHHHHHHHhcCCCCCCCCChhH-HHHHHHhcCC
Q 011154 283 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR----SYGTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADP 357 (492)
Q Consensus 283 l~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~-~~~~i~~~~~ 357 (492)
|+|||+|++......+.+.|||+.|.|||++.. .+..++||||+|||||.+|+|.+||....... ..+.|.++.+
T Consensus 320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 999999999998888999999999999999863 25568999999999999999999998877666 8899999999
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 358 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.|....|..+|+++++||.+||.+||++|||+.|+|+||||+..
T Consensus 400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 99999999999999999999999999999999999999999964
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-59 Score=471.12 Aligned_cols=322 Identities=54% Similarity=0.912 Sum_probs=293.7
Q ss_pred CccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEE
Q 011154 128 FSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAF 207 (492)
Q Consensus 128 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~ 207 (492)
....+...|++++.||+|.||+||.++.+. +|+.+|+|+|.+.........+.+.+|+.+|+.|.+|||||.++++|
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~ 105 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF 105 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 345677899999999999999999999776 69999999999888776666778999999999997799999999999
Q ss_pred EeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC-CCcEEEEec
Q 011154 208 EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE-SSQLKAIDF 286 (492)
Q Consensus 208 ~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~-~~~~kl~Df 286 (492)
++.+.+++|||+|.||+|+++|... .++|.++..++.||+.++.|||+.||+||||||+|+|+...+. ++.+|++||
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999999999887 4999999999999999999999999999999999999987654 458999999
Q ss_pred ccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
|+|............+||++|+|||++. ..|+..+||||+||++|.|++|..||++.+..+.+..|..+...|..+.|+
T Consensus 184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~ 263 (382)
T KOG0032|consen 184 GLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD 263 (382)
T ss_pred CCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc
Confidence 9999998877889999999999999998 689999999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc-ccCCCccHHHHHHHHHHhhhhhhHHHHHHhhhcccchhhHHH
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN-NVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFY 444 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~a~l~~l~~~l~~~e~~~ 444 (492)
.+|..+++||++||..||.+|+|+.++|+|||++... ....+.+..+...++++...+++++.+++.....++ ...
T Consensus 264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 340 (382)
T KOG0032|consen 264 DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISG 340 (382)
T ss_pred ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHH
Confidence 9999999999999999999999999999999999863 344556666777788888888888887777766655 777
Q ss_pred HHHHHhhhCCCCC
Q 011154 445 LKEQFALLEPNKN 457 (492)
Q Consensus 445 l~~~F~~~D~~~~ 457 (492)
++++|..+|.+++
T Consensus 341 ~~~~~~~~~~~~~ 353 (382)
T KOG0032|consen 341 LKEMFKLMDTDNN 353 (382)
T ss_pred HHHHHHhhccccc
Confidence 8999999999877
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-60 Score=474.28 Aligned_cols=255 Identities=36% Similarity=0.639 Sum_probs=239.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.+|..++.||+|||+.||.++... +|+.||+|+|++..+......+.+.+||+|.+.|+ |||||+++++|++.+++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCce
Confidence 679999999999999999998654 89999999999988888888889999999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|||+|+|..|+|..++. +.+.++|.+++.+++||+.||.|||+++|||||||..|+|+ +++.+|||+|||||+.+.
T Consensus 94 YivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeec
Confidence 99999999999988665 56899999999999999999999999999999999999999 788899999999999987
Q ss_pred CC-CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PD-ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.+ ++..+.||||.|.|||++.+ .++.++||||+|||||.||+|++||...+-.++++.|...++.++. .+|.++
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A 245 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEA 245 (592)
T ss_pred CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHH
Confidence 55 77889999999999999864 5999999999999999999999999999999999999999988876 799999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
++||.+||..||.+|||+.+||.|+||+.
T Consensus 246 ~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 246 KDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 99999999999999999999999999943
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-61 Score=431.00 Aligned_cols=297 Identities=34% Similarity=0.643 Sum_probs=270.3
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.+.|++.+.||+|.|+.|+++..+. +|+.+|+|+|....+... ..+++.+|+.|.+.|+ |||||+|++.+.+.+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcC-CCcEeehhhhhcccc
Confidence 56789999999999999999987654 899999999987666544 6678999999999996 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..|||+|+|.||+|...|.++ ..++|..+-.+++||+++|.|||.+||||||+||+|+|+.+++...-+||+|||+|..
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred eeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999999999988877 5789999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
+..+......+|||+|||||++.+ .|+..+|||+.|||||.||.|.+|||+.+...+++.|.++...++...|+.++++
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 987777788999999999999875 5999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccccccccC-CCccHHHHHHHHHHhhhhhhHHHHHHhhh
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVK-VPLDISILKLMKAYMQSSSLRRAALKALS 434 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~a~l~~l~ 434 (492)
+++||++||..||.+|+|+.|+|+|||+++....- ..--......|++|....+|+.+++..+.
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~ 307 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVI 307 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999854321 11223567889999999999999888764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-56 Score=428.45 Aligned_cols=265 Identities=35% Similarity=0.627 Sum_probs=238.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
....+|.+.+.||+|+||+||+|+++. ++..||||.|.+... ....++.+..|+++|+.|. |||||+|+++++++
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDD 81 (429)
T ss_pred cccccceehhhccCcceEEEEEeEecc---CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecC
Confidence 345789999999999999999999987 679999999988765 4456677899999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCC---CcEEEEecc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES---SQLKAIDFG 287 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~---~~~kl~DfG 287 (492)
+.+|||||||+||+|.++|+.+ +.++|..++.++.||+.||++||+++||||||||+||||+..... ..+||+|||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999999999999876 689999999999999999999999999999999999999875333 689999999
Q ss_pred cccccCCCCCccccccCccccccccc-cCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 288 LSDFVRPDERLNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 288 la~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
+|+.+.+.....+.||++.|||||++ ..+|+.|+|+||+|+|+|+|++|+.||...+..+++..+.++....+... ..
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~ 239 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AE 239 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hh
Confidence 99999988888999999999999998 47899999999999999999999999999999999998877664443322 24
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++....+|+..+|..+|..|.+..+-+.|+++....
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 677788999999999999999999999999998653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-56 Score=448.05 Aligned_cols=257 Identities=34% Similarity=0.652 Sum_probs=237.8
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.-|++++.||.|+-|.|-+|++.. +|+.+|||+|.+...........+.+||-||+.|. ||||+++|++|++..++
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHL 87 (786)
T ss_pred cceeccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceE
Confidence 568999999999999999998665 99999999999875555445566899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|.||++||.|++++..+ +.+++.+++++++||+.|+.|||..+|+||||||+|+|+ |...++||+|||+|..-.
T Consensus 88 ylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeeccc
Confidence 9999999999999999887 789999999999999999999999999999999999999 666679999999999988
Q ss_pred CCCCccccccCccccccccccCC-C-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLHRS-Y-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
++.-+.+.||+++|.|||++.+. | +.++||||+|||||.||||++||.+.+...++.++.++.+..+. .+|.++
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~ea 239 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEA 239 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHH
Confidence 88889999999999999998764 4 67899999999999999999999999999999999999888874 799999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++||++||.+||++|+|.+||++|||+.++.
T Consensus 240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 240 QDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-56 Score=423.15 Aligned_cols=259 Identities=33% Similarity=0.639 Sum_probs=236.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||.++.+. +++.||+|+++|.........+...+|..||..+. ||.||.++-.|++.+.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEK 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCe
Confidence 4789999999999999999999774 89999999999988877777888999999999994 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc-
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF- 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~- 291 (492)
+|||+||+.||+|+.+|.+. +.|+|..++.++..|+.||.|||++|||||||||+|||+ |..++++|+||||++.
T Consensus 100 LylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhc
Confidence 99999999999999888544 799999999999999999999999999999999999999 8899999999999985
Q ss_pred cCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
+..+....+.|||+.|||||++. ..|+..+|.|||||++|+|++|.+||.+.+...+.++|.+....+... .++.+
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ 252 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEE 252 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHH
Confidence 44455667789999999999876 569999999999999999999999999999999999999987444332 48999
Q ss_pred HHHHHHHccccCcCCCC----CHHHHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRM----TAAQALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rp----s~~e~l~hp~~~~~~ 402 (492)
+++||+++|..||++|. ++.++-+||||+..+
T Consensus 253 ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 253 ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 99999999999999995 799999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-56 Score=421.10 Aligned_cols=259 Identities=30% Similarity=0.508 Sum_probs=225.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC-e
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD-N 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~-~ 212 (492)
++.+....||+|..|+||+++++. +++.+|+|+|... .+....+++.+|+++++.. +|||||.+|+.|.+++ .
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKP---TGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcC---CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCce
Confidence 456778899999999999999886 8899999999433 3455677899999999999 5999999999999999 4
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
++|+||||+||||.+.+... ++++|.....|+.++++||.|||+ ++||||||||+|||+ +..+.|||||||.++.
T Consensus 153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGI 228 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHH
Confidence 99999999999998876544 789999999999999999999996 899999999999999 5567899999999998
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCC-----ChhHHHHHHHhcCCC-CCCCCC
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWAR-----TESGIFRAVLKADPS-FDDGSW 364 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~-----~~~~~~~~i~~~~~~-~~~~~~ 364 (492)
+... ..++.+||..|||||.+++ .|+.++||||||+.++||.+|+.||... ...+++..|....+. ++..
T Consensus 229 lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-- 305 (364)
T KOG0581|consen 229 LVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-- 305 (364)
T ss_pred hhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--
Confidence 7644 5578899999999999986 6999999999999999999999999764 456677777774433 3322
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccccCC
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKV 406 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~ 406 (492)
.+|+++++||..||++||.+|||+.|+++|||++++.....
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v 346 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV 346 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence 48999999999999999999999999999999998765443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-56 Score=406.85 Aligned_cols=265 Identities=34% Similarity=0.625 Sum_probs=242.4
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCC-----CCHHHHHHHHHHHHHHHHccCCCCccEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM-----TTAIAVEDVRREVKILRALSGHSNLVKFY 204 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~-----~~~~~~~~~~~Ev~~l~~l~~hpniv~l~ 204 (492)
+.+...|+-.+.||.|..+.|-++..+. +|+.+|+|+|..... +.....+.-.+|+.||+++.+||+|+.+.
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~---t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcc---cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 3456788889999999999998888766 788999999854322 12233455678999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 205 DAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 205 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
++|+++..+++|+|+|+.|+|+|++.+. -.++|.+.+.||+|+++|++|||.++||||||||+|||+ +++.++||+
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~is 165 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKIS 165 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEe
Confidence 9999999999999999999999999765 579999999999999999999999999999999999999 788899999
Q ss_pred ecccccccCCCCCccccccCcccccccccc-------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
|||+|+.+.+++.....||||+|+|||.+. ..|+.++|+|++|||||.||.|.+|||++..--+++.|..+.+
T Consensus 166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 999999999999999999999999999873 3589999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 358 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.|..+.|..+|.+.+|||.+||++||.+|+|++|+|.||||.+.
T Consensus 246 qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 246 QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 99999999999999999999999999999999999999999654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-55 Score=433.42 Aligned_cols=259 Identities=36% Similarity=0.652 Sum_probs=237.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
-.+|.+++.||.|+|++|++|+.+. +++.||||++.|.-+.....++-+.+|-.+|.+|.+||.|++|+-.|+|+..
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred hhhcchhheeccccceeEEEeeecC---CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4689999999999999999999776 8999999999887766666666788999999999889999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|+||+++|+|+++|.+. +.|++..++.++.||+.||+|||++|||||||||+|||| |.++++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccC
Confidence 99999999999999998765 899999999999999999999999999999999999999 88999999999999987
Q ss_pred CCCCCc--------------cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 293 RPDERL--------------NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 293 ~~~~~~--------------~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
.+.... .+.+||..|.+||+|.. ..+..+|||+||||+|+|+.|.+||.+.++.-+++.|...++
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 643221 45799999999999975 477889999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.|+. .+++.++|||+++|..||++|+|+.||.+||||.+..
T Consensus 305 ~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 305 EFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred cCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 8886 6789999999999999999999999999999998754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=434.27 Aligned_cols=259 Identities=40% Similarity=0.738 Sum_probs=233.3
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH--HHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA--IAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~--~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
....+|.+++.||+|+||.|+.|+... ++..||||++.+...... ...+.+.+|+.+++.+..||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 345789999999999999999998765 779999998877533211 234567799999999966999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCC-CcEEEEecc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES-SQLKAIDFG 287 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~-~~~kl~DfG 287 (492)
....+|+|||||.||+|++++.+ .+++.|.+++.+++||++||+|||++||+||||||+|||+ +.+ +++||+|||
T Consensus 91 t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 91 TPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFG 166 (370)
T ss_pred cCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEeccc
Confidence 99999999999999999999988 6899999999999999999999999999999999999999 555 899999999
Q ss_pred ccccc-CCCCCccccccCccccccccccC-C-CC-CccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 288 LSDFV-RPDERLNDIVGSAYYVAPEVLHR-S-YG-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 288 la~~~-~~~~~~~~~~gt~~y~aPE~~~~-~-~~-~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
++... ..+....+.+||+.|+|||++.+ . |+ .++||||+||+||.|++|..||...+...++..|..+...++.
T Consensus 167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~-- 244 (370)
T KOG0583|consen 167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS-- 244 (370)
T ss_pred cccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC--
Confidence 99988 56778889999999999999975 3 54 6899999999999999999999999988999999888877765
Q ss_pred CCCC-CHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 364 WPSL-SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 364 ~~~~-s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
.+ |.++++||.+||..||.+|+|+.++++||||+.
T Consensus 245 --~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 245 --YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 34 999999999999999999999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=400.56 Aligned_cols=255 Identities=35% Similarity=0.621 Sum_probs=237.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
-++|+..+.||.|+||.|.+++.+. +|..||+|++.+...-.-..++...+|..+|+.+. ||.++++++.|.+.++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSN 118 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCe
Confidence 3678899999999999999999875 78999999999888777777888999999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+||||.+||+|+.++++. ++|++..++.++.||+.||+|||+.+|++|||||+|||+ |.++.+||+|||+|+.+
T Consensus 119 lymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEe
Confidence 99999999999999988654 799999999999999999999999999999999999999 88999999999999988
Q ss_pred CCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 293 RPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.. +..+.||||.|+|||+++ +.|+.++|.|||||++|||++|..||.+.+...++++|+.++..|+. .+++++
T Consensus 195 ~~--rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~ 268 (355)
T KOG0616|consen 195 SG--RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDA 268 (355)
T ss_pred cC--cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHH
Confidence 53 477899999999999886 57999999999999999999999999999999999999999999886 689999
Q ss_pred HHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
++||+++|++|-.+|. ...+|.+||||+..
T Consensus 269 kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 269 KDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 9999999999999993 57899999999965
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-55 Score=403.14 Aligned_cols=259 Identities=29% Similarity=0.536 Sum_probs=225.9
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|+...++|+|+||+||+++.+. +|+.||||.+..+. .+....+-..|||++|++|+ |+|+|.|+++|.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhccee
Confidence 578888999999999999999775 89999999995443 23334445789999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+||+|||+. ++++.+......++.+.++.++.|++.|+.|||++++|||||||+|||+ ..++.+||||||+|+.+.
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLS 152 (396)
T ss_pred EEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhc
Confidence 999999987 7777787777889999999999999999999999999999999999999 567799999999999987
Q ss_pred -CCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC----------
Q 011154 294 -PDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---------- 360 (492)
Q Consensus 294 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~---------- 360 (492)
+++..+.++.|+||+|||.+-+ .|+..+||||+||++.||++|.+.|.+.++-+.+-.|.+....+.
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 7777889999999999998865 599999999999999999999999999988776665544222111
Q ss_pred -----------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 361 -----------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 361 -----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+..++.++.-+.||+++||+.||.+|++.+|+|+|+||.++
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 11246678889999999999999999999999999999665
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=422.35 Aligned_cols=264 Identities=32% Similarity=0.550 Sum_probs=236.3
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+.-.++|++...||+|+||.||+|+.+. +|..+|+|+++|+.+.....++.++.|-.+|... ++|+||+||-.|++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQD 212 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEcc---CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecC
Confidence 4456899999999999999999999776 8999999999999888888888999999999996 79999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+++||||||++||++...|... +.|++.+++.++.+++.||+.||++|+|||||||+|+|| |..|++||+||||+
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLS 288 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeecccccc
Confidence 99999999999999999877654 789999999999999999999999999999999999999 89999999999998
Q ss_pred cccCC----------------------C--C------------------------CccccccCccccccccccC-CCCCc
Q 011154 290 DFVRP----------------------D--E------------------------RLNDIVGSAYYVAPEVLHR-SYGTE 320 (492)
Q Consensus 290 ~~~~~----------------------~--~------------------------~~~~~~gt~~y~aPE~~~~-~~~~~ 320 (492)
+-+.. . . .....+|||.|||||++.+ .|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 53211 0 0 0113589999999998864 59999
Q ss_pred cchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCC---HHHHhcCcc
Q 011154 321 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMT---AAQALSHPW 397 (492)
Q Consensus 321 ~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~e~l~hp~ 397 (492)
||.|||||||||||.|.+||.+.+..+.+++|......+..+.-..++++++|||.+||+ ||.+|.. ++||..|||
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPf 447 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPF 447 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCc
Confidence 999999999999999999999999999999999888665555556789999999999999 9999985 999999999
Q ss_pred ccccc
Q 011154 398 IRNYN 402 (492)
Q Consensus 398 ~~~~~ 402 (492)
|+...
T Consensus 448 F~~v~ 452 (550)
T KOG0605|consen 448 FKGVD 452 (550)
T ss_pred cccCC
Confidence 99764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=420.70 Aligned_cols=262 Identities=34% Similarity=0.500 Sum_probs=230.9
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|.+.++||.|.||.||+|+.+. +|..||||.+++.- ..++... -+|||+.|++|..|||||+|.+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf-~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKF-YSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhh-ccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 456899999999999999999998665 78899999996543 3333322 358999999995599999999999988
Q ss_pred C-eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 D-NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 ~-~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
+ .+|+|||||+. +|++.+..+...|++..++.|+.||++||+|+|.+|+.||||||||||+. ....|||+|||+|
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLA 157 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccc
Confidence 8 99999999987 89999999988899999999999999999999999999999999999994 3558999999999
Q ss_pred cccCCCCCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC---
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW--- 364 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~--- 364 (492)
+.+......+.++.|+||+|||++- +.|+.+.|||++|||++|+.+-++.|.+.++-+.+.+|+..........|
T Consensus 158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 9999888899999999999999874 46999999999999999999999999999988887777765544444433
Q ss_pred -----------------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 365 -----------------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 -----------------------~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+..+.++.+||.+||..||.+||||.|+|+||||+..
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 3468899999999999999999999999999999854
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=393.03 Aligned_cols=263 Identities=37% Similarity=0.668 Sum_probs=237.9
Q ss_pred ccccceeec-ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 131 EVTSRLEVG-EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 131 ~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
.++++|.+. ++||-|-.|.|-.+..+. +++.+|+|++... ...++||++.-...+|||||.++++|+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKR---TQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEecc---chhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 467889885 579999999999988776 8899999998433 3467899988877789999999999864
Q ss_pred ----CCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 ----LDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 ----~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
...+.+|||.|+||+|+.+|.+++ +.|+|.++..|++||+.|+.|||+.+|.||||||+|+|++.+..+..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 467899999999999999998774 359999999999999999999999999999999999999998889999999
Q ss_pred ecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh----hHHHHHHHhcCCCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSF 359 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~----~~~~~~i~~~~~~~ 359 (492)
|||+|+.-.....+.+.|-|++|.|||++. ..|+..+|+||+|||+|.||||.+||+.... .++.+.|..+.+.|
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 999999887777888999999999999996 5699999999999999999999999986543 46788999999999
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccccc
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV 404 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 404 (492)
+.+.|..+|++++|+|+.+|..+|.+|.|+.++++|||+.++..+
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v 331 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV 331 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence 999999999999999999999999999999999999999987644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-53 Score=382.64 Aligned_cols=259 Identities=33% Similarity=0.554 Sum_probs=230.8
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.+|...++||+|.||.||+|++.. +|+.||||.|+.....+... ....|||+.|+.++ |+||+.++++|-+.+++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~-h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELK-HPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccccccCcc-HHHHHHHHHHHHcc-CcchhhhhhhccCCCce
Confidence 578899999999999999999765 89999999998765443322 34678999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
.||+||++. +|...|..+...++..+++.++.+++.||+|||++.|+||||||+|+|+ +.++.+||+|||+|+.+.
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccC
Confidence 999999976 9999998888889999999999999999999999999999999999999 677899999999999887
Q ss_pred CCCCc-cccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC----
Q 011154 294 PDERL-NDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS---- 366 (492)
Q Consensus 294 ~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 366 (492)
..... ...+-|+||+|||.+-+ .|+..+||||.|||+.||+.|.+-|.+.++-+.+..|...........|++
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 55543 34489999999998864 699999999999999999999999999999999999988777777777754
Q ss_pred --------------------CCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 367 --------------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 367 --------------------~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.++++.||+.+||..||.+|+|+.|+|+|+||+..
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 45788999999999999999999999999999974
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-53 Score=412.82 Aligned_cols=262 Identities=32% Similarity=0.508 Sum_probs=232.7
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..-.+.|+..++||+|.||.||+|+... +|+.||+|.+..+.... .......|||.||++| +||||++|.+...+
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l-~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDNEKE-GFPITAIREIKILRRL-DHPNIIKLEEIVTS 187 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecc---cCcEEEEEEeecccCCC-cchHHHHHHHHHHHhc-CCCcccceeeEEEe
Confidence 3446789999999999999999999665 89999999997765433 2344567999999999 69999999999887
Q ss_pred C--CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 210 L--DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 210 ~--~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
. ..+|||+|||+. +|.-++....-+|++.+++.+|+||+.||+|||.+||+|||||.+|||| |.++.+||+|||
T Consensus 188 ~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFG 263 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFG 263 (560)
T ss_pred cCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEecccc
Confidence 6 689999999988 8888776666689999999999999999999999999999999999999 788899999999
Q ss_pred cccccCCCC--CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 288 LSDFVRPDE--RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 288 la~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
||+++.... ..+..+-|.||+|||++.+ .|+.++|+||+||||.||++|++.|.+.++.+.+..|.+......+..
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 999876555 4677889999999998875 599999999999999999999999999999999999998877777777
Q ss_pred CC-------------------------CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 364 WP-------------------------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 364 ~~-------------------------~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
|+ .++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 75 25678899999999999999999999999999954
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=409.42 Aligned_cols=263 Identities=29% Similarity=0.495 Sum_probs=227.8
Q ss_pred cCCccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEE
Q 011154 126 FGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYD 205 (492)
Q Consensus 126 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~ 205 (492)
.....+-...|...++||+|+-|.||.|+... +++.||||++....... .+-+.+|+.+|+.++ |+|||.+++
T Consensus 265 v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~-H~NiVnfl~ 337 (550)
T KOG0578|consen 265 VVSQGDPRSKYTDFKKIGQGATGGVYVARKIS---TKQEVAIKRMDLRKQPK---KELLLNEILVMRDLH-HPNIVNFLD 337 (550)
T ss_pred eccCCChhhhhcchhhhccccccceeeeeecc---CCceEEEEEEEeccCCc---hhhhHHHHHHHHhcc-chHHHHHHH
Confidence 34445667889999999999999999998665 78899999997765443 345889999999995 999999999
Q ss_pred EEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 206 AFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 206 ~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
.|.-.+++|+|||||+||+|.|.+... .++|.+++.|+++++.||+|||.+||+|||||.+|||+ +.++.+||+|
T Consensus 338 Sylv~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltD 412 (550)
T KOG0578|consen 338 SYLVGDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTD 412 (550)
T ss_pred HhcccceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEee
Confidence 999889999999999999999987653 69999999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCC-CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 286 FGLSDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 286 fGla~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
||++..+.... ...+.+||++|||||++. +.|+.++||||||+++.||+-|++||...+....+..|.... ......
T Consensus 413 FGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-~P~lk~ 491 (550)
T KOG0578|consen 413 FGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPKLKN 491 (550)
T ss_pred eeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-CCCcCC
Confidence 99998887665 567889999999999886 569999999999999999999999998766655555554432 223334
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+..+|+.++|||.+||+.|+.+|++|.++|+||||+..
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 56899999999999999999999999999999999653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-53 Score=387.19 Aligned_cols=254 Identities=27% Similarity=0.532 Sum_probs=219.8
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEE-EEEeC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYD-AFEDL 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~-~~~~~ 210 (492)
-..+|++.++||+|+||.||++.+.. +|..||.|.|.-.. .+......+..|+.+|++| +|||||++++ .|.++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQFGM-MDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIED 91 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeecc---Ccchhhhhhcchhh-ccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhcc
Confidence 34679999999999999999999765 88999999997444 3556677889999999999 5999999998 55555
Q ss_pred Ce-EEEEEeecCCCchHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHHHH--cC--CcccCCCCCceEeecCCCCCcEE
Q 011154 211 DN-VYIVMELCEGGELLDRIL---SRCGKYSEDEAKAVLVQILNVVAFCHL--HG--VVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 211 ~~-~~lv~E~~~ggsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~ylH~--~~--ivHrDlkp~NILl~~~~~~~~~k 282 (492)
+. ++||||||.+|+|...|. +....++|..+++++.|++.||..||. .. |+||||||.||++ +.++.+|
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvK 168 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVK 168 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCcee
Confidence 55 999999999999988775 334579999999999999999999999 44 9999999999999 7788999
Q ss_pred EEecccccccCCCCCc-cccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC
Q 011154 283 AIDFGLSDFVRPDERL-NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 360 (492)
Q Consensus 283 l~DfGla~~~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 360 (492)
|+||||++++.....+ .+.+|||+||+||+++ ..|+.++||||+||++|||+.-..||.+++-.++..+|.+++....
T Consensus 169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL 248 (375)
T ss_pred eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC
Confidence 9999999999766554 4689999999999887 5699999999999999999999999999999999999999865422
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
. -..+|.++..||..|+.+||+.||+. +|++.+
T Consensus 249 p--~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 249 P--DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred c--HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence 1 13689999999999999999999996 555544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=398.24 Aligned_cols=258 Identities=36% Similarity=0.654 Sum_probs=239.6
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
.+...+|++.+.||+|.||.|-+|+... .|+.||||.|.++...+.+.+-.+++||+||..| +||||+.+|++|+.
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~---sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFEN 124 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHK---SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFEN 124 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhcc---CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcC
Confidence 4567899999999999999999998654 7999999999999999888888999999999999 69999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.+.|||||..+|+|+|++.++ +.++|.+++.+++||.+|+.|||.+++||||||.+|||+ |.++++||+||||+
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLS 200 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLS 200 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchh
Confidence 99999999999999999999776 789999999999999999999999999999999999999 88889999999999
Q ss_pred cccCCCCCccccccCccccccccccCC-C-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLHRS-Y-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
..+....-++++||++.|.+||++++. | +.++|-|||||+||.|+.|..||.+.+...+.+.|..+.+.-+ .-
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~ 275 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----ET 275 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----CC
Confidence 999888888999999999999999864 4 6789999999999999999999999999999999988776544 35
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
+.++.-||++||.++|++|.|+.++..|=|+.-
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 678999999999999999999999999988863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=413.02 Aligned_cols=254 Identities=33% Similarity=0.605 Sum_probs=230.7
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|.+.+.||+|+||.||+|+.|. +.+.||+|.+.|..... ..++.+.+|++|++.|+ |||||.++++|++..++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLK-HPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---ceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceE
Confidence 578999999999999999999776 78999999998877654 45678999999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|+|||.| +|...+. ..+.++|+.+..|+.|++.||.|||+++|+|||+||.|||+ +..+.+|+||||+|+.+.
T Consensus 77 ~vVte~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEEehhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcc
Confidence 999999987 9988664 45899999999999999999999999999999999999999 788999999999999887
Q ss_pred CCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.+.. .+.+.|||.|||||++.+ .|+..+|+||+|||+|||.+|++||......++.+.|.......+. .+|.++
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f 227 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSF 227 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHH
Confidence 6554 456789999999998874 6999999999999999999999999999999999999887655543 789999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..|++.+|.+||.+|+|+.+++.|||+++.
T Consensus 228 ~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 228 VNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 999999999999999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=375.04 Aligned_cols=257 Identities=32% Similarity=0.621 Sum_probs=235.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
-++|++++.||+|.||.||.|+.++ ++-.||+|++.++.........++.+|++|-..|+ ||||+++|++|.+...
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKR 96 (281)
T ss_pred hhhccccccccCCccccEeEeeecc---CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccce
Confidence 4789999999999999999999887 78899999999887766666778999999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.||++||...|+|+..+... ..++++..++.++.|++.||.|||..+||||||||+|+|+ +..+.+||+|||.+..
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVH 173 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceee
Confidence 99999999999999998743 3569999999999999999999999999999999999999 5556899999999976
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.. .....+.|||..|.+||+..+ .++..+|+|++|++.||++.|..||...+..+.++.|.+.+..++. .++.+
T Consensus 174 ~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~ 248 (281)
T KOG0580|consen 174 AP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGG 248 (281)
T ss_pred cC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChh
Confidence 55 556678999999999998875 5999999999999999999999999999999999999999888873 79999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++|||.+||.++|.+|....|++.|||+...
T Consensus 249 a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 249 AADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 9999999999999999999999999999753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=416.58 Aligned_cols=258 Identities=30% Similarity=0.537 Sum_probs=238.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|.+.+.||+|+||+|+++.++. +++.||||+++|..+-....++....|..|+.....||.++.|+..|++.++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 4789999999999999999999887 7889999999999988888899999999999998789999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+||||+.||++... .+.+.|++..++.++..|+.||.|||++||||||||.+|||+ |..+++||+|||+++..
T Consensus 444 l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEeccccccccc
Confidence 9999999999995432 334689999999999999999999999999999999999999 88999999999999865
Q ss_pred C-CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 R-PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
. .+....+.|||+.|||||++.+ .|+..+|.|||||+|||||.|..||.+.++++++..|...++.++. .+|.+
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~e 594 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKE 594 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHH
Confidence 4 5667889999999999999975 5999999999999999999999999999999999999998888775 68999
Q ss_pred HHHHHHHccccCcCCCCC-----HHHHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRMT-----AAQALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~~ 402 (492)
+.++++++|.++|++|.. +.+|..||||+..+
T Consensus 595 a~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 595 AIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 999999999999999986 58999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=397.32 Aligned_cols=258 Identities=33% Similarity=0.521 Sum_probs=214.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC-
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD- 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~- 211 (492)
..+|..++.||+|+||.||++..++ +|...|||.+..... ...+.+.+|+.+|++|+ |||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELEDS---PTSESLEREIRILSRLN-HPNIVQYYGSSSSREN 88 (313)
T ss_pred cchhhhhccccCccceEEEEEEecC---CCcceeeeeeecccc---hhHHHHHHHHHHHHhCC-CCCEEeeCCccccccC
Confidence 3567889999999999999999775 588999999966522 12667899999999996 999999999855544
Q ss_pred -eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC-CCcEEEEecccc
Q 011154 212 -NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE-SSQLKAIDFGLS 289 (492)
Q Consensus 212 -~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~-~~~~kl~DfGla 289 (492)
.++++|||+++|+|.+.+.+.++.++|..++.+.+||++||.|||++|||||||||+|||+ +. ++.+||+|||++
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLA 165 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCccc
Confidence 6999999999999999998776689999999999999999999999999999999999999 55 578999999999
Q ss_pred cccCC----CCCccccccCccccccccccCCCC--CccchHHHHHHHHHHhcCCCCCCCC-ChhHHHHHHHhcCCCCCCC
Q 011154 290 DFVRP----DERLNDIVGSAYYVAPEVLHRSYG--TEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 290 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~--~~~DvwSlGvil~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~ 362 (492)
+.... ........||+.|||||++..... .++|||||||++.||+||+.||... ...+.+-.+....... .
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P--~ 243 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP--E 243 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC--C
Confidence 87763 122345789999999999874433 3899999999999999999999873 3333333343333111 2
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
....+|.++++||.+||..||++||||.++|+|||+++..
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 3346999999999999999999999999999999998754
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=396.48 Aligned_cols=261 Identities=33% Similarity=0.658 Sum_probs=239.6
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+..-|.+.+.||+|.|++|-+|++.- +|..||||+|.+.++... ....+..||..|+.++ |||||+||++....
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVF---TGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhc---ccceeEEEEecccccchh-hhhHHHHHHHHHHHhc-CcCeeeeeehhccc
Confidence 456779999999999999999998654 899999999998876543 3456788999999996 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
..+|||+|+-++|+|+|+|.+....+.|+.+++++.||+.|+.|||+..+|||||||+||.+. ..-+.|||.|||++.
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSN 167 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccc
Confidence 999999999999999999999988999999999999999999999999999999999999886 456789999999999
Q ss_pred ccCCCCCccccccCccccccccccCC-CCC-ccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHRS-YGT-EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
.+.+++.+++.||+..|-|||++.+. |+. ++||||||||||.|+||+.||...++.+.+-.|....+..+. .+|
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS 243 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVS 243 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhh
Confidence 99999999999999999999998764 764 689999999999999999999999999999999888777664 799
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+++|||..||..||++|.+.++|..|+|++...
T Consensus 244 ~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 244 KECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 9999999999999999999999999999999754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=397.53 Aligned_cols=261 Identities=33% Similarity=0.623 Sum_probs=223.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH-----------HHHHHHHHHHHHHHHccCCCC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA-----------IAVEDVRREVKILRALSGHSN 199 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~-----------~~~~~~~~Ev~~l~~l~~hpn 199 (492)
..-+.|++++.||+|.||+|-+|+.. .+++.||||++++...... ..++.+.+||.||++|. |||
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~---~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~n 169 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDE---VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPN 169 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeec---CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcC
Confidence 34578999999999999999999854 4899999999987543321 12467899999999995 999
Q ss_pred ccEEEEEEEeC--CeEEEEEeecCCCchHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC
Q 011154 200 LVKFYDAFEDL--DNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 200 iv~l~~~~~~~--~~~~lv~E~~~ggsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~ 276 (492)
||+|+++..+. +.+|||+|||..|.+...- . .+. +++.++++|+++++.||+|||.+|||||||||+|+|| +
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~ 244 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-P-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---S 244 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCC-C-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---c
Confidence 99999999864 5799999999999875421 1 233 8999999999999999999999999999999999999 6
Q ss_pred CCCcEEEEecccccccCC------CCCccccccCccccccccccC---C--CCCccchHHHHHHHHHHhcCCCCCCCCCh
Q 011154 277 ESSQLKAIDFGLSDFVRP------DERLNDIVGSAYYVAPEVLHR---S--YGTEADVWSIGVIAYILLCGSRPFWARTE 345 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~------~~~~~~~~gt~~y~aPE~~~~---~--~~~~~DvwSlGvil~~lltg~~pf~~~~~ 345 (492)
+++++||+|||.+..+.. +..+...+|||.|+|||.+.+ . .+.+.||||+||+||.|+.|++||.+...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 778999999999987632 223445789999999998764 1 35678999999999999999999999999
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 346 SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 346 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+++.+|......|+.. +.+..+++|||++||++||++|+++.++..|||.....
T Consensus 325 ~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 325 LELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred HHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 99999999988777664 36899999999999999999999999999999998763
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=379.67 Aligned_cols=265 Identities=30% Similarity=0.472 Sum_probs=228.2
Q ss_pred CCccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEE
Q 011154 127 GFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDA 206 (492)
Q Consensus 127 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~ 206 (492)
+-++.+ +.|+..++|++|+||.||+|+++. +++.||+|+++.+.....-.+ ...|||.+|.+++ |||||.+-++
T Consensus 70 ~gCrsv-~efe~lnrI~EGtyGiVYRakdk~---t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~-H~NIV~vkEV 143 (419)
T KOG0663|consen 70 GGCRSV-EEFEKLNRIEEGTYGVVYRAKDKK---TDEIVALKRLKMEKEKEGFPI-TSLREINILLKAR-HPNIVEVKEV 143 (419)
T ss_pred cCcccH-HHHHHHhhcccCcceeEEEeccCC---cceeEEeeecccccccCCCcc-hhHHHHHHHHhcC-CCCeeeeEEE
Confidence 334443 679999999999999999999776 889999999976653322222 2468999999996 9999999998
Q ss_pred EEe--CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 207 FED--LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 207 ~~~--~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
... -+.+|+|||||+. +|...+.....+|...+++.++.|++.||+|||.+.|+|||||++|+|+ ...+.+||+
T Consensus 144 VvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKia 219 (419)
T KOG0663|consen 144 VVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIA 219 (419)
T ss_pred EeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEec
Confidence 764 4679999999988 8888888777799999999999999999999999999999999999999 566789999
Q ss_pred ecccccccCCC-CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC
Q 011154 285 DFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD 361 (492)
Q Consensus 285 DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (492)
|||+|+.+... ..++..+-|.||+|||++-+ .|++..|+||+|||+.||+++++.|.+..+.+.+..|.+......+
T Consensus 220 DFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 220 DFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred ccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence 99999988654 34677889999999998865 5999999999999999999999999999999988888876655555
Q ss_pred CCCCC----------------------------CCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 362 GSWPS----------------------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 362 ~~~~~----------------------------~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..|+. +++...+|+..+|..||.+|.||.|+|+|.||...
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 55543 45788999999999999999999999999999974
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=384.84 Aligned_cols=265 Identities=34% Similarity=0.585 Sum_probs=221.6
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
..++..+|...+.||+|+||.||.+.++. +|+.||||.|.. .+......++..+|+++|+.++ |+||+.+.+++.
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~ 91 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKR---TGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFR 91 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcC---CCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecc
Confidence 34566778778999999999999999776 789999999953 2445566778899999999996 999999999986
Q ss_pred e-----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 209 D-----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 209 ~-----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
. -+.+|+|+|+|+ -+|...| +....+++.++..++.||++||+|+|+.+|+||||||+|+|+ +.+..+||
T Consensus 92 p~~~~~f~DvYiV~elMe-tDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI 166 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELME-TDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKI 166 (359)
T ss_pred cccccccceeEEehhHHh-hHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEe
Confidence 5 357999999994 3666655 444569999999999999999999999999999999999999 56667999
Q ss_pred EecccccccCC---CCCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC--
Q 011154 284 IDFGLSDFVRP---DERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-- 356 (492)
Q Consensus 284 ~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~-- 356 (492)
||||+|+.... ...++.++.|.||+|||++. ..|+...||||+|||+.|||+|+..|.+....+.+..|....
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 99999998864 45567889999999999874 469999999999999999999999998876655544443322
Q ss_pred ---------------------CCCCCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 357 ---------------------PSFDDG----SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 357 ---------------------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
+..+.. .+++.++++.||+.+||..||.+|+|++|+|.|||+..+.+
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 222221 24678999999999999999999999999999999998754
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=386.05 Aligned_cols=260 Identities=31% Similarity=0.521 Sum_probs=234.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|.-|.||+++.++ ++..+|+|++.+..+.....+.++..|-+||+.+ +||.++.||..|+.++..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYS 152 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeecccee
Confidence 578899999999999999999886 6689999999998887777788899999999999 699999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
|+|||||+||+|....+++. +.|++..++.++..++.||+|||-.|||+|||||+|||| .++++|.|+||.|+...
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccC
Confidence 99999999999998776654 469999999999999999999999999999999999999 78899999999986432
Q ss_pred CC-----------------------------------C----------------------CCccccccCccccccccccC
Q 011154 293 RP-----------------------------------D----------------------ERLNDIVGSAYYVAPEVLHR 315 (492)
Q Consensus 293 ~~-----------------------------------~----------------------~~~~~~~gt~~y~aPE~~~~ 315 (492)
.. . .+....+||--|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 0 01234589999999999986
Q ss_pred C-CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCC----HH
Q 011154 316 S-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMT----AA 390 (492)
Q Consensus 316 ~-~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~~ 390 (492)
. .+.++|.|+|||++||||.|..||.+.+..+.+.+|......|+... .++..++|||+++|.+||.+|.. |+
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchH
Confidence 4 89999999999999999999999999999999999999999988764 78999999999999999999998 99
Q ss_pred HHhcCccccccc
Q 011154 391 QALSHPWIRNYN 402 (492)
Q Consensus 391 e~l~hp~~~~~~ 402 (492)
||.+||||++.+
T Consensus 388 eIK~HpFF~gVn 399 (459)
T KOG0610|consen 388 EIKRHPFFEGVN 399 (459)
T ss_pred HhhcCccccCCC
Confidence 999999999865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=386.97 Aligned_cols=261 Identities=31% Similarity=0.515 Sum_probs=228.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+.|++.+.||.|.-++||+|++.. .++.||||++..++.... .+.+.+|+..|+.+ +||||++++..|..+.+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLEKCNND--LDALRKEVQTMSLI-DHPNIVTYHCSFVVDSE 98 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhc-CCCCcceEEEEEEecce
Confidence 4789999999999999999999886 779999999987776553 78899999999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+|+||.||.+||+++.+.... ..++|..+..|+++++.||.|||.+|.||||||+.|||| +.++.|||+|||.+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSAS 175 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeee
Confidence 999999999999999887653 359999999999999999999999999999999999999 7889999999998766
Q ss_pred cCCCC-----CccccccCcccccccccc---CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC-----
Q 011154 292 VRPDE-----RLNDIVGSAYYVAPEVLH---RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----- 358 (492)
Q Consensus 292 ~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~----- 358 (492)
+.... ++++.+||++|||||++. ..|+.|+||||||+..+||.+|..||.....-.++-.-+++.+.
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 53322 125679999999999954 35999999999999999999999999888877766666666553
Q ss_pred -CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 359 -FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 359 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++.+....++..++.+|..||.+||.+|||++++|+|+||++..
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 23334456788999999999999999999999999999999754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-51 Score=377.96 Aligned_cols=262 Identities=35% Similarity=0.622 Sum_probs=230.7
Q ss_pred cceee-cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 134 SRLEV-GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 134 ~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
+-|++ .+.||+|+||.|-.+..-. +|..||||+|.+.. ......+.+||+++...++|+||+.|+++|+++.+
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~---t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQ---TGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeec---cchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 44554 4689999999988877544 88999999998763 23456789999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|||||.|.||.|+.+|.++ ..|+|.++..++++|+.||.|||.+||.||||||+|||-...+.-.-||||||.|..-+
T Consensus 151 FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 99999999999999999876 68999999999999999999999999999999999999988777788999999987544
Q ss_pred CCCC--------CccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCC--------------
Q 011154 293 RPDE--------RLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWART-------------- 344 (492)
Q Consensus 293 ~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~-------------- 344 (492)
.... .+.+.+|+..|||||+.. ..|+.++|.||||||+|.||+|.+||.+..
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~ 309 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV 309 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence 3221 234678999999999753 249999999999999999999999995432
Q ss_pred -hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 345 -ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 345 -~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
...++..|..+.+.|++..|..+|.+++|||..+|..|+.+|.++.++++|||++...
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 3568899999999999999999999999999999999999999999999999998754
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=386.76 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=218.2
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
|++.+.||+|+||.||+|..+. +|+.||||.+.+...........+.+|+.+++.+ +|+||++++++|.+.+.+++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEE
Confidence 7888999999999999999775 7899999999765444333445678999999999 49999999999999999999
Q ss_pred EEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 216 VMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
|||||++|+|.+.+.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCC
Confidence 999999999988876543 368999999999999999999999999999999999999 6677899999999987755
Q ss_pred CCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011154 295 DERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKD 373 (492)
Q Consensus 295 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 373 (492)
........||..|+|||++. ..|+.++|||||||++|+|++|+.||...........+..............++.++.+
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 234 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS 234 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence 55555678999999999886 46899999999999999999999999876553333333222222222333468999999
Q ss_pred HHHHccccCcCCCCC-----HHHHhcCccccccc
Q 011154 374 FVKLLLNKDPRKRMT-----AAQALSHPWIRNYN 402 (492)
Q Consensus 374 li~~~L~~dP~~Rps-----~~e~l~hp~~~~~~ 402 (492)
||++||+.||.+||+ ++++++||||.+..
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 999999999999997 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=390.43 Aligned_cols=254 Identities=29% Similarity=0.535 Sum_probs=223.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.+. +++.||||++...........+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeE
Confidence 478999999999999999998765 68899999997544333344566889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhcc
Confidence 9999999999999988654 679999999999999999999999999999999999999 567789999999998764
Q ss_pred CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+++..+......++. .++..++
T Consensus 153 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~ 226 (291)
T cd05612 153 D--RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAK 226 (291)
T ss_pred C--CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHH
Confidence 3 2334679999999998864 5889999999999999999999999998888888888877655543 5689999
Q ss_pred HHHHHccccCcCCCCC-----HHHHhcCcccccc
Q 011154 373 DFVKLLLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
+||++||+.||.+|++ +.++++||||...
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 9999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=396.36 Aligned_cols=255 Identities=32% Similarity=0.567 Sum_probs=223.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+.+|+.+. ||||+++++++.+++.
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENR 92 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCE
Confidence 3689999999999999999999765 68899999997654333344567889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||.||+|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEc
Confidence 99999999999999988654 679999999999999999999999999999999999999 66789999999999876
Q ss_pred CCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 293 RPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+..+...++. .++.++
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 242 (329)
T PTZ00263 169 PDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRA 242 (329)
T ss_pred CCC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHH
Confidence 432 335679999999998864 5889999999999999999999999988888888888776554432 478999
Q ss_pred HHHHHHccccCcCCCCC-----HHHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
++||.+||+.||.+|++ +.++++||||++.
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999999999997 7999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=399.21 Aligned_cols=259 Identities=27% Similarity=0.456 Sum_probs=219.8
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.+. +++.||||++.+...........+.+|+.++..+ +|+||+++++.+.+.+.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeE
Confidence 478999999999999999998764 7889999999765443444556788999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccc
Confidence 9999999999999988654 679999999999999999999999999999999999999 667799999999987653
Q ss_pred CCC------------------------------------CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcC
Q 011154 294 PDE------------------------------------RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCG 336 (492)
Q Consensus 294 ~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg 336 (492)
... .....+||+.|+|||++. ..++.++|||||||++|+|++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 211 012457999999999875 4589999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCC---CCCHHHHhcCcccccc
Q 011154 337 SRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRK---RMTAAQALSHPWIRNY 401 (492)
Q Consensus 337 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~---Rps~~e~l~hp~~~~~ 401 (492)
..||.+.+..+.+..+...........+..+++++++||.+|+. +|.+ ||+++|+++||||+..
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 233 YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 99999988888888887644333333334689999999999876 4554 5899999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=394.39 Aligned_cols=250 Identities=30% Similarity=0.549 Sum_probs=218.1
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|+.+. +|+.||||++.+...........+.+|+.+|+.+. ||||++++++|.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeC
Confidence 469999999999998765 78999999997654433444566889999999995 99999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC-CCCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~-~~~~~ 298 (492)
++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++... .....
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 77 ANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcc
Confidence 9999999888654 679999999999999999999999999999999999999 667789999999987542 22334
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......++ ..++.++.+||.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 45689999999998864 589999999999999999999999998888888887776665554 3689999999999
Q ss_pred ccccCcCCCC-----CHHHHhcCcccccc
Q 011154 378 LLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 378 ~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
||+.||++|| ++.++++||||...
T Consensus 229 ~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 229 LLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=390.64 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=213.8
Q ss_pred ceeecceeccccceEEEEEEEecCCccccE-EEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC-e
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQK-VAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD-N 212 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~-vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~-~ 212 (492)
...+.+.||+|+||+||++.|++ +. ||||++......... .+.|.+|+.+|.+|+ |||||+++|+|.+.. .
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g-----~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRG-----TDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGS 114 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCC-----ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCc
Confidence 34556669999999999999864 55 999999776555444 778999999999995 999999999999987 7
Q ss_pred EEEEEeecCCCchHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccCCCCCceEeecCCCCC-cEEEEecccc
Q 011154 213 VYIVMELCEGGELLDRILS-RCGKYSEDEAKAVLVQILNVVAFCHLHG-VVHRDLKPENFLYTSKDESS-QLKAIDFGLS 289 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~ylH~~~-ivHrDlkp~NILl~~~~~~~-~~kl~DfGla 289 (492)
++|||||+++|+|.+++.. +...+++..+..++.||++||.|||+++ ||||||||+|||+ +... ++||+|||++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLS 191 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccc
Confidence 9999999999999999987 3678999999999999999999999999 9999999999999 6665 9999999999
Q ss_pred cccCCC-CCccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 290 DFVRPD-ERLNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 290 ~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
+..... .......||+.|||||++.+ .|+.|+|||||||++|||+||+.||.+....+....+.........+ .
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~ 269 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--K 269 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--c
Confidence 887654 34455789999999999984 39999999999999999999999999888866666665444333322 2
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+++.+..|+.+||..||.+||+..+++.
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 38899999999999999999999998875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=397.52 Aligned_cols=259 Identities=30% Similarity=0.535 Sum_probs=222.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+... +|+.||||++.+...........+.+|+.+|+.+. ||||++++++|.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeE
Confidence 479999999999999999999765 68899999997654333445566889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred EEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecc
Confidence 9999999999999988654 579999999999999999999999999999999999999 677899999999987543
Q ss_pred CCC---------------------------------------CccccccCcccccccccc-CCCCCccchHHHHHHHHHH
Q 011154 294 PDE---------------------------------------RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYIL 333 (492)
Q Consensus 294 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~l 333 (492)
... .....+||+.|+|||++. ..++.++|||||||++|+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 211 011346999999999875 4589999999999999999
Q ss_pred hcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCC---HHHHhcCcccccc
Q 011154 334 LCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMT---AAQALSHPWIRNY 401 (492)
Q Consensus 334 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~ 401 (492)
++|..||......+....+......+.......+++++++||.+||. +|.+|++ +.+++.||||+..
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999888877777777655444433344689999999999997 9999998 9999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=390.99 Aligned_cols=258 Identities=33% Similarity=0.515 Sum_probs=223.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|++.. +++.||||++.+...........+.+|++++..+. ||||+++++++.+.+.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEE
Confidence 469999999999999999999765 67899999997654433344567889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccc
Confidence 9999999999999988654 679999999999999999999999999999999999999 667789999999998664
Q ss_pred CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC----CCCC
Q 011154 294 PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW----PSLS 368 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s 368 (492)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+......+....+ ..++
T Consensus 153 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 153 T--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred c--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 3 3455689999999998764 5899999999999999999999999988888877777654433322222 2578
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.++.+||.+||..+|.+||++.++++||||...
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=397.11 Aligned_cols=260 Identities=29% Similarity=0.463 Sum_probs=218.7
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+.|++.+.||+|+||.||+|+.+. +++.||||++.+...........+.+|+++++.+. ||||+++++++.+.+.+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEE
Confidence 368999999999999999998765 78999999997665545555677899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCcccc
Confidence 9999999999999988654 579999999999999999999999999999999999999 667799999999975431
Q ss_pred CCC------------------------------------------------CccccccCcccccccccc-CCCCCccchH
Q 011154 294 PDE------------------------------------------------RLNDIVGSAYYVAPEVLH-RSYGTEADVW 324 (492)
Q Consensus 294 ~~~------------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Dvw 324 (492)
... .....+||+.|+|||++. ..|+.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 100 012357999999999876 4589999999
Q ss_pred HHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcccc--CcCCCCCHHHHhcCcccccc
Q 011154 325 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNK--DPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 325 SlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~Rps~~e~l~hp~~~~~ 401 (492)
||||++|+|++|..||......+....+...........+..+++++++||.+||.. ++..|+++.++++||||...
T Consensus 233 SlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999999999999988877766666655443344444456899999999996654 45559999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=391.77 Aligned_cols=256 Identities=32% Similarity=0.544 Sum_probs=223.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|.++.. .+..||||++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESY 105 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCE
Confidence 46799999999999999999987642 34689999997654433444567889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeec
Confidence 99999999999999988654 679999999999999999999999999999999999999 66789999999999876
Q ss_pred CCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 293 RPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+...+...+......++. .+++++
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 255 (340)
T PTZ00426 182 DT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNC 255 (340)
T ss_pred CC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHH
Confidence 43 2345689999999998864 5889999999999999999999999998888888888776655443 578999
Q ss_pred HHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
++||++||+.||.+|+ +++++++||||.+.
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999996 89999999999874
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=397.62 Aligned_cols=259 Identities=28% Similarity=0.496 Sum_probs=218.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+++.+. +++.||||++.+.........+.+.+|+++++.+ +||||++++++|.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCee
Confidence 478999999999999999998765 7899999999765433444566788999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++... +.+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccc
Confidence 9999999999999988654 679999999999999999999999999999999999999 667789999999986432
Q ss_pred CCCC------------------------------------------------ccccccCcccccccccc-CCCCCccchH
Q 011154 294 PDER------------------------------------------------LNDIVGSAYYVAPEVLH-RSYGTEADVW 324 (492)
Q Consensus 294 ~~~~------------------------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~Dvw 324 (492)
.... ....+||+.|+|||++. ..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 1000 01247999999999875 4599999999
Q ss_pred HHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCC---CCHHHHhcCcccccc
Q 011154 325 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKR---MTAAQALSHPWIRNY 401 (492)
Q Consensus 325 SlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~e~l~hp~~~~~ 401 (492)
||||++|+|++|..||.+....+.+..+......+....+..++.++++||.+||. +|.+| +++.+++.||||+..
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999999999999888877777776544333333334689999999999997 77765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=394.66 Aligned_cols=261 Identities=30% Similarity=0.477 Sum_probs=224.7
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+++.+. +++.||||++.+...........+.+|+.+++.+ +||||+++++++.+.+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDK 116 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence 35789999999999999999998765 7889999999764433333445678899999999 5999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceee
Confidence 99999999999999988754 368999999999999999999999999999999999999 6778999999999987
Q ss_pred cCCCC--CccccccCccccccccccC-----CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 292 VRPDE--RLNDIVGSAYYVAPEVLHR-----SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 292 ~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+............
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 65332 2235679999999998753 3788999999999999999999999998888888888765544443444
Q ss_pred CCCCHHHHHHHHHccccCcCC--CCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRK--RMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~--Rps~~e~l~hp~~~~~ 401 (492)
..+|.++++||.+||..+|.+ |+|+.++++||||++.
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 568999999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=396.26 Aligned_cols=259 Identities=32% Similarity=0.521 Sum_probs=220.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.+. +++.||||++.+...........+.+|+++++.+ +|||||+++++|.+.+.+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEE
Confidence 368999999999999999998765 7889999999765443444566789999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCcccc
Confidence 9999999999999988654 679999999999999999999999999999999999999 677899999999975321
Q ss_pred CC------------------------------------------------CCccccccCcccccccccc-CCCCCccchH
Q 011154 294 PD------------------------------------------------ERLNDIVGSAYYVAPEVLH-RSYGTEADVW 324 (492)
Q Consensus 294 ~~------------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Dvw 324 (492)
.. ......+||+.|+|||++. ..|+.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 00 0012357999999999875 4699999999
Q ss_pred HHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCC---HHHHhcCcccccc
Q 011154 325 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMT---AAQALSHPWIRNY 401 (492)
Q Consensus 325 SlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~ 401 (492)
||||++|+|++|+.||.+....+....+...........+..+++++.+||.+|+ .+|.+|++ +.++++||||+..
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999999999999988877777777665544444445678999999999987 59999997 9999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=385.75 Aligned_cols=248 Identities=29% Similarity=0.556 Sum_probs=216.5
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecC
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ 221 (492)
||+|+||.||+|+.+. +++.||||++.+...........+.+|+.+|+.+ +||||++++++|.+.+..|+|||||+
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCC
Confidence 7999999999998764 6889999999765443444556788999999999 59999999999999999999999999
Q ss_pred CCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCCccc
Q 011154 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERLND 300 (492)
Q Consensus 222 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~~~~ 300 (492)
||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... ......
T Consensus 77 ~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 77 GGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCcccc
Confidence 99999988654 679999999999999999999999999999999999999 6677899999999986432 223445
Q ss_pred cccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011154 301 IVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379 (492)
Q Consensus 301 ~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 379 (492)
.+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++ ..+++++++||.+||
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L 228 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLL 228 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHc
Confidence 689999999998764 589999999999999999999999998888888888877655544 368899999999999
Q ss_pred ccCcCCCC---CHHHHhcCcccccc
Q 011154 380 NKDPRKRM---TAAQALSHPWIRNY 401 (492)
Q Consensus 380 ~~dP~~Rp---s~~e~l~hp~~~~~ 401 (492)
..||.+|| ++.++|+||||.+.
T Consensus 229 ~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 229 SRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999997 58999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=379.40 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=212.7
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||.|+||.||+|+.+. ++..||+|++....... ....+.+|+.+++.+. ||||+++++++.+.+..
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEG--APCTAIREVSLLKNLK-HANIVTLHDIIHTERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---CCCEEEEEEecccccCC--cchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeE
Confidence 579999999999999999998765 78899999996543221 2345778999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKS 154 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeecc
Confidence 999999975 8998887665678999999999999999999999999999999999999 667789999999997654
Q ss_pred CCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC--------
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG-------- 362 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-------- 362 (492)
... ......||+.|+|||++.+ .++.++||||+||++|+|+||+.||.+.+..+.+..+..........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 322 2345678999999998753 58899999999999999999999998877666655554322111111
Q ss_pred ------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 363 ------------------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 363 ------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
..+.++.++++||++||+.||.+|||+.|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=389.06 Aligned_cols=259 Identities=31% Similarity=0.546 Sum_probs=217.7
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+|++.+.||+|+||.||+++...+..+++.||+|++.+.... .....+.+.+|+.+++.+++|+||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999988766668899999999654322 2233456789999999997799999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++|||||+||+|.+++..+ ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 9999999999999988654 579999999999999999999999999999999999999 666789999999998653
Q ss_pred CCC--CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCC----hhHHHHHHHhcCCCCCCCCCC
Q 011154 294 PDE--RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 294 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 365 (492)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ...+...+....+.+ ..
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~ 232 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF----PS 232 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC----CC
Confidence 332 2335679999999998864 37889999999999999999999996432 233444444444333 23
Q ss_pred CCCHHHHHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
.++..+++||.+||+.||++|| ++.++++||||+..
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 6899999999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=386.65 Aligned_cols=250 Identities=31% Similarity=0.549 Sum_probs=217.2
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+++.+. +|+.||||++.+...........+.+|+.+|+.+. ||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeC
Confidence 469999999999998765 78999999997654444445567889999999995 99999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~~ 298 (492)
+++|+|.+.+... ..+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 77 ~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 77 VNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccc
Confidence 9999998877554 679999999999999999999999999999999999999 6677899999999876432 2233
Q ss_pred cccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
...+||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+......++ ..++.++.+||.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSG 228 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHH
Confidence 4568999999999886 4689999999999999999999999998888777777766555544 3689999999999
Q ss_pred ccccCcCCCC-----CHHHHhcCcccccc
Q 011154 378 LLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 378 ~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
||..||.+|+ ++.++++||||...
T Consensus 229 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 229 LLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=396.10 Aligned_cols=259 Identities=31% Similarity=0.514 Sum_probs=219.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.+. +++.||||++.+...........+.+|+.+|+.+. |+||+++++.|.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEE
Confidence 479999999999999999998765 68999999996543333334556889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|..+.
T Consensus 77 ~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccc
Confidence 9999999999999988654 678999999999999999999999999999999999999 667799999999975331
Q ss_pred CC--------------------------------------------CCccccccCccccccccccC-CCCCccchHHHHH
Q 011154 294 PD--------------------------------------------ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGV 328 (492)
Q Consensus 294 ~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGv 328 (492)
.. ......+||+.|||||++.+ .++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 00 00123579999999998864 5899999999999
Q ss_pred HHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCC---CHHHHhcCcccccc
Q 011154 329 IAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRM---TAAQALSHPWIRNY 401 (492)
Q Consensus 329 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~~ 401 (492)
++|+|++|+.||.+....+....+...........+..++.++.+||.+|+ .+|.+|+ ++.++++||||+..
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999999999988877776666655444444445578999999999987 5999999 99999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=385.28 Aligned_cols=251 Identities=32% Similarity=0.572 Sum_probs=217.3
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|+.+. +++.||||++.+.........+.+.+|+.++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 469999999999998765 68899999997654333344566788999998876799999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~~ 298 (492)
|+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 78 VNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcc
Confidence 9999999877654 679999999999999999999999999999999999999 6677899999999876432 2334
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+++..+......++. .++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~ 229 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKA 229 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHH
Confidence 45679999999998864 5889999999999999999999999999888888888776554432 478999999999
Q ss_pred ccccCcCCCCCH------HHHhcCcccccc
Q 011154 378 LLNKDPRKRMTA------AQALSHPWIRNY 401 (492)
Q Consensus 378 ~L~~dP~~Rps~------~e~l~hp~~~~~ 401 (492)
||+.||.+|+++ .+++.||||...
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 999999999998 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=384.87 Aligned_cols=250 Identities=30% Similarity=0.550 Sum_probs=216.5
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+++.+. +|+.||+|++.+...........+.+|+++++.+. ||||++++++|.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeC
Confidence 469999999999998765 78999999997654333344566788999999995 99999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~~ 298 (492)
|++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 77 ANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcc
Confidence 9999998877554 579999999999999999999999999999999999999 6677899999999876422 2333
Q ss_pred cccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
....||+.|+|||++. +.++.++|||||||++|+|++|+.||...+.......+......++. .+++++.+||.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~ 228 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG 228 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHH
Confidence 4567999999999875 46899999999999999999999999988888888777766555443 689999999999
Q ss_pred ccccCcCCCC-----CHHHHhcCcccccc
Q 011154 378 LLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 378 ~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
||..||.+|+ ++.++++|+||.+.
T Consensus 229 ~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred HccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999998 99999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=383.76 Aligned_cols=256 Identities=30% Similarity=0.498 Sum_probs=221.3
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||+|+.+. +++.||||++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 48899999999999999998765 678999999976544334455678889999999975567999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC-
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR- 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~- 293 (492)
+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCC
Confidence 999999999999888654 679999999999999999999999999999999999999 667789999999987532
Q ss_pred CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
........+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+....+.+..+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 229 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 2233445679999999998864 589999999999999999999999999888888888877655544 36899999
Q ss_pred HHHHHccccCcCCCCCH-----HHHhcCcccccc
Q 011154 373 DFVKLLLNKDPRKRMTA-----AQALSHPWIRNY 401 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~ 401 (492)
+||.+||..||.+|+++ .++++||||+..
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999999986 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=391.83 Aligned_cols=263 Identities=28% Similarity=0.458 Sum_probs=223.3
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
....++|++.+.||+|+||.||+++.+. +++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~ 114 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQD 114 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc
Confidence 3345789999999999999999999765 6889999999754433333445688999999999 59999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
++.+|+|||||+||+|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a 189 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTC 189 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccc
Confidence 9999999999999999998854 368999999999999999999999999999999999999 67789999999999
Q ss_pred cccCCCCC--ccccccCccccccccccC-----CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011154 290 DFVRPDER--LNDIVGSAYYVAPEVLHR-----SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 290 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (492)
........ ....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+..+......+...
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p 269 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP 269 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC
Confidence 87653322 245679999999998753 27889999999999999999999999988888888887655444333
Q ss_pred CCCCCCHHHHHHHHHccccCcCC--CCCHHHHhcCcccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRK--RMTAAQALSHPWIRNY 401 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~--Rps~~e~l~hp~~~~~ 401 (492)
....++..+++||.+||..++.+ |+++.++++||||+..
T Consensus 270 ~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 34468999999999999865544 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=391.54 Aligned_cols=259 Identities=34% Similarity=0.590 Sum_probs=224.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+... +|+.||||++.+...........+.+|++++..+. ||||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeE
Confidence 479999999999999999999765 78999999997654333344567889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMN 152 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCc
Confidence 9999999999999988765 689999999999999999999999999999999999999 677899999999998765
Q ss_pred CCC------------------------------CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCC
Q 011154 294 PDE------------------------------RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWA 342 (492)
Q Consensus 294 ~~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~ 342 (492)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 433 2234679999999998864 589999999999999999999999998
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCC-HHHHhcCcccccc
Q 011154 343 RTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMT-AAQALSHPWIRNY 401 (492)
Q Consensus 343 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-~~e~l~hp~~~~~ 401 (492)
.........+......+.......+++++.+||.+||. ||.+|++ +.++++||||+..
T Consensus 233 ~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 233 DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred CCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 88877777777643333333344589999999999997 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=388.29 Aligned_cols=260 Identities=33% Similarity=0.515 Sum_probs=224.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.+. +|+.||||++.+...........+.+|+.+++.+ +|+||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeE
Confidence 468999999999999999998765 7889999999765443444556788999999998 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLT 153 (330)
T ss_pred EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECC
Confidence 99999999999999987765789999999999999999999999999999999999999 677899999999998765
Q ss_pred CCCCc--cccccCcccccccccc-------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 294 PDERL--NDIVGSAYYVAPEVLH-------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 294 ~~~~~--~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
..... ....||+.|+|||++. ..++.++|||||||++|+|++|..||........+..+............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCC
Confidence 44322 2357999999999874 34788999999999999999999999888887777777765433333334
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+.++.++.+||.+||. ||.+|||+.+++.||||...
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 4689999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=366.95 Aligned_cols=261 Identities=31% Similarity=0.491 Sum_probs=223.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCC-ccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN-LVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpn-iv~l~~~~~~~~ 211 (492)
...|...++||+|+||+||+|+.+. +|+.||+|.+....... ..-....+|+.+|+.|+ |+| ||+|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~E-G~P~taiREisllk~L~-~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLS-HANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEecccccc-CCCchhhHHHHHHHHhC-CCcceEEEEeeeeecc
Confidence 4568888899999999999999876 78999999997654321 11123578999999996 999 999999998877
Q ss_pred ------eEEEEEeecCCCchHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEE
Q 011154 212 ------NVYIVMELCEGGELLDRILSRC---GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 212 ------~~~lv~E~~~ggsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~k 282 (492)
.+++|+||++. +|..++.... ..++...++.++.||+.||.|||+++|+||||||+|||| ++.+.+|
T Consensus 85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lK 160 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLK 160 (323)
T ss_pred cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEe
Confidence 89999999976 8888887654 358889999999999999999999999999999999999 6688999
Q ss_pred EEecccccccC-CCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC
Q 011154 283 AIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 283 l~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
|+|||+|+... +......-++|.+|+|||++-+ .|+...||||+|||++||++++..|.+..+.+.+..|.......
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 99999999776 4444677789999999998864 49999999999999999999999999999988888887766555
Q ss_pred CCCCCCC--------------------------CCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 360 DDGSWPS--------------------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 360 ~~~~~~~--------------------------~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+..|+. .+.+..+++.+||+.+|.+|.|+..+|+||||....
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 5555543 234789999999999999999999999999999763
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=382.97 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=207.5
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+++. +++.||||++.... .......+.+|+++++.+. |+||+++++++.+.+.+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEI 147 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeE
Confidence 567788999999999999998765 68899999996543 2334567899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||++|+|.+. ....+..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 148 ~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 148 QVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILA 219 (353)
T ss_pred EEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecc
Confidence 999999999998653 346788889999999999999999999999999999999 667789999999998765
Q ss_pred CCC-CccccccCccccccccccC-----C-CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR-----S-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~-----~-~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
... .....+||..|+|||++.. . ++.++|||||||++|+|++|+.||......+....+..............
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 332 2345679999999998742 2 34689999999999999999999974433322222221111112222346
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++.++++||.+||..||++|||+.|+|+||||.+..
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 889999999999999999999999999999999753
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=382.97 Aligned_cols=251 Identities=30% Similarity=0.524 Sum_probs=217.9
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|+.+. +++.||||++.+.........+.+..|++++..+.+||||++++++|.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 469999999999998765 68899999997654434444566778999998876799999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~~ 298 (492)
|+||+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 78 VNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccc
Confidence 9999999887654 679999999999999999999999999999999999999 6677999999999875432 2233
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
...+||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+......++. .++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~ 229 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKA 229 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 45679999999998864 5899999999999999999999999999988888888876654432 478999999999
Q ss_pred ccccCcCCCC-------CHHHHhcCcccccc
Q 011154 378 LLNKDPRKRM-------TAAQALSHPWIRNY 401 (492)
Q Consensus 378 ~L~~dP~~Rp-------s~~e~l~hp~~~~~ 401 (492)
||+.||++|+ ++.++++||||...
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 9999999999 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=377.49 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=209.6
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+.+. +++.||||++....... ....+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEEEG--TPFTAIREASLLKGLK-HANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---CCCEEEEEEeccccccc--cchhHHHHHHHHhhCC-CCCcCeEEEEEecCCe
Confidence 4789999999999999999998764 68899999996543221 2235678999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++|||||. ++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAK 153 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceec
Confidence 999999996 58888887766789999999999999999999999999999999999999 66778999999998754
Q ss_pred CCC-CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChh-HHHHHHHhcCCC----------
Q 011154 293 RPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPS---------- 358 (492)
Q Consensus 293 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-~~~~~i~~~~~~---------- 358 (492)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... +.+..+......
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 23345678999999998753 4788999999999999999999999765432 222222211000
Q ss_pred ----CCCCC------------C--CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 359 ----FDDGS------------W--PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 359 ----~~~~~------------~--~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+.... | ..+++++++||.+||+.||++|||+.|+|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00000 1 1245789999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=382.16 Aligned_cols=256 Identities=28% Similarity=0.490 Sum_probs=222.4
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||+|+.+. +++.||||++.+.........+.+..|..++..+.+|++|+++++++.+.+.+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 48899999999999999998765 678999999976544334445567788889888877999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+||||+++|+|.+.+... +.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 78 lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCC
Confidence 999999999999887654 679999999999999999999999999999999999999 6677999999999975432
Q ss_pred -CCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 295 -DERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 295 -~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
.......+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+.....++..+......++. .++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 229 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAV 229 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHH
Confidence 22344568999999999876 45899999999999999999999999998888888888876655443 5899999
Q ss_pred HHHHHccccCcCCCCC-----HHHHhcCcccccc
Q 011154 373 DFVKLLLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
+||.+||+.||.+|++ ..++++||||+..
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999998 4899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=382.97 Aligned_cols=251 Identities=30% Similarity=0.530 Sum_probs=212.0
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|+++. +++.||||++++.........+.+.+|+.++..+.+||||++++++|.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 469999999999999765 78899999998765444455667889999999997799999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc-CCCCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV-RPDERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~-~~~~~~ 298 (492)
|+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.. ......
T Consensus 78 ~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 78 VSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcc
Confidence 9999998877554 689999999999999999999999999999999999999 66778999999998753 233344
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC---------hhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART---------ESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
...+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .......+......++ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~ 229 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCC
Confidence 56789999999998864 58999999999999999999999995321 1223444554444333 2578
Q ss_pred HHHHHHHHHccccCcCCCCC------HHHHhcCcccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMT------AAQALSHPWIRNY 401 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps------~~e~l~hp~~~~~ 401 (492)
.++.+||.+||+.||.+|++ +.++++||||...
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999999999997 7999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=388.98 Aligned_cols=259 Identities=29% Similarity=0.500 Sum_probs=219.7
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.+. +++.||||++.+...........+.+|+.++..+ +||||+++++.+.+.+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEE
Confidence 468999999999999999999765 7889999999754433344556788999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccc
Confidence 9999999999999988654 679999999999999999999999999999999999999 667899999999987543
Q ss_pred CCC------------------------------------CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcC
Q 011154 294 PDE------------------------------------RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCG 336 (492)
Q Consensus 294 ~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg 336 (492)
... .....+||+.|+|||++. ..++.++|||||||++|+|++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 211 012357999999999876 4589999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCC---CHHHHhcCcccccc
Q 011154 337 SRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRM---TAAQALSHPWIRNY 401 (492)
Q Consensus 337 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~~ 401 (492)
..||...+....+..+......+.......++.++++||.+|+ .||.+|+ ++.++++||||.+.
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 9999998888888877764433332233358999999999987 5999998 58999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=384.02 Aligned_cols=250 Identities=30% Similarity=0.549 Sum_probs=216.7
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+++.+. +|+.||||++.+...........+.+|+++++.+. ||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeC
Confidence 469999999999998764 78999999997654444445567788999999995 99999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEecccccccC-CCCC
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDER 297 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~-~~~~ 297 (492)
|+||+|.+++... +.+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 77 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 77 ANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcc
Confidence 9999998877544 579999999999999999999997 799999999999999 667789999999987543 2333
Q ss_pred ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011154 298 LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376 (492)
Q Consensus 298 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 376 (492)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+......++. .+++++.+||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 228 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLS 228 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHH
Confidence 44567999999999886 46899999999999999999999999988888888877766555543 58899999999
Q ss_pred HccccCcCCCC-----CHHHHhcCcccccc
Q 011154 377 LLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 377 ~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+||+.||++|+ ++.++++||||.+.
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 99999999997 99999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=382.99 Aligned_cols=255 Identities=30% Similarity=0.519 Sum_probs=221.9
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
..|...+.||+|.||.||+|.+.. +++.||+|++..... ...++++..|+.+|.++. ++||.++|+.|..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeecc---ccceEEEEEechhhc--chhhHHHHHHHHHHHhcC-cchHHhhhhheeecccH
Confidence 457777999999999999999765 889999999976653 345678999999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+++||||.||++.+.+. .++.+.|.++..++++++.||.|||.++.+|||||+.|||+ ...+.+||+|||.+..+.
T Consensus 87 wiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---SESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---eccCcEEEEecceeeeee
Confidence 99999999999999774 34556999999999999999999999999999999999999 555899999999998876
Q ss_pred CCCCc-cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDERL-NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
..... .+.+||++|||||++.+ .|+.|+||||||++++||.+|.+|+........+-.|.+..+..... .+|+.+
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~---~~S~~~ 239 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG---DFSPPF 239 (467)
T ss_pred chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc---ccCHHH
Confidence 55433 78899999999999875 69999999999999999999999998777755555555544333332 678999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++||..||++||+.||+|.++|+|+|++..
T Consensus 240 kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 240 KEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 999999999999999999999999999984
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=379.97 Aligned_cols=251 Identities=28% Similarity=0.526 Sum_probs=214.4
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|+++. +|+.||||++.+.........+.+..|..++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 469999999999999765 78899999997643222223455677888888765799999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~~ 298 (492)
|.||+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 78 ~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 78 LNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCce
Confidence 9999999888654 679999999999999999999999999999999999999 6677899999999875322 2234
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+++..+....+.++. .++.++++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~ 229 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEK 229 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHH
Confidence 45789999999998864 5899999999999999999999999988888888877766554432 478999999999
Q ss_pred ccccCcCCCCCH-HHHhcCcccccc
Q 011154 378 LLNKDPRKRMTA-AQALSHPWIRNY 401 (492)
Q Consensus 378 ~L~~dP~~Rps~-~e~l~hp~~~~~ 401 (492)
||+.||++|+++ +++++||||+..
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCC
Confidence 999999999998 589999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=380.39 Aligned_cols=253 Identities=32% Similarity=0.555 Sum_probs=217.0
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEe
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E 218 (492)
+.||+|+||.||+++...+...++.||||++.+.... .......+.+|+.+|+.+. ||||++++++|.+++.+|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence 6799999999999987655567899999999754321 1223345788999999995 9999999999999999999999
Q ss_pred ecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCC
Q 011154 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DER 297 (492)
Q Consensus 219 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~ 297 (492)
|++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... ...
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 81 YLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred CCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCc
Confidence 99999999988654 678999999999999999999999999999999999999 6677999999999875432 223
Q ss_pred ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011154 298 LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376 (492)
Q Consensus 298 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 376 (492)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......++ +.+++++.+||.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~ 232 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLK 232 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 345679999999998764 588899999999999999999999998888888888777654443 357899999999
Q ss_pred HccccCcCCCC-----CHHHHhcCcccccc
Q 011154 377 LLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 377 ~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+||..||++|| ++.++++||||+..
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=368.47 Aligned_cols=258 Identities=30% Similarity=0.482 Sum_probs=218.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..-.|.-.+.+|+|+||.||.|.... +++.||||.+-.+.... .+|+++|+.+ +|||||+|.-+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d~r~k-------nrEl~im~~l-~HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQDKRYK-------NRELQIMRKL-DHPNIVRLLYFFSSST 90 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcC---CCceeEEEEecCCCCcC-------cHHHHHHHhc-CCcCeeeEEEEEEecC
Confidence 44568888999999999999999876 58899999986554332 3699999998 5999999999886432
Q ss_pred -----eEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 212 -----NVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 212 -----~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
...+||||++. +|.+.+.. ...+++.-+++-++.||++||.|||+.||+||||||.|+|++ .+.+.+||
T Consensus 91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKi 167 (364)
T KOG0658|consen 91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKI 167 (364)
T ss_pred CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEe
Confidence 45689999986 89888863 246799999999999999999999999999999999999995 34589999
Q ss_pred EecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC--
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF-- 359 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~-- 359 (492)
||||.|+.+..++...++..|++|+|||.+-+ .|+.+.||||.|||+.||+-|++.|.+.+..+.+..|.+.....
T Consensus 168 cDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred ccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999998888889999999999998764 59999999999999999999999999988877777765532111
Q ss_pred ------------------CCCCC-----CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 360 ------------------DDGSW-----PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 360 ------------------~~~~~-----~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
....| ..+++++.+|+.++|..+|.+|.++.|++.||||....+
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11122 357899999999999999999999999999999987543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=379.18 Aligned_cols=251 Identities=31% Similarity=0.558 Sum_probs=213.9
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|++.. +++.||||++.+.........+.+..|..++..+.+||||+++++++...+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999998765 68899999997654333334455667888887665799999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~~ 298 (492)
|+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 78 LNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcc
Confidence 9999999887654 579999999999999999999999999999999999999 6677899999999976432 2334
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+++..+....+.++ ..++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~ 229 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSK 229 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 45689999999998764 589999999999999999999999999888888887776554443 2578999999999
Q ss_pred ccccCcCCCCCH-HHHhcCcccccc
Q 011154 378 LLNKDPRKRMTA-AQALSHPWIRNY 401 (492)
Q Consensus 378 ~L~~dP~~Rps~-~e~l~hp~~~~~ 401 (492)
||..||.+||++ .++++||||+..
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCCC
Confidence 999999999986 588999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=379.62 Aligned_cols=253 Identities=31% Similarity=0.528 Sum_probs=217.1
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHH---HccCCCCccEEEEEEEeCCe
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR---ALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~---~l~~hpniv~l~~~~~~~~~ 212 (492)
|++.+.||+|+||.||+|.++. +++.||||++.+.........+.+.+|+.++. .+ +||||+++++++.+.+.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCE
Confidence 6788999999999999998765 78999999997654333334556777776664 45 49999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|...+.. +.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEG 151 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccC
Confidence 9999999999999887743 579999999999999999999999999999999999999 66779999999998754
Q ss_pred CC-CCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RP-DERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.. .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++. .++.+
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~ 227 (324)
T cd05589 152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSRE 227 (324)
T ss_pred CCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence 32 233445789999999998764 5889999999999999999999999998888888888776655443 57999
Q ss_pred HHHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+.+||.+||..||.+|| ++.++++||||++.
T Consensus 228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=379.60 Aligned_cols=251 Identities=31% Similarity=0.548 Sum_probs=217.4
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999999765 67899999997654433444566788999999886799999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC-CCCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~-~~~~~ 298 (492)
|+||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 78 VNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcc
Confidence 9999999887654 579999999999999999999999999999999999999 667789999999987532 22233
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......++ ..++.++.+||++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKS 229 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHH
Confidence 45679999999998864 689999999999999999999999998888888887776655443 2578999999999
Q ss_pred ccccCcCCCCCH-----HHHhcCcccccc
Q 011154 378 LLNKDPRKRMTA-----AQALSHPWIRNY 401 (492)
Q Consensus 378 ~L~~dP~~Rps~-----~e~l~hp~~~~~ 401 (492)
||..||.+||++ .++++||||+..
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999 999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=385.95 Aligned_cols=262 Identities=28% Similarity=0.454 Sum_probs=222.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|+.+. +++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~ 115 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDD 115 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcC
Confidence 345789999999999999999998765 7889999999654333333445678899999999 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCcee
Confidence 999999999999999998754 368999999999999999999999999999999999999 667789999999998
Q ss_pred ccCCCCC--ccccccCccccccccccC-----CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 291 FVRPDER--LNDIVGSAYYVAPEVLHR-----SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 291 ~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......+....
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 7653322 235679999999998753 278899999999999999999999999888888888877554444444
Q ss_pred CCCCCHHHHHHHHHccccCcCC--CCCHHHHhcCcccccc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRK--RMTAAQALSHPWIRNY 401 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~--Rps~~e~l~hp~~~~~ 401 (492)
...++.++++||.+||..++.+ |+++.++++|+||++.
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 4578999999999999844433 7899999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=371.09 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=217.8
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
.|++.+.||+|+||.||++.... +++.||||++.............+.+|+.+++.+ +||||+++++.+.+++.++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEE
Confidence 48889999999999999998654 6889999999765443333445578899999999 5999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+|||||.+|+|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++ ++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecC
Confidence 9999999999998876543 469999999999999999999999999999999999999 667889999999998775
Q ss_pred CCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
........+|+..|+|||++. ..++.++||||+||++|+|++|..||.+.........+..............++..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 544445568999999999875 4588999999999999999999999987665443333332222222223346899999
Q ss_pred HHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 373 DFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 373 ~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+||.+||..||.+|| +++++++||||...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999999999 99999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=370.98 Aligned_cols=256 Identities=30% Similarity=0.469 Sum_probs=210.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+++. +++.||||++...... ....+.+.+|+.+++.+. ||||++++++|.+++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---CCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCC-CccccchhhhEecCCEE
Confidence 479999999999999999999765 6789999999765332 233456789999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||++++.+. .+......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~~~~l~-~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 76 YLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEEecCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccc
Confidence 9999999986554 454555679999999999999999999999999999999999999 667789999999998764
Q ss_pred CCC--CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-------------
Q 011154 294 PDE--RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------------- 357 (492)
Q Consensus 294 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~------------- 357 (492)
... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 332 233467999999999875 4589999999999999999999999987665444333322111
Q ss_pred -CC-----CC---------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 358 -SF-----DD---------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 358 -~~-----~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.+ +. ..+..+|.++.+||++||+.||++|||++|+|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 00 0112478889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=379.11 Aligned_cols=251 Identities=29% Similarity=0.534 Sum_probs=211.4
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|+.+. +++.||+|++.+...........+.+|+.++.++.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 469999999999999765 68899999998765545555667889999998886799999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC-CCCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~-~~~~~ 298 (492)
|++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... .....
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 78 VNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcc
Confidence 9999998877554 679999999999999999999999999999999999999 667789999999987542 23334
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCC---------ChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWAR---------TESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||... ....+...+......++ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~ 229 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCC
Confidence 45789999999998764 5889999999999999999999999521 12223444554444333 3688
Q ss_pred HHHHHHHHHccccCcCCCCC------HHHHhcCcccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMT------AAQALSHPWIRNY 401 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps------~~e~l~hp~~~~~ 401 (492)
.++.+||.+||+.||++|++ +.++++||||++.
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999999999998 5899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=378.05 Aligned_cols=261 Identities=29% Similarity=0.502 Sum_probs=219.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+++.+. +++.||||++.+.........+.+.+|+.++..+ +|+||++++++|.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeE
Confidence 479999999999999999998765 6889999999754333334455688999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||++||+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLL 153 (331)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecC
Confidence 99999999999999987656689999999999999999999999999999999999999 667789999999987664
Q ss_pred CCCCc--cccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC-CCCC
Q 011154 294 PDERL--NDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-DGSW 364 (492)
Q Consensus 294 ~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-~~~~ 364 (492)
..... ...+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+....+.+..+......+. ...+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCcc
Confidence 43322 2357999999999885 3478899999999999999999999988887777777765433222 1223
Q ss_pred CCCCHHHHHHHHHccccCcCC--CCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRK--RMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~--Rps~~e~l~hp~~~~~ 401 (492)
..++.++++||++||+.++++ |+++.++++||||...
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 458999999999999765544 7899999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=368.66 Aligned_cols=258 Identities=30% Similarity=0.430 Sum_probs=210.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc--CCCCccEEEEEEE---
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS--GHSNLVKFYDAFE--- 208 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~--~hpniv~l~~~~~--- 208 (492)
++|++.+.||+|+||.||+|+... ..++.||||++........ ....+.+|+.+++.+. +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC--CCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 479999999999999999998643 2468899999865433221 2234567888777763 4999999999985
Q ss_pred --eCCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 209 --DLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 209 --~~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~D 153 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 153 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcc
Confidence 3456999999996 58888886542 458999999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC--
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG-- 362 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-- 362 (492)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+..........
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99998776555555678999999999875 568999999999999999999999999888877776665432111111
Q ss_pred ---------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 363 ---------------------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 363 ---------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
..+.++..+++||.+||+.||++|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 123577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=375.62 Aligned_cols=251 Identities=31% Similarity=0.526 Sum_probs=213.6
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|++.. +++.||||++.+..............|..++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 469999999999998765 67899999997653322223455677888888765799999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~~ 298 (492)
++||+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 78 LNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCce
Confidence 9999999888653 579999999999999999999999999999999999999 6677899999999875422 2234
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+....+.++. .++.++++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~ 229 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----WLTREAKDILVK 229 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHH
Confidence 45679999999998764 5899999999999999999999999988888888777665544332 478999999999
Q ss_pred ccccCcCCCCCHH-HHhcCcccccc
Q 011154 378 LLNKDPRKRMTAA-QALSHPWIRNY 401 (492)
Q Consensus 378 ~L~~dP~~Rps~~-e~l~hp~~~~~ 401 (492)
||+.||.+|+++. ++++||||+..
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCC
Confidence 9999999999996 99999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=380.20 Aligned_cols=258 Identities=32% Similarity=0.519 Sum_probs=231.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|.+++.+|+|+||.+++++++. .++.|++|.|......... .+...+|+.++++++ |||||.+.+.|+.++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc---CCceEEEEEEeccccCchh-hHHHHHHHHHHHhcc-CCCeeeeccchhcCCc
Confidence 4689999999999999999998776 6679999999877766543 336789999999996 9999999999999888
Q ss_pred -EEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 213 -VYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 213 -~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
++|||+||+||+|.+.|.++. ..|+|+.+..|+.||+.|+.|||+++|+|||||+.||++ ..+..|||+|||+|+
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAK 154 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhh
Confidence 999999999999999998765 579999999999999999999999999999999999999 556678999999999
Q ss_pred ccCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
.+.+.. ...+++||++||.||++.+ .|+.|+|||||||++|||++-+.+|.+.+-.++..+|.+....... ..++
T Consensus 155 ~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys 231 (426)
T KOG0589|consen 155 ILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYS 231 (426)
T ss_pred hcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---cccc
Confidence 998877 6678999999999999985 6999999999999999999999999999999999999887733322 3689
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.+++.||+.||..+|..||++.++|.+|.+..+
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 999999999999999999999999999988743
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=375.70 Aligned_cols=256 Identities=30% Similarity=0.503 Sum_probs=220.6
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence 47788999999999999998765 788999999976543333445667889999998876788999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+|||||+||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 78 lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCC
Confidence 999999999999887554 679999999999999999999999999999999999999 6677899999999876432
Q ss_pred CC-CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 295 DE-RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 295 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
.. .....+||+.|+|||++. +.++.++|||||||++|+|++|..||.+.........+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 229 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence 22 234567999999999876 4589999999999999999999999999888888888877665443 35789999
Q ss_pred HHHHHccccCcCCCCC-----HHHHhcCcccccc
Q 011154 373 DFVKLLLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
+|+.+||+.||.+|++ ..++++||||+..
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 9999999999999997 5899999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=380.63 Aligned_cols=260 Identities=35% Similarity=0.631 Sum_probs=235.9
Q ss_pred cceee--cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 134 SRLEV--GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 134 ~~y~~--~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.-|++ .+.||+|.||+||-|.+++ +|+.||||+|.|.+....+. ..+++|+.||..+. ||.||.|.-.|++.+
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~-HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLH-HPGIVNLECMFETPE 636 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecc---cCceeeeeeeecccCCCchH-HHHHHHHHHHHhcC-CCCeeEEEEeecCCc
Confidence 34554 4789999999999999876 89999999999888766543 67999999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.+++|||.+.| +.++.|+.. .+++++...+.++.||+.||.|||.++|||+||||+|||+.+.+...++||||||+|+
T Consensus 637 rvFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 637 RVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred eEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecccccee
Confidence 99999999955 777777643 5789999999999999999999999999999999999999988888899999999999
Q ss_pred ccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
++.+..-..+++||+.|+|||+++ +.|+..-|+||+|||+|.-|.|..||.. ++++-..|.+....++...|..++.
T Consensus 716 iIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~ 793 (888)
T KOG4236|consen 716 IIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISP 793 (888)
T ss_pred ecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCH
Confidence 998777778899999999999986 5699999999999999999999999954 4457788888889999999999999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++.|||..+|++.-++|.|+.+.|.|||++++
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999999999986
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=366.88 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=208.1
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecC
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ 221 (492)
||+|+||.||++.++. +++.||||.+.+.........+.+..|+.+++.+ +|+||+++++++.+.+.+|+|||||+
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCC
Confidence 7999999999998765 7889999999765544444456678899999999 59999999999999999999999999
Q ss_pred CCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCC-
Q 011154 222 GGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER- 297 (492)
Q Consensus 222 ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~- 297 (492)
||+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCcc
Confidence 9999887753 23469999999999999999999999999999999999999 6677899999999976654332
Q ss_pred ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011154 298 LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376 (492)
Q Consensus 298 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 376 (492)
.....||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+..............++.++.+|+.
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHH
Confidence 33467999999999876 46889999999999999999999999765432222222211111112223468999999999
Q ss_pred HccccCcCCCC-----CHHHHhcCcccccc
Q 011154 377 LLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 377 ~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+||+.||++|| +++++++||||+..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999999999 88999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=390.67 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=208.3
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
...+|++++.||+|+||.||+|+... +++.||||++.... ....+|+.+|+.+. |||||+++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTEC 132 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeecc
Confidence 45789999999999999999998764 68899999885432 12357999999995 99999999987532
Q ss_pred -------CeEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCc
Q 011154 211 -------DNVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 211 -------~~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~ 280 (492)
..+++|||||++ +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++. ....
T Consensus 133 ~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~ 209 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHT 209 (440)
T ss_pred cccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCc
Confidence 247799999975 67666642 3457999999999999999999999999999999999999942 2346
Q ss_pred EEEEecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC
Q 011154 281 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 358 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~ 358 (492)
+||+|||+|+.+.........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+....+.+..+.+....
T Consensus 210 vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred eeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999999988766555566789999999998754 5899999999999999999999999888766655554432110
Q ss_pred -----------------CCCC--------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 359 -----------------FDDG--------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 359 -----------------~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++.. .....+.++++||.+||.+||.+|||+.|+|+||||....
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 1100 0113678999999999999999999999999999998654
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=375.90 Aligned_cols=250 Identities=28% Similarity=0.517 Sum_probs=211.7
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHH-HHHHccCCCCccEEEEEEEeCCeEEEEEe
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK-ILRALSGHSNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~-~l~~l~~hpniv~l~~~~~~~~~~~lv~E 218 (492)
+.||+|+||.||+|+.+. +|+.||||++.+...........+.+|.. +++.+ +||||+++++++.+.+.+|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEc
Confidence 469999999999999765 78999999997644333333345555655 45667 59999999999999999999999
Q ss_pred ecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCC
Q 011154 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DER 297 (492)
Q Consensus 219 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~ 297 (492)
||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 77 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 77 YVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCc
Confidence 99999999887654 679999999999999999999999999999999999999 6677999999999875432 233
Q ss_pred ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011154 298 LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376 (492)
Q Consensus 298 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 376 (492)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||......+++..+........ +.++.++.+||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLE 228 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 445679999999998764 589999999999999999999999999888888888876554433 467999999999
Q ss_pred HccccCcCCCCCH----HHHhcCcccccc
Q 011154 377 LLLNKDPRKRMTA----AQALSHPWIRNY 401 (492)
Q Consensus 377 ~~L~~dP~~Rps~----~e~l~hp~~~~~ 401 (492)
+||+.||.+||++ .++++||||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 229 GLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred HHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999997 699999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=376.10 Aligned_cols=258 Identities=30% Similarity=0.490 Sum_probs=207.9
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC----
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL---- 210 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~---- 210 (492)
+|++.+.||+|+||.||+|+.+. +|+.||||++..... .......+.+|+.+++.++ ||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCC
Confidence 58999999999999999998765 789999999864322 2223456889999999995 99999999988643
Q ss_pred -CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 -DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
..+|+|||||. ++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~ 150 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLA 150 (338)
T ss_pred CceEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccc
Confidence 35899999995 6888877544 579999999999999999999999999999999999999 67789999999999
Q ss_pred cccCCCC----CccccccCcccccccccc---CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHh--------
Q 011154 290 DFVRPDE----RLNDIVGSAYYVAPEVLH---RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-------- 354 (492)
Q Consensus 290 ~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~-------- 354 (492)
+...... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 7643221 123467999999999875 3588999999999999999999999977654332221111
Q ss_pred -------------------cCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 355 -------------------ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 355 -------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.........++.+++++.+||.+||..||++|||+.|+|+||||+...
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 111111122356788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=374.18 Aligned_cols=251 Identities=29% Similarity=0.519 Sum_probs=211.4
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|+.+. +++.||||++.+.........+.+.+|+.++.++.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 469999999999998765 68899999998765444455667889999999997799999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc-CCCCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV-RPDERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~-~~~~~~ 298 (492)
|+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.. ......
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 78 VNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCce
Confidence 9999998877544 679999999999999999999999999999999999999 66778999999998753 223344
Q ss_pred cccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCC-------hhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 299 NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWART-------ESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
...+||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......+......++ ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~ 229 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVK 229 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHH
Confidence 5678999999999875 468999999999999999999999996422 2234444444333332 357899
Q ss_pred HHHHHHHccccCcCCCCC------HHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRMT------AAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps------~~e~l~hp~~~~~ 401 (492)
+.++|.+||..||++|++ +.++++||||+..
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 999999999999999998 5799999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=370.66 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=213.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+++++. ++..||+|++.... .....+.+.+|+++|+.+. ||||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCE
Confidence 4789999999999999999999765 78899999996542 2334567899999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+++||||++||+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccc
Confidence 99999999999999987654 5799999999999999999999986 69999999999999 5667899999999976
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-------------
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------------- 357 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~------------- 357 (492)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......++...+.....
T Consensus 154 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ccc-cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 643 23345679999999998864 589999999999999999999999976554433222111000
Q ss_pred -------------------------------CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 -------------------------------SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 -------------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.........++.++++||.+||..||++|||+.++++||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 000011124688999999999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=374.89 Aligned_cols=261 Identities=28% Similarity=0.483 Sum_probs=219.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+++.+. +++.||+|++.+...........+.+|+.++..+ +|+||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEE
Confidence 478999999999999999998765 6789999999654333333445588899999998 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||++|+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 153 (332)
T ss_pred EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecc
Confidence 99999999999999997766789999999999999999999999999999999999999 667789999999987654
Q ss_pred CCCC--ccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC-CCC
Q 011154 294 PDER--LNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD-GSW 364 (492)
Q Consensus 294 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~ 364 (492)
.... ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||......+.+..+......+.. ..+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcc
Confidence 3322 23457999999999874 34888999999999999999999999988888888777665433221 223
Q ss_pred CCCCHHHHHHHHHccccCcCC--CCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRK--RMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~--Rps~~e~l~hp~~~~~ 401 (492)
..++.++++||++||+.++.+ |+++.++++||||.+.
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 468999999999999765554 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=379.14 Aligned_cols=250 Identities=31% Similarity=0.561 Sum_probs=212.9
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc--CCCCccEEEEEEEeCCeEEEEEee
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS--GHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~--~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
||+|+||.||+|+.+. +++.||||++.+...........+..|..++..+. +||||+++++++.+.+.+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999998765 78899999996544333333445566777776654 699999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC-CCCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~-~~~~ 298 (492)
+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 78 MSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCc
Confidence 9999999887654 679999999999999999999999999999999999999 6677899999999876432 2334
Q ss_pred cccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 376 (492)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+......++. ..++.++.+||+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~ 230 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVK 230 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHH
Confidence 46789999999998753 4889999999999999999999999998888888888776655543 247899999999
Q ss_pred HccccCcCCCC----CHHHHhcCcccccc
Q 011154 377 LLLNKDPRKRM----TAAQALSHPWIRNY 401 (492)
Q Consensus 377 ~~L~~dP~~Rp----s~~e~l~hp~~~~~ 401 (492)
+||+.||.+|| ++.++++||||...
T Consensus 231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 231 GLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=376.07 Aligned_cols=252 Identities=29% Similarity=0.527 Sum_probs=217.3
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+++...+..+|+.||||++.+.... ......+.+|+++|+++. ||||+++++++.+++.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999987655567899999999754322 122345678999999995 99999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC-CCc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERL 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~-~~~ 298 (492)
|++|+|.+++.+. ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ...
T Consensus 80 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 80 LRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCce
Confidence 9999999988654 579999999999999999999999999999999999999 66778999999999865443 233
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+......++ ..++.++.+||++
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~ 231 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRA 231 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 45689999999998864 588899999999999999999999998888888887776655443 2578999999999
Q ss_pred ccccCcCCCCC-----HHHHhcCcccccc
Q 011154 378 LLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 378 ~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
||+.||++||+ +.+++.||||...
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=384.14 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=204.3
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc-----CCCCccEEEEE
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS-----GHSNLVKFYDA 206 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~-----~hpniv~l~~~ 206 (492)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... .....+..|+.+++.++ +|.+|++++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 45789999999999999999998765 67899999995432 12344667888887774 24568999999
Q ss_pred EEeC-CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCC-------
Q 011154 207 FEDL-DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDE------- 277 (492)
Q Consensus 207 ~~~~-~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~------- 277 (492)
|..+ +.+|+|||++ |++|.+++.+. +.+++.+++.|+.||+.||.|||+ .|||||||||+|||+...+.
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence 8764 5789999998 77899888654 679999999999999999999998 59999999999999964321
Q ss_pred ------CCcEEEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 011154 278 ------SSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFR 350 (492)
Q Consensus 278 ------~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~ 350 (492)
...+||+|||++.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred cccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 1259999999886432 23345789999999998764 59999999999999999999999998877655554
Q ss_pred HHHhcCCCCCCCC------------------------------------CC--CCCHHHHHHHHHccccCcCCCCCHHHH
Q 011154 351 AVLKADPSFDDGS------------------------------------WP--SLSSDAKDFVKLLLNKDPRKRMTAAQA 392 (492)
Q Consensus 351 ~i~~~~~~~~~~~------------------------------------~~--~~s~~~~~li~~~L~~dP~~Rps~~e~ 392 (492)
.+......++... +. ..+..+.|||.+||+.||.+|||+.|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 4433221111000 00 013567899999999999999999999
Q ss_pred hcCccccccc
Q 011154 393 LSHPWIRNYN 402 (492)
Q Consensus 393 l~hp~~~~~~ 402 (492)
|+||||.++.
T Consensus 436 L~Hp~~~~~~ 445 (467)
T PTZ00284 436 TTHPYVLKYY 445 (467)
T ss_pred hcCccccccC
Confidence 9999999854
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=374.22 Aligned_cols=261 Identities=26% Similarity=0.473 Sum_probs=219.9
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+++.+. +++.||||++.+...........+.+|+.++..+ +|+||+++++++.+.+..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEE
Confidence 479999999999999999998765 6789999999654333333445578899999998 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeecc
Confidence 99999999999999987756789999999999999999999999999999999999999 667789999999998765
Q ss_pred CCCCc--cccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC-CCCC
Q 011154 294 PDERL--NDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-DGSW 364 (492)
Q Consensus 294 ~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-~~~~ 364 (492)
..... ...+||+.|+|||++. +.++.++|||||||++|+|++|+.||......+.+..+......+. ...+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence 43322 2357999999999875 3578899999999999999999999998887777777766443322 1223
Q ss_pred CCCCHHHHHHHHHccccCcCC--CCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRK--RMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~--Rps~~e~l~hp~~~~~ 401 (492)
..++.++++||.+||+.++.+ |++++++++|+||+..
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 467999999999999976654 5799999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=368.83 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=214.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|.+.+.||+|+||.||+|+.+. +++.||||++....... ....+.+|+.+++.++ ||||+++++++.+++..
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIVHTDKSL 79 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccCC--cchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeE
Confidence 679999999999999999998765 67899999986543222 2235678999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+++ +|.+.+......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKS 155 (309)
T ss_pred EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecC
Confidence 999999975 8888887666678999999999999999999999999999999999999 667789999999997654
Q ss_pred CCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC---------
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD--------- 361 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~--------- 361 (492)
... ......+|+.|+|||++.+ .++.++|||||||++|+|+||+.||.+.+..+.+..+.........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 322 2334578999999998753 5888999999999999999999999887766555444332111000
Q ss_pred -----------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 362 -----------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 362 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
...+.++.++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 11235788999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=381.66 Aligned_cols=261 Identities=33% Similarity=0.472 Sum_probs=217.5
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-----CCccEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-----SNLVKFY 204 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-----pniv~l~ 204 (492)
+.+..+|++.+.||+|+||+|.+|++.+ +++.||||+|+.... ...+...||.+|..|..| -|||+++
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecC---CCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 4556699999999999999999999776 899999999976542 345567899999999633 3899999
Q ss_pred EEEEeCCeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 205 DAFEDLDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 205 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
++|...+++|||+|++.- +|+++|+.+ ...++...++.|+.||+.||.+||+.||||+|||||||||...+. ..|||
T Consensus 255 d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-~~vKV 332 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-SRIKV 332 (586)
T ss_pred eccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-CceeE
Confidence 999999999999999955 999999864 456999999999999999999999999999999999999987554 48999
Q ss_pred EecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC--
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 360 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-- 360 (492)
+|||.|.+... ...+++-+++|+|||++-+ .|+.+.||||||||++||++|.+.|.+.++.+.+..|.......+
T Consensus 333 IDFGSSc~~~q--~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 333 IDFGSSCFESQ--RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred EecccccccCC--cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 99999998753 3348889999999998764 799999999999999999999999988888777666543221110
Q ss_pred ------------CC-C--------------------------------CC------------CCCHHHHHHHHHccccCc
Q 011154 361 ------------DG-S--------------------------------WP------------SLSSDAKDFVKLLLNKDP 383 (492)
Q Consensus 361 ------------~~-~--------------------------------~~------------~~s~~~~~li~~~L~~dP 383 (492)
.. . .+ .-...+.|||++||..||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 00 0 01 112357899999999999
Q ss_pred CCCCCHHHHhcCcccccc
Q 011154 384 RKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 384 ~~Rps~~e~l~hp~~~~~ 401 (492)
.+|+|+.|+|+||||...
T Consensus 491 ~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTGT 508 (586)
T ss_pred hhcCCHHHHhcCcccccc
Confidence 999999999999999954
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=373.51 Aligned_cols=250 Identities=27% Similarity=0.504 Sum_probs=211.6
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHH-HHHccCCCCccEEEEEEEeCCeEEEEEe
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI-LRALSGHSNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~-l~~l~~hpniv~l~~~~~~~~~~~lv~E 218 (492)
+.||+|+||.||+|+.+. +|+.||||++.+...........+..|..+ ++.+ +||||++++++++..+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEc
Confidence 469999999999998765 789999999976543333344456666654 5667 59999999999999999999999
Q ss_pred ecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC-CCCC
Q 011154 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDER 297 (492)
Q Consensus 219 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~-~~~~ 297 (492)
||+||+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 77 FVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCC
Confidence 9999999887764 4679999999999999999999999999999999999999 667799999999987542 2233
Q ss_pred ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011154 298 LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376 (492)
Q Consensus 298 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 376 (492)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||......+++..+......+. +.++..+.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~ 228 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILE 228 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHH
Confidence 445689999999998864 589999999999999999999999999888888888776544332 368899999999
Q ss_pred HccccCcCCCCCH----HHHhcCcccccc
Q 011154 377 LLLNKDPRKRMTA----AQALSHPWIRNY 401 (492)
Q Consensus 377 ~~L~~dP~~Rps~----~e~l~hp~~~~~ 401 (492)
+||..||.+||++ .++++||||...
T Consensus 229 ~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 9999999999976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=362.51 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=214.7
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
.|++.+.||+|+||.||++.+.. +++.||||.+.+...........+.+|+.+++.+. |+||+.+++.+.+.+.++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEE
Confidence 37788899999999999998775 78899999997655444444556788999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+||||++||+|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++....
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecC
Confidence 9999999999998886543 359999999999999999999999999999999999999 667789999999998765
Q ss_pred CCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhH---HHHHHHhcCCCCCCCCCCCCCH
Q 011154 294 PDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.........||..|+|||++. ..++.++|||||||++|+|++|..||....... ....+... ........++.
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (285)
T cd05630 154 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEEYSEKFSP 230 (285)
T ss_pred CCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhhcCccCCH
Confidence 544445568999999999875 458999999999999999999999997654321 22222111 11122346889
Q ss_pred HHHHHHHHccccCcCCCCC-----HHHHhcCcccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
++++||.+||+.||++||| +.|+++||||+..
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 9999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=353.30 Aligned_cols=261 Identities=31% Similarity=0.554 Sum_probs=237.9
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+.-.++|+..+.||+|.||.|.+++.+. +++.||||++++...-....+..-..|-.+|+..+ ||.+..|--.|+.
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQT 239 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecc---cCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhcc
Confidence 3446789999999999999999998765 89999999999887766666677788999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.+|+||||..||+|+-++. +...|+|..++.+-..|+.||.|||+++||+||||.+|.|+ |.++++||+||||+
T Consensus 240 ~drlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLC 315 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLC 315 (516)
T ss_pred CceEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccc
Confidence 999999999999999988774 44679999999999999999999999999999999999999 88999999999999
Q ss_pred cc-cCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 290 DF-VRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 290 ~~-~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
+. +..+..+.+.||||.|+|||++. ..|+..+|.|.+||+||||+||++||+......++..|+..+..|+. .+
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~l 391 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TL 391 (516)
T ss_pred hhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cC
Confidence 75 45566778899999999999997 56999999999999999999999999999999999999999999886 79
Q ss_pred CHHHHHHHHHccccCcCCCC-----CHHHHhcCccccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~ 402 (492)
+++++.|+..+|.+||.+|. .+.|+.+|+||...+
T Consensus 392 s~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 392 SPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred CHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 99999999999999999997 489999999998754
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=371.25 Aligned_cols=250 Identities=28% Similarity=0.519 Sum_probs=209.8
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHH-HHHHccCCCCccEEEEEEEeCCeEEEEEe
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK-ILRALSGHSNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~-~l~~l~~hpniv~l~~~~~~~~~~~lv~E 218 (492)
+.||+|+||.||+|+++. +++.||+|++.+...........+..|.. +++.+ +||||+++++++.+.+.+|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEe
Confidence 469999999999998765 67899999997543322223334445544 45667 59999999999999999999999
Q ss_pred ecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC-CCCC
Q 011154 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDER 297 (492)
Q Consensus 219 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~-~~~~ 297 (492)
||+||+|.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... ....
T Consensus 77 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 77 YINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCC
Confidence 99999999888654 578999999999999999999999999999999999999 667789999999997543 2233
Q ss_pred ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011154 298 LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376 (492)
Q Consensus 298 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 376 (492)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......+ .+.++.++.+||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~ 228 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLE 228 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHH
Confidence 445689999999998864 58899999999999999999999999988888888776654333 2468999999999
Q ss_pred HccccCcCCCCCHH----HHhcCcccccc
Q 011154 377 LLLNKDPRKRMTAA----QALSHPWIRNY 401 (492)
Q Consensus 377 ~~L~~dP~~Rps~~----e~l~hp~~~~~ 401 (492)
+||+.||.+|+++. ++++|+||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 229 GLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 99999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=361.39 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=207.8
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc--CCCCccEEEEEEEe---
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS--GHSNLVKFYDAFED--- 209 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~--~hpniv~l~~~~~~--- 209 (492)
+|++.+.||+|+||.||+|+.+. +++.||||.+........ ....+.+|+.+++.+. +||||+++++++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 58899999999999999999765 789999999875432221 1224556777777663 59999999999865
Q ss_pred --CCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEec
Q 011154 210 --LDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 210 --~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
...+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~df 152 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADF 152 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcc
Confidence 3458999999975 8888776543 358999999999999999999999999999999999999 66678999999
Q ss_pred ccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC-----
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD----- 360 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~----- 360 (492)
|++.............||..|+|||++. ..++.++||||+||++|+|++|..||.+....+.+..+........
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 9998776555555667899999999875 4689999999999999999999999988777666555543211100
Q ss_pred ------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 361 ------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 361 ------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
....+.++.++.+||.+||+.||++|||+.|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01124578889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=372.65 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=215.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+.+.+++.||+|.||+||+|+|.+ .||||++.......+ ..+.|++||.++++-+ |-||+-+.|+|..+..
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTR-HENILLFMGACMNPPL 462 (678)
T ss_pred HHHhhccceeccccccceeeccccc------ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcc-hhhheeeehhhcCCce
Confidence 4567788999999999999999986 489999987766544 7788999999999996 9999999999998777
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.||+.+|+|.+|+.+|+-...+|.......|++||++|+.|||.++|||||||..||++ .+++.|||+||||+..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeee
Confidence 99999999999999999877889999999999999999999999999999999999999 66789999999998643
Q ss_pred ---CCCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC-CCC
Q 011154 293 ---RPDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD-GSW 364 (492)
Q Consensus 293 ---~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~ 364 (492)
..........|...|||||+++ ..|+..+||||||+|+|||+||.+||.....+.++-.+-++...... ...
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 3344556677999999999885 35999999999999999999999999977777776666555222211 123
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
...++++++|+..||.+++++||...+||.
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 456779999999999999999999999987
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=358.84 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=219.0
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
.|+..+.||+|+||.||++.+.. +++.||+|.+.+...........+.+|+.+|+.++ |+||+.+++.+.+++..+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEE
Confidence 36778899999999999998765 68899999997654444444456788999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+||||+.+|+|.+.+.... ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecC
Confidence 9999999999998886543 369999999999999999999999999999999999999 566789999999997765
Q ss_pred CCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
.........|+..|+|||++. ..++.++|||||||++|+|++|..||...........+..............++.++.
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAK 233 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHH
Confidence 444445567999999999875 4589999999999999999999999987765544444433222222333456889999
Q ss_pred HHHHHccccCcCCCCC-----HHHHhcCccccccc
Q 011154 373 DFVKLLLNKDPRKRMT-----AAQALSHPWIRNYN 402 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~~ 402 (492)
+|+.+||..||++||+ +.+++.|+||+...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 9999999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=376.24 Aligned_cols=256 Identities=34% Similarity=0.596 Sum_probs=233.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
...|.+...||+|.|+.|.++++.. ++..||||+|++....... ...+.+|+++|+.| +|||||+++.+.+....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSL-NHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChHH-HHHHHHHHHHHHhc-CCcceeeeeeeeeecce
Confidence 4679999999999999999998765 7899999999988766543 34488999999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+||||+.+|++++++.+. +.+.+..+..++.|++++++|||+++|||||||++|||| +.+.++||+|||++.++
T Consensus 130 lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFF 205 (596)
T ss_pred eEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceee
Confidence 99999999999999999876 678889999999999999999999999999999999999 78888999999999999
Q ss_pred CCCCCccccccCccccccccccCC--CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RPDERLNDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.......+.||++.|.|||++.+. -+.++|+||+|+++|.|++|.+||.+.+..+.-..++.+....+. .++.+
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~d 281 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCD 281 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeech
Confidence 988889999999999999999753 467899999999999999999999999988888888877776654 58899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+++||+++|..+|.+|++++++..|.|+...
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 9999999999999999999999999998753
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=373.43 Aligned_cols=258 Identities=29% Similarity=0.478 Sum_probs=208.8
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+++... +|+.||||++.+... .......+.+|+.+++.+. ||||++++++|...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 92 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQ 92 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEeccccc-chhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccC
Confidence 356889999999999999999998654 789999999965432 2334566789999999995 99999999998654
Q ss_pred C------eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 D------NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ~------~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+ .+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~ 165 (359)
T cd07876 93 KSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKIL 165 (359)
T ss_pred CCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEe
Confidence 3 57999999976 5666553 358999999999999999999999999999999999999 667789999
Q ss_pred ecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhc--------
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA-------- 355 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~-------- 355 (492)
|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 166 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred cCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9999987655544556789999999998764 5899999999999999999999999876654433322211
Q ss_pred --------------CCCCCC----------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 356 --------------DPSFDD----------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 356 --------------~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
.+.+.. ......++++++||.+||..||++|||+.|+|+||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 111110 001124678999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=369.11 Aligned_cols=250 Identities=28% Similarity=0.499 Sum_probs=209.8
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHH-HHHHccCCCCccEEEEEEEeCCeEEEEEe
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK-ILRALSGHSNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~-~l~~l~~hpniv~l~~~~~~~~~~~lv~E 218 (492)
+.||+|+||.||+|+.+. +++.||||++.+...........+.+|.. +++.+ +||||+++++++.+.+.+|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEc
Confidence 469999999999998765 68899999997654333333444555654 56777 59999999999999999999999
Q ss_pred ecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC-CCCC
Q 011154 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDER 297 (492)
Q Consensus 219 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~-~~~~ 297 (492)
||+||+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 77 YVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCc
Confidence 9999999887754 3679999999999999999999999999999999999999 667789999999987532 2233
Q ss_pred ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011154 298 LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376 (492)
Q Consensus 298 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 376 (492)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+....+..+......++ +..+.++.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLV 228 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 345679999999998764 589999999999999999999999998888777777776544433 357889999999
Q ss_pred HccccCcCCCCCH----HHHhcCcccccc
Q 011154 377 LLLNKDPRKRMTA----AQALSHPWIRNY 401 (492)
Q Consensus 377 ~~L~~dP~~Rps~----~e~l~hp~~~~~ 401 (492)
+||+.||.+|+++ .++++|+||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 229 GLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 9999999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=358.32 Aligned_cols=250 Identities=25% Similarity=0.443 Sum_probs=207.3
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecC
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ 221 (492)
||+|+||.||+++.+. +|+.||+|++.............+..|+++++.+ +||||++++++++++..+|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEcc---CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCC
Confidence 7999999999998765 6899999999754433333334566799999999 59999999999999999999999999
Q ss_pred CCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccc
Q 011154 222 GGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND 300 (492)
Q Consensus 222 ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~ 300 (492)
||+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++...........
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeec
Confidence 999998886543 358999999999999999999999999999999999999 6677899999999987765544455
Q ss_pred cccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh----hHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011154 301 IVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSWPSLSSDAKDFV 375 (492)
Q Consensus 301 ~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 375 (492)
..||..|+|||++. ..++.++||||+||++|+|++|..||..... .++...+......+. ...++.++++||
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 230 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDIC 230 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHH
Confidence 67999999999875 4589999999999999999999999976433 223333333222221 236899999999
Q ss_pred HHccccCcCCCCCH----HHHhcCcccccc
Q 011154 376 KLLLNKDPRKRMTA----AQALSHPWIRNY 401 (492)
Q Consensus 376 ~~~L~~dP~~Rps~----~e~l~hp~~~~~ 401 (492)
.+||+.||.+||++ .+++.|+||+..
T Consensus 231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 99999999999999 778899999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=374.13 Aligned_cols=251 Identities=19% Similarity=0.327 Sum_probs=203.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
..+|++.+.||+|+||.||+|++.. +++.||||.... ..+.+|+++|+.|. |||||+++++|.....
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---CCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCe
Confidence 4679999999999999999998765 789999997532 24678999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++|+|++. ++|.+++... ..+++.+++.++.||+.||.|||++|||||||||+|||+ +..+.+||+|||+|...
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFP 232 (391)
T ss_pred eEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccc
Confidence 999999995 6888887654 579999999999999999999999999999999999999 66678999999999754
Q ss_pred CCC--CCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh-------hHHHHHHHhcCC-----
Q 011154 293 RPD--ERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE-------SGIFRAVLKADP----- 357 (492)
Q Consensus 293 ~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~-------~~~~~~i~~~~~----- 357 (492)
... ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ...+..+.....
T Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 322 2234568999999999876 4589999999999999999999988764321 111111111100
Q ss_pred ---------------------C--CCCCCC---CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 358 ---------------------S--FDDGSW---PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 358 ---------------------~--~~~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
. .....| ..++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0 000111 1356789999999999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=368.68 Aligned_cols=245 Identities=27% Similarity=0.436 Sum_probs=211.7
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+.+.+.+.||+|.||.||.+.+.. ...||||.+...... .+.|.+|+++|++|+ |+|||+++++|..++.+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~----~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG----STKVAVKTIKEGSMS----PEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC----CCcccceEEeccccC----hhHHHHHHHHHHhCc-ccCeEEEEEEEecCCce
Confidence 456678899999999999999874 347999999765433 256789999999996 99999999999998899
Q ss_pred EEEEeecCCCchHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILS-RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
|||||||+.|+|.++|.. .+..+...+.+.++.|||+|++||+++++|||||-..|||| +++..+||+|||||+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEccccccccc
Confidence 999999999999999987 45679999999999999999999999999999999999999 77889999999999965
Q ss_pred CCCCCccc--cccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 293 RPDERLND--IVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 293 ~~~~~~~~--~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
..+..... ..-..-|.|||.+. +.|+.++|||||||+||||+| |+.||.+.+..+.++.+.++..-... ..++
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---~~CP 430 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---EGCP 430 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---CCCC
Confidence 54443221 12234699999886 679999999999999999999 99999999999999999887544332 3799
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHh
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQAL 393 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l 393 (492)
+++.+++..||+.+|++|||++.+.
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999999998654
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=359.64 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=214.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|.+.+.||+|+||.||+|+.+. +++.||+|.+....... ....+.+|+.+++.|. ||||+++++++.+.+.+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL 79 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEecccccC--chhHHHHHHHHHHhcC-CCCcceEEEEEecCCeE
Confidence 679999999999999999998764 67899999986543222 2335678999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+. ++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKS 155 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccC
Confidence 99999997 58988887766679999999999999999999999999999999999999 666789999999987654
Q ss_pred CCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC---------
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD--------- 361 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~--------- 361 (492)
... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+.........
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 322 2334567899999998754 4788999999999999999999999887765555444332111100
Q ss_pred -----------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 362 -----------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 362 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
...+.+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 11235788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=381.35 Aligned_cols=256 Identities=29% Similarity=0.408 Sum_probs=218.5
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
..|.+.+.||+|+||.||+|....+ .+..||+|.+... .......+.+|+.+|+.+ +|||||+++++|.+++.+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVMLN---DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEE
Confidence 4599999999999999999986541 2678999987443 333445678899999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 214 YIVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
|||||||+||+|.+.+... ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCce
Confidence 9999999999999887543 3468999999999999999999999999999999999999 667789999999998
Q ss_pred ccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
.+..... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+++..+..+.... ....
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~ 294 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCP 294 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCcc
Confidence 7653322 34567999999999886 458999999999999999999999999888888888877654432 1235
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++.++++||.+||..||++||++.+++.|+|++..
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 78999999999999999999999999999999753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=367.89 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=210.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
+.++|++.+.||+|+||.||+++... .++.||||++.+... .......+.+|+.+++.+. ||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcC-CCCccccceeecccc
Confidence 45789999999999999999998664 678999999965432 2233456788999999994 99999999988643
Q ss_pred -----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 211 -----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 211 -----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
..+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~D 169 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 169 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEe
Confidence 458999999975 6777663 358899999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC------
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------ 358 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~------ 358 (492)
||+++............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 999987765544556789999999998764 5899999999999999999999999887776665555432111
Q ss_pred ----------------CC----------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 359 ----------------FD----------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 359 ----------------~~----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+. .......+.++++||.+||..||.+|||+.|+|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00 00011235678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=370.39 Aligned_cols=257 Identities=30% Similarity=0.482 Sum_probs=210.8
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC---
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD--- 211 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~--- 211 (492)
+|++.+.||+|+||.||++.... +|+.||||++.... ......+.+.+|+++|+.++ |+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---CCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccc
Confidence 47889999999999999998654 78999999986432 23334567889999999995 999999999998876
Q ss_pred --eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 212 --NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 212 --~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
..|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a 150 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLA 150 (372)
T ss_pred cceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccce
Confidence 8999999996 5788777543 679999999999999999999999999999999999999 66779999999999
Q ss_pred cccCCCC--CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC---------
Q 011154 290 DFVRPDE--RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--------- 356 (492)
Q Consensus 290 ~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~--------- 356 (492)
....... ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 8654332 2334578999999998764 47899999999999999999999998877655554443211
Q ss_pred --------------CCCCC-----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 357 --------------PSFDD-----GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 357 --------------~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..... ......+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00000 1123468899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.85 Aligned_cols=258 Identities=28% Similarity=0.478 Sum_probs=208.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
+.++|++.+.||+|+||.||+++... .++.||||++..... .......+.+|+.+++.+. ||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccc
Confidence 45789999999999999999998654 688999999965432 2334456788999999995 99999999998643
Q ss_pred -----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 211 -----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 211 -----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
..+|+|||||++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~D 162 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 162 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEee
Confidence 357999999976 6666653 358999999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC--------
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-------- 356 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~-------- 356 (492)
||+++............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+....
T Consensus 163 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999987665545556789999999998764 58999999999999999999999998766544333222110
Q ss_pred --------------CCCC----------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 357 --------------PSFD----------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 357 --------------~~~~----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+.+. .......+.++++||.+||..||++|||+.|+|+||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0000 00112345788999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=361.88 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=210.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||++.++. ++..||+|++.... .......+.+|+++++.+. ||||++++++|.+++.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCE
Confidence 4789999999999999999998764 67899999986542 2334567899999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+++||||+++|+|.+++... +.+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchh
Confidence 99999999999999988654 5799999999999999999999985 79999999999999 5667899999999876
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHH------------------
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAV------------------ 352 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i------------------ 352 (492)
+.. .......||..|+|||++.+ .++.++|||||||++|+|++|+.||.......+...+
T Consensus 154 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hhh-hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 532 22344579999999998864 5888999999999999999999999765443322111
Q ss_pred --------------------------HhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 353 --------------------------LKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 353 --------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..... .......++.++++||.+||+.||++|||+.|++.||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000 0000113578899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=380.36 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=220.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|.+.+.||+|+||.||+|+... +|+.||||++...... ......+.+|+.++..+ +|+||+++++.+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKK 103 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcC-CCCcEEEeecceecc
Confidence 345799999999999999999998765 7899999999765443 34556788999999999 499999999887543
Q ss_pred C--------eEEEEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCC
Q 011154 211 D--------NVYIVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS 279 (492)
Q Consensus 211 ~--------~~~lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~ 279 (492)
+ .+++||||+++|+|.+.+..+ ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCC
Confidence 2 378999999999999988653 2468999999999999999999999999999999999999 5677
Q ss_pred cEEEEecccccccCCC---CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhc
Q 011154 280 QLKAIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 355 (492)
Q Consensus 280 ~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~ 355 (492)
.+||+|||+++.+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+....+++..+...
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 8999999999865432 22345689999999998864 5899999999999999999999999988887777777665
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 356 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.... ..+.+++++.+||.+||+.||.+||++.++++|||++..
T Consensus 261 ~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 261 RYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 4332 224688999999999999999999999999999998754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=363.67 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=203.5
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++.+.||+|+||.||+|.+.. ...++..||||++.... .......+.+|+.+|..+.+||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4689999999999999999998642 22356789999996432 2234467889999999996699999999998764
Q ss_pred -CeEEEEEeecCCCchHHHHHhhC--------------------------------------------------------
Q 011154 211 -DNVYIVMELCEGGELLDRILSRC-------------------------------------------------------- 233 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~~-------------------------------------------------------- 233 (492)
+.+++|||||++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 46899999999999999886431
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCC---ccccccCc
Q 011154 234 -----GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSA 305 (492)
Q Consensus 234 -----~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~ 305 (492)
..+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... .....++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 247888999999999999999999999999999999999 6677899999999986543221 12345678
Q ss_pred ccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCc
Q 011154 306 YYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDP 383 (492)
Q Consensus 306 ~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 383 (492)
.|+|||++. ..++.++|||||||++|||++ |..||.+....+.+........... ....++.++.+||.+||+.||
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--APENATPEIYRIMLACWQGDP 318 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHccCCh
Confidence 899999875 458999999999999999997 9999987654433333332222111 123578899999999999999
Q ss_pred CCCCCHHHHhc
Q 011154 384 RKRMTAAQALS 394 (492)
Q Consensus 384 ~~Rps~~e~l~ 394 (492)
.+|||+.++++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.80 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=195.4
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--CCeEEEE
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--LDNVYIV 216 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--~~~~~lv 216 (492)
+++||+|+||.||+|+.+. ..+++.||||.+..... ...+.+|+.+|+.+. ||||++++++|.+ +..+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~-~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD-GKDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEcc-CCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEE
Confidence 5689999999999998753 23678899999965432 234678999999995 9999999999864 4578999
Q ss_pred EeecCCCchHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC-CCCCcEEEEecc
Q 011154 217 MELCEGGELLDRILSR--------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK-DESSQLKAIDFG 287 (492)
Q Consensus 217 ~E~~~ggsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~-~~~~~~kl~DfG 287 (492)
|||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 999965 888776532 1258999999999999999999999999999999999999643 345689999999
Q ss_pred cccccCCCC----CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChh---------HHHHHH
Q 011154 288 LSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTES---------GIFRAV 352 (492)
Q Consensus 288 la~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~---------~~~~~i 352 (492)
++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 998764332 2345689999999998754 4889999999999999999999999654321 112222
Q ss_pred HhcCCCCC----------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 353 LKADPSFD----------------------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 353 ~~~~~~~~----------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
........ .......+.++.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11100000 00011235678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=360.52 Aligned_cols=264 Identities=28% Similarity=0.444 Sum_probs=231.1
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
-.+.|+.-++||+||||.||-++.+. +|+.||+|.+.+............++|-.||.++. .+.||.+--.|++.+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRA---TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKD 258 (591)
T ss_pred cccceeeeEEEecccccceeEEEEec---chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCC
Confidence 34678888999999999999999876 89999999998776666666667889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.++||+..|+||+|.-+|.+.+ ..|++..+..++.+|+.||++||+.+||+|||||+|||+ |+.++++|+|+|||.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAV 335 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEE
Confidence 9999999999999988887664 369999999999999999999999999999999999999 889999999999999
Q ss_pred ccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.+..++.....+||.+|||||++++ .|+...|.|||||++|||+.|+.||..+....-...+.+....-+..+....|+
T Consensus 336 ei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 336 EIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred ecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 9998888888899999999999874 599999999999999999999999987665433333333333333344457999
Q ss_pred HHHHHHHHccccCcCCCCC-----HHHHhcCccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMT-----AAQALSHPWIRNYN 402 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~~ 402 (492)
++++|.+.+|++||++|.. ++++.+||||+..+
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 9999999999999999984 67999999999865
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=352.62 Aligned_cols=254 Identities=41% Similarity=0.686 Sum_probs=210.3
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
|++++.||+|+||+||+++... +++.||+|++......... .....+|+.+++.+ +||||+++++++.+.+..++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSEIEEEE-REENIREIKILRRL-RHPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC---CCeEEEEEEeccccccccc-cchhhhhhhccccc-cccccccccccccccccccc
Confidence 7899999999999999999775 7789999999776533222 22345699999999 59999999999999999999
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc-CC
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV-RP 294 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~-~~ 294 (492)
|||||.+++|.+++. ..+.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||.+... ..
T Consensus 76 v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccc
Confidence 999999999999887 34689999999999999999999999999999999999999 67788999999999763 33
Q ss_pred CCCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCC---hhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 295 DERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 295 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
........+|..|+|||++. ..++.++||||||+++|+|++|..||.... ...................+...+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 34455678999999999987 568889999999999999999999998773 2333333332221111111122348
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
++.+||.+||+.||++|||+.++++||||
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=367.14 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=204.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
...|.+.+.||+|+||.||++.+.. .++.||||.... ..+.+|+++|++|. |+|||++++++...+.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---CCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCE
Confidence 4579999999999999999998765 678999996421 23568999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++|||++. ++|.+++......+++.+++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.+
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceec
Confidence 999999995 68999887766679999999999999999999999999999999999999 56678999999999876
Q ss_pred CCCCC---ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC--------hhHHHHHHHhcCCC--
Q 011154 293 RPDER---LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART--------ESGIFRAVLKADPS-- 358 (492)
Q Consensus 293 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~--------~~~~~~~i~~~~~~-- 358 (492)
..... ....+||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ...+.+.+......
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43321 224579999999998764 58999999999999999999887654321 22333333332211
Q ss_pred -------------------------CCCCCCC---CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 359 -------------------------FDDGSWP---SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 359 -------------------------~~~~~~~---~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
+....|. .++.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 1111122 45678999999999999999999999999999975
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=391.08 Aligned_cols=265 Identities=30% Similarity=0.519 Sum_probs=218.1
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.....++|++.+.||+|+||.||+|.++. ++..||+|++...... ......+.+|+.+|+.|. |||||+++++|.
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~ 82 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELK-HKNIVRYIDRFL 82 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcC-CCCcCeEEEEEE
Confidence 45566899999999999999999999765 6789999999765433 334567889999999995 999999999986
Q ss_pred e--CCeEEEEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHc-------CCcccCCCCCceEeecC-
Q 011154 209 D--LDNVYIVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLH-------GVVHRDLKPENFLYTSK- 275 (492)
Q Consensus 209 ~--~~~~~lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~-------~ivHrDlkp~NILl~~~- 275 (492)
+ ...+|||||||++|+|.++|... .+.+++..++.|+.||+.||.|||.. +||||||||+||||...
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 5 45799999999999999988653 35799999999999999999999995 49999999999999542
Q ss_pred -------------CCCCcEEEEecccccccCCCCCccccccCcccccccccc---CCCCCccchHHHHHHHHHHhcCCCC
Q 011154 276 -------------DESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH---RSYGTEADVWSIGVIAYILLCGSRP 339 (492)
Q Consensus 276 -------------~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlGvil~~lltg~~p 339 (492)
+....+||+|||++..+.........+||+.|+|||++. ..++.++||||||||||+|+||..|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 223459999999998776554455678999999999874 3488999999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 340 FWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 340 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
|........+.......+.++ ....+.++.+||..||..+|.+||++.|+|.|+||+..
T Consensus 243 F~~~~~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 243 FHKANNFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcCCcHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 976655443333333333222 23578999999999999999999999999999999744
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.28 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=202.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
...|++.+.||+|+||.||+|.... +++.||+|+..+.. ...|+.+++.+. ||||+++++++.+.+.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~~---------~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKGT---------TLIEAMLLQNVN-HPSVIRMKDTLVSGAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCccc---------cHHHHHHHHhCC-CCCCcChhheEEeCCe
Confidence 3579999999999999999998765 67889999864332 246999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++||||+. |+|.+++......+++..+..|+.||+.||.|||++|||||||||+|||+ +..+.+||+|||++...
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFP 207 (357)
T ss_pred eEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCcccccc
Confidence 999999995 58999888777789999999999999999999999999999999999999 66778999999999865
Q ss_pred CCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChh----------HHHHHHHhc-C---C
Q 011154 293 RPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES----------GIFRAVLKA-D---P 357 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~----------~~~~~i~~~-~---~ 357 (492)
..........||+.|+|||++. ..|+.++|||||||++|+|+++..++...... ..+..+... . .
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 5444445678999999999876 46899999999999999999865555332110 111111111 0 0
Q ss_pred CCCC--------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 358 SFDD--------------------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 358 ~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
.+.. .....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0110 001245778889999999999999999999999999985
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=366.02 Aligned_cols=259 Identities=29% Similarity=0.546 Sum_probs=210.0
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|.+.+.||+|+||.||+|.... +++.||||++.+... .......+.+|+.+|+.+. ||||++++++|...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPA 86 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccc
Confidence 456889999999999999999998764 678999999865432 2233456778999999995 99999999988643
Q ss_pred ------CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 ------DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ------~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
..+|+++|++ +++|.+.+. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 87 ~~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~ 160 (343)
T cd07878 87 TSIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRIL 160 (343)
T ss_pred ccccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEc
Confidence 4579999998 678877664 3579999999999999999999999999999999999999 667789999
Q ss_pred ecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-----
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP----- 357 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~----- 357 (492)
|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.....
T Consensus 161 Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 161 DFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred CCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999987643 3345679999999998764 588999999999999999999999987665444443322111
Q ss_pred ------------------CCCC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 ------------------SFDD----GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ------------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.... ..+...++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0000 01234567789999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=394.36 Aligned_cols=262 Identities=30% Similarity=0.486 Sum_probs=228.6
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
-.++|++.+.||+|+||.|++++.+. +++.||+|++.+-.+.......-|..|-.+|.-- +.+-||.++-.|++++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDER 148 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeec---cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCcc
Confidence 45899999999999999999999886 8899999999874444333445688888898765 6899999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
++|+|||||+||+|...+.+. .++++++++.++..|+.||.-||+.|+|||||||+|||| |..|++||+|||.+-.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~-~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF-DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc-CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHh
Confidence 999999999999999977655 489999999999999999999999999999999999999 8899999999999887
Q ss_pred cCCCCC--ccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 292 VRPDER--LNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 292 ~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
+..+.. ....+|||.|++||+++ +.|+..||.||+||++|||++|..||+..+..+.+.+|..-.-.+..+.
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 765543 34568999999999984 4599999999999999999999999999999999999987643333333
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCC---HHHHhcCccccccc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMT---AAQALSHPWIRNYN 402 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~ 402 (492)
-..+|.++++||.++|+ +|+.|.. ++++..||||.+..
T Consensus 305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 34699999999999996 6889998 99999999998753
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=351.22 Aligned_cols=254 Identities=33% Similarity=0.614 Sum_probs=221.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|.+.+.||+|+||.||++.+.. +++.||||++.+.........+.+.+|+++++.+. ||||+++++++.+.+.+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeE
Confidence 478999999999999999999765 67899999997655444445667899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||+++++|.+++... +.+++..+..++.||+.||.|||+.||+||||+|+|||+ +.++.+||+|||++....
T Consensus 77 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccC
Confidence 9999999999999988665 689999999999999999999999999999999999999 667789999999998765
Q ss_pred CCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
.. .....|++.|+|||.+. ..++.++||||||+++|+|++|..||...........+......++. .++..++
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~ 226 (290)
T cd05580 153 GR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAK 226 (290)
T ss_pred CC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHH
Confidence 44 34457899999999875 45788999999999999999999999887776677777655544432 5689999
Q ss_pred HHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 373 DFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 373 ~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
++|.+||..||.+|+ +++++++||||+..
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=346.55 Aligned_cols=256 Identities=29% Similarity=0.493 Sum_probs=211.4
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...+.|++.+.||+|+||.||+|+.+. +++.||||++..... ....+.+|+.+++.+.+|+||++++++|...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 345789999999999999999998765 678999999865432 2346788999999986799999999998753
Q ss_pred ------CeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 211 ------DNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 211 ------~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
..+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||++ ++++.+||
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l 152 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKL 152 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEE
Confidence 4689999999999999988764 3468999999999999999999999999999999999999 66778999
Q ss_pred EecccccccCCCC-CccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC
Q 011154 284 IDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 356 (492)
Q Consensus 284 ~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~ 356 (492)
+|||++....... ......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+....
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~ 232 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 232 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC
Confidence 9999998654322 234567999999999874 247889999999999999999999997665544443333221
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 357 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
........++.++.+||.+||..||.+|||+.+++.||||
T Consensus 233 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 --APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred --CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 1222234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.83 Aligned_cols=255 Identities=26% Similarity=0.454 Sum_probs=212.8
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC--HHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT--AIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~--~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.|++.+.||+|+||.||.+.... +++.||||.+....... ......+.+|+.+++++ +||||+++++++++.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCC
Confidence 468999999999999999998654 68899999986543322 22345688999999999 5999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++||||++|++|.+.+... +.+++..+..++.||+.||.|||+.||+||||+|+||++ +.++.++|+|||++..
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKR 153 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeccccee
Confidence 999999999999999887654 579999999999999999999999999999999999999 5667899999999876
Q ss_pred cCCCCCc----cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 292 VRPDERL----NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 292 ~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
....... ....|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+...... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSH 231 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCcc
Confidence 5432211 33568899999998864 4888999999999999999999999776655554444333222 122236
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
++.++.+||.+||..+|.+|||+.++++|+||
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 232 VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 88999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=369.72 Aligned_cols=258 Identities=29% Similarity=0.474 Sum_probs=221.4
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+.|+++..||.|+||.||+|..+. ++-.-|-|+|... ....++++.-||+||..+ +||+||+|++.|..++.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvIetk---seEELEDylVEIeILa~C-dHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVIETK---SEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhccc---chhhhhhhhhccc---chhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCc
Confidence 4668889999999999999998764 6667788988433 456788899999999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+||..|||.||-+...+..-+..+++.++..+++|++.||.|||+++|||||||..|||+ .-++.++|+|||.+...
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKN 180 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccc
Confidence 999999999999988888888889999999999999999999999999999999999999 45668999999987543
Q ss_pred -CCCCCccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 293 -RPDERLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 293 -~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
.......+++|||||||||++. ..|+.++||||||+.|.||..+.+|-..-+.-..+-+|.+..+.-.. ...
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl-qPS 259 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL-QPS 259 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc-Ccc
Confidence 3334456789999999999763 46999999999999999999999998776666666666655443221 223
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..+..+.||+++||.+||..||+++++|+|||+.+.
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 578899999999999999999999999999999865
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=347.92 Aligned_cols=258 Identities=31% Similarity=0.509 Sum_probs=219.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||.|+||.||++.... ++..||+|++... .....+.+.+|+++++++. ||||+++++++.+++.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCe
Confidence 4679999999999999999998764 6789999998543 3344567889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.|+||||+++++|.+++.+....+++..++.++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKN 153 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhh
Confidence 999999999999999887766679999999999999999999999999999999999999 66778999999998765
Q ss_pred CCC-CCccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 293 RPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 293 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
... .......||..|+|||++. ..++.++|||||||++|+|++|..||...........+........ ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 232 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPS 232 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcc
Confidence 332 2234457899999999864 2367799999999999999999999988776666666655432211 1123
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.++.++.+||.+||+.||.+||++.++++||||.+.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 578999999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.23 Aligned_cols=256 Identities=22% Similarity=0.369 Sum_probs=207.0
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+..+|++.+.||+|+||.||++.... ...+..||||.+.... ...+|+++|+.|. |||||+++++|...
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~-~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~-h~~iv~~~~~~~~~ 158 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHG-DEQRKKVIVKAVTGGK--------TPGREIDILKTIS-HRAIINLIHAYRWK 158 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcC-CccceeEEEEeccccc--------cHHHHHHHHHhcC-CCCccceeeeEeeC
Confidence 345689999999999999999997653 3467889999986432 3457999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+|||++. ++|.+++ .....+++.+++.++.||+.||.|||++|||||||||+|||+ +..+.+||+|||++.
T Consensus 159 ~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAAC 233 (392)
T ss_pred CEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCcccc
Confidence 99999999996 5888887 444689999999999999999999999999999999999999 667789999999997
Q ss_pred ccCCCCC---ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCCh---hHHHHHHHhcCC----CC
Q 011154 291 FVRPDER---LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADP----SF 359 (492)
Q Consensus 291 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~---~~~~~~i~~~~~----~~ 359 (492)
.+..... .....||+.|+|||++.. .|+.++|||||||++|+|++|..||.+... ...+..+.+... .+
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 6643322 234679999999998864 589999999999999999999999976542 122222221110 00
Q ss_pred CC------------------CC--------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 360 DD------------------GS--------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 360 ~~------------------~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+. .. ...++.++++||++||..||.+|||+.++|.||||++.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00 00 01356789999999999999999999999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=352.76 Aligned_cols=260 Identities=34% Similarity=0.581 Sum_probs=222.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|.... +++.||||.+.+.........+.+.+|+++++.+. |+||+++++.+.+.+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEE
Confidence 468999999999999999998765 68899999998765554445677899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
|+||||+.|++|.+.+... ...+++..+..++.||+.||.|||+.|++||||||+||++ +.++.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhcc
Confidence 9999999999999988653 2569999999999999999999999999999999999999 56678999999998754
Q ss_pred CCCC------------------------------CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCC
Q 011154 293 RPDE------------------------------RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFW 341 (492)
Q Consensus 293 ~~~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~ 341 (492)
.... ......||..|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 3221 1123468999999998764 48889999999999999999999998
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCC----HHHHhcCccccccc
Q 011154 342 ARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMT----AAQALSHPWIRNYN 402 (492)
Q Consensus 342 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~ 402 (492)
+......+..+......+... ..++.++.+||.+||..||++||| ++++|.||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 234 GSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CCchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 888777777776554444332 237899999999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.86 Aligned_cols=256 Identities=32% Similarity=0.546 Sum_probs=217.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||.|+||.||+|+... +++.||+|++.... .......+.+|+.+++.+. |+||+++++++.++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeE
Confidence 468899999999999999998765 68899999986543 2234456889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|+||+++++|.+++... .+++..+..++.||+.||.|||+++++||||+|+||++ +.++.++|+|||+++.+.
T Consensus 75 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLT 149 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeec
Confidence 9999999999999988653 79999999999999999999999999999999999999 667789999999998775
Q ss_pred CC-CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PD-ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.. .......|+..|+|||++.+ .++.++|||||||++|+|+||..||...........+......... ...++.++
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 227 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPF 227 (274)
T ss_pred ccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHH
Confidence 44 23345678999999998764 5899999999999999999999999876665555555444322111 11278899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.++|.+||..||++|||++++++||||++..
T Consensus 228 ~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 228 KDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=324.56 Aligned_cols=260 Identities=28% Similarity=0.482 Sum_probs=222.5
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+.+....||.|+-|+|++++++. +|...|||.+.+.. +....+++++.+.++..-.+.|+||+.+|+|..+..++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcc---cceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 34556779999999999999886 78999999997664 44556778899999887767899999999999999999
Q ss_pred EEEeecCCCchHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 215 IVMELCEGGELLDRILS-RCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+.||.|. ...+.++. ..+.++|.-+-++...++.||.||.++ ||+|||+||+|||+ |+.+++||||||++.++
T Consensus 168 IcMelMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 168 ICMELMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeeccccccee
Confidence 9999984 34455544 356799999999999999999999885 89999999999999 89999999999999988
Q ss_pred CCCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCC-CChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 293 RPDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
-.....+...|-+.|||||.+. ..|+.++||||||+.++||.||..||.+ .++.+.+..|++..+...... ...
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~-~gF 321 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH-MGF 321 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc-cCc
Confidence 7777677788999999999884 3599999999999999999999999977 466788888888665333222 348
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCcccccccccC
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVK 405 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~ 405 (492)
|+++++|+..||.+|+.+||...++|+|||++.+....
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE 359 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence 99999999999999999999999999999999886443
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=341.88 Aligned_cols=256 Identities=32% Similarity=0.526 Sum_probs=216.8
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||.|+||.||+|.... ++..||+|++....... ....+.+|+++++.+. |+||+++++.+...+.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEE
Confidence 478999999999999999998764 67899999996554332 5577899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 214 YIVMELCEGGELLDRILSRC--GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
|+||||+++++|.+.+.... ..+++..+..++.||+.||.|||+.||+||||+|+||++ ++++.++|+|||++..
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~ 151 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSAS 151 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHH
Confidence 99999999999999987642 468999999999999999999999999999999999999 5667899999999877
Q ss_pred cCCCCCc-----cccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC--
Q 011154 292 VRPDERL-----NDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG-- 362 (492)
Q Consensus 292 ~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-- 362 (492)
+...... ....|+..|+|||++.. .++.++|||||||++|+|++|+.||........+..+..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA 231 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcc
Confidence 6543322 34568999999998764 48889999999999999999999998777666665555543322111
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.+..++.++.+||.+||..||++|||+.++++||||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 134688999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.84 Aligned_cols=241 Identities=19% Similarity=0.271 Sum_probs=206.6
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe----CCeEEE
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED----LDNVYI 215 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~----~~~~~l 215 (492)
..||+|++|.||+|.+ +|+.||||++.+.........+.+.+|+.+|+++. |||||++++++.+ ...+++
T Consensus 26 ~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred eEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEE
Confidence 5689999999999986 46899999997765545445677889999999995 9999999999977 357899
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
|||||+||+|.+++.+. +.+++.....++.|++.||.|||+. +++||||||+|||+ +.++.+||+|||+++.+..
T Consensus 100 v~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 100 ILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcc
Confidence 99999999999988654 5799999999999999999999984 99999999999999 6678999999999986643
Q ss_pred CCCccccccCcccccccccc---CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 295 DERLNDIVGSAYYVAPEVLH---RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 295 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.. ....||..|+|||++. +.++.++|||||||++|+|++|..||.+.+..+++..+......+... ..++.++
T Consensus 176 ~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l 251 (283)
T PHA02988 176 PP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEI 251 (283)
T ss_pred cc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHH
Confidence 22 3456899999999985 468999999999999999999999999888888888776554443322 2578999
Q ss_pred HHHHHHccccCcCCCCCHHHHhc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++||.+||+.||++|||+.++++
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999999985
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.24 Aligned_cols=255 Identities=31% Similarity=0.448 Sum_probs=206.7
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||+|+.+. +++.||||++....... ...+.+.+|+.+++.+. ||||+++++++.+++.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---CCcEEEEEEeccccccC-CchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEE
Confidence 48899999999999999998764 67899999986543222 23356788999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 215 IVMELCEGGELLDRILSRC--GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeec
Confidence 9999997 58888776432 568999999999999999999999999999999999999 66778999999998765
Q ss_pred CCCCC-ccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC-----------
Q 011154 293 RPDER-LNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----------- 358 (492)
Q Consensus 293 ~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~----------- 358 (492)
..... .....+++.|+|||++.+ .++.++|||||||++|+|+||+.||.+.........+......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 43322 233467899999998754 4788999999999999999999999876554333222111100
Q ss_pred --------------CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 359 --------------FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 359 --------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.....+..+++++++||++||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0011234578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=346.44 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=217.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+.|++.+.||.|+||.||+|.... +++.||+|++... .....+.+.+|+.+++.+. |+||+++++++..++.
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGK 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC---CCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCe
Confidence 4679999999999999999998764 6789999998654 3445667889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+||||++|++|...+.+....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceec
Confidence 999999999999988887666779999999999999999999999999999999999999 56678999999998754
Q ss_pred CCC-CCccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 293 RPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 293 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
... .......++..|+|||++. ..++.++|||||||++|+|++|..||...........+....... .....
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 239 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPS 239 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCc
Confidence 322 2234457889999999873 236789999999999999999999998776655555554432211 11123
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.++.++.+||.+||..||++||++.++++||||....
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 5788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=338.47 Aligned_cols=253 Identities=28% Similarity=0.482 Sum_probs=217.1
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|.+.+.||+|+||.||+|..+. +++.|++|.+...... ......+.+|+++++.++ ||||+++++++.+.+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEE
Confidence 47888999999999999998765 6889999998654433 345567899999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+||||++|++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++..+.
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceecc
Confidence 999999999999988765 4579999999999999999999999999999999999999 566789999999988765
Q ss_pred CCCC-ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDER-LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.... .....|++.|+|||++. +.++.++|||||||++|+|++|+.||...........+......... ..++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQL 229 (256)
T ss_pred CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence 4332 23457899999999876 45888999999999999999999999888877766666654332211 2578899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.++|.+||+.+|++||++.++++|||+
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=351.11 Aligned_cols=255 Identities=29% Similarity=0.520 Sum_probs=206.9
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||+|+++. +|+.||+|++....... .....+.+|+.+++.+. ||||+++++++.+.+.++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDE-GVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---CCcEEEEEEeecccccc-cCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceE
Confidence 58899999999999999999765 68899999996543222 22345778999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+|+||+.+ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 76 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCC
Confidence 99999974 8888887666789999999999999999999999999999999999999 5667899999999986543
Q ss_pred CC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCC-CChhHHHHHHHhcCCC------------
Q 011154 295 DE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPS------------ 358 (492)
Q Consensus 295 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~-~~~~~~~~~i~~~~~~------------ 358 (492)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.+..+......
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 32 2334568899999998754 378899999999999999999988644 3333333333221100
Q ss_pred --C------C-----CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 359 --F------D-----DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 359 --~------~-----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
+ . ....+.++.++.+||.+||..||.+|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=346.99 Aligned_cols=261 Identities=29% Similarity=0.452 Sum_probs=214.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||++.+.. +++.||+|.+.... .......+.+|+.+++++ +|+||+++++.+...+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeE
Confidence 468899999999999999998764 68899999986432 333456788999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 214 YIVMELCEGGELLDRILSR--CGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
|+|||||+|++|..++... ...+++..+..++.||+.||.|||+ .||+||||||+||++ +.++.+||+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 151 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSG 151 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcc
Confidence 9999999999998877543 2379999999999999999999997 599999999999999 556789999999987
Q ss_pred ccCCCCCccccccCccccccccccC-------CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHR-------SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
.+... ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||...........+...........
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 152 NLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred cccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 65422 2344568899999998742 257899999999999999999999976655444443332221222223
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccccc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV 404 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 404 (492)
.+.++.++.+||.+||..+|.+||++.++++||||......
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 34589999999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=363.26 Aligned_cols=255 Identities=28% Similarity=0.468 Sum_probs=223.7
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
..|.-.+.||.|+||.||.|++.. +.+.||||.+.-+.......+.++..||..|++|. |||+|.+-++|..+...
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~---n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccC---ccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchH
Confidence 456667889999999999999765 78999999998887777778889999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|||||||-| |-.|.+.-..+++-+.++..|+.+.+.||.|||+++.||||||..|||+ .+.+.|||+|||.|..+.
T Consensus 102 WLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 102 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcC
Confidence 999999965 7677665555789999999999999999999999999999999999999 678899999999998876
Q ss_pred CCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC-CCCCCCCCCCCC
Q 011154 294 PDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-PSFDDGSWPSLS 368 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s 368 (492)
+. ++++|||+|||||++. +.|+-++||||||++..||.-.++|+...+.-..+-.|.+.+ +.+.. +..|
T Consensus 178 PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs---~eWS 251 (948)
T KOG0577|consen 178 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---NEWS 251 (948)
T ss_pred ch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC---chhH
Confidence 54 5678999999999763 679999999999999999999999998888766666666554 33433 3568
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..+..||..||.+-|.+|||.+++|.|+|+....
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 8999999999999999999999999999998643
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=343.23 Aligned_cols=256 Identities=31% Similarity=0.492 Sum_probs=215.4
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
.|++.+.||+|+||.||++.... ++..+|+|.+... .....+.+.+|+++++.+ +||||++++++|...+..|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEE
Confidence 47888999999999999998765 6788999998543 234556788999999999 5999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+||||+++|+|.+.+......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccc
Confidence 9999999999988877655679999999999999999999999999999999999999 6667899999999876532
Q ss_pred C-CCccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 295 D-ERLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 295 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
. .......|+..|+|||++. ..++.++|||||||++|+|++|..||......+....+....... ......+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 234 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRW 234 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCcccc
Confidence 2 2234457899999999873 237789999999999999999999998877666655554433221 1122357
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+.++.+||.+||+.||.+||++.++++||||+..
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 8999999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=353.58 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=206.9
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
-...|++.++||+||.+.||++... +.+.||+|.+.... .+...+.-+.+|+..|.+|++|.+||+||+|-..++
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s----~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS----DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC----CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 3567999999999999999999743 34677888774433 345667789999999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+||||-+. +|...|.++...++.-.++.+..|++.++.++|.+||||.||||.|+|+. .+.+||+|||+|..
T Consensus 434 ~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 434 YLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANA 508 (677)
T ss_pred eEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcc
Confidence 99999998654 88877766655566568999999999999999999999999999999994 46899999999998
Q ss_pred cCCCCC---ccccccCccccccccccC------------CCCCccchHHHHHHHHHHhcCCCCCCCCC-hhHHHHHHHhc
Q 011154 292 VRPDER---LNDIVGSAYYVAPEVLHR------------SYGTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKA 355 (492)
Q Consensus 292 ~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlGvil~~lltg~~pf~~~~-~~~~~~~i~~~ 355 (492)
+..+.. ....+||+.||+||.+.. ..+.++||||||||||+|+.|+.||.... ...-+..|...
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 875543 245689999999997731 14678999999999999999999995433 22223333332
Q ss_pred CCCCCCCCCCCCC--HHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 356 DPSFDDGSWPSLS--SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 356 ~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+-.. .++.++ .++.++++.||..||++|||+.++|+|||+.-.
T Consensus 589 ~~~I---efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 589 NHEI---EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred Cccc---cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 2211 222333 349999999999999999999999999999864
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=348.44 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=210.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||++.+.. ++..||+|.+.... .......+.+|+++++.+ +||||++++++|.+++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---CCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEE
Confidence 368999999999999999998765 67889999986432 233456688999999999 499999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
++||||++|++|.+++... +.+++..+..++.||+.||.|||+ .+++||||||+|||+ +.++.+||+|||++...
T Consensus 75 ~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 150 (308)
T ss_pred EEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCcccc
Confidence 9999999999999988654 679999999999999999999998 589999999999999 56678999999998765
Q ss_pred CCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC------------
Q 011154 293 RPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------------ 359 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~------------ 359 (492)
... ......|+..|+|||++.+ .++.++|||||||++|+|++|..||...........+.......
T Consensus 151 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 151 IDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 422 2345678999999998764 48889999999999999999999997655433322221110000
Q ss_pred ----------------------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 360 ----------------------DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 360 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+......++.++++||.+||..||++|||+.++++||||.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000112367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=344.98 Aligned_cols=256 Identities=30% Similarity=0.489 Sum_probs=214.0
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||+|.+.. +|..||||++....... .....+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEG-GIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---CCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeE
Confidence 58999999999999999998765 68899999997654322 33467889999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+||||+ +++|.+.+......+++.++..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccC
Confidence 999999 999999987766779999999999999999999999999999999999999 5577899999999987654
Q ss_pred CC--CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC-----------
Q 011154 295 DE--RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----------- 359 (492)
Q Consensus 295 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~----------- 359 (492)
.. ......|+..|+|||++.+ .++.++||||+||++|+|++|..||.+......+..+.......
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 33 2344578999999998753 46889999999999999999988887776655555443321110
Q ss_pred --------C-------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 360 --------D-------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 360 --------~-------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
. ...++.++.++.+||.+||..||.+|||++++|+||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 011235678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.30 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=209.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|.+.+.||+|+||.||+|+... +++.||+|+++... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~ 80 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDK 80 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE
Confidence 4689999999999999999998765 67899999986543 22345678899999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+||||+++++|.+++... +.+++.++..++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQI 156 (267)
T ss_pred EEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEc
Confidence 99999999999999987654 679999999999999999999999999999999999999 66678999999998765
Q ss_pred CCCC-CccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC-CCCCC
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD-GSWPS 366 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~ 366 (492)
.... ......|+..|+|||++. +.++.++|||||||++|+|++|..||...........+......... .....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence 4322 223457999999999863 35888999999999999999999999765544333333222221111 11124
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCcc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 397 (492)
++..+.+||.+||..||++|||+.++++|||
T Consensus 237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 6788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=339.88 Aligned_cols=253 Identities=32% Similarity=0.514 Sum_probs=212.4
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|.... +++.||||++.+...........+..|..++....+|+||+++++++...+.+|+||||
T Consensus 2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 569999999999998765 67899999997654333333344566666655554799999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCcc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLN 299 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~ 299 (492)
++|++|.+++... +.+++.++..++.||+.||.|||+.||+||||+|+||++ +.++.+||+|||++..... ..
T Consensus 79 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~ 151 (260)
T cd05611 79 LNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NK 151 (260)
T ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cc
Confidence 9999999887544 679999999999999999999999999999999999999 5667899999999876543 23
Q ss_pred ccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011154 300 DIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378 (492)
Q Consensus 300 ~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 378 (492)
...|+..|+|||.+.+ .++.++||||||+++|+|++|..||........+..+......+.......++.++.++|.+|
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 4568899999998764 478899999999999999999999988888777777766665555544556899999999999
Q ss_pred cccCcCCCC---CHHHHhcCccccccc
Q 011154 379 LNKDPRKRM---TAAQALSHPWIRNYN 402 (492)
Q Consensus 379 L~~dP~~Rp---s~~e~l~hp~~~~~~ 402 (492)
|..||++|| ++.|+++||||++.+
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 999999999 558999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=342.67 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=208.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|++.. +++.||||++.... .......+.+|+++++++ +||||++++++|...+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEE
Confidence 367888999999999999998664 68899999996543 233456788999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+++|+|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 75 SICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecc
Confidence 999999999988543 368899999999999999999999999999999999999 667889999999997664
Q ss_pred CCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChh-------HHHHHHHhcCCCCCCCCCC
Q 011154 294 PDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES-------GIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~ 365 (492)
.. .....+||..|+|||++. ..++.++|||||||++|+|++|..||...... +....+..... ......
T Consensus 147 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 223 (279)
T cd06619 147 NS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVG 223 (279)
T ss_pred cc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCC
Confidence 32 334567999999999876 45889999999999999999999999653221 22222222211 111223
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.++.++.+||.+||+.||.+||++.++++||||+..+
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 5788999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=344.39 Aligned_cols=256 Identities=30% Similarity=0.524 Sum_probs=209.5
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.+. +|+.||+|++....... ...+.+.+|+++++.+. |+||+++++++...+.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEE
Confidence 479999999999999999998765 68899999986543221 22345788999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+++++|...+ .....+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 76 ~~v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 76 HLVFEYCDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEEeccCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecC
Confidence 9999999987766554 444579999999999999999999999999999999999999 566789999999998765
Q ss_pred CCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC------------
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------ 358 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~------------ 358 (492)
... ......++..|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 443 2334568899999998753 4788999999999999999999999877665444333221100
Q ss_pred -------CCC--------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 359 -------FDD--------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 359 -------~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.+. ..++.++..+.+||.+||..||++||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 1124578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=346.60 Aligned_cols=259 Identities=29% Similarity=0.503 Sum_probs=219.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||++..+. +++.||||.+.+...........+.+|+.+++.+. ||||+++++.+.+++.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEE
Confidence 368999999999999999998765 67899999997654433445567889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++ +..+.+||+|||+++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccC
Confidence 9999999999999988654 679999999999999999999999999999999999999 667789999999986421
Q ss_pred CCC----------------CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC
Q 011154 294 PDE----------------RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 356 (492)
Q Consensus 294 ~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~ 356 (492)
... ......|+..|+|||.+. ..++.++|||||||++|+|++|..||.+....+.+..+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 100 011246788999999765 568899999999999999999999999888888777776655
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCC---HHHHhcCcccccc
Q 011154 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMT---AAQALSHPWIRNY 401 (492)
Q Consensus 357 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~ 401 (492)
...+...+ .++.++.+||.+||+.||++||+ +.++|+||||+..
T Consensus 233 ~~~~~~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 233 IEWPEGDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred cCCCCccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 44443322 67899999999999999999998 7999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=374.65 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=211.0
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEE-EEe-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDA-FED- 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~-~~~- 209 (492)
-..+++|.+.|.+|||+.||+|.... .|..||+|++-.. +...++.+.+||++|++|++|+|||.+++. ...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecC---CCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 35678899999999999999999765 4489999998443 667888999999999999999999999993 321
Q ss_pred -----CCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCcE
Q 011154 210 -----LDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQL 281 (492)
Q Consensus 210 -----~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~~ 281 (492)
..+++|.||||.||.|.|++..+. ..|+|.++++|+.|+++||.+||... |||||||-||||| ..++++
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~ 185 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNY 185 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCE
Confidence 136899999999999999997552 45999999999999999999999998 9999999999999 666799
Q ss_pred EEEecccccccCCCC-Ccc---------ccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhH
Q 011154 282 KAIDFGLSDFVRPDE-RLN---------DIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESG 347 (492)
Q Consensus 282 kl~DfGla~~~~~~~-~~~---------~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~ 347 (492)
||||||.|+-.-... ... ....|+.|+|||++. ...+.|+|||+|||+||-|+....||......
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l- 264 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL- 264 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-
Confidence 999999987532222 111 235799999999874 34899999999999999999999999776553
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 348 IFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.|+.+.+.|+. .+.++..+++||+.||+.||.+||++.|++++-+.
T Consensus 265 ---aIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 ---AILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ---eEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 45566666654 36899999999999999999999999999987543
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=349.87 Aligned_cols=252 Identities=29% Similarity=0.451 Sum_probs=194.1
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--CCeEEEE
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--LDNVYIV 216 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--~~~~~lv 216 (492)
+.+||+|+||.||+|+.+. ..++..||+|.+..... ...+.+|+.+|+.+. ||||+++++++.. +..+++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~-~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKD-GKDEKEYALKQIEGTGI-----SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecC-CCccceEEEEEecCCCC-----cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEE
Confidence 4689999999999998753 23568899999865432 234678999999995 9999999999854 5678999
Q ss_pred EeecCCCchHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC-CCCCcEEEEecc
Q 011154 217 MELCEGGELLDRILSR--------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK-DESSQLKAIDFG 287 (492)
Q Consensus 217 ~E~~~ggsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~-~~~~~~kl~DfG 287 (492)
|||+.+ +|.+.+... ...+++..++.++.||+.||.|||+.||+||||||+|||+... +..+.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 999975 787776422 1248899999999999999999999999999999999999543 345689999999
Q ss_pred cccccCCCC----CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChh---------HHHHHH
Q 011154 288 LSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTES---------GIFRAV 352 (492)
Q Consensus 288 la~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~---------~~~~~i 352 (492)
+++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||..||...... ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 998764332 2345678999999998754 4889999999999999999999999654321 111111
Q ss_pred HhcCCCCC----------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 353 LKADPSFD----------------------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 353 ~~~~~~~~----------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
........ .......+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11000000 00011235678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=352.25 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=203.5
Q ss_pred ecceeccc--cceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 138 VGEEVGRG--HFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 138 ~~~~lG~G--~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
+.++||+| +||+||+++.+. +|+.||||++...... ....+.+.+|+.+++.+ +||||++++++|.+++..|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEACT-NEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecc---cCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEE
Confidence 56789999 678999998775 7899999999655432 33455688899999999 59999999999999999999
Q ss_pred EEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 216 VMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++++|||.+.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccc
Confidence 99999999999988654 3459999999999999999999999999999999999999 5667899999986543321
Q ss_pred C-CC-------ccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC---
Q 011154 295 D-ER-------LNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--- 360 (492)
Q Consensus 295 ~-~~-------~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--- 360 (492)
. .. .....++..|+|||++.+ .|+.++|||||||++|+|++|..||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 1 10 112356778999998863 488999999999999999999999976554433332222111000
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 361 ---------------------------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 361 ---------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
......+++++.+||.+||+.||++|||++++++||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00112356789999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=339.99 Aligned_cols=253 Identities=19% Similarity=0.296 Sum_probs=212.4
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
..+|++.+.||+|+||.||+|.++.....+..||+|.+.... .......+.+|+.+++.+ +||||+++++++...+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCC
Confidence 357999999999999999999887555567899999996543 233456788999999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++||||+++|+|.+++......+++..+..++.||+.||.|||++|++||||||+|||+ +.+..+|++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 999999999999999887765689999999999999999999999999999999999999 56778999999987654
Q ss_pred CCCCCcc--ccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 293 RPDERLN--DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 293 ~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
....... ...++..|+|||++. +.++.++|||||||++|+|++ |..||+.....+....+...... .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---PAPRNCP 234 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCC
Confidence 3222111 234567899999875 568999999999999999775 99999998888777777554322 2234678
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
..+.+++.+||..+|.+||++.++++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=365.67 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=212.7
Q ss_pred eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeec
Q 011154 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELC 220 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~ 220 (492)
.||+|.||+||.|++.. +...+|||-|+... .....-+..||.+.+.|+ |.|||+++|.+.+++.+-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPEKD---SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeecccc---ceeEEEeeeccccc---chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecC
Confidence 59999999999999765 77889999996543 234456889999999997 999999999999999999999999
Q ss_pred CCCchHHHHHhhCCCC--CHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC-CCCC
Q 011154 221 EGGELLDRILSRCGKY--SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDER 297 (492)
Q Consensus 221 ~ggsL~~~l~~~~~~~--~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~-~~~~ 297 (492)
+||+|.+.+..+.+++ .|..+..+.+||++||.|||++.|||||||-+|||++ .-.+.+||+|||-++.+. -+..
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCcc
Confidence 9999999999988988 8999999999999999999999999999999999996 567899999999998764 3345
Q ss_pred ccccccCcccccccccc---CCCCCccchHHHHHHHHHHhcCCCCCCCCChh--HHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 298 LNDIVGSAYYVAPEVLH---RSYGTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 298 ~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
..+..||..|||||++. +.|+.++|||||||.+.||.||++||..-... .+++ .+.+..-.+....+|.+++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---VGmyKvHP~iPeelsaeak 809 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---VGMYKVHPPIPEELSAEAK 809 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---hcceecCCCCcHHHHHHHH
Confidence 66788999999999985 35999999999999999999999999654332 2221 1222222222346899999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 373 DFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.||.+|+.+||.+||++.++|.+||++..+
T Consensus 810 ~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 810 NFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 999999999999999999999999998763
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=345.93 Aligned_cols=259 Identities=31% Similarity=0.513 Sum_probs=231.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
..+|.+...||+|+||.|.++..++ +.+.||||+++++..-+...++--..|-++|......|.+++++.+|++-+.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5689999999999999999998765 7789999999987766555555556788888776667899999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+||||+.||+|.-+|.+ .+++.|..+..++..|+-||-|||++|||+||||.+|||+ |..+++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccc
Confidence 9999999999999988755 4899999999999999999999999999999999999999 88899999999998753
Q ss_pred -CCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 -RPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 -~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
-.+....+.||||.|+|||++. ..|+.++|.||+||+|||||.|+.||.+.++.++++.|......++. .+|.+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkE 576 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKE 576 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHH
Confidence 3345567899999999999875 78999999999999999999999999999999999999998877765 79999
Q ss_pred HHHHHHHccccCcCCCCCH-----HHHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTA-----AQALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~~ 402 (492)
+.++.+.+|.+.|.+|..+ .++.+||||+...
T Consensus 577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred HHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 9999999999999999864 7899999999754
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=335.30 Aligned_cols=254 Identities=30% Similarity=0.506 Sum_probs=217.2
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||++.... +++.+|||++....... .....+.+|+++++.+. ||||+++++.+...+.++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---CCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEE
Confidence 58899999999999999998764 78899999997654433 34567899999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++. .+..+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecC
Confidence 9999999999999987653 35899999999999999999999999999999999999942 34468999999998876
Q ss_pred CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
.........|+..|+|||.+.+ .++.++||||||+++|+|++|..||...........+...... .....++.++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 230 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLR 230 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCCcCHHHH
Confidence 5555555678999999998864 4788999999999999999999999887766666665543322 11235789999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccc
Q 011154 373 DFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
+||.+||..||.+|||+.|++.||||
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=342.48 Aligned_cols=255 Identities=28% Similarity=0.507 Sum_probs=218.9
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+-|.+.++||+|+||.||+|.++. .|+.||||.++.+. .+.++.+|+.||.++ +.|+||++||.|.....+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV~s-----DLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPVDT-----DLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCccc-----hHHHHHHHHHHHHHc-CCchhhhhhhhhccCCce
Confidence 457889999999999999999876 89999999997653 466788999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|||||||..|++.|.+..+.+.++|+++..+++..+.||+|||...-||||||..|||+ +.+++.||+|||.|..+.
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLT 180 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhh
Confidence 99999999999999999888999999999999999999999999999999999999999 667899999999997764
Q ss_pred CC-CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHH-hcCCCCCCCCCCCCCHH
Q 011154 294 PD-ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL-KADPSFDDGSWPSLSSD 370 (492)
Q Consensus 294 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~s~~ 370 (492)
.. ...+++.||+.|||||+++. .|+.++||||||+...||.-|++||.+...-...-.|. +..+.|.. ....|++
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~K--PE~WS~~ 258 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKK--PEEWSSE 258 (502)
T ss_pred hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCC--hHhhhhH
Confidence 32 34567899999999999975 69999999999999999999999996544322111111 11222222 1246889
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+.|||++||.+.|++|-|+.++++|||+++..
T Consensus 259 F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 259 FNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 99999999999999999999999999999864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=342.59 Aligned_cols=253 Identities=29% Similarity=0.461 Sum_probs=209.4
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecC
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ 221 (492)
||+|+||.||+|.... +|+.||+|++.+...........+.+|+++|+.++ ||||++++++++..+.+|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcC---CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCC
Confidence 6999999999998664 68899999997654433334455778999999995 9999999999999999999999999
Q ss_pred CCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccc
Q 011154 222 GGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND 300 (492)
Q Consensus 222 ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~ 300 (492)
+++|.+++.... ..+++.++..++.|++.||.|||+.|++||||+|+||++ ++++.+||+|||++...........
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCcccc
Confidence 999999887653 369999999999999999999999999999999999999 6677899999999987654444455
Q ss_pred cccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011154 301 IVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379 (492)
Q Consensus 301 ~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 379 (492)
..++..|+|||++. +.++.++|||||||++|+|++|+.||...........+..............+++++.+||.+||
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 67888999999875 45888999999999999999999999765542222222222222222333467899999999999
Q ss_pred ccCcCCCC-----CHHHHhcCcccccc
Q 011154 380 NKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 380 ~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+.||.+|| ++.++++||||...
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred cCChhHccCCCcccHHHHHhChhhhcC
Confidence 99999999 89999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=341.52 Aligned_cols=253 Identities=29% Similarity=0.466 Sum_probs=208.2
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--CeE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL--DNV 213 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~--~~~ 213 (492)
|++.+.||+|+||.||+|.... +++.||||++.+...... .....+|+.+++++.+|+||+++++++.+. +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcC---CCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 6788999999999999998764 678999999865432221 123457999999997799999999999987 899
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+. |+|.+.+..+...+++..+..++.||+.||.|||+.||+||||||+||++ +. +.+||+|||++..+.
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccc
Confidence 99999997 48888887765679999999999999999999999999999999999999 44 799999999998776
Q ss_pred CCCCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC-------------
Q 011154 294 PDERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------- 358 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~------------- 358 (492)
.........++..|+|||++. +.++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 555445567899999999764 34788999999999999999999999877765554444321110
Q ss_pred -----CCCC-------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 359 -----FDDG-------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 359 -----~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
++.. ..+.++.++.+||.+||..||++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1000 013568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=357.37 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=206.1
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++++.||+|+||.||+|++.. ...++..||||++..... ....+.+.+|+.+++.+.+|+|||+++++|.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3579999999999999999998643 223456899999965432 233566889999999995699999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC---------------------------------------------------------
Q 011154 211 DNVYIVMELCEGGELLDRILSRC--------------------------------------------------------- 233 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~--------------------------------------------------------- 233 (492)
+.+++|||||++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999886431
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCc---
Q 011154 234 ------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL--- 298 (492)
Q Consensus 234 ------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~--- 298 (492)
..+++.++..++.||+.||.|||++||+||||||+|||+ +.+..+||+|||+++.+......
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeec
Confidence 247888999999999999999999999999999999999 56678999999999865433221
Q ss_pred cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 376 (492)
....++..|||||++. ..++.++|||||||++|+|++ |+.||........+..+......... ...++.++.++|.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~ 349 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIMK 349 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHHH
Confidence 1233566799999875 569999999999999999997 99999876655444444433322221 1246899999999
Q ss_pred HccccCcCCCCCHHHHhc
Q 011154 377 LLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 377 ~~L~~dP~~Rps~~e~l~ 394 (492)
+||+.||.+|||+.++++
T Consensus 350 ~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 350 MCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.89 Aligned_cols=253 Identities=28% Similarity=0.498 Sum_probs=210.3
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC------HHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT------AIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~------~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
+|.++..||+|+||.||+|.... +++.||+|.+....... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Confidence 47788999999999999998654 67899999986543322 123456889999999995 999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
+.+..++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||+|+||++ +.++.+||+|||+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~ 152 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGI 152 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCC
Confidence 999999999999999999888654 678999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCCCC-------CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC
Q 011154 289 SDFVRPDE-------RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 360 (492)
Q Consensus 289 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 360 (492)
++...... ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||...........+.... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~ 229 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---S 229 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---C
Confidence 88765221 1123468899999998764 58889999999999999999999998766544444443321 1
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
......++.++.+||++||+.||.+||++.++++||||
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 11223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.42 Aligned_cols=253 Identities=23% Similarity=0.468 Sum_probs=212.4
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe-CCeE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-LDNV 213 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-~~~~ 213 (492)
.|++.+.||+|+||.||++..+. +++.||||.+...... ....+.+.+|+++++.++ |+||+++++.+.. +..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEE
Confidence 48999999999999999998764 6788999999654332 334556889999999995 9999999998874 4468
Q ss_pred EEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
|+||||+++++|.+++... ...+++.+++.++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVL 152 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEe
Confidence 9999999999999988764 3458999999999999999999999999999999999999 66778999999999876
Q ss_pred CCCC-CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.... ......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+..+... .....++++
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 229 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPE 229 (257)
T ss_pred cccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHH
Confidence 4332 233457899999999876 45888999999999999999999999877766665555544321 122367899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
+.+||.+||+.||.+|||+.++++||||
T Consensus 230 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=344.11 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=208.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe-
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN- 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~- 212 (492)
++|++.+.||+|+||.||+|.+.. +++.||||++...... ......+.+|+.+++.+.+||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence 468999999999999999998765 6889999998654322 12234678899999999768999999999987665
Q ss_pred ----EEEEEeecCCCchHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 213 ----VYIVMELCEGGELLDRILSRC----GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 213 ----~~lv~E~~~ggsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++. .++.+||+
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~ 153 (295)
T cd07837 77 GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIA 153 (295)
T ss_pred CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEe
Confidence 8999999986 8888876542 35899999999999999999999999999999999999942 26789999
Q ss_pred ecccccccCCC-CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC
Q 011154 285 DFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD 361 (492)
Q Consensus 285 DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (492)
|||++...... .......+++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.........
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99998765322 22233467889999998753 4788999999999999999999999887665554444332111100
Q ss_pred ------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 362 ------------------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 362 ------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
...+.++.++.+||.+||..||.+||++.+++.||||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01135788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=347.48 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=212.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL-- 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~-- 210 (492)
.++|++.+.||+|+||.||+|.++. +|+.||+|++........ ....+.+|+.++++++ |+||+++++++.+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDG-IPISSLREITLLLNLR-HPNIVELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhCC-CCCCcceEEEEecCCC
Confidence 4679999999999999999998765 788999999865432221 1224567999999995 99999999999765
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+++||||+.+ +|.+.+......+++.++..++.||+.||.|||+.|++||||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~ 156 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLAR 156 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceee
Confidence 578999999975 8888776655679999999999999999999999999999999999999 667789999999998
Q ss_pred ccCCCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC----
Q 011154 291 FVRPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS---- 363 (492)
Q Consensus 291 ~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~---- 363 (492)
...... ......++..|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 765432 2233456888999998753 478999999999999999999999988887777766654321111111
Q ss_pred ----------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 364 ----------------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 364 ----------------------~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
...+++++.+||.+||+.||++|||+.+++.||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 12358889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=340.53 Aligned_cols=252 Identities=33% Similarity=0.581 Sum_probs=216.0
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||.|+||.||+|+... +++.||+|++.+.........+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEE
Confidence 48899999999999999998654 6889999999876554545667899999999999 5999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+|+||+.|++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++ ++++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTP 152 (258)
T ss_pred EEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCC
Confidence 999999999999988655 689999999999999999999999999999999999999 6677899999999987765
Q ss_pred CCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCCh---hHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 295 DERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 295 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
........|+..|+|||++.+ .++.++||||||+++|+|++|..||..... ............. ....++.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 228 (258)
T cd05578 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL----YPATWSTE 228 (258)
T ss_pred CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc----CcccCcHH
Confidence 544456678999999998764 478999999999999999999999987664 3333222222222 22357899
Q ss_pred HHHHHHHccccCcCCCCCH--HHHhcCccc
Q 011154 371 AKDFVKLLLNKDPRKRMTA--AQALSHPWI 398 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~--~e~l~hp~~ 398 (492)
+.++|.+||..||.+||++ .|+++||||
T Consensus 229 ~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 9999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.95 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=218.1
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||.|+||.||.++... +++.|++|.+...... ......+.+|+.+++++ +|+||+++++++.+.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTRLS-EKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEE
Confidence 58999999999999999988654 7889999998655433 33456788999999999 5999999999999999999
Q ss_pred EEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+|||||++|+|.+.+... ...+++.++..++.|++.||.|||+.|++||||+|+||++ +.++.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcc
Confidence 999999999999988765 3568999999999999999999999999999999999999 566789999999998764
Q ss_pred CCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||......+....+......... ..++.++
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSEL 229 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence 433 3345678999999998754 4788999999999999999999999888877777777665433222 4678999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.++|.+||..+|.+||++.++++|+|+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.01 Aligned_cols=255 Identities=30% Similarity=0.469 Sum_probs=213.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||.|+||.||+|.... +++.+|+|++..... ...+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEPG---DDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCch---hhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCE
Confidence 3689999999999999999998765 568899999975432 2456789999999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|++|||+++++|.+++......+++.++..++.|++.||.|||++||+|+||+|+||++ +.++.+||+|||++...
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQL 151 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhh
Confidence 999999999999999887665789999999999999999999999999999999999999 66778999999999876
Q ss_pred CCCC-CccccccCccccccccccC----CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC-CCCCCC
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLHR----SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-DGSWPS 366 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~ 366 (492)
.... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||...........+........ ......
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 5332 2344578999999998753 588899999999999999999999988765554444443321111 111234
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCcc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 397 (492)
++.++.+||.+||..||.+|||+.+++.|+|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=339.57 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=208.2
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
...+|++.+.||+|+||.||+|..+. +++.||+|++..... .....+.+|+.+++.+. ||||+++++++...+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~ 79 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLEPG---DDFSLIQQEIFMVKECK-HCNIVAYFGSYLSRE 79 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecCcc---chHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCC
Confidence 35689999999999999999998765 678999999864432 22346789999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+||||+++|+|.+++..+ +.+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++..
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAK 155 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCcccee
Confidence 999999999999999988654 679999999999999999999999999999999999999 6667899999999986
Q ss_pred cCCCC-CccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC-CCCC
Q 011154 292 VRPDE-RLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD-GSWP 365 (492)
Q Consensus 292 ~~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~ 365 (492)
+.... ......|+..|+|||.+. ..++.++|||||||++|+|++|..||...........+......... ....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06646 156 ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKT 235 (267)
T ss_pred ecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccc
Confidence 64322 223457899999999873 34778999999999999999999999655433322222222111111 1112
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCcc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 397 (492)
.++..+.+||.+||..||++|||++++|+|+|
T Consensus 236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 46889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.01 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=215.4
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
....+|++.+.||+|+||.||+++... +++.||+|.+...... ..+.+.+|+.+++.+ +|+||+++++.|.+.
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~ 89 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVG 89 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecCCcc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEEeC
Confidence 345789999999999999999998654 6789999999765432 245688999999999 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
...|+||||++|++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~ 164 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCA 164 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccch
Confidence 999999999999999998754 468999999999999999999999999999999999999 566789999999987
Q ss_pred ccCCCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
....... .....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||...........+.... .........++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (296)
T cd06654 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLS 243 (296)
T ss_pred hccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccC
Confidence 6543332 234578999999998764 47889999999999999999999998776544333332221 11112224678
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..+.+||.+||..||.+|||+.++++||||....
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 8999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.08 Aligned_cols=257 Identities=30% Similarity=0.495 Sum_probs=216.6
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
..+|++.+.||.|+||.||++.... +++.||||.+...... ..+.+.+|+.+++.++ ||||+++++++...+.
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQKQP---KKELIINEILVMKELK-NPNIVNFLDSFLVGDE 90 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEecccCc---hHHHHHHHHHHHHhcC-CCceeeeeeeEecCce
Confidence 3679999999999999999998654 7889999999654322 3456889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|+||+++++|.+++.. ..+++.++..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhc
Confidence 9999999999999987754 368999999999999999999999999999999999999 56778999999998766
Q ss_pred CCCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RPDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
..... .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||...........+...... .......++..
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (296)
T cd06655 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPI 244 (296)
T ss_pred ccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHH
Confidence 54332 234578999999998764 5889999999999999999999999887765554444432211 11223468899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+.+||.+||..||.+||++.+++.||||+...
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=356.78 Aligned_cols=256 Identities=26% Similarity=0.368 Sum_probs=205.2
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++++.||+|+||.||+|.+.. ...++..||||++..... ....+.+.+|+.+|+.+.+||||++++++|.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3579999999999999999997532 223567899999965432 223456889999999996699999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC---------------------------------------------------------
Q 011154 211 DNVYIVMELCEGGELLDRILSRC--------------------------------------------------------- 233 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~--------------------------------------------------------- 233 (492)
+..++|||||+||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCC
Q 011154 234 -----------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296 (492)
Q Consensus 234 -----------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~ 296 (492)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.+..+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcc
Confidence 147888999999999999999999999999999999999 556789999999998764332
Q ss_pred Cc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 297 RL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 297 ~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.. ....++..|+|||++. ..++.++|||||||++|+|++ |..||........+........... .....+.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 346 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEM 346 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHH
Confidence 21 1234566799999875 468999999999999999998 8999977654433333333222211 123467899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcC
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++||.+||+.||++|||+.++++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=345.72 Aligned_cols=260 Identities=30% Similarity=0.463 Sum_probs=213.3
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC--CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT--TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
+|++.+.||+|+||.||+|.... +++.||||.+...... .......+.+|+++++.+. |+||+++++++.+.+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCE
Confidence 48889999999999999998765 5789999999765433 1223345778999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSF 152 (298)
T ss_pred EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeec
Confidence 99999999 889999886654479999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC--------
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD-------- 361 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 361 (492)
.... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||.+....+.+..+.........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 5432 2334467889999998753 4788999999999999999998888777665555554432111100
Q ss_pred ----------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 362 ----------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 362 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..+...+.++.+||.+||..||++|||+.++++|+||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 01234578899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=336.67 Aligned_cols=252 Identities=31% Similarity=0.539 Sum_probs=212.7
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||++.... +++.||+|.+.... ..+.+.+|+++++.+ +|+||+++++++.+...+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcE
Confidence 579999999999999999998765 57899999985432 156789999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+++||+.+++|.+.+......+++..+..++.||+.||.|||+.||+||||+|+||++ +.++.+||+|||++....
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcc
Confidence 99999999999999887666789999999999999999999999999999999999999 566789999999998765
Q ss_pred CCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
... ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+....... ......++.++
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (256)
T cd06612 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEF 229 (256)
T ss_pred cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC-CCchhhcCHHH
Confidence 443 2334568899999998764 58889999999999999999999997765544433332221111 11123577899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.+||.+||+.||++|||+.|+|.||||
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.26 Aligned_cols=255 Identities=30% Similarity=0.498 Sum_probs=209.1
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-- 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-- 209 (492)
..+.|++.+.||.|+||.||+|+... +++.||+|++.... .....+..|+.+++++.+|+||++++++|..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 34689999999999999999999765 67899999985532 2345688899999999779999999999853
Q ss_pred ----CCeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 ----LDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 ----~~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.+.+|+|||||.+|+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||++ +.++.++|+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~ 163 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLV 163 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEe
Confidence 46799999999999999988653 3458999999999999999999999999999999999999 567789999
Q ss_pred ecccccccCCC-CCccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 285 DFGLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 285 DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
|||++...... .......|+..|+|||.+. ..++.++|||||||++|+|++|..||...........+.....
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 243 (282)
T cd06636 164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243 (282)
T ss_pred eCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC
Confidence 99998765422 2234467899999999874 3478899999999999999999999976654443333322211
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 358 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.......++.++.+||.+||..||.+|||+.|+|+||||
T Consensus 244 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 --PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 111223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=342.98 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=204.6
Q ss_pred ccceeecceeccccceEEEEEEEecC-------------CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG-------------EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~-------------~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpn 199 (492)
.++|++.++||+|+||.||+|++... ..++..||||++.... ......++.+|+++|++++ |||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence 46899999999999999999986432 1245579999986543 2334567899999999995 999
Q ss_pred ccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhC------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCc
Q 011154 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC------------------GKYSEDEAKAVLVQILNVVAFCHLHGVV 261 (492)
Q Consensus 200 iv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~------------------~~~~~~~~~~i~~qi~~~l~ylH~~~iv 261 (492)
|+++++++.+.+..++|||||.+|+|.+++.... ..+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999885431 2467889999999999999999999999
Q ss_pred ccCCCCCceEeecCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc--
Q 011154 262 HRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-- 335 (492)
Q Consensus 262 HrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-- 335 (492)
||||||+|||+ +.++.+||+|||++..+..... .....++..|+|||++. +.++.++|||||||++|+|++
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999 5677899999999986643332 12345678899999865 568999999999999999986
Q ss_pred CCCCCCCCChhHHHHHHHhcC----CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 336 GSRPFWARTESGIFRAVLKAD----PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 336 g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+..||......+....+.... ........+.++..+.+|+.+||..||.+|||+.++..
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 677887766665554443211 11111122457889999999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.72 Aligned_cols=239 Identities=27% Similarity=0.391 Sum_probs=206.0
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEe
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E 218 (492)
.+-||.|+-|.||+++++ ++.||||.++.- =..+|+-|++|+ ||||+.|.|+|...-.++||||
T Consensus 129 LeWlGSGaQGAVF~Grl~-----netVAVKKV~el----------kETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-----NETVAVKKVREL----------KETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeecc-----CceehhHHHhhh----------hhhhHHHHHhcc-CcceeeEeeeecCCceeEEeee
Confidence 467999999999999875 578999988422 135899999995 9999999999999999999999
Q ss_pred ecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCc
Q 011154 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL 298 (492)
Q Consensus 219 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~ 298 (492)
||..|.|...|... ..++......|..+|+.|+.|||.+.|||||||.-||||..+| .|||+|||-++........
T Consensus 193 fCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d---~VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD---VVKISDFGTSKELSDKSTK 268 (904)
T ss_pred ccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc---eEEeccccchHhhhhhhhh
Confidence 99999999977654 7899999999999999999999999999999999999996544 7999999999988776666
Q ss_pred cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
-.++||..|||||++++ ..+.|+|||||||||||||||..||.+.....|+.-+-.....++. ...+++.++-||++
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv--PstcP~GfklL~Kq 346 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV--PSTCPDGFKLLLKQ 346 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC--cccCchHHHHHHHH
Confidence 67899999999999975 5899999999999999999999999877776665544443333322 24688999999999
Q ss_pred ccccCcCCCCCHHHHhcCcccc
Q 011154 378 LLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 378 ~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
||+-.|..||++.++|.|-=|.
T Consensus 347 cw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 347 CWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHhcCCCCCccHHHHHHHHhhc
Confidence 9999999999999999995443
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.75 Aligned_cols=256 Identities=32% Similarity=0.522 Sum_probs=210.6
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|..+. +++.|++|++..... ..+.+.+|+.+++++.+|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 45889999999999999999998764 678999999865432 34568899999999967999999999997644
Q ss_pred ------eEEEEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEE
Q 011154 212 ------NVYIVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 212 ------~~~lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~k 282 (492)
.+|+||||+++++|.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~ 153 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVK 153 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEE
Confidence 489999999999999887643 3579999999999999999999999999999999999999 6677899
Q ss_pred EEecccccccCCCC-CccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhc
Q 011154 283 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 355 (492)
Q Consensus 283 l~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~ 355 (492)
|+|||++....... ......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+...
T Consensus 154 l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 154 LVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 99999987654322 233457899999999874 23678899999999999999999999766554444444433
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 356 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
..... .....++.++++||.+||..||++|||+.++++|||+
T Consensus 234 ~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 234 PPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 22111 1112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=335.68 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=209.7
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC---CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT---TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+|.+++.||+|+||.||+|... +++.+|||.+...... .......+.+|+++++.+. |+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCC
Confidence 4788999999999999999642 5788999998654322 2233456889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++||||++|++|.+++.+. +.+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARR 151 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHh
Confidence 999999999999999988654 578999999999999999999999999999999999999 6677899999999876
Q ss_pred cCCC-------CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 292 VRPD-------ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 292 ~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
.... .......|+..|+|||++.+ .++.++|||||||++|+|++|..||...........+.......+ ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 230 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RL 230 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-CC
Confidence 4321 11234568999999998864 588899999999999999999999987665544444433221111 12
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
...++.++.+||.+||..+|.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 24688999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.80 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=203.2
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+.+++.|.-...||+|+||.||+|... +|..||||++....... ..+|.+|+.+|.+++ |||||+|+|||.+
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~----~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLS----DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLLGYCLE 142 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEEC----CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEEEEEec
Confidence 567789999999999999999999876 34889999886544321 345999999999996 9999999999999
Q ss_pred CC-eEEEEEeecCCCchHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHcC---CcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 LD-NVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLHG---VVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 ~~-~~~lv~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~ylH~~~---ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.+ +.+||||||++|+|.++++.... .++|..+.+|+.+++.||+|||... |||||||++|||+ |++...||+
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKls 219 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLS 219 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEcc
Confidence 88 59999999999999999987766 8999999999999999999999964 9999999999999 889999999
Q ss_pred ecccccccCC-CCCcccc-ccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCC---hhHHHH----HHHh
Q 011154 285 DFGLSDFVRP-DERLNDI-VGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWART---ESGIFR----AVLK 354 (492)
Q Consensus 285 DfGla~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~---~~~~~~----~i~~ 354 (492)
|||+|+.... ....... .||.+|+|||++. +..+.++|||||||+|+||+||+.+..... ...+.. .+..
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999977654 3333333 8999999999875 679999999999999999999998876432 111111 1111
Q ss_pred cC-CCCCCCC-C-CCCC-----HHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 355 AD-PSFDDGS-W-PSLS-----SDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 355 ~~-~~~~~~~-~-~~~s-----~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.. ..+.+.. . .... ..+..+..+|++.+|.+||++.|+++
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11 0111111 1 1222 23556789999999999999999743
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.76 Aligned_cols=251 Identities=30% Similarity=0.591 Sum_probs=213.4
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecC
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ 221 (492)
||.|+||.||+++... +++.||+|++.+.........+.+.+|+++++.+ +||||+++++++.+++.+|+||||++
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCC
Confidence 7999999999999764 6889999999876554444557799999999999 59999999999999999999999999
Q ss_pred CCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCcccc
Q 011154 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI 301 (492)
Q Consensus 222 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~ 301 (492)
+++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++............
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 77 GGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred CCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccc
Confidence 99999988654 568999999999999999999999999999999999999 56778999999999877654444456
Q ss_pred ccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCC--hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011154 302 VGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWART--ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378 (492)
Q Consensus 302 ~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 378 (492)
.|+..|++||.+. ..++.++|+||||+++|+|++|..||.... .......+.........+ ...+.++.+||.+|
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~ 230 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQL 230 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHH
Confidence 7899999999875 458899999999999999999999998776 555555555322221111 24588999999999
Q ss_pred cccCcCCCCC-----HHHHhcCccccccc
Q 011154 379 LNKDPRKRMT-----AAQALSHPWIRNYN 402 (492)
Q Consensus 379 L~~dP~~Rps-----~~e~l~hp~~~~~~ 402 (492)
|..||.+|++ +.|+++||||+.+.
T Consensus 231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred ccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 9999999999 99999999998753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=332.83 Aligned_cols=266 Identities=31% Similarity=0.469 Sum_probs=213.7
Q ss_pred cceeecceeccccceEEEEEEEecCCc-cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe-CC
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEH-KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-LD 211 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-~~ 211 (492)
..|++...||+|.||.||+|.-+.... ..+.+|||.++..+..+.. .....||+.+++.|+ ||||+.|..+|.. +.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-SMSACREIALLRELK-HPNVISLVKVFLSHDK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhc-CCcchhHHHHHhccCc
Confidence 568999999999999999996554321 2458999999766443322 234678999999996 9999999999987 88
Q ss_pred eEEEEEeecCCCchHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC-CCCCcEEEEec
Q 011154 212 NVYIVMELCEGGELLDRILSR----CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK-DESSQLKAIDF 286 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~-~~~~~~kl~Df 286 (492)
.+++++||.+. +|+..|+-. ...++...++.|+.||+.|+.|||++-|+||||||.|||+..+ .+.+.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999987 899888632 2458999999999999999999999999999999999999654 24589999999
Q ss_pred ccccccCCCC----CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCCh---------hHHHHH
Q 011154 287 GLSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTE---------SGIFRA 351 (492)
Q Consensus 287 Gla~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~---------~~~~~~ 351 (492)
|+++.+...- ....++-|.+|+|||.+.+ .|+.+.|||++|||+.||||-++.|.+... .+.+..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999875432 3456788999999998864 599999999999999999999998865432 234445
Q ss_pred HHhcCCCCCCCCCCC---------------------------------CCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 352 VLKADPSFDDGSWPS---------------------------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 352 i~~~~~~~~~~~~~~---------------------------------~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
|...........|+. -++.+.+|+.+||..||.+|+|++|+|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 554444444444432 23458899999999999999999999999999
Q ss_pred cccc
Q 011154 399 RNYN 402 (492)
Q Consensus 399 ~~~~ 402 (492)
+...
T Consensus 341 ~~d~ 344 (438)
T KOG0666|consen 341 TEDP 344 (438)
T ss_pred ccCC
Confidence 9753
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=339.16 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=211.6
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|.+.+.||+|+||.||++..+. +++.||+|++..... ....+.+|+.+++++.+||||++++++|...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 456889999999999999999998765 688999999864321 2346778999999996799999999998753
Q ss_pred -----CeEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEE
Q 011154 211 -----DNVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 211 -----~~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~k 282 (492)
+.+|+||||++||+|.+++.. ....+++..++.++.|++.||.|||+.||+||||||+||++ +.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEE
Confidence 368999999999999987753 34578999999999999999999999999999999999999 5667899
Q ss_pred EEecccccccCCCC-CccccccCccccccccccC------CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhc
Q 011154 283 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR------SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 355 (492)
Q Consensus 283 l~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~ 355 (492)
|+|||++....... ......|+..|+|||++.. .++.++|||||||++|+|++|+.||...........+...
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 99999988764332 2234578999999998742 2678999999999999999999999877665555555443
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 356 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
..... .....++.++.+||.+||..||.+||++.++++||||+
T Consensus 249 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 22111 11124678899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.86 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=206.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+++.+. +|+.||||++....... ....+..|+.++.+..+||||+++++++..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 468999999999999999999765 78999999997653322 2334566777644444799999999999999999
Q ss_pred EEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 214 YIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
|+||||++ |+|.+.+.. ....+++..++.++.||+.||.|||++ +++||||||+|||+ +.++.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccc
Confidence 99999997 577776654 234689999999999999999999998 99999999999999 66778999999999
Q ss_pred cccCCCCCccccccCcccccccccc-----CCCCCccchHHHHHHHHHHhcCCCCCCCCC-hhHHHHHHHhc-CCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH-----RSYGTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKA-DPSFDDG 362 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlGvil~~lltg~~pf~~~~-~~~~~~~i~~~-~~~~~~~ 362 (492)
.............|+..|+|||++. ..++.++|||||||++|+|++|+.||.... ..+.+..+... ...++.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA- 230 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc-
Confidence 8765433334457899999999874 346789999999999999999999996532 22333333322 222221
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..++.++.+||.+||..+|.+||++.++++||||++..
T Consensus 231 --~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 231 --EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred --cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 25789999999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.70 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=200.6
Q ss_pred eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHc--cCCCCccEEEEEEEeCCeEEEEEe
Q 011154 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL--SGHSNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l--~~hpniv~l~~~~~~~~~~~lv~E 218 (492)
.||+|+||.||++.... +++.||||.+.+.............+|..+++.+ .+||||+.+++++.+++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECC---CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 48999999999998764 6889999999765443332223344555444433 259999999999999999999999
Q ss_pred ecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCc
Q 011154 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL 298 (492)
Q Consensus 219 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~ 298 (492)
|++||+|.+++..+ +.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++....... .
T Consensus 78 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~ 152 (279)
T cd05633 78 LMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-P 152 (279)
T ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-c
Confidence 99999998887654 679999999999999999999999999999999999999 667789999999987654322 2
Q ss_pred cccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011154 299 NDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376 (492)
Q Consensus 299 ~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 376 (492)
....||..|+|||.+. ..++.++||||+||++|+|++|..||........ ..+..............++.++.+||.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLE 231 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHH
Confidence 3457999999999875 3488999999999999999999999975433211 111111112222233468899999999
Q ss_pred HccccCcCCCC-----CHHHHhcCccccccc
Q 011154 377 LLLNKDPRKRM-----TAAQALSHPWIRNYN 402 (492)
Q Consensus 377 ~~L~~dP~~Rp-----s~~e~l~hp~~~~~~ 402 (492)
+||..||.+|+ ++.++++||||+...
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 99999999999 699999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.05 Aligned_cols=258 Identities=30% Similarity=0.500 Sum_probs=208.5
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE-
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE- 208 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~- 208 (492)
....++|++.+.||+|+||.||+|..+. +++.||+|++..... ....+.+|+.+++.+.+||||++++++|.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECC---CCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4567899999999999999999998764 678999998854321 23457889999999966999999999884
Q ss_pred ----eCCeEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcE
Q 011154 209 ----DLDNVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281 (492)
Q Consensus 209 ----~~~~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~ 281 (492)
..+.+++||||++||+|.+.+.. ....+++..+..++.|++.||.|||+++|+||||||+||++ +.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCE
Confidence 34679999999999999987753 23568999999999999999999999999999999999999 556789
Q ss_pred EEEecccccccCCCC-CccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHh
Q 011154 282 KAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 354 (492)
Q Consensus 282 kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~ 354 (492)
||+|||++....... ......|++.|+|||++. ..++.++||||+||++|+|++|+.||........+..+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 999999998764332 223457999999999874 3478899999999999999999999987655444333322
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 355 ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 355 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.... .......++.++.+||.+||+.||.+|||+.++++|+||
T Consensus 244 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2111 111112357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=338.42 Aligned_cols=257 Identities=29% Similarity=0.484 Sum_probs=213.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||++..+. +++.||+|++..... ......+.+|+++++.+. ||||+++++++...+.+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEE
Confidence 368888999999999999998765 688999999876532 244567889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
++|+||+++++|.+++......+++..+..++.||+.||.|||+ .|++||||||+||++ +.++.++|+|||++...
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhh
Confidence 99999999999999887655789999999999999999999999 999999999999999 56778999999998766
Q ss_pred CCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC-----hhHHHHHHHhcCCCCCCCCCCC
Q 011154 293 RPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART-----ESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
..... ....|+..|+|||.+.+ .++.++|||||||++|+|++|..||.... ..+....+....... .....
T Consensus 152 ~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 228 (265)
T cd06605 152 VNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR--LPSGK 228 (265)
T ss_pred HHHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC--CChhh
Confidence 43222 22678899999998764 58899999999999999999999996542 222333333322111 11112
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++.++.+||.+||..||++|||+.+++.||||+.+.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 788999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=333.04 Aligned_cols=253 Identities=27% Similarity=0.527 Sum_probs=215.8
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||++.... +|+.||||.+...... ....+.+.+|+.+++.+. ||||+++++++++.+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMS-PKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEE
Confidence 58899999999999999998764 6889999998654332 234567899999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+||||+.+++|.+.+.... ..+++.++..++.|++.||.|||++|++|+||+|+|||+ +.+..++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecC
Confidence 9999999999999887643 368999999999999999999999999999999999999 566789999999997664
Q ss_pred CCCC-ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDER-LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.... .....|+..|+|||++. +.++.++|||||||++|+|++|..||......+....+..+..... ...++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDL 229 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHH
Confidence 4322 22346889999999876 4578899999999999999999999988877777777665543221 23578999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.++|.+||+.+|.+||++.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=338.06 Aligned_cols=255 Identities=29% Similarity=0.495 Sum_probs=214.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
..|+..+.||.|+||.||.|.++. ++..||||++..... ......+.+|+++++.+ +|+||+++++++.+.+.+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEecccc--HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEE
Confidence 467888999999999999998765 678999999865432 33456789999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||++||+|.+++.. +.+++.++..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceecc
Confidence 999999999999998754 478999999999999999999999999999999999999 566789999999997664
Q ss_pred CCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.... .....++..|+|||++.+ .++.++|||||||++|+|++|..||...........+..... ......++.++
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPF 229 (277)
T ss_pred CCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHH
Confidence 3332 233568899999998754 588899999999999999999999987766555544433222 12223567889
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+||.+||..+|.+||++.+++.|+||.+..
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=341.69 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=210.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|.++. +++.||+|++.+..... ...+.+.+|+++++.+. ||||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeE
Confidence 468999999999999999998764 67899999987654332 34456889999999994 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||+++++|.+... ....+++.++..++.||+.||.|||+.||+||||+|+||++ ++++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEEecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeecc
Confidence 99999999987776543 33569999999999999999999999999999999999999 667789999999988764
Q ss_pred CCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC----------
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---------- 360 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~---------- 360 (492)
... ......++..|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+......+.
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 332 2334568899999998753 477899999999999999999999977665444433332111110
Q ss_pred -----------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 361 -----------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 361 -----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
...++.++..+.+|+.+||..+|.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 01134678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=336.91 Aligned_cols=248 Identities=25% Similarity=0.466 Sum_probs=199.1
Q ss_pred cceeeccee--ccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 134 SRLEVGEEV--GRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 134 ~~y~~~~~l--G~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.|++.+.+ |+|+||.||+++.+. ++..+|+|++....... .|+.+...+.+||||+++++.|...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKP---TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcC---CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 456666655 999999999998765 68899999986543221 13333333446999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCC-cEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS-QLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~-~~kl~DfGla~ 290 (492)
.+|+||||+++|+|.+++... ..+++.++..++.||+.||.|||+.|++||||||+||++. .++ .++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCK 158 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccce
Confidence 999999999999999988665 4899999999999999999999999999999999999994 444 89999999987
Q ss_pred ccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHH-HHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIF-RAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s 368 (492)
..... ....|+..|+|||++. ..++.++|||||||++|+|++|..||.......+. ..+.... ......++.++
T Consensus 159 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (267)
T PHA03390 159 IIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVS 234 (267)
T ss_pred ecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccC
Confidence 66432 2346899999999886 45889999999999999999999999755443321 1121111 22223344789
Q ss_pred HHHHHHHHHccccCcCCCCC-HHHHhcCccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMT-AAQALSHPWIRN 400 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps-~~e~l~hp~~~~ 400 (492)
..+++||.+||+.||.+|++ ++++|+||||++
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999999999996 699999999974
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=342.46 Aligned_cols=260 Identities=26% Similarity=0.403 Sum_probs=208.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|...+.||+|+||.||++.... +++.||||.+...... .....+.+|+.++.++.+|+||+++++++..++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC---CCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 356677899999999999998765 6899999998754432 34567889999999996699999999999999999
Q ss_pred EEEEeecCCCchHHHH---Hh-hCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 214 YIVMELCEGGELLDRI---LS-RCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l---~~-~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
+++|||+.+ +|.+.. .. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~ 154 (288)
T cd06616 79 WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGI 154 (288)
T ss_pred EEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecch
Confidence 999999964 554432 22 235799999999999999999999985 99999999999999 5667899999999
Q ss_pred ccccCCCCCccccccCccccccccccC----CCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHHHHhcC-CCCCCC
Q 011154 289 SDFVRPDERLNDIVGSAYYVAPEVLHR----SYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKAD-PSFDDG 362 (492)
Q Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~i~~~~-~~~~~~ 362 (492)
+..+..........|+..|+|||++.+ .++.++|||||||++|+|++|+.||..... .+....+.... +.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCc
Confidence 987654443344578999999998763 488899999999999999999999965442 11222222211 222222
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+..++.++.+||.+||..||.+|||+.+++.||||+...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 3345889999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=341.17 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=215.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
....+|++.+.||+|+||.||+|.... +++.||+|++.............+.+|+++++.+. ||||++++++|.+.
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~ 87 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLRE 87 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeC
Confidence 445679999999999999999998765 67899999997655444455567889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..|+||||+. |+|.+.+......+++..+..++.||+.||.|||+.||+||||+|+||++ +.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~ 163 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSAS 163 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcce
Confidence 99999999997 47777776555679999999999999999999999999999999999999 667789999999987
Q ss_pred ccCCCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-CCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP-SFDDGSWP 365 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~ 365 (492)
..... ....|+..|+|||++. +.++.++|||||||++|+|++|..||...........+..... ... ..
T Consensus 164 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 237 (307)
T cd06607 164 LVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS---SN 237 (307)
T ss_pred ecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC---ch
Confidence 65433 3456889999999863 4588899999999999999999999987766555444433221 111 12
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.++.++.+||.+||..||.+||++.+++.||||...
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred hhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 467899999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=333.76 Aligned_cols=255 Identities=26% Similarity=0.450 Sum_probs=207.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC--CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT--TAIAVEDVRREVKILRALSGHSNLVKFYDAFED-- 209 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-- 209 (492)
.+|++.+.||+|+||.||+|.... ++..||+|++...... .......+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRA 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCC
Confidence 368899999999999999998654 6889999998654322 2334567889999999995 9999999999875
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.++++|||+++++|.+.+... +.+++..++.++.||+.||.|||+.+|+||||||+||++ +.++.+||+|||++
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~ 153 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGAS 153 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCc
Confidence 36789999999999999988654 568999999999999999999999999999999999999 66778999999998
Q ss_pred cccCCC----CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 290 DFVRPD----ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 290 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
..+... .......|+..|+|||.+.+ .++.++|||||||++|+|++|+.||...........+...... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~ 231 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLP 231 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCc
Confidence 765422 11233568899999998764 5888999999999999999999999876554444433322111 1112
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
..+++.+++|| +||..+|++||+++|+++||||+
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 35678899999 67778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=341.10 Aligned_cols=260 Identities=27% Similarity=0.466 Sum_probs=215.0
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
....+|.+.+.||+|+||.||+++... +++.||||.+...... ..+.+.+|+.+++.+ +|+||++++++|...
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~ 88 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVG 88 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecCccc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence 345789999999999999999998654 6889999999654332 235678999999999 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..|+||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCA 163 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccce
Confidence 999999999999999998754 468999999999999999999999999999999999999 667789999999987
Q ss_pred ccCCCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
....... .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+.... .........++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 242 (297)
T cd06656 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLS 242 (297)
T ss_pred EccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccC
Confidence 7654332 234578999999998764 58889999999999999999999997765433322222211 11111223578
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
..+++||.+||..||.+||++.++++||||+....
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 89999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=335.23 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=211.1
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-------CHHHHHHHHHHHHHHHHccCCCCccEEEEEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-------TAIAVEDVRREVKILRALSGHSNLVKFYDAF 207 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-------~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~ 207 (492)
+|.+.+.||.|+||.||+|.... +|+.||||.+...... .....+.+.+|+.+++.+. |+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFE 77 (272)
T ss_pred ceeecceecccCceEEEEEeecC---CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEe
Confidence 58889999999999999998654 6889999988542211 1123456889999999995 99999999999
Q ss_pred EeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 208 EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 208 ~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
...+..++||||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~ 153 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFG 153 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecc
Confidence 9999999999999999999988665 679999999999999999999999999999999999999 667799999999
Q ss_pred cccccCCCC---CccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhc--CCCC
Q 011154 288 LSDFVRPDE---RLNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--DPSF 359 (492)
Q Consensus 288 la~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~--~~~~ 359 (492)
++....... ......|+..|+|||.+.. .++.++||||||+++|+|++|..||......+....+... ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence 987653221 1234568899999998753 3788999999999999999999999765554444333222 2233
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
....++.++.++.+||.+||..||.+|||+.++|+|||+
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 344456789999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=339.16 Aligned_cols=255 Identities=28% Similarity=0.452 Sum_probs=204.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||++..+. +++.||||.+....... ....+.+|+++++.+. |+||+++++++.+.+..
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEHEEG--APFTAIREASLLKDLK-HANIVTLHDIIHTKKTL 78 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEecccccC--CchhHHHHHHHHhhCC-CcceeeEEEEEecCCeE
Confidence 689999999999999999998654 67899999986543221 1234668999999994 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+.+ +|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKS 154 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccC
Confidence 999999975 9999887666678999999999999999999999999999999999999 667789999999987543
Q ss_pred CCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCC-hhHHHHHHHhcCCCCC---------
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFD--------- 360 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~--------- 360 (492)
... ......++..|+|||++.+ .++.++||||+||++|+|++|..||.... ..+.+..+........
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 222 1223457889999998753 47889999999999999999999997655 2222222211100000
Q ss_pred -----------------CCCCCCCC--HHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 361 -----------------DGSWPSLS--SDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 361 -----------------~~~~~~~s--~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
...++.++ .++.++|.+||+.||++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00112344 788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.41 Aligned_cols=256 Identities=31% Similarity=0.448 Sum_probs=210.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--C
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL--D 211 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~--~ 211 (492)
++|++.+.||.|+||.||+|.+.. +++.||||.+....... .....+.+|+.+++++. ||||+++++++... +
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEKEKE-GFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCC
Confidence 578999999999999999998764 67899999997554332 22345678999999995 99999999999887 8
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..|+||||+.+ +|.+.+......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLARE 155 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceee
Confidence 99999999975 8988877655579999999999999999999999999999999999999 6677899999999987
Q ss_pred cCCC-CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC---------
Q 011154 292 VRPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--------- 359 (492)
Q Consensus 292 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~--------- 359 (492)
.... .......++..|+|||++.+ .++.++|||||||++|+|++|..||...........+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 6543 23344568899999998754 36889999999999999999999998777665554443221100
Q ss_pred -----------------CCCCCCC--CCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 360 -----------------DDGSWPS--LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 360 -----------------~~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
....++. +++.+.+||++||+.||++|||+.|+|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011122 48889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=303.56 Aligned_cols=259 Identities=29% Similarity=0.528 Sum_probs=222.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.+|...++||+|.||+|++++.+. +++.||+|.+..+..... .-....+||.+|+.|. |.|||+++++...++.+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~---t~eivalkrvrlddddeg-vpssalreicllkelk-hknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRE---THEIVALKRVRLDDDDEG-VPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCC---ccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhh-hcceeehhhhhccCcee
Confidence 357778899999999999998664 889999999976543322 1234678999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
.+|+|||.. +|..+.-.-.+.++.+.++.++.|+++||.|||++++.||||||.|.|| +.++.+||+|||+|+-+.
T Consensus 77 tlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafg 152 (292)
T KOG0662|consen 77 TLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFG 152 (292)
T ss_pred EEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcC
Confidence 999999965 7777776667889999999999999999999999999999999999999 677899999999998775
Q ss_pred CCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC---
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS--- 366 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--- 366 (492)
-.- ....-+-|.+|++|.++-+ -|++..|+||.|||+.|+.. |++.|.+.+..+.+..|........++.|+.
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 433 3455678999999999865 49999999999999999986 7777888888888888888776666666654
Q ss_pred ----------------------CCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 367 ----------------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 367 ----------------------~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++...+||++++|.-+|.+|++++++|+||||...
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 34567899999999999999999999999999865
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=330.55 Aligned_cols=254 Identities=32% Similarity=0.535 Sum_probs=211.4
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|.+.+.||+|+||.||++.... +++.||+|++...... ....+.+.+|+.+++.+. |+||+++++++.+.+.++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEE
Confidence 58899999999999999998654 6789999999765443 345678999999999994 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+|+||+++++|.+.+... ..+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCC
Confidence 999999999999987654 568999999999999999999999999999999999999 5677899999999987654
Q ss_pred CCC-----ccccccCccccccccccC-C---CCCccchHHHHHHHHHHhcCCCCCCCCChhH-HHHHHHhcCCCCCCCCC
Q 011154 295 DER-----LNDIVGSAYYVAPEVLHR-S---YGTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDDGSW 364 (492)
Q Consensus 295 ~~~-----~~~~~gt~~y~aPE~~~~-~---~~~~~DvwSlGvil~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 364 (492)
... .....++..|+|||++.+ . ++.++||||||+++|+|++|..||....... ....+.. ........+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDS 230 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcc
Confidence 332 223568899999998763 2 7889999999999999999999997653322 2222222 222222333
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
..++..+.+||.+||+.+|.+|||+.+++.|||+
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 231 LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 4568999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=334.41 Aligned_cols=258 Identities=24% Similarity=0.422 Sum_probs=208.8
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC---HHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT---AIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+|+.++.||+|+||.||++.... +++.||+|++....... ....+.+.+|+++++.++ |+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCC
Confidence 47888999999999999998654 78899999997543221 224567899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+++||||++|++|.+.+.+. +.+++..+..++.||+.||.|||++|++||||+|+||+++. ....+||+|||++..
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~ 153 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAAR 153 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccc
Confidence 999999999999999887654 67999999999999999999999999999999999999942 223699999999877
Q ss_pred cCCCCC-----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-CCCCCCC
Q 011154 292 VRPDER-----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP-SFDDGSW 364 (492)
Q Consensus 292 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~ 364 (492)
...... .....||..|+|||++. ..++.++||||+||++|+|++|..||...........+..... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc
Confidence 653321 12346889999999875 4588899999999999999999999965443333332222111 1111222
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
..++.++.+++.+||..+|.+||++.++++||||+
T Consensus 234 ~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 234 EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 35789999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=330.84 Aligned_cols=253 Identities=35% Similarity=0.551 Sum_probs=214.6
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--CCe
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--LDN 212 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--~~~ 212 (492)
+|++.+.||.|+||.||++.... +++.||+|++...... ....+.+.+|+++++.+. |+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCE
Confidence 58899999999999999998765 6789999998765443 344567889999999995 9999999998764 456
Q ss_pred EEEEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHH-----HcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 213 VYIVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCH-----LHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH-----~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.+++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||++ +.++.+||+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~ 152 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLG 152 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEe
Confidence 89999999999999988653 467999999999999999999999 8899999999999999 566799999
Q ss_pred ecccccccCCCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011154 285 DFGLSDFVRPDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 285 DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (492)
|||++........ .....|+..|+|||++.+ .++.++||||||+++|+|++|..||...........+.......
T Consensus 153 d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 229 (265)
T cd08217 153 DFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR--- 229 (265)
T ss_pred cccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---
Confidence 9999987765443 345678999999998764 58889999999999999999999998887666666665543321
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
....++.++.+|+.+||..+|.+||++.++++|||+
T Consensus 230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 123678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=335.42 Aligned_cols=256 Identities=27% Similarity=0.505 Sum_probs=212.2
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc--CCCCccEEEEEEEeCCe
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS--GHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~--~hpniv~l~~~~~~~~~ 212 (492)
.|++.+.||+|+||.||+|.+.. +++.||||++..... ......+.+|+.+++.+. .||||+++++++.+...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 57888999999999999999765 678999999865432 234567889999999995 49999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++||||++|++|.+++.. +.+++..+..++.||+.||.|||+.||+||||+|+||++ +..+.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeec
Confidence 9999999999999988754 479999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCCC-ccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 293 RPDER-LNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 293 ~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
..... .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||...........+.... ........++.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 229 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PPRLEDNGYSK 229 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CCCCCcccCCH
Confidence 54332 334579999999998754 36889999999999999999999997765544433332221 11111223788
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++.+|+.+||..||.+||++.+++.|+||++..
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=331.49 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=208.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCC--CCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--TTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
.+|++++.||+|+||.||.++.+. ++..||||.+..... ......+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCC
Confidence 578999999999999999998764 788999998854321 22344567899999999995 99999999998763
Q ss_pred -CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 -DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
..+++||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+|||+ +.++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~ 153 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGAS 153 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccc
Confidence 5688999999999999987654 568999999999999999999999999999999999999 56778999999998
Q ss_pred cccCCC----CCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 290 DFVRPD----ERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 290 ~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
...... .......|+..|+|||.+. ..++.++|||||||++|+|++|+.||...........+...... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCc
Confidence 765421 1223456899999999875 45888999999999999999999999776554444443322111 1122
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
..++..+.++|.+||. +|++||+++++++|||+.
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 3577889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=336.11 Aligned_cols=249 Identities=28% Similarity=0.423 Sum_probs=200.4
Q ss_pred eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHH---HHHccCCCCccEEEEEEEeCCeEEEEE
Q 011154 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI---LRALSGHSNLVKFYDAFEDLDNVYIVM 217 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~---l~~l~~hpniv~l~~~~~~~~~~~lv~ 217 (492)
.||+|+||.||+|+... +++.||||.+.+...........+..|..+ ++.. +||||+++++++.+.+.+++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEE
Confidence 48999999999998654 688999999976544322222233444433 4444 5999999999999999999999
Q ss_pred eecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCC
Q 011154 218 ELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER 297 (492)
Q Consensus 218 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~ 297 (492)
||+.||+|.+++.. .+.+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.+||+|||++..+... .
T Consensus 77 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~-~ 151 (278)
T cd05606 77 DLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK-K 151 (278)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCcc-C
Confidence 99999999887754 4679999999999999999999999999999999999999 66778999999998765432 2
Q ss_pred ccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCC---hhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 298 LNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 298 ~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
.....|+..|+|||++.+ .++.++||||+||++|+|++|..||.... .......+...... .+..++.++.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~ 227 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELR 227 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHH
Confidence 234579999999998863 48899999999999999999999997663 22222222222222 2235789999
Q ss_pred HHHHHccccCcCCCC-----CHHHHhcCccccccc
Q 011154 373 DFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402 (492)
Q Consensus 373 ~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~ 402 (492)
++|.+||..+|.+|+ ++.++++||||+...
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 999999999999999 999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.58 Aligned_cols=255 Identities=31% Similarity=0.495 Sum_probs=207.2
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||.|+||.||+|+.+. +|+.||||.+....... .....+.+|+++++++. ||||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETE-GVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---CCCEEEEEEcccccccc-ccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEE
Confidence 48899999999999999998764 68899999986543222 23346889999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+||||+. ++|.+++... ...+++..+..++.||+.||.|||+.|++||||+|+||++ +.++.+||+|||++....
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcc
Confidence 9999996 5888877643 3568999999999999999999999999999999999999 667789999999987654
Q ss_pred CCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC---------
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD--------- 361 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~--------- 361 (492)
... ......++..|+|||++.+ .++.++|||||||++|+|+||+.||...........+.........
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 332 2233467889999998754 3688899999999999999999999876654443333221111000
Q ss_pred ----------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 362 ----------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 362 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
...+.++.++++||.+||+.||.+|||+++++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=341.26 Aligned_cols=255 Identities=29% Similarity=0.500 Sum_probs=212.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+.|+..+.||+|+||.||+|.+.. +++.||||.+..... ....+.+.+|+++++.+. ||||+++++++...+.+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCce
Confidence 457788899999999999998754 678999999865432 234567899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||+++++|.+.+.. +.+++..+..++.||+.||.|||++|++|+||+|+||++ ++++.++|+|||++..+.
T Consensus 78 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEcccccccccc
Confidence 999999999999987753 578999999999999999999999999999999999999 566789999999998765
Q ss_pred CCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.... .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||...........+...... .....++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPF 229 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHH
Confidence 3322 233468899999998764 5888999999999999999999999766555444443332211 1112567899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+||.+||..+|.+||++.++++||||....
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=338.05 Aligned_cols=260 Identities=31% Similarity=0.535 Sum_probs=214.7
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.|++.+.||.|+||.||+|+...+..+|..||+|++...... .....+.+.+|+.+++.+.+|+||+.++++++.++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999988765567899999999654322 1223456788999999997799999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||+|+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 9999999999999988654 578999999999999999999999999999999999999 567799999999998764
Q ss_pred CCC--CccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCCh----hHHHHHHHhcCCCCCCCCC
Q 011154 294 PDE--RLNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 294 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 364 (492)
... ......|+..|+|||.+.. .++.++|||||||++|+|++|..||..... .++...+......++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---- 232 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----
Confidence 432 2234568999999998753 467899999999999999999999964332 333333333333222
Q ss_pred CCCCHHHHHHHHHccccCcCCCC-----CHHHHhcCccccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~ 402 (492)
..++..+.+|+.+||..||.+|+ ++.+++.||||...+
T Consensus 233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 35788999999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=330.62 Aligned_cols=246 Identities=28% Similarity=0.459 Sum_probs=208.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||++.++. +..+|+|.+...... .+.+.+|+.+|+.+. ||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----QIKVAIKAINEGAMS----EEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----CceEEEEecccCCcc----HHHHHHHHHHHHHCC-CCCceeEEEEEccCCCE
Confidence 568899999999999999998753 457999998654322 356888999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+++|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++...
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccC
Confidence 99999999999999887655679999999999999999999999999999999999999 567789999999998654
Q ss_pred CCCCc--cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 294 PDERL--NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 294 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
..... ....++..|+|||++. ..++.++|||||||++|+|++ |+.||......+....+......... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~ 228 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASM 228 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCH
Confidence 33222 1234566899999876 468899999999999999999 99999888888888777765433222 24678
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.+|+.+||..||.+||++.++++
T Consensus 229 ~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 229 TVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 8999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=341.04 Aligned_cols=257 Identities=30% Similarity=0.441 Sum_probs=204.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC-
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD- 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~- 211 (492)
.++|++.+.||+|+||.||+|.... +++.||||.+....... .....+.+|+.+++++. ||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCC-CCCccceEEEEecccc
Confidence 3579999999999999999998665 78999999986543222 12234568999999995 999999999987654
Q ss_pred -------eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 212 -------NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 212 -------~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
..++||||+.+ +|.+.+......+++.+++.++.||+.||.|||++|++|+||||+||++ +.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~ 161 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLA 161 (310)
T ss_pred cccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEEC
Confidence 45999999965 8888877665579999999999999999999999999999999999999 667799999
Q ss_pred ecccccccCCCCC-----ccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 285 DFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 285 DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
|||++..+..... .....++..|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999986643221 234567889999998754 378899999999999999999999987765544443333221
Q ss_pred CCCCCCC----------------------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 358 SFDDGSW----------------------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 358 ~~~~~~~----------------------------~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.++...+ ...+..+.+||.+||..||.+|||++++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1111111 0135678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=329.34 Aligned_cols=254 Identities=31% Similarity=0.476 Sum_probs=213.2
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCC--CCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--TTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
+|+..+.||+|+||.||+|..+. ++..|++|.+..... ......+.+.+|+.+++.+ +|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCe
Confidence 47788999999999999998764 678999999865432 2234456789999999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceec
Confidence 99999999999999887654 568999999999999999999999999999999999999 56778999999998876
Q ss_pred CCCCCccccccCcccccccccc-CC-CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RPDERLNDIVGSAYYVAPEVLH-RS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
..........|+..|+|||.+. .. ++.++|+|||||++|+|++|..||...........+..... .......++.+
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 230 (258)
T cd06632 153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE--LPPIPDHLSDE 230 (258)
T ss_pred cccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc--CCCcCCCcCHH
Confidence 5444445667899999999765 34 78899999999999999999999977665444444433111 11223467899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
+.+|+.+||..+|.+||++.+++.|||+
T Consensus 231 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 231 AKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=348.77 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=208.1
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
+.++|++.+.||+|+||.||+|+... +|+.||||++.+... .......+.+|+.+++.+. |+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCC
Confidence 46889999999999999999998765 788999999865432 2234456778999999994 99999999998643
Q ss_pred -----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 211 -----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 211 -----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
...|+|||||.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~D 161 (353)
T cd07850 89 SLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 161 (353)
T ss_pred CccccCcEEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEcc
Confidence 357999999965 88887643 38999999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC------
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------ 358 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~------ 358 (492)
||++.............||..|+|||++. ..++.++|||||||++|+|++|+.||........+..+......
T Consensus 162 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 162 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998776554445567899999999875 45899999999999999999999999876654444433221100
Q ss_pred ----------------C---------CCCC--------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 359 ----------------F---------DDGS--------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 359 ----------------~---------~~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
. .... +...+.++++||.+||+.||++|||+.|+|.||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0 0000 1134567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=337.18 Aligned_cols=261 Identities=28% Similarity=0.460 Sum_probs=210.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|..+. +|+.||||.+....... ...+.+.+|+++++.+. ||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhccccc-cchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeE
Confidence 579999999999999999998764 68899999986543322 23356788999999994 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
|+||||++ ++|.+.+..... .+++..+..++.||+.||.|||++||+||||+|+||+++. .+..+||+|||++...
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAF 153 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEccccccccc
Confidence 99999996 488887755432 3688999999999999999999999999999999999952 3457999999999765
Q ss_pred CCCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC-------
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG------- 362 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~------- 362 (492)
.... ......|++.|+|||++.+ .++.++|||||||++|+|+||..||......+....+..........
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 4322 2234567899999998754 47889999999999999999999998776655554443211111110
Q ss_pred ------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 363 ------------------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 363 ------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..+.++.++.+||.+||+.||++||++.++++||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 1235788999999999999999999999999999998753
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=335.84 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=204.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
..+|.+.+.||+|+||.||+|.... +|..||||++....... ....+.+|+.+++.+. |+||+++++++.+.+.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTEEG--VPFTAIREASLLKGLK-HANIVLLHDIIHTKET 77 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCe
Confidence 4789999999999999999998765 67899999996543222 2235678999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.|+||||+. ++|.+.+......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAK 153 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEecccccccc
Confidence 999999996 68888776665678999999999999999999999999999999999999 56678999999998764
Q ss_pred CCCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChh-HHHHHHHhcC------------
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKAD------------ 356 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-~~~~~i~~~~------------ 356 (492)
.... ......++..|+|||++.+ .++.++|||||||++|+|++|..||.+.... +.+..+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 3222 2334567899999998754 4788999999999999999999999765432 2222211100
Q ss_pred --CCCCC------------CCCC--CCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 357 --PSFDD------------GSWP--SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 357 --~~~~~------------~~~~--~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
+.+.. ..|. ..+.++.+||.+||..||++|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 0011 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=335.70 Aligned_cols=253 Identities=20% Similarity=0.334 Sum_probs=212.3
Q ss_pred cceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
++|++.+.||+|+||.||+|...... .....||+|.+.... .......+.+|+.+++.+. ||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence 57889999999999999999876432 244789999986443 3344567899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC
Q 011154 212 NVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~ 276 (492)
..+++|||+++|+|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||+ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence 9999999999999999886531 458889999999999999999999999999999999999 5
Q ss_pred CCCcEEEEecccccccCCCC---CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHH
Q 011154 277 ESSQLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 351 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~ 351 (492)
+++.+||+|||++....... ......+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....++...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 66789999999998654332 123446788999999765 568999999999999999998 9999998888888777
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+....... ....++.++.+|+.+||+.||.+||++.+++++
T Consensus 239 i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 76544322 123688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=330.20 Aligned_cols=256 Identities=31% Similarity=0.486 Sum_probs=216.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|++|.||+|.... +++.||||++...... .....+.+|+.++..++ |+||+++++++...+.+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeE
Confidence 368899999999999999998765 6899999998765432 34567899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .|++||||+|+||++ +.++.++|+|||++...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVL 150 (264)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceec
Confidence 9999999999999988654 679999999999999999999999 999999999999999 66778999999999876
Q ss_pred CCCCCc-cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC---hhHHHHHHHhcCCCCCCCCCCC-
Q 011154 293 RPDERL-NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDDGSWPS- 366 (492)
Q Consensus 293 ~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~- 366 (492)
...... ....++..|+|||.+.. .++.++||||||+++|+|++|..||.... ..+....+....... ....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 227 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS---LPAEE 227 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC---CCccc
Confidence 544332 25678899999998764 57889999999999999999999997763 344444444322211 1123
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++..+.++|.+||..+|++||++.++++|||++...
T Consensus 228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 228 FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 788999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.53 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=213.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|.++....+...||||++.... .......+.+|+.+++.+. ||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence 57899999999999999999987544456789999986543 3334567889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+++|+|.+++....+.+++..+..++.|++.||.|||++||+||||||+|||+ ++++.+||+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence 99999999999999987766789999999999999999999999999999999999999 667789999999998775
Q ss_pred CCC-Cc--cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 294 PDE-RL--NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 294 ~~~-~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
... .. ....++..|+|||.+. ..++.++||||||+++|+|++ |..||+..........+....... ....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---PPMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence 211 11 1234567899999876 468899999999999999998 999998888777777776542221 123578
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..+.+|+.+||+.+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.29 Aligned_cols=259 Identities=30% Similarity=0.554 Sum_probs=214.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..+.|.....||+|+||.||++.... ++..||||.+.... ....+.+.+|+.+++.+. |+||+++++.+...+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~ 92 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKH---TGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGD 92 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECC---CCCEEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCC
Confidence 34556666789999999999998654 67899999985432 334566889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..|+||||+++++|.+++.. +.+++.++..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQ 167 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhh
Confidence 99999999999999887643 468999999999999999999999999999999999999 6667899999999876
Q ss_pred cCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 292 VRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 292 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
..... ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||........+..+........ .....++.
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 246 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-KDSHKVSS 246 (292)
T ss_pred cccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-ccccccCH
Confidence 53222 2234578999999998764 588999999999999999999999988777666655544322211 11235788
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
.+.+||.+||..||.+|||++++++||||+....
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 9999999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=363.32 Aligned_cols=265 Identities=21% Similarity=0.284 Sum_probs=198.1
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEE--------------EccCCCCCCHHHHHHHHHHHHHHHHcc
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIK--------------VIPKSKMTTAIAVEDVRREVKILRALS 195 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK--------------~i~~~~~~~~~~~~~~~~Ev~~l~~l~ 195 (492)
..+.++|++.+.||+|+||.||++.++.. .+..+++| ++.+...........+.+|+.+|+.|.
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~ 221 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRAS--TEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN 221 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEecc--chhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC
Confidence 45668999999999999999999876532 22222222 121111122234556889999999994
Q ss_pred CCCCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceE
Q 011154 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC----GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFL 271 (492)
Q Consensus 196 ~hpniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NIL 271 (492)
|||||++++++.+.+..|+|+|++. ++|.+++.... ......+++.|+.||+.||.|||++|||||||||+|||
T Consensus 222 -HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL 299 (501)
T PHA03210 222 -HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF 299 (501)
T ss_pred -CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9999999999999999999999995 57888775431 23456778899999999999999999999999999999
Q ss_pred eecCCCCCcEEEEecccccccCCCCC--ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCCh---
Q 011154 272 YTSKDESSQLKAIDFGLSDFVRPDER--LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTE--- 345 (492)
Q Consensus 272 l~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~--- 345 (492)
+ +.++.+||+|||++..+..... ....+||..|+|||++.+ .|+.++|||||||++|||++|..+++....
T Consensus 300 l---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 300 L---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred E---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 9 6677899999999987654332 234679999999998864 599999999999999999998865543221
Q ss_pred hHHHHHHHhcC----CCCCCC------------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcc
Q 011154 346 SGIFRAVLKAD----PSFDDG------------------------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397 (492)
Q Consensus 346 ~~~~~~i~~~~----~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 397 (492)
...+..+.... ..++.. ....++.++.++|.+||+.||.+|||+.|+|.|||
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 11222211110 000000 00135677889999999999999999999999999
Q ss_pred cccc
Q 011154 398 IRNY 401 (492)
Q Consensus 398 ~~~~ 401 (492)
|...
T Consensus 457 f~~~ 460 (501)
T PHA03210 457 FSAE 460 (501)
T ss_pred hhcC
Confidence 9864
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=330.48 Aligned_cols=253 Identities=26% Similarity=0.477 Sum_probs=209.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.+. +++.||||.+.............+.+|+++++.++ ||||+++++++.+.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeE
Confidence 579999999999999999999765 67899999987655445555667889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 214 YIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
++||||+++|+|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccce
Confidence 999999999999887753 23458999999999999999999999999999999999999 566789999999988
Q ss_pred ccCCCCC-ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDER-LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 366 (492)
....... .....|+..|+|||.+. ..++.++|||||||++|+|++|..||..... ......+.... +.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEH 232 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhh
Confidence 7653322 23457889999999875 4588899999999999999999999965432 33444433322 22222235
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++..+.+||.+||..+|.+||++.++++.
T Consensus 233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred cCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 77899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=335.24 Aligned_cols=254 Identities=27% Similarity=0.482 Sum_probs=208.9
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||.|++|.||+|+... +|+.||||++...... .....+.+|+.+++.+. |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDAEE--GTPSTAIREISLMKELK-HENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---CCeEEEEEEecccccc--cchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEE
Confidence 58899999999999999999764 6889999999755332 12345678999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 215 IVMELCEGGELLDRILSRC--GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++ ++++.++|+|||++...
T Consensus 75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAF 150 (284)
T ss_pred EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhh
Confidence 99999985 8888876543 468999999999999999999999999999999999999 66778999999999765
Q ss_pred CCCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC-------
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG------- 362 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~------- 362 (492)
.... ......++..|++||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..........
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 4322 2234567899999998754 47889999999999999999999998877666555443321111000
Q ss_pred ------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 363 ------------------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 363 ------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
..+.++.++.++|.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 012467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=346.55 Aligned_cols=259 Identities=32% Similarity=0.532 Sum_probs=207.2
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
+.++|++.+.||+|+||.||+|+... +|+.||||++.... .......+.+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeeccc
Confidence 46789999999999999999998764 78899999986422 2234456788999999995 99999999987654
Q ss_pred ----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEec
Q 011154 211 ----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 211 ----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
...|+|+||+.+ +|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~df 150 (336)
T cd07849 77 FESFNDVYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDF 150 (336)
T ss_pred ccccceEEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcc
Confidence 358999999965 88776643 479999999999999999999999999999999999999 66778999999
Q ss_pred ccccccCCCCC----ccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC---
Q 011154 287 GLSDFVRPDER----LNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP--- 357 (492)
Q Consensus 287 Gla~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~--- 357 (492)
|++........ .....||..|+|||.+. ..++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99876543221 23457899999999764 3588899999999999999999999976654333222211000
Q ss_pred --------------------CCCCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 --------------------SFDDG----SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 --------------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..... ..+.++.++.+||.+||+.||++|||+.++++||||+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 1235688899999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=355.35 Aligned_cols=258 Identities=23% Similarity=0.422 Sum_probs=218.2
Q ss_pred cce-eecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 134 SRL-EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 134 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.+| +...+||+|+|-+||+|.+. .+|..||--.++...+. .....+.|..|+.+|+.|. |||||++|++|.+..
T Consensus 39 gRy~k~~evLGrGafKtVYka~De---~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDE---EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTD 114 (632)
T ss_pred Cceeehhhhcccccceeeeecccc---ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCC
Confidence 344 34578999999999999864 47888886555433332 3445678999999999995 999999999999876
Q ss_pred e--EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 212 N--VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 212 ~--~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
+ +.+|+|++..|+|..++.+. ++++...++.|++||+.||.|||++. |||||||.+||+|+ +..+.|||+|+|
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLG 191 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLG 191 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchh
Confidence 6 88999999999999987654 78999999999999999999999996 99999999999997 667899999999
Q ss_pred cccccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCC-ChhHHHHHHHhcCCCCCCCCCCC
Q 011154 288 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 288 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
||+.+... ....++|||-|||||+....|+..+||||||+.|+||+|+..||... +...+++++..+...-.. ..-
T Consensus 192 LAtl~r~s-~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl--~kV 268 (632)
T KOG0584|consen 192 LATLLRKS-HAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL--SKV 268 (632)
T ss_pred HHHHhhcc-ccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh--hcc
Confidence 99988644 34458999999999999999999999999999999999999999764 456788888876543211 112
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
-.+++++||.+||.. .++|+|+.|+|.||||....
T Consensus 269 ~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 269 KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 367999999999999 99999999999999999753
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=334.19 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=212.5
Q ss_pred ccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|.+.+.||+|+||.||+|..... ..++..||||++.... .....+.+.+|+++|+.+. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence 35688999999999999999987543 2356889999986543 2334567899999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC
Q 011154 211 DNVYIVMELCEGGELLDRILSRC-------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~-------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~ 277 (492)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||+ +.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cC
Confidence 99999999999999999986542 347899999999999999999999999999999999999 66
Q ss_pred CCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHH
Q 011154 278 SSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 352 (492)
Q Consensus 278 ~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i 352 (492)
++.+||+|||++........ .....+++.|+|||++. +.++.++|||||||++|+|++ |..||......+....+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 68999999999976533221 12334678899999875 468999999999999999998 99999988888877777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 353 LKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 353 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
..+...... ..++..+.+||.+||..||.+||++.|+++
T Consensus 238 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 755433222 357899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=354.80 Aligned_cols=246 Identities=35% Similarity=0.537 Sum_probs=211.8
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.+.|++...+|.|+|+.|-.+..+. +++..+||++.+... +..+|+.++...++||||++++++|.+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccc---cccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCC
Confidence 457889999999999999988887665 788999999987632 2346888888888999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.+.|+|||++.||.|++.+... +....++..|+.+|+.++.|||++|||||||||+|||+. +..++++|+|||.++
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~--~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSK--PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWS 464 (612)
T ss_pred ceeeeeehhccccHHHHHHHhc--chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhh
Confidence 9999999999999999998765 333388889999999999999999999999999999995 356789999999998
Q ss_pred ccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChh-HHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 368 (492)
..... ..+.+-|..|.|||++. ..|+.+||+||||++||+||+|+.||...... ++...|..+... ..+|
T Consensus 465 ~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS 536 (612)
T KOG0603|consen 465 ELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVS 536 (612)
T ss_pred hCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccC
Confidence 87654 44567789999999987 46999999999999999999999999877665 555555443322 3799
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.++++||.+||++||.+|+++.+++.|||+
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 999999999999999999999999999999
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.88 Aligned_cols=254 Identities=29% Similarity=0.513 Sum_probs=212.5
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+-|++.+.||+|+||.||+|.... ++..||||++..... ......+.+|+.+++.+. ||||+++++++.+++.+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC---CCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeE
Confidence 347788899999999999998654 678999999865432 234467889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||+++++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||++ +.++.++|+|||++..+.
T Consensus 78 ~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecc
Confidence 999999999999988753 468999999999999999999999999999999999999 566789999999987664
Q ss_pred CCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
... ......|+..|+|||.+.. .++.++|||||||++|+|++|..||...........+...... .....++.++
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPL 229 (277)
T ss_pred cchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHH
Confidence 332 2233568899999998754 5788999999999999999999999876665555554433221 1123578899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.++|.+||..+|.+||++.++++||||.+.
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 230 KEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.71 Aligned_cols=249 Identities=32% Similarity=0.515 Sum_probs=211.7
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||.|+||.||++..+. +++.||+|.+..... ....+.+.+|+.+++.+. |+||+++++.+++.+.+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence 58899999999999999998764 688999999865432 234567889999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++....
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeec
Confidence 999999999999988653 3458999999999999999999999999999999999999 667789999999997764
Q ss_pred CCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.... .....|+..|+|||++.+ .++.++||||||+++|+|++|..||...........+........ ...++.++
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYEL 228 (255)
T ss_pred ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHH
Confidence 3322 234678999999998864 588899999999999999999999988777666666655443322 13578899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcC
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.+||.+||+.||.+|||+.+++.-
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.63 Aligned_cols=255 Identities=23% Similarity=0.345 Sum_probs=205.1
Q ss_pred ccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|.+++.||+|+||.||+|.+... ...+..||||++.... .....+.+.+|+++|+.+..|||||+++++|.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 46899999999999999999986432 1235679999996543 2334467899999999995599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC---------------------------------------------------------
Q 011154 211 DNVYIVMELCEGGELLDRILSRC--------------------------------------------------------- 233 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~--------------------------------------------------------- 233 (492)
+.+|||||||++|+|.+++..+.
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999999886431
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC
Q 011154 234 --------------------------------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK 275 (492)
Q Consensus 234 --------------------------------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~ 275 (492)
..+++.++..++.||+.||.|||+.+|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill--- 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL--- 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---
Confidence 247888899999999999999999999999999999999
Q ss_pred CCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHH
Q 011154 276 DESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 350 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~ 350 (492)
+.+..+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|+|++ |..||........+.
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 5667899999999986543322 22345678899999875 458999999999999999997 999997765443333
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 351 AVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 351 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.......... ....++.++.+++.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3323222221 22467899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=338.62 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=205.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|.++.+ .....+|+|.+... ........+.+|++++.++.+|+||+++++++.+.+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~-~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccC-CceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 36789999999999999999997642 12234677776432 2334556788999999999669999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC
Q 011154 213 VYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~ 277 (492)
+|+||||+++|+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cC
Confidence 999999999999999886542 257899999999999999999999999999999999999 66
Q ss_pred CCcEEEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhc
Q 011154 278 SSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 355 (492)
Q Consensus 278 ~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~ 355 (492)
++.+||+|||++.............++..|+|||++.+ .++.++|||||||++|+|+| |..||......+....+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 67899999999864322111122234667999998754 58889999999999999998 99999887777766665433
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 356 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
. .......++.++.+||.+||+.+|++||++.+++.+
T Consensus 240 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 Y---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred C---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 111223578899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.12 Aligned_cols=251 Identities=29% Similarity=0.434 Sum_probs=202.8
Q ss_pred eecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEE
Q 011154 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIV 216 (492)
Q Consensus 137 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv 216 (492)
.....||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++ |+||+++++++.+.+..++|
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLS---TQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred CceEEEecCCceEEEEeEecC---CCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEE
Confidence 334579999999999998754 67889999986542 334567899999999995 99999999999999999999
Q ss_pred EeecCCCchHHHHHhhCCCC--CHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 217 MELCEGGELLDRILSRCGKY--SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 217 ~E~~~ggsL~~~l~~~~~~~--~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+||+++++|.+.+......+ ++..+..++.||+.||.|||+.||+||||||+||+++. ....++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheeccc
Confidence 99999999999987665556 88999999999999999999999999999999999942 245899999999876543
Q ss_pred CCC-ccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCChhHH-HHHHHhcCCCCCCCCCCCCCH
Q 011154 295 DER-LNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 295 ~~~-~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~ 369 (492)
... .....|+..|+|||++.+ .++.++|||||||++|+|++|..||........ ...+.. ..........++.
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 239 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPEIPESLSA 239 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--hccCCCCCcccCH
Confidence 222 233468999999998753 378899999999999999999999965433211 111110 0111112235788
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
++.+|+.+||..+|.+|||+.+++.||||
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=334.57 Aligned_cols=256 Identities=36% Similarity=0.577 Sum_probs=208.8
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|.... +++.||||++..... .....+.+.+|+++++.+. |+||+++++++.+.+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEE
Confidence 479999999999999999998765 678999999865432 2233467889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||++++.+. .+..+...+++.++..++.||+.||.|||++||+||||+|+||++ +.++.+||+|||++....
T Consensus 76 ~iv~e~~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 76 YLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEEecCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccC
Confidence 9999999885554 444555679999999999999999999999999999999999999 667899999999998775
Q ss_pred CCC--CccccccCcccccccccc-C-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC-----------
Q 011154 294 PDE--RLNDIVGSAYYVAPEVLH-R-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----------- 358 (492)
Q Consensus 294 ~~~--~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~----------- 358 (492)
... ......++..|+|||++. . .++.++||||||+++|+|++|..||.+....+....+......
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 544 334567889999999875 3 5788999999999999999999999876654443333221100
Q ss_pred ---CC-----CC--------CCC-CCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 359 ---FD-----DG--------SWP-SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 359 ---~~-----~~--------~~~-~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
+. .. .++ .++.++.+||++||..+|++|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 00 011 248899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=343.46 Aligned_cols=256 Identities=24% Similarity=0.367 Sum_probs=204.9
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe-
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED- 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~- 209 (492)
.++|++.+.||+|+||.||+|+..+ +..+++.||+|++.... .....+.+.+|+.+++++.+|+||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3589999999999999999997643 22356899999986432 233455678899999999669999999998865
Q ss_pred CCeEEEEEeecCCCchHHHHHhhC--------------------------------------------------------
Q 011154 210 LDNVYIVMELCEGGELLDRILSRC-------------------------------------------------------- 233 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~-------------------------------------------------------- 233 (492)
+..++++|||+++|+|.+.+....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 457899999999999999886421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCC---ccccccCcc
Q 011154 234 ----GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAY 306 (492)
Q Consensus 234 ----~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~ 306 (492)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+..... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 257899999999999999999999999999999999999 5567899999999987643221 223456778
Q ss_pred cccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcC
Q 011154 307 YVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPR 384 (492)
Q Consensus 307 y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 384 (492)
|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+............ ....+.++.+++.+||+.+|+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChh
Confidence 99999765 569999999999999999997 99999875544444333332222111 125688999999999999999
Q ss_pred CCCCHHHHhcC
Q 011154 385 KRMTAAQALSH 395 (492)
Q Consensus 385 ~Rps~~e~l~h 395 (492)
+||++.++++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=333.36 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=218.7
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
......|+..+.||+|+||.||+++... ++..||||++.............+.+|+.+++.+. |||++++++++.+
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 96 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLR 96 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee
Confidence 3445568889999999999999998765 67899999997655545555667889999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
++..|+||||+.| +|.+.+......+++.++..++.||+.||.|||++||+||||+|+||++ +.++.+||+|||++
T Consensus 97 ~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~ 172 (317)
T cd06635 97 EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSA 172 (317)
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCc
Confidence 9999999999975 8888776666779999999999999999999999999999999999999 56678999999998
Q ss_pred cccCCCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
..... .....|+..|+|||.+. +.++.++|||||||++|+|++|..||...........+........ ...
T Consensus 173 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 247 (317)
T cd06635 173 SIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSN 247 (317)
T ss_pred cccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCc
Confidence 76543 23456899999999863 4588899999999999999999999988776666665555432211 123
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.++..+++||.+||..+|.+||++.++++|+|+....
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 5788999999999999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=334.48 Aligned_cols=254 Identities=34% Similarity=0.655 Sum_probs=218.9
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|.+.+.||+|+||.||++.... +++.||+|++.+...........+.+|+++++.+.+|+||+++++++.+.+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 478999999999999999998765 78999999997755545455577889999999995599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+.+++|.+.+.+. +.+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccC
Confidence 9999999999999988654 579999999999999999999999999999999999999 567789999999987664
Q ss_pred CCCC---------------------ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 011154 294 PDER---------------------LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 351 (492)
Q Consensus 294 ~~~~---------------------~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~ 351 (492)
.... .....|+..|+|||++. ..++.++||||||+++++|++|..||........+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 3221 12346789999999875 4578899999999999999999999988877666666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCH----HHHhcCccc
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTA----AQALSHPWI 398 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~----~e~l~hp~~ 398 (492)
+......++ ..+++.+.+||.+||+.||.+||++ .++++||||
T Consensus 234 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 665444333 3578999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.23 Aligned_cols=254 Identities=31% Similarity=0.503 Sum_probs=210.9
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--CeE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL--DNV 213 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~--~~~ 213 (492)
|++.+.||.|+||.||+|.... +++.||||++.... ........+.+|+.+++.+. |+||+++++++.+. +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcE
Confidence 6788999999999999998765 67899999997654 22233456788999999995 99999999999988 899
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+++ +|.+.+......+++..+..++.||+.||.|||+.|++|+||+|+|||+ ++++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYT 151 (287)
T ss_pred EEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeecc
Confidence 999999975 8888886655679999999999999999999999999999999999999 667889999999998765
Q ss_pred CCC--CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC----
Q 011154 294 PDE--RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP---- 365 (492)
Q Consensus 294 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---- 365 (492)
... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||...........+...........|+
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 443 2334567889999997653 47889999999999999999999998877766655554432222111111
Q ss_pred ----------------------C-CCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 366 ----------------------S-LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 366 ----------------------~-~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
. ++.++.++|.+||..+|.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 1 27889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=336.11 Aligned_cols=261 Identities=27% Similarity=0.428 Sum_probs=217.5
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
....+.|...+.||+|+||.||+|+... +++.||||++.............+.+|+++++.++ |||++++++++.+
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 92 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLK 92 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEe
Confidence 3444557778889999999999998654 68899999997665545555567889999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+..|+||||+. |+|.+.+......+++.++..++.||+.||.|||++||+||||+|+||++ +.++.+||+|||++
T Consensus 93 ~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~ 168 (313)
T cd06633 93 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSA 168 (313)
T ss_pred CCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCC
Confidence 999999999996 58888877666679999999999999999999999999999999999999 56678999999998
Q ss_pred cccCCCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
.... ......|+..|+|||++. +.++.++|||||||++|+|++|..||...........+...... .....
T Consensus 169 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 243 (313)
T cd06633 169 SKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQSN 243 (313)
T ss_pred cccC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCcc
Confidence 6543 223457899999999873 45888999999999999999999999887665555555443221 11223
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
.++..+++||.+||+.+|.+||++.+++.||||+....
T Consensus 244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 244 EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 56788999999999999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=334.59 Aligned_cols=261 Identities=30% Similarity=0.450 Sum_probs=211.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|.+.. +++.||||++.+.... .....+.+|+.++..+.+|+||+++++++.+...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3678999999999999999998764 5789999999754322 2345567788878777679999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.|+||||+. ++|.+.+......+++..+..++.||+.||.|||+ .||+||||+|+||++ +.++.+||+|||++..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchh
Confidence 999999985 47777666555679999999999999999999997 599999999999999 6677899999999987
Q ss_pred cCCCCCccccccCccccccccccC-----CCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHHHHhcCCCCCCCCCC
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-----SYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 365 (492)
+..........++..|+|||.+.+ .++.++|||||||++|+|++|+.||..... .+.+..+........ ....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 243 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNE 243 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCC
Confidence 654444444568889999998753 378899999999999999999999976332 334444443322111 1112
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
.++.++.+||.+||..||.+||++.+++.|||++....
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 47889999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.11 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=217.6
Q ss_pred ccceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
+.+.++.+.||+|+||.||+|+...-. ...+.||||.++... +.+...+|++|+++|..|+ |||||+|+|+|..+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCREG 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccC
Confidence 456777899999999999999876543 345789999996553 4557789999999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC---------C----CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC
Q 011154 211 DNVYIVMELCEGGELLDRILSRC---------G----KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~---------~----~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~ 277 (492)
+-+|+|+|||..|||.++|..+. . .++..+...|+.||+.|+.||-++.+|||||-..|+|| ++
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---cc
Confidence 99999999999999999997542 2 28899999999999999999999999999999999999 78
Q ss_pred CCcEEEEecccccccCCCCCcc---ccccCcccccccc-ccCCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHH
Q 011154 278 SSQLKAIDFGLSDFVRPDERLN---DIVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 352 (492)
Q Consensus 278 ~~~~kl~DfGla~~~~~~~~~~---~~~gt~~y~aPE~-~~~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i 352 (492)
+..|||+||||++.+-..+... ...-...||+||. +.+.|++++|||||||+|||+++ |+.||.+.+.++.++.|
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 8999999999998765444322 1223468999995 56899999999999999999998 99999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHh
Q 011154 353 LKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQAL 393 (492)
Q Consensus 353 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l 393 (492)
.++.. +..+ ..++.++.+|+..||+..|++||++.||-
T Consensus 719 ~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 88776 3222 37899999999999999999999999874
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.16 Aligned_cols=255 Identities=19% Similarity=0.317 Sum_probs=208.3
Q ss_pred cccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..++|++.+.||+|+||.||+|.++.. ...+..||||++.... ......++.+|+.+++.+. ||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 467899999999999999999987532 2346789999985432 2233456889999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRC---------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~ 280 (492)
....++||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+.|++||||||+|||+ ++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence 999999999999999999886532 235778899999999999999999999999999999999 56778
Q ss_pred EEEEecccccccCCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhc
Q 011154 281 LKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 355 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~ 355 (492)
+||+|||++......... ....++..|+|||++. +.++.++|||||||++|+|++ |..||.+.........+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998765432211 1234577899999876 458999999999999999999 78999887777766666554
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 356 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..... ...++..+.+||.+||+.||++|||+.+++++
T Consensus 238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32211 13578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=368.40 Aligned_cols=254 Identities=27% Similarity=0.390 Sum_probs=205.9
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|++.. +|+.||||++...........+.+.+|+++++.+. ||||+++++++.+.+..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEE
Confidence 589999999999999999998764 68899999997654444455667899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhh----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 214 YIVMELCEGGELLDRILSR----------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~----------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
|+|||||+||+|.+.+... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEE
Confidence 9999999999999988642 1235667889999999999999999999999999999999 66778999
Q ss_pred EecccccccCCCC-------------------CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCC
Q 011154 284 IDFGLSDFVRPDE-------------------RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWAR 343 (492)
Q Consensus 284 ~DfGla~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~ 343 (492)
+|||++....... .....+||+.|||||++.+ .++.++|||||||++|+|+||..||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999998662110 0123579999999998764 5889999999999999999999999775
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 344 TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
....+........+ .....+..+++.+.+++.+||..||++|++..+.+.+
T Consensus 235 ~~~ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54433322111111 1112234688999999999999999999887776654
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=330.93 Aligned_cols=256 Identities=31% Similarity=0.572 Sum_probs=214.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
..|...+.||+|++|.||++.... +++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKS---TGRQVAVKKMDLRK---QQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECC---CCCEEEEEEEeccc---hhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeE
Confidence 345556789999999999998654 67899999985432 23345688999999999 499999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++|+||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||++ +.++.++|+|||++....
T Consensus 92 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhc
Confidence 999999999999988765 579999999999999999999999999999999999999 667799999999887654
Q ss_pred CCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
... ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||...........+......... ....++..+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 245 (285)
T cd06648 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRL 245 (285)
T ss_pred cCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHH
Confidence 322 2234568999999998764 5889999999999999999999999887776666666554322221 123478899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+||.+||..+|++|||+.++++||||++..
T Consensus 246 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 9999999999999999999999999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=330.49 Aligned_cols=259 Identities=28% Similarity=0.474 Sum_probs=208.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--CC
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--LD 211 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--~~ 211 (492)
++|+..+.||.|++|.||++.... +++.||+|++..... ......+.+|+++++.+. ||||++++++|.+ .+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDPN--PDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---CCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCC
Confidence 468899999999999999999765 678999999875432 234567899999999995 9999999999865 34
Q ss_pred eEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 212 NVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
.+|+||||++|++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~ 151 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGV 151 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccc
Confidence 79999999999999887643 34568999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCC-----hhHHHHHHHhcCC-CCCC
Q 011154 289 SDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWART-----ESGIFRAVLKADP-SFDD 361 (492)
Q Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~-----~~~~~~~i~~~~~-~~~~ 361 (492)
+....... .....++..|+|||.+. ..++.++|||||||++|+|++|..||.... ..+....+..... .+..
T Consensus 152 ~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd06621 152 SGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230 (287)
T ss_pred cccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc
Confidence 87654322 22456788999999875 468899999999999999999999997652 2333333333211 1111
Q ss_pred CCC--CCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 362 GSW--PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 362 ~~~--~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
... ...++.+.+||.+||..+|.+|||+.|++.||||++..
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 110 13467899999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=347.80 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=216.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCc-cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEH-KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++..+.++||+|+||.||+|.++.... ....||||....+.......+.++.+|.++|++| +|||||++||+.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEE 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCC
Confidence 3556667999999999999999987533 1223999999765555677888999999999999 5999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
-+|||||+|.||+|.++|.+..+.++..+...++.+++.||+|||++++|||||-..|+|+ .....+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccC
Confidence 9999999999999999999887779999999999999999999999999999999999999 5555689999999876
Q ss_pred cCCCCCcc-ccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 292 VRPDERLN-DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 292 ~~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
........ ...-...|+|||.+. +-|+.++|||||||++||+.+ |..||.+....++...|.......... ...+
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p 389 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTP 389 (474)
T ss_pred CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCH
Confidence 54111111 112346799999886 569999999999999999999 889999999999999996655444333 2677
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.++..++.+|+..||++|||+.++.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH
Confidence 88999999999999999999998876
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=329.23 Aligned_cols=250 Identities=34% Similarity=0.579 Sum_probs=213.8
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecC
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ 221 (492)
||.|+||.||++++.. +|+.||+|++...........+.+.+|+++++.+. ||||+++++.+.+.+..|+||||++
T Consensus 1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCC
Confidence 6899999999998764 68899999997665544455677899999999995 9999999999999999999999999
Q ss_pred CCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCC-----
Q 011154 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE----- 296 (492)
Q Consensus 222 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~----- 296 (492)
+++|.+++... +.+++..+..++.||+.||.|||+.|++||||+|+||++ +.++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 77 GGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccc
Confidence 99999888654 479999999999999999999999999999999999999 667789999999987654331
Q ss_pred ----CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 297 ----RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 297 ----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
......++..|+|||.+. ..++.++||||||+++|+|++|..||......+.+..+......++.. ..++..+
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 230 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHH
Confidence 223456888999999875 458889999999999999999999998888888877776644443322 1358999
Q ss_pred HHHHHHccccCcCCCCCH---HHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRMTA---AQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~---~e~l~hp~~~~~ 401 (492)
.+||.+||+.+|.+|||+ .++|+||||++.
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 999999999999999999 999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=333.91 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=206.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.+.+. ....+++|.++.. ......+.+.+|+.++.++.+||||+++++++.+.+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-CcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 57999999999999999999876521 2345788887532 23334567889999999996699999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCC
Q 011154 214 YIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES 278 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~ 278 (492)
|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCC
Confidence 99999999999999986532 358899999999999999999999999999999999999 567
Q ss_pred CcEEEEecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcC
Q 011154 279 SQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 356 (492)
Q Consensus 279 ~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~ 356 (492)
..+||+|||++..............+..|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 789999999986432211111223355799999875 458999999999999999997 999998888777777665532
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 357 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.. .....++.++.+||.+||..+|.+|||++++++.
T Consensus 236 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 1223588999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=332.92 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=210.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||++.... +|+.||+|++.... .....+.+.+|+++++.+. ||||+++++++.+.+.+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEE
Confidence 678999999999999999998765 67899999986543 2334567899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
++||||+++|+|.+++... +.+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.++|+|||++...
T Consensus 79 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGEL 154 (284)
T ss_pred EEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccch
Confidence 9999999999998877553 679999999999999999999997 689999999999999 66778999999998755
Q ss_pred CCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChh-----------HHHHHHHhcCCCCC
Q 011154 293 RPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES-----------GIFRAVLKADPSFD 360 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-----------~~~~~i~~~~~~~~ 360 (492)
... ......|+..|+|||++. +.++.++|||||||++|+|++|..||...... +....+......
T Consensus 155 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 231 (284)
T cd06620 155 INS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP-- 231 (284)
T ss_pred hhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--
Confidence 322 223457999999999875 56888999999999999999999999764431 222333222111
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
......++.++.+||.+||..||.+|||+.|+++|+||.+..
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 111123778999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=326.93 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=208.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||.+.+.. +..||||.+..... ..+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPI 74 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCc
Confidence 568999999999999999997653 34699999865432 2356889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+.+|+|.+++......+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecC
Confidence 99999999999999887655579999999999999999999999999999999999999 566789999999988664
Q ss_pred CCCCc--cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 294 PDERL--NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 294 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
..... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||......+....+......+.. ...+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASE 228 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCH
Confidence 33221 1233567899999886 468899999999999999998 99999887777777777665433222 24678
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.+.+++.+||+.||.+||++.+++++
T Consensus 229 ~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 229 KVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=329.25 Aligned_cols=257 Identities=19% Similarity=0.310 Sum_probs=210.2
Q ss_pred ccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|.+.+.||+|+||.||+|.+... ...+..||+|.+.... .......+.+|+.+++.+. |+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 46799999999999999999987641 1256789999886433 2334456889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 DNVYIVMELCEGGELLDRILSRC------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+..++||||++||+|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||+...+....+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999887543 258999999999999999999999999999999999999755445679999
Q ss_pred ecccccccCCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCC
Q 011154 285 DFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 285 DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
|||+++.+...... ....++..|+|||++. ..++.++|||||||++|+|++ |..||......++...+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~- 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL- 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence 99999876322211 1223356799999875 569999999999999999997 99999888777776665543221
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.....++..+.+|+.+||+.+|++|||+.++++|
T Consensus 241 --~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 --DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1123678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=337.10 Aligned_cols=255 Identities=29% Similarity=0.573 Sum_probs=212.9
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
.|+....||+|+||.||++.... +++.||||++...... ..+.+.+|+.+++.+ +||||++++++|...+..|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELW 94 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcC---CCCEEEEEEEEecccc---hHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEE
Confidence 34455679999999999998654 6789999998654322 245688999999999 4999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+||||+++++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 95 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred EEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccc
Confidence 99999999999886643 468999999999999999999999999999999999999 6678999999999876543
Q ss_pred CC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 295 DE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 295 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
.. ......|+..|+|||++.+ .++.++|||||||++|+|++|..||......+....+...... ....+..++.++.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 248 (297)
T cd06659 170 DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLR 248 (297)
T ss_pred ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHH
Confidence 32 2334678999999998864 5889999999999999999999999877766666555433222 2223446788999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 373 DFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+||.+||+.+|.+||++.++++||||.+..
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 249 DFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 999999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=337.48 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=206.5
Q ss_pred cceeecceeccccceEEEEEEEecCC-ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGE-HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+|++.+.||+|+||.||+|++..+. ..+..||||++.... .....+++.+|+.+++.+ +||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-C
Confidence 57999999999999999999876422 224469999986432 334456788999999999 499999999999864 5
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++|+||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.+..+||+|||+++.+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence 789999999999999998766679999999999999999999999999999999999999 56678999999999877
Q ss_pred CCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 293 RPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 293 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
...... ....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....++...+ ........ .+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~--~~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQ--PPIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCC--CCCC
Confidence 543332 2233467899999875 568999999999999999997 99999877666554433 33322222 2357
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+.++.+++.+||..||.+||++.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=348.00 Aligned_cols=261 Identities=30% Similarity=0.510 Sum_probs=224.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+-|..++.||-|+||.||+++..+ +...||+|.+.+..+.....+..++.|-.||... +.+-||+||-.|.+.++
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCc
Confidence 3567888999999999999998654 6789999999988777777777899999999998 69999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+||+|++||++..+|... +-|.|..++.++..+.+|+++.|..|+|||||||+|||| |.+++|||.||||++-+
T Consensus 704 LYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred eEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccc
Confidence 99999999999999988765 789999999999999999999999999999999999999 88999999999998643
Q ss_pred C---------CCC----------------------------------CccccccCcccccccccc-CCCCCccchHHHHH
Q 011154 293 R---------PDE----------------------------------RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGV 328 (492)
Q Consensus 293 ~---------~~~----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGv 328 (492)
. .+. .....+||+.|+|||++. ..|+..||.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 2 000 012357999999999876 56999999999999
Q ss_pred HHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCC---HHHHhcCccccccc
Q 011154 329 IAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMT---AAQALSHPWIRNYN 402 (492)
Q Consensus 329 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~ 402 (492)
|||||+.|+.||.+.+..+....|.+....+...+...+|.++.+||.++++ +++.|.. ++|+..||||+...
T Consensus 860 il~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence 9999999999999988877766666555444445556899999999998774 6788874 67899999999753
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=330.82 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=209.9
Q ss_pred ccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
..+|.+.+.||+|+||.||++..... ..++..||+|.+... .......+.+|+.+++++. ||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence 35789999999999999999976432 234567999998643 2344567899999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCC
Q 011154 211 DNVYIVMELCEGGELLDRILSRC------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES 278 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~ 278 (492)
+.+++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 99999999999999999887542 248999999999999999999999999999999999999 667
Q ss_pred CcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHH
Q 011154 279 SQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 353 (492)
Q Consensus 279 ~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~ 353 (492)
+.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||......+....+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 7899999999986543321 12334577899999876 458899999999999999998 999998888777777776
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 354 KADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 354 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
....... ...++.++.+|+.+||+.||.+|||+.+++.
T Consensus 237 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6543221 1257889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=342.59 Aligned_cols=261 Identities=32% Similarity=0.514 Sum_probs=209.8
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
+..+|.+.+.||+|+||.||+++... +++.||||.+..... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecC---CCCeEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCccchHHheeccc
Confidence 45789999999999999999998654 789999999865432 222345677899999999 599999999988654
Q ss_pred ----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEec
Q 011154 211 ----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 211 ----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
...|+||||+. ++|.+.+... +.+++..+..++.||+.||.|||+++++||||||+||++ +.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Df 152 (337)
T cd07858 78 REAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDF 152 (337)
T ss_pred ccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcC
Confidence 35899999996 5888877543 679999999999999999999999999999999999999 56678999999
Q ss_pred ccccccCCC-CCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC-------
Q 011154 287 GLSDFVRPD-ERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD------- 356 (492)
Q Consensus 287 Gla~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~------- 356 (492)
|++...... .......|+..|+|||.+. ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 999876543 2334557899999999775 358899999999999999999999997665433322221100
Q ss_pred ----------------CCCC----CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 357 ----------------PSFD----DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 357 ----------------~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.... ...++.++.++.+||++||+.||++|||+.++++||||....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0000 112346889999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=328.68 Aligned_cols=252 Identities=25% Similarity=0.485 Sum_probs=208.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+++.+. ++..||||.+............++.+|+.+++.+ +|+||++++++|.+++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeE
Confidence 468899999999999999998765 6789999998765544445556788999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 214 YIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
++||||+++++|.+.+.. ....+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhh
Confidence 999999999999988753 23468999999999999999999999999999999999999 566789999999987
Q ss_pred ccCCCCC-ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDER-LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 366 (492)
....... .....|+..|+|||.+. ..++.++||||||+++|+|++|..||.+... ......+... .+....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDH 232 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCccc
Confidence 7643322 23457899999999875 4588899999999999999999999975543 2333333322 222223345
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++++||.+||..||.+|||+.++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 233 YSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 7889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=329.80 Aligned_cols=261 Identities=19% Similarity=0.321 Sum_probs=211.5
Q ss_pred cccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..++|++.+.||+|+||.||+|..+. ....+..||+|.+.... .......+.+|+.+++.+. ||||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 35789999999999999999997653 12245689999986443 2223345788999999994 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRC---------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~ 280 (492)
.+..|+||||+++|+|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCc
Confidence 999999999999999999986532 235677889999999999999999999999999999999 56778
Q ss_pred EEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhc
Q 011154 281 LKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 355 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~ 355 (492)
+||+|||+++....... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876543221 11234567899999875 568999999999999999998 78999887777776666544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc------Ccccccc
Q 011154 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS------HPWIRNY 401 (492)
Q Consensus 356 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~------hp~~~~~ 401 (492)
..... ...++..++++|.+||+.||++|||+.++++ ||||+..
T Consensus 238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 238 GYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 32211 1246789999999999999999999999987 8888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=326.29 Aligned_cols=254 Identities=29% Similarity=0.541 Sum_probs=212.1
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||++..+. +|..||+|.+....... ...+.+.+|+.+++.++ |+||+++++.+.+.+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEE
Confidence 58899999999999999999765 67889999986643322 23456789999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+|+||+++++|.+++....+ .+++..+..++.|++.||.|||+.+|+|+||||+||+++. ....+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhcc
Confidence 99999999999998876433 5899999999999999999999999999999999999942 22457999999998765
Q ss_pred CCCC-ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDER-LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.... .....|++.|+|||++. ..++.++|||||||++|+|++|..||...........+...... ...+.++.++
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDL 230 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHH
Confidence 4332 23346899999999875 45888999999999999999999999877666655555443322 1224678899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.++|.+||..+|++|||+.+++.||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=332.18 Aligned_cols=254 Identities=31% Similarity=0.465 Sum_probs=206.8
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
|++.+.||.|++|.||+|.++. +|..||||++....... .....+.+|+++++.+. ||||+++++++.+.+..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLETEDE-GVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---CCCEEEEEEeecccccc-cchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEE
Confidence 6778899999999999998765 68899999997554322 22345778999999995 9999999999999999999
Q ss_pred EEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 216 VMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
||||++ ++|.+++.... ..+++..+..++.||+.||.|||+++++||||+|+||++ +.++.++|+|||++.....
T Consensus 76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCC
Confidence 999995 58988876543 368999999999999999999999999999999999999 5577899999999976543
Q ss_pred CC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC-------------
Q 011154 295 DE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------- 358 (492)
Q Consensus 295 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~------------- 358 (492)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|..||...+.......+......
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 22 2233467889999998753 4788999999999999999999999877664444333321110
Q ss_pred ------------CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 359 ------------FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 359 ------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
......+.++.++.+||.+||+.||.+|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0011134577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=323.78 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=200.7
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|..+. +++.||+|.+.... .......+.+|+++++.+ +||||+++++++.+.+.+++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEec---CCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEee
Confidence 469999999999999765 67899999885432 334456789999999999 599999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCcc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLN 299 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~ 299 (492)
+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..........
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc
Confidence 99999999887665679999999999999999999999999999999999999 566789999999987654321111
Q ss_pred ---ccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011154 300 ---DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374 (492)
Q Consensus 300 ---~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 374 (492)
...++..|+|||.+. +.++.++|||||||++|+|++ |..||...........+...... .....++..+.+|
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 228 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRL 228 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHH
Confidence 112345699999875 458889999999999999997 99999877766665555543221 2223578999999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q 011154 375 VKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 375 i~~~L~~dP~~Rps~~e~l~ 394 (492)
+.+||+.||++|||+.++++
T Consensus 229 i~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=324.11 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=210.9
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|........+..||||++....... ..+.+.+|+++++.++ |+||+++++++.+...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 46999999999999987543447899999997654322 4677899999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 220 CEGGELLDRILSR--------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 220 ~~ggsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+++++|.+++... ...+++.+++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence 9999999998765 4679999999999999999999999999999999999999 6668999999999987
Q ss_pred cCCCC---CccccccCccccccccccC-CCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 292 VRPDE---RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 292 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
..... ......++..|+|||.+.. .++.++|||||||++|+|++ |..||......++...+...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence 75442 2334567889999998764 68899999999999999999 69999888877777777653221 12235
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++.++.+++.+||+.+|++|||+.|++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.89 Aligned_cols=261 Identities=31% Similarity=0.475 Sum_probs=203.5
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--Ce
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL--DN 212 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~--~~ 212 (492)
+|++.+.||+|+||.||+|..+.. ..++.||||++...........+.+.+|+.+++.+. ||||+++++++.+. +.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCce
Confidence 588999999999999999997642 257899999997643222223456788999999995 99999999999988 88
Q ss_pred EEEEEeecCCCchHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeec-CCCCCcEEEEecc
Q 011154 213 VYIVMELCEGGELLDRILSRC----GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS-KDESSQLKAIDFG 287 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~-~~~~~~~kl~DfG 287 (492)
+++||||+++ +|.+.+.... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999975 6777664321 36899999999999999999999999999999999999943 1127889999999
Q ss_pred cccccCCCCC----ccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhH---------HHHHH
Q 011154 288 LSDFVRPDER----LNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESG---------IFRAV 352 (492)
Q Consensus 288 la~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~---------~~~~i 352 (492)
++..+..... .....+|..|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987643322 234578899999997754 47889999999999999999999997654322 11111
Q ss_pred HhcCC---------------------CCCCCCC------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 353 LKADP---------------------SFDDGSW------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 353 ~~~~~---------------------~~~~~~~------------~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
..... ......+ ...+.++.++|.+||..||++|||+.|+++||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 10000 0000111 1567789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=320.10 Aligned_cols=252 Identities=35% Similarity=0.583 Sum_probs=212.3
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||++.... +++.|++|++..... .....+.+|+.+++.+. |+||+++++++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---CCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence 47888999999999999998765 678999999966543 34567899999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+++||+++++|.+.+......+++..+..++.|++.||.|||..|++||||+|+||++ +.++.++|+|||++.....
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeeccccccccc
Confidence 9999999999999887655689999999999999999999999999999999999999 5677899999999988765
Q ss_pred CCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011154 295 DERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKD 373 (492)
Q Consensus 295 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 373 (492)
........|+..|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+....... ......++..+.+
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG-LRNPEKWSDEFKD 229 (253)
T ss_pred cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC-cCcccccCHHHHH
Confidence 443455678999999998764 47889999999999999999999998775444443333322111 1111224889999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcc
Q 011154 374 FVKLLLNKDPRKRMTAAQALSHPW 397 (492)
Q Consensus 374 li~~~L~~dP~~Rps~~e~l~hp~ 397 (492)
+|.+||..||++|||+.++++|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.70 Aligned_cols=259 Identities=31% Similarity=0.539 Sum_probs=212.5
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC-HHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT-AIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+|++.+.||+|+||.||+++...+..+++.||||++.+..... ....+.+.+|+.++..+++||||+++++.+...+.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999877655678899999986543221 223456789999999997799999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||+.+|+|.+.+... ..+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 9999999999999988654 579999999999999999999999999999999999999 666789999999987754
Q ss_pred CCCC--ccccccCccccccccccCC---CCCccchHHHHHHHHHHhcCCCCCCCCCh----hHHHHHHHhcCCCCCCCCC
Q 011154 294 PDER--LNDIVGSAYYVAPEVLHRS---YGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 294 ~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~DvwSlGvil~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 364 (492)
.... .....|+..|+|||.+.+. .+.++||||||+++|+|++|..||..... .++...+...... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 232 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP----FP 232 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC----CC
Confidence 3322 2235689999999987542 67899999999999999999999954322 2333333333222 22
Q ss_pred CCCCHHHHHHHHHccccCcCCCCC---HHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMT---AAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~ 401 (492)
..++.++.+||.+||+.||++||| +.++|+||||+..
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 357889999999999999999998 5678999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=330.91 Aligned_cols=255 Identities=22% Similarity=0.379 Sum_probs=211.2
Q ss_pred ccceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++.+.||+|+||.||++..+... .....||+|.+.... .......+.+|+.+++.+.+|+||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 467999999999999999999876432 345789999986543 2334566889999999995699999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhh---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC
Q 011154 211 DNVYIVMELCEGGELLDRILSR---------------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK 275 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~ 275 (492)
+.+++||||+++|+|.+++..+ ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~--- 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--- 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence 9999999999999999988642 2468999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHH
Q 011154 276 DESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 350 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~ 350 (492)
+.++.+||+|||++..+..... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 5677899999999987654322 12233567899999865 568899999999999999997 999998887777776
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 351 AVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 351 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.+...... ......+.++.+|+.+||..||++|||+.+++++
T Consensus 246 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66544321 1223578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=333.94 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=215.7
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
......|...+.||+|+||.||+|+.+. ++..||||.+............++.+|+++++.+. |+|++++++++.+
T Consensus 11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 86 (308)
T cd06634 11 DDPEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR 86 (308)
T ss_pred CCcHHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEc
Confidence 4455668888999999999999999765 67899999987544444445567889999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+..++||||+. |+|.+.+......+++.++..++.|++.||.|||+.+++||||||+|||+ +.++.+||+|||++
T Consensus 87 ~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~ 162 (308)
T cd06634 87 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSA 162 (308)
T ss_pred CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccc
Confidence 999999999996 58888776655679999999999999999999999999999999999999 55678999999998
Q ss_pred cccCCCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
...... ....|+..|+|||.+. +.++.++|||||||++|+|++|..||......+....+....... ....
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 237 (308)
T cd06634 163 SIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSG 237 (308)
T ss_pred eeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC--cCcc
Confidence 766433 3456889999999863 457889999999999999999999998766555544444332211 1123
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.++..+.+||.+||..+|.+||++.++++|||+...
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 578899999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=325.61 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=210.8
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.+|++.+.||+|+||.||+|+++.....+..||+|.+.... .....+.+.+|+.+++.+. ||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence 57899999999999999999876544455689999986543 2334567899999999994 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||+++|+|.+++....+.+++.++..++.|++.||.|||++|++||||||+|||+ +.++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 99999999999999987766679999999999999999999999999999999999999 567789999999998765
Q ss_pred CCCCc----cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 294 PDERL----NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 294 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
..... ....++..|+|||.+. +.++.++|||||||++|++++ |..||......+....+..... . .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-L--PAPMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-C--CCCCCC
Confidence 43211 1122356899999886 468999999999999999886 9999988877777766655421 1 122357
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=321.39 Aligned_cols=253 Identities=31% Similarity=0.557 Sum_probs=217.2
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||.|+||.||++.+.. ++..||+|++...... ......+.+|+++++.+. |+|++++++.+...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEE
Confidence 58899999999999999999765 6789999999765432 344567889999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 215 IVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+|+||+++++|.+++... ...+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceee
Confidence 999999999999988765 3679999999999999999999999999999999999999 5667899999999987
Q ss_pred cCCCC-CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 292 VRPDE-RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 292 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
..... ......|++.|+|||.+. ..++.++||||+|+++|+|++|..||.......+...+........ ...++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI---PSQYSS 229 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCH
Confidence 65443 233457899999999765 4588899999999999999999999988877776666655432221 126789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
++.+++.+||..+|.+|||+.++|+||||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=328.76 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=208.8
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc--CCCCccEEEEEEEeCCe-
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS--GHSNLVKFYDAFEDLDN- 212 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~--~hpniv~l~~~~~~~~~- 212 (492)
|++.+.||+|+||.||+|+++. +++.||||++....... .....+.+|+.+++.++ +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---CCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 6788999999999999999764 68899999997544322 22345667888887774 59999999999998776
Q ss_pred ----EEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 213 ----VYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 213 ----~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
++++|||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.+++|+||+|+||++ +.++.+||+|||
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg 152 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFG 152 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccC
Confidence 9999999975 8888776543 369999999999999999999999999999999999999 666899999999
Q ss_pred cccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC------
Q 011154 288 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD------ 360 (492)
Q Consensus 288 la~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------ 360 (492)
++.............++..|+|||++. ..++.++|||||||++|+|++|..||......+.+..+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 153 LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred cceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 998776554445566889999999876 4588899999999999999999999988877766666544211100
Q ss_pred -----------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 361 -----------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 361 -----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
....+.++..+.+||.+||+.||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00012456788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.91 Aligned_cols=260 Identities=28% Similarity=0.525 Sum_probs=235.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++++.+..||-||||.|-++..+. ....+|+|++++...-+....+.+..|-.||...+ .|.||++|-.|.+...+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~---~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNS---QKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYV 495 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecc---cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhh
Confidence 455667789999999999998764 23358999999887777777788999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+.||-|-||+|+..+.++ +.|.+..++.++..+++|++|||++|||+|||||+|.|+ +.++.+||.|||+|+.+.
T Consensus 496 YmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhc
Confidence 9999999999999988766 789999999999999999999999999999999999999 888999999999999999
Q ss_pred CCCCccccccCcccccccc-ccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PDERLNDIVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~-~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
.+..+.+.|||+.|.|||+ +++..+.++|.||||+++||||+|++||.+.+.-..+..|+++.-....+ ..++..+.
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~ 649 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTAT 649 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHH
Confidence 9999999999999999996 46779999999999999999999999999999999999999876444332 36899999
Q ss_pred HHHHHccccCcCCCCC-----HHHHhcCcccccccc
Q 011154 373 DFVKLLLNKDPRKRMT-----AAQALSHPWIRNYNN 403 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~~~ 403 (492)
+||+++...+|.+|.. +.+|-+|.||.+++.
T Consensus 650 ~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 650 DLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred HHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 9999999999999986 899999999998753
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=325.79 Aligned_cols=252 Identities=20% Similarity=0.316 Sum_probs=207.4
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe---
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN--- 212 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~--- 212 (492)
|.+++.||+|+||.||.|....+...+..||||++..... .....+.+.+|+++++.+ +||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence 5678999999999999998876544568899999975433 234456789999999999 59999999998866544
Q ss_pred ---EEEEEeecCCCchHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 213 ---VYIVMELCEGGELLDRILSR-----CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 213 ---~~lv~E~~~ggsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.++||||+++|+|.+.+... ...+++..+..++.|++.||.|||+.||+||||||+||++ +++..+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence 89999999999999888543 1368999999999999999999999999999999999999 667789999
Q ss_pred ecccccccCCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCC
Q 011154 285 DFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 285 DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
|||+++.+...... ....++..|+|||.+. ..++.++|||||||++|||++ |..||.+....+.+..+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999876433221 1233567899999876 458899999999999999999 999998887777777666543221
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
....++.++.+++.+||..||.+|||+.+++++
T Consensus 236 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 123678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.91 Aligned_cols=254 Identities=26% Similarity=0.480 Sum_probs=209.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCC--CCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSK--MTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
.+|++.+.||+|+||.||++..+. +++.||+|++.... .........+.+|+.+++.++ |+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCC
Confidence 579999999999999999998764 78899999985432 123345567899999999995 99999999998764
Q ss_pred -CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 -DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
+.+++|+||+++++|.+++... +.+++..+..++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~ 153 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGAS 153 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccc
Confidence 5689999999999999988654 568999999999999999999999999999999999999 56678999999999
Q ss_pred cccCCC----CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 290 DFVRPD----ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 290 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
...... .......|+..|+|||++.+ .++.++|||||||++|+|++|..||...........+...... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK--PMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC--CCCC
Confidence 765321 12234568999999998764 4888999999999999999999999876655554444432211 2223
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
..+++++.++|.+||. +|..||++.++++|||+
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 4688999999999998 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=327.83 Aligned_cols=249 Identities=30% Similarity=0.504 Sum_probs=204.0
Q ss_pred eecceeccccceEEEEEEEe-cCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 137 EVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 137 ~~~~~lG~G~fg~V~~~~~~-~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
++.+.||.|.||.||+|.++ .....+..|+||.+... ......+.+.+|+++++++ +||||+++++++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence 46789999999999999998 44556889999999442 2344577899999999999 59999999999998888999
Q ss_pred EEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 216 VMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
|||||++|+|.+++... ...+++.++..|+.||+.||.|||+++|+|+||+++|||+ +.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 99999999999999876 5679999999999999999999999999999999999999 5567999999999987733
Q ss_pred CCCc---cccccCccccccccccC-CCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 295 DERL---NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 295 ~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.... ....+...|+|||.+.. .++.++||||||+++|||++ |+.||......++...+....... ....++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhH
Confidence 2221 23456778999999864 58999999999999999999 789998888888777775543322 1235789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+.++|.+||..||++|||+.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=337.90 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=211.4
Q ss_pred ccccceee-cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHH-----------HHHHHHHHHHHHHHccCCC
Q 011154 131 EVTSRLEV-GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAI-----------AVEDVRREVKILRALSGHS 198 (492)
Q Consensus 131 ~~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~-----------~~~~~~~Ev~~l~~l~~hp 198 (492)
.+.++|.. .+.||.|+||.||+|+.+. +++.||||++......... ....+.+|+++++.+. |+
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ 80 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HE 80 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Cc
Confidence 45677875 5779999999999998664 6889999998654322100 0124678999999995 99
Q ss_pred CccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCC
Q 011154 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES 278 (492)
Q Consensus 199 niv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~ 278 (492)
||+++++++...+..++||||+. |+|.+.+... ..+++..+..++.||+.||.|||+.||+||||+|+|||+ +.+
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~ 155 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSK 155 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCC
Confidence 99999999999999999999997 5888887543 579999999999999999999999999999999999999 666
Q ss_pred CcEEEEecccccccCC---------------CCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCC
Q 011154 279 SQLKAIDFGLSDFVRP---------------DERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFW 341 (492)
Q Consensus 279 ~~~kl~DfGla~~~~~---------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~ 341 (492)
+.+||+|||++..... ........++..|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 7899999999876541 111223457889999998754 37889999999999999999999998
Q ss_pred CCChhHHHHHHHhcCCCCCCC------------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcc
Q 011154 342 ARTESGIFRAVLKADPSFDDG------------------------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397 (492)
Q Consensus 342 ~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 397 (492)
+....+.+..+.......... ..+..+.++.+||.+||..||++|||++|+|.|||
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred CCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 887766665554322111111 11345788999999999999999999999999999
Q ss_pred ccccc
Q 011154 398 IRNYN 402 (492)
Q Consensus 398 ~~~~~ 402 (492)
|+...
T Consensus 316 ~~~~~ 320 (335)
T PTZ00024 316 FKSDP 320 (335)
T ss_pred cCCCC
Confidence 99764
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=327.52 Aligned_cols=253 Identities=20% Similarity=0.335 Sum_probs=209.3
Q ss_pred cceeecceeccccceEEEEEEEec-CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
++|++.+.||+|+||.||+|.+.. +...+..||+|.+.... .......+.+|+.+++.++ ||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 578899999999999999998642 22356889999996432 3345567889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC
Q 011154 213 VYIVMELCEGGELLDRILSRC----------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~----------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~ 276 (492)
.|+||||+++|+|.+++..+. ..+++.++..++.||+.||.|||++||+||||||+|||+ +
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence 999999999999999885331 247889999999999999999999999999999999999 5
Q ss_pred CCCcEEEEecccccccCCCC---CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHH
Q 011154 277 ESSQLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 351 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~ 351 (492)
.+..+||+|||+++...... ......++..|+|||++. +.++.++|||||||++|+|++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 66789999999998764332 123345677899999875 558999999999999999998 9999988777666666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+...... ..+..++..+.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6543322 2234678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=332.54 Aligned_cols=255 Identities=22% Similarity=0.375 Sum_probs=209.1
Q ss_pred ccceeecceeccccceEEEEEEEecCC----ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE----HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.++|.+++.||+|+||.||++++.... ..+..||+|.+.... .......+.+|+.+++.+.+||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 478999999999999999999865321 234679999997543 23345678889999999966999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
..+..|+||||+++|+|.+++..+. ..+++.++..++.||+.||.|||++|++||||||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 173 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 173 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE-
Confidence 9999999999999999999997542 248899999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+.++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 174 --~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 174 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred --cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 5667899999999876643221 11223456899999876 458899999999999999998 8899988777666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
...+..... . .....++.++++||.+||..+|.+|||+.+++++
T Consensus 252 ~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 666654432 1 1223678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=339.25 Aligned_cols=260 Identities=29% Similarity=0.510 Sum_probs=212.5
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|.+.+.||+|+||.||++.... ++..||||++.+.. ........+.+|+.+|+.+. ||||+++++++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 85 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTP 85 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECC---CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecC
Confidence 4467899999999999999999998664 68899999986532 23334456889999999995 9999999999976
Q ss_pred CC------eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 210 LD------NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 210 ~~------~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
+. .+++||||+ |++|.+.+.. ..+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl 159 (343)
T cd07880 86 DLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKI 159 (343)
T ss_pred CccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEE
Confidence 54 469999999 6788876643 479999999999999999999999999999999999999 56678999
Q ss_pred EecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC--
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF-- 359 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~-- 359 (492)
+|||++..... ......+++.|+|||.+.+ .++.++|||||||++|+|++|..||........+..+.......
T Consensus 160 ~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 160 LDFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred eeccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999986543 2334568899999998764 47889999999999999999999998776555444443321110
Q ss_pred ---------------------C----CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 360 ---------------------D----DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 360 ---------------------~----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
. ...++.++.++.++|.+||+.||.+|||+.+++.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 012346788999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=323.88 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=207.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.+. |+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN----NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec----CCceEEEEEccCCch----hHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCC
Confidence 367999999999999999999864 356799999865332 3467889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+++||||||+||++ +.++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARV 152 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCcccee
Confidence 99999999999999988754 3568999999999999999999999999999999999999 6677899999999987
Q ss_pred cCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
...... .....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+..... ......+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (261)
T cd05072 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---MPRMENC 229 (261)
T ss_pred cCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCC
Confidence 653322 12234567899999875 458889999999999999998 9999988877777776655432 1223468
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+.++.+||.+||..+|++||+++++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=333.22 Aligned_cols=259 Identities=30% Similarity=0.485 Sum_probs=210.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|..+. +|+.||||++....... .....+.+|+++++.++ ||||+++++++.+.
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~ 78 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNEKE-GFPITAIREIKILRQLN-HRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCC-CCCeeeeeheecCc
Confidence 345789999999999999999999765 67899999996543221 22345778999999995 99999999998765
Q ss_pred C----------eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCc
Q 011154 211 D----------NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 211 ~----------~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~ 280 (492)
. .+++|+||+++ +|.+.+......+++..+..++.||+.||.|||+.||+||||||+||++ ++++.
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~ 154 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQ 154 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCc
Confidence 5 79999999986 7777776655679999999999999999999999999999999999999 66778
Q ss_pred EEEEecccccccCCCCC--ccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC
Q 011154 281 LKAIDFGLSDFVRPDER--LNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 356 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~ 356 (492)
+||+|||++........ .....++..|+|||.+.+ .++.++|||||||++|+|++|+.||......+.+..+....
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999999987654331 223456788999997753 47889999999999999999999998766655554444321
Q ss_pred CCCCC--------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 357 PSFDD--------------------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 357 ~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
..... ..+..++..+.+||.+||..||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 11100 1123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=327.74 Aligned_cols=261 Identities=28% Similarity=0.493 Sum_probs=218.8
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
....+.|++.+.||+|+||.||++.+.. ++..||+|++..... ..+.+.+|+++++.+. |+||+++++++..
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 86 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLV 86 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEE
Confidence 4566789999999999999999998764 678899999965432 4566889999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+..|+|+||++|++|.+++......+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchh
Confidence 999999999999999999987764489999999999999999999999999999999999999 56678999999998
Q ss_pred cccCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 290 DFVRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 290 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
....... ......++..|+|||++.+ .++.++|||||||++|+|++|..||...........+...... .......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 242 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKW 242 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhC
Confidence 7654332 2234468889999998754 5889999999999999999999999877665555544433221 11122347
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+.++++||.+||+.+|.+|||+.++++|+||++..
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 88999999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=332.77 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=212.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||++.... ++..||+|.+..... ...+.+.+|+.+++.++ ||||++++++|...+.
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-HPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccccc---hHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCc
Confidence 4789999999999999999998654 678899999854322 23456889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.|+|+||+++++|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecc
Confidence 9999999999999998864 368999999999999999999999999999999999999 56678999999998765
Q ss_pred CCCCC-ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RPDER-LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
..... .....|++.|+|||.+. +.++.++|||||||++|+|++|..||...........+.... ......+..++..
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAI 244 (293)
T ss_pred cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHH
Confidence 44332 33457899999999875 458889999999999999999999997765544333222211 1111223457889
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+++||.+||..+|.+||++.+++.|+||+...
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=324.16 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=206.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.+|++.+.||+|+||.||++.++ .+..+|||++.+.... ...+.+|+++++.+. ||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR----GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec----CCccEEEEEeccCCCC----HHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCce
Confidence 45889999999999999999764 3467999998654332 245778999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||++|++|.+++..+...+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVL 151 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecc
Confidence 99999999999999987766679999999999999999999999999999999999999 667789999999997664
Q ss_pred CCCCcc--ccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 294 PDERLN--DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 294 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
...... ...++..|+|||.+. ..++.++|||||||++|+|++ |..||......+....+...... .....++.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---YRPKLAPT 228 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCH
Confidence 322211 122345799999876 568899999999999999999 89999887777777666544221 12235789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++.+++.+||..+|++|||+.++++.
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=324.59 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=210.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
..|++.+.||+|+||.||+|.++.....+..||||++.... .......+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence 46899999999999999999987654455689999986542 3445567999999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+++|+|.+++....+.+++.++..++.|++.||.|||++|++||||||+|||+ +.+..+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence 99999999999999887766779999999999999999999999999999999999999 667789999999987664
Q ss_pred CCCCc---cccc---cCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 294 PDERL---NDIV---GSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 294 ~~~~~---~~~~---gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
..... .... ++..|+|||.+. +.++.++|||||||++|||++ |..||+.....+....+.... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY---RLPPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---cCCCcc
Confidence 33221 1111 245799999876 468899999999999999886 999999888777777664332 112224
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.++..+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=313.96 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=204.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL-- 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~-- 210 (492)
.++|++.+.||+|||+.||++. +..++..||+|.|.... ....+...+|++..+++ +||||++++++...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~---~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVK---GLSTGHLYALKKILCHS---QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEK 92 (302)
T ss_pred CceEEEeeeecCCCceeeeeec---ccCcccchhhheeeccc---hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhc
Confidence 5799999999999999999997 45588999999995543 45677899999999999 599999999886432
Q ss_pred ---CeEEEEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCcEE
Q 011154 211 ---DNVYIVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 211 ---~~~~lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~~k 282 (492)
...||+++|...|+|++.+... +..++|.++..|+.+|++||++||+.. ++||||||.|||+ .+.+.++
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~v 169 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLPV 169 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCceE
Confidence 3599999999999999998643 346999999999999999999999998 9999999999999 4567899
Q ss_pred EEecccccccCCCC----------CccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChh--
Q 011154 283 AIDFGLSDFVRPDE----------RLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTES-- 346 (492)
Q Consensus 283 l~DfGla~~~~~~~----------~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-- 346 (492)
|.|||.++...-.- ....-..|..|+|||.+. ...+.++|||||||+||.|+.|..||......
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 99999987653211 111235788999999885 23678999999999999999999999432221
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 347 GIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 347 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.+.-++..+...++.. ..+|+.+.+||+.||++||.+||++.+++.+
T Consensus 250 SlaLAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1222344444555444 3589999999999999999999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.92 Aligned_cols=260 Identities=32% Similarity=0.546 Sum_probs=208.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe---
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--- 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--- 209 (492)
.++|++.+.||+|+||.||+|..+. +|+.||+|++...... ......+.+|+.+|+.+. ||||++++++|..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEecccccc-ccchHHHHHHHHHHHhcC-CCCccCHHHhccccCC
Confidence 4789999999999999999998765 6889999999754322 223456778999999995 9999999998863
Q ss_pred -CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 210 -LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 210 -~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~ 153 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGM 153 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccc
Confidence 357899999995 5888877544 569999999999999999999999999999999999999 6678899999999
Q ss_pred ccccCCCCC-----ccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhc------
Q 011154 289 SDFVRPDER-----LNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA------ 355 (492)
Q Consensus 289 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~------ 355 (492)
+........ .....|+..|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 976543221 234578999999998753 4889999999999999999999999766543332222211
Q ss_pred -----------------CCCCCCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 356 -----------------DPSFDDG----SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 356 -----------------~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
....... .++.++.++.+||++||+.||.+|||+.+++.||||.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0111111 1245789999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=323.75 Aligned_cols=247 Identities=22% Similarity=0.358 Sum_probs=208.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.+|.+.+.||+|+||.||+|.++. .++.||+|++.... .....+.+|+++++.+. |+||+++++++..++.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCc
Confidence 568899999999999999999875 67899999986432 23467889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||+ ++++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 154 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCcccccc
Confidence 99999999999999886543 458999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCCCcc--ccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 293 RPDERLN--DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 293 ~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
....... ...++..|+|||.+. ..++.++|||||||++|+|++ |..||.+....+.+..+..... ......++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCP 231 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCC
Confidence 5432211 223456799999876 458889999999999999998 9999988877777776655322 12224678
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.++.+||.+||..||++|||+.++++
T Consensus 232 ~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 232 PKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=339.97 Aligned_cols=259 Identities=32% Similarity=0.517 Sum_probs=208.0
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
+..+|.+.+.||.|+||.||+|..+. +|+.||+|.+..... ...+.+.+|+++++.+ +||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTDP---QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSG 75 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCCC---chHHHHHHHHHHHHhc-CCCcchhhHhhhcccc
Confidence 35789999999999999999998764 788999999865443 3346688999999999 499999999876643
Q ss_pred -------------CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC
Q 011154 211 -------------DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277 (492)
Q Consensus 211 -------------~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~ 277 (492)
...|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. .
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~ 150 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--E 150 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--C
Confidence 36899999997 488877643 47999999999999999999999999999999999999952 3
Q ss_pred CCcEEEEecccccccCCCCC----ccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 011154 278 SSQLKAIDFGLSDFVRPDER----LNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 351 (492)
Q Consensus 278 ~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~ 351 (492)
+..+||+|||++..+..... .....|+..|+|||++. ..++.++|||||||++|+|++|+.||.+....+....
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 230 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 45799999999976543221 12346888999999764 3488899999999999999999999987766555444
Q ss_pred HHhcCCCCC--------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 352 VLKADPSFD--------------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 352 i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+....+... ....+.++.++.+||.+||..||.+|||+.++|.||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 433211100 001235788999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=329.39 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=208.3
Q ss_pred ccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|.+.+.||+|+||.||++.+... ...+..||||++..... ....+.+.+|+.+++++.+||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 46799999999999999999986431 23567899999865432 334567899999999995699999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
+..|+||||+.+|+|.+++.... ..+++.++..++.||+.||.|||+++|+|+||||+|||+ +.+..+||+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence 99999999999999999887543 348999999999999999999999999999999999999 56678999999999
Q ss_pred cccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 290 DFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 290 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
........ .....++..|+|||.+. +.++.++||||+||++|+|++ |..||......+.+........... ..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 266 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--QP 266 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--CC
Confidence 86643322 12234677899999875 458899999999999999998 9999987666555544443322221 22
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
...+.++.+|+.+||..+|++|||+.+++.
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.44 Aligned_cols=252 Identities=26% Similarity=0.482 Sum_probs=208.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|.... +|+.||+|.++..........+.+.+|+++++++ +|+||+++++++.+.+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeE
Confidence 579999999999999999998764 6889999998765444445567789999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 214 YIVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.||+||||+|+||++ +.++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceee
Confidence 9999999999999887542 3458999999999999999999999999999999999999 567789999999987
Q ss_pred ccCCCC-CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 366 (492)
...... ......|+..|+|||.+. ..++.++|||||||++|+|++|..||..... ......+.... +.......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADH 232 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--CCCCChhh
Confidence 664332 223456899999999875 4588999999999999999999999965432 22333333322 12222236
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++.++|.+||..+|.+|||+.++++
T Consensus 233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=330.31 Aligned_cols=255 Identities=21% Similarity=0.359 Sum_probs=211.1
Q ss_pred ccceeecceeccccceEEEEEEEec----CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK----GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
..+|.+.+.||+|+||.||+|++.. ....+..||+|.+.... .......+.+|+.+++.+.+||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 5789999999999999999998642 22345689999986432 23345678999999999966999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
..+..|+||||+++|+|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili- 170 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV- 170 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence 9999999999999999999987542 247888999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+.++.+||+|||+++.+..... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....++
T Consensus 171 --~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 171 --TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred --cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 5667899999999987643322 22334667899999876 458999999999999999998 8899988888887
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
...+....... ....++.++++||.+||..+|.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 77765543221 123678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=318.54 Aligned_cols=253 Identities=32% Similarity=0.520 Sum_probs=212.3
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--Ce
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL--DN 212 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~--~~ 212 (492)
+|.+.+.||+|++|.||+|.... +++.|++|++...... ....+.+.+|+.+++++. |+||+++++.+.+. +.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---CCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCe
Confidence 47888999999999999998764 6889999999665432 345677899999999995 99999999999988 89
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+++|+||+++++|.+++.+. ..+++.++..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEec
Confidence 99999999999999988665 489999999999999999999999999999999999999 55678999999999887
Q ss_pred CCCCC---ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC-hhHHHHHHHhcCCCCCCCCCCCC
Q 011154 293 RPDER---LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 293 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
..... .....++..|+|||.+.. .++.++||||||+++|+|++|..||.... .......+... .........+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 229 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHL 229 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCccc
Confidence 65543 445678999999998764 48899999999999999999999997765 22222222211 1111222356
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
+.++.+||.+||..||.+||++.+++.||||
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=328.06 Aligned_cols=253 Identities=19% Similarity=0.301 Sum_probs=210.4
Q ss_pred cceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.+|++.+.||+|+||.||+|.+... ...++.||||++.... .....+.+.+|+.++..+. ||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence 4688899999999999999987542 2346789999996443 2334566889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhh---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC
Q 011154 212 NVYIVMELCEGGELLDRILSR---------------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~ 276 (492)
..++++||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||+ +
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence 999999999999999988532 1347889999999999999999999999999999999999 5
Q ss_pred CCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHH
Q 011154 277 ESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 351 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~ 351 (492)
++..+||+|||+++....... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+....++...
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 667899999999886543322 22345678999999864 568999999999999999998 8889988888888887
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+........ ...++.++.+|+.+||+.+|.+||++.+++..
T Consensus 239 i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 776554322 23688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=338.34 Aligned_cols=263 Identities=30% Similarity=0.496 Sum_probs=211.5
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|.+.. +|+.||||++.+... .......+.+|+.+++++.+||||++++++|..
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence 3467889999999999999999998764 678999999865322 223345677899999999559999999999865
Q ss_pred C--CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 210 L--DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 210 ~--~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
. ..+|+||||+.+ +|.+.+... .+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g 152 (337)
T cd07852 79 ENDKDIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFG 152 (337)
T ss_pred CCCceEEEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeecc
Confidence 3 468999999974 888877543 78999999999999999999999999999999999999 677899999999
Q ss_pred cccccCCCC------CccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC--
Q 011154 288 LSDFVRPDE------RLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP-- 357 (492)
Q Consensus 288 la~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~-- 357 (492)
++....... ......||..|+|||++. ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 998664332 223457899999999774 3478899999999999999999999977655443333222111
Q ss_pred -------------------------CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 -------------------------SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 -------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.......+.++.++.+||.+||+.||.+|||+.++++|||+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 111112345788999999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=363.41 Aligned_cols=149 Identities=30% Similarity=0.522 Sum_probs=134.7
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|.+.+.||+|+||.||+|++.. +++.||||++.+...........+.+|+.+++.+. ||||+++++++...+.+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNV 79 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEE
Confidence 689999999999999999999765 68899999998766555556677899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
|||||||.|++|.+++... +.+++..++.|+.||+.||.|||.+|||||||||+|||+ +.++.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999999999987543 678999999999999999999999999999999999999 566789999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.06 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=210.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|+..+.||+|+||.||+|..+........||||.+.... .....+.+.+|+++++.+. |+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCC
Confidence 357888999999999999999987544345689999986543 2334567889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.|+||||+++++|.+++....+.+++..+..++.|++.||.|||+.|++||||||+||++ +.+..+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 999999999999999887766789999999999999999999999999999999999999 56778999999998766
Q ss_pred CCCCCc--c--ccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 293 RPDERL--N--DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 293 ~~~~~~--~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
...... . ....+..|+|||++. +.++.++|||||||++|+|++ |..||+.....+....+...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~ 234 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---PAPMD 234 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC---CCCCC
Confidence 432211 1 122345799999875 468899999999999999997 99999988887777777654322 12235
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++.+|+.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=328.06 Aligned_cols=254 Identities=35% Similarity=0.512 Sum_probs=208.8
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
|++.+.||+|+||.||+|+... +++.||||++....... ......+|+..++++.+|+||+++++++.+++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 6788999999999999999765 67899999986543221 222345799999999669999999999999999999
Q ss_pred EEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 216 VMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
||||+ +|+|.+.+.... ..+++..+..++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccC
Confidence 99999 779998887653 478999999999999999999999999999999999999 6678999999999987765
Q ss_pred CCCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC-----------
Q 011154 295 DERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD----------- 361 (492)
Q Consensus 295 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~----------- 361 (492)
........|+..|+|||++. ..++.++||||||+++|+|++|..||......+.+..+.........
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 54555567899999999874 34788999999999999999999999777665554443321111100
Q ss_pred ---------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 362 ---------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 362 ---------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
...+..+.++.+||.+||..||++|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0112346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=331.02 Aligned_cols=266 Identities=30% Similarity=0.484 Sum_probs=213.9
Q ss_pred cCCccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-C----Cc
Q 011154 126 FGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-S----NL 200 (492)
Q Consensus 126 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-p----ni 200 (492)
+.....+..+|.+...||+|.||.|..+.+.. ++..||||+++.-. ...+..+-|+++|.+|..+ | -+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 34456778999999999999999999998765 48999999995322 2344567799999999422 2 37
Q ss_pred cEEEEEEEeCCeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC---
Q 011154 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD--- 276 (492)
Q Consensus 201 v~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~--- 276 (492)
|.+.++|+-.++.+||+|.+ |-|++|++.++ ..+++..+++.+..||+++++|||+.+++|-||||+|||+.+.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 88889999999999999998 56999999764 45699999999999999999999999999999999999996432
Q ss_pred --------------CCCcEEEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCC
Q 011154 277 --------------ESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFW 341 (492)
Q Consensus 277 --------------~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~ 341 (492)
.+..|+|+|||.|++... ....++.|..|+|||++.+ .|+..|||||+||||+||.||...|.
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 245799999999988643 3477899999999998765 79999999999999999999999998
Q ss_pred CCChhH---HHHHHHhcCCCC-------------CCCCCCCC--------------------------CHHHHHHHHHcc
Q 011154 342 ARTESG---IFRAVLKADPSF-------------DDGSWPSL--------------------------SSDAKDFVKLLL 379 (492)
Q Consensus 342 ~~~~~~---~~~~i~~~~~~~-------------~~~~~~~~--------------------------s~~~~~li~~~L 379 (492)
.....+ +++.|+...+.- ..-.|+.. -.++.|||++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 877655 444444321110 00112111 125789999999
Q ss_pred ccCcCCCCCHHHHhcCcccccc
Q 011154 380 NKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 380 ~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..||.+|+|+.|+|.||||...
T Consensus 391 ~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 391 EFDPARRITLREALSHPFFARL 412 (415)
T ss_pred ccCccccccHHHHhcCHHhhcC
Confidence 9999999999999999999864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.35 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=210.1
Q ss_pred ccceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|.+.+.||+|+||.||++..+... ..+..||+|.+.... .......+.+|+.+++.+ +|+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC
Confidence 468999999999999999999886532 356889999986443 223345688999999999 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcE
Q 011154 211 DNVYIVMELCEGGELLDRILSRC---------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~ 281 (492)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence 99999999999999999886432 247888999999999999999999999999999999999 667789
Q ss_pred EEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcC
Q 011154 282 KAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 356 (492)
Q Consensus 282 kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~ 356 (492)
||+|||+++.+..... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+.+..+..+.+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 9999999876543321 22345778999999875 568899999999999999998 999998888777777666432
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 357 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.. . ....++.++.+||.+||+.+|++|||+.++++
T Consensus 239 ~~-~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 HL-D--LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CC-C--CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 21 1 11246899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=337.57 Aligned_cols=256 Identities=24% Similarity=0.370 Sum_probs=202.6
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++++.||+|+||.||+|.+.+ ...+++.||||++..... ......+.+|+.+|..+.+||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3689999999999999999998643 234678999999965432 233556889999999997799999999988654
Q ss_pred -CeEEEEEeecCCCchHHHHHhhC--------------------------------------------------------
Q 011154 211 -DNVYIVMELCEGGELLDRILSRC-------------------------------------------------------- 233 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~~-------------------------------------------------------- 233 (492)
..+++|||||++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 56899999999999999886431
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCC---ccc
Q 011154 234 ----------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER---LND 300 (492)
Q Consensus 234 ----------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~ 300 (492)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence 236788889999999999999999999999999999999 6677899999999976533221 122
Q ss_pred cccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011154 301 IVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378 (492)
Q Consensus 301 ~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 378 (492)
..++..|+|||++. ..++.++|||||||++|+|++ |..||...................... ..+++++.+++.+|
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~c 318 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHH
Confidence 34567899999875 458999999999999999997 999997654433333332222222221 23678999999999
Q ss_pred cccCcCCCCCHHHHhcC
Q 011154 379 LNKDPRKRMTAAQALSH 395 (492)
Q Consensus 379 L~~dP~~Rps~~e~l~h 395 (492)
|+.||.+|||+.++++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.16 Aligned_cols=260 Identities=32% Similarity=0.571 Sum_probs=213.7
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|+... +++.||||++..... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 86 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPA 86 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECC---CCcEEEEEecccccc-hhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhcc
Confidence 467889999999999999999999765 678999999865422 223445678899999999 599999999988765
Q ss_pred Ce------EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 DN------VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ~~------~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+. +++|+||+ +++|.+.+.. ..+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~ 160 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKIL 160 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEc
Confidence 54 89999999 6699887754 479999999999999999999999999999999999999 567789999
Q ss_pred ecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC--
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 360 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-- 360 (492)
|||++...... .....++..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+........
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99999876432 345578899999998754 578899999999999999999999987776655555443221110
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 361 -------------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 361 -------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
...+..++.++.+||.+||+.||.+|||+.++++||||.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 0112346889999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=335.15 Aligned_cols=261 Identities=31% Similarity=0.506 Sum_probs=207.4
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe----C
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED----L 210 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~----~ 210 (492)
+|++.+.||+|+||.||+++.... ..+..||||++.... ........+.+|+.+++++.+||||+++++.+.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-CcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 488999999999999999997642 127889999986432 2222345678899999999779999999997543 2
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
..+|+++||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLAR 153 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCce
Confidence 46889999986 588887754 4679999999999999999999999999999999999999 667789999999998
Q ss_pred ccCCCC-----CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC------
Q 011154 291 FVRPDE-----RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------ 357 (492)
Q Consensus 291 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~------ 357 (492)
.+.... ......||..|+|||++.+ .++.++||||+||++|+|++|..||........+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 654322 1234578999999997653 588999999999999999999999987665444433222110
Q ss_pred ---------------------CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 ---------------------SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ---------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
......++.++.++.+||.+||+.||.+|||+.+++.|||++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 001112345788999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=330.25 Aligned_cols=254 Identities=21% Similarity=0.363 Sum_probs=208.4
Q ss_pred ccceeecceeccccceEEEEEEEecC----CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG----EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.++|.+++.||+|+||.||+|..... ......||+|++.... .......+.+|+.+++.+.+||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 36899999999999999999976421 2245679999986443 23345678899999999966999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
+.+.+|+||||+++|+|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 167 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV- 167 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE-
Confidence 9999999999999999999986532 348899999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+.++.+||+|||+++....... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred --cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 5567899999999986643221 11223456799999875 458899999999999999999 8999988887777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+..+...... .....++.++++||.+||..||++|||+.++++
T Consensus 246 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7766554321 112367889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.36 Aligned_cols=246 Identities=25% Similarity=0.411 Sum_probs=206.9
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|.+.........||||.+...... ...+.+.+|+.+++++. ||||+++++++.+ ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 4689999999999998754334457999999766543 45677899999999995 9999999999998 899999999
Q ss_pred cCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCC-
Q 011154 220 CEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER- 297 (492)
Q Consensus 220 ~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~- 297 (492)
+++|+|.+.+.+.. ..+++..++.++.|++.||.|||++|++||||||+||++ +.++.+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence 99999999997765 578999999999999999999999999999999999999 5667999999999987654221
Q ss_pred ---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 298 ---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 298 ---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
.....++..|+|||.+. ..++.++|||||||++|+|++ |..||...+..+....+......... ...++..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence 12345778899999876 468899999999999999998 99999887777777776653322221 235788999
Q ss_pred HHHHHccccCcCCCCCHHHHhc
Q 011154 373 DFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+++.+||..+|++|||+.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=326.81 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=208.0
Q ss_pred cceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|..... ..++..|++|.+.... ....+.+.+|+.+++.+. |+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence 5688999999999999999986532 2356679999985432 334456889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC
Q 011154 212 NVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~ 276 (492)
..++||||+++++|.+++.... +.+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence 9999999999999999986532 348999999999999999999999999999999999999 6
Q ss_pred CCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHH
Q 011154 277 ESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 351 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~ 351 (492)
.++.+||+|||++........ .....|+..|+|||.+. ..++.++|||||||++|+|+| |..||......+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 677999999999976543321 22345678899999775 558889999999999999998 9999988777777666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+....... .....+..+.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 65543322 12356889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=336.76 Aligned_cols=255 Identities=20% Similarity=0.324 Sum_probs=200.9
Q ss_pred ceeccc--cceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEE
Q 011154 140 EEVGRG--HFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVM 217 (492)
Q Consensus 140 ~~lG~G--~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~ 217 (492)
..||+| +||+||++++.. +|+.||||++...... ....+.+.+|+.+++.+. ||||++++++|...+..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---CCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEE
Confidence 456666 889999998654 7899999998755433 344577899999999995 999999999999999999999
Q ss_pred eecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCC
Q 011154 218 ELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296 (492)
Q Consensus 218 E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~ 296 (492)
||+.+|+|.+.+.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+|++|||.+.......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccC
Confidence 9999999999876543 358999999999999999999999999999999999999 556789999998654332111
Q ss_pred Cc--------cccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC-----
Q 011154 297 RL--------NDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD----- 360 (492)
Q Consensus 297 ~~--------~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~----- 360 (492)
.. ....++..|+|||++.+ .++.++|||||||++|+|++|..||...........+.......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 10 11235567999998864 378899999999999999999999977655444333322211000
Q ss_pred --------------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 361 --------------------------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 361 --------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
......++.++.+||++||+.||++|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 001123567899999999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=332.65 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=206.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL-- 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~-- 210 (492)
.++|++.+.||.|+||.||+|..+. +++.||||++........ ....+.+|+++++.+. ||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDG-FPITALREIKILKKLK-HPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcC-CCCccchhhheecccc
Confidence 5789999999999999999999765 678999999865432221 1234678999999995 99999999987543
Q ss_pred ------CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 ------DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ------~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
..+++||||+.+ +|...+......+++..+..++.||++||.|||++||+||||||+|||+ +.++.+||+
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~ 157 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIA 157 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEC
Confidence 357999999965 7777776655679999999999999999999999999999999999999 667799999
Q ss_pred ecccccccCCCCC------------ccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 011154 285 DFGLSDFVRPDER------------LNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFR 350 (492)
Q Consensus 285 DfGla~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~ 350 (492)
|||++........ .....|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~ 237 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999976543221 123467889999998753 47889999999999999999999998777665555
Q ss_pred HHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 351 AVLKADPSFDD--------------------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 351 ~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
.+......... ..+..++.++.+||.+||..||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 44332111100 0123455788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.11 Aligned_cols=255 Identities=33% Similarity=0.531 Sum_probs=204.8
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-- 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-- 209 (492)
...+|+..+.||+||||.||+|+.+- +|+.||||+|+... +......+.+|+++|.+| +|||||+++..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKL---DGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVEST 550 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecc---cchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccC
Confidence 34678888999999999999999665 89999999997654 445566799999999999 59999999977600
Q ss_pred ----------------------------------------------------------------------------C---
Q 011154 210 ----------------------------------------------------------------------------L--- 210 (492)
Q Consensus 210 ----------------------------------------------------------------------------~--- 210 (492)
.
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 0
Q ss_pred --------------------------------------CeEEEEEeecCCCchHHHHHhhCCCC--CHHHHHHHHHHHHH
Q 011154 211 --------------------------------------DNVYIVMELCEGGELLDRILSRCGKY--SEDEAKAVLVQILN 250 (492)
Q Consensus 211 --------------------------------------~~~~lv~E~~~ggsL~~~l~~~~~~~--~~~~~~~i~~qi~~ 250 (492)
-.+||.||||+.-.|.+.+..+ .+ ....++.+++||++
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNSQRDEAWRLFREILE 708 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccchhhHHHHHHHHHHHH
Confidence 1378999999986555555433 34 47889999999999
Q ss_pred HHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC-------------------CCCCccccccCccccccc
Q 011154 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-------------------PDERLNDIVGSAYYVAPE 311 (492)
Q Consensus 251 ~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~-------------------~~~~~~~~~gt~~y~aPE 311 (492)
||.|+|+.|||||||||.||++ ++...|||+|||+|+... .....+..+||..|+|||
T Consensus 709 GLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 9999999999999999999999 677899999999998721 011345678999999999
Q ss_pred cccC----CCCCccchHHHHHHHHHHhcCCCCCCCC-ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 011154 312 VLHR----SYGTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKR 386 (492)
Q Consensus 312 ~~~~----~~~~~~DvwSlGvil~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 386 (492)
++.+ .|+.|+|+|||||||+||+. ||... ....++.++.++...++...+..--+.-..+|++||+.||.+|
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 9852 59999999999999999983 57543 3455667777665555533344444567789999999999999
Q ss_pred CCHHHHhcCccccc
Q 011154 387 MTAAQALSHPWIRN 400 (492)
Q Consensus 387 ps~~e~l~hp~~~~ 400 (492)
|||.|+|++.||--
T Consensus 863 PtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 863 PTATELLNSELLPP 876 (1351)
T ss_pred CCHHHHhhccCCCc
Confidence 99999999999974
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.80 Aligned_cols=243 Identities=23% Similarity=0.361 Sum_probs=200.8
Q ss_pred eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeec
Q 011154 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELC 220 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~ 220 (492)
+||+|+||.||+|.++. ..++..||||++.... ......+.+.+|+.+++.+ +||||+++++++.. +.+++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~-~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM-KKSEKTVAVKILKNDN-NDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEec-CCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecC
Confidence 68999999999997653 2367889999986443 2334566789999999999 59999999998864 5679999999
Q ss_pred CCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCc--
Q 011154 221 EGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL-- 298 (492)
Q Consensus 221 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~-- 298 (492)
++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||.|||+ +.+..+||+|||++..+......
T Consensus 78 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 78 ELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeee
Confidence 999999988644 579999999999999999999999999999999999999 56678999999999876543321
Q ss_pred --cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011154 299 --NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374 (492)
Q Consensus 299 --~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 374 (492)
....++..|+|||.+. ..++.++|||||||++|||++ |..||......++...+...... .....++.++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~l 230 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM---ECPQRCPPEMYDL 230 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCHHHHHH
Confidence 1223457899999876 458889999999999999998 99999888777777777654321 1223588999999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q 011154 375 VKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 375 i~~~L~~dP~~Rps~~e~l~ 394 (492)
|.+||+.||.+||++.+|..
T Consensus 231 i~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 231 MKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHhccCchhCcCHHHHHH
Confidence 99999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.47 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=208.5
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
..+|.+.++||+|+||.||++.... ...++..+|+|.+... .....+.+.+|+++++.+. |+||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecC
Confidence 3578889999999999999997542 2235678999988643 2344567999999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC
Q 011154 211 DNVYIVMELCEGGELLDRILSRC--------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~ 276 (492)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---G 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---c
Confidence 99999999999999999887542 248899999999999999999999999999999999999 5
Q ss_pred CCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHH
Q 011154 277 ESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 351 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~ 351 (492)
++..+||+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||......+....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 677899999999876543221 12234567899999775 458999999999999999998 9999988777777766
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+....... ....+++.+.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 65543321 12367899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=327.08 Aligned_cols=256 Identities=22% Similarity=0.267 Sum_probs=208.2
Q ss_pred ccceeecceeccccceEEEEEEEecCC-------------ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE-------------HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-------------~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpn 199 (492)
.++|++.+.||+|+||.||+|...... ..+..||+|.+..... ....+.+.+|+++++.++ |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcC-CCC
Confidence 468999999999999999999875421 1335689999865432 245567899999999995 999
Q ss_pred ccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCc
Q 011154 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC----------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPEN 269 (492)
Q Consensus 200 iv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~N 269 (492)
|++++++|..++..++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999886543 268999999999999999999999999999999999
Q ss_pred eEeecCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc--CCCCCCCC
Q 011154 270 FLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC--GSRPFWAR 343 (492)
Q Consensus 270 ILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt--g~~pf~~~ 343 (492)
|++ +.++.++|+|||++........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999 5667899999999876543321 22345678899999876 468999999999999999998 78898777
Q ss_pred ChhHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 344 TESGIFRAVLKA----DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 344 ~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.....+..+... .........+.++.++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 776666665443 111111112356789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=327.94 Aligned_cols=254 Identities=30% Similarity=0.553 Sum_probs=211.1
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
|.....||+|+||.||++..+. +++.||||.+.... ......+.+|+.+++.+. |+||+++++++...+..++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 94 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKS---SGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV 94 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcC---CCeEEEEEEecccc---hhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEE
Confidence 3344679999999999998765 78899999985332 234566889999999995 9999999999999999999
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~ 295 (492)
||||+++++|.+.+.. ..+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||++......
T Consensus 95 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 95 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccc
Confidence 9999999999886643 468999999999999999999999999999999999999 66778999999998765432
Q ss_pred C-CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011154 296 E-RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKD 373 (492)
Q Consensus 296 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 373 (492)
. ......|+..|+|||.+. ..++.++||||+||++|+|++|..||.+.........+....+... .....++.++.+
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 248 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL-KNLHKVSPSLKG 248 (292)
T ss_pred cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc-CCcccCCHHHHH
Confidence 2 223457899999999875 4588899999999999999999999987766655555544332221 123467899999
Q ss_pred HHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 374 FVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 374 li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++.+||..||.+||++.++++||||....
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 99999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=327.71 Aligned_cols=254 Identities=34% Similarity=0.539 Sum_probs=210.7
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
|++.+.||+|++|.||++.... +++.+|+|.+...... ......+.+|+.+++.+. |+||+++++++.+.+..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRFES-EGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---CCcEEEEEEecccccc-chhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEE
Confidence 5678899999999999998654 6889999998655432 234467889999999995 9999999999999999999
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~ 295 (492)
||||+++ +|.+.+......+++..+..++.||+.||.|||++||+|+||||+||++ +.++.+||+|||.+......
T Consensus 76 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCC
Confidence 9999975 8888887766789999999999999999999999999999999999999 56678999999999877554
Q ss_pred C-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC------------
Q 011154 296 E-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD------------ 360 (492)
Q Consensus 296 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------------ 360 (492)
. ......++..|+|||.+.+ .++.++|||||||++|+|++|+.||...+..+.+..+........
T Consensus 152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 3 2334568889999998753 578899999999999999999999987776555444432211100
Q ss_pred --------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 361 --------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 361 --------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
...++.++.++.+||.+||..||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01223577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=337.15 Aligned_cols=260 Identities=30% Similarity=0.527 Sum_probs=209.0
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|.+.+.||+|+||.||++.... +++.||||++.+... .....+.+.+|+.++++++ ||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~ 87 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTP 87 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcC-CCcccceeeeeee
Confidence 3567899999999999999999998654 688999999965322 2233456788999999995 9999999999864
Q ss_pred C------CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 210 L------DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 210 ~------~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
. +..|++++++ |++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl 161 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKI 161 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEE
Confidence 3 3478899887 7788776643 469999999999999999999999999999999999999 66778999
Q ss_pred EecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC----
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP---- 357 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~---- 357 (492)
+|||++..... ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 162 ~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 162 LDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred ecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999876532 3344578999999998754 478899999999999999999999977665444433322111
Q ss_pred -------------------CCCC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 -------------------SFDD----GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 -------------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..+. ..+...+.++.+||.+||+.||.+||++.++++||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0000 11124678899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=323.65 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=205.4
Q ss_pred ccceeecceeccccceEEEEEEEecCCc-cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEH-KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..+|++.+.||+|+||.||+|.+..... ....||||++.... .......+.+|+.+++.+. |+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-C
Confidence 3678999999999999999998764221 12358999986443 3334567889999999994 9999999999875 4
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++++||+++|+|.+.+....+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceee
Confidence 5789999999999999987766679999999999999999999999999999999999999 5566899999999987
Q ss_pred cCCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 292 VRPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 292 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
+...... ....++..|+|||.+. ..++.++|||||||++|||++ |..||.......+...+...... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL---PQPPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC---CCCcc
Confidence 6533322 1223567899999875 458999999999999999998 99999776666665555443222 12346
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++.++|.+||..||++||++.++++
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=377.02 Aligned_cols=260 Identities=33% Similarity=0.539 Sum_probs=217.9
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
..++.-++.-+..||.|.||.||.|..- .+|...|||-|...... ......+.+|+++|..| +|||+|++||+-.
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~---~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNL---DTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEV 1304 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecC---CccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceee
Confidence 3456677888899999999999999854 48999999998654433 44566788999999999 5999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
+.+.++|.||||.||+|.+.+ +.++-.+|.....+..|++.|+.|||++|||||||||+|||+ +.++.+|++|||.
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGS 1380 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccc
Confidence 999999999999999999865 555667888888899999999999999999999999999999 6778999999999
Q ss_pred ccccCCCC-----CccccccCccccccccccC----CCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHHHHhcC-C
Q 011154 289 SDFVRPDE-----RLNDIVGSAYYVAPEVLHR----SYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKAD-P 357 (492)
Q Consensus 289 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~i~~~~-~ 357 (492)
|..+.... ..+...||+.|||||++.+ ....+.||||+|||++||+||++||...+. -.++-.+-.+. +
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence 98876442 2356789999999999864 345689999999999999999999865443 34444444433 3
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 358 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.++. .+|++.+|||.+||..||++|+++.|+|+|-|-+..
T Consensus 1461 q~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1461 QIPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred CCch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 3333 599999999999999999999999999999987653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.78 Aligned_cols=245 Identities=36% Similarity=0.648 Sum_probs=212.0
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecC
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ 221 (492)
||+|+||.||++.... +++.||+|++.+...........+.+|+++++.+. |+||+++++.+++++..|+||||++
T Consensus 1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCC
Confidence 6999999999998754 67899999998766555556678899999999995 9999999999999999999999999
Q ss_pred CCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC-CCccc
Q 011154 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLND 300 (492)
Q Consensus 222 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~-~~~~~ 300 (492)
+++|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||++ +.++.++|+|||++...... .....
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 77 GGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccC
Confidence 99999988654 479999999999999999999999999999999999999 56678999999999876543 23445
Q ss_pred cccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011154 301 IVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379 (492)
Q Consensus 301 ~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 379 (492)
..|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+......++ ..++.++.+||++||
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l 228 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLL 228 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHh
Confidence 678999999998764 478899999999999999999999988777666777665433333 246899999999999
Q ss_pred ccCcCCCCCH---HHHhcCccc
Q 011154 380 NKDPRKRMTA---AQALSHPWI 398 (492)
Q Consensus 380 ~~dP~~Rps~---~e~l~hp~~ 398 (492)
..||++||++ .++++||||
T Consensus 229 ~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 229 QKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred cCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=340.17 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=206.4
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|.+++.||+|+||.||+|+++. ....++.||||++..... ....+.+.+|+++|.++..|||||+++++|.+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 4578899999999999999998754 223567899999965432 223456889999999995599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC---------------------------------------------------------
Q 011154 211 DNVYIVMELCEGGELLDRILSRC--------------------------------------------------------- 233 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~--------------------------------------------------------- 233 (492)
+..++|||||++|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999986431
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 234 ----------------------------------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 234 ----------------------------------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
..+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl- 272 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI- 272 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence 136777889999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+....+||+|||+++....... .....++..|+|||.+. ..++.++|||||||++|||++ |..||......+.
T Consensus 273 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 273 --CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred --eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 5567899999999986533221 12345778899999875 458889999999999999998 8999977655554
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
............ ....++.++.+|+.+||..+|.+||++.++++.
T Consensus 351 ~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 351 FYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444333332221 223578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=320.09 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=205.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|.+. .++.||||.+..... ..+.+.+|+.+++++. ||||+++++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec----CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCC
Confidence 467999999999999999999864 346799999865432 2356889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARV 152 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEE
Confidence 999999999999999987653 468999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCCCc--cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDERL--NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
....... ....++..|+|||++. ..++.++|||||||++|+|++ |+.||.+......+..+..... . .....+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 229 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-M--PCPPGC 229 (261)
T ss_pred ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcC
Confidence 6532211 1122345799999876 458899999999999999999 9999988777777766654322 1 122357
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+..+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=319.65 Aligned_cols=243 Identities=22% Similarity=0.341 Sum_probs=200.7
Q ss_pred eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeec
Q 011154 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELC 220 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~ 220 (492)
.||+|+||.||+|.++.. ..+..||||++.... .....+.+.+|+.+++.+. ||||++++++++. +..++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~-~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~-~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCEA-EALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecC-CCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEcC-CCeEEEEEeC
Confidence 489999999999987632 246679999986543 2344567899999999995 9999999999864 5789999999
Q ss_pred CCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCc--
Q 011154 221 EGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL-- 298 (492)
Q Consensus 221 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~-- 298 (492)
++|+|.+++......+++..+..++.||+.||.|||++|++||||||+|||+ +.+..+||+|||++.........
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCcccee
Confidence 9999999887666789999999999999999999999999999999999999 56678999999999865433221
Q ss_pred --cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011154 299 --NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374 (492)
Q Consensus 299 --~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 374 (492)
....++..|+|||++. ..++.++|||||||++|+|++ |..||......+....+..+.... .....+.++.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 230 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYAL 230 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHH
Confidence 1123357899999875 468889999999999999996 999998888777776666544321 123578999999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q 011154 375 VKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 375 i~~~L~~dP~~Rps~~e~l~ 394 (492)
|.+||..||++||++.++++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=318.89 Aligned_cols=244 Identities=22% Similarity=0.346 Sum_probs=201.9
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
++||+|+||.||+|.+......+..||+|.+...... ...+.+.+|+.+++.+ +|+||+++++++.. +.+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCKG-EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC-CceEEEEEe
Confidence 4699999999999988764445588999999765443 3456788999999999 59999999998764 568999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCcc
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLN 299 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~ 299 (492)
+++|+|.+++... ..+++..+..++.|++.||.|||..+++||||||+|||+ +.++.+||+|||++..........
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 77 APLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCccc
Confidence 9999999988765 479999999999999999999999999999999999999 567789999999998764433211
Q ss_pred ----ccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011154 300 ----DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKD 373 (492)
Q Consensus 300 ----~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 373 (492)
...++..|+|||.+. ..++.++|||||||++|+|++ |..||......+....+...... .....++..+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 229 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYS 229 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHH
Confidence 122346799999875 458899999999999999998 99999887776666666554322 222467899999
Q ss_pred HHHHccccCcCCCCCHHHHhc
Q 011154 374 FVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 374 li~~~L~~dP~~Rps~~e~l~ 394 (492)
+|.+||..+|++||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=332.59 Aligned_cols=265 Identities=30% Similarity=0.491 Sum_probs=218.4
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHH----HHHHHHHHHHHHHccCCCCccEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIA----VEDVRREVKILRALSGHSNLVKFY 204 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~----~~~~~~Ev~~l~~l~~hpniv~l~ 204 (492)
...+.++|-+...||+|||+.||+|.+-. ..+.||||+-...+.+.... .+...+|..|.+.| +||.||++|
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlY 533 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLY 533 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeee
Confidence 34567889999999999999999998654 67899999976555443322 33467899999999 699999999
Q ss_pred EEEE-eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCcE
Q 011154 205 DAFE-DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQL 281 (492)
Q Consensus 205 ~~~~-~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~~ 281 (492)
++|. +.+.+|-|+|||+|.+|.-++ ++...++|.+++.|+.||+.||.||.+.. |||-||||.|||+.+....+.+
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence 9996 567899999999998876555 55578999999999999999999999985 9999999999999988889999
Q ss_pred EEEecccccccCCCCC--------ccccccCcccccccccc-C----CCCCccchHHHHHHHHHHhcCCCCCCCCC-hhH
Q 011154 282 KAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLH-R----SYGTEADVWSIGVIAYILLCGSRPFWART-ESG 347 (492)
Q Consensus 282 kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~DvwSlGvil~~lltg~~pf~~~~-~~~ 347 (492)
||.||||++.+..+.. .....||.||++||++- + ..+.++||||+|||+|.++.|+.||.... ..+
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 9999999999865432 23468999999999763 2 47889999999999999999999996543 333
Q ss_pred HHHH--HHh-cCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 348 IFRA--VLK-ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 348 ~~~~--i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
+++. |++ ....|+. -|.+++++++||++||.+--+.|..+.++..||||.-
T Consensus 693 ILqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred HHhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 4332 222 2233433 3579999999999999999999999999999999975
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=336.74 Aligned_cols=258 Identities=35% Similarity=0.553 Sum_probs=214.5
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC---
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD--- 211 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~--- 211 (492)
+|++.+.||+|+||.||+|+... +++.||||++..... .....+.+.+|+.+++.+. |+||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCccc
Confidence 58999999999999999998654 688999999865432 2334567889999999995 999999999998775
Q ss_pred --eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 212 --NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 212 --~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+|+||||+.+ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 76 ~~~~~lv~e~~~~-~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~ 150 (330)
T cd07834 76 FNDVYIVTELMET-DLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLA 150 (330)
T ss_pred ccceEEEecchhh-hHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCce
Confidence 79999999974 888877544 589999999999999999999999999999999999999 66689999999999
Q ss_pred cccCCCC----CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC-
Q 011154 290 DFVRPDE----RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG- 362 (492)
Q Consensus 290 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~- 362 (492)
....... ......+|..|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 8775543 2345678999999998753 58889999999999999999999998887766665554432211110
Q ss_pred --------------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 363 --------------------------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 363 --------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..+.++.++.+||.+||+.||.+|||+.+++.||||++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1234688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=315.87 Aligned_cols=252 Identities=32% Similarity=0.564 Sum_probs=213.5
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||++.... .++.||||.+...... ....+.+.+|+++++++. |+||+++++++.+.+.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEE
Confidence 58899999999999999998664 6788999999766543 235567999999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+||||+++++|.+.+... ..+++..+..++.|++.||.|||+.||+||||+|+||++ +.++.++|+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 76 IILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLND 151 (254)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCC
Confidence 999999999999887655 689999999999999999999999999999999999999 5567899999999987654
Q ss_pred CCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 295 DER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 295 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
... .....|+..|+|||.+.+ .++.++||||+|+++|+|++|..||+..........+..... ......++..+.
T Consensus 152 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 228 (254)
T cd06627 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---PPLPEGISPELK 228 (254)
T ss_pred CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC---CCCCCCCCHHHH
Confidence 433 234568999999998753 478899999999999999999999987665444444332211 122346789999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccc
Q 011154 373 DFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
++|.+||..+|++|||+.+++.||||
T Consensus 229 ~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=318.43 Aligned_cols=260 Identities=30% Similarity=0.495 Sum_probs=219.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe---
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--- 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--- 209 (492)
.+.|+...+||+|.||.|++|+.+. +|+.||+|++-.+....... ....+|+++|..|. |+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlmeneKeGfp-italreikiL~~lk-Henv~nliEic~tk~T 90 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLMENEKEGFP-ITALREIKILQLLK-HENVVNLIEICRTKAT 90 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhc-chhHHHHHHHHhhccC
Confidence 3578888899999999999999776 78889998774322111111 23568999999995 9999999998853
Q ss_pred -----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 -----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 -----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
...+|+|+.+|+. +|...+.+...+++..+++.++.+++.||.|+|+..|+|||+|++|+|| +.++.+||+
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklA 166 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLA 166 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEee
Confidence 2459999999987 8888777766789999999999999999999999999999999999999 777899999
Q ss_pred ecccccccCCCC-----CccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 285 DFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 285 DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
|||+++.+.... ..+..+-|.+|++||.+. +.|+.+.|||..|||+.||.|+++.|.+.++...+..|..-..
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 999997654322 345567899999999875 4699999999999999999999999999999998888888777
Q ss_pred CCCCCCCCCC-------------------------------CHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 358 SFDDGSWPSL-------------------------------SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 358 ~~~~~~~~~~-------------------------------s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++..+.||++ .+++.||+.+||..||.+|+++.++|+|.||...
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 7777777653 2378899999999999999999999999999864
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.95 Aligned_cols=251 Identities=20% Similarity=0.314 Sum_probs=202.9
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-----
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL----- 210 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~----- 210 (492)
|.+++.||+|+||.||+|++.... ....||||.++.... .....+.+.+|+.+++.+ +|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-CeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccC
Confidence 357889999999999999876421 224699999865432 344567789999999999 599999999987532
Q ss_pred -CeEEEEEeecCCCchHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 -DNVYIVMELCEGGELLDRILSR-----CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
...++||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 154 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVA 154 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEEC
Confidence 3578999999999998887532 2348999999999999999999999999999999999999 667789999
Q ss_pred ecccccccCCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCC
Q 011154 285 DFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 285 DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
|||++..+...... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||......++...+.......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999876533221 2234567899999875 458999999999999999999 899998877777777766544321
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..+.++..+.++|.+||+.||.+|||+.+++++
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 ---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 123678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=323.10 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=197.1
Q ss_pred cce-eecceeccccceEEEEEEEec-CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 134 SRL-EVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 134 ~~y-~~~~~lG~G~fg~V~~~~~~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
++| .+.+.||+|+||.||++.++. ...++..||+|++.... .......+.+|+++|+.+. ||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 455 889999999999999887543 22367889999986542 2234456889999999995 99999999988753
Q ss_pred -CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 -DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
..+++||||+++|+|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||+ +.+..+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~ 154 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLA 154 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccc
Confidence 468999999999999998865 369999999999999999999999999999999999999 56678999999999
Q ss_pred cccCCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChh--H------------HHH
Q 011154 290 DFVRPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES--G------------IFR 350 (492)
Q Consensus 290 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~--~------------~~~ 350 (492)
........ .....++..|+|||++. ..++.++|||||||++|+|++|..||...... + .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 87653322 12234567799999875 56889999999999999999999998543211 0 000
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 351 AVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 351 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
......... .....++.++.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111111 112356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=322.93 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=203.0
Q ss_pred cceeecceeccccceEEEEEEEecCCc-cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEH-KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+|++.+.||+|+||.||+|.+..+.. ....|++|.+.... ......++..|+.+++.+ +||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-Cc
Confidence 578899999999999999998764211 12357888875322 233446788899999999 59999999998764 56
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++|+||+++|+|.+++....+.+++..+..++.||+.||.|||++|++||||||+|||+ ++++.+||+|||+++.+
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence 789999999999999998766789999999999999999999999999999999999999 66778999999999876
Q ss_pred CCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 293 RPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 293 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
..... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+.....+...+..+..... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCCC
Confidence 43322 23345778899999875 569999999999999999998 9999987766655555543332211 1245
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+.++.+++.+||..||.+|||+.++++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 778999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.17 Aligned_cols=258 Identities=31% Similarity=0.565 Sum_probs=208.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+..+|.+.+.||+|+||.||+|+.+. +|+.||||++.+.... ......+.+|+.+++.+. ||||++++++|...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 86 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSA 86 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcC-CCCccchhheeccc
Confidence 345789999999999999999998754 6889999998654322 223456789999999995 99999999998754
Q ss_pred ------CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 ------DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ------~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
..+|+|+||+.+ +|...+ ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~ 159 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKIL 159 (342)
T ss_pred ccCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEe
Confidence 357999999964 666543 2468999999999999999999999999999999999999 667789999
Q ss_pred ecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC------
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD------ 356 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~------ 356 (492)
|||++..... ......||..|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+....
T Consensus 160 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 160 DFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred eCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999876532 2344578899999998754 48889999999999999999999998776554444433211
Q ss_pred -----------------CCCCC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 357 -----------------PSFDD----GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 357 -----------------~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+.+.. ..++.++.++.+||.+||+.||.+||++.+++.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 01111 11345788899999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=321.09 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=198.6
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|+.+.+. ....+|+|.+.... .....+.+.+|++++.++.+||||+++++++...+.+|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-CeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 36899999999999876521 22457888886332 2334567889999999996799999999999999999999999
Q ss_pred cCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 220 CEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 220 ~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+++|+|.+++.... ..+++.++..++.|++.||+|||++|++||||||+|||+ +.++.+||+
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEEC
Confidence 99999999987542 247899999999999999999999999999999999999 667789999
Q ss_pred ecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (492)
|||++..............+..|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+..+..... . .
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~--~ 231 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-L--E 231 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC-C--C
Confidence 999986432111111223456799999875 458889999999999999997 9999988777777766654321 1 1
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
....++.++.+|+.+||..||.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 22357889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=318.13 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=214.0
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+|++.+.||+|+||.||++..+. +++.+|||.+....... .....+.+|+++++.+. |+||+++++++.+....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEE
Confidence 58899999999999999998654 67899999997654432 34556788999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 215 IVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+|+||++ +.+..+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhh
Confidence 999999999999887652 2468999999999999999999999999999999999999 4567899999999987
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.... ......|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...+..+....+....... ....++.+
T Consensus 153 ~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (256)
T cd08530 153 LKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP---IPPIYSQD 228 (256)
T ss_pred hccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---CchhhCHH
Confidence 7544 3334568999999998754 58889999999999999999999998887766666655433221 11267889
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
++++|.+||..+|.+||++.++++||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=318.76 Aligned_cols=258 Identities=29% Similarity=0.518 Sum_probs=232.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++...||+|+|+.|.++++++ +.+.||+|++++.-.+....++.+..|-.+..+.++||.+|-|+.+|+++..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred cccceeeeeecCcchhhhhheehcc---cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 4689999999999999999999887 7899999999999888888889999999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc-
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF- 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~- 291 (492)
+++|.||++||+|.-++..+ .+++|++++.+...|+.||.|||+.|||+||||.+|||+ |..+++||.|+|+.+.
T Consensus 326 lffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~ 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcC
Confidence 99999999999998777554 689999999999999999999999999999999999999 8889999999999875
Q ss_pred cCCCCCccccccCccccccccccCC-CCCccchHHHHHHHHHHhcCCCCCC--------CCChhHHHHHHHhcCCCCCCC
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFW--------ARTESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DvwSlGvil~~lltg~~pf~--------~~~~~~~~~~i~~~~~~~~~~ 362 (492)
+.++....+.||||.|.|||++++. |+..+|.|+|||+|+||+.|+.||. ..+++-+++-|+......+.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr- 480 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR- 480 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc-
Confidence 5667778889999999999999874 9999999999999999999999994 23445567777777766654
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCC------HHHHhcCcccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMT------AAQALSHPWIRNY 401 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps------~~e~l~hp~~~~~ 401 (492)
.+|-.+..+++..|++||.+|.. ..++..|+||+..
T Consensus 481 ---slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 481 ---SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred ---eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 57778889999999999999974 6899999999954
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.05 Aligned_cols=254 Identities=31% Similarity=0.518 Sum_probs=209.9
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
|++.+.||+|+||.||+|.... +++.||+|++..... .....+.+.+|+.+++.+. |+||+++++++.+.+.+++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNE-EEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecC---CCcEEEEEEeccccc-cccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEE
Confidence 5678899999999999998765 688999999976542 2223456778999999995 9999999999999999999
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~ 295 (492)
||||+. ++|.+.+......+++..+..++.|++.||.|||++||+||||+|+||++ +.++.+||+|||++......
T Consensus 76 v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred EecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCC
Confidence 999997 48999887765679999999999999999999999999999999999999 66788999999999876543
Q ss_pred C-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC------------
Q 011154 296 E-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD------------ 360 (492)
Q Consensus 296 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------------ 360 (492)
. ......++..|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+........
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 3 2334456788999998753 588899999999999999999999988776655554433111000
Q ss_pred -------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 361 -------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 361 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
...++.++.++.++|.+||..||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 01223467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=323.76 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=204.9
Q ss_pred ceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
+|++.+.||+|+||.||+|+..... .....+|+|.+.... .......+.+|+.+++.+. ||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 4788999999999999999865321 234679999886543 2334567889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhh-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCc
Q 011154 213 VYIVMELCEGGELLDRILSR-----------------------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPEN 269 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~N 269 (492)
.++||||+.+|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999987642 1347899999999999999999999999999999999
Q ss_pred eEeecCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCC
Q 011154 270 FLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWART 344 (492)
Q Consensus 270 ILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~ 344 (492)
||+ ++++.+||+|||++........ .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+..
T Consensus 158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 5667899999999976533221 12234567899999765 458899999999999999998 999998887
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 345 ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 345 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
...++..+.... .. .....++.++.+|+.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~-~~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGY-RM--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCC-CC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 777666554432 11 122367899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=330.67 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=209.0
Q ss_pred ccceeecceeccccceEEEEEEEecCC----ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE----HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
..+|++++.||+|+||.||+|++.... ..+..||+|.+.... .....+.+.+|+.+++++.+||||++++++|.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 357999999999999999999865321 123479999886432 33445678999999999966999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
+.+..++||||+++|+|.+++..+. ..+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill- 167 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV- 167 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE-
Confidence 9999999999999999999886532 247888999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+.++.+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 168 --TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred --cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 5667899999999986643321 12233456799999875 458899999999999999998 8999988887777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+..+...... .....++.++.+||.+||+.+|.+|||+.+++++
T Consensus 246 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7776554321 1123578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=329.89 Aligned_cols=260 Identities=35% Similarity=0.565 Sum_probs=209.1
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||.|+||.||+|+.+. +++.||||++.+.... ....+.+.+|+++++.+. ||||++++++|..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 80 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLR-HENIISLSDIFIS 80 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECC---CCCEEEEEEecccccc-cchhHHHHHHHHHHHhcC-CCCeeeEeeeEec
Confidence 4567899999999999999999998664 7889999998654322 223456788999999995 9999999999876
Q ss_pred -CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 210 -LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 210 -~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
....|+||||+ +++|.+.+.. ..+++..+..++.||+.||.|||+.||+||||+|+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~ 154 (328)
T cd07856 81 PLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGL 154 (328)
T ss_pred CCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCcccc
Confidence 56789999999 5688776643 468999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC----------
Q 011154 289 SDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---------- 356 (492)
Q Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~---------- 356 (492)
+..... ......++..|+|||++.+ .++.++|||||||++|+|++|..||........+..+....
T Consensus 155 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 155 ARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 876532 2344578899999998754 58899999999999999999999997765433222211100
Q ss_pred -----------------CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 357 -----------------PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 357 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
........+.++.++.++|.+||+.+|++|||+.+++.||||....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 0000111235788999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=324.15 Aligned_cols=255 Identities=21% Similarity=0.277 Sum_probs=203.7
Q ss_pred cceeecceeccccceEEEEEEEecCC-----------ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGE-----------HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVK 202 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----------~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~ 202 (492)
.+|++.+.||+|+||.||+++..... .....||||.+.... .....+.+.+|+++++++. |+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence 58999999999999999999864311 123458999986542 3344567899999999995 999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCchHHHHHhhC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceE
Q 011154 203 FYDAFEDLDNVYIVMELCEGGELLDRILSRC-----------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFL 271 (492)
Q Consensus 203 l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NIL 271 (492)
+++++...+..++|||||.+++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999885432 13688999999999999999999999999999999999
Q ss_pred eecCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc--CCCCCCCCCh
Q 011154 272 YTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC--GSRPFWARTE 345 (492)
Q Consensus 272 l~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt--g~~pf~~~~~ 345 (492)
+ +.++.+||+|||++..+..... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.....
T Consensus 162 l---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 V---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred E---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9 5567899999999976543321 12234567899999765 568999999999999999988 7788887776
Q ss_pred hHHHHHHHhcC----CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 346 SGIFRAVLKAD----PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 346 ~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+....+.... ........+.++..+.+|+.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66655543311 11111123357889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=318.07 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=203.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.++||+|+||.||+|.+.. ...||||++..... ..+.+.+|+++++.+. ||||+++++++.+ +.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CC
Confidence 4679999999999999999998653 24599999975432 2246889999999995 9999999998754 56
Q ss_pred EEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+||++ ++++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 151 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceee
Confidence 899999999999999987543 458999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCCCc--cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDERL--NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
+...... ....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+...... .....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPEC 228 (262)
T ss_pred ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---CCcccc
Confidence 6533321 2334667899999875 568999999999999999999 88899887777777666543221 112367
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+..+.+||.+||+.||.+||++.++++
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=319.70 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=209.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
..+|++.+.||.|+||.||+|.++. +..+|+|++.... ......+.+|+.+++.++ |+||+++++++.+.+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEP 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCC
Confidence 4579999999999999999998753 6789999986543 223456889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ ++++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARL 153 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhh
Confidence 99999999999999998764 3468999999999999999999999999999999999999 6677899999999977
Q ss_pred cCCCCC-ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 292 VRPDER-LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 292 ~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
...... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||......+.+..+..... ......++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 230 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---MPCPAKCP 230 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---CCCCCCCC
Confidence 643321 22334667899999875 468889999999999999998 8999988777777777664322 12224688
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
..+.++|.+||..||.+|||+.++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=315.72 Aligned_cols=247 Identities=27% Similarity=0.467 Sum_probs=207.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.+|++.+.||+|+||.||++.+. .+..+|+|.+...... ...+.+|+++++.+. ||||+++++++......
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~----~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPI 74 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe----CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCC-CCCeeeEEEEEccCCce
Confidence 47889999999999999999865 3567999998654432 246788999999994 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+.+|+|.+++....+.++++.+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecc
Confidence 99999999999999887766678999999999999999999999999999999999999 566789999999987654
Q ss_pred CCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 294 PDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 294 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||......+....+......+.. ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQ 228 (256)
T ss_pred cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCH
Confidence 3221 11223557899999876 568889999999999999998 99999888877777777654332221 23678
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.+.+|+.+||+.+|.+|||+.+++++
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=316.14 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=198.4
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE-eCCeEEEEEe
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE-DLDNVYIVME 218 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~-~~~~~~lv~E 218 (492)
+.||+|+||.||+|.+......+..||||.+.... .....+.+.+|+.+++.+ +||||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence 46899999999999876544456789999985432 334456788999999999 4999999999875 4566899999
Q ss_pred ecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCC-
Q 011154 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER- 297 (492)
Q Consensus 219 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~- 297 (492)
|+.+|+|.+++......+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence 999999999987665667888899999999999999999999999999999999 5677899999999976543211
Q ss_pred ----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcC-CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 298 ----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 298 ----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.....++..|+|||.+. ..++.++|||||||++|+|++| ..||......+....+........ ...++..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 12334677899999875 5688999999999999999995 666766666566555554332211 12468899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcC
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.+++.+||..+|++||++.+++..
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=321.94 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=208.6
Q ss_pred ccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++.+.||+|+||.||+|..... ..++..||+|++.... .......+.+|+.+++.+ +||||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC
Confidence 46799999999999999999987531 2356889999986543 234456788999999999 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCc
Q 011154 211 DNVYIVMELCEGGELLDRILSRC---------------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPEN 269 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~---------------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~N 269 (492)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986432 247888999999999999999999999999999999
Q ss_pred eEeecCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCC
Q 011154 270 FLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWART 344 (492)
Q Consensus 270 ILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~ 344 (492)
||+ +.++.+||+|||++..+..... .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+..
T Consensus 161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999 6677899999999876543321 12234566799999865 568999999999999999997 889998888
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 345 ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 345 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
..+....+........ ...++.++.+||.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777777665443211 1257889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=316.70 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=203.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|... .+..||+|.+...... .+.+.+|+.+++++. |+||+++++++. .+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN----GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLR-HDKLVQLYAVVS-EEP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec----CCceeEEEEecCCCCC----HHHHHHHHHHHHhcC-CCceEEEEeEEC-CCC
Confidence 467999999999999999999764 3567999998754432 246889999999995 999999999885 456
Q ss_pred EEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++ ++++.++|+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeee
Confidence 899999999999999887542 458999999999999999999999999999999999999 5667899999999987
Q ss_pred cCCCCCc--cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDERL--NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
+...... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+....+....+...... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDC 228 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence 6433221 2234566799999875 458889999999999999999 89999887777777766543221 122357
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+..+.+|+.+||..||.+|||+.++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=328.22 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=197.8
Q ss_pred eecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEE
Q 011154 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIV 216 (492)
Q Consensus 137 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv 216 (492)
.+++.+|.|+++.||++ +. +++.||||++..... .....+.+.+|+++++.++ |+||++++++|.+.+..+++
T Consensus 5 ~i~~~~~~~~~v~~~~~--~~---~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 77 (314)
T cd08216 5 LIGKCFEDLMIVHLAKH--KP---TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVV 77 (314)
T ss_pred hhhHhhcCCceEEEEEe--cC---CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEE
Confidence 34455555555544443 33 688999999976533 3345677999999999995 99999999999999999999
Q ss_pred EeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC
Q 011154 217 MELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 217 ~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~ 295 (492)
||||++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||.+......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~ 154 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKH 154 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccc
Confidence 9999999999988754 3468999999999999999999999999999999999999 55678999999988654322
Q ss_pred CC--------ccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC-----
Q 011154 296 ER--------LNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----- 359 (492)
Q Consensus 296 ~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~----- 359 (492)
.. .....++..|+|||++.. .|+.++|||||||++|+|++|..||..............+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234 (314)
T ss_pred cccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccC
Confidence 11 233457888999998854 48889999999999999999999997655433322111111000
Q ss_pred --C-----------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 360 --D-----------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 360 --~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
. ......++.++.+||.+||..||++|||+.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0 000012346789999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=316.64 Aligned_cols=247 Identities=24% Similarity=0.402 Sum_probs=205.4
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.++||+|+||.||+|..+ +++.||+|.+...... ...+.+|+.+++.+. |+||+++++++. .+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~ 73 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQ-HPRLVRLYAVVT-QE 73 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC----CCceEEEEEecCCCCc----HHHHHHHHHHHHhcC-CcCeeeEEEEEc-cC
Confidence 3578999999999999999999854 4678999998755432 356889999999995 999999999875 46
Q ss_pred eEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.+++||||+.+|+|.+++... ...+++.++..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~ 150 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCccee
Confidence 789999999999999988654 3468999999999999999999999999999999999999 667789999999997
Q ss_pred ccCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
....... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 227 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDN 227 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCC
Confidence 7653221 12334667899999875 458889999999999999999 9999988877777666544321 122345
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++.+||.+||..+|++||+++++++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=321.53 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=201.1
Q ss_pred ceeecceeccccceEEEEEEEec-CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--C
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL--D 211 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~--~ 211 (492)
.|++.+.||+|+||.||++.+.. +..++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.+. .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence 46888999999999999998642 23468899999986443 2334567899999999995 99999999999875 5
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++||||++|++|.+++......+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccc
Confidence 7899999999999999887655578999999999999999999999999999999999999 5567899999999987
Q ss_pred cCCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh--------------hHHHHHH
Q 011154 292 VRPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE--------------SGIFRAV 352 (492)
Q Consensus 292 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~--------------~~~~~~i 352 (492)
+..... .....|+..|+|||++. +.++.++|||||||++|+|+++..|+..... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 654332 12345777899999865 4588999999999999999998776532211 0111111
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 353 LKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 353 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
...... ...+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGKR--LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCcc--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 111111 12234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.35 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=208.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCc-cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEH-KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..+|++.+.||+|+||.||+|.++.... ....||+|.+..... ......+.+|+.+++.+. ||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVD-HPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-C
Confidence 3678999999999999999998765221 234699998865532 345567889999999994 9999999999987 7
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++||||+++|+|.+++......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence 8999999999999999998766679999999999999999999999999999999999999 5667899999999987
Q ss_pred cCCCCCcc---ccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 292 VRPDERLN---DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 292 ~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
........ ...++..|+|||.+. ..++.++|||||||++|+|++ |..||.+....++...+...... .. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL-PQ--PPI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC-CC--CCC
Confidence 65433221 122356799999875 568899999999999999998 99999888777777666654322 11 124
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+.++.+++.+||..||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.43 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=200.7
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||++... ++..||+|++.... .......+.+|+.+++.+ +||||+++++++...+..++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec----CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEEC
Confidence 46899999999999753 46789999986543 233345688999999999 599999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCc-
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL- 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~- 298 (492)
+++|+|.+++......+++..+..++.|++.+|.|||++|++||||||+||++ +.++.+||+|||++.........
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceecccccccc
Confidence 99999999887666678999999999999999999999999999999999999 66778999999998764332211
Q ss_pred -cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011154 299 -NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFV 375 (492)
Q Consensus 299 -~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 375 (492)
....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+...... .....++.++.+|+
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li 227 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVM 227 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence 1223456799999876 458889999999999999998 99999887776666666543221 22246789999999
Q ss_pred HHccccCcCCCCCHHHHhc
Q 011154 376 KLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 376 ~~~L~~dP~~Rps~~e~l~ 394 (492)
.+||..+|.+||++.++++
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 228 QRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHcccCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.33 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=208.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
..+|.+.+.||+|+||.||+|.+.........||||...... .....+.+.+|+.+++.+. ||||+++++++.+ +.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CC
Confidence 356889999999999999999876543345679999885443 2344567899999999995 9999999999876 55
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.|+||||+++|+|.+++......+++..+..++.||+.||.|||+.|++||||||+|||+ +..+.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence 789999999999999987655579999999999999999999999999999999999999 55678999999999876
Q ss_pred CCCCCc--cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 293 RPDERL--NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 293 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
...... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||......+....+...... .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence 543221 1223456799999875 458899999999999999986 99999888777776666554322 1234678
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.++.+||.+||..+|.+|||+.+++..
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=320.23 Aligned_cols=244 Identities=19% Similarity=0.254 Sum_probs=194.5
Q ss_pred ceeccccceEEEEEEEecCC----ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 140 EEVGRGHFGYTCTARYKKGE----HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
+.||+|+||.||+|..+... .....||+|.+.... ....+.+.+|+.+++.+. ||||+++++++..++..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 46999999999999875422 124458888875432 234456888999999994 9999999999999999999
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC-----CCcEEEEeccccc
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE-----SSQLKAIDFGLSD 290 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~-----~~~~kl~DfGla~ 290 (492)
|||||++|+|.+++..+...+++..+..++.||+.||.|||++||+||||||+|||++.++. ...++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999998776667999999999999999999999999999999999999965332 1247999999987
Q ss_pred ccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCC-CCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGS-RPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
..... ....++..|+|||++.+ .++.++|||||||++|+|++|. .||........ ..+......++. ..
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~----~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA----PK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC----CC
Confidence 65432 33568889999998864 4788999999999999999995 55554444333 223333233322 45
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+.++.+||.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.07 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=209.4
Q ss_pred eeecceeccccceEEEEEEEecCC-ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGE-HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+++.+.||.|+||.||+++..... ..+..||+|++..... ....+.+.+|+.+++.+ +|+||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence 356789999999999999876521 2348899999965432 22456789999999999 6999999999999999999
Q ss_pred EEEeecCCCchHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 215 IVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
+||||+++++|.+.+...... +++..+..++.||+.||.|||+.|++||||||+||++ +.++.++|+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence 999999999999988765444 9999999999999999999999999999999999999 666789999999998765
Q ss_pred CCCCcc--ccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 294 PDERLN--DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 294 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
...... ...++..|+|||.+. ..++.++||||+||++|+|++ |..||...........+........ ...++.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCH
Confidence 442222 133778999999875 458899999999999999998 8899988877777777766543322 234789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.+++.+||..||++|||+.|+++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=315.57 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=202.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE-eCCe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE-DLDN 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~-~~~~ 212 (492)
.+|++.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.+++.+. |+||+++++++. +.+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGG 74 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-----cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCc
Confidence 5789999999999999999865 36789999985432 2356889999999995 999999999764 5567
Q ss_pred EEEEEeecCCCchHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.++||||+++|+|.+++.++.. .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKE 151 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCcccee
Confidence 9999999999999999876543 48999999999999999999999999999999999999 6677899999999876
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
..... ....++..|+|||++.+ .++.++|||||||++|+|++ |+.||......+....+.+.... ...+.++.
T Consensus 152 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 226 (256)
T cd05082 152 ASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPP 226 (256)
T ss_pred ccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCH
Confidence 54322 23345678999998764 58889999999999999997 99999887777776666554222 22346789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+.++|.+||+.||++|||+.++++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=317.64 Aligned_cols=244 Identities=20% Similarity=0.242 Sum_probs=193.1
Q ss_pred ceeccccceEEEEEEEecCC---------ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 140 EEVGRGHFGYTCTARYKKGE---------HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~---------~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
+.||+|+||.||++...... .....||+|++.... ......+.+|+.+++.+. ||||+++++++.+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 46899999999999864211 134468999875432 233456788999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC----CCcEEEEec
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE----SSQLKAIDF 286 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~----~~~~kl~Df 286 (492)
...++||||+++|+|..++..+...+++.++..++.||+.||.|||++||+||||||+|||+..++. ...+|++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998887766667999999999999999999999999999999999999953221 123899999
Q ss_pred ccccccCCCCCccccccCcccccccccc--CCCCCccchHHHHHHHHHHh-cCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
|++...... ....|+..|+|||++. +.++.++|||||||++|+|+ +|..||......+... ........
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~---- 228 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCML---- 228 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccC----
Confidence 998765322 3356888999999875 45889999999999999998 5888887655443322 22222211
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
....+.++.+||.+||+.||.+||++.+|+++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 12356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.91 Aligned_cols=256 Identities=19% Similarity=0.266 Sum_probs=203.0
Q ss_pred ccceeecceeccccceEEEEEEEec-------------CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK-------------GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~-------------~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpn 199 (492)
.++|++.+.||+|+||.||++.+.. ...++..||||++.... .......+.+|+.+|+.++ |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence 3579999999999999999986542 11234579999986542 2334567899999999995 999
Q ss_pred ccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCc
Q 011154 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC----------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPEN 269 (492)
Q Consensus 200 iv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~N 269 (492)
|+++++++.+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999886532 237788999999999999999999999999999999
Q ss_pred eEeecCCCCCcEEEEecccccccCCCCC---ccccccCccccccccc-cCCCCCccchHHHHHHHHHHhc--CCCCCCCC
Q 011154 270 FLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLC--GSRPFWAR 343 (492)
Q Consensus 270 ILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~DvwSlGvil~~llt--g~~pf~~~ 343 (492)
||+ +.++.++|+|||++..+..... .....++..|+|||+. .+.++.++|||||||++|+|++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999 5667899999999986543321 1223446789999965 4669999999999999999998 78999877
Q ss_pred ChhHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 344 TESGIFRAVLKA----DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 344 ~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
...+........ ...........++..+.+|+.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 666555433211 011111112356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=314.03 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=205.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||.|+||.||+|.. .|+.||||.+..... ..+.+.+|+.+++.+. |+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-----RGQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-----cCcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCC
Confidence 35788999999999999999975 368899999965432 4567889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKE 151 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccc
Confidence 999999999999999887653 268999999999999999999999999999999999999 6677899999999987
Q ss_pred cCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
..... ....++..|+|||.+. +.++.++|||||||++|+|++ |..||......+....+..... . .....+++
T Consensus 152 ~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~ 226 (256)
T cd05039 152 ASQGQ--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-M--EAPEGCPP 226 (256)
T ss_pred ccccc--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C--CCccCCCH
Confidence 64322 2334566799999875 568889999999999999997 9999988877766665554321 1 11235789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.+||.+||..+|++|||+.+++.
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=317.59 Aligned_cols=253 Identities=27% Similarity=0.482 Sum_probs=204.4
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC--CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT--TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
+|.+.+.||+|+||.||+++... .+..+++|+++..... .......+.+|+.+++.+. ||||+++++++.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCc
Confidence 58899999999999999998765 3444555554332211 1112345678999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 213 VYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.++||||+++++|.+.+.. ....+++.+++.++.|++.||.|||+.|++|+||+|+||++. +..+||+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCce
Confidence 9999999999999888764 335699999999999999999999999999999999999994 245999999998
Q ss_pred cccCCCCC-ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 290 DFVRPDER-LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 290 ~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
........ .....|+..|+|||.+. ..++.++||||||+++|+|++|..||...........+....... ....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 229 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETY 229 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---Ccchh
Confidence 77643332 33456889999999875 457889999999999999999999998776666555554432221 11357
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
+.++.++|.+||..||++||++.++++||||
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.58 Aligned_cols=247 Identities=20% Similarity=0.328 Sum_probs=195.7
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|..... .....+|+|.+.... .......+.+|+.+++.+ +|+||+++++.+.+.+.+|+||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEe
Confidence 3699999999999976533 355679999875432 233456688999999999 599999999999999999999999
Q ss_pred cCCCchHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC
Q 011154 220 CEGGELLDRILSRCG----KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~ 295 (492)
+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccc
Confidence 999999999876432 34678889999999999999999999999999999999 66778999999998654332
Q ss_pred CC---ccccccCcccccccccc--------CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcC-CCCCCC
Q 011154 296 ER---LNDIVGSAYYVAPEVLH--------RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD-PSFDDG 362 (492)
Q Consensus 296 ~~---~~~~~gt~~y~aPE~~~--------~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~-~~~~~~ 362 (492)
.. .....++..|+|||++. ..++.++|||||||++|+|++ |..||......+.+..+.... ..++..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 21 12334667899999864 236779999999999999999 788887777666655544432 222222
Q ss_pred C-CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 363 S-WPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 363 ~-~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
. ...++..+.+++..|+ .||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 2 2357888999999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=314.56 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=203.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+++.+. |+||+++++++.. +.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CC
Confidence 3679999999999999999998653 34699999865432 2356788999999995 9999999998864 56
Q ss_pred EEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++ ++++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceE
Confidence 899999999999999887543 348999999999999999999999999999999999999 6677899999999987
Q ss_pred cCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
...... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+...... .....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---PCPQGC 228 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCccc
Confidence 643322 12234667899999875 458889999999999999999 99999888777777666543221 223467
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+..+.+|+.+||..||.+||+++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.18 Aligned_cols=243 Identities=20% Similarity=0.229 Sum_probs=193.8
Q ss_pred eeccccceEEEEEEEecC---------------------CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCC
Q 011154 141 EVGRGHFGYTCTARYKKG---------------------EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN 199 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~---------------------~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpn 199 (492)
.||+|+||.||+|..... ......||+|++.... ......+.+|+.+++.+. |||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence 599999999999986421 1123568999985432 233456888999999995 999
Q ss_pred ccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC---
Q 011154 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD--- 276 (492)
Q Consensus 200 iv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~--- 276 (492)
|+++++++.+.+..++|||||++|+|...+....+.+++.++..++.||+.||.|||++||+||||||+|||++..+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888876567899999999999999999999999999999999999996421
Q ss_pred -CCCcEEEEecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHh-cCCCCCCCCChhHHHHHH
Q 011154 277 -ESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAV 352 (492)
Q Consensus 277 -~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~ll-tg~~pf~~~~~~~~~~~i 352 (492)
....+||+|||++...... ....++..|+|||.+.+ .++.++|||||||++|+|+ +|..||......+....+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 2335899999988654322 23457888999998753 4889999999999999984 799999877665543332
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 353 LKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 353 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.....++. ..+.++.+||.+||+.+|++|||+.++|++
T Consensus 235 -~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 -EKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222222 356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=313.55 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=207.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|... .++.||||.+..... ..+++.+|+.+++.+. |+||+++++++.+..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~----~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 74 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN----GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEE 74 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc----CCceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCC
Confidence 3578999999999999999999864 346799999875443 2356889999999995 999999999999989
Q ss_pred eEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~ 151 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLAR 151 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccce
Confidence 9999999999999999987654 468999999999999999999999999999999999999 666899999999998
Q ss_pred ccCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
.+..... .....++..|+|||.+. +.++.++|||||||++|+|++ |+.||.+.........+...... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---PRPPN 228 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCC
Confidence 7653221 11223456899999876 458889999999999999998 99999888777777776554221 11235
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+.++.+++.+||..+|.+||++.++++
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=353.23 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=217.8
Q ss_pred cccceeecceeccccceEEEEEEEecCCcc--ccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHK--DQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
-.....+.+.||+|+||.||.|.+...... ...||||.+.+. .+.+...+|.+|..+|+.+ +|||||+++|++.+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD 766 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC
Confidence 356778889999999999999998764333 345888888654 4666788899999999999 59999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 210 LDNVYIVMELCEGGELLDRILSR------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
....+|++|||+||+|..+|.+. ...++..+...++.||+.|+.||+++++|||||-..|+|| ++...+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEE
Confidence 99999999999999999999876 5679999999999999999999999999999999999999 66789999
Q ss_pred EecccccccCCCCCcc-cc--ccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCC
Q 011154 284 IDFGLSDFVRPDERLN-DI--VGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPS 358 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~-~~--~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~ 358 (492)
+|||+|+.+...+... .. .-...|||||.+. +.|+.++|||||||++||++| |..||.+....+++..+..+. .
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R 922 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R 922 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence 9999999554333221 11 1224799999887 679999999999999999999 999999999999988777666 3
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 359 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.+ ..++..+.+++..||+.+|++||++..|++
T Consensus 923 L~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 3332 468999999999999999999999999998
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=313.94 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=194.7
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||+|.+.. ..++..+|+|.+..... ......+.+|+.+++.++ ||||+++++++.+...+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-GYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcC-CCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEEC
Confidence 368999999999998753 33567899999865432 233456889999999995 99999999999999999999999
Q ss_pred cCCCchHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC
Q 011154 220 CEGGELLDRILSRC----GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 220 ~~ggsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~ 295 (492)
+++|+|.+++.... ...++..+..++.|++.||.|||+.|++||||||+||++ +.+..+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCc
Confidence 99999999886532 245777888999999999999999999999999999999 56778999999998754332
Q ss_pred CC---ccccccCccccccccccC--------CCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHh-cCCCCCCC
Q 011154 296 ER---LNDIVGSAYYVAPEVLHR--------SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLK-ADPSFDDG 362 (492)
Q Consensus 296 ~~---~~~~~gt~~y~aPE~~~~--------~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~-~~~~~~~~ 362 (492)
.. .....|+..|+|||++.+ .++.++|||||||++|+|++ |..||......+....... ....+...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 21 123457888999998753 25779999999999999996 9999977665554433222 22222222
Q ss_pred C-CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 363 S-WPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 363 ~-~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
. ....+..+.+++.+|+ .+|.+|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1 1246788999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=316.11 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=199.1
Q ss_pred cceeecceeccccceEEEEEEEec-CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--C
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--L 210 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--~ 210 (492)
.+|++.+.||+|+||.||.+.++. +..++..||||.+... .....+.+.+|+++++.+. ||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 578999999999999999998642 3346889999998644 2344567899999999995 9999999998754 3
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
..+++||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence 56899999999999999987665679999999999999999999999999999999999999 667789999999998
Q ss_pred ccCCCCCc----cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhH---------------HHH
Q 011154 291 FVRPDERL----NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESG---------------IFR 350 (492)
Q Consensus 291 ~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~---------------~~~ 350 (492)
.+...... ....++..|+|||++.+ .++.++|||||||++|+|++|..++......- .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 76433221 11234456999998764 58889999999999999999877754322110 011
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 351 AVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 351 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+......+. ....++.++.+||.+||..+|++|||+.+++.
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1122111111 12357889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=315.14 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=209.6
Q ss_pred cceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
++|++.+.||+|+||.||+|+.+... ...+.||+|.+.... .....+.+.+|+++++++. |+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 67889999999999999999976432 245779999886433 2234567899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 212 NVYIVMELCEGGELLDRILSRC--------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +..+.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence 9999999999999999887543 158999999999999999999999999999999999999 55678999
Q ss_pred EecccccccCCCC--CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCC
Q 011154 284 IDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 284 ~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
+|||++....... ......++..|+|||.+. ..++.++|||||||++|+|++ |..||...........+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999987543222 223445678899999875 457889999999999999998 889998777777766665444333
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.. ...++..+.+++.+||..||.+|||+.+++..
T Consensus 239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 22 23678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=315.28 Aligned_cols=253 Identities=20% Similarity=0.285 Sum_probs=207.1
Q ss_pred ccceeecceeccccceEEEEEEEecCC-ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe-C
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE-HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-L 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-~ 210 (492)
.++|.+.+.||+|+||.||+|.+.... ..+..|++|++... ......+.+.+|+.+++.+ +|+||+++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence 478999999999999999999976422 23688999998643 2344567789999999999 59999999998766 5
Q ss_pred CeEEEEEeecCCCchHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 211 DNVYIVMELCEGGELLDRILSRC-------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
...++++||+++|+|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||+ +.+..+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence 77899999999999999886532 458999999999999999999999999999999999999 56678999
Q ss_pred EecccccccCCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCC
Q 011154 284 IDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPS 358 (492)
Q Consensus 284 ~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~ 358 (492)
+|||+++.+...... ....++..|+|||++. ..++.++|||||||++|++++ |+.||......++...+.... .
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence 999999865433211 2234667899999875 458899999999999999998 999998777666655554432 2
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 359 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+. ....+++++.+++.+||..||++|||+.++++
T Consensus 238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 21 23357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=309.16 Aligned_cols=242 Identities=23% Similarity=0.337 Sum_probs=200.7
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||++.+. .++.||+|++...... .....+.+|+++++++ +|+||+++++++.+.+..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~----~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK----GNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEe----CCCcEEEEeccccCCH--HHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEc
Confidence 46999999999999864 2688999998654332 3456789999999999 499999999999999999999999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCc-
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL- 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~- 298 (492)
+.+++|.+++......+++..+..++.|++.||.|||+++++||||||+|||+ +.++.+||+|||++.........
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee
Confidence 99999999987766678999999999999999999999999999999999999 66778999999998765422211
Q ss_pred --cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011154 299 --NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374 (492)
Q Consensus 299 --~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 374 (492)
....++..|+|||.+. +.++.++|||||||++|+|++ |..||...........+.... .. .....++.++.+|
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~l 227 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RM--PAPQLCPEEIYRL 227 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CC--CCCccCCHHHHHH
Confidence 1123356799999875 468899999999999999999 899998777666665554432 11 1223578899999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q 011154 375 VKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 375 i~~~L~~dP~~Rps~~e~l~ 394 (492)
+.+||..+|.+|||+.++++
T Consensus 228 i~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=310.10 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=204.7
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||++.+. .+..+|+|.+.... ...+.+.+|+.+++.+. |+||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec----CCccEEEEecCCCh----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-C
Confidence 3578999999999999999999754 34569999886432 23467889999999995 9999999999987 7
Q ss_pred eEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
..+++|||+++|+|.+++... ...+++..+..++.||+.||.|||+.|++||||||+||++ +..+.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCccee
Confidence 889999999999999998754 3458899999999999999999999999999999999999 667799999999997
Q ss_pred ccCCCCCc--cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDERL--NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
........ ....++..|+|||++. +.++.++|||||||++|++++ |..||.+.........+...... .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 227 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPEN 227 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---CCccc
Confidence 66433221 2234567799999876 458889999999999999998 99999887777776666543221 22346
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 8899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=312.71 Aligned_cols=254 Identities=28% Similarity=0.502 Sum_probs=209.6
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCC-------CCCHHHHHHHHHHHHHHHHccCCCCccEEEEEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSK-------MTTAIAVEDVRREVKILRALSGHSNLVKFYDAF 207 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~-------~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~ 207 (492)
.|++.+.||+|+||.||++..+.+ .++.+|||.+.... ........++.+|+.++.+..+||||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence 478889999999999999997642 46789999885432 123344566788999887644699999999999
Q ss_pred EeCCeEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEE
Q 011154 208 EDLDNVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 208 ~~~~~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
.+++..++||||++|++|.+.+.. ....+++..++.++.|++.||.|||+ .||+|+||+|+|||+ +.++.+||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l 155 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTI 155 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEE
Confidence 999999999999999999887743 34579999999999999999999996 689999999999999 66778999
Q ss_pred EecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (492)
+|||++.............|+..|+|||++.+ .++.++||||||+++|+|++|..||...........+........
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 99999987665544556679999999998764 588999999999999999999999987766666655554433221
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
....++.++.+||.+||..||++||++.|+..+
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 122578899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=310.50 Aligned_cols=241 Identities=20% Similarity=0.231 Sum_probs=190.2
Q ss_pred ceeccccceEEEEEEEecCC-------ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 140 EEVGRGHFGYTCTARYKKGE-------HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~-------~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
+.||+|+||.||+|.++... .....|++|++..... ....+.+|+.+++.+. ||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 46999999999999987522 0114578887754321 1467889999999995 9999999999988 78
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC----CCCcEEEEeccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD----ESSQLKAIDFGL 288 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~----~~~~~kl~DfGl 288 (492)
.++||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 8999999999999998877655799999999999999999999999999999999999995332 112799999999
Q ss_pred ccccCCCCCccccccCccccccccccC---CCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 289 SDFVRPDERLNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
+..... .....++..|+|||++.+ .++.++|||||||++|+|++ |..||......+........ .....
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~--- 227 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPM--- 227 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCC---
Confidence 987543 223457788999998764 48889999999999999999 57888666543333322211 11111
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.....+.+||.+||..+|.+|||+.++++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 -PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=317.57 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=203.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCc-cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEH-KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|+..+.||+|+||.||+|.+..... ....||+|++..... ......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASM-DHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-
Confidence 3578889999999999999998764211 123689998865432 33345688999999999 599999999998764
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++++||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccccc
Confidence 5679999999999999987766679999999999999999999999999999999999999 5567899999999987
Q ss_pred cCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 292 VRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 292 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
+..... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+.. ...+. ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~--~~~~ 235 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-GERLP--QPPI 235 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCC--CCCC
Confidence 653322 22334577899999876 458899999999999999997 9999977665555444433 22222 2245
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.+.++.+++.+||..+|++||++.+++..
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=311.84 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=205.0
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC----
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD---- 211 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~---- 211 (492)
|.+.+.||+|+||.||+|.++.+..+++.||||++..... .....+++.+|+++++.+. ||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 5678899999999999999876666789999999965433 3345677889999999995 999999999886532
Q ss_pred --eEEEEEeecCCCchHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 212 --NVYIVMELCEGGELLDRILSRC-----GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 212 --~~~lv~E~~~ggsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
..++++||+.+|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.+..+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence 2478999999999988775321 247899999999999999999999999999999999999 567789999
Q ss_pred ecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCC
Q 011154 285 DFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 285 DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
|||+++....... .....++..|++||.+. +.++.++|||||||++|+|++ |..||.+....+....+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999987643321 12334567899999875 458889999999999999999 899998777777766665543221
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..+..+..+.+++.+||..+|++|||+.+++.+
T Consensus 236 ---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 ---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 113577899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=313.47 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=203.8
Q ss_pred cceeecceeccccceEEEEEEEecC-CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--C
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKG-EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--L 210 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--~ 210 (492)
.+|++.+.||+|+||.||+|.+... ..++..||||++...... ...+.+.+|+++++.+. |+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 4678889999999999999987532 335789999999765432 34567999999999995 9999999999887 5
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
...++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 67999999999999999997765579999999999999999999999999999999999999 566899999999998
Q ss_pred ccCCCCCc----cccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhH--------------HHHH
Q 011154 291 FVRPDERL----NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESG--------------IFRA 351 (492)
Q Consensus 291 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~--------------~~~~ 351 (492)
........ ....++..|+|||.+. ..++.++|||||||++|+|++|..||....... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 77533221 1234556799999775 458889999999999999999999986532211 1122
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.......... ...++.++.+|+.+||..+|.+|||+.++++
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222222221 2356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=308.65 Aligned_cols=247 Identities=19% Similarity=0.280 Sum_probs=194.3
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.||+|+||.||++....+ .....+++|.+.... .....+.+.+|+.+++.+ +||||+++++.|.+....|+||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~-~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTD-TGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcC-CCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEec
Confidence 3699999999999976532 234567778775433 233456789999999999 599999999999999999999999
Q ss_pred cCCCchHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCC
Q 011154 220 CEGGELLDRILSRC---GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296 (492)
Q Consensus 220 ~~ggsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~ 296 (492)
|++|+|.+++.+.. ..+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcch
Confidence 99999999887542 346777888999999999999999999999999999999 667789999999986432221
Q ss_pred ---CccccccCccccccccccC--------CCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcC-CCCCCC-
Q 011154 297 ---RLNDIVGSAYYVAPEVLHR--------SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD-PSFDDG- 362 (492)
Q Consensus 297 ---~~~~~~gt~~y~aPE~~~~--------~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~-~~~~~~- 362 (492)
......|+..|+|||++.. .++.++|||||||++|+|++ |..||......+.+..+.... ......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 1234568899999998742 35678999999999999996 577887777766666654433 222211
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
....+++.+.+++..|| .+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 22347888999999999 68999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=335.33 Aligned_cols=260 Identities=29% Similarity=0.501 Sum_probs=218.8
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..-++.|++.+.||.|.+|+||+++.++ +++.+|||+....... .++++.|..||+.+.+|||++.+|++|..
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445789999999999999999998765 7888999988654432 35677899999999999999999999863
Q ss_pred -----CCeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 210 -----LDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 210 -----~~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
++.+|||||||.|||..|.+.+- +.++.|..+..|++.++.|+.+||.+.++|||||-.|||+ ..++.|||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEE
Confidence 57899999999999999988653 4579999999999999999999999999999999999999 56778999
Q ss_pred EecccccccCCC-CCccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC
Q 011154 284 IDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 356 (492)
Q Consensus 284 ~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~ 356 (492)
+|||++..+... .+.++.+||++|||||++. ..|+..+|+||||++..||--|.+|+.+......+-.|...
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN- 243 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN- 243 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-
Confidence 999999877544 3456789999999999874 23778999999999999999999999776664444333322
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 357 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
+......|...+.++.+||..||.+|-.+||+..++|.|||++.
T Consensus 244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 22233345677899999999999999999999999999999994
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=311.38 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=200.2
Q ss_pred ceeccccceEEEEEEEecCC---ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEE
Q 011154 140 EEVGRGHFGYTCTARYKKGE---HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIV 216 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv 216 (492)
+.||+|+||.||+|..+... ..++.||||.+.+... ......+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 36899999999999876421 2346899999865432 223457889999999994 99999999999999999999
Q ss_pred EeecCCCchHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC--CCCcEEEEeccc
Q 011154 217 MELCEGGELLDRILSR------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD--ESSQLKAIDFGL 288 (492)
Q Consensus 217 ~E~~~ggsL~~~l~~~------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~--~~~~~kl~DfGl 288 (492)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+.+++|+||||+|||++.++ ....+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999998753 23478999999999999999999999999999999999996433 223799999999
Q ss_pred ccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 289 SDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 289 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
+........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||......+....+...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CC
Confidence 876543321 12234567899999876 568999999999999999998 99999877776666655433211 12
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
...++..+.+||.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2467899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=307.66 Aligned_cols=241 Identities=25% Similarity=0.396 Sum_probs=200.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||.+.. +++.||+|.+.... ..+.+.+|+.+++.+. ||||+++++++..+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----CCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-Cc
Confidence 5689999999999999998753 56789999985432 2356889999999995 99999999998764 57
Q ss_pred EEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+|||+ +.++.+||+|||++...
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVG 150 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceec
Confidence 99999999999999987653 358999999999999999999999999999999999999 56678999999998764
Q ss_pred CCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
... ......+..|+|||.+. +.++.++|||||||++|+|++ |..||......+....+.+... . .....++..
T Consensus 151 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~ 225 (254)
T cd05083 151 SMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-M--EPPEGCPAD 225 (254)
T ss_pred ccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-C--CCCCcCCHH
Confidence 322 22334457899999875 568899999999999999997 9999988777766666654321 1 122467899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+.+|+.+||+.+|.+||++.++++
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=335.80 Aligned_cols=247 Identities=30% Similarity=0.453 Sum_probs=198.0
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC---
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD--- 211 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~--- 211 (492)
.+...+.||+|+||.||+++.+. +|+.||||.+.+... ....+..-+|+++|++|. |+|||+++++-++..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKESS--LRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGL 87 (732)
T ss_pred ceeehhhhcCCccceeeeecccc---cccchhHHhhhhhcc--cchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCc
Confidence 45567889999999999999776 899999999976442 224566789999999995 999999999876544
Q ss_pred ---eEEEEEeecCCCchHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC-CCCcEEEEe
Q 011154 212 ---NVYIVMELCEGGELLDRILS--RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAID 285 (492)
Q Consensus 212 ---~~~lv~E~~~ggsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~-~~~~~kl~D 285 (492)
...+|||||.||||...+.+ +...+++.+...++..+..||.|||++|||||||||.||++.... .....||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 57899999999999998863 345699999999999999999999999999999999999986533 445689999
Q ss_pred cccccccCCCCCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCCh----hHHHHHHHhcCCCC
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSF 359 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~----~~~~~~i~~~~~~~ 359 (492)
||.|+.+..+....+.+||+.|++||+.. +.|+..+|.|||||++|++.||.+||-.... .++...+....+.-
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99999999999999999999999999886 5689999999999999999999999954322 22333333322211
Q ss_pred C-----------------CCCCCCCCHH----HHHHHHHccccCcCCCC
Q 011154 360 D-----------------DGSWPSLSSD----AKDFVKLLLNKDPRKRM 387 (492)
Q Consensus 360 ~-----------------~~~~~~~s~~----~~~li~~~L~~dP~~Rp 387 (492)
. .+..-.++.. +...+..+|..+|++|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0 0001123333 44668889999999999
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=336.71 Aligned_cols=258 Identities=25% Similarity=0.411 Sum_probs=224.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+...+.+.||.|.||.||.++++........||||.++... ......+|+.|..||-++ +||||++|.|+.....-+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCcee
Confidence 44567889999999999999999866677889999996443 455677899999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
.||+|||++|+|..+|.++.+.|+..+..-+++.|+.|++||-+.|+|||||-..|||+ +.+..+|++||||++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999 778899999999999886
Q ss_pred CCCC--cccccc--Ccccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 294 PDER--LNDIVG--SAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 294 ~~~~--~~~~~g--t~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
++.. .++.-| ...|.|||.+. +.++.++||||+||+|||.++ |.+|||+.+..+.+..|.++-.-.+ ...+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp---PmDC 859 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP---PMDC 859 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC---CCCC
Confidence 5441 122222 25799999774 889999999999999998876 9999999999999999987643322 2478
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcC--ccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSH--PWIRN 400 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~h--p~~~~ 400 (492)
+..+..|+..||++|=.+||.+.||+.+ ..+++
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 9999999999999999999999999874 34443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=305.53 Aligned_cols=228 Identities=24% Similarity=0.337 Sum_probs=186.1
Q ss_pred ccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecCCCc
Q 011154 145 GHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGE 224 (492)
Q Consensus 145 G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ggs 224 (492)
|.||.||+|+++. +++.||+|++.+.. ...+|...+... .||||+++++++.+.+.+++||||++||+
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCC
Confidence 8899999999765 78899999996543 123444555555 49999999999999999999999999999
Q ss_pred hHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccccccC
Q 011154 225 LLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304 (492)
Q Consensus 225 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt 304 (492)
|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++..+... .....++
T Consensus 72 L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~ 145 (237)
T cd05576 72 LWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVE 145 (237)
T ss_pred HHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcC
Confidence 99988654 569999999999999999999999999999999999999 66678999999987665432 2344567
Q ss_pred cccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCc
Q 011154 305 AYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDP 383 (492)
Q Consensus 305 ~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 383 (492)
..|+|||.+. +.++.++||||+||++|+|++|..||...... + .....+. ....++..+++||.+||+.||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~--~~~~~~~~~~~li~~~l~~dp 217 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLN--IPEWVSEEARSLLQQLLQFNP 217 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccC--CcccCCHHHHHHHHHHccCCH
Confidence 8899999876 45888999999999999999999987543221 0 0001111 113578999999999999999
Q ss_pred CCCCCH-----HHHhcCccc
Q 011154 384 RKRMTA-----AQALSHPWI 398 (492)
Q Consensus 384 ~~Rps~-----~e~l~hp~~ 398 (492)
++|+++ +++++||||
T Consensus 218 ~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 218 TERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHhcCCCccchHHHHcCCCC
Confidence 999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.11 Aligned_cols=261 Identities=21% Similarity=0.263 Sum_probs=177.9
Q ss_pred cccceeecceeccccceEEEEEEEecC-CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEE----
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKG-EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDA---- 206 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~---- 206 (492)
..++|++.+.||+|+||.||+|++..+ ...+..||||++..... .+....| .++.. .+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~-~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRA-CPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhh-chhhHHHHHHhhhcc
Confidence 357899999999999999999998652 11278999998854321 1111111 11122 12333322222
Q ss_pred --EEeCCeEEEEEeecCCCchHHHHHhhCCC-------------------CCHHHHHHHHHHHHHHHHHHHHcCCcccCC
Q 011154 207 --FEDLDNVYIVMELCEGGELLDRILSRCGK-------------------YSEDEAKAVLVQILNVVAFCHLHGVVHRDL 265 (492)
Q Consensus 207 --~~~~~~~~lv~E~~~ggsL~~~l~~~~~~-------------------~~~~~~~~i~~qi~~~l~ylH~~~ivHrDl 265 (492)
..+...+++||||+.+++|.+++...... ..+..+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 24567899999999999999988654211 123456789999999999999999999999
Q ss_pred CCCceEeecCCCCCcEEEEecccccccCCCC--CccccccCcccccccccc-C----------------------CCCCc
Q 011154 266 KPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-R----------------------SYGTE 320 (492)
Q Consensus 266 kp~NILl~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~----------------------~~~~~ 320 (492)
||+|||++. ..+.+||+|||+|+.+.... .....+||+.|||||.+. . .++.+
T Consensus 282 KP~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999942 34689999999998664332 234568999999999642 1 23456
Q ss_pred cchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC-----------CCC------CCCCCCCHHHHHHHHHccccCc
Q 011154 321 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS-----------FDD------GSWPSLSSDAKDFVKLLLNKDP 383 (492)
Q Consensus 321 ~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~-----------~~~------~~~~~~s~~~~~li~~~L~~dP 383 (492)
+||||||||+|||+++..++.... ......+...... ... .........+.+||.+||++||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 799999999999999877653221 1111111111100 000 0011123346699999999999
Q ss_pred CCCCCHHHHhcCcccccccc
Q 011154 384 RKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 384 ~~Rps~~e~l~hp~~~~~~~ 403 (492)
++|||+.|+|+||||+....
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999987643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=314.82 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=209.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
++...++++||+|.||.|.++... .+..||||.++... ......+|.+|+++|.+|+ |||||+|+++|..++-
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE----GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDP 609 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec----CceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCc
Confidence 467788999999999999998754 35899999997654 3345678999999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+++|+|||++|+|..++.++..+ +.......|+.||+.|++||.+.++|||||.+.|+|+ |.++++||+|||+++.
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRN 686 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccc
Confidence 99999999999999999876333 3555667799999999999999999999999999999 8899999999999997
Q ss_pred cCCCCCcc---ccccCccccccc-cccCCCCCccchHHHHHHHHHHh--cCCCCCCCCChhHHHHHHHhcCCCCCCC---
Q 011154 292 VRPDERLN---DIVGSAYYVAPE-VLHRSYGTEADVWSIGVIAYILL--CGSRPFWARTESGIFRAVLKADPSFDDG--- 362 (492)
Q Consensus 292 ~~~~~~~~---~~~gt~~y~aPE-~~~~~~~~~~DvwSlGvil~~ll--tg~~pf~~~~~~~~~~~i~~~~~~~~~~--- 362 (492)
+-.++... ..+-...|||+| ++.+++++++|||+|||.+||++ |...||...+++++.++.......-...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 76555432 234557899999 56799999999999999999875 6899999888888777665433222211
Q ss_pred -CCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 363 -SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 363 -~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
..+-++..+.+|+.+||..|-++||+.+++-.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 12357889999999999999999999999744
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=309.17 Aligned_cols=254 Identities=15% Similarity=0.209 Sum_probs=187.9
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHH--------HHHHHHHHHHHHccCCCCcc
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAV--------EDVRREVKILRALSGHSNLV 201 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~--------~~~~~Ev~~l~~l~~hpniv 201 (492)
+....+|++.+.||+|+||.||+|.+..+...+..+|+|+............ .....++..+..+ +|+||+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIP 86 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCC
Confidence 3445789999999999999999999776433366778886543322110000 0112233444556 599999
Q ss_pred EEEEEEEeCC----eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC
Q 011154 202 KFYDAFEDLD----NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277 (492)
Q Consensus 202 ~l~~~~~~~~----~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~ 277 (492)
++++++.... ..++++|++.. ++.+.+. .....++..++.++.||+.||.|||+.+|+||||||+|||+ +.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~ 161 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DG 161 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cC
Confidence 9999876543 45788888744 5655543 33457899999999999999999999999999999999999 56
Q ss_pred CCcEEEEecccccccCCCC--------CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChh-H
Q 011154 278 SSQLKAIDFGLSDFVRPDE--------RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTES-G 347 (492)
Q Consensus 278 ~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-~ 347 (492)
++.+||+|||+|+.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... .
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 6789999999998664221 1123469999999998764 5899999999999999999999999776332 2
Q ss_pred H--------HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 348 I--------FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 348 ~--------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
. ...+..... ..+..+.++.+++..|+..+|++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 222222221 22356889999999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=290.37 Aligned_cols=255 Identities=27% Similarity=0.554 Sum_probs=210.3
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
-.++|++.+++|+|.|+.|+.|.... +++.++||+++.- ..+.+.+|++||..|++||||++|+++..+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC---CCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 46889999999999999999998544 6788999999533 3467899999999999999999999998875
Q ss_pred -CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 -DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
....||+||+++.+... + ...++.-+++.++.+++.||.|||+.||+|||+||.|++|+. +...++|+|+|||
T Consensus 107 SktpaLiFE~v~n~Dfk~-l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQ-L---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--ELRKLRLIDWGLA 180 (338)
T ss_pred ccCchhHhhhhccccHHH-H---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--hhceeeeeecchH
Confidence 45789999998866443 3 256899999999999999999999999999999999999963 4557999999999
Q ss_pred cccCCCCCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCC-CChhHHHHHHHh------------
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLK------------ 354 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~-~~~~~~~~~i~~------------ 354 (492)
.+..++...+-.+.+.+|--||.+- +.|+.+-|+|||||++..|+..+.||.. .+..+.+..|.+
T Consensus 181 EFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 181 EFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 9999998888889999999999874 5699999999999999999999999854 333333333221
Q ss_pred -cC----CCC-------CCCCCC---------CCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 355 -AD----PSF-------DDGSWP---------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 355 -~~----~~~-------~~~~~~---------~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
-. +.+ ....|. -+++++.|||.++|..|-.+|+|+.|++.||||...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 11 111 111221 246899999999999999999999999999999753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=325.31 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=219.7
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++..+.++||+|+||.|++|.|+.-..+--.||||++....... ...+|++|+.+|.+|+ |+|+++|||+..+ .-.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence 45667889999999999999998754455679999997665543 5678999999999995 9999999999987 778
Q ss_pred EEEEeecCCCchHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRILS-RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.+|||+|++|+|+++|.+ ....|.......++.||+.|+.||..+++|||||-..|+|+.. ...|||+||||.+-+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceecc
Confidence 899999999999999987 4467889999999999999999999999999999999999954 458999999999988
Q ss_pred CCCCCcccccc----Ccccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 293 RPDERLNDIVG----SAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 293 ~~~~~~~~~~g----t~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
..++......+ ...|.|||.++ +.++.++|||+|||.+|||+| |+-||.+.....++++|..+. .++.. +.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-rLpRP--k~ 339 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-RLPRP--KY 339 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-cCCCC--CC
Confidence 76665443322 34699999886 779999999999999999998 899999999999999987443 23222 36
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
+++++.+++++||..+|.+|||+..|.+.-+++.
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 8999999999999999999999999987666654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=324.65 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=192.2
Q ss_pred cccceeecceeccccceEEEEEEEec-------------CCccccEEEEEEccCCCCCCHH-----------HHHHHHHH
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKK-------------GEHKDQKVAIKVIPKSKMTTAI-----------AVEDVRRE 187 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~-------------~~~~~~~vavK~i~~~~~~~~~-----------~~~~~~~E 187 (492)
-.++|++.++||+|+||.||+|.+.. ....++.||||++......... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 36789999999999999999997521 1224578999998543211100 01123457
Q ss_pred HHHHHHccCCCC-----ccEEEEEEEe--------CCeEEEEEeecCCCchHHHHHhhCC--------------------
Q 011154 188 VKILRALSGHSN-----LVKFYDAFED--------LDNVYIVMELCEGGELLDRILSRCG-------------------- 234 (492)
Q Consensus 188 v~~l~~l~~hpn-----iv~l~~~~~~--------~~~~~lv~E~~~ggsL~~~l~~~~~-------------------- 234 (492)
+.++.+++ |.+ +++++++|.. .+..+|||||+++|+|.+++....+
T Consensus 223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 77888885 544 4677777753 3568999999999999998864321
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCcccc--ccCccccc
Q 011154 235 ---KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI--VGSAYYVA 309 (492)
Q Consensus 235 ---~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~--~gt~~y~a 309 (492)
.+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++..+......... .+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 24567889999999999999999999999999999999 56678999999999766543333322 34789999
Q ss_pred cccccCC---------------------CC--CccchHHHHHHHHHHhcCCC-CCCCCC-----------hhHHHHHHHh
Q 011154 310 PEVLHRS---------------------YG--TEADVWSIGVIAYILLCGSR-PFWART-----------ESGIFRAVLK 354 (492)
Q Consensus 310 PE~~~~~---------------------~~--~~~DvwSlGvil~~lltg~~-pf~~~~-----------~~~~~~~i~~ 354 (492)
||.+... |+ .+.||||+|||+|+|++|.. ||.... ....++.+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 9976421 12 24799999999999999986 764321 1112222222
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHccccCc---CCCCCHHHHhcCccccc
Q 011154 355 ADPSFDDGSWPSLSSDAKDFVKLLLNKDP---RKRMTAAQALSHPWIRN 400 (492)
Q Consensus 355 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~Rps~~e~l~hp~~~~ 400 (492)
.... ...|..+++.++||+.+||..+| .+|+|+.|+|+||||..
T Consensus 459 ~~~~--~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKYD--FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cCCC--cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 3333 33567889999999999999876 68999999999999964
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=305.05 Aligned_cols=264 Identities=29% Similarity=0.482 Sum_probs=204.1
Q ss_pred ccccc-cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-------CCc
Q 011154 129 SKEVT-SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-------SNL 200 (492)
Q Consensus 129 ~~~~~-~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-------pni 200 (492)
.+.+. .+|.+.++||.|.|++||++++.. ..+.||+|+++.... ..+....||++|++++.+ .+|
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 35566 899999999999999999999665 678999999975543 334567899999998733 379
Q ss_pred cEEEEEEEe----CCeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeec
Q 011154 201 VKFYDAFED----LDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTS 274 (492)
Q Consensus 201 v~l~~~~~~----~~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~ 274 (492)
|+|++.|.. ..++++|+|++ |-+|+..|... .+.++...++.|++||+.||.|||.. ||||-||||+|||+..
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence 999999975 45899999999 67899888754 45699999999999999999999996 8999999999999910
Q ss_pred C-------------------------------------------------------------------------------
Q 011154 275 K------------------------------------------------------------------------------- 275 (492)
Q Consensus 275 ~------------------------------------------------------------------------------- 275 (492)
.
T Consensus 224 ~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~ 303 (590)
T KOG1290|consen 224 TEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESY 303 (590)
T ss_pred cccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccc
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 011154 276 -------------------------------------------------------------------------------- 275 (492)
Q Consensus 276 -------------------------------------------------------------------------------- 275 (492)
T Consensus 304 n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~ 383 (590)
T KOG1290|consen 304 NNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPD 383 (590)
T ss_pred ccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCC
Confidence
Q ss_pred ----CCCCcEEEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCCh-----
Q 011154 276 ----DESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTE----- 345 (492)
Q Consensus 276 ----~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~----- 345 (492)
..+.++||+|||-|.++. ..++.-+-|+.|+|||++-+ .|+..+||||++|++|||.||...|.-...
T Consensus 384 ~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r 461 (590)
T KOG1290|consen 384 IPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR 461 (590)
T ss_pred CCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence 001257899999998863 45666678999999998765 699999999999999999999999943211
Q ss_pred -hHHHHHHHh------------cCC--CC-----------CCCCCC---------CC----CHHHHHHHHHccccCcCCC
Q 011154 346 -SGIFRAVLK------------ADP--SF-----------DDGSWP---------SL----SSDAKDFVKLLLNKDPRKR 386 (492)
Q Consensus 346 -~~~~~~i~~------------~~~--~~-----------~~~~~~---------~~----s~~~~~li~~~L~~dP~~R 386 (492)
++.+..|.. +.. .| ....|+ .. ..++.+||.-||+.+|++|
T Consensus 462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR 541 (590)
T KOG1290|consen 462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR 541 (590)
T ss_pred cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence 111111111 110 00 001222 11 2467899999999999999
Q ss_pred CCHHHHhcCccccccc
Q 011154 387 MTAAQALSHPWIRNYN 402 (492)
Q Consensus 387 ps~~e~l~hp~~~~~~ 402 (492)
+||.++|+||||....
T Consensus 542 ~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 542 PTAAQCLKHPWLNPVA 557 (590)
T ss_pred ccHHHHhcCccccCCC
Confidence 9999999999998653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=298.48 Aligned_cols=260 Identities=24% Similarity=0.343 Sum_probs=211.5
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+.+-...||.|+||+|++-.++. .|+..|||+|..... .....+++.|++...+-.+.||||++||.+..++..|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCc---cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 34445679999999999998876 899999999976554 3455678999998888778999999999999999999
Q ss_pred EEEeecCCCchHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 215 IVMELCEGGELLDRIL----SRCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~----~~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
+.||+|+- ||..+.. -+...++|.-+..|....+.||.||-.. +|||||+||+|||+ +..+.+||||||++
T Consensus 140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGIC 215 (361)
T ss_pred eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccch
Confidence 99999964 5433222 1235799999999999999999999875 89999999999999 88889999999998
Q ss_pred cccCCCCCccccccCcccccccccc---CCCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHHHHhcCCCCCCCC--
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH---RSYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGS-- 363 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~-- 363 (492)
..+...-..+.-+|-..|||||.+. ..|+.++||||||+.|||+.||..||..... .+.+..+..+++......
T Consensus 216 GqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 216 GQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc
Confidence 7765443344457889999999885 3499999999999999999999999965443 344455555555433222
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
--+++..+..||.-||.+|-+.||...+++++||++.+..
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 1357899999999999999999999999999999998753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=316.09 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=212.4
Q ss_pred cceeecceeccccceEEEEEEEecC-CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKG-EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
+...+.+.||.|-||.||.|.+..- ....-.||||.-+.+.. ....+.|..|..+|+.+ +|||||+|+|+|.+ .-
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnf-dHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhC-CCcchhheeeeeec-cc
Confidence 4445567899999999999998653 22345689998866443 33467899999999999 69999999999986 56
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.|||||+++-|+|..++..+...++......++.||+.+|.|||+.++|||||-..|||+.+ ...|||+||||++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS---p~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS---PQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC---cceeeecccchhhhc
Confidence 89999999999999999988788999999999999999999999999999999999999954 448999999999999
Q ss_pred CCCCCcccccc--Ccccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 293 RPDERLNDIVG--SAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 293 ~~~~~~~~~~g--t~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
..........| ..-|||||-++ +.++.++|||-|||.+||++. |..||.+-...+.+-.|.++..... .+.++
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~---P~nCP 618 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC---PPNCP 618 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---CCCCC
Confidence 87766554444 34699999876 679999999999999999886 9999999888887777777664432 24789
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+.+..|+.+||..||.+||++.++..
T Consensus 619 p~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHHH
Confidence 99999999999999999999877643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=315.70 Aligned_cols=265 Identities=27% Similarity=0.460 Sum_probs=218.4
Q ss_pred hcCCccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc-----CCCC
Q 011154 125 RFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS-----GHSN 199 (492)
Q Consensus 125 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~-----~hpn 199 (492)
++.+.+.+-.+|.+....|+|-|++|+.|.+.. .|..||||+|..+... .+.=++|++||++|. +--|
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhH
Confidence 345567788999999999999999999998654 6789999999765443 234467999999996 2348
Q ss_pred ccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC
Q 011154 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG--KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277 (492)
Q Consensus 200 iv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~ 277 (492)
+++|+..|...+++|||+|-+.- +|.+.|.+-+. .|....+..++.|++.||..|-..||+|.||||+|||++ ..
T Consensus 496 clrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~ 572 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ES 572 (752)
T ss_pred HHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cC
Confidence 99999999999999999998854 88888765433 478889999999999999999999999999999999996 44
Q ss_pred CCcEEEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC
Q 011154 278 SSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 356 (492)
Q Consensus 278 ~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~ 356 (492)
...+||||||.|.++..++ .+.+..+..|.|||++.+ .|+...|+||+||.||||.||+..|.+.+...+++......
T Consensus 573 k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred cceeeeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 5689999999998887554 444556788999998776 69999999999999999999999999999888877765544
Q ss_pred CCCCCCCC-------------------------------------------------CCCC-------HHHHHHHHHccc
Q 011154 357 PSFDDGSW-------------------------------------------------PSLS-------SDAKDFVKLLLN 380 (492)
Q Consensus 357 ~~~~~~~~-------------------------------------------------~~~s-------~~~~~li~~~L~ 380 (492)
..|+.... +.++ ..+++||.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 44432110 0111 357899999999
Q ss_pred cCcCCCCCHHHHhcCccccc
Q 011154 381 KDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 381 ~dP~~Rps~~e~l~hp~~~~ 400 (492)
.||.+|.|+.|+|.||||..
T Consensus 732 LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 732 LDPEKRITVNQALKHPFITE 751 (752)
T ss_pred cChhhcCCHHHHhcCCcccC
Confidence 99999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.23 Aligned_cols=242 Identities=46% Similarity=0.777 Sum_probs=204.7
Q ss_pred cceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecCCCch
Q 011154 146 HFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGEL 225 (492)
Q Consensus 146 ~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ggsL 225 (492)
+||.||++.... +|+.||+|++........ .+.+.+|++.++++ +|+||+++++++......++++||+.+++|
T Consensus 1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKK--RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECC---CCcEEEEEEecccccccH--HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 589999999765 678999999976544322 56789999999999 599999999999999999999999999999
Q ss_pred HHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccccccCc
Q 011154 226 LDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305 (492)
Q Consensus 226 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~ 305 (492)
.+++... ..+++..+..++.+++.++.|||+.+|+|+||+|.||++ +.++.++|+|||++.............++.
T Consensus 75 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTP 150 (244)
T ss_pred HHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCc
Confidence 9988654 348999999999999999999999999999999999999 556789999999998876655556677899
Q ss_pred ccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCC-CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCc
Q 011154 306 YYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDP 383 (492)
Q Consensus 306 ~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 383 (492)
.|++||.+. ..++.++||||||+++|+|++|..||.. .....+...+....... ...+..++.++.+++.+||..+|
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-PPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-ccccccCCHHHHHHHHHHccCCc
Confidence 999999875 5688899999999999999999999987 44444555444433332 22222388999999999999999
Q ss_pred CCCCCHHHHhcCccc
Q 011154 384 RKRMTAAQALSHPWI 398 (492)
Q Consensus 384 ~~Rps~~e~l~hp~~ 398 (492)
++||++.++++||||
T Consensus 230 ~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 230 EKRLTAEEALQHPFF 244 (244)
T ss_pred hhccCHHHHhhCCCC
Confidence 999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.08 Aligned_cols=249 Identities=31% Similarity=0.463 Sum_probs=199.2
Q ss_pred cceeccccce-EEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEE
Q 011154 139 GEEVGRGHFG-YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVM 217 (492)
Q Consensus 139 ~~~lG~G~fg-~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~ 217 (492)
.+.+|.|+-| .||+|.+ .|+.||||++-.. ......+||..|+.-.+|||||++|+.-.+....||..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-----e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-----EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred HHHcccCCCCcEEEEEee-----CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 4678999998 7888887 5689999998432 23456899999999989999999999999999999999
Q ss_pred eecCCCchHHHHHhhCCC--C-CHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC--CCCcEEEEeccccccc
Q 011154 218 ELCEGGELLDRILSRCGK--Y-SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD--ESSQLKAIDFGLSDFV 292 (492)
Q Consensus 218 E~~~ggsL~~~l~~~~~~--~-~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~--~~~~~kl~DfGla~~~ 292 (492)
|+|.. +|.|++...... . .....+.++.|++.||++||+.+||||||||.||||...+ ....++|+|||+++.+
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99976 999988763111 1 1145678999999999999999999999999999998643 3457999999999988
Q ss_pred CCCCC----ccccccCccccccccccCC-CCCccchHHHHHHHHHHhcC-CCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 293 RPDER----LNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 293 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DvwSlGvil~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
..+.. ..+..||-+|+|||++... -+.++||||+|||+|+.++| ..||..... ...+|+.+......-. +.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~-~~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLE-PL 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeec-cC
Confidence 75543 4567899999999998754 45679999999999999885 999965443 2345666555443211 11
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
...+++|||.+||++||..||+|.++|.||+|....
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 112899999999999999999999999999998753
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=306.99 Aligned_cols=243 Identities=23% Similarity=0.399 Sum_probs=207.4
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
.....+||-|.||.||.++|++ -...||||.++.+. ..+++|+.|..+|+.+. |||+|+|+|+|..+--+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKEDt----MeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred eeeeeccCCCcccceeeeeeec---cceeeehhhhhhcc----hhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEE
Confidence 3345789999999999999997 44679999996554 35788999999999995 9999999999999999999
Q ss_pred EEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 216 VMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
|+|||..|+|+|+|.+-. ..++--....++.||.+|++||..+++|||||-..|+|+ +++..|||+||||++++..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcC
Confidence 999999999999997643 346677778899999999999999999999999999999 7888999999999999874
Q ss_pred CCCcccccc---Ccccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 295 DERLNDIVG---SAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 295 ~~~~~~~~g---t~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
+. .+...| .+-|.|||-+. +.++.|+|||+|||+|||+.| |..||.+.+....+..+.++. .... ...+++
T Consensus 418 DT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-RM~~--PeGCPp 493 (1157)
T KOG4278|consen 418 DT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-RMDG--PEGCPP 493 (1157)
T ss_pred Cc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-cccC--CCCCCH
Confidence 43 333334 35699999775 679999999999999999988 999999999888887766543 3332 247999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHh
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQAL 393 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l 393 (492)
...+|++.||+.+|.+||+++|+-
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHH
Confidence 999999999999999999998863
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=295.02 Aligned_cols=255 Identities=29% Similarity=0.499 Sum_probs=206.4
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
+..+|.-...+|.|.- .|+.+.+. ..++.||+|.+... .......+...+|..++..+ +|+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~---v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQ---VLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchh---hccCceehhhhcCc-cccCccchhhhhhhhhhhhh-cccceeeeeeccCccc
Confidence 3457777888999987 67777643 47899999998655 33344556788999999999 599999999999533
Q ss_pred -----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 211 -----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 211 -----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
.++|+|||||.. +|...++. .++-..+..|+.|+++|++|||+.||+||||||+||++ ..+..+||.|
T Consensus 89 ~l~~~~e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~d 161 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILD 161 (369)
T ss_pred cHHHHHhHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeecc
Confidence 469999999975 88887763 57888999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-------
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------- 357 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~------- 357 (492)
||+|+.....-.++.++.|++|+|||++-+ .|...+||||+|||+.||++|...|.+...-+.+.++.....
T Consensus 162 fg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 162 FGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred chhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 999998877767788999999999997643 499999999999999999999999987665544444322111
Q ss_pred ------------------------CCCCCCCCC-------CCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 358 ------------------------SFDDGSWPS-------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 358 ------------------------~~~~~~~~~-------~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
.|++..|+. -+..+++|+.+||..||++|.++.++|+|||++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 112222221 234689999999999999999999999999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=284.09 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=201.2
Q ss_pred ecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-----Ce
Q 011154 138 VGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL-----DN 212 (492)
Q Consensus 138 ~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~-----~~ 212 (492)
-.+.||-|+||+||.+.+-. +|+.||+|.+.. ....-...+.+.+|+++|...+ |.|++..++...-. .+
T Consensus 57 PDRPIGYGAFGVVWsVTDPR---dgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPR---SGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCCcccccceeEEEeccCCC---CccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHH
Confidence 34679999999999998544 899999998853 2334445677899999999996 99999999877543 35
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|+|+|.. +|...|.. ...++.++++-++.||++||+|||+.+|.||||||.|.|+ +.+-.+||||||+|+..
T Consensus 132 iYV~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEeccccccccc
Confidence 7899999964 66665543 4789999999999999999999999999999999999999 66778999999999987
Q ss_pred CCCCC--ccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-----------
Q 011154 293 RPDER--LNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP----------- 357 (492)
Q Consensus 293 ~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~----------- 357 (492)
..++. ++.-+-|.+|+|||++.+ .|+...||||+|||+.|||..+..|...+.-+.++.|..-..
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 65543 455678999999999875 599999999999999999998999987766555544432111
Q ss_pred ------------CCCC-C-CC-----CCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 358 ------------SFDD-G-SW-----PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 358 ------------~~~~-~-~~-----~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
..+. . .+ ..-..+..+++.+||..||++|++.++++.|+++..
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1000 0 01 012246789999999999999999999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.15 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=209.7
Q ss_pred cceeecceeccccceEEEEEEEecCCcc----ccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHK----DQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
++..+.+.||+|.||.|++|..+..... ...||||.++..... ...+.+..|+++|+.+..|+||+.++++|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3446677999999999999987643322 567999998655433 5567899999999999889999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeec
Q 011154 210 LDNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS 274 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~ 274 (492)
.+.+++|+|||..|+|.+++..+. ..++..+...++.||+.|++||++..+|||||-..|||+
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi-- 451 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI-- 451 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe--
Confidence 999999999999999999998765 248999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecccccccCCCCCcc--ccccC--ccccccccccC-CCCCccchHHHHHHHHHHhc-CCCCCCCCC-hhH
Q 011154 275 KDESSQLKAIDFGLSDFVRPDERLN--DIVGS--AYYVAPEVLHR-SYGTEADVWSIGVIAYILLC-GSRPFWART-ESG 347 (492)
Q Consensus 275 ~~~~~~~kl~DfGla~~~~~~~~~~--~~~gt--~~y~aPE~~~~-~~~~~~DvwSlGvil~~llt-g~~pf~~~~-~~~ 347 (492)
..+..+||+|||+|+......... ...|+ ..|||||.+.. .|+.++|||||||+|||+.+ |..||.+.. ..+
T Consensus 452 -~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 452 -TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred -cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 666799999999998765444332 22332 34999998874 69999999999999999998 899998755 556
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 348 IFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+++.+..+...... ..+++++.++++.||+.+|++||+..++.+
T Consensus 531 l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 531 LLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 66655555433222 257999999999999999999999998765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=257.22 Aligned_cols=212 Identities=27% Similarity=0.416 Sum_probs=175.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+....+..||+|+||.|-+.++.. +|+..|+|.+.... ..+..+++++|+.+..+..++|.+|.+||.+..+..+
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~---sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQ---SGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhhhhhcCCccchhhheeecc---CCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 445567889999999998888776 89999999996543 2445677889999988877899999999999999999
Q ss_pred EEEEeecCCCchHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 214 YIVMELCEGGELLDRI---LSRCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l---~~~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
|+.||.|.- ||..+. .++++.++|..+-+|+..++.||.|||++ .|||||+||+|||+ +..+++||||||.+
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGIS 196 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccc
Confidence 999999965 654443 35678899999999999999999999997 89999999999999 77889999999999
Q ss_pred cccCCCCCccccccCcccccccccc-----CCCCCccchHHHHHHHHHHhcCCCCCCC-CChhHHHHHHHh
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH-----RSYGTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLK 354 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlGvil~~lltg~~pf~~-~~~~~~~~~i~~ 354 (492)
..+...-..+--.|-..|||||.+. ..|+.++||||||+.+.||.+++.||.. .+..+.+.++..
T Consensus 197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 8775433333356788999999874 3589999999999999999999999954 345556665554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=331.95 Aligned_cols=241 Identities=22% Similarity=0.299 Sum_probs=183.6
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
...|...+.||+|+||.||+|+.+. ++..||||.+...... ...|++++++++ |||||+++++|.+.+.
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-------~~~~~~~l~~l~-HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVNSI-------PSSEIADMGKLQ-HPNIVKLIGLCRSEKG 757 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCccc-------cHHHHHHHhhCC-CCCcceEEEEEEcCCC
Confidence 3456777899999999999998765 6789999998643321 134688999994 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH---LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH---~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.|+|||||++|+|.+++. .+++..+..|+.||+.||.||| +.+|+||||||+||++ +.+...++. ||.+
T Consensus 758 ~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~ 829 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLP 829 (968)
T ss_pred CEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-eccc
Confidence 999999999999999884 4899999999999999999999 6699999999999999 455556654 6655
Q ss_pred cccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh--hHHHHHHHhc----------C
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKA----------D 356 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~--~~~~~~i~~~----------~ 356 (492)
..... .....||+.|||||++. ..|+.++|||||||++|||+||+.||..... ..+....... +
T Consensus 830 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (968)
T PLN00113 830 GLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906 (968)
T ss_pred ccccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC
Confidence 43321 12346899999999876 4599999999999999999999999853221 1111111100 0
Q ss_pred CCCCCC--CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 357 PSFDDG--SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 357 ~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+..... .......++.+++.+||+.||++|||+.|+++.
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000 000112356789999999999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=286.19 Aligned_cols=261 Identities=28% Similarity=0.434 Sum_probs=204.1
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.+.|.++++||.|+|+.||++.+.......+.||+|.|...... ..+.+|+++|..+.++.||+.+.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 45667899999999999999999987654346789999999655433 3578999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
++.+.+|+||++..+..+++ ..++..++..+++.++.||.++|.+|||||||||+|||++. ....-.|+|||||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGLA 180 (418)
T ss_pred CCeeEEEecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechhH
Confidence 99999999999998777665 35789999999999999999999999999999999999974 4457889999998
Q ss_pred cccC-----------------C--C--------------------------CCccccccCccccccccccC--CCCCccc
Q 011154 290 DFVR-----------------P--D--------------------------ERLNDIVGSAYYVAPEVLHR--SYGTEAD 322 (492)
Q Consensus 290 ~~~~-----------------~--~--------------------------~~~~~~~gt~~y~aPE~~~~--~~~~~~D 322 (492)
.... . + ...-...||++|+|||++.+ ..++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6211 0 0 00013479999999999864 5788999
Q ss_pred hHHHHHHHHHHhcCCCCCCCCChh--------------------------------------HHHHHHHhc----CCC--
Q 011154 323 VWSIGVIAYILLCGSRPFWARTES--------------------------------------GIFRAVLKA----DPS-- 358 (492)
Q Consensus 323 vwSlGvil~~lltg~~pf~~~~~~--------------------------------------~~~~~i~~~----~~~-- 358 (492)
|||.|||++.++++..||....++ +........ ...
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999999432110 000000000 000
Q ss_pred ---CCCCCC-CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 359 ---FDDGSW-PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 359 ---~~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.....| ...+..+.||+.+||+.||.+|+|++++|.||||...
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 011111 2345588999999999999999999999999999854
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=300.91 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=212.4
Q ss_pred eeecceeccccceEEEEEEEecC-CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKG-EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
.+..++||+|+||+||+|.|-.. +.-..+||||++.... ......++..|+-+|.+| +|||+++|++++.... +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HH
Confidence 34567899999999999988543 2335789999986543 344567899999999999 5999999999998755 88
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
||++|+++|.|+|+++.+...+.-+....|..||++|+.|||.+++|||||-..|||+ ....++||.|||+|+.+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCc
Confidence 9999999999999999888899999999999999999999999999999999999999 5666999999999999876
Q ss_pred CCCcccc---ccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 295 DERLNDI---VGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 295 ~~~~~~~---~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
+...-.. .--+-|||=|.++ +.|+.++|||||||.+||++| |..|+.+....++-..+..++. +. ..+..+.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Ls--qPpiCti 927 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LS--QPPICTI 927 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CC--CCCCccH
Confidence 6543222 2235699999775 679999999999999999999 9999999999999888877765 32 2357899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.-++.+||..|+..||+++++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999988764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=289.21 Aligned_cols=201 Identities=33% Similarity=0.576 Sum_probs=175.9
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHH-----HHHHHHHHHHcc--CCCCccEEEEE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVED-----VRREVKILRALS--GHSNLVKFYDA 206 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~-----~~~Ev~~l~~l~--~hpniv~l~~~ 206 (492)
.+|...+.||.|+||.|++|.++. +...|+||.|.|++......+++ +-.||.||..|. .|+||++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecc---cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 459999999999999999999987 57899999998877654333332 567999999993 39999999999
Q ss_pred EEeCCeEEEEEeec-CCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 207 FEDLDNVYIVMELC-EGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 207 ~~~~~~~~lv~E~~-~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
|++++++||+||-. +|-+|+++|.-+ ..++|.+++.|++|++.|+++||++||||||||-+||.+ +.++-+||+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klid 713 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLID 713 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEee
Confidence 99999999999976 455999988544 689999999999999999999999999999999999999 7888999999
Q ss_pred cccccccCCCCCccccccCccccccccccCC--CCCccchHHHHHHHHHHhcCCCCCCC
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWA 342 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwSlGvil~~lltg~~pf~~ 342 (492)
||.|.... ...+...+||..|.|||++.+. .+..-|||++|++||.++....||+.
T Consensus 714 fgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99998776 4457788999999999999864 46779999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=296.64 Aligned_cols=260 Identities=28% Similarity=0.459 Sum_probs=214.3
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
+-.++|++...+|.|.||.||+++++. +++..|||+++..... ...-+..|+-+++..+ |||||.+++.|...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~---s~elaavkvVkLep~d---d~~~iqqei~~~~dc~-h~nivay~gsylr~ 84 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCR-HPNIVAYFGSYLRR 84 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccc---cCchhhheeeeccCCc---cccccccceeeeecCC-CcChHHHHhhhhhh
Confidence 456889999999999999999999765 8899999999655432 2344678999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..|++||||.||+|.|..+ -.+.++|.++..+.+..+.||+|||+.|-+|||||-.|||+ .+.+.+|++|||.+.
T Consensus 85 dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchh
Confidence 99999999999999998554 34789999999999999999999999999999999999999 566789999999986
Q ss_pred ccCCC-CCccccccCccccccccc----cCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC-CCC
Q 011154 291 FVRPD-ERLNDIVGSAYYVAPEVL----HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD-GSW 364 (492)
Q Consensus 291 ~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~ 364 (492)
.+... .+.....||++|||||+- .+.|+..||||++|+...|+---+.|.........+....+..+..+. ..-
T Consensus 161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence 55322 234567899999999974 367999999999999999998888886555544444333333322221 112
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
...++.+-+|++.+|.++|++||+++.+|.|||+...
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 3467889999999999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=275.51 Aligned_cols=242 Identities=25% Similarity=0.391 Sum_probs=187.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc-CCCCccEEEEEEEeCC-
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS-GHSNLVKFYDAFEDLD- 211 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~-~hpniv~l~~~~~~~~- 211 (492)
....+.+.||+|.||.||+|.+. ++.||||+++.. ..+.+.+|-.|.+... .|+||++++++-+...
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-----~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-----NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-----CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 34567789999999999999874 589999999543 3445666766665431 4999999999876544
Q ss_pred ---eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCcccCCCCCceEeecCCCCC
Q 011154 212 ---NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH---------GVVHRDLKPENFLYTSKDESS 279 (492)
Q Consensus 212 ---~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~---------~ivHrDlkp~NILl~~~~~~~ 279 (492)
.++||+||.+.|+|.++|..+ .++|....+|+.-+++||+|||+. .|+|||||..|||+ .++.
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~Dl 353 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDL 353 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCC
Confidence 899999999999999999765 799999999999999999999984 49999999999999 7788
Q ss_pred cEEEEecccccccCCCCC---ccccccCccccccccccCCCCC-------ccchHHHHHHHHHHhcCCC-----------
Q 011154 280 QLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHRSYGT-------EADVWSIGVIAYILLCGSR----------- 338 (492)
Q Consensus 280 ~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-------~~DvwSlGvil~~lltg~~----------- 338 (492)
+.-|+|||||..+.++.. ....+||..|||||++.+..+. ..||||+|.|||||++.-.
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 999999999988865543 3347899999999999875332 4899999999999997432
Q ss_pred -CCC-----CCChhHHHHHHHhcC--CCCCCCCCCC--CCHHHHHHHHHccccCcCCCCCHHHH
Q 011154 339 -PFW-----ARTESGIFRAVLKAD--PSFDDGSWPS--LSSDAKDFVKLLLNKDPRKRMTAAQA 392 (492)
Q Consensus 339 -pf~-----~~~~~~~~~~i~~~~--~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~e~ 392 (492)
||. ..+.+++...+.... +.++. .|.. --.-+++.+..||..|++-|.|+.=+
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~-~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPD-AWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChh-hhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 332 123344444443322 33322 2322 22457899999999999999998644
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=272.20 Aligned_cols=246 Identities=23% Similarity=0.394 Sum_probs=188.3
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHH--ccCCCCccEEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA--LSGHSNLVKFYDAF 207 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~--l~~hpniv~l~~~~ 207 (492)
+.+..+..+.+.||+|-||.||+|+|+ |+.||||++..... +.+.+|-+|... |+ |+||+.+++.-
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-----Ge~VAVKiF~srdE------~SWfrEtEIYqTvmLR-HENILgFIaaD 274 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-----GEDVAVKIFSSRDE------RSWFRETEIYQTVMLR-HENILGFIAAD 274 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-----CCceEEEEecccch------hhhhhHHHHHHHHHhc-cchhhhhhhcc
Confidence 567788999999999999999999985 57899999964432 345667776654 54 99999999875
Q ss_pred EeCC----eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCcccCCCCCceEeecC
Q 011154 208 EDLD----NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH--------GVVHRDLKPENFLYTSK 275 (492)
Q Consensus 208 ~~~~----~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~--------~ivHrDlkp~NILl~~~ 275 (492)
..++ .+|||++|.+.|||+|+|.. ..++.+...+++..+++||++||.. .|.|||||..|||+
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--- 349 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--- 349 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---
Confidence 4332 59999999999999999965 5799999999999999999999974 39999999999999
Q ss_pred CCCCcEEEEecccccccCCCC-----CccccccCccccccccccCCCC-------CccchHHHHHHHHHHhcC-------
Q 011154 276 DESSQLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHRSYG-------TEADVWSIGVIAYILLCG------- 336 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~DvwSlGvil~~lltg------- 336 (492)
..++..-|+|+|||....... ..+..+||..|||||++....+ ..+||||||+|+||+...
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 778899999999998765442 2356799999999999975432 248999999999999752
Q ss_pred ---CCCCCCCCh-----hHHHHHHHhcCCCC-CCCCCCCCC--HHHHHHHHHccccCcCCCCCHHHH
Q 011154 337 ---SRPFWARTE-----SGIFRAVLKADPSF-DDGSWPSLS--SDAKDFVKLLLNKDPRKRMTAAQA 392 (492)
Q Consensus 337 ---~~pf~~~~~-----~~~~~~i~~~~~~~-~~~~~~~~s--~~~~~li~~~L~~dP~~Rps~~e~ 392 (492)
.+||++... +++..-+....... ....|...+ ..+..+++.||..+|.-|.|+-.+
T Consensus 430 eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred hhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 478865322 23333222222221 223343322 245678999999999999998654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=257.46 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=203.1
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEE-EEeC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDA-FEDL 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~-~~~~ 210 (492)
+.+.|.+.+.||+|.||.+-+++++. +.+.+++|.+++.. ..+.+|.+|...--.|+.|.||+.-|++ |++.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 45789999999999999999999886 77899999997654 3457888998877778789999998875 7888
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+++++|||+.|+|.+-+.. ..+.|...+.++.|+++||.|+|++++||||||.+||||...| ..+|||||||+.+
T Consensus 95 d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTR 171 (378)
T ss_pred ceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeeccccc
Confidence 899999999999999887754 4688999999999999999999999999999999999998654 3499999999986
Q ss_pred ccCCCCCccccccCcccccccccc----CC--CCCccchHHHHHHHHHHhcCCCCCCCCCh----hHHHHHHHhcCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLH----RS--YGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFD 360 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~----~~--~~~~~DvwSlGvil~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~ 360 (492)
.... .....--+..|.+||++. +. .+..+|||.||+|+|.+|||.+||..... .-.+....+....-.
T Consensus 172 k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 172 KVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 5432 122223445689999653 22 46789999999999999999999953221 112222333322223
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCC---CCHHHHhcCccccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKR---MTAAQALSHPWIRN 400 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~e~l~hp~~~~ 400 (492)
...+..+|+.+..+.++-|..++++| .++.......|...
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 33445689999999999999999999 77777777788764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-31 Score=243.40 Aligned_cols=211 Identities=46% Similarity=0.792 Sum_probs=183.0
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecC
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ 221 (492)
||+|++|.||++.... +++.++||++....... ..+.+.+|+.+++.+. |++|+++++++......++++||+.
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999998754 57899999997654322 3467899999999996 9999999999999999999999999
Q ss_pred CCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC-CCcEEEEecccccccCCCC-Ccc
Q 011154 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE-SSQLKAIDFGLSDFVRPDE-RLN 299 (492)
Q Consensus 222 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~-~~~~kl~DfGla~~~~~~~-~~~ 299 (492)
|++|.+++......+++..+..++.+++.+|.|||+.|++|+||+|.||++. . ...++|+|||.+....... ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcchhh
Confidence 9999998865435789999999999999999999999999999999999994 4 5789999999998765432 133
Q ss_pred ccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011154 300 DIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377 (492)
Q Consensus 300 ~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 377 (492)
...++..|++||.+.. .++.+.|+|++|+++++| ..+.+++.+
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~ 196 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRK 196 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHH
Confidence 4567889999998865 678899999999999999 567899999
Q ss_pred ccccCcCCCCCHHHHhcCc
Q 011154 378 LLNKDPRKRMTAAQALSHP 396 (492)
Q Consensus 378 ~L~~dP~~Rps~~e~l~hp 396 (492)
||..||.+||++.++++|+
T Consensus 197 ~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 197 MLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HhhCCcccCcCHHHHhhCC
Confidence 9999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=305.19 Aligned_cols=198 Identities=19% Similarity=0.235 Sum_probs=149.9
Q ss_pred CCccEEEEEE-------EeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCce
Q 011154 198 SNLVKFYDAF-------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENF 270 (492)
Q Consensus 198 pniv~l~~~~-------~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NI 270 (492)
.||++++++| .+...+++++||+ +++|.++|......+++.+++.++.||+.||.|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 6888888877 3345688889988 5599999876556799999999999999999999999999999999999
Q ss_pred Eeec----------------CCCCCcEEEEecccccccCCCC-----------------CccccccCcccccccccc-CC
Q 011154 271 LYTS----------------KDESSQLKAIDFGLSDFVRPDE-----------------RLNDIVGSAYYVAPEVLH-RS 316 (492)
Q Consensus 271 Ll~~----------------~~~~~~~kl~DfGla~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~ 316 (492)
||.. .+.+..+||+|||+++...... .....+||++|||||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9953 1234567888888876432100 011246899999999875 46
Q ss_pred CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCc
Q 011154 317 YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396 (492)
Q Consensus 317 ~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp 396 (492)
|+.++|||||||+||||++|..|+.... ..+..+.... ++.. +........+++.+||++||.+||++.|+|+||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQ-ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChh-hhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 9999999999999999999998875322 1222222211 1111 112245678999999999999999999999999
Q ss_pred ccccc
Q 011154 397 WIRNY 401 (492)
Q Consensus 397 ~~~~~ 401 (492)
||...
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=242.61 Aligned_cols=212 Identities=43% Similarity=0.725 Sum_probs=178.9
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
|.+.+.||.|++|.||++.... +++.+|||.+...... ...+.+.+|++.++.+ +|+|++++++++......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEE
Confidence 5678899999999999998764 5789999999765432 2456789999999999 59999999999999999999
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~ 295 (492)
++||+++++|.+.+......+++..+..++.+++.++.|||+.+++|+||+|.||++ +.+..++|+|||++......
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCc
Confidence 999999999999886653338999999999999999999999999999999999999 55679999999999877554
Q ss_pred C--CccccccCccccccccc-c-CCCCCccchHHHHHHHHHHhcCCCCCCC--CChhHHHHHHHhcC
Q 011154 296 E--RLNDIVGSAYYVAPEVL-H-RSYGTEADVWSIGVIAYILLCGSRPFWA--RTESGIFRAVLKAD 356 (492)
Q Consensus 296 ~--~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwSlGvil~~lltg~~pf~~--~~~~~~~~~i~~~~ 356 (492)
. ......++..|++||.+ . ..++.++|||+||+++|+|++|+.||.. .....+.+.+..+.
T Consensus 152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 3 34456788899999987 3 3477799999999999999999999977 33445666666544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=243.72 Aligned_cols=265 Identities=18% Similarity=0.263 Sum_probs=212.9
Q ss_pred hhhhhcCCccccccceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC
Q 011154 121 ELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS 198 (492)
Q Consensus 121 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp 198 (492)
+...+.......+.++++...+-+|.||.||.|.|+... .+.+.|-||.++.. .+...+..++.|--.|..+. ||
T Consensus 271 e~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~ 347 (563)
T KOG1024|consen 271 EFNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HP 347 (563)
T ss_pred HHhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CC
Confidence 344444444455678889999999999999999887533 24566888888543 35566778999999999996 99
Q ss_pred CccEEEEEEEe-CCeEEEEEeecCCCchHHHHHh-------hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCce
Q 011154 199 NLVKFYDAFED-LDNVYIVMELCEGGELLDRILS-------RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENF 270 (492)
Q Consensus 199 niv~l~~~~~~-~~~~~lv~E~~~ggsL~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NI 270 (492)
|+..+.+++.+ ....++++.++.-|+|..++.. ..+.++..+...++.|++.|++|||.+||||.||-..|+
T Consensus 348 nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNC 427 (563)
T KOG1024|consen 348 NLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNC 427 (563)
T ss_pred CccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcc
Confidence 99999998765 4568889999999999998872 123578889999999999999999999999999999999
Q ss_pred EeecCCCCCcEEEEecccccccCCCCCcc---ccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCCh
Q 011154 271 LYTSKDESSQLKAIDFGLSDFVRPDERLN---DIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTE 345 (492)
Q Consensus 271 Ll~~~~~~~~~kl~DfGla~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~ 345 (492)
+| |+..++||+|=.+++.+-+.+... .-.-...||++|.+. ..|+..+|||||||+||||+| |+.|+-..+.
T Consensus 428 vI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 428 VI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred ee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 99 778999999999998776554321 112345699999876 569999999999999999998 9999988888
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 346 SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 346 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.++..-+..+. ....+ -++++++..++.-||..+|++||+.+|+..
T Consensus 505 fEm~~ylkdGy-RlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 505 FEMEHYLKDGY-RLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHhccc-eecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 77766665543 33222 379999999999999999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=225.20 Aligned_cols=163 Identities=29% Similarity=0.383 Sum_probs=130.1
Q ss_pred CchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccccc
Q 011154 223 GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV 302 (492)
Q Consensus 223 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~ 302 (492)
|+|.+.+..+...+++.+++.|+.||+.||.|||+++ ||+|||+ +.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899999876677999999999999999999999998 9999999 66778898 99998765432 36
Q ss_pred cCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHHHHhcCCCCCC---CCCCCCCH--HHHHHH
Q 011154 303 GSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDD---GSWPSLSS--DAKDFV 375 (492)
Q Consensus 303 gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li 375 (492)
||+.|||||++. ..|+.++|||||||++|+|+||+.||..... ...+..+......... .....++. ++++||
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999886 4689999999999999999999999976543 2333343332222111 11112333 699999
Q ss_pred HHccccCcCCCCCHHHHhcCccccc
Q 011154 376 KLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 376 ~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
.+||..||.+||++.++++|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-27 Score=229.70 Aligned_cols=256 Identities=37% Similarity=0.612 Sum_probs=208.2
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC-CccEEEEEEEeCCeEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS-NLVKFYDAFEDLDNVY 214 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp-niv~l~~~~~~~~~~~ 214 (492)
|.+.+.||.|+||.||.+... ..+++|.+.............+.+|+.+++.+. |+ +|+++++++......+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEE
Confidence 778899999999999999865 678999997766554445677999999999996 66 8999999998888889
Q ss_pred EEEeecCCCchHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCC-cEEEEecccccc
Q 011154 215 IVMELCEGGELLDRILSRC--GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS-QLKAIDFGLSDF 291 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~-~~kl~DfGla~~ 291 (492)
++++|+.++++.+.+.... ..+++..+..++.|++.++.|+|..+++|||+||+||++ +... .++++|||++..
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCccee
Confidence 9999999999996665443 279999999999999999999999999999999999999 5555 699999999986
Q ss_pred cCCCC-------CccccccCccccccccccC----CCCCccchHHHHHHHHHHhcCCCCCCCCCh----hHHHHHHHhcC
Q 011154 292 VRPDE-------RLNDIVGSAYYVAPEVLHR----SYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKAD 356 (492)
Q Consensus 292 ~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlGvil~~lltg~~pf~~~~~----~~~~~~i~~~~ 356 (492)
..... ......||..|+|||.+.+ .++...|+||+|++++++++|..||..... ......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 54433 2466789999999998764 578889999999999999999999876663 44555554444
Q ss_pred CC-CCCCCCCCC----CHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 357 PS-FDDGSWPSL----SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 357 ~~-~~~~~~~~~----s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.. ......... ...+.+++.+++..+|..|.+..+...++|....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 33 222221111 2578999999999999999999999999777653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-29 Score=266.25 Aligned_cols=260 Identities=29% Similarity=0.452 Sum_probs=195.3
Q ss_pred cce-eecceeccccceEEEEEEEecCCccccEEEEEEccC---CCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 134 SRL-EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK---SKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 134 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~---~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+.| .....+|.|++|.|+.+.... .....+.|.... ...........+..|+.+-..|. |+|++..+..+.+
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~---~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~ 392 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRS---DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQE 392 (601)
T ss_pred cccCCccceeeecccCceEEEEecC---CCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhh
Confidence 345 356789999999777766543 223333333221 11122222223677888888885 9999988888777
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
....+-+||||++ +|+.++... +.++..++..+++||+.||.|+|..||.|||||++|+++ ...+.+||+|||.+
T Consensus 393 ~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 393 IDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAA 467 (601)
T ss_pred cccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcc
Confidence 7777777999999 999988654 579999999999999999999999999999999999999 56679999999998
Q ss_pred cccCCCCC-----ccccccCccccccccccC-CCCCc-cchHHHHHHHHHHhcCCCCCCCCChhHHH--HHHHhcCCCC-
Q 011154 290 DFVRPDER-----LNDIVGSAYYVAPEVLHR-SYGTE-ADVWSIGVIAYILLCGSRPFWARTESGIF--RAVLKADPSF- 359 (492)
Q Consensus 290 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~-~DvwSlGvil~~lltg~~pf~~~~~~~~~--~~i~~~~~~~- 359 (492)
..+..... ....+|+..|+|||++.+ .|+.. .||||.|+|++.|++|+.||......+.. ..........
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 77643322 346789999999998864 57764 79999999999999999999654443221 1111111111
Q ss_pred --CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 360 --DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 360 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
....|..++...+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 1122446788899999999999999999999999999999754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=254.37 Aligned_cols=245 Identities=27% Similarity=0.457 Sum_probs=212.9
Q ss_pred eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeec
Q 011154 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELC 220 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~ 220 (492)
.+|+|.||.|++++...+...|..||+|+..+......... ....|-.++...++||.+|+++-.|+.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 37999999999998777777889999999987655433322 45568888888877999999999999999999999999
Q ss_pred CCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccc
Q 011154 221 EGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND 300 (492)
Q Consensus 221 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~ 300 (492)
.||+|..++.+. ..+.+...+.+...++.+++++|+.+|+|||+|++||++ +.++++++.|||+++..-..+..
T Consensus 80 rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred ccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc--
Confidence 999999887654 578889999999999999999999999999999999999 88999999999999876543332
Q ss_pred cccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccc
Q 011154 301 IVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLN 380 (492)
Q Consensus 301 ~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 380 (492)
|||.-|||||+++ .....+|.||||+++++|+||..||.. ++...|.+....++. .++.++++++..++.
T Consensus 154 -cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFK 223 (612)
T ss_pred -ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHh
Confidence 9999999999998 667789999999999999999999977 788888887766665 678899999999999
Q ss_pred cCcCCCCC-----HHHHhcCccccccc
Q 011154 381 KDPRKRMT-----AAQALSHPWIRNYN 402 (492)
Q Consensus 381 ~dP~~Rps-----~~e~l~hp~~~~~~ 402 (492)
.+|..|.- +.++++|+||....
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeee
Confidence 99999985 47999999998754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-26 Score=227.36 Aligned_cols=255 Identities=23% Similarity=0.275 Sum_probs=193.3
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccC---CCCccEEEEEE-EeC
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG---HSNLVKFYDAF-EDL 210 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~---hpniv~l~~~~-~~~ 210 (492)
+|.+.+.||+|+||.||.|...... ...+|+|+......... ..+..|+.++..+.. -.++..+++.+ ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 8999999999999999999876532 46899998865432221 146789999999862 36999999999 578
Q ss_pred CeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC--CCcEEEEecc
Q 011154 211 DNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE--SSQLKAIDFG 287 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~--~~~~kl~DfG 287 (492)
...|+||+++ |.+|.+...... +.++...+..|+.|++.+|++||+.|++||||||+|+++..... ...+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 8899999998 779998765554 68999999999999999999999999999999999999975432 2579999999
Q ss_pred cccccC---CCC-------C-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhc
Q 011154 288 LSDFVR---PDE-------R-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 355 (492)
Q Consensus 288 la~~~~---~~~-------~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~ 355 (492)
+++.+. ... . .....||..|.++.+..+ ..+.+.|+||++.++.+++.|.+||.+.........+.+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998322 111 1 123569999999998764 5889999999999999999999999665543223332222
Q ss_pred CCCCCCC-CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 356 DPSFDDG-SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 356 ~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
....... .....+.++..+...+-..+...+|....+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2221111 222345677777777777888888887776554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=231.75 Aligned_cols=166 Identities=19% Similarity=0.237 Sum_probs=129.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCC--CCHHHHHHHHHHHHHHHHccCCCCccE-EEEEE
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--TTAIAVEDVRREVKILRALSGHSNLVK-FYDAF 207 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~~~~Ev~~l~~l~~hpniv~-l~~~~ 207 (492)
.+.++|.+.+.||+|+||.||+|+++. .+++.||||++..... ......+.+.+|+++|+.|. |+||+. +++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~-- 89 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAG--DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLA-- 89 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcC--CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEE--
Confidence 456789999999999999999998764 2467789998753311 12334566899999999995 999885 543
Q ss_pred EeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCC-CCCceEeecCCCCCcEEEEec
Q 011154 208 EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDL-KPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 208 ~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDl-kp~NILl~~~~~~~~~kl~Df 286 (492)
.+..|||||||+|++|.. + . ... ...++.|++.+|.|||++||+|||| ||+|||+ +.++.+||+||
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~-~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDF 156 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-A-R---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDF 156 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-h-C---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEEC
Confidence 256899999999999862 2 1 111 1468899999999999999999999 9999999 55668999999
Q ss_pred ccccccCCCCC---------ccccccCcccccccccc
Q 011154 287 GLSDFVRPDER---------LNDIVGSAYYVAPEVLH 314 (492)
Q Consensus 287 Gla~~~~~~~~---------~~~~~gt~~y~aPE~~~ 314 (492)
|+|+.+..... .....+++.|+|||++.
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99987654331 23567889999999985
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=202.83 Aligned_cols=248 Identities=20% Similarity=0.278 Sum_probs=193.1
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
...+|.++++||+|+||.+|.+..-. .|..||||+-...... .++..|.++.+.|++...|..+..++.+.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc---CCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 45789999999999999999998654 8999999987554332 246789999999987889999999998889
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.-.+||+++ |.||.+...--...|+..++.-++-|++.-++|+|.+++|||||||+|+|..-..-...+.|+|||+|+.
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 999999998 7799887654446799999999999999999999999999999999999997666677899999999987
Q ss_pred cCCCCC--------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCCh---hHHHHHHHhcCCCC
Q 011154 292 VRPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPSF 359 (492)
Q Consensus 292 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~---~~~~~~i~~~~~~~ 359 (492)
+..... -....||..|.+=-..-+ ..+...|+-|+|.+|..+.-|.+||.+-.. ..-++.|.......
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 653321 234679999988665433 356789999999999999999999976443 34455555443332
Q ss_pred C-CCCCCCCCHHHHHHHHHccccCcCCCCC
Q 011154 360 D-DGSWPSLSSDAKDFVKLLLNKDPRKRMT 388 (492)
Q Consensus 360 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps 388 (492)
+ +.....++.++.-.+.-|=..--++-|.
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 2 2223456777777777665554444554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=206.53 Aligned_cols=213 Identities=23% Similarity=0.390 Sum_probs=173.9
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.-.|+++++||+|+||..+.+. +..+++.||||.-+.... ..++..|....+.|.+.++|...|-+..+.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~---Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGK---NLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred EecccceeccccccCcceeeeccc---ccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 345689999999999999999887 445899999998765432 245778999999998899999999888888
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC--CCCcEEEEeccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD--ESSQLKAIDFGL 288 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~--~~~~~kl~DfGl 288 (492)
.+-.||+|++ |.||.|...--+.+|+...+..++.|++.-++|+|++.+|.|||||+|+||.... ....|.|+|||+
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 8889999998 7799886654456799999999999999999999999999999999999996432 335799999999
Q ss_pred ccccCCCCC--------ccccccCccccccccc-cCCCCCccchHHHHHHHHHHhcCCCCCCCC---ChhHHHHHH
Q 011154 289 SDFVRPDER--------LNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAV 352 (492)
Q Consensus 289 a~~~~~~~~--------~~~~~gt~~y~aPE~~-~~~~~~~~DvwSlGvil~~lltg~~pf~~~---~~~~~~~~i 352 (492)
|+....... .....||..||+=-.. -+..+.+.|+-|||-+++..|-|.+||.+- +..+-+++|
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 998765432 2356799999996643 345788899999999999999999999653 334444444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=199.69 Aligned_cols=175 Identities=18% Similarity=0.181 Sum_probs=134.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHH------HHHHHHHHHHccCCCCccEEE
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVED------VRREVKILRALSGHSNLVKFY 204 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~------~~~Ev~~l~~l~~hpniv~l~ 204 (492)
-+..+|++.+.||.|+||.||++.. ++..+|||++............. +.+|+..+.+|. |++|..+.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~ 101 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLN 101 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcce
Confidence 4578999999999999999998643 35579999997655444444333 579999999995 99999999
Q ss_pred EEEEeC--------CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC
Q 011154 205 DAFEDL--------DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 205 ~~~~~~--------~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~ 276 (492)
+++... +..+|||||++|.+|.+.. .+++ ..+.+|+.+|..||+.|++|||+||+||+++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~--- 169 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS--- 169 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---
Confidence 987643 3589999999999987752 2333 3466999999999999999999999999994
Q ss_pred CCCcEEEEecccccccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHh
Q 011154 277 ESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILL 334 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~ll 334 (492)
.++ ++|+|||............. =++.+.|+.++|+||||+.+..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 445 99999998765532221111 023456888999999999876654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=190.02 Aligned_cols=189 Identities=21% Similarity=0.219 Sum_probs=142.1
Q ss_pred eecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH-HHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA-IAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 137 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~-~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
.+...|++|+||+|+.+.. .+..++.+.+........ .....+.+|+++|++|.+|++|++++++ +..++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHL 75 (218)
T ss_pred ccceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEE
Confidence 3567899999999997642 457778777754433211 1223578999999999767999999986 45699
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCC-CCCceEeecCCCCCcEEEEecccccccCC
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDL-KPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDl-kp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+|||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||+ +.++.++|+|||+|.....
T Consensus 76 vmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCC
Confidence 9999999888653311 1 2457889999999999999999999 7999999 5567899999999986654
Q ss_pred CCCc----c----------ccccCccccccccc--cCCCC-CccchHHHHHHHHHHhcCCCCCCCCCh
Q 011154 295 DERL----N----------DIVGSAYYVAPEVL--HRSYG-TEADVWSIGVIAYILLCGSRPFWARTE 345 (492)
Q Consensus 295 ~~~~----~----------~~~gt~~y~aPE~~--~~~~~-~~~DvwSlGvil~~lltg~~pf~~~~~ 345 (492)
.... . -...++.|++|+.. ....+ ...+.++.|+-+|.++|+..++|+..+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 3321 0 12367788888743 22333 457888999999999999999987665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-24 Score=226.39 Aligned_cols=222 Identities=30% Similarity=0.525 Sum_probs=174.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|+.++.|-.|+||.||.++++. +.+.+|+| |.+... +.+- |+... +.|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~---trqrfa~k-iNkq~l--------ilRn--ilt~a-~npfvv---------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKE---TRQRFAMK-INKQNL--------ILRN--ILTFA-GNPFVV---------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccc---cccchhhc-ccccch--------hhhc--ccccc-CCccee----------
Confidence 34788999999999999999999875 66888984 433321 1111 22222 344444
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
|+....+. ..+.++.+. +.+++|||+.||+|||+||+|.|| ..-+++|+.|||+++.
T Consensus 136 -----------gDc~tllk-~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 -----------GDCATLLK-NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKK 192 (1205)
T ss_pred -----------chhhhhcc-cCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhh
Confidence 45555443 335555544 789999999999999999999999 6678999999999865
Q ss_pred cCCCC----------------CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHh
Q 011154 292 VRPDE----------------RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 354 (492)
Q Consensus 292 ~~~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~ 354 (492)
.-... .-..+|||+.|+|||++. +.|+..+|.|++|+|+|+.+-|..||.+.+.++++..+..
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 31110 113569999999999765 6799999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHccccCcCCCC---CHHHHhcCccccccc
Q 011154 355 ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRM---TAAQALSHPWIRNYN 402 (492)
Q Consensus 355 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~~~ 402 (492)
....+++..+ .+.++++++|.++|..+|..|. .+-++.+|+||+...
T Consensus 273 d~i~wpE~de-a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 273 DDIEWPEEDE-ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred hhccccccCc-CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 8888887754 6889999999999999999995 578889999998754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=191.62 Aligned_cols=143 Identities=20% Similarity=0.190 Sum_probs=109.6
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHH-----------------------HHHHHHHHHHHHHHcc
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAI-----------------------AVEDVRREVKILRALS 195 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~-----------------------~~~~~~~Ev~~l~~l~ 195 (492)
...||+|+||.||+|... +|+.||||+++........ ......+|+++|..|.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467999999999999863 6899999999764321100 0122346999999995
Q ss_pred CCCCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccCCCCCceEeec
Q 011154 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC-HLHGVVHRDLKPENFLYTS 274 (492)
Q Consensus 196 ~hpniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~yl-H~~~ivHrDlkp~NILl~~ 274 (492)
++++.....+... ..+|||||++|+++...+.. ...+++..+..++.||+.+|.|+ |+.||+||||||+|||++
T Consensus 78 -~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 78 -TAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred -HCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 7776443333222 23899999999877655433 35799999999999999999999 799999999999999994
Q ss_pred CCCCCcEEEEecccccccC
Q 011154 275 KDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 275 ~~~~~~~kl~DfGla~~~~ 293 (492)
++.++|+|||+|....
T Consensus 153 ---~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 ---DGKLYIIDVSQSVEHD 168 (190)
T ss_pred ---CCcEEEEEccccccCC
Confidence 2579999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=201.53 Aligned_cols=235 Identities=24% Similarity=0.369 Sum_probs=152.9
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccC---------CCCccEEEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG---------HSNLVKFYD 205 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~---------hpniv~l~~ 205 (492)
.+..++.||.|+|+.||.+.+.. +|+.+|||+...........++.+++|.-....+.+ |-.++..++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~---t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE---TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred EEEEccccccCCceEEEEEEEcc---CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 45678899999999999999765 899999999876555555567778877755544332 323443334
Q ss_pred EEE---------eC---C-----eEEEEEeecCCCchHHHHH---hhCCC---CCHHHHHHHHHHHHHHHHHHHHcCCcc
Q 011154 206 AFE---------DL---D-----NVYIVMELCEGGELLDRIL---SRCGK---YSEDEAKAVLVQILNVVAFCHLHGVVH 262 (492)
Q Consensus 206 ~~~---------~~---~-----~~~lv~E~~~ggsL~~~l~---~~~~~---~~~~~~~~i~~qi~~~l~ylH~~~ivH 262 (492)
... .. . +.+++|+-+. ++|.+.+. ..... +.......+..|++..+++||..||||
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH 168 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH 168 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence 332 11 1 3477888885 48877653 22111 112223455689999999999999999
Q ss_pred cCCCCCceEeecCCCCCcEEEEecccccccCCCCCccccccCccccccccccC---------CCCCccchHHHHHHHHHH
Q 011154 263 RDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR---------SYGTEADVWSIGVIAYIL 333 (492)
Q Consensus 263 rDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DvwSlGvil~~l 333 (492)
+||+|+|+|+ +.++.++|+||+.....+. .......+..|.+||.... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll---~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLL---DQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEE---cCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999 7788999999987765432 2222345578999997532 367789999999999999
Q ss_pred hcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 011154 334 LCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKR 386 (492)
Q Consensus 334 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 386 (492)
.||..||........... .|..- ..+++..++||.+||+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW------DFSRC--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence 999999975544322111 22221 2688999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=199.84 Aligned_cols=190 Identities=31% Similarity=0.457 Sum_probs=141.8
Q ss_pred CCCCccEEEEEEEe---------------------------CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHH
Q 011154 196 GHSNLVKFYDAFED---------------------------LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI 248 (492)
Q Consensus 196 ~hpniv~l~~~~~~---------------------------~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi 248 (492)
.|||||++..+|.+ ...+|+||.-.+. +|..++..+ ..+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 69999999998843 2358999998876 888888654 67888889999999
Q ss_pred HHHHHHHHHcCCcccCCCCCceEeecC-CCCCcEEEEecccccccCC-------CCCccccccCccccccccccC---C-
Q 011154 249 LNVVAFCHLHGVVHRDLKPENFLYTSK-DESSQLKAIDFGLSDFVRP-------DERLNDIVGSAYYVAPEVLHR---S- 316 (492)
Q Consensus 249 ~~~l~ylH~~~ivHrDlkp~NILl~~~-~~~~~~kl~DfGla~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~- 316 (492)
++|+.|||.+||.|||||.+|||+.-+ |+...+.|+|||++---+. .......-|....||||+... .
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 999999999999999999999999754 4456789999997632111 011123457788999998752 2
Q ss_pred --C-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHH
Q 011154 317 --Y-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAA 390 (492)
Q Consensus 317 --~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 390 (492)
. -.++|.|+.|.+.||+++...||+.+.+..+-..-.+.. . .......+++.+++||..+|+.||++|++..
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~-q-LPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES-Q-LPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh-h-CCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 1 237999999999999999999998855422111111100 0 1112236788999999999999999999853
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=184.44 Aligned_cols=144 Identities=19% Similarity=0.189 Sum_probs=112.6
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC-----------------------HHHHHHHHHHHHHHHHcc
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT-----------------------AIAVEDVRREVKILRALS 195 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~-----------------------~~~~~~~~~Ev~~l~~l~ 195 (492)
...||+|+||.||+|+.. +|+.||||++....... ......+.+|...+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 568999999999999853 68999999997653210 001223468999999995
Q ss_pred CCCCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeec
Q 011154 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTS 274 (492)
Q Consensus 196 ~hpniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~ 274 (492)
|++|.....+.... .||||||++|+++...+... ..+++.++..++.|++.+|.++|. .||+||||||+|||+.
T Consensus 78 -~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 78 -EAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred -hCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 88875554444332 48999999988665443333 568899999999999999999999 9999999999999994
Q ss_pred CCCCCcEEEEecccccccCC
Q 011154 275 KDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 275 ~~~~~~~kl~DfGla~~~~~ 294 (492)
++.++|+|||++..+..
T Consensus 153 ---~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 ---DGKPYIIDVSQAVELDH 169 (190)
T ss_pred ---CCCEEEEEcccceecCC
Confidence 46899999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-24 Score=224.63 Aligned_cols=239 Identities=22% Similarity=0.303 Sum_probs=175.7
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCC-CCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM-TTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+|...+.||.+.|=.|+++++.. |. |+||++-+..- -.-....+...|++ ...+ .|||++.+.-+-+.+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHH
Confidence 67888999999999999987653 44 89999865442 22223334445666 3344 599999999888888899
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc-
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV- 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~- 292 (492)
|||-+|..+ +|+|++..+ .-+..-+.+.|+.||+.||.-||..||+|||||.+|||| .....+.|+||..-+-.
T Consensus 97 ylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCcc
Confidence 999999976 999999655 457888899999999999999999999999999999999 56678999999765422
Q ss_pred -CCCC--Cc----cccccCccccccccccC-----------C-CCCccchHHHHHHHHHHhc-CCCCCCC-------CCh
Q 011154 293 -RPDE--RL----NDIVGSAYYVAPEVLHR-----------S-YGTEADVWSIGVIAYILLC-GSRPFWA-------RTE 345 (492)
Q Consensus 293 -~~~~--~~----~~~~gt~~y~aPE~~~~-----------~-~~~~~DvwSlGvil~~llt-g~~pf~~-------~~~ 345 (492)
..+. .+ .+..--.+|+|||.+.. . .+.+.||||+||+++||++ |++||.- ...
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~ 251 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN 251 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC
Confidence 1111 11 12222347999997632 1 3567899999999999998 6888821 000
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 346 SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 346 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
....+.++... -+..++.||..|++.||++|.+|++.|+.
T Consensus 252 ~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11111111110 12368899999999999999999999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=178.90 Aligned_cols=138 Identities=21% Similarity=0.237 Sum_probs=106.9
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc----CCCCccEEEEEEEeCC---
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS----GHSNLVKFYDAFEDLD--- 211 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~----~hpniv~l~~~~~~~~--- 211 (492)
.+.||+|+||.||. +.. ++.. +||++..... ...+.+.+|+++++.|. +||||++++++++++.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~---~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE---DAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cceecCCCceEEEE--CCC---CcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 46799999999995 332 3344 7999865432 23467899999999994 3799999999999874
Q ss_pred e-EEEEEee--cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHH-HHHHHcCCcccCCCCCceEeecCC-CCCcEEEEec
Q 011154 212 N-VYIVMEL--CEGGELLDRILSRCGKYSEDEAKAVLVQILNVV-AFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAIDF 286 (492)
Q Consensus 212 ~-~~lv~E~--~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l-~ylH~~~ivHrDlkp~NILl~~~~-~~~~~kl~Df 286 (492)
. +.+|+|| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++||||||||+|||+...+ ....++|+||
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 4 3478999 558999999854 356666 46688888888 999999999999999999996533 3458999995
Q ss_pred ccc
Q 011154 287 GLS 289 (492)
Q Consensus 287 Gla 289 (492)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-22 Score=181.27 Aligned_cols=242 Identities=20% Similarity=0.251 Sum_probs=186.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+...+.-+|.+...|..|++++.+ ..+++|++.....+.. ..++|..|.-.|+-+. ||||+.+++.|....++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqg-----ndivakil~vr~~t~r-isrdfneefp~lrifs-hpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQG-----NDIVAKILNVREVTAR-ISRDFNEEFPALRIFS-HPNILPVLGACNSPPNL 262 (448)
T ss_pred hhhhhhhhhccCCCcccccccccC-----cchhhhhhhhhhcchh-hcchhhhhCcceeeec-CCchhhhhhhccCCCCc
Confidence 344566778999999999999864 4567788866554433 3457888999998885 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCcEEE--Eeccc
Q 011154 214 YIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQLKA--IDFGL 288 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~~kl--~DfGl 288 (492)
.++..||+.|+|+..+++..+ -.+..++.+++.+|++|+.|||+.. |.---|....+++ |++.+.+| +|--+
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kf 339 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKF 339 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheeccccee
Confidence 999999999999999987643 3678899999999999999999975 4444588999999 66665554 34322
Q ss_pred ccccCCCCCccccccCccccccccccCC----CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 289 SDFVRPDERLNDIVGSAYYVAPEVLHRS----YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
+.. -....-.+.||+||.+++. --.++|+|||.+++|||.|...||..-..-+.-.+|.-.... ....
T Consensus 340 sfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr--v~ip 411 (448)
T KOG0195|consen 340 SFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR--VHIP 411 (448)
T ss_pred eee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc--ccCC
Confidence 211 1123456889999998754 224689999999999999999999877776655554332222 1223
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHh
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQAL 393 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l 393 (492)
+.++..+..|+.-|++.||.+||....++
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 58899999999999999999999976653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-22 Score=196.70 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=170.7
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEE------EEEE
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFY------DAFE 208 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~------~~~~ 208 (492)
.+.+.+..+.+++|.+...+...+......++.+....+. ........+++-.+.-...|+..+..- ..+.
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 3445566677777766555444332233445555443332 122333445655555554454443322 0111
Q ss_pred -----eCCeEEEEEeecCCCchHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcE
Q 011154 209 -----DLDNVYIVMELCEGGELLDRILSR--CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281 (492)
Q Consensus 209 -----~~~~~~lv~E~~~ggsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~ 281 (492)
...++||.|++|.-.+|.++|..+ ....+....+.++.|++.|++| +|.+|||+||.||++. .+..+
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~ 395 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQL 395 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhh
Confidence 123589999999999999999643 2357788999999999999999 9999999999999994 44589
Q ss_pred EEEecccccccCCCC-------CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHH
Q 011154 282 KAIDFGLSDFVRPDE-------RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 352 (492)
Q Consensus 282 kl~DfGla~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i 352 (492)
||.|||+........ ..+..+||.+||+||.+. +.|+.++||||||+||+||+. =...| .....+..+
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~ 472 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDI 472 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhh
Confidence 999999998876555 556778999999999887 569999999999999999996 23332 122233333
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 353 LKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 353 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
..+.. +...|... ++-.+|+.+||...|.+||++.+.--|+|++
T Consensus 473 r~g~i--p~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 473 RDGII--PPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hcCCC--ChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 33322 21222222 3456899999999999999988888888763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.5e-20 Score=198.89 Aligned_cols=199 Identities=22% Similarity=0.279 Sum_probs=159.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.-...|.|.+.||+|+||.||+|... +|+.||+|+-+....+.-....++...++ +. --+-|..+...+.-.
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~----~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~---~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHS----NGKLVALKVEKPPNPWEFYICLQVMERLK-PQ---MLPSIMHISSAHVFQ 766 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecC----CCcEEEEEeecCCCceeeeehHHHHHhhc-hh---hhcchHHHHHHHccC
Confidence 34578999999999999999999854 38999999987665543332333333333 11 124566666666667
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeec----CCCCCcEEEEec
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS----KDESSQLKAIDF 286 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~----~~~~~~~kl~Df 286 (492)
+.-+||+||.+.|+|++++. ..+.++|..+..++.|++..|+.||..+|||+||||+|+||.. +.+..-++|+||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 88899999999999999875 4567999999999999999999999999999999999999963 234567999999
Q ss_pred cccccc---CCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCC
Q 011154 287 GLSDFV---RPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSR 338 (492)
Q Consensus 287 Gla~~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~ 338 (492)
|.+..+ ..+..+...++|-.+-.+|+..+ .|+..+|.|.|..+++.||.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 998654 34456778899999999999875 59999999999999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-22 Score=214.65 Aligned_cols=261 Identities=28% Similarity=0.468 Sum_probs=209.7
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
..|.+.+.||+|+|+.|-.+.... .....+|+|.+.... ......+....|..+-+.+..|.|++.+++...+.+..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~--~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSR--DPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcC--CCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 457777889999999887765433 245667888776543 12233445667888888886799999999999999999
Q ss_pred EEEEeecCCCchHHHH-HhhCCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccCCCCCceEeecCCCCC-cEEEEeccccc
Q 011154 214 YIVMELCEGGELLDRI-LSRCGKYSEDEAKAVLVQILNVVAFCH-LHGVVHRDLKPENFLYTSKDESS-QLKAIDFGLSD 290 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l-~~~~~~~~~~~~~~i~~qi~~~l~ylH-~~~ivHrDlkp~NILl~~~~~~~-~~kl~DfGla~ 290 (492)
+++++|..||++.+.+ .......+...+..++.|+..++.|+| ..++.||||||+|.++ +..+ .+|++|||+|.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLAT 173 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhc
Confidence 9999999999999988 443336888899999999999999999 9999999999999999 5555 89999999998
Q ss_pred ccCC-CC---Ccccccc-CccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHH-HHHHHhcCCCCCCC
Q 011154 291 FVRP-DE---RLNDIVG-SAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDDG 362 (492)
Q Consensus 291 ~~~~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~ 362 (492)
.+.. .. .....+| ++.|+|||...+ ......|+||+|+++..+++|..|+........ +.........+...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL 253 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence 8765 22 2345678 999999998765 356779999999999999999999865443321 12222222344566
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
.|..++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 254 ~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 254 PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 78899999999999999999999999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-20 Score=187.92 Aligned_cols=226 Identities=28% Similarity=0.343 Sum_probs=170.0
Q ss_pred HHccCCCCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCC-cccCCCCCce
Q 011154 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV-VHRDLKPENF 270 (492)
Q Consensus 192 ~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~i-vHrDlkp~NI 270 (492)
+.+. |.|+.+++|.+.+....++|.+||..|+|+|.+......+++--...++++|+.||.|||..-| .|+.|+..|+
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4564 9999999999999999999999999999999998877788999999999999999999999866 9999999999
Q ss_pred EeecCCCCCcEEEEecccccccCCC---CCccccccCccccccccccCC--------CCCccchHHHHHHHHHHhcCCCC
Q 011154 271 LYTSKDESSQLKAIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLHRS--------YGTEADVWSIGVIAYILLCGSRP 339 (492)
Q Consensus 271 Ll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DvwSlGvil~~lltg~~p 339 (492)
++ +....+||+|||+....... .......-...|.|||.+... .+.++||||||+|++|+++.+.|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 88899999999998776421 111112234569999988642 46679999999999999999999
Q ss_pred CCCCCh----hHHHHHHHh-cCCCCCCCCC--CCCCHHHHHHHHHccccCcCCCCCHHHHhcCc-ccccccccCCCccHH
Q 011154 340 FWARTE----SGIFRAVLK-ADPSFDDGSW--PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP-WIRNYNNVKVPLDIS 411 (492)
Q Consensus 340 f~~~~~----~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp-~~~~~~~~~~~~~~~ 411 (492)
|..... .++...+.. +...+....+ ....+++..++.+||..+|.+||++.++-..- .+......+..+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D~ 237 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMDS 237 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHHH
Confidence 965322 345555555 2222222222 14556799999999999999999999986531 111111122244445
Q ss_pred HHHHHHHHhh
Q 011154 412 ILKLMKAYMQ 421 (492)
Q Consensus 412 ~~~~~~~~~~ 421 (492)
.++.+.+|..
T Consensus 238 m~~~le~Y~~ 247 (484)
T KOG1023|consen 238 LFRMLESYAD 247 (484)
T ss_pred HHHHHHHHHh
Confidence 5666666644
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=175.53 Aligned_cols=147 Identities=20% Similarity=0.184 Sum_probs=112.4
Q ss_pred ceeecceeccccceEEEEEE-EecCCccccEEEEEEccCCCCCC-------------------H--HHHHHHHHHHHHHH
Q 011154 135 RLEVGEEVGRGHFGYTCTAR-YKKGEHKDQKVAIKVIPKSKMTT-------------------A--IAVEDVRREVKILR 192 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~-~~~~~~~~~~vavK~i~~~~~~~-------------------~--~~~~~~~~Ev~~l~ 192 (492)
-|.+.+.||+|+||.||+|. ... +|+.||||++....... . .....+.+|+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 47889999999999999997 332 68999999997543210 0 01123678999999
Q ss_pred HccCCC--CccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccCCCCCc
Q 011154 193 ALSGHS--NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG-VVHRDLKPEN 269 (492)
Q Consensus 193 ~l~~hp--niv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~-ivHrDlkp~N 269 (492)
++. +. .+.+++++ ...++||||++|++|....... ..+...++..++.||+.+|.+||.+| |+||||||+|
T Consensus 106 ~L~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 106 RLY-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred HHH-hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 995 42 34444432 2358999999998887654333 45667778899999999999999999 9999999999
Q ss_pred eEeecCCCCCcEEEEecccccccCC
Q 011154 270 FLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 270 ILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
|++. .+.++|+|||++.....
T Consensus 180 Ili~----~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH----DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE----CCCEEEEEChhhhccCC
Confidence 9994 46799999999876543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.3e-19 Score=163.78 Aligned_cols=137 Identities=28% Similarity=0.356 Sum_probs=112.5
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH-----HHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA-----IAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+.||+|++|.||+|++ .|..|+||+......... .....+.+|+.++..+. |++|+....++.+.+..+
T Consensus 2 ~~l~~G~~~~vy~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFI 75 (211)
T ss_pred cccccCceEEEEEEee-----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCE
Confidence 5799999999999975 456799998654332211 12245788999999995 999888777777788899
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+||||++|++|.+.+... .. ....++.+++.+|.++|+.|++|||++|.|||+. .+.++|+|||++..
T Consensus 76 lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 999999999999887542 22 8889999999999999999999999999999994 46799999999865
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=186.08 Aligned_cols=148 Identities=24% Similarity=0.298 Sum_probs=115.2
Q ss_pred cCCccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCC-----CCHHHHHHHHHHHHHHHHccCCCCc
Q 011154 126 FGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM-----TTAIAVEDVRREVKILRALSGHSNL 200 (492)
Q Consensus 126 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~-----~~~~~~~~~~~Ev~~l~~l~~hpni 200 (492)
+.........|...+.||+|+||.||++.+.. ..+++|+...... ......+.+.+|+++++.++ |++|
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i 398 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLG-----RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGV 398 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecC-----ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCC
Confidence 33334445566778999999999999988643 2344443322111 11123456889999999995 9999
Q ss_pred cEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCc
Q 011154 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 201 v~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~ 280 (492)
+..+.++.+....++||||++|++|.+.+. ....++.|++.+|.|||+.||+||||||+|||+. +..
T Consensus 399 ~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~ 465 (535)
T PRK09605 399 PTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDR 465 (535)
T ss_pred CeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCc
Confidence 998888877778899999999999988774 3567999999999999999999999999999992 347
Q ss_pred EEEEeccccccc
Q 011154 281 LKAIDFGLSDFV 292 (492)
Q Consensus 281 ~kl~DfGla~~~ 292 (492)
++|+|||+++..
T Consensus 466 ~~liDFGla~~~ 477 (535)
T PRK09605 466 LYLIDFGLGKYS 477 (535)
T ss_pred EEEEeCcccccC
Confidence 999999999764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=161.27 Aligned_cols=134 Identities=28% Similarity=0.311 Sum_probs=106.2
Q ss_pred eeccccceEEEEEEEecCCccccEEEEEEccCCCCCC-----HHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT-----AIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~-----~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
.||+|+||.||++.+ .|..|++|+........ ......+.+|+++++.+. |+++.....++.+.+..++
T Consensus 1 ~ig~G~~~~vy~~~~-----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeec-----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEE
Confidence 489999999999984 45789999865432221 122356789999999996 7776555555566677899
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
||||++|++|.+.+.... . .++.|++.+|.+||+.|++|||++|.||++. .+.++++|||++...
T Consensus 75 v~e~~~g~~l~~~~~~~~-~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN-D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEECCccHHHHHhhcH-H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 999999999988764321 1 8899999999999999999999999999994 568999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=160.37 Aligned_cols=141 Identities=23% Similarity=0.284 Sum_probs=108.1
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH-------------------HHHHHHHHHHHHHHHcc
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA-------------------IAVEDVRREVKILRALS 195 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~-------------------~~~~~~~~Ev~~l~~l~ 195 (492)
.|.+.+.||+|+||.||++... +|+.||||++........ .....+.+|+.++..+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 3788899999999999999753 688999999765331000 01123678999999995
Q ss_pred CCC--CccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 196 GHS--NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 196 ~hp--niv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
|+ .++..++ .+..++||||++|++|.+... ......++.+|+.++.++|+.||+||||||+||++
T Consensus 92 -~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill- 158 (198)
T cd05144 92 -EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV- 158 (198)
T ss_pred -HcCCCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE-
Confidence 76 4555544 245689999999998865421 14566789999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCC
Q 011154 274 SKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~ 294 (492)
++++.++|+|||++.....
T Consensus 159 --~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 --DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred --cCCCcEEEEECCccccCCC
Confidence 5677999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=152.75 Aligned_cols=142 Identities=20% Similarity=0.221 Sum_probs=100.9
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHH---------------------HHHHHHHHHHccCC
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVED---------------------VRREVKILRALSGH 197 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~---------------------~~~Ev~~l~~l~~h 197 (492)
.+.||+|+||.||+|... +|+.||||++............. ...|...+..+.++
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 567999999999999753 57899999986543221111111 14677777777422
Q ss_pred -CCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecC
Q 011154 198 -SNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSK 275 (492)
Q Consensus 198 -pniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~ 275 (492)
-.+.+.+++ ...++||||++|+.+......... . ..++..++.+++.++.++|. .||+||||||+||+++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-- 149 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-- 149 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE--
Confidence 235555543 246899999999654322222111 1 16788999999999999999 9999999999999994
Q ss_pred CCCCcEEEEecccccccCC
Q 011154 276 DESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~~~ 294 (492)
++.++|+|||.+.....
T Consensus 150 --~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 --DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred --CCcEEEEECcccccccC
Confidence 56899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=169.43 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=202.5
Q ss_pred cccceeecceecc--ccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGR--GHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+...+.+...+|. |.+|.||.+.... ..++..+|+|.-+.-.. .......=.+|+...+++.-|+|.++.+..++.
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCccccc
Confidence 4456677888999 9999999998721 34788899998322111 111112234688888888789999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHH----HHHHHHHcCCcccCCCCCceEeecCCCC-CcEEEE
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN----VVAFCHLHGVVHRDLKPENFLYTSKDES-SQLKAI 284 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~----~l~ylH~~~ivHrDlkp~NILl~~~~~~-~~~kl~ 284 (492)
.+..|+-+|+|. .+|.++.......+++..++.++.+... ||..+|..+++|-|+||.||+.. .+ ...+++
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~ 265 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLT 265 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecC
Confidence 999999999995 6999998888777999999999999999 99999999999999999999994 44 689999
Q ss_pred ecccccccCCCCCc------cccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC
Q 011154 285 DFGLSDFVRPDERL------NDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 358 (492)
Q Consensus 285 DfGla~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~ 358 (492)
|||+...+....-. ....|...|++||.+++-++...|||++|.++.+..+|..++..+... .+..+.+..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~-- 342 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGY-- 342 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccccccccc--
Confidence 99999887655421 122577889999999999999999999999999999887776443111 111111111
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 359 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.+.+.....+.++...+..|+..+|..|++++.++.|+++...
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 2222333567777779999999999999999999999999854
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.4e-16 Score=151.58 Aligned_cols=138 Identities=22% Similarity=0.239 Sum_probs=102.3
Q ss_pred ceec-cccceEEEEEEEecCCccccEEEEEEccCCCC----------CCHHHHHHHHHHHHHHHHccCCCCc--cEEEEE
Q 011154 140 EEVG-RGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM----------TTAIAVEDVRREVKILRALSGHSNL--VKFYDA 206 (492)
Q Consensus 140 ~~lG-~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~----------~~~~~~~~~~~Ev~~l~~l~~hpni--v~l~~~ 206 (492)
..|| .||.|+||.+... +..++||++..... ........+.+|+.++..|. |++| ++.+++
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~ 110 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAA 110 (239)
T ss_pred ceeecCCCCccEEEEEeC-----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEee
Confidence 4577 7888888888643 56789998854221 11123345789999999995 8774 777776
Q ss_pred EEeCC-e---EEEEEeecCC-CchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcE
Q 011154 207 FEDLD-N---VYIVMELCEG-GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281 (492)
Q Consensus 207 ~~~~~-~---~~lv~E~~~g-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~ 281 (492)
..... . .++|||+++| .+|.+.+.. ..+++. .+.||+.+|.+||++||+||||||+|||+ +.++.+
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v 181 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKF 181 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCE
Confidence 54332 2 3599999998 588777643 355554 36789999999999999999999999999 445589
Q ss_pred EEEeccccccc
Q 011154 282 KAIDFGLSDFV 292 (492)
Q Consensus 282 kl~DfGla~~~ 292 (492)
+|+|||.+...
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=140.10 Aligned_cols=134 Identities=26% Similarity=0.303 Sum_probs=111.1
Q ss_pred ecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-CCccEEEEEEEeCCeEEEE
Q 011154 138 VGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-SNLVKFYDAFEDLDNVYIV 216 (492)
Q Consensus 138 ~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-pniv~l~~~~~~~~~~~lv 216 (492)
+.+.||+|.++.||++... +..++||++..... ...+.+|+.+++.|+++ .++++++.++...+..+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL 71 (155)
T ss_pred cceecccccccceEEEEec-----CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence 3567999999999999863 26799999865432 34688999999999734 6999999999888899999
Q ss_pred EeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 217 MELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH---GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 217 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~---~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
|||+.|+++... +......++.+++.+|.++|.. +++|+||+|+|||++ ....++++|||++...
T Consensus 72 ~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 72 MEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGYG 139 (155)
T ss_pred EEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccCC
Confidence 999998776542 5567778899999999999995 699999999999994 4578999999998653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.6e-16 Score=168.16 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=197.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
-+.+.+.+-+-+|.||.+..+.-.. .|...++|+..+...-.....+..+.+-.++-.- .+|-+++..-.+.....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~---sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAG---SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred CccceecccccCCCCcccccCCccc---cccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCC
Confidence 4566777888899999888876443 4545566555433221111222233333333222 25666655544556678
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.+||++|..|++|...+++. +..+.+-+...+..+..+++|||...++|||++|.|+|. ...++.++.|||.....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred cchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCcccccccc
Confidence 99999999999999988765 467888888999999999999999999999999999999 67789999999843221
Q ss_pred CC---------------------C-----------CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCC
Q 011154 293 RP---------------------D-----------ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRP 339 (492)
Q Consensus 293 ~~---------------------~-----------~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~p 339 (492)
.. . .......||+.|.+||.+.+ .....+|.|++|+++++.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0 01123579999999998764 577889999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHH---HHhcCccccccc
Q 011154 340 FWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAA---QALSHPWIRNYN 402 (492)
Q Consensus 340 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~---e~l~hp~~~~~~ 402 (492)
|.+.+.+.++++|..++...+... ...+.++++++.++|..+|.+|..+. ++-.|+||+...
T Consensus 1035 ~na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred CCCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 999999999999998876665443 25788999999999999999999988 999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.3e-14 Score=146.87 Aligned_cols=144 Identities=21% Similarity=0.256 Sum_probs=97.3
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH---------------------------HHHH----------
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA---------------------------IAVE---------- 182 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~---------------------------~~~~---------- 182 (492)
+.||.|++|+||+|+.+ +|+.||||+........- ...+
T Consensus 123 ~plasaSigQVh~A~l~----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El 198 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL 198 (437)
T ss_pred cceeeeehhheEEEEec----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence 57999999999999875 578999999865421100 0000
Q ss_pred HHHHHHHHHHHcc----CCCCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHH-HHHHHHH
Q 011154 183 DVRREVKILRALS----GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN-VVAFCHL 257 (492)
Q Consensus 183 ~~~~Ev~~l~~l~----~hpniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~-~l~ylH~ 257 (492)
++.+|...+.++. ++++|.-..-+++.....+|||||++|++|.+........+ ....++.+++. .+..+|.
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh
Confidence 2445555555543 34443322222222345799999999999988664322222 23456666665 4688999
Q ss_pred cCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 258 ~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
.|++|+|+||.||++ +.++.++|+|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 999999999999999 566789999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.6e-15 Score=149.51 Aligned_cols=251 Identities=22% Similarity=0.232 Sum_probs=186.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
..+|..+..||.|.|+.|+.+... ..++..|++|.+.+........+ .-..|+.+...|.-|.++++++..|....+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeec--CCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 345777889999999999888733 34678899998866554433222 245688888888779999999999998889
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.|+-.|||+++++...+.- ...+.+...+.+..|++.++.++|+..++|+|+||+||++.+++ +..++.|||.++.+
T Consensus 341 ~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRL 417 (524)
T ss_pred ccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhcccccccccc
Confidence 9999999999988766632 24688899999999999999999999999999999999996543 78899999998653
Q ss_pred CCCCCccccccCcccc-ccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 293 RPDERLNDIVGSAYYV-APEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~-aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.- ......+.-+++ ..|++.. .+..+.|++|||.-+.+.++|..--+.... +..|..+.... .+....
T Consensus 418 ~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~----~~~~~~ 488 (524)
T KOG0601|consen 418 AF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPN----LPGLKL 488 (524)
T ss_pred ce--ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccC----CCchHH
Confidence 21 111122333444 3666543 367899999999999999998765433322 12222222111 124457
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
+++.+.+.++..|+..|+.+.++..|.=|
T Consensus 489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 489 QLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhhhhhcCCccccchhhhhhcccchh
Confidence 88899999999999999999998887644
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.2e-14 Score=149.94 Aligned_cols=152 Identities=18% Similarity=0.298 Sum_probs=97.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC--------------------------C-H----HHH
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT--------------------------T-A----IAV 181 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~--------------------------~-~----~~~ 181 (492)
-..|+. +.||+|++|+||.|+.+. +|+.||||++...... . . +..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 355665 789999999999999874 5899999999754210 0 0 111
Q ss_pred HHHHH------HHHHHHHcc---CCCCccEEEEEEEe-CCeEEEEEeecCCCchHHHHH-hhCC----CCCHHHHHHHHH
Q 011154 182 EDVRR------EVKILRALS---GHSNLVKFYDAFED-LDNVYIVMELCEGGELLDRIL-SRCG----KYSEDEAKAVLV 246 (492)
Q Consensus 182 ~~~~~------Ev~~l~~l~---~hpniv~l~~~~~~-~~~~~lv~E~~~ggsL~~~l~-~~~~----~~~~~~~~~i~~ 246 (492)
+.+.+ |...+.+++ .+.+.+.+-.+|.+ ....+||||||.|+.+.+.-. ...+ .+.+..+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 22333 443333332 12333333333322 345689999999999876421 1212 244555555666
Q ss_pred HHHHHHHHHHHcCCcccCCCCCceEeecCC-CCCcEEEEecccccccCCC
Q 011154 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 247 qi~~~l~ylH~~~ivHrDlkp~NILl~~~~-~~~~~kl~DfGla~~~~~~ 295 (492)
|++ ..|++|+|+||.||++..++ ..+.++++|||++..+...
T Consensus 275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 655 58999999999999995321 2238999999999877543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.1e-13 Score=120.22 Aligned_cols=129 Identities=19% Similarity=0.220 Sum_probs=95.3
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEe
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E 218 (492)
.+.|+.|.++.||++.. .+..|++|+...... ....+.+|+.+++.+.+...+.+++.+.. ...++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~-----~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEE-----CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEE
Confidence 35689999999999875 357899999854421 11245789999999863333455665543 34579999
Q ss_pred ecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCC-----cccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV-----VHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 219 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~i-----vHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
|++|.++.+. ......++.+++.+|..||..++ +|+|++|.||+++ +..++++|||.+..
T Consensus 72 ~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 72 FIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred ecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 9999887542 11123467899999999999985 9999999999994 34699999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.6e-11 Score=121.64 Aligned_cols=289 Identities=16% Similarity=0.211 Sum_probs=197.6
Q ss_pred ce-EEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE----eCCeEEEEEeecC
Q 011154 147 FG-YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE----DLDNVYIVMELCE 221 (492)
Q Consensus 147 fg-~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~----~~~~~~lv~E~~~ 221 (492)
|. +.|++.... +|..|++|+++..+.... ...-.-+++++++. |+|||.+.++|. .+..+++||+|.+
T Consensus 288 ~~~Ttyk~~s~~---DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 288 FSITTYKATSNV---DGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred ccceeEeeeecc---CCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCC
Confidence 44 788887654 789999999954332221 12234678899995 999999999987 3567999999998
Q ss_pred C-CchHHHHHhh--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEec
Q 011154 222 G-GELLDRILSR--------------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 222 g-gsL~~~l~~~--------------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
+ ++|.+..... +...+|..+|.++.||..||.++|+.|+.-+-|.+.+||+ ....+++|.-+
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C 437 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGC 437 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecc
Confidence 6 4777766432 2346889999999999999999999999999999999999 45558999999
Q ss_pred ccccccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChh--HHHHHHHhcCCCCCCCCC
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 364 (492)
|....+..+.. |-+. --.+-|.-.||.+++.|.||..--|..+.. ..+..|.
T Consensus 438 ~i~Dvl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~----------- 491 (655)
T KOG3741|consen 438 GIMDVLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT----------- 491 (655)
T ss_pred cceeeecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------
Confidence 88877654430 1111 123568899999999999997654333221 1123332
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCc---ccccccccCCCccHHHHHHHHHHhhhhhhHHHHHHhhh--cccc-
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP---WIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALS--KTLT- 438 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~a~l~~l~--~~l~- 438 (492)
+.+|.+++++|.-+...++++ -++.+++.+- ||..........+. .-..+..-++..+|-|...++.. .+..
T Consensus 492 ~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q~~~d~-mE~~Ls~emENGRLfRll~Kln~I~dR~e~ 569 (655)
T KOG3741|consen 492 TTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQLKTDV-METELSREMENGRLFRLLLKLNFIDDRPEY 569 (655)
T ss_pred hhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHHHHHHH-HHHHHHHHHhcchHHHHHHHHhhhccCccc
Confidence 368899999999999999987 6888988763 44433222211111 11223334555666665544332 1110
Q ss_pred --------hhhH---HHH-HHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 439 --------VDER---FYL-KEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 439 --------~~e~---~~l-~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
..+. .-+ ...|...|.|+.-.+++..+-++|.++.
T Consensus 570 ~~D~~WSesG~~fmi~LFRDYlFHqvtedg~p~lDlaHvl~CLNKLD 616 (655)
T KOG3741|consen 570 VDDPDWSESGDRFMIKLFRDYLFHQVTEDGKPWLDLAHVLQCLNKLD 616 (655)
T ss_pred ccCCcchhccceehHHHHHHhhheEeccCCChhhhHHHHHHHhhhcc
Confidence 0111 112 3468888999999999999999998874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-12 Score=114.27 Aligned_cols=148 Identities=23% Similarity=0.250 Sum_probs=112.7
Q ss_pred ecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-----CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 138 VGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-----TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 138 ~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
....|-+|+-++|+++.+ .|+...||.-...... .........+|.++|.++. --.|.--.=+|.+...
T Consensus 11 ~l~likQGAEArv~~~~~-----~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYG 84 (229)
T ss_pred cceeeeccceeeEeeecc-----CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCC
Confidence 456788999999999876 4566677654332222 2233455788999999985 4455555556777777
Q ss_pred EEEEEeecCC-CchHHHHHhhCCCCCHHHH-HHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 213 VYIVMELCEG-GELLDRILSRCGKYSEDEA-KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 213 ~~lv~E~~~g-gsL~~~l~~~~~~~~~~~~-~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
-.|+|||++| .++.+++......-.++.. ..++++|-+.|.-||.++|||+||..+||++.+++....+.++|||++.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 8899999987 4778888766544444444 7899999999999999999999999999999988887888999999985
Q ss_pred c
Q 011154 291 F 291 (492)
Q Consensus 291 ~ 291 (492)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.1e-12 Score=116.09 Aligned_cols=146 Identities=18% Similarity=0.154 Sum_probs=103.3
Q ss_pred cceeccccceEEEEEEEecC---CccccEEEEEEccCCCCC---------------------CH--HHHHHHHHHHHHHH
Q 011154 139 GEEVGRGHFGYTCTARYKKG---EHKDQKVAIKVIPKSKMT---------------------TA--IAVEDVRREVKILR 192 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~---~~~~~~vavK~i~~~~~~---------------------~~--~~~~~~~~Ev~~l~ 192 (492)
...||.|--+.||.|....+ ...+..+|||+....... +. ......++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 34689999999999974321 113578999987432110 00 11112448999999
Q ss_pred HccCC-CCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccCCCCCce
Q 011154 193 ALSGH-SNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC-HLHGVVHRDLKPENF 270 (492)
Q Consensus 193 ~l~~h-pniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~yl-H~~~ivHrDlkp~NI 270 (492)
+|... -++...+++ ..-+|||||+.++.+.....+. ..+++.+...++.+++.+|..| |..||||+||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 98633 567777765 4568999999765443322222 2466677888899999999998 899999999999999
Q ss_pred EeecCCCCCcEEEEecccccccC
Q 011154 271 LYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 271 Ll~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+. ++.+.|+|||.+....
T Consensus 157 L~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE----CCcEEEEECCCceeCC
Confidence 994 2469999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3e-11 Score=124.95 Aligned_cols=164 Identities=23% Similarity=0.302 Sum_probs=123.1
Q ss_pred cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHH
Q 011154 161 KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDE 240 (492)
Q Consensus 161 ~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~ 240 (492)
++.+|.|.+.+.+.. ...+...+-++.|+.|+ ||||+++++.++.++..|||+|-+.- |..++.+ ++...
T Consensus 36 ~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~----l~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE----LGKEE 105 (690)
T ss_pred cCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeecccc--HHHHHHH----hHHHH
Confidence 678899998865543 33455788899999997 99999999999999999999999853 4455543 34778
Q ss_pred HHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCC-ccccccCccccccccccCCCC
Q 011154 241 AKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLHRSYG 318 (492)
Q Consensus 241 ~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 318 (492)
+...+.||+.||.|||. .+++|++|.-+.|++ +..+..||++|-++........ .....--..|..|+.+... .
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-E 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-c
Confidence 88899999999999985 579999999999999 6778999999988754432111 1111112235666654311 1
Q ss_pred CccchHHHHHHHHHHhcCCC
Q 011154 319 TEADVWSIGVIAYILLCGSR 338 (492)
Q Consensus 319 ~~~DvwSlGvil~~lltg~~ 338 (492)
-..|.|-|||++++++.|..
T Consensus 182 ~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cchhhhhHHHHHHHHhCccc
Confidence 24699999999999999943
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.4e-13 Score=125.50 Aligned_cols=199 Identities=19% Similarity=0.211 Sum_probs=139.7
Q ss_pred HHHccCCCCccEEEEEEEeC-----CeEEEEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHcC--C
Q 011154 191 LRALSGHSNLVKFYDAFEDL-----DNVYIVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLHG--V 260 (492)
Q Consensus 191 l~~l~~hpniv~l~~~~~~~-----~~~~lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~~--i 260 (492)
|-.| .|.|||+++.+|.+. ....+++|||..|+|..+|.+. ...+.....++|+-||+.||.|||+.. |
T Consensus 121 llql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 3445 499999999998654 3588999999999999888643 346888888999999999999999985 9
Q ss_pred cccCCCCCceEeecCCCCCcEEEEecccccccCCC----C--CccccccCcccccccccc-CCCCCccchHHHHHHHHHH
Q 011154 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD----E--RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYIL 333 (492)
Q Consensus 261 vHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~----~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~l 333 (492)
+|+++..+-|++ ..++-+||+- +--...... . ....-.|-++|.|||.=. ...+..+|||+||+..++|
T Consensus 200 ihgnlTc~tifi---q~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 200 IHGNLTCDTIFI---QHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred ccCCcchhheee---cCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 999999999999 4556677642 111111100 0 011124668899999643 3456689999999999999
Q ss_pred hcCCCCC-CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 334 LCGSRPF-WARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 334 ltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..|..-- ........-.++......... ..-++++.+||+..|..||++.++|-||.+-+.
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 8876542 222222222223222222111 123578999999999999999999999987654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.8e-11 Score=108.31 Aligned_cols=135 Identities=25% Similarity=0.317 Sum_probs=99.2
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH-----HHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA-----IAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
..+++|+-+.++.+.+. |..+++|.=.+...... ...+...+|..+|.++. --.|..-+=++.+.++..
T Consensus 2 ~~i~~GAEa~i~~~~~~-----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred chhhCCcceeEEeeecc-----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCE
Confidence 35789999999998664 34466665333222221 22334678999999986 445555555566778889
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
|+|||.+|-.|.+.+... ...+++.+-.-+.-||..||||+||.++||++.. ..+.++||||+.+-
T Consensus 76 I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~----~~i~~IDfGLg~~s 141 (204)
T COG3642 76 IVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG----GRIYFIDFGLGEFS 141 (204)
T ss_pred EEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC----CcEEEEECCccccc
Confidence 999999987777776443 2568888888899999999999999999999953 34999999998754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.2e-11 Score=110.84 Aligned_cols=143 Identities=26% Similarity=0.412 Sum_probs=104.8
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-CCccEEEEEEEeC---CeEEE
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-SNLVKFYDAFEDL---DNVYI 215 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-pniv~l~~~~~~~---~~~~l 215 (492)
+.||.|.++.||++... +|..+++|+....... .....+.+|+++++.+..+ .++.+++.+.... +..++
T Consensus 4 ~~l~~G~~n~~~~v~~~----~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred eecCCCccceEEEEEec----CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence 56899999999999763 2578999998654321 1234678999999999632 3467777776653 36789
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-------------------------------------- 257 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-------------------------------------- 257 (492)
||||++|.++.+.+.. ..+++.+...++.+++.+|.+||+
T Consensus 78 v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 78 VMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9999999887664421 356777777778888888877773
Q ss_pred ------------------cCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 258 ------------------HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 258 ------------------~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++|+|+++.|||++.+ ....+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999532 145689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.5e-09 Score=101.38 Aligned_cols=107 Identities=19% Similarity=0.180 Sum_probs=81.2
Q ss_pred HHHHHHHHHHccCCCC--ccEEEEEEEe-----CCeEEEEEeecCCC-chHHHHHhh-CCCCCHHHHHHHHHHHHHHHHH
Q 011154 184 VRREVKILRALSGHSN--LVKFYDAFED-----LDNVYIVMELCEGG-ELLDRILSR-CGKYSEDEAKAVLVQILNVVAF 254 (492)
Q Consensus 184 ~~~Ev~~l~~l~~hpn--iv~l~~~~~~-----~~~~~lv~E~~~gg-sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~y 254 (492)
+.+|...+..|. .-+ ++..+.+++. ...-+||||++++- +|.+++... ....+......++.+++..+.-
T Consensus 75 a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 75 ADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 678888888874 222 3344555543 23578999999886 787776432 2346677888999999999999
Q ss_pred HHHcCCcccCCCCCceEeecC----CCCCcEEEEecccccc
Q 011154 255 CHLHGVVHRDLKPENFLYTSK----DESSQLKAIDFGLSDF 291 (492)
Q Consensus 255 lH~~~ivHrDlkp~NILl~~~----~~~~~~kl~DfGla~~ 291 (492)
||..||+|+||++.|||+..+ ++...+.|+||+.+..
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999999999999999999641 3356899999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-09 Score=99.58 Aligned_cols=129 Identities=28% Similarity=0.317 Sum_probs=81.9
Q ss_pred EEEEEEecCCccccEEEEEEccCCCC-----------------------CCHHHHHHHHHHHHHHHHccCC-CCccEEEE
Q 011154 150 TCTARYKKGEHKDQKVAIKVIPKSKM-----------------------TTAIAVEDVRREVKILRALSGH-SNLVKFYD 205 (492)
Q Consensus 150 V~~~~~~~~~~~~~~vavK~i~~~~~-----------------------~~~~~~~~~~~Ev~~l~~l~~h-pniv~l~~ 205 (492)
||.|... +|..+|||+...... ..........+|.+.|.++... -++.+.++
T Consensus 2 Vy~~~~~----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~ 77 (188)
T PF01163_consen 2 VYHAIDP----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD 77 (188)
T ss_dssp EEEEEEC----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred EEEEECC----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence 7777643 567899998744211 1112234578999999999633 25777775
Q ss_pred EEEeCCeEEEEEeecC--CCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHH-HHHcCCcccCCCCCceEeecCCCCCcEE
Q 011154 206 AFEDLDNVYIVMELCE--GGELLDRILSRCGKYSEDEAKAVLVQILNVVAF-CHLHGVVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 206 ~~~~~~~~~lv~E~~~--ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~y-lH~~~ivHrDlkp~NILl~~~~~~~~~k 282 (492)
+. .-+|||||++ |..+ ..+... .++......++.+++..+.. +|..||||+||.+.|||+. ++ .+.
T Consensus 78 ~~----~~~ivME~I~~~G~~~-~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~---~~-~~~ 146 (188)
T PF01163_consen 78 YN----RNVIVMEYIGEDGVPL-PRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD---DG-KVY 146 (188)
T ss_dssp EE----TTEEEEE--EETTEEG-GCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---TT-CEE
T ss_pred Ee----CCEEEEEecCCCccch-hhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---cc-eEE
Confidence 53 2369999998 5444 334332 23356677888888886555 6799999999999999994 33 799
Q ss_pred EEecccccccC
Q 011154 283 AIDFGLSDFVR 293 (492)
Q Consensus 283 l~DfGla~~~~ 293 (492)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.2e-10 Score=119.12 Aligned_cols=154 Identities=23% Similarity=0.272 Sum_probs=111.5
Q ss_pred HHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCcc----------ccccCccccccccc
Q 011154 245 LVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLN----------DIVGSAYYVAPEVL 313 (492)
Q Consensus 245 ~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~----------~~~gt~~y~aPE~~ 313 (492)
+.+++.|+.|+|.. ++||+.|.|++|.+ +..+.+||+-|+++.......... -..-...|.|||++
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34445999999986 79999999999999 677889999999886654422111 11234569999987
Q ss_pred cC-CCCCccchHHHHHHHHHHh-cCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHH
Q 011154 314 HR-SYGTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQ 391 (492)
Q Consensus 314 ~~-~~~~~~DvwSlGvil~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 391 (492)
.. ..+.++|+||+||++|.+. .|+.-+.+......+..-......-.......+++++++=|.++|..++..||++.+
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 64 4677899999999999998 566555444332222221111111111122478999999999999999999999999
Q ss_pred HhcCcccccc
Q 011154 392 ALSHPWIRNY 401 (492)
Q Consensus 392 ~l~hp~~~~~ 401 (492)
++..|||.+.
T Consensus 262 l~~~~ff~D~ 271 (700)
T KOG2137|consen 262 LLSIPFFSDP 271 (700)
T ss_pred hhcccccCCc
Confidence 9999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.1e-08 Score=100.68 Aligned_cols=240 Identities=17% Similarity=0.162 Sum_probs=156.2
Q ss_pred eecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEE------EeC
Q 011154 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAF------EDL 210 (492)
Q Consensus 137 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~------~~~ 210 (492)
..++.||+|+-+.+|..-... .. +-|++..-..... ...+..|...-+||-+-.-+.+= -+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-----d~-VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~ 81 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-----DQ-VAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRR 81 (637)
T ss_pred CCCccccCCccceeeecchhh-----ch-hheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence 356789999999888764221 22 4477754432111 12334455554566544311111 111
Q ss_pred -CeEEEEEeecCCCchHHHHH------hhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 211 -DNVYIVMELCEGGELLDRIL------SRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~------~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
...-+.|..+.|..=-..+. +......|.-+.++.+.|+.+...||.+|.+-+|+.++|||+ .+++.|.|
T Consensus 82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~L 158 (637)
T COG4248 82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVL 158 (637)
T ss_pred cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEE
Confidence 23678888887753222221 123457899999999999999999999999999999999999 56678999
Q ss_pred EecccccccCCCCCccccccCcccccccccc-C-----CCCCccchHHHHHHHHHHhcC-CCCCCCCChh----HHHH-H
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-R-----SYGTEADVWSIGVIAYILLCG-SRPFWARTES----GIFR-A 351 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DvwSlGvil~~lltg-~~pf~~~~~~----~~~~-~ 351 (492)
+|-..-.....+......+|...|.+||.-. + .-+...|.|.|||++++||.| +.||.+.... .-++ .
T Consensus 159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 8855443333344455678999999999654 2 235578999999999999986 9999653210 0111 1
Q ss_pred HHhcC------------CCCCCCCCCCCCHHHHHHHHHccccC--cCCCCCHHH
Q 011154 352 VLKAD------------PSFDDGSWPSLSSDAKDFVKLLLNKD--PRKRMTAAQ 391 (492)
Q Consensus 352 i~~~~------------~~~~~~~~~~~s~~~~~li~~~L~~d--P~~Rps~~e 391 (492)
|..+. +......|.-++++++.|..+|+... +.-|||++.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 21111 11223345678899999999999763 558999754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.8e-08 Score=93.82 Aligned_cols=142 Identities=18% Similarity=0.178 Sum_probs=97.0
Q ss_pred EEEEEEecCCccccEEEEEEccCCCCCC----HHHHHHHHHHHHHHHHccC-CCCccEEEEEEEeC----CeEEEEEeec
Q 011154 150 TCTARYKKGEHKDQKVAIKVIPKSKMTT----AIAVEDVRREVKILRALSG-HSNLVKFYDAFEDL----DNVYIVMELC 220 (492)
Q Consensus 150 V~~~~~~~~~~~~~~vavK~i~~~~~~~----~~~~~~~~~Ev~~l~~l~~-hpniv~l~~~~~~~----~~~~lv~E~~ 220 (492)
++.+........++.|-+|........+ ........+|...+..|.. .=.+.+.+.+.+.. ...+||+|++
T Consensus 20 ~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l 99 (206)
T PF06293_consen 20 GWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEAL 99 (206)
T ss_pred EEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeC
Confidence 3444433323355667776543211111 1122346778887777641 22355666666553 2468999999
Q ss_pred CCC-chHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 221 EGG-ELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 221 ~gg-sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|. +|.+.+... ...+......++.+++..+.-||..||+|+|+++.|||+..++....+.|+||+-+...
T Consensus 100 ~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 100 PGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred CCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 985 677776543 23777888999999999999999999999999999999976555568999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.7e-08 Score=91.85 Aligned_cols=140 Identities=25% Similarity=0.283 Sum_probs=103.9
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCC-----------------CCCCH--HHHHHHHHHHHHHHHccC
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKS-----------------KMTTA--IAVEDVRREVKILRALSG 196 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~-----------------~~~~~--~~~~~~~~Ev~~l~~l~~ 196 (492)
+.++..||-|--+.||.|... .|.++|||.=... ...++ .......+|.++|.+|..
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECC----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 457889999999999999854 5789999964221 00111 223346899999999953
Q ss_pred C-CCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC
Q 011154 197 H-SNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK 275 (492)
Q Consensus 197 h-pniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~ 275 (492)
+ -.|.+.++ .+...+||||++|-.|... +++.+....++..|++-+.-+-..||||+|+.+-|||+
T Consensus 169 ~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV--- 235 (304)
T COG0478 169 EGVKVPKPIA----WNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV--- 235 (304)
T ss_pred cCCCCCCccc----cccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---
Confidence 3 35777765 3566899999999665432 23566677788888888877779999999999999999
Q ss_pred CCCCcEEEEeccccccc
Q 011154 276 DESSQLKAIDFGLSDFV 292 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~ 292 (492)
++++.+.++||--+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 66778999999766543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.4e-09 Score=112.00 Aligned_cols=246 Identities=18% Similarity=0.239 Sum_probs=170.6
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCC-ccEEEEEEEe
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN-LVKFYDAFED 209 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpn-iv~l~~~~~~ 209 (492)
+-+..|.....+++|+++.+++.+... + +....+.+... ....-++++|.++ +||| .++.++-++.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRpta---e-klL~h~fvs~~--------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~ 305 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTA---E-KLLQHPFVSQT--------LSRRLAIELLDKV-NNPNPVVRYLEDYDG 305 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCCh---h-hheeceeeccc--------hhhHHHHHHHHHc-cCCCCcccccccCCc
Confidence 334566677789999999998877433 2 23336665322 2345688999999 5999 8888888888
Q ss_pred CCeEEEEEeecCCC-chHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 210 LDNVYIVMELCEGG-ELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 210 ~~~~~lv~E~~~gg-sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
+...++++++|.+| +..+.+....-.+.+-+...+.+.-+++++|+|+.-=+||| |||.. +...|..||+.
T Consensus 306 E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v 377 (829)
T KOG0576|consen 306 EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAV 377 (829)
T ss_pred ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccC
Confidence 89999999999887 32222211112344556667788888999999998889999 88873 35789999999
Q ss_pred ccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC--CCCCC-CCC
Q 011154 289 SDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFDD-GSW 364 (492)
Q Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~--~~~~~-~~~ 364 (492)
...+......++..+|+.++|||+.. +.+....|+|++|+-..++--|-.|-..... ....+-.+. +.... ..|
T Consensus 378 ~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw 455 (829)
T KOG0576|consen 378 PPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAW 455 (829)
T ss_pred CcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhc
Confidence 88877666667788999999999765 5689999999999876777777776432100 000000000 00000 122
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..... .++...|+..-|..|+....++-|.+|...
T Consensus 456 ~~~~~--~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 456 SPVFH--RDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred Ccccc--cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 22211 258889999999999999999999888753
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.3e-07 Score=83.15 Aligned_cols=142 Identities=20% Similarity=0.241 Sum_probs=93.0
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHH------HHHHHHHHHHHcc--CCCCccE
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVE------DVRREVKILRALS--GHSNLVK 202 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~------~~~~Ev~~l~~l~--~hpniv~ 202 (492)
-+..+|.+.+.+-......|.+... +|+.+++|.........+.... ...+++..+.++. +--..+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-----~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-----DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-----CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 3467788888888888888877654 5688999987543322211111 1234455444443 2333334
Q ss_pred EEEEEEe-----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC
Q 011154 203 FYDAFED-----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277 (492)
Q Consensus 203 l~~~~~~-----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~ 277 (492)
++-+.+- ....++||||++|..|.+.. .+++ .+...|.+++.-||+.|++|+|.+|.|+++..
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~--- 170 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN--- 170 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC---
Confidence 3333322 24567899999998876542 2333 24466778899999999999999999999952
Q ss_pred CCcEEEEeccccc
Q 011154 278 SSQLKAIDFGLSD 290 (492)
Q Consensus 278 ~~~~kl~DfGla~ 290 (492)
..++++||+..+
T Consensus 171 -~~i~iID~~~k~ 182 (229)
T PF06176_consen 171 -NGIRIIDTQGKR 182 (229)
T ss_pred -CcEEEEECcccc
Confidence 349999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.1e-07 Score=97.15 Aligned_cols=147 Identities=20% Similarity=0.262 Sum_probs=95.9
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC---------------------------HHHHH----------
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT---------------------------AIAVE---------- 182 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~---------------------------~~~~~---------- 182 (492)
+-|+.++-|+||.|+++ +|+.||||+....-... ...++
T Consensus 131 ~PiAsASIaQVH~A~L~----sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 131 EPIASASIAQVHRAVLK----SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred CchhhhhHhhheeEEec----CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 57999999999999987 48999999986532111 00111
Q ss_pred HHHHHHHHHHHc----cCCCCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 011154 183 DVRREVKILRAL----SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258 (492)
Q Consensus 183 ~~~~Ev~~l~~l----~~hpniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~ 258 (492)
++.+|..-+.++ ++.++|.--.=+++-...-.|+|||++|-.+.+...-....++...+.....++. +.-+-..
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 133454444444 2455554444444555677899999999888776432223455333333222221 2333347
Q ss_pred CCcccCCCCCceEeecCCCCCcEEEEecccccccCCC
Q 011154 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 259 ~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~ 295 (492)
|++|.|.+|.||++ +.++.+-+.|||+...+.+.
T Consensus 285 gffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 GFFHADPHPGNILV---RSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred CccccCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence 99999999999999 56689999999998777543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-06 Score=80.86 Aligned_cols=143 Identities=15% Similarity=0.104 Sum_probs=98.7
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCC---HHHHHHHHHHHHHHHHccCC-CCccEEEEEEE-e----CCe
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT---AIAVEDVRREVKILRALSGH-SNLVKFYDAFE-D----LDN 212 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~Ev~~l~~l~~h-pniv~l~~~~~-~----~~~ 212 (492)
-|+||-+-|+...+. |+.+-||.-......+ ......|.+|+..|..|... -.+.+.. ++. . ...
T Consensus 26 ~~rgG~SgV~r~~~~-----g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r 99 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR 99 (216)
T ss_pred cCCCCcceEEEEEeC-----CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence 366888878776653 3468888874211111 22445688999999888521 2255555 332 1 234
Q ss_pred EEEEEeecCCC-chHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 213 VYIVMELCEGG-ELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 213 ~~lv~E~~~gg-sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.+||+|-+.|- +|.+.+.+. ....++.....++.+++..|.-||+.|+.|+|+.+.|||+..++ ...++++||--++
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r 178 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccc
Confidence 78999988653 777666443 23567888889999999999999999999999999999995322 3459999997654
Q ss_pred c
Q 011154 291 F 291 (492)
Q Consensus 291 ~ 291 (492)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.8e-07 Score=98.81 Aligned_cols=204 Identities=21% Similarity=0.256 Sum_probs=143.6
Q ss_pred HHHHHHHHHHHccCCCCccEEEEEEEeCCe----EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 011154 183 DVRREVKILRALSGHSNLVKFYDAFEDLDN----VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258 (492)
Q Consensus 183 ~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~----~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~ 258 (492)
...-|+..+.++. |+|++.++.+-..... ..+..|+|..-++...+.. -+..+...++.+..++++||.|+|+.
T Consensus 228 ~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3556777888886 9999999998755433 3345688988888876644 47889999999999999999999999
Q ss_pred CCcccCCCCCceEeecCCCCCcEEEE--ecccccccCCCCCccccccCccccccccccCC-CC--CccchHHHHHHHHHH
Q 011154 259 GVVHRDLKPENFLYTSKDESSQLKAI--DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YG--TEADVWSIGVIAYIL 333 (492)
Q Consensus 259 ~ivHrDlkp~NILl~~~~~~~~~kl~--DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~--~~~DvwSlGvil~~l 333 (492)
.+.|.-|..+-..-...+..+.+.++ ||+.+.............-+..|.++|..... +. ...|+|.+|..+..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 66666555543222222455566666 88888776655544444455668888876543 33 346999999999999
Q ss_pred hcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC-HHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 334 LCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS-SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 334 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s-~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..|..+-. .......++. ..+ .+..+++.+|+.-|+++|+++.+++.|+|++-..
T Consensus 386 ~~~~~i~~---~~~~~~~~l~-----------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 386 SQGEDISE---KSAVPVSLLD-----------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhcCcccc---cccchhhhhc-----------cccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 88765421 1111111111 112 2678899999999999999999999999998654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=3e-06 Score=80.03 Aligned_cols=73 Identities=23% Similarity=0.264 Sum_probs=54.2
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC-CccEEEEEEEeCCeEEEEEe
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS-NLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp-niv~l~~~~~~~~~~~lv~E 218 (492)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+.... .+.+.+++.++.+...+|||
T Consensus 7 ~~i~~G~t~~~y~~-------~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe-------cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence 46899999999973 13457889875432 2235688999999986332 35788888888888899999
Q ss_pred ecCCCc
Q 011154 219 LCEGGE 224 (492)
Q Consensus 219 ~~~ggs 224 (492)
+++|.+
T Consensus 75 ~i~G~~ 80 (226)
T TIGR02172 75 LIVGKR 80 (226)
T ss_pred ecCCcc
Confidence 999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.3e-06 Score=89.30 Aligned_cols=148 Identities=19% Similarity=0.200 Sum_probs=90.8
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC----------------------------HHHHHH------H
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT----------------------------AIAVED------V 184 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~----------------------------~~~~~~------~ 184 (492)
.+.||.-+.|+|++|+.+. |+.||||+-+..-... ++..+. |
T Consensus 166 ~~piaaASlaQVhrA~L~~----G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN----GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred cchhhhcchhheEEEEecC----CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 3679999999999999874 8999999975532111 000111 2
Q ss_pred HHHHHHHHHcc---CCCC------ccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHH
Q 011154 185 RREVKILRALS---GHSN------LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255 (492)
Q Consensus 185 ~~Ev~~l~~l~---~hpn------iv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~yl 255 (492)
.+|.+-..+.+ .|-+ |.++|-.+ .....|+||||+|..+.|.-.-....++...+...+.++..-+ |
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--I 317 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--I 317 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--H
Confidence 23332222211 2444 44444332 3467899999999866554322223566664444433333222 2
Q ss_pred HHcCCcccCCCCCceEeecC-CCCCcEEEEecccccccCC
Q 011154 256 HLHGVVHRDLKPENFLYTSK-DESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 256 H~~~ivHrDlkp~NILl~~~-~~~~~~kl~DfGla~~~~~ 294 (492)
=..|++|+|=+|.||++..+ ..+..+.+-|||+...+..
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 23589999999999999743 3467899999999877653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.5e-06 Score=75.33 Aligned_cols=133 Identities=25% Similarity=0.359 Sum_probs=91.7
Q ss_pred eecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEE
Q 011154 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIV 216 (492)
Q Consensus 137 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv 216 (492)
++.+.||+|++|+||++.++ |..+|+|+-..+. ....+..|.++|..+.+----.++|.+-++ ++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-----~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-----GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIR 90 (201)
T ss_pred hhhhhhhcccccEEEEeecc-----CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhh
Confidence 45678999999999999875 4578999875443 235688999999998644444566665443 455
Q ss_pred EeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC-CC-ceEeecCCCCCcEEEEecccccccCC
Q 011154 217 MELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLK-PE-NFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 217 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlk-p~-NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
|||..|-.|.+.... .+ .+-+..+++.-.-|-..||-|..|. |. ||++ .+..+.|+||.-|++...
T Consensus 91 me~i~G~~L~~~~~~----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 91 MEYIDGRPLGKLEIG----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATFKKK 158 (201)
T ss_pred hhhhcCcchhhhhhc----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhhccC
Confidence 999999887664321 12 2334455666566777899999985 54 5555 233799999999885443
Q ss_pred C
Q 011154 295 D 295 (492)
Q Consensus 295 ~ 295 (492)
.
T Consensus 159 p 159 (201)
T COG2112 159 P 159 (201)
T ss_pred C
Confidence 3
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=7e-07 Score=77.90 Aligned_cols=64 Identities=23% Similarity=0.368 Sum_probs=54.1
Q ss_pred HHHHhhhccc-chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 428 AALKALSKTL-TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 428 a~l~~l~~~l-~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++.+|...+ ..+..++|+.+|+.||.|+||+|+..||+.+|..+|. .++++||++||+.+|.|
T Consensus 76 ~Fl~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge-~~~deev~~ll~~~d~d 140 (160)
T COG5126 76 EFLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGE-RLSDEEVEKLLKEYDED 140 (160)
T ss_pred HHHHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcc-cCCHHHHHHHHHhcCCC
Confidence 3445555555 3455678999999999999999999999999999997 69999999999999964
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.6e-06 Score=79.73 Aligned_cols=75 Identities=19% Similarity=0.221 Sum_probs=54.3
Q ss_pred eccccc-eEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeec
Q 011154 142 VGRGHF-GYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELC 220 (492)
Q Consensus 142 lG~G~f-g~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~ 220 (492)
|-.|.. ..||++.. .+..+.||+..... ...+.+|+++++.|..+--+.+++++....+..++|||++
T Consensus 6 ~~~g~~~~~v~~~~~-----~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 74 (244)
T cd05150 6 VTEGQSGATVYRLDG-----KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV 74 (244)
T ss_pred cCCCCCcCeEEEEcC-----CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence 445555 58888753 23568889875442 2346789999999976656778888887777789999999
Q ss_pred CCCchHH
Q 011154 221 EGGELLD 227 (492)
Q Consensus 221 ~ggsL~~ 227 (492)
+|.+|..
T Consensus 75 ~G~~l~~ 81 (244)
T cd05150 75 PGVPAAA 81 (244)
T ss_pred CCccHhH
Confidence 9876653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.7e-06 Score=77.93 Aligned_cols=79 Identities=23% Similarity=0.250 Sum_probs=56.1
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-CCccEEEEEEEe---CCeEE
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-SNLVKFYDAFED---LDNVY 214 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-pniv~l~~~~~~---~~~~~ 214 (492)
++.|+.|..+.||.+... +..+++|+.... .....+.+|+.+++.|..+ ..+.+++.+... ....+
T Consensus 2 i~~l~~G~~n~~~~v~~~-----~~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD-----DGRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEET-----TSEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEEC-----CcEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 357899999999998753 248999997432 3456788999999988644 236677765433 34579
Q ss_pred EEEeecCCCchHH
Q 011154 215 IVMELCEGGELLD 227 (492)
Q Consensus 215 lv~E~~~ggsL~~ 227 (492)
++|++++|..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999999987766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.3e-06 Score=76.95 Aligned_cols=149 Identities=20% Similarity=0.166 Sum_probs=96.5
Q ss_pred cccceeecceec---cccceEEEEEEEecCCccccEEEEEEccCCCCCCH---------------------HHHHHHHHH
Q 011154 132 VTSRLEVGEEVG---RGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA---------------------IAVEDVRRE 187 (492)
Q Consensus 132 ~~~~y~~~~~lG---~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~---------------------~~~~~~~~E 187 (492)
+.++..+.+..| .|--+.||.|... ++..||||++........ .......+|
T Consensus 43 L~~rg~i~~~~g~istGKEA~Vy~a~~~----~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kE 118 (268)
T COG1718 43 LLSRGVITELVGCISTGKEANVYLAETG----DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKE 118 (268)
T ss_pred HhcCCceeeeEeeecCCcceEEEeeccC----CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHH
Confidence 344455555555 5555588888642 578999999854322111 111235678
Q ss_pred HHHHHHccC-CCCccEEEEEEEeCCeEEEEEeecCCCchH-HHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccC
Q 011154 188 VKILRALSG-HSNLVKFYDAFEDLDNVYIVMELCEGGELL-DRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRD 264 (492)
Q Consensus 188 v~~l~~l~~-hpniv~l~~~~~~~~~~~lv~E~~~ggsL~-~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrD 264 (492)
+.-|+++.. +=.+.+-+.+.. -.|||||+....+- =.|. .-.+...++..+..++++.+.-|-. .++||+|
T Consensus 119 f~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgD 192 (268)
T COG1718 119 FRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGD 192 (268)
T ss_pred HHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCccccc
Confidence 887877741 345556665543 37999999543110 0111 1123444788889999999988777 8999999
Q ss_pred CCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 265 LKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 265 lkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
|..=|||+. ++.+.|+|||-|.....
T Consensus 193 LSEyNiL~~----~~~p~iID~~QaV~~~h 218 (268)
T COG1718 193 LSEYNILVH----DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred chhhheEEE----CCeEEEEECccccccCC
Confidence 999999994 45799999999876653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.2e-05 Score=73.28 Aligned_cols=129 Identities=24% Similarity=0.295 Sum_probs=92.2
Q ss_pred cceeecceeccccc-eEEEEEEEecCCccccEEEEEEccC---CC-------CC-C-------HHHHHHHHHHHHHHHHc
Q 011154 134 SRLEVGEEVGRGHF-GYTCTARYKKGEHKDQKVAIKVIPK---SK-------MT-T-------AIAVEDVRREVKILRAL 194 (492)
Q Consensus 134 ~~y~~~~~lG~G~f-g~V~~~~~~~~~~~~~~vavK~i~~---~~-------~~-~-------~~~~~~~~~Ev~~l~~l 194 (492)
.+++..+.||.|.- |.||+++. .|+.||+|++.. .. .. . ......|..|.....+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 78899999999999 99999986 567999999321 00 00 0 01233577888877777
Q ss_pred c--CCCCc--cEEEEEEEeC------------------CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHH
Q 011154 195 S--GHSNL--VKFYDAFEDL------------------DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252 (492)
Q Consensus 195 ~--~hpni--v~l~~~~~~~------------------~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l 252 (492)
+ ++.++ |+++|+..-. -.+.||.||.+... .++ ..-+.+|.+-|
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl 177 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDL 177 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHH
Confidence 5 34566 9999987321 12567888876643 122 23456788888
Q ss_pred HHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 253 ~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
..+|..||+-+|+++.|..= -||+|||.+
T Consensus 178 ~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HHHHHCCeeeccCccccccC--------CEEEecccC
Confidence 99999999999999999872 399999965
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.7e-05 Score=71.58 Aligned_cols=138 Identities=24% Similarity=0.334 Sum_probs=97.6
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-------------CHHHHHHHHHHHHHHHHcc-----CCCCc
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-------------TAIAVEDVRREVKILRALS-----GHSNL 200 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-------------~~~~~~~~~~Ev~~l~~l~-----~hpni 200 (492)
...||+|+.=.||.-- .....+||++...... .....++..+|+.....+. .+.+|
T Consensus 6 ~~~i~~G~~R~cy~HP------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i 79 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHI 79 (199)
T ss_pred CcccccCCCceEEECC------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccc
Confidence 3568999988777632 3345799998766500 0112345667777666653 37899
Q ss_pred cEEEEEEEeCCeEEEEEeecCC------CchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeec
Q 011154 201 VKFYDAFEDLDNVYIVMELCEG------GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS 274 (492)
Q Consensus 201 v~l~~~~~~~~~~~lv~E~~~g------gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~ 274 (492)
.+++|+.+++...-+|+|.+.. -+|.+++.+ +.+++ .+...+-+-..||-+++|+.+||+|.||++..
T Consensus 80 ~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 80 PRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred ccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 9999999999999999998743 267777633 34655 34444455567889999999999999999987
Q ss_pred CCCCC-cEEEEe-ccc
Q 011154 275 KDESS-QLKAID-FGL 288 (492)
Q Consensus 275 ~~~~~-~~kl~D-fGl 288 (492)
.++.. .+.|+| ||-
T Consensus 154 ~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGE 169 (199)
T ss_pred cCCCceEEEEEeCCCC
Confidence 66655 788888 343
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.3e-05 Score=89.97 Aligned_cols=83 Identities=25% Similarity=0.395 Sum_probs=58.3
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCc--cEEEEEEEeC---CeE
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL--VKFYDAFEDL---DNV 213 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpni--v~l~~~~~~~---~~~ 213 (492)
.+.|+.|.+..+|+.....+. ....+++|+.+...... ....+.+|+++|+.|.+|.+| .+++.+|.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-SVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-cceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 466899999999988754321 12467888775543221 224678999999999646654 7888888764 468
Q ss_pred EEEEeecCCCc
Q 011154 214 YIVMELCEGGE 224 (492)
Q Consensus 214 ~lv~E~~~ggs 224 (492)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999999864
|
|
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.1e-06 Score=72.81 Aligned_cols=55 Identities=16% Similarity=0.331 Sum_probs=50.4
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
..+...++++++++|.++|.|+||.|..++|+..|..+|.. .++++|++||+++.
T Consensus 24 amf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~-~~d~elDaM~~Ea~ 78 (171)
T KOG0031|consen 24 AMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKI-ASDEELDAMMKEAP 78 (171)
T ss_pred HHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999984 99999999999874
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.4e-06 Score=66.79 Aligned_cols=51 Identities=10% Similarity=0.081 Sum_probs=46.2
Q ss_pred hHHHHHHHHhhhCC-CCCcccchHHHHHHHHh-hccccccH-HHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEP-NKNGCIAFENIKTVLMK-NATDAMKE-SRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~-~~~G~Is~~el~~~l~~-~g~~~~~~-~ei~~~i~~~D~~ 492 (492)
-+..|+++|..||. +++|+|+.+||+.+|+. +|. .+++ +++++||+++|.|
T Consensus 6 ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~-~ls~~~~v~~mi~~~D~d 59 (89)
T cd05022 6 AIETLVSNFHKASVKGGKESLTASEFQELLTQQLPH-LLKDVEGLEEKMKNLDVN 59 (89)
T ss_pred HHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhh-hccCHHHHHHHHHHhCCC
Confidence 35678999999999 99999999999999999 886 5888 9999999999976
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.6e-06 Score=52.15 Aligned_cols=29 Identities=34% Similarity=0.520 Sum_probs=26.6
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKN 472 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~ 472 (492)
+++++|+.+|+|+||+|+.+||+.+|+++
T Consensus 1 E~~~~F~~~D~d~dG~I~~~Ef~~~~~~L 29 (29)
T PF00036_consen 1 ELKEAFREFDKDGDGKIDFEEFKEMMKKL 29 (29)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHT
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHhC
Confidence 47899999999999999999999999764
|
This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D .... |
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.5e-06 Score=74.33 Aligned_cols=51 Identities=20% Similarity=0.313 Sum_probs=47.2
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...+++++|+.||.|+||+|+.+||+.+|+.+|. ..++++++.||+.+|.|
T Consensus 83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~-~~~~~e~~~mi~~~d~d 133 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGDGFISASELKKVLTSLGE-KLTDEECKEMIREVDVD 133 (151)
T ss_pred cHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCC-cCCHHHHHHHHHhcCCC
Confidence 3458999999999999999999999999999998 69999999999999964
|
|
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.3e-06 Score=65.74 Aligned_cols=50 Identities=8% Similarity=0.094 Sum_probs=45.0
Q ss_pred HHHHHHHHhhhC-CCCCc-ccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLE-PNKNG-CIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D-~~~~G-~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+..++++|..|| .|||| .|+.+||+.+|+. +|. ..++++|++||+.+|.|
T Consensus 7 ~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~-~~~~~~v~~~i~~~D~n 63 (88)
T cd05027 7 MVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEE-IKEQEVVDKVMETLDSD 63 (88)
T ss_pred HHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcC-CCCHHHHHHHHHHhCCC
Confidence 457899999998 89999 5999999999999 776 68999999999999975
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=6.9e-06 Score=71.73 Aligned_cols=58 Identities=24% Similarity=0.311 Sum_probs=53.6
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
....++.++.++++++|.++|+|++|.|+..+|..+|+.+|. ..++++|.+|++.+|.
T Consensus 10 ~~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~-~~s~~ei~~l~~~~d~ 67 (160)
T COG5126 10 TFTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGF-NPSEAEINKLFEEIDA 67 (160)
T ss_pred hcccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCC-CCcHHHHHHHHHhccC
Confidence 355678899999999999999999999999999999999998 6999999999999984
|
|
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.4e-05 Score=68.34 Aligned_cols=51 Identities=20% Similarity=0.357 Sum_probs=47.4
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...+++.+|+++|-|++|.|+..+|+.+...||. +++++|+.+||+++|.+
T Consensus 104 t~eEi~~afrl~D~D~~Gkis~~~lkrvakeLge-nltD~El~eMIeEAd~d 154 (172)
T KOG0028|consen 104 TKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGE-NLTDEELMEMIEEADRD 154 (172)
T ss_pred cHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCc-cccHHHHHHHHHHhccc
Confidence 4567899999999999999999999999999998 79999999999999864
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.3e-05 Score=70.70 Aligned_cols=54 Identities=26% Similarity=0.357 Sum_probs=49.7
Q ss_pred chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 438 TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 438 ~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+.++..+++++|..||.|++|+|+..||..+|+.+|. .++++++..|++++|.|
T Consensus 3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~-~~t~~el~~~~~~~D~d 56 (151)
T KOG0027|consen 3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQ-NPTEEELRDLIKEIDLD 56 (151)
T ss_pred CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 4466788999999999999999999999999999998 69999999999999964
|
|
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.7e-05 Score=64.14 Aligned_cols=53 Identities=15% Similarity=0.324 Sum_probs=47.1
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.++...++++|..+|.|++|.|+.+||+.+|+.+| ++++++++|++.+|.|
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~---~~~~ev~~i~~~~d~~ 56 (96)
T smart00027 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG---LPQTLLAKIWNLADID 56 (96)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC---CCHHHHHHHHHHhcCC
Confidence 4567888999999999999999999999999998864 6788999999998864
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.7e-05 Score=59.17 Aligned_cols=49 Identities=22% Similarity=0.331 Sum_probs=40.8
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccc---cccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATD---AMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~---~~~~~ei~~~i~~~D~~ 492 (492)
+|+++|+.+|.|++|+|+.+||+.++..++.. ...++.++.+++.+|.|
T Consensus 1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d 52 (66)
T PF13499_consen 1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTD 52 (66)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTT
T ss_pred CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCC
Confidence 47899999999999999999999999999851 23455666669998875
|
... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=3.1e-05 Score=70.75 Aligned_cols=101 Identities=21% Similarity=0.258 Sum_probs=80.6
Q ss_pred HHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecCCCchHHHH--HhhCCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 011154 185 RREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRI--LSRCGKYSEDEAKAVLVQILNVVAFCHL---HG 259 (492)
Q Consensus 185 ~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l--~~~~~~~~~~~~~~i~~qi~~~l~ylH~---~~ 259 (492)
..|.-+|+.+.+.+++++++|+|-+ ++|.||...++++... ..+.-..+|..+.+|+.++++.+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 3588899999765799999999843 6789999877765321 0112356899999999999999999998 35
Q ss_pred CcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 260 ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+.-.|++++||-+ ++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence 8889999999999 56678999999876554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13405 EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J_B 1OE9_B 1W7I_B 1KFU_S 1KFX_S 2BL0_B 1Y1X_B 3MSE_B | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.4e-05 Score=49.86 Aligned_cols=30 Identities=27% Similarity=0.614 Sum_probs=26.4
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHH-hhc
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLM-KNA 473 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~-~~g 473 (492)
+++++|+.+|.|+||+|+.+||+.+|+ .+|
T Consensus 1 ~l~~~F~~~D~d~dG~I~~~el~~~l~~~lG 31 (31)
T PF13405_consen 1 RLREAFKMFDKDGDGFIDFEELRAILRKSLG 31 (31)
T ss_dssp HHHHHHHHH-TTSSSEEEHHHHHHHHHHHTT
T ss_pred CHHHHHHHHCCCCCCcCcHHHHHHHHHHhcC
Confidence 478999999999999999999999998 565
|
... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=1.1e-06 Score=98.58 Aligned_cols=209 Identities=15% Similarity=0.033 Sum_probs=137.5
Q ss_pred HHHHHHHHHHccCCCCccEEEEEEE--eCCeEEEEEeecCCCchHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHc
Q 011154 184 VRREVKILRALSGHSNLVKFYDAFE--DLDNVYIVMELCEGGELLDRILSRCG---KYSEDEAKAVLVQILNVVAFCHLH 258 (492)
Q Consensus 184 ~~~Ev~~l~~l~~hpniv~l~~~~~--~~~~~~lv~E~~~ggsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~ylH~~ 258 (492)
...|..-++.+. |++++..+.-.. +....|.+++||.+|.+++.|.+... .+.+.-+.....+.+.+..-+|+.
T Consensus 1276 ll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 445555566664 998887766543 23467899999999999999876433 344445555556657787787775
Q ss_pred C-----CcccCCCCCceEeecCCCCCcEEEEecccccccCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHH
Q 011154 259 G-----VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAY 331 (492)
Q Consensus 259 ~-----ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~ 331 (492)
. .+|++||+-|.+| ..+.++|++++|+.+...+.. .....++++.|+++++.+. .++.++|+|..|+-+|
T Consensus 1355 tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred ccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 2 7999999999999 566689999999998443332 3445678999999998875 5777799999999999
Q ss_pred HHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 332 ILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 332 ~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
++.-|..+|........ ..+......+.-+. -.+.++-.....+|-..-..||.-...+..+.+-
T Consensus 1432 ~rs~~n~~fi~flq~~L-kgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFFLQPAL-KGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHhcccHHHHHHHHHHH-cCcccccccccccc--cCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999888732222111 11111111111111 1123333344444444455788777777766553
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0001 Score=70.09 Aligned_cols=73 Identities=19% Similarity=0.151 Sum_probs=46.2
Q ss_pred ceeccccce-EEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC--CccEEEEEEEeC---CeE
Q 011154 140 EEVGRGHFG-YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS--NLVKFYDAFEDL---DNV 213 (492)
Q Consensus 140 ~~lG~G~fg-~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp--niv~l~~~~~~~---~~~ 213 (492)
+.|+.|+.. .||... ..+++|+.+... ....+.+|.++|+.|..+- -+.++++..... ...
T Consensus 3 ~~~~~gG~~n~vy~~~--------~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRLG--------DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEcC--------CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 457777776 577651 246778754321 2346889999999886431 345555544332 245
Q ss_pred EEEEeecCCCch
Q 011154 214 YIVMELCEGGEL 225 (492)
Q Consensus 214 ~lv~E~~~ggsL 225 (492)
+++|++++|.++
T Consensus 70 ~~l~~~i~G~~l 81 (235)
T cd05155 70 WSVYRWLEGETA 81 (235)
T ss_pred eEEEEeecCCCC
Confidence 889999998766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.79 E-value=4.4e-05 Score=65.39 Aligned_cols=57 Identities=30% Similarity=0.433 Sum_probs=51.6
Q ss_pred hcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 434 SKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 434 ~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
...+..++.+.++++|.+||.+++|+|..+||+-+++.+|.+ ++.+||..||.++|.
T Consensus 24 ~~~l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE-~~k~ei~kll~d~dk 80 (172)
T KOG0028|consen 24 KSELTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGFE-PKKEEILKLLADVDK 80 (172)
T ss_pred CccccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCC-cchHHHHHHHHhhhh
Confidence 445566777899999999999999999999999999999984 999999999999986
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00056 Score=69.65 Aligned_cols=81 Identities=17% Similarity=0.212 Sum_probs=54.8
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCC---CC-HHHHHHHHHHHHHHHHccCC--CCccEEEEEEEeCCe
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM---TT-AIAVEDVRREVKILRALSGH--SNLVKFYDAFEDLDN 212 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~---~~-~~~~~~~~~Ev~~l~~l~~h--pniv~l~~~~~~~~~ 212 (492)
.+.||-|.+..||++.... .++.|+||.-..... .. ....+....|.+.|+.+..+ .++++++.+ +.+.
T Consensus 31 ~~elggGn~N~VyrV~~~~---g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE---GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCC---CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC
Confidence 3578999999999998642 225799998532111 00 12345677788888886433 467778776 4466
Q ss_pred EEEEEeecCCCc
Q 011154 213 VYIVMELCEGGE 224 (492)
Q Consensus 213 ~~lv~E~~~ggs 224 (492)
.++||||+++..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 789999998754
|
|
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=97.69 E-value=7.1e-05 Score=60.21 Aligned_cols=50 Identities=10% Similarity=0.076 Sum_probs=43.0
Q ss_pred HHHHHHHHhhhCC-CC-CcccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEP-NK-NGCIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~-~~-~G~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|..||. |+ +|.|+.+||+.+|+. +|. .++++++++|++.+|.|
T Consensus 7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~-~~s~~ei~~~~~~~D~~ 63 (94)
T cd05031 7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKN-QKDPMAVDKIMKDLDQN 63 (94)
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhc-cccHHHHHHHHHHhCCC
Confidence 4568999999997 98 699999999999986 344 57899999999999864
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00058 Score=64.68 Aligned_cols=76 Identities=22% Similarity=0.334 Sum_probs=48.5
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
+.|..|-...+|++....+ .+..|++|+...... ..-...+|+.+++.+..+.-.++++..+. + .+||||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~ 73 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--NQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEF 73 (235)
T ss_pred EEcCCcccceEEEEEcCCC--CCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEe
Confidence 4577777779998863311 246788997753311 11234579999999864545566665443 2 379999
Q ss_pred cCCCch
Q 011154 220 CEGGEL 225 (492)
Q Consensus 220 ~~ggsL 225 (492)
++|.++
T Consensus 74 i~G~~l 79 (235)
T cd05157 74 IPGRTL 79 (235)
T ss_pred eCCCcC
Confidence 998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=97.64 E-value=8.6e-05 Score=59.46 Aligned_cols=50 Identities=10% Similarity=0.068 Sum_probs=42.3
Q ss_pred HHHHHHHhhhC-CCCCc-ccchHHHHHHHHh-hccc---cccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLE-PNKNG-CIAFENIKTVLMK-NATD---AMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D-~~~~G-~Is~~el~~~l~~-~g~~---~~~~~ei~~~i~~~D~~ 492 (492)
..++++|..|| .|++| .|+.+||+.+|+. +|.. .++++++++||+.+|.|
T Consensus 9 ~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d 64 (92)
T cd05025 9 ETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDEN 64 (92)
T ss_pred HHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCC
Confidence 56899999997 99999 5999999999986 5431 25889999999999874
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00011 Score=58.21 Aligned_cols=53 Identities=8% Similarity=0.045 Sum_probs=44.3
Q ss_pred hhHHHHHHHHhhhCC--CCCcccchHHHHHHHHh-hccc---cccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEP--NKNGCIAFENIKTVLMK-NATD---AMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~--~~~G~Is~~el~~~l~~-~g~~---~~~~~ei~~~i~~~D~~ 492 (492)
+++..++++|..+|. |++|.|+.+||+.+++. +|.. .+++.+|+.|++.+|.|
T Consensus 5 ~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~ 63 (88)
T cd00213 5 KAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVN 63 (88)
T ss_pred HHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccC
Confidence 456779999999999 89999999999999986 4531 23589999999998864
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0001 Score=54.89 Aligned_cols=44 Identities=20% Similarity=0.345 Sum_probs=39.3
Q ss_pred HHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 446 KEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 446 ~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+++|..+|.|++|.|+.+|++.+|+.+| .+++++++|++.+|.|
T Consensus 2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g---~~~~~~~~i~~~~d~~ 45 (67)
T cd00052 2 DQIFRSLDPDGDGLISGDEARPFLGKSG---LPRSVLAQIWDLADTD 45 (67)
T ss_pred hHHHHHhCCCCCCcCcHHHHHHHHHHcC---CCHHHHHHHHHHhcCC
Confidence 6789999999999999999999999875 3788999999998864
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >PF14658 EF-hand_9: EF-hand domain | Back alignment and domain information |
|---|
Probab=97.55 E-value=9.9e-05 Score=54.09 Aligned_cols=45 Identities=22% Similarity=0.318 Sum_probs=42.4
Q ss_pred HHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 448 QFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 448 ~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+|..||.++.|.|...+|+..|+.++....+|+++++|.+++|++
T Consensus 3 ~F~~fD~~~tG~V~v~~l~~~Lra~~~~~p~e~~Lq~l~~elDP~ 47 (66)
T PF14658_consen 3 AFDAFDTQKTGRVPVSDLITYLRAVTGRSPEESELQDLINELDPE 47 (66)
T ss_pred chhhcCCcCCceEeHHHHHHHHHHHcCCCCcHHHHHHHHHHhCCC
Confidence 699999999999999999999999988679999999999999985
|
|
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00015 Score=58.12 Aligned_cols=51 Identities=10% Similarity=0.096 Sum_probs=41.8
Q ss_pred HHHHHHHHhhhC-CCCCc-ccchHHHHHHHHhh-c---cccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLE-PNKNG-CIAFENIKTVLMKN-A---TDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D-~~~~G-~Is~~el~~~l~~~-g---~~~~~~~ei~~~i~~~D~~ 492 (492)
+..++++|..|| .|+|| +|+.+||+.+|... + ....++.+|++|++++|.|
T Consensus 9 ~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n 65 (93)
T cd05026 9 MDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSN 65 (93)
T ss_pred HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCC
Confidence 456899999999 78999 59999999999773 2 1234778999999999975
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00017 Score=57.17 Aligned_cols=51 Identities=14% Similarity=0.191 Sum_probs=43.6
Q ss_pred hHHHHHHHHhhhCC-CC-CcccchHHHHHHHHh---hccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEP-NK-NGCIAFENIKTVLMK---NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~-~~-~G~Is~~el~~~l~~---~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.+..+-+.|..+|. || +|+|+.+||+.+|++ +|. .+++++|++|++++|.|
T Consensus 8 ~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~-k~t~~ev~~m~~~~D~d 63 (88)
T cd05029 8 AIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGS-KLQDAEIAKLMEDLDRN 63 (88)
T ss_pred HHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCC-CCCHHHHHHHHHHhcCC
Confidence 34567889999998 78 899999999999974 575 68999999999999875
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00074 Score=66.43 Aligned_cols=138 Identities=17% Similarity=0.165 Sum_probs=80.8
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC-CccEEEEE------EEeCC
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS-NLVKFYDA------FEDLD 211 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp-niv~l~~~------~~~~~ 211 (492)
.+.|..|....+|++.. .+..+++|+.... . .+.+..|+.++..|..+- .+.+++.. ....+
T Consensus 19 i~~i~~G~~n~~y~v~~-----~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 19 FEGISAGIENTNYFVTT-----DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred eecccCccccceEEEEe-----CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 45677777778888753 2346889987541 1 235667888888885331 35555442 23345
Q ss_pred eEEEEEeecCCCchHH--------------HHHhhCCCC----------CHHHH----------HHHHHHHHHHHHHHHH
Q 011154 212 NVYIVMELCEGGELLD--------------RILSRCGKY----------SEDEA----------KAVLVQILNVVAFCHL 257 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~--------------~l~~~~~~~----------~~~~~----------~~i~~qi~~~l~ylH~ 257 (492)
..++|+++++|..+.. .++.....+ .+... ......+..++.++..
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999999865421 111110011 11100 0011123334445443
Q ss_pred -------cCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 258 -------HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 258 -------~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.+++|+|+.|.|||+ +++..+.|+||+.+.
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~ 204 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLF---DGDELSGVIDFYFAC 204 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEE---eCCceEEEeehhhhc
Confidence 369999999999999 444456899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13202 EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ_B 1UHI_A 1UHH_B 1EJ3_B 1UHK_A 2ZFD_A 1UHN_A | Back alignment and domain information |
|---|
Probab=97.52 E-value=9.9e-05 Score=43.43 Aligned_cols=25 Identities=28% Similarity=0.658 Sum_probs=22.6
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHH
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVL 469 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l 469 (492)
|+++|+.+|.|+||.|+.+|+++++
T Consensus 1 l~~~F~~~D~d~DG~is~~E~~~~~ 25 (25)
T PF13202_consen 1 LKDAFQQFDTDGDGKISFEEFQRLV 25 (25)
T ss_dssp HHHHHHHHTTTSSSEEEHHHHHHHH
T ss_pred CHHHHHHHcCCCCCcCCHHHHHHHC
Confidence 5779999999999999999999864
|
... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00013 Score=70.63 Aligned_cols=137 Identities=18% Similarity=0.281 Sum_probs=94.4
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCC-----------------CCCCHHHHH--HHHHHHHHHHHcc
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKS-----------------KMTTAIAVE--DVRREVKILRALS 195 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~-----------------~~~~~~~~~--~~~~Ev~~l~~l~ 195 (492)
-+.+++.||-|--+-+|.+-+. .|...++|.-... ...++..+. ...+|+..|+.|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~----~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~ 168 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE----EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY 168 (465)
T ss_pred hhhhccccccccccceEEEecC----CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence 4678999999999999999754 4677888753211 111122222 2468999999997
Q ss_pred CCC-CccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeec
Q 011154 196 GHS-NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS 274 (492)
Q Consensus 196 ~hp-niv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~ 274 (492)
.|- -|.+.++ .+..++|||++.|-.|...- ....+..+...+..-+.-|-.+|+||+|..==||++
T Consensus 169 e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~-------~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv-- 235 (465)
T KOG2268|consen 169 ERGFPVPKPID----HNRHCVVMELVDGYPLRQVR-------HVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV-- 235 (465)
T ss_pred HcCCCCCCccc----ccceeeHHHhhcccceeeee-------ecCChHHHHHHHHHHHHHHHHcCceecccchheeEE--
Confidence 553 3445554 35568999999987665321 112334455556666677889999999999999999
Q ss_pred CCCCCcEEEEecccc
Q 011154 275 KDESSQLKAIDFGLS 289 (492)
Q Consensus 275 ~~~~~~~kl~DfGla 289 (492)
+++..++++||--.
T Consensus 236 -~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 236 -KDDDKIVVIDFPQM 249 (465)
T ss_pred -ecCCCEEEeechHh
Confidence 55678999999654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0012 Score=65.52 Aligned_cols=139 Identities=14% Similarity=0.117 Sum_probs=78.3
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-CCccEEEEEE------EeCC
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-SNLVKFYDAF------EDLD 211 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-pniv~l~~~~------~~~~ 211 (492)
.+.++.|.-..+|++... +..+++|+..... . .+.+..|+.++..|.++ -.+.+++... ...+
T Consensus 27 i~~~~~G~~n~~y~v~t~-----~~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-----VGRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ccccCCccccceEEEEeC-----CCcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 455777776788887532 2357889874421 1 23455677888777422 1244544421 2245
Q ss_pred eEEEEEeecCCCchH----H----------HHHhhCCCCC-----------HHHH--H----------HHHHHHHHHHHH
Q 011154 212 NVYIVMELCEGGELL----D----------RILSRCGKYS-----------EDEA--K----------AVLVQILNVVAF 254 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~----~----------~l~~~~~~~~-----------~~~~--~----------~i~~qi~~~l~y 254 (492)
..++++||++|.++. + .++.....++ |... . .....+...+.+
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999985431 1 1111111110 0000 0 011123334555
Q ss_pred HHH-------cCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 255 CHL-------HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 255 lH~-------~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.. .+++|+|+++.||++. .+..+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 543 5799999999999994 44456899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0005 Score=66.16 Aligned_cols=134 Identities=21% Similarity=0.162 Sum_probs=74.4
Q ss_pred eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeecC
Q 011154 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221 (492)
Q Consensus 142 lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~~ 221 (492)
+..|-.+.+|+... ++..+++|+....... ..+ ...+|..+++.+..+.-..+++.... -++||||++
T Consensus 4 ~~~G~tn~~y~~~~-----~~~~~vlR~~~~~~~~--~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-----PGISFVWRPQSPVCKA--LGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEEe-----CCccEEEeeCCccccc--ccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEecc
Confidence 45566678887752 4567889876433211 001 24679999999864433345554432 268999999
Q ss_pred CCchHH----------H-------HHhhC---CCCCHH-HHHHHHHHH---------HHHHHHHHH--------cCCccc
Q 011154 222 GGELLD----------R-------ILSRC---GKYSED-EAKAVLVQI---------LNVVAFCHL--------HGVVHR 263 (492)
Q Consensus 222 ggsL~~----------~-------l~~~~---~~~~~~-~~~~i~~qi---------~~~l~ylH~--------~~ivHr 263 (492)
|..+.. . ++... ..++.. .+..+..++ ...+..+-. ..++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 865431 1 11110 111211 112222122 111222221 148999
Q ss_pred CCCCCceEeecCCCCCcEEEEecccccc
Q 011154 264 DLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 264 Dlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
|+.|.||+++ +++ +.|+||..|..
T Consensus 152 Dl~~~Nil~~---~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVT---PQG-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEe---CCC-CEEEeccccCc
Confidence 9999999995 333 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00026 Score=59.29 Aligned_cols=53 Identities=21% Similarity=0.249 Sum_probs=47.7
Q ss_pred chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 438 TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 438 ~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
+.+++.+++++|.+||..+||.|+...+..+|+.+|. ++|++||..-+.+.+.
T Consensus 6 ~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~-nPT~aeV~k~l~~~~~ 58 (152)
T KOG0030|consen 6 TPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQ-NPTNAEVLKVLGQPKR 58 (152)
T ss_pred CcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcC-CCcHHHHHHHHcCccc
Confidence 4567789999999999999999999999999999998 6999999988877654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0068 Score=60.28 Aligned_cols=75 Identities=11% Similarity=0.054 Sum_probs=43.7
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-CCccEEEE------EEEeCCe
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-SNLVKFYD------AFEDLDN 212 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-pniv~l~~------~~~~~~~ 212 (492)
+.|+.|....+|.+... +..+++|++. . . . .+.+..|+.+++.|..+ -.+.+.+. +....+.
T Consensus 28 ~~l~~G~~n~~y~v~t~-----~g~~vLK~~~-~-~-~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~ 96 (319)
T PRK05231 28 KGIAEGIENSNFFLTTT-----QGEYVLTLFE-R-L-T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGK 96 (319)
T ss_pred chhccccccceEEEEeC-----CCcEEEEEec-c-C-C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCE
Confidence 45667777788887642 2358899875 1 1 1 12344566666666311 12344442 1233567
Q ss_pred EEEEEeecCCCch
Q 011154 213 VYIVMELCEGGEL 225 (492)
Q Consensus 213 ~~lv~E~~~ggsL 225 (492)
.++++||++|..+
T Consensus 97 ~~~l~~~l~G~~~ 109 (319)
T PRK05231 97 PAAIVTFLEGKWP 109 (319)
T ss_pred EEEEEEecCCCCC
Confidence 8999999998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0015 Score=64.48 Aligned_cols=78 Identities=19% Similarity=0.217 Sum_probs=47.8
Q ss_pred eeccccceEEEEEEEecC---CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEE
Q 011154 141 EVGRGHFGYTCTARYKKG---EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVM 217 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~---~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~ 217 (492)
.|..|--..||++....+ ...++.|++|+...... ......+|+++++.|..+.-..+++.++.. .+|+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 344455558888764321 11357899999754321 123467899999988644444566666542 3689
Q ss_pred eecCCCchH
Q 011154 218 ELCEGGELL 226 (492)
Q Consensus 218 E~~~ggsL~ 226 (492)
||++|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999987653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 492 | ||||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-58 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-58 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-58 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-57 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-55 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-55 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-55 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-55 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-54 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-53 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-53 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-53 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-52 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-52 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-52 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-52 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-52 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-50 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-50 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-50 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-49 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-47 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-47 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-47 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-45 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-44 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-44 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-44 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-44 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-44 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-44 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-44 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-44 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-44 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-44 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-44 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-44 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-44 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-44 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-44 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-43 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-43 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-43 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-43 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-43 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-43 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-43 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-43 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-43 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-43 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-43 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-42 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-42 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-42 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-42 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-42 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-42 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-41 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-41 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-41 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-41 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-41 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-40 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-40 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-40 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-40 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-39 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-39 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-39 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-39 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-39 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-39 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-39 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-38 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-38 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-38 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-38 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-38 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-37 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-37 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-36 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-36 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-36 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-36 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-36 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-35 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-35 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-35 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-35 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-35 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-35 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-35 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-35 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-35 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-35 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-35 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-35 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-35 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-35 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-35 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-35 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-35 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-35 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-35 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-35 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-35 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-35 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-35 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-35 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-35 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-35 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-35 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-35 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-35 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-34 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-34 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-34 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-34 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-34 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-34 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-34 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-34 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-34 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-34 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-34 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-34 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-34 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-34 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-34 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-34 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-34 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-34 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-34 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-34 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-34 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-33 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-33 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-33 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-33 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-33 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-33 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-33 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-33 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-33 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-33 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-33 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-32 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-32 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-32 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-32 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-32 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-32 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-32 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-31 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-31 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-31 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-31 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-31 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-30 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-29 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-28 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-28 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-27 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-27 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-27 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-27 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-27 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-27 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-27 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-27 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-27 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-27 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-27 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-27 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-27 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-27 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-27 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-27 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-27 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-27 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-27 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-27 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-27 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-27 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-27 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-27 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-27 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-27 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-27 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-27 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-27 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-27 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-27 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-27 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-27 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-27 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-27 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-27 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-26 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-26 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-26 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-26 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-26 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-26 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-26 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-26 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-26 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-26 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-26 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-26 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-26 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-26 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-26 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-26 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-26 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-26 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-26 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-26 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-26 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-25 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-25 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-25 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-25 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-25 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-25 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-25 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-25 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-25 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-25 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-25 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-25 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-25 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-25 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-25 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-25 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-25 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-25 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-25 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-25 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-25 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-25 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-25 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-24 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-24 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-24 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-24 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-24 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-24 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-24 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-24 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-24 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-24 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-23 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-23 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-23 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-23 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-23 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-23 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-23 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-23 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-23 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-23 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-23 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-23 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-23 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-23 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-23 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-23 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-23 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-23 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-23 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-23 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-23 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-23 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-23 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-23 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-23 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-23 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-23 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-23 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-23 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-23 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-23 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-23 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-23 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-23 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-22 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-22 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-22 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-22 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-22 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-22 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-22 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-22 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-22 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-22 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-22 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-22 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-22 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-22 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-22 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-22 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-22 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-22 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-22 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-22 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-22 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-22 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-22 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-22 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-22 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-22 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-22 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-22 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-22 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-22 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-22 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-22 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-22 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-22 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-22 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-22 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-22 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-22 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-22 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-22 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-22 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-22 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-22 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-22 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-22 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-22 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-22 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-22 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-22 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-21 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-21 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-21 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-21 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-21 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-21 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-21 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-21 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-21 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-21 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-21 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-21 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-21 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-21 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-21 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-21 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-21 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-21 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-21 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-20 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-20 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-20 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-20 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-20 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-20 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-20 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-20 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-20 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-20 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-20 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-20 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-20 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-20 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-20 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-20 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-19 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-19 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-19 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-19 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-18 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-15 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-15 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-15 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-15 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-15 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-15 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-15 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-15 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-15 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-15 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-15 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-15 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-15 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-15 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-15 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-15 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-13 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-13 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-13 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-13 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-13 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-13 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-13 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-13 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-13 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-13 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-13 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 8e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-11 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 3e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-11 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 4e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-08 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-07 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 5e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-07 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 6e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-07 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 7e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-05 |
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 501 bits (1292), Expect = e-175
Identities = 127/387 (32%), Positives = 200/387 (51%), Gaps = 25/387 (6%)
Query: 123 DKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVE 182
+ F R + +G+G FG + + Q+ A+KVI K+
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNK-DTS 66
Query: 183 DVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAK 242
+ REV++L+ L H N++K ++ ED + YIV EL GGEL D I+ R ++SE +A
Sbjct: 67 TILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAA 124
Query: 243 AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV 302
++ Q+ + + + H H +VHRDLKPEN L SK++ +K IDFGLS + + ++ D +
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 303 GSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362
G+AYY+APEVL +Y + DVWS GVI YILL G+ PF+ + E I + V +FD
Sbjct: 185 GTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244
Query: 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVK-----VPLDISILKLMK 417
W ++S DAKD ++ +L P R+TA Q L HPWI+ Y++ +P S + ++
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIR 304
Query: 418 AYMQSSSLRRAALKALSKTL-TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMK----- 471
+ L +AAL ++ L T+DE L E F L+ N +G + + + +
Sbjct: 305 QFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLK 364
Query: 472 --------NATDAMKESRISDLLAPSD 490
+ E +I L+ D
Sbjct: 365 GVDSNSLIQNEGSTIEDQIDSLMPLLD 391
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 487 bits (1255), Expect = e-170
Identities = 123/377 (32%), Positives = 195/377 (51%), Gaps = 20/377 (5%)
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREV 188
+ + R + +G+G FG + K Q+ A+KVI K ++ E + REV
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREV 77
Query: 189 KILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI 248
++L+ L H N++K Y+ FED Y+V E+ GGEL D I+SR ++SE +A ++ Q+
Sbjct: 78 QLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQV 135
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV 308
L+ + + H + +VHRDLKPEN L SK + + ++ IDFGLS +++ D +G+AYY+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195
Query: 309 APEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368
APEVLH +Y + DVWS GVI YILL G PF E I + V K +F+ W +S
Sbjct: 196 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN----NVKVPLDISILKLMKAYMQSSS 424
AKD ++ +L P R++A AL H WI+ Y +V VP + + ++ + +
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQK 315
Query: 425 LRRAALKALSKTL-TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMK----------NA 473
L +AAL + L + DE L F ++ N +G + + +
Sbjct: 316 LAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASML 375
Query: 474 TDAMKESRISDLLAPSD 490
+ E + +L D
Sbjct: 376 DASAVEHEVDQVLDAVD 392
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 487 bits (1256), Expect = e-170
Identities = 127/375 (33%), Positives = 211/375 (56%), Gaps = 19/375 (5%)
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREV 188
++ + +++G G +G R K + AIK+I K+ ++T+ + + EV
Sbjct: 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVT---HVERAIKIIRKTSVSTS-SNSKLLEEV 87
Query: 189 KILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI 248
+L+ L H N++K YD FED N Y+VME +GGEL D I+ R K++E +A ++ Q+
Sbjct: 88 AVLKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQV 145
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV 308
L+ V + H H +VHRDLKPEN L SK++ + +K +DFGLS +++ + +G+AYY+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 309 APEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368
APEVL + Y + DVWSIGVI +ILL G PF +T+ I R V K +FD W ++S
Sbjct: 206 APEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN-----NVKVPLDISILKLMKAYMQSS 423
AKD +K +L D ++R++A QAL HPWI+ +++P + ++ M+ + S
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQ 325
Query: 424 SLRRAALKALSKTL-TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMK---- 478
L +AAL ++ L + +E L + F ++ N +G + + + K + + +
Sbjct: 326 KLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDL 385
Query: 479 ---ESRISDLLAPSD 490
ES + +L +D
Sbjct: 386 PQIESEVDAILGAAD 400
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 488 bits (1257), Expect = e-170
Identities = 127/384 (33%), Positives = 197/384 (51%), Gaps = 27/384 (7%)
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIA-------- 180
++ ++G G +G + K G + AIKVI KS+
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNG---HSEKAIKVIKKSQFDKGRYSDDNKNIE 87
Query: 181 --VEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSE 238
E++ E+ +L++L H N++K +D FED Y+V E EGGEL ++I++R K+ E
Sbjct: 88 KFHEEIYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDE 145
Query: 239 DEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL 298
+A ++ QIL+ + + H H +VHRD+KPEN L +K+ +K +DFGLS F D +L
Sbjct: 146 CDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 299 NDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 358
D +G+AYY+APEVL + Y + DVWS GVI YILLCG PF + + I + V K
Sbjct: 206 RDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
Query: 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKV----PLDISILK 414
FD W ++S +AK+ +KL+L D KR TA +AL+ WI+ Y N L
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALS 325
Query: 415 LMKAYMQSSSLRRAALKALSKTL-TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473
M+ + S L +AA+ + L T++ER L + F L+ N +G + + +
Sbjct: 326 NMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLR 385
Query: 474 TDAMK-------ESRISDLLAPSD 490
+ E + ++L D
Sbjct: 386 NFKNELGELKNVEEEVDNILKEVD 409
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 451 bits (1163), Expect = e-157
Identities = 109/363 (30%), Positives = 178/363 (49%), Gaps = 14/363 (3%)
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREV 188
T ++ EE+G+G F Q+ A +I K++ + + RE
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLSA-RDHQKLEREA 61
Query: 189 KILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI 248
+I R L H N+V+ +D+ + + Y++ +L GGEL + I++R YSE +A + QI
Sbjct: 62 RICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQI 119
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDERLNDIVGSAYY 307
L V CH GVVHR+LKPEN L SK + + +K DFGL+ V + G+ Y
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 308 VAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366
++PEVL + YG D+W+ GVI YILL G PFW + +++ + F W +
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239
Query: 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDISILKLMKAYMQSSSL 425
++ +AKD + +L +P KR+TAA+AL HPWI + + V + +K + L
Sbjct: 240 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKL 299
Query: 426 RRAALK--ALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRIS 483
+ A L ++ +V ++ +K L+E NG T + A + +
Sbjct: 300 KGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDF---ESYTKMCDPGMTAFEPEALG 356
Query: 484 DLL 486
+L+
Sbjct: 357 NLV 359
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 443 bits (1143), Expect = e-156
Identities = 107/280 (38%), Positives = 162/280 (57%), Gaps = 6/280 (2%)
Query: 124 KRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVED 183
+ F R + +G+G FG + + Q+ A+KVI K+
Sbjct: 12 ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNK-DTST 67
Query: 184 VRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKA 243
+ REV++L+ L H N++K ++ ED + YIV EL GGEL D I+ R ++SE +A
Sbjct: 68 ILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAAR 125
Query: 244 VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVG 303
++ Q+ + + + H H +VHRDLKPEN L SK++ +K IDFGLS + + ++ D +G
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 304 SAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363
+AYY+APEVL +Y + DVWS GVI YILL G+ PF+ + E I + V +FD
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245
Query: 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
W ++S DAKD ++ +L P R+TA Q L HPWI+ Y++
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 443 bits (1141), Expect = e-155
Identities = 84/328 (25%), Positives = 159/328 (48%), Gaps = 13/328 (3%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK 189
KE+ + + E++GRG FG + K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKGTD----QVLVKKEIS 53
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL 249
IL H N++ +++FE ++ + ++ E G ++ +RI + + +E E + + Q+
Sbjct: 54 ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVA 309
+ F H H + H D++PEN +Y ++ SS +K I+FG + ++P + + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 310 PEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368
PEV H T D+WS+G + Y+LL G PF A T I ++ A+ +FD+ ++ +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRA 428
+A DFV LL K+ + RMTA++AL HPW++ + +++ +K +L +
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE---RVSTKVIRTLKHRRYYHTLIKK 288
Query: 429 ALKALSKTLTVDERFYLKEQFALLEPNK 456
L + + ++ Q +
Sbjct: 289 DLNMVVSAARISCGGAIRSQKGVSVAKV 316
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-154
Identities = 103/285 (36%), Positives = 164/285 (57%), Gaps = 10/285 (3%)
Query: 127 GFSKE-VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVR 185
G +K + + +GRG +G A K + A K IPK + V+ +
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGT---RIRRAAKKIPKYFVE---DVDRFK 54
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
+E++I+++L H N+++ Y+ FED ++Y+VMELC GGEL +R++ + + E +A ++
Sbjct: 55 QEIEIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIM 112
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
+L+ VA+CH V HRDLKPENFL+ + S LK IDFGL+ +P + + VG+
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172
Query: 306 YYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365
YYV+P+VL YG E D WS GV+ Y+LLCG PF A T+S + + + +F + W
Sbjct: 173 YYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL 232
Query: 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDI 410
++S A+ ++ LL K P++R+T+ QAL H W P ++
Sbjct: 233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK-QLSSSPRNL 276
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 439 bits (1132), Expect = e-153
Identities = 103/353 (29%), Positives = 172/353 (48%), Gaps = 24/353 (6%)
Query: 61 SPAYIFKKSLSGSKKGGNLTPMRVFRMPPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAP 120
A + L + +R R PS + ++ A ++ + E + P
Sbjct: 20 RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79
Query: 121 ELD-KRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTT 177
E + + +KE + + + +GRG ++ H+ + A+K++ +
Sbjct: 80 EDELPDWAAAKEFYQKYDPKDVIGRGVSSVV-----RRCVHRATGHEFAVKIMEVTAERL 134
Query: 178 AI-----AVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR 232
+ E RRE ILR ++GH +++ D++E +++V +L GEL D + +
Sbjct: 135 SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK 194
Query: 233 CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292
SE E ++++ +L V+F H + +VHRDLKPEN L D++ Q++ DFG S +
Sbjct: 195 -VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHL 250
Query: 293 RPDERLNDIVGSAYYVAPEVL-------HRSYGTEADVWSIGVIAYILLCGSRPFWARTE 345
P E+L ++ G+ Y+APE+L H YG E D+W+ GVI + LL GS PFW R +
Sbjct: 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310
Query: 346 SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
+ R +++ F W SS KD + LL DP R+TA QAL HP+
Sbjct: 311 ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 434 bits (1119), Expect = e-152
Identities = 96/281 (34%), Positives = 148/281 (52%), Gaps = 10/281 (3%)
Query: 123 DKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVE 182
+ F + ++G G FG + + IK I K + + +E
Sbjct: 11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRS--QVPME 65
Query: 183 DVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC---GKYSED 239
+ E+++L++L H N++K ++ FED N+YIVME CEGGELL+RI+S SE
Sbjct: 66 QIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 240 EAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLN 299
++ Q++N +A+ H VVH+DLKPEN L+ S +K IDFGL++ + DE
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 300 DIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359
+ G+A Y+APEV R + D+WS GV+ Y LL G PF + + + +P++
Sbjct: 185 NAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244
Query: 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
P L+ A D +K +L KDP +R +AAQ L H W +
Sbjct: 245 AVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 431 bits (1110), Expect = e-150
Identities = 92/334 (27%), Positives = 162/334 (48%), Gaps = 17/334 (5%)
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTT--AIAVEDV 184
E+ E +G+G F ++ +++ Q+ A+K++ +K T+ ++ ED+
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVV-----RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 185 RREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR---CGKYSEDEA 241
+RE I L H ++V+ + + +Y+V E +G +L I+ R YSE A
Sbjct: 74 KREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 242 KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLND 300
+ QIL + +CH + ++HRD+KP L SK+ S+ +K FG++
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 301 IVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359
VG+ +++APEV+ R YG DVW GVI +ILL G PF+ T+ +F ++K
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKM 251
Query: 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDISILKLMKA 418
+ W +S AKD V+ +L DP +R+T +AL+HPW++ + ++ ++
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 311
Query: 419 YMQSSSLRRAALKALSKTLTVDERFYLKEQFALL 452
+ L+ A L A+S E+
Sbjct: 312 FNARRKLKGAVLAAVSSHKFNSFYGDPPEELPDF 345
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 429 bits (1104), Expect = e-149
Identities = 106/360 (29%), Positives = 173/360 (48%), Gaps = 15/360 (4%)
Query: 108 SSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKV 165
A ++ + S + + +V EE+G+G F ++ HK +
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVV-----RRCVHKTTGLEF 57
Query: 166 AIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGEL 225
A K+I K++ A + + RE +I R L H N+V+ +D+ ++ Y+V +L GGEL
Sbjct: 58 AAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
Query: 226 LDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285
+ I++R YSE +A + QIL +A+CH +G+VHR+LKPEN L SK + + +K D
Sbjct: 116 FEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWART 344
FGL+ V E + G+ Y++PEVL + Y D+W+ GVI YILL G PFW
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234
Query: 345 ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV 404
+ ++ + + W +++ +AK + +L +P+KR+TA QAL PWI N V
Sbjct: 235 QHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 294
Query: 405 -KVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFE 463
+ +K + L+ A L + T + L + E
Sbjct: 295 ASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSN---LGRNLLNKKEQGPPSTIKE 351
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 419 bits (1080), Expect = e-146
Identities = 99/292 (33%), Positives = 159/292 (54%), Gaps = 13/292 (4%)
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRR 186
S + + +V EE+G+G F ++ HK + A K+I K++ A + + R
Sbjct: 1 STKFSDNYDVKEELGKGAFSVV-----RRCVHKTTGLEFAAKIINTKKLS-ARDFQKLER 54
Query: 187 EVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV 246
E +I R L H N+V+ +D+ ++ Y+V +L GGEL + I++R YSE +A +
Sbjct: 55 EARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQ 112
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY 306
QIL +A+CH +G+VHR+LKPEN L SK + + +K DFGL+ V E + G+
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 172
Query: 307 YVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365
Y++PEVL + Y D+W+ GVI YILL G PFW + ++ + + W
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232
Query: 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV--KVPLDISILKL 415
+++ +AK + +L +P+KR+TA QAL PWI N V + ++ L
Sbjct: 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCL 284
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 417 bits (1073), Expect = e-145
Identities = 81/297 (27%), Positives = 148/297 (49%), Gaps = 12/297 (4%)
Query: 139 GEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+E+GRG F ++ K Q+ A K + K + ++ E+ +L
Sbjct: 34 SKELGRGKFAVV-----RQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKS 87
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFC 255
++ ++ +E+ + +++E GGE+ L SE++ ++ QIL V +
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 256 HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR 315
H + +VH DLKP+N L +S +K +DFG+S + L +I+G+ Y+APE+L+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207
Query: 316 S-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
T D+W+IG+IAY+LL + PF + + + + + + ++ S+S A DF
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF 267
Query: 375 VKLLLNKDPRKRMTAAQALSHPWIRNY--NNVKVPLDISILKLMKAYMQSSSLRRAA 429
++ LL K+P KR TA LSH W++ + N+ P + S + + SS + +
Sbjct: 268 IQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTS 324
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 412 bits (1062), Expect = e-143
Identities = 113/346 (32%), Positives = 170/346 (49%), Gaps = 13/346 (3%)
Query: 88 PPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHF 147
S L + + +++ P+ ++ EV E+GRG
Sbjct: 7 HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGAT 66
Query: 148 GYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAF 207
+ K + A+KV+ K+ + VR E+ +L LS H N++K + F
Sbjct: 67 SIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIF 117
Query: 208 EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKP 267
E + +V+EL GGEL DRI+ + G YSE +A + QIL VA+ H +G+VHRDLKP
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKP 176
Query: 268 ENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSI 326
EN LY + + LK DFGLS V + + G+ Y APE+L +YG E D+WS+
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSV 236
Query: 327 GVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRK 385
G+I YILLCG PF+ + +FR +L + F W +S +AKD V+ L+ DP+K
Sbjct: 237 GIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKK 296
Query: 386 RMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALK 431
R+T QAL HPW+ + K ++ + L+ A
Sbjct: 297 RLTTFQALQHPWVTG-KAANFVHMDTAQKKLQEFNARRKLKAAVKA 341
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 410 bits (1057), Expect = e-143
Identities = 97/294 (32%), Positives = 147/294 (50%), Gaps = 24/294 (8%)
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAV----- 181
+ E E +GRG ++ HK ++ A+K+I + + A
Sbjct: 12 THGFYENYEPKEILGRGVSSVV-----RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 182 -EDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDE 240
E +EV ILR +SGH N+++ D +E ++V +L + GEL D + + SE E
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKE 125
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND 300
+ ++ +L V+ H +VHRDLKPEN L D+ +K DFG S + P E+L +
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 301 IVGSAYYVAPEVL-------HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 353
+ G+ Y+APE++ H YG E D+WS GVI Y LL GS PFW R + + R ++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 354 KADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVP 407
+ F W S KD V L P+KR TA +AL+HP+ + Y +V
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 403 bits (1039), Expect = e-140
Identities = 104/287 (36%), Positives = 161/287 (56%), Gaps = 14/287 (4%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTT---AIAVEDVRR 186
V E+GEE+G G F +K K ++ A K I K ++++ ++ E++ R
Sbjct: 3 VEDHYEMGEELGSGQFAIV-----RKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 57
Query: 187 EVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV 246
EV ILR + H N++ +D FE+ +V +++EL GGEL D + + +EDEA L
Sbjct: 58 EVNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLK 115
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
QIL+ V + H + H DLKPEN + K+ + ++K IDFG++ + +I G+
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP 175
Query: 306 YYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364
+VAPE+++ G EAD+WSIGVI YILL G+ PF T+ + + FD+ +
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 235
Query: 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDIS 411
+ S AKDF++ LL KDP++RMT AQ+L H WI+ V + S
Sbjct: 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDS 282
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 407 bits (1049), Expect = e-140
Identities = 109/404 (26%), Positives = 172/404 (42%), Gaps = 33/404 (8%)
Query: 70 LSGSKKGGNLTPMRVFRMPPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELD-KRFGF 128
LS S+ P PP P A+ ++ L K+
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTP--ALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAI 59
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREV 188
+ + +G G G K+ +K A+K++ RREV
Sbjct: 60 IDDYK---VTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQDC--------PKARREV 105
Query: 189 KILRALSGHSNLVKFYDAFEDL----DNVYIVMELCEGGELLDRILSRCGK-YSEDEAKA 243
++ S ++V+ D +E+L + IVME +GGEL RI R + ++E EA
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165
Query: 244 VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVG 303
++ I + + H + HRD+KPEN LYTSK ++ LK DFG + L
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225
Query: 304 SAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPS 358
+ YYVAPEVL Y D+WS+GVI YILLCG PF++ G+ +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285
Query: 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDISILKLMK 417
F + W +S + K ++ LL +P +RMT + ++HPWI V + PL S + L +
Sbjct: 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV-LKE 344
Query: 418 AYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIA 461
+ ++ AL+ E+ +K+ +E N +
Sbjct: 345 DKERWEDVKEEMTSALATMRVDYEQIKIKK----IEDASNPLLL 384
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 409 bits (1054), Expect = e-138
Identities = 109/414 (26%), Positives = 176/414 (42%), Gaps = 28/414 (6%)
Query: 81 PMRVFRMPPSPAKHIKAV-------LRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKE-V 132
P +P K + + R K T S+ + + + + V
Sbjct: 96 PTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHV 155
Query: 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
++ EE+G G FG + A K + + E VR+E++ +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHESD---KETVRKEIQTMS 209
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
L H LV +DAFED + + ++ E GGEL +++ K SEDEA + Q+ +
Sbjct: 210 VLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 268
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 312
H + VH DLKPEN ++T+K + LK IDFGL+ + P + + G+A + APEV
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
Query: 313 L-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371
+ G D+WS+GV++YILL G PF + R V D + DD ++ +S D
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387
Query: 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV--KVPLDISILKLMKAYMQS------- 422
KDF++ LL DP RMT QAL HPW+ N + S ++ +++
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPE 447
Query: 423 --SSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT 474
L R + + + E + E + + ++A
Sbjct: 448 PLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQSAN 501
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-138
Identities = 106/335 (31%), Positives = 170/335 (50%), Gaps = 23/335 (6%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTT---AIAVEDV 184
+ V + GEE+G G F KK K + A K I K + + ++ ED+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVV-----KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 185 RREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
REV IL+ + H N++ ++ +E+ +V +++EL GGEL D + + +E+EA
Sbjct: 62 EREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEF 119
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAIDFGLSDFVRPDERLNDIVG 303
L QILN V + H + H DLKPEN + ++ ++K IDFGL+ + +I G
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 304 SAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362
+ +VAPE+++ G EAD+WSIGVI YILL G+ PF T+ V + F+D
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 239
Query: 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQS 422
+ + S+ AKDF++ LL KDP+KRMT +L HPWI+ + + L + +
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA------LSRKASAVNM 293
Query: 423 SSLRRAALKALSKTLTVDERFYLKEQFALLEPNKN 457
++ A + S + L + F + +
Sbjct: 294 EKFKKFAARKKSNNGSGGG---LNDIFEAQKIEWH 325
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 391 bits (1007), Expect = e-135
Identities = 97/315 (30%), Positives = 165/315 (52%), Gaps = 34/315 (10%)
Query: 139 GEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+ +G G F +K HK Q A+K+I K + ++E+ L+ G
Sbjct: 16 DKPLGEGSFSIC-----RKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEG 64
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H N+VK ++ F D + ++VMEL GGEL +RI + +SE EA ++ ++++ V+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMH 123
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR 315
GVVHRDLKPEN L+T ++++ ++K IDFG + PD + L + +Y APE+L++
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 316 S-YGTEADVWSIGVIAYILLCGSRPFWARTES-------GIFRAVLKADPSFDDGSWPSL 367
+ Y D+WS+GVI Y +L G PF + S I + + K D SF+ +W ++
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPL---------DISILKLMK 417
S +AKD ++ LL DP KR+ + + W+++ + + PL ++ +K
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVK 303
Query: 418 A-YMQSSSLRRAALK 431
A + + +R
Sbjct: 304 ATFHAFNKYKREGFC 318
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 390 bits (1004), Expect = e-133
Identities = 100/345 (28%), Positives = 164/345 (47%), Gaps = 16/345 (4%)
Query: 101 RRKSTKKSSAEEGAPEEAAPELDKRFGF------SKEVTSRLEVGEEVGRGHFGYTCTAR 154
+ K + ++ ++ K++ V ++ EE+G G FG
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 155 YKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214
K + K I V+ E+ I+ L H L+ +DAFED +
Sbjct: 72 EKATG---RVFVAKFINTPYPLD---KYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMV 124
Query: 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS 274
+++E GGEL DRI + K SE E + Q + H H +VH D+KPEN + +
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184
Query: 275 KDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYIL 333
K ++S +K IDFGL+ + PDE + +A + APE++ R G D+W+IGV+ Y+L
Sbjct: 185 K-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 243
Query: 334 LCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQAL 393
L G PF + + V + D FD+ ++ S+S +AKDF+K LL K+PRKR+T AL
Sbjct: 244 LSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303
Query: 394 SHPWIRNYN-NVKVPLDISILKLMKAYMQSSSLRRAALKALSKTL 437
HPW++ + N+ + S ++ ++ A + +
Sbjct: 304 EHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRI 348
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 386 bits (995), Expect = e-133
Identities = 104/314 (33%), Positives = 165/314 (52%), Gaps = 16/314 (5%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTT---AIAVEDV 184
++V ++GEE+G G F KK K + A K I K + ++ E++
Sbjct: 8 QKVEDFYDIGEELGSGQFAIV-----KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 185 RREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
REV ILR + H N++ +D +E+ +V +++EL GGEL D + + SE+EA +
Sbjct: 63 EREVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSF 120
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE-SSQLKAIDFGLSDFVRPDERLNDIVG 303
+ QIL+ V + H + H DLKPEN + K+ +K IDFGL+ + +I G
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180
Query: 304 SAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362
+ +VAPE+++ G EAD+WSIGVI YILL G+ PF T+ + FD+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240
Query: 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQS 422
+ S AKDF++ LL K+ RKR+T +AL HPWI +N + + + ++ + +
Sbjct: 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQ 300
Query: 423 SSLRR--AALKALS 434
RR + +S
Sbjct: 301 YVRRRWKLSFSIVS 314
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 385 bits (991), Expect = e-132
Identities = 103/311 (33%), Positives = 161/311 (51%), Gaps = 14/311 (4%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTT---AIAVEDV 184
++V ++GEE+G G F KK K + A K I K + + E++
Sbjct: 8 QKVEDFYDIGEELGSGQFAIV-----KKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62
Query: 185 RREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
REV ILR + H N++ +D +E+ +V +++EL GGEL D + + SE+EA +
Sbjct: 63 EREVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSF 120
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAIDFGLSDFVRPDERLNDIVG 303
+ QIL+ V + H + H DLKPEN + K+ +K IDFGL+ + +I G
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180
Query: 304 SAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362
+ +VAPE+++ G EAD+WSIGVI YILL G+ PF T+ + FD+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240
Query: 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQS 422
+ S AKDF++ LL K+ RKR+T +AL HPWI + + + + ++ + +
Sbjct: 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQ 300
Query: 423 SSLRRAALKAL 433
RR L
Sbjct: 301 YVRRRWKLSFS 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 385 bits (991), Expect = e-131
Identities = 101/332 (30%), Positives = 161/332 (48%), Gaps = 14/332 (4%)
Query: 88 PPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSK--EVTSRLEVG--EEVG 143
+ R +K++SA D R +K V S V E +G
Sbjct: 39 AKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILG 98
Query: 144 RGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKF 203
G FG K+A K+I M E+V+ E+ ++ L H+NL++
Sbjct: 99 GGRFGQVHKCEETAT---GLKLAAKIIKTRGMKD---KEEVKNEISVMNQLD-HANLIQL 151
Query: 204 YDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHR 263
YDAFE +++ +VME +GGEL DRI+ +E + + QI + H ++H
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 264 DLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YGTEAD 322
DLKPEN L ++D Q+K IDFGL+ +P E+L G+ ++APEV++ D
Sbjct: 212 DLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTD 270
Query: 323 VWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKD 382
+WS+GVIAY+LL G PF ++ +L +D + +S +AK+F+ LL K+
Sbjct: 271 MWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKE 330
Query: 383 PRKRMTAAQALSHPWIRNYNNVKVPLDISILK 414
R++A++AL HPW+ + + + L K
Sbjct: 331 KSWRISASEALKHPWLSD-HKLHSRLSAQKKK 361
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 383 bits (986), Expect = e-131
Identities = 110/328 (33%), Positives = 164/328 (50%), Gaps = 32/328 (9%)
Query: 129 SKEVTSRLEVGEEV-GRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVR 185
VT ++ ++V G G G + H+ QK A+K++ S R
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKV-----LECFHRRTGQKCALKLLYDSP--------KAR 69
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDN----VYIVMELCEGGELLDRILSR-CGKYSEDE 240
+EV SG ++V D +E++ + + I+ME EGGEL RI R ++E E
Sbjct: 70 QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE 129
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND 300
A ++ I + F H H + HRD+KPEN LYTSK++ + LK DFG + + L
Sbjct: 130 AAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQT 188
Query: 301 IVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTES----GIFRAVLKA 355
+ YYVAPEVL Y D+WS+GVI YILLCG PF++ T G+ R +
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248
Query: 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDIS-IL 413
F + W +S DAK ++LLL DP +R+T Q ++HPWI V + PL + +L
Sbjct: 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVL 308
Query: 414 KLMKAYMQSSSLRRAALKALSKTLTVDE 441
+ K + ++ AL+ T+ VD
Sbjct: 309 QEDKDHWD--EVKEEMTSALA-TMRVDY 333
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-131
Identities = 92/337 (27%), Positives = 157/337 (46%), Gaps = 54/337 (16%)
Query: 116 EEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM 175
L + G E+ + + +G+G +G A + AIK++ K+K+
Sbjct: 8 SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTR---AIRAIKIMNKNKI 64
Query: 176 --TTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR- 232
VE ++ EV++++ L H N+ + Y+ +ED + +VMELC GG LLD++
Sbjct: 65 RQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 233 --------------------------------------CGKYSEDEAKAVLVQILNVVAF 254
E ++ QI + + +
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-----DERLNDIVGSAYYVA 309
H G+ HRD+KPENFL+++ ++S ++K +DFGLS + G+ Y+VA
Sbjct: 184 LHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 310 PEVLH---RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366
PEVL+ SYG + D WS GV+ ++LL G+ PF ++ VL F++ ++
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNV 302
Query: 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
LS A+D + LLN++ +R A +AL HPWI +++
Sbjct: 303 LSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-131
Identities = 95/314 (30%), Positives = 146/314 (46%), Gaps = 42/314 (13%)
Query: 128 FSKEVTSRLEVGEEV-GRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDV 184
FS ++ E+V G G + + Q+ A+K+I K V
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARV-----QTCINLITSQEYAVKIIEKQPGHI---RSRV 57
Query: 185 RREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
REV++L GH N+++ + FE+ D Y+V E GG +L I R ++E EA V
Sbjct: 58 FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVV 116
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI--- 301
+ + + + F H G+ HRDLKPEN L ++ S +K DF L ++ + + I
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 302 -----VGSAYYVAPEVL------HRSYGTEADVWSIGVIAYILLCGSRPFWAR------- 343
GSA Y+APEV+ Y D+WS+GVI YILL G PF R
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236
Query: 344 --------TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
++ +F ++ + F D W +S AKD + LL +D ++R++AAQ L H
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296
Query: 396 PWIRNYNNVKVPLD 409
PW++ + L
Sbjct: 297 PWVQGCAP-ENTLP 309
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 380 bits (978), Expect = e-130
Identities = 99/326 (30%), Positives = 157/326 (48%), Gaps = 25/326 (7%)
Query: 128 FSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTT-----AIA 180
+ K + + + +G G G K + +KVAIK+I K K A
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEV-----KLAFERKTCKKVAIKIISKRKFAIGSAREADP 58
Query: 181 VEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDE 240
+V E++IL+ L+ H ++K + F+ ++ YIV+EL EGGEL D+++ + E
Sbjct: 59 ALNVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGN-KRLKEAT 115
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND 300
K Q+L V + H +G++HRDLKPEN L +S++E +K DFG S + +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 301 IVGSAYYVAPEVL----HRSYGTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKA 355
+ G+ Y+APEVL Y D WS+GVI +I L G PF RT+ + +
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKL 415
+F W +S A D VK LL DP+ R T +AL HPW+++ + L
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE-----DMKRKFQDL 290
Query: 416 MKAYMQSSSLRRAALKALSKTLTVDE 441
+ +S++L + + + E
Sbjct: 291 LSEENESTALPQVLAQPSTSRKRPRE 316
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-129
Identities = 111/324 (34%), Positives = 163/324 (50%), Gaps = 28/324 (8%)
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRR 186
S + T EV E++G G + K+ HK + A+K+I KSK D
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVC-----KRCIHKATNMEFAVKIIDKSK-------RDPTE 64
Query: 187 EVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV 246
E++IL H N++ D ++D VY+V EL +GGELLD+IL + +SE EA AVL
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLF 123
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDE-SSQLKAIDFGLSDFVRPDER-LNDIVGS 304
I V + H GVVHRDLKP N LY + ++ DFG + +R + L +
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT 183
Query: 305 AYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKADPSFD 360
A +VAPEVL R Y D+WS+GV+ Y +L G PF T I + S
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243
Query: 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDISILK-LMKA 418
G W S+S AKD V +L+ DP +R+TAA L HPWI +++ + + L+ L+K
Sbjct: 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKG 303
Query: 419 YMQSS-----SLRRAALKALSKTL 437
M ++ + L+ + ++
Sbjct: 304 AMAATYSALNRNQSPVLEPVGRST 327
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-128
Identities = 90/309 (29%), Positives = 139/309 (44%), Gaps = 44/309 (14%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+ +G G G K+ +K A+K++ RREV++ S
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQDC--------PKARREVELHWRASQ 69
Query: 197 HSNLVKFYDAFEDL----DNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNV 251
++V+ D +E+L + IVME +GGEL RI R + ++E EA ++ I
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 311
+ + H + HRD+KPEN LYTSK ++ LK DFG A E
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKE 169
Query: 312 VLHRSYGTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDDGSWPSL 367
Y D+WS+GVI YILLCG PF++ G+ + F + W +
Sbjct: 170 TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDIS-ILKLMKAYMQSSSL 425
S + K ++ LL +P +RMT + ++HPWI V + PL S +LK K + +
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE--DV 287
Query: 426 RRAALKALS 434
+ AL+
Sbjct: 288 KEEMTSALA 296
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 370 bits (951), Expect = e-125
Identities = 96/303 (31%), Positives = 152/303 (50%), Gaps = 20/303 (6%)
Query: 120 PELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTT 177
+D + + K + + + +G G G K + +KVAI++I K K
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEV-----KLAFERKTCKKVAIRIISKRKFAI 175
Query: 178 -----AIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR 232
A +V E++IL+ L+ H ++K + F+ ++ YIV+EL EGGEL D+++
Sbjct: 176 GSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGN 233
Query: 233 CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292
+ E K Q+L V + H +G++HRDLKPEN L +S++E +K DFG S +
Sbjct: 234 -KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
Query: 293 RPDERLNDIVGSAYYVAPEVL----HRSYGTEADVWSIGVIAYILLCGSRPFWA-RTESG 347
+ + G+ Y+APEVL Y D WS+GVI +I L G PF RT+
Sbjct: 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352
Query: 348 IFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVP 407
+ + +F W +S A D VK LL DP+ R T +AL HPW+++ + +
Sbjct: 353 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 412
Query: 408 LDI 410
D+
Sbjct: 413 QDL 415
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-108
Identities = 78/361 (21%), Positives = 147/361 (40%), Gaps = 42/361 (11%)
Query: 105 TKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQK 164
+ S ++ EE + + + F + +G G G +G ++
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISF--------CPKDVLGHGAEGTI----VYRGMFDNRD 50
Query: 165 VAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGE 224
VA+K I REV++LR H N+++++ +D YI +ELC
Sbjct: 51 VAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AAT 103
Query: 225 LLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284
L + + + + E +L Q + +A H +VHRDLKP N L + + ++KA+
Sbjct: 104 LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAM 163
Query: 285 --DFGLSDFVRPDE----RLNDIVGSAYYVAPEVL----HRSYGTEADVWSIGVIAYILL 334
DFGL + R + + G+ ++APE+L + D++S G + Y ++
Sbjct: 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223
Query: 335 C-GSRPFWARTESGIFRAVLKADPSFDDGS-WPSLSSDAKDFVKLLLNKDPRKRMTAAQA 392
GS PF + +L S D A++ ++ ++ DP+KR +A
Sbjct: 224 SEGSHPFGKSLQRQAN--ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
Query: 393 LSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKT----LTVDERFYLKEQ 448
L HP+ + + + + ++ SL +K L + + +D R +
Sbjct: 282 LKHPFFWSLEKQ-----LQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVP 336
Query: 449 F 449
Sbjct: 337 L 337
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 321 bits (825), Expect = e-106
Identities = 78/317 (24%), Positives = 137/317 (43%), Gaps = 45/317 (14%)
Query: 128 FSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRRE 187
F + + + + + +G G G +G + + VA+K + + E
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTV----VFQGSFQGRPVAVKRMLIDFC------DIALME 58
Query: 188 VKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR------CGKYSEDEA 241
+K+L H N++++Y + +YI +ELC L D + S+ E
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 242 KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD----------ESSQLKAIDFGLSDF 291
++L QI + VA H ++HRDLKP+N L ++ E+ ++ DFGL
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 292 VRPDE-----RLNDIVGSAYYVAPEVL--------HRSYGTEADVWSIGVIAYILLC-GS 337
+ + LN+ G++ + APE+L R D++S+G + Y +L G
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 338 RPFWAR--TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
PF + ES I R + D SL ++A D + +++ DP KR TA + L H
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 396 PWIRNYN-NVKVPLDIS 411
P + ++ L +S
Sbjct: 297 PLFWPKSKKLEFLLKVS 313
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 2e-92
Identities = 72/312 (23%), Positives = 116/312 (37%), Gaps = 50/312 (16%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+ + +G+G +G HK AIKV V+ RE ++L+ L
Sbjct: 12 LLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKL 64
Query: 195 SGHSNLVKFYDAFEDL--DNVYIVMELCEGGELLDRILS--RCGKYSEDEAKAVLVQILN 250
+ H N+VK + E+ + ++ME C G L + E E VL ++
Sbjct: 65 N-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 251 VVAFCHLHGVVHRDLKPENFLY-TSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVA 309
+ +G+VHR++KP N + +D S K DFG + + DE+ + G+ Y+
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 310 PEVL---------HRSYGTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKAD 356
P++ + YG D+WSIGV Y GS PF R + ++
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 357 P-----------------SFDDGSWPSLSSDAKD----FVKLLLNKDPRKRMTAAQALSH 395
P S D SLS + + +L D K Q +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 396 PW-IRNYNNVKV 406
I + N
Sbjct: 304 TSDILHRGNSHH 315
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 2e-91
Identities = 77/298 (25%), Positives = 127/298 (42%), Gaps = 47/298 (15%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
E +G+G FG + K + + AIK I ++ + + EV +L +L
Sbjct: 9 EEIAVLGQGAFG-----QVVKARNALDSRYYAIKKIRHTEE----KLSTILSEVMLLASL 59
Query: 195 SGHSNLVKFYDAFEDLDN-------------VYIVMELCEGGELLDRILSRCGKYSEDEA 241
+ H +V++Y A+ + N ++I ME CE G L D I S DE
Sbjct: 60 N-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 242 KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS------------ 289
+ QIL +++ H G++HRDLKP N DES +K DFGL+
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 290 ---DFVRPDERLNDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWART 344
+ + L +G+A YVA EVL + Y + D++S+G+I + ++
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGME 233
Query: 345 ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402
I + + F + K ++LL++ DP KR A L+ W+ +
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 3e-89
Identities = 104/354 (29%), Positives = 162/354 (45%), Gaps = 28/354 (7%)
Query: 89 PSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFG 148
P+PA KA + + +A A E +D R R G +G+G F
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR------RRYVRGRFLGKGGF- 54
Query: 149 YTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDA 206
A+ + D + A K++PKS + E + E+ I R+L+ H ++V F+
Sbjct: 55 ----AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGF 109
Query: 207 FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLK 266
FED D V++V+ELC LL+ R +E EA+ L QI+ + H + V+HRDLK
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 267 PENFLYTSKDESSQLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVL-HRSYGTEADVW 324
N +E ++K DFGL+ V ER + G+ Y+APEVL + + E DVW
Sbjct: 169 LGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVW 225
Query: 325 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSDAKDFVKLLLNKDP 383
SIG I Y LL G PF + + K + S P ++ A ++ +L DP
Sbjct: 226 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI-----PKHINPVAASLIQKMLQTDP 280
Query: 384 RKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAY-MQSSSLRRAALKALSKT 436
R T + L+ + + + L I+ L + + + SSL + K L+
Sbjct: 281 TARPTINELLNDEFFTS-GYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 333
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 9e-89
Identities = 91/270 (33%), Positives = 145/270 (53%), Gaps = 19/270 (7%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+VG +G+G F + E +VAIK+I K M A V+ V+ EVKI L
Sbjct: 14 KVGNLLGKGSFA-----GVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H ++++ Y+ FED + VY+V+E+C GE+ + +R +SE+EA+ + QI+ + +
Sbjct: 69 K-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVL 313
H HG++HRDL N L + +K DFGL+ + P E+ + G+ Y++PE+
Sbjct: 128 LHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 314 -HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSDA 371
++G E+DVWS+G + Y LL G PF T V+ AD PS LS +A
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM-----PSFLSIEA 239
Query: 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
KD + LL ++P R++ + L HP++
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 270 bits (694), Expect = 4e-88
Identities = 87/277 (31%), Positives = 134/277 (48%), Gaps = 21/277 (7%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
G +G+G F A+ + D + A K++PKS + E + E+ I R+L
Sbjct: 18 VRGRFLGKGGF-----AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
+ H ++V F+ FED D V++V+ELC LL+ R +E EA+ L QI+ +
Sbjct: 73 A-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQY 130
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVL 313
H + V+HRDLK N +E ++K DFGL+ V ER + G+ Y+APEVL
Sbjct: 131 LHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187
Query: 314 -HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSDA 371
+ + E DVWSIG I Y LL G PF + + K + S P ++ A
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI-----PKHINPVA 242
Query: 372 KDFVKLLLNKDPRKRMTAAQALSHPWIR-NYNNVKVP 407
++ +L DP R T + L+ + Y ++P
Sbjct: 243 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP 279
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 1e-87
Identities = 76/365 (20%), Positives = 134/365 (36%), Gaps = 54/365 (14%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+ + +G+G +G HK AIKV V+ RE ++L+ L
Sbjct: 12 LLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKL 64
Query: 195 SGHSNLVKFYDAFEDL--DNVYIVMELCEGGELLDRILS--RCGKYSEDEAKAVLVQILN 250
+ H N+VK + E+ + ++ME C G L + E E VL ++
Sbjct: 65 N-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 251 VVAFCHLHGVVHRDLKPENFLY-TSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVA 309
+ +G+VHR++KP N + +D S K DFG + + DE+ + G+ Y+
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 310 PEVL---------HRSYGTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKAD 356
P++ + YG D+WSIGV Y GS PF R + ++
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 357 PSFDDGSW---------------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
PS L + +L D K Q +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 396 PW-IRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALS---KTLTVDERFYLKEQFAL 451
I + + V + + K Y+ S + + + K ++ ++ + + +
Sbjct: 304 TSDILHRMVIHV-FSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLV 362
Query: 452 LEPNK 456
LEP +
Sbjct: 363 LEPGR 367
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 9e-87
Identities = 76/330 (23%), Positives = 136/330 (41%), Gaps = 32/330 (9%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD-QKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
+ +++G G + + ++ Q AIK + + ++ R E+ L L
Sbjct: 12 SILKQIGSGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQ 65
Query: 196 GHS-NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
HS +++ YD +Y+VME C +L + + E K+ +L V
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHT 123
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPE 311
H HG+VH DLKP NFL LK IDFG+++ ++PD + VG+ Y+ PE
Sbjct: 124 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 312 VLHRS------------YGTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPS 358
+ ++DVWS+G I Y + G PF A++ +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239
Query: 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKA 418
+ D +D +K L +DP++R++ + L+HP+++ + + + MK
Sbjct: 240 IEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 297
Query: 419 YMQSSSLRRAALKALSKTLTVDERFYLKEQ 448
+ + L T+ E + E
Sbjct: 298 VLGQLVGLNSPNSILKAAKTLYEHYSGGES 327
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 4e-86
Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 30/284 (10%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD-QKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
+ +++G G + + ++ Q AIK + + ++ R E+ L L
Sbjct: 31 SILKQIGSGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQ 84
Query: 196 GHS-NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
HS +++ YD +Y+VME C +L + + E K+ +L V
Sbjct: 85 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHT 142
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPE 311
H HG+VH DLKP NFL LK IDFG+++ ++PD + VG+ Y+ PE
Sbjct: 143 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 312 VLHRS------------YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359
+ ++DVWS+G I Y + G PF I + DP+
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNH 257
Query: 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
+ D +D +K L +DP++R++ + L+HP+++ +
Sbjct: 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 7e-85
Identities = 83/378 (21%), Positives = 148/378 (39%), Gaps = 33/378 (8%)
Query: 88 PPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHF 147
S K A R+ ++A+ ++ + +++G G
Sbjct: 13 RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR---IYSILKQIGSGGS 69
Query: 148 GYTCTARYKKGEHKD-QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS-NLVKFYD 205
+ + ++ Q AIK + + ++ R E+ L L HS +++ YD
Sbjct: 70 S-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 206 AFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDL 265
+Y+VME C +L + + E K+ +L V H HG+VH DL
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 181
Query: 266 KPENFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHRS------ 316
KP NFL LK IDFG+++ ++PD + VG+ Y+ PE +
Sbjct: 182 KPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 317 ------YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370
++DVWS+G I Y + G PF I + DP+ + D
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIPEKD 296
Query: 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAAL 430
+D +K L +DP++R++ + L+HP+++ + + + MK + +
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 356
Query: 431 KALSKTLTVDERFYLKEQ 448
L T+ E + E
Sbjct: 357 SILKAAKTLYEHYSGGES 374
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 7e-85
Identities = 82/269 (30%), Positives = 135/269 (50%), Gaps = 14/269 (5%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
E+G +G+G FG AR K +A+KV+ K+++ A +RREV+I
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREK---QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H N+++ Y F D VY+++E G + L + K+ E + ++ N ++
Sbjct: 66 LR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRE-LQKLSKFDEQRTATYITELANALS 123
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 313
+CH V+HRD+KPEN L + +LK DFG S P R D+ G+ Y+ PE++
Sbjct: 124 YCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMI 179
Query: 314 -HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372
R + + D+WS+GV+ Y L G PF A T ++ + + + +F ++ A+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGAR 235
Query: 373 DFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
D + LL +P +R + L HPWI
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWITAN 264
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 4e-83
Identities = 82/282 (29%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
++G +G+G FG AR K +A+KV+ KS++ +RRE++I
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREK---QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H N+++ Y+ F D +Y+++E GEL L + G++ E + + ++ + +
Sbjct: 71 LR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALH 128
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 313
+CH V+HRD+KPEN L +LK DFG S P R + G+ Y+ PE++
Sbjct: 129 YCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMI 184
Query: 314 -HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSDA 371
+++ + D+W GV+ Y L G PF + + + R ++ D F P LS +
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF-----PPFLSDGS 239
Query: 372 KDFVKLLLNKDPRKRMTAAQALSHPWIR-NYNNVKVPLDISI 412
KD + LL P +R+ + HPW++ N V P+ S
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 8e-83
Identities = 90/300 (30%), Positives = 150/300 (50%), Gaps = 35/300 (11%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+ + +G+G+F + K H ++VAIK+I K+++ +++ + REV+I++ L
Sbjct: 18 RLLKTIGKGNFA-----KVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKIL 71
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
+ H N+VK ++ E +Y++ME GGE+ D +++ G+ E EA++ QI++ V +
Sbjct: 72 N-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQY 129
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 314
CH +VHRDLK EN L D +K DFG S+ +L+ G+ Y APE+
Sbjct: 130 CHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ 186
Query: 315 -RSY-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDDGSWPSLSS 369
+ Y G E DVWS+GVI Y L+ GS PF + + VL+ P + +S+
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY-------MST 239
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV----------KVPLDISILKLMKAY 419
D ++ +K L +P KR T Q + WI + D + +M
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 9e-82
Identities = 97/279 (34%), Positives = 139/279 (49%), Gaps = 25/279 (8%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+G+ +G G FG + K GEH+ KVA+K++ + K+ + V ++RE++ L+
Sbjct: 14 VLGDTLGVGTFG-----KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H +++K Y + ++VME GGEL D I G+ E EA+ + QIL+ V +
Sbjct: 69 R-HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDY 126
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 313
CH H VVHRDLKPEN L D K DFGLS+ + E L GS Y APEV+
Sbjct: 127 CHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183
Query: 314 HRSY-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDDGSWPSLSS 369
R Y G E D+WS GVI Y LLCG+ PF +F+ + P + L+
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY-------LNR 236
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIR-NYNNVKVP 407
+ +L DP KR T H W + + + P
Sbjct: 237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFP 275
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 5e-80
Identities = 77/349 (22%), Positives = 143/349 (40%), Gaps = 40/349 (11%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
E+ E +G G FG + H+D ++VAIK + E E++I++ L
Sbjct: 17 EMKERLGTGGFG-----YVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKL 69
Query: 195 SGHSNLVKFYDAFEDL------DNVYIVMELCEGGELLDRILS--RCGKYSEDEAKAVLV 246
+ H N+V + + L D + ME CEGG+L + C E + +L
Sbjct: 70 N-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY 306
I + + + H + ++HRDLKPEN + + K ID G + + E + VG+
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188
Query: 307 YVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW- 364
Y+APE+L + Y D WS G +A+ + G RPF + + ++ + +
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 365 -------------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVK 405
L+ + +++ +L R+R T Q + + +++
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308
Query: 406 VPLDISILKLMKAYMQSSSLRRA-ALKALSKTLTVDERFYLKEQFALLE 453
+S++ ++ + + + L+ L L D +EQ L
Sbjct: 309 SLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQA 357
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 7e-80
Identities = 53/358 (14%), Positives = 96/358 (26%), Gaps = 53/358 (14%)
Query: 86 RMPPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRG 145
R + L+ + ++ P+ A +D + +L++ E + G
Sbjct: 17 REEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLS---QGERKLKLVEPLRVG 73
Query: 146 HFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL--------- 194
+ + A+KV + +E + L
Sbjct: 74 DRS-----VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 195 --------------SGHSNLVKFYDAFEDLD--NVYIVMELCEG-----GELLDRILSRC 233
+ +D N ++M LD +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 234 GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293
G + Q++ + A G+VH P+N +L D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSAL--WK 243
Query: 294 PDERLNDIVGSAYYVAPEVLHRS---YGTEADVWSIGVIAYILLCGSRPFWARTESGIFR 350
R Y E L+ S + + W +G+ Y + C PF T
Sbjct: 244 VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 351 AVLKAD-----PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
+ S GS L K + LN D R+R+ +A+ P N
Sbjct: 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 4e-79
Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 22/271 (8%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
++ + +G G +G + ++ + VA+K++ + E++++E+ I + L
Sbjct: 10 DLVQTLGEGAYG-----EVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKML 62
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
+ H N+VKFY + + Y+ +E C GGEL DRI E +A+ Q++ V +
Sbjct: 63 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVY 120
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP---DERLNDIVGSAYYVAPE 311
H G+ HRD+KPEN L DE LK DFGL+ R + LN + G+ YVAPE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 312 VL-HRSY-GTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDDGSWPSLS 368
+L R + DVWS G++ +L G P+ ++S + + + W +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKID 235
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
S + +L ++P R+T W
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 4e-79
Identities = 94/300 (31%), Positives = 143/300 (47%), Gaps = 34/300 (11%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+ E +G G FG + K H QKVA+K I + + + V RE+ L+ L
Sbjct: 12 IIRETLGEGSFG-----KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL 66
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H +++K YD ++ +V+E GGEL D I+ + + +EDE + QI+ + +
Sbjct: 67 R-HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEY 123
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 313
CH H +VHRDLKPEN L D++ +K DFGLS+ + L GS Y APEV+
Sbjct: 124 CHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 314 HRSY-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDDGSWPSLSS 369
+ Y G E DVWS G++ Y++L G PF +F+ V P F LS
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF-------LSP 233
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIR-NYNNVKVP--------LDISILKLMKAYM 420
A+ ++ ++ DP +R+T + PW N + P D I+ + M
Sbjct: 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAM 293
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 5e-79
Identities = 88/325 (27%), Positives = 145/325 (44%), Gaps = 33/325 (10%)
Query: 87 MPPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGH 146
M S H + + + + + + AP +K + + S+ +VG +G G
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEK-----EPLESQYQVGPLLGSGG 55
Query: 147 FGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVED---VRREVKILRALS-GHSNL 200
FG G VAIK + K +++ + + V EV +L+ +S G S +
Sbjct: 56 FG-----SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 201 VKFYDAFEDLDNVYIVMELCEG-GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG 259
++ D FE D+ +++E E +L D I R G E+ A++ Q+L V CH G
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG 169
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSY- 317
V+HRD+K EN L +LK IDFG + D D G+ Y PE + + Y
Sbjct: 170 VLHRDIKDENILIDL--NRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 318 GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377
G A VWS+G++ Y ++CG PF + I R + +SS+ + ++
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVF-FRQR-------VSSECQHLIRW 276
Query: 378 LLNKDPRKRMTAAQALSHPWIRNYN 402
L P R T + +HPW+++
Sbjct: 277 CLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 1e-78
Identities = 99/283 (34%), Positives = 142/283 (50%), Gaps = 25/283 (8%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+G+ +G G FG + K G+H+ KVA+K++ + K+ + V +RRE++ L+
Sbjct: 19 ILGDTLGVGTFG-----KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H +++K Y ++++VME GGEL D I G+ E E++ + QIL+ V +
Sbjct: 74 R-HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDY 131
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 313
CH H VVHRDLKPEN L D K DFGLS+ + E L GS Y APEV+
Sbjct: 132 CHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 188
Query: 314 HRSY-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDDGSWPSLSS 369
R Y G E D+WS GVI Y LLCG+ PF +F+ + P + L+
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY-------LNP 241
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIR-NYNNVKVPLDIS 411
+K +L DP KR T H W + + P D S
Sbjct: 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPS 284
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 1e-78
Identities = 79/291 (27%), Positives = 127/291 (43%), Gaps = 30/291 (10%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVED-----VRREVKIL 191
+G G FG+ TA K+ K+++V +K I K K+ +ED V E+ IL
Sbjct: 27 STMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMEL-CEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
+ H+N++K D FE+ +VME G +L I + E A + Q+++
Sbjct: 84 SRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVS 141
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 310
V + L ++HRD+K EN + E +K IDFG + ++ + G+ Y AP
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198
Query: 311 EVLH-RSY-GTEADVWSIGVIAYILLCGSRPF--WARTESGIFRAVLKADPSFDDGSWPS 366
EVL Y G E ++WS+GV Y L+ PF T P
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIH-----PPYL------- 246
Query: 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMK 417
+S + V LL P +R T + ++ PW+ N+ + ++ K
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNK 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 1e-78
Identities = 65/312 (20%), Positives = 126/312 (40%), Gaps = 51/312 (16%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKS--------------KMTTAIAVE 182
+ + +G F + E ++ A+K KS K++ +
Sbjct: 34 RIIRTLNQGKFN-----KIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 183 DVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILS-------RCGK 235
D + E++I+ + + + + D VYI+ E E +L
Sbjct: 89 DFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 236 YSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294
K ++ +LN ++ H + HRD+KP N L D++ ++K DFG S+++
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYM-V 203
Query: 295 DERLNDIVGSAYYVAPEVLHRS---YGTEADVWSIGVIAYILLCGSRPFWA-RTESGIFR 350
D+++ G+ ++ PE G + D+WS+G+ Y++ PF + +F
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 351 AVLKADPSF---------------DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
+ + + S LS++ DF+KL L K+P +R+T+ AL H
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323
Query: 396 PWIRNYNNVKVP 407
W+ + N +
Sbjct: 324 EWLADTNIEDLR 335
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 2e-78
Identities = 81/307 (26%), Positives = 126/307 (41%), Gaps = 32/307 (10%)
Query: 104 STKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD- 162
TK P P + + + +G +G+G FG G
Sbjct: 3 LTKPLQGPPAPPGTPTPPPGGKDR--EAFEAEYRLGPLLGKGGFG-----TVFAGHRLTD 55
Query: 163 -QKVAIKVIPKSKMTTAIAVED---VRREVKILRALS---GHSNLVKFYDAFEDLDNVYI 215
+VAIKVIP++++ + D EV +L + GH +++ D FE + +
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115
Query: 216 VMEL-CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS 274
V+E +L D I + G E ++ Q++ + CH GVVHRD+K EN L
Sbjct: 116 VLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL 174
Query: 275 KDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSY-GTEADVWSIGVIAYI 332
K IDFG + DE D G+ Y PE + Y A VWS+G++ Y
Sbjct: 175 --RRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYD 231
Query: 333 LLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQA 392
++CG PF + I A L P+ +S D ++ L P R + +
Sbjct: 232 MVCGDIPF--ERDQEILEAELH-FPAH-------VSPDCCALIRRCLAPKPSSRPSLEEI 281
Query: 393 LSHPWIR 399
L PW++
Sbjct: 282 LLDPWMQ 288
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 2e-78
Identities = 77/295 (26%), Positives = 134/295 (45%), Gaps = 45/295 (15%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKM------------------- 175
+ +E+G+G +G K +++ A+KV+ K K+
Sbjct: 16 TLKDEIGKGSYG-----VVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 176 ----TTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL--DNVYIVMELCEGGELLDRI 229
+E V +E+ IL+ L H N+VK + +D D++Y+V EL G +++
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 230 LSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289
SED+A+ ++ + + H ++HRD+KP N L E +K DFG+S
Sbjct: 130 --TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVS 184
Query: 290 -DFVRPDERLNDIVGSAYYVAPEVL---HRSY-GTEADVWSIGVIAYILLCGSRPFWART 344
+F D L++ VG+ ++APE L + + G DVW++GV Y + G PF
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 345 ESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
+ + F D P ++ D KD + +L+K+P R+ + HPW+
Sbjct: 245 IMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 6e-78
Identities = 86/271 (31%), Positives = 134/271 (49%), Gaps = 22/271 (8%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+ +++G G+FG + K + VA+K I + E+V+RE+ R+L
Sbjct: 23 DFVKDIGSGNFG-----VARLMRDKLTKELVAVKYIERGA----AIDENVQREIINHRSL 73
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H N+V+F + ++ I+ME GGEL +RI + G++SEDEA+ Q+L+ V++
Sbjct: 74 R-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSY 131
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 313
CH + HRDLK EN L + +LK DFG S + VG+ Y+APEVL
Sbjct: 132 CHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 314 HRSY-GTEADVWSIGVIAYILLCGSRPFWARTESGIFR----AVLKADPSFDDGSWPSLS 368
+ Y G ADVWS GV Y++L G+ PF E +R +L S D +S
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--IS 248
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
+ + + DP R++ + +H W
Sbjct: 249 PECCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 6e-78
Identities = 74/324 (22%), Positives = 116/324 (35%), Gaps = 27/324 (8%)
Query: 81 PMRVFRMPPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGE 140
V + L+ R+ + + A E F + +
Sbjct: 8 SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS----FQRLS 63
Query: 141 EVGRGHFG--YTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+G G +G + K K+ + A+K EV +
Sbjct: 64 RLGHGSYGEVF-------KVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQ 115
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H V+ A+E+ +Y+ ELC G L + E + L L +A H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS 316
G+VH D+KP N + K DFGL + G Y+APE+L S
Sbjct: 175 SQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS 231
Query: 317 YGTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFV 375
YGT ADV+S+G+ + C P + + L P F LSS+ + +
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--PEF----TAGLSSELRSVL 285
Query: 376 KLLLNKDPRKRMTAAQALSHPWIR 399
++L DP+ R TA L+ P +R
Sbjct: 286 VMMLEPDPKLRATAEALLALPVLR 309
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 6e-78
Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 22/271 (8%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
++ + +G G +G + ++ + VA+K++ + E++++E+ I + L
Sbjct: 10 DLVQTLGEGAYG-----EVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKML 62
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
+ H N+VKFY + + Y+ +E C GGEL DRI E +A+ Q++ V +
Sbjct: 63 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVY 120
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP---DERLNDIVGSAYYVAPE 311
H G+ HRD+KPEN L DE LK DFGL+ R + LN + G+ YVAPE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 312 VL-HRSY-GTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDDGSWPSLS 368
+L R + DVWS G++ +L G P+ ++S + + + W +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKID 235
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
S + +L ++P R+T W
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 1e-75
Identities = 80/279 (28%), Positives = 129/279 (46%), Gaps = 23/279 (8%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
EV +G G +G R K + + K + MT A + + EV +LR L
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLRELK- 63
Query: 197 HSNLVKFYDAFEDLDN--VYIVMELCEGGELLDRI--LSRCGKY-SEDEAKAVLVQILNV 251
H N+V++YD D N +YIVME CEGG+L I ++ +Y E+ V+ Q+
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 252 VAFCH-----LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL-NDIVGSA 305
+ CH H V+HRDLKP N K +K DFGL+ + D VG+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQ---NVKLGDFGLARILNHDTSFAKTFVGTP 180
Query: 306 YYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364
YY++PE + SY ++D+WS+G + Y L PF A ++ + + + +
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
S + + + +LN R + + L +P I +++
Sbjct: 241 ---SDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-73
Identities = 52/358 (14%), Positives = 108/358 (30%), Gaps = 67/358 (18%)
Query: 92 AKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSR---LEVGEEVGRGHFG 148
I R S SA + + + F E+ R L G +G+
Sbjct: 28 FNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPY 87
Query: 149 YTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL------------ 194
Y + ++ + + V ++ + A++ ++ EV LR L
Sbjct: 88 -----AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 195 ------------SGHSNLVKFYDAFEDLD--NVYIVMELCEG-----GELLDRILSRCGK 235
+++ D+ + + + + GE+L S
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 236 YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295
+ +Q++ ++A H +G+VH L+P + + D+ + F D
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHL---VRD 256
Query: 296 ERLNDIVGSAYYVAPEVLHRS------------YGTEADVWSIGVIAYILLCGSRPFWAR 343
S + PE+ R D W++G++ Y + C P
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316
Query: 344 TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
G + + S ++ + ++ L R+ QA+ P
Sbjct: 317 AALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-73
Identities = 72/289 (24%), Positives = 128/289 (44%), Gaps = 31/289 (10%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVED-VRREVKILRA 193
+G+ +G G +G + K+ + + A+K++ K K+ E V++E+++LR
Sbjct: 8 LMGDLLGEGSYG-----KVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 194 LSGHSNLVKFYD--AFEDLDNVYIVMELCEGG--ELLDRILSRCGKYSEDEAKAVLVQIL 249
L H N+++ D E+ +Y+VME C G E+LD + ++ +A Q++
Sbjct: 63 LR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLI 119
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS---DFVRPDERLNDIVGSAY 306
+ + + H G+VH+D+KP N L LK G++ D+ GS
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 307 YVAPEVL--HRSY-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363
+ PE+ ++ G + D+WS GV Y + G PF +F + K +
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI---- 232
Query: 364 WPS-LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR-NYNNVKVPLDI 410
P D +K +L +P KR + Q H W R + + P+ I
Sbjct: 233 -PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPI 280
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 7e-73
Identities = 71/271 (26%), Positives = 127/271 (46%), Gaps = 20/271 (7%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHK--DQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+++G G FG A + ++ IK I S+M++ E+ RREV +L +
Sbjct: 27 VRLQKIGEGSFG---KAI--LVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANM 80
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY-SEDEAKAVLVQILNVVA 253
H N+V++ ++FE+ ++YIVM+ CEGG+L RI ++ G ED+ VQI +
Sbjct: 81 K-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 312
H ++HRD+K +N T ++ DFG++ E +G+ YY++PE+
Sbjct: 140 HVHDRKILHRDIKSQNIFLTKDG---TVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 313 L-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSD 370
++ Y ++D+W++G + Y L F A + + ++ S D
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP----PVSLHYSYD 252
Query: 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
+ V L ++PR R + L +I
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 5e-71
Identities = 75/300 (25%), Positives = 123/300 (41%), Gaps = 52/300 (17%)
Query: 122 LDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHK--DQKVAIKVIPKSKMTTAI 179
+DKRFG + E +G G FG K +H+ + IK + +
Sbjct: 5 VDKRFG------MDFKEIELIGSGGFG---QVF--KAKHRIDGKTYVIKRVKYNN----- 48
Query: 180 AVEDVRREVKILRALSGHSNLVKFYDAFEDLD----------------NVYIVMELCEGG 223
E REVK L L H N+V + ++ D ++I ME C+ G
Sbjct: 49 --EKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKG 105
Query: 224 ELLDRILSRCGKY-SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPEN-FLYTSKDESSQL 281
L I R G+ + A + QI V + H +++RDLKP N FL ++ Q+
Sbjct: 106 TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL----VDTKQV 161
Query: 282 KAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPF 340
K DFGL ++ D + G+ Y++PE + + YG E D++++G+I LL
Sbjct: 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 341 WARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
+ ++ F + S K ++ LL+K P R ++ L +
Sbjct: 222 FETSK--FFTDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 6e-66
Identities = 57/285 (20%), Positives = 96/285 (33%), Gaps = 32/285 (11%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+++G G F Y A+K I + E+ +RE + R
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHD---GHFYALKRILCHEQQ---DREEAQREADMHRLF 83
Query: 195 SGHSNLVKFYDAFEDLDN----VYIVMELCEGGELLDRI---LSRCGKYSEDEAKAVLVQ 247
H N+++ ++++ + G L + I + +ED+ +L+
Sbjct: 84 -NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 248 ILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD----------ER 297
I + H G HRDLKP N L + Q +D G + +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEG---QPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 298 LNDIVGSAYYVAPEVL----HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 353
+ Y APE+ H DVWS+G + Y ++ G P+ + G A L
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-L 258
Query: 354 KADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
P SS + ++ DP +R LS
Sbjct: 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 8e-65
Identities = 71/309 (22%), Positives = 133/309 (43%), Gaps = 27/309 (8%)
Query: 105 TKKSSAEEGAPE-EAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD- 162
++S +G P + P+ R + + +++GRG F +
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFS---EVY--RAACLLD 56
Query: 163 -QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221
VA+K + + A A D +E+ +L+ L+ H N++K+Y +F + + + IV+EL +
Sbjct: 57 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELAD 115
Query: 222 GGELLDRI--LSRCGKY-SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPEN-FLYTSKDE 277
G+L I + + E VQ+ + + H V+HRD+KP N F+
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI----TA 171
Query: 278 SSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLC 335
+ +K D GL F + +VG+ YY++PE + Y ++D+WS+G + Y +
Sbjct: 172 TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 336 GSRPFWARTES--GIFRAVLKADPSFDDGSWPS--LSSDAKDFVKLLLNKDPRKRMTAAQ 391
PF+ + + + + + D PS S + + V + +N DP KR
Sbjct: 232 LQSPFYGDKMNLYSLCKKIEQCDYP----PLPSDHYSEELRQLVNMCINPDPEKRPDVTY 287
Query: 392 ALSHPWIRN 400
+
Sbjct: 288 VYDVAKRMH 296
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 6e-64
Identities = 78/299 (26%), Positives = 123/299 (41%), Gaps = 52/299 (17%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E + +GRG FG A+ K D AIK I A E V REVK L L
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVD---DCNYAIKRIRLPNRELAR--EKVMREVKALAKLE- 61
Query: 197 HSNLVKFYDAFEDLDN------------VYIVMELCEGGELLDRILSRCGKYSEDEAKA- 243
H +V++++A+ + + +YI M+LC L D + RC + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 244 -VLVQILNVVAFCHLHGVVHRDLKPEN-FLYTSKDESSQLKAIDFGLS------------ 289
+ +QI V F H G++HRDLKP N F +K DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFF----TMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 290 -DFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESG 347
+ R VG+ Y++PE +H SY + D++S+G+I + LL PF + E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234
Query: 348 IFRAVLKADPSFDDGSWPSL----SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402
++ + +P L V+ +L+ P +R A + + + +
Sbjct: 235 RTLTDVR------NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-62
Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 44/297 (14%)
Query: 133 TSRLEVGEEVGRGHFG--YTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREV 188
T+ E++G G FG + K + AIK K + ++ REV
Sbjct: 10 TTEFHELEKIGSGEFGSVF-------KCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREV 61
Query: 189 KILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY---SEDEAKAVL 245
L HS++V+++ A+ + D++ I E C GG L D I E E K +L
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI----------------DFGLS 289
+Q+ + + H +VH D+KP N + + D G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH- 180
Query: 290 DFVRPDERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESG 347
V G + ++A EVL ++ +AD++++ + G+ P +
Sbjct: 181 --VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRNGDQ- 236
Query: 348 IFRAVLKAD-PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
+ + + P LS + + +K++++ DP +R +A + H + + +
Sbjct: 237 -WHEIRQGRLPRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-60
Identities = 54/355 (15%), Positives = 105/355 (29%), Gaps = 64/355 (18%)
Query: 92 AKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSR---LEVGEEVGRGHFG 148
I R S SA + + + F E+ R L G +G+
Sbjct: 33 FNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPY 92
Query: 149 YTCTARYKKGEHK--DQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG---------- 196
Y + + + + V ++ + A++ ++ EV LR L G
Sbjct: 93 -----AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 197 -----------HSNLVKFYDAFEDLD-----NVYIVMELCEG-----GELLDRILSRCGK 235
K D + + + + GE+L S
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 236 YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295
+ +Q++ ++A H +G+VH L+P + + D+ + F VR
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHL--VRDG 262
Query: 296 ERLNDIVGSAY----YVAPEVLHRS------YGTEADVWSIGVIAYILLCGSRPFWARTE 345
+G + A +L D W++G+ Y + C P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
Query: 346 SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
G + + S ++ + ++ L R+ QA+ P
Sbjct: 323 LGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-59
Identities = 66/307 (21%), Positives = 121/307 (39%), Gaps = 46/307 (14%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
RL V + G F + A+ ++ A+K + ++ + +EV ++ L
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGS---GREYALKRLLSNEEE---KNRAIIQEVCFMKKL 82
Query: 195 SGHSNLVKFYDAF----EDLDN----VYIVMELCEGGELLDRILSRC--GKYSEDEAKAV 244
SGH N+V+F A E+ D ++ ELC+G L++ + G S D +
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCDTVLKI 141
Query: 245 LVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD------- 295
Q V H ++HRDLK EN L +++ +K DFG + +
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG---TIKLCDFGSATTISHYPDYSWSA 198
Query: 296 ------ERLNDIVGSAYYVAPEVL----HRSYGTEADVWSIGVIAYILLCGSRPFWARTE 345
E + Y PE++ + G + D+W++G I Y+L PF E
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----E 254
Query: 346 SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW-IRNYNNV 404
G ++ + + + ++ +L +P +R++ A+ + I NV
Sbjct: 255 DGAKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312
Query: 405 KVPLDIS 411
I+
Sbjct: 313 NPKSPIT 319
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-59
Identities = 57/334 (17%), Positives = 112/334 (33%), Gaps = 33/334 (9%)
Query: 89 PSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFG 148
P K I +L S + P + + F + + + V +G G F
Sbjct: 21 PWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEF-QLGSKLVYVHHLLGEGAFA 79
Query: 149 --YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDA 206
Y T QK +KV + + ++ L+ +KFY A
Sbjct: 80 QVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSM-QHMFMKFYSA 135
Query: 207 FEDLDNVYIVMELCEGGELLDRILSR----CGKYSEDEAKAVLVQILNVVAFCHLHGVVH 262
+ +V EL G LL+ I + + +++L ++ H ++H
Sbjct: 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIH 195
Query: 263 RDLKPENFLYTSK--------DESSQLKAIDFGLSDFVR---PDERLNDIVGSAYYVAPE 311
D+KP+NF+ + D S+ L ID G S ++ ++ + E
Sbjct: 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255
Query: 312 VL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDDGSWPSLSS 369
+L ++ + + D + + Y +L G+ + + P D W
Sbjct: 256 MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDM--W----- 308
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
+F ++LN + + L + +
Sbjct: 309 --NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-56
Identities = 85/308 (27%), Positives = 137/308 (44%), Gaps = 27/308 (8%)
Query: 108 SSAEEGAPEEAAPELDKRFGFSKEVTSR-LEVGEEVGRGHFGYTCTARYKKGEHKDQKVA 166
+A E P + + + ++ + G+ +G G F AR ++ A
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLAREL---ATSREYA 59
Query: 167 IKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELL 226
IK++ K + V V RE ++ L H VK Y F+D + +Y + + GELL
Sbjct: 60 IKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 227 DRILSRCGKYSEDEAKAVLVQILNVVAFCHLH--GVVHRDLKPENFLYTSKDESSQLKAI 284
+ + G + E + +I V A +LH G++HRDLKPEN L +E ++
Sbjct: 119 KY-IRKIGSFDETCTRFYTAEI--VSALEYLHGKGIIHRDLKPENILL---NEDMHIQIT 172
Query: 285 DFGLS---DFVRPDERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPF 340
DFG + R N VG+A YV+PE+L +D+W++G I Y L+ G PF
Sbjct: 173 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232
Query: 341 WARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQA------LS 394
A E IF+ ++K + F A+D V+ LL D KR+ + +
Sbjct: 233 RAGNEYLIFQKIIKLEYDF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 288
Query: 395 HPWIRNYN 402
HP+ +
Sbjct: 289 HPFFESVT 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-56
Identities = 76/343 (22%), Positives = 125/343 (36%), Gaps = 44/343 (12%)
Query: 71 SGSKKGGNLTPMRVFRMPPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSK 130
SGS G + S AK + + E+ +L +
Sbjct: 2 SGSVSSGQAHSL------ASLAKTWSS-GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYR 54
Query: 131 EVTSRLEVGEEVGRGHFG--YTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVR- 185
E + VGRG FG + + + K + A+K + +E R
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVH-------RMKDKQTGFQCAVKKVR---------LEVFRV 98
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
E+ LS +V Y A + V I MEL EGG L ++ + G ED A L
Sbjct: 99 EELVACAGLS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYL 156
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS------DFVRPDERLN 299
Q L + + H ++H D+K +N L +S S+ DFG + + +
Sbjct: 157 GQALEGLEYLHTRRILHGDVKADNVLLSSD--GSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 300 DIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESG--IFRAVLKAD 356
I G+ ++APEV+ + D+WS + +L G P W + G + +
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEPP 273
Query: 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
P + PS + ++ L K+P R +A +
Sbjct: 274 PIREIP--PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-55
Identities = 74/282 (26%), Positives = 124/282 (43%), Gaps = 30/282 (10%)
Query: 139 GEEVGRGHFG--YTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+G+G +G Y G ++AIK IP+ + + E+ + + L
Sbjct: 27 RVVLGKGTYGIVY-------AGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHL 76
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEA--KAVLVQILNVV 252
H N+V++ +F + + I ME GG L + S+ G ++E QIL +
Sbjct: 77 K-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPE 311
+ H + +VHRD+K +N L + LK DFG S + G+ Y+APE
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYS--GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
Query: 312 VLH---RSYGTEADVWSIGVIAYILLCGSRPFWARTE--SGIFR-AVLKADPSFDDGSWP 365
++ R YG AD+WS+G + G PF+ E + +F+ + K P +
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE---- 249
Query: 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVP 407
S+S++AK F+ DP KR A L +++ + K
Sbjct: 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT 291
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-54
Identities = 70/272 (25%), Positives = 134/272 (49%), Gaps = 26/272 (9%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKV-AIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
+G+G FG C + +K+ A+K + K K V +V +E++I++ L H L
Sbjct: 23 IGKGSFGKVCIVQKND----TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFL 77
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-- 258
V + +F+D +++++V++L GG+L L + + E+ K + ++ V+A +L
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVHFKEETVKLFICEL--VMALDYLQNQ 134
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-- 316
++HRD+KP+N L DE + DF ++ + + ++ + G+ Y+APE+
Sbjct: 135 RIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 317 --YGTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDDGSWPSLSSDA 371
Y D WS+GV AY LL G RP+ R+ + I ++ + S +
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEM 247
Query: 372 KDFVKLLLNKDPRKRMTAAQAL-SHPWIRNYN 402
+K LL +P +R + + + P++ + N
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 90/313 (28%), Positives = 151/313 (48%), Gaps = 30/313 (9%)
Query: 102 RKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRL---EVGEEVGRGHFGYTCTARYKKG 158
+K +++ S +E +A + K++ + T++L + + +G G FG ++K
Sbjct: 7 KKGSEQESVKEFL-AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK-- 63
Query: 159 EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVME 218
A+K++ K K+ +E E +IL+A++ LVK +F+D N+Y+VME
Sbjct: 64 -ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVME 121
Query: 219 LCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH--GVVHRDLKPENFLYTSKD 276
GGE+ L R G++SE A+ QI V+ F +LH +++RDLKPEN L D
Sbjct: 122 YVAGGEMF-SHLRRIGRFSEPHARFYAAQI--VLTFEYLHSLDLIYRDLKPENLLI---D 175
Query: 277 ESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLC 335
+ ++ DFG + V R + G+ +APE++ Y D W++GV+ Y +
Sbjct: 176 QQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 336 GSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSDAKDFVKLLLNKDPRKRMTAAQA-- 392
G PF+A I+ ++ F PS SSD KD ++ LL D KR +
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGV 288
Query: 393 ---LSHPWIRNYN 402
+H W +
Sbjct: 289 NDIKNHKWFATTD 301
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-51
Identities = 69/312 (22%), Positives = 124/312 (39%), Gaps = 37/312 (11%)
Query: 102 RKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFG--YTCTARYKKGE 159
++ + + E A + F K E+GRG F Y KG
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLK-------FDIEIGRGSFKTVY-------KGL 46
Query: 160 HKD--QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL----DNV 213
+ +VA + K+T + + + E ++L+ L H N+V+FYD++E +
Sbjct: 47 DTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCI 104
Query: 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFL 271
+V EL G L L R ++ QIL + F H ++HRDLK +N
Sbjct: 105 VLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163
Query: 272 YTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAY 331
T +K D GL+ R ++G+ ++APE+ Y DV++ G+
Sbjct: 164 ITGPT--GSVKIGDLGLATLKRASFA-KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 220
Query: 332 ILLCGSRPFWARTESG-IFRAVLKADP--SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMT 388
+ P+ + I+R V SFD + K+ ++ + ++ +R +
Sbjct: 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV----AIPEVKEIIEGCIRQNKDERYS 276
Query: 389 AAQALSHPWIRN 400
L+H + +
Sbjct: 277 IKDLLNHAFFQE 288
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-51
Identities = 84/305 (27%), Positives = 143/305 (46%), Gaps = 39/305 (12%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E+ E VG G +G R+ K Q AIKV+ T E++++E+ +L+ S
Sbjct: 27 ELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 197 HSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRI-LSRCGKYSEDEAKAVLVQIL 249
H N+ +Y AF D +++VME C G + D I ++ E+ + +IL
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYV 308
++ H H V+HRD+K +N L T E++++K +DFG+S R R N +G+ Y++
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 309 APEVLHR------SYGTEADVWSIGVIAYIL------LCGSRPFWARTESGIFRAVLKAD 356
APEV+ +Y ++D+WS+G+ A + LC P A +F
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIPRNPA 251
Query: 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLM 416
P W S + F++ L K+ +R Q + HP+IR+ N + + I + +
Sbjct: 252 PRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER-QVRIQLKDHI 307
Query: 417 KAYMQ 421
+
Sbjct: 308 DRTKK 312
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-50
Identities = 78/324 (24%), Positives = 125/324 (38%), Gaps = 29/324 (8%)
Query: 89 PSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKR----FGFSKEVTSRLEVGEEVGR 144
H + + + + A L F + E+G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 145 GHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFY 204
G FG AR + + VAIK + S + +D+ +EV+ L+ L H N +++
Sbjct: 65 GSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYR 120
Query: 205 DAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRD 264
+ ++VME C G D + E E AV L +A+ H H ++HRD
Sbjct: 121 GCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 265 LKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS----YGTE 320
+K N L + E +K DFG + + N VG+ Y++APEV+ Y +
Sbjct: 180 VKAGNILLS---EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 321 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDDGSWPSLSSDAKDFVK 376
DVWS+G+ L P + A+ P+ G W S ++FV
Sbjct: 234 VDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSGHW---SEYFRNFVD 287
Query: 377 LLLNKDPRKRMTAAQALSHPWIRN 400
L K P+ R T+ L H ++
Sbjct: 288 SCLQKIPQDRPTSEVLLKHRFVLR 311
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 3e-50
Identities = 79/264 (29%), Positives = 124/264 (46%), Gaps = 14/264 (5%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG A +K +Q AIK + K + VE E ++L H L
Sbjct: 25 LGKGSFGKVFLAEFK---KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ F+ +N++ VME GG+L+ I C K+ A +I+ + F H G+V
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYGT 319
+RDLK +N L D+ +K DFG+ + + D + N G+ Y+APE+L Y
Sbjct: 141 YRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 197
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D WS GV+ Y +L G PF + E +F ++ +P + L +AKD + L
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLLVKLF 253
Query: 380 NKDPRKRMTAAQAL-SHPWIRNYN 402
++P KR+ + HP R N
Sbjct: 254 VREPEKRLGVRGDIRQHPLFREIN 277
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-50
Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 24/269 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G G FG R + H + A+KV+ K + VE E +L ++ H ++
Sbjct: 14 LGTGSFGRVHLIRSR---HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFII 69
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH--G 259
+ + F+D ++++M+ EGGEL L + ++ AK ++ +A +LH
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEV--CLALEYLHSKD 126
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YG 318
+++RDLKPEN L D++ +K DFG + +V + + G+ Y+APEV+ Y
Sbjct: 127 IIYRDLKPENILL---DKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYN 181
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
D WS G++ Y +L G PF+ + +L A+ F P + D KD + L
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSRL 237
Query: 379 LNKDPRKRM-----TAAQALSHPWIRNYN 402
+ +D +R+ +HPW +
Sbjct: 238 ITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-50
Identities = 82/306 (26%), Positives = 138/306 (45%), Gaps = 27/306 (8%)
Query: 114 APEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKS 173
A L + E++G+G FG + + VAIK+I
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLE 58
Query: 174 KMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC 233
+ I ED+++E+ +L + K+Y ++ ++I+ME GG LD L
Sbjct: 59 EAEDEI--EDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEP 113
Query: 234 GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFV 292
G E + +L +IL + + H +HRD+K N L + E ++K DFG++
Sbjct: 114 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLT 170
Query: 293 RPDERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 351
+ N VG+ +++APEV+ +S Y ++AD+WS+G+ A L G P E +
Sbjct: 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS---ELHPMKV 227
Query: 352 VL---KADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPL 408
+ K +P +G++ S K+FV+ LNK+P R TA + L H +I +
Sbjct: 228 LFLIPKNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFIL-----RNAK 279
Query: 409 DISILK 414
S L
Sbjct: 280 KTSYLT 285
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-50
Identities = 82/307 (26%), Positives = 130/307 (42%), Gaps = 51/307 (16%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-----TAIAVEDVRREVKIL 191
E ++G G +G R + Q VAIK +S+ A+ RE+++L
Sbjct: 6 EKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESEDDPVIKKIAL------REIRML 56
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNV 251
+ L H NLV + F +++V E C+ +L + E K++ Q L
Sbjct: 57 KQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQA 114
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAP 310
V FCH H +HRD+KPEN L T +K DFG + P + +D V + +Y +P
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 311 EVL--HRSYGTEADVWSIGVIAYILLCGSRPFW-ARTE----SGIFRAV----------L 353
E+L YG DVW+IG + LL G P W +++ I + +
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230
Query: 354 KADPSFDDGS-------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
+ F +P++S A +K L+ DP +R+T Q L HP+ N
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290
Query: 401 YNNVKVP 407
++
Sbjct: 291 IREIEDL 297
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-49
Identities = 79/281 (28%), Positives = 131/281 (46%), Gaps = 26/281 (9%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E+ E+G G FG A+ K+ A KVI + +ED E++IL
Sbjct: 22 EIVGELGDGAFGKVYKAKNKE---TGALAAAKVIE---TKSEEELEDYIVEIEILATCD- 74
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H +VK A+ ++I++E C GG + +L +E + + V Q+L + F H
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR 315
++HRDLK N L T ++ DFG+S ++ + +G+ Y++APEV+
Sbjct: 135 SKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 316 ------SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK----ADPSFDDGSWP 365
Y +AD+WS+G+ + P E R +LK P+ S
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSDPPTLLTPS-- 246
Query: 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKV 406
S + +DF+K+ L+K+P R +AAQ L HP++ + + K
Sbjct: 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-49
Identities = 80/286 (27%), Positives = 130/286 (45%), Gaps = 32/286 (11%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E+ E +G G A K +KVAIK I K T++ +++ +E++ +
Sbjct: 18 ELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQTSM--DELLKEIQAMSQCH- 71
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLD-------RILSRCGKYSEDEAKAVLVQIL 249
H N+V +Y +F D +++VM+L GG +LD + + G E +L ++L
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-------DFVRPDERLNDIV 302
+ + H +G +HRD+K N L E ++ DFG+S D R R V
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR-KTFV 187
Query: 303 GSAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP--- 357
G+ ++APEV+ + Y +AD+WS G+ A L G+ P+ + L+ DP
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 358 ---SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
D + + L L KDP KR TAA+ L H + +
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 70/286 (24%), Positives = 121/286 (42%), Gaps = 31/286 (10%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAV-EDVRREVKILRAL 194
LE E+GRG +G R+ Q +A+K I T + + ++ I
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPS---GQIMAVKRIR---ATVNSQEQKRLLMDLDISMRT 62
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGG--ELLDRILSRCGKYSEDEAKAVLVQILNVV 252
V FY A +V+I MEL + + +++ + ED + V I+
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK-- 120
Query: 253 AFCHLHG---VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVA 309
A HLH V+HRD+KP N L + Q+K DFG+S ++ D + G Y+A
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINAL---GQVKMCDFGISGYLVDDVAKDIDAGCKPYMA 177
Query: 310 PEVLH-----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRA----VLKADPSFD 360
PE ++ + Y ++D+WS+G+ L P+ + F+ V + P
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLP 235
Query: 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKV 406
+ S++ DF L K+ ++R T + + HP+ + +
Sbjct: 236 ADKF---SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 80/298 (26%), Positives = 151/298 (50%), Gaps = 28/298 (9%)
Query: 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
L+ ++G G G C AR K H ++VA+K++ + E + EV I+R
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREK---HSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 97
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
H N+V+ Y ++ + ++++ME +GG L D + + +E++ V +L +
Sbjct: 98 DYQ-HFNVVEMYKSYLVGEELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQAL 154
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPE 311
A+ H GV+HRD+K ++ L T ++K DFG + D + +VG+ Y++APE
Sbjct: 155 AYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211
Query: 312 VLHRS-YGTEADVWSIGVIAYILLCGSRPFW----ARTESGIFRAVLKADPSFDDGSWPS 366
V+ RS Y TE D+WS+G++ ++ G P++ + + R P +
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRDSPPPKLKNSH--K 266
Query: 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSS 424
+S +DF++ +L +DP++R TA + L HP++ + ++ L++ Y + +S
Sbjct: 267 VSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE-----CLVPLIQLYRKQTS 319
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-49
Identities = 76/300 (25%), Positives = 121/300 (40%), Gaps = 35/300 (11%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAV-EDVRREVKILRAL 194
L+ E+GRG +G +K Q +A+K I T + + ++ ++
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRIR---STVDEKEQKQLLMDLDVVMRS 77
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY-----SEDEAKAVLVQIL 249
S +V+FY A + +I MEL D+ E+ + + +
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 250 NVVAFCHLH---GVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSA 305
A HL ++HRD+KP N L +K DFG+S V + D G
Sbjct: 136 K--ALNHLKENLKIIHRDIKPSNILLDRS---GNIKLCDFGISGQLVDSIAKTRD-AGCR 189
Query: 306 YYVAPEVLH-----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRA---VLKAD- 356
Y+APE + + Y +DVWS+G+ Y L G P+ + +F V+K D
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDP 247
Query: 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLM 416
P + S +FV L L KD KR + L HP+I Y V + + K++
Sbjct: 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKIL 307
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-49
Identities = 69/268 (25%), Positives = 122/268 (45%), Gaps = 18/268 (6%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG + K D+ A+K++ K + VE E ++L L
Sbjct: 28 LGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ + F+ +D +Y VME GG+L+ I + G++ E A +I + F G++
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 143
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYGT 319
+RDLK +N + D +K DFG+ + + G+ Y+APE++ YG
Sbjct: 144 YRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D W+ GV+ Y +L G PF E +F+++++ + ++ S+S +A K L+
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLM 256
Query: 380 NKDPRKRMTAAQA-----LSHPWIRNYN 402
K P KR+ H + R +
Sbjct: 257 TKHPGKRLGCGPEGERDIKEHAFFRYID 284
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-49
Identities = 71/271 (26%), Positives = 129/271 (47%), Gaps = 17/271 (6%)
Query: 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
+ E++G+G G TA Q+VAI+ + + E + E+ ++R
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
+ N+V + D++ D +++VME GG L D + E + AV + L +
Sbjct: 73 ENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQAL 129
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPE 311
F H + V+HRD+K +N L +K DFG + P++ + + +VG+ Y++APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 312 VLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGSWPSLSS 369
V+ R YG + D+WS+G++A ++ G P+ ++ P + LS+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSA 244
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
+DF+ L D KR +A + L H +++
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 5e-49
Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 19/269 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG AR K A+KV+ K + VE E +IL H L
Sbjct: 31 LGKGSFGKVMLARVK---ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ + F+ D ++ VME GG+L+ I + ++ E A+ +I++ + F H G++
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEIISALMFLHDKGII 146
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYGT 319
+RDLK +N L D K DFG+ + + G+ Y+APE+L YG
Sbjct: 147 YRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D W++GV+ Y +LCG PF A E +F A+L + + L DA +K +
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGILKSFM 259
Query: 380 NKDPRKRM-----TAAQAL-SHPWIRNYN 402
K+P R+ A+ HP+ + +
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKEID 288
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-49
Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 20/271 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG FG R+K + A+K++ K +M E I+ A + +V
Sbjct: 77 IGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVV 132
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ + AF+D +Y+VME GG+L+ ++S E A+ +++ + H G +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLV-NLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVL-----H 314
HRD+KP+N L D+S LK DFG + + R + VG+ Y++PEVL
Sbjct: 191 HRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 315 RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
YG E D WS+GV Y +L G PF+A + G + ++ S +S +AK+
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 375 VKLLLNKDPRKRMTAAQAL---SHPWIRNYN 402
+ L D R+ H + +N
Sbjct: 308 ICAFL-TDREVRLGRNGVEEIKRHLFFKNDQ 337
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-48
Identities = 78/300 (26%), Positives = 124/300 (41%), Gaps = 34/300 (11%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
LE E+G G G R++K +A+K + +S + + ++ ++
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKT---GHVIAVKQMRRSGNKEEN--KRILMDLDVVLKSH 81
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255
+V+ + F +V+I MEL G E + V I+ + +
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTC-AEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 256 H-LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 313
HGV+HRD+KP N L + Q+K DFG+S + D+ + G A Y+APE +
Sbjct: 141 KEKHGVIHRDVKPSNILLDER---GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID 197
Query: 314 -----HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFR---AVLKADPSFDDGSWP 365
Y ADVWS+G+ L G P+ + F VL+ +P P
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEP-------P 248
Query: 366 SL------SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAY 419
L S D + FVK L KD RKR + L H +I+ Y ++V + +M
Sbjct: 249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKT 308
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 82/297 (27%), Positives = 138/297 (46%), Gaps = 28/297 (9%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+V E++G G +G A +K+ Q VAIK +P ++++ +E+ I++
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQCD- 82
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
++VK+Y ++ +++IVME C G + D I R +EDE +L L + + H
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR 315
+HRD+K N L K DFG++ + N ++G+ +++APEV+
Sbjct: 143 FMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 316 S-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDDGSWPSLSSD 370
Y AD+WS+G+ A + G P+ + RA+ P+F S +
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMIPTNPPPTFRKPEL--WSDN 254
Query: 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRR 427
DFVK L K P +R TA Q L HP++R+ V + L+ M R+
Sbjct: 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS-----ILRDLINEAMDVKLKRQ 306
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-48
Identities = 78/276 (28%), Positives = 127/276 (46%), Gaps = 24/276 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG F + K Q A+K++ K M V R E +L +
Sbjct: 69 IGRGAFSEVAVVKMK---QTGQVYAMKIMNKWDMLKRGEVSCFREERDVL-VNGDRRWIT 124
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLHGV 260
+ + AF+D + +Y+VME GG+LL +LS+ G + + A+ L +I+ + H G
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY 183
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLHR--- 315
VHRD+KP+N L D ++ DFG +R D R VG+ Y++PE+L
Sbjct: 184 VHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 316 -----SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSS 369
SYG E D W++GV AY + G PF+A + + + ++ +
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 370 DAKDFVKLLLNKDPRKRMTAAQAL---SHPWIRNYN 402
+A+DF++ LL P R+ A +HP+ +
Sbjct: 301 EARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 9e-48
Identities = 82/297 (27%), Positives = 119/297 (40%), Gaps = 51/297 (17%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-----TAIAVEDVRREVKIL 191
E VG G +G R K + VAIK +S A+ RE+K+L
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDDDKMVKKIAM------REIKLL 78
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNV 251
+ L H NLV + + Y+V E + +LD + + L QI+N
Sbjct: 79 KQLR-HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAP 310
+ FCH H ++HRD+KPEN L +S +K DFG + P E +D V + +Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
Query: 311 EVL--HRSYGTEADVWSIGVIAYILLCGSRPFW-ARTE----SGIFRAV----------L 353
E+L YG DVW+IG + + G P + ++ I +
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252
Query: 354 KADPSFDDGSWP-------------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
+P F P LS D K L+ DP KR A+ L H +
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 76/269 (28%), Positives = 126/269 (46%), Gaps = 17/269 (6%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAI-AVEDVRREVKILRALSGHSNL 200
+G+G +G R G + + A+KV+ K+ + + E IL + H +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFI 83
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
V AF+ +Y+++E GGEL + L R G + ED A L +I + H G+
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YG 318
++RDLKPEN + + +K DFGL + + + G+ Y+APE+L RS +
Sbjct: 143 IYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378
D WS+G + Y +L G+ PF +LK + P L+ +A+D +K L
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARDLLKKL 255
Query: 379 LNKDPRKRMTAAQA-----LSHPWIRNYN 402
L ++ R+ A +HP+ R+ N
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFRHIN 284
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-47
Identities = 69/268 (25%), Positives = 122/268 (45%), Gaps = 18/268 (6%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG + K D+ A+K++ K + VE E ++L L
Sbjct: 349 LGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ + F+ +D +Y VME GG+L+ I + G++ E A +I + F G++
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 464
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYGT 319
+RDLK +N + D +K DFG+ + + G+ Y+APE++ YG
Sbjct: 465 YRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D W+ GV+ Y +L G PF E +F+++++ + ++ S+S +A K L+
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLM 577
Query: 380 NKDPRKRMTAAQA-----LSHPWIRNYN 402
K P KR+ H + R +
Sbjct: 578 TKHPGKRLGCGPEGERDIKEHAFFRYID 605
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 19/268 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG R K + A+K++ K + V E ++L + H L
Sbjct: 13 LGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 68
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
AF+ D + VME GGEL LSR ++E+ A+ +I++ + + H VV
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYGT 319
+RD+K EN + D+ +K DFGL + + + G+ Y+APEVL YG
Sbjct: 128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D W +GV+ Y ++CG PF+ + +F +L + F +LS +AK + LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLL 240
Query: 380 NKDPRKRMTAAQA-----LSHPWIRNYN 402
KDP++R+ + + H + + N
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-47
Identities = 64/317 (20%), Positives = 121/317 (38%), Gaps = 55/317 (17%)
Query: 126 FGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVR 185
++ ++GRG + A ++KV +K++ K
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKKKKIK------ 78
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDN---VYIVMELCEGGELLDRILSRCGKYSEDEAK 242
RE+KIL L G N++ D +D + + + ++ ++ + +
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQ---TLTDYDIR 133
Query: 243 AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV 302
+ +IL + +CH G++HRD+KP N + + +L+ ID+GL++F P + N V
Sbjct: 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHPGQEYNVRV 191
Query: 303 GSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPF-------------------- 340
S Y+ PE+L ++ Y D+WS+G + ++ PF
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251
Query: 341 -----WARTESGIFRAVLKADPSFDDGSW---------PSLSSDAKDFVKLLLNKDPRKR 386
+ + W +S +A DF+ LL D + R
Sbjct: 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311
Query: 387 MTAAQALSHPWIRNYNN 403
+TA +A+ HP+
Sbjct: 312 LTAREAMEHPYFYTVVK 328
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG FG + K + D+ A+K++ K +M R E +L +
Sbjct: 82 IGRGAFGEVAVVKLK---NADKVFAMKILNKWEMLKRAETACFREERDVL-VNGDSKWIT 137
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH--G 259
+ AF+D +N+Y+VM+ GG+LL + + E+ A+ L ++ V+A +H
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM--VIAIDSVHQLH 195
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVL---- 313
VHRD+KP+N L D + ++ DFG + D + + VG+ Y++PE+L
Sbjct: 196 YVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 314 --HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS-LSSD 370
YG E D WS+GV Y +L G PF+A + + ++ F + + +S +
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSEN 312
Query: 371 AKDFVKLLLNKDPRKRMTAAQAL---SHPWIRNYN 402
AKD ++ L+ R+ HP+ +
Sbjct: 313 AKDLIRRLICSRE-HRLGQNGIEDFKKHPFFSGID 346
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 77/270 (28%), Positives = 135/270 (50%), Gaps = 21/270 (7%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG + G Q A+KV+ K+ + V + E IL ++ H +V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN-HPFIV 89
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH--G 259
K + AF+ +Y++++ GG+L R LS+ ++E++ K L ++ +A HLH G
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAEL--ALALDHLHSLG 146
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-Y 317
+++RDLKPEN L DE +K DFGLS + + +++ G+ Y+APEV++R +
Sbjct: 147 IIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 318 GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKL 377
AD WS GV+ + +L G+ PF + +LKA LS +A+ +++
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRM 259
Query: 378 LLNKDPRKRM-----TAAQALSHPWIRNYN 402
L ++P R+ + H + +
Sbjct: 260 LFKRNPANRLGAGPDGVEEIKRHSFFSTID 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 65/306 (21%), Positives = 107/306 (34%), Gaps = 40/306 (13%)
Query: 124 KRFGFSKEVTSRLEVGEEVG-----------RGHFGYTCTARYKKGEHKDQKVAIKVIPK 172
KR +R +V EV R + T K E D+
Sbjct: 37 KRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTD 96
Query: 173 SKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR 232
+++ ++ +++ + S N V +YI M+LC L D + R
Sbjct: 97 WPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 233 CGKYSEDEAKA--VLVQILNVVAFCHLHGVVHRDLKPEN-FLYTSKDESSQLKAIDFGLS 289
C + + +QI V F H G++HRDLKP N F +K DFGL
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF----TMDDVVKVGDFGLV 211
Query: 290 -------------DFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC 335
+ VG+ Y++PE +H +Y + D++S+G+I + LL
Sbjct: 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
Query: 336 GSRPFWARTE-SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394
F + E I V + V+ +L+ P +R A +
Sbjct: 272 ---SFSTQMERVRIITDVRNLKFPLL---FTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
Query: 395 HPWIRN 400
+ N
Sbjct: 326 NAIFEN 331
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-47
Identities = 76/278 (27%), Positives = 130/278 (46%), Gaps = 28/278 (10%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG + R K D+ A+KV+ K + ++ V+ E + S H LV
Sbjct: 17 IGRGSYAKVLLVRLK---KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ F+ ++ V+E GG+L+ + R K E+ A+ +I + + H G++
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 132
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYGT 319
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L YG
Sbjct: 133 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 189
Query: 320 EADVWSIGVIAYILLCGSRPFW---------ARTESGIFRAVLKADPSFDDGSWPSLSSD 370
D W++GV+ + ++ G PF TE +F+ +L+ SLS
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVK 245
Query: 371 AKDFVKLLLNKDPRKRM-----TAAQAL-SHPWIRNYN 402
A +K LNKDP++R+ T + HP+ RN +
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-46
Identities = 74/267 (27%), Positives = 126/267 (47%), Gaps = 17/267 (6%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG AR+K ++ A+KV+ K + + + E +L H LV
Sbjct: 46 IGKGSFGKVLLARHK---AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ +F+ D +Y V++ GGEL L R + E A+ +I + + + H +V
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YGT 319
+RDLKPEN L D + DFGL + + + + G+ Y+APEVLH+ Y
Sbjct: 162 YRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 320 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLL 379
D W +G + Y +L G PF++R + ++ +L P++++ A+ ++ LL
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLL 274
Query: 380 NKDPRKRM----TAAQALSHPWIRNYN 402
KD KR+ + SH + N
Sbjct: 275 QKDRTKRLGAKDDFMEIKSHVFFSLIN 301
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-46
Identities = 80/271 (29%), Positives = 125/271 (46%), Gaps = 24/271 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG + K + A+K++ K + V E ++L S H L
Sbjct: 156 LGKGTFGKVILVKEK---ATGRYYAMKILKKEVIVAKDEVAHTLTENRVL-QNSRHPFLT 211
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH--- 258
+F+ D + VME GGEL LSR +SED A+ +I V A +LH
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEI--VSALDYLHSEK 268
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS- 316
VV+RDLK EN + D+ +K DFGL + ++ + G+ Y+APEVL +
Sbjct: 269 NVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVK 376
YG D W +GV+ Y ++CG PF+ + +F +L + F +L +AK +
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLS 381
Query: 377 LLLNKDPRKRMTAAQA-----LSHPWIRNYN 402
LL KDP++R+ + H +
Sbjct: 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-46
Identities = 82/278 (29%), Positives = 139/278 (50%), Gaps = 27/278 (9%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSK-MTTAIAVEDVRREVKILRALSGHSNL 200
+G G +G R G + A+KV+ K+ + A E R E ++L + L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-- 258
V + AF+ ++++++ GGEL LS+ +++E E + + +I V+A HLH
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTH-LSQRERFTEHEVQIYVGEI--VLALEHLHKL 178
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLS--DFVRPDERLNDIVGSAYYVAPEVLHRS 316
G+++RD+K EN L D + + DFGLS ER D G+ Y+AP+++
Sbjct: 179 GIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 235
Query: 317 ---YGTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDDGSWPSLSS 369
+ D WS+GV+ Y LL G+ PF +++ I R +LK++P + +S+
Sbjct: 236 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSA 291
Query: 370 DAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
AKD ++ LL KDP+KR+ A + H + + N
Sbjct: 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-46
Identities = 80/378 (21%), Positives = 143/378 (37%), Gaps = 69/378 (18%)
Query: 103 KSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD 162
K ++ +E + L ++ + E E+G G+ G +K
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPS---G 58
Query: 163 QKVAIKVIPKSKMTTAIAV-EDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCE 221
+A K+I + A+ + RE+++L + +V FY AF + I ME +
Sbjct: 59 LVMARKLIH---LEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMD 114
Query: 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH-LHGVVHRDLKPENFLYTSKDESSQ 280
GG LD++L + G+ E V + ++ + + H ++HRD+KP N L S+ +
Sbjct: 115 GG-SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GE 170
Query: 281 LKAIDFG----LSDFVRPDERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLC 335
+K DFG L D + N VG+ Y++PE L + Y ++D+WS+G+ +
Sbjct: 171 IKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 336 GSRPFWARTES---------------------------------------GIF----RAV 352
G P IF V
Sbjct: 226 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285
Query: 353 LKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISI 412
+ P G + S + +DFV L K+P +R Q + H +I+ + +V +
Sbjct: 286 NEPPPKLPSGVF---SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 342
Query: 413 LKLMKAYMQSSSLRRAAL 430
+ S+ A +
Sbjct: 343 CSTIGLNQPSTPTHAAGV 360
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-46
Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 28/278 (10%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG + R K D+ A++V+ K + ++ V+ E + S H LV
Sbjct: 60 IGRGSYAKVLLVRLK---KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVV 261
+ F+ ++ V+E GG+L+ + R K E+ A+ +I + + H G++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 175
Query: 262 HRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYGT 319
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L YG
Sbjct: 176 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 320 EADVWSIGVIAYILLCGSRPFW---------ARTESGIFRAVLKADPSFDDGSWPSLSSD 370
D W++GV+ + ++ G PF TE +F+ +L+ SLS
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVK 288
Query: 371 AKDFVKLLLNKDPRKRM-----TAAQAL-SHPWIRNYN 402
A +K LNKDP++R+ T + HP+ RN +
Sbjct: 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-45
Identities = 75/298 (25%), Positives = 125/298 (41%), Gaps = 31/298 (10%)
Query: 124 KRFGFSKEVTSRLEVGEE-------VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT 176
RF K V + + +GRG FG R + A+K + K ++
Sbjct: 172 TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIK 228
Query: 177 TAIAVEDVRREVKILRALSGHSN--LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG 234
E +L +S +V AF D + +++L GG+L LS+ G
Sbjct: 229 MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHG 287
Query: 235 KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294
+SE + + +I+ + H VV+RDLKP N L DE ++ D GL+
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF-S 343
Query: 295 DERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESG---IF 349
++ + VG+ Y+APEVL + +Y + AD +S+G + + LL G PF I
Sbjct: 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
Query: 350 RAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
R L S S + + ++ LL +D +R+ A + P+ R+ +
Sbjct: 404 RMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+GRG FG + K + A K + K ++ + E KIL + +V
Sbjct: 193 LGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIV 248
Query: 202 KFYDAFEDLDNVYIVMELCEGGEL---LDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH 258
AFE ++ +VM + GG++ + + + E A QI++ + H
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 259 GVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-S 316
+++RDLKPEN L D+ ++ D GL+ + + G+ ++APE+L
Sbjct: 309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 317 YGTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDDGSWPSLSSDAK 372
Y D +++GV Y ++ PF AR E + + VL+ ++ D S +K
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----KFSPASK 421
Query: 373 DFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
DF + LL KDP KR+ + +HP R+ +
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 88/343 (25%), Positives = 133/343 (38%), Gaps = 70/343 (20%)
Query: 105 TKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFG--YTCTARYKKGEHK- 161
A + + S R ++G G +G Y K
Sbjct: 5 HHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVY-------KAIDTV 57
Query: 162 -DQKVAIKVIPKSKM--------TTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212
++ VAIK I ++ TAI REV +L+ L H N+++
Sbjct: 58 TNETVAIKRI---RLEHEEEGVPGTAI------REVSLLKELQ-HRNIIELKSVIHHNHR 107
Query: 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLY 272
++++ E E L + + + S K+ L Q++N V FCH +HRDLKP+N L
Sbjct: 108 LHLIFEYAEND--LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL 165
Query: 273 TSKDESS--QLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--HRSYGTEADVWSIG 327
+ D S LK DFGL+ F P + + + +Y PE+L R Y T D+WSI
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIA 225
Query: 328 VIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSWP------------------ 365
I +L + F +E IF VL P D +WP
Sbjct: 226 CIWAEMLMKTPLFPGDSEIDQLFKIFE-VLGL-PD--DTTWPGVTALPDWKQSFPKFRGK 281
Query: 366 --------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
L + D + +L DP KR++A AL HP+ +
Sbjct: 282 TLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 2e-44
Identities = 91/304 (29%), Positives = 136/304 (44%), Gaps = 58/304 (19%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--------TTAIAVEDVRREV 188
E++G G +G A+ GE A+K I ++ +T I RE+
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGE----TFALKKI---RLEKEDEGIPSTTI------REI 51
Query: 189 KILRALSGHSNLVKFYDAFEDLDNVYIVMELCEG--GELLDRILSRCGKYSEDEAKAVLV 246
IL+ L HSN+VK YD + +V E + +LLD G AK+ L+
Sbjct: 52 SILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLL 107
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSA 305
Q+LN +A+CH V+HRDLKP+N L + +LK DFGL+ F P + + +
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 306 YYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRA-------- 351
+Y AP+VL + Y T D+WS+G I ++ G+ F +E IFR
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 352 ---VLK---ADPSFDDGS-------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
V + DP+F L D + +L DP +R+TA QAL H +
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
Query: 399 RNYN 402
+ N
Sbjct: 285 KENN 288
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-44
Identities = 89/329 (27%), Positives = 144/329 (43%), Gaps = 57/329 (17%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM-------TTAIAVEDVRREVKILR 192
+++G G + + K D VA+K I ++ TAI REV +L+
Sbjct: 8 DKLGEGTYATVYKGKSKL---TDNLVALKEI---RLEHEEGAPCTAI------REVSLLK 55
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNV 251
L H+N+V +D ++ +V E + L + L CG + K L Q+L
Sbjct: 56 DLK-HANIVTLHDIIHTEKSLTLVFEYLDKD--LKQYLDDCGNIINMHNVKLFLFQLLRG 112
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAP 310
+A+CH V+HRDLKP+N L +E +LK DFGL+ P + ++ V + +Y P
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169
Query: 311 EVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAV----------LK 354
++L Y T+ D+W +G I Y + G F T IFR + +
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229
Query: 355 ADPSFDDGS------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402
++ F + P L SD D + LL + R R++A A+ HP+ +
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 403 N--VKVPLDISILKLMKAYMQSSSLRRAA 429
K+P SI L + +Q + R+A
Sbjct: 290 ERIHKLPDTTSIFALKEIQLQKEASLRSA 318
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-44
Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 24/273 (8%)
Query: 142 VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLV 201
+G+G FG C + + + A K + K ++ E +IL +V
Sbjct: 192 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVNSRFVV 247
Query: 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK--YSEDEAKAVLVQILNVVAFCHLHG 259
A+E D + +V+ L GG+L I G+ + E A +I + H
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHI-YHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYG 318
+V+RDLKPEN L D+ ++ D GL+ V + + VG+ Y+APEV+ Y
Sbjct: 307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 319 TEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDDGSWPSLSSDAKDF 374
D W++G + Y ++ G PF R + + R V + + + S A+
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE----RFSPQARSL 419
Query: 375 VKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
LL KDP +R+ +A + HP + N
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-44
Identities = 78/301 (25%), Positives = 133/301 (44%), Gaps = 56/301 (18%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--------TTAIAVEDVRREVKIL 191
E++G G +G A+ ++ + VA+K + ++ ++A+ RE+ +L
Sbjct: 8 EKIGEGTYGTVFKAKNRET---HEIVALKRV---RLDDDDEGVPSSAL------REICLL 55
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILN 250
+ L H N+V+ +D + +V E C+ L + C + K+ L Q+L
Sbjct: 56 KELK-HKNIVRLHDVLHSDKKLTLVFEFCDQD--LKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 309
+ FCH V+HRDLKP+N L +LK +FGL+ F P + V + +Y
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 310 PEVL--HRSYGTEADVWSIGVIAYILLCGSRP-FWARTE----SGIFRAV---------- 352
P+VL + Y T D+WS G I L RP F IFR +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 353 ------LKADPSFDDGS-----WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
K P + + P L++ +D ++ LL +P +R++A +AL HP+ ++
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
Query: 402 N 402
Sbjct: 290 C 290
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 84/307 (27%), Positives = 133/307 (43%), Gaps = 57/307 (18%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--------TTAIAVEDVR 185
+ + E+VG G +G A+ +G VA+K I ++ +TAI
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGR----IVALKRI---RLDAEDEGIPSTAI------ 67
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAV 244
RE+ +L+ L H N+V D + +V E E L ++L + + K
Sbjct: 68 REISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIY 124
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVG 303
L Q+L VA CH H ++HRDLKP+N L S LK DFGL+ F P V
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLARAFGIPVRSYTHEVV 181
Query: 304 SAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAV----- 352
+ +Y AP+VL + Y T D+WSIG I ++ G F T+ IF +
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241
Query: 353 -----LKADPSFDDGS------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
++ P + + P + D + +L DP KR++A A++H
Sbjct: 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301
Query: 396 PWIRNYN 402
P+ ++ +
Sbjct: 302 PYFKDLD 308
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 63/367 (17%), Positives = 132/367 (35%), Gaps = 67/367 (18%)
Query: 137 EVGEEVGRGH--FGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
E+ +G+G ARYK + V ++ I + + V ++ E+ + +
Sbjct: 28 ELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNEM-VTFLQGELHVSKLF 83
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVA 253
+ H N+V + F + +++V G D I + +E +L +L +
Sbjct: 84 N-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLN-------DIVGSA 305
+ H G VHR +K + L + ++ + + +R V
Sbjct: 143 YIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 306 YYVAPEVLHRS---YGTEADVWSIGVIAYILLCGSRPF---------------------- 340
+++PEVL ++ Y ++D++S+G+ A L G PF
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 341 --------------WARTESGIFRAVLKADPSFDDGSWPS------LSSDAKDFVKLLLN 380
+ SG+ ++ + P +G PS S FV+ L
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 381 KDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVD 440
++P R +A+ L+H + + K ++ +L++ ++ + + S +
Sbjct: 320 RNPDARPSASTLLNHSFFKQI---KRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLV 376
Query: 441 ERFYLKE 447
E
Sbjct: 377 TNLEELE 383
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 59/291 (20%)
Query: 157 KGEHK--DQKVAIKVIPKSKM-------TTAIAVEDVRREVKILRALSGHSNLVKFYDAF 207
KG +K VA+K + K+ +TAI RE+ +++ L H N+V+ YD
Sbjct: 23 KGLNKTTGVYVALKEV---KLDSEEGTPSTAI------REISLMKELK-HENIVRLYDVI 72
Query: 208 EDLDNVYIVMELCEG--GELLD--RILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHR 263
+ + +V E + + +D + + + K Q+L +AFCH + ++HR
Sbjct: 73 HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHR 132
Query: 264 DLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--HRSYGTE 320
DLKP+N L + + LK DFGL+ F P + V + +Y AP+VL R+Y T
Sbjct: 133 DLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTS 189
Query: 321 ADVWSIGVIAYILLCGSRPFWARTE----SGIFR--------------------AVLKAD 356
D+WS G I ++ G F + IF ++
Sbjct: 190 IDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQR 249
Query: 357 PS------FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
P + L + DF+ LL +P R++A QAL HPW Y
Sbjct: 250 PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 64/315 (20%), Positives = 112/315 (35%), Gaps = 54/315 (17%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIA-----VEDVR 185
+ S V + G +G C +G VAIK + + +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGI----PVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 186 ---REVKILRALSGHSNLVKFYDAF-----EDLDNVYIVMELCEGGELLDRIL-SRCGKY 236
RE+++L H N++ D F + +Y+V EL L +++ +
Sbjct: 75 RVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVI 131
Query: 237 SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
S + + IL + H GVVHRDL P N L +++ + DF L+ D
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADA 188
Query: 297 RLNDIVGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCG------------------ 336
V +Y APE++ + + D+WS G + +
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 337 -----SRPFWARTESGIFRAVLKAD-PSFDDGSW----PSLSSDAKDFVKLLLNKDPRKR 386
S R L+ + +W P+ A D + +L +P++R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308
Query: 387 MTAAQALSHPWIRNY 401
++ QAL HP+ +
Sbjct: 309 ISTEQALRHPYFESL 323
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 83/328 (25%), Positives = 134/328 (40%), Gaps = 66/328 (20%)
Query: 125 RFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDV 184
GF ++ SR + +G G G +A D++VAIK I + +
Sbjct: 4 IHGF--DLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLTDPQSVK----- 53
Query: 185 R--REVKILRALSGHSNLVKFYDAF--------------EDLDNVYIVMELCEGGELLDR 228
RE+KI+R L H N+VK ++ +L++VYIV E E L
Sbjct: 54 HALREIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LAN 110
Query: 229 ILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288
+L G E+ A+ + Q+L + + H V+HRDLKP N ++D LK DFGL
Sbjct: 111 VL-EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED--LVLKIGDFGL 167
Query: 289 SDFVRPDERLNDI----VGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCG------ 336
+ + P + + +Y +P +L +Y D+W+ G I +L G
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227
Query: 337 -----------------SRPFWARTESGIFRAVLKADPSFDDGSW----PSLSSDAKDFV 375
S ++ D + P +S +A DF+
Sbjct: 228 AHELEQMQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFL 286
Query: 376 KLLLNKDPRKRMTAAQALSHPWIRNYNN 403
+ +L P R+TA +ALSHP++ Y+
Sbjct: 287 EQILTFSPMDRLTAEEALSHPYMSIYSF 314
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 86/305 (28%), Positives = 127/305 (41%), Gaps = 61/305 (20%)
Query: 137 EVGEEVGRGHFG--YTCTARYKKGEHK--DQKVAIKVIPKSKMT--------TAIAVEDV 184
E + +G G F Y K K +Q VAIK I + TA+
Sbjct: 13 EKLDFLGEGQFATVY-------KARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----- 60
Query: 185 RREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKA 243
RE+K+L+ LS H N++ DAF N+ +V + E L+ I+ + KA
Sbjct: 61 -REIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKA 116
Query: 244 VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIV 302
++ L + + H H ++HRDLKP N L DE+ LK DFGL+ F P+ V
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQV 173
Query: 303 GSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWA-RTE----SGIFRAV--- 352
+ +Y APE+L R YG D+W++G I LL PF ++ + IF +
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLDQLTRIFETLGTP 232
Query: 353 -------------LKADPSFDDGSW----PSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
SF + D D ++ L +P R+TA QAL
Sbjct: 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292
Query: 396 PWIRN 400
+ N
Sbjct: 293 KYFSN 297
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-41
Identities = 78/312 (25%), Positives = 125/312 (40%), Gaps = 60/312 (19%)
Query: 127 GFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR 186
G + + +G G FG A+ + VAIK + + K R
Sbjct: 47 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRFKN-------R 96
Query: 187 EVKILRALSGHSNLVKFYDAF----EDLDNVYI--VMELCEGGELLDRILSRCGKY---- 236
E++I+R L H N+V+ F E D VY+ V++ E + R+ +
Sbjct: 97 ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTL 153
Query: 237 SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
K + Q+ +A+ H G+ HRD+KP+N L +++ LK DFG + + E
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGE 211
Query: 297 RLNDIVGSAYYVAPEVLHRS--YGTEADVWSIG-VIAYILLCGSRPFWARTESG------ 347
+ S YY APE++ + Y + DVWS G V+A +LL +P + +SG
Sbjct: 212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIF-PGDSGVDQLVE 268
Query: 348 IFRAVL----KAD-------------PSFDDGSW-----PSLSSDAKDFVKLLLNKDPRK 385
I + VL + P W P +A LL P
Sbjct: 269 IIK-VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 386 RMTAAQALSHPW 397
R+T +A +H +
Sbjct: 328 RLTPLEACAHSF 339
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-41
Identities = 81/309 (26%), Positives = 125/309 (40%), Gaps = 59/309 (19%)
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREV 188
++ + +G G FG A+ + +VAIK + + K RE+
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVE----SDEVAIKKVLQDK-------RFKNREL 83
Query: 189 KILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKY----SE 238
+I+R + H N+V F +D + +V+E E + R K
Sbjct: 84 QIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP--ETVYRASRHYAKLKQTMPM 140
Query: 239 DEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL 298
K + Q+L +A+ H G+ HRD+KP+N L S LK IDFG + + E
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGVLKLIDFGSAKILIAGEPN 198
Query: 299 NDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWARTESG------IFR 350
+ S YY APE++ + Y T D+WS G + L+ G +P + ESG I +
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLF-PGESGIDQLVEIIK 256
Query: 351 AVL--------------KADPSF---DDGSW-----PSLSSDAKDFVKLLLNKDPRKRMT 388
VL + F + P DA D + LL P R+T
Sbjct: 257 -VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315
Query: 389 AAQALSHPW 397
A +AL HP+
Sbjct: 316 AIEALCHPF 324
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 81/311 (26%), Positives = 136/311 (43%), Gaps = 58/311 (18%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK--SKMTTAIAVEDVR--R 186
EV R + VG G +G C A K +VA+K + + + A R R
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAK-----RTYR 77
Query: 187 EVKILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDE 240
E+++L+ + H N++ D F E+ ++VY+V L L+ I+ +C K ++D
Sbjct: 78 ELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIV-KCQKLTDDH 133
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERLN 299
+ ++ QIL + + H ++HRDLKP N +E +LK +DFGL+ R + +
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA---RHTADEMT 187
Query: 300 DIVGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCG--------------------- 336
V + +Y APE++ Y D+WS+G I LL G
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 337 --SRPFWARTESGIFRAVLKADPSFDDGSW----PSLSSDAKDFVKLLLNKDPRKRMTAA 390
+ S R +++ ++ + A D ++ +L D KR+TAA
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
Query: 391 QALSHPWIRNY 401
QAL+H + Y
Sbjct: 308 QALAHAYFAQY 318
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 84/311 (27%), Positives = 137/311 (44%), Gaps = 59/311 (18%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK--SKMTTAIAVEDVR--R 186
E+ VG G +G C+A K+ +KVAIK + + A R R
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAK-----RAYR 72
Query: 187 EVKILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDE 240
E+ +L+ + H N++ D F + + Y+VM + L +I+ K+SE++
Sbjct: 73 ELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL--KFSEEK 127
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERLN 299
+ ++ Q+L + + H GVVHRDLKP N +E +LK +DFGL+ R D +
Sbjct: 128 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLA---RHADAEMT 181
Query: 300 DIVGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCG--------------------- 336
V + +Y APEV+ Y D+WS+G I +L G
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241
Query: 337 --SRPFWARTESGIFRAVLKADPSFDDGSW----PSLSSDAKDFVKLLLNKDPRKRMTAA 390
F + ++ +++ P + P S A D ++ +L D KR+TAA
Sbjct: 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301
Query: 391 QALSHPWIRNY 401
QAL+HP+ +
Sbjct: 302 QALTHPFFEPF 312
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 76/267 (28%), Positives = 117/267 (43%), Gaps = 40/267 (14%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+EV E VGRG FG C K + + + VAIK I + E++ L
Sbjct: 8 KEIEVEEVVGRGAFGVVC-----KAKWRAKDVAIKQIESESER-----KAFIVELRQLSR 57
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
++ H N+VK Y A L+ V +VME EGG L + + A A+ +
Sbjct: 58 VN-HPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM--SWCLQCS 112
Query: 254 F--CHLH-----GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY 306
+LH ++HRDLKP N L + LK DFG + + + + GSA
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTACDI--QTHMTNNKGSAA 168
Query: 307 YVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFW--ARTESGIFRAVLKADPSFDDGS 363
++APEV +Y + DV+S G+I + ++ +PF I AV G+
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-------GT 221
Query: 364 WPSLSSDAKDFVKLLL----NKDPRKR 386
P L + ++ L+ +KDP +R
Sbjct: 222 RPPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 79/311 (25%), Positives = 136/311 (43%), Gaps = 58/311 (18%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK--SKMTTAIAVEDVR--R 186
EV + + VG G +G C+A + KVAIK + + A R R
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFAK-----RAYR 73
Query: 187 EVKILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDE 240
E+++L+ + H N++ D F +D + Y+VM L +++ + K ED
Sbjct: 74 ELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD--LGKLM-KHEKLGEDR 129
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP-DERLN 299
+ ++ Q+L + + H G++HRDLKP N +E +LK +DFGL+ R D +
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA---RQADSEMT 183
Query: 300 DIVGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCG--------------------- 336
V + +Y APEV+ Y D+WS+G I ++ G
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243
Query: 337 --SRPFWARTESGIFRAVLKADPSFDDGSW----PSLSSDAKDFVKLLLNKDPRKRMTAA 390
F R +S + +K P + + + S A + ++ +L D +R+TA
Sbjct: 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303
Query: 391 QALSHPWIRNY 401
+AL+HP+ +
Sbjct: 304 EALAHPYFESL 314
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-40
Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 40/274 (14%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+LE+GE +G+G FG R+ +VAI++I + ++ +REV R
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWH------GEVAIRLIDIERDNED-QLKAFKREVMAYRQ 85
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
H N+V F A ++ I+ LC+G L + ++ + + +I+ +
Sbjct: 86 TR-HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMG 144
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS------DFVRPDERLNDIVGSAYY 307
+ H G++H+DLK +N Y + + DFGL R +++L G +
Sbjct: 145 YLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 308 VAPEVL----------HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357
+APE++ + +DV+++G I Y L PF + I +
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT--- 257
Query: 358 SFDDGSWPSLSSDA--KDFVKLLL---NKDPRKR 386
G P+LS K+ +LL + +R
Sbjct: 258 ----GMKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 85/311 (27%), Positives = 129/311 (41%), Gaps = 57/311 (18%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--------TTAIAVEDVRREVKIL 191
E+G G +G AR K + + VA+K + ++ + I REV +L
Sbjct: 17 AEIGEGAYGKVFKARDLK--NGGRFVALKRV---RVQTGEEGMPLSTI------REVAVL 65
Query: 192 RALSG--HSNLVKFYDAF-----EDLDNVYIVMELCEG--GELLDRILSRCGKYSEDEAK 242
R L H N+V+ +D + + +V E + LD++ + K
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIK 123
Query: 243 AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV 302
++ Q+L + F H H VVHRDLKP+N L TS Q+K DFGL+ L +V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSVV 180
Query: 303 GSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAV----- 352
+ +Y APEVL SY T D+WS+G I + F ++ I +
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 353 -----LKADPSFDDGSW---------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
A P S + KD + L +P KR++A ALSHP+
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300
Query: 399 RNYNNVKVPLD 409
++ K LD
Sbjct: 301 QDLERCKENLD 311
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI----PKSKMTTAIAVEDVRREVKIL 191
+E +++G+G FG R K VAIK + + + ++ +REV I+
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNV 251
L+ H N+VK Y + +VME G+L R+L + +++ I
Sbjct: 78 SNLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI--A 132
Query: 252 VAFCHLHG----VVHRDLKPENFLYTSKDESSQ--LKAIDFGLSDFVRPDERLNDIVGSA 305
+ ++ +VHRDL+ N S DE++ K DFGLS ++ ++G+
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNF 190
Query: 306 YYVAPEVL---HRSYGTEADVWSIGVIAYILLCGSRPF 340
++APE + SY +AD +S +I Y +L G PF
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 67/265 (25%), Positives = 106/265 (40%), Gaps = 30/265 (11%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L + E++G G FG A + VA+K++ + V + REV I++
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH-----GSDVAVKILMEQDFHAE-RVNEFLREVAIMKR 90
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H N+V F A N+ IV E G L + + DE + + + VA
Sbjct: 91 LR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR--RLSMAYDVA 147
Query: 254 F--CHLHG----VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER-LNDIVGSAY 306
+LH +VHR+LK N L D+ +K DFGLS G+
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE 204
Query: 307 YVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365
++APEVL ++DV+S GVI + L +P+ + + AV
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF------KCKRL 258
Query: 366 SLSSDAKDFVKLLL----NKDPRKR 386
+ + V ++ +P KR
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 87/312 (27%), Positives = 127/312 (40%), Gaps = 56/312 (17%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI-PKSKMTTAIAVEDVR--RE 187
+V R +G G +G C+A +VAIK I P T R RE
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFEHQTYCQ-----RTLRE 75
Query: 188 VKILRALSGHSNLVKFYDAF-----EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAK 242
+KIL H N++ D E + +VYIV +L E L ++L + S D
Sbjct: 76 IKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHIC 131
Query: 243 AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI- 301
L QIL + + H V+HRDLKP N L + + LK DFGL+ PD
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 302 ---VGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCG-------------------- 336
V + +Y APE++ + Y D+WS+G I +L
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 337 ---SRPFWARTESGIFRAVLKADPSFDDGSW----PSLSSDAKDFVKLLLNKDPRKRMTA 389
S+ + R L + P + W P+ S A D + +L +P KR+
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308
Query: 390 AQALSHPWIRNY 401
QAL+HP++ Y
Sbjct: 309 EQALAHPYLEQY 320
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 75/305 (24%), Positives = 117/305 (38%), Gaps = 61/305 (20%)
Query: 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM-----------TTAIAVEDVRREV 188
E+G G +G AR VA+K + ++ + + REV
Sbjct: 15 AEIGVGAYGTVYKARDPH---SGHFVALKSV---RVPNGGGGGGGLPISTV------REV 62
Query: 189 KILRALSG--HSNLVKFYDAF-----EDLDNVYIVMELCEGGELLDRILSRCGK--YSED 239
+LR L H N+V+ D + V +V E + L L + +
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD--LRTYLDKAPPPGLPAE 120
Query: 240 EAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLN 299
K ++ Q L + F H + +VHRDLKPEN L TS +K DFGL+ L
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALT 177
Query: 300 DIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAV-- 352
+V + +Y APEVL +Y T D+WS+G I + F +E IF +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237
Query: 353 --------LKADPSFDDGSW---------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
+ P P + + +L +P KR++A +AL H
Sbjct: 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297
Query: 396 PWIRN 400
++
Sbjct: 298 SYLHK 302
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-39
Identities = 76/320 (23%), Positives = 126/320 (39%), Gaps = 65/320 (20%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK--SKMTTAIAVEDVR--R 186
V R + + +G G G C A ++ VAIK + + T A R R
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAK-----RAYR 73
Query: 187 EVKILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDE 240
E+ +++ + H N++ + F E+ +VYIVMEL + L +++ + +
Sbjct: 74 ELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHER 128
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND 300
+L Q+L + H G++HRDLKP N + LK +DFGL+ +
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTP 185
Query: 301 IVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCG----------------------- 336
V + YY APEV L Y D+WS+G I ++ G
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 337 SRPFWARTESGI--------------FRAVL-KADPSFDDGSWPSLSSDAKDFVKLLLNK 381
F + + + F + D +S A+D + +L
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 382 DPRKRMTAAQALSHPWIRNY 401
D KR++ +AL HP+I +
Sbjct: 306 DASKRISVDEALQHPYINVW 325
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-39
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-TAIAVEDVRREVKILR 192
+ L + E +G G FG A + +VA+K + +E+VR+E K+
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI-----GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
L H N++ N+ +VME GG L + + + D VQI +
Sbjct: 62 MLK-HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGM 118
Query: 253 AFCHLHG---VVHRDLKPENFLYTSKDESSQ-----LKAIDFGLSDFVRPDERLNDIVGS 304
+ H ++HRDLK N L K E+ LK DFGL+ +++ G+
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177
Query: 305 AYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPF 340
++APEV+ + +DVWS GV+ + LL G PF
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 8e-38
Identities = 76/320 (23%), Positives = 126/320 (39%), Gaps = 65/320 (20%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK--SKMTTAIAVEDVR--R 186
V R + + +G G G C A D+ VAIK + + T A R R
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAK-----RAYR 110
Query: 187 EVKILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDE 240
E+ +++ + H N++ + F E+ +VY+VMEL + L +++ + +
Sbjct: 111 ELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHER 165
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND 300
+L Q+L + H G++HRDLKP N + LK +DFGL+ +
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTP 222
Query: 301 IVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCG----------------------- 336
V + YY APEV L Y D+WS+G I ++
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 337 SRPFWARTESGI--------------FRAVL-KADPSFDDGSWPSLSSDAKDFVKLLLNK 381
F + + + F + + D +S A+D + +L
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 382 DPRKRMTAAQALSHPWIRNY 401
DP KR++ AL HP+I +
Sbjct: 343 DPAKRISVDDALQHPYINVW 362
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
++ VG+ +G G FG ++ VA+K++ + T ++ + EV +LR
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQ-QLQAFKNEVGVLRK 76
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
H N++ F + IV + CEG L + + K+ + + Q +
Sbjct: 77 TR-HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS---DFVRPDERLNDIVGSAYYVAP 310
+ H ++HRDLK N E + +K DFGL+ + + GS ++AP
Sbjct: 135 YLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 311 EVL----HRSYGTEADVWSIGVIAYILLCGSRPF 340
EV+ Y ++DV++ G++ Y L+ G P+
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 76/333 (22%), Positives = 129/333 (38%), Gaps = 78/333 (23%)
Query: 134 SRLEVGEEVGRGHFGYTCTAR-YKKGEHKDQKVAIKVI-PKSKMTTAIAVEDVRREVKIL 191
+R + ++G GHF A+ H VA+K++ T A E+K+L
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTH----VAMKIVRGDKVYTEA-----AEDEIKLL 69
Query: 192 RALS----------GHSNLVKFYDAFE----DLDNVYIVMELCEGGELLDRI-LSRCGKY 236
+ ++ G ++++K D F + +V +V E+ G LL I
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI 128
Query: 237 SEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFL---YTSKDESSQLKAIDFGLSDFV 292
K + Q+L + + H G++H D+KPEN L S + Q+K D G + +
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 293 RPDERLNDIVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFR- 350
DE + + + Y +PEV L +G AD+WS + + L+ G F +
Sbjct: 189 --DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 351 --------AVLKADPS------------FDD-GSWPSLSSDA------------------ 371
+L PS F+ G ++S
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 372 ----KDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
DF+ +L DPRKR A ++HPW+++
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 86/320 (26%), Positives = 131/320 (40%), Gaps = 64/320 (20%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI-PKSKMTTAIAVEDVR--RE 187
++S ++ +G G +G C+A +K + VAIK I P K A+ R RE
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPFDKPLFAL-----RTLRE 59
Query: 188 VKILRALSGHSNLVKFYDAF-----EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAK 242
+KIL+ H N++ ++ E+ + VYI+ EL + L R++ S+D +
Sbjct: 60 IKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVI-STQMLSDDHIQ 115
Query: 243 AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV 302
+ Q L V H V+HRDLKP N L + + LK DFGL+ + N
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 303 GSA-----------YYVAPEVL--HRSYGTEADVWSIGVIAYILLCG------------- 336
+Y APEV+ Y DVWS G I L
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232
Query: 337 -----------SRPFWARTESGIFRAVLKADPSFDDGSW----PSLSSDAKDFVKLLLNK 381
S ES R +K+ P + P ++ D ++ +L
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 382 DPRKRMTAAQALSHPWIRNY 401
DP KR+TA +AL HP+++ Y
Sbjct: 293 DPAKRITAKEALEHPYLQTY 312
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 77/321 (23%), Positives = 122/321 (38%), Gaps = 67/321 (20%)
Query: 126 FGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVR 185
S++ R +V G+G FG + K VAIK + +
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEK---STGMSVAIKKVIQDPRFR-------N 64
Query: 186 REVKILRALS--GHSNLVKFYDAF-----EDLDNVY--IVMELCEGGELLDRILSRCGKY 236
RE++I++ L+ H N+V+ F D ++Y +VME + L R +
Sbjct: 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRR 122
Query: 237 ----SEDEAKAVLVQILNVVAFCHL--HGVVHRDLKPENFLYTSKDESS-QLKAIDFGLS 289
K L Q++ + HL V HRD+KP N L +E+ LK DFG +
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV---NEADGTLKLCDFGSA 179
Query: 290 DFVRPDERLNDIVGSAYYVAPEVL--HRSYGTEADVWSIG-VIAYILL-----CG----- 336
+ P E + S YY APE++ ++ Y T D+WS+G + A ++L G
Sbjct: 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239
Query: 337 ------------SRPFWARTESGIFRAVLKADPSFDDGSW--------PSLSSDAKDFVK 376
SR + + W + +A D +
Sbjct: 240 QLHEIVRVLGCPSREVLRKLNPSHTD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296
Query: 377 LLLNKDPRKRMTAAQALSHPW 397
LL P +RM +AL HP+
Sbjct: 297 ALLQYLPEERMKPYEALCHPY 317
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 8e-37
Identities = 72/294 (24%), Positives = 115/294 (39%), Gaps = 48/294 (16%)
Query: 113 GAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFG--YTCTARYKKGEHK---DQKVAI 167
G+P P+L+ V + EV + G G Y + + V +
Sbjct: 63 GSPYSFLPQLNPG----DIVAGQYEVKGCIAHGGLGWIY-------LALDRNVNGRPVVL 111
Query: 168 KVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN-----VYIVMELCEG 222
K + S A A+ E + L + H ++V+ ++ E D YIVME G
Sbjct: 112 KGLVHSGDAEAQAM--AMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGG 168
Query: 223 GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLK 282
L K EA A L++IL +++ H G+V+ DLKPEN + T QLK
Sbjct: 169 QSLKRSK---GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQLK 221
Query: 283 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWA 342
ID G V + G+ + APE++ D++++G L
Sbjct: 222 LIDLGA---VSRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNG 278
Query: 343 RTESGIFR--AVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394
R G+ VLK S+ ++ ++ DPR+R T A+ +S
Sbjct: 279 RYVDGLPEDDPVLKTYDSYG------------RLLRRAIDPDPRQRFTTAEEMS 320
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 73/265 (27%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHK-DQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
R ++ +++G G Y + + KVAIK I ++ REV
Sbjct: 12 RYKIVDKLGGGGMSTV----YLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
LS H N+V D E+ D Y+VME EG L + I S G S D A QIL+ +
Sbjct: 68 LS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIK 125
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL---NDIVGSAYYVAP 310
H +VHRD+KP+N L + LK DFG++ + + L N ++G+ Y +P
Sbjct: 126 HAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSP 181
Query: 311 E-VLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDDGSWPSLS 368
E + D++SIG++ Y +L G PF T I + + + P+ +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQAL 393
+ + KD R Q +
Sbjct: 242 QSLSNVILRATEKDKANRYKTIQEM 266
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 80/326 (24%), Positives = 130/326 (39%), Gaps = 74/326 (22%)
Query: 138 VGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM-TTAIAVEDVRREVKILRALSG 196
G +VGRG +G+ A+ K G+ D+ A+K I + + +A RE+ +LR L
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGISMSAC------REIALLRELK- 76
Query: 197 HSNLVKFYDAFED--LDNVYIVMELCEG--GELLD-----RILSRCGKYSEDEAKAVLVQ 247
H N++ F V+++ + E ++ + + + K++L Q
Sbjct: 77 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 248 ILNVVAFCHLHGVVHRDLKPENFLYTSK-DESSQLKAIDFGL----SDFVRPDERLNDIV 302
IL+ + + H + V+HRDLKP N L + E ++K D G + ++P L+ +V
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 303 GSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKAD--- 356
+ +Y APE+L R Y D+W+IG I LL P F R E D
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQLD 255
Query: 357 --------PSFDDGSWP----------------------------------SLSSDAKDF 374
P+ D W S A
Sbjct: 256 RIFNVMGFPA--DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313
Query: 375 VKLLLNKDPRKRMTAAQALSHPWIRN 400
++ LL DP KR+T+ QA+ P+
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPYFLE 339
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 86/333 (25%), Positives = 124/333 (37%), Gaps = 79/333 (23%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI-PKSKMTTAIAVEDVRREVKI 190
V R EV + +G+G FG A K Q VA+K++ + + E++I
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEKRFHRQA-----AEEIRI 146
Query: 191 LRALSGH-----SNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY---SEDEAK 242
L L N++ + F +++ + EL L + L + K+ S +
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYE--LIKKNKFQGFSLPLVR 203
Query: 243 AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV 302
IL + H + ++H DLKPEN L + S +K IDFG S + +R+ +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIKVIDFGSSCYE--HQRVYTYI 260
Query: 303 GSAYYVAPEV-LHRSYGTEADVWSIGVIA------YILLCGS------------------ 337
S +Y APEV L YG D+WS+G I Y LL G
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320
Query: 338 -------------------RPFWARTESGI---------FRAVLKADPSFDDGSWPSLSS 369
R T S R L+ P +
Sbjct: 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGC 380
Query: 370 DA---KDFVKLLLNKDPRKRMTAAQALSHPWIR 399
D DF+K L DP RMT QAL HPW+R
Sbjct: 381 DDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 77/346 (22%), Positives = 131/346 (37%), Gaps = 87/346 (25%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK--SKMTTAIAVEDVR--R 186
V + E+ +++G+G +G + ++ + VA+K I T A R R
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAFQNSTDAQ-----RTFR 57
Query: 187 EVKILRALSGHSNLVKFYDAF--EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
E+ IL LSGH N+V + ++ +VY+V + E L ++ R + V
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVI-RANILEPVHKQYV 114
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
+ Q++ V+ + H G++HRD+KP N L + +K DFGLS R+ + +
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 305 A----------------------YYVAPEVL--HRSYGTEADVWSIGVIAYILLCG---- 336
+ +Y APE+L Y D+WS+G I +LCG
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231
Query: 337 -------------------------------------SRPFWARTESGIFRAVLKADPSF 359
S R + +
Sbjct: 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291
Query: 360 DDGSWP--SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
P + +A D + LL +P KR++A AL HP++ ++N
Sbjct: 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-35
Identities = 41/217 (18%), Positives = 77/217 (35%), Gaps = 29/217 (13%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
L ++ H G R++ + +KV+ +T D E LR S
Sbjct: 12 LNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFS 65
Query: 196 GHSNLVKFYDAFED--LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
H N++ A + + ++ G L + +L + D+++AV + +A
Sbjct: 66 -HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAV--KFALDMA 121
Query: 254 F--CHLHG----VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYY 307
LH + L + + DE + + + + + +
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFS----FQSPGRMYAPAW 174
Query: 308 VAPEVL-HRSYGTE---ADVWSIGVIAYILLCGSRPF 340
VAPE L + T AD+WS V+ + L+ PF
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 73/337 (21%), Positives = 118/337 (35%), Gaps = 82/337 (24%)
Query: 132 VTSRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVI-PKSKMTTAIAVEDVRREV 188
+ R E+ +G G FG C + VA+K+I K A R E+
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQ----VALKIIRNVGKYREA-----ARLEI 67
Query: 189 KILRAL-----SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY---SEDE 240
+L+ + V D F ++ I EL G + + +
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE--FLKENNFQPYPLPH 124
Query: 241 AKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD----------------ESSQLKAI 284
+ + Q+ + + F H + + H DLKPEN L+ + + +++ ++
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 285 DFGLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCGSRPFWAR 343
DFG + F E IV + +Y PEV L + DVWSIG I + G F
Sbjct: 185 DFGSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242
Query: 344 TE---------------SGIFRAVLKADPSFDDGS-WPSLSSDAK--------------- 372
S + K + G W SSD +
Sbjct: 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 302
Query: 373 ---------DFVKLLLNKDPRKRMTAAQALSHPWIRN 400
D ++ +L DP +R+T A+AL HP+
Sbjct: 303 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-35
Identities = 88/359 (24%), Positives = 135/359 (37%), Gaps = 92/359 (25%)
Query: 125 RFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--------T 176
F EV S+ E ++G+G FG AR++K QKVA+K K M
Sbjct: 9 ECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALK---KVLMENEKEGFPI 61
Query: 177 TAIAVEDVRREVKILRALSGHSNLVKFYD--------AFEDLDNVYIVMELCEGGELLDR 228
TA+ RE+KIL+ L H N+V + ++Y+V + CE L
Sbjct: 62 TAL------REIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD--LAG 112
Query: 229 ILSRCG-KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287
+LS K++ E K V+ +LN + + H + ++HRD+K N L T LK DFG
Sbjct: 113 LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFG 169
Query: 288 LSDFVRPDERLNDIVGSAY--------YVAPEVL--HRSYGTEADVWSIGVIAYILLCGS 337
L+ + + Y Y PE+L R YG D+W G I +
Sbjct: 170 LARAFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR- 225
Query: 338 RP-FWARTESG----IFRAVLKADPSFDDGSWP--------------------------- 365
P TE I + S WP
Sbjct: 226 SPIMQGNTEQHQLALISQLC----GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA 281
Query: 366 -SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSS 423
A D + LL DP +R+ + AL+H + + P+ + ++ ++ S
Sbjct: 282 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS-----DPMPSDLKGMLSTHLTSM 335
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 52/223 (23%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
S L GE +G+G FG +++ + + +K + + +EVK++R
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIR---FDEETQRTFLKEVKVMRC 63
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H N++KF + + E +GG L I S +Y + + I + +A
Sbjct: 64 LE-HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND------------- 300
+ H ++HRDL N L E+ + DFGL+ + ++ +
Sbjct: 123 YLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 301 --IVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPF 340
+VG+ Y++APE++ RSY + DV+S G++ ++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 69/338 (20%), Positives = 120/338 (35%), Gaps = 90/338 (26%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
+ + +G+ +G G FG C ++ A+K + + RE+ I+
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDI---ESGKRFALKKVLQDPRYK-------NRELDIM 54
Query: 192 RALSGHSNLVKFYDAF--------------------------------------EDLDNV 213
+ L H N++K D F +
Sbjct: 55 KVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 214 YIVMELCEGGELLDRILSRCGKY----SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPEN 269
++ME + L ++L + + + Q+ V F H G+ HRD+KP+N
Sbjct: 114 NVIMEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 270 FLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIG 327
L SKD + LK DFG + + P E + S +Y APE++ Y D+WSIG
Sbjct: 172 LLVNSKD--NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
Query: 328 -VIAYILL-----CG-----------------SRPFWARTESGIFRAVLKADPSFDDGSW 364
V ++L G ++ R P+ W
Sbjct: 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDW 286
Query: 365 PSL-----SSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397
+ S A D ++ +L +P R+ +A++HP+
Sbjct: 287 RKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 77/333 (23%), Positives = 124/333 (37%), Gaps = 76/333 (22%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI-PKSKMTTAIAVEDVRREVKI 190
+++R E+ + +G G FG K + VA+K++ + A E +++
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKA--GGRHVAVKIVKNVDRYCEAARSE-----IQV 64
Query: 191 LRAL-----SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK--YSEDEAKA 243
L L + V+ + FE ++ IV EL G D + G + D +
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYD-FIKENGFLPFRLDHIRK 122
Query: 244 VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD----------------ESSQLKAIDFG 287
+ QI V F H + + H DLKPEN L+ D + +K +DFG
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 288 LSDFVRPDERLNDIVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCGSRPFWARTES 346
+ + DE + +V + +Y APEV L + DVWSIG I G F
Sbjct: 183 SATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 347 ----------GIF-RAVLKADPS---FDDGS--WPSLSSDAK------------------ 372
G + +++ F W SS +
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 373 ------DFVKLLLNKDPRKRMTAAQALSHPWIR 399
D ++ +L DP KR+T +AL HP+
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 71/269 (26%), Positives = 118/269 (43%), Gaps = 19/269 (7%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHK-DQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
R E+GE +G G + + + + VA+KV+ RRE + A
Sbjct: 13 RYELGEILGFGGMSEV----HLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 194 LSGHSNLVKFYDAFEDLDN----VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL 249
L+ H +V YD E YIVME +G L D + + G + A V+
Sbjct: 69 LN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADAC 126
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL----SDFVRPDERLNDIVGSA 305
+ F H +G++HRD+KP N + + ++ +K +DFG+ +D + ++G+A
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 306 YYVAPE-VLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364
Y++PE S +DV+S+G + Y +L G PF + + ++ DP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQAL 393
LS+D V L K+P R A +
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 29/302 (9%)
Query: 100 RRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFG--YTCTARYKK 157
S+ A +FG + VGRG G Y +
Sbjct: 7 HHHHSSGLVPRGSHMDGTAESREGTQFG-------PYRLRRLVGRGGMGDVY-------E 52
Query: 158 GEH--KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215
E +++ VA+K++ ++ + + ++RE + L ++V +D E +Y+
Sbjct: 53 AEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV 111
Query: 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK 275
M L G +L +L R G + A A++ QI + + H G HRD+KPEN L ++
Sbjct: 112 DMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD 170
Query: 276 DESSQLKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLHRSYGTE-ADVWSIGVIAY 331
D +DFG++ DE+L + VG+ YY+APE S+ T AD++++ + Y
Sbjct: 171 D---FAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLY 226
Query: 332 ILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQ 391
L GS P+ S + + +A P P + + + K+P R
Sbjct: 227 ECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR-PGIPVAFDAVIARGMAKNPEDRYVTCG 285
Query: 392 AL 393
L
Sbjct: 286 DL 287
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 83/404 (20%), Positives = 141/404 (34%), Gaps = 119/404 (29%)
Query: 100 RRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGE 159
+++ ++ P + P + ++ R E+ +G G +G+ C A K
Sbjct: 23 SQQEGQQRKQHHSSKPTASMPRPHSDW----QIPDRYEIRHLIGTGSYGHVCEAYDKL-- 76
Query: 160 HKDQKVAIKVIPK--SKMTTAIAVEDVR--REVKILRALSGHSNLVKFYD-----AFEDL 210
+ + VAIK I + + R RE+ IL L+ H ++VK D E
Sbjct: 77 -EKRVVAIKKILRVFEDLIDCK-----RILREIAILNRLN-HDHVVKVLDIVIPKDVEKF 129
Query: 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENF 270
D +Y+V+E+ + ++ +E K +L +L V + H G++HRDLKP N
Sbjct: 130 DELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANC 187
Query: 271 LYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA------------------------- 305
L ++ +K DFGL+ V E N + +
Sbjct: 188 LV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244
Query: 306 ---YYVAPEVL--HRSYGTEADVWSIGVI----------AYILLCGSRPF---------- 340
+Y APE++ +Y DVWSIG I P
Sbjct: 245 VTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLS 304
Query: 341 --WARTESGIFRAVLKAD-----------PSFDDGSWPSLSSD-AKDFVKL--------- 377
F D PS +D +L + AK ++++
Sbjct: 305 PDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEED--IEALEKEDAKRYIRIFPKREGTDL 362
Query: 378 -------------LLNK----DPRKRMTAAQALSHPWIRNYNNV 404
LL + +P KR+T + L+HP+ +
Sbjct: 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 67/339 (19%), Positives = 120/339 (35%), Gaps = 84/339 (24%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVI-PKSKMTTAIAVEDVRREVKI 190
+ + V ++G G FG ++ + A+KV+ K T + + E I
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNIKKYTRS-----AKIEADI 84
Query: 191 LRALSGH----SNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK--YSEDEAKAV 244
L+ + +N+VK++ F D++ ++ E G L + I++R + ++ K
Sbjct: 85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYE-IITRNNYNGFHIEDIKLY 142
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKD----------------------ESSQLK 282
++IL + + + H DLKPEN L +S+ +K
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 283 AIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCGSRPFW 341
IDFG + F + I+ + Y APEV L+ + +D+WS G + L GS F
Sbjct: 203 LIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260
Query: 342 ARTES----------GIF------RAVLKADPSFDDGSWPSLSSDAK------------- 372
A + + L+
Sbjct: 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320
Query: 373 -------------DFVKLLLNKDPRKRMTAAQALSHPWI 398
DF+ +L DP R + A+ L H ++
Sbjct: 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 76/362 (20%), Positives = 124/362 (34%), Gaps = 103/362 (28%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK--SKMTTAIAVEDVR--R 186
V + +GRG +GY A K ++ VAIK + + + R R
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMFEDLIDCK-----RILR 74
Query: 187 EVKILRALSGHSNLVKFYDAF-----EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEA 241
E+ IL L +++ YD D +YIV+E+ + L ++ +E+
Sbjct: 75 EITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHI 131
Query: 242 KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI 301
K +L +L F H G++HRDLKP N L ++ +K DFGL+ + ++ N +
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 302 VGSA-----------------------YYVAPEVL--HRSYGTEADVWSIGVIAYILLCG 336
+Y APE++ +Y D+WS G I LL
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 337 SRPFWARTESG--IFRAVLKADPSFDDGSWPSLSSD------------------------ 370
+ + +F S D S
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN 308
Query: 371 ---AKDFVKL----------------------LLNK----DPRKRMTAAQALSHPWIRNY 401
++KL LL +P KR+T QAL HP++++
Sbjct: 309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368
Query: 402 NN 403
Sbjct: 369 RK 370
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 25/234 (10%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L + E++G G FG + K VA+K + ++ A++D REV + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H NL++ Y + +V EL G LLDR+ G + VQ+ +
Sbjct: 78 LD-HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 308
+ +HRDL N L ++D +K DFGL + ++ Y +
Sbjct: 136 YLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQND-------DHYVMQEHRK 185
Query: 309 ------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
APE L R++ +D W GV + + G P+ S I + K
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 56/253 (22%), Positives = 100/253 (39%), Gaps = 37/253 (14%)
Query: 114 APEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPK 172
AP +A + K + + + +G G FG + +GE VAIK + +
Sbjct: 3 APNQALLRILKE--------TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 173 SKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR 232
+ T+ A +++ E ++ ++ + ++ + V ++ +L G LLD +
Sbjct: 55 A--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH 110
Query: 233 CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292
VQI + + +VHRDL N L + +K DFGL+ +
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLL 167
Query: 293 RPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRP 339
+E Y A E + HR Y ++DVWS GV + ++ GS+P
Sbjct: 168 GAEE--------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 340 FWARTESGIFRAV 352
+ S I +
Sbjct: 220 YDGIPASEISSIL 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 69/370 (18%), Positives = 124/370 (33%), Gaps = 110/370 (29%)
Query: 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
R V ++G GHF + + VA+KV+ ++ T E E+++L+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSW---DIQGKKFVAMKVVKSAEHYT----ETALDEIRLLK 88
Query: 193 ALS-------GHSNLVKFYDAFE----DLDNVYIVMELCEGGELLD-RILSRCGKYSEDE 240
++ +V+ D F+ + ++ +V E+ G LL I S
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPC 147
Query: 241 AKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKD----------------------- 276
K ++ Q+L + + H ++H D+KPEN L + +
Sbjct: 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 277 ------------------ESSQLKAIDFGLSDF---VRPDERLNDIVGSAYYVAPEV-LH 314
E + + ++D + + + + Y + EV +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG 267
Query: 315 RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFR---------AVLKADPS------- 358
Y T AD+WS +A+ L G F + R +L P
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327
Query: 359 -----FD-DGSWPSLSS-------------------DAK---DFVKLLLNKDPRKRMTAA 390
F G ++ +A DF+ +L P KR TAA
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387
Query: 391 QALSHPWIRN 400
+ L HPW+ +
Sbjct: 388 ECLRHPWLNS 397
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 31/261 (11%), Positives = 58/261 (22%), Gaps = 38/261 (14%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
R + G A D++VA+ + + +++ L +
Sbjct: 32 RYRLLIFHGGVPPLQFWQAL---DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
+ + D +V E GG L + + S A + +
Sbjct: 89 D-KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP---SPVGAIRAMQSLAAAADA 144
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 314
H GV P V D + ++ +
Sbjct: 145 AHRAGVALSIDHPSRVR--------------------VSIDGDV--VLAYPATMPDA--- 179
Query: 315 RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK---ADPSFDDGSWPSLSSDA 371
+ D+ IG Y LL P + P +
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 372 KDFVKLLLNKDPRKRMTAAQA 392
+ D R +
Sbjct: 237 SAVAARSVQGDGGIRSASTLL 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 26/226 (11%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQK-VAIKVI-PKSKMTTAIAVEDVRREVK 189
R E+ +G+G FG A + +Q+ VAIK+I K + EV+
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAY----DRVEQEWVAIKIIKNKKAFLNQA-----QIEVR 102
Query: 190 ILRALSGH-----SNLVKFYDAFEDLDNVYIVMELCEGG--ELLDRILSRCGKYSEDEAK 242
+L ++ H +V F +++ +V E+ +LL R + G S + +
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLL-RNTNFRG-VSLNLTR 160
Query: 243 AVLVQILNVVAFCHLH--GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND 300
Q+ + F ++H DLKPEN L + S +K +DFG S + +R+
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIYQ 217
Query: 301 IVGSAYYVAPEV-LHRSYGTEADVWSIGVIAYILLCGSRPFWARTE 345
+ S +Y +PEV L Y D+WS+G I + G F E
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 9/28 (32%), Positives = 16/28 (57%)
Query: 372 KDFVKLLLNKDPRKRMTAAQALSHPWIR 399
KD + +L+ DP+ R+ AL H + +
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 58/235 (24%), Positives = 95/235 (40%), Gaps = 32/235 (13%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L +GE++GRG+FG + R + + VA+K ++ +E +IL+
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRETLPPDLK--AKFLQEARILKQ 168
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
S H N+V+ +YIVMEL +GG+ L + + + ++ +
Sbjct: 169 YS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 308
+ +HRDL N L T K+ LK DFG+S Y
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNV---LKISDFGMSREEADGV---------YAASGGLR 275
Query: 309 -------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
APE L + Y +E+DVWS G++ + G+ P+ + V K
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 61/328 (18%), Positives = 117/328 (35%), Gaps = 80/328 (24%)
Query: 115 PEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSK 174
P L +R + + + E +G+G FG +G+ + ++VA+K+ +
Sbjct: 28 SGSGLPLLVQR-----TIARTIVLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSRE 77
Query: 175 MTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV----YIVMELCEGGELLDRI- 229
+ E+ L H N++ F A + ++V + E G L D +
Sbjct: 78 ERSWFR----EAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 132
Query: 230 -----LSRCGKYSEDEAKAVLVQILNVVAFCHLH----------GVVHRDLKPENFLYTS 274
+ K + A + HLH + HRDLK +N L
Sbjct: 133 RYTVTVEGMIKLALSTASGL----------AHLHMEIVGTQGKPAIAHRDLKSKNILV-- 180
Query: 275 KDESSQLKAIDFGLSDFVRPDERLNDI-----VGSAYYVAPEVL-------HRSYGTEAD 322
++ D GL+ DI VG+ Y+APEVL H AD
Sbjct: 181 -KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239
Query: 323 VWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDD---------------GSWPS 366
++++G++ + + + + + ++ +DPS ++ W S
Sbjct: 240 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 299
Query: 367 LSSDAKDFVKLL---LNKDPRKRMTAAQ 391
+ + K++ + R+TA +
Sbjct: 300 CEAL-RVMAKIMRECWYANGAARLTALR 326
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 57/255 (22%), Positives = 101/255 (39%), Gaps = 37/255 (14%)
Query: 114 APEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPK 172
AP +A + K + + + +G G FG + +GE VAIK + +
Sbjct: 3 APNQALLRILKE--------TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 173 SKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR 232
+ T+ A +++ E ++ ++ + ++ + V ++ +L G LLD +
Sbjct: 55 A--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH 110
Query: 233 CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292
VQI + + +VHRDL N L + +K DFGL+ +
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLL 167
Query: 293 RPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRP 339
+E Y A E + HR Y ++DVWS GV + ++ GS+P
Sbjct: 168 GAEE--------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 340 FWARTESGIFRAVLK 354
+ S I + K
Sbjct: 220 YDGIPASEISSILEK 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 63/232 (27%), Positives = 94/232 (40%), Gaps = 29/232 (12%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
R+E+G +G G FG Y E+ VAIK + E +E +R
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 72
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
H ++VK + + V+I+MELC GEL + R Q+ +A
Sbjct: 73 FD-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 308
+ VHRD+ N L +S D +K DFGLS R + S YY
Sbjct: 131 YLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS---R------YMEDSTYYKASKGK 178
Query: 309 ------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
APE + R + + +DVW GV + IL+ G +PF + + +
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 58/232 (25%), Positives = 88/232 (37%), Gaps = 29/232 (12%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ + +G G FG Y + + VA+K K T E E I++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKN 69
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H ++VK E+ + +I+MEL GEL + +QI +A
Sbjct: 70 LD-HPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 308
+ VHRD+ N L S + +K DFGLS R I YY
Sbjct: 128 YLESINCVHRDIAVRNILVASPE---CVKLGDFGLS---R------YIEDEDYYKASVTR 175
Query: 309 ------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
+PE + R + T +DVW V + IL G +PF+ + +
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 66/312 (21%), Positives = 114/312 (36%), Gaps = 79/312 (25%)
Query: 136 LEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+++ +++G+G +G + G+ + +KVA+KV TT A E+
Sbjct: 39 IQMVKQIGKGRYGEVW-------MGKWRGEKVAVKVFF----TTEEASWFRETEIYQTVL 87
Query: 194 LSGHSNLVKFYDA----FEDLDNVYIVMELCEGGELLDRI------LSRCGKYSEDEAKA 243
+ H N++ F A +Y++ + E G L D + K +
Sbjct: 88 MR-HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSG 146
Query: 244 VLVQILNVVAFCHLH----------GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293
+ CHLH + HRDLK +N L ++ D GL+
Sbjct: 147 L----------CHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFI 193
Query: 294 PDERLNDI-----VGSAYYVAPEVL-------HRSYGTEADVWSIGVIAYILLCGSRPFW 341
D DI VG+ Y+ PEVL H AD++S G+I + +
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
Query: 342 ARTESGI-FRAVLKADPSFDD---------------GSWPSLSSDAKDFVKLL---LNKD 382
E + + ++ +DPS++D W S + KL+ +
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL-RQMGKLMTECWAHN 312
Query: 383 PRKRMTAAQALS 394
P R+TA +
Sbjct: 313 PASRLTALRVKK 324
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 27/239 (11%)
Query: 128 FSKEVT-SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR 186
F++E+ SR+ + + +G G G C R + +D VAIK + D
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLS 99
Query: 187 EVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLV 246
E I+ H N+++ IV E E G L + + G+++ + +L
Sbjct: 100 EASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY 306
+ + + G VHRDL N L D + K DFGLS + D A
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDP-------DAA 208
Query: 307 YV-----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
Y APE + R++ + +DVWS GV+ + +L G RP+W T + +V
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 64/252 (25%), Positives = 100/252 (39%), Gaps = 35/252 (13%)
Query: 114 APEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKS 173
E A ELD + + + + VG G FG C+ R K K+ VAIK +
Sbjct: 34 TVHEFAKELDA---------TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 174 KMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC 233
T D E I+ H N+++ V IV E E G L +
Sbjct: 85 --YTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 234 GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293
+++ + +L I + + + G VHRDL N L S K DFGL +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL---VCKVSDFGLGRVLE 198
Query: 294 PDERLNDIVGSAYYV-----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPF 340
D A Y +PE + +R + + +DVWS G++ + ++ G RP+
Sbjct: 199 DDP-------EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 341 WARTESGIFRAV 352
W + + +AV
Sbjct: 252 WEMSNQDVIKAV 263
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 53/257 (20%), Positives = 96/257 (37%), Gaps = 52/257 (20%)
Query: 136 LEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI--L 191
+ + E VG+G +G + +G + + VA+K+ + RE ++
Sbjct: 10 ITLLECVGKGRYGEVW-------RGSWQGENVAVKIFSSRDE------KSWFRETELYNT 56
Query: 192 RALSGHSNLVKFYDA----FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQ 247
L H N++ F + ++++ E G L D + + +++
Sbjct: 57 VMLR-HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLS 113
Query: 248 ILNVVAFCHLH----------GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER 297
I + HLH + HRDLK +N L ++ Q D GL+
Sbjct: 114 IAS--GLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTN 168
Query: 298 LNDI-----VGSAYYVAPEVL-------HRSYGTEADVWSIGVIAYILLCGSRPFWARTE 345
D+ VG+ Y+APEVL D+W+ G++ + + +
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
Query: 346 SGI-FRAVLKADPSFDD 361
F V+ DPSF+D
Sbjct: 229 YKPPFYDVVPNDPSFED 245
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 32/242 (13%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
L+ ++G+G+FG RY G++ VA+K + + + D +RE++IL+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILK 79
Query: 193 ALSGHSNLVKFYD--AFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
AL +VK+ ++ +VME G L D + + QI
Sbjct: 80 ALH-SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV-- 308
+ + VHRDL N L S+ +K DFGL+ + D+ YYV
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEA---HVKIADFGLAKLLPLDK--------DYYVVR 187
Query: 309 ----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKAD 356
APE L + ++DVWS GV+ Y + + E +
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
Query: 357 PS 358
P+
Sbjct: 248 PA 249
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 45/237 (18%), Positives = 81/237 (34%), Gaps = 31/237 (13%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYK----KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK 189
L E +G+G F + G+ + +V +KV+ K+ + E
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAAS 64
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL 249
++ LS H +LV Y D +V E + G L + + V Q+
Sbjct: 65 MMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQL-----KAIDFGLSDFVRPDERLNDIVGS 304
+ F + ++H ++ +N L +++ K D G+S V P +
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-------- 175
Query: 305 AYY------VAPEVLH--RSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
V PE + ++ D WS G + I G +P A +
Sbjct: 176 -ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 56/256 (21%), Positives = 100/256 (39%), Gaps = 38/256 (14%)
Query: 113 GAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIP 171
GA + A + + L + +G G FG + +GE V IKVI
Sbjct: 1 GAMKVLARIFKE---------TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE 51
Query: 172 KSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILS 231
+ + + V + + +L H+++V+ ++ +V + G LLD +
Sbjct: 52 DK--SGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ 107
Query: 232 RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291
G VQI + + HG+VHR+L N L S Q++ DFG++D
Sbjct: 108 HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS---QVQVADFGVADL 164
Query: 292 VRPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSR 338
+ PD+ + A E + Y ++DVWS GV + ++ G+
Sbjct: 165 LPPDD--------KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
Query: 339 PFWARTESGIFRAVLK 354
P+ + + + K
Sbjct: 217 PYAGLRLAEVPDLLEK 232
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 34/232 (14%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
S L +E+G G FG + KVAIK I + M + ED E +++
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLN----KDKVAIKTIREGAM----SEEDFIEEAEVMMK 59
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
LS H LV+ Y + + +V E E G L D + ++ G ++ + + + + +A
Sbjct: 60 LS-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 308
+ V+HRDL N L E+ +K DFG++ FV D+ Y
Sbjct: 119 YLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ---------YTSSTGTK 166
Query: 309 ------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
+PEV Y +++DVWS GV+ + + G P+ R+ S + +
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 61/306 (19%), Positives = 109/306 (35%), Gaps = 67/306 (21%)
Query: 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
+ L++ E RG FG K + ++ VA+K+ P EV L
Sbjct: 23 SMPLQLLEVKARGRFGCVW-----KAQLLNEYVAVKIFP----IQDKQSWQNEYEVYSLP 73
Query: 193 ALSGHSNLVKFYDAFEDLDNV----YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI 248
+ H N+++F A + +V +++ E G L D + + ++E L I
Sbjct: 74 GMK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNE------LCHI 126
Query: 249 LNVVA--FCHLH------------GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294
+A +LH + HRD+K +N L + DFGL+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEA 183
Query: 295 DERLNDI---VGSAYYVAPEVL------HRSYGTEADVWSIGVIAYILLCGSRPFWARTE 345
+ D VG+ Y+APEVL R D++++G++ + L +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 346 SGI--FRAVLKADPSFDD---------------GSWPSLSSDAKDFVKLLL---NKDPRK 385
+ F + PS +D W + A + + + D
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM-LCETIEECWDHDAEA 302
Query: 386 RMTAAQ 391
R++A
Sbjct: 303 RLSAGC 308
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ + +E+G G FG ++K VA+K+I + M + ++ +E + +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKG----QYDVAVKMIKEGSM----SEDEFFQEAQTMMK 59
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
LS H LVKFY +YIV E G LL+ + S + + + +A
Sbjct: 60 LS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 308
F H +HRDL N L D +K DFG++ +V D+ Y
Sbjct: 119 FLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ---------YVSSVGTK 166
Query: 309 ------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
APEV + Y +++DVW+ G++ + + G P+ T S + V
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 28/240 (11%)
Query: 128 FSKEVT-SRLEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVR 185
F+ E+ S + + +G G FG K K+ VAIK + T D
Sbjct: 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFL 94
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
E I+ S H N+++ + I+ E E G L + + G++S + +L
Sbjct: 95 GEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
I + + VHRDL N L + + K DFGLS + D A
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDP-------EA 203
Query: 306 YYV-----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
Y APE + +R + + +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 65/252 (25%), Positives = 98/252 (38%), Gaps = 38/252 (15%)
Query: 114 APEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKS 173
P E+ + R+E+G +G G FG Y E+ VAIK
Sbjct: 379 MPSTRDYEIQR---------ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC 429
Query: 174 KMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC 233
T+ E +E +R H ++VK + + V+I+MELC GEL + R
Sbjct: 430 --TSDSVREKFLQEALTMRQFD-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK 485
Query: 234 GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293
Q+ +A+ VHRD+ N L +S D +K DFGLS
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSR--- 539
Query: 294 PDERLNDIVGSAYYV-----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPF 340
+ S YY APE + R + + +DVW GV + IL+ G +PF
Sbjct: 540 ------YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593
Query: 341 WARTESGIFRAV 352
+ + +
Sbjct: 594 QGVKNNDVIGRI 605
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/318 (19%), Positives = 110/318 (34%), Gaps = 82/318 (25%)
Query: 133 TSRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
L++ E +GRG +G Y KG ++ VA+KV + ++ E I
Sbjct: 12 LDNLKLLELIGRGRYGAVY-------KGSLDERPVAVKVFSFANR------QNFINEKNI 58
Query: 191 LR-ALSGHSNLVKFYDA-----FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
R L H N+ +F + +VME G L + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVS------ 112
Query: 245 LVQILNVVA--FCHLH-----------GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291
++ + V +LH + HRDL N L DFGLS
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMR 169
Query: 292 VRPDERL---------NDIVGSAYYVAPEVL--------HRSYGTEADVWSIGVIAYILL 334
+ + + VG+ Y+APEVL S + D++++G+I + +
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 335 ---CGSRPFWARTESGI-FRAVLKADPSFDD---------------GSWPSLSSDAKDFV 375
P + E + F+ + P+F+D +W S +
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 376 KLLL---NKDPRKRMTAA 390
+ + ++D R+TA
Sbjct: 290 ETIEDCWDQDAEARLTAQ 307
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 54/234 (23%), Positives = 95/234 (40%), Gaps = 34/234 (14%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L +E+G G FG +++ VAIK+I + M + ++ E K++
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSM----SEDEFIEEAKVMMN 75
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
LS H LV+ Y ++I+ E G LL+ + ++ + + + +
Sbjct: 76 LS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 308
+ +HRDL N L + +K DFGLS +V DE Y
Sbjct: 135 YLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE---------YTSSVGSK 182
Query: 309 ------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
PEVL + + +++D+W+ GV+ + I G P+ T S + +
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 51/229 (22%), Positives = 91/229 (39%), Gaps = 22/229 (9%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ + + ++G G +G +KK VA+K + + M VE+ +E +++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTME----VEEFLKEAAVMKE 272
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
+ H NLV+ YI+ E G LLD + + VL+ + ++
Sbjct: 273 IK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS---AVVLLYMATQIS 328
Query: 254 ----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYY-- 307
+ +HR+L N L +K DFGLS + D
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGENH---LVKVADFGLSRLMTGDTYTAHAGAKFPIKW 385
Query: 308 VAPEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
APE L + + ++DVW+ GV+ + I G P+ S ++ + K
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 60/243 (24%), Positives = 105/243 (43%), Gaps = 35/243 (14%)
Query: 105 TKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYK-KGEHKDQ 163
T ++ +GA A + D F + L+ +++G+G+FG RY ++ +
Sbjct: 16 TTENLYFQGAMGSAFEDRDPTQ-FEER---HLKFLQQLGKGNFGSVEMCRYDPLQDNTGE 71
Query: 164 KVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDA--FEDLDNVYIVMELCE 221
VA+K + + +T + D RE++IL++L H N+VK+ N+ ++ME
Sbjct: 72 VVAVKKL---QHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLP 127
Query: 222 GGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281
G L D + + + QI + + +HRDL N L +++ ++
Sbjct: 128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---RV 184
Query: 282 KAIDFGLSDFVRPDERLNDIVGSAYYV------------APEVL-HRSYGTEADVWSIGV 328
K DFGL+ + D+ YY APE L + +DVWS GV
Sbjct: 185 KIGDFGLTKVLPQDK--------EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236
Query: 329 IAY 331
+ Y
Sbjct: 237 VLY 239
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
L+ +++G+G+FG RY ++ + VA+K + + +T + D RE++IL+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILK 66
Query: 193 ALSGHSNLVKFYDA--FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
+L H N+VK+ N+ ++ME G L D + + + QI
Sbjct: 67 SLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV-- 308
+ + +HRDL N L +++ ++K DFGL+ + D+ ++
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK--------EFFKVK 174
Query: 309 ----------APEVL-HRSYGTEADVWSIGVIAY 331
APE L + +DVWS GV+ Y
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
E+G G+FG Y+ K VAIKV+ + T E++ RE +I+ L + +
Sbjct: 17 ELGCGNFGSVRQGVYR-MRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYI 72
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
V+ + + +VME+ GG L ++ + + +L Q+ + +
Sbjct: 73 VRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV------------ 308
VHRDL N L ++ K DFGLS + D+ +YY
Sbjct: 132 VHRDLAARNVLLVNRH---YAKISDFGLSKALGADD--------SYYTARSAGKWPLKWY 180
Query: 309 APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
APE + R + + +DVWS GV + L G +P+ + +
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 57/261 (21%), Positives = 98/261 (37%), Gaps = 35/261 (13%)
Query: 115 PEEAAPELDKRFGFSKEVT-SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIP 171
P KEV + + +G G FG Y + +VA+K +P
Sbjct: 10 PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 172 KSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILS 231
+ D E I+ + H N+V+ +I+MEL GG+L +
Sbjct: 70 EVCSEQDE--LDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRE 126
Query: 232 RCGKYSEDEAKAV--LVQILNVVAF--CHL--HGVVHRDLKPENFLYTSKDESSQLKAID 285
+ S+ + A+ L+ + +A +L + +HRD+ N L T K D
Sbjct: 127 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186
Query: 286 FGLSDFVRPDERLNDIVGSAYYV------------APEVL-HRSYGTEADVWSIGVIAY- 331
FG++ R DI ++YY PE + ++ D WS GV+ +
Sbjct: 187 FGMA---R------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237
Query: 332 ILLCGSRPFWARTESGIFRAV 352
I G P+ +++ + V
Sbjct: 238 IFSLGYMPYPSKSNQEVLEFV 258
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 56/238 (23%), Positives = 91/238 (38%), Gaps = 42/238 (17%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L + ++G+G FG + +VAIK + M+ E +E ++++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTMS----PEAFLQEAQVMKK 235
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H LV+ Y + + +YIV E G LLD + GKY LV + +A
Sbjct: 236 LR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIA 290
Query: 254 ----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV- 308
+ VHRDL+ N L K DFGL+ + +E Y
Sbjct: 291 SGMAYVERMNYVHRDLRAANILVGENL---VCKVADFGLARLIEDNE---------YTAR 338
Query: 309 ----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
APE + + ++DVWS G++ + G P+ + V +
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/292 (19%), Positives = 105/292 (35%), Gaps = 35/292 (11%)
Query: 84 VFRMPPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVT-SRLEVGEEV 142
++ ++ + K + + P KEV + + +
Sbjct: 20 LYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGL 79
Query: 143 GRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
G G FG Y + +VA+K +P+ + D E I+ + H N+
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNI 136
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV--LVQILNVVA----F 254
V+ +I++EL GG+L + + S+ + A+ L+ + +A +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 308
+ +HRD+ N L T K DFG++ R DI + YY
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRAGYYRKGGCAM 247
Query: 309 ------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
PE + ++ D WS GV+ + I G P+ +++ + V
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 62/270 (22%), Positives = 103/270 (38%), Gaps = 49/270 (18%)
Query: 99 LRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKG 158
L + K + + A + + L+ L++ + +G+G FG G
Sbjct: 167 LIKPKVMEGTVAAQDEFYRSGWALNM---------KELKLLQTIGKGEFGDVM-----LG 212
Query: 159 EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDA-FEDLDNVYIVM 217
+++ KVA+K I + E ++ L HSNLV+ E+ +YIV
Sbjct: 213 DYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVT 266
Query: 218 ELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA----FCHLHGVVHRDLKPENFLYT 273
E G L+D + SR L++ V + + VHRDL N L +
Sbjct: 267 EYMAKGSLVDYLRSRGRSVLG---GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 323
Query: 274 SKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV-------APEVL-HRSYGTEADVWS 325
E + K DFGL+ + + APE L + + T++DVWS
Sbjct: 324 ---EDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 371
Query: 326 IGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
G++ + I G P+ + V K
Sbjct: 372 FGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
L+ ++G GHFG RY +G++ ++VA+K + K + + D+++E++ILR
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGN-HIADLKKEIEILR 78
Query: 193 ALSGHSNLVKFYDA--FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
L H N+VK+ + + + ++ME G L + + K + + VQI
Sbjct: 79 NLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV-- 308
+ + VHRDL N L + Q+K DFGL+ + D+ YY
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDK--------EYYTVK 186
Query: 309 ----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTES 346
APE L + +DVWS GV + +L
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 30/229 (13%)
Query: 138 VGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH 197
+E+G G+FG Y+ + + VA+K++ K++ +++ E +++ L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQ-MKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLD-N 77
Query: 198 SNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL 257
+V+ + ++ +VME+ E G L L + + ++ Q+ + +
Sbjct: 78 PYIVRMI-GICEAESWMLVMEMAELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV--------- 308
VHRDL N L ++ K DFGLS +R DE YY
Sbjct: 136 SNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADE--------NYYKAQTHGKWPV 184
Query: 309 ---APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
APE + + + +++DVWS GV+ + G +P+ S + +
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 63/289 (21%), Positives = 108/289 (37%), Gaps = 33/289 (11%)
Query: 78 NLTPMRVFRMPPSPAKHIKAVLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLE 137
+ + P PA+ R S E + + K F +
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI--- 339
Query: 138 VGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH 197
E+G G+FG Y+ K VAIKV+ + T E++ RE +I+ L +
Sbjct: 340 ADIELGCGNFGSVRQGVYR-MRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-N 395
Query: 198 SNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL 257
+V+ + + +VME+ GG L ++ + + +L Q+ + +
Sbjct: 396 PYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV--------- 308
VHR+L N L ++ K DFGLS + D+ +YY
Sbjct: 455 KNFVHRNLAARNVLLVNRH---YAKISDFGLSKALGADD--------SYYTARSAGKWPL 503
Query: 309 ---APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
APE + R + + +DVWS GV + L G +P+ + +
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 42/238 (17%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L++ +++G G FG A Y K KVA+K + M+ VE E +++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPGSMS----VEAFLAEANVMKT 239
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H LVK + + +YI+ E G LLD + S G L+ +A
Sbjct: 240 LQ-HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQP---LPKLIDFSAQIA 294
Query: 254 ----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV- 308
F +HRDL+ N L S K DFGL+ + +E Y
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE---------YTAR 342
Query: 309 ----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
APE + S+ ++DVWS G++ I+ G P+ + + RA+ +
Sbjct: 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-23
Identities = 57/259 (22%), Positives = 103/259 (39%), Gaps = 49/259 (18%)
Query: 113 GAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK 172
G+P E+++ + + + ++G G +G +KK VA+K + +
Sbjct: 1 GSPNYDKWEMER---------TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKE 48
Query: 173 SKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSR 232
M VE+ +E +++ + H NLV+ YI+ E G LLD +
Sbjct: 49 DTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 103
Query: 233 CGKYSEDEAKAVLVQILNVVA----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288
+ + + VL+ + ++ + +HRDL N L E+ +K DFGL
Sbjct: 104 NRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGL 157
Query: 289 SDFVRPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADVWSIGVIAY-ILLC 335
S + D Y APE L + + ++DVW+ GV+ + I
Sbjct: 158 SRLMTGDT---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 336 GSRPFWARTESGIFRAVLK 354
G P+ S ++ + K
Sbjct: 209 GMSPYPGIDLSQVYELLEK 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-22
Identities = 56/238 (23%), Positives = 91/238 (38%), Gaps = 42/238 (17%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L + ++G+G FG + +VAIK + M+ E +E ++++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTMS----PEAFLQEAQVMKK 318
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H LV+ Y + + +YIV E G LLD + GKY LV + +A
Sbjct: 319 LR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIA 373
Query: 254 ----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV- 308
+ VHRDL+ N L K DFGL+ + +E Y
Sbjct: 374 SGMAYVERMNYVHRDLRAANILVGENL---VCKVADFGLARLIEDNE---------YTAR 421
Query: 309 ----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
APE + + ++DVWS G++ + G P+ + V +
Sbjct: 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 53/238 (22%), Positives = 92/238 (38%), Gaps = 32/238 (13%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ E +GRGHFG + K A+K + + T V E I++
Sbjct: 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKD 82
Query: 194 LSGHSNLVKFYDA-FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
S H N++ + +V+ + G+L + I + + + +Q+ +
Sbjct: 83 FS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 141
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV---- 308
+ VHRDL N + DE +K DFGL+ R D+ YY
Sbjct: 142 KYLASKKFVHRDLAARNCML---DEKFTVKVADFGLA---R------DMYDKEYYSVHNK 189
Query: 309 ----------APEVLH-RSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
A E L + + T++DVWS GV+ + ++ G+ P+ I +L+
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 50/245 (20%), Positives = 96/245 (39%), Gaps = 38/245 (15%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ L +G+ +G G FG K+ + KVA+K + K ++ +E+ E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92
Query: 194 LSGHSNLVKFY-----DAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDE-AKAVLVQ 247
S H N+++ + + + +++ + G+L +L + L++
Sbjct: 93 FS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 248 ILNVVAF--CHL--HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVG 303
+ +A +L +HRDL N + + + DFGLS + I
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLS---K------KIYS 199
Query: 304 SAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 349
YY A E L R Y +++DVW+ GV + I G P+ ++
Sbjct: 200 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 350 RAVLK 354
+L
Sbjct: 260 DYLLH 264
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 40/233 (17%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L++ + +G+G FG G+++ KVA+K I + E ++
Sbjct: 21 KELKLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQ 70
Query: 194 LSGHSNLVKFYDA-FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
L HSNLV+ E+ +YIV E G L+D + SR L++ V
Sbjct: 71 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG---GDCLLKFSLDV 126
Query: 253 AF--CHL--HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV 308
+L + VHRDL N L E + K DFGL+ + + +
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---K------EASSTQDTG 174
Query: 309 -------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
APE L + + T++DVWS G++ + I G P+ + V
Sbjct: 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 59/267 (22%), Positives = 108/267 (40%), Gaps = 43/267 (16%)
Query: 113 GAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPK 172
G +E +L+ ++ + +G +G+G FG A+ K+ + KVA+K++ K
Sbjct: 6 GISDELKEKLED-VLIPEQ---QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-K 60
Query: 173 SKMTTAIAVEDVRREVKILRALSGHSNLVKFY------DAFEDLDNVYIVMELCEGGELL 226
+ + + +E+ RE ++ H ++ K A L +++ + G+L
Sbjct: 61 ADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLH 119
Query: 227 DRILS-RCGKYSEDEAKAVLVQILNVVAF--CHL--HGVVHRDLKPENFLYTSKDESSQL 281
+L+ R G+ + LV+ + +A +L +HRDL N + E +
Sbjct: 120 AFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTV 176
Query: 282 KAIDFGLSDFVRPDERLNDIVGSAYYV------------APEVLH-RSYGTEADVWSIGV 328
DFGLS R I YY A E L Y +DVW+ GV
Sbjct: 177 CVADFGLS---R------KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227
Query: 329 IAY-ILLCGSRPFWARTESGIFRAVLK 354
+ I+ G P+ + I+ ++
Sbjct: 228 TMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 42/238 (17%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L++ E +G G FG Y KVA+K + + M+ + E +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG----HTKVAVKSLKQGSMS----PDAFLAEANLMKQ 64
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H LV+ Y + +YI+ E E G L+D + + G L+ + +A
Sbjct: 65 LQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL---TINKLLDMAAQIA 119
Query: 254 ----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV- 308
F +HRDL+ N L ++ K DFGL+ + +E Y
Sbjct: 120 EGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE---------YTAR 167
Query: 309 ----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
APE + + ++ ++DVWS G++ I+ G P+ T + + + +
Sbjct: 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 43/235 (18%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
+ L+ G+ +G G FG TA E KVA+K++ + A E + E+KI+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIM 103
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNV 251
L H N+V A V ++ E C G+LL+ + + D A A+ +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 252 ---VAFC--------HL--HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL 298
+ F L +HRD+ N L T K DFGL+ R
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA---R----- 212
Query: 299 NDIVGSAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRP 339
DI+ + Y+ APE + Y ++DVWS G++ + I G P
Sbjct: 213 -DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 61/248 (24%), Positives = 99/248 (39%), Gaps = 47/248 (18%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ ++ + +G G+FG AR KK AIK + + + D E+++L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEY--ASKDDHRDFAGELEVLCK 81
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD-----RILSRCGKYSEDEAKAVLVQI 248
L H N++ A E +Y+ +E G LLD R+L ++ + A +
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 249 LNVVAFC--------HL--HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL 298
++ F +L +HRDL N L E+ K DFGLS R
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RG 191
Query: 299 NDIVGSAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWART 344
+ YV A E L + Y T +DVWS GV+ + I+ G P+ T
Sbjct: 192 QE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246
Query: 345 ESGIFRAV 352
+ ++ +
Sbjct: 247 CAELYEKL 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-22
Identities = 52/242 (21%), Positives = 86/242 (35%), Gaps = 46/242 (19%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
S + EE+G FG Y + Q VAIK + E+ R E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLR 66
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD--RILSRCGKYSEDEAKAVLVQIL 249
L H N+V + ++ C G+L + + S + + L
Sbjct: 67 ARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 250 NVVAFCHL-------------HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
F HL H VVH+DL N L + +K D GL R
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF---R--- 176
Query: 297 RLNDIVGSAYYV------------APE-VLHRSYGTEADVWSIGVIAY-ILLCGSRPFWA 342
++ + YY APE +++ + ++D+WS GV+ + + G +P+
Sbjct: 177 ---EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 343 RT 344
+
Sbjct: 234 YS 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 60/239 (25%), Positives = 92/239 (38%), Gaps = 47/239 (19%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
+RL G+ +G G FG TA VA+K++ S E + E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVL 80
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD-------RILSRCGKYSEDEAKAV 244
L H N+V A ++ E C G+LL+ + + E +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 245 LVQILNVVAFC--------HL--HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294
+ + ++++F L +HRDL N L T K DFGL+ R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---R- 193
Query: 295 DERLNDIVGSAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRP 339
DI + YV APE + + Y E+DVWS G+ + + GS P
Sbjct: 194 -----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 56/238 (23%), Positives = 95/238 (39%), Gaps = 32/238 (13%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+G+GHFG Y + AIK + + T VE RE ++R
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRG 78
Query: 194 LSGHSNLVKFYDAFEDLDNV-YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
L+ H N++ + + ++++ G+LL I S + + + +Q+ +
Sbjct: 79 LN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV---- 308
+ VHRDL N + DES +K DFGL+ R DI+ YY
Sbjct: 138 EYLAEQKFVHRDLAARNCML---DESFTVKVADFGLA---R------DILDREYYSVQQH 185
Query: 309 ----------APEVLH-RSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
A E L + T++DVWS GV+ + +L G+ P+ + + +
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 52/238 (21%), Positives = 91/238 (38%), Gaps = 32/238 (13%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ E +GRGHFG + K A+K + + T V E I++
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKD 146
Query: 194 LSGHSNLVKFYDA-FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
S H N++ + +V+ + G+L + I + + + +Q+ +
Sbjct: 147 FS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV---- 308
F VHRDL N + DE +K DFGL+ R D+ +
Sbjct: 206 KFLASKKFVHRDLAARNCML---DEKFTVKVADFGLA---R------DMYDKEFDSVHNK 253
Query: 309 ----------APEVLH-RSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 354
A E L + + T++DVWS GV+ + ++ G+ P+ I +L+
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 46/240 (19%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
RL++G+ +GRG FG A + VA+K++ + T + E+KIL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKIL 84
Query: 192 RALSGHSNLVKFYDAFEDLDN-VYIVMELCEGGELLD-----RILSRCGKYSEDEAKAVL 245
+ H N+V A + +++E C+ G L R K + ++
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 246 VQILNVVAFC--------HL--HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295
+ + +++ + L +HRDL N L + E + +K DFGL+ R
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA---R-- 196
Query: 296 ERLNDIVGSAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFW 341
DI YV APE + R Y ++DVWS GV+ + I G+ P+
Sbjct: 197 ----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 55/236 (23%), Positives = 86/236 (36%), Gaps = 33/236 (13%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYK-KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
L+ ++G GHFG Y + + VA+K + K+ ++E+ ILR
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQ-HRSGWKQEIDILR 88
Query: 193 ALSGHSNLVKFYDA--FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
L H +++K+ ++ +VME G L D + + QI
Sbjct: 89 TLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICE 145
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV-- 308
+A+ H +HRDL N L + +K DFGL+ V YY
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHE--------YYRVR 194
Query: 309 ----------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 352
APE L + +DVWS GV Y +L T+ +
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 52/246 (21%), Positives = 100/246 (40%), Gaps = 40/246 (16%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
++ + E+G+G FG Y A+ + + +VAIK + ++ + + E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVM 82
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL------ 245
+ ++V+ ++MEL G+L + S + + A
Sbjct: 83 KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 246 ---VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV 302
+I + +A+ + + VHRDL N + E +K DFG++ R DI
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---R------DIY 189
Query: 303 GSAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGI 348
+ YY +PE L + T +DVWS GV+ + I +P+ + +
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 349 FRAVLK 354
R V++
Sbjct: 250 LRFVME 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 57/242 (23%), Positives = 95/242 (39%), Gaps = 47/242 (19%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
+ + E+G G FG + VA+K + + A +D +RE ++L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELL 71
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD-----RILSRCGKYSEDEAKAVLV 246
L H ++VKFY D D + +V E + G+L + + +
Sbjct: 72 TNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 247 QILNVVAFC--------HL--HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
+ ++ +L VHRDL N L + +K DFG+S R
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---R--- 181
Query: 297 RLNDIVGSAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWA 342
D+ + YY PE + +R + TE+DVWS GVI + I G +P++
Sbjct: 182 ---DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 238
Query: 343 RT 344
+
Sbjct: 239 LS 240
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 71/267 (26%), Positives = 108/267 (40%), Gaps = 54/267 (20%)
Query: 99 LRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFG--YTCTARYK 156
L+ + T S E + E D ++ F +E LE G+ +G G FG TA
Sbjct: 13 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRE---NLEFGKVLGSGAFGKVMNATAYGI 69
Query: 157 KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIV 216
+VA+K++ + + E + E+K++ L H N+V A +Y++
Sbjct: 70 SKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127
Query: 217 MELCEGGELLDRILSRCGKYSEDEAKAVLVQILNV------------VAFC--------H 256
E C G+LL+ + S+ K+SEDE + + L + F
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187
Query: 257 L--HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 308
L VHRDL N L T +K DFGL+ R DI+ + YV
Sbjct: 188 LEFKSCVHRDLAARNVLVT---HGKVVKICDFGLA---R------DIMSDSNYVVRGNAR 235
Query: 309 ------APEVL-HRSYGTEADVWSIGV 328
APE L Y ++DVWS G+
Sbjct: 236 LPVKWMAPESLFEGIYTIKSDVWSYGI 262
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 46/241 (19%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
+ + E+G G FG + E VA+K + K + A +D +RE ++L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELL 97
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD-----RILSRCGKYSEDEAKAV-- 244
L H ++V+F+ + + +V E G+L ++ ED A
Sbjct: 98 TMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 245 ---LVQILNVVA----FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER 297
L+ + + VA + VHRDL N L + +K DFG+S R
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---R---- 206
Query: 298 LNDIVGSAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWAR 343
DI + YY PE + +R + TE+DVWS GV+ + I G +P++
Sbjct: 207 --DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264
Query: 344 T 344
+
Sbjct: 265 S 265
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-20
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 37/228 (16%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKV-IPKSKMTTAIAVEDVRREVKI 190
V +R +G ++G G FG ++VAIK+ K+K + E KI
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVKTKHPQ------LHIESKI 57
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVL---V 246
+ + G + + D +VMEL G L+ + + C K+S K VL
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFS---LKTVLLLAD 112
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR--------PDERL 298
Q+++ + + H +HRD+KP+NFL + + + IDFGL+ R P
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 299 NDIVGSAYYVAPEVLHRSYGTEA----DVWSIG-VIAYILLCGSRPFW 341
++ G+A Y + ++ G E D+ S+G V+ Y GS P W
Sbjct: 173 KNLTGTARYAS---INTHLGIEQSRRDDLESLGYVLMY-FNLGSLP-W 215
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKV-IPKSKMTTAIAVEDVRREVKI 190
V VG+++G G+FG + + ++ VAIK+ KS+ + E +
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNL---YTNEYVAIKLEPMKSRAPQ------LHLEYRF 57
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVL---V 246
+ L + + Y +V+EL G L+ + C +S K VL +
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFS---LKTVLMIAI 112
Query: 247 QILNVVAFCHLHGVVHRDLKPENFL--YTSKDESSQLKAIDFGLS-DFVRPDERL----- 298
Q+++ + + H +++RD+KPENFL + IDF L+ +++ P+ +
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 299 --NDIVGSAYYVAPEVLHRSYGTEA----DVWSIGVIAYILLCGSRPFW 341
+ G+A Y++ ++ G E D+ ++G + L GS P W
Sbjct: 173 EHKSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP-W 217
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 61/252 (24%), Positives = 102/252 (40%), Gaps = 47/252 (18%)
Query: 134 SRLEVGEEVGRGHFG--YTCTAR--YKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK 189
RL +G+ +G G FG A K ++ KVA+K++ T + D+ E++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEME 126
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD-----RILSRCGKYSEDEAKAV 244
+++ + H N++ A +Y+++E G L + R Y+
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 245 LVQILNVVAFC--------HL--HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294
+ ++V+ +L +HRDL N L T E + +K DFGL+ R
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---R- 239
Query: 295 DERLNDIVGSAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPF 340
DI YY APE L R Y ++DVWS GV+ + I G P+
Sbjct: 240 -----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 341 WARTESGIFRAV 352
+F+ +
Sbjct: 295 PGVPVEELFKLL 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 64/264 (24%), Positives = 102/264 (38%), Gaps = 52/264 (19%)
Query: 98 VLRRRKSTKKSSAEEGAPEEAAPELDKRFGFSKEVT-SRLEVGEEVGRGHFG--YTCTAR 154
+ R ST + G E PE K E +L +G+ +G G FG A
Sbjct: 49 ITTRLSSTADTPMLAGVSEYELPEDPK-----WEFPRDKLTLGKPLGEGCFGQVVMAEAV 103
Query: 155 --YKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212
K + VA+K++ T + D+ E+++++ + H N++ A
Sbjct: 104 GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161
Query: 213 VYIVMELCEGGELLD-----RILSRCGKYSEDEAKAVLVQILNVVAFC--------HL-- 257
+Y+++E G L + R Y + + ++V+ +L
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV--------- 308
+HRDL N L T E++ +K DFGL+ R DI YY
Sbjct: 222 QKCIHRDLAARNVLVT---ENNVMKIADFGLA---R------DINNIDYYKKTTNGRLPV 269
Query: 309 ---APEVL-HRSYGTEADVWSIGV 328
APE L R Y ++DVWS GV
Sbjct: 270 KWMAPEALFDRVYTHQSDVWSFGV 293
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 46/227 (20%)
Query: 134 SRLEVGEEVGRGHFG--YTCTAR--YKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK 189
+L +G+ +G G FG A K + VA+K++ T + D+ E++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD-----RILSRCGKYSEDEAKAV 244
+++ + H N++ A +Y+++E G L + R Y +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 245 LVQILNVVAFC--------HL--HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294
+ ++V+ +L +HRDL N L T E++ +K DFGL+ R
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R- 205
Query: 295 DERLNDIVGSAYYV------------APEVL-HRSYGTEADVWSIGV 328
DI YY APE L R Y ++DVWS GV
Sbjct: 206 -----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 50/238 (21%), Positives = 89/238 (37%), Gaps = 52/238 (21%)
Query: 138 VGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH 197
+G+++G G FG A KD + +KV + + E+K + ++
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-------LFSELKFYQRVAKK 93
Query: 198 SNLVKFYD------------------AFEDLDNVYIVMELCEGGELLDRILSRCGKYSED 239
+ K+ + F+ ++VME G L +I + G + +
Sbjct: 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKK- 150
Query: 240 EAKAVL---VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
VL +++L+V+ + H + VH D+K N L K+ Q+ D+GLS P+
Sbjct: 151 --STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP-DQVYLADYGLSYRYCPNG 207
Query: 297 RLNDI--------VGSAYYVAPEVLHRSYGTEA----DVWSIG-VIAYILLCGSRPFW 341
G+ + H+ G DV +G + LCG P W
Sbjct: 208 NHKQYQENPRKGHNGTIEF-TSLDAHK--GVALSRRSDVEILGYCMLR-WLCGKLP-W 260
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 60/258 (23%), Positives = 102/258 (39%), Gaps = 54/258 (20%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
L +G+ +G G FG TA + KG VA+K++ ++ + + D+ E +L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVL 80
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD-------------RILSRCGKYSE 238
+ + H +++K Y A + +++E + G L S
Sbjct: 81 KQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 239 DEAKAVLVQILNVVAFC--------HL--HGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288
D + + ++++F +L +VHRDL N L E ++K DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGL 196
Query: 289 SDFVRPDERLNDIVGSAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILL 334
S R D+ YV A E L Y T++DVWS GV+ + I+
Sbjct: 197 S---R------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 335 CGSRPFWARTESGIFRAV 352
G P+ +F +
Sbjct: 248 LGGNPYPGIPPERLFNLL 265
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIP-KSKMTTAIAVEDVRREVKI 190
V +VG +G G FG +Q+VAIK P +S +R E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNL---LNNQQVAIKFEPRRSDAPQ------LRDEYRT 58
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVL---V 246
+ L+G + + Y ++ + +V++L G L+ +L CG K+S K V
Sbjct: 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFS---VKTVAMAAK 113
Query: 247 QILNVVAFCHLHGVVHRDLKPENFL--YTSKDESSQLKAIDFGLS-DFVRPDERL----- 298
Q+L V H +V+RD+KP+NFL + ++ + +DFG+ + P +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 299 --NDIVGSAYYVAPEVLHRSYGTEA----DVWSIGVIAYILLCGSRPFW 341
++ G+A Y++ ++ G E D+ ++G + L GS P W
Sbjct: 174 EKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIP-KSKMTTAIAVEDVRREVKI 190
V ++ +G ++G G FG +++VAIK+ K+K + E KI
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKHPQ------LLYESKI 55
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVL---V 246
R L G + + + D +VM+L G L+ + + C K S K VL
Sbjct: 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLS---LKTVLMLAD 110
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR--------PDERL 298
Q++N V F H +HRD+KP+NFL ++Q+ IDFGL+ R P
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 299 NDIVGSAYYVAPEVLHRSYGTEA----DVWSIGVIAYILLCGSRPFW 341
++ G+A Y + ++ G E D+ S+G + L GS P W
Sbjct: 171 KNLTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 48/282 (17%), Positives = 92/282 (32%), Gaps = 64/282 (22%)
Query: 100 RRRKSTKKSSAEEGAPEEAAPE---LDKRFGFSKEVTSRLEVGEEVGRGHFG--YTCTAR 154
+ + S+ + E + + +VG +G+G FG Y
Sbjct: 4 VKAAQAGRQSSAKRHLAEQFAVGEIITDMAA------AAWKVGLPIGQGGFGCIYLADMN 57
Query: 155 YKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKF----------- 203
+ D +KV P + E+K + + + K+
Sbjct: 58 SSESVGSDAPCVVKVEPSDNGP-------LFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110
Query: 204 -------YDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVL---VQILNVV 252
+++M+ G L +I ++S K VL ++IL+++
Sbjct: 111 PKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSR---KTVLQLSLRILDIL 165
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDI--------VGS 304
+ H H VH D+K N L K+ Q+ +D+GL+ P+ G+
Sbjct: 166 EYIHEHEYVHGDIKASNLLLNYKNP-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT 224
Query: 305 AYYVAPEVLHRSYGTEA----DVWSIG-VIAYILLCGSRPFW 341
+ + + G D+ +G + L G P W
Sbjct: 225 IEFTS---IDAHNGVAPSRRGDLEILGYCMIQ-WLTGHLP-W 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 54/250 (21%), Positives = 91/250 (36%), Gaps = 54/250 (21%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
+ +E ++G G FG + A VA+K++ + +A D +RE ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALM 104
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD--RILSRCGKYSEDEAKAVLVQIL 249
+ N+VK + ++ E G+L + R +S S + +
Sbjct: 105 AEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 250 NVVAFCHL---------------------HGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288
+ L VHRDL N L E+ +K DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGL 220
Query: 289 SDFVRPDERLNDIVGSAYYV------------APEVL-HRSYGTEADVWSIGVIAY-ILL 334
S R +I + YY PE + + Y TE+DVW+ GV+ + I
Sbjct: 221 S---R------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 335 CGSRPFWART 344
G +P++
Sbjct: 272 YGLQPYYGMA 281
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 42/235 (17%), Positives = 77/235 (32%), Gaps = 43/235 (18%)
Query: 138 VGEEVGRGHFG-----YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR----EV 188
+ R + G + + QK ++K+ K R +V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 189 KILRALSGHSNL----VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGK--YSEDEAK 242
+ L L + +D ++V+ G L L K SE +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL--GRSLQSALDVSPKHVLSE---R 159
Query: 243 AVL---VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD---- 295
+VL ++L+ + F H + VH ++ EN +D+ SQ+ +G + P
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCPSGKHV 218
Query: 296 ---ERLND-IVGSAYYVAPEVLHRSYGTEA----DVWSIG-VIAYILLCGSRPFW 341
E G +++ + G D+ S+G + L G P W
Sbjct: 219 AYVEGSRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLK-WLYGFLP-W 268
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-14
Identities = 23/102 (22%), Positives = 41/102 (40%), Gaps = 3/102 (2%)
Query: 391 QALSHPWIRNYNNV--KVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQ 448
H R V L ++LK +K + + + L++ AL ++K L E L+
Sbjct: 3 HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62
Query: 449 FALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490
F L+ + +G ++ + I L K I +L D
Sbjct: 63 FIALDVDNSGTLSSQEILDGLKKIGYQ-KIPPDIHQVLRDID 103
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 1e-13
Identities = 36/190 (18%), Positives = 60/190 (31%), Gaps = 55/190 (28%)
Query: 133 TSRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTA-----IAVEDVR 185
T +L+ E++G G FG + + VAIK+I E++
Sbjct: 19 TEKLQRCEKIGEGVFGEVF-------QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 186 REVKILRALSG--------HSNLVKFYDAF------------------------------ 207
E+ I + LS +
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 208 EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH-LHGVVHRDLK 266
D ++IV+E GG L+++ ++ S AK++L Q+ +A HRDL
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 267 PENFLYTSKD 276
N L
Sbjct: 190 WGNVLLKKTS 199
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 16/80 (20%), Positives = 31/80 (38%), Gaps = 1/80 (1%)
Query: 393 LSHPWIRNY-NNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFAL 451
+ H + I +L+ K Y ++ A+ +++ + LK F +
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 452 LEPNKNGCIAFENIKTVLMK 471
L+ + G I E +K L K
Sbjct: 61 LDEDGKGYITKEQLKKGLEK 80
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 65/294 (22%), Positives = 109/294 (37%), Gaps = 59/294 (20%)
Query: 100 RRRKSTKKSSAEEGAPEEAAPELDKRFGFS--KEVTSRLEVGEEVGRGHFGYTCTARYKK 157
+ S + + P R +E T+ + +G G FG YK
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKV----YK- 57
Query: 158 GEHKD-QKVAIKVI-PKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215
G +D KVA+K P+S +E+ E++ L H +LV ++ + + +
Sbjct: 58 GVLRDGAKVALKRRTPESSQ----GIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMIL 112
Query: 216 VMELCEGGELLDRILSRCGKYSEDEAKAVL--VQILNVV-------AFCHLHGVVHRDLK 266
+ + E G L + Y D + Q L + + H ++HRD+K
Sbjct: 113 IYKYMENGNLKRHL------YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK 166
Query: 267 PENFLYTSKDESSQLKAIDFGLS-DFVRPDE-----RLNDIVGSAYYVAPEVLHRSYGTE 320
N L DE+ K DFG+S D+ + G+ Y+ PE + TE
Sbjct: 167 SINILL---DENFVPKITDFGISKKGTELDQTHLSTV---VKGTLGYIDPEYFIKGRLTE 220
Query: 321 -ADVWSIGVIAYILLCGSRPF-------------WART--ESGIFRAVLKADPS 358
+DV+S GV+ + +LC WA +G + DP+
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI--VDPN 272
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 38/189 (20%), Positives = 70/189 (37%), Gaps = 20/189 (10%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
RL++G+ +GRG FG A + VA+K++ + T + E+KIL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKIL 79
Query: 192 RALSGHSNLVKFYDAFEDLDN-VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
+ H N+V A + +++E C+ G L + S+ ++ +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-----VPYKTKGAR 134
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER----------LND 300
G + DLK TS S+ ++ V +E L
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 301 IVGSAYYVA 309
++ ++ VA
Sbjct: 195 LICYSFQVA 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 33/107 (30%), Positives = 46/107 (42%), Gaps = 26/107 (24%)
Query: 247 QILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAY 306
Q+ + F +HRDL N L + E + +K DFGL+ R DI
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA-------R--DIYKDPD 248
Query: 307 YV------------APEVL-HRSYGTEADVWSIGVIAY-ILLCGSRP 339
YV APE + R Y ++DVWS GV+ + I G+ P
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 74/328 (22%), Positives = 114/328 (34%), Gaps = 89/328 (27%)
Query: 111 EEGAPEEAAPELDKRFGFS--KEVT------SRLEVGEEVGRGHFGYTCTARYKKGEHKD 162
E + E + F F K VT G ++G G FG YK G +
Sbjct: 1 ENKSLEVSDTRF-HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVV----YK-GYVNN 54
Query: 163 QKVAIKVIPKSKMTTAIAVEDV------RREVKILRALSGHSNLVKFYDAFEDLDN---V 213
VA+K K+ + + +E+K++ H NLV+ D D+ V
Sbjct: 55 TTVAVK-----KLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLV 108
Query: 214 YIVMELCEGGELLDRILSRCG----------KYSEDEAKAVLVQILNVVAFCHLHGVVHR 263
Y G LLDR+ G K ++ A + F H + +HR
Sbjct: 109 Y---VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI--------NFLHENHHIHR 157
Query: 264 DLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND----------IVGSAYYVAPEVL 313
D+K N L DE+ K DFGL+ R ++ IVG+ Y+APE L
Sbjct: 158 DIKSANILL---DEAFTAKISDFGLA-------RASEKFAQTVMTSRIVGTTAYMAPEAL 207
Query: 314 HRSYGTEADVWSIGVIAYILLCGSRPF-----------WAR---TESGIFRAVLKADPSF 359
++D++S GV+ ++ G E D
Sbjct: 208 RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY--IDKKM 265
Query: 360 DDGSWPSLSSDAKDFVKLL-LNKDPRKR 386
+D S+ + V L++ KR
Sbjct: 266 NDADSTSVEAMYS--VASQCLHEKKNKR 291
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 408 LDISILKLMKAYMQSSSLRRAALKALSKTLTV--DERFYLKEQFALLEPNKNGCIAFENI 465
+ ++L MK+YM+ S++R + ++ L+V + Y+ E F L+ N NG ++ I
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61
Query: 466 KTVLMKNATDAMKESRISDLLAPSD 490
TVL +K+ I+ +L D
Sbjct: 62 YTVLASV---GIKKWDINRILQALD 83
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 60/250 (24%), Positives = 97/250 (38%), Gaps = 43/250 (17%)
Query: 115 PEEAAPELD----KRFGFS--KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD-QKVAI 167
P E PE+ KRF + + +GRG FG YK G D VA+
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKV----YK-GRLADGTLVAV 59
Query: 168 KVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLD 227
K + K + T ++ + EV+++ H NL++ +V G +
Sbjct: 60 KRL-KEERTQGGELQ-FQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSVAS 116
Query: 228 RILSRCGKYSEDEAKAVL-----VQILNVVA--------FCHLHGVVHRDLKPENFLYTS 274
+ R E++ L +I A C ++HRD+K N L
Sbjct: 117 CLRER------PESQPPLDWPKRQRIALGSARGLAYLHDHCDPK-IIHRDVKAANILL-- 167
Query: 275 KDESSQLKAIDFGLSDFVRPDERLN---DIVGSAYYVAPEVLHRSYGTE-ADVWSIGVIA 330
DE + DFGL+ + + + + G+ ++APE L +E DV+ GV+
Sbjct: 168 -DEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 225
Query: 331 YILLCGSRPF 340
L+ G R F
Sbjct: 226 LELITGQRAF 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 4e-07
Identities = 78/548 (14%), Positives = 163/548 (29%), Gaps = 148/548 (27%)
Query: 12 NPYAPRNTQNDLSIPPTPNTTT-NKNNDAVNDDKQSHSAALSPFFPLYTPSPAYI--FKK 68
+P Q P+ T + D + +D Q F ++
Sbjct: 96 SPIKTEQRQ------PSMMTRMYIEQRDRLYNDNQ-------VFAKYNVSRLQPYLKLRQ 142
Query: 69 SLSGSKKGGNLTPMRVFRMPPSPAKHIKA--VLRRRKSTKK--------SSAEEGAPEEA 118
+L + N+ + + S K A V K K + +PE
Sbjct: 143 ALLELRPAKNVL---IDGVLGS-GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV 198
Query: 119 APELDKRFG-FSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQK---VAIKVIPKSK 174
L K TSR + ++ + + + + + K
Sbjct: 199 LEMLQKLLYQIDPNWTSRSD-----------HSSNIKLRIHSIQAELRRLLKSKPYENC- 246
Query: 175 MTTAIAVEDVRREVKILRALSGHSN-LV--KFYDAFEDLDN---VYIVMELCEGGELLDR 228
+ + +V+ K A + L+ +F + L +I ++
Sbjct: 247 ---LLVLLNVQ-NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT----- 297
Query: 229 ILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG- 287
+ DE K++L++ L+ DL E + + +I
Sbjct: 298 -------LTPDEVKSLLLKYLDCRPQ---------DLPRE-----VLTTNPRRLSI-IAE 335
Query: 288 -LSDFV-RPD-------ERLNDIVGSAY-YVAPEVLHRSYGT----EADVWSIGVIAYIL 333
+ D + D ++L I+ S+ + P + + I IL
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH----IPTIL 391
Query: 334 LCGSRPFWA---RTESGIF------RAVLKADPSFDDGSWPSLSSDAKDFV-------KL 377
L W +++ + ++++ P S PS+ + K + +
Sbjct: 392 LS---LIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS 448
Query: 378 LLNKDPRKRMTAAQALSHPWIRNY---------NNV----------KVPLDISILKLMKA 418
+++ + + L P++ Y N+ V LD + ++
Sbjct: 449 IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD---FRFLEQ 505
Query: 419 YMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMK 478
++ S A ++ TL +FY K +P + I L K + +
Sbjct: 506 KIRHDSTAWNASGSILNTLQ-QLKFY-KPYICDNDPKYERLV--NAILDFLPKIEENLIC 561
Query: 479 ESRISDLL 486
S+ +DLL
Sbjct: 562 -SKYTDLL 568
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 19/133 (14%), Positives = 44/133 (33%), Gaps = 13/133 (9%)
Query: 364 WPSLSSDAKDFVKLLLNKDPR------KRMTAAQALSHPWIRNYNNVKVPLDISILKLMK 417
++ ++ L D + R A + + K L + L
Sbjct: 43 EAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARG-DAAAEKQRLASLLKDLED 101
Query: 418 AYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAM 477
+ LR + L+ ++ L++ F + +G +F+++K V + D +
Sbjct: 102 DASGYNRLRPSK-----PMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQV-LAKYADTI 155
Query: 478 KESRISDLLAPSD 490
E + L +
Sbjct: 156 PEGPLKKLFVMVE 168
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 19/95 (20%), Positives = 34/95 (35%), Gaps = 11/95 (11%)
Query: 407 PLDISILKLMKAYMQSSSLRRAALKALSKTL-TVDERFYLKEQFALLEPNKNGCIAFENI 465
L MK + S L +AA+ + L T++E L + F L+ N +G + + +
Sbjct: 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKEL 62
Query: 466 KTVLMKNATDA----------MKESRISDLLAPSD 490
K E+ + +L D
Sbjct: 63 IEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSVD 97
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 11/70 (15%), Positives = 30/70 (42%), Gaps = 4/70 (5%)
Query: 421 QSSSLRRAALK----ALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDA 476
+ + R+ A + A+ + T + + E F + N+ G + ++ + + ++
Sbjct: 22 KKAKDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLD 81
Query: 477 MKESRISDLL 486
SR+ D+
Sbjct: 82 EFTSRVRDIT 91
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 20/111 (18%), Positives = 37/111 (33%), Gaps = 13/111 (11%)
Query: 185 RREVKILRALSGHSNLVKFYDA------FEDLDNVYIVMELCEGGEL-LDRILSRCGKYS 237
+E + NL + +A ++ME EL ++ +
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 238 EDEAKAVLVQILN-VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287
E + + + ++ V +VH DL N +Y K + ID G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK-----VYFIDMG 214
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 7e-05
Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 1/66 (1%)
Query: 425 LRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISD 484
++ AL+ ++++L+ +E LKE F +++ +K+G I FE +K +K +KES I D
Sbjct: 9 FKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAG-LKRVGANLKESEILD 67
Query: 485 LLAPSD 490
L+ +D
Sbjct: 68 LMQAAD 73
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 18/60 (30%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 431 KALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490
K +++ L+ +E LKE F +++ + +G I F+ +K +K + ES I DL+ +D
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDG-LKRVGSELMESEIKDLMDAAD 69
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 28/103 (27%), Positives = 40/103 (38%), Gaps = 17/103 (16%)
Query: 185 RREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
R E + L+ L G + K Y + ++MEL + EL + V
Sbjct: 152 RNEFRALQKLQGL-AVPKVYA----WEGNAVLMELIDAKELYR--------VRVENPDEV 198
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287
L IL VA + G+VH DL N L + + IDF
Sbjct: 199 LDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFP 237
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 38/150 (25%), Positives = 56/150 (37%), Gaps = 22/150 (14%)
Query: 153 ARYKKGEHKDQKVAIKV-IPKS----KMTTAIAVEDVRREVKILRALSGHS-NLVKFYDA 206
A K+ + D V IK + K ++ I RE + L + +D
Sbjct: 350 ADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV 409
Query: 207 FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLK 266
DLDN I+M G D I ++ + +I +V H + V+H DL
Sbjct: 410 --DLDNKRIMMSYINGKLAKDVI---------EDNLDIAYKIGEIVGKLHKNDVIHNDLT 458
Query: 267 PENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
NF++ L IDFGL DE
Sbjct: 459 TSNFIF-----DKDLYIIDFGLGKISNLDE 483
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.11 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.65 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.64 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 98.54 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 98.53 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 98.42 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 98.4 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.39 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 98.38 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 98.37 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 98.36 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.35 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 98.34 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 98.29 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 98.29 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 98.28 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.27 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 98.23 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 98.22 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 98.21 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 98.2 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.2 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.19 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.19 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 98.17 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 98.16 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 98.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 98.14 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 98.12 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 98.12 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 98.11 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 98.1 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 98.09 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 98.08 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 98.08 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 98.08 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 98.07 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 98.05 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 98.05 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 98.04 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 98.04 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 98.03 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 98.03 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 98.03 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 98.02 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 98.01 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 98.01 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 98.0 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 97.99 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 97.98 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 97.97 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 97.96 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 97.95 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 97.95 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 97.94 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 97.94 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 97.92 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 97.91 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 97.9 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 97.88 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 97.88 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 97.88 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 97.87 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 97.87 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 97.87 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 97.87 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 97.87 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.86 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 97.85 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 97.84 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 97.82 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 97.82 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 97.81 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 97.81 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 97.81 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 97.81 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 97.8 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 97.79 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 97.77 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 97.76 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 97.75 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 97.75 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 97.75 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 97.75 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 97.74 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 97.74 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 97.72 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 97.72 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 97.71 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 97.7 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 97.69 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.69 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 97.68 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.67 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 97.66 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.66 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 97.65 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 97.64 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 97.63 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.61 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 97.61 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 97.59 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.58 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.57 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 97.56 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 97.55 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 97.55 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 97.54 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 97.54 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 97.54 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 97.52 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 97.52 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 97.5 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 97.5 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 97.5 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 97.48 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.47 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 97.46 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 97.45 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 97.44 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 97.44 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 97.44 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 97.44 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.44 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 97.42 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 97.42 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 97.42 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 97.41 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 97.41 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.39 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 97.38 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 97.37 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 97.36 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 97.36 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 97.35 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 97.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.33 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 97.33 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 97.32 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 97.3 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 97.3 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 97.29 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.29 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 97.29 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 97.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.25 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 97.25 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 97.24 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 97.21 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 97.21 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 97.21 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 97.2 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 97.2 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 97.19 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 97.17 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 97.15 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 97.14 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.13 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 97.13 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 97.11 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 97.09 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 97.08 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 97.08 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 97.07 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 97.06 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 97.05 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 97.04 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 97.03 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 97.03 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 97.02 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 97.02 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 97.01 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 96.99 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 96.99 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 96.97 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 96.97 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 96.96 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 96.94 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 96.94 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 96.92 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 96.88 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 96.87 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 96.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.81 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 96.79 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 96.79 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 96.79 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 96.75 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 96.73 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 96.7 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 96.64 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 96.62 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.61 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 96.61 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 96.59 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 96.59 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 96.58 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 96.56 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.53 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 96.48 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 96.47 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 96.47 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 96.46 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 96.44 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 96.44 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 96.43 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 96.42 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 96.38 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 96.36 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 96.35 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 96.21 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 96.14 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 96.14 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 96.13 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 96.13 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 96.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.07 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 96.07 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 96.04 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.03 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 95.97 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 95.93 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 95.86 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 95.81 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 95.76 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 95.72 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 95.68 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 95.64 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 95.62 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 95.53 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 95.49 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-66 Score=504.52 Aligned_cols=257 Identities=32% Similarity=0.577 Sum_probs=231.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++++.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+++|+.|. |||||+++++|++++++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEE
Confidence 579999999999999999999775 78999999997654333334567899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|||||||+||+|.+++.+. +.+++.+++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 108 yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecC
Confidence 9999999999999998765 689999999999999999999999999999999999999 677899999999999875
Q ss_pred CCC---CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 294 PDE---RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 294 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
... ...+.+||+.|||||++.+ .|+.++||||+||++|+|+||+.||.+.+..+++..|......++. .+|+
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~ 259 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFP 259 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCH
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCH
Confidence 432 3457899999999999864 6999999999999999999999999999999999999998877654 6899
Q ss_pred HHHHHHHHccccCcCCCCCHHH------HhcCccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQ------ALSHPWIRNYN 402 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e------~l~hp~~~~~~ 402 (492)
++++||.+||++||++|||++| +++||||++.+
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 9999999999999999999987 68999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-65 Score=490.48 Aligned_cols=254 Identities=36% Similarity=0.634 Sum_probs=212.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+++|+.|+ |||||+++++|++++.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 589999999999999999998664 78999999998876655556677999999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
||||||| +|+|.+++.++ +.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 89 ~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC----
T ss_pred EEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecC
Confidence 9999999 67999988765 689999999999999999999999999999999999999 667899999999999887
Q ss_pred CCCCccccccCccccccccccCC-C-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLHRS-Y-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
......+.+||+.|||||++.+. | +.++||||+||++|+|+||+.||.+.+..++++.+......++ ..+|+++
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGA 239 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHH
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence 76667788999999999998753 4 6799999999999999999999999999999999988876654 3689999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
++||.+||+.||++|||++|+|+||||+.
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-64 Score=502.10 Aligned_cols=258 Identities=26% Similarity=0.496 Sum_probs=225.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+.... ....+.+.+|+++|++|+ |||||+++++|++++.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRMS-SKEREESRREVAVLANMK-HPNIVQYRESFEENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETT---TCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCE
Confidence 3789999999999999999999765 7899999999876654 345678999999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+|||||||+||+|.++|..+. ..+++.+++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARV 174 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEccccccee
Confidence 999999999999999997653 458999999999999999999999999999999999999 6678999999999988
Q ss_pred cCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 292 VRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 292 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
+.... ...+.+||+.|||||++.+ .|+.++||||||||+|||+||+.||.+.+..+++..|...... ..+..+|+
T Consensus 175 ~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~ 251 (350)
T 4b9d_A 175 LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSY 251 (350)
T ss_dssp CCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCH
T ss_pred ecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCH
Confidence 75432 2346789999999999875 5999999999999999999999999999999999999887643 23457899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++++||.+||++||++|||+.|+|+||||++.
T Consensus 252 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 252 DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 99999999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-64 Score=498.62 Aligned_cols=257 Identities=30% Similarity=0.558 Sum_probs=228.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+.|++.++||+|+||.||+|+++. +|+.||||++.+..... .+.+.+|+.+|+.|. |||||+++++|++++.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCchhH---HHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 4679999999999999999999775 78999999997654332 345789999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|||||||+||+|.+++.+ +.+++.+++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+
T Consensus 146 ~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceec
Confidence 9999999999999998754 579999999999999999999999999999999999999 67789999999999987
Q ss_pred CCC-CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
... ....+.+||+.|||||++.+ .|+.++||||||||+|||++|+.||.+.+..+.+..|..... .....|..+|++
T Consensus 221 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~ 299 (346)
T 4fih_A 221 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPS 299 (346)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHH
T ss_pred CCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHH
Confidence 544 34567899999999999874 699999999999999999999999999999888888876543 333456789999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+++||.+||++||++|||+.|+|+||||++..
T Consensus 300 ~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 300 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-63 Score=520.80 Aligned_cols=358 Identities=35% Similarity=0.586 Sum_probs=313.1
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH----------HHHHHHHHHHHHHHHccCCCC
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA----------IAVEDVRREVKILRALSGHSN 199 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~----------~~~~~~~~Ev~~l~~l~~hpn 199 (492)
..+.++|++.+.||+|+||.||+|+.+. +++.||||++.+...... ...+.+.+|+.+|+.|. |||
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn 107 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN 107 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred CCcccceEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence 3567899999999999999999999765 788999999976543221 23457889999999995 999
Q ss_pred ccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCC
Q 011154 200 LVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS 279 (492)
Q Consensus 200 iv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~ 279 (492)
|++++++|.+.+.+|+|||||+||+|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||+..++...
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999999999988765 6799999999999999999999999999999999999997655556
Q ss_pred cEEEEecccccccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC
Q 011154 280 QLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 280 ~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
.+||+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+..+...+
T Consensus 187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 89999999999887776777788999999999999889999999999999999999999999999999999999988888
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccccCCC----ccHHHHHHHHHHhhhhhhHHHHHHhhhc
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVP----LDISILKLMKAYMQSSSLRRAALKALSK 435 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~a~l~~l~~ 435 (492)
....|..+++++++||.+||..||.+|||+.|+|+||||++....... .....+..+++|.....++++++..+..
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~ 346 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGS 346 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHH
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhc
Confidence 777788999999999999999999999999999999999976543221 2234577788999999999999998887
Q ss_pred cc-chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc-------ccccHHHHHHHHhcccCC
Q 011154 436 TL-TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT-------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 436 ~l-~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~-------~~~~~~ei~~~i~~~D~~ 492 (492)
.+ +.++..+++++|..+|.|+||.|+.+||+.+|..++. ...++.+++++++.+|.|
T Consensus 347 ~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d 411 (504)
T 3q5i_A 347 KLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFD 411 (504)
T ss_dssp HTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTT
T ss_pred cCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCC
Confidence 77 7888999999999999999999999999999988732 147789999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-63 Score=524.29 Aligned_cols=356 Identities=36% Similarity=0.622 Sum_probs=313.1
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|+++. ++..||||++.+...... ....+.+|+.+|+.|. |||||+++++|.+.
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 108 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLD-HPNIMKLYDFFEDK 108 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 456789999999999999999999765 788999999976543221 2456889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+|||||.||+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+...+....+||+|||++.
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999999999988766 679999999999999999999999999999999999999766666789999999999
Q ss_pred ccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......+....|..++++
T Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 88777667778899999999999888999999999999999999999999999999999999999988888889999999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccccccc-----cCCCccHHHHHHHHHHhhhhhhHHHHHHhhhccc-chhhHHH
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN-----VKVPLDISILKLMKAYMQSSSLRRAALKALSKTL-TVDERFY 444 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~a~l~~l~~~l-~~~e~~~ 444 (492)
+++||.+||+.||.+|||+.|+|+||||++... ...+.....+..+++|.....++++++..++..+ +.++..+
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~ 347 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKE 347 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHH
Confidence 999999999999999999999999999987432 2334445677889999999999999999888777 7888999
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccc-------cccHHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATD-------AMKESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~-------~~~~~ei~~~i~~~D~~ 492 (492)
++++|..+|.|+||.|+.+||+.+|..+|.+ ..++++++++++.+|.|
T Consensus 348 l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d 402 (494)
T 3lij_A 348 LTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFD 402 (494)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998642 35689999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-63 Score=521.53 Aligned_cols=357 Identities=34% Similarity=0.588 Sum_probs=315.9
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+|+.| +||||++++++|.+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED 97 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 3456889999999999999999998765 7899999999776554444567789999999999 49999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.+|+|||||.||+|.+.+... +.+++.+++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999999999988765 67999999999999999999999999999999999999976666789999999999
Q ss_pred cccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
..+.........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......+....|..+++
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 177 THFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp HHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred EEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 98877766777889999999999998999999999999999999999999999999999999999988888888889999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccccc----cCCCccHHHHHHHHHHhhhhhhHHHHHHhhhccc-chhhHHH
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN----VKVPLDISILKLMKAYMQSSSLRRAALKALSKTL-TVDERFY 444 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~a~l~~l~~~l-~~~e~~~ 444 (492)
++++||.+||+.||.+|||+.|+|+||||+.... ...+.....+..+++|...+.++++++..++..+ +.++...
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~ 336 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKE 336 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHH
Confidence 9999999999999999999999999999987643 2344556677888999999999999999988776 7788899
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHH----Hhhcccccc-------HHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVL----MKNATDAMK-------ESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l----~~~g~~~~~-------~~ei~~~i~~~D~~ 492 (492)
++++|..+|.|+||.|+.+||..++ +.+|. ..+ +++++++++.+|.|
T Consensus 337 l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~-~~~~~~~~~~~~~~~~~~~~~D~d 394 (484)
T 3nyv_A 337 LTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQ-DASMLDASAVEHEVDQVLDAVDFD 394 (484)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHHHHC-----CGGGCSHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHhCcCCCceEeHHHHHHHHHHHhhhccc-ccccccccccHHHHHHHHHHhCCC
Confidence 9999999999999999999995554 44454 355 88999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-64 Score=490.66 Aligned_cols=258 Identities=28% Similarity=0.520 Sum_probs=223.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+...+..+++.||||++.+...... ....+.+|+++|++|. |||||+++++|++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 679999999999999999999876666789999999976543221 1235788999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|||||||+||+|.+++.+. +.+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence 9999999999999998765 689999999999999999999999999999999999999 677899999999998754
Q ss_pred C-CCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 P-DERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
. .....+.+||+.|||||++. ..|+.++|||||||++|||+||+.||.+.+..+++..|.+....++ ..+|+++
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 253 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEA 253 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHH
Confidence 3 33456789999999999986 4699999999999999999999999999999999999998876654 3689999
Q ss_pred HHHHHHccccCcCCCCC-----HHHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
++||.+||++||++||| ++|+++||||++.
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 99999999999999998 5899999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-62 Score=515.82 Aligned_cols=355 Identities=35% Similarity=0.629 Sum_probs=309.4
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|+.+. +++.||||++.+..... .....+.+|+++|+.|. ||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN-KDTSTILREVELLKKLD-HPNIMKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcC
Confidence 456899999999999999999998765 78999999986432211 12456889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+|||||.||+|.+.+... +.+++.+++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999999999988766 679999999999999999999999999999999999999776667789999999999
Q ss_pred ccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......+....|..+|++
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 88776667778899999999999989999999999999999999999999999999999999999888888888899999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccccccccCC-----CccHHHHHHHHHHhhhhhhHHHHHHhhhccc-chhhHHH
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKV-----PLDISILKLMKAYMQSSSLRRAALKALSKTL-TVDERFY 444 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~a~l~~l~~~l-~~~e~~~ 444 (492)
+++||.+||..||.+|||+.|+|+||||++...... +........+++|.....++++++..+...+ +.++..+
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~ 332 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQ 332 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHH
Confidence 999999999999999999999999999997653321 1223456778889999999999999888776 7788899
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhh----cccccc----------HHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKN----ATDAMK----------ESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~----g~~~~~----------~~ei~~~i~~~D~~ 492 (492)
++++|..+|.|+||.|+.+||..++..+ |. ..+ +++++++++.+|.|
T Consensus 333 l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~D~d 393 (486)
T 3mwu_A 333 LTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGV-DSNSLIQNEGSTIEDQIDSLMPLLDMD 393 (486)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTC-CGGGHHHHTSSCHHHHHHHHHHHHCTT
T ss_pred HHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcc-cchhcccccchhhHHHHHHHHHHhcCC
Confidence 9999999999999999999997666543 43 233 88999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-62 Score=501.08 Aligned_cols=259 Identities=30% Similarity=0.554 Sum_probs=230.6
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...+.|++.++||+|+||.||+|+++. +|+.||||++....... .+.+.+|+.+|+.|+ |||||+++++|++.
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVG 220 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccchhH---HHHHHHHHHHHHhCC-CCCCCceEEEEEEC
Confidence 345789999999999999999999775 78999999997654433 345789999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|||||||+||+|.+++.. +.+++.+++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCA 295 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccce
Confidence 999999999999999998754 479999999999999999999999999999999999999 667899999999998
Q ss_pred ccCCC-CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
.+... ....+.+||++|||||++.+ .|+.++||||||||+|||++|+.||.+.+..+.+..|..... .....|..+|
T Consensus 296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s 374 (423)
T 4fie_A 296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVS 374 (423)
T ss_dssp ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSC
T ss_pred ECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCC
Confidence 87544 34567899999999999864 599999999999999999999999999999888888876543 2334567899
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+++++||.+||.+||++|||+.|+|+||||++..
T Consensus 375 ~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 375 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-62 Score=477.93 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=218.1
Q ss_pred cce-eecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe---
Q 011154 134 SRL-EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--- 209 (492)
Q Consensus 134 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--- 209 (492)
.+| ++.++||+|+||.||+|+++. ++..||||++.+.... ....+.+.+|+++|++|+ |||||+++++|++
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 99 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEET
T ss_pred CceEEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccC
Confidence 344 788899999999999999765 7899999999765443 345677999999999995 9999999999976
Q ss_pred -CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCcEEEEec
Q 011154 210 -LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 210 -~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
++.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||.|||++| ||||||||+||||+ +.++.+||+||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DF 176 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL 176 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCT
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeC
Confidence 35689999999999999998765 68999999999999999999999998 99999999999994 23578999999
Q ss_pred ccccccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHHHHhcCCCCCCCCCC
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 365 (492)
|+|+... .....+.+||+.|||||++.+.|+.++|||||||++|||+||+.||.+... ..++..+..... +...+.
T Consensus 177 Gla~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~ 253 (290)
T 3fpq_A 177 GLATLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDK 253 (290)
T ss_dssp TGGGGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGG
T ss_pred cCCEeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCc
Confidence 9998654 345567899999999999998999999999999999999999999976554 445555544322 122234
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
.+++++++||.+||..||++|||+.|+|+||||++
T Consensus 254 ~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 67899999999999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=479.77 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=220.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+.|++.++||+|+||.||+|+++. +|+.||||++++.... .+|+.+|+.|+ |||||+++++|++++.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 3579999999999999999999775 7899999999765432 36999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCC-cEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS-QLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~-~~kl~DfGla~~ 291 (492)
+|||||||+||+|.++|.+. +.+++.+++.|+.||+.||.|||++|||||||||+|||| +.++ ++||+|||+|+.
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALC 200 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeE
Confidence 99999999999999998765 689999999999999999999999999999999999999 4444 699999999998
Q ss_pred cCCCCC------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 292 VRPDER------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 292 ~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
+..... ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+....+++..|....+.+. ..+
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~ 279 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIP 279 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSC
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcC
Confidence 754332 234689999999998875 599999999999999999999999999888888888887654432 345
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHH-------------hcCcccccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQA-------------LSHPWIRNYNN 403 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~-------------l~hp~~~~~~~ 403 (492)
+.+++++++||.+||++||.+|||+.|+ |+|||+..+..
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 6899999999999999999999999997 67999987643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=478.95 Aligned_cols=262 Identities=29% Similarity=0.492 Sum_probs=224.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe-
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED- 209 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~- 209 (492)
.+.++|++++.||+|+||.||+|+++. +|+.||||++++... .....+.+.+|+++|+.|+ |||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPT 125 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECC---CCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeecc
Confidence 456789999999999999999999765 789999999976543 3345567889999999995 9999999999864
Q ss_pred -----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 -----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 -----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.+.+|||||||+ |+|.+++.+ .+.+++.+++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+
T Consensus 126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~ 200 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIG 200 (398)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEEC
T ss_pred cccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEe
Confidence 367999999996 689988755 4689999999999999999999999999999999999999 677899999
Q ss_pred ecccccccCCC-----CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 285 DFGLSDFVRPD-----ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 285 DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
|||+|+.+... ....+.+||++|||||++.+ .|+.++||||+|||+|||++|+.||.+.+..+.+..|.....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999876432 23456799999999998764 479999999999999999999999999999888888876443
Q ss_pred CCCCCC---------------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 SFDDGS---------------------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ~~~~~~---------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+.... ++.++++++|||.+||..||.+|||+.|+|+||||++..
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 332211 246799999999999999999999999999999999764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=472.80 Aligned_cols=262 Identities=26% Similarity=0.483 Sum_probs=215.5
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
...+.++|++.+.||+|+||.||+|+.+....+++.||||++.+... ...+.+|+++|+.+.+|||||+++++|+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 34577899999999999999999999876555789999999865432 2457899999999977999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
+.+++|||||||+||+|.+.+ +.+++.+++.++.||+.||+|||++|||||||||+|||++. +.+.+||+|||+
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGl 164 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGL 164 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTT
T ss_pred ECCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCC
Confidence 999999999999999999987 46999999999999999999999999999999999999953 336899999999
Q ss_pred ccccCCCC-----------------------------CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCC
Q 011154 289 SDFVRPDE-----------------------------RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGS 337 (492)
Q Consensus 289 a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~ 337 (492)
|+...... ...+.+||++|||||++.+ .|+.++||||+|||+|+|+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 97654321 2345689999999998864 4899999999999999999999
Q ss_pred CCCCCCC-hhHHHHHHHhc--------------------------------------C------------CCCCCCCCCC
Q 011154 338 RPFWART-ESGIFRAVLKA--------------------------------------D------------PSFDDGSWPS 366 (492)
Q Consensus 338 ~pf~~~~-~~~~~~~i~~~--------------------------------------~------------~~~~~~~~~~ 366 (492)
.||.... +.+.+..|... . .......|..
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 9996544 33333333210 0 0111234678
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+|++++|||.+||+.||++|+|++|+|+||||++.
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-59 Score=496.77 Aligned_cols=264 Identities=37% Similarity=0.634 Sum_probs=242.4
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|+++. +|+.||||++.+.. ....+.+.+|+.+|+.|+ |||||+++++|++.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDD 226 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECS
T ss_pred cCccccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence 345789999999999999999999775 78999999997643 334567899999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|||||||+||+|.++|.++.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+|+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTA 305 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCE
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeecccee
Confidence 99999999999999999997776789999999999999999999999999999999999999642 34689999999999
Q ss_pred ccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.+.........+||+.|||||++.+ .|+.++||||||||+|+|++|..||.+.+..+.+..|......+....|..+|+
T Consensus 306 ~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 306 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp ECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred EccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 9987777788899999999999875 599999999999999999999999999999999999999988888888889999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 999999999999999999999999999999754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=453.95 Aligned_cols=257 Identities=23% Similarity=0.389 Sum_probs=219.7
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|.+.+.||+|+||.||+|++.. ...++..||||+++.. .....++|.+|+++|++|+ |||||+++++|.+.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence 4789999999999999999998763 2236789999999654 3455678999999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCC
Q 011154 211 DNVYIVMELCEGGELLDRILSRC------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES 278 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~ 278 (492)
+.+|||||||+||+|.++|.... ..+++.++..|+.||+.||.|||+++||||||||+|||+ +.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence 99999999999999999997642 469999999999999999999999999999999999999 667
Q ss_pred CcEEEEecccccccCCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHH
Q 011154 279 SQLKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 353 (492)
Q Consensus 279 ~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~ 353 (492)
+.+||+|||+|+........ ...+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 89999999999876544322 2357999999999886 579999999999999999998 999999999999999888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 354 KADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 354 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.+.... ....+++++.+||.+||+.||++|||+.|+ ++||++.
T Consensus 245 ~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 245 QGRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp HTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred cCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 765422 224689999999999999999999999999 4577643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=453.47 Aligned_cols=254 Identities=31% Similarity=0.512 Sum_probs=199.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC--
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD-- 211 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~-- 211 (492)
++|++.+.||+|+||.||+|+++. +|+.||||++.... .....+.+.+|+++|++|+ |||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC--
T ss_pred hhCEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCcc
Confidence 569999999999999999999765 78999999997543 3445667999999999995 999999999997654
Q ss_pred ----------eEEEEEeecCCCchHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCC
Q 011154 212 ----------NVYIVMELCEGGELLDRILSRCG--KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS 279 (492)
Q Consensus 212 ----------~~~lv~E~~~ggsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~ 279 (492)
.+|||||||+||+|.+++..+.. ...+..++.|+.||+.||.|||++|||||||||+|||+ +.++
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~ 155 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD 155 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTC
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCC
Confidence 37999999999999999875432 35567789999999999999999999999999999999 6677
Q ss_pred cEEEEecccccccCCCCC-------------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCCh
Q 011154 280 QLKAIDFGLSDFVRPDER-------------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTE 345 (492)
Q Consensus 280 ~~kl~DfGla~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~ 345 (492)
.+||+|||+|+.+..... ..+.+||+.|||||++.+ .|+.++||||||||+|||++ ||.....
T Consensus 156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~ 232 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME 232 (299)
T ss_dssp CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence 899999999988754322 234689999999999875 59999999999999999996 8865332
Q ss_pred h-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 346 S-GIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 346 ~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
. ..+..+... .++ ..+...++.+.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 233 ~~~~~~~~~~~--~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 233 RVRTLTDVRNL--KFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHHHHTT--CCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHHHhcC--CCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 2 223333322 221 22335677889999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-58 Score=448.72 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=208.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++++++++||+|+||.||+|+++. .||||+++.... .....+.|.+|+.+|++|+ |||||++++++.+ +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~------~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG------DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS------EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC------cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-Ce
Confidence 4678899999999999999998542 489999965443 4456778999999999995 9999999998754 67
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|||||||+||+|.++|....+.+++.++..|+.||+.||.|||+++||||||||+|||| ++++.+||+|||+|+..
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVK 182 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceec
Confidence 899999999999999998777789999999999999999999999999999999999999 66789999999999876
Q ss_pred CCCC---CccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC--CCC
Q 011154 293 RPDE---RLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--DGS 363 (492)
Q Consensus 293 ~~~~---~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--~~~ 363 (492)
.... .....+||+.|||||++. +.|+.++|||||||++|||+||+.||.+.+....+..+.......+ ...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 5322 345678999999999885 2489999999999999999999999988766555544444332221 234
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+..+++++.+||.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 56789999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=451.75 Aligned_cols=253 Identities=22% Similarity=0.363 Sum_probs=211.6
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|.+.++||+|+||.||+|+++. ...+++.||||+++.. .....++|.+|+++|++|+ |||||+++++|.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 4678899999999999999999864 2346889999999654 4456678999999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC
Q 011154 211 DNVYIVMELCEGGELLDRILSRC--------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~ 276 (492)
+.+|||||||+||+|.+++.+.. +.+++.++..|+.||+.||.|||+++||||||||+|||| +
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence 99999999999999999987532 459999999999999999999999999999999999999 6
Q ss_pred CCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHH
Q 011154 277 ESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 351 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~ 351 (492)
.++.+||+|||+|+.+..... ....+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..+++..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 778999999999987654332 23568999999999886 469999999999999999999 9999999999888888
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+..+... .....+++++.+|+.+||+.||++|||+.|++++
T Consensus 273 i~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8776422 1224689999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-57 Score=445.87 Aligned_cols=254 Identities=20% Similarity=0.311 Sum_probs=217.1
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+++++.++||+|+||.||+|++.. +..+++.||||+++... .....++|.+|+.+|++|+ |||||+++|+|.++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKD 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEEC
Confidence 4678899999999999999999853 23367899999996543 2234567999999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC
Q 011154 211 DNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK 275 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~ 275 (492)
+.++||||||++|+|.++|..+. ..+++.++..|+.||+.||.|||+++||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl--- 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--- 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---
Confidence 99999999999999999997532 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecccccccCCCC---CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHH
Q 011154 276 DESSQLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 350 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~ 350 (492)
++++.+||+|||+|+.+.... .....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+.+..++..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 677899999999998764332 234568999999999875 679999999999999999998 899999999999988
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 351 AVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 351 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.+..+.... ....++.++.+|+.+||+.||++|||+.||+++
T Consensus 259 ~i~~~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 887754322 234689999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=483.11 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=219.4
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHH---HHHHHHHccCCCCccEEEEEEEe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR---EVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~---Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+...........+.+ ++.+++.+ +|||||+++++|++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEE
Confidence 4789999999999999999999775 88999999997543221112223334 45566666 59999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.+|||||||+||+|.++|.+. +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++++||+|||+|
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA 339 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLA 339 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEeccccee
Confidence 99999999999999999998765 689999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCCCCccccccCcccccccccc-C-CCCCccchHHHHHHHHHHhcCCCCCCCCC---hhHHHHHHHhcCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH-R-SYGTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlGvil~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~ 364 (492)
+.+... ...+.+||+.|||||++. + .|+.++||||||||+|||++|..||.+.. ..++...+......++
T Consensus 340 ~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p---- 414 (689)
T 3v5w_A 340 CDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---- 414 (689)
T ss_dssp EECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----
T ss_pred eecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----
Confidence 887543 456689999999999985 3 59999999999999999999999997643 3456666766655544
Q ss_pred CCCCHHHHHHHHHccccCcCCCCC-----HHHHhcCccccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMT-----AAQALSHPWIRNYN 402 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~~ 402 (492)
..+|+++++||.+||++||.+|++ ++||++||||++.+
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 478999999999999999999998 79999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-56 Score=444.92 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=214.5
Q ss_pred ccceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++++.||+|+||.||+|.+.... ..++.||||++.... .....+.+.+|+++|++|.+|||||+++++|.+.
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 478999999999999999999987532 356789999997543 3344567999999999997669999999999764
Q ss_pred -CeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeec
Q 011154 211 -DNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS 274 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~ 274 (492)
+.+|||||||++|+|.++|.+.. ..+++.++..|+.||+.||.|||+++||||||||+|||+
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl-- 218 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 218 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence 56899999999999999997532 348999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhH-H
Q 011154 275 KDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESG-I 348 (492)
Q Consensus 275 ~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~-~ 348 (492)
+.++.+||+|||+|+.+..... ....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+....+ +
T Consensus 219 -~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 219 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred -CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 6677999999999997754432 23568999999999876 569999999999999999998 999998866544 4
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
...+..+. .+.. ...+++++.+||.+||+.||++|||+.|+++|
T Consensus 298 ~~~i~~g~-~~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEGT-RMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCC-CCCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44444432 2222 23689999999999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=455.34 Aligned_cols=322 Identities=33% Similarity=0.582 Sum_probs=270.7
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|..+. +|+.||+|++.+.... ....+.+.+|+.+|+.| +|||||+++++|.+
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 81 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLS-ARDHQKLEREARICRLL-KHPNIVRLHDSISE 81 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHC-CBTTBCCEEEEEEC
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEE
Confidence 3456889999999999999999998765 7899999999766543 33456789999999999 49999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+..|+|||||.||+|.+.+..+ +.+++.++..++.||+.||.|||++||+||||||+|||++.+..++.+||+|||++
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred CCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999999999999998765 67999999999999999999999999999999999999976556789999999999
Q ss_pred cccCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 290 DFVRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 290 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||++....+++..+..+...++...|+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 8775443 3456789999999999875 5999999999999999999999999999999999999999999998899999
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCccccccccc-CCCccHHHHHHHHHHhhhhhhHHHHHHhhh--cccc--hhhH
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDISILKLMKAYMQSSSLRRAALKALS--KTLT--VDER 442 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~a~l~~l~--~~l~--~~e~ 442 (492)
++++++||.+||+.||.+|||+.|+|+||||+..... ...........+++|.....++.+++..+. ..+. .++.
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~~~~~~~~~~~~e~ 320 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEI 320 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEECCCCSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccchHHH
Confidence 9999999999999999999999999999999865322 223345677888999999999888877653 2222 2333
Q ss_pred HHHHHHHhhhCCCCC
Q 011154 443 FYLKEQFALLEPNKN 457 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~ 457 (492)
..+.+.|.....++|
T Consensus 321 ~~~~~~~l~~i~~gD 335 (444)
T 3soa_A 321 IKVTEQLIEAISNGD 335 (444)
T ss_dssp HHHHHHHHHHHHHTC
T ss_pred HHHHHHHHhhhhcCC
Confidence 344444544444444
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=439.43 Aligned_cols=298 Identities=34% Similarity=0.633 Sum_probs=260.4
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|.++. +|+.||||++...... ....+.+.+|+.+|+.|. ||||++++++|.+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~ 99 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQE 99 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe
Confidence 3456789999999999999999998765 7899999999766543 345667899999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+..|+|||||.||+|.+.+..+ ..+++.++..++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 100 ESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999999999988654 57999999999999999999999999999999999999976655678999999999
Q ss_pred cccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||++....+++..+..+...++...|..++
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp BCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred eEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 98876666667889999999998875 59999999999999999999999999999999999999988888888888999
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCccccccccc-CCCccHHHHHHHHHHhhhhhhHHHHHHhh
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDISILKLMKAYMQSSSLRRAALKAL 433 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~a~l~~l 433 (492)
+++++||.+||..||.+|||+.|+|+||||+..... ...........+++|.....++.+++..+
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 324 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTM 324 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999864322 12233456677788888888877766544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=434.35 Aligned_cols=267 Identities=37% Similarity=0.641 Sum_probs=237.8
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH---HHHHHHHHHHHHHHHccCCCCccEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA---IAVEDVRREVKILRALSGHSNLVKFYDA 206 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ev~~l~~l~~hpniv~l~~~ 206 (492)
..+.++|++++.||+|+||.||+|+.+. +|+.||||++.+...... ...+.+.+|+.+|+.|. ||||++++++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~ 83 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDV 83 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEE
Confidence 4567899999999999999999999765 789999999976543221 12457889999999995 9999999999
Q ss_pred EEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC-CCcEEEEe
Q 011154 207 FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE-SSQLKAID 285 (492)
Q Consensus 207 ~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~-~~~~kl~D 285 (492)
|++.+.+|+|||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||+..++. ...+||+|
T Consensus 84 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 84 YENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999999998854 367999999999999999999999999999999999999953221 22799999
Q ss_pred cccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
||++..+.........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+......+....|
T Consensus 163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 999998876666677889999999998864 6999999999999999999999999999999999999998888877777
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..++.++++||.+||..||.+|||+.|+|+||||+..
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 8899999999999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=427.36 Aligned_cols=263 Identities=30% Similarity=0.582 Sum_probs=237.9
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|.++. +++.||+|++.... .....+.+|+.+|+.+. ||||++++++|.+.
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred chhhceEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecCc----ccHHHHHHHHHHHHhCC-CCCCCeEeEEEecC
Confidence 467899999999999999999998765 78999999996432 23456889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+|||||+||+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||++.
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCe
Confidence 99999999999999999987665679999999999999999999999999999999999999542 26789999999999
Q ss_pred ccCCCCCccccccCccccccccccCC-CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.+..........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+++..+......+....|+.++.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 88776666778899999999998754 78999999999999999999999999999999999999888887777788999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++++||.+||..||.+|||+.|+|+||||++..
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 999999999999999999999999999998753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=426.02 Aligned_cols=293 Identities=38% Similarity=0.666 Sum_probs=234.8
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|+++. +++.||||++.... ..+.+.+|+.+|+.|. ||||++++++|.+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 119 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFET 119 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEEC
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEec
Confidence 4567889999999999999999999765 67899999997543 2346789999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.+++|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 99999999999999999988654 57999999999999999999999999999999999999976555789999999999
Q ss_pred cccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhH-HHHHHHhcCCCCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 367 (492)
+...........+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+..+......+....|..+
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 199 KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred cccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 88766555567789999999998865 58999999999999999999999998766544 67778777777777778899
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCcccccccccCCCccHHHHHHHHHHhhhhhhHHHHHHhh
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKAL 433 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~a~l~~l 433 (492)
+.++++||.+||..||++|||+.|+|+||||.......... ....+.+++|....+++++.....
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 343 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHM-DTAQKKLQEFNARRKLKAAVKAVV 343 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSCC-HHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhhh-cchHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999865444433 345677888888888887765544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=421.59 Aligned_cols=258 Identities=34% Similarity=0.614 Sum_probs=232.1
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|++.. +|+.||||++.+... .....+.+.+|+++|+.++ ||||+++++++.+.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 35789999999999999999998765 789999999976543 3445677899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNE 163 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGG
T ss_pred EEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCcee
Confidence 999999999999999998765 679999999999999999999999999999999999999 6778999999999998
Q ss_pred cCCCCCccccccCccccccccccC-CC-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SY-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
..........+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+....++...+..+...++. .+++
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 239 (328)
T 3fe3_A 164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 239 (328)
T ss_dssp GSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred cCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCH
Confidence 877777778899999999998865 34 47899999999999999999999999999999999887766543 5899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++.+||++||..||.+|||+.|+++||||+...
T Consensus 240 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-54 Score=431.25 Aligned_cols=298 Identities=30% Similarity=0.565 Sum_probs=240.0
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC--CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT--TAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+.++|++.+.||+|+||.||+|+++. +|+.||||++...... .....+.+.+|+.+++.|. ||||++++++|.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSS 97 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 45789999999999999999998765 7899999998542211 1112457889999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEec
Q 011154 210 LDNVYIVMELCEGGELLDRILSRC---GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
.+.+|+|||||+||+|.+.+..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 999999999999999998886542 35899999999999999999999999999999999999976555667999999
Q ss_pred ccccccCCCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 287 GLSDFVRPDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 287 Gla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
|++........ ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+. ....+..+......+....|
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc
Confidence 99988765433 345789999999998864 5899999999999999999999999875 45677778777776666667
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccccc-CCCccHHHHHHHHHHhhhhhhHHHHHHhhh
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDISILKLMKAYMQSSSLRRAALKALS 434 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~a~l~~l~ 434 (492)
..++.++++||.+||..||.+|||+.|+|+||||+..... ...........+++|....+++.+++..++
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 327 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVS 327 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC----------
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 7899999999999999999999999999999999875321 111123445667777777777777665543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=428.11 Aligned_cols=258 Identities=30% Similarity=0.547 Sum_probs=224.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+.+|+.+.+||||++++++|.+.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 4789999999999999999999765 7899999999754333333456688999999998679999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeec
Confidence 99999999999999988765 679999999999999999999999999999999999999 67789999999999864
Q ss_pred C-CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 R-PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
. ........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+++..|......++. .++.+
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~ 250 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHED 250 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHH
Confidence 3 2334556789999999998864 5999999999999999999999999999999999999988776653 58999
Q ss_pred HHHHHHHccccCcCCCCCH------HHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTA------AQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~------~e~l~hp~~~~~ 401 (492)
+++||++||..||.+||++ .++++||||++.
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999999999999999 999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=419.16 Aligned_cols=257 Identities=29% Similarity=0.532 Sum_probs=227.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+.+. +|+.||||++.+...........+.+|+.+|+.+. ||||++++++|.+.+.
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCE
Confidence 3689999999999999999998765 78999999996542212223456889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhc
Confidence 99999999999999988654 679999999999999999999999999999999999999 67789999999999864
Q ss_pred C-CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 R-PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
. ........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....++..+......++. .++++
T Consensus 156 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 231 (337)
T 1o6l_A 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPE 231 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHH
Confidence 3 3344567789999999998864 5899999999999999999999999999988899888887766553 68999
Q ss_pred HHHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+++||.+||..||.+|| ++.|+++||||+..
T Consensus 232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999999 99999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=422.00 Aligned_cols=257 Identities=33% Similarity=0.571 Sum_probs=205.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+++.+. +++.||||++.+..... +.+.+|+.+++.|+ ||||+++++++.+.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGAAID----ENVQREIINHRSLR-HPNIVRFKEVILTPTH 90 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESSTTSC----HHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCcccc----HHHHHHHHHHHhCC-CCCCCcEEEEEeeCCE
Confidence 4789999999999999999999765 78999999997654333 45789999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.+ ....+||+|||+++..
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCccccc
Confidence 99999999999999988665 579999999999999999999999999999999999999432 2335999999999865
Q ss_pred CCCCCccccccCccccccccccC-CCCCc-cchHHHHHHHHHHhcCCCCCCCCCh----hHHHHHHHhcCCCCCCCCCCC
Q 011154 293 RPDERLNDIVGSAYYVAPEVLHR-SYGTE-ADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~-~DvwSlGvil~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~ 366 (492)
.........+||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+... ......+......++ ....
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 246 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP--DDIR 246 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC--TTSC
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC--CcCC
Confidence 55555566789999999998754 45555 8999999999999999999987544 344444554444333 2346
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+++++++||.+||..||.+|||+.|+++||||.+.
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 89999999999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=426.01 Aligned_cols=258 Identities=29% Similarity=0.542 Sum_probs=224.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+.+. +++.||||++.+.........+.+.+|..+|.++.+|||||+++++|.+.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 4689999999999999999999775 7899999999876555555556688999999988679999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc-
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF- 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~- 291 (492)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeec
Confidence 99999999999999988765 679999999999999999999999999999999999999 6778999999999986
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCC---------ChhHHHHHHHhcCCCCCC
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWAR---------TESGIFRAVLKADPSFDD 361 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~---------~~~~~~~~i~~~~~~~~~ 361 (492)
..........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||... ....+...+......++.
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 344455667899999999998864 5899999999999999999999999632 234466777776666553
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCCH------HHHhcCcccccc
Q 011154 362 GSWPSLSSDAKDFVKLLLNKDPRKRMTA------AQALSHPWIRNY 401 (492)
Q Consensus 362 ~~~~~~s~~~~~li~~~L~~dP~~Rps~------~e~l~hp~~~~~ 401 (492)
.++.++++||++||+.||.+||++ .|+++||||++.
T Consensus 284 ----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 284 ----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp ----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 689999999999999999999985 899999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=417.31 Aligned_cols=267 Identities=37% Similarity=0.661 Sum_probs=234.9
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH---HHHHHHHHHHHHHHHccCCCCccEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA---IAVEDVRREVKILRALSGHSNLVKFYDA 206 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ev~~l~~l~~hpniv~l~~~ 206 (492)
..+.++|++.+.||+|+||.||+|+.+. +|+.||||++.+...... ...+.+.+|+.+|+.|. ||||++++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 82 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEV 82 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEE
Confidence 3456789999999999999999998765 789999999976543211 13467889999999995 9999999999
Q ss_pred EEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC-CCCcEEEEe
Q 011154 207 FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAID 285 (492)
Q Consensus 207 ~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~-~~~~~kl~D 285 (492)
|.+.+.+++|||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999999998854 46799999999999999999999999999999999999995432 223799999
Q ss_pred cccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
||++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+....+
T Consensus 162 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 162 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp CTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 99999887666666788999999999886 46899999999999999999999999999988888888887777766666
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..++.++++||.+||..||.+|||+.|+|+||||+..
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 7899999999999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=414.66 Aligned_cols=258 Identities=29% Similarity=0.530 Sum_probs=226.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+.+++.+.+||||++++++|.+.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 4689999999999999999999765 7899999999877666666777899999999998669999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCS
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccc
Confidence 99999999999999988765 679999999999999999999999999999999999999 67789999999999864
Q ss_pred C-CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCC---------CChhHHHHHHHhcCCCCCC
Q 011154 293 R-PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWA---------RTESGIFRAVLKADPSFDD 361 (492)
Q Consensus 293 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~---------~~~~~~~~~i~~~~~~~~~ 361 (492)
. ........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .....+...+......++.
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 240 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC
Confidence 3 3344567789999999998864 589999999999999999999999965 3344566677776655543
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCCH------HHHhcCcccccc
Q 011154 362 GSWPSLSSDAKDFVKLLLNKDPRKRMTA------AQALSHPWIRNY 401 (492)
Q Consensus 362 ~~~~~~s~~~~~li~~~L~~dP~~Rps~------~e~l~hp~~~~~ 401 (492)
.++.++++||.+||+.||.+||++ .|+++||||++.
T Consensus 241 ----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 241 ----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp ----TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred ----CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 689999999999999999999995 899999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=400.59 Aligned_cols=267 Identities=36% Similarity=0.680 Sum_probs=241.0
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|.++. +|+.||||++..... .....+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcC
Confidence 467899999999999999999998765 688999999976543 3445577899999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..++|||||+||+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++.
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999999999988765 679999999999999999999999999999999999999765556679999999998
Q ss_pred ccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
............||+.|+|||++.+ .++.++|||||||++|+|++|..||++.........+......++...+..+++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 8776666667789999999998864 589999999999999999999999999999999999998888888888889999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=419.33 Aligned_cols=259 Identities=31% Similarity=0.520 Sum_probs=227.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|..+|..+.+||||++++++|.+.+.
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 4789999999999999999999765 7899999999654221112345678899999887569999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhc
Confidence 99999999999999988764 679999999999999999999999999999999999999 67789999999999865
Q ss_pred CC-CCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RP-DERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.. .......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+++..+......++. .++.+
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 244 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKE 244 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHH
Confidence 32 334566789999999998864 5899999999999999999999999999999999999887766543 58999
Q ss_pred HHHHHHHccccCcCCCCCHH-HHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAA-QALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~-e~l~hp~~~~~~ 402 (492)
+++||.+||..||.+||++. ++++||||+...
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 99999999999999999998 999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=422.52 Aligned_cols=264 Identities=36% Similarity=0.614 Sum_probs=236.9
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|..+. +|+.||+|++.... ......+.+|+.+|+.|. ||||++++++|.+.
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDK 120 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECS
T ss_pred ccccceEEEEEEecCCCEEEEEEEECC---CCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeC
Confidence 356789999999999999999998765 78899999996543 334457889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+++|||||.||+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||++.
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLAT 199 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccce
Confidence 99999999999999999887665679999999999999999999999999999999999999532 34679999999999
Q ss_pred ccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
...........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......+....+..+++
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 8876666666789999999998864 588999999999999999999999999998889999988888888778889999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++++||.+||..||.+|||+.|+|+||||+...
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 999999999999999999999999999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=413.53 Aligned_cols=248 Identities=20% Similarity=0.274 Sum_probs=191.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC-
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD- 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~- 211 (492)
..+|.+.++||+|+||.||+|++ +|+.||||++.... ........|+..+..|+ |||||+++++|.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-----~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-----TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCC
Confidence 46799999999999999999986 46899999995432 11222345666667785 999999999998764
Q ss_pred ---eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCcccCCCCCceEeecCCCCCc
Q 011154 212 ---NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH--------GVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 212 ---~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~--------~ivHrDlkp~NILl~~~~~~~~ 280 (492)
.+|||||||+||+|.+++.. ..++++++..++.|++.||.|||++ +||||||||+|||+ +.++.
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~ 146 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred CceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCC
Confidence 58999999999999999865 4799999999999999999999987 89999999999999 77789
Q ss_pred EEEEecccccccCCCCC-----ccccccCccccccccccCC-------CCCccchHHHHHHHHHHhcCCCCCCCC-----
Q 011154 281 LKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-------YGTEADVWSIGVIAYILLCGSRPFWAR----- 343 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DvwSlGvil~~lltg~~pf~~~----- 343 (492)
+||+|||+|+....... ....+||+.|||||++.+. |+.++|||||||++|||+||..||...
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 99999999987754432 2346899999999998642 567899999999999999997765321
Q ss_pred ----------ChhHHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 344 ----------TESGIFRAVLKADPSFDDG-SW--PSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 344 ----------~~~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
....+...+.........+ .+ ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1122333333322211111 11 1123468899999999999999999998863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=417.32 Aligned_cols=260 Identities=39% Similarity=0.666 Sum_probs=229.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|+++. +|+.||||++.+.... ..+|+++|.++.+||||++++++|++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 456889999999999999999999765 7899999999766432 346888998886799999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC-CCCcEEEEecccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAIDFGLS 289 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~-~~~~~kl~DfGla 289 (492)
+.+|+|||||+||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+...+ ....+||+|||++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999999999988654 6799999999999999999999999999999999999985432 2346999999999
Q ss_pred cccCCC-CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCC---CChhHHHHHHHhcCCCCCCCCC
Q 011154 290 DFVRPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWA---RTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 290 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~---~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
+..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ ....+++..+..+...+....|
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 876543 33456789999999998865 488999999999999999999999986 4566788889888888888888
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..+++++++||.+||..||++|||+.++++||||.+.
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 9999999999999999999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=417.52 Aligned_cols=258 Identities=27% Similarity=0.480 Sum_probs=227.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|..+|..+.+||||++++++|.+.+.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 4789999999999999999999765 7899999999654322222345678899999888679999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCccccc
Confidence 99999999999999988765 579999999999999999999999999999999999999 67789999999999864
Q ss_pred C-CCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 R-PDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
. ........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+++..|......++. .++.+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 247 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKE 247 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence 3 333456678999999999886 46899999999999999999999999999999999999987766653 68999
Q ss_pred HHHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+++||.+||..||.+|| ++.++++||||+..
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 99999999999999999 47999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=423.11 Aligned_cols=260 Identities=34% Similarity=0.611 Sum_probs=217.4
Q ss_pred cccceeec-ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe-
Q 011154 132 VTSRLEVG-EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED- 209 (492)
Q Consensus 132 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~- 209 (492)
+.++|.+. +.||+|+||.||+++++. +|+.||||++... ..+.+|+.++.++.+||||++++++|+.
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECC---CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 34667776 789999999999998765 7899999999632 3567899998666679999999999976
Q ss_pred ---CCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 210 ---LDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 210 ---~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
.+.+|||||||+||+|.+++..+. ..+++.+++.|+.||+.||.|||++||+||||||+|||++..+.++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 567999999999999999997653 3699999999999999999999999999999999999996544478999999
Q ss_pred cccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChh----HHHHHHHhcCCCCC
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES----GIFRAVLKADPSFD 360 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~----~~~~~i~~~~~~~~ 360 (492)
||+++...........+||+.|+|||++. ..|+.++||||||||+|+|++|..||.+.... .....+..+...+.
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 99999876666667788999999999886 46999999999999999999999999776543 35667777777888
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
...|..++.++++||.+||..||.+|||+.|+|+||||.+..
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 778889999999999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=410.94 Aligned_cols=255 Identities=26% Similarity=0.555 Sum_probs=226.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+++.+ +||||++++++|.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCE
Confidence 4689999999999999999998765 7899999999654322222345678999999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEEC
T ss_pred EEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceec
Confidence 99999999999999988654 679999999999999999999999999999999999999 67789999999999876
Q ss_pred CCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 293 RPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+......++. .++.++
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 230 (318)
T 1fot_A 157 PD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDV 230 (318)
T ss_dssp SS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred CC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHH
Confidence 43 3456789999999998864 5899999999999999999999999999998999999887766543 689999
Q ss_pred HHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
++||.+||..||.+|+ +++++++||||+..
T Consensus 231 ~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 9999999999999999 99999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=401.06 Aligned_cols=263 Identities=38% Similarity=0.763 Sum_probs=238.6
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|.++. ++..||+|++.+..... .+.+.+|+++++.+ +||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVED---VDRFKQEIEIMKSL-DHPNIIRLYETFEDN 78 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhhccch---HHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence 456789999999999999999998765 67899999997644332 45788999999999 499999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..++|||||++++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 9999999999999999988765 679999999999999999999999999999999999999766677899999999999
Q ss_pred ccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
............||+.|+|||++.+.++.++|||||||++|+|++|..||......+....+......++...|..++++
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 88777667778899999999999888999999999999999999999999999999999999888877776666789999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=401.26 Aligned_cols=264 Identities=36% Similarity=0.664 Sum_probs=225.3
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
-.+.++|.+.+.||+|+||.||+|+.+. ++..||||++....... ..+.+.+|+++|+.+. ||||+++++++.+
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 91 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLD-HPNIIKIFEVFED 91 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred CChhhheeecceeccCCCeEEEEEEEcc---CCceEEEEEeeccccch--hHHHHHHHHHHHHhCC-CchHHhHHHheec
Confidence 3456889999999999999999998765 68899999997654322 3467889999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEec
Q 011154 210 LDNVYIVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
.+..++|||||++|+|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 99999999999999999988643 367999999999999999999999999999999999999976566778999999
Q ss_pred ccccccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
|++.............||+.|+|||++.+.++.++|||||||++|+|++|..||.+....+....+......+.... ..
T Consensus 172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~ 250 (285)
T 3is5_A 172 GLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RP 250 (285)
T ss_dssp CCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CC
T ss_pred ecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-Cc
Confidence 99988776666667789999999999988899999999999999999999999999888888777776665554332 34
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 7999999999999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=429.04 Aligned_cols=263 Identities=28% Similarity=0.456 Sum_probs=226.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+.+++.+ +|||||+++++|.+.
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDD 141 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC
Confidence 345789999999999999999999765 7899999998652211111123477899999999 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeE
Confidence 999999999999999998854 479999999999999999999999999999999999999 777899999999998
Q ss_pred ccCCCCC--ccccccCccccccccccCC-----CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 291 FVRPDER--LNDIVGSAYYVAPEVLHRS-----YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 291 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-----~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
.+..... ....+||+.|+|||++.+. |+.++|||||||++|+|++|..||.+.+..+.+..|......+....
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 7765432 3467899999999988532 78899999999999999999999999999999999887543333344
Q ss_pred CCCCCHHHHHHHHHccccCcCC--CCCHHHHhcCccccccc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRK--RMTAAQALSHPWIRNYN 402 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~--Rps~~e~l~hp~~~~~~ 402 (492)
+..++.++++||.+||..+|.+ |++++|+++||||++..
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 5679999999999999999988 99999999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=405.27 Aligned_cols=264 Identities=28% Similarity=0.453 Sum_probs=220.2
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.+.+.++|++.+.||+|+||.||+|++. +|+.||||++...... ......+.+|+++|+.+. ||||+++++++.
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 89 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDAED-EGIPSTAIREISLLKELH-HPNIVSLIDVIH 89 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcC-CCCEeeeeeEEc
Confidence 3567789999999999999999999863 4789999999654322 223456889999999995 999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
+.+.+++|||||++ +|.+.+......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 90 SERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGL 165 (311)
T ss_dssp CSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred cCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcC
Confidence 99999999999985 8888888776779999999999999999999999999999999999999 6667899999999
Q ss_pred ccccCCC-CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC--
Q 011154 289 SDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS-- 363 (492)
Q Consensus 289 a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-- 363 (492)
+...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...........
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 9876533 33445689999999998754 589999999999999999999999998887777766654222221111
Q ss_pred ------------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 364 ------------------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 364 ------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+.+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 134788999999999999999999999999999999753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=430.28 Aligned_cols=265 Identities=27% Similarity=0.466 Sum_probs=227.2
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+...++|++.+.||+|+||.||+|+++. +++.||||++.+...........+.+|+.++..+ +||||++++++|.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQD 145 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEEC
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee
Confidence 3456899999999999999999999775 6889999999643211111122378899999999 59999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.+|||||||+||+|.+++....+.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhh
Confidence 999999999999999999997756789999999999999999999999999999999999999 67789999999999
Q ss_pred cccCCCCC--ccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC--CCC
Q 011154 290 DFVRPDER--LNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSF 359 (492)
Q Consensus 290 ~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~--~~~ 359 (492)
+....... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+.+..+.+..|.... ..+
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 87654443 23468999999999875 358999999999999999999999999999988888887543 233
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCC--CCCHHHHhcCccccccc
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRK--RMTAAQALSHPWIRNYN 402 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~--Rps~~e~l~hp~~~~~~ 402 (492)
+. .+..+++++++||++||+.+|++ |++++|+++||||++..
T Consensus 303 p~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 303 PT-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp CS-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred Cc-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 22 23568999999999999999988 99999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=418.50 Aligned_cols=258 Identities=34% Similarity=0.608 Sum_probs=220.9
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|++.. +++.||||++.+...........+.+|+.+|+.++ ||||+++++++.+.
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTP 81 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 345789999999999999999999765 78999999986432211122346889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+++||||+ +|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 82 TDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSN 156 (336)
T ss_dssp SEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTB
T ss_pred CEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccce
Confidence 9999999999 78999988765 679999999999999999999999999999999999999 667799999999999
Q ss_pred ccCCCCCccccccCccccccccccCC-C-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHRS-Y-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
...........+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.........+......++ ..++
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 232 (336)
T 3h4j_B 157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLS 232 (336)
T ss_dssp TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSC
T ss_pred eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCC
Confidence 88777777788999999999998754 4 6789999999999999999999987665554443333322222 3589
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+++++||.+||..||.+|||+.|+++||||+..
T Consensus 233 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=413.45 Aligned_cols=255 Identities=30% Similarity=0.537 Sum_probs=227.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+.+|+.+ +||||+++++++.+.+.
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCE
Confidence 4789999999999999999999765 7899999999654322222346788999999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceec
Confidence 99999999999999988765 679999999999999999999999999999999999999 67789999999999876
Q ss_pred CCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 293 RPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.. .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+....+++..+......++. .++.++
T Consensus 192 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 265 (350)
T 1rdq_E 192 KG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDL 265 (350)
T ss_dssp SS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHH
T ss_pred cC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence 43 334678999999999876 45899999999999999999999999999999999999888766543 689999
Q ss_pred HHHHHHccccCcCCCCC-----HHHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
++||.+||+.||.+||+ +.++++||||+..
T Consensus 266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 99999999999999998 9999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=398.03 Aligned_cols=259 Identities=27% Similarity=0.494 Sum_probs=218.5
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+++. +++.||||++....... .....+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDE-GVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEE
Confidence 589999999999999999999765 78999999997655332 34467889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++|||||++ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecC
Confidence 999999975 7777777766789999999999999999999999999999999999999 667799999999998765
Q ss_pred CC-CCccccccCccccccccccC-C-CCCccchHHHHHHHHHHhcCCCCC-CCCChhHHHHHHHhcCCCCCCCC------
Q 011154 294 PD-ERLNDIVGSAYYVAPEVLHR-S-YGTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDDGS------ 363 (492)
Q Consensus 294 ~~-~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlGvil~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~------ 363 (492)
.. ......+||+.|+|||++.+ . ++.++|||||||++|+|++|..|| .+....+.+..+...........
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 33 33455689999999998854 3 899999999999999999988885 55555566666654322222211
Q ss_pred -------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 364 -------------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 364 -------------------~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.+.++.++++||.+||+.||++|||++|+|+||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 23578999999999999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=403.81 Aligned_cols=267 Identities=34% Similarity=0.590 Sum_probs=221.0
Q ss_pred ccccccceeec-ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEE
Q 011154 129 SKEVTSRLEVG-EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAF 207 (492)
Q Consensus 129 ~~~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~ 207 (492)
...+.++|++. +.||+|+||.||+|+... +++.||||++.+.... ..+.+.+|+.+|.++.+||||+++++++
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSS---SCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcC---CCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 44567889995 789999999999998654 7899999999765432 2456889999999965799999999999
Q ss_pred EeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 208 EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 208 ~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
.+.+.+|+|||||+||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 9999999999999999999998765 579999999999999999999999999999999999999654444569999999
Q ss_pred cccccCCCC--------CccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCCh--------
Q 011154 288 LSDFVRPDE--------RLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTE-------- 345 (492)
Q Consensus 288 la~~~~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~-------- 345 (492)
++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987654221 123456999999999875 3488999999999999999999999976542
Q ss_pred -------hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 346 -------SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 346 -------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..++..+......++...|..++.++++||.+||..||.+|||+.|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 346677777776666555667899999999999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=416.36 Aligned_cols=260 Identities=34% Similarity=0.606 Sum_probs=227.7
Q ss_pred cceee--cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 134 SRLEV--GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 134 ~~y~~--~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.|.+ .+.||+|+||.||+|.... +|+.||||++.... ....+.+.+|+.+|+.|. ||||++++++|.+.+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETA---TGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred cceeeecceEEecCcCEEEEEEEEcC---CCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 34554 6789999999999998765 78999999997643 344567899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.++||||||+||+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||+++.
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCcee
Confidence 999999999999999999876667999999999999999999999999999999999999954 3456899999999998
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
+.........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......+....+..++++
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred cCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence 876666667789999999998864 5888999999999999999999999999999999999888777777777889999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+++||.+||..||.+|||+.|+|+||||++.
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 9999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=397.30 Aligned_cols=259 Identities=27% Similarity=0.462 Sum_probs=223.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|++.. +|+.||||++....... .+.+.+|+.+++.+. ||||++++++|.+.
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPK---KELIINEILVMRENK-NPNIVNYLDSYLVG 89 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeecccccH---HHHHHHHHHHHhcCC-CCCCCeEeEEEEEC
Confidence 456789999999999999999998654 78999999986544333 356889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+|||||+||+|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCA 164 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCce
Confidence 9999999999999999988654 69999999999999999999999999999999999999 667789999999998
Q ss_pred ccCCCC-CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
...... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.........+....... ......++
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 243 (297)
T 3fxz_A 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLS 243 (297)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGSC
T ss_pred ecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCccccC
Confidence 765443 344568999999999876 458999999999999999999999999888777666655443221 12234689
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 9999999999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=416.17 Aligned_cols=257 Identities=25% Similarity=0.547 Sum_probs=224.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+.+. +++.||||++.+.........+.+.+|+.+|+.+ +|||||+++++|.+.+.
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEED 89 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE
Confidence 4789999999999999999998765 7899999999654322223356788999999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeec
Confidence 99999999999999888654 679999999999999999999999999999999999999 67789999999999988
Q ss_pred CCCCCccccccCccccccccccC----CCCCccchHHHHHHHHHHhcCCCCCCCCC---hhHHHHHHHhcCCCCCCCCCC
Q 011154 293 RPDERLNDIVGSAYYVAPEVLHR----SYGTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlGvil~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 365 (492)
.........+||+.|+|||++.. .|+.++|||||||++|+|++|..||.... ..++...+......++ .
T Consensus 166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~ 241 (384)
T 4fr4_A 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----S 241 (384)
T ss_dssp CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----T
T ss_pred cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----C
Confidence 77777778899999999998852 48899999999999999999999997543 3455556665555444 3
Q ss_pred CCCHHHHHHHHHccccCcCCCCC-HHHHhcCcccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMT-AAQALSHPWIRNY 401 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps-~~e~l~hp~~~~~ 401 (492)
.++.++.+||.+||+.||.+||+ +.++++||||...
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 68999999999999999999998 9999999999865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=403.78 Aligned_cols=261 Identities=28% Similarity=0.509 Sum_probs=218.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC-HHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT-AIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
..++|++.+.||+|+||.||+|+...+..+|+.||||++.+..... ......+.+|+.+|+.+. ||||+++++++.+.
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcC
Confidence 3578999999999999999999987555688999999997654322 223456789999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCK 169 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC-
T ss_pred CEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccc
Confidence 9999999999999999988665 679999999999999999999999999999999999999 667799999999997
Q ss_pred ccCCC-CCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPD-ERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
..... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......++ +.++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~ 245 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLT 245 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCC
Confidence 64332 3345678999999999876 4589999999999999999999999999998888888888766554 3689
Q ss_pred HHHHHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
.++++||.+||..||.+|| ++.++++||||+..
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999999999999999999 89999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=422.88 Aligned_cols=263 Identities=29% Similarity=0.472 Sum_probs=225.1
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+|..+ +||||++++++|.+.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDE 133 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECS
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeC
Confidence 346899999999999999999999765 7899999999653222222233478999999999 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|||||||+||+|.+++.+....+++..++.++.||+.||.|||++|||||||||+|||+ +.++++||+|||+++
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCL 210 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhhe
Confidence 99999999999999999998766689999999999999999999999999999999999999 777899999999998
Q ss_pred ccCCCCC--ccccccCcccccccccc--------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC--CC
Q 011154 291 FVRPDER--LNDIVGSAYYVAPEVLH--------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PS 358 (492)
Q Consensus 291 ~~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~--~~ 358 (492)
....... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+.+..+.+..|.... ..
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 7765443 23468999999999885 358999999999999999999999999999988888887533 22
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCC---CCHHHHhcCccccccc
Q 011154 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKR---MTAAQALSHPWIRNYN 402 (492)
Q Consensus 359 ~~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~e~l~hp~~~~~~ 402 (492)
++. ....++.++++||++||+ +|.+| ++++|+++||||+...
T Consensus 291 ~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 291 LPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp CC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred CCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 221 124689999999999999 99998 5999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=412.99 Aligned_cols=258 Identities=29% Similarity=0.514 Sum_probs=218.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHH-HHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI-LRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~-l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|++.+.||+|+||.||+|+++. +++.||||++.+...........+.+|..+ ++.+ +||||++++++|.+.+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTAD 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCC
Confidence 4689999999999999999999765 789999999987665544455567778777 4556 5999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++++||+|||+++.
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGG
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccc
Confidence 999999999999999988664 679999999999999999999999999999999999999 6778999999999986
Q ss_pred c-CCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 292 V-RPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 292 ~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
. .........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+++..|......++ +.++.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 264 (373)
T 2r5t_A 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITN 264 (373)
T ss_dssp GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCH
T ss_pred cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCH
Confidence 4 33345567789999999998864 589999999999999999999999999999999999988765554 36899
Q ss_pred HHHHHHHHccccCcCCCCCH----HHHhcCccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTA----AQALSHPWIRNYN 402 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~----~e~l~hp~~~~~~ 402 (492)
++++||.+||+.||.+||++ .++++||||+...
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 99999999999999999986 6999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=409.99 Aligned_cols=260 Identities=35% Similarity=0.649 Sum_probs=207.5
Q ss_pred ccceeec---ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 133 TSRLEVG---EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 133 ~~~y~~~---~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
.++|++. +.||+|+||.||+|+++. +++.||||++.+. ....+.+|+.+++.+.+||||++++++|.+
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETT---TCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhccccccCCCccccCCCeEEEEEEECC---CCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 3567774 789999999999999765 7899999999643 235678899999999779999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+..|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+..++....+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred CCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 99999999999999999988764 67999999999999999999999999999999999999976555568999999999
Q ss_pred cccCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC-------hhHHHHHHHhcCCCCC
Q 011154 290 DFVRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART-------ESGIFRAVLKADPSFD 360 (492)
Q Consensus 290 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~ 360 (492)
+...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.... ..+++..+..+...+.
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp EECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred eecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 8765433 3456789999999998864 58999999999999999999999997643 3467777777777777
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
...|..+++++++||.+||..||.+|||+.|+++||||++..
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 777778999999999999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=396.84 Aligned_cols=258 Identities=29% Similarity=0.471 Sum_probs=214.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.. +|+.||||++...... ....+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKED-EGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEcC----CCCEEEEEEEeccccc-cccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeE
Confidence 57999999999999999999862 5789999999654322 122356789999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++||||+++ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHC
T ss_pred EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccC
Confidence 999999976 9999887766789999999999999999999999999999999999999 667799999999998765
Q ss_pred CC-CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC--------
Q 011154 294 PD-ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG-------- 362 (492)
Q Consensus 294 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-------- 362 (492)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+..........
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 32 23345679999999998854 48999999999999999999999999888877776665421111111
Q ss_pred -----------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 363 -----------------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 363 -----------------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
....++.++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 123578999999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=410.72 Aligned_cols=264 Identities=34% Similarity=0.663 Sum_probs=234.3
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-C----HHHHHHHHHHHHHHHHccCCCCccEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-T----AIAVEDVRREVKILRALSGHSNLVKFY 204 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-~----~~~~~~~~~Ev~~l~~l~~hpniv~l~ 204 (492)
..+.++|++.+.||+|+||.||+|+++. +|+.||||++...... . ....+.+.+|+.+++.+.+||||++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 3456789999999999999999998764 6899999999765421 1 122456789999999996699999999
Q ss_pred EEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 205 DAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 205 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+++...+..|+|||||+||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEE
Confidence 9999999999999999999999988765 679999999999999999999999999999999999999 667899999
Q ss_pred ecccccccCCCCCccccccCccccccccccC-------CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-------SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
|||++..+.........+||+.|+|||++.+ .++.++|||||||++|+|++|..||+.......+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999998877666777899999999998742 478899999999999999999999999988888888888877
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 358 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
.+....|..++.++.+||.+||..||++|||+.++|+||||+.
T Consensus 323 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 7766667789999999999999999999999999999999973
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=405.95 Aligned_cols=273 Identities=28% Similarity=0.525 Sum_probs=234.8
Q ss_pred cCCccccccceeec-ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEE
Q 011154 126 FGFSKEVTSRLEVG-EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFY 204 (492)
Q Consensus 126 ~~~~~~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~ 204 (492)
|...+.+.++|.+. +.||+|+||.||+|+.+. +++.||||++.+..... .....+.+|+.+++.+.+||||++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 34446678889987 899999999999998765 78999999997644322 23457889999999998789999999
Q ss_pred EEEEeCCeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 205 DAFEDLDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 205 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
++|.+.+.+|+|||||.||+|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|||++.....+.+||
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEE
Confidence 9999999999999999999999887543 357999999999999999999999999999999999999965444678999
Q ss_pred EecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (492)
+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......+...
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 176 VDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp CCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred eeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 9999999887666666778999999999886 458999999999999999999999999999988888888888888888
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+..++..+.+||.+||..||.+|||+.++|+||||++..
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 8889999999999999999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=398.18 Aligned_cols=265 Identities=28% Similarity=0.422 Sum_probs=217.0
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC--CHHHHHHHHHHHHHHHHcc--CCCCccEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT--TAIAVEDVRREVKILRALS--GHSNLVKFYD 205 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ev~~l~~l~--~hpniv~l~~ 205 (492)
..+.++|++.+.||+|+||.||+|++.. +++.||||++...... .......+.+|+.+++.+. +||||+++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTT---TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 3456899999999999999999998654 7899999998643211 1111234567887777764 4999999999
Q ss_pred EEEeCC-----eEEEEEeecCCCchHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCC
Q 011154 206 AFEDLD-----NVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS 279 (492)
Q Consensus 206 ~~~~~~-----~~~lv~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~ 279 (492)
+|.+.. .+++||||+. |+|.+++..... .+++.+++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~ 157 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGG 157 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTS
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCC
Confidence 998765 5899999997 599998876532 39999999999999999999999999999999999999 6677
Q ss_pred cEEEEecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC
Q 011154 280 QLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 358 (492)
Q Consensus 280 ~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~ 358 (492)
.+||+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred CEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 89999999999887666667789999999999875 56999999999999999999999999999988888777664333
Q ss_pred CCCCCC-----------------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 359 FDDGSW-----------------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 359 ~~~~~~-----------------------~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.....| +.+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 332222 3578999999999999999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=403.16 Aligned_cols=267 Identities=37% Similarity=0.642 Sum_probs=232.7
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH---HHHHHHHHHHHHHHHccCCCCccEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA---IAVEDVRREVKILRALSGHSNLVKFYDA 206 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ev~~l~~l~~hpniv~l~~~ 206 (492)
..+.++|++.+.||+|+||.||+|+.+. +|+.||||++........ ...+.+.+|+.+++.+. ||||++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 83 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDV 83 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEE
Confidence 3456789999999999999999999765 789999999976543221 13467889999999995 9999999999
Q ss_pred EEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC-CCcEEEEe
Q 011154 207 FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE-SSQLKAID 285 (492)
Q Consensus 207 ~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~-~~~~kl~D 285 (492)
+.+.+.+++|||||+|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+..++. ...+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999999998865 367999999999999999999999999999999999999953221 12799999
Q ss_pred cccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+....+
T Consensus 163 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp CTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 99998877666666778999999999886 45899999999999999999999999999988888888887766655555
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..++.++.+||.+||..||.+|||+.|+|+||||...
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 6789999999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=392.75 Aligned_cols=265 Identities=35% Similarity=0.622 Sum_probs=236.1
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC------HHHHHHHHHHHHHHHHccCCCCccEEE
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT------AIAVEDVRREVKILRALSGHSNLVKFY 204 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~------~~~~~~~~~Ev~~l~~l~~hpniv~l~ 204 (492)
.+.++|++.+.||+|+||.||+|+++. +|+.||||++....... ....+.+.+|+.+++++.+||||++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcC---cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 456899999999999999999998765 78999999997653211 223456889999999997799999999
Q ss_pred EEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 205 DAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 205 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+++.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~ 166 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLT 166 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEEC
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEe
Confidence 9999999999999999999999988765 679999999999999999999999999999999999999 667789999
Q ss_pred ecccccccCCCCCccccccCcccccccccc-------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 999998887666667778999999999874 3478899999999999999999999999998888888888887
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+....+..++.++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 777777788999999999999999999999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=422.40 Aligned_cols=258 Identities=29% Similarity=0.530 Sum_probs=217.8
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|+.+. +|+.||||++.+...........+.+|+.+|+.+. ||||++++++|.+.+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHD 221 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETT
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCC
Confidence 45789999999999999999998765 78999999997543333344556788999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||+ +|||||||||+|||+ +.++.+||+|||+|+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCC
T ss_pred EEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCce
Confidence 999999999999999988665 689999999999999999999998 899999999999999 667799999999998
Q ss_pred ccC-CCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVR-PDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
... ........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.........+......++. .++
T Consensus 298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~ 373 (446)
T 4ejn_A 298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLG 373 (446)
T ss_dssp TTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred eccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCC
Confidence 643 333456678999999999886 46999999999999999999999999999999999998887766553 689
Q ss_pred HHHHHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+++.+||.+||..||.+|| ++.|+++||||.+.
T Consensus 374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 9999999999999999999 99999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=401.65 Aligned_cols=260 Identities=28% Similarity=0.475 Sum_probs=206.6
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|..+. +|+.||||++....... ..+.+.+|+.+|+.+. ||||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEVKLDSEEG--TPSTAIREISLMKELK-HENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECSS---SCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---CCcEEEEEEeecccccc--cHHHHHHHHHHHHhcC-CCCcceEEEEEEECCe
Confidence 4689999999999999999998654 78999999997654221 2346789999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 213 VYIVMELCEGGELLDRILSRC-----GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
+|+|||||+ |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCS
T ss_pred EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCc
Confidence 999999998 59999887542 359999999999999999999999999999999999999 667789999999
Q ss_pred cccccCCC-CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC-
Q 011154 288 LSDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS- 363 (492)
Q Consensus 288 la~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~- 363 (492)
++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 99876533 23455689999999998864 589999999999999999999999999888887777654322111111
Q ss_pred -----------------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 364 -----------------------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 364 -----------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
...++.++++||.+||+.||++|||+.|+|+||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 125788999999999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=413.74 Aligned_cols=263 Identities=28% Similarity=0.489 Sum_probs=211.1
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+.+.++|++.+.||+|+||.||+|.++. +|+.||||++.+.. ........+.+|+.+|+.+.+||||+++++++..
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETT---TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 4456899999999999999999998765 78999999996543 3445566788999999999779999999999986
Q ss_pred CC--eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 210 LD--NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 210 ~~--~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
.+ .+|+|||||+ |+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG 154 (388)
T 3oz6_A 81 DNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFG 154 (388)
T ss_dssp TTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred CCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCc
Confidence 54 7999999997 588888765 479999999999999999999999999999999999999 667799999999
Q ss_pred cccccCC----------------------CCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCC
Q 011154 288 LSDFVRP----------------------DERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWAR 343 (492)
Q Consensus 288 la~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~ 343 (492)
+|+.+.. .......+||++|+|||++.+ .|+.++||||||||+|+|++|+.||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9986532 112345689999999998854 5899999999999999999999999998
Q ss_pred ChhHHHHHHHhcCCCCC------------------------------C-------------CCCCCCCHHHHHHHHHccc
Q 011154 344 TESGIFRAVLKADPSFD------------------------------D-------------GSWPSLSSDAKDFVKLLLN 380 (492)
Q Consensus 344 ~~~~~~~~i~~~~~~~~------------------------------~-------------~~~~~~s~~~~~li~~~L~ 380 (492)
+..+.+..+........ . ..+..+++++.+||.+||.
T Consensus 235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 88777766653211110 0 0112678999999999999
Q ss_pred cCcCCCCCHHHHhcCccccccc
Q 011154 381 KDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 381 ~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.||.+|||+.|+|+||||+.+.
T Consensus 315 ~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 315 FNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp SSGGGSCCHHHHTTSTTTTTTC
T ss_pred cCcccCCCHHHHhCCHHHHHhc
Confidence 9999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=425.33 Aligned_cols=259 Identities=35% Similarity=0.619 Sum_probs=228.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|.+++.||+|+||.||+|++.. +|+.||||++.+.........+.+.+|+.+|+.+. ||||+++++++.+.
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTP 88 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 345789999999999999999998765 78999999996543222223457889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+|||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSN 164 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchh
Confidence 999999999999999998854 3679999999999999999999999999999999999999 667789999999999
Q ss_pred ccCCCCCccccccCccccccccccCC-C-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHRS-Y-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
...........+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+......+..+..+....+ ..++
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 240 (476)
T 2y94_A 165 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLN 240 (476)
T ss_dssp ECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCC
T ss_pred hccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCC
Confidence 88766666778999999999998754 3 6789999999999999999999999888888888887665443 2589
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+++.+||.+||..||.+|||+.|+++||||++.
T Consensus 241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=398.61 Aligned_cols=258 Identities=25% Similarity=0.328 Sum_probs=214.1
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.++||+|+||.||+|+++. +|+.||||++...... .........|+..+..+.+||||++++++|.+
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 3455789999999999999999999765 6899999998654433 33444566677777666569999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.+|+||||| +|+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLL 204 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTC
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceee
Confidence 99999999999 669999998877789999999999999999999999999999999999999 66678999999999
Q ss_pred cccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.............||+.|+|||++.+.++.++|||||||++|+|++|..||+.... ...+.... .....+..+++
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~ 279 (311)
T 3p1a_A 205 VELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFTAGLSS 279 (311)
T ss_dssp EECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHHTTSCH
T ss_pred eecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccccCCCH
Confidence 88766655666789999999999988999999999999999999999877765332 23332221 12222346899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
++.+||.+||+.||++|||+.|+|+||||++
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=395.81 Aligned_cols=256 Identities=29% Similarity=0.588 Sum_probs=215.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH-----------------------HHHHHHHHHHH
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA-----------------------IAVEDVRREVK 189 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~-----------------------~~~~~~~~Ev~ 189 (492)
.++|++.+.||+|+||.||+|+... +++.||||++.+...... ...+.+.+|++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 4789999999999999999998764 789999999976543211 12356889999
Q ss_pred HHHHccCCCCccEEEEEEEe--CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 011154 190 ILRALSGHSNLVKFYDAFED--LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKP 267 (492)
Q Consensus 190 ~l~~l~~hpniv~l~~~~~~--~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp 267 (492)
+|+.|. ||||+++++++.+ .+.+|+|||||++|+|.+.+ ....+++.+++.++.||+.||.|||++||+||||||
T Consensus 89 ~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 89 ILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999995 9999999999987 57899999999999998754 235799999999999999999999999999999999
Q ss_pred CceEeecCCCCCcEEEEecccccccCCCC-CccccccCccccccccccCC----CCCccchHHHHHHHHHHhcCCCCCCC
Q 011154 268 ENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS----YGTEADVWSIGVIAYILLCGSRPFWA 342 (492)
Q Consensus 268 ~NILl~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DvwSlGvil~~lltg~~pf~~ 342 (492)
+|||+ +.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||..
T Consensus 166 ~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 166 SNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999 667799999999998765433 23456899999999998643 36789999999999999999999998
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 343 RTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 343 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
.........+......++. .+.+++++.+||.+||+.||++|||+.|+|+||||+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred ccHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 8887777777766554432 357899999999999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=420.75 Aligned_cols=267 Identities=35% Similarity=0.612 Sum_probs=218.3
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-----CHHHHHHHHHHHHHHHHccCCCCccEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-----TAIAVEDVRREVKILRALSGHSNLVKF 203 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ev~~l~~l~~hpniv~l 203 (492)
...+.++|.+.+.||+|+||.||+|..+. +++.||||++.+.... .......+.+|+.+|++| +||||+++
T Consensus 130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l 205 (419)
T 3i6u_A 130 PKALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKI 205 (419)
T ss_dssp CHHHHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCC
T ss_pred chhhhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeE
Confidence 34567899999999999999999998765 7899999999764322 112223478999999999 59999999
Q ss_pred EEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 204 YDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 204 ~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
++++.. +.+|+|||||++|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++....+||
T Consensus 206 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 206 KNFFDA-EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp CEEEES-SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred EEEEec-CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEE
Confidence 999864 5689999999999999877543 67999999999999999999999999999999999999976666678999
Q ss_pred EecccccccCCCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHHHHhcCCC
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPS 358 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~i~~~~~~ 358 (492)
+|||+++...........+||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ......+......
T Consensus 284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363 (419)
T ss_dssp CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence 9999999887666667788999999999874 4578899999999999999999999976543 3455666666666
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 359 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+....|..+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 364 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 6555667899999999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=400.14 Aligned_cols=265 Identities=28% Similarity=0.446 Sum_probs=213.0
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+.+|+.+|+.+. ||||+++++++.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECC---CCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecC
Confidence 345789999999999999999998765 789999999976543 2233456789999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC--CCCcEEEEeccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD--ESSQLKAIDFGL 288 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~--~~~~~kl~DfGl 288 (492)
+.+|+|||||+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||+
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred CEEEEEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999999999975 999888654 5799999999999999999999999999999999999996432 345699999999
Q ss_pred ccccCCC-CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 289 SDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 289 a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
+...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...........|+
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 9876533 23455678999999998864 48999999999999999999999999988887777776543322222221
Q ss_pred --------------------------CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 366 --------------------------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 366 --------------------------~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 1678999999999999999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=392.30 Aligned_cols=266 Identities=40% Similarity=0.751 Sum_probs=237.6
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|+.+. +++.||||++....... ...+.+.+|+++++++ +||||+++++++.+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN-KDTSTILREVELLKKL-DHPNIMKLFEILED 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEecccccch-HHHHHHHHHHHHHHhc-cCCCccEEEEEEeC
Confidence 4556899999999999999999998764 68899999986543322 2346788999999999 49999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.+|+||||+++++|.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999999999988765 57999999999999999999999999999999999999976555668999999999
Q ss_pred cccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.............||+.|+|||++.+.++.++|||||||++|+|++|..||.+....++...+......+....+..++.
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred eeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 88776665666779999999999988899999999999999999999999999998888888888877776666778999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=400.59 Aligned_cols=259 Identities=29% Similarity=0.519 Sum_probs=215.8
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.++|++.+.||+|+||.||+|+++. +++.||||++...... ...+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEccccc--chHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 45789999999999999999998765 7889999999654332 22356889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..|+|||||+||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccce
Confidence 999999999999999987543 579999999999999999999999999999999999999 6677899999999986
Q ss_pred cCCCC---CccccccCccccccccccC-C-CCCccchHHHHHHHHHHhcCCCCCCCCChhHH-HHHHHhcCCCCCCCCCC
Q 011154 292 VRPDE---RLNDIVGSAYYVAPEVLHR-S-YGTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDDGSWP 365 (492)
Q Consensus 292 ~~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 365 (492)
+.... .....+||+.|+|||++.+ . ++.++|||||||++|+|++|..||........ +..+.... .....|.
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~ 232 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWK 232 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC--TTSTTGG
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc--ccCCccc
Confidence 54322 2345789999999998864 3 46789999999999999999999987665433 33333222 2223456
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.++.++.+||.+||..||.+|||+.|+++||||++..
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 7999999999999999999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=426.07 Aligned_cols=260 Identities=26% Similarity=0.445 Sum_probs=225.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|+.+. +|+.||||++.+...........+.+|+.+|+.+. |||||+++++|.+.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~ 256 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETK 256 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeC
Confidence 345789999999999999999999765 78999999996543222223456789999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
+.+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla 333 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLA 333 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccc
Confidence 99999999999999999887643 349999999999999999999999999999999999999 67789999999999
Q ss_pred cccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC----hhHHHHHHHhcCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 364 (492)
+.+.........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. ...+...+......++
T Consensus 334 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p---- 409 (576)
T 2acx_A 334 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS---- 409 (576)
T ss_dssp EECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----
T ss_pred eecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----
Confidence 98876666677899999999998865 59999999999999999999999998764 3456666665544443
Q ss_pred CCCCHHHHHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
..++.++++||.+||+.||.+|| ++.|+++||||++.
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 46899999999999999999999 89999999999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=420.18 Aligned_cols=259 Identities=28% Similarity=0.474 Sum_probs=210.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++.+.. ......+.+.+|+.+|+.+ +|||||+++++|...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQ 133 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSC
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECccc-cChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccC
Confidence 456899999999999999999998765 78999999997543 3344567789999999999 599999999999654
Q ss_pred ------CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 ------DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ------~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
..+|||||||++ +|.+.+. ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 134 ~~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~ 206 (464)
T 3ttj_A 134 KTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKIL 206 (464)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEEC
T ss_pred CccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEE
Confidence 468999999976 5666653 359999999999999999999999999999999999999 667799999
Q ss_pred ecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC----
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF---- 359 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~---- 359 (492)
|||+|+...........+||++|+|||++.+ .|+.++||||||||+|+|++|+.||.+.+..+.+..+.......
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred EEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9999998876666677899999999998764 69999999999999999999999999988777776665422111
Q ss_pred ------------------CCCCCC----C------------CCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 360 ------------------DDGSWP----S------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 360 ------------------~~~~~~----~------------~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
....++ . .++++++||.+||..||.+|||++|+|+||||+..
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 110000 0 15679999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=397.62 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=225.7
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
....++|++.+.||+|+||.||+|+... +|+.||||++...........+.+.+|+++|+.++ ||||++++++|.+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 125 (348)
T 1u5q_A 50 DDPEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR 125 (348)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred cchhhheeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEE
Confidence 4455779999999999999999998654 78999999998765555556678999999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+..|+|||||. |+|.+.+......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 126 ~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 126 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSA 201 (348)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTC
T ss_pred CCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCc
Confidence 999999999997 58888887766789999999999999999999999999999999999999 56679999999999
Q ss_pred cccCCCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
..... ....+||+.|+|||++. +.++.++|||||||++|+|++|..||...........+........ ...
T Consensus 202 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 276 (348)
T 1u5q_A 202 SIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSG 276 (348)
T ss_dssp BSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCT
T ss_pred eecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCC
Confidence 87643 24567999999999873 4689999999999999999999999998887777666665543221 224
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.++.++++||.+||+.||.+|||+.++|+||||....
T Consensus 277 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 6789999999999999999999999999999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=437.58 Aligned_cols=260 Identities=27% Similarity=0.478 Sum_probs=230.3
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
-.++|++.+.||+|+||.||+|+++. +++.||||++.+.........+.+.+|..+|..+.+||||++++++|++.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred cccceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 35789999999999999999999875 789999999975432222234567889999998877999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|||||||+||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEE
T ss_pred EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeec
Confidence 999999999999999988765 679999999999999999999999999999999999999 6778999999999986
Q ss_pred cC-CCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 292 VR-PDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 292 ~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.. ........+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+++..|......++. .++.
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 567 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSK 567 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCH
Confidence 43 334456789999999999886 56999999999999999999999999999999999999988776654 6899
Q ss_pred HHHHHHHHccccCcCCCCCH-----HHHhcCccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTA-----AQALSHPWIRNYN 402 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~~ 402 (492)
++++||++||+.||.+|+++ .||++||||+..+
T Consensus 568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 99999999999999999997 9999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=402.18 Aligned_cols=265 Identities=24% Similarity=0.392 Sum_probs=221.5
Q ss_pred hcCCccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc----CCCCc
Q 011154 125 RFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS----GHSNL 200 (492)
Q Consensus 125 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~----~hpni 200 (492)
.+.....+.++|++.+.||+|+||.||+|++.. +++.||||++... ......+.+|+.+++.+. +||||
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 344456778999999999999999999999765 6889999999642 334556788999999995 49999
Q ss_pred cEEEEEEEeCCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC----
Q 011154 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK---- 275 (492)
Q Consensus 201 v~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~---- 275 (492)
+++++++...+.+++||||| +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+...
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 99999999999999999999 889999987653 359999999999999999999999999999999999999531
Q ss_pred ------------------CCCCcEEEEecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcC
Q 011154 276 ------------------DESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCG 336 (492)
Q Consensus 276 ------------------~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg 336 (492)
...+.+||+|||++..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 1267899999999987543 334568999999999876 4699999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCC---------------------CCC---------------------CCCHHHHHH
Q 011154 337 SRPFWARTESGIFRAVLKADPSFDDG---------------------SWP---------------------SLSSDAKDF 374 (492)
Q Consensus 337 ~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~s~~~~~l 374 (492)
+.||......+.+..+......++.. .|+ ..++.+.+|
T Consensus 256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 335 (360)
T 3llt_A 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF 335 (360)
T ss_dssp SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence 99999888877776665543322210 011 123678899
Q ss_pred HHHccccCcCCCCCHHHHhcCcccc
Q 011154 375 VKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 375 i~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
|.+||+.||.+|||+.|+|+||||+
T Consensus 336 i~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 336 LYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHhcCChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999995
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=400.65 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=214.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+.+. +++.||||++...... .....+.+|+.+|+.+. ||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEeccccc--ccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEE
Confidence 579999999999999999998765 7889999999654321 11123557999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++|||||+ |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-
T ss_pred EEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCccccccc
Confidence 99999997 59999988776779999999999999999999999999999999999999 666789999999998664
Q ss_pred CCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC------
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW------ 364 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------ 364 (492)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+...........|
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 332 3345689999999998754 5899999999999999999999999999888887777664333333322
Q ss_pred --------------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 365 --------------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 365 --------------------~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
+.+++++.+||.+||+.||.+|||+.|+|+||||.+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 356889999999999999999999999999999997653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=389.19 Aligned_cols=266 Identities=38% Similarity=0.700 Sum_probs=226.9
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH---HHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA---IAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
+.++|++.+.||+|+||.||+|+.+. +|+.||||++........ ...+.+.+|+.+++.+. ||||+++++++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 78 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFE 78 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheec
Confidence 34689999999999999999999765 688999999976543221 13567899999999995 999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC-CCCcEEEEecc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAIDFG 287 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~-~~~~~kl~DfG 287 (492)
+.+..++||||+++++|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||+..++ ....+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999999988664 5799999999999999999999999999999999999995432 23379999999
Q ss_pred cccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 288 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 288 la~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+.+..+......+....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 998876655566678999999999886 4689999999999999999999999999988888888887766665555567
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 899999999999999999999999999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=389.00 Aligned_cols=258 Identities=31% Similarity=0.612 Sum_probs=222.1
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|.+.. +++.||||++.+...........+.+|+.+++.+. ||||++++++|.+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDAT 82 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCC
Confidence 34789999999999999999998765 68899999986543222223456889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++||||+++|+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESC
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEecccccc
Confidence 999999999999999988765 679999999999999999999999999999999999999 6677999999999866
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+......++. .++.+
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 233 (279)
T 3fdn_A 159 APSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEG 233 (279)
T ss_dssp C---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHH
T ss_pred CCcc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHH
Confidence 5432 3345689999999998864 5788999999999999999999999999888888888776655543 57899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 234 ~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 234 ARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 99999999999999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=399.57 Aligned_cols=266 Identities=36% Similarity=0.612 Sum_probs=221.2
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-----CHHHHHHHHHHHHHHHHccCCCCccEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-----TAIAVEDVRREVKILRALSGHSNLVKFY 204 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ev~~l~~l~~hpniv~l~ 204 (492)
..+.++|++.+.||+|+||.||+|+++. +++.||||++...... .......+.+|+.+|+.+ +||||++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~ 81 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIK 81 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEe
Confidence 4567899999999999999999998765 7899999999765321 112234578999999999 599999999
Q ss_pred EEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 205 DAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 205 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+++...+ +|+|||||++|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+
T Consensus 82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 82 NFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEESSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eEEcCCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 9997655 89999999999999987543 679999999999999999999999999999999999999765555679999
Q ss_pred ecccccccCCCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChh-HHHHHHHhcCCCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSF 359 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-~~~~~i~~~~~~~ 359 (492)
|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||...... .+...+......+
T Consensus 160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 999998876554455678999999999863 45889999999999999999999999765443 4455566655555
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
....+..++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 444456789999999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=399.06 Aligned_cols=260 Identities=29% Similarity=0.451 Sum_probs=222.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe---
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--- 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--- 209 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++....... .....+.+|+.+|+.+. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEecccccc-cchHHHHHHHHHHHhcc-CCCcccHhheeecccc
Confidence 4789999999999999999999765 78999999996654332 22345778999999995 9999999999987
Q ss_pred -----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 -----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 -----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.+.+|+|||||.+ +|.+.+......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~ 166 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLA 166 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEEC
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEc
Confidence 4578999999975 8888887776789999999999999999999999999999999999999 667799999
Q ss_pred ecccccccCCC-----CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 285 DFGLSDFVRPD-----ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 285 DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
|||++..+... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999876422 23345689999999998754 489999999999999999999999999998888888776655
Q ss_pred CCCCCCCCCC----------------------------CHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 358 SFDDGSWPSL----------------------------SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 358 ~~~~~~~~~~----------------------------s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.+....|+.+ ++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 5555555443 6789999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=414.46 Aligned_cols=262 Identities=31% Similarity=0.500 Sum_probs=199.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe-
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED- 209 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~- 209 (492)
.+.++|++.+.||+|+||.||+|+++. +++.||||++.+. .......+.+.+|+++|+.|. |||||+++++|..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 124 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPK 124 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC-----CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecC
Confidence 356889999999999999999999765 7899999999654 334556678999999999995 9999999999954
Q ss_pred ----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 210 ----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 210 ----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
.+.+|+||||+. |+|.+.+.. ...+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|
T Consensus 125 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~D 199 (458)
T 3rp9_A 125 DVEKFDELYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCD 199 (458)
T ss_dssp CTTTCCCEEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECC
T ss_pred CcccCceEEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecc
Confidence 357999999984 688887754 4679999999999999999999999999999999999999 6777999999
Q ss_pred cccccccCCCC----------------------------CccccccCccccccccc-c-CCCCCccchHHHHHHHHHHhc
Q 011154 286 FGLSDFVRPDE----------------------------RLNDIVGSAYYVAPEVL-H-RSYGTEADVWSIGVIAYILLC 335 (492)
Q Consensus 286 fGla~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwSlGvil~~llt 335 (492)
||+|+.+.... .....+||++|+|||++ . ..|+.++||||||||+|||++
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 99998764221 23456899999999975 3 459999999999999999999
Q ss_pred -----------CCCCCCCCCh--------------------hHHHHHHHhc-----------------------CC----
Q 011154 336 -----------GSRPFWARTE--------------------SGIFRAVLKA-----------------------DP---- 357 (492)
Q Consensus 336 -----------g~~pf~~~~~--------------------~~~~~~i~~~-----------------------~~---- 357 (492)
|..+|.+... .+.+..|... .+
T Consensus 280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (458)
T 3rp9_A 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG 359 (458)
T ss_dssp TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence 6666755431 1122222110 00
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
......++.++.++.+||.+||..||.+|||++|+|+||||++..
T Consensus 360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 001123466799999999999999999999999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=405.47 Aligned_cols=262 Identities=20% Similarity=0.311 Sum_probs=216.0
Q ss_pred ccceeecceeccc--cceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRG--HFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G--~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++.+.||+| +||.||+|+++. +|+.||||++..... .....+.+.+|+.+|+.+. |||||+++++|.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEEC
Confidence 4789999999999 999999999765 789999999976543 3455677899999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 DNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
+.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccc
Confidence 9999999999999999988764 2569999999999999999999999999999999999999 66779999999998
Q ss_pred cccCCCC--------CccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC
Q 011154 290 DFVRPDE--------RLNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 358 (492)
Q Consensus 290 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~ 358 (492)
....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.........+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 6542211 1223579999999998864 5899999999999999999999999876665554433322110
Q ss_pred ------------------------------------------CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCc
Q 011154 359 ------------------------------------------FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396 (492)
Q Consensus 359 ------------------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp 396 (492)
.....+..+++++++||.+||+.||++|||+.|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 01112346789999999999999999999999999999
Q ss_pred cccccc
Q 011154 397 WIRNYN 402 (492)
Q Consensus 397 ~~~~~~ 402 (492)
||+...
T Consensus 336 ~f~~~~ 341 (389)
T 3gni_B 336 FFKQIK 341 (389)
T ss_dssp GGGGC-
T ss_pred HHHHHh
Confidence 998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=404.45 Aligned_cols=268 Identities=34% Similarity=0.635 Sum_probs=226.1
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC--CHHHHHHHHHHHHHHHHccCCCCccEEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT--TAIAVEDVRREVKILRALSGHSNLVKFYDAF 207 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~ 207 (492)
..+.++|++.+.||+|+||.||+|+.+. +++.||||++.+.... .....+.+.+|+.+|+.++ ||||++++++|
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 97 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY 97 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hhhhhheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh
Confidence 3456899999999999999999998765 7889999998653211 1234567899999999995 99999999999
Q ss_pred EeCCeEEEEEeecCCCchHHHHHhh---------------------------------------CCCCCHHHHHHHHHHH
Q 011154 208 EDLDNVYIVMELCEGGELLDRILSR---------------------------------------CGKYSEDEAKAVLVQI 248 (492)
Q Consensus 208 ~~~~~~~lv~E~~~ggsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi 248 (492)
.+.+..++|||||+||+|.+++... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999999999987310 1124678899999999
Q ss_pred HHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCC-----CccccccCcccccccccc---CCCCCc
Q 011154 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLH---RSYGTE 320 (492)
Q Consensus 249 ~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~ 320 (492)
+.||.|||++||+||||||+|||++. +....+||+|||++..+.... ......||+.|+|||++. ..++.+
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999999999999999999953 223389999999998653321 234567999999999885 458899
Q ss_pred cchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 321 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 321 ~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
+|||||||++|+|++|..||.+....+....+......+....+..+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 99999999999999999999999999999999888887777777779999999999999999999999999999999998
Q ss_pred cc
Q 011154 401 YN 402 (492)
Q Consensus 401 ~~ 402 (492)
..
T Consensus 337 ~~ 338 (345)
T 3hko_A 337 FS 338 (345)
T ss_dssp TS
T ss_pred Ch
Confidence 64
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=390.29 Aligned_cols=261 Identities=30% Similarity=0.490 Sum_probs=214.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|++.. +|+.||||++..... .....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESED-DPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCC-CCCccchhheeecCCe
Confidence 4689999999999999999999765 689999999866543 3444567889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++|||||++++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLL 152 (311)
T ss_dssp EEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhc
Confidence 9999999999888776543 4679999999999999999999999999999999999999 66779999999999876
Q ss_pred CCCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC-----------
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----------- 358 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~----------- 358 (492)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 5332 3455689999999998853 5899999999999999999999999988877666555432111
Q ss_pred --------CCC--------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 359 --------FDD--------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 359 --------~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
... ..++.++.++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 000 01246889999999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=387.00 Aligned_cols=260 Identities=29% Similarity=0.606 Sum_probs=225.6
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+... +++.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKR 88 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCE
Confidence 4789999999999999999998764 67899999986432211222456889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccC
Confidence 99999999999999988765 579999999999999999999999999999999999999 66678999999999765
Q ss_pred CCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 293 RPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+......++ +.++.++
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 239 (284)
T 2vgo_A 165 PS-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGS 239 (284)
T ss_dssp SS-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHH
T ss_pred cc-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHH
Confidence 43 23345679999999998864 588999999999999999999999999888888888877665543 3689999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCcccccccccC
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVK 405 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~ 405 (492)
++||.+||..||.+|||+.++++||||+......
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~ 273 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence 9999999999999999999999999999765433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=396.94 Aligned_cols=265 Identities=28% Similarity=0.448 Sum_probs=222.9
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
...+.++|++.+.||+|+||.||+|++.. +++.||||++.............+.+|+.+++.+. ||||+++++++.
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 82 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGE 82 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeee
Confidence 45567899999999999999999999765 78999999998776666666778999999999995 999999999987
Q ss_pred eCC----eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 209 DLD----NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 209 ~~~----~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
... ..|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~ 158 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVM 158 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEEC
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEe
Confidence 654 359999999999999988765 679999999999999999999999999999999999999 556789999
Q ss_pred ecccccccCCCC----CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC
Q 011154 285 DFGLSDFVRPDE----RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 285 DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
|||++..+.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238 (311)
T ss_dssp CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence 999998765432 2234579999999998864 58999999999999999999999999988888777777766555
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
....+..++.++.+||.+||+.||.+||++.+++.|+|++..
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 444456789999999999999999999999999999999854
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=418.57 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=223.9
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|+.+. +|+.||||++.+...........+.+|+.+|+.+. ||||++++++|.+.+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKT 258 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCC
Confidence 34789999999999999999999765 78999999996543222223456889999999994 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 212 NVYIVMELCEGGELLDRILSR---CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
.+|+|||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGl 335 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGL 335 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecce
Confidence 999999999999999988754 2469999999999999999999999999999999999999 6778999999999
Q ss_pred ccccCCCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC----hhHHHHHHHhcCCCCCCC
Q 011154 289 SDFVRPDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 289 a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~ 362 (492)
++.+..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. ..++...+......++
T Consensus 336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p-- 413 (543)
T 3c4z_A 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP-- 413 (543)
T ss_dssp CEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--
T ss_pred eeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--
Confidence 988765443 345689999999998865 59999999999999999999999998753 3567777777665554
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCC-----HHHHhcCcccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
..++.++++||.+||+.||.+||+ +.++++||||+..
T Consensus 414 --~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 414 --DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred --cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 368999999999999999999996 5899999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=388.77 Aligned_cols=255 Identities=29% Similarity=0.550 Sum_probs=220.1
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
..|+..+.||+|+||.||+|+.+. +|+.||||++...... ..+.+.+|+.+++.++ ||||++++++|...+..
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred hhhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEeccchh---HHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEE
Confidence 347778899999999999998764 7899999999765433 2456889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 118 ~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp EEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecc
Confidence 999999999999987743 479999999999999999999999999999999999999 667789999999998765
Q ss_pred CCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 371 (492)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+....... ......+++++
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 271 (321)
T 2c30_A 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVL 271 (321)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHH
T ss_pred cCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHH
Confidence 432 3355689999999998864 58999999999999999999999999888877777776644322 12234688999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 372 KDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 372 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.+||.+||..||++|||+.++|+||||.+.
T Consensus 272 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 272 RDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 999999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=387.28 Aligned_cols=259 Identities=34% Similarity=0.595 Sum_probs=197.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+... +|+.||||++...........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNY 85 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSE
T ss_pred cccceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCe
Confidence 3679999999999999999998754 78999999996432222222467889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.|+|||||++++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeec
Confidence 999999999999999988766789999999999999999999999999999999999999 66778999999999876
Q ss_pred CCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+....... ...++.+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 238 (278)
T 3cok_A 163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM----PSFLSIE 238 (278)
T ss_dssp C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC----CTTSCHH
T ss_pred cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC----ccccCHH
Confidence 5322 2345679999999998764 58889999999999999999999998776655554443332222 2357899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+.+||.+||..||.+|||+.++++||||....
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999999999998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=398.67 Aligned_cols=260 Identities=28% Similarity=0.503 Sum_probs=215.1
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|+++. +|+.||||++.... ......+.+.+|+++|+.++ ||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 95 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTP 95 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECS
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEec
Confidence 3457899999999999999999998765 78999999996543 34455677899999999995 9999999999986
Q ss_pred CC------eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 210 LD------NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 210 ~~------~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
.+ .+|+||||| +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl 169 (367)
T 1cm8_A 96 DETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKI 169 (367)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEE
T ss_pred CCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEE
Confidence 53 469999999 7899887754 579999999999999999999999999999999999999 66778999
Q ss_pred EecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC---
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS--- 358 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~--- 358 (492)
+|||+++.... .....+||++|+|||++.+ .|+.++||||+||++|+|++|+.||.+....+.+..+......
T Consensus 170 ~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 170 LDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp CCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred Eeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999987643 3456789999999998754 6999999999999999999999999988877776666442211
Q ss_pred --------------------CCC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 359 --------------------FDD----GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 359 --------------------~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
... ..++.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 111 12356799999999999999999999999999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=398.15 Aligned_cols=263 Identities=29% Similarity=0.426 Sum_probs=215.9
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC--HHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT--AIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~--~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..++|++.+.||+|+||.||+|+++. +|+.||||++....... ....+.+.+|+++++.+. ||||++++++|.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGH 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEee
Confidence 35789999999999999999998654 78999999997543221 111245789999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+..++|||||++ +|.+.+......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLA 159 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGG
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccc
Confidence 9999999999986 8888887666679999999999999999999999999999999999999 66779999999999
Q ss_pred cccCCC-CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC--
Q 011154 290 DFVRPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW-- 364 (492)
Q Consensus 290 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-- 364 (492)
+.+... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...........|
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 876433 33456789999999998853 4888999999999999999999999999888887777654322222222
Q ss_pred ----------------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 365 ----------------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 365 ----------------------~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..++.++++||.+||..||.+|||+.|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 45678999999999999999999999999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=383.17 Aligned_cols=258 Identities=35% Similarity=0.616 Sum_probs=215.8
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|.+++.||+|+||.||+|.++. +|+.||||++...........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPT 84 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECC---CCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCC
Confidence 45789999999999999999998764 68899999986432212223457889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..|+|||||++++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGC
T ss_pred eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccc
Confidence 999999999999999988765 579999999999999999999999999999999999999 6677899999999988
Q ss_pred cCCCCCccccccCccccccccccCC-C-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHRS-Y-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
...........||+.|+|||++.+. + +.++||||||+++|+|++|..||...........+......++ ..++.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 236 (276)
T 2h6d_A 161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNR 236 (276)
T ss_dssp CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCH
T ss_pred cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCH
Confidence 7665555667899999999998754 3 5789999999999999999999998888888888877655443 25789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++.+||.+||+.||.+|||+.++++||||++.
T Consensus 237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 99999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=392.84 Aligned_cols=258 Identities=33% Similarity=0.487 Sum_probs=228.6
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|.+++.||+|+||.||++++.. +++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND 114 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 35789999999999999999998765 68899999998766556666778999999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+|||||++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCcee
Confidence 999999999999999987654 679999999999999999999999999999999999999 6677899999999987
Q ss_pred cCCC-CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 292 VRPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 292 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+......++. .++.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~ 266 (335)
T 2owb_A 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINP 266 (335)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCH
T ss_pred cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCH
Confidence 6533 33445689999999998864 5888999999999999999999999988888888877776655443 6789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=383.66 Aligned_cols=259 Identities=32% Similarity=0.484 Sum_probs=228.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|.+.+.||+|+||.||+|.++. +++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDN 87 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred CcccceEEEEEEeecCCEEEEEEEECC---CCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccC
Confidence 345789999999999999999998765 6889999999776655666677899999999999 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..++|||||++++|.+.+... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLAT 163 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCce
Confidence 9999999999999999977654 679999999999999999999999999999999999999 667789999999998
Q ss_pred ccCCC-CCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+......++ ..++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 239 (294)
T 2rku_A 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHIN 239 (294)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSC
T ss_pred ecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccC
Confidence 76533 23445679999999998864 588899999999999999999999999888888877776655443 3678
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.++.+||.+||+.||++|||+.|+++||||...
T Consensus 240 ~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 999999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=399.45 Aligned_cols=257 Identities=27% Similarity=0.476 Sum_probs=213.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccC-CCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG-HSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~-hpniv~l~~~~~~~~ 211 (492)
..+|++.+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.+|+.|.+ ||||+++++++...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 457999999999999999999753 378999999976544 34566789999999999964 699999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+||| |.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||+++.
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ 203 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCC
T ss_pred EEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCcccc
Confidence 9999999 5688999988765 5899999999999999999999999999999999999993 36899999999987
Q ss_pred cCCCCC---ccccccCccccccccccC------------CCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHHHHhc
Q 011154 292 VRPDER---LNDIVGSAYYVAPEVLHR------------SYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKA 355 (492)
Q Consensus 292 ~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~i~~~ 355 (492)
+..... ....+||+.|+|||++.+ .|+.++||||||||+|+|++|..||..... ...+..+...
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 754332 345689999999998854 588899999999999999999999987543 3455555544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 356 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
...+... ...+.++++||.+||..||.+|||+.|+|+||||+...
T Consensus 284 ~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 284 NHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp TSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 4333222 24578999999999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=401.77 Aligned_cols=261 Identities=30% Similarity=0.525 Sum_probs=219.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|++.+.||+|+||.||+|+...+..+++.||||++.+.... .....+.+.+|+++|+.+.+||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 37899999999999999999998655568899999998653221 11122346789999999977999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+|||||++|+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 999999999999999988765 579999999999999999999999999999999999999 6677999999999986
Q ss_pred cCCCC--CccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCC----hhHHHHHHHhcCCCCCCC
Q 011154 292 VRPDE--RLNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 292 ~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~ 362 (492)
+.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ...+...+....+.++
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP-- 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--
Confidence 64322 2345689999999999863 37889999999999999999999997543 3445555555544433
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
..++..+++||.+||..||.+|| |+.|+++||||++.
T Consensus 287 --~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 287 --QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred --cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 36899999999999999999999 99999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=402.80 Aligned_cols=262 Identities=29% Similarity=0.517 Sum_probs=208.7
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|+++. +++.||||++.+. .......+.+.+|+++|+.|. ||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRM-FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPD 97 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecC
Confidence 456899999999999999999999765 7899999999654 334555678999999999995 99999999999876
Q ss_pred -----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 211 -----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 211 -----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
+.+|+|||||. |+|.+.+.. ...+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~D 172 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCD 172 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECC
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEcc
Confidence 57999999996 599988754 3679999999999999999999999999999999999999 6677999999
Q ss_pred cccccccCCCC-----------------------CccccccCccccccccc-c-CCCCCccchHHHHHHHHHHhcCCCC-
Q 011154 286 FGLSDFVRPDE-----------------------RLNDIVGSAYYVAPEVL-H-RSYGTEADVWSIGVIAYILLCGSRP- 339 (492)
Q Consensus 286 fGla~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwSlGvil~~lltg~~p- 339 (492)
||+|+...... .....+||++|+|||++ . ..|+.++||||||||+|+|++|..|
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 99998765432 23567899999999975 3 4599999999999999999985443
Q ss_pred ----------CCCCCh-----------------hHHHHHHHh-----------------------cCCCCCC----CCCC
Q 011154 340 ----------FWARTE-----------------SGIFRAVLK-----------------------ADPSFDD----GSWP 365 (492)
Q Consensus 340 ----------f~~~~~-----------------~~~~~~i~~-----------------------~~~~~~~----~~~~ 365 (492)
|.+... .+.+..+.. ....... ..++
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 333220 111111111 1111100 1135
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 6899999999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=383.48 Aligned_cols=264 Identities=28% Similarity=0.392 Sum_probs=220.2
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.+.+.++|++.+.||+|+||.||+|++.. +++.||||++...........+.+.+|+.+++.+. ||||+++++++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~ 81 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDE 81 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeee
Confidence 35567899999999999999999998664 78999999997776666777788999999999995 999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
+.+.+|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGI 157 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSS
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCC
Confidence 999999999999999999988765 679999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCCCC--CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-CCCCCCC
Q 011154 289 SDFVRPDE--RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP-SFDDGSW 364 (492)
Q Consensus 289 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~ 364 (492)
+....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+............... .......
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSC
T ss_pred ccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcc
Confidence 98765433 2334679999999998764 588899999999999999999999998887766555544332 2222334
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
+.+++.+.++|.+||..||.+||+..+.+.+.|..-
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 578999999999999999999997677777776543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=385.94 Aligned_cols=256 Identities=27% Similarity=0.503 Sum_probs=212.9
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-- 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-- 209 (492)
..++|++.+.||+|+||.||+|+... +++.||||++.... .+.+.+|+.+|+.|.+||||+++++++.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECC---CCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 35889999999999999999998765 78999999996432 35688999999999779999999999998
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
....++||||+.+++|.+.+ ..+++.+++.++.||+.||.|||++||+||||||+|||++. +...+||+|||++
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLA 178 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTC
T ss_pred CCceEEEEeccCchhHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCc
Confidence 67899999999999998876 35899999999999999999999999999999999999952 3348999999999
Q ss_pred cccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHH-------------HH
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRA-------------VL 353 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~-------------i~ 353 (492)
+............||+.|+|||++.+ .++.++|||||||++|+|++|..||..... .+.+.. +.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 98877666777889999999998754 589999999999999999999999954432 222221 11
Q ss_pred hcCCCCC--------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 354 KADPSFD--------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 354 ~~~~~~~--------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.....+. ......+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1111110 111223799999999999999999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=376.77 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=214.4
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
...+.++|++.+.||+|+||.||+|+++. +++.||||++........ ....+.+|+.++..+.+||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~ 81 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWA 81 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 34567899999999999999999998765 689999999976544333 45678899999999956999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC---------
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRC---GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD--------- 276 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~--------- 276 (492)
+.+..++|||||+||+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 9999999999999999999987542 5699999999999999999999999999999999999996433
Q ss_pred -------CCCcEEEEecccccccCCCCCccccccCccccccccccCC--CCCccchHHHHHHHHHHhcCCCCCCCCChhH
Q 011154 277 -------ESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWARTESG 347 (492)
Q Consensus 277 -------~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwSlGvil~~lltg~~pf~~~~~~~ 347 (492)
....+||+|||++....... ...||+.|+|||++.+. ++.++|||||||++|+|++|..++....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 235 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--- 235 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred ccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence 45589999999998765432 34699999999998754 5578999999999999999998775432
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 348 IFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
....+...... .....+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 236 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 236 QWHEIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 34444443322 1224689999999999999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=395.55 Aligned_cols=254 Identities=30% Similarity=0.501 Sum_probs=215.7
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH-----HHHHHHHHHHHHHHHccCCCCccEEEE
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA-----IAVEDVRREVKILRALSGHSNLVKFYD 205 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~Ev~~l~~l~~hpniv~l~~ 205 (492)
.+.++|++.+.||+|+||.||+|+++. +++.||||++.+...... .....+.+|+.+|+.+. ||||+++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~ 96 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLD 96 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence 456899999999999999999998765 789999999977643221 12334678999999994 999999999
Q ss_pred EEEeCCeEEEEEeecCCC-chHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 206 AFEDLDNVYIVMELCEGG-ELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 206 ~~~~~~~~~lv~E~~~gg-sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+|.+.+.+++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~ 172 (335)
T 3dls_A 97 IFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLI 172 (335)
T ss_dssp EEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEe
Confidence 999999999999999777 88887754 4679999999999999999999999999999999999999 667899999
Q ss_pred ecccccccCCCCCccccccCccccccccccCC-C-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-Y-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (492)
|||++............+||+.|+|||++.+. + +.++|||||||++|+|++|..||...... ..... .
T Consensus 173 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~----~ 242 (335)
T 3dls_A 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VEAAI----H 242 (335)
T ss_dssp CCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TTTCC----C
T ss_pred ecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hhhcc----C
Confidence 99999988776666778899999999988643 4 77899999999999999999999753221 11111 1
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
....+++++.+||.+||..||.+|||+.++++||||++..
T Consensus 243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 2235899999999999999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=405.52 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=211.4
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+....+|++.+.||+|+||.||+|++.. ++ .||+|++...... ..+|+++|+.+. ||||++++++|..
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~---~~-~~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~~ 103 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVE---SD-EVAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFYS 103 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETT---TE-EEEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECC---CC-eEEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEEe
Confidence 3455789999999999999999998754 33 4888888654322 236999999995 9999999999965
Q ss_pred CCe------EEEEEeecCCCchHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCc
Q 011154 210 LDN------VYIVMELCEGGELLDRIL---SRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 210 ~~~------~~lv~E~~~ggsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~ 280 (492)
.+. +++|||||+++ +.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++ ..++.
T Consensus 104 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~ 180 (394)
T 4e7w_A 104 NGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGV 180 (394)
T ss_dssp ESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTE
T ss_pred cCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCc
Confidence 443 88999999874 444443 2346799999999999999999999999999999999999994 25678
Q ss_pred EEEEecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-
Q 011154 281 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP- 357 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~- 357 (492)
+||+|||+|+...........+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+....+.+..+.+...
T Consensus 181 ~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260 (394)
T ss_dssp EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999998876666677889999999998754 589999999999999999999999999887777666654211
Q ss_pred ----------------CCCC--------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 ----------------SFDD--------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ----------------~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.++. ...+.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 1110 01234889999999999999999999999999999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=402.21 Aligned_cols=263 Identities=29% Similarity=0.477 Sum_probs=201.0
Q ss_pred ccccceee-cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 131 EVTSRLEV-GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 131 ~~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
.+.+.|++ +++||+|+||.||+|+++. ..+++.||||++...... ..+.+|+.+|+.|+ |||||+++++|.+
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~-hpniv~~~~~~~~ 89 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKD-GKDDKDYALKQIEGTGIS-----MSACREIALLRELK-HPNVISLQKVFLS 89 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESS-SSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCC-CTTBCCCCEEEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEcc-CCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcC-CCCeeeEeeEEec
Confidence 45567887 5689999999999998763 236789999999755432 35778999999995 9999999999965
Q ss_pred --CCeEEEEEeecCCCchHHHHHhhC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC-CCC
Q 011154 210 --LDNVYIVMELCEGGELLDRILSRC--------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK-DES 278 (492)
Q Consensus 210 --~~~~~lv~E~~~ggsL~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~-~~~ 278 (492)
...+|+|||||.+ +|.+.+.... ..+++..++.|+.||+.||.|||++||+||||||+|||+... +..
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 6789999999975 8888775321 249999999999999999999999999999999999999654 456
Q ss_pred CcEEEEecccccccCCC----CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCCh-------
Q 011154 279 SQLKAIDFGLSDFVRPD----ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTE------- 345 (492)
Q Consensus 279 ~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~------- 345 (492)
+.+||+|||+|+.+... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|..||.+...
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 78999999999876533 23345789999999998864 489999999999999999999999976554
Q ss_pred --hHHHHHHHhcCCCCCCCCCCC----------------------------------CCHHHHHHHHHccccCcCCCCCH
Q 011154 346 --SGIFRAVLKADPSFDDGSWPS----------------------------------LSSDAKDFVKLLLNKDPRKRMTA 389 (492)
Q Consensus 346 --~~~~~~i~~~~~~~~~~~~~~----------------------------------~s~~~~~li~~~L~~dP~~Rps~ 389 (492)
.+.+..+...........|.. .+.++.+||.+||..||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 244444444333333333322 27789999999999999999999
Q ss_pred HHHhcCcccccc
Q 011154 390 AQALSHPWIRNY 401 (492)
Q Consensus 390 ~e~l~hp~~~~~ 401 (492)
.|+|+||||+..
T Consensus 329 ~e~L~hp~f~~~ 340 (405)
T 3rgf_A 329 EQAMQDPYFLED 340 (405)
T ss_dssp HHHHTSGGGTSS
T ss_pred HHHhcChhhccC
Confidence 999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=395.79 Aligned_cols=259 Identities=28% Similarity=0.466 Sum_probs=206.0
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|+... +++.||||++..... .....+.+.+|+.+++.+. ||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQ 96 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSC
T ss_pred chhhheeEeeeeEecCCEEEEEEEECC---CCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcC-CCCccceEEeeccc
Confidence 346899999999999999999998764 788999999976432 3445667889999999995 99999999999866
Q ss_pred C------eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 D------NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ~------~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+ .+|+|||||++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~ 169 (371)
T 2xrw_A 97 KSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKIL 169 (371)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEEC
T ss_pred cccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEE
Confidence 5 78999999975 7888774 469999999999999999999999999999999999999 667789999
Q ss_pred ecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC---
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--- 360 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--- 360 (492)
|||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 170 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp CCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred EeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999988765555566789999999998764 589999999999999999999999999888777776654322110
Q ss_pred -------------------CCC---------CC-------CCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 361 -------------------DGS---------WP-------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 361 -------------------~~~---------~~-------~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
... ++ ..+.++++||.+||..||.+|||+.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 000 00 015679999999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=376.58 Aligned_cols=258 Identities=22% Similarity=0.373 Sum_probs=215.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe---
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--- 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--- 209 (492)
...|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.+|+.+. ||||++++++|.+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 99 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESS
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC---CceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccC
Confidence 4568999999999999999998765 788999999975543 3445677899999999995 9999999999876
Q ss_pred -CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCcEEEEec
Q 011154 210 -LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 210 -~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
...+++|||||++|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ +.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Df 176 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL 176 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCT
T ss_pred CCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeC
Confidence 45689999999999999988654 67999999999999999999999999 99999999999994 25678999999
Q ss_pred ccccccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhH-HHHHHHhcCCCCCCCCCC
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 365 (492)
|++..... .......||+.|+|||++.+.++.++|||||||++|+|++|..||....... ....+..... ......
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~ 253 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDK 253 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGG
T ss_pred CCcccccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--ccccCC
Confidence 99976543 3344567999999999998889999999999999999999999998755443 3343333221 112223
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 567899999999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=390.83 Aligned_cols=255 Identities=30% Similarity=0.484 Sum_probs=206.0
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.++|++.+.||+|+||.||+|+++. +|+.||||++..... ....+.+.+|+++|++|+ ||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE-HPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEec
Confidence 34689999999999999999999765 788999999976542 234567899999999995 999999999986643
Q ss_pred ---------------------------------------------------------eEEEEEeecCCCchHHHHHhhC-
Q 011154 212 ---------------------------------------------------------NVYIVMELCEGGELLDRILSRC- 233 (492)
Q Consensus 212 ---------------------------------------------------------~~~lv~E~~~ggsL~~~l~~~~- 233 (492)
.+++|||||+||+|.+++....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 3899999999999999887543
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCC-------------Ccc
Q 011154 234 -GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-------------RLN 299 (492)
Q Consensus 234 -~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~-------------~~~ 299 (492)
...++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...... ...
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 235677899999999999999999999999999999999 666799999999998876542 223
Q ss_pred ccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011154 300 DIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378 (492)
Q Consensus 300 ~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 378 (492)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..|+.. .......+.... + ...+...++++.+||.+|
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~--~-~~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK--F-PLLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC--C-CHHHHHHCHHHHHHHHHH
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC--C-CcccccCChhHHHHHHHH
Confidence 4579999999998864 689999999999999999999877521 122223332221 1 111234678899999999
Q ss_pred cccCcCCCCCHHHHhcCccccc
Q 011154 379 LNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 379 L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
|+.||.+|||+.|+|+||||++
T Consensus 310 l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 310 LSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccCCCCcCCCHHHHhhchhhhc
Confidence 9999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=400.63 Aligned_cols=260 Identities=29% Similarity=0.430 Sum_probs=215.2
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc-----CCCCccEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS-----GHSNLVKFY 204 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~-----~hpniv~l~ 204 (492)
..+..+|++.+.||+|+||.||+|++.. +++.||||++... ......+.+|+.+++.++ +|+||++++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECC---CCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 4567889999999999999999998765 6899999999643 334456788999998884 477999999
Q ss_pred EEEEeCCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCc--E
Q 011154 205 DAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ--L 281 (492)
Q Consensus 205 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~--~ 281 (492)
++|...+.+++|||||. |+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++ .++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcce
Confidence 99999999999999996 58999887653 4599999999999999999999999999999999999994 4444 9
Q ss_pred EEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC
Q 011154 282 KAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 360 (492)
Q Consensus 282 kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 360 (492)
||+|||++.... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....+.+..+........
T Consensus 242 kL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 242 KVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp EECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EEeecccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999999997654 33456789999999998764 599999999999999999999999999888777666553211100
Q ss_pred C--------------------------------------------------CC-----CCCCCHHHHHHHHHccccCcCC
Q 011154 361 D--------------------------------------------------GS-----WPSLSSDAKDFVKLLLNKDPRK 385 (492)
Q Consensus 361 ~--------------------------------------------------~~-----~~~~s~~~~~li~~~L~~dP~~ 385 (492)
. .. ....++++.+||.+||+.||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 0 00 0123788999999999999999
Q ss_pred CCCHHHHhcCccccccc
Q 011154 386 RMTAAQALSHPWIRNYN 402 (492)
Q Consensus 386 Rps~~e~l~hp~~~~~~ 402 (492)
|||+.|+|+||||++..
T Consensus 400 Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRRL 416 (429)
T ss_dssp SCCHHHHHTSTTTC---
T ss_pred CCCHHHHhCChhhccCC
Confidence 99999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=395.75 Aligned_cols=260 Identities=30% Similarity=0.524 Sum_probs=202.4
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+.+|+.+|+.+. ||||+++++++..
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 99 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTP 99 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETT---TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECS
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEec
Confidence 4567899999999999999999998664 78999999996543 34445667889999999995 9999999999975
Q ss_pred C------CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 210 L------DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 210 ~------~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
. ..+|+||||+ +++|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL 173 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKI 173 (367)
T ss_dssp CSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEE
T ss_pred CCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEE
Confidence 4 5689999999 6799887754 579999999999999999999999999999999999999 66779999
Q ss_pred EecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC---
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS--- 358 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~--- 358 (492)
+|||+++.... .....+||++|+|||++.+ .|+.++|||||||++|+|++|+.||.+....+.+..+......
T Consensus 174 ~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 174 LDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp CC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred eeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999987543 3455789999999998764 6899999999999999999999999988877766666542111
Q ss_pred --------------------CCCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 359 --------------------FDDG----SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 359 --------------------~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.... .++.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 1111 1245788999999999999999999999999999999764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=388.38 Aligned_cols=261 Identities=30% Similarity=0.463 Sum_probs=214.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|++.. +|+.||||++..... .....+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKK 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhhhheeeeEEeecCCEEEEEEEECC---CCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCC
Confidence 35789999999999999999999765 689999999866543 3445566889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+||||+++++|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 98 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFART 173 (331)
T ss_dssp EEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC--
T ss_pred EEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCcee
Confidence 9999999999888776544 44679999999999999999999999999999999999999 6677999999999987
Q ss_pred cCCC-CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC---------
Q 011154 292 VRPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--------- 359 (492)
Q Consensus 292 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~--------- 359 (492)
+... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 6543 23455689999999998865 58899999999999999999999999888776665554321110
Q ss_pred -----CC-------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 360 -----DD-------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 360 -----~~-------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.. ..++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 00 0124678999999999999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=388.01 Aligned_cols=260 Identities=38% Similarity=0.651 Sum_probs=191.1
Q ss_pred ccccceeecc-eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 131 EVTSRLEVGE-EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 131 ~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
.+.++|.+.+ .||+|+||.||+|+++. +|+.||||++... . ...+|+..+.++.+||||++++++|..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~----~----~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDS----P----KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESS----H----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECC---CCCEEEEEEecCc----H----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 4568899955 69999999999999765 6899999999643 1 223344443333369999999999986
Q ss_pred ----CCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 ----LDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 ----~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
...+++|||||+||+|.+++..+. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++..+.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 456899999999999999997653 369999999999999999999999999999999999999766667789999
Q ss_pred ecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHH----HHHHHhcCCCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGI----FRAVLKADPSF 359 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~----~~~i~~~~~~~ 359 (492)
|||++..... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||........ ...+......+
T Consensus 174 Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 174 DFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 9999987653 3345568999999999885 4588899999999999999999999977665443 33444455556
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
....|..++.++++||.+||..||.+|||+.|+|+||||++..
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 6666778999999999999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=386.52 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=215.4
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|++.. +++.||||++....... ..+.+.+|+++|+.++ ||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLN-HKNIVKLFAIEEET 79 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCC-CTTBCCEEEEEECT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECC---CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcC-CCCcceEEEEeecC
Confidence 456789999999999999999999765 68899999996543222 2456789999999995 99999999999876
Q ss_pred C--eEEEEEeecCCCchHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeec-CCCCCcEEEEe
Q 011154 211 D--NVYIVMELCEGGELLDRILSRCG--KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS-KDESSQLKAID 285 (492)
Q Consensus 211 ~--~~~lv~E~~~ggsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~-~~~~~~~kl~D 285 (492)
+ ..++|||||+||+|.+++..... .+++.+++.++.||+.||.|||++||+||||||+|||+.. ++....+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 5 78999999999999999876432 3999999999999999999999999999999999999743 34556799999
Q ss_pred cccccccCCCCCccccccCcccccccccc---------CCCCCccchHHHHHHHHHHhcCCCCCCCCC----hhHHHHHH
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLH---------RSYGTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAV 352 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DvwSlGvil~~lltg~~pf~~~~----~~~~~~~i 352 (492)
||+++............||+.|+|||++. ..++.++|||||||++|+|++|..||.... ..+.+..+
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 99999887776667788999999999874 568899999999999999999999996433 34556666
Q ss_pred HhcCCCC-------------------C--CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCc
Q 011154 353 LKADPSF-------------------D--DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396 (492)
Q Consensus 353 ~~~~~~~-------------------~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp 396 (492)
....+.. + ......++..+.+||.+||+.||++|||+.|+|+||
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 6554321 0 011123456789999999999999999999999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=395.03 Aligned_cols=256 Identities=26% Similarity=0.451 Sum_probs=213.3
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-- 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-- 209 (492)
..++|++++.||+|+||.||+|++.. +|+.||||++...... ..+|+++|+.|. |||||+++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRY-------KNRELDIMKVLD-HVNIIKLVDYFYTTG 73 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECCTTS-------CCHHHHHHTTCC-CTTBCCEEEEEEEC-
T ss_pred ccceEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecCcch-------HHHHHHHHHHcC-CCCccchhheeeecC
Confidence 45789999999999999999998765 7899999999655322 237999999995 9999999999844
Q ss_pred ------------------------------------CCeEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHH
Q 011154 210 ------------------------------------LDNVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILN 250 (492)
Q Consensus 210 ------------------------------------~~~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~ 250 (492)
...+++|||||++ +|.+.+.. ....+++..++.++.||+.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp ------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 3348999999985 87776653 3467999999999999999
Q ss_pred HHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHH
Q 011154 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGV 328 (492)
Q Consensus 251 ~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGv 328 (492)
||.|||++||+||||||+|||++. .++.+||+|||+|+.+..........||+.|+|||++.+ .|+.++||||+||
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999999999999999999952 456899999999998876666777889999999998754 4899999999999
Q ss_pred HHHHHhcCCCCCCCCChhHHHHHHHhcC------------CCCCC--------C-----CCCCCCHHHHHHHHHccccCc
Q 011154 329 IAYILLCGSRPFWARTESGIFRAVLKAD------------PSFDD--------G-----SWPSLSSDAKDFVKLLLNKDP 383 (492)
Q Consensus 329 il~~lltg~~pf~~~~~~~~~~~i~~~~------------~~~~~--------~-----~~~~~s~~~~~li~~~L~~dP 383 (492)
++|+|++|..||.+....+.+..+.... ..+.. . ....++.++.+||.+||..||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999988877776665421 11111 1 112478899999999999999
Q ss_pred CCCCCHHHHhcCcccccc
Q 011154 384 RKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 384 ~~Rps~~e~l~hp~~~~~ 401 (492)
.+|||+.|+|+||||+..
T Consensus 311 ~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GGSCCHHHHHTSGGGHHH
T ss_pred hhCCCHHHHhcCHHHHHH
Confidence 999999999999999865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=397.51 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=211.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL-- 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~-- 210 (492)
..+|++.+.||+|+||.||+|+++. +|+.||||++...... ..+|+++|+.|. |||||+++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~~-------~~~E~~il~~l~-hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEEEET
T ss_pred cceEEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEecccchh-------HHHHHHHHHHcC-CCCccceeeEEeccCC
Confidence 4579999999999999999999765 6899999999654322 347999999995 99999999998542
Q ss_pred ----CeEEEEEeecCCCchHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 211 ----DNVYIVMELCEGGELLDRIL---SRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 211 ----~~~~lv~E~~~ggsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
..+++||||+++ +|.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++. +...+||
T Consensus 122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~kl 198 (420)
T 1j1b_A 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKL 198 (420)
T ss_dssp TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEEE
T ss_pred CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEEe
Confidence 237799999986 6666554 23467999999999999999999999999999999999999952 3457899
Q ss_pred EecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhc------
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA------ 355 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~------ 355 (492)
+|||+++.+.........+||++|+|||++.+ .|+.++||||||||+|||++|+.||.+....+.+..+.+.
T Consensus 199 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 199 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp CCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999998766666667789999999998753 5899999999999999999999999988876666555432
Q ss_pred ------CCCCCCC--------C-----CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 356 ------DPSFDDG--------S-----WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 356 ------~~~~~~~--------~-----~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
...+... . .+.++.++++||.+||..||.+|||+.|+|+||||....
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 1111111 1 135689999999999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=375.32 Aligned_cols=259 Identities=28% Similarity=0.500 Sum_probs=223.8
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...+.|++.+.||+|+||.||+|+... +++.||||++....... ..+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAED--EIEDIQQEITVLSQC-DSPYVTKYYGSYLKD 92 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTCST--THHHHHHHHHHHHHC-CCTTBCCEEEEEEET
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECC---CCcEEEEEEecccccHH--HHHHHHHHHHHHHhC-CCCCEeEEEEEEecC
Confidence 345779999999999999999998754 78899999997654332 356789999999999 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAG 167 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccce
Confidence 999999999999999998743 579999999999999999999999999999999999999 667789999999998
Q ss_pred ccCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+....... ....++
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 244 (303)
T 3a7i_A 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYS 244 (303)
T ss_dssp ECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCC
T ss_pred ecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccC
Confidence 765433 2345679999999998864 58899999999999999999999998888777776666554322 234689
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
.++.+||.+||+.||.+|||+.++++||||.....
T Consensus 245 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 99999999999999999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=391.35 Aligned_cols=260 Identities=31% Similarity=0.514 Sum_probs=218.3
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|+... +++.||||++.... .....+.+.+|+++|+.+. ||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAP 97 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCS
T ss_pred cccccEEEEEEeecCCCeEEEEEEECC---CCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecC
Confidence 445799999999999999999998764 78899999996432 3445577899999999995 99999999999765
Q ss_pred -----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 211 -----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 211 -----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
..+|+||||+. |+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 98 ~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~D 171 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICD 171 (364)
T ss_dssp STTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECC
T ss_pred CccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEe
Confidence 46999999997 489988754 479999999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCCC----ccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC
Q 011154 286 FGLSDFVRPDER----LNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 286 fGla~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
||++........ ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+.......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999987653322 34568999999999864 348999999999999999999999999888777766665321111
Q ss_pred C-----------------------C----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 360 D-----------------------D----GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 360 ~-----------------------~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
. . ..++.++.++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 1 0 01246789999999999999999999999999999999763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=384.83 Aligned_cols=257 Identities=27% Similarity=0.478 Sum_probs=209.0
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-CCccEEEEEEEeC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-SNLVKFYDAFEDL 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-pniv~l~~~~~~~ 210 (492)
..++|++.+.||+|+||.||++... +++.||||++..... .....+.+.+|+.+|+.|.+| |||+++++++.+.
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 3578999999999999999999753 578999999976543 445567899999999999632 9999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|+||| +.+|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||+++
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN 155 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred CEEEEEEe-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeeccccc
Confidence 99999999 5578999988764 6899999999999999999999999999999999999994 3579999999998
Q ss_pred ccCCCCC---ccccccCcccccccccc------------CCCCCccchHHHHHHHHHHhcCCCCCCCCChh-HHHHHHHh
Q 011154 291 FVRPDER---LNDIVGSAYYVAPEVLH------------RSYGTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLK 354 (492)
Q Consensus 291 ~~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-~~~~~i~~ 354 (492)
.+..... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||...... ..+..+..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 7754332 23568999999999874 45888999999999999999999999765432 33334433
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 355 ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 355 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..... ......+.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 236 ~~~~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 236 PNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp TTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCccc--CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 22222 2223567899999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=375.31 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=198.9
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|+... +|+.||||++..... .....+.+.++...++.+ +||||+++++++.+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccC
Confidence 45789999999999999999999765 789999999965432 222233344444456666 5999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 212 NVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
..++|||||+| +|.+.+.. ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 155 (290)
T 3fme_A 80 DVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFG 155 (290)
T ss_dssp SEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-
T ss_pred CEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecC
Confidence 99999999975 88776653 456799999999999999999999998 99999999999999 667799999999
Q ss_pred cccccCCCCCccccccCcccccccccc-----CCCCCccchHHHHHHHHHHhcCCCCCCCC-ChhHHHHHHHhcCCCCCC
Q 011154 288 LSDFVRPDERLNDIVGSAYYVAPEVLH-----RSYGTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDD 361 (492)
Q Consensus 288 la~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlGvil~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~ 361 (492)
++.............||+.|+|||++. ..++.++|||||||++|+|++|..||... ........+...... .
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~ 233 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--Q 233 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--C
T ss_pred CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--C
Confidence 998876665555668999999999862 35888999999999999999999999763 333333333333221 1
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 362 GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 362 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.....++.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 22246899999999999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=379.41 Aligned_cols=261 Identities=28% Similarity=0.491 Sum_probs=215.8
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.....++|++.+.||+|+||.||+|++.. +|+.||||++...... .+.+.+|+.+++++.+||||+++++++.
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 34567899999999999999999999765 6889999999755432 3568899999999966999999999998
Q ss_pred e------CCeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcE
Q 011154 209 D------LDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281 (492)
Q Consensus 209 ~------~~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~ 281 (492)
. .+.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCE
Confidence 7 56899999999999999988764 2579999999999999999999999999999999999999 667789
Q ss_pred EEEecccccccCCCC-CccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHh
Q 011154 282 KAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 354 (492)
Q Consensus 282 kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~ 354 (492)
||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+..
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 999999998765332 234567999999999874 4588999999999999999999999988877766666655
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 355 ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 355 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.... ......++..+.+||.+||..||.+|||+.++++||||++.
T Consensus 249 ~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 249 NPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp SCCC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred Cccc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 4322 12234689999999999999999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=399.01 Aligned_cols=260 Identities=18% Similarity=0.195 Sum_probs=201.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc-CCCCccEEE-------
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS-GHSNLVKFY------- 204 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~-~hpniv~l~------- 204 (492)
...|++.+.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.+++.|+ +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 3459999999999999999999765 68999999998876655666777889977666664 499988765
Q ss_pred EEEEeC-----------------CeEEEEEeecCCCchHHHHHhhCCCCCHHHH------HHHHHHHHHHHHHHHHcCCc
Q 011154 205 DAFEDL-----------------DNVYIVMELCEGGELLDRILSRCGKYSEDEA------KAVLVQILNVVAFCHLHGVV 261 (492)
Q Consensus 205 ~~~~~~-----------------~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~------~~i~~qi~~~l~ylH~~~iv 261 (492)
+++... ..+|||||||+ |+|.+++......+.+..+ ..++.||+.||.|||++||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv 216 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV 216 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence 555543 34899999998 7999999876455666666 67789999999999999999
Q ss_pred ccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCC
Q 011154 262 HRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSR 338 (492)
Q Consensus 262 HrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~ 338 (492)
||||||+|||+ +.++.+||+|||+|+.... ......||+.|+|||++.+ .|+.++|||||||++|+|+||+.
T Consensus 217 HrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFI---MPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEE---CTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEE---CCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999 6677899999999987642 2225567799999998864 58999999999999999999999
Q ss_pred CCCCCChhHH--HHH---HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 339 PFWARTESGI--FRA---VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 339 pf~~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
||.+...... +.. .......+....++.+++++.+||.+||+.||++|||+.++|+||||++.
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 9976643211 000 11112223333446789999999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=388.88 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=217.5
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.....++|++.+.||+|+||.||+|++.. +++.||+|++.... .....+.+.+|+.+|+.+. ||||+++++++.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 101 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFY 101 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECC---CCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEE
Confidence 34556899999999999999999999765 78999999997653 3445677999999999994 999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
+.+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 177 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFG 177 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECC
Confidence 999999999999999999988665 5799999999999999999999996 99999999999999 667789999999
Q ss_pred cccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHH---------------
Q 011154 288 LSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRA--------------- 351 (492)
Q Consensus 288 la~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~--------------- 351 (492)
++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....
T Consensus 178 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 178 VSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp CCHHHHH-HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred CCccccc-ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 9976532 22345689999999998864 589999999999999999999999977665443221
Q ss_pred ---------------------------HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 352 ---------------------------VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 352 ---------------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+..... .......++.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 121111 1112235789999999999999999999999999999999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=373.53 Aligned_cols=259 Identities=29% Similarity=0.520 Sum_probs=217.6
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.++|++.+.||+|+||.||+|+.+. +++.||||++...... ...+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred eecceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCC
Confidence 34789999999999999999998764 6889999999654332 23467899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..|+||||+++|+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccc
Confidence 99999999999999987744 3579999999999999999999999999999999999999 6677899999999986
Q ss_pred cCCCC---CccccccCccccccccccC-C-CCCccchHHHHHHHHHHhcCCCCCCCCChh-HHHHHHHhcCCCCCCCCCC
Q 011154 292 VRPDE---RLNDIVGSAYYVAPEVLHR-S-YGTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 292 ~~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlGvil~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 365 (492)
..... ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||...... ..+..+...... ...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 232 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWK 232 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGG
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchh
Confidence 54322 2345679999999998864 3 467899999999999999999999876654 233333332222 23356
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.++.++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 7899999999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=387.06 Aligned_cols=255 Identities=21% Similarity=0.368 Sum_probs=218.4
Q ss_pred ccceeecceeccccceEEEEEEEec----CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK----GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.++|++++.||+|+||.||+|++.. ...++..||||++.... .....+.+.+|+.+|+.+.+||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 4789999999999999999998753 22356789999996543 44556789999999999955999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
+.+.+|+|||||+||+|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll- 236 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 236 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE-
Confidence 9999999999999999999987653 348999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+.++.+||+|||+++.+..... .....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.+....++
T Consensus 237 --~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 237 --TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp --CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred --CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 6678999999999987654332 23456788999999875 458999999999999999999 9999999888888
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+..+...... .....++.++.+||.+||..||.+|||+.|++++
T Consensus 315 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8777665432 1224688999999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=389.22 Aligned_cols=264 Identities=17% Similarity=0.239 Sum_probs=223.6
Q ss_pred ccccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
...++|++.+.||+|+||.||+|++.. +..+++.||||++.... .......+.+|+.+++.+. |||||++++++.
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 144 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSL 144 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence 346789999999999999999999754 23467899999996432 3445567889999999994 999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEE
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRC------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~k 282 (492)
+.+..|+|||||+||+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+..+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997653 3599999999999999999999999999999999999996555666799
Q ss_pred EEecccccccCCC---CCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCC
Q 011154 283 AIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 283 l~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~ 357 (492)
|+|||+++.+... .......||+.|+|||++. +.++.++|||||||++|+|++ |..||......++...+.....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999754222 2234467899999999875 569999999999999999998 9999999998888888876553
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 358 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
... ...++.++.+||.+||+.||.+|||+.+++++.|...
T Consensus 305 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 305 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 322 2468899999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=381.90 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=218.2
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|+++.....+..||||++.... .....+.+.+|+.+|+.|. ||||+++++++.+.+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 3578999999999999999999987655566789999996543 3445677999999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+|||||+||+|.+++....+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRV 200 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccc
Confidence 9999999999999999997776789999999999999999999999999999999999999 6678999999999987
Q ss_pred cCCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 292 VRPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 292 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
...... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||++....+....+....... ...
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 277 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---APM 277 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCT
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CCC
Confidence 754322 22345678899999886 568999999999999999999 999999999988888877653222 224
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.++.++.+||.+||..||.+|||+.++++
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 68999999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=377.35 Aligned_cols=261 Identities=28% Similarity=0.473 Sum_probs=218.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|+++. +++.||+|++..... ...+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETKSE---EELEDYIVEIEILATCD-HPYIVKLLGAYYHD 88 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC
T ss_pred CCccceeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeC
Confidence 456889999999999999999999765 688999999965432 23467889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..++|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSA 165 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCc
Confidence 99999999999999999888766789999999999999999999999999999999999999 666789999999975
Q ss_pred ccCCC-CCccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 291 FVRPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 291 ~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
..... .......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+........ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 244 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LT 244 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SS
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CC
Confidence 43211 1223457999999999872 4588899999999999999999999998888777777766543321 12
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
...++.++.+||.+||..||.+|||+.++++||||+...
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 246789999999999999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=390.12 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=216.7
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCC-----ccEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN-----LVKF 203 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpn-----iv~l 203 (492)
.+.+.++|++.+.||+|+||.||+|+.+. +++.||||++... ......+.+|+.+++.+..|++ |+++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 45677899999999999999999998765 7889999999643 3345678889999999865664 9999
Q ss_pred EEEEEeCCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH--HcCCcccCCCCCceEeecCCCCCc
Q 011154 204 YDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCH--LHGVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 204 ~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH--~~~ivHrDlkp~NILl~~~~~~~~ 280 (492)
++++...+.+|+|||||.+ +|.+++.... ..+++..++.++.||+.||.||| +.|||||||||+|||+.. +..+.
T Consensus 122 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~ 199 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSA 199 (382)
T ss_dssp EEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCC
T ss_pred eeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCc
Confidence 9999999999999999965 9999887653 46999999999999999999999 468999999999999954 23568
Q ss_pred EEEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC
Q 011154 281 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
+||+|||+++.... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+....+.+..+.......
T Consensus 200 ~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp EEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999999987743 3456789999999998864 59999999999999999999999999988887777765432111
Q ss_pred C------------------CCCC-----------------CC-------------------------CCHHHHHHHHHcc
Q 011154 360 D------------------DGSW-----------------PS-------------------------LSSDAKDFVKLLL 379 (492)
Q Consensus 360 ~------------------~~~~-----------------~~-------------------------~s~~~~~li~~~L 379 (492)
+ ...| .. .++++++||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 0 0000 00 0137899999999
Q ss_pred ccCcCCCCCHHHHhcCcccccc
Q 011154 380 NKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 380 ~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+.||++|||+.|+|+||||++.
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=375.07 Aligned_cols=260 Identities=29% Similarity=0.507 Sum_probs=216.3
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+...++|++.+.||+|+||.||+|.++. +|+.||||++..... .+.+.+|+.+++.+ +||||+++++++.+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVESD-----LQEIIKEISIMQQC-DSPHVVKYYGSYFK 95 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETTSC-----CHHHHHHHHHHHTC-CCTTBCCEEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCchHH-----HHHHHHHHHHHHhC-CCCCCccEEEEEEe
Confidence 4456889999999999999999998764 689999999976432 35688999999999 49999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.+|+|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~ 172 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVA 172 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccc
Confidence 999999999999999999987666789999999999999999999999999999999999999 66678999999999
Q ss_pred cccCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 290 DFVRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 290 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+...... .......+
T Consensus 173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 251 (314)
T 3com_A 173 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELW 251 (314)
T ss_dssp EECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGS
T ss_pred hhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccC
Confidence 8765432 2345679999999998864 5899999999999999999999999887776655555443322 11222357
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 89999999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=402.84 Aligned_cols=250 Identities=18% Similarity=0.219 Sum_probs=202.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc--CCCCccEEE------
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS--GHSNLVKFY------ 204 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~--~hpniv~l~------ 204 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+.+|+.|+ +|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECC---CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 5789999999999999999998754 68999999997654444456678999995554443 599999998
Q ss_pred -EEEEeCCe-----------------EEEEEeecCCCchHHHHHhhCCCCC-------HHHHHHHHHHHHHHHHHHHHcC
Q 011154 205 -DAFEDLDN-----------------VYIVMELCEGGELLDRILSRCGKYS-------EDEAKAVLVQILNVVAFCHLHG 259 (492)
Q Consensus 205 -~~~~~~~~-----------------~~lv~E~~~ggsL~~~l~~~~~~~~-------~~~~~~i~~qi~~~l~ylH~~~ 259 (492)
+++++.+. .|+||||| +|+|.+++... +.++ +..+..|+.||+.||.|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 77776643 89999999 67999998764 2344 4888899999999999999999
Q ss_pred CcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccccccCccccccccccC------------CCCCccchHHHH
Q 011154 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR------------SYGTEADVWSIG 327 (492)
Q Consensus 260 ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlG 327 (492)
|+||||||+|||+ +.++.+||+|||+|+... ......+| +.|+|||++.+ .|+.++||||||
T Consensus 227 ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEE---CTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEE---cCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 9999999999999 666799999999998643 34456678 99999998763 599999999999
Q ss_pred HHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 328 VIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 328 vil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
|++|+|++|..||.+.........+.. .+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 999999999999976654433332221 235789999999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=380.07 Aligned_cols=266 Identities=29% Similarity=0.423 Sum_probs=219.0
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc--CCCCccEEEEEEE-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS--GHSNLVKFYDAFE- 208 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~--~hpniv~l~~~~~- 208 (492)
..++|++.+.||+|+||.||+|++.. .+|+.||||++........ ....+.+|+.+++.+. +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--CCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 45789999999999999999998742 2678999999864332111 1124567888877763 5999999999997
Q ss_pred ----eCCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 209 ----DLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 209 ----~~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
....+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEE
Confidence 5567999999998 59999887653 349999999999999999999999999999999999999 66778999
Q ss_pred EecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC--
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 360 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-- 360 (492)
+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+........
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 9999998776555556678999999999875 4689999999999999999999999999888777777654211110
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccccc
Q 011154 361 ---------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV 404 (492)
Q Consensus 361 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 404 (492)
...+..++.++++||.+||..||.+|||+.|+|+||||++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 11235688999999999999999999999999999999986543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=384.93 Aligned_cols=257 Identities=24% Similarity=0.361 Sum_probs=214.0
Q ss_pred cccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..++|++++.||+|+||.||+|++.. ...+++.||||++.... .....+.+.+|+++|+++.+||||++++++|.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 45889999999999999999998764 34578999999996543 344456799999999999779999999999987
Q ss_pred CCe-EEEEEeecCCCchHHHHHhhCC------------------------------------------------------
Q 011154 210 LDN-VYIVMELCEGGELLDRILSRCG------------------------------------------------------ 234 (492)
Q Consensus 210 ~~~-~~lv~E~~~ggsL~~~l~~~~~------------------------------------------------------ 234 (492)
.+. +++|||||+||+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 654 9999999999999999876432
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCC---ccc
Q 011154 235 -----------KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER---LND 300 (492)
Q Consensus 235 -----------~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~ 300 (492)
.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+..... ...
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchhccc
Confidence 18999999999999999999999999999999999999 5667899999999987643332 234
Q ss_pred cccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011154 301 IVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLL 378 (492)
Q Consensus 301 ~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 378 (492)
..||+.|+|||++. ..++.++|||||||++|+|+| |..||.+....+.............. ...+++++.+||.+|
T Consensus 255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDC 332 (359)
T ss_dssp CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHH
T ss_pred cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC--CCCCCHHHHHHHHHH
Confidence 67899999999875 568999999999999999998 99999887755554444443322222 235889999999999
Q ss_pred cccCcCCCCCHHHHhcC
Q 011154 379 LNKDPRKRMTAAQALSH 395 (492)
Q Consensus 379 L~~dP~~Rps~~e~l~h 395 (492)
|..||.+|||+.|+++|
T Consensus 333 l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEH 349 (359)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCCCHHHHHHH
Confidence 99999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=386.89 Aligned_cols=264 Identities=24% Similarity=0.401 Sum_probs=211.1
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCC--------CCHHHHHHHHHHHHHHHHccCCCCc
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--------TTAIAVEDVRREVKILRALSGHSNL 200 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~~~~Ev~~l~~l~~hpni 200 (492)
...+.++|++.+.||+|+||.||+|+.. +|+.||||++..... ......+.+.+|+.+|+.+. ||||
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i 91 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNI 91 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECT----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTB
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECC----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCc
Confidence 3456789999999999999999999853 478999999854322 12334577899999999995 9999
Q ss_pred cEEEEEEEe-----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC
Q 011154 201 VKFYDAFED-----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK 275 (492)
Q Consensus 201 v~l~~~~~~-----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~ 275 (492)
+++++++.. ...+|+|||||. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~--- 167 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--- 167 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---
Confidence 999999954 336899999997 58999888776789999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecccccccCCCCCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHH
Q 011154 276 DESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 353 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~ 353 (492)
+.++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 667789999999998766555566678999999999875 458999999999999999999999999888777766664
Q ss_pred hcCCC------------------------CCCCC----CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 354 KADPS------------------------FDDGS----WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 354 ~~~~~------------------------~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..... ..... .+.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 32111 11111 23568899999999999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=377.86 Aligned_cols=261 Identities=30% Similarity=0.524 Sum_probs=199.6
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|++.. +++.||||++..... ....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDE 87 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC-------CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSC
T ss_pred hhhhhhhheeccccceEEEEEEECC---CCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCC
Confidence 5789999999999999999998654 678999999865432 223456889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHh-------hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 213 VYIVMELCEGGELLDRILS-------RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
.++||||++||+|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEe
Confidence 9999999999999998864 23569999999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCC------CccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 286 FGLSDFVRPDE------RLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 286 fGla~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.................
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 99997764332 123457999999999885 3589999999999999999999999988877766655554433
Q ss_pred CCC------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 SFD------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ~~~------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
... ...+..++.++.+||.+||+.||.+|||+.++++||||++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 221 122356889999999999999999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=387.50 Aligned_cols=259 Identities=31% Similarity=0.535 Sum_probs=214.5
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|.+.+.||+|+||.||+|+++. +|+.||||++.... ......+.+.+|+.+++.++ ||||++++++|..
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 112 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTP 112 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECS
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheec
Confidence 3567899999999999999999998765 78999999997543 34455677899999999995 9999999999987
Q ss_pred CCeE------EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 210 LDNV------YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 210 ~~~~------~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
.+.. |+||||+. |+|.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 113 ~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL 185 (371)
T 4exu_A 113 ASSLRNFYDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKI 185 (371)
T ss_dssp CSSSTTCCCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEE
T ss_pred cCCcccceeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEE
Confidence 7654 99999997 5887765 2459999999999999999999999999999999999999 66778999
Q ss_pred EecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC--
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF-- 359 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~-- 359 (492)
+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.......
T Consensus 186 ~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 186 LDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp CSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 99999986643 3455689999999998764 68999999999999999999999999888777666664421111
Q ss_pred ---------------------CC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 360 ---------------------DD----GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 360 ---------------------~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.. ..++.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 00 11246789999999999999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=374.49 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=209.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|++ +|+.||||++..... .....+.+.+|+++|++++ ||||+++++++.+.+
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 457899999999999999999975 467899999976543 3455677999999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 212 NVYIVMELCEGGELLDRILSRCG--KYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
.+++|||||++|+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCC
Confidence 99999999999999998875421 3999999999999999999999999 9999999999999 667799999999
Q ss_pred cccccCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 288 LSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 288 la~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+........ ...
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~ 262 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPR 262 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--CCT
T ss_pred CCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCc
Confidence 998654332 2345689999999998864 589999999999999999999999998888877777654443332 224
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhc--Cccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALS--HPWIRN 400 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~~ 400 (492)
.+++++.+||.+||..||.+|||+.++++ ++|++.
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 68999999999999999999999999987 455543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=374.16 Aligned_cols=256 Identities=32% Similarity=0.517 Sum_probs=211.7
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-- 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-- 209 (492)
+.++|++.+.||+|+||.||+|+... +|+.||||++.. .....+.+.+|+.+++.+. ||||++++++|.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERR 75 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECC
T ss_pred ccccchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEec----cHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhc
Confidence 45789999999999999999998764 789999999953 2345567899999999995 9999999999865
Q ss_pred -----------CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCC
Q 011154 210 -----------LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES 278 (492)
Q Consensus 210 -----------~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~ 278 (492)
.+..|+|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~ 152 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DES 152 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTT
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCC
Confidence 457899999999999999998766678999999999999999999999999999999999999 667
Q ss_pred CcEEEEecccccccCCC---------------CCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCC
Q 011154 279 SQLKAIDFGLSDFVRPD---------------ERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFW 341 (492)
Q Consensus 279 ~~~kl~DfGla~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~ 341 (492)
+.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 78999999999876432 22345679999999998864 58999999999999999998 554
Q ss_pred CC-ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 342 AR-TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 342 ~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.. ........+......++.......+..+++||.+||+.||.+|||+.++++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 32 3345556666665666655556788899999999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=391.62 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=209.4
Q ss_pred CccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc-------CCCCc
Q 011154 128 FSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS-------GHSNL 200 (492)
Q Consensus 128 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~-------~hpni 200 (492)
....+.++|++.+.||+|+||.||+|+... +++.||||++... ....+.+.+|+.+|+.++ +|+||
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 345667899999999999999999998764 7899999999643 344567889999999995 27889
Q ss_pred cEEEEEEE----eCCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeec
Q 011154 201 VKFYDAFE----DLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTS 274 (492)
Q Consensus 201 v~l~~~~~----~~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~ 274 (492)
++++++|. +...+|+||||| +|+|.+.+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence 99999998 556899999999 567777776543 5699999999999999999999999 9999999999999953
Q ss_pred CC----------------------------------------------CCCcEEEEecccccccCCCCCccccccCcccc
Q 011154 275 KD----------------------------------------------ESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV 308 (492)
Q Consensus 275 ~~----------------------------------------------~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~ 308 (492)
++ ....+||+|||++..... .....+||+.|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~ 260 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYR 260 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGC
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCccc
Confidence 22 113799999999987643 345568999999
Q ss_pred ccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCCh------hHHHHHHHhcCCCCCC--------------------
Q 011154 309 APEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTE------SGIFRAVLKADPSFDD-------------------- 361 (492)
Q Consensus 309 aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~------~~~~~~i~~~~~~~~~-------------------- 361 (492)
|||++.+ .|+.++|||||||++|+|++|..||..... ...+..+.......+.
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9998764 599999999999999999999999976542 2222222221110000
Q ss_pred ------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 362 ------------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 362 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
......+.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 001123467889999999999999999999999999973
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=378.34 Aligned_cols=261 Identities=30% Similarity=0.503 Sum_probs=216.0
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|++.. +|+.||||++.... .......+.+|+.+++.++ ||||+++++++..
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPFD--KPLFALRTLREIKILKHFK-HENIITIFNIQRP 80 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeecccc--cchHHHHHHHHHHHHHhCc-CCCcCCeeeeecc
Confidence 4567899999999999999999998764 78999999996432 3445567889999999995 9999999999876
Q ss_pred C-----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 L-----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 ~-----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
. ...|+||||+. |+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~ 154 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVC 154 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEEC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEE
Confidence 4 67999999997 589888765 479999999999999999999999999999999999999 667789999
Q ss_pred ecccccccCCCCC-----------ccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 011154 285 DFGLSDFVRPDER-----------LNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 351 (492)
Q Consensus 285 DfGla~~~~~~~~-----------~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~ 351 (492)
|||++........ ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 9999987643221 22357899999999864 4588999999999999999999999998877665554
Q ss_pred HHhcCCC------------------------CCC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 352 VLKADPS------------------------FDD----GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 352 i~~~~~~------------------------~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+...... ... ..++.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 4321111 110 11346889999999999999999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=376.55 Aligned_cols=260 Identities=32% Similarity=0.531 Sum_probs=212.2
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE-
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE- 208 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~- 208 (492)
..+.++|++.+.||+|+||.||+|.+.. +|+.||||++... .....+.+.+|+++++.+. ||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGP 79 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETT---TTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECT
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccc
Confidence 3567899999999999999999998764 6899999999654 3455678899999999995 999999999873
Q ss_pred -------------eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC
Q 011154 209 -------------DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK 275 (492)
Q Consensus 209 -------------~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~ 275 (492)
+.+..|+||||+. |+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~- 155 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT- 155 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET-
T ss_pred cccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-
Confidence 4478999999997 599987743 57999999999999999999999999999999999999952
Q ss_pred CCCCcEEEEecccccccCCC----CCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHH
Q 011154 276 DESSQLKAIDFGLSDFVRPD----ERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIF 349 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~ 349 (492)
.+..+||+|||++...... .......||..|+|||++. ..++.++|||||||++|+|++|..||.+....+..
T Consensus 156 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 156 -EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp -TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred -CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4568999999999876432 2234457899999999874 45889999999999999999999999988887777
Q ss_pred HHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 350 RAVLKADPSFDD--------------------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 350 ~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..+....+.... ..++.++.++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 766554322110 1124689999999999999999999999999999999865
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=380.78 Aligned_cols=259 Identities=27% Similarity=0.389 Sum_probs=203.6
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++....... ....+|++.++.+. ||||++++++|...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR----NRELQIMQDLAVLH-HPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HTTEEEC----------CEEEEETT---TCCEEEEEEEECCTTCC----CHHHHHHHHHHHHC-CTTBCCEEEEEEEECS
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecCcccc----HHHHHHHHHHHhcC-CCCcccHHHhhhcccc
Confidence 4789999999999999999998765 68899999986654322 24567888888884 9999999999976443
Q ss_pred -------EEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHH--HcCCcccCCCCCceEeecCCCCCc
Q 011154 213 -------VYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCH--LHGVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 213 -------~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH--~~~ivHrDlkp~NILl~~~~~~~~ 280 (492)
+++|||||++ +|.+.+.. ....+++..++.++.||+.||.||| ++||+||||||+|||++. .++.
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~ 170 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGT 170 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTTE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCCc
Confidence 8999999987 55554442 4467999999999999999999999 999999999999999942 3678
Q ss_pred EEEEecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC
Q 011154 281 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 358 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~ 358 (492)
+||+|||++..+..........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 99999999998876666667789999999998753 4899999999999999999999999998887777766542111
Q ss_pred CC----------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 359 FD----------------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 359 ~~----------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.. .......+.++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 10 001123568899999999999999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=378.02 Aligned_cols=264 Identities=27% Similarity=0.434 Sum_probs=216.8
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC------CccE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS------NLVK 202 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp------niv~ 202 (492)
...+.++|++.+.||+|+||.||+|.+.. .+++.||||++... ....+.+.+|+.+++.+. |+ +|++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~ 81 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQ 81 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCC
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecC--CCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeEe
Confidence 45667899999999999999999998632 26789999999643 334567889999999985 55 5999
Q ss_pred EEEEEEeCCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC----
Q 011154 203 FYDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE---- 277 (492)
Q Consensus 203 l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~---- 277 (492)
+++++.+.+.+++||||| +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+...+.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 889999887653 36899999999999999999999999999999999999954221
Q ss_pred ------------CCcEEEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC
Q 011154 278 ------------SSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART 344 (492)
Q Consensus 278 ------------~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~ 344 (492)
++.+||+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 56799999999987543 3345689999999998864 68999999999999999999999998887
Q ss_pred hhHHHHHHHhcCCCCCC----------------CCCC------------------------CCCHHHHHHHHHccccCcC
Q 011154 345 ESGIFRAVLKADPSFDD----------------GSWP------------------------SLSSDAKDFVKLLLNKDPR 384 (492)
Q Consensus 345 ~~~~~~~i~~~~~~~~~----------------~~~~------------------------~~s~~~~~li~~~L~~dP~ 384 (492)
..+....+......++. ..|. ..++++.+||.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 76665554332221110 0111 2246788999999999999
Q ss_pred CCCCHHHHhcCccccccc
Q 011154 385 KRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 385 ~Rps~~e~l~hp~~~~~~ 402 (492)
+|||+.|+|+||||+...
T Consensus 319 ~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 319 KRITLREALKHPFFDLLK 336 (339)
T ss_dssp TSCCHHHHTTSGGGGGGG
T ss_pred cccCHHHHhcCHHHHHHh
Confidence 999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=365.29 Aligned_cols=248 Identities=26% Similarity=0.444 Sum_probs=216.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|++. +++.||||++...... .+.+.+|++++++++ ||||+++++++.+.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET----TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred hhhceeeheecCCCccEEEEEEec----CCCeEEEEEecccccC----HHHHHHHHHHHHhCC-CCCEeeEEEEEecCCc
Confidence 478999999999999999999865 4567999999765433 246889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++|||||++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGB
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccc
Confidence 999999999999999998776789999999999999999999999999999999999999 56678999999999876
Q ss_pred CCCC--CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 293 RPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 293 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
.... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||......+....+......... ..++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 233 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLAS 233 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSC
T ss_pred cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCC
Confidence 4332 223456788899999886 568999999999999999999 99999999888888888765433222 3578
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.++.+||.+||+.||.+|||+.++++|
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=381.77 Aligned_cols=256 Identities=21% Similarity=0.362 Sum_probs=219.8
Q ss_pred cccceeecceeccccceEEEEEEEecC----CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEE
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKG----EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAF 207 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~ 207 (492)
..++|.+++.||+|+||.||+|++... ...+..||||++.... .......+.+|+++++.+.+|||||+++++|
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 357899999999999999999997542 2345789999996543 3455677999999999996699999999999
Q ss_pred EeCCeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEe
Q 011154 208 EDLDNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLY 272 (492)
Q Consensus 208 ~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl 272 (492)
.+.+..++|||||++|+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 99999999999999999999997653 359999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCCCC---CccccccCccccccccccC-CCCCccchHHHHHHHHHHhc-CCCCCCCCChhH
Q 011154 273 TSKDESSQLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLC-GSRPFWARTESG 347 (492)
Q Consensus 273 ~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~ 347 (492)
+.++.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+
T Consensus 225 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 225 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp ---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 667799999999998765432 2334567899999998764 58999999999999999999 999999988888
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 348 IFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+...+....... ....+++++.+||.+||+.||++|||+.|++++
T Consensus 302 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 887777654322 224689999999999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=366.48 Aligned_cols=258 Identities=30% Similarity=0.484 Sum_probs=220.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--C
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--L 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--~ 210 (492)
.++|++.+.||+|+||.||+|+.+. +++.||||++...... ....+.+.+|+.+++.++ ||||+++++++.+ .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCC
Confidence 4789999999999999999998765 7899999999765543 345667999999999995 9999999998854 5
Q ss_pred CeEEEEEeecCCCchHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHcC-----CcccCCCCCceEeecCCCCCcEE
Q 011154 211 DNVYIVMELCEGGELLDRILSRC---GKYSEDEAKAVLVQILNVVAFCHLHG-----VVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~ylH~~~-----ivHrDlkp~NILl~~~~~~~~~k 282 (492)
+.+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~k 156 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVK 156 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEE
Confidence 78999999999999999987542 34999999999999999999999999 9999999999999 6677899
Q ss_pred EEecccccccCCCCC-ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC
Q 011154 283 AIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 360 (492)
Q Consensus 283 l~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 360 (492)
|+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......++...+........
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred EecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC
Confidence 999999987654332 234579999999998764 588999999999999999999999999888888877777654321
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
...++.++.+||.+||..||.+|||+.|+|+|+|+...
T Consensus 237 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 237 ---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 23688999999999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=375.30 Aligned_cols=264 Identities=19% Similarity=0.321 Sum_probs=200.0
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++++.||+|+||.||+|+++........||||++....... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEF-DHPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHC-CCCceehhhceeecc
Confidence 44678999999999999999999877543333489999997654333 3467799999999999 599999999999887
Q ss_pred CeE------EEEEeecCCCchHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCC
Q 011154 211 DNV------YIVMELCEGGELLDRILSRC-----GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS 279 (492)
Q Consensus 211 ~~~------~lv~E~~~ggsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~ 279 (492)
+.. ++|||||.+|+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCC
Confidence 665 99999999999999886542 259999999999999999999999999999999999999 6678
Q ss_pred cEEEEecccccccCCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHh
Q 011154 280 QLKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLK 354 (492)
Q Consensus 280 ~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~ 354 (492)
.+||+|||++......... ....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 9999999999876544322 2345778999999876 458999999999999999999 9999999888888888776
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCC-------HHHHhcCccccccc
Q 011154 355 ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMT-------AAQALSHPWIRNYN 402 (492)
Q Consensus 355 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-------~~e~l~hp~~~~~~ 402 (492)
..... ..+.++.++.+||.+||..||.+||| ++++++|+|+....
T Consensus 255 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 255 GNRLK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp TCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CCCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 54322 22468899999999999999999999 88889999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=366.75 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=206.7
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|++......+..||||++.... .....+.+.+|+.+++.+. ||||+++++++. +
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-E 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-S
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-c
Confidence 34679999999999999999999987655567889999986542 3455677999999999995 999999999984 5
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..|+|||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECcccccc
Confidence 67899999999999999998776679999999999999999999999999999999999999 455689999999998
Q ss_pred ccCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+...... ...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~ 241 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPN 241 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTT
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCCC
Confidence 7654332 23345788999999876 568999999999999999996 99999988888888877765432 22347
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+++++.+||.+||..||.+|||+.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999998863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=375.98 Aligned_cols=259 Identities=25% Similarity=0.473 Sum_probs=216.3
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-CHHHHHHHHHHHHHHHHccCCCCccEEEEEEE--
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-TAIAVEDVRREVKILRALSGHSNLVKFYDAFE-- 208 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~-- 208 (492)
+.++|++++.||+|+||.||+|.... +++.||||++...... .....+.+.+|+++++.++ ||||+++++++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNE 78 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC
T ss_pred cccceeEeeEEecCCCeEEEEEEECC---CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcC
Confidence 45789999999999999999998654 7889999999643211 1123467899999999995 999999999984
Q ss_pred eCCeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
+.+..|+|||||.+| |.+.+... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg 154 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALG 154 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccc
Confidence 456899999999876 66766543 3569999999999999999999999999999999999999 667789999999
Q ss_pred cccccCCC---CCccccccCccccccccccCC---CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC
Q 011154 288 LSDFVRPD---ERLNDIVGSAYYVAPEVLHRS---YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD 361 (492)
Q Consensus 288 la~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (492)
++...... .......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+....+......++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~- 233 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP- 233 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC-
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC-
Confidence 99876432 223456799999999988642 46789999999999999999999999888888888887765543
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 362 GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 362 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..++.++.+||.+||..||.+|||+.|+++||||++..
T Consensus 234 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 234 ---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp ---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ---CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 36889999999999999999999999999999998753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=369.83 Aligned_cols=263 Identities=29% Similarity=0.438 Sum_probs=199.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++...... ....+.+..+..+++.+ +||||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT---TCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSE
T ss_pred hccccccceeeecCCeeEEEEEEec---CCeEEEEEEecccccc-hHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCc
Confidence 4789999999999999999999765 6889999999765422 22223344444566666 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+++||||+ ++.+..........+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++..
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC--
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchh
Confidence 99999999 5455554444457899999999999999999999995 99999999999999 6677899999999987
Q ss_pred cCCCCCccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCC-ChhHHHHHHHhcCCCCCCCCC
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~ 364 (492)
...........||+.|+|||++. ..++.++|||||||++|+|++|..||... ...+.+..+........ ..+
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 253 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGH 253 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSS
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-Ccc
Confidence 76555556678999999999873 35888999999999999999999999873 44556666665543322 223
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccccC
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVK 405 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~ 405 (492)
..++.++.+||.+||..||.+|||+.++++||||++.....
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccccc
Confidence 46899999999999999999999999999999998765433
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=377.42 Aligned_cols=258 Identities=31% Similarity=0.534 Sum_probs=213.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|.+.+.||+|+||.||+|+++. +|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++...
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA 95 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEecc
Confidence 456899999999999999999998765 78999999997643 34445677899999999995 99999999999876
Q ss_pred Ce------EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 DN------VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ~~------~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+. +|+||||+. |+|.+.+. ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 96 ~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~ 168 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKIL 168 (353)
T ss_dssp SSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEEC
T ss_pred cccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEe
Confidence 54 599999997 58877652 359999999999999999999999999999999999999 667789999
Q ss_pred ecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-----
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP----- 357 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~----- 357 (492)
|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.....
T Consensus 169 Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 169 DFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred ecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999987543 2345689999999998764 589999999999999999999999998887666655543210
Q ss_pred ----------------------CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 ----------------------SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ----------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
......++.++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 001123456899999999999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=362.02 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=216.3
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|.++ ++..||||++...... .+.+.+|+++++.+. ||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK----GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLS-HPKLVKFYGVCSKEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred chhheeeeeeeccCCCceEEEEEec----CceeEEEEEeccCCCc----HHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence 3578999999999999999999765 4567999999765432 246889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++|||||++|+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEE
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCcccee
Confidence 9999999999999999998776679999999999999999999999999999999999999 6677999999999987
Q ss_pred cCCCCCc--cccccCccccccccccC-CCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDERL--NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
....... ....||+.|+|||++.+ .++.++|||||||++|+|++ |..||...........+......... ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 230 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLA 230 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTS
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcC
Confidence 6544322 23456778999998864 68999999999999999999 99999988888888777765543332 357
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++++.+||.+||+.||.+|||+.+++++
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=384.46 Aligned_cols=262 Identities=23% Similarity=0.453 Sum_probs=221.6
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH--------------HHHHHHHHHHHHHHHcc
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA--------------IAVEDVRREVKILRALS 195 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~--------------~~~~~~~~Ev~~l~~l~ 195 (492)
....++|++.+.||+|+||.||+|.+ +|+.||||++........ ...+.+.+|+.+++.|+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 34568999999999999999999986 578999999864322111 11267899999999995
Q ss_pred CCCCccEEEEEEEeCCeEEEEEeecCCCchHHH------HHhh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCC
Q 011154 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDR------ILSR-CGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKP 267 (492)
Q Consensus 196 ~hpniv~l~~~~~~~~~~~lv~E~~~ggsL~~~------l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp 267 (492)
||||+++++++.+.+.+|+|||||++|+|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||
T Consensus 102 -h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p 180 (348)
T 2pml_X 102 -NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP 180 (348)
T ss_dssp -CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred -CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence 99999999999999999999999999999987 4432 4679999999999999999999999 9999999999
Q ss_pred CceEeecCCCCCcEEEEecccccccCCCCCccccccCccccccccccCC--CCC-ccchHHHHHHHHHHhcCCCCCCCCC
Q 011154 268 ENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YGT-EADVWSIGVIAYILLCGSRPFWART 344 (492)
Q Consensus 268 ~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DvwSlGvil~~lltg~~pf~~~~ 344 (492)
+|||+ +.++.+||+|||++...... ......||+.|+|||++.+. ++. ++|||||||++|+|++|..||....
T Consensus 181 ~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 181 SNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp GGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999 66779999999999876543 44567899999999998654 555 8999999999999999999998877
Q ss_pred h-hHHHHHHHhcCCCCCCCC---------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 345 E-SGIFRAVLKADPSFDDGS---------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 345 ~-~~~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
. .+....+......++... ...++.++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 7 677777766655544211 14689999999999999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=375.93 Aligned_cols=265 Identities=25% Similarity=0.397 Sum_probs=216.3
Q ss_pred CccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCC------cc
Q 011154 128 FSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN------LV 201 (492)
Q Consensus 128 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpn------iv 201 (492)
....+.++|++.+.||+|+||.||+|+.... .++.||||++... ....+.+.+|+.+++.|. |++ ++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~ 85 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHAR--GKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCV 85 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBC
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCC--CceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEE
Confidence 3456778999999999999999999987542 3478999999643 234567889999999996 655 99
Q ss_pred EEEEEEEeCCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC-----
Q 011154 202 KFYDAFEDLDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK----- 275 (492)
Q Consensus 202 ~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~----- 275 (492)
.+++++...+.+++||||| +++|.+.+.... ..+++.+++.++.||+.||.|||++||+||||||+|||+...
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 667888776653 469999999999999999999999999999999999999543
Q ss_pred -----------CCCCcEEEEecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCC
Q 011154 276 -----------DESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWAR 343 (492)
Q Consensus 276 -----------~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~ 343 (492)
+..+.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||...
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 2467899999999987543 334568999999999875 46899999999999999999999999988
Q ss_pred ChhHHHHHHHhcCCCCCC----------------CCCC------------------------CCCHHHHHHHHHccccCc
Q 011154 344 TESGIFRAVLKADPSFDD----------------GSWP------------------------SLSSDAKDFVKLLLNKDP 383 (492)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~----------------~~~~------------------------~~s~~~~~li~~~L~~dP 383 (492)
...+.+..+......++. ..|+ ..+.++.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 776665554432221110 0111 123578899999999999
Q ss_pred CCCCCHHHHhcCccccccc
Q 011154 384 RKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 384 ~~Rps~~e~l~hp~~~~~~ 402 (492)
.+|||+.|+|+||||++..
T Consensus 323 ~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp TTSCCHHHHTTSGGGGGCC
T ss_pred hhCcCHHHHhcChhhcCCC
Confidence 9999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=367.82 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=209.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|.+++.||+|+||.||+|.+.. +++.||||++... .....+.+.+|+++|+.++ ||||+++++++.+++.
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 81 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKR 81 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred hhHeeccceecCCCCEEEEEEEECC---CCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCe
Confidence 4789999999999999999999765 6899999998543 4556678999999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++|||||+||+|.+++......+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLM 158 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceec
Confidence 999999999999999998767789999999999999999999999999999999999999 67778999999999876
Q ss_pred CCCCCc---------------cccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhH-----HHHH
Q 011154 293 RPDERL---------------NDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESG-----IFRA 351 (492)
Q Consensus 293 ~~~~~~---------------~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~-----~~~~ 351 (492)
...... ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 433221 15679999999998864 58999999999999999999999986532211 1111
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
..... ..+.+++++.+||.+||+.||.+|||+.++++ ||..
T Consensus 239 ~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 239 FLDRY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp HHHHT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred ccccc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 11111 11367889999999999999999999999987 5543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=368.67 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=216.0
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++.+.||+|+||.||+|.+.. ...+++.||||++.... .....+.+.+|+.++++|.+||||+++++++.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 4789999999999999999998753 33468899999997543 3344577999999999995599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 211 DNVYIVMELCEGGELLDRILSRCG-----------------KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
+..++|||||++|+|.+++..... .+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~- 178 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE-
Confidence 999999999999999999876533 48999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+......
T Consensus 179 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred --cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 5667899999999987754433 23456788999999875 568999999999999999999 9999988776555
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
...+........ ....++.++.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 257 FYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 555444433222 224689999999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=367.50 Aligned_cols=257 Identities=28% Similarity=0.428 Sum_probs=206.7
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
|.....||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.+. ||||+++++++.+.+..++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLS---NQVRIAIKEIPERDS---RYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETT---TCCEEEEEEEECCCC------HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECC---CCeEEEEEEccCCch---HHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEE
Confidence 4444589999999999998765 688999999976532 33467889999999995 9999999999999999999
Q ss_pred EEeecCCCchHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 216 VMELCEGGELLDRILSRCG--KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
||||+++++|.+++....+ .+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEESC
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeecccccccC
Confidence 9999999999998876533 4679999999999999999999999999999999999952 25689999999998765
Q ss_pred CCC-CccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCChhHH-HHHHHhcCCCCCCCCCCCCC
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s 368 (492)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........ ........ ........++
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 252 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESMS 252 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--CCCCCCTTSC
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--ccccccccCC
Confidence 432 2345679999999998853 388899999999999999999999976543322 11111111 1112234689
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
.++.+||.+||+.||++|||+.++|+||||+....
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 99999999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=376.33 Aligned_cols=250 Identities=19% Similarity=0.262 Sum_probs=206.6
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.++|++.+.||+|+||.||+|+... +|+.||||++...... +.+.+|+.+++.|.+||||+++++++.+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred EcCCeEEEEEeeccCCceEEEEEECC---CCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 45789999999999999999998654 7899999999755432 247789999999966999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCc-----EEEEec
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ-----LKAIDF 286 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~-----~kl~Df 286 (492)
..++||||| +|+|.+++....+.+++.++..++.||+.||.|||++||+||||||+|||++ .++. +||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEc
Confidence 999999999 8999999877667899999999999999999999999999999999999994 4444 999999
Q ss_pred ccccccCCCCC--------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCCh---hHHHHHHHh
Q 011154 287 GLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLK 354 (492)
Q Consensus 287 Gla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~---~~~~~~i~~ 354 (492)
|+++.+..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... .+.+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 99987644332 245789999999998864 589999999999999999999999987443 344444433
Q ss_pred cCCCCCCCC-CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 355 ADPSFDDGS-WPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 355 ~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
......... ...++ ++.+||.+||..||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 322221111 11244 9999999999999999999998876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=363.16 Aligned_cols=249 Identities=23% Similarity=0.377 Sum_probs=213.4
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||++.+. ++..||||++...... .+.+.+|+++++.+. ||||+++++++.+.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET----TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc----CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCC-CCCEeeEEEEEecCC
Confidence 4578999999999999999999765 4678999999765433 246889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+++|||||++|+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRY 169 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccc
Confidence 9999999999999999998766789999999999999999999999999999999999999 6677899999999987
Q ss_pred cCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
...... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||......+....+......... ..+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 246 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLA 246 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcC
Confidence 643321 22345778899999876 568999999999999999998 99999998888888887765433322 357
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++++.+||.+||+.||.+|||+.++++|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 8999999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=373.86 Aligned_cols=255 Identities=22% Similarity=0.302 Sum_probs=217.8
Q ss_pred cccceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..++|++.+.||+|+||.||+|++.... .+++.||||++.... .....+.+.+|+.+++.+. ||||+++++++.+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAV 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcc
Confidence 4578999999999999999999987422 356899999997543 3445677999999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Q 011154 210 LDNVYIVMELCEGGELLDRILSRC-----------------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLK 266 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlk 266 (492)
.+.+|+|||||++|+|.+++.... ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999999999999999999987642 569999999999999999999999999999999
Q ss_pred CCceEeecCCCCCcEEEEecccccccCCCC---CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCC
Q 011154 267 PENFLYTSKDESSQLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFW 341 (492)
Q Consensus 267 p~NILl~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~ 341 (492)
|+|||+ +.++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.
T Consensus 202 p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 202 TRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp GGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999 666789999999998664332 223457899999999875 568999999999999999999 999999
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 342 ARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 342 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+....++...+........ ...++.++.+||.+||..||.+|||+.+++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9988888888776554322 23688999999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=363.68 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=209.8
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHH----HHHHHHHHHHHHccCCCCccEEEEE
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAV----EDVRREVKILRALSGHSNLVKFYDA 206 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~----~~~~~Ev~~l~~l~~hpniv~l~~~ 206 (492)
...++|++.+.||+|+||.||+|++.. +++.||||++........... +.+.+|+.+++.+. ||||++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~ 91 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGL 91 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred hhhccceehhccccCCceeEEEEEEcC---CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhhee
Confidence 345789999999999999999999765 788999999976544332222 57889999999995 9999999999
Q ss_pred EEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCC--CCcEE
Q 011154 207 FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDE--SSQLK 282 (492)
Q Consensus 207 ~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~--~~~~k 282 (492)
+.+.. ++||||+++|+|.+.+......+++..++.++.||+.||.|||++| |+||||||+|||+..++. ...+|
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 97655 6999999999999999887778999999999999999999999999 999999999999953321 22399
Q ss_pred EEecccccccCCCCCccccccCcccccccccc---CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHH--HHHHHhcCC
Q 011154 283 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH---RSYGTEADVWSIGVIAYILLCGSRPFWARTESGI--FRAVLKADP 357 (492)
Q Consensus 283 l~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~--~~~i~~~~~ 357 (492)
|+|||+++... .......||+.|+|||++. ..++.++|||||||++|+|++|..||........ ...+.....
T Consensus 170 l~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 170 VADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp ECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred eCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 99999997543 3345678999999999883 3478899999999999999999999977655443 333333322
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 358 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.......+++++.+||.+||+.||.+|||+.++++
T Consensus 248 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 --RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22233578999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=379.75 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=206.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++....++..||||++.... .....+.+.+|+.+|+++. ||||+++++++.+.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence 468999999999999999999877544567889999996543 3445677999999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+++|||||+||+|.+++......+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccc
Confidence 999999999999999998776689999999999999999999999999999999999999 66789999999999876
Q ss_pred CCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 293 RPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 293 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
..... .....+|+.|+|||++. +.++.++|||||||++|+|++ |..||+.....++...+...... .....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~ 274 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL---PPPMD 274 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC---CCCTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence 54322 12234577899999876 569999999999999999998 99999998888887777654321 12236
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++.+||.+||+.||.+||++.++++
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 7899999999999999999999999886
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=372.19 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=192.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHH-HHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK-ILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~-~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|++.+.||+|+||.||+|..+. +|+.||||++.... .......+.+|+. +++.+ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREG 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSS
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---CCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCC
Confidence 4789999999999999999998765 68999999997653 2334455667776 55555 6999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecCCCCCcEEEEec
Q 011154 212 NVYIVMELCEGGELLDRILS----RCGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
..++|||||.+ +|.+.+.. ....+++..+..++.|++.||.|||+. ||+||||||+|||+ +.++.+||+||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Df 170 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDF 170 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCC
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccC
Confidence 99999999986 77776653 246799999999999999999999999 99999999999999 56678999999
Q ss_pred ccccccCCCCCccccccCcccccccccc-----CCCCCccchHHHHHHHHHHhcCCCCCCCCChh-HHHHHHHhcC-CCC
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLH-----RSYGTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKAD-PSF 359 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-~~~~~i~~~~-~~~ 359 (492)
|++.............||+.|+|||++. ..++.++|||||||++|+|++|..||...... +.+..+.... +.+
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 9998776555455568999999999873 35889999999999999999999999764321 2221121111 222
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccccc
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV 404 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 404 (492)
....+..++.++.+||.+||..||.+|||+.++++||||......
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence 333345689999999999999999999999999999999876433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=374.02 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=214.1
Q ss_pred cccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..++|++++.||+|+||.||+|.+... ..++..||||++.... .....+.+.+|+.+|++|.+||||+++++++.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 357899999999999999999997532 2357789999997543 223346789999999999559999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCG----------------------KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKP 267 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp 267 (492)
.+.+++|||||++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 9999999999999999999976532 379999999999999999999999999999999
Q ss_pred CceEeecCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCC
Q 011154 268 ENFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWA 342 (492)
Q Consensus 268 ~NILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~ 342 (492)
+|||+ +.++.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|+| |..||.+
T Consensus 201 ~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 201 RNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999 5667999999999987654332 23456788999999875 568999999999999999998 9999988
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcc
Q 011154 343 RTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397 (492)
Q Consensus 343 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 397 (492)
......+..+........ ....+++++.+||.+||..||.+|||+.++++|-.
T Consensus 278 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 776655555555443322 22467999999999999999999999999998653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=359.01 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=214.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|++.....++..||||++.... .....+.+.+|+.+++.+. ||||+++++++.+ +
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE-E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS-S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-C
Confidence 3578999999999999999999987655567789999997653 3345677999999999995 9999999999875 4
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..|+||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCcc
Confidence 5689999999999999998776779999999999999999999999999999999999999 4556899999999987
Q ss_pred cCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
...... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||......+....+........ ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 239 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDLC 239 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTTC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCCC
Confidence 654332 23456788999999886 568999999999999999998 9999988888777777766543221 2368
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++.+.+||.+||..||.+|||+.+++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 8999999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=371.44 Aligned_cols=265 Identities=18% Similarity=0.242 Sum_probs=218.8
Q ss_pred cccccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAF 207 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~ 207 (492)
+...++|++.+.||+|+||.||+|++.. +..+++.||||++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 102 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKF-NHQNIVRCIGVS 102 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhC-CCCCCCeEEEEE
Confidence 3456899999999999999999998643 23468899999996432 344556789999999999 599999999999
Q ss_pred EeCCeEEEEEeecCCCchHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcE
Q 011154 208 EDLDNVYIVMELCEGGELLDRILSRC------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281 (492)
Q Consensus 208 ~~~~~~~lv~E~~~ggsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~ 281 (492)
.+.+..|+|||||+||+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++....+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999997653 348999999999999999999999999999999999999755566789
Q ss_pred EEEecccccccCCCC---CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcC
Q 011154 282 KAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 356 (492)
Q Consensus 282 kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~ 356 (492)
||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|+| |..||......+....+....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999997653322 223456899999999875 568999999999999999998 999998888888777776654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 357 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
... ....++..+.+||.+||..||.+|||+.++++|.|...
T Consensus 263 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 RMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 322 22468999999999999999999999999999988654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=364.76 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=205.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|++.. +++.||||++...........+.+.+|+.+++.+. ||||+++++++.+++.
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCe
Confidence 4789999999999999999998764 68899999997665555556678999999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+||||++|++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccc
Confidence 99999999999999988765 679999999999999999999999999999999999999 56678999999999876
Q ss_pred CCCC--CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 293 RPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 293 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.....+...+ ..........++.++.
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 263 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPV 263 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCT
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCH
Confidence 5432 233567999999999886 45889999999999999999999999876665443333 3333333344567899
Q ss_pred HHHHHHHHccccCcCCCC-CHHHHhc
Q 011154 370 DAKDFVKLLLNKDPRKRM-TAAQALS 394 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rp-s~~e~l~ 394 (492)
++.+||.+||..||++|| +++++++
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999999 7877765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=381.17 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=213.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|.+.+.||+|+||.||+|+++. +++.||||++.... .....+.+.+|+++|+.+. ||||+++++++.+.+.
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCC
Confidence 4789999999999999999999865 67899999986442 3344556889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++......+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREE 263 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceec
Confidence 999999999999999998776679999999999999999999999999999999999999 66779999999999865
Q ss_pred CCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 293 RPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 293 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
...... ....+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+....... ....+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 340 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP---CPELC 340 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC---CCTTC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCC
Confidence 432211 1223577899999886 568999999999999999998 999999888877777666543221 22357
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++++.+||.+||+.||.+|||+.++++
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=374.21 Aligned_cols=255 Identities=31% Similarity=0.548 Sum_probs=212.4
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH---HHHHHHHHHHHHHHHcc-CCCCccEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA---IAVEDVRREVKILRALS-GHSNLVKFYD 205 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ev~~l~~l~-~hpniv~l~~ 205 (492)
+.+.++|++.+.||+|+||.||+|++.. +++.||||++........ ...+.+.+|+.+++.+. +|+||+++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 4467889999999999999999998765 789999999965433221 11134668999999996 3799999999
Q ss_pred EEEeCCeEEEEEeecCC-CchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 206 AFEDLDNVYIVMELCEG-GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 206 ~~~~~~~~~lv~E~~~g-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
++.+.+.+++||||+.+ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL~ 192 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLI 192 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEEC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEEe
Confidence 99999999999999986 8999988765 67999999999999999999999999999999999999942 45689999
Q ss_pred ecccccccCCCCCccccccCccccccccccC-C-CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-S-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (492)
|||++..... .......||+.|+|||++.+ . ++.++|||||||++|+|++|..||.... .+......+.
T Consensus 193 Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~-- 263 (320)
T 3a99_A 193 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR-- 263 (320)
T ss_dssp CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--
T ss_pred eCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc--
Confidence 9999987753 33445679999999998753 3 4678999999999999999999996432 2233332222
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..+++++.+||.+||..||.+|||+.++++||||++.
T Consensus 264 --~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 264 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp --SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 3689999999999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=366.35 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=217.0
Q ss_pred ccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|.+.+.||+|+||.||+|.+... ..+++.||||++.... .....+.+.+|+.+|+.|. ||||+++++++.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQD 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEEecC
Confidence 57899999999999999999987432 2356899999997543 3455677999999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 011154 211 DNVYIVMELCEGGELLDRILSRC-----------------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKP 267 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp 267 (492)
+.+++|||||++|+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 99999999999999999987643 2389999999999999999999999999999999
Q ss_pred CceEeecCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCC
Q 011154 268 ENFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWA 342 (492)
Q Consensus 268 ~NILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~ 342 (492)
+|||+ +.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+
T Consensus 179 ~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 179 RNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp GGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred heEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999 5667899999999987654432 23446788999999875 458999999999999999999 9999998
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 343 RTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 343 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.....+...+...... .....+++++.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8888887777665422 2234789999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=364.84 Aligned_cols=255 Identities=18% Similarity=0.225 Sum_probs=208.3
Q ss_pred cccccceeecceeccccceEEEEEEEecCCc----cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEH----KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYD 205 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~ 205 (492)
+...++|.+.+.||+|+||.||+|+++.... .+..||+|++.... ....+.+.+|+.+++.++ ||||+++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~ 79 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYG 79 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEE
Confidence 3446899999999999999999999875221 13679999996432 234567899999999995 999999999
Q ss_pred EEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCC-----Cc
Q 011154 206 AFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES-----SQ 280 (492)
Q Consensus 206 ~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~-----~~ 280 (492)
++.+.+..++|||||+||+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.++.. ..
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999998765569999999999999999999999999999999999999643321 12
Q ss_pred EEEEecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC
Q 011154 281 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 358 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~ 358 (492)
+||+|||++...... ....||+.|+|||++.+ .++.++|||||||++|+|++|..|++..........+......
T Consensus 160 ~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 160 IKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp EEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred eeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 999999998765432 34568999999998864 5899999999999999999966655555444444444444333
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 359 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++ ...+.++.+||.+||+.||.+|||+.++++|
T Consensus 237 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 LP----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33 2467889999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=364.46 Aligned_cols=257 Identities=21% Similarity=0.278 Sum_probs=211.7
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|+... +|+.||||++...... +.+.+|+.+++.+.+|+||+++++++.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 3456889999999999999999998654 7899999999754432 3477899999999779999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC--CCCcEEEEecc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD--ESSQLKAIDFG 287 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~--~~~~~kl~DfG 287 (492)
....++||||+ +++|.+++......+++.++..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99999999999 9999999987666799999999999999999999999999999999999995432 23349999999
Q ss_pred cccccCCCCC--------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC---hhHHHHHHHhc
Q 011154 288 LSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKA 355 (492)
Q Consensus 288 la~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~---~~~~~~~i~~~ 355 (492)
++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ....+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9987654322 345679999999998864 58999999999999999999999997743 33344443332
Q ss_pred CCCC-CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 356 DPSF-DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 356 ~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.... .......+++++.+||.+||..||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2111 111223688999999999999999999999998763
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=364.89 Aligned_cols=267 Identities=19% Similarity=0.283 Sum_probs=211.7
Q ss_pred hhhhhcCCccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCc
Q 011154 121 ELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200 (492)
Q Consensus 121 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpni 200 (492)
++...+.......++|.+++.||+|+||.||+|.+..+..+++.||||++..... .....+.+.+|+.+++.++ ||||
T Consensus 21 el~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i 98 (313)
T 3brb_A 21 ELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNV 98 (313)
T ss_dssp ---CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTB
T ss_pred hhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCe
Confidence 3333344444556899999999999999999999887666788999999975543 3445677899999999995 9999
Q ss_pred cEEEEEEEeCC-----eEEEEEeecCCCchHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCce
Q 011154 201 VKFYDAFEDLD-----NVYIVMELCEGGELLDRILSR-----CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENF 270 (492)
Q Consensus 201 v~l~~~~~~~~-----~~~lv~E~~~ggsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NI 270 (492)
+++++++.+.+ ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 99 v~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NI 178 (313)
T 3brb_A 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178 (313)
T ss_dssp CCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGE
T ss_pred eeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 99999998755 359999999999999988532 35699999999999999999999999999999999999
Q ss_pred EeecCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCCh
Q 011154 271 LYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTE 345 (492)
Q Consensus 271 Ll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~ 345 (492)
|+ +.++.+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.....
T Consensus 179 li---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 179 ML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp EE---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 99 6677899999999987654322 23346788999999876 458999999999999999999 9999998888
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 346 SGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 346 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.+....+....... ....++.++.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 256 HEMYDYLLHGHRLK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp GGHHHHHHTTCCCC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88887777654322 224688999999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=357.42 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=201.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC-HHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT-AIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|++.+.||+|+||.||+|.+ .++.||||++....... ....+.+.+|+++++.++ ||||+++++++.+.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEP 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC-
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 47899999999999999999985 36789999997643322 233567899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccCCCCCceEeecCC-----CCCcEEE
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG---VVHRDLKPENFLYTSKD-----ESSQLKA 283 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~---ivHrDlkp~NILl~~~~-----~~~~~kl 283 (492)
..++|||||+||+|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++... .++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999988774 357999999999999999999999999 89999999999996422 2668999
Q ss_pred EecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG 362 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (492)
+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+........
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 234 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-- 234 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--
Confidence 9999998765433 23567999999999876 4589999999999999999999999998888777766665544332
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 363 SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 363 ~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
....+++++.+||.+||..||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 224689999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=366.06 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=212.7
Q ss_pred cccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..++|++.+.||+|+||.||+|++.. ...+++.||||++.... .....+.+.+|+.+++.+.+||||+++++++.+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 35789999999999999999998754 33478999999997543 344556789999999999669999999999987
Q ss_pred CC-eEEEEEeecCCCchHHHHHhhCCC---------------CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 210 LD-NVYIVMELCEGGELLDRILSRCGK---------------YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 210 ~~-~~~lv~E~~~ggsL~~~l~~~~~~---------------~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
.+ .+++|||||++|+|.+++...... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~- 181 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL- 181 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE-
Confidence 55 499999999999999998765332 8999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+......
T Consensus 182 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 182 --SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp --CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred --CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 5667899999999987654332 23456889999999875 568999999999999999998 9999987665444
Q ss_pred H-HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 349 F-RAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 349 ~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+ ..+.... ... ....+++++.+||.+||..||.+|||+.++++|
T Consensus 260 ~~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGT-RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCc-cCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 3343332 221 123578999999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=364.15 Aligned_cols=259 Identities=27% Similarity=0.461 Sum_probs=210.0
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccC-CCCccEEEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG-HSNLVKFYDAFE 208 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~-hpniv~l~~~~~ 208 (492)
....++|++.+.||+|+||.||++... +++.||||++..... .....+.+.+|+.+++++.+ ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC----CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 344578999999999999999999763 478899999976543 34556789999999999963 699999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
+.+.+|+||| +.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||+
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~ 172 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGI 172 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSS
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccc
Confidence 9999999999 5678999988764 6799999999999999999999999999999999999994 26899999999
Q ss_pred ccccCCCCC---ccccccCccccccccccC------------CCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHHH
Q 011154 289 SDFVRPDER---LNDIVGSAYYVAPEVLHR------------SYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAV 352 (492)
Q Consensus 289 a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~i 352 (492)
+........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 987654332 234579999999998754 578899999999999999999999976543 2333444
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 353 LKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 353 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
....... ......+.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 253 ~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 253 IDPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HCTTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred Hhccccc--CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 4332222 1223568899999999999999999999999999999865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=369.81 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=207.7
Q ss_pred ccceeecceeccccceEEEEEEEecCC-ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE-HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|++.+.||+|+||.||+|++..+. .-...||+|.+.... .....+.+.+|+.+++++. ||||++++++|.+.+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 478999999999999999999976421 123356888885432 2234567899999999995 999999999998754
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.++|+||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeE
Confidence 789999999999999998877789999999999999999999999999999999999999 5567899999999987
Q ss_pred cCCCCCc---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 292 VRPDERL---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 292 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
....... ....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+....++...+....... ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCcc
Confidence 6544322 2345788999999875 568999999999999999999 999999888877777666544222 2246
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++.++.+||.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 88999999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=363.61 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=208.4
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|++......+..||||++...........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence 578999999999999999999876544445679999997665444556778999999999995 999999999998765
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++||||+++|+|.+++....+.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccccccc
Confidence 889999999999999998776789999999999999999999999999999999999999 45568999999999877
Q ss_pred CCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 293 RPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 293 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
..... .....+|..|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+......+.. ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence 54432 22356788999999876 458889999999999999999 99999998888888888765544332 346
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++.+||.+||..||.+|||+.++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8999999999999999999999999997
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=363.32 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=203.7
Q ss_pred cccceeecceeccccceEEEEEEEec-CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe-
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED- 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~- 209 (492)
..++|++.+.||+|+||.||+|++.. +..+++.||||++... .....+.+.+|+.+|+.++ ||||+++++++..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 83 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 45789999999999999999998642 2347899999999654 3455677999999999995 9999999999865
Q ss_pred -CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 210 -LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 210 -~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
...+++|||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCcc
Confidence 356899999999999999998766679999999999999999999999999999999999999 5567899999999
Q ss_pred ccccCCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChh----------------H
Q 011154 289 SDFVRPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES----------------G 347 (492)
Q Consensus 289 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~----------------~ 347 (492)
+........ .....||..|+|||++. ..++.++|||||||++|+|+||..||...... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987654332 22345788899999876 56899999999999999999999998543211 1
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 348 IFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
....+... ... .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNN-GRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTT-CCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhcc-CcC--CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 12222222 111 223468999999999999999999999999886
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=384.64 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=200.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
..+|++.+.||+|+||.|+.... .+|+.||||++...... .+.+|+++|+.+.+|||||++++++.+.+.
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~----~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM----FDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE----SSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred cEEEecCCeeecCcCEEEEEEEE----eCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 45799999999999998654322 26789999999654322 246899999999669999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC--CCCcEEEEeccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD--ESSQLKAIDFGLSD 290 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~--~~~~~kl~DfGla~ 290 (492)
.|||||||. |+|.+++......+.+.++..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+++
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 999999996 599999987766677778889999999999999999999999999999996432 33468899999998
Q ss_pred ccCCCC----CccccccCcccccccccc----CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCC-
Q 011154 291 FVRPDE----RLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFD- 360 (492)
Q Consensus 291 ~~~~~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~- 360 (492)
...... .....+||+.|+|||++. ..++.++|||||||++|+|+| |..||.......... + .......
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~-~~~~~~~~ 249 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-L-LGACSLDC 249 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-H-TTCCCCTT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-H-hccCCccc
Confidence 775432 234568999999999885 347779999999999999999 999996554433322 2 2221111
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.......+..+++||.+||+.||.+|||+.++++||||...
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 11112345668999999999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=360.51 Aligned_cols=254 Identities=26% Similarity=0.485 Sum_probs=202.1
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|.... +|+.||||++...........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDN 105 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred cccceEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence 34689999999999999999998764 68899999998765556667778999999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 212 NVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccc
Confidence 99999999999999998864 24569999999999999999999999999999999999999 6677999999999
Q ss_pred ccccCCCC-CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh--hHHHHHHHhcCCCCCCCCC
Q 011154 289 SDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 289 a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 364 (492)
+....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ......+.... +.....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 260 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPS 260 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCT
T ss_pred eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCcc
Confidence 98765432 234467999999999876 4588999999999999999999999976532 34444444432 222233
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
..++.++.+||.+||..||.+|||+.++++
T Consensus 261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 568999999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=368.66 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=211.9
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccE--EEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQK--VAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDA 206 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~--vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~ 206 (492)
+..-.++|++.+.||+|+||.||+|+++. ++.. ||||++.... .....+.+.+|+.+|+++.+||||++++++
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred ccccHHHccceeeeecCCCceEEEEEEcc---CCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 33345789999999999999999999875 4554 5999986432 223445688999999999569999999999
Q ss_pred EEeCCeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceE
Q 011154 207 FEDLDNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFL 271 (492)
Q Consensus 207 ~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NIL 271 (492)
+.+.+.+|+|||||++|+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 174 (327)
T 1fvr_A 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 174 (327)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEE
Confidence 999999999999999999999987542 46999999999999999999999999999999999999
Q ss_pred eecCCCCCcEEEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHH
Q 011154 272 YTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIF 349 (492)
Q Consensus 272 l~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~ 349 (492)
+ +.++.+||+|||++.............+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+..
T Consensus 175 ~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 175 V---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp E---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred E---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 9 5667899999999975543333344567889999998864 58899999999999999998 99999998888877
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 350 RAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 350 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..+...... .....++.++.+||.+||..||.+|||+.+++++
T Consensus 252 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGGGTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 776654221 2224688999999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=368.46 Aligned_cols=256 Identities=29% Similarity=0.541 Sum_probs=203.1
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHH---HHHHHHHHHHHHHHcc---CCCCccEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAI---AVEDVRREVKILRALS---GHSNLVKF 203 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~---~~~~~~~Ev~~l~~l~---~hpniv~l 203 (492)
+.+.++|++.+.||+|+||.||+|++.. +++.||||++......... ....+.+|+.+++++. +||||+++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 4556889999999999999999998654 7889999999765433221 2233667999999983 49999999
Q ss_pred EEEEEeCCeEEEEEee-cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEE
Q 011154 204 YDAFEDLDNVYIVMEL-CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 204 ~~~~~~~~~~~lv~E~-~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~k 282 (492)
++++.+.+..++|||| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. .++.+|
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~k 180 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAK 180 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEE
Confidence 9999999999999999 7899999988765 57999999999999999999999999999999999999941 567899
Q ss_pred EEecccccccCCCCCccccccCccccccccccC-CC-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC
Q 011154 283 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SY-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 360 (492)
Q Consensus 283 l~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 360 (492)
|+|||++...... ......||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.... .+......+.
T Consensus 181 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~ 253 (312)
T 2iwi_A 181 LIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP 253 (312)
T ss_dssp ECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC
T ss_pred EEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc
Confidence 9999999877543 3456679999999998753 34 458999999999999999999996432 2333333332
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..++.++.+||.+||+.||++|||+.|+++||||+...
T Consensus 254 ----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 254 ----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 36899999999999999999999999999999999753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=366.54 Aligned_cols=255 Identities=21% Similarity=0.358 Sum_probs=216.4
Q ss_pred ccceeecceeccccceEEEEEEEecC----CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG----EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.++|++++.||+|+||.||+|++... ..++..||||++.... .....+.+.+|+.+++.+.+||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 57899999999999999999987531 2357889999997543 34456779999999999956999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
+.+.+|+|||||++|+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll- 190 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 190 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE-
Confidence 9999999999999999999987643 248999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....++
T Consensus 191 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 191 --TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp --CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred --cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 6677899999999987654432 23346788999999875 458999999999999999999 9999998888888
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
...+....... ....++.++.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 269 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77776654322 224689999999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=376.24 Aligned_cols=260 Identities=25% Similarity=0.431 Sum_probs=207.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc----------CCCCccE
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS----------GHSNLVK 202 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~----------~hpniv~ 202 (492)
.++|++.+.||+|+||.||+|++.. +++.||||++... ....+.+.+|+++++.+. +||||++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 4689999999999999999998764 7899999999643 234566889999999885 2789999
Q ss_pred EEEEEEeCC----eEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEeecC-
Q 011154 203 FYDAFEDLD----NVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSK- 275 (492)
Q Consensus 203 l~~~~~~~~----~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~-~ivHrDlkp~NILl~~~- 275 (492)
+++++...+ .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||+...
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998754 799999999 88999988764 34599999999999999999999998 99999999999999643
Q ss_pred --CCCCcEEEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC------hh
Q 011154 276 --DESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART------ES 346 (492)
Q Consensus 276 --~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~------~~ 346 (492)
+....+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ..
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 2345799999999987643 3445689999999998864 58999999999999999999999997654 22
Q ss_pred HHHHHHHhcCCCCCC--------------------------------------CCCCCCCHHHHHHHHHccccCcCCCCC
Q 011154 347 GIFRAVLKADPSFDD--------------------------------------GSWPSLSSDAKDFVKLLLNKDPRKRMT 388 (492)
Q Consensus 347 ~~~~~i~~~~~~~~~--------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps 388 (492)
..+..+.......+. .....++.++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 222222221111000 001134568899999999999999999
Q ss_pred HHHHhcCccccccc
Q 011154 389 AAQALSHPWIRNYN 402 (492)
Q Consensus 389 ~~e~l~hp~~~~~~ 402 (492)
+.|+|+||||++..
T Consensus 328 ~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 328 AGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhhChhhhccc
Confidence 99999999999754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=364.46 Aligned_cols=256 Identities=19% Similarity=0.310 Sum_probs=217.8
Q ss_pred ccccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
...++|++.+.||+|+||.||+|+++. ...+++.||||++.... .......+.+|+.+++.+. ||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 98 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS 98 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEEC
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEc
Confidence 456889999999999999999998763 22357899999996543 3344567899999999995 999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCC
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRC---------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS 279 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~ 279 (492)
+.+..++|||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCC
Confidence 9999999999999999999887532 457999999999999999999999999999999999999 6677
Q ss_pred cEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHh
Q 011154 280 QLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLK 354 (492)
Q Consensus 280 ~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~ 354 (492)
.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 999999999986643322 23346789999999876 568999999999999999999 8999998888888877766
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 355 ADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 355 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..... ....++.++.+||.+||..||.+|||+.|+++|
T Consensus 256 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 256 GGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 54322 224689999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=358.19 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=214.9
Q ss_pred ccceeecc-eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGE-EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|.+.+ .||+|+||.||+|.+... .++..||||++.... .....+.+.+|+++++.+. ||||+++++++ ..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAE 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESS
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-CCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCC
Confidence 46777776 999999999999986532 357889999997542 3455677999999999995 99999999999 456
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceee
Confidence 7999999999999999887666779999999999999999999999999999999999999 4566899999999987
Q ss_pred cCCCCCc----cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 292 VRPDERL----NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 292 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
....... ....||+.|+|||++. ..++.++|||||||++|+|++ |..||......+....+...... ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~ 236 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP 236 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCC
Confidence 7544322 2345789999999886 568999999999999999998 99999988888888777765422 1224
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCcc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 397 (492)
.+++++.+||.+||..||.+|||+.+++++.+
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 78999999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=353.85 Aligned_cols=248 Identities=26% Similarity=0.435 Sum_probs=214.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+++++.+. ||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred hhheeeeeEecCCCceeEEEEEec----CCCeEEEEEccccCCC----HHHHHHHHHHHHhCC-CCCEeeEEEEEccCCC
Confidence 468999999999999999999875 4578999999765432 256889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFV 154 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGB
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccc
Confidence 999999999999999998776779999999999999999999999999999999999999 56678999999999876
Q ss_pred CCCC--CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 293 RPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 293 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
.... ......||..|+|||++. ..++.++||||||+++|+|++ |..||......+....+........ ...++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~ 231 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAS 231 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCc
Confidence 4322 123346788999999886 568899999999999999999 8999998888888888776543322 23578
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.++.+||.+||..||.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 232 THVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=358.65 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=199.6
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
+...++|++.+.||+|+||.||+|++. ..||||++..... .....+.+.+|+.+|+.+. ||||+++++++ .
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~------~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~ 90 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-T 90 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS------SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-C
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc------CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-c
Confidence 455688999999999999999999743 3499999965543 4455677999999999995 99999999955 5
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+..++|||||++++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLA 167 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC--
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceec
Confidence 667899999999999999987666789999999999999999999999999999999999999 55678999999999
Q ss_pred cccCCC---CCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHH-HHHhcCCCCC-
Q 011154 290 DFVRPD---ERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFR-AVLKADPSFD- 360 (492)
Q Consensus 290 ~~~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~-~i~~~~~~~~- 360 (492)
...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||......+... .+........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 765432 2334567999999999874 357889999999999999999999998766554444 4433332222
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
......+++++.+||.+||..||.+|||+.++++
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2234578899999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=370.52 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=208.7
Q ss_pred ccceeecceeccccceEEEEEEEecCCc-cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEH-KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|++.+.||+|+||.||+|++..+.. ....||+|++...... .....+.+|+.+++.+. ||||+++++++. ++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CC
Confidence 4689999999999999999999765221 1234888887543321 12234678999999995 999999999986 46
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++|||||.+|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 7899999999999999998766689999999999999999999999999999999999999 6677899999999988
Q ss_pred cCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 292 VRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 292 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
+..... .....||..|+|||++. +.++.++|||||||++|+|+| |..||.+....++...+......... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---Cc
Confidence 754432 24457888999999886 569999999999999999999 99999988888887777665432222 24
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++.++.+||.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77889999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=364.42 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=210.9
Q ss_pred cccceeecceeccccceEEEEEEEecCC-ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGE-HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
..++|.+.+.||+|+||.||+|.++... ..+..||||++.... .......+.+|+.+++.+. ||||+++++++.+.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence 3578999999999999999999876432 235679999996543 3345567899999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..++|||||++|+|.+++....+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence 99999999999999999998776789999999999999999999999999999999999999 667799999999998
Q ss_pred ccCCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 291 FVRPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 291 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||......++...+...... ...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~~~ 272 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTP 272 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---CCc
Confidence 7654322 12335688999999886 468999999999999999999 99999998888888777665322 122
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..++.++.+||.+||..||.+||++.+++++
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4688999999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=377.96 Aligned_cols=261 Identities=16% Similarity=0.227 Sum_probs=199.0
Q ss_pred ccccceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHH--------HHHHHHHHHHHHccCCCCc
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAV--------EDVRREVKILRALSGHSNL 200 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~--------~~~~~Ev~~l~~l~~hpni 200 (492)
...++|++.+.||+|+||.||+|.++.+. ..++.||||++........... ..+..|+..++.+ +||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCC
Confidence 34569999999999999999999886532 2368899999876531100000 1123344555566 39999
Q ss_pred cEEEEEEEeC----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC
Q 011154 201 VKFYDAFEDL----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 201 v~l~~~~~~~----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~ 276 (492)
+++++++.+. ...||||||| ||+|.+++....+.+++.+++.|+.||+.||.|||++||+||||||+|||++. +
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~ 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence 9999999775 4589999999 99999998877678999999999999999999999999999999999999953 1
Q ss_pred CCCcEEEEecccccccCCCCC--------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhH
Q 011154 277 ESSQLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESG 347 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~ 347 (492)
.++.+||+|||+++.+..... ....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 567899999999987643321 134569999999998875 48999999999999999999999998643322
Q ss_pred HHHHHHhcC--CC---CCCC--CCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 348 IFRAVLKAD--PS---FDDG--SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 348 ~~~~i~~~~--~~---~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
......... .. +... ....++.++.+||..||..||.+||++.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 221111100 00 0000 01367899999999999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=381.48 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=201.0
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
...+.+.|.+.+.||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.+|+.+.+|||||++++++.
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~~----~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 79 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQGS----FQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSET 79 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEEE----SSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEEE----ECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 345667788889999999999976532 26899999998543 23457889999998756999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCC------CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC-------
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGK------YSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK------- 275 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~------~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~------- 275 (492)
+.+.+|+|||||. |+|.+++...... .++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 9999999999996 5999988654211 1334567899999999999999999999999999999643
Q ss_pred ---CCCCcEEEEecccccccCCCCC-----ccccccCcccccccccc--------CCCCCccchHHHHHHHHHHhc-CCC
Q 011154 276 ---DESSQLKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLH--------RSYGTEADVWSIGVIAYILLC-GSR 338 (492)
Q Consensus 276 ---~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~~DvwSlGvil~~llt-g~~ 338 (492)
+....+||+|||+++.+..... ....+||+.|+|||++. ..++.++|||||||++|+|+| |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 2456899999999988764432 23468999999999885 358889999999999999999 999
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 339 PFWARTESGIFRAVLKADPSFDDGS---WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 339 pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
||....... ..+........... ...++.++.+||.+||+.||.+|||+.++++||||...
T Consensus 239 Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 239 PFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp TTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred CCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 997655433 34444443332211 12346789999999999999999999999999999753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=361.96 Aligned_cols=242 Identities=33% Similarity=0.594 Sum_probs=195.2
Q ss_pred ccccceeec-ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 131 EVTSRLEVG-EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 131 ~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
.+.++|.+. +.||+|+||.||+|..+. +++.||||++... ..+.+|+.++.++.+||||++++++|.+
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcC---CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 345678877 789999999999998765 7899999999642 3567899998666579999999999987
Q ss_pred ----CCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 ----LDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 ----~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.+.+++|||||+||+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 678999999999999999987653 369999999999999999999999999999999999999654447889999
Q ss_pred ecccccccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHH----hcCCCCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFD 360 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~----~~~~~~~ 360 (492)
|||++..... ..|+.++|||||||++|+|++|..||...........+. .....++
T Consensus 163 Dfg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 222 (299)
T 3m2w_A 163 DFGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222 (299)
T ss_dssp CCTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred cccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence 9999865431 346778999999999999999999997665443321111 1111122
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
...+..+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 2222468999999999999999999999999999999987653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=355.01 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=215.7
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|.++. ++..||||++.... ...+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 81 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 456889999999999999999999875 68899999996543 23567889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
+.+++|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccc
Confidence 99999999999999999987643 459999999999999999999999999999999999999 56678999999999
Q ss_pred cccCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 290 DFVRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 290 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||...........+...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 235 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE 235 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCC
Confidence 87754432 23356788999999876 568999999999999999999 99999888887777776654322 2234
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+++++.+||.+||..||.+|||+.++++
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 78999999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=358.88 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=210.4
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE-eCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE-DLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~-~~~ 211 (492)
..+|++.+.||+|+||.||+|.+..+...+..||||.+.... .....+.+.+|+.+++++. ||||+++++++. .++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence 457999999999999999999987654456679999986533 4455677999999999995 999999999864 566
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccccc
Confidence 8899999999999999998766779999999999999999999999999999999999999 6677999999999987
Q ss_pred cCCCCC-----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 292 VRPDER-----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 292 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
...... .....||+.|+|||++. ..++.++|||||||++|+|++ |.+||......+....+.........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence 653321 23456788999999876 568999999999999999999 66777777777777777665544332
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
..++.++.+||.+||..||.+|||+.++++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 357899999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=356.77 Aligned_cols=254 Identities=20% Similarity=0.253 Sum_probs=206.5
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCC-ccEEEEEEEe
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN-LVKFYDAFED 209 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpn-iv~l~~~~~~ 209 (492)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++...... +.+.+|+.+++.+. |++ +..+..++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~-~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQ-GGVGIPTIRWCGAE 76 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCSSC-----CHHHHHHHHHHHHT-TSTTCCCEEEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCcch-----hHHHHHHHHHHHhh-cCCCCCccccccCC
Confidence 456899999999999999999998754 7899999998765433 25788999999997 555 5555555577
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+..++||||+ +++|.+++......+++.++..++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 88899999999 89999999766678999999999999999999999999999999999999964456678999999999
Q ss_pred cccCCCCC--------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCC---hhHHHHHHHhcCC
Q 011154 290 DFVRPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADP 357 (492)
Q Consensus 290 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~---~~~~~~~i~~~~~ 357 (492)
........ .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. ....+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 87654432 245689999999998865 58899999999999999999999997633 2233333333221
Q ss_pred CCC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 358 SFD-DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 358 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
... ......+++++.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 111 1112368899999999999999999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=355.90 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=211.4
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.-.|++++.||+|+||.||+|++..+..++..||||++... ......+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEG 96 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCC
Confidence 34678889999999999999998766556678999999653 34455678899999999995 9999999999987666
Q ss_pred E-EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 V-YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~-~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
. ++||||+.+|+|.+++......+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARD 173 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCccc
Confidence 5 99999999999999998766789999999999999999999999999999999999999 6677999999999986
Q ss_pred cCCCC-----CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCC-CCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 292 VRPDE-----RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 292 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..| |......+....+........ .
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~ 250 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---P 250 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---C
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---C
Confidence 54322 2234578899999998865 589999999999999999995555 555555566665555442222 2
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
..++.++.+||.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 368899999999999999999999999887
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=380.42 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=211.7
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|+++. +|+.||||++....... ..+.+.+|+++|+.++ ||||+++++++.+.
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLN-HKNIVKLFAIEEET 79 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCC-CTTBCCEEEEEECT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcC-CCCCCeEEEeeccC
Confidence 456789999999999999999999765 78999999996543222 2456789999999995 99999999999876
Q ss_pred C--eEEEEEeecCCCchHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeec-CCCCCcEEEEe
Q 011154 211 D--NVYIVMELCEGGELLDRILSRC--GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS-KDESSQLKAID 285 (492)
Q Consensus 211 ~--~~~lv~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~-~~~~~~~kl~D 285 (492)
+ ..++|||||+||+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+.. ++....+||+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence 5 7899999999999999886542 23999999999999999999999999999999999999843 24556799999
Q ss_pred cccccccCCCCCccccccCcccccccccc---------CCCCCccchHHHHHHHHHHhcCCCCCCC----CChhHHHHHH
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLH---------RSYGTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAV 352 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DvwSlGvil~~lltg~~pf~~----~~~~~~~~~i 352 (492)
||+++...........+||+.|+|||++. ..++.++|||||||++|+|++|+.||.. ....+.+..+
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 99999887666666788999999999875 3577899999999999999999999964 3334566666
Q ss_pred HhcCCCCC---------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 353 LKADPSFD---------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 353 ~~~~~~~~---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..+.+... ......++..+.+||.+||..||++|||+.|++++
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 66543211 00112244578899999999999999999998653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=359.13 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=205.3
Q ss_pred ccceeecceeccccceEEEEEEEec-CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL- 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~- 210 (492)
..+|++.+.||+|+||.||+|++.. +..+++.||||++..... ....+.+.+|+.+|+.++ ||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLY-HENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence 4679999999999999999998642 334789999999975432 223467889999999995 99999999999876
Q ss_pred -CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 -DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
+.+++|||||++|+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLT 173 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECccccc
Confidence 67999999999999999997777789999999999999999999999999999999999999 45668999999999
Q ss_pred cccCCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCC--------------Chh-HHH
Q 011154 290 DFVRPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWAR--------------TES-GIF 349 (492)
Q Consensus 290 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~--------------~~~-~~~ 349 (492)
........ .....||..|+|||++. ..++.++|||||||++|+|++|..|+... ... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87765432 23457888999999875 45888999999999999999999886321 111 122
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 350 RAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 350 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
..+... . .......+++++.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEG-K--RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTT-C--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhcc-C--CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 222222 2 22233578999999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=365.21 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=213.6
Q ss_pred cccceeecceeccccceEEEEEEEecCC--ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGE--HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..++|++.+.||+|+||.||+|.+.... ..+..||||++.... .....+.+.+|+.+|+.|.+||||+++++++.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3578999999999999999999876422 234689999996543 334567789999999999559999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhh-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC
Q 011154 210 LDNVYIVMELCEGGELLDRILSR-------------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~-------------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~ 276 (492)
.+.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---T 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---E
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---C
Confidence 99999999999999999998754 2458999999999999999999999999999999999999 5
Q ss_pred CCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHH
Q 011154 277 ESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 351 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~ 351 (492)
.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+......+..
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 567899999999987643332 23456788999999875 568999999999999999998 9999988776665555
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+......... ...++.++.+||.+||+.||.+|||+.++++
T Consensus 279 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 279 LVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5554433322 2357899999999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=357.29 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=211.9
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
...+..+|++.+.||+|+||.||+|++.. +++.||||++.... +.+.+|+++++.+. ||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~ 74 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWD 74 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEe
Confidence 34566889999999999999999998764 68899999997543 24678999999995 999999999986
Q ss_pred e----------------CCeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceE
Q 011154 209 D----------------LDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFL 271 (492)
Q Consensus 209 ~----------------~~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NIL 271 (492)
. ...+++|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 154 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence 5 45689999999999999998754 357999999999999999999999999999999999999
Q ss_pred eecCCCCCcEEEEecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 011154 272 YTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFR 350 (492)
Q Consensus 272 l~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~ 350 (492)
+ +.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....
T Consensus 155 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~ 229 (284)
T 2a19_B 155 L---VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT 229 (284)
T ss_dssp E---EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred E---cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence 9 4566899999999988776665666789999999998764 5899999999999999999999987432 23333
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 351 AVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 351 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
.+.... + ...++.++++||.+||..||.+|||+.|+++|.|...
T Consensus 230 ~~~~~~--~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 230 DLRDGI--I----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHTTC--C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred Hhhccc--c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 333322 1 2357899999999999999999999999999988654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=350.75 Aligned_cols=246 Identities=19% Similarity=0.254 Sum_probs=210.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL-- 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~-- 210 (492)
.++|++.+.||+|+||.||+|++. ++.||||++..... .....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPA 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-----TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-----CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCC
Confidence 478999999999999999999863 67899999976543 3445567999999999995 99999999999887
Q ss_pred CeEEEEEeecCCCchHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCcEEEEecc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQLKAIDFG 287 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~~kl~DfG 287 (492)
+.+++|||||++|+|.+++..... .+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~ 158 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMAD 158 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGG
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEecc
Confidence 789999999999999999876533 5899999999999999999999999 9999999999999 667789999998
Q ss_pred cccccCCCCCccccccCccccccccccCC-CC---CccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 288 LSDFVRPDERLNDIVGSAYYVAPEVLHRS-YG---TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 288 la~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~---~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
++.... .....||+.|+|||++.+. ++ .++|||||||++|+|++|..||...........+........ .
T Consensus 159 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 232 (271)
T 3kmu_A 159 VKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--I 232 (271)
T ss_dssp SCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--C
T ss_pred ceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--C
Confidence 876533 2345789999999988643 33 379999999999999999999998888877777766543332 2
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
...++.++.+||.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3478999999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=373.23 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=204.5
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE-eCCe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE-DLDN 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~-~~~~ 212 (492)
..|++.+.||+|+||.||+|.+......+..||||.+.... .....+.+.+|+.+|++++ ||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence 46889999999999999999987654456679999986532 3345678999999999995 999999999875 4568
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++|||||++|+|.+++......+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccc
Confidence 899999999999999998776779999999999999999999999999999999999999 66779999999999866
Q ss_pred CCCCC-----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 293 RPDER-----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 293 ~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
..... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||......+....+..+..... ..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PE 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CT
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 43321 23346788999999876 568999999999999999999 7788877777777776666543322 23
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.++.++.+||.+||..||.+|||+.+++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 688999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=382.84 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=214.4
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|+++. ++..||||++..... ..+.+.+|+.+|++|+ |||||+++++|.+.+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP 289 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 35679999999999999999999875 678999999975533 2467899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.+|||||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSR 366 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEE
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccce
Confidence 9999999999999999997643 469999999999999999999999999999999999999 666789999999998
Q ss_pred ccCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
....... .....++..|+|||++. +.++.++|||||||++|+|+| |..||.+....++...+...... .....
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 443 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEG 443 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTT
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCC
Confidence 7654332 22345678899999876 568999999999999999999 99999988888777776654321 22347
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++.+||.+||+.||.+|||+.++++
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 8999999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=376.13 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=208.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
-.++|++.+.||+|+||.||++.+. |+.||||+++... ..+.+.+|+.+|++|+ |||||++++++.+.+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEK 259 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-----TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTT
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCC
Confidence 3578999999999999999999763 5789999997543 2356889999999995 999999999987765
Q ss_pred -eEEEEEeecCCCchHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 212 -NVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 212 -~~~lv~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+|+|||||++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT 336 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCc
Confidence 79999999999999999987644 37999999999999999999999999999999999999 66779999999999
Q ss_pred cccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
+..... .....+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+... .....+
T Consensus 337 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~p~~~ 411 (450)
T 1k9a_A 337 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGC 411 (450)
T ss_dssp EECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC---CCCTTC
T ss_pred cccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence 865432 23346789999999886 569999999999999999998 99999988888888777665322 223468
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++++.+||.+||..||.+|||+.++++
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=353.45 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=209.3
Q ss_pred ccceeecc-eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGE-EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|.+.+ .||+|+||.||+|.+.. ...++.||||++...... ....+.+.+|+.+++.+. ||||+++++++ ..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQM-KKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLD-NPYIVRMIGIC-EAE 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEEC-SSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESS
T ss_pred chhhhhccCccccccCeeeEeeeecC-CCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCC
Confidence 46899988 99999999999997653 236789999999765332 334567999999999995 99999999999 567
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+++||||+++|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCccee
Confidence 889999999999999988654 679999999999999999999999999999999999999 4556899999999987
Q ss_pred cCCCCCc----cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 292 VRPDERL----NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 292 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
....... ....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....++...+...... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 243 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPA 243 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 7544332 2245678999999886 458889999999999999999 99999998888877777665422 1224
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.++.++.+||.+||+.||.+|||+.++++
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68999999999999999999999999886
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=356.53 Aligned_cols=255 Identities=20% Similarity=0.262 Sum_probs=200.9
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.+|+++++.+.+|++|..+..++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 456899999999999999999998654 7889999987654332 24778999999997444455555556788
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..++||||| +|+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 8999999999 899999987666789999999999999999999999999999999999999655566789999999998
Q ss_pred ccCCCCC--------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChh---HHHHHHHhcCCC
Q 011154 291 FVRPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPS 358 (492)
Q Consensus 291 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~---~~~~~i~~~~~~ 358 (492)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... ..+..+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 7654332 235689999999998864 5889999999999999999999999764322 233333222111
Q ss_pred CC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 359 FD-DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 359 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+ ......+++++.+||.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11 1112357899999999999999999999999886
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=369.40 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=206.8
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
....++|++.+.||+|+||.||+|+++ +|+.||||++..... ...+.+.+|+.+++.++ ||||+++++++.+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPESS---QGIEEFETEIETLSFCR-HPHLVSLIGFCDE 106 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCC-CTTBCCEEEECCC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC----CCCEEEEEEecccCh---HHHHHHHHHHHHHHhCC-CCCEeeEEEEEcC
Confidence 346789999999999999999999853 578999999865432 24567899999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEec
Q 011154 210 LDNVYIVMELCEGGELLDRILSRC---GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
.+..++|||||++|+|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeec
Confidence 999999999999999999875432 258999999999999999999999999999999999999 67789999999
Q ss_pred ccccccCCCC---CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHH-----HhcCC
Q 011154 287 GLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAV-----LKADP 357 (492)
Q Consensus 287 Gla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i-----~~~~~ 357 (492)
|++....... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.+....+....+ .....
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 9998654322 223456999999999875 56999999999999999999999999765432211110 01111
Q ss_pred CC--------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCc
Q 011154 358 SF--------DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396 (492)
Q Consensus 358 ~~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp 396 (492)
.+ .....+..+.++.+|+.+||+.||++|||+.|++++-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11 1111123456789999999999999999999999764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=362.27 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=204.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCc-cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEH-KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|++.+.||+|+||.||+|++..+.. -...||+|.+...... ...+.+.+|+.+++.+. ||||++++++|.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence 4789999999999999999999765211 1234688877544322 23467889999999995 999999999998754
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.++|+||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence 889999999999999998877789999999999999999999999999999999999999 5566899999999987
Q ss_pred cCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 292 VRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 292 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
...... .....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.+....++...+....... ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence 654332 23345788999999875 568999999999999999999 999999888888777776654322 2246
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++.+||.+||..||.+|||+.|+++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8899999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=365.04 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=197.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC-
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD- 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~- 211 (492)
.++|++.+.||+|+||.||+|++. ++.||||++.... .......+|+.+|++++ |||||++++++.+..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTS 92 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred hhhchhhheecccCceEEEEEEEC-----CCEEEEEEeecCc----hHHHHHHHHHHHHhcCC-CCCchhhcceeccCCC
Confidence 468999999999999999999753 6889999995432 23345667999999995 999999999998744
Q ss_pred ---eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCcccCCCCCceEeecCCCC
Q 011154 212 ---NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH----------GVVHRDLKPENFLYTSKDES 278 (492)
Q Consensus 212 ---~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~----------~ivHrDlkp~NILl~~~~~~ 278 (492)
.+++|||||++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||+ +.+
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~ 167 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNN 167 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTT
T ss_pred CCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCC
Confidence 47999999999999998865 4699999999999999999999999 99999999999999 667
Q ss_pred CcEEEEecccccccCCCCC---ccccccCccccccccccC------CCCCccchHHHHHHHHHHhcCCCCCCCCCh----
Q 011154 279 SQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHR------SYGTEADVWSIGVIAYILLCGSRPFWARTE---- 345 (492)
Q Consensus 279 ~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DvwSlGvil~~lltg~~pf~~~~~---- 345 (492)
+.+||+|||+++.+..... ....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.+...
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 7999999999987654332 334679999999998864 355688999999999999999999965422
Q ss_pred ------------hHHHHHHHhcCCCCCC-CCCC--CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 346 ------------SGIFRAVLKADPSFDD-GSWP--SLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 346 ------------~~~~~~i~~~~~~~~~-~~~~--~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
......+......... ..|. ..+.++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1222222222111111 1111 12345999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=377.61 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=212.1
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++.+.||+|+||.||+|.++ .+..||||++..... ..+.+.+|+.+|+.|+ |||||++++++. .
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVT-K 254 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET----TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCC-CTTBCCEEEEEC-S
T ss_pred echHHeEEEEEcccCCceEEEEEEEC----CccEEEEEEecCCCc----cHHHHHHHHHHHhhCC-CCCEeeEEEEEe-C
Confidence 34678999999999999999999875 357899999976542 2467899999999995 999999999986 5
Q ss_pred CeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
+.+|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCc
Confidence 67899999999999999997542 368999999999999999999999999999999999999 66779999999999
Q ss_pred cccCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 290 DFVRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 290 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
+....... .....+|..|+|||++. +.++.++|||||||++|||+| |..||.+....++...+..+... ....
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~ 408 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPE 408 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCT
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 87653221 22345678899999886 669999999999999999999 99999998888888887765322 1224
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+++++.+||.+||..||.+|||+.++++
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 68999999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=361.20 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=209.0
Q ss_pred ccceeecceeccccceEEEEEEEec-CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE--e
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE--D 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~--~ 209 (492)
.++|++.+.||+|+||.||+|++.. +..+++.||||++... .....+.+.+|+++++.+ +||||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Confidence 3789999999999999999998643 2347899999999654 344556789999999999 5999999999987 4
Q ss_pred CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 210 LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+.+++|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccc
Confidence 567999999999999999998766679999999999999999999999999999999999999 55678999999999
Q ss_pred cccCCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChh---------------HHH
Q 011154 290 DFVRPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES---------------GIF 349 (492)
Q Consensus 290 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~---------------~~~ 349 (492)
........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||...... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87754432 23456888999999876 45888999999999999999999998543321 122
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 350 RAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 350 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..+.... .......+++++.+||.+||..||.+|||+.+++++
T Consensus 255 ~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQ---RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhccc---CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222222 122235789999999999999999999999999764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=358.10 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=206.3
Q ss_pred cccccce-eecceeccccceEEEEEEEec-CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEE
Q 011154 130 KEVTSRL-EVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAF 207 (492)
Q Consensus 130 ~~~~~~y-~~~~~lG~G~fg~V~~~~~~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~ 207 (492)
..+.++| ++.+.||+|+||.||++.++. +..+++.||||++.... .....+.+.+|+++|+.+. ||||+++++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 102 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCC 102 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEE
Confidence 3455566 999999999999999997643 33478999999997553 3445677999999999995 99999999999
Q ss_pred Ee--CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 208 ED--LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 208 ~~--~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
.+ ...+++|||||++|+|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~D 177 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGD 177 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECC
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECC
Confidence 88 46799999999999999988543 59999999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCCC----ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChh--------------
Q 011154 286 FGLSDFVRPDER----LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTES-------------- 346 (492)
Q Consensus 286 fGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-------------- 346 (492)
||++........ .....||..|+|||++.+ .++.++|||||||++|+|++|..||......
T Consensus 178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 3lxp_A 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257 (318)
T ss_dssp GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred ccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence 999988765432 234568889999998864 5888999999999999999999998653221
Q ss_pred -HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 347 -GIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 347 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.....+... . .......++.++.+||.+||+.||.+|||+.++++
T Consensus 258 ~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 258 LRLTELLERG-E--RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcc-c--CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111222222 1 12223468999999999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=361.26 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=187.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE----
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE---- 208 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~---- 208 (492)
..+|++.+.||+|+||.||+|++.. +++.||||++... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred CceEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 4689999999999999999999765 7889999998544 34455678999999999977999999999994
Q ss_pred ----eCCeEEEEEeecCCCchHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCc
Q 011154 209 ----DLDNVYIVMELCEGGELLDRILS--RCGKYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 209 ----~~~~~~lv~E~~~ggsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~ 280 (492)
....+++|||||. |+|.+++.. ..+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~ 176 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGT 176 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSC
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCC
Confidence 3445899999996 699998865 3457999999999999999999999999 9999999999999 66778
Q ss_pred EEEEecccccccCCCCCc-------------cccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCC
Q 011154 281 LKAIDFGLSDFVRPDERL-------------NDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWAR 343 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~ 343 (492)
+||+|||++......... ....||+.|+|||++. ..++.++|||||||++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999876543221 1456999999999873 34788999999999999999999999765
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcc
Q 011154 344 TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPW 397 (492)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 397 (492)
....+... .... ......+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 257 ~~~~~~~~----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 257 AKLRIVNG----KYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hHHHhhcC----cccC--CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 54433222 1121 223457788999999999999999999999999754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=348.17 Aligned_cols=247 Identities=23% Similarity=0.409 Sum_probs=209.9
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|.+. ++..||||++...... .+.+.+|+++++.+. ||||+++++++.+ +
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-E 80 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCCccc----HHHHHHHHHHHHhCC-CcCcceEEEEEcC-C
Confidence 3578999999999999999999864 4578999999755432 356889999999995 9999999999864 5
Q ss_pred eEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
..++||||+++|+|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccc
Confidence 6899999999999999886432 269999999999999999999999999999999999999 667899999999998
Q ss_pred ccCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
....... .....+|..|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 234 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDN 234 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTT
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---Cccc
Confidence 7754332 23345788999999886 568899999999999999999 999999888888877776653222 2246
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++.++.+||.+||..||++|||+.++++
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999999886
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=368.41 Aligned_cols=260 Identities=18% Similarity=0.217 Sum_probs=198.8
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHH--------HHHHHHHHHHHHHHccCCCCccEE
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAI--------AVEDVRREVKILRALSGHSNLVKF 203 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~--------~~~~~~~Ev~~l~~l~~hpniv~l 203 (492)
..++|++.+.||+|+||.||+|++.....++..||||++......... ....+.+|+.+++.+. ||||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence 457899999999999999999998765557889999999765321111 1123567888899994 9999999
Q ss_pred EEEEEe----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCC
Q 011154 204 YDAFED----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS 279 (492)
Q Consensus 204 ~~~~~~----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~ 279 (492)
++++.+ ....|+||||| |++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++ ..
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CC
Confidence 999988 78899999999 99999987654 4899999999999999999999999999999999999995422 23
Q ss_pred cEEEEecccccccCCCCC--------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCCh--hHH
Q 011154 280 QLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTE--SGI 348 (492)
Q Consensus 280 ~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~--~~~ 348 (492)
.+||+|||+++.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 899999999987643221 245679999999998875 489999999999999999999999965322 222
Q ss_pred HHHHHhcCCCCCCC-----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 349 FRAVLKADPSFDDG-----SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 349 ~~~i~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..........++.. ....++.++.+||.+||..||.+|||+.++++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 21111111111110 012688999999999999999999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=359.76 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=202.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe---
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--- 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--- 209 (492)
.++|++.+.||+|+||.||+++... +|+.||||++... .....+.+.+|+.+++.+. ||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERG 100 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEET
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccC
Confidence 4789999999999999999998754 7899999998543 3455677899999999994 9999999999873
Q ss_pred -CCeEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 210 -LDNVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 210 -~~~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
....|+|||||.+|+|.+++.. ....+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~d 177 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMD 177 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEe
Confidence 3478999999999999998875 34679999999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCCC----------ccccccCccccccccccC----CCCCccchHHHHHHHHHHhcCCCCCCCCC--hhHHH
Q 011154 286 FGLSDFVRPDER----------LNDIVGSAYYVAPEVLHR----SYGTEADVWSIGVIAYILLCGSRPFWART--ESGIF 349 (492)
Q Consensus 286 fGla~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlGvil~~lltg~~pf~~~~--~~~~~ 349 (492)
||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .....
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 999876532111 123468999999998853 26889999999999999999999995321 11122
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCc
Q 011154 350 RAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396 (492)
Q Consensus 350 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp 396 (492)
..+.. ...+ ...+.++.++.+||.+||+.||.+|||+.+++++-
T Consensus 258 ~~~~~-~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 258 LAVQN-QLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHHC-C--C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhhc-cCCC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 22222 2222 22356899999999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=376.04 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=210.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|++.. +++.||||++....... .+.+|+++++.|.+|++|+.+..++.+.
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~~-----~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKHP-----QLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTCSSC-----CHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEeccccccH-----HHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 456899999999999999999998764 68999999987554332 4678999999998668888888888889
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..+|||||| +++|.+++......+++.+++.|+.||+.||.|||++|||||||||+||||...+..+.+||+|||+++
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999999999 899999987666789999999999999999999999999999999999999655567799999999998
Q ss_pred ccCCCCC--------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCCh---hHHHHHHHhcCCC
Q 011154 291 FVRPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPS 358 (492)
Q Consensus 291 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~---~~~~~~i~~~~~~ 358 (492)
.+..... ....+||+.|+|||++.+ .++.++||||||||+|+|++|+.||.+... ...+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 7654432 225689999999998764 589999999999999999999999976443 3333333222111
Q ss_pred -CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 359 -FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 359 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
........++.++.+||.+||..||.+||++.+|++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111111367899999999999999999999998875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=353.09 Aligned_cols=248 Identities=22% Similarity=0.352 Sum_probs=196.5
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHH--ccCCCCccEEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA--LSGHSNLVKFYDAF 207 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~--l~~hpniv~l~~~~ 207 (492)
+.+.++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. + +||||+++++++
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~ 71 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASD 71 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEee
Confidence 45678999999999999999999975 4788999998543 23455667777777 6 599999999987
Q ss_pred EeC----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCcccCCCCCceEeecC
Q 011154 208 EDL----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH--------LHGVVHRDLKPENFLYTSK 275 (492)
Q Consensus 208 ~~~----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH--------~~~ivHrDlkp~NILl~~~ 275 (492)
.+. ..+++|||||++|+|.+++.. ..+++..+..++.||+.||.||| +.||+||||||+|||+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill--- 146 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV--- 146 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---
Confidence 643 468999999999999998843 57999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEEecccccccCCCCC-----ccccccCccccccccccCC-------CCCccchHHHHHHHHHHhcC-------
Q 011154 276 DESSQLKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-------YGTEADVWSIGVIAYILLCG------- 336 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DvwSlGvil~~lltg------- 336 (492)
+.++.+||+|||++........ ....+||+.|+|||++.+. ++.++|||||||++|+|++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 6677999999999987654332 2334899999999988653 34689999999999999999
Q ss_pred ---CCCCCCCCh----hHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 337 ---SRPFWARTE----SGIFRAVLKADPSFDDGS----WPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 337 ---~~pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
..||..... ......+........... ...++.++.+||.+||+.||.+|||+.++++
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 889865322 223333332222111110 0124567999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=384.90 Aligned_cols=251 Identities=22% Similarity=0.344 Sum_probs=208.4
Q ss_pred ccceeecc-eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGE-EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.+++.+.+ .||+|+||.||+|.++.. .++..||||+++..... ...+.+.+|+++|+.|+ |||||+++++|.+ +
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-E 408 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECS-SCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-S
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecC-CCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-C
Confidence 34566666 899999999999988642 25678999999765322 24567899999999995 9999999999986 5
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+|||||.+|+|.+++......+++.++..++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKA 485 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTT
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCccc
Confidence 6999999999999999987766779999999999999999999999999999999999999 5567899999999987
Q ss_pred cCCCCCc----cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 292 VRPDERL----NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 292 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
+...... ....+|+.|+|||++. +.++.++|||||||++|||++ |..||.+....++...+..+.... ...
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~ 562 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPP 562 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC---CCT
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence 6543321 1234568999999886 579999999999999999998 999999988888888887654321 224
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.+++++.+||.+||..||.+||++.++++
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 68999999999999999999999999854
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=372.15 Aligned_cols=247 Identities=24% Similarity=0.378 Sum_probs=206.1
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|.++. +..||||++...... .+.+.+|+.+|++|+ ||||+++++++.+ +
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 251 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC----CceEEEEEeccCCCC----HHHHHHHHHHHHhCC-CCCEeeEEEEEcC-C
Confidence 45789999999999999999998753 467999999765432 356889999999995 9999999999876 7
Q ss_pred eEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
..|+|||||++|+|.+++... ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccce
Confidence 789999999999999998653 3569999999999999999999999999999999999999 566789999999998
Q ss_pred ccCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
....... .....+|..|+|||++. +.++.++|||||||++|+|++ |..||.+....++...+..+... .....
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~ 405 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPE 405 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCC
Confidence 7653322 22345778999999875 569999999999999999999 99999998888888877665322 12246
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+++++.+||.+||..||++|||+.++++
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8999999999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=361.45 Aligned_cols=260 Identities=19% Similarity=0.249 Sum_probs=204.9
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
....++|++.+.||+|+||.||+|+.. +|+.||||++....... ....+.+|+++++.+. ||||+++++++.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 98 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAV-HRNLLRLRGFCMT 98 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCch--HHHHHHHHHHHHHhcc-CCCccceEEEEec
Confidence 345689999999999999999999743 57899999997543221 1235889999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccCCCCCceEeecCCCCCcEEE
Q 011154 210 LDNVYIVMELCEGGELLDRILSRC---GKYSEDEAKAVLVQILNVVAFCHLH---GVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 210 ~~~~~lv~E~~~ggsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~ylH~~---~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
.+..++|||||++|+|.+++.... ..+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl 175 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVV 175 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEE
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEe
Confidence 999999999999999999987643 2499999999999999999999999 99999999999999 66779999
Q ss_pred EecccccccCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCC-----CChhHHHHHHHhc
Q 011154 284 IDFGLSDFVRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWA-----RTESGIFRAVLKA 355 (492)
Q Consensus 284 ~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~-----~~~~~~~~~i~~~ 355 (492)
+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|..||.. .........+...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999987653332 34456999999999875 5689999999999999999999999942 1111111111110
Q ss_pred CCC----------CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 356 DPS----------FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 356 ~~~----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
... .........+.++.+|+.+||+.||.+|||+.++++|-+-.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 000 00011112346799999999999999999999999986543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=355.30 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=203.8
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCC-CCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM-TTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
|..++.||+|+||.||+|.+ +++.||||++..... ......+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCE
T ss_pred cccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceE
Confidence 44568999999999999974 467899999975432 23334567899999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 215 IVMELCEGGELLDRILSR--CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARAS 183 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccc
Confidence 999999999999988743 3469999999999999999999999999999999999999 66779999999999876
Q ss_pred CCCCC---ccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhH----HHHHHHhcCCCC------
Q 011154 293 RPDER---LNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSF------ 359 (492)
Q Consensus 293 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~----~~~~i~~~~~~~------ 359 (492)
..... .....||+.|+|||++.+.++.++|||||||++|+|++|..||....... +...+......+
T Consensus 184 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 184 EKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp CSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred ccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence 54322 23457999999999998889999999999999999999999997654432 222222211111
Q ss_pred -CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 360 -DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 360 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
........+..+.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011112345678999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=347.83 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=200.4
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC-C
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL-D 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~-~ 211 (492)
.++|++.+.||+|+||.||++.+ +|+.||||++.... ..+.+.+|+.+++.++ ||||+++++++.+. +
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 88 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred hhhceEEeEEecCCCceEEEEEE-----cCCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCC
Confidence 47899999999999999999975 36889999996543 3456889999999995 99999999997554 5
Q ss_pred eEEEEEeecCCCchHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.+++||||+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 165 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccc
Confidence 79999999999999999876532 38999999999999999999999999999999999999 667799999999997
Q ss_pred ccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
..... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......+....+..... ......++
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 240 (278)
T 1byg_A 166 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCP 240 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCC
T ss_pred ccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCC
Confidence 65432 23346889999999875 568999999999999999998 9999998888777777655432 22234789
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+++.+||.+||..||.+|||+.++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999999886
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=362.99 Aligned_cols=249 Identities=16% Similarity=0.181 Sum_probs=200.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCc-----cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccE-----
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEH-----KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVK----- 202 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~----- 202 (492)
.++|++.+.||+|+||.||+|+++.+.. .++.||||++... +.+.+|+++++.+. ||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 4789999999999999999999865211 4789999999754 24778999999995 999887
Q ss_pred ----------EEEEEEe-CCeEEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCce
Q 011154 203 ----------FYDAFED-LDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENF 270 (492)
Q Consensus 203 ----------l~~~~~~-~~~~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NI 270 (492)
+++++.. .+.+|+||||| +|+|.+++... ...+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777776 78899999999 99999998764 36799999999999999999999999999999999999
Q ss_pred EeecCCCCC--cEEEEecccccccCCCCC--------ccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCC
Q 011154 271 LYTSKDESS--QLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRP 339 (492)
Q Consensus 271 Ll~~~~~~~--~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~p 339 (492)
|++ .++ .+||+|||+++.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus 191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 994 455 899999999987643221 234589999999998875 689999999999999999999999
Q ss_pred CCCCC--hhHHHHHHH---hcCCCCC--CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 340 FWART--ESGIFRAVL---KADPSFD--DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 340 f~~~~--~~~~~~~i~---~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
|.... ...+..... .....+. ...|..++.++.+||.+||..||.+|||+.++++
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 97754 233332222 2222221 1223467999999999999999999999999886
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=364.67 Aligned_cols=251 Identities=19% Similarity=0.251 Sum_probs=199.0
Q ss_pred cccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccC--CCCccEEEEEE
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG--HSNLVKFYDAF 207 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~--hpniv~l~~~~ 207 (492)
..++|.+.+.||+|+||.||+|.+.. ...+++.||||++.... ..++.+|+.+++.|.. |+||+++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 35789999999999999999996432 23478999999996542 3457788888888842 89999999999
Q ss_pred EeCCeEEEEEeecCCCchHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeec--------C
Q 011154 208 EDLDNVYIVMELCEGGELLDRILS----RCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS--------K 275 (492)
Q Consensus 208 ~~~~~~~lv~E~~~ggsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~--------~ 275 (492)
...+..|+|||||+||+|.+++.. ....+++.+++.|+.||+.||.|||++|||||||||+|||++. .
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999999875 2456999999999999999999999999999999999999954 1
Q ss_pred CCCCcEEEEecccccccC---CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 011154 276 DESSQLKAIDFGLSDFVR---PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 351 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~ 351 (492)
+..+.+||+|||+|+.+. ........+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 226899999999997543 3334556789999999998865 489999999999999999999999965433110
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCc
Q 011154 352 VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396 (492)
Q Consensus 352 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp 396 (492)
.....+.. . ..++.+.+++..||+.+|.+|++..+.+.+.
T Consensus 294 --~~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 294 --KPEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp --EECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred --eechhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 01111111 1 2467899999999999999997665555543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.17 Aligned_cols=242 Identities=31% Similarity=0.474 Sum_probs=193.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||++.+. ++.||||++... ...+.+.+|+++|+++. ||||+++++++.+ .
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-----AKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACLN--P 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-----TEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--T
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-----CeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--C
Confidence 468999999999999999999863 578999998543 23467889999999995 9999999998873 4
Q ss_pred EEEEEeecCCCchHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHH---cCCcccCCCCCceEeecCCCCC-cEEEEec
Q 011154 213 VYIVMELCEGGELLDRILSRCG--KYSEDEAKAVLVQILNVVAFCHL---HGVVHRDLKPENFLYTSKDESS-QLKAIDF 286 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~ylH~---~~ivHrDlkp~NILl~~~~~~~-~~kl~Df 286 (492)
.++|||||+||+|.+++..... .+++..+..++.||+.||.|||+ +||+||||||+|||++ .++ .+||+||
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Df 150 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDF 150 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCC
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccc
Confidence 7899999999999998875432 47899999999999999999999 8999999999999995 334 4899999
Q ss_pred ccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChh--HHHHHHHhcCCCCCCCC
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDDGS 363 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 363 (492)
|++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .+...+..... ...
T Consensus 151 g~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 225 (307)
T 2eva_A 151 GTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPL 225 (307)
T ss_dssp CC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCC
T ss_pred ccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCc
Confidence 999765432 334579999999998865 5899999999999999999999999754432 23333333221 223
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
...++..+.+||.+||+.||.+|||+.+++++
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 35789999999999999999999999999873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=382.66 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=205.5
Q ss_pred eee-cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 136 LEV-GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 136 y~~-~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
+.+ .+.||+|+||.||+|.+.. ...++.||||+++.... .....+.+.+|+++|+.|+ |||||++++++.+ +.++
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQM-KKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEC-SSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEE
T ss_pred ccccCCEeccCCCEEEEEEEEcC-CCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEE
Confidence 444 3479999999999997753 23678999999965432 2334577999999999995 9999999999975 5689
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCC
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP 294 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~ 294 (492)
+|||||++|+|.+++.. ...+++.+++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.+..
T Consensus 446 lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC
T ss_pred EEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCcccccc
Confidence 99999999999998865 4679999999999999999999999999999999999999 5566899999999987754
Q ss_pred CCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 295 DER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 295 ~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
... .....||+.|+|||++. ..|+.++|||||||++|||++ |..||.+....++...+..+.... ....++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~ 598 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCP 598 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCC
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence 432 22345788999999886 469999999999999999998 999999999888888887754322 223689
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.++.+||.+||..||++|||+.++++
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=377.06 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=210.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|.++. +..||||++...... .+.+.+|+++|+.|+ |||||++++++.+ +.
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----TEEEEEEEECTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC----CceEEEEEeCCCCCC----HHHHHHHHHHHHhCC-CCCEeeEEEEEee-cc
Confidence 5679999999999999999998753 467999999765432 356899999999995 9999999999876 67
Q ss_pred EEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+|||||||.+|+|.+++... ...+++.++..|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 412 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEccccccee
Confidence 89999999999999998653 3569999999999999999999999999999999999999 5667899999999987
Q ss_pred cCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
+..... .....++..|+|||++. +.++.++|||||||++|||++ |..||.+....+++..+..+... .....+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~ 489 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPEC 489 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTC
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence 653221 22345778999999875 569999999999999999999 99999998888888877665322 122468
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+.++.+||.+||..||++|||+.++++.
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=380.59 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=214.8
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
...++|++++.||+|+||.||+|.+......+..||||++.... .....+.+.+|+.+|+.+. ||||+++++++. +
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-E 462 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-S
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-c
Confidence 34578999999999999999999987655567889999986432 3445677999999999995 999999999985 5
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..|+|||||++|+|.+++..+...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCe
Confidence 67899999999999999998766679999999999999999999999999999999999999 456789999999998
Q ss_pred ccCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011154 291 FVRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366 (492)
Q Consensus 291 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (492)
....... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+....... ..+.
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~ 616 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPN 616 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTT
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence 7754332 22346788999999875 568999999999999999997 999999988888888887654322 2246
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 367 ~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+++++.+||.+||..||.+|||+.++++
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999999886
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=389.94 Aligned_cols=263 Identities=26% Similarity=0.406 Sum_probs=210.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe---
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--- 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--- 209 (492)
.++|++.+.||+|+||.||+|++.. +|+.||||++.... .....+.+.+|+.+|+.+. ||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQK 86 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCceeeeeccccc
Confidence 4789999999999999999998654 78899999986542 4455677999999999995 9999999999765
Q ss_pred ---CCeEEEEEeecCCCchHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 ---LDNVYIVMELCEGGELLDRILSRC--GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 ---~~~~~lv~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.+..|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++....+||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999887543 269999999999999999999999999999999999999765555679999
Q ss_pred ecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHH---------HH--
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFR---------AV-- 352 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~---------~i-- 352 (492)
|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||........+. .+
T Consensus 167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 999999887666667788999999999886 468999999999999999999999997653321110 00
Q ss_pred ---HhcCCCC------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 353 ---LKADPSF------DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 353 ---~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..+...+ +......++.++.+||.+||..||++|||+.++++||||+..
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 0011111 111223467889999999999999999999999999999753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=351.46 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=205.1
Q ss_pred ccceeecceeccccceEEEEEEEec-CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|++.+.||+|+||.||+|++.. +..+++.||||++... .....+.+.+|+++++.++ ||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecC
Confidence 4679999999999999999998643 2347899999999654 2345567999999999995 999999999987644
Q ss_pred --eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 212 --NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 212 --~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+++||||+++|+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcch
Confidence 7899999999999999998776679999999999999999999999999999999999999 45668999999999
Q ss_pred cccCCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCCh------------h----HH
Q 011154 290 DFVRPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTE------------S----GI 348 (492)
Q Consensus 290 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~------------~----~~ 348 (492)
........ .....+|..|+|||++. ..++.++|||||||++|+|+||..||..... . .+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87754432 22346788899999876 4588899999999999999999999853211 0 11
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
...+.. .... .....++.++.+||.+||..||.+|||+.++++
T Consensus 273 ~~~~~~-~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IELLKN-NGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHT-TCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhc-CCCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122222 1111 223468999999999999999999999999885
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=363.88 Aligned_cols=251 Identities=21% Similarity=0.249 Sum_probs=198.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-----CHHHHHHHHHHHHHHHHcc--------CCCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-----TAIAVEDVRREVKILRALS--------GHSN 199 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ev~~l~~l~--------~hpn 199 (492)
.++|++.+.||+|+||.||+|++ +|+.||||++...... .....+.+.+|+.+|+.|+ .|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 46899999999999999999986 4689999999765421 2223467889999999985 4888
Q ss_pred ccEEEEEEE------------------------------eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHH
Q 011154 200 LVKFYDAFE------------------------------DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL 249 (492)
Q Consensus 200 iv~l~~~~~------------------------------~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~ 249 (492)
||++++++. +.+.+|||||||++|++++.+.+ +.+++.+++.++.||+
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLT 171 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHH
Confidence 888888754 26789999999999988877744 5789999999999999
Q ss_pred HHHHHHH-HcCCcccCCCCCceEeecCC-----------------CCCcEEEEecccccccCCCCCccccccCccccccc
Q 011154 250 NVVAFCH-LHGVVHRDLKPENFLYTSKD-----------------ESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 311 (492)
Q Consensus 250 ~~l~ylH-~~~ivHrDlkp~NILl~~~~-----------------~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE 311 (492)
.||.||| ++|||||||||+|||++.++ ....+||+|||+|+..... ..+||+.|+|||
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE 247 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence 9999999 99999999999999996543 1238999999999877532 458999999999
Q ss_pred cccCCCCCccchHHHHHH-HHHHhcCCCCCCCCCh-hHHHHHHHhcC---CCCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 011154 312 VLHRSYGTEADVWSIGVI-AYILLCGSRPFWARTE-SGIFRAVLKAD---PSFDDGSWPSLSSDAKDFVKLLLNKDPRKR 386 (492)
Q Consensus 312 ~~~~~~~~~~DvwSlGvi-l~~lltg~~pf~~~~~-~~~~~~i~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 386 (492)
++.+..+.++||||+|++ .+++++|..||.+... ......+.... .......++.+++++++||.+||+.|
T Consensus 248 ~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 998777889999998776 7789999999843211 12223333211 11111123457889999999999977
Q ss_pred CCHHHHh-cCcccc
Q 011154 387 MTAAQAL-SHPWIR 399 (492)
Q Consensus 387 ps~~e~l-~hp~~~ 399 (492)
|+.|+| +||||+
T Consensus 324 -sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -SATDLLCQHSLFK 336 (336)
T ss_dssp -SHHHHHHHCGGGC
T ss_pred -CHHHHHhcCCCcC
Confidence 999999 999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=355.40 Aligned_cols=248 Identities=23% Similarity=0.403 Sum_probs=206.3
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|.+.. .||||++....... ...+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERDNE-DQLKAFKREVMAYRQTR-HENVVLFMGACMSPPH 103 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCc
Confidence 5789999999999999999998642 49999997543322 12345678999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+++|||||+|++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC--
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcccc
Confidence 9999999999999998876655799999999999999999999999999999999999993 458999999998765
Q ss_pred CC------CCCccccccCccccccccccC----------CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcC
Q 011154 293 RP------DERLNDIVGSAYYVAPEVLHR----------SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 356 (492)
Q Consensus 293 ~~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~ 356 (492)
.. ........||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 32 122334569999999998753 37889999999999999999999999888887777776654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 357 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.... ....++.++.+||.+||..||.+|||+.++++
T Consensus 260 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 260 KPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3222 22368899999999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=349.53 Aligned_cols=250 Identities=21% Similarity=0.330 Sum_probs=193.4
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc-CCCCccEEEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS-GHSNLVKFYDAFE 208 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~-~hpniv~l~~~~~ 208 (492)
..+.++|++.+.||+|+||.||+|++ +++.||||++.... .....+|.+++..+. +||||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-----RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-----CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 44568999999999999999999976 36899999985331 233445656555441 5999999999999
Q ss_pred eC----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCcccCCCCCceEeecCC
Q 011154 209 DL----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH--------GVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 209 ~~----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~--------~ivHrDlkp~NILl~~~~ 276 (492)
+. ..+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~ 176 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---K 176 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---C
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---C
Confidence 87 789999999999999999865 3799999999999999999999999 99999999999999 6
Q ss_pred CCCcEEEEecccccccCCCCCc-----cccccCccccccccccCC-CCCc------cchHHHHHHHHHHhcC--------
Q 011154 277 ESSQLKAIDFGLSDFVRPDERL-----NDIVGSAYYVAPEVLHRS-YGTE------ADVWSIGVIAYILLCG-------- 336 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~------~DvwSlGvil~~lltg-------- 336 (492)
.++.+||+|||++..+...... ...+||+.|+|||++.+. +... +|||||||++|+|+||
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 6779999999999776443322 245899999999988654 4443 8999999999999999
Q ss_pred --CCCCCCCCh----hHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 337 --SRPFWARTE----SGIFRAVLKADPSFDDGS----WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 337 --~~pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..||..... .................. ...+++++.+||.+||+.||.+|||+.++++|
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 777754321 222222222111111100 01355679999999999999999999999885
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=368.72 Aligned_cols=250 Identities=17% Similarity=0.202 Sum_probs=194.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-CCc-----------
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-SNL----------- 200 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-pni----------- 200 (492)
...|.+++.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.+++.|. | +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIF 152 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCC
T ss_pred ceeEEEecccccCCCEEEEEEEecC---CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhccccc
Confidence 3458889999999999999999765 78899999997555444445677999999999995 5 322
Q ss_pred ----------cEEEEEEEe-----CCeEEEEEeecCCCchHHHHHh------hCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 011154 201 ----------VKFYDAFED-----LDNVYIVMELCEGGELLDRILS------RCGKYSEDEAKAVLVQILNVVAFCHLHG 259 (492)
Q Consensus 201 ----------v~l~~~~~~-----~~~~~lv~E~~~ggsL~~~l~~------~~~~~~~~~~~~i~~qi~~~l~ylH~~~ 259 (492)
..+..++.. ...++++|+++ +++|.+++.. ....+++..+..++.||+.||.|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 111122222 23578888877 5799888742 1345788899999999999999999999
Q ss_pred CcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccccccCccccccccc----------cC-CCCCccchHHHHH
Q 011154 260 VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----------HR-SYGTEADVWSIGV 328 (492)
Q Consensus 260 ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~DvwSlGv 328 (492)
||||||||+|||+ +.++.+||+|||+++..... ....+| +.|+|||++ .+ .|+.++|||||||
T Consensus 232 iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999 66778999999999875432 456678 999999987 32 3778999999999
Q ss_pred HHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 329 IAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 329 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++|+|+||+.||......+....+.. .+..+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 99999999999987665444333322 234688999999999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=349.15 Aligned_cols=249 Identities=21% Similarity=0.334 Sum_probs=200.8
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHH--ccCCCCccEEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA--LSGHSNLVKFYDAF 207 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~--l~~hpniv~l~~~~ 207 (492)
..+.++|++.+.||+|+||.||+|.+ +|+.||||++... ....+.+|++++.. + +||||+++++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~ni~~~~~~~ 105 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR------EERSWFREAEIYQTVML-RHENILGFIAAD 105 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHSCC-CCTTBCCEEEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch------hHHHHHHHHHHHHHhhc-CCCcEEEEEeee
Confidence 34567899999999999999999985 4789999999533 23567789999988 5 599999999999
Q ss_pred EeCC----eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCcccCCCCCceEeecC
Q 011154 208 EDLD----NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH--------LHGVVHRDLKPENFLYTSK 275 (492)
Q Consensus 208 ~~~~----~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH--------~~~ivHrDlkp~NILl~~~ 275 (492)
.+.+ .+++||||+++|+|.+++.+ ..+++.+++.++.||+.||.||| +.||+||||||+|||+
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll--- 180 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--- 180 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---
Confidence 8876 89999999999999998865 47999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEecccccccCCCCC-----ccccccCccccccccccCC-------CCCccchHHHHHHHHHHhcC-------
Q 011154 276 DESSQLKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-------YGTEADVWSIGVIAYILLCG------- 336 (492)
Q Consensus 276 ~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DvwSlGvil~~lltg------- 336 (492)
+.++.+||+|||++........ .....||+.|+|||++.+. ++.++|||||||++|+|+||
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 6677999999999987654432 2456799999999998654 23579999999999999999
Q ss_pred ---CCCCCCCC-----hhHHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 337 ---SRPFWART-----ESGIFRAVLKADPSFDDG-SW--PSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 337 ---~~pf~~~~-----~~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..||.... ...+...+.......... .| ...+..+.+||.+||+.||.+|||+.++++|
T Consensus 261 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 88986643 223333333222111110 01 1234578999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=350.06 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=190.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHH--HHHccCCCCccEEEEEEEe-
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI--LRALSGHSNLVKFYDAFED- 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~--l~~l~~hpniv~l~~~~~~- 209 (492)
.++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.++ +..+ +||||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERV 79 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheeccccc
Confidence 47899999999999999999965 56899999996432 2233344444 4456 59999999987653
Q ss_pred ----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCcccCCCCCceEeecCC
Q 011154 210 ----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH---------GVVHRDLKPENFLYTSKD 276 (492)
Q Consensus 210 ----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~---------~ivHrDlkp~NILl~~~~ 276 (492)
...+++|||||++|+|.+++... ..++..++.++.||+.||.|||+. ||+||||||+|||+ +
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~ 154 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---K 154 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---C
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---c
Confidence 23689999999999999988654 569999999999999999999999 99999999999999 6
Q ss_pred CCCcEEEEecccccccCCCC---------CccccccCccccccccccC--------CCCCccchHHHHHHHHHHhcCCCC
Q 011154 277 ESSQLKAIDFGLSDFVRPDE---------RLNDIVGSAYYVAPEVLHR--------SYGTEADVWSIGVIAYILLCGSRP 339 (492)
Q Consensus 277 ~~~~~kl~DfGla~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DvwSlGvil~~lltg~~p 339 (492)
.++.+||+|||++..+.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 67799999999998765322 1234579999999998864 356789999999999999999877
Q ss_pred CCCCCh-----------------hHHHHHHHhcC---CCCCCC--CCCCCCHHHHHHHHHccccCcCCCCCHHHHh----
Q 011154 340 FWARTE-----------------SGIFRAVLKAD---PSFDDG--SWPSLSSDAKDFVKLLLNKDPRKRMTAAQAL---- 393 (492)
Q Consensus 340 f~~~~~-----------------~~~~~~i~~~~---~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l---- 393 (492)
|..... ........... +.++.. ....+++++.+||.+||..||++|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 643221 11111111111 111111 1112445799999999999999999999994
Q ss_pred --cCccccccc
Q 011154 394 --SHPWIRNYN 402 (492)
Q Consensus 394 --~hp~~~~~~ 402 (492)
-++|.++..
T Consensus 315 ~ll~~~~~~~~ 325 (336)
T 3g2f_A 315 ELMMIWERNKS 325 (336)
T ss_dssp HHHHCCCC---
T ss_pred HHHHHHHhccc
Confidence 467776643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.18 Aligned_cols=229 Identities=14% Similarity=0.063 Sum_probs=189.0
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTR 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEEC
Confidence 456889999999999999999998754 6899999999877666666677899999999999 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+..|+|||||+|++|.+++.. .....++..|+.||+.||.|||++||+||||||+|||+ +.++.+||+++|
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA--- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC---
T ss_pred CcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc---
Confidence 999999999999999998732 34667889999999999999999999999999999999 556789987543
Q ss_pred ccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHH---HHHhcCCCCCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFR---AVLKADPSFDDGSWPSL 367 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~ 367 (492)
|++| ++.++|||||||++|+|+||+.||.+.+..+.+. ..............+.+
T Consensus 175 ----------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 175 ----------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp ----------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred ----------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence 3443 6889999999999999999999998765432110 01111111111223568
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++++.+||.+||+.||.+| |+.|+++.
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=380.55 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=203.0
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
...+.++|++.+.||+|+||.||+|++.. .+|+.||||++.... .......+.+|+.+|+.|. |||||+++++|.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 149 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVE 149 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGG--GTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEE
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcC--CCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEe
Confidence 34566899999999999999999998753 257899999986532 3445667899999999995 999999999998
Q ss_pred eCCe-----EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEE
Q 011154 209 DLDN-----VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283 (492)
Q Consensus 209 ~~~~-----~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl 283 (492)
+.+. .|||||||+|++|.+.+.. .+++.+++.|+.||+.||.|||++|||||||||+|||++ . ..+||
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl 222 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKL 222 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEE
Confidence 8665 7999999999999886643 799999999999999999999999999999999999994 3 37999
Q ss_pred EecccccccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011154 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363 (492)
Q Consensus 284 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (492)
+|||+++..... ...+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.....+ .....
T Consensus 223 ~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~~~ 289 (681)
T 2pzi_A 223 IDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDP 289 (681)
T ss_dssp CCCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CTTCH
T ss_pred EecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccccc----------ccccc
Confidence 999999876543 45679999999999987788899999999999999999999865322110 00011
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
...+++.+.+||.+||+.||.+||+..+++.|+|+.
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 112467899999999999999999999999998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=318.81 Aligned_cols=232 Identities=17% Similarity=0.145 Sum_probs=159.4
Q ss_pred eeccccceEEEEEEEecCCccccEEEEEEccCCCCC-------CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-------TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-------~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.++.|++|.+..++... .|+.||||++.+.... .....+++.+|+++|+++.+|+||+++++++++++.+
T Consensus 241 ~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp C-C--------CCEEEE---ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred ccccCCccccccccccc---ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 45677777666655443 6889999999765322 1334567999999999998899999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|||||||+||+|.++|... +.+++. .|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 318 yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC
T ss_pred EEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCC
Confidence 9999999999999998654 677765 489999999999999999999999999999 667899999999998775
Q ss_pred CC-CCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PD-ERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
.. ....+.+||+.|||||++.+.+..++|+||+|+++++|.++..+| ...+.. .+ .. ...+.
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~-~~---~~-----~~~~~ 453 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQ-EP---VE-----RWNFV 453 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHT-SC---GG-----GCSHH
T ss_pred CCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhc-CC---CC-----CCcHH
Confidence 43 345567899999999999988888999999999999887765543 111111 10 00 11245
Q ss_pred HHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 373 DFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
+++..++..+|..|+.......++|..
T Consensus 454 ~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 454 LLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred HHHHHHhCCCCCCCCChhhhccchhHH
Confidence 667777778888888777777777764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=269.42 Aligned_cols=184 Identities=24% Similarity=0.273 Sum_probs=143.4
Q ss_pred eecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHH-----HHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAI-----AVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 137 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~-----~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
...+.||+|+||.||++.+ .+..+|+|++......... ..+.+.+|+++|++++ ||||+++..++.+.+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLD 412 (540)
T ss_dssp ---------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETT
T ss_pred CCCCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCC
Confidence 3467899999999999943 4678999987554433221 2345899999999995 999996665666777
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..|||||||+||+|.+++.. +..++.||+.||.|||++||+||||||+|||+ +. .+||+|||+|+.
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl---~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF---DK--DLYIIDFGLGKI 478 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE---SS--SEEECCCTTCEE
T ss_pred ccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE---CC--eEEEEECccCEE
Confidence 88999999999999998743 66899999999999999999999999999999 44 899999999998
Q ss_pred cCCCCC--------ccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCC
Q 011154 292 VRPDER--------LNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPF 340 (492)
Q Consensus 292 ~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf 340 (492)
...... ....+||++|||||++.. .|+..+|+||..+-.++.+-++.+|
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 765432 135689999999999863 5888899999998888877776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-26 Score=221.28 Aligned_cols=159 Identities=25% Similarity=0.283 Sum_probs=122.8
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH---------------HHHHHHHHHHHHHHHccCCC
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA---------------IAVEDVRREVKILRALSGHS 198 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~---------------~~~~~~~~Ev~~l~~l~~hp 198 (492)
..|.+++.||+|+||.||+|.+ . +|+.||||++........ .....+.+|+.+|+.+. |
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~---~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~- 163 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-E---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G- 163 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-T---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T-
T ss_pred eEEEecCEeccCCCceEEEEEe-C---CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C-
Confidence 4567779999999999999987 3 688999999965322110 23456899999999996 4
Q ss_pred CccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCC
Q 011154 199 NLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDES 278 (492)
Q Consensus 199 niv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~ 278 (492)
+++++++.. +..|+|||||+||+|.+ + ...+...++.||+.||.|||++||+||||||+|||+ + +
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~ 228 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-V-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-E 228 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-C-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-T
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-c-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-C
Confidence 455554444 55699999999999987 4 113456799999999999999999999999999999 4 6
Q ss_pred CcEEEEecccccccCCCCCccccccCcccccccccc-----------CCCCCccchHH
Q 011154 279 SQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-----------RSYGTEADVWS 325 (492)
Q Consensus 279 ~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-----------~~~~~~~DvwS 325 (492)
+.+||+|||+|+. +..|+|||++. +.|+..+|+|.
T Consensus 229 ~~vkl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 229 EGIWIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TEEEECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CcEEEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 7899999999863 34578999874 23566667765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-22 Score=193.36 Aligned_cols=142 Identities=16% Similarity=0.160 Sum_probs=107.7
Q ss_pred ceeecceeccccceEEEEEEEecCCccccE--EEEEEccCCCCCC---------------------HHHHHHHHHHHHHH
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQK--VAIKVIPKSKMTT---------------------AIAVEDVRREVKIL 191 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~--vavK~i~~~~~~~---------------------~~~~~~~~~Ev~~l 191 (492)
-|++.+.||+|+||.||+|.+.. +|+. ||||++....... ......+.+|+.+|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 37889999999999999998744 6778 9999975432110 11223588999999
Q ss_pred HHccCCCCc--cEEEEEEEeCCeEEEEEeecCC-C----chHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH-HcCCccc
Q 011154 192 RALSGHSNL--VKFYDAFEDLDNVYIVMELCEG-G----ELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH-LHGVVHR 263 (492)
Q Consensus 192 ~~l~~hpni--v~l~~~~~~~~~~~lv~E~~~g-g----sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH-~~~ivHr 263 (492)
+.|. |++| +.++++ +..+||||||.+ | +|.+... ..++.++..++.||+.||.||| +.|||||
T Consensus 125 ~~l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 125 ERAK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHHH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HHHH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 9996 7753 444442 356899999942 3 5555432 2346678899999999999999 9999999
Q ss_pred CCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 264 DLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 264 Dlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
||||+|||+ +. .++|+|||+|....
T Consensus 196 Dlkp~NILl---~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMY---ID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEE---SS--SEEECCCTTCEETT
T ss_pred CCCHHHEEE---cC--cEEEEECcccccCC
Confidence 999999999 44 89999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.6e-18 Score=172.14 Aligned_cols=144 Identities=15% Similarity=0.195 Sum_probs=101.1
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC--------------C-HH----HHHHHHHHHHHHHHcc
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT--------------T-AI----AVEDVRREVKILRALS 195 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~--------------~-~~----~~~~~~~Ev~~l~~l~ 195 (492)
-|+++..||+|+||.||+|... +|+.||||+++..... . .. ..-...+|...|.+|.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 3899999999999999999853 5889999997542110 0 00 0112356888888884
Q ss_pred CCCCccEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecC
Q 011154 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSK 275 (492)
Q Consensus 196 ~hpniv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~ 275 (492)
+.++.... .+... ..+|||||++|++|... ....++..++.||+.+|.|||+.|||||||||.|||+..+
T Consensus 172 -~~gv~vp~-p~~~~-~~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 172 -EEGFPVPE-PIAQS-RHTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp -HTTCSCCC-EEEEE-TTEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred -hcCCCCCe-eeecc-CceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 44432221 12112 23799999999887542 1223556789999999999999999999999999999654
Q ss_pred CCC-------CcEEEEeccccccc
Q 011154 276 DES-------SQLKAIDFGLSDFV 292 (492)
Q Consensus 276 ~~~-------~~~kl~DfGla~~~ 292 (492)
++. ..+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 321 14899999977554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=5.7e-13 Score=127.36 Aligned_cols=141 Identities=15% Similarity=0.115 Sum_probs=110.9
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
..|++...+|.|+++.||++.. .+..+++|+........ ...+.+|+.+|+.|..+..+.++++++.+.+..
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred ccceeEeeccCCCCCeEEEEEC-----CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 4688888899999999999863 35789999986421111 134789999999997678899999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL------------------------------------ 257 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~------------------------------------ 257 (492)
|+||||++|.+|.+.+ .+......++.+++.+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999999887642 1223345788999999999998
Q ss_pred -----------------------cCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 258 -----------------------HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 258 -----------------------~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++|+|++|.|||+. +...+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence 4589999999999994 344567999997743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=1.4e-11 Score=117.11 Aligned_cols=136 Identities=12% Similarity=0.087 Sum_probs=97.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC-CccEEEEEEEeCCe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS-NLVKFYDAFEDLDN 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp-niv~l~~~~~~~~~ 212 (492)
..|.+....+.|..+.||++... +|..++||+..... ...+.+|+.+++.|..|. .+.++++++.+.+.
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~----~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECT----TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred CCCceEecccCCCCceEEEEecC----CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 34555444445666899998532 46779999975431 134778999999997552 26679998888888
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcC---------------------------------
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG--------------------------------- 259 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~--------------------------------- 259 (492)
.++||||++|.+|. . .... ...++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~----~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--S----SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EEEEEECCSSEETT--T----SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CEEEEEecCCcccC--c----CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 99999999998873 2 1122 2356677777777777643
Q ss_pred -------------------------CcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 260 -------------------------VVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 260 -------------------------ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
++|+|++|.|||+. ++..+.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence 99999999999994 344567999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=5.3e-11 Score=119.14 Aligned_cols=142 Identities=25% Similarity=0.401 Sum_probs=104.9
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEcc--CCCCCCHHHHHHHHHHHHHHHHccC-CCCccEEEEEEEeC---Ce
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIP--KSKMTTAIAVEDVRREVKILRALSG-HSNLVKFYDAFEDL---DN 212 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~--~~~~~~~~~~~~~~~Ev~~l~~l~~-hpniv~l~~~~~~~---~~ 212 (492)
.+.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.|.. +..+++++.++.+. +.
T Consensus 43 ~~~l~~G~sn~~y~v~~~-----~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-----GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp EEECCC-CCSCEEEEECS-----SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred EEEcCCcccceEEEEEEC-----CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 467899999999998642 3578899875 33211 123467899999999963 35688999988776 45
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL----------------------------------- 257 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~----------------------------------- 257 (492)
.|+||||++|..+.+.. ...++..+...++.+++..|..||.
T Consensus 116 ~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp CEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred eEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 89999999998775421 2357888999999999999999997
Q ss_pred -----------------------cCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 258 -----------------------HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 258 -----------------------~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++|+|+++.|||+..++ ...+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECcccccc
Confidence 3589999999999995322 13469999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=4.9e-11 Score=116.55 Aligned_cols=184 Identities=15% Similarity=0.222 Sum_probs=123.9
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCC--ccEEEEEEEeCC---eEE
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSN--LVKFYDAFEDLD---NVY 214 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpn--iv~l~~~~~~~~---~~~ 214 (492)
+.++.|....||.+. ..+++|+... ......+.+|+.+|+.|..+.. +.+++......+ ..|
T Consensus 26 ~~~~~G~~n~v~~v~--------~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~ 92 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN--------RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF 92 (304)
T ss_dssp CEEEECSSEEEEEST--------TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred EecCCCCcceEEEEC--------CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence 458999999888752 3588998642 2345678999999999854433 445555543333 358
Q ss_pred EEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 011154 215 IVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL------------------------------------- 257 (492)
Q Consensus 215 lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~------------------------------------- 257 (492)
+|||+++|.+|.+... ..++..+...++.|++..|..||+
T Consensus 93 ~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 8999999988876443 357888888999999999999996
Q ss_pred ---------------------cCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccccccCcccccccccc--
Q 011154 258 ---------------------HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-- 314 (492)
Q Consensus 258 ---------------------~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-- 314 (492)
..++|+|+++.|||+..+ ....+.|+||+.+....+............-..|+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence 136999999999999532 14568899999987643321111111000002333211
Q ss_pred -CCCCC------------ccchHHHHHHHHHHhcCCCCC
Q 011154 315 -RSYGT------------EADVWSIGVIAYILLCGSRPF 340 (492)
Q Consensus 315 -~~~~~------------~~DvwSlGvil~~lltg~~pf 340 (492)
..|.. -.+.|++|.++|.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11221 258999999999999999886
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.11 E-value=7.7e-11 Score=107.64 Aligned_cols=98 Identities=23% Similarity=0.249 Sum_probs=78.5
Q ss_pred cCcccccccccCCCccHHHHHHHHHHhhhhhhHHHHHHhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 394 SHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 394 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~a~l~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
.|||.+.......+++..+++.+++|...+.++++++..++..++.++...++++|..+|.|++|.|+.+||+.+|..+|
T Consensus 8 ~~~~~~~~~~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g 87 (197)
T 3pm8_A 8 SSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKIG 87 (197)
T ss_dssp ---------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHC
T ss_pred cchHhhhccCCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhC
Confidence 58999998888899999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccHHHHHHHHhcccCC
Q 011154 474 TDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 474 ~~~~~~~ei~~~i~~~D~~ 492 (492)
. .+++.++..+++.+|.|
T Consensus 88 ~-~~~~~~~~~l~~~~D~d 105 (197)
T 3pm8_A 88 Y-QKIPPDIHQVLRDIDSN 105 (197)
T ss_dssp -----CHHHHHHHHC----
T ss_pred C-CCCHHHHHHHHHHhCCC
Confidence 7 58999999999999864
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=98.99 E-value=4.2e-10 Score=102.11 Aligned_cols=97 Identities=20% Similarity=0.179 Sum_probs=80.6
Q ss_pred cCcccccccccCCCccHHHHHHHHHHhhhhhhHHHHHHhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 394 SHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 394 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~a~l~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
.|||+-.......+++..+++.+++|...+.++++++..++..++.++...++++|..+|.|++|.|+.+||+.+|..+|
T Consensus 3 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g 82 (191)
T 3k21_A 3 HHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKDG 82 (191)
T ss_dssp -----------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTT
T ss_pred CCccccCCccccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC
Confidence 57887776677788899999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccHHHHHHHHhcccCC
Q 011154 474 TDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 474 ~~~~~~~ei~~~i~~~D~~ 492 (492)
. ..+ .++..+++.+|.|
T Consensus 83 ~-~~~-~~~~~l~~~~D~d 99 (191)
T 3k21_A 83 L-KLP-YNFDLLLDQIDSD 99 (191)
T ss_dssp C-CCC-TTHHHHHHHHCTT
T ss_pred C-CcH-HHHHHHHHHhCCC
Confidence 7 466 8999999998865
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.74 E-value=7.3e-09 Score=83.44 Aligned_cols=57 Identities=18% Similarity=0.212 Sum_probs=52.6
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.++..+++++|+.||.|++|+|+.+||+.+|+.+|. .++++||++|++.+|.|
T Consensus 28 ~~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~-~~~~~ei~~l~~~~D~d 84 (100)
T 2lv7_A 28 VDIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGY-MPNEVELEVIIQRLDMD 84 (100)
T ss_dssp CCCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTC-CCCTTTHHHHHHHHCSS
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCC
Confidence 3567788899999999999999999999999999999997 69999999999999975
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=4.1e-07 Score=88.72 Aligned_cols=137 Identities=18% Similarity=0.308 Sum_probs=94.4
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC--CccEEEEEEE-eCCeEEEE
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS--NLVKFYDAFE-DLDNVYIV 216 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp--niv~l~~~~~-~~~~~~lv 216 (492)
+.++.|....||.+ |..++||+-. .......+.+|+.+|+.|..|- .|.+.+.++. ..+..++|
T Consensus 25 ~~l~~G~~n~v~~v--------g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v 91 (306)
T 3tdw_A 25 ESLGEGFRNYAILV--------NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG 91 (306)
T ss_dssp EEEEECSSEEEEEE--------TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred eecCCCcceeEEEE--------CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence 45788888888886 2457888842 2234567899999999996442 3567777764 45567899
Q ss_pred EeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc--------------------------------------
Q 011154 217 MELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH-------------------------------------- 258 (492)
Q Consensus 217 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~-------------------------------------- 258 (492)
||+++|..|.+... ..++..+...++.++...|..||+.
T Consensus 92 ~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 92 YRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 99999988866332 2345556666666666666666542
Q ss_pred ----------------------CCcccCCCCCceEeecCCCCCc-EEEEeccccccc
Q 011154 259 ----------------------GVVHRDLKPENFLYTSKDESSQ-LKAIDFGLSDFV 292 (492)
Q Consensus 259 ----------------------~ivHrDlkp~NILl~~~~~~~~-~kl~DfGla~~~ 292 (492)
.++|+|+++.|||+..++.++. +.|+||+.+..-
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999953222344 589999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=1.8e-07 Score=89.31 Aligned_cols=133 Identities=18% Similarity=0.209 Sum_probs=94.6
Q ss_pred eccccce-EEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEeec
Q 011154 142 VGRGHFG-YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELC 220 (492)
Q Consensus 142 lG~G~fg-~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~~ 220 (492)
+..|..| .||+..... .+..++||+-+.. ....+.+|..+|+.|..+--+.+++.++++.+..|+|||++
T Consensus 32 ~~~G~S~~~v~rl~~~~---~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKP---NAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECCT---TCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccCCCcCCeEEEEEecC---CCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 4445555 688776432 5677999987432 34568899999999976656888999999999999999999
Q ss_pred CCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 011154 221 EGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLH------------------------------------------ 258 (492)
Q Consensus 221 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~------------------------------------------ 258 (492)
+|.++.+..... ......+..++...|.-||..
T Consensus 103 ~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 103 PGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp CSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred CCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 998876654321 122334555566666666621
Q ss_pred ----------------CCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 259 ----------------GVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 259 ----------------~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.++|+|+.+.|||+ +....+-|+||+.+..
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECccccc
Confidence 16899999999999 4445567999998754
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.54 E-value=9.6e-08 Score=85.81 Aligned_cols=85 Identities=22% Similarity=0.223 Sum_probs=77.6
Q ss_pred CccHHHHHHHHHHhhhhhhHHHHHHhhhccc-chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhh-----------cc
Q 011154 407 PLDISILKLMKAYMQSSSLRRAALKALSKTL-TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKN-----------AT 474 (492)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~l~~a~l~~l~~~l-~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~-----------g~ 474 (492)
|++..+++.+++|...+.++++++..++..+ +.++...++++|..+|.|++|.|+.+||+.+|..+ +.
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~ 82 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS 82 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence 5667889999999999999999999998888 78888999999999999999999999999999987 65
Q ss_pred ccccHHHHHHHHhcccCC
Q 011154 475 DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 475 ~~~~~~ei~~~i~~~D~~ 492 (492)
..++.++..+++.+|.|
T Consensus 83 -~~~~~~~~~~~~~~D~d 99 (191)
T 3khe_A 83 -SQIEAEVDHILQSVDFD 99 (191)
T ss_dssp -HHHHHHHHHHHHHTCTT
T ss_pred -hhhHHHHHHHHHHhCCC
Confidence 58899999999999864
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=98.53 E-value=1.9e-07 Score=83.43 Aligned_cols=82 Identities=28% Similarity=0.425 Sum_probs=74.2
Q ss_pred ccHHHHHHHHHHhhhhhhHHHHHHhhhcccc--hhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHH
Q 011154 408 LDISILKLMKAYMQSSSLRRAALKALSKTLT--VDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDL 485 (492)
Q Consensus 408 ~~~~~~~~~~~~~~~~~l~~a~l~~l~~~l~--~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~ 485 (492)
++..++..+++|...+.++++++..++..++ .++...++++|..+|.|++|.|+.+||+.+|..+|. +..++..+
T Consensus 2 ~~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~---~~~~~~~~ 78 (180)
T 3mse_B 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGI---KKWDINRI 78 (180)
T ss_dssp CCHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC---CHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC---CHHHHHHH
Confidence 4567889999999999999999999998886 788899999999999999999999999999999875 36899999
Q ss_pred HhcccCC
Q 011154 486 LAPSDGF 492 (492)
Q Consensus 486 i~~~D~~ 492 (492)
++.+|.|
T Consensus 79 ~~~~D~d 85 (180)
T 3mse_B 79 LQALDIN 85 (180)
T ss_dssp HHHHCTT
T ss_pred HHHhCCC
Confidence 9998864
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=98.42 E-value=3.4e-07 Score=71.00 Aligned_cols=59 Identities=14% Similarity=0.149 Sum_probs=53.1
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHH---HHHHHhcccCC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESR---ISDLLAPSDGF 492 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~e---i~~~i~~~D~~ 492 (492)
+...++.++...++++|..||.|++|+|+.+||+.+|+.+|. .+++.+ +.+|++.+|.|
T Consensus 4 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~~~~d~~ 65 (86)
T 1j7q_A 4 KARALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQ-TYTKRETEAIMKEARGPKGD 65 (86)
T ss_dssp CCCCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSC-CCSHHHHHHHHHHHHCSSCS
T ss_pred ccccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcC-CCCHHHHHHHHHHHHHhCCC
Confidence 445667788889999999999999999999999999999997 699999 99999999864
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=98.40 E-value=3.2e-07 Score=71.10 Aligned_cols=57 Identities=14% Similarity=0.147 Sum_probs=49.3
Q ss_pred hcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 434 SKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 434 ~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+..++.++...++++|..+|.|++|+|+.+||+.+|..+| .+++.+++.+++.+|.|
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g--~~~~~~~~~~~~~~D~~ 58 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG--SVTPDEVRRMMAEIDTD 58 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT--TCCHHHHHHHHHHHCTT
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC--CCCHHHHHHHHHHhCCC
Confidence 4556777888999999999999999999999999999998 58999999999999865
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=98.38 E-value=3.9e-07 Score=71.37 Aligned_cols=59 Identities=14% Similarity=0.187 Sum_probs=53.2
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+...++.++...++.+|..+|.|++|+|+.+||+.+|+.+|. .+++.++.+|++.+|.|
T Consensus 10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~D~~ 68 (90)
T 1avs_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDED 68 (90)
T ss_dssp HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 455677788889999999999999999999999999999987 69999999999999864
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.37 E-value=4.4e-07 Score=79.37 Aligned_cols=75 Identities=31% Similarity=0.500 Sum_probs=65.2
Q ss_pred HHHhhhhhhHHHHHHhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 417 KAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 417 ~~~~~~~~l~~a~l~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++|...+.++++++..+...++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 1 ~~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~ 75 (166)
T 2aao_A 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGA-NLKESEILDLMQAADVD 75 (166)
T ss_dssp -----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTC-CCCHHHHHHHHHHHCTT
T ss_pred CchhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 3577888999999999999999889999999999999999999999999999999987 68999999999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.5e-07 Score=92.05 Aligned_cols=85 Identities=15% Similarity=0.164 Sum_probs=56.9
Q ss_pred eccee-ccccceEEEEEEEec---CCccccEEEEEEccCCC---CCCHHHHHHHHHHHHHHHHccCC--CCccEEEEEEE
Q 011154 138 VGEEV-GRGHFGYTCTARYKK---GEHKDQKVAIKVIPKSK---MTTAIAVEDVRREVKILRALSGH--SNLVKFYDAFE 208 (492)
Q Consensus 138 ~~~~l-G~G~fg~V~~~~~~~---~~~~~~~vavK~i~~~~---~~~~~~~~~~~~Ev~~l~~l~~h--pniv~l~~~~~ 208 (492)
..+.| +.|....+|++.... +..++..+++|+..... ... ...+.+|+.+|+.|..+ -.+.+++.++.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 34667 788888999876530 00025678999875432 101 13467899999988654 35778888876
Q ss_pred eC---CeEEEEEeecCCCch
Q 011154 209 DL---DNVYIVMELCEGGEL 225 (492)
Q Consensus 209 ~~---~~~~lv~E~~~ggsL 225 (492)
+. +..|+||||++|..+
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCC
T ss_pred CCCccCCceEEEEecCCCCh
Confidence 65 357899999998654
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.36 E-value=4.5e-07 Score=80.88 Aligned_cols=57 Identities=28% Similarity=0.379 Sum_probs=53.2
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..|+.+++.+++++|..||.|+||.|+.+||+.+|+.+|. .+++.++.++++.+|.|
T Consensus 3 ~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~-~~~~~~~~~~~~~~d~d 59 (176)
T 2lhi_A 3 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDVD 59 (176)
T ss_dssp CCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTC-CCCHHHHHHHHTTTCSS
T ss_pred CcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCC-ChhHHHHHHHHHHhCcC
Confidence 4678899999999999999999999999999999999998 69999999999999864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.1e-06 Score=88.84 Aligned_cols=82 Identities=18% Similarity=0.247 Sum_probs=51.1
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCC-CCH---HHHHHHHHHHHHHHHccCC-C-CccEEEEEEEeCCe
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM-TTA---IAVEDVRREVKILRALSGH-S-NLVKFYDAFEDLDN 212 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~-~~~---~~~~~~~~Ev~~l~~l~~h-p-niv~l~~~~~~~~~ 212 (492)
.+.||.|.++.||++.... .++.|+||....... ... ...+.+..|.++|+.+..+ + .+.+++.+ +.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEECCCCceEEEEEEEECC---CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc
Confidence 4578999999999996542 457899998653221 000 1123467899999888533 3 34456643 4455
Q ss_pred EEEEEeecCCCch
Q 011154 213 VYIVMELCEGGEL 225 (492)
Q Consensus 213 ~~lv~E~~~ggsL 225 (492)
.++|||+++|...
T Consensus 110 ~~lvmE~l~g~~~ 122 (397)
T 2olc_A 110 AVTVMEDLSHLKI 122 (397)
T ss_dssp TEEEECCCTTSEE
T ss_pred cEEEEEeCCCcch
Confidence 6899999987543
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=98.34 E-value=5.3e-07 Score=68.14 Aligned_cols=54 Identities=24% Similarity=0.419 Sum_probs=49.2
Q ss_pred chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 438 TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 438 ~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~~ 55 (77)
T 2joj_A 2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGF-DVKKPEILELMNEYDRE 55 (77)
T ss_dssp CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTC-CCHHHHHHHHHHHHCCS
T ss_pred CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCC
Confidence 4567788999999999999999999999999999987 68999999999999864
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.29 E-value=8.2e-07 Score=70.53 Aligned_cols=53 Identities=11% Similarity=0.258 Sum_probs=47.3
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.++...++++|..||.|+||+|+.+||+.+|+.+| ++++++.+|++.+|.|
T Consensus 4 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g---~~~~~~~~i~~~~D~d 56 (95)
T 1c07_A 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG---LPSTLLAHIWSLCDTK 56 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT---CCHHHHHHHHHHHCTT
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC---CCHHHHHHHHHHHCCC
Confidence 3556788899999999999999999999999999875 6789999999999864
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.29 E-value=7.7e-07 Score=70.25 Aligned_cols=53 Identities=26% Similarity=0.331 Sum_probs=47.2
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.++...++++|+.||.|+||+|+.+||+.+|+.+| ++++++.+|++.+|.|
T Consensus 3 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g---~~~~~~~~i~~~~D~d 55 (92)
T 1fi6_A 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK---LPILELSHIWELSDFD 55 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS---SCHHHHHHHHHHHCTT
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC---CCHHHHHHHHHHHCCC
Confidence 3556788899999999999999999999999999875 5789999999999864
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=98.28 E-value=1.9e-07 Score=91.75 Aligned_cols=121 Identities=17% Similarity=0.209 Sum_probs=82.4
Q ss_pred CCCHHHHHHHHHcc---ccCcCCCCCHHHHhcC------cccccccccC-CC-----------------------ccHHH
Q 011154 366 SLSSDAKDFVKLLL---NKDPRKRMTAAQALSH------PWIRNYNNVK-VP-----------------------LDISI 412 (492)
Q Consensus 366 ~~s~~~~~li~~~L---~~dP~~Rps~~e~l~h------p~~~~~~~~~-~~-----------------------~~~~~ 412 (492)
.++.++.+|.++++ ..+|..|...++.+.| +|+..+.... .+ ....+
T Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~v 95 (323)
T 1ij5_A 16 KVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASL 95 (323)
T ss_dssp HHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHHH
Confidence 45678899999998 8899999999999999 9988762110 00 01123
Q ss_pred HHHHH-HHhhhhhhHHHHHHhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 413 LKLMK-AYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 413 ~~~~~-~~~~~~~l~~a~l~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
+..++ +|...+.+++ ++..++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..|++.+|.
T Consensus 96 l~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~-~~~~~~i~~l~~~~D~ 169 (323)
T 1ij5_A 96 LKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYAD-TIPEGPLKKLFVMVEN 169 (323)
T ss_dssp HHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHT-TSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhcC
Confidence 33343 4445555544 346778888999999999999999999999999999999987 6899999999998875
Q ss_pred C
Q 011154 492 F 492 (492)
Q Consensus 492 ~ 492 (492)
|
T Consensus 170 d 170 (323)
T 1ij5_A 170 D 170 (323)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.27 E-value=7.3e-07 Score=77.55 Aligned_cols=51 Identities=14% Similarity=0.238 Sum_probs=46.7
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++++|+.||.|++|+|+.+||+.+|..+|. .+++++|++||+.+|.|
T Consensus 83 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~-~ls~~ei~~~~~~~D~~ 133 (153)
T 3i5g_B 83 PEDALRNAFSMFDEDGQGFIPEDYLKDLLENMGD-NFSKEEIKNVWKDAPLK 133 (153)
T ss_dssp CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSS-CCCHHHHHHHHTTCCEE
T ss_pred cHHHHHHHHhccccCCCCeEeHHHHHHHHHHcCC-cCCHHHHHHHHHHhCCC
Confidence 3457999999999999999999999999999997 79999999999999853
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.1e-06 Score=69.64 Aligned_cols=52 Identities=15% Similarity=0.336 Sum_probs=47.2
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+....++++|..+|.|++|+|+.+||+.+|+.+|. .++++++++|++.+|.|
T Consensus 26 ~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~e~~~l~~~~D~d 77 (94)
T 2kz2_A 26 DSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGE-KLTDEEVDEMIREADID 77 (94)
T ss_dssp SCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTT
T ss_pred CHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 34567899999999999999999999999999987 69999999999999864
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=98.22 E-value=7.7e-07 Score=71.46 Aligned_cols=52 Identities=13% Similarity=0.094 Sum_probs=45.1
Q ss_pred hhHHHHHHHHhhhC-CCCC-cccchHHHHHHHHh-h----ccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNKN-GCIAFENIKTVLMK-N----ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~~-G~Is~~el~~~l~~-~----g~~~~~~~ei~~~i~~~D~~ 492 (492)
.....|+++|..|| +||+ |+|+.+||+.+|+. + |. .+++++|++||+++|.|
T Consensus 7 ~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~-~~~~~ev~~~i~~~D~d 65 (101)
T 3nso_A 7 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPT-EFRECDYNKFMSVLDTN 65 (101)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCC-TTCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCC-CCCHHHHHHHHHHhCCC
Confidence 34577999999997 8998 99999999999986 3 44 68999999999999865
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=98.21 E-value=1.7e-06 Score=67.81 Aligned_cols=54 Identities=19% Similarity=0.389 Sum_probs=48.7
Q ss_pred chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 438 TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 438 ~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++...++++|..+|.|++|+|+.+||+.+|..+|. .++++++.+|++.+|.|
T Consensus 4 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~ 57 (92)
T 2kn2_A 4 DTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGE-KLTDEEVEQMIKEADLD 57 (92)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSS
T ss_pred CccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 4456778999999999999999999999999999987 68999999999999864
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.4e-06 Score=68.40 Aligned_cols=56 Identities=14% Similarity=0.180 Sum_probs=49.2
Q ss_pred hcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 434 SKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 434 ~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.++...++++|..+|.|++|.|+.+||+.+|..+| +++.++++|++.+|.|
T Consensus 18 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g---~~~~~~~~~~~~~D~d 73 (91)
T 2pmy_A 18 GADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR---VRPADAEAVFQRLDAD 73 (91)
T ss_dssp -CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT---CCHHHHHHHHHHHCTT
T ss_pred hccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC---cCHHHHHHHHHHhCCC
Confidence 4455677888999999999999999999999999999987 6789999999999864
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.19 E-value=6.6e-07 Score=69.40 Aligned_cols=59 Identities=29% Similarity=0.455 Sum_probs=51.2
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+...++.++...++++|..+|.|++|+|+.+||+.+|+.+|. .++++++.+|++.+|.|
T Consensus 13 ~~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~d~~ 71 (87)
T 1s6j_A 13 MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADID 71 (87)
T ss_dssp SSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTS-SCCHHHHHHHHHHHCTT
T ss_pred HHHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 344455556677899999999999999999999999999987 69999999999999864
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.19 E-value=2.1e-06 Score=74.67 Aligned_cols=55 Identities=20% Similarity=0.433 Sum_probs=51.1
Q ss_pred ccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 436 TLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
.|+.+++.+++++|..||.|++|.|+.+||+.+|+.+|. .+++.++..++...|.
T Consensus 9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~-~~~~~~~~~~~~~~~~ 63 (153)
T 3i5g_B 9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGR-VPPDDELNAMLKECPG 63 (153)
T ss_dssp TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTS-CCCHHHHHHHHHTSSS
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCC-CccHHHHHHHHHhccC
Confidence 578899999999999999999999999999999999998 6999999999988764
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=98.17 E-value=1.5e-06 Score=71.18 Aligned_cols=53 Identities=11% Similarity=0.113 Sum_probs=46.0
Q ss_pred hhhHHHHHHHHhhhC-CCCCc-ccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 439 VDERFYLKEQFALLE-PNKNG-CIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D-~~~~G-~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++...++++|..|| .|+|| +|+.+||+.+|+. +|. .+++++|++||+++|.|
T Consensus 18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~-~~t~~ev~~li~~~D~d 77 (113)
T 2lnk_A 18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGK-RTDEAAFQKLMSNLDSN 77 (113)
T ss_dssp HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTT-CCCTTHHHHHHHHHCSS
T ss_pred hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCC-CCCHHHHHHHHHHhCCC
Confidence 356678999999999 89997 9999999999986 554 57899999999999875
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.7e-06 Score=86.23 Aligned_cols=58 Identities=22% Similarity=0.355 Sum_probs=54.2
Q ss_pred hcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 434 SKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 434 ~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+++.+|+.+|+++|+.||.|+||.|+.+||+.+|+.+|. .++++||++|++.+|.|
T Consensus 293 ~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~-~~TeeEI~~Lf~~~D~D 350 (440)
T 3u0k_A 293 RDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDAD 350 (440)
T ss_dssp CBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSS
T ss_pred HhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 46778899999999999999999999999999999999998 69999999999999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=3.1e-05 Score=76.01 Aligned_cols=136 Identities=13% Similarity=0.131 Sum_probs=77.1
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-CCccEEEE------EEEeCCe
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-SNLVKFYD------AFEDLDN 212 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-pniv~l~~------~~~~~~~ 212 (492)
+.|+.|..+.||++... +..+++|+.... . ..+..|+.+++.|..+ -.+.+++. +....+.
T Consensus 38 ~~l~gG~~n~~~~v~~~-----~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~ 105 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD-----SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSF 105 (346)
T ss_dssp EECC----CEEEEEEET-----TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTE
T ss_pred eeccccccCcEEEEEeC-----CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCE
Confidence 45666778899988642 234899998642 1 2344566666655421 12333332 2235678
Q ss_pred EEEEEeecCCCchH--------------HHHHhhCCCC-------------CHHH-------------------------
Q 011154 213 VYIVMELCEGGELL--------------DRILSRCGKY-------------SEDE------------------------- 240 (492)
Q Consensus 213 ~~lv~E~~~ggsL~--------------~~l~~~~~~~-------------~~~~------------------------- 240 (492)
.++||||++|.++. ..++.....+ .+..
T Consensus 106 ~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 185 (346)
T 2q83_A 106 LFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFS 185 (346)
T ss_dssp EEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHH
T ss_pred EEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHH
Confidence 89999999986541 2233211111 1111
Q ss_pred ------HHHHHHHHHHHHHHHHH-------------cCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 241 ------AKAVLVQILNVVAFCHL-------------HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 241 ------~~~i~~qi~~~l~ylH~-------------~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
...+..++..++.+|+. ..++|+|+++.|||+ +.+..+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 186 QLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLL---GENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEE---CGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEE---eCCCcEEEEehhhcc
Confidence 11122234445666653 469999999999999 444579999999764
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=98.14 E-value=2.8e-06 Score=74.36 Aligned_cols=49 Identities=20% Similarity=0.255 Sum_probs=45.4
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
...++++|+.||.|++|+|+.+||+.+|..+|. .++++|+++||+.+|.
T Consensus 84 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~-~ls~~e~~~l~~~~D~ 132 (159)
T 3i5g_C 84 ADEFMEAFKTFDREGQGLISSAEIRNVLKMLGE-RITEDQCNDIFTFCDI 132 (159)
T ss_dssp HHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSS-CCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCc
Confidence 456899999999999999999999999999997 6999999999998874
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.9e-06 Score=63.82 Aligned_cols=51 Identities=10% Similarity=0.227 Sum_probs=46.3
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++++|..+|.|++|+|+.+||+.+|..+|. .+++.+++.|++.+|.|
T Consensus 4 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~~ 54 (71)
T 2b1u_A 4 GLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQ-PLPQEELDAMIREADVD 54 (71)
T ss_dssp THHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTC-SSCHHHHHHHHHHCCSS
T ss_pred cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 3457899999999999999999999999999987 69999999999999864
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.12 E-value=2.7e-06 Score=62.13 Aligned_cols=48 Identities=17% Similarity=0.279 Sum_probs=44.4
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++++|..+|.|++|.|+.+||+.++..+|. .++++++..+++.+|.|
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~D~~ 49 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSP-YFTQEDIVKFFEEIDVD 49 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCT-TSCHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCC
Confidence 4789999999999999999999999999987 69999999999999864
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.11 E-value=2.2e-06 Score=68.58 Aligned_cols=50 Identities=10% Similarity=0.135 Sum_probs=44.9
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++...++++|+.||.|+||+|+.+|++.+|+.+| ++++++.+|++.+|.|
T Consensus 8 ~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~---l~~~~l~~i~~~~D~d 57 (99)
T 1qjt_A 8 SGNPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG---LPDLILGKIWDLADTD 57 (99)
T ss_dssp TTCTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSS---SCHHHHHHHHHHHCCS
T ss_pred hhHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC---CCHHHHHHHHHHHCCC
Confidence 4566799999999999999999999999999875 6799999999999864
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=98.10 E-value=2.7e-06 Score=67.50 Aligned_cols=52 Identities=12% Similarity=0.088 Sum_probs=45.4
Q ss_pred hhHHHHHHHHhhhC-CCCCc-ccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNKNG-CIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~~G-~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++...++++|+.|| .|++| +|+.+||+.+|+. +|. .+++.+|++||+.+|.|
T Consensus 9 ~~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~-~~~~~~v~~~~~~~D~d 67 (95)
T 2wcb_A 9 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKN-IKDKAVIDEIFQGLDAN 67 (95)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHH-CCCHHHHHHHHTTSSSS
T ss_pred HHHHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccc-cccHHHHHHHHHHHcCC
Confidence 45678999999999 89998 9999999999986 554 57899999999999875
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.09 E-value=3.4e-06 Score=68.06 Aligned_cols=53 Identities=11% Similarity=0.110 Sum_probs=44.6
Q ss_pred hhHHHHHHHHhhhC-CCCC-cccchHHHHHHHHh-hcc---ccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNKN-GCIAFENIKTVLMK-NAT---DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~~-G~Is~~el~~~l~~-~g~---~~~~~~ei~~~i~~~D~~ 492 (492)
.....++++|..|| .|+| |+|+.+||+.+|.. +|. +.+++++|++||+++|.|
T Consensus 10 ~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d 68 (104)
T 3zwh_A 10 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSN 68 (104)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCC
Confidence 45678999999997 7886 89999999999986 652 246899999999999976
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=3.7e-06 Score=66.46 Aligned_cols=53 Identities=11% Similarity=0.110 Sum_probs=43.7
Q ss_pred hhHHHHHHHHhhhC-CCCC-cccchHHHHHHHHh-hcc---ccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNKN-GCIAFENIKTVLMK-NAT---DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~~-G~Is~~el~~~l~~-~g~---~~~~~~ei~~~i~~~D~~ 492 (492)
.....++++|..|| .||| |+|+.+||+.+|+. +|. +..++++|++||+++|.|
T Consensus 7 ~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d 65 (93)
T 4eto_A 7 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSN 65 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCC
Confidence 34678999999997 6885 89999999999986 652 245799999999999975
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=98.08 E-value=1.9e-06 Score=74.18 Aligned_cols=56 Identities=21% Similarity=0.318 Sum_probs=51.5
Q ss_pred ccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 436 TLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++.+++.+++++|..+|.|++|.|+.+||+.+|+.+|. .+++.++..++..+|.+
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~-~~~~~~~~~~~~~~d~~ 58 (148)
T 2lmt_A 3 ELTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQ-NPTEAELQDLIAEAENN 58 (148)
T ss_dssp SCCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTC-CCCHHHHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCC-CchHHHHHHHHHhcccC
Confidence 367889999999999999999999999999999999998 69999999999988764
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.08 E-value=3.5e-06 Score=68.98 Aligned_cols=53 Identities=15% Similarity=0.275 Sum_probs=46.8
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.++...++++|..||.|+||+|+.+||+.+|+ +. .++++++.+|++.+|.|
T Consensus 8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~-~~~~~~~~~i~~~~D~d 60 (111)
T 2kgr_A 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILM--QS-SLPQAQLASIWNLSDID 60 (111)
T ss_dssp SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TT-CCCHHHHHHHHHHHCSS
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hC-CCCHHHHHHHHHHHCCC
Confidence 4556778899999999999999999999999998 44 58899999999999864
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=98.07 E-value=3.7e-06 Score=67.27 Aligned_cols=52 Identities=10% Similarity=0.032 Sum_probs=45.1
Q ss_pred hhHHHHHHHHhhhC-CCCCc-ccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNKNG-CIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~~G-~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++...++++|..|| .|++| +|+.+||+.+|+. +|. .+++.+|++||+.+|.|
T Consensus 7 ~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~-~~~~~~v~~l~~~~D~d 65 (99)
T 2y5i_A 7 GAMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMS-QKDPMLVEKIMNDLDSN 65 (99)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTT-SCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccc-cccHHHHHHHHHHHCCC
Confidence 45678999999997 89998 9999999999986 454 57899999999999875
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=98.05 E-value=5e-06 Score=71.52 Aligned_cols=50 Identities=14% Similarity=0.333 Sum_probs=46.3
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|+.||.|++|+|+.+||+.+|..+|. .+++.++++|++.+|.|
T Consensus 82 ~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~e~~~l~~~~D~d 131 (148)
T 2lmt_A 82 EEEMREAFKIFDRDGDGFISPAELRFVMINLGE-KVTDEEIDEMIREADFD 131 (148)
T ss_dssp HHHHHHHHHHHHSSCSSEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCc-cccHHHHHHHHHHhCCC
Confidence 346899999999999999999999999999997 69999999999999875
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=98.05 E-value=5.7e-06 Score=66.57 Aligned_cols=51 Identities=10% Similarity=0.183 Sum_probs=46.5
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++++|..||.|++|+|+.+||+.+|..+|. .+++.++++|++.+|.|
T Consensus 22 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~e~~~l~~~~d~~ 72 (105)
T 1wlz_A 22 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQ-ILTDEQFDRLWNEMPVN 72 (105)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTC-CCCHHHHHHHHTTSCBC
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHcCCC
Confidence 3567899999999999999999999999999987 69999999999999854
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=98.04 E-value=2.2e-06 Score=65.77 Aligned_cols=53 Identities=17% Similarity=0.333 Sum_probs=46.8
Q ss_pred hhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhc--cccccHHHHHH----HHhcccCC
Q 011154 439 VDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNA--TDAMKESRISD----LLAPSDGF 492 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g--~~~~~~~ei~~----~i~~~D~~ 492 (492)
.++...++++|..+|.|++|+|+.+||+.++..+| . .++++++.+ +++.+|.|
T Consensus 3 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~D~~ 61 (83)
T 1yx7_A 3 CKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYK-ALSKDKVKEASAKLIKMADKN 61 (83)
T ss_dssp SCSCTHHHHHHHHHSSSCSSSCSHHHHHHHHHHHTTCT-TTTTTTTHHHHHHHHTTTCSS
T ss_pred ccHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccc-CCCHHHHHHHHHHHHHHhCCC
Confidence 34556789999999999999999999999999998 5 588899999 99999864
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.04 E-value=8.9e-07 Score=72.41 Aligned_cols=53 Identities=25% Similarity=0.315 Sum_probs=46.7
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.++..+++++|+.||.|+||+|+.+||+.+|+.+| ++++++.+|++.+|.|
T Consensus 16 ls~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g---l~~~el~~i~~~~D~d 68 (110)
T 1iq3_A 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK---LSIPELSYIWELSDAD 68 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS---CSSCCHHHHHHHHCSS
T ss_pred CCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC---CCHHHHHHHHHHHcCC
Confidence 4566788899999999999999999999999998775 5678999999999864
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=98.03 E-value=5.3e-06 Score=67.21 Aligned_cols=52 Identities=19% Similarity=0.289 Sum_probs=46.7
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.++..+++++|+.||+ +||+|+.+|++.+|+++| ++++++.+|++.+|.|
T Consensus 9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g---l~~~el~~i~~~~D~d 60 (106)
T 1eh2_A 9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK---LPVDILGRVWELSDID 60 (106)
T ss_dssp SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT---CCHHHHHHHHHHHCSS
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC---CCHHHHHHHHHHHcCC
Confidence 456778889999999999 999999999999999875 6799999999999864
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=98.03 E-value=3.8e-06 Score=66.66 Aligned_cols=52 Identities=12% Similarity=0.144 Sum_probs=40.6
Q ss_pred hhHHHHHHHHhhhC-CCC-CcccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNK-NGCIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~-~G~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++...++++|+.|| .|+ +|+|+.+||+.+|+. +|. .+++.+|++||+.+|.|
T Consensus 6 ~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~-~~~~~~v~~l~~~~D~d 64 (95)
T 1j55_A 6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQS-GKDKDAVDKLLKDLDAN 64 (95)
T ss_dssp HHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC-------CHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhccc-ccCHHHHHHHHHHhCCC
Confidence 45678999999999 798 589999999999987 454 57889999999999875
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.5e-06 Score=62.20 Aligned_cols=47 Identities=17% Similarity=0.328 Sum_probs=43.1
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++++|..+|.|++|.|+.+||+.++..+|. .++++++..+++.+|.|
T Consensus 2 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~~ 48 (66)
T 3li6_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRA-IKNEQLLQLIFKSIDAD 48 (66)
T ss_dssp CCHHHHHHCTTCSSSCCHHHHHHHHHHHHH-HHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHccC-CCcHHHHHHHHHHHCCC
Confidence 467899999999999999999999999987 68999999999999875
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.02 E-value=6.6e-06 Score=73.22 Aligned_cols=50 Identities=24% Similarity=0.414 Sum_probs=45.8
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
+....++++|+.||.|++|+|+.+||+.+|..+|. .+++++|++||+.+|
T Consensus 81 ~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~-~~~~~ei~~l~~~~d 130 (176)
T 2lhi_A 81 DSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGE-KLTDAEVDDMLREVS 130 (176)
T ss_dssp HHHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTC-CCCHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCc-ccchHHHHHHHHhhc
Confidence 34567899999999999999999999999999987 699999999999887
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=98.01 E-value=5.1e-06 Score=62.83 Aligned_cols=48 Identities=15% Similarity=0.234 Sum_probs=43.9
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|..+|.|++|+|+.+||+.+|..+| .++++++..+++.+|.|
T Consensus 3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g--~~~~~~~~~~~~~~D~~ 50 (78)
T 1k9u_A 3 DDMERIFKRFDTNGDGKISLSELTDALRTLG--STSADEVQRMMAEIDTD 50 (78)
T ss_dssp CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH--TCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC--CCCHHHHHHHHHHhCCC
Confidence 3578999999999999999999999999998 58999999999999864
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=98.01 E-value=8e-06 Score=69.65 Aligned_cols=50 Identities=18% Similarity=0.395 Sum_probs=46.1
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.+|..+|. .++++++++||+.+|.|
T Consensus 78 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~D~d 127 (143)
T 2obh_A 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGE-NLTDEELQEMIDEADRD 127 (143)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 456899999999999999999999999999987 69999999999999875
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=98.00 E-value=4.8e-06 Score=71.08 Aligned_cols=53 Identities=17% Similarity=0.325 Sum_probs=48.0
Q ss_pred hhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 439 VDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++..+++++|..||.|++|.|+.+||+.+|+.+|. .+++.++..|++.+|.|
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~~ 54 (143)
T 2obh_A 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGF-EPKKEEIKKMISEIDKE 54 (143)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 356778999999999999999999999999999997 58999999999998864
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.99 E-value=6.4e-06 Score=66.70 Aligned_cols=53 Identities=19% Similarity=0.192 Sum_probs=48.6
Q ss_pred hhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 439 VDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++...++.+|..+|.|++|+|+.+||+.+|..+|. .+++.++.++++.+|.|
T Consensus 28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~l~~~~D~d 80 (107)
T 2d58_A 28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEKLGV-PKTHLELKKLIGEVSSG 80 (107)
T ss_dssp HHHHHHHHHHHTTSCCCTTSCEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 566788999999999999999999999999999987 69999999999999864
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=97.98 E-value=2.9e-06 Score=74.19 Aligned_cols=52 Identities=19% Similarity=0.221 Sum_probs=47.5
Q ss_pred ccchhhHHHHHHHHhhhCC--CCCcccchHHHHHHHHhhccccccHHHHHHHHhc
Q 011154 436 TLTVDERFYLKEQFALLEP--NKNGCIAFENIKTVLMKNATDAMKESRISDLLAP 488 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~--~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~ 488 (492)
+|+.+++.++|++|..||. |++|.|+.+||+.+|+.+|. .+++++|.+|+..
T Consensus 2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~-~~t~~el~~~~~~ 55 (159)
T 3i5g_C 2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGM-NPTEAQVHQHGGT 55 (159)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTC-CCCHHHHHTTTCC
T ss_pred CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCC-CCCHHHHHHHHcc
Confidence 5778899999999999995 89999999999999999998 6999999998764
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=97.97 E-value=3.3e-06 Score=64.46 Aligned_cols=51 Identities=22% Similarity=0.476 Sum_probs=45.6
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhc-cccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNA-TDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g-~~~~~~~ei~~~i~~~D~~ 492 (492)
+....++ +|..+|.|++|+|+.+||+.+|..+| . .+++.++.+|++.+|.|
T Consensus 6 ~~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~-~~~~~~~~~~~~~~D~~ 57 (81)
T 1c7v_A 6 DEEEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEE-PLTDAEVEEAMKEADED 57 (81)
T ss_dssp -CHHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTC-CCCHHHHHHHHHHHCSS
T ss_pred cHHHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCC-CCCHHHHHHHHHHhCCC
Confidence 3456789 99999999999999999999999998 6 68999999999999864
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=97.96 E-value=1.3e-05 Score=64.21 Aligned_cols=53 Identities=15% Similarity=0.171 Sum_probs=43.6
Q ss_pred hhHHHHHHHHhhhCCCC---CcccchHHHHHHHHhhccccc----cHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNK---NGCIAFENIKTVLMKNATDAM----KESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~---~G~Is~~el~~~l~~~g~~~~----~~~ei~~~i~~~D~~ 492 (492)
.....|+++|..||.++ +|+|+.+||+.+|+..+...+ ++.+|++||+++|.|
T Consensus 8 ~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d 67 (100)
T 3nxa_A 8 KAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDAN 67 (100)
T ss_dssp HHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCC
T ss_pred HHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCC
Confidence 34567999999999964 799999999999987543233 478999999999975
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=97.95 E-value=9.4e-06 Score=69.50 Aligned_cols=56 Identities=25% Similarity=0.374 Sum_probs=50.2
Q ss_pred ccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 436 TLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++.++...++++|..+|.|++|.|+.+||+.+|+.+|. .+++.++..|++.+|.|
T Consensus 3 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~ 58 (148)
T 1exr_A 3 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDAD 58 (148)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTT
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHHCCC
Confidence 456778888999999999999999999999999999987 58999999999998864
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=97.95 E-value=1.1e-05 Score=69.53 Aligned_cols=53 Identities=17% Similarity=0.157 Sum_probs=48.6
Q ss_pred hhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 439 VDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++...++++|..||.|++|.|+.+||+.+|..+|. .+++.++++|++.+|.|
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~-~~~~~~~~~l~~~~D~d 96 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGV-PKTHLELKRLIREVSSG 96 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 467788999999999999999999999999999987 69999999999999864
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=97.94 E-value=9.2e-06 Score=63.91 Aligned_cols=51 Identities=10% Similarity=0.171 Sum_probs=45.1
Q ss_pred hhHHHHHHHHhhhCCCCCc---ccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNG---CIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G---~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+..++++|..|| ++|| +|+.+||+.+|+. +|. .+++.++++||+.+|.|
T Consensus 6 ~~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~-~~~~~~v~~~~~~~D~d 64 (92)
T 3rm1_A 6 KAVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEE-IKEQEVVDKVMETLDSN 64 (92)
T ss_dssp HHHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCC-CCSHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccC-cccHHHHHHHHHHHcCC
Confidence 34567999999999 7777 9999999999999 886 68999999999999975
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=97.94 E-value=3.5e-06 Score=68.29 Aligned_cols=53 Identities=6% Similarity=0.045 Sum_probs=43.5
Q ss_pred hhHHHHHHHHhhhC-CCCC-cccchHHHHHHHHh-hccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNKN-GCIAFENIKTVLMK-NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~~-G~Is~~el~~~l~~-~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++...++++|..|| .|++ |+|+.+||+.+|+. +|....++++|++||+++|.|
T Consensus 19 ~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d 74 (106)
T 2h2k_A 19 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVN 74 (106)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCC
Confidence 45678999999999 7997 79999999999986 564222357899999999875
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.92 E-value=9e-06 Score=68.87 Aligned_cols=52 Identities=15% Similarity=0.067 Sum_probs=46.4
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.||.|++|+|+.+||+.+|..+|.+.++++++++|++.+|.|
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~~~D~d 89 (135)
T 3h4s_E 38 FVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVREGDLD 89 (135)
T ss_dssp HHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHHHHCSS
T ss_pred hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCC
Confidence 4567899999999999999999999999999983269999999999999864
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=97.91 E-value=5e-06 Score=62.38 Aligned_cols=50 Identities=16% Similarity=0.235 Sum_probs=45.6
Q ss_pred HHHHHHHHhhh-CCCCC-cccchHHHHHHHHhhccccc--cHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALL-EPNKN-GCIAFENIKTVLMKNATDAM--KESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~-D~~~~-G~Is~~el~~~l~~~g~~~~--~~~ei~~~i~~~D~~ 492 (492)
...++++|..+ |.|++ |+|+.+||+.+|..+|. .+ +++++.+|++.+|.|
T Consensus 4 ~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~l~~~~D~~ 57 (76)
T 1qx2_A 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGP-SLLKGMSTLDEMIEEVDKN 57 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGG-GSCTTSCSHHHHHHHHCTT
T ss_pred HHHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCC-CcCCCHHHHHHHHHHhCCC
Confidence 45789999999 99999 99999999999999987 58 899999999999864
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=97.90 E-value=8.5e-06 Score=75.27 Aligned_cols=76 Identities=12% Similarity=0.144 Sum_probs=65.9
Q ss_pred HHHHhhhhhhHHHHHHhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 416 MKAYMQSSSLRRAALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 416 ~~~~~~~~~l~~a~l~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...+...+.+++.....+...++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++++++.+++.+|.|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~~~~~l~~~~D~d 99 (220)
T 3sjs_A 24 ACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGI-RLSPQTALRMMRIFDTD 99 (220)
T ss_dssp HHHHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGB-CCCHHHHHHHHHHHCTT
T ss_pred hhccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 34556666677776667788889999999999999999999999999999999999987 69999999999999864
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=97.88 E-value=8.7e-06 Score=63.83 Aligned_cols=52 Identities=10% Similarity=0.074 Sum_probs=46.1
Q ss_pred hhHHHHHHHHhhhC-CCCCc-ccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNKNG-CIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~~G-~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++...++++|..+| .|++| .|+.+||+.+|.. +|. .+++.++++|++.+|.|
T Consensus 6 ~~~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~-~~~~~~~~~~~~~~D~d 64 (93)
T 1k2h_A 6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDV-QKDADAVDKIMKELDEN 64 (93)
T ss_dssp HHHHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHC-CCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 45567999999999 79999 9999999999998 876 68999999999998753
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=97.88 E-value=1.2e-05 Score=68.13 Aligned_cols=50 Identities=20% Similarity=0.185 Sum_probs=44.8
Q ss_pred hhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 439 VDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++..+++++|+.|| |+||+|+.+|++.+|++.| ++++++.+|++.+|.|
T Consensus 47 ~~e~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~g---l~~~el~~I~~~~D~d 96 (139)
T 2jq6_A 47 GKDKPTYDEIFYTLS-PVNGKITGANAKKEMVKSK---LPNTVLGKIWKLADVD 96 (139)
T ss_dssp GGTHHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTT---CCHHHHHHHHHHHCSS
T ss_pred hHHHHHHHHHHHHhC-CCCCeECHHHHHHHHHHhC---cCHHHHHHHHHHhCCC
Confidence 356778999999999 9999999999999999865 7799999999999864
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=97.88 E-value=1.2e-05 Score=64.89 Aligned_cols=52 Identities=21% Similarity=0.302 Sum_probs=46.6
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhh---ccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKN---ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~---g~~~~~~~ei~~~i~~~D~~ 492 (492)
.....++.+|+.+|.|++|+|+.+||+.+|..+ |. .++++++++|++.+|.|
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~-~~~~~~~~~~~~~~D~~ 92 (109)
T 1rwy_A 38 KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDAR-DLSAKETKTLMAAGDKD 92 (109)
T ss_dssp SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCC-CCCHHHHHHHHHHHCTT
T ss_pred chHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCC-CCCHHHHHHHHHHHCCC
Confidence 345678999999999999999999999999998 55 69999999999999864
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=97.87 E-value=1.1e-05 Score=65.27 Aligned_cols=51 Identities=27% Similarity=0.389 Sum_probs=46.3
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhh---ccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKN---ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~---g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.+|.|++|+|+.+||+.+|..+ |. .+++++++.+++.+|.|
T Consensus 39 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~-~~~~~~~~~~~~~~D~~ 92 (109)
T 5pal_A 39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGR-DLNDTETKALLAAGDSD 92 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCC-CCCHHHHHHHHHHHCTT
T ss_pred cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 45578999999999999999999999999998 76 69999999999999875
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=97.87 E-value=1.1e-05 Score=65.18 Aligned_cols=51 Identities=22% Similarity=0.313 Sum_probs=46.2
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhh---ccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKN---ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~---g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|..+|.|++|+|+.+||+.+|..+ |. .++++++++|++.+|.|
T Consensus 40 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~-~~~~~~~~~~~~~~D~~ 93 (109)
T 1bu3_A 40 SADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGAR-ALTDAETKAFLKAGDSD 93 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCC-CCCHHHHHHHHHHHCTT
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCC-CCCHHHHHHHHHHhCCC
Confidence 45678999999999999999999999999998 55 69999999999999864
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=97.87 E-value=1.5e-05 Score=67.67 Aligned_cols=59 Identities=27% Similarity=0.390 Sum_probs=50.8
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
|+..++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 1 m~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~d~~ 59 (147)
T 4ds7_A 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGL-SPSEAEVADLMNEIDVD 59 (147)
T ss_dssp ---CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred CCCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCC-CCCHHHHHHHHHHhccC
Confidence 345677888899999999999999999999999999999987 58999999999988864
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=97.87 E-value=1.7e-05 Score=64.13 Aligned_cols=52 Identities=19% Similarity=0.251 Sum_probs=46.8
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhh---ccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKN---ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~---g~~~~~~~ei~~~i~~~D~~ 492 (492)
.....++.+|..+|.|++|+|+.+||+.+|..+ |. .++++++++|++.+|.|
T Consensus 39 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~-~~~~~~~~~~~~~~d~~ 93 (110)
T 1pva_A 39 MSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGR-DLTDAETKAFLKAADKD 93 (110)
T ss_dssp SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCC-CCCHHHHHHHHHHHCTT
T ss_pred chHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCC-CCCHHHHHHHHHHhCCC
Confidence 456679999999999999999999999999998 55 69999999999999864
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=97.87 E-value=1.9e-05 Score=63.74 Aligned_cols=52 Identities=23% Similarity=0.312 Sum_probs=46.7
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhh---ccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKN---ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~---g~~~~~~~ei~~~i~~~D~~ 492 (492)
.....++.+|+.+|.|++|+|+.+||+.+|..+ |. .++++++++|++.+|.|
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~-~~~~~~~~~~~~~~D~~ 92 (108)
T 2pvb_A 38 KSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSAR-ALTDAETKAFLADGDKD 92 (108)
T ss_dssp SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSC-CCCHHHHHHHHHHHCTT
T ss_pred hHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCC-CCCHHHHHHHHHHhCCC
Confidence 345678999999999999999999999999998 65 69999999999999864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00013 Score=66.28 Aligned_cols=122 Identities=16% Similarity=0.072 Sum_probs=80.4
Q ss_pred chHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCccccc
Q 011154 224 ELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIV 302 (492)
Q Consensus 224 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~~~~~ 302 (492)
+|.+.|...+.+++|+++|.++.|.+.+|.-+-. ..-..+=+-|..|+| ..+|.|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD-----------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------c
Confidence 7999998888999999999999999999876522 121233345688888 4555665543 1110 1
Q ss_pred cCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcccc
Q 011154 303 GSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNK 381 (492)
Q Consensus 303 gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 381 (492)
....+.+||......+.+.=|||||+++|..+--..| ...-..+|+++..||..|..-
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence 2234678888765566788999999999998843332 122237999999999999866
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=97.85 E-value=2e-05 Score=63.67 Aligned_cols=52 Identities=23% Similarity=0.323 Sum_probs=46.8
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhh---ccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKN---ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~---g~~~~~~~ei~~~i~~~D~~ 492 (492)
.....++.+|..+|.|++|+|+.+||+.+|..+ |. .+++++++.+++.+|.|
T Consensus 39 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~~~~D~~ 93 (109)
T 3fs7_A 39 KTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSAR-VLTSAETKAFLAAGDTD 93 (109)
T ss_dssp CCHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSC-CCCHHHHHHHHHHHCTT
T ss_pred CcHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccc-cCCHHHHHHHHHHhCCC
Confidence 345678999999999999999999999999998 65 69999999999999875
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=97.84 E-value=7.6e-06 Score=64.40 Aligned_cols=52 Identities=21% Similarity=0.272 Sum_probs=44.5
Q ss_pred hhHHHHHHHHhhhC-CCCCc-ccchHHHHHHHHhhcc--ccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNKNG-CIAFENIKTVLMKNAT--DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~~G-~Is~~el~~~l~~~g~--~~~~~~ei~~~i~~~D~~ 492 (492)
++...++++|..|| .|++| +|+.+||+.+|+..+. . +++.+|++||+.+|.|
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~-~~~~~i~~~~~~~D~d 62 (92)
T 2kax_A 7 KALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGE-MKESSIDDLMKSLDKN 62 (92)
T ss_dssp HHHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTT-TCCTTHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCC-CCHHHHHHHHHHhCCC
Confidence 45677999999999 99999 9999999999987322 3 7888999999999875
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=97.82 E-value=1.7e-05 Score=68.49 Aligned_cols=53 Identities=15% Similarity=0.252 Sum_probs=48.1
Q ss_pred hhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 439 VDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++...++++|..||.|++|.|+.+||+.+|..+|. .+++.++++|++.+|.|
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~e~~~l~~~~D~d 98 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGV-PKTHLEMKKMISEVTGG 98 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHCCC
Confidence 356678999999999999999999999999999987 69999999999999864
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=97.82 E-value=2.7e-05 Score=66.62 Aligned_cols=50 Identities=16% Similarity=0.319 Sum_probs=45.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|.|
T Consensus 82 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~d 131 (148)
T 1exr_A 82 EEELIEAFKVFDRDGNGLISAAELRHVMTNLGE-KLTDDEVDEMIREADID 131 (148)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 456889999999999999999999999999987 69999999999999864
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=97.81 E-value=1.1e-05 Score=69.02 Aligned_cols=59 Identities=17% Similarity=0.240 Sum_probs=53.2
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
|+..++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 1 m~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~d~~ 59 (153)
T 3ox6_A 1 MDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGY-MPTEMELIELSQQINMN 59 (153)
T ss_dssp CCSCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTC-CCCHHHHHHHHHHHHTT
T ss_pred CcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 345678888999999999999999999999999999999987 69999999999988764
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=2.3e-05 Score=64.23 Aligned_cols=53 Identities=9% Similarity=0.004 Sum_probs=45.1
Q ss_pred hhHHHHHHHHhhhCC-CCCc-ccchHHHHHHHH-hhccc---c-ccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEP-NKNG-CIAFENIKTVLM-KNATD---A-MKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~-~~~G-~Is~~el~~~l~-~~g~~---~-~~~~ei~~~i~~~D~~ 492 (492)
++...++++|..||. |++| +|+.+||+.+|+ .+|.. . +++.+|++||+.+|.|
T Consensus 9 ~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d 68 (113)
T 1xk4_C 9 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTN 68 (113)
T ss_dssp HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCC
Confidence 446779999999995 9999 999999999998 67641 2 6899999999999875
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=97.81 E-value=2e-05 Score=78.58 Aligned_cols=51 Identities=14% Similarity=0.343 Sum_probs=46.5
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++++|+.||.|++|+|+.+||+.+|..+|. .++++||++||+.+|.|
T Consensus 373 ~eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe-~LSdeEIdeLfke~D~D 423 (440)
T 3u0k_A 373 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGE-KLTDEEVDEMIREADID 423 (440)
T ss_dssp -CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTT
T ss_pred hHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 3457899999999999999999999999999997 69999999999999875
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=97.81 E-value=2.3e-05 Score=67.73 Aligned_cols=59 Identities=14% Similarity=0.227 Sum_probs=52.6
Q ss_pred hhcccchhhHHHHHHHHhhhCCCC-CcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNK-NGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~-~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+...++.++...++++|..+|.|+ +|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 8 ~~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~~ 67 (161)
T 1dtl_A 8 AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDED 67 (161)
T ss_dssp GGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred HHhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 455677788899999999999999 999999999999999987 68999999999998864
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=97.80 E-value=9.2e-06 Score=63.95 Aligned_cols=52 Identities=8% Similarity=0.040 Sum_probs=45.3
Q ss_pred hhHHHHHHHHhhhCC-CCCc-ccchHHHHHHH-HhhccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEP-NKNG-CIAFENIKTVL-MKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~-~~~G-~Is~~el~~~l-~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+....++++|..||. |++| .|+.+||+.+| +.+|. .+++.++++|++.+|.|
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~g~-~~~~~~~~~l~~~~D~d 61 (93)
T 1xk4_A 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQ-YIRKKGADVWFKELDIN 61 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCH-HHHTTCHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHhhcCCCcCeECHHHHHHHHHHHCcc-cCCHHHHHHHHHHhCCC
Confidence 345678999999999 9999 99999999999 77876 57778999999999865
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=97.79 E-value=2.8e-05 Score=62.73 Aligned_cols=53 Identities=19% Similarity=0.300 Sum_probs=46.4
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhc--cccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNA--TDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g--~~~~~~~ei~~~i~~~D~~ 492 (492)
.+...++.+|+.+|.|++|+|+.+||+.+|..++ ...++++++++|++.+|.|
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~ 92 (108)
T 1rro_A 38 MSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADND 92 (108)
T ss_dssp SCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCS
T ss_pred ccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCC
Confidence 3456789999999999999999999999999983 2368999999999999864
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.77 E-value=1.1e-05 Score=66.87 Aligned_cols=51 Identities=10% Similarity=0.158 Sum_probs=45.1
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+..|+.+|..||.| +|+|+.+||+.+|++ ++. ..++++|++||+++|.|
T Consensus 12 ~~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~-~~~~~~v~~~i~~~D~d 67 (121)
T 4drw_A 12 HAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLEN-QKDPLAVDKIMKDLDQC 67 (121)
T ss_dssp HHHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTT-SSCTTHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhccc-CCCHHHHHHHHHHHcCC
Confidence 3467899999999998 899999999999987 565 68899999999999986
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=97.76 E-value=3.3e-05 Score=65.79 Aligned_cols=50 Identities=10% Similarity=0.241 Sum_probs=46.2
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|.|+.+||+.+|..+|. .++++++++|++.+|.|
T Consensus 82 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~d 131 (148)
T 1m45_A 82 TEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGE-KLTDAEVDELLKGVEVD 131 (148)
T ss_dssp THHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTT-CCCHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 456899999999999999999999999999987 69999999999999875
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=97.75 E-value=1.4e-05 Score=62.13 Aligned_cols=52 Identities=13% Similarity=0.192 Sum_probs=45.6
Q ss_pred hhHHHHHHHHhhhC-CCCCc-ccchHHHHHHHHh---hccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNKNG-CIAFENIKTVLMK---NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~~G-~Is~~el~~~l~~---~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+....++.+|..+| .|++| .|+.+||+.+|+. +|. .+++.++++|++.+|.|
T Consensus 7 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~-~~~~~~~~~~~~~~D~~ 63 (90)
T 1k8u_A 7 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGS-KLQDAEIARLMEDLDRN 63 (90)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGG-GTTSHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHhcccCC-CCCHHHHHHHHHHhCCC
Confidence 34567899999999 59999 9999999999997 886 68899999999998754
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.75 E-value=2.8e-05 Score=65.68 Aligned_cols=53 Identities=23% Similarity=0.394 Sum_probs=44.8
Q ss_pred hhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 439 VDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~d~~ 54 (142)
T 2bl0_C 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGV-RVEPAAFNEMFNEADAT 54 (142)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCcC
Confidence 356677889999999999999999999999988887 58888899999888764
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=97.75 E-value=2.7e-05 Score=67.22 Aligned_cols=59 Identities=20% Similarity=0.371 Sum_probs=52.5
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 13 ~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~d~~ 71 (161)
T 3fwb_A 13 LNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGF-ELPKREILDLIDEYDSE 71 (161)
T ss_dssp TTTTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCcC
Confidence 345677788899999999999999999999999999999987 68999999999998864
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.74 E-value=2.6e-05 Score=65.98 Aligned_cols=50 Identities=10% Similarity=0.244 Sum_probs=46.2
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|.|
T Consensus 75 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~~~~~~~~~~D~d 124 (143)
T 3j04_B 75 EDVIRNAFACFDEEASGFIHEDHLRELLTTMGD-RFTDEEVDEMYREAPID 124 (143)
T ss_dssp HHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSS-CCCHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCC
Confidence 456899999999999999999999999999987 69999999999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00016 Score=70.35 Aligned_cols=76 Identities=17% Similarity=0.150 Sum_probs=60.0
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC--CCccEEEEEEEeCCeEEEE
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH--SNLVKFYDAFEDLDNVYIV 216 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h--pniv~l~~~~~~~~~~~lv 216 (492)
.+.|+.|....+|++.. .+..++||+.... ....+..|...|+.|..+ ..+++++.+....+..++|
T Consensus 41 ~~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv 109 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL 109 (312)
T ss_dssp EEEECCSSSSEEEEEES-----SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred eEEeCCccceeeeEEEE-----CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence 45689999999999863 3567899987532 245688999999988643 5688899998888899999
Q ss_pred EeecCCCch
Q 011154 217 MELCEGGEL 225 (492)
Q Consensus 217 ~E~~~ggsL 225 (492)
|||++|..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0001 Score=74.92 Aligned_cols=77 Identities=12% Similarity=-0.001 Sum_probs=44.3
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCC--CCH----HHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKM--TTA----IAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~--~~~----~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+.||.|..+.||++.. .+..++||....... ... .....+..|+..+..-..+..+.+++.+. .+.
T Consensus 39 i~~l~~G~~n~vyrv~~-----~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~ 111 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-----SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTM 111 (420)
T ss_dssp EEECCCSSSCEEEEEEC-----SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTT
T ss_pred EEEccCCCcEEEEEEEc-----CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCc
Confidence 45689999999999852 456899994321100 000 01122334443332211234567777665 567
Q ss_pred EEEEEeec-CC
Q 011154 213 VYIVMELC-EG 222 (492)
Q Consensus 213 ~~lv~E~~-~g 222 (492)
.++||||+ +|
T Consensus 112 ~~lv~e~l~~g 122 (420)
T 2pyw_A 112 ALIGMRYLEPP 122 (420)
T ss_dssp TEEEECCCCTT
T ss_pred cEEEEeecCCc
Confidence 78999999 77
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=97.72 E-value=3.5e-05 Score=68.64 Aligned_cols=52 Identities=13% Similarity=0.274 Sum_probs=45.4
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHH-hhccccc------cHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLM-KNATDAM------KESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~-~~g~~~~------~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.||.|+||+|+.+||+.+|. .+|...+ +++++++||+.+|.|
T Consensus 96 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d 154 (179)
T 3a8r_A 96 FDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPT 154 (179)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTT
T ss_pred HHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCC
Confidence 456799999999999999999999999998 7775325 889999999999875
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=97.72 E-value=1.1e-05 Score=64.65 Aligned_cols=52 Identities=12% Similarity=0.130 Sum_probs=43.3
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHh-----hcc-ccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMK-----NAT-DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~-----~g~-~~~~~~ei~~~i~~~D~~ 492 (492)
++...++++|..||.+ +|+|+.+||+.+|+. +|. ..+++.+|++||+++|.|
T Consensus 7 ~~~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~d 64 (100)
T 1psr_A 7 RSIIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKN 64 (100)
T ss_dssp HHHHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTT
T ss_pred HHHHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCCC
Confidence 4567899999999976 899999999999987 342 037788999999999875
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.71 E-value=6.6e-05 Score=63.49 Aligned_cols=52 Identities=17% Similarity=0.316 Sum_probs=47.1
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.....++.+|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|.|
T Consensus 73 ~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~-~~~~~~~~~~~~~~d~~ 124 (145)
T 2bl0_B 73 EQSKEMLDAFRALDKEGNGTIQEAELRQLLLNLGD-ALTSSEVEELMKEVSVS 124 (145)
T ss_dssp GGHHHHHHHHHHHCSSSSSEEEHHHHHHHHHHSSS-CCCHHHHHHHHTTCCCC
T ss_pred ccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCC
Confidence 34567899999999999999999999999999987 69999999999999865
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=97.70 E-value=4.1e-05 Score=66.83 Aligned_cols=57 Identities=19% Similarity=0.308 Sum_probs=51.2
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 20 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~~ 76 (169)
T 3qrx_A 20 VGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGF-EPKKEEIKKMISEIDKD 76 (169)
T ss_dssp CCCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSC-CCCHHHHHHHHHHHCSS
T ss_pred CCCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCC
Confidence 3456788899999999999999999999999999999987 68999999999998864
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=97.69 E-value=4.1e-05 Score=65.99 Aligned_cols=57 Identities=23% Similarity=0.335 Sum_probs=51.4
Q ss_pred cccchhhHHHHHHHHhhhC-CCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 435 KTLTVDERFYLKEQFALLE-PNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D-~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.++...++++|..+| .|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 5 ~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~D~~ 62 (158)
T 2jnf_A 5 SKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGI-QQTKSTIRQLIDEFDPF 62 (158)
T ss_dssp TTSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTC-SCSHHHHHHHHHHHCTT
T ss_pred hhCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 3466778889999999999 999999999999999999987 58999999999998864
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=97.69 E-value=4.6e-05 Score=64.74 Aligned_cols=55 Identities=13% Similarity=0.158 Sum_probs=49.6
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcc---cCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPS---DGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~---D~~ 492 (492)
++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+ |.|
T Consensus 2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~~~~d~~ 59 (149)
T 2mys_C 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQ-NPTNAEINKILGNPSKEEMN 59 (149)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhhhcccc
Confidence 45677889999999999999999999999999999987 68999999999988 754
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=97.68 E-value=2.1e-05 Score=62.44 Aligned_cols=51 Identities=10% Similarity=0.146 Sum_probs=43.1
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++...++++|..||. +||+|+.+||+.+|+. +|. .+++.+|++||+.+|.|
T Consensus 6 ~~~~~l~~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~-~~~~~ev~~l~~~~D~d 61 (96)
T 1a4p_A 6 HAMETMMFTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLEN-QKDPLAVDKIMKDLDQC 61 (96)
T ss_dssp HHHHHHHHHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHH-SCCTTHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHcC-CCCeECHHHHHHHHHHHccccccc-ccCHHHHHHHHHHhCCC
Confidence 456789999999994 6779999999999986 454 47889999999999875
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=97.67 E-value=4.6e-05 Score=66.37 Aligned_cols=54 Identities=15% Similarity=0.346 Sum_probs=48.4
Q ss_pred ccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc-ccccHHHHHHHHhccc
Q 011154 436 TLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT-DAMKESRISDLLAPSD 490 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~-~~~~~~ei~~~i~~~D 490 (492)
.++.++...++++|..+|.|++|.|+.+||+.+|..+|. . +++.++..|++..|
T Consensus 18 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~-~~~~~~~~l~~~~d 72 (166)
T 2mys_B 18 MFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLN-VKNEELDAMIKEAS 72 (166)
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCC-CCHHHHHHHHHHCC
Confidence 567788899999999999999999999999999999985 4 88999999988764
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=97.66 E-value=9e-06 Score=61.27 Aligned_cols=51 Identities=16% Similarity=0.180 Sum_probs=44.7
Q ss_pred hHHHHHHHHhhhCC-CCCc-ccchHHHHHHHHh-hccccc-cHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEP-NKNG-CIAFENIKTVLMK-NATDAM-KESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~-~~~G-~Is~~el~~~l~~-~g~~~~-~~~ei~~~i~~~D~~ 492 (492)
+...++.+|..+|. |++| .|+.+||+.+|+. +|. .+ ++.++++|++.+|.|
T Consensus 5 ~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~-~~~~~~~~~~~~~~~D~~ 59 (78)
T 1cb1_A 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPS-LLKGPRTLDDLFQELDKN 59 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSS-CCSSCCCSSHHHHHTCCC
T ss_pred HHHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhh-hcccHHHHHHHHHHhcCC
Confidence 45678999999999 9999 9999999999986 775 45 888999999999865
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=97.66 E-value=5.5e-05 Score=65.86 Aligned_cols=50 Identities=16% Similarity=0.239 Sum_probs=46.1
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|.|
T Consensus 94 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~D~d 143 (166)
T 2mys_B 94 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGG-RFTPEEIKNMWAAFPPD 143 (166)
T ss_pred HHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCC-CCCHHHHHHHHHhcCCC
Confidence 456899999999999999999999999999987 69999999999999875
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=97.64 E-value=5.1e-05 Score=65.55 Aligned_cols=59 Identities=14% Similarity=0.187 Sum_probs=52.9
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+...++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 10 ~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~ 68 (162)
T 1top_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDED 68 (162)
T ss_dssp HHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred hhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHcCC
Confidence 445677888899999999999999999999999999999987 58999999999998864
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=97.61 E-value=6.3e-05 Score=64.68 Aligned_cols=51 Identities=12% Similarity=0.174 Sum_probs=46.4
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhc--ccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAP--SDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~--~D~~ 492 (492)
....++.+|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++. +|.|
T Consensus 82 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~~~D~d 134 (156)
T 1wdc_C 82 TFADYMEAFKTFDREGQGFISGAELRHVLTALGE-RLSDEDVDEIIKLTDLQED 134 (156)
T ss_dssp CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSS-CCCHHHHHHHHHHHTCCCC
T ss_pred hHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCC
Confidence 3456899999999999999999999999999987 6999999999999 8864
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.61 E-value=7e-05 Score=63.11 Aligned_cols=50 Identities=14% Similarity=0.266 Sum_probs=45.7
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
....++.+|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|.
T Consensus 74 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~ 123 (140)
T 1ggw_A 74 DPEEFVKGFQVFDKDATGMIGVGELRYVLTSLGE-KLSNEEMDELLKGVPV 123 (140)
T ss_dssp CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHS-CSCHHHHHHHHHHTTC
T ss_pred cHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCC-CCCHHHHHHHHHhccC
Confidence 3467899999999999999999999999999987 6999999999999874
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=97.59 E-value=4.8e-05 Score=65.01 Aligned_cols=48 Identities=21% Similarity=0.279 Sum_probs=43.5
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
...++.+|..+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|
T Consensus 86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~d 133 (151)
T 1w7j_B 86 YEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGE-KMTEEEVETVLAGHE 133 (151)
T ss_dssp --CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSS-CCCHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHhcc
Confidence 445788999999999999999999999999987 699999999999998
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=97.58 E-value=9.4e-05 Score=63.62 Aligned_cols=56 Identities=18% Similarity=0.349 Sum_probs=48.3
Q ss_pred hcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 434 SKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 434 ~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
...++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..|++..|
T Consensus 9 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~~ 64 (156)
T 1wdc_B 9 LTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGR-APDDKELTAMLKEAP 64 (156)
T ss_dssp ---CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSS-CCCHHHHHHHHTTSS
T ss_pred hccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHhCC
Confidence 44567788889999999999999999999999999999987 689999999997654
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=97.57 E-value=4.9e-05 Score=65.46 Aligned_cols=50 Identities=12% Similarity=0.189 Sum_probs=45.8
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|++|+|+.+||+.+|..+|. .+++++++.|++.+|.|
T Consensus 86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~~ 135 (156)
T 1wdc_B 86 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGD-NFNKDEMRMTFKEAPVE 135 (156)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSS-CCCHHHHHHHHHHCCEE
T ss_pred HHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCC-CCCHHHHHHHHHhcCCC
Confidence 456899999999999999999999999999987 69999999999999864
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=97.56 E-value=8.7e-05 Score=63.95 Aligned_cols=51 Identities=16% Similarity=0.271 Sum_probs=46.7
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.+|.|++|+|+.+||+.+|..+|. .+++++++.+++.+|.|
T Consensus 94 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~~ 144 (161)
T 3fwb_A 94 PLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGE-TLTDEELRAMIEEFDLD 144 (161)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHTTCSS
T ss_pred cHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 3567899999999999999999999999999987 69999999999999864
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00031 Score=59.95 Aligned_cols=52 Identities=19% Similarity=0.332 Sum_probs=46.1
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHh-hccccccHHHHHHHHhc----ccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMK-NATDAMKESRISDLLAP----SDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~-~g~~~~~~~ei~~~i~~----~D~~ 492 (492)
.....++.+|+.+|.|++|.|+.+||+.++.. +|. .+++.++.++++. +|.|
T Consensus 72 ~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~D~~ 128 (155)
T 3ll8_B 72 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGN-NLKDTQLQQIVDKTIINADKD 128 (155)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGG-GSCHHHHHHHHHHHHHHHCTT
T ss_pred CHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcc-CCCHHHHHHHHHHHHHHhCCC
Confidence 34567899999999999999999999999998 576 6999999999998 8864
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=97.55 E-value=2.3e-05 Score=67.06 Aligned_cols=54 Identities=17% Similarity=0.253 Sum_probs=44.2
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~ 57 (151)
T 1w7j_B 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQ-NPTNAEVLKVLGNPKS 57 (151)
T ss_dssp -------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTC-CCCHHHHHHHTTCCCH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCc
Confidence 45677888999999999999999999999999999987 6899999999998874
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.54 E-value=7.7e-05 Score=62.95 Aligned_cols=48 Identities=17% Similarity=0.386 Sum_probs=44.7
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
...++.+|..+|.|++|.|+.+||+.+|..+|. .++++++++|++.+|
T Consensus 78 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~d 125 (142)
T 2bl0_C 78 EDILRQAFRTFDPEGTGYIPKAALQDALLNLGD-RLKPHEFAEFLGITE 125 (142)
T ss_dssp HHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSS-CCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhC
Confidence 456899999999999999999999999999987 699999999999988
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=97.54 E-value=7e-05 Score=64.47 Aligned_cols=51 Identities=18% Similarity=0.325 Sum_probs=46.4
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.+|.|++|+|+.+||+.+|..+|. .++++++..|++.+|.|
T Consensus 89 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~D~d 139 (158)
T 2jnf_A 89 MQQELREAFRLYDKEGNGYISTDVMREILAELDE-TLSSEDLDAMIDEIDAD 139 (158)
T ss_dssp TSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCT-TCCHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCC-cCCHHHHHHHHHHhCCC
Confidence 3456899999999999999999999999999987 69999999999999864
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=97.54 E-value=0.0001 Score=64.23 Aligned_cols=50 Identities=18% Similarity=0.399 Sum_probs=46.1
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|.|+.+||+.+|..+|. .+++++++++++.+|.|
T Consensus 100 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~D~~ 149 (169)
T 3qrx_A 100 REEILKAFRLFDDDNSGTITIKDLRRVAKELGE-NLTEEELQEMIAEADRN 149 (169)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 456889999999999999999999999999986 69999999999999875
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.52 E-value=6e-05 Score=66.82 Aligned_cols=46 Identities=4% Similarity=0.073 Sum_probs=42.6
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhh----ccccccHHHHHHHHhccc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKN----ATDAMKESRISDLLAPSD 490 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g~~~~~~~ei~~~i~~~D 490 (492)
..++++|+.|| |++|+|+.+||+.+|..+ |. .++++++++|++.+|
T Consensus 76 ~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~-~~~~~~~~~l~~~~d 125 (174)
T 2i7a_A 76 VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGI-FISRELLHLVTLRYS 125 (174)
T ss_dssp HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTC-CCCHHHHHHHHHHHS
T ss_pred HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCC-CCCHHHHHHHHHHHc
Confidence 35899999999 999999999999999999 87 699999999999887
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=6.9e-05 Score=66.99 Aligned_cols=62 Identities=16% Similarity=0.110 Sum_probs=51.5
Q ss_pred HHhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHH-----HHHHhhccccccHH-----HHHHHHhcccCC
Q 011154 430 LKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIK-----TVLMKNATDAMKES-----RISDLLAPSDGF 492 (492)
Q Consensus 430 l~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~-----~~l~~~g~~~~~~~-----ei~~~i~~~D~~ 492 (492)
+..++..++.++...++++|..+|.|++|.|+.+||+ .+|..+|. .+++. ++..+++.+|.|
T Consensus 7 ~~~~~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~-~~~~~~~~~~~~~~l~~~~D~d 78 (195)
T 1qv0_A 7 VKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEA-TPEQTKRHQVCVEAFFRGCGME 78 (195)
T ss_dssp CCCSCCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTC-CHHHHHHHHHHHHHHHHHTTCC
T ss_pred hhcCcccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCC-CccHHHHHHHHHHHHHHHcCCC
Confidence 3445555678889999999999999999999999999 78888887 46665 689999998864
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=97.50 E-value=8.1e-05 Score=67.10 Aligned_cols=49 Identities=8% Similarity=0.116 Sum_probs=44.8
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..||.|++|+|+.+||+.+| .+|. .+++++++.||+.+|.|
T Consensus 125 ~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~-~~~~~~~~~l~~~~D~d 173 (196)
T 3dtp_E 125 EDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGE-KFSQDEVDQALSEAPID 173 (196)
T ss_dssp HHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSS-CCCHHHHHHHHHSSCEE
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCC-CCCHHHHHHHHHHcCCC
Confidence 4568999999999999999999999999 9987 69999999999999853
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00012 Score=62.37 Aligned_cols=50 Identities=14% Similarity=0.222 Sum_probs=45.6
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHh-hccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMK-NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~-~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|++|.|+.+||+.+|.. +|. .+++++++++++.+|.|
T Consensus 87 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~~d~~ 137 (153)
T 3ox6_A 87 VKELRDAFREFDTNGDGEISTSELREAMRALLGH-QVGHRDIEEIIRDVDLN 137 (153)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSS-CCCHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcC-CCCHHHHHHHHHHhCCC
Confidence 456899999999999999999999999998 776 69999999999999864
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=97.50 E-value=7.2e-05 Score=59.25 Aligned_cols=52 Identities=12% Similarity=-0.045 Sum_probs=44.4
Q ss_pred hhHHHHHHHHhhhC-CCCCc-ccchHHHHHHHHh-hc----cccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLE-PNKNG-CIAFENIKTVLMK-NA----TDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D-~~~~G-~Is~~el~~~l~~-~g----~~~~~~~ei~~~i~~~D~~ 492 (492)
+....++.+|..+| .|++| .|+.+||+.+|.. ++ . .+++.++++|++.+|.|
T Consensus 10 ~~~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~-~~~~~~~~~l~~~~D~~ 68 (99)
T 1qls_A 10 RCIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQN-QKDPGVLDRMMKKLDLD 68 (99)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHH-CCCTHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccc-cCCHHHHHHHHHHhCCC
Confidence 34567899999998 99999 9999999999984 43 4 57889999999999865
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00015 Score=61.25 Aligned_cols=48 Identities=21% Similarity=0.383 Sum_probs=44.5
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
...++.+|..+|.|++|.|+.+||+.++..+|. .++++++.++++.+|
T Consensus 83 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d 130 (147)
T 4ds7_A 83 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGE-KLTDAEVDEMLREVS 130 (147)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHS
T ss_pred HHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCC-CCCHHHHHHHHHHhc
Confidence 356889999999999999999999999999987 699999999999988
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00017 Score=61.18 Aligned_cols=51 Identities=16% Similarity=0.212 Sum_probs=45.9
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.....++.+|..+|.|++|.|+.+||+.+|..+|. .++++++.+|++. |.|
T Consensus 82 ~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~-d~~ 132 (149)
T 2mys_C 82 GTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGE-KMTEEEVEELMKG-QED 132 (149)
T ss_pred chHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCC-CCCHHHHHHHHhh-CCC
Confidence 34567899999999999999999999999999987 6999999999998 864
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.46 E-value=9.9e-05 Score=62.33 Aligned_cols=50 Identities=16% Similarity=0.346 Sum_probs=45.4
Q ss_pred chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhc
Q 011154 438 TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAP 488 (492)
Q Consensus 438 ~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~ 488 (492)
+.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~ 51 (143)
T 3j04_B 2 DQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGK-NPTDEYLEGMMSE 51 (143)
T ss_dssp CHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSC-CCCHHHHHTTTTT
T ss_pred CHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCC-CCCHHHHHHHHHh
Confidence 4677889999999999999999999999999999997 6899999988865
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00015 Score=61.56 Aligned_cols=48 Identities=21% Similarity=0.243 Sum_probs=43.9
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcc
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPS 489 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~ 489 (492)
....++.+|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.+
T Consensus 82 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~ 129 (146)
T 2qac_A 82 NVEELIKMFAHFDNNCTGYLTKSQMKNILTTWGD-ALTDQEAIDALNAF 129 (146)
T ss_dssp CHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSS-CCCHHHHHHHHHHH
T ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCC-CCCHHHHHHHHHHc
Confidence 3457899999999999999999999999999986 69999999999876
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00015 Score=62.43 Aligned_cols=51 Identities=25% Similarity=0.388 Sum_probs=46.2
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.+|.|++|.|+.+||+.+|..+|. .++++++..+++.+|.|
T Consensus 94 ~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~-~~~~~~~~~~~~~~d~~ 144 (162)
T 1top_A 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGE-HVTEEDIEDLMKDSDKN 144 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTC-CCCHHHHHHHHHHHCTT
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 3456899999999999999999999999999986 69999999999999875
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0002 Score=64.61 Aligned_cols=52 Identities=19% Similarity=0.275 Sum_probs=46.6
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhh-ccccccHHHHHHHHhc----ccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKN-ATDAMKESRISDLLAP----SDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~-g~~~~~~~ei~~~i~~----~D~~ 492 (492)
.....++.+|+.+|.|++|+|+.+||+.+|..+ |. .++++++++|++. +|.|
T Consensus 111 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~-~~~~~~~~~~~~~~~~~~D~d 167 (202)
T 2bec_A 111 SRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGV-QVTEEQLENIADRTVQEADED 167 (202)
T ss_dssp SHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCS-CCCHHHHHHHHHHHHHHHCSS
T ss_pred cHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCC-CCCHHHHHHHHHHHHHHcCCC
Confidence 445678999999999999999999999999998 86 6999999999998 8864
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=97.44 E-value=1.1e-05 Score=65.03 Aligned_cols=51 Identities=27% Similarity=0.369 Sum_probs=45.6
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhh---ccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKN---ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~---g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.+|.|++|+|+.+||+.+|..+ |. .++++++++|++.+|.|
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~-~~~~~~~~~~~~~~D~d 92 (108)
T 2kyc_A 39 SSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGAR-VLTASETKTFLAAADHD 92 (108)
T ss_dssp CSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCC-CCCTTTTHHHHTTTCCS
T ss_pred cHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccC-CCCHHHHHHHHHHhCCC
Confidence 34568999999999999999999999999998 55 68999999999999864
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=97.44 E-value=7.9e-05 Score=64.06 Aligned_cols=54 Identities=17% Similarity=0.203 Sum_probs=47.4
Q ss_pred cchhhHHHHHHHHhhhCC--CCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEP--NKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~--~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.++...++++|..+|. |++|.|+.+||+.+|..+|. .+++.++..| +.+|.|
T Consensus 3 ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l-~~~D~~ 58 (156)
T 1wdc_C 3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGI-NPRNEDVFAV-GGTHKM 58 (156)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTC-CCCHHHHHHT-TCCSST
T ss_pred CCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCC-CCCHHHHHHH-HhhCCC
Confidence 566778889999999999 99999999999999999987 6889999999 888764
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=97.42 E-value=9.3e-05 Score=66.82 Aligned_cols=50 Identities=20% Similarity=0.300 Sum_probs=43.4
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh--ccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN--ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~--g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.+|..+ |. .++++++++|++.+|.|
T Consensus 128 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~-~~~~~~~~~l~~~~D~d 179 (197)
T 3pm8_A 128 KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIEN-PLIDKAIDSLLQEVDLN 179 (197)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHC----CC-HHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC-CCCHHHHHHHHHHHcCC
Confidence 3578999999999999999999999999887 55 58999999999999875
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00013 Score=64.83 Aligned_cols=46 Identities=13% Similarity=0.211 Sum_probs=43.0
Q ss_pred HHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 446 KEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 446 ~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+.+|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|.|
T Consensus 112 ~~~F~~~D~d~~G~Is~~El~~~l~~~g~-~~~~~~~~~~~~~~D~d 157 (191)
T 1uhk_A 112 DALFDIVDKDQNGAITLDEWKAYTKAAGI-IQSSEDCEETFRVCDID 157 (191)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHHTS-CCSHHHHHHHHHHSCCC
T ss_pred HHHHHHhcCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 49999999999999999999999999987 69999999999999875
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00012 Score=65.34 Aligned_cols=46 Identities=11% Similarity=0.138 Sum_probs=39.0
Q ss_pred HHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 446 KEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 446 ~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+.+|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|.|
T Consensus 116 ~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~~~~~~~~~~D~d 161 (195)
T 1qv0_A 116 DAVFDIFDKDGSGTITLDEWKAYGKISGI-SPSQEDCEATFRHCDLD 161 (195)
T ss_dssp HHHHHHTC----CEECHHHHHHHHHHHSS-CCCHHHHHHHHHHSCCC
T ss_pred HHHHHHhcCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 38999999999999999999999999987 69999999999999875
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00018 Score=64.74 Aligned_cols=55 Identities=20% Similarity=0.343 Sum_probs=49.5
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
..++.++...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..|+..+|
T Consensus 49 ~~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~-~~~~~~~~~l~~~~~ 103 (196)
T 3dtp_E 49 AMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGR-LCTEQELDSMVAEAP 103 (196)
T ss_dssp CSSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSC-CCCHHHHHHHHTTSS
T ss_pred hhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHcc
Confidence 4567788899999999999999999999999999999997 699999999998763
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00039 Score=61.52 Aligned_cols=51 Identities=14% Similarity=0.203 Sum_probs=44.5
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc----ccccHHHHHH----HHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT----DAMKESRISD----LLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~----~~~~~~ei~~----~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.+|..++. ..++++++.+ |++.+|.|
T Consensus 97 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d 155 (183)
T 1dgu_A 97 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDID 155 (183)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCC
Confidence 357899999999999999999999999998875 3588899886 89988864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00022 Score=68.87 Aligned_cols=72 Identities=10% Similarity=-0.026 Sum_probs=45.3
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEe
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E 218 (492)
.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+..+.-..+++.++ .+.-++|+|
T Consensus 23 i~~l~gG~tN~~~~~---------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE---------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred eeEcCCcccccccee---------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence 567888988999988 24788887543110 112356888888876443335666543 334478999
Q ss_pred ec-CCCch
Q 011154 219 LC-EGGEL 225 (492)
Q Consensus 219 ~~-~ggsL 225 (492)
|+ +|.+|
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66544
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=97.38 E-value=4.8e-05 Score=64.67 Aligned_cols=53 Identities=11% Similarity=0.028 Sum_probs=47.7
Q ss_pred hhhHHHHHHHHhhhCCCC-CcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 439 VDERFYLKEQFALLEPNK-NGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~-~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++...++++|..+|.|+ +|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 10 ~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~ 63 (146)
T 2qac_A 10 LEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGL-APSSIDEKKIKELYGDN 63 (146)
T ss_dssp HHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSE
T ss_pred HHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 355677999999999999 999999999999999997 68999999999998864
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=97.37 E-value=8.8e-05 Score=65.82 Aligned_cols=57 Identities=11% Similarity=0.127 Sum_probs=48.6
Q ss_pred hcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhh------ccccccHHHHHHHH---------hcccC
Q 011154 434 SKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKN------ATDAMKESRISDLL---------APSDG 491 (492)
Q Consensus 434 ~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~------g~~~~~~~ei~~~i---------~~~D~ 491 (492)
...++.++...++++|..+|.|++|.|+.+||+.+|..+ |. .+++.++..|+ +.+|.
T Consensus 5 ~~~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~-~~~~~~~~~l~~~~~~~~~f~~~D~ 76 (186)
T 2hps_A 5 TESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSA-EKAEETRQEFLRVADQLGLAPGVRI 76 (186)
T ss_dssp CHHHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCH-HHHHHHHHHHHHHHHHHTCCTTCEE
T ss_pred cccccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCC-CCCcHHHHHHHHHHHHHHHHHhcCC
Confidence 345566788899999999999999999999999999876 76 58899999985 77764
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00019 Score=63.10 Aligned_cols=50 Identities=14% Similarity=0.349 Sum_probs=44.2
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|++|.|+.+||+.+|..+|. .+++++++.+++.+|.|
T Consensus 83 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~-~~~~~~~~~~~~~~D~~ 132 (179)
T 2f2o_A 83 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGE-KLTDEEVDEMIREADID 132 (179)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHC---CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHcCCC
Confidence 456889999999999999999999999999987 69999999999999865
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=97.36 E-value=3.9e-05 Score=65.28 Aligned_cols=50 Identities=16% Similarity=0.181 Sum_probs=43.8
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcc-cCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPS-DGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~-D~~ 492 (492)
+..++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+ |.|
T Consensus 3 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~~D~~ 53 (148)
T 1m45_A 3 TRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGY-NPTNQLVQDIINADSSLR 53 (148)
T ss_dssp CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHC--CC-
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCC-CCCHHHHHHHHHHhhCCC
Confidence 445788999999999999999999999999987 68999999999998 764
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00019 Score=65.19 Aligned_cols=51 Identities=16% Similarity=0.234 Sum_probs=45.5
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhh-ccccccHHHHHHH----HhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKN-ATDAMKESRISDL----LAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~-g~~~~~~~ei~~~----i~~~D~~ 492 (492)
....++.+|+.+|.|++|+|+.+||+.+|..+ |. .++++++++| ++.+|.|
T Consensus 111 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~-~~s~~~~~~l~~~~~~~~D~d 166 (208)
T 2ct9_A 111 RSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGV-NISDEQLGSIADRTIQEADQD 166 (208)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCT-TCCHHHHHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCC-CCCHHHHHHHHHHHHHHhCCC
Confidence 45678999999999999999999999999987 76 6999999998 8888864
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00018 Score=64.07 Aligned_cols=58 Identities=14% Similarity=0.188 Sum_probs=49.8
Q ss_pred hcccchhhHHHHHHHHhhh-CCCCCcccchHHHHHHHHhh----ccccccHHHHHHHH-----------hcccCC
Q 011154 434 SKTLTVDERFYLKEQFALL-EPNKNGCIAFENIKTVLMKN----ATDAMKESRISDLL-----------APSDGF 492 (492)
Q Consensus 434 ~~~l~~~e~~~l~~~F~~~-D~~~~G~Is~~el~~~l~~~----g~~~~~~~ei~~~i-----------~~~D~~ 492 (492)
+..++..+...++++|..+ |.|+||.|+.+||+.++..+ |. ..++.++..++ +.+|.|
T Consensus 3 ~~~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~-~~~~~~~~~l~~~~~~~~~~~~~~~D~d 76 (191)
T 2ccm_A 3 AHQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSW-PTDGKKHNEARATLKLIWDGLRKYADEN 76 (191)
T ss_dssp CCCCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTC-CTTSHHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred hhhccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3455677788899999999 99999999999999999988 76 57888999998 877754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00028 Score=68.69 Aligned_cols=139 Identities=14% Similarity=0.095 Sum_probs=77.3
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC-CccEEEE------EEEeCC
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS-NLVKFYD------AFEDLD 211 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp-niv~l~~------~~~~~~ 211 (492)
.+.|+.|....+|++... + ..+++|+..... ..+.+..|+.+++.|..+. .+.+++. +....+
T Consensus 27 ~~~i~~G~~n~~~~v~~~----~-g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT----K-DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEECC---EEEEEEEES----S-CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred eeccCCCcccceEEEEeC----C-ccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 456777888899988643 2 358899986521 1234567888888775331 1333332 122346
Q ss_pred eEEEEEeecCCCchH--------------HHHHhhCCCC--------C---HHHHHH------------HHHHHHHHHHH
Q 011154 212 NVYIVMELCEGGELL--------------DRILSRCGKY--------S---EDEAKA------------VLVQILNVVAF 254 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~--------------~~l~~~~~~~--------~---~~~~~~------------i~~qi~~~l~y 254 (492)
..+++|+|++|..+. ..++.....+ . +..... +...+...+.+
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 789999999986431 1222211111 1 111000 00113445555
Q ss_pred HHH-------cCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 255 CHL-------HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 255 lH~-------~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
++. .+++|+|+++.|||+. ++..+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 553 3699999999999994 33345799998764
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00022 Score=63.92 Aligned_cols=49 Identities=14% Similarity=0.302 Sum_probs=44.4
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++++|+.+|.|++|.|+.+||+.+|..+|. .++++++++|++.+|.|
T Consensus 93 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~-~~~~~~~~~~~~~~D~d 141 (191)
T 1y1x_A 93 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGY-QVSEQTFQALMRKFDRQ 141 (191)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSC-CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 45789999999999999999999999999987 69999999999999864
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00014 Score=65.49 Aligned_cols=53 Identities=11% Similarity=0.086 Sum_probs=42.3
Q ss_pred hhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 439 VDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 33 ~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~d 85 (204)
T 3e3r_A 33 ASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGL-VLDQAEAEGVCRKWDRN 85 (204)
T ss_dssp -------CHHHHHHCTTCCSSBCHHHHHHHHHTTTC-CCCHHHHHHHHHHHCTT
T ss_pred chhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCC-CCCHHHHHHHHHHhccC
Confidence 356678899999999999999999999999999987 58999999999998864
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00021 Score=63.45 Aligned_cols=55 Identities=15% Similarity=0.140 Sum_probs=47.9
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHH-----HHHHhhccccccHH-----HHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIK-----TVLMKNATDAMKES-----RISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~-----~~l~~~g~~~~~~~-----ei~~~i~~~D~~ 492 (492)
++.++...++++|..+|.|++|.|+.+||+ .+|..+|. .+++. ++..+++.+|.|
T Consensus 10 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~-~~~~~~~~~~~~~~l~~~~D~d 74 (191)
T 1uhk_A 10 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGA-TPEQAKRHKDAVEAFFGGAGMK 74 (191)
T ss_dssp TCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCC-CHHHHHHHHHHHHHHHHHTTCC
T ss_pred CCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCC-CchhHHHHHHHHHHHHHHhCcC
Confidence 366778899999999999999999999999 88888887 46666 799999999864
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00015 Score=65.82 Aligned_cols=58 Identities=7% Similarity=0.054 Sum_probs=44.8
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccc-cccHHHHHHHH-------hcccCC
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATD-AMKESRISDLL-------APSDGF 492 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~-~~~~~ei~~~i-------~~~D~~ 492 (492)
..++.++...++++|..+|.|++|.|+.+||+.+|..+|.. .++++++..++ +.+|.|
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d 93 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVE 93 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCC
Confidence 44566778899999999999999999999999999998751 38899999999 888764
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00027 Score=61.01 Aligned_cols=47 Identities=13% Similarity=0.196 Sum_probs=43.2
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|+.+|.|++|.|+.+||+.++..+| ++++++.++++.+|.|
T Consensus 98 ~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~---~~~~~~~~~~~~~D~d 144 (166)
T 3akb_A 98 PFLHAALGVADTDGDGAVTVADTARALTAFG---VPEDLARQAAAALDTD 144 (166)
T ss_dssp HHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT---CCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC---CCHHHHHHHHHHhCCC
Confidence 4589999999999999999999999999887 7899999999999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0005 Score=67.29 Aligned_cols=34 Identities=29% Similarity=0.511 Sum_probs=25.8
Q ss_pred cCCcccCCCCCceEeecCCC-CCcEEEEecccccc
Q 011154 258 HGVVHRDLKPENFLYTSKDE-SSQLKAIDFGLSDF 291 (492)
Q Consensus 258 ~~ivHrDlkp~NILl~~~~~-~~~~kl~DfGla~~ 291 (492)
..++|+|+.+.|||+..+.. ...+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 35999999999999953211 25789999998754
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00028 Score=61.73 Aligned_cols=49 Identities=14% Similarity=0.121 Sum_probs=45.0
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|..+|.|++|.|+.+||+.+|..+|. .+++++++.+++.+|.|
T Consensus 74 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~~ 122 (172)
T 2znd_A 74 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGY-RLSDQFHDILIRKFDRQ 122 (172)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 46889999999999999999999999999987 68999999999999874
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00027 Score=58.06 Aligned_cols=52 Identities=23% Similarity=0.386 Sum_probs=46.0
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.++..+++++|+.+|+ +||+|+-+|++.+|++.| ++++++.+|++.+|.|
T Consensus 27 it~ee~~~y~~iF~~lD~-~dG~Isg~elr~~~~~sg---Lp~~~L~~Iw~laD~d 78 (121)
T 3fia_A 27 ITVEERAKHDQQFHSLKP-ISGFITGDQARNFFFQSG---LPQPVLAQIWALADMN 78 (121)
T ss_dssp CCHHHHHHHHHHHHHTCC-BTTBEEHHHHHHHHGGGC---CCHHHHHHHHHHHCTT
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeECHHHHHHHHHHcC---CCHHHHHHHHHHHcCC
Confidence 466888899999999998 899999999999998763 6789999999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00072 Score=65.88 Aligned_cols=75 Identities=8% Similarity=0.084 Sum_probs=47.4
Q ss_pred eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC-CccEEEEE-----EEeCCeEE
Q 011154 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS-NLVKFYDA-----FEDLDNVY 214 (492)
Q Consensus 141 ~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp-niv~l~~~-----~~~~~~~~ 214 (492)
.|+ |....||.+... +|+.+++|+...... . .+.+..|+.+++.|..+. .+++++.. ....+..+
T Consensus 33 ~l~-g~~n~~y~v~~~----~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE----DRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF 103 (328)
T ss_dssp EEC-CSSSEEEEECCT----TCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred eec-CcccceEEEEcC----CCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence 456 777788887532 456799999863322 1 245667888888875331 23444432 23356778
Q ss_pred EEEeecCCCc
Q 011154 215 IVMELCEGGE 224 (492)
Q Consensus 215 lv~E~~~ggs 224 (492)
+||++++|..
T Consensus 104 ~l~~~i~G~~ 113 (328)
T 1zyl_A 104 AVFPSVGGRQ 113 (328)
T ss_dssp EEEECCCCEE
T ss_pred EEEEecCCCC
Confidence 9999998854
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0029 Score=60.43 Aligned_cols=80 Identities=15% Similarity=0.047 Sum_probs=55.6
Q ss_pred ceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC--CccEEEEEEEeCCe
Q 011154 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS--NLVKFYDAFEDLDN 212 (492)
Q Consensus 135 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp--niv~l~~~~~~~~~ 212 (492)
...-.+.+|.|..+.||++... +|+.|+||+-+...... ...+.+|...|+.|...- -+.+++.+ +.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~----DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~-- 84 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA----DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD-- 84 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET----TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--
T ss_pred CeEEEEecCCCCCeEEEEEEEC----CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--
Confidence 4455678999999999999754 57889999875443221 234778999999985332 34555554 22
Q ss_pred EEEEEeecCCCch
Q 011154 213 VYIVMELCEGGEL 225 (492)
Q Consensus 213 ~~lv~E~~~ggsL 225 (492)
-++||||++++..
T Consensus 85 ~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 RTLAMEWVDERPP 97 (288)
T ss_dssp TEEEEECCCCCCC
T ss_pred ceEEEEeecccCC
Confidence 3789999987643
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00012 Score=63.07 Aligned_cols=51 Identities=24% Similarity=0.429 Sum_probs=44.6
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|..+|.|++|.|+.+||+.++..+|. .+++++++.+++.+|.|
T Consensus 93 ~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~-~~~~~~~~~~~~~~D~d 143 (161)
T 1dtl_A 93 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGE-TITEDDIEELMKDGDKN 143 (161)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC---CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 3456899999999999999999999999999986 69999999999999864
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00025 Score=65.29 Aligned_cols=47 Identities=11% Similarity=0.005 Sum_probs=44.2
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
..++.+|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|
T Consensus 117 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~~~~~l~~~~d 163 (220)
T 3sjs_A 117 ELAYNLFVMNARARSGTLEPHEILPALQQLGF-YINQRTSLLLHRLFA 163 (220)
T ss_dssp HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhc
Confidence 56899999999999999999999999999997 699999999999988
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00033 Score=61.17 Aligned_cols=48 Identities=10% Similarity=0.042 Sum_probs=43.4
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.++..+| +++++++++++.+|.|
T Consensus 93 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g---~~~~~~~~~~~~~D~d 140 (174)
T 1q80_A 93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG---LDKTMAPASFDAIDTN 140 (174)
T ss_dssp HTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT---CCGGGHHHHHHHHCTT
T ss_pred HHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC---CCHHHHHHHHHHhCCC
Confidence 45689999999999999999999999999885 6788999999999865
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00024 Score=58.81 Aligned_cols=48 Identities=15% Similarity=0.083 Sum_probs=25.4
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHH---hhccccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLM---KNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~---~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++..|..+|.|++|.|+.+|+..++. ..+. ..+..++..+++.+|.|
T Consensus 37 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~-~~~~~~~~~~f~~~D~d 87 (134)
T 1jfj_A 37 LLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDL-SDDKIGLKVLYKLMDVD 87 (134)
T ss_dssp HHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSS-HHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHcCCCCCeEcHHHHHHHHHHhccccc-CCCHHHHHHHHHHHCCC
Confidence 345555566666666666666655553 2222 24455555555555543
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00014 Score=66.86 Aligned_cols=51 Identities=20% Similarity=0.105 Sum_probs=45.4
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.||.|++|+|+.+||+.+|..+|...++++++++||+.+|.|
T Consensus 129 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~d 179 (219)
T 3cs1_A 129 FFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKN 179 (219)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCTT
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCCC
Confidence 356899999999999999999999999999885348889999999999865
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00044 Score=61.51 Aligned_cols=48 Identities=15% Similarity=0.149 Sum_probs=43.5
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|.|+.+||+.++..+| +++++++++++.+|.|
T Consensus 108 ~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g---~~~~~~~~~~~~~D~d 155 (191)
T 2ccm_A 108 TKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG---IPKSDCDAAFDTLSDG 155 (191)
T ss_dssp HHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT---CCHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC---CCHHHHHHHHHHhCCC
Confidence 45689999999999999999999999998886 7899999999999875
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00023 Score=64.46 Aligned_cols=45 Identities=11% Similarity=0.273 Sum_probs=42.1
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.+|+.+|.|++|.|+.+||+.++..+| ++++++++|++.+|.|
T Consensus 130 ~~~~F~~~D~d~~G~Is~~El~~~l~~~g---~~~~~~~~~~~~~D~d 174 (208)
T 2hpk_A 130 SNSYYDVLDDDGDGTVDVDELKTMMKAFD---VPQEAAYTFFEKADTD 174 (208)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHTT---SCTTHHHHHHHHHCTT
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHHhC---cCHHHHHHHHHHhCCC
Confidence 78999999999999999999999999887 7889999999999865
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00018 Score=61.44 Aligned_cols=51 Identities=12% Similarity=0.132 Sum_probs=39.4
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc-------ccccHHHHHHHH----hcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT-------DAMKESRISDLL----APSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~-------~~~~~~ei~~~i----~~~D~~ 492 (492)
...++.+|+.||.|+||+|+.+||+.++..++. ..++++++.+|+ +.+|.|
T Consensus 67 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s~~e~~~~~~~~f~~~D~d 128 (143)
T 3a4u_B 67 QELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDDKN 128 (143)
T ss_dssp HHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CCHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCCHHHHHHHHHHHHHHcCCC
Confidence 346788999999999999999999999988741 258899998777 777764
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00037 Score=60.86 Aligned_cols=47 Identities=15% Similarity=0.181 Sum_probs=43.3
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|+.+|.|++|.|+.+||+.++..+| ++++++..+++.+|.|
T Consensus 102 ~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g---~~~~~~~~~~~~~D~d 148 (176)
T 1nya_A 102 PVVKGIVGMCDKNADGQINADEFAAWLTALG---MSKAEAAEAFNQVDTN 148 (176)
T ss_dssp HHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT---CCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC---CCHHHHHHHHHHhCCC
Confidence 4689999999999999999999999999887 7899999999999875
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00039 Score=63.65 Aligned_cols=51 Identities=14% Similarity=0.203 Sum_probs=43.6
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc----ccccHHHHHH----HHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT----DAMKESRISD----LLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~----~~~~~~ei~~----~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.+|..++. ..++++++++ +++.+|.|
T Consensus 128 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~d 186 (214)
T 2l4h_A 128 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDID 186 (214)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCCC
Confidence 457899999999999999999999999998875 2578788776 88888864
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00045 Score=59.98 Aligned_cols=47 Identities=9% Similarity=0.217 Sum_probs=42.9
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
..++.+|+.+|.|++|.|+.+||+.+|..+|. .++++++++|++.+|
T Consensus 70 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~d 116 (165)
T 1k94_A 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGY-RLSPQTLTTIVKRYS 116 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTC-CCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCceECHHHHHHHHHHhCC-CCCHHHHHHHHHHhC
Confidence 46889999999999999999999999999987 699999999998763
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0012 Score=66.02 Aligned_cols=144 Identities=15% Similarity=0.156 Sum_probs=83.3
Q ss_pred ceeccccceEEEEEEEecC----CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 140 EEVGRGHFGYTCTARYKKG----EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
+.|.-|-...+|++....+ ...+..|++|+.... .. ....+.+|..+++.|..+.-..++++++.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 4566666678888875321 113578999986321 11 234566899999998755555677766543 29
Q ss_pred EEeecCCCchHH----------H-------HHhhC----CCC--CHHHHHHHHHHHHH-------------------HHH
Q 011154 216 VMELCEGGELLD----------R-------ILSRC----GKY--SEDEAKAVLVQILN-------------------VVA 253 (492)
Q Consensus 216 v~E~~~ggsL~~----------~-------l~~~~----~~~--~~~~~~~i~~qi~~-------------------~l~ 253 (492)
||||++|.+|.. . ++... ... -+.++..++.++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999855421 1 11111 112 24566666655432 233
Q ss_pred HHHH--------cCCcccCCCCCceEeecC-CCCCcEEEEecccccc
Q 011154 254 FCHL--------HGVVHRDLKPENFLYTSK-DESSQLKAIDFGLSDF 291 (492)
Q Consensus 254 ylH~--------~~ivHrDlkp~NILl~~~-~~~~~~kl~DfGla~~ 291 (492)
.|.+ ..++|+|+.+.|||+..+ +....+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 148999999999999643 1235799999998753
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00049 Score=69.90 Aligned_cols=57 Identities=23% Similarity=0.363 Sum_probs=49.6
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.++...++++|..+|.|+||.|+.+||+.+|..++. .++++++..|++.+|.|
T Consensus 304 ~~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~-~~s~eel~~Lf~~~D~D 360 (450)
T 3sg6_A 304 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDAD 360 (450)
T ss_dssp -CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHTTCTT
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhccC
Confidence 3456677788999999999999999999999999999987 58999999999999865
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00035 Score=64.07 Aligned_cols=55 Identities=16% Similarity=0.270 Sum_probs=46.2
Q ss_pred hhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHh-hccccccHHHHHHHHh
Q 011154 432 ALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMK-NATDAMKESRISDLLA 487 (492)
Q Consensus 432 ~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~-~g~~~~~~~ei~~~i~ 487 (492)
.+...++.++...++++|..+|.|++|.|+.+||+.+|.. +|. .+++.++..+++
T Consensus 37 ~~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~-~~~~~~~~~~~~ 92 (219)
T 3cs1_A 37 AIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKL-DEFTSRVRDITK 92 (219)
T ss_dssp HSCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCG-GGTCSCHHHHHH
T ss_pred HhcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCC-CccHHHHHHHHH
Confidence 3456677888999999999999999999999999999987 676 477777777654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00096 Score=67.93 Aligned_cols=77 Identities=18% Similarity=0.117 Sum_probs=50.6
Q ss_pred cceeccccceEEEEEEEecCC----ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 139 GEEVGRGHFGYTCTARYKKGE----HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
.+.|+.|....||++....+. ..+..|++|+.... .. .+.+.+|..+++.|..+.-..++++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 456788888899998764211 12568999988432 11 1345579999998875544467777654 2 2
Q ss_pred EEEeecCCCc
Q 011154 215 IVMELCEGGE 224 (492)
Q Consensus 215 lv~E~~~ggs 224 (492)
+|+||++|.+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998744
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0004 Score=60.90 Aligned_cols=47 Identities=9% Similarity=0.131 Sum_probs=43.4
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
..++.+|+.+|.|++|.|+.+||+.+|..+|. .+++++++.|++.+|
T Consensus 77 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~d 123 (173)
T 1alv_A 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGF-HLNEHLYSMIIRRYS 123 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTC-CCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCC-CCCHHHHHHHHHHhc
Confidence 46889999999999999999999999999987 699999999999886
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00042 Score=58.38 Aligned_cols=43 Identities=12% Similarity=0.356 Sum_probs=40.0
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhc
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAP 488 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~ 488 (492)
++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.
T Consensus 7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~ 49 (145)
T 2bl0_B 7 IQECFQIFDKDNDGKVSIEELGSALRSLGK-NPTNAELNTIKGQ 49 (145)
T ss_dssp HHHHHHHHCTTCSSCEEGGGHHHHHHHTTC-CCCHHHHHHHHHH
T ss_pred HHHHHHHhCCCCcCccCHHHHHHHHHHhCC-CCCHHHHHHHHHh
Confidence 899999999999999999999999999987 6899999999875
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0004 Score=55.47 Aligned_cols=49 Identities=18% Similarity=0.252 Sum_probs=39.7
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHh-----hccccccH-----------HHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMK-----NATDAMKE-----------SRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~-----~g~~~~~~-----------~ei~~~i~~~D~~ 492 (492)
..++.+|..+|.|+||+|+.+||+.++.. +|. ..++ ..+..|++.+|.|
T Consensus 20 ~~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~-~~~~~~~~~~~e~~~~~~~~~~~~~D~d 84 (103)
T 1snl_A 20 FNPKTFFILHDINSDGVLDEQELEALFTKELEKVYDP-KNEEDDMREMEEERLRMREHVMKNVDTN 84 (103)
T ss_dssp CCHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCC-SSCSSHHHHTTHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHHhcc-CCCCccHHHHHHHHHHHHHHHHHHcCCC
Confidence 45899999999999999999999999986 353 2322 3589999999875
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00038 Score=58.47 Aligned_cols=45 Identities=18% Similarity=0.238 Sum_probs=40.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHh
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLA 487 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~ 487 (492)
...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++
T Consensus 4 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~ 48 (140)
T 1ggw_A 4 DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQ-NPTLAEITEIES 48 (140)
T ss_dssp CTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSC-CCCHHHHHHHHT
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHh
Confidence 456899999999999999999999999999987 688999999987
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00042 Score=61.52 Aligned_cols=48 Identities=19% Similarity=0.256 Sum_probs=43.1
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|.|+.+||+.++. +. .++++++.++++.+|.|
T Consensus 122 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~-~~~~~~~~~~~~~~D~~ 169 (191)
T 3khe_A 122 RERLLAAFQQFDSDGSGKITNEELGRLFG--VT-EVDDETWHQVLQECDKN 169 (191)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHTT--SS-CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHCCCCcCcCCHHHHHHHHc--cC-CCCHHHHHHHHHHhCCC
Confidence 35689999999999999999999999997 55 68999999999999875
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00056 Score=59.51 Aligned_cols=47 Identities=6% Similarity=0.218 Sum_probs=43.0
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
..++.+|+.+|.|++|.|+.+||+.+|..+|. .++++++++|++.+|
T Consensus 72 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~d 118 (167)
T 1gjy_A 72 NGWRQHFISFDSDRSGTVDPQELQKALTTMGF-RLNPQTVNSIAKRYS 118 (167)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTC-CCCHHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHhC
Confidence 46899999999999999999999999999987 699999999998873
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00055 Score=61.55 Aligned_cols=59 Identities=15% Similarity=0.296 Sum_probs=47.0
Q ss_pred hhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHh-------hccccccHHHHHHHHhcccC
Q 011154 432 ALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMK-------NATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 432 ~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~-------~g~~~~~~~ei~~~i~~~D~ 491 (492)
.+...........++.+|..+|.|++|+|+.+||+.++.. .|. .+++++++++++.+|.
T Consensus 98 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~D~ 163 (204)
T 3e3r_A 98 ALRPPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGE-WTEDEVLRRFLDNFDS 163 (204)
T ss_dssp HTSCCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTS-SCHHHHHHHHHHHHSC
T ss_pred HHHhhcCchHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCC-CChHHHHHHHHHHhhc
Confidence 3333333344567899999999999999999999999974 344 5788999999999986
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00069 Score=68.83 Aligned_cols=50 Identities=14% Similarity=0.349 Sum_probs=46.0
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|.|
T Consensus 384 ~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~-~ls~eei~~Lf~~~D~D 433 (450)
T 3sg6_A 384 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGE-KLTDEEVDEMIREADID 433 (450)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTT
T ss_pred hhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 456899999999999999999999999999987 69999999999999864
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00039 Score=61.48 Aligned_cols=47 Identities=15% Similarity=0.404 Sum_probs=42.6
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|..+|.|++|+|+.+||+.+|. +. .++++++++|++.+|.|
T Consensus 108 ~~~~~~F~~~D~d~~G~I~~~El~~~l~--~~-~~~~~~~~~~~~~~d~~ 154 (180)
T 3mse_B 108 TFLKAAFNKIDKDEDGYISKSDIVSLVH--DK-VLDNNDIDNFFLSVHSI 154 (180)
T ss_dssp CHHHHHHHHHCTTCSSCBCHHHHHHHTT--TS-SCCHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHc--CC-CCCHHHHHHHHHHhhhc
Confidence 5689999999999999999999999997 43 68999999999999874
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00038 Score=62.24 Aligned_cols=50 Identities=18% Similarity=0.227 Sum_probs=40.6
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|..+|.|++|.|+.+||+.+|..+|. .+++.++..+++.+|.|
T Consensus 26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~-~~~~~~~~~l~~~~D~d 75 (191)
T 1y1x_A 26 NQELMEWFRAVDTDGSGAISVPELNAALSSAGV-PFSLATTEKLLHMYDKN 75 (191)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTB-CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 346788888889889999999999888866665 57888888888888764
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00065 Score=61.04 Aligned_cols=47 Identities=6% Similarity=0.208 Sum_probs=43.1
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
..++++|+.+|.|++|.|+.+||+.+|..+|. .++++++++|++.+|
T Consensus 103 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~l~~~~d 149 (198)
T 1juo_A 103 NGWRQHFISFDTDRSGTVDPQELQKALTTMGF-RLSPQAVNSIAKRYS 149 (198)
T ss_dssp HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHhC
Confidence 46899999999999999999999999999987 699999999998874
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00043 Score=64.88 Aligned_cols=56 Identities=7% Similarity=0.104 Sum_probs=47.7
Q ss_pred ccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccH------HHHHHHHhcccCC
Q 011154 436 TLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKE------SRISDLLAPSDGF 492 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~------~ei~~~i~~~D~~ 492 (492)
.++..+..+++++|..+|.|++|.|+.+||+.+|..+|. .++. .++..+++.+|.|
T Consensus 9 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~-~~~~~~~~~~~~~~~l~~~~D~~ 70 (263)
T 2f33_A 9 QSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQ-ARKKAGLELSPEMKTFVDQYGQR 70 (263)
T ss_dssp TTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHH-HHHHHTCCCCHHHHHHHHHHTTG
T ss_pred hcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHh-hcCCCccchHHHHHHHHHHhCCC
Confidence 455566778999999999999999999999999999886 4554 7899999988864
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00068 Score=59.78 Aligned_cols=51 Identities=20% Similarity=0.247 Sum_probs=40.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh----ccc---ccc----HHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN----ATD---AMK----ESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g~~---~~~----~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|.|+.+||+.++..+ |.. .++ ++++.++++.+|.|
T Consensus 91 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d 152 (183)
T 1s6c_A 91 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKN 152 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCC
Confidence 3568999999999999999999999999886 421 133 48999999999875
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00025 Score=63.79 Aligned_cols=54 Identities=9% Similarity=0.059 Sum_probs=46.8
Q ss_pred chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccc----cccHHHHHHHHhcccCC
Q 011154 438 TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATD----AMKESRISDLLAPSDGF 492 (492)
Q Consensus 438 ~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~----~~~~~ei~~~i~~~D~~ 492 (492)
+..+..++++ |..+|.|++|.|+.+||+.+|..+|.. .+++.++..+++.+|.|
T Consensus 28 ~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d 85 (198)
T 1juo_A 28 PGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRD 85 (198)
T ss_dssp TTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTT
T ss_pred CccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCC
Confidence 3456677899 999999999999999999999998752 47899999999999865
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0011 Score=60.33 Aligned_cols=50 Identities=22% Similarity=0.220 Sum_probs=42.2
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhc-----ccccc-HHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNA-----TDAMK-ESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g-----~~~~~-~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.++..++ . .++ ++.+.++++.+|.|
T Consensus 92 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~-~~~~~~~~~~~f~~~D~d 147 (211)
T 2ggz_A 92 EQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQ-TLSPEEFINLVFHKIDIN 147 (211)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCC-SCTHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCc-cccHHHHHHHHHHHhCCC
Confidence 45688999999999999999999999999886 3 344 45699999999875
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0011 Score=61.09 Aligned_cols=51 Identities=18% Similarity=0.233 Sum_probs=42.2
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh----cc-------ccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN----AT-------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g~-------~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.++..+ |. +...+++++++++.+|.|
T Consensus 124 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d 185 (224)
T 1s1e_A 124 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKN 185 (224)
T ss_dssp HHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCC
Confidence 3468899999999999999999999999876 42 122458999999999875
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0006 Score=63.03 Aligned_cols=51 Identities=18% Similarity=0.232 Sum_probs=42.0
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhc-----------cccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNA-----------TDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g-----------~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|+||+|+.+||+.++..++ ...+++.+++.+++.+|.|
T Consensus 137 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d 198 (229)
T 3dd4_A 137 QEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKN 198 (229)
T ss_dssp HHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSS
T ss_pred HHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCC
Confidence 34689999999999999999999999998873 1247788999999999875
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00089 Score=59.87 Aligned_cols=50 Identities=12% Similarity=0.302 Sum_probs=42.0
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh--ccccccH---HHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN--ATDAMKE---SRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~--g~~~~~~---~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.+|... +. .+++ ++++++++.+|.|
T Consensus 121 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~-~l~~~~~~~~~~~~~~~D~d 175 (191)
T 3k21_A 121 KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKG-NITQRDVNRVKRMIRDVDKN 175 (191)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCS-CCCHHHHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCC-CCCHhHHHHHHHHHHHhcCC
Confidence 4568899999999999999999999999873 33 4655 4799999999875
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00022 Score=63.76 Aligned_cols=47 Identities=17% Similarity=0.315 Sum_probs=42.1
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|..+|.|++|+|+.+||+.+|..+| ++++++++|++.+|.|
T Consensus 82 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g---~~~~~~~~~~~~~D~d 128 (188)
T 1s6i_A 82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG---LDDIHIDDMIKEIDQD 128 (188)
T ss_dssp CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT---CCTTHHHHHHHHHCSS
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC---CCHHHHHHHHHHHCCC
Confidence 4578999999999999999999999998876 6788999999999865
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00076 Score=59.58 Aligned_cols=49 Identities=10% Similarity=0.213 Sum_probs=43.0
Q ss_pred HHHHHHH--hhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQF--ALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F--~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+| ..||.|++|+|+.+||+.+|..+|. .++++++.++++.+|.|
T Consensus 100 ~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~-~~~~~~~~~~~~~~D~d 150 (186)
T 2hps_A 100 AVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGP-DLTDDKAITCFNTLDFN 150 (186)
T ss_dssp TTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCT-TCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHHcCC
Confidence 3456666 7889999999999999999999986 69999999999999865
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00029 Score=72.99 Aligned_cols=50 Identities=10% Similarity=0.305 Sum_probs=27.4
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|+.||.|+||.|+.+||+.+|..+|. .++++++++||+.+|.|
T Consensus 416 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~-~~~~~~~~~~~~~~D~d 465 (486)
T 3mwu_A 416 RERMERAFKMFDKDGSGKISTKELFKLFSQADS-SIQMEELESIIEQVDNN 465 (486)
T ss_dssp HHHHHHHHHHHCSSCSSSBCSSCC---------------------CCCCSS
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 356899999999999999999999999999987 69999999999999975
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00031 Score=64.84 Aligned_cols=56 Identities=11% Similarity=0.156 Sum_probs=46.2
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHH-HhhccccccHHHHHHHHhcc
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVL-MKNATDAMKESRISDLLAPS 489 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l-~~~g~~~~~~~ei~~~i~~~ 489 (492)
+...++.++...++++|..+|.|++|.|+.+||+.++ +.+|. .+++.++..+++.+
T Consensus 41 l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~-~~~~~~~~~~~~~~ 97 (226)
T 2lvv_A 41 IPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKL-DEFTTHLPDIVQRA 97 (226)
T ss_dssp SCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCC-TTTSSSCHHHHHHH
T ss_pred hchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCC-CCCHHHHHHHHHHH
Confidence 4556778889999999999999999999999999955 55565 57777888888765
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00044 Score=59.89 Aligned_cols=48 Identities=17% Similarity=0.263 Sum_probs=36.4
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|++|.|+.+||+.++..+| ++++++++|++.+|.|
T Consensus 98 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~---~~~~~~~~~~~~~d~~ 145 (166)
T 2aao_A 98 EDHLFAAFTYFDKDGSGYITPDELQQACEEFG---VEDVRIEELMRDVDQD 145 (166)
T ss_dssp THHHHHHHHHHCTTCSSSBCHHHHHHHTCC-----------CCHHHHHCTT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC---CCHHHHHHHHHHhCCC
Confidence 35689999999999999999999999998775 5688999999999865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0013 Score=65.41 Aligned_cols=79 Identities=13% Similarity=0.107 Sum_probs=45.6
Q ss_pred cceeccccceEEEEEEEecCC-----ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 139 GEEVGRGHFGYTCTARYKKGE-----HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
.+.|+.|....+|++....+. ..+..|++|+...... .......|..+++.|..+.-+.++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 346777777899998754210 0126788898744211 1112467888998886443345777554 23
Q ss_pred EEEEeecCCCch
Q 011154 214 YIVMELCEGGEL 225 (492)
Q Consensus 214 ~lv~E~~~ggsL 225 (492)
++||||++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999988543
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.00043 Score=63.89 Aligned_cols=50 Identities=14% Similarity=0.156 Sum_probs=41.4
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|+.+|.|++|+|+.+||+.+|..++...++.+++++||+.+|.|
T Consensus 133 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~e~~~~~~~~D~d 182 (226)
T 2lvv_A 133 FELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDITDATTVFNEIDTN 182 (226)
T ss_dssp HHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCCSCHHHHHHHCCS
T ss_pred HHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHHHHHHHHHHhCCC
Confidence 46899999999999999999999999988732123445699999999875
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.00046 Score=60.76 Aligned_cols=48 Identities=6% Similarity=0.076 Sum_probs=42.6
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|.|+.+||+.++..+| ++++++.++++.+|.|
T Consensus 104 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g---~~~~~~~~~~~~~D~d 151 (185)
T 2sas_A 104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ---LQCADVPAVYNVITDG 151 (185)
T ss_dssp HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC---CCCSSHHHHHHHHHTT
T ss_pred HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhC---CCHHHHHHHHHHhcCC
Confidence 35689999999999999999999999998776 5688999999998875
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0016 Score=58.22 Aligned_cols=51 Identities=22% Similarity=0.256 Sum_probs=41.8
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc-----cccc-HHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT-----DAMK-ESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~-----~~~~-~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|++|.|+.+||+.++..++. ..++ ++.+..+++.+|.|
T Consensus 87 ~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d 143 (198)
T 2r2i_A 87 DQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDIN 143 (198)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCCC
Confidence 346889999999999999999999999998752 1344 45599999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0014 Score=67.70 Aligned_cols=48 Identities=17% Similarity=0.290 Sum_probs=42.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|+.||.|+||+|+.+||+.+|.. ..++++++++||+.+|.|
T Consensus 417 ~~~~~~~F~~~D~d~dG~I~~~El~~~l~~---~~~~~~~~~~~~~~~D~d 464 (484)
T 3nyv_A 417 RERLERAFRMFDSDNSGKISSTELATIFGV---SDVDSETWKSVLSEVDKN 464 (484)
T ss_dssp HHHHHHHHHHHCTTCCSEEEHHHHHHHHHH---TTCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHh---cCCCHHHHHHHHHHhcCC
Confidence 456899999999999999999999999976 258899999999999975
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0017 Score=57.49 Aligned_cols=51 Identities=18% Similarity=0.248 Sum_probs=42.8
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh----c-------cccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN----A-------TDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g-------~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|++|.|+.+||+.++..+ | .+.++++++.++++.+|.|
T Consensus 98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d 159 (190)
T 1g8i_A 98 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKN 159 (190)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCC
Confidence 4468899999999999999999999999873 2 1247889999999999865
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0012 Score=59.42 Aligned_cols=51 Identities=16% Similarity=0.143 Sum_probs=40.2
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++..|..+|.|++|.|+.+|+..++..++. ..+++++..+++.+|.|
T Consensus 57 ~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~-~~~~~~~~~~F~~~D~d 107 (204)
T 1jba_A 57 ATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLR-GTLEHKLKWTFKIYDKD 107 (204)
T ss_dssp THHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSS-CCCTHHHHHHHHHHCSS
T ss_pred cHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHcc-CCHHHHHHHHHHHhCCC
Confidence 3446778888888888888888888888887765 46778888888888764
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0013 Score=59.10 Aligned_cols=52 Identities=13% Similarity=0.130 Sum_probs=44.6
Q ss_pred ccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 436 TLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++.+++..++++|..+|.|++|.|+.+||+.+ ..+|.. .+ +..+++.+|.|
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~-~~---~~~l~~~~D~d 73 (202)
T 2bec_A 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVN-PL---GDRIIESFFPD 73 (202)
T ss_dssp CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHS-TT---HHHHHHTTSCS
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCC-cc---HHHHHHHhCCC
Confidence 457788889999999999999999999999999 777763 43 88899988864
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0022 Score=57.64 Aligned_cols=51 Identities=18% Similarity=0.285 Sum_probs=42.6
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh----cc------------ccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN----AT------------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g~------------~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|++|.|+.+||+.++..+ |. ...+++++.++++.+|.|
T Consensus 94 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d 160 (204)
T 1jba_A 94 EHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDEN 160 (204)
T ss_dssp THHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCC
Confidence 3468899999999999999999999999877 31 125678999999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.03 Score=57.28 Aligned_cols=76 Identities=20% Similarity=0.156 Sum_probs=47.8
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEe
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E 218 (492)
.+.|+.|-...+|++.... .+..|++|+...... . . -...+|..+|+.|..+.-..++++.+. +. +|||
T Consensus 113 i~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~~-~--~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS---KQAKYLIRLYGPKTD-E--I-INREREKKISCILYNKNIAKKIYVFFT--NG--RIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETT---TTEEEEEEEECC-CC-S--C-SCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEE
T ss_pred EEEcCCCeEeEEEEEEECC---CCceEEEEECCCChh-h--h-cCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEE
Confidence 4567778788999987532 246788998743211 1 0 012579999999975444467887762 32 5999
Q ss_pred ecCCCch
Q 011154 219 LCEGGEL 225 (492)
Q Consensus 219 ~~~ggsL 225 (492)
|++|.+|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987544
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0026 Score=59.70 Aligned_cols=51 Identities=22% Similarity=0.320 Sum_probs=43.5
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh----cc-------ccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN----AT-------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g~-------~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.++..+ |. +.+++++++++++.+|.|
T Consensus 164 ~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d 225 (256)
T 2jul_A 164 HEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRN 225 (256)
T ss_dssp HHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCS
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCC
Confidence 3468899999999999999999999999876 41 245789999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0012 Score=68.56 Aligned_cols=48 Identities=17% Similarity=0.321 Sum_probs=42.0
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.||.|+||+|+.+||+.+|.. ..++++++++||+.+|.|
T Consensus 425 ~~~~~~~F~~~D~d~~G~Is~~El~~~l~~---~~~~~~~~~~~~~~~D~d 472 (494)
T 3lij_A 425 KDKLESAFQKFDQDGNGKISVDELASVFGL---DHLESKTWKEMISGIDSN 472 (494)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHC-C---CSCCCHHHHHHHHTTCSS
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHh---cCCCHHHHHHHHHHhCCC
Confidence 456899999999999999999999999865 358899999999999975
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0029 Score=56.04 Aligned_cols=51 Identities=18% Similarity=0.290 Sum_probs=42.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh----cc-------ccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN----AT-------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g~-------~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|++|.|+.+||+.++..+ |. +..+++++.++++.+|.|
T Consensus 98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d 159 (190)
T 2l2e_A 98 NDKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKN 159 (190)
T ss_dssp HHHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCC
T ss_pred HHHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCC
Confidence 4568899999999999999999999999873 32 236789999999999875
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=96.58 E-value=0.00025 Score=58.85 Aligned_cols=46 Identities=13% Similarity=0.193 Sum_probs=37.8
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++...++++|+.|| |+|+.+||+.+|+.+|. +++++++||+.+|.|
T Consensus 47 ~~~~~l~~aF~~fD----G~I~~~El~~~l~~lG~---t~~ei~~~~~~~D~d 92 (123)
T 2kld_A 47 NTVDDISESLRQGG----GKLNFDELRQDLKGKGH---TDAEIEAIFTKYDQD 92 (123)
T ss_dssp ----CCSCSSTTTT----TCEEHHHHHHHTTTCCS---SHHHHHHHHHHHSSS
T ss_pred hHHHHHHHHHHHhC----CCCCHHHHHHHHHHhCC---CHHHHHHHHHHHcCC
Confidence 34456788999998 99999999999999874 899999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0015 Score=67.80 Aligned_cols=48 Identities=23% Similarity=0.370 Sum_probs=42.7
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|+.||.|+||+|+.+||+.+|... .++++++++||+.+|.|
T Consensus 434 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~---~~~~~~~~~~~~~~D~d 481 (504)
T 3q5i_A 434 EERLRRAFNLFDTDKSGKITKEELANLFGLT---SISEKTWNDVLGEADQN 481 (504)
T ss_dssp HHHHHHHHHHHCTTCCSEECHHHHHHHTTCS---CCCHHHHHHHHHTTCSS
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHhhC---CCCHHHHHHHHHHhCCC
Confidence 3578999999999999999999999998652 48899999999999975
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0073 Score=59.25 Aligned_cols=69 Identities=12% Similarity=0.043 Sum_probs=43.5
Q ss_pred ccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC--CCccEEEEE------EEeCCeEE
Q 011154 143 GRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH--SNLVKFYDA------FEDLDNVY 214 (492)
Q Consensus 143 G~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h--pniv~l~~~------~~~~~~~~ 214 (492)
|.|....||++... +| .+++|+...... ..|+.+++.|..+ |++++.+.. ....+..+
T Consensus 32 G~g~~N~vy~v~~~----~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~ 97 (339)
T 3i1a_A 32 GADTNAFAYQADSE----SK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKI 97 (339)
T ss_dssp TSCSSCEEEEEECS----SC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEE
T ss_pred cCccccceEEEEeC----CC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEE
Confidence 34445688988632 34 799998765432 3466677666422 334555432 23457889
Q ss_pred EEEeecCCCch
Q 011154 215 IVMELCEGGEL 225 (492)
Q Consensus 215 lv~E~~~ggsL 225 (492)
+||+|++|..+
T Consensus 98 ~l~~~i~G~~~ 108 (339)
T 3i1a_A 98 IAYPFIHAPNG 108 (339)
T ss_dssp EEEECCCCCBT
T ss_pred EEEeccCCCcC
Confidence 99999998765
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0028 Score=58.21 Aligned_cols=51 Identities=18% Similarity=0.327 Sum_probs=42.2
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHH----hhccccccHHHHHHHHh----cccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLM----KNATDAMKESRISDLLA----PSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~----~~g~~~~~~~ei~~~i~----~~D~~ 492 (492)
....++.+|..+|.|++|+|+.+||+.++. ..|. .+++++++++++ .+|.|
T Consensus 120 ~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~-~~~~~~~~~~~~~~f~~~D~d 178 (226)
T 2zfd_A 120 IDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGM-NLKDTVIEDIIDKTFEEADTK 178 (226)
T ss_dssp HHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTC-CCCHHHHHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCC-CCCHHHHHHHHHHHHHHhCCC
Confidence 345689999999999999999999999996 4565 688888887775 77754
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0015 Score=72.72 Aligned_cols=59 Identities=15% Similarity=0.284 Sum_probs=52.5
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.++...++.+|..||.|+||.|+.+||+.+|..+|. .+++.+++.|++.+|.|
T Consensus 715 ~~~~l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~~~~~~~~~~D~d 773 (863)
T 1sjj_A 715 DAKGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGY-NMGEAEFARIMSIVDPN 773 (863)
T ss_dssp CCCCSSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTC-CCCTHHHHHHHHHHCTT
T ss_pred hccCCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 345566677888999999999999999999999999999997 58999999999999864
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0045 Score=55.70 Aligned_cols=51 Identities=20% Similarity=0.276 Sum_probs=41.7
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHH----hhccccccHHHHHHHHh----cccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLM----KNATDAMKESRISDLLA----PSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~----~~g~~~~~~~ei~~~i~----~~D~~ 492 (492)
....++.+|+.+|.|++|+|+.+||+.++. ..|. .+++++++++++ .+|.|
T Consensus 109 ~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~-~~~~~~~~~~~~~~f~~~D~d 167 (207)
T 2ehb_A 109 VHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESEL-VLSEDMIEVMVDKAFVQADRK 167 (207)
T ss_dssp HHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTC-CCCHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHccc-ccCHHHHHHHHHHHHHHhCCC
Confidence 345689999999999999999999999996 4465 688888877774 77754
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0024 Score=59.98 Aligned_cols=51 Identities=12% Similarity=0.192 Sum_probs=43.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc---ccccHHHHHH----HHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT---DAMKESRISD----LLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~---~~~~~~ei~~----~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.+|..++. ..+++++++. |++.+|.|
T Consensus 195 ~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~d 252 (272)
T 2be4_A 195 KRDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMN 252 (272)
T ss_dssp HHHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCC
Confidence 346889999999999999999999999988764 1488899887 99999865
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0013 Score=64.14 Aligned_cols=48 Identities=17% Similarity=0.223 Sum_probs=44.4
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHH-HhhccccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVL-MKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l-~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++.+|..+|.|++|+|+.+||+.+| ..+|. .++++++..|++.+|.|
T Consensus 254 ~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~-~ls~~e~~~l~~~~D~d 302 (323)
T 1ij5_A 254 VLRILYAFADFDKSGQLSKEEVQKVLEDAHIP-ESARKKFEHQFSVVDVD 302 (323)
T ss_dssp HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCC-GGGCSTHHHHHHHHTTT
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHHHcCC-CCCHHHHHHHHHHHCCC
Confidence 57899999999999999999999999 98886 69999999999999864
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0024 Score=57.49 Aligned_cols=49 Identities=18% Similarity=0.221 Sum_probs=41.5
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhh----c----ccccc------HHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKN----A----TDAMK------ESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g----~~~~~------~~ei~~~i~~~D~~ 492 (492)
..++.+|+.+|.|++|.|+.+||+.+|..+ | . .++ +++++++++.+|.|
T Consensus 107 ~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~-~l~~~~~~~~~~~~~~f~~~D~d 169 (207)
T 2d8n_A 107 QKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVK-LLPDDENTPEKRAEKIWKYFGKN 169 (207)
T ss_dssp TTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHH-TSCTTTSSHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCC-CcccccccHHHHHHHHHHHcCCC
Confidence 457889999999999999999999999886 5 3 333 47899999999875
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0015 Score=61.39 Aligned_cols=50 Identities=10% Similarity=0.208 Sum_probs=41.8
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHH----hhccc-cccHHHHHHHH
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLM----KNATD-AMKESRISDLL 486 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~----~~g~~-~~~~~ei~~~i 486 (492)
++..+..+++++|..+|.|++|.|+.+||+.+|+ .+|.. .+++.++..++
T Consensus 5 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~ 59 (272)
T 2be4_A 5 FANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIK 59 (272)
T ss_dssp CCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHH
T ss_pred HHhcCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 3444566799999999999999999999999998 78762 48888888765
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0032 Score=58.77 Aligned_cols=50 Identities=14% Similarity=0.258 Sum_probs=44.0
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh----ccccccHHHHHH----HHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN----ATDAMKESRISD----LLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g~~~~~~~ei~~----~i~~~D~~ 492 (492)
...++++|..+|.|++|.|+.+||+.+|..+ |. .+++.++.+ |++.+|.|
T Consensus 102 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~-~~~~~~~~~~~~~~~~~~d~~ 159 (263)
T 2f33_A 102 CEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANK-TVDDTKLAEYTDLMLKLFDSN 159 (263)
T ss_dssp HHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTS-CCCHHHHHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCC-CCCHHHHHHHHHHHHHhcCCC
Confidence 4568999999999999999999999999988 66 688998887 88888864
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0033 Score=51.68 Aligned_cols=45 Identities=16% Similarity=0.333 Sum_probs=39.0
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|+.+|.|++|.|+.+||+.++..+|.. + +.++++.+|.|
T Consensus 75 ~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~-~----~~~~~~~~D~~ 119 (134)
T 1jfj_A 75 IGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGIE-K----VAEQVMKADAN 119 (134)
T ss_dssp HHHHHHHHHHCCSSSSEEEHHHHHHHHTTTTCH-H----HHHHHHHHHCS
T ss_pred HHHHHHHHHHCCCCCCccCHHHHHHHHHHhCHH-H----HHHHHHHhCCC
Confidence 348999999999999999999999999988753 3 88999988764
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0022 Score=56.79 Aligned_cols=49 Identities=16% Similarity=0.203 Sum_probs=42.3
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|..+|.|++|.|+.+|+..++..++. ..+++++..+++.+|.|
T Consensus 63 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~-~~~~~~~~~~f~~~D~d 111 (190)
T 2l2e_A 63 AFAEYVFNVFDADKNGYIDFKEFICALSVTSR-GELNDKLIWAFQLYDLD 111 (190)
T ss_dssp HHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSC-SCSHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcC-CCHHHHHHHHHhHccCC
Confidence 45778899999999999999999999988876 57889999999998864
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0038 Score=55.17 Aligned_cols=50 Identities=24% Similarity=0.372 Sum_probs=42.5
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhh----cc-------ccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKN----AT-------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g~-------~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|+.+|.|++|.|+.+||+.++..+ |. +..++.++.++++.+|.|
T Consensus 99 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d 159 (190)
T 1fpw_A 99 EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKN 159 (190)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCC
Confidence 467889999999999999999999999873 31 237789999999999865
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0041 Score=55.92 Aligned_cols=47 Identities=17% Similarity=0.176 Sum_probs=26.4
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
+.+.|..+|.|++|.|+.+|+..++...+.....++++..+++.+|.
T Consensus 76 ~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~ 122 (207)
T 2ehb_A 76 ADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYDL 122 (207)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHCT
T ss_pred HHHHHHHhcCCCCCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhCC
Confidence 34456666666666666666666665544323445556666666554
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=96.14 E-value=0.0061 Score=54.38 Aligned_cols=51 Identities=18% Similarity=0.199 Sum_probs=45.1
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++..|..+|.|++|.|+.+||..++..++. ..+++++..+++.+|.|
T Consensus 50 ~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~-~~~~~~~~~~F~~~D~d 100 (198)
T 2r2i_A 50 ANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLK-GKVDQKLRWYFKLYDVD 100 (198)
T ss_dssp HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSS-CCHHHHHHHHHHHHCTT
T ss_pred hHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHcc-CchHHHHHHHHHHhcCC
Confidence 3456899999999999999999999999998876 57889999999999875
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=96.14 E-value=0.004 Score=67.52 Aligned_cols=47 Identities=6% Similarity=0.091 Sum_probs=44.1
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
..++.+|+.+|.|++|.|+.+||+.+|..+|. .++++++++|++.+|
T Consensus 605 ~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~-~ls~~~~~~l~~~~D 651 (714)
T 3bow_A 605 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGF-KLPCQLHQVIVARFA 651 (714)
T ss_dssp HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTE-ECCHHHHHHHHHHHS
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCC-CCCHHHHHHHHHHhC
Confidence 56899999999999999999999999999987 699999999999987
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0021 Score=57.07 Aligned_cols=49 Identities=16% Similarity=0.200 Sum_probs=43.6
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|..+|.|++|.|+.+|+..++..++. ..+++++..+++.+|.|
T Consensus 63 ~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~~f~~~D~d 111 (193)
T 1bjf_A 63 KFAEHVFRTFDANGDGTIDFREFIIALSVTSR-GKLEQKLKWAFSMYDLD 111 (193)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTS-SCHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcC-CCHHHHHHHHHhhcCCC
Confidence 45789999999999999999999999998876 57889999999999875
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0045 Score=54.68 Aligned_cols=48 Identities=25% Similarity=0.356 Sum_probs=43.6
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++.+|..+|.|++|.|+.+|+..++..++. ..+++++..+++.+|.|
T Consensus 64 ~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~-~~~~~~~~~~f~~~D~d 111 (190)
T 1fpw_A 64 FANHLFTVFDKDNNGFIHFEEFITVLSTTSR-GTLEEKLSWAFELYDLN 111 (190)
T ss_dssp HHHHHHHTCCSSCSSEECHHHHHHHHHHHSC-CCSTHHHHHHHHHHCSS
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHHHHHHHcc-CCcHHHHHHHHHHhcCC
Confidence 5789999999999999999999999998886 57889999999999864
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=96.11 E-value=0.0071 Score=53.04 Aligned_cols=50 Identities=16% Similarity=0.173 Sum_probs=44.0
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++..|..+|.|++|.|+.+|+..++..++. ..+++++..+++.+|.|
T Consensus 55 ~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~~f~~~D~d 104 (183)
T 1s6c_A 55 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLR-GTVHEKLRWTFNLYDIN 104 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcC-CCHHHHHHHHHHHhCCC
Confidence 456788999999999999999999999998876 57889999999999865
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=96.07 E-value=0.0044 Score=54.15 Aligned_cols=50 Identities=20% Similarity=0.287 Sum_probs=37.7
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+...|..+|.|++|.|+.+|+..++.........+.++..+++.+|.|
T Consensus 47 ~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~F~~~D~d 96 (179)
T 2f2o_A 47 AELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKD 96 (179)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHhccCCCCCCcHHHHHHHHHHHccCcccHHHHHHHHHHhCCC
Confidence 34677888889999999999999888866533234567788888888764
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=96.04 E-value=0.0044 Score=56.83 Aligned_cols=46 Identities=22% Similarity=0.285 Sum_probs=23.5
Q ss_pred HHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 446 KEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 446 ~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
++.|..+|.|++|.|+.+|+..++...+.....++++..+++.+|.
T Consensus 88 ~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~ 133 (226)
T 2zfd_A 88 DRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDL 133 (226)
T ss_dssp HHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCT
T ss_pred HHHHHHHcCCCCCcCcHHHHHHHHHHHccCCCHHHHHHHHHHHhCC
Confidence 4455555555555555555555555443222344455555555554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0074 Score=61.10 Aligned_cols=79 Identities=14% Similarity=0.145 Sum_probs=49.1
Q ss_pred cceeccccceEEEEEEEecCCcc----ccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEE
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHK----DQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVY 214 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~ 214 (492)
.+.|..|-...+|++....+..+ +..|++++...... . .-+..+|..+++.|..+.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-K---FYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-h---hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 34566666678998876532212 57899998644221 1 112457999998886554456677543 23 6
Q ss_pred EEEeecCCCch
Q 011154 215 IVMELCEGGEL 225 (492)
Q Consensus 215 lv~E~~~ggsL 225 (492)
+||||++|.+|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998653
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=95.97 E-value=0.0043 Score=67.29 Aligned_cols=55 Identities=13% Similarity=0.107 Sum_probs=48.7
Q ss_pred ccchhh-HHHHHHHHhhhCCCCCcccchHHHHHHHHhh--------ccccccHHHHHHHHhcccCC
Q 011154 436 TLTVDE-RFYLKEQFALLEPNKNGCIAFENIKTVLMKN--------ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 436 ~l~~~e-~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~--------g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++.++ ..+++++|..+| |+||.|+.+||+.+|..+ +. .+++++++.|++.+|.|
T Consensus 524 ~ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~-~~s~~~~~~l~~~~D~d 587 (714)
T 3bow_A 524 EANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSD-GFSIETCKIMVDMLDED 587 (714)
T ss_dssp CCSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCS-CCCHHHHHHHHHHHCCS
T ss_pred CCChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCC-CCCHHHHHHHHHHhCCC
Confidence 356666 789999999999 999999999999999997 54 68999999999999875
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.93 E-value=0.014 Score=50.49 Aligned_cols=48 Identities=8% Similarity=0.003 Sum_probs=38.4
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhcccccc-------HHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMK-------ESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~-------~~ei~~~i~~~D~~ 492 (492)
++..|..+|.|++|.|+.+|+..++......... +.++..+++.+|.|
T Consensus 60 ~~~lf~~~D~d~dg~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d 114 (176)
T 1nya_A 60 FDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKN 114 (176)
T ss_dssp HHHHHHHHTSCTTCCBCHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSS
T ss_pred HHHHHHHhCCCCCCeEcHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCC
Confidence 3488999999999999999999999876542221 46789999988864
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.86 E-value=0.0079 Score=53.20 Aligned_cols=32 Identities=19% Similarity=0.227 Sum_probs=28.3
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhh
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKN 472 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~ 472 (492)
....++.+|..+|.|++|.|+.+||+.++..+
T Consensus 97 ~~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~ 128 (193)
T 1bjf_A 97 LEQKLKWAFSMYDLDGNGYISKAEMLEIVQAI 128 (193)
T ss_dssp HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCCCeECHHHHHHHHHHH
Confidence 34568899999999999999999999999765
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=95.81 E-value=0.0069 Score=54.43 Aligned_cols=49 Identities=14% Similarity=0.214 Sum_probs=43.9
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|..+|.|++|.|+.+||..++..++. ..+++++..+++.+|.|
T Consensus 71 ~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~-~~~~~~~~~~f~~~D~d 119 (207)
T 2d8n_A 71 AYAQHVFRSFDSNLDGTLDFKEYVIALHMTTA-GKTNQKLEWAFSLYDVD 119 (207)
T ss_dssp HHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSC-SSSSTTHHHHHHHHCTT
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcC-CCHHHHHHHHHHHhcCC
Confidence 46889999999999999999999999998876 57788999999999864
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.76 E-value=0.01 Score=53.67 Aligned_cols=51 Identities=12% Similarity=0.150 Sum_probs=44.6
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....+++.|..+|.|++|.|+.+||..++..++. ..+++++..+++.+|.|
T Consensus 55 ~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~-~~~~~~l~~~F~~~D~d 105 (211)
T 2ggz_A 55 ANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQ-EKMEQKLKWYFKLYDAD 105 (211)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSC-SSHHHHHHHHHHHHCTT
T ss_pred hHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhcc-CchHHHHHHHHHHhcCC
Confidence 3456899999999999999999999999998876 47788999999999864
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=95.72 E-value=0.009 Score=52.66 Aligned_cols=49 Identities=16% Similarity=0.191 Sum_probs=43.5
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++..|..+|.|++|.|+.+|+..++..++. ..+++++..+++.+|.|
T Consensus 63 ~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~f~~~D~d 111 (190)
T 1g8i_A 63 KFATFVFNVFDENKDGRIEFSEFIQALSVTSR-GTLDEKLRWAFKLYDLD 111 (190)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhcCCCCeEeHHHHHHHHHHhcC-CCHHHHHHHHHHhhcCC
Confidence 34789999999999999999999999998876 47788999999999864
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.68 E-value=0.011 Score=54.21 Aligned_cols=50 Identities=16% Similarity=0.173 Sum_probs=44.0
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+++..|+.+|.|++|.|+.+|+..++..++. ...++++..+++.+|.|
T Consensus 88 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~-~~~~~~l~~~F~~~D~d 137 (224)
T 1s1e_A 88 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLR-GTVHEKLRWTFNLYDIN 137 (224)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHcc-CCHHHHHHHHHHHHcCC
Confidence 346788999999999999999999999998875 47788999999999865
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=95.64 E-value=0.008 Score=53.06 Aligned_cols=57 Identities=9% Similarity=0.151 Sum_probs=41.6
Q ss_pred HHHHhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 428 AALKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 428 a~l~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
.-+.+++......+..+++++|..+| +||.|+.+||+.+| |. ..++.++.+|++.+|
T Consensus 13 ~~l~~~~~~~~~~~~~~~~~~F~~~D--~dG~I~~~el~~~l---g~-~~~~~~~~~i~~~~d 69 (179)
T 3a8r_A 13 KGLQFVTAKVGNDGWAAVEKRFNQLQ--VDGVLLRSRFGKCI---GM-DGSDEFAVQMFDSLA 69 (179)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHHHHHC--BTTBEEGGGHHHHH---TC-CSCHHHHHHHHHHHH
T ss_pred HHHHHHHhccchhhHHHHHHHHhccC--CCCCCcHHHHHHHH---CC-CCcHHHHHHHHHHHH
Confidence 33445555444456778899999998 79999999999875 54 467777888877665
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.62 E-value=0.02 Score=49.93 Aligned_cols=47 Identities=19% Similarity=0.190 Sum_probs=37.7
Q ss_pred HHHHhhhCCCCCcccchHHHHHHHHhhccc--------cccHHHHHHHHhcccCC
Q 011154 446 KEQFALLEPNKNGCIAFENIKTVLMKNATD--------AMKESRISDLLAPSDGF 492 (492)
Q Consensus 446 ~~~F~~~D~~~~G~Is~~el~~~l~~~g~~--------~~~~~ei~~~i~~~D~~ 492 (492)
...|..+|.|++|.|+.+|+..++...... ...+.++..+++.+|.|
T Consensus 63 ~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d 117 (185)
T 2sas_A 63 RDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVS 117 (185)
T ss_dssp HHHHHHHCTTCSSCEEHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTT
T ss_pred HHHHHhcCCCCCCeEcHHHHHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCC
Confidence 356999999999999999999998765321 12457899999999875
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=95.53 E-value=0.012 Score=65.72 Aligned_cols=47 Identities=9% Similarity=0.063 Sum_probs=44.2
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
..++++|+.+|.|++|.|+.+||+.+|..+|. .+++++++.|++.+|
T Consensus 607 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~-~l~~~~~~~l~~~~d 653 (900)
T 1qxp_A 607 RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGF-KLPCQLHQVIVARFA 653 (900)
T ss_dssp HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTE-ECCHHHHHHHHHHTS
T ss_pred HHHHHHHHhhCCCCCCeECHHHHHHHHHHhCC-CCCHHHHHHHHHHhC
Confidence 57899999999999999999999999999997 699999999999987
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=95.49 E-value=0.011 Score=55.20 Aligned_cols=50 Identities=18% Similarity=0.152 Sum_probs=44.2
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|++|.|+.+||..++..++. ..+++++..+++.+|.|
T Consensus 128 ~~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~-~~~~~~l~~~F~~~D~d 177 (256)
T 2jul_A 128 TTYAHFLFNAFDADGNGAIHFEDFVVGLSILLR-GTVHEKLKWAFNLYDIN 177 (256)
T ss_dssp HHHHHHHHHHSSCSCCSEECSHHHHHHHHHHHS-CCHHHHHHHHHHHTCCS
T ss_pred HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHhc-cChHHHHHHHHHHhCCC
Confidence 346788999999999999999999999998875 57889999999999864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 492 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-86 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-86 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-85 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-83 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-82 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-82 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-78 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-77 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-77 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-76 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-75 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-74 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-74 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-72 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-71 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-71 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-70 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-70 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-67 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-65 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-63 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-63 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-62 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-62 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-62 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-60 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-59 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-59 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-59 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-59 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-58 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-57 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-55 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-54 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-44 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 2e-06 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 2e-04 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 266 bits (681), Expect = 2e-86
Identities = 114/301 (37%), Positives = 167/301 (55%), Gaps = 8/301 (2%)
Query: 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREV 188
++++ + + +G G F A K+ + VAIK I K + + E+
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRT---QKLVAIKCIAKKALEGK--EGSMENEI 58
Query: 189 KILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI 248
+L + H N+V D +E ++Y++M+L GGEL DRI+ + G Y+E +A ++ Q+
Sbjct: 59 AVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQV 116
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV 308
L+ V + H G+VHRDLKPEN LY S DE S++ DFGLS P L+ G+ YV
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 309 APEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367
APEVL + Y D WSIGVIAYILLCG PF+ ++ +F +LKA+ FD W +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRR 427
S AKDF++ L+ KDP KR T QAL HPWI + + S+ + +K S ++
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 296
Query: 428 A 428
A
Sbjct: 297 A 297
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 266 bits (681), Expect = 5e-86
Identities = 98/311 (31%), Positives = 156/311 (50%), Gaps = 10/311 (3%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK 189
V ++ EE+G G FG K + K I + V+ E+
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYP---LDKYTVKNEIS 78
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL 249
I+ L H L+ +DAFED + +++E GGEL DRI + K SE E + Q
Sbjct: 79 IMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVA 309
+ H H +VH D+KPEN + +K +S +K IDFGL+ + PDE + +A + A
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNPDEIVKVTTATAEFAA 196
Query: 310 PEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368
PE++ R G D+W+IGV+ Y+LL G PF + + V + D FD+ ++ S+S
Sbjct: 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIR-NYNNVKVPLDISILKLMKAYMQSSSLRR 427
+AKDF+K LL K+PRKR+T AL HPW++ +++N+ + S ++ ++
Sbjct: 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 316
Query: 428 AALKALSKTLT 438
A + +
Sbjct: 317 PAPQPAIGRIA 327
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 264 bits (675), Expect = 4e-85
Identities = 98/289 (33%), Positives = 145/289 (50%), Gaps = 9/289 (3%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK 189
V ++ EE+G G FG + A K + + E VR+E++
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHES---DKETVRKEIQ 75
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL 249
+ L H LV +DAFED + + ++ E GGEL +++ K SEDEA + Q+
Sbjct: 76 TMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVA 309
+ H + VH DLKPEN ++T+ S++LK IDFGL+ + P + + G+A + A
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 310 PEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368
PEV + G D+WS+GV++YILL G PF + R V D + DD ++ +S
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMK 417
D KDF++ LL DP RMT QAL HPW+ N I + K
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 257 bits (657), Expect = 2e-83
Identities = 95/280 (33%), Positives = 142/280 (50%), Gaps = 20/280 (7%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIA------VEDVRREV 188
E E +GRG +K ++ A+K+I + + A E +EV
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 189 KILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQI 248
ILR +SGH N+++ D +E ++V +L + GEL D + + SE E + ++ +
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRAL 119
Query: 249 LNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYV 308
L V+ H +VHRDLKPEN L D+ +K DFG S + P E+L ++ G+ Y+
Sbjct: 120 LEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 309 APEVL-------HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD 361
APE++ H YG E D+WS GVI Y LL GS PFW R + + R ++ + F
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 362 GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
W S KD V L P+KR TA +AL+HP+ + Y
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 256 bits (656), Expect = 1e-82
Identities = 83/308 (26%), Positives = 153/308 (49%), Gaps = 13/308 (4%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK 189
KE+ + + E++GRG FG + K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVKVKGTD----QVLVKKEIS 53
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL 249
IL H N++ +++FE ++ + ++ E G ++ +RI + + +E E + + Q+
Sbjct: 54 ILNIAR-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVA 309
+ F H H + H D++PEN +Y + SS +K I+FG + ++P + + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 310 PEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368
PEV H T D+WS+G + Y+LL G PF A T I ++ A+ +FD+ ++ +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRRA 428
+A DFV LL K+ + RMTA++AL HPW++ + +++ +K +L +
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE---RVSTKVIRTLKHRRYYHTLIKK 288
Query: 429 ALKALSKT 436
L +
Sbjct: 289 DLNMVVSA 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (645), Expect = 9e-82
Identities = 84/271 (30%), Positives = 139/271 (51%), Gaps = 14/271 (5%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
E+G +G+G FG AR K+ +A+KV+ K+++ A +RREV+I
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
L H N+++ Y F D VY+++E G + R L + K+ E + ++ N ++
Sbjct: 63 LR-HPNILRLYGYFHDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALS 120
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 313
+CH V+HRD+KPEN L S +LK DFG S P R + G+ Y+ PE++
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAG---ELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMI 176
Query: 314 -HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372
R + + D+WS+GV+ Y L G PF A T ++ + + + +F D ++ A+
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGAR 232
Query: 373 DFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403
D + LL +P +R + L HPWI ++
Sbjct: 233 DLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (625), Expect = 2e-78
Identities = 82/278 (29%), Positives = 132/278 (47%), Gaps = 18/278 (6%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
E+ E+G G FG A+ K+ A KVI +ED E+ IL +
Sbjct: 15 EIIGELGDGAFGKVYKAQNKET---SVLAAAKVIDTKSEE---ELEDYMVEIDILASCD- 67
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H N+VK DAF +N++I++E C GG + +L +E + + V Q L+ + + H
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH- 314
+ ++HRDLK N L+ +K DFG+S R +R + +G+ Y++APEV+
Sbjct: 128 DNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 315 -----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369
R Y +ADVWS+G+ + P + + K++P SS
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSS 243
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVP 407
+ KDF+K L K+ R T +Q L HP++ +N +
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 281
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 1e-77
Identities = 102/285 (35%), Positives = 158/285 (55%), Gaps = 11/285 (3%)
Query: 128 FSKE-VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA---IAVED 183
F +E V + GEE+G G F R K + A K I K + ++ ++ ED
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 184 VRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKA 243
+ REV IL+ + H N++ ++ +E+ +V +++EL GGEL D + + +E+EA
Sbjct: 60 IEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE 117
Query: 244 VLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESS-QLKAIDFGLSDFVRPDERLNDIV 302
L QILN V + H + H DLKPEN + ++ ++K IDFGL+ + +I
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 303 GSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD 361
G+ +VAPE++ + G EAD+WSIGVI YILL G+ PF T+ V + F+D
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 362 GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKV 406
+ + S+ AKDF++ LL KDP+KRMT +L HPWI+ + +
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 8e-77
Identities = 81/275 (29%), Positives = 133/275 (48%), Gaps = 16/275 (5%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK 189
K+ + G+ +G G F AR ++ AIK++ K + V V RE
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 190 ILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL 249
++ L H VK Y F+D + +Y + + GELL I + G + E + +I+
Sbjct: 61 VMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIV 118
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE---RLNDIVGSAY 306
+ + + H G++HRDLKPEN L +E ++ DFG + + P+ R N VG+A
Sbjct: 119 SALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 307 YVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365
YV+PE+L +S +D+W++G I Y L+ G PF A E IF+ ++K + F
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PE 231
Query: 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400
A+D V+ LL D KR+ + + ++
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 241 bits (615), Expect = 1e-76
Identities = 79/318 (24%), Positives = 134/318 (42%), Gaps = 19/318 (5%)
Query: 120 PELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAI 179
P++ + F F + E+G G FG AR + + VAIK + S +
Sbjct: 2 PDVAELF-FKDDPEKLFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNE 57
Query: 180 AVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSED 239
+D+ +EV+ L+ L H N +++ + ++VME C G + + E
Sbjct: 58 KWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEV 115
Query: 240 EAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLN 299
E AV L +A+ H H ++HRD+K N L E +K DFG + + P N
Sbjct: 116 EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---N 169
Query: 300 DIVGSAYYVAPEVL----HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 355
VG+ Y++APEV+ Y + DVWS+G+ L P + + +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKL 415
+ S ++FV L K P+ R T+ L H ++ V +D+ I +
Sbjct: 230 ESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL-IQRT 286
Query: 416 MKAYMQSSSLRRAALKAL 433
A + +L+ +K +
Sbjct: 287 KDAVRELDNLQYRKMKKI 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 7e-75
Identities = 73/295 (24%), Positives = 143/295 (48%), Gaps = 20/295 (6%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
+ + E++G+G G TA Q+VAI+ + + E + E+ +
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILV 70
Query: 191 LRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILN 250
+R + N+V + D++ D +++VME GG L D + C E + AV + L
Sbjct: 71 MRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQ 127
Query: 251 VVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSAYYVA 309
+ F H + V+HRD+K +N L +K DFG + P++ + + +VG+ Y++A
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 310 PEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368
PEV+ ++YG + D+WS+G++A ++ G P+ + + + + + LS
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLS 243
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSS 423
+ +DF+ L+ D KR +A + L H +++ + S+ L+ A +++
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS-----SLTPLIAAAKEAT 293
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (603), Expect = 1e-74
Identities = 97/322 (30%), Positives = 152/322 (47%), Gaps = 23/322 (7%)
Query: 138 VGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH 197
+ +G G G K+ +K A+K++ RREV++ S
Sbjct: 16 TSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDCPK--------ARREVELHWRASQC 64
Query: 198 SNLVKFYDAFEDL----DNVYIVMELCEGGELLDRILSRCGK-YSEDEAKAVLVQILNVV 252
++V+ D +E+L + IVME +GGEL RI R + ++E EA ++ I +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 312
+ H + HRD+KPEN LYTSK ++ LK DFG + L + YYVAPEV
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184
Query: 313 L-HRSYGTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDDGSWPSL 367
L Y D+WS+GVI YILLCG PF++ G+ + F + W +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNV-KVPLDISILKLMKAYMQSSSLR 426
S + K ++ LL +P +RMT + ++HPWI V + PL S + L + + ++
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV-LKEDKERWEDVK 303
Query: 427 RAALKALSKTLTVDERFYLKEQ 448
AL+ E+ +K+
Sbjct: 304 EEMTSALATMRVDYEQIKIKKI 325
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 3e-74
Identities = 77/268 (28%), Positives = 131/268 (48%), Gaps = 16/268 (5%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
++ + +G G +G A + ++ VA+K++ + E++++E+ I + L+
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVT---EEAVAVKIVDMKRAVDC--PENIKKEICINKMLN- 61
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H N+VKFY + + Y+ +E C GGEL DRI E +A+ Q++ V + H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH 120
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVL 313
G+ HRD+KPEN L +D LK DFGL+ R + R LN + G+ YVAPE+L
Sbjct: 121 GIGITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 314 HRS--YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371
R + DVWS G++ +L G P+ ++S + K ++ + W + S
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKIDSAP 236
Query: 372 KDFVKLLLNKDPRKRMTAAQALSHPWIR 399
+ +L ++P R+T W
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 9e-72
Identities = 80/269 (29%), Positives = 127/269 (47%), Gaps = 14/269 (5%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+ + +G+G FG A +KK +Q AIK + K + VE E ++L
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H L + F+ +N++ VME GG+L+ I C K+ A +I+ + F H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL-H 314
G+V+RDLK +N L D+ +K DFG+ + + D + N G+ Y+APE+L
Sbjct: 121 SKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 315 RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
+ Y D WS GV+ Y +L G PF + E +F ++ +P + L +AKD
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDL 233
Query: 375 VKLLLNKDPRKRMTAAQA-LSHPWIRNYN 402
+ L ++P KR+ HP R N
Sbjct: 234 LVKLFVREPEKRLGVRGDIRQHPLFREIN 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 226 bits (577), Expect = 1e-71
Identities = 72/279 (25%), Positives = 119/279 (42%), Gaps = 11/279 (3%)
Query: 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVK 189
++ R E+GE +G G AR + + VA+KV+ RRE +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 190 ILRALSGHSNLVKFYDAFEDLDN----VYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
AL+ H +V YD E YIVME +G L D I+ G + A V+
Sbjct: 60 NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVI 117
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFG-LSDFVRPDERLNDIVGS 304
+ F H +G++HRD+KP N + ++ + + ++D + ++G+
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 305 AYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363
A Y++PE S +DV+S+G + Y +L G PF + + ++ DP
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402
LS+D V L K+P R A + +R +N
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 2e-71
Identities = 60/271 (22%), Positives = 113/271 (41%), Gaps = 18/271 (6%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
L+ E+GRG F + +VA + K+T + + + E ++L+ L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQ 66
Query: 196 GHSNLVKFYDAFEDL----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNV 251
H N+V+FYD++E + +V EL G L L R ++ QIL
Sbjct: 67 -HPNIVRFYDSWESTVKGKKCIVLVTELMTSG-TLKTYLKRFKVMKIKVLRSWCRQILKG 124
Query: 252 VAFCHLHG--VVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVA 309
+ F H ++HRDLK +N T + +K D GL+ R ++G+ ++A
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMA 181
Query: 310 PEVLHRSYGTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDDGSWPSLS 368
PE+ Y DV++ G+ + P+ + + I+R V
Sbjct: 182 PEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAI 239
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
+ K+ ++ + ++ +R + L+H + +
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-70
Identities = 79/274 (28%), Positives = 132/274 (48%), Gaps = 22/274 (8%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVED---VRREVKI 190
S+ +VG +G G FG + + VAIK + K +++ + + V EV +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 191 LRALS-GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQIL 249
L+ +S G S +++ D FE D+ +++E E + L ++ G E+ A++ Q+L
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 250 NVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVA 309
V CH GV+HRD+K EN L +LK IDFG + D D G+ Y
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALL-KDTVYTDFDGTRVYSP 177
Query: 310 PEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367
PE + HR +G A VWS+G++ Y ++CG PF E +++ F +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRV 227
Query: 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
SS+ + ++ L P R T + +HPW+++
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 1e-70
Identities = 72/318 (22%), Positives = 123/318 (38%), Gaps = 53/318 (16%)
Query: 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
E E+G G+ G +K +A K+I + RE+++L
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAI--RNQIIRELQVLH 59
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
+ +V FY AF + I ME +GG L D++L + G+ E V + ++ +
Sbjct: 60 ECN-SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 253 AFCH-LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 311
+ H ++HRD+KP N L S+ E +K DFG+S + D N VG+ Y++PE
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPE 173
Query: 312 VLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPSFDDG----- 362
L Y ++D+WS+G+ + G P +F ++ D +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 363 --------------------------------SWPSLSSDAKDFVKLLLNKDPRKRMTAA 390
S + +DFV L K+P +R
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 391 QALSHPWIRNYNNVKVPL 408
Q + H +I+ + +V
Sbjct: 294 QLMVHAFIKRSDAEEVDF 311
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 8e-70
Identities = 80/274 (29%), Positives = 123/274 (44%), Gaps = 23/274 (8%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
EV +G G +G R K + + K + MT A + + EV +LR L
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLRELK- 61
Query: 197 HSNLVKFYDAFEDLDN--VYIVMELCEGGELLDRI---LSRCGKYSEDEAKAVLVQILNV 251
H N+V++YD D N +YIVME CEGG+L I E+ V+ Q+
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 252 VAFCHL-----HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-RLNDIVGSA 305
+ CH H V+HRDLKP N D +K DFGL+ + D VG+
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178
Query: 306 YYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364
YY++PE ++R SY ++D+WS+G + Y L PF A ++ + + +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P 235
Query: 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398
S + + + +LN R + + L +P I
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 3e-67
Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 21/271 (7%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
++ VG+ +G G FG ++ VA+K++ + T ++ + EV +LR
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQ-QLQAFKNEVGVLRK 60
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
H N++ F + + IV + CEG L + K+ + + Q +
Sbjct: 61 TR-HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAP 310
+ H ++HRDLK N E +K DFGL+ + + GS ++AP
Sbjct: 119 YLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 311 EVL----HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS--W 364
EV+ Y ++DV++ G++ Y L+ G P+ ++ D S
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
+ K + L K +R Q L+
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 213 bits (544), Expect = 2e-65
Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 18/275 (6%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS- 195
V +GRG FG R + A+K + K ++ E +L +S
Sbjct: 7 SVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 196 -GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
+V AF D + +++L GG+L LS+ G +SE + + +I+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 314
H VV+RDLKP N L DE ++ D GL+ ++ + VG+ Y+APEVL
Sbjct: 123 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQ 178
Query: 315 R--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372
+ +Y + AD +S+G + + LL G PF + + + S S + +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELR 237
Query: 373 DFVKLLLNKDPRKRMT-----AAQALSHPWIRNYN 402
++ LL +D +R+ A + P+ R+ +
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 211 bits (538), Expect = 3e-65
Identities = 69/272 (25%), Positives = 126/272 (46%), Gaps = 20/272 (7%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
++ +G G FG R + H + A+KV+ K + VE E +L ++
Sbjct: 7 QILRTLGTGSFGRVHLIRSR---HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT- 62
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H +++ + F+D ++++M+ EGGEL + ++ AK ++ + + H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH 121
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HR 315
+++RDLKPEN L D++ +K DFG + +V + + G+ Y+APEV+ +
Sbjct: 122 SKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTK 176
Query: 316 SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFV 375
Y D WS G++ Y +L G PF+ + +L A+ F P + D KD +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLL 232
Query: 376 KLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
L+ +D +R+ +HPW +
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-63
Identities = 79/304 (25%), Positives = 122/304 (40%), Gaps = 37/304 (12%)
Query: 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
+ E E+G G +G AR K + + VA+K + + REV +LR
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMP-LSTIREVAVLR 62
Query: 193 ALSG--HSNLVKFYDAF-----EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
L H N+V+ +D + + +V E + + K ++
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
Q+L + F H H VVHRDLKP+N L S Q+K DFGL+ L +V +
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTL 179
Query: 306 YYVAPEVLHRS-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364
+Y APEVL +S Y T D+WS+G I + F ++ +L + W
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 365 P-----------------------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
P + KD + L +P KR++A ALSHP+ ++
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299
Query: 402 NNVK 405
K
Sbjct: 300 ERCK 303
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-63
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 19/273 (6%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+ + +G+G FG R K + A+K++ K + V E ++L+
Sbjct: 8 DYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR- 63
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H L AF+ D + VME GGEL + SR ++E+ A+ +I++ + + H
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH 122
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHR 315
VV+RD+K EN + D+ +K DFGL + G+ Y+APEVL
Sbjct: 123 SRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 316 S-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
+ YG D W +GV+ Y ++CG PF+ + +F +L + F +LS +AK
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSL 235
Query: 375 VKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
+ LL KDP++R+ A + + H + + N
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-63
Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 15/279 (5%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-TAIAVEDVRREVKILRA 193
E+ + +G G +G R G + A+KV+ K+ + A E R E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
+ LV + AF+ ++++++ GGEL LS+ +++E E + + +I+ +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRP--DERLNDIVGSAYYVAPE 311
H G+++RD+K EN L D + + DFGLS ER D G+ Y+AP+
Sbjct: 144 HLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 312 VL---HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368
++ + D WS+GV+ Y LL G+ PF E + + + +S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 369 SDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402
+ AKD ++ LL KDP+KR+ A + H + + N
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-62
Identities = 61/267 (22%), Positives = 99/267 (37%), Gaps = 13/267 (4%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
L + E++G G FG + K VA+K + ++ A++D REV + +L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H NL++ Y + +V EL G LLDR+ G + VQ+ + +
Sbjct: 69 D-HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE----RLNDIVGSAYYVAP 310
+HRDL N L ++D +K DFGL + ++ + AP
Sbjct: 127 LESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 311 EVL-HRSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368
E L R++ +D W GV + + G P+ S I + K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCP 241
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALSH 395
D + + P R T
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 4e-62
Identities = 80/294 (27%), Positives = 121/294 (41%), Gaps = 37/294 (12%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA--IAVEDVRREVKILRAL 194
E + +G G F AR K +Q VAIK I + A RE+K+L+ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNT---NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
S H N++ DAF N+ +V + E + I + KA ++ L + +
Sbjct: 58 S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 313
H H ++HRDLKP N L DE+ LK DFGL+ F P+ V + +Y APE+L
Sbjct: 116 LHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
Query: 314 --HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP------ 365
R YG D+W++G I LL ++ + + + + WP
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 366 ------------------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
+ D D ++ L +P R+TA QAL + N
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 202 bits (514), Expect = 4e-62
Identities = 82/293 (27%), Positives = 130/293 (44%), Gaps = 38/293 (12%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+ E++G G +G A+ G + A+K I K I RE+ IL+ L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGI-PSTTIREISILKEL 57
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
HSN+VK YD + +V E + +L + G AK+ L+Q+LN +A+
Sbjct: 58 K-HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVL 313
CH V+HRDLKP+N L + +LK DFGL+ P + + + +Y AP+VL
Sbjct: 116 CHDRRVLHRDLKPQNLLINREG---ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 314 HRS--YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP------ 365
S Y T D+WS+G I ++ G+ F +E+ + + + + +WP
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 366 -------------------SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399
L D + +L DP +R+TA QAL H + +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 5e-62
Identities = 91/342 (26%), Positives = 136/342 (39%), Gaps = 54/342 (15%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
+V R +G G +G C+A +VAIK I + T + RE+KI
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVN---KVRVAIKKISPFEHQTY--CQRTLREIKI 59
Query: 191 LRALSGHSNLVKFYDAF-----EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
L H N++ D E + +VY+V L G +L + + S D L
Sbjct: 60 LLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL--KTQHLSNDHICYFL 115
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE----RLNDI 301
QIL + + H V+HRDLKP N L + + LK DFGL+ PD L +
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEY 172
Query: 302 VGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359
V + +Y APE++ S Y D+WS+G I +L F + +L S
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
Query: 360 DDGSW---------------------------PSLSSDAKDFVKLLLNKDPRKRMTAAQA 392
P+ S A D + +L +P KR+ QA
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
Query: 393 LSHPWIRNYNNVKVPLDISILKLMKAY-MQSSSLRRAALKAL 433
L+HP++ Y + P D I + + M+ L + LK L
Sbjct: 293 LAHPYLEQYYD---PSDEPIAEAPFKFDMELDDLPKEKLKEL 331
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 200 bits (510), Expect = 6e-61
Identities = 70/306 (22%), Positives = 132/306 (43%), Gaps = 53/306 (17%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
++ ++GRG + A ++KV +K++ K + ++RE+KIL L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKK------KKIKREIKILENL 86
Query: 195 SGHSNLVKFYDAFEDLDN--VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
G N++ D +D + +V E + ++ + + + +IL +
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKAL 142
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 312
+CH G++HRD+KP N + + +L+ ID+GL++F P + N V S Y+ PE+
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200
Query: 313 L--HRSYGTEADVWSIGVIAYILLCGSRPFWA------------------RTESGIFRAV 352
L ++ Y D+WS+G + ++ PF+ I +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 353 LKADPSFDD----------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396
++ DP F+D + +S +A DF+ LL D + R+TA +A+ HP
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
Query: 397 WIRNYN 402
+
Sbjct: 321 YFYTVV 326
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-60
Identities = 69/304 (22%), Positives = 117/304 (38%), Gaps = 39/304 (12%)
Query: 121 ELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTA 178
E D ++ F +E LE G+ +G G FG A +VA+K++ + ++
Sbjct: 27 EYDLKWEFPRE---NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE 83
Query: 179 IAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSE 238
E + E+K++ L H N+V A +Y++ E C G+LL+ + S+ K+SE
Sbjct: 84 --REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141
Query: 239 D----------------------EAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276
D + Q+ + F VHRDL N L
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---T 198
Query: 277 ESSQLKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAY- 331
+K DFGL+ + D + ++APE L Y ++DVWS G++ +
Sbjct: 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258
Query: 332 ILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQ 391
I G P+ F +++ D + + ++ D RKR +
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 392 ALSH 395
S
Sbjct: 317 LTSF 320
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 6e-60
Identities = 60/266 (22%), Positives = 102/266 (38%), Gaps = 23/266 (8%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L++ + +G+G FG G+++ KVA+K I + E ++
Sbjct: 7 KELKLLQTIGKGEFG-----DVMLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQ 56
Query: 194 LSGHSNLVKFYDAF-EDLDNVYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNV 251
L HSNLV+ E+ +YIV E G L+D + SR D + +
Sbjct: 57 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 311
+ + + VHRDL N L E + K DFGL+ + + APE
Sbjct: 116 MEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPE 170
Query: 312 VL-HRSYGTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369
L + + T++DVWS G++ + + G P+ + V K + +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPP 227
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSH 395
+ +K + D R + Q
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-60
Identities = 58/264 (21%), Positives = 107/264 (40%), Gaps = 19/264 (7%)
Query: 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
L +E+G G FG +++ VAIK+I + M+ ++ E K++ LS
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEGSMSE----DEFIEEAKVMMNLS 57
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255
H LV+ Y ++I+ E G LL+ + ++ + + + + +
Sbjct: 58 -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 256 HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVL 313
+HRDL N L ++ +K DFGLS +V DE + PEVL
Sbjct: 117 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 314 -HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDA 371
+ + +++D+W+ GV+ + I G P+ T S + + + S
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKV 230
Query: 372 KDFVKLLLNKDPRKRMTAAQALSH 395
+ ++ +R T LS+
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-59
Identities = 67/317 (21%), Positives = 111/317 (35%), Gaps = 48/317 (15%)
Query: 127 GFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRR 186
G + + +G G FG A+ + VAIK + + K R
Sbjct: 13 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDK-------RFKNR 62
Query: 187 EVKILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGG--ELLDRILSRCGKYSE 238
E++I+R L H N+V+ F +D + +V++ +
Sbjct: 63 ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 239 DEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL 298
K + Q+ +A+ H G+ HRD+KP+N L +L DFG + + E
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL--CDFGSAKQLVRGEPN 179
Query: 299 NDIVGSAYYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA- 355
+ S YY APE++ + Y + DVWS G + LL G F + ++K
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 356 ------------------------DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQ 391
+ P +A LL P R+T +
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299
Query: 392 ALSHPWIRNYNNVKVPL 408
A +H + + V L
Sbjct: 300 ACAHSFFDELRDPNVKL 316
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 1e-59
Identities = 87/312 (27%), Positives = 146/312 (46%), Gaps = 26/312 (8%)
Query: 103 KSTKKSSAEEGAPE---EAAPELDKRFGFSKEVTSRL---EVGEEVGRGHFGYTCTARYK 156
+ KK S +E E +A + K++ + T++L + + +G G FG ++K
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 157 KGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIV 216
+ A+K++ K K+ +E E +IL+A++ LVK +F+D N+Y+V
Sbjct: 64 E---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV 119
Query: 217 MELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD 276
ME GGE+ L R G++SE A+ QI+ + H +++RDLKPEN L D
Sbjct: 120 MEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---D 175
Query: 277 ESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLC 335
+ ++ DFG + R R + G+ +APE++ + Y D W++GV+ Y +
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 336 GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRM-----TAA 390
G PF+A I+ ++ F SSD KD ++ LL D KR
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289
Query: 391 QALSHPWIRNYN 402
+H W +
Sbjct: 290 DIKNHKWFATTD 301
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-59
Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 19/266 (7%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
S L +E+G G FG + KVAIK I + M+ ED E +++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAMSE----EDFIEEAEVMMK 56
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
LS H LV+ Y + + +V E E G L D + ++ G ++ + + + + +A
Sbjct: 57 LS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND--IVGSAYYVAPE 311
+ V+HRDL N L E+ +K DFG++ FV D+ + + +PE
Sbjct: 116 YLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 312 VL-HRSYGTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDDGSWPSLSS 369
V Y +++DVWS GV+ + + + + R+ S + + + S+
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 229
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSH 395
+ + P R ++ L
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-59
Identities = 78/320 (24%), Positives = 127/320 (39%), Gaps = 55/320 (17%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
S+ E ++G+G FG AR++K QKVA+K + RE+KIL+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGF-PITALREIKILQL 65
Query: 194 LSGHSNLVKFYDAFEDLD--------NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
L H N+V + ++Y+V + CE L + + K++ E K V+
Sbjct: 66 LK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVM 123
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE-----RLND 300
+LN + + H + ++HRD+K N L LK DFGL+ + R +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 301 IVGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 358
V + +Y PE+L R YG D+W G I + S TE + + S
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 359 FDDGSWPSL----------------------------SSDAKDFVKLLLNKDPRKRMTAA 390
WP++ A D + LL DP +R+ +
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 391 QALSHPWIRNYNNVKVPLDI 410
AL+H + + +P D+
Sbjct: 301 DALNHDFFWSD---PMPSDL 317
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (496), Expect = 3e-59
Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 20/290 (6%)
Query: 127 GFSKEVT-SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVR 185
F+KE+ S +++ + +G G FG C+ K ++ VAIK + T D
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFL 75
Query: 186 REVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
E I+ H N++ V I+ E E G L + G+++ + +L
Sbjct: 76 SEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND----- 300
I + + VHRDL N L + + K DFGLS F+ D
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 301 -IVGSAYYVAPEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADP 357
+ APE + +R + + +DVWS G++ + ++ G RP+W T + A+ +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--- 248
Query: 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH--PWIRNYNNVK 405
+ S + KD R Q ++ IRN N++K
Sbjct: 249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-59
Identities = 77/324 (23%), Positives = 139/324 (42%), Gaps = 56/324 (17%)
Query: 125 RFGFSK--------EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT 176
R GF + EV + + VG G +G C+A + KVAIK + + +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQS 57
Query: 177 TAIAVEDVRREVKILRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRIL 230
+ + RE+++L+ + H N++ D F +D + Y+VM G L +++
Sbjct: 58 -ELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM 113
Query: 231 SRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290
K ED + ++ Q+L + + H G++HRDLKP N +E +LK +DFGL+
Sbjct: 114 KH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 169
Query: 291 FVRPDERLNDIVGSAYYVAPEVL--HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGI 348
D + V + +Y APEV+ Y D+WS+G I ++ G F
Sbjct: 170 Q--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227
Query: 349 FRAVLKADPSFDDGSW---------------------------PSLSSDAKDFVKLLLNK 381
+ ++K + + S A + ++ +L
Sbjct: 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 287
Query: 382 DPRKRMTAAQALSHPWIRNYNNVK 405
D +R+TA +AL+HP+ + ++ +
Sbjct: 288 DAEQRVTAGEALAHPYFESLHDTE 311
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-59
Identities = 64/266 (24%), Positives = 106/266 (39%), Gaps = 14/266 (5%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
R+E+G +G G FG Y E+ VAIK T+ E +E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQ 64
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVA 253
H ++VK + + V+I+MELC GEL + R Q+ +A
Sbjct: 65 FD-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 254 FCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPE 311
+ VHRD+ N L +S D +K DFGLS ++ + + ++APE
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 312 VL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369
+ R + + +DVW GV + IL+ G +PF + + + + P+
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PPNCPP 236
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALSH 395
+ DP +R + +
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-58
Identities = 79/294 (26%), Positives = 124/294 (42%), Gaps = 36/294 (12%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSG 196
+ E++G G +G AR K + VA+K I T + RE+ +L+ L+
Sbjct: 5 QKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGV-PSTAIREISLLKELN- 59
Query: 197 HSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCH 256
H N+VK D + +Y+V E S K+ L Q+L +AFCH
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 257 LHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVLHR 315
H V+HRDLKP+N L + +K DFGL+ P V + +Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 316 S--YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPS------- 366
Y T D+WS+G I ++ F +E + + + D+ WP
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 367 ------------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402
L D + + +L+ DP KR++A AL+HP+ ++
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 3e-58
Identities = 55/299 (18%), Positives = 106/299 (35%), Gaps = 25/299 (8%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
V +R +G ++G G FG ++VAIK+ + E KI
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTK-----HPQLHIESKIY 56
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNV 251
+ + G + + D +VMEL L D K+S + Q+++
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPS-LEDLFNFCSRKFSLKTVLLLADQMISR 115
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--------RLNDIVG 303
+ + H +HRD+KP+NFL + + + IDFGL+ R ++ G
Sbjct: 116 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 304 SAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----PS 358
+A Y + D+ S+G + GS P+ + + + +
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
Query: 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAA---QALSHPWIRNYNNVKVPLDISILK 414
+ S+ ++ + + + Q + + R + D ++LK
Sbjct: 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 294
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-57
Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 21/276 (7%)
Query: 133 TSRLEVGE-EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
L + + E+G G+FG Y+ + K VAIKV+ + T E++ RE +I+
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQG--TEKADTEEMMREAQIM 63
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNV 251
L + +V+ + + + +VME+ GG L ++ + + +L Q+
Sbjct: 64 HQLD-NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND----IVGSAYY 307
+ + VHRDL N L K DFGLS + D+ +
Sbjct: 122 MKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178
Query: 308 VAPEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365
APE + R + + +DVWS GV + L G +P+ + + + P
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PP 235
Query: 366 SLSSDAKDFVKLLLNKDPRKRMTAA---QALSHPWI 398
+ + R Q + +
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-57
Identities = 63/281 (22%), Positives = 108/281 (38%), Gaps = 23/281 (8%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L + ++G+G FG + +VAIK + M + E +E ++++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTM----SPEAFLQEAQVMKK 68
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYS-EDEAKAVLVQILNVV 252
L H LV+ Y + + +YIV E G LLD + GKY + + QI + +
Sbjct: 69 LR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 310
A+ VHRDL+ N L E+ K DFGL+ + +E + AP
Sbjct: 127 AYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 311 EVL-HRSYGTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDDGSWPSLS 368
E + + ++DVWS G++ L R + + V + + P
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECP 240
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALS--HPWIRNYNNVKVP 407
D + K+P +R T + + + P
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 8e-57
Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 38/296 (12%)
Query: 135 RLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRAL 194
+ E E++G G +G A+ ++ + VA+K + + RE+ +L+ L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGV-PSSALREICLLKEL 58
Query: 195 SGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAF 254
H N+V+ +D + +V E C+ G + K+ L Q+L + F
Sbjct: 59 K-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGF 116
Query: 255 CHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 313
CH V+HRDLKP+N L E K +FGL+ F P + V + +Y P+VL
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 314 HRS--YGTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKADPSFDDGSWPS---- 366
+ Y T D+WS G I L RP F + + + + + WPS
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 367 ---------------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401
L++ +D ++ LL +P +R++A +AL HP+ ++
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-55
Identities = 59/271 (21%), Positives = 111/271 (40%), Gaps = 20/271 (7%)
Query: 141 EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNL 200
E+G G+FG Y+ + + VA+K++ A+ +++ E +++ L + +
Sbjct: 14 ELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPAL-KDELLAEANVMQQLD-NPYI 70
Query: 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGV 260
V+ E ++ +VME+ E G L ++ L + + ++ Q+ + +
Sbjct: 71 VRMIGICEA-ESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 261 VHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLND----IVGSAYYVAPEVL-HR 315
VHRDL N L ++ K DFGLS +R DE + APE + +
Sbjct: 129 VHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 316 SYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDF 374
+ +++DVWS GV+ + G +P+ S + + K + G + D
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDL 242
Query: 375 VKLLLNKDPRKRMTAAQ---ALSHPWIRNYN 402
+ L D R A L + + N
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-55
Identities = 67/295 (22%), Positives = 111/295 (37%), Gaps = 34/295 (11%)
Query: 123 DKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIA 180
D ++ F + RL G+ +G G FG A D VA+K++ S T
Sbjct: 15 DHKWEFPRN---RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-- 69
Query: 181 VEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY---- 236
E + E+K+L L H N+V A ++ E C G+LL+ + + +
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 237 -------------SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283
++ + Q+ +AF +HRDL N L T + K
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KI 186
Query: 284 IDFGLSDFVRPDERL---NDIVGSAYYVAPEVLHRSYGT-EADVWSIGVIAYILLCGSRP 339
DFGL+ ++ D + ++APE + T E+DVWS G+ + L
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 340 -FWARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQAL 393
+ F ++K ++ D +K + DP KR T Q +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 8e-55
Identities = 76/307 (24%), Positives = 131/307 (42%), Gaps = 46/307 (14%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
EV R + VG G +G C A K +VA+K + + + I + RE+++
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSI-IHAKRTYRELRL 70
Query: 191 LRALSGHSNLVKFYDAFEDLD-----NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVL 245
L+ + H N++ D F N ++ G +L + + +C K ++D + ++
Sbjct: 71 LKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLI 127
Query: 246 VQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSA 305
QIL + + H ++HRDLKP N +E +LK +DFGL+ D+ + V +
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATR 182
Query: 306 YYVAPEVLHRS--YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS 363
+Y APE++ Y D+WS+G I LL G F + +L+ +
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 364 W---------------------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHP 396
+ A D ++ +L D KR+TAAQAL+H
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 397 WIRNYNN 403
+ Y++
Sbjct: 303 YFAQYHD 309
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-54
Identities = 59/266 (22%), Positives = 109/266 (40%), Gaps = 21/266 (7%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
L++ E +G G FG Y KVA+K + + M + + E +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCG-KYSEDEAKAVLVQILNVV 252
L H LV+ Y + +YI+ E E G L+D + + G K + ++ + QI +
Sbjct: 65 LQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 310
AF +HRDL+ N L + K DFGL+ + +E + AP
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 311 EVL-HRSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368
E + + ++ ++DVWS G++ ++ G P+ T + + + + +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCP 236
Query: 369 SDAKDFVKLLLNKDPRKRMTAAQALS 394
+ ++L + P R T S
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-54
Identities = 60/279 (21%), Positives = 107/279 (38%), Gaps = 26/279 (9%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ ++ + +G G+FG AR KK + AIK + + D E+++L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRMKEYASKDD--HRDFAGELEVLCK 66
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC---------------GKYSE 238
L H N++ A E +Y+ +E G LLD + S
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 239 DEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL 298
+ + + + +HRDL N L E+ K DFGLS +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKK 183
Query: 299 NDIVGSAYYVAPEVLHRS-YGTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKAD 356
++A E L+ S Y T +DVWS GV+ + ++ G P+ T + ++ + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 242
Query: 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
+ + + D ++ + P +R + AQ L
Sbjct: 243 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-53
Identities = 75/316 (23%), Positives = 126/316 (39%), Gaps = 57/316 (18%)
Query: 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKI 190
V R + + +G G G C A D+ VAIK + + + RE+ +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQT-HAKRAYRELVL 69
Query: 191 LRALSGHSNLVKFYDAF------EDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAV 244
++ ++ H N++ + F E+ +VY+VMEL + + + +
Sbjct: 70 MKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYL 124
Query: 245 LVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGS 304
L Q+L + H G++HRDLKP N + S LK +DFGL+ + V +
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLARTAGTSFMMTPYVVT 181
Query: 305 AYYVAPE-VLHRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA-------- 355
YY APE +L Y D+WS+G I ++ F R + V++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 356 --------------DPSFDDGSWPSL----------------SSDAKDFVKLLLNKDPRK 385
P + ++P L +S A+D + +L DP K
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 386 RMTAAQALSHPWIRNY 401
R++ AL HP+I +
Sbjct: 302 RISVDDALQHPYINVW 317
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (447), Expect = 4e-52
Identities = 54/265 (20%), Positives = 102/265 (38%), Gaps = 17/265 (6%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+ + + ++G G +G +KK VA+K + + M VE+ +E +++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 194 LSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRIL-SRCGKYSEDEAKAVLVQILNVV 252
+ H NLV+ YI+ E G LLD + + S + QI + +
Sbjct: 70 IK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 310
+ +HRDL N L E+ +K DFGLS + D + AP
Sbjct: 129 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 311 EVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369
E L + + ++DVW+ GV+ + + + + +L+ D +
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCPE 243
Query: 370 DAKDFVKLLLNKDPRKRMTAAQALS 394
+ ++ +P R + A+
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-52
Identities = 55/294 (18%), Positives = 115/294 (39%), Gaps = 29/294 (9%)
Query: 123 DKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARY----KKGEHKDQKVAIKVIPKSKMTTA 178
D R+ ++ RL +G+ +G G FG A K ++ KVA+K++ T
Sbjct: 5 DPRWELPRD---RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TE 59
Query: 179 IAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRC----- 233
+ D+ E+++++ + H N++ A +Y+++E G L + + +R
Sbjct: 60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119
Query: 234 ----------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKA 283
+ S + + Q+ + + +HRDL N L T +
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 179
Query: 284 IDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAY-ILLCGSRPFW 341
+ ++ + ++APE L R Y ++DVWS GV+ + I G P+
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239
Query: 342 ARTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
+F+ + + + +++ ++ + P +R T Q +
Sbjct: 240 GVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-51
Identities = 56/265 (21%), Positives = 101/265 (38%), Gaps = 16/265 (6%)
Query: 137 EVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS 195
+ + +G G FG + GE VAIK + ++ A +++ E ++ ++
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 69
Query: 196 GHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFC 255
+ ++ + V ++ +L G LLD + VQI + +
Sbjct: 70 -NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 256 HLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEV 312
+VHRDL N L +K DFGL+ + +E+ ++A E
Sbjct: 128 EDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 313 L-HRSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370
+ HR Y ++DVWS GV + L+ GS+P+ S I + K + P + D
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICTID 241
Query: 371 AKDFVKLLLNKDPRKRMTAAQALSH 395
+ D R + +
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 3e-50
Identities = 53/291 (18%), Positives = 102/291 (35%), Gaps = 39/291 (13%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
+ +E ++G G FG + A VA+K++ + D +RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 70
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKY--------------- 236
+ N+VK + ++ E G+L + + S
Sbjct: 71 AEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 237 --------SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288
S E + Q+ +A+ VHRDL N L E+ +K DFGL
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGL 186
Query: 289 SDFVRPDERL---NDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSR-PFWAR 343
S + + + ++ PE + + Y TE+DVW+ GV+ + + P++
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 344 TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394
+ V + + + + ++L +K P R +
Sbjct: 247 AHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (426), Expect = 4e-49
Identities = 55/270 (20%), Positives = 100/270 (37%), Gaps = 24/270 (8%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
V +VG +G G FG +Q+VAIK P+ +R E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTY 54
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNV 251
+ L+G + + Y ++ + +V++L G L D + K+S Q+L
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 113
Query: 252 VAFCHLHGVVHRDLKPENFLYTSKD--ESSQLKAIDFGLSDFVRPDE--------RLNDI 301
V H +V+RD+KP+NFL + ++ + +DFG+ F R ++
Sbjct: 114 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 302 VGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKAD 356
G+A Y++ R D+ ++G + L GS P+ + R K
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233
Query: 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKR 386
+ + ++ N
Sbjct: 234 STPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-49
Identities = 59/286 (20%), Positives = 106/286 (37%), Gaps = 19/286 (6%)
Query: 120 PELDKRFGFSKEVTSRLEV--GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT 177
PEL + S L V E +GRGHFG + K A+K + +++T
Sbjct: 11 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITD 68
Query: 178 AIAVEDVRREVKILRALSGHSNLVKFYDA-FEDLDNVYIVMELCEGGELLDRILSRCGKY 236
V E I++ S H N++ + +V+ + G+L + I +
Sbjct: 69 IGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 127
Query: 237 SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE 296
+ + +Q+ + F VHRDL N + DE +K DFGL+ + E
Sbjct: 128 TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKE 184
Query: 297 -----RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWA-RTESGIF 349
++A E L + + T++DVWS GV+ + L+ P + I
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244
Query: 350 RAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
+L+ + + + R + ++ +S
Sbjct: 245 VYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-48
Identities = 63/281 (22%), Positives = 112/281 (39%), Gaps = 18/281 (6%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKK-GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR 192
S + + +G G FG K K+ VAIK + T D E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMG 64
Query: 193 ALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVV 252
S H N+++ + I+ E E G L + + G++S + +L I +
Sbjct: 65 QFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 253 AFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDER----LNDIVGSAYYV 308
+ VHRDL N L + + K DFGLS + D + +
Sbjct: 124 KYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 309 APEVL-HRSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPS 366
APE + +R + + +DVWS G++ + ++ G RP+W + + +A+ + F +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMD 237
Query: 367 LSSDAKDFVKLLLNKDPRKRMTAAQALS--HPWIRNYNNVK 405
S + ++ +R A +S IR +++K
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-46
Identities = 50/291 (17%), Positives = 114/291 (39%), Gaps = 31/291 (10%)
Query: 134 SRLEVGEEVGRGHFG--YTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
++ + E+G+G FG Y A+ + + +VAIK + ++ + E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 77
Query: 192 RALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRI---------LSRCGKYSEDEAK 242
+ + ++V+ ++MEL G+L + S +
Sbjct: 78 KEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 243 AVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL---N 299
+ +I + +A+ + + VHRDL N + E +K DFG++ + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 300 DIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADP 357
+ +++PE L + T +DVWS GV+ + + + P+ + + R V++
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253
Query: 358 SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS------HPWIRNYN 402
+ + +++ +P+ R + + +S P R +
Sbjct: 254 LD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-44
Identities = 61/285 (21%), Positives = 114/285 (40%), Gaps = 30/285 (10%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKD--QKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
RL++G+ +GRG FG A + + VA+K++ + + + E+KIL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 70
Query: 192 RALSGHSNLVKFYDA-FEDLDNVYIVMELCEGGELLDRILSRCGKY-------------- 236
+ H N+V A + + +++E C+ G L + S+ ++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 237 -SEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295
+ + Q+ + F +HRDL N L E + +K DFGL+ + D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKD 187
Query: 296 E---RLNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSR-PFWARTESGIFR 350
R D ++APE + R Y ++DVWS GV+ + + P+ F
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 351 AVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395
LK + + + + + +P +R T ++ + H
Sbjct: 248 RRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 9e-44
Identities = 53/316 (16%), Positives = 109/316 (34%), Gaps = 54/316 (17%)
Query: 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKIL 191
+ + + E +G+G FG +G+ + ++VA+K+ + + E+
Sbjct: 1 IARTIVLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWFR----EAEIYQT 51
Query: 192 RALSGHSNLVKFYDAFEDLDN----VYIVMELCEGGELLDRI------LSRCGKYSEDEA 241
L H N++ F A + +++V + E G L D + + K + A
Sbjct: 52 VMLR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTA 110
Query: 242 KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDE----- 296
+ + +V + HRDLK +N L ++ D GL+
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDI 167
Query: 297 RLNDIVGSAYYVAPEVL-------HRSYGTEADVWSIGVIAYILLCGSRPFWARTESG-- 347
N VG+ Y+APEVL H AD++++G++ + + +
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 348 -------------IFRAVL--KADPSF-DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQ 391
+ + V K P+ + ++ + R+TA +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 392 ALSH-PWIRNYNNVKV 406
+ +K+
Sbjct: 288 IKKTLSQLSQQEGIKM 303
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (369), Expect = 3e-40
Identities = 68/333 (20%), Positives = 121/333 (36%), Gaps = 68/333 (20%)
Query: 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRA 193
+R + ++G GHF A+ + VA+K++ K+ T E E+K+L+
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVN---NTHVAMKIVRGDKVYT----EAAEDEIKLLQR 65
Query: 194 LS----------GHSNLVKFYDAFE----DLDNVYIVMELCEGGELLDRILSRCGKYSED 239
++ G ++++K D F + +V +V E+ L
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 240 EAKAVLVQILNVVAFCHLH-GVVHRDLKPENFLYTSKDESSQLKAI-DFGLSDFVRPDER 297
K + Q+L + + H G++H D+KPEN L D L I L + DE
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 298 LNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVIAYILLCGSRPFWARTESG--------- 347
+ + + Y +PEVL +G AD+WS + + L+ G F
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 348 ------------IFRAVLKADPSFDDGS-----------------------WPSLSSDAK 372
+ R F+ + +
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 373 DFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVK 405
DF+ +L DPRKR A ++HPW+++ ++
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.8 bits (227), Expect = 4e-22
Identities = 44/213 (20%), Positives = 72/213 (33%), Gaps = 41/213 (19%)
Query: 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT---------------TAIAV 181
+G+ +G G +K + +K + + +A+
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58
Query: 182 EDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEA 241
R E + L+ L + K Y + ++MEL + + +
Sbjct: 59 RSARNEFRALQKLQ-GLAVPKVYAWEGN----AVLMELIDAK--------ELYRVRVENP 105
Query: 242 KAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD-ERLND 300
VL IL VA + G+VH DL N L + + + IDF S V E +
Sbjct: 106 DEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQS--VEVGEEGWRE 159
Query: 301 IVGSAYYVAPEVLHRSYGTEADVWSIGVIAYIL 333
I+ R+Y TE D+ S I IL
Sbjct: 160 ILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 23/184 (12%), Positives = 55/184 (29%), Gaps = 4/184 (2%)
Query: 151 CTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210
A+ K +++ + +K+ T DV RE ++ L G + K
Sbjct: 26 SPAKVYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHD 82
Query: 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENF 270
++M +G + E A +++ + + D +
Sbjct: 83 GWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL 142
Query: 271 LYTSKDESSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYGTEADVWSIGVI 329
Y ++ + + ++ + L D + + V H G G +
Sbjct: 143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV 202
Query: 330 AYIL 333
+ +
Sbjct: 203 SGFI 206
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 41.3 bits (96), Expect = 2e-04
Identities = 30/198 (15%), Positives = 66/198 (33%), Gaps = 10/198 (5%)
Query: 107 KSSAEEGAPEEAAPELDKRFGFSKEVTSRLEVGEEVGRGHFGYTCTARYKKGEH----KD 162
K+ E E +A L + G S L +E+G G+ Y ++ + K
Sbjct: 1 KTPLYETLNESSAVALAVKLGLFPS-KSTLTC-QEIGDGNLNYVFHIYDQEHDRALIIKQ 58
Query: 163 QKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMELCEG 222
KV+ +S + ++ R E L H + + D + VME
Sbjct: 59 AVPYAKVVGES---WPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVMEDLSH 115
Query: 223 GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLK 282
++ + L G+ ++ + + + + + + + K +T+ + +
Sbjct: 116 LKIARKGLIE-GENYPHLSQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITE 174
Query: 283 AIDFGLSDFVRPDERLND 300
+ F F +
Sbjct: 175 RLVFTDPFFDHDTNDFEE 192
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.87 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.84 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.78 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.78 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 98.74 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 98.67 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 98.65 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 98.63 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.59 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.59 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 98.58 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 98.55 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 98.52 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 98.44 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 98.3 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 98.21 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.14 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.1 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.09 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.07 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.06 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 98.05 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 98.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.01 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 98.0 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.0 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 97.95 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 97.93 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 97.93 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.89 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 97.87 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 97.85 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 97.8 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 97.8 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 97.76 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 97.76 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 97.75 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.74 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 97.74 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 97.67 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 97.66 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 97.62 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 97.59 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 97.59 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 97.57 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 97.57 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 97.57 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.56 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 97.53 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 97.5 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 97.48 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 97.48 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 97.39 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 97.38 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 97.33 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 97.32 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 97.31 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 97.31 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 97.29 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 97.25 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 97.23 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 97.22 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 97.19 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 97.13 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 97.09 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 97.06 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 97.05 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 97.03 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.0 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 96.98 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 96.93 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 96.92 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 96.92 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 96.9 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 96.89 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 96.78 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 96.78 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 96.75 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 96.64 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 96.58 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 96.5 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 96.44 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 96.38 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 96.38 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 96.26 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 96.04 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 95.95 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 95.94 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 95.58 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 95.51 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 95.51 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.43 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 95.31 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 95.12 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 95.05 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 95.04 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 94.93 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 94.88 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 94.82 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 94.66 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 94.39 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 94.09 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 94.08 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 94.05 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 94.03 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 93.84 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 93.78 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 93.49 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 93.36 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 93.31 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 93.29 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 93.07 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 92.98 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 92.72 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 92.68 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 92.53 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 92.49 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 92.44 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 92.32 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 92.18 | |
| d1j7qa_ | 86 | Calcium vector protein {Amphioxus (Branchiostoma l | 92.17 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 92.07 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 91.88 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 91.73 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 91.65 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 91.19 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 90.85 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 90.63 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 90.42 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 90.41 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 90.21 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 89.85 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 89.4 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 89.39 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 89.38 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 89.32 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 88.79 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 88.73 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 88.69 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 88.51 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 88.1 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 88.07 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 87.73 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 87.64 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 86.37 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 85.81 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 84.52 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 84.36 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 84.36 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 84.25 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 84.13 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 83.62 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 83.55 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 82.96 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 81.6 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 80.71 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 80.02 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-64 Score=497.06 Aligned_cols=292 Identities=39% Similarity=0.708 Sum_probs=238.0
Q ss_pred ccccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 129 SKEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 129 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.+++.++|++.+.||+|+||.||+|+++. +|+.||||++.+..... ....+.+|+.+|+.|. |||||+++++|+
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 77 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK-HPNIVALDDIYE 77 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence 35677889999999999999999998765 78999999998765432 2356889999999995 999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccc
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGL 288 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGl 288 (492)
+++.+|||||||+||+|.+++..+ +.+++.++..++.||+.||.|||++|||||||||+|||+...++++.+||+|||+
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred ECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccce
Confidence 999999999999999999988654 6899999999999999999999999999999999999998766778999999999
Q ss_pred ccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 289 SDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
|+.........+.+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+....++...+......+....++.+
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred eEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCC
Confidence 998877777778899999999999865 5999999999999999999999999999999999999999888888888899
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCcccccccccCCCccHHHHHHHHHHhhhhhhHH
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSSLRR 427 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 427 (492)
|+++++||.+||++||++|||+.|+|+||||++.......+...+...++++...+++++
T Consensus 237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 296 (307)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCCCCCHHHHHHHHHHHSCCCTTTS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccccccchhHHHHHHHHHHHhhhhh
Confidence 999999999999999999999999999999997655555556666666666655555544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-63 Score=473.73 Aligned_cols=255 Identities=31% Similarity=0.613 Sum_probs=228.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++++.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+++|+.+. |||||++++++.+++.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRV 81 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEE
Confidence 679999999999999999999765 78999999996543333334567889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++... +.+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 82 ~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCC
T ss_pred EEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecC
Confidence 9999999999999988765 679999999999999999999999999999999999999 667789999999998765
Q ss_pred CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
. ......+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++..+.+....++. .+|++++
T Consensus 158 ~-~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 232 (263)
T d2j4za1 158 S-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGAR 232 (263)
T ss_dssp C-CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHH
T ss_pred C-CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHH
Confidence 3 34456789999999999875 5899999999999999999999999999999999999887766543 6899999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 373 DFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 373 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+||.+||+.||++|||+.|+|+||||+..
T Consensus 233 ~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 233 DLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 99999999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-61 Score=483.59 Aligned_cols=263 Identities=37% Similarity=0.636 Sum_probs=240.0
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.++|++++.||+|+||.||+|+++. +|+.||||++.+.. ....+.+.+|+.+|++|+ |||||+++++|++++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETT
T ss_pred CccCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 45789999999999999999999765 78999999996543 334567899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|||||||+||+|.+++.+..+.+++.+++.|+.||+.||.|||++|||||||||+|||+..+ .++.+||+|||+|+.
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchhee
Confidence 9999999999999999987766789999999999999999999999999999999999999642 356899999999999
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
+.........+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+..+.+..+......+....++.+|++
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 887777778899999999999875 5899999999999999999999999999999999999998888887777889999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+++||.+||+.||++|||++|+|+||||+...
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-62 Score=469.16 Aligned_cols=258 Identities=30% Similarity=0.528 Sum_probs=217.6
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+.... ...+.+.+|+++|++|+ |||||++++++.+++.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCce
Confidence 4689999999999999999999775 7899999999765432 23456899999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|||||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+
T Consensus 78 ~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 153 (271)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred eEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheee
Confidence 9999999999999998754 4679999999999999999999999999999999999999 66678999999999876
Q ss_pred CCCC---CccccccCccccccccccC-CC-CCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 293 RPDE---RLNDIVGSAYYVAPEVLHR-SY-GTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 293 ~~~~---~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
.... .....+||+.|||||++.+ .+ +.++|||||||++|+|+||+.||.................. ....|..+
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKI 232 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGS
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccC
Confidence 5332 2456789999999998864 44 67899999999999999999999776654433333333222 23446789
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
|+++++||.+||+.||++|||++|+|+||||++.
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 233 DSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-61 Score=471.43 Aligned_cols=267 Identities=37% Similarity=0.665 Sum_probs=238.6
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC---HHHHHHHHHHHHHHHHccCCCCccEEEEE
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT---AIAVEDVRREVKILRALSGHSNLVKFYDA 206 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~Ev~~l~~l~~hpniv~l~~~ 206 (492)
+++.++|++++.||+|+||.||+|+++. +|+.||||++.+..... ....+.+.+|+.+|++|+ |||||+++++
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~ 81 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEV 81 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEE
Confidence 4567889999999999999999999765 78999999997654322 123567899999999995 9999999999
Q ss_pred EEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC-CCCcEEEEe
Q 011154 207 FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD-ESSQLKAID 285 (492)
Q Consensus 207 ~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~-~~~~~kl~D 285 (492)
|++.+.+|||||||+||+|.+++.++ +.+++.+++.++.||+.||+|||++|||||||||+|||++.++ ....+||+|
T Consensus 82 ~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 82 YENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecc
Confidence 99999999999999999999988765 6899999999999999999999999999999999999996433 223699999
Q ss_pred cccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
||+|..+..........||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.+..+.+..+......+....+
T Consensus 161 fG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 161 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp CTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred hhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 999998877777778899999999999875 5999999999999999999999999999999999999988887776666
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+.+|.++++||++||+.||++|||++|+|+||||+..
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 7899999999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-61 Score=481.09 Aligned_cols=262 Identities=36% Similarity=0.613 Sum_probs=239.6
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.++|++.+.||+|+||.||+|+++. +|+.||||++.+.. ....+.+.+|+++|++|. |||||+++++|++++
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY 99 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred cccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 45789999999999999999999765 78999999997653 334456889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|||||||+||+|.+.+......+++.+++.|+.||+.||.|||++|||||||||+|||+.. ..++.+||+|||+|+.
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATK 178 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeeccccee
Confidence 999999999999999988777668999999999999999999999999999999999999953 2457899999999999
Q ss_pred cCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
+..........||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+..+.+..+......++...++.+|++
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred cCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 887777778899999999999875 5999999999999999999999999999999999999999988888888899999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+++||.+||+.||.+|||+.|+|+||||+..
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-60 Score=460.00 Aligned_cols=262 Identities=35% Similarity=0.633 Sum_probs=237.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCC------HHHHHHHHHHHHHHHHccCCCCccEEEEE
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTT------AIAVEDVRREVKILRALSGHSNLVKFYDA 206 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~------~~~~~~~~~Ev~~l~~l~~hpniv~l~~~ 206 (492)
.++|++.+.||+|+||+||+|+.+. +|+.||||++.+..... ....+.+.+|+.+|++|..|||||+++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 78 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 78 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee
Confidence 5789999999999999999998765 78999999997765432 12344688999999999779999999999
Q ss_pred EEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEec
Q 011154 207 FEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 207 ~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
|.+++.+|||||||+||+|.+++..+ +.+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+||
T Consensus 79 ~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DF 154 (277)
T d1phka_ 79 YETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDF 154 (277)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCC
T ss_pred cccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccc
Confidence 99999999999999999999999765 689999999999999999999999999999999999999 67789999999
Q ss_pred ccccccCCCCCccccccCcccccccccc-------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCC
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 359 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 359 (492)
|+++.+.........+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+..+....+......+
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9999887776777789999999999874 236889999999999999999999999999999999999988887
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
....++.+|+++++||.+||+.||++|||++|+|+||||+++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 777788999999999999999999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-60 Score=465.45 Aligned_cols=256 Identities=27% Similarity=0.477 Sum_probs=224.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+..... .+.+.+|+.+|+.+. |||||+++++|.+++.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPK---KELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecccChH---HHHHHHHHHHHHhCC-CCCEeeEeEEEEECCE
Confidence 4689999999999999999998664 78999999997654333 356899999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|||||||+||+|.+.+.+ +.+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+
T Consensus 92 ~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheee
Confidence 9999999999999987654 479999999999999999999999999999999999999 56678999999999987
Q ss_pred CCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.... .....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+..+.+..+...... ....+..+|++
T Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~ 245 (293)
T d1yhwa1 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAI 245 (293)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHH
T ss_pred ccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHH
Confidence 5443 4456789999999998875 5899999999999999999999999988887777666654332 22334578999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
+++||.+||+.||++|||+.|+|+||||+..
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-61 Score=470.42 Aligned_cols=257 Identities=32% Similarity=0.577 Sum_probs=225.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++++.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+++|++|. |||||+++++|++++.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEE
Confidence 679999999999999999999765 78999999997543322334567899999999994 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 84 ~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecc
Confidence 9999999999999987665 689999999999999999999999999999999999999 677899999999998875
Q ss_pred CCC---CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 294 PDE---RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 294 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
... .....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+..+++..|.+....++. .+++
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 235 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFP 235 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCH
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCH
Confidence 332 3446789999999999864 5999999999999999999999999999999999999988766643 6899
Q ss_pred HHHHHHHHccccCcCCCCCHHH------HhcCccccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQ------ALSHPWIRNYN 402 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e------~l~hp~~~~~~ 402 (492)
++++||.+||+.||++|||++| +++||||++.+
T Consensus 236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 9999999999999999999987 58899998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-61 Score=466.26 Aligned_cols=258 Identities=31% Similarity=0.483 Sum_probs=227.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.+.|++.+.||+|+||.||+|+++. +|+.||||++.+... ...+.+.+|+++|++|+ |||||+++++|.+++.
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTKSE---EELEDYMVEIDILASCD-HPNIVKLLDAFYYENN 83 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCe
Confidence 3579999999999999999999775 789999999976532 23457889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|||||||+||+|.+++.+..+.+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+..
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhcc
Confidence 999999999999999888776789999999999999999999999999999999999999 66778999999999765
Q ss_pred CCC-CCccccccCcccccccccc------CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 293 RPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 293 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
... ......+||+.|||||++. ..|+.++|||||||++|+|+||+.||.+.+..+.+..+........ ..+.
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~ 239 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPS 239 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGG
T ss_pred CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-Cccc
Confidence 432 2234678999999999873 3488999999999999999999999999999899888888764332 2335
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.+|+++++||.+||+.||++|||+.|+|+||||+..
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 789999999999999999999999999999999853
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-60 Score=471.85 Aligned_cols=262 Identities=30% Similarity=0.586 Sum_probs=238.3
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
++.++|++++.||+|+||.||+|+++. +|+.||||++++.. .....+.+|+++|+.++ |||||+++++|+++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred CCccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence 567899999999999999999999765 78999999997653 22345889999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+++|||||||+||+|.+++..+...+++.+++.|+.||+.||.|||++||+||||||+|||++.+ ....+||+|||+++
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhh
Confidence 99999999999999999997766689999999999999999999999999999999999999542 45689999999999
Q ss_pred ccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
...........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..|......++...|+.+|+
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 8877666777889999999998764 589999999999999999999999999999999999999988888777888999
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++++||.+||..||++|||+.|+|+||||++.
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-60 Score=465.99 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=226.9
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..+.|++.+.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+++|++|+ |||||+++++|.+++
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 88 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETT
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECC
Confidence 44579999999999999999999765 78999999998877666667778999999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|+|||||.||+|...+. ..+.+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 ~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBS
T ss_pred EEEEEEEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccc
Confidence 9999999999998865544 44789999999999999999999999999999999999999 5667999999999987
Q ss_pred cCCCCCccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDERLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
... ....+||+.|||||++. +.|+.++|||||||++|+|++|..||.+....+.+..+........ ....+
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~ 239 (309)
T d1u5ra_ 165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHW 239 (309)
T ss_dssp SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTS
T ss_pred cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCC
Confidence 643 34568999999999874 3589999999999999999999999999888888877777654332 23468
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
|+++++||.+||+.||.+|||++|+|+||||.+.
T Consensus 240 s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 9999999999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-60 Score=469.96 Aligned_cols=257 Identities=29% Similarity=0.532 Sum_probs=230.4
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+|+.+. |||||+++++|++.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 79 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccc
Confidence 3689999999999999999999765 78999999997643322234567889999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+..
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred cccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeeccccccc
Confidence 99999999999999988665 689999999999999999999999999999999999999 67789999999999876
Q ss_pred CC-CCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RP-DERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.. .......+||+.|||||++. ..|+.++|||||||++|+|++|+.||.+.+..+++..+......++. .+|++
T Consensus 156 ~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 231 (337)
T d1o6la_ 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPE 231 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHH
Confidence 43 44556789999999999986 46999999999999999999999999999999999999988776653 68999
Q ss_pred HHHHHHHccccCcCCCCC-----HHHHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
+++||.+||++||.+|++ +.|+++||||++.
T Consensus 232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 999999999999999994 9999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-60 Score=454.48 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=216.2
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe----CC
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED----LD 211 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~----~~ 211 (492)
|++.++||+|+||.||+|+++. +++.||||++...... ....+.+.+|+++|++|+ |||||+++++|++ ..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCC
Confidence 4788899999999999999765 7889999999765443 345667999999999995 9999999999976 35
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEeecCCCCCcEEEEecccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHG--VVHRDLKPENFLYTSKDESSQLKAIDFGLS 289 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~--ivHrDlkp~NILl~~~~~~~~~kl~DfGla 289 (492)
.+|+|||||+||+|.+++.+. ..+++.+++.++.||+.||.|||+++ ||||||||+|||++ ++++.+||+|||+|
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence 689999999999999988665 68999999999999999999999999 99999999999994 34578999999999
Q ss_pred cccCCCCCccccccCccccccccccCCCCCccchHHHHHHHHHHhcCCCCCCCCCh-hHHHHHHHhcCCCCCCCCCCCCC
Q 011154 290 DFVRPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlGvil~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
+... .......+||+.|||||++.+.|+.++|||||||++|+|++|+.||.+... ..+.+.+...... ...+..++
T Consensus 163 ~~~~-~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~ 239 (270)
T d1t4ha_ 163 TLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAI 239 (270)
T ss_dssp GGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCC
T ss_pred eecc-CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccCccCC
Confidence 8654 334556789999999999998999999999999999999999999976554 4455555443221 22234678
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
+++++||.+||+.||++|||++|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-60 Score=456.67 Aligned_cols=255 Identities=30% Similarity=0.492 Sum_probs=213.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--C
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--L 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--~ 210 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||++...... ....+.+.+|+++|++|. |||||++++++.+ +
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC---
T ss_pred chhCEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCC
Confidence 3689999999999999999999765 7899999999876554 445677999999999995 9999999999965 4
Q ss_pred CeEEEEEeecCCCchHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CcccCCCCCceEeecCCCCCcEE
Q 011154 211 DNVYIVMELCEGGELLDRILS---RCGKYSEDEAKAVLVQILNVVAFCHLHG-----VVHRDLKPENFLYTSKDESSQLK 282 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ylH~~~-----ivHrDlkp~NILl~~~~~~~~~k 282 (492)
+.+|||||||+||+|.+++.+ ....+++.+++.++.||+.||.|||++| ||||||||+|||+ +.++.+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vk 154 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVK 154 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEE
Confidence 668999999999999998864 3467999999999999999999999976 9999999999999 6677999
Q ss_pred EEecccccccCCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC
Q 011154 283 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 360 (492)
Q Consensus 283 l~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 360 (492)
|+|||+|+.+.... .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.+..++...+.......
T Consensus 155 l~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~- 233 (269)
T d2java1 155 LGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 233 (269)
T ss_dssp ECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-
T ss_pred EeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 99999999876543 3456789999999999864 59999999999999999999999999999999888888765442
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWI 398 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 398 (492)
....+|+++++||.+||+.||++|||+.|+|+|||+
T Consensus 234 --~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 --IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 234689999999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-59 Score=466.07 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=215.4
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
..++|++.+.||+|+||.||+|+++. +|+.||||++++.... ...+.+.+|+.+|+.|+ |||||+++++|.+++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEIKP--AIRNQIIRELQVLHECN-SPYIVGFYGAFYSDG 77 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCC-CTTBCCEEEEEECSS
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 35789999999999999999999765 7899999999765432 23467899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
++|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+|+
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCH
T ss_pred EEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCcc
Confidence 999999999999999988765 679999999999999999999997 599999999999999 667789999999998
Q ss_pred ccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHH------------------
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRA------------------ 351 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~------------------ 351 (492)
.+.. ....+.+||+.|||||++.+ .|+.++||||+||++|||++|+.||.+.+.......
T Consensus 154 ~~~~-~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 154 QLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred ccCC-CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 7643 23456799999999998875 699999999999999999999999977554322110
Q ss_pred ------------------------HHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 352 ------------------------VLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 352 ------------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
+.... .+......+|.++++||.+||+.||.+|||++|+|+||||++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 01000 001111246889999999999999999999999999999987543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-59 Score=462.23 Aligned_cols=254 Identities=27% Similarity=0.574 Sum_probs=227.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++++.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+.+|+.++ |||||++++++.+.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCee
Confidence 579999999999999999999765 78999999996543322234567899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||+||+|...+... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 80 ~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp EEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECS
T ss_pred eeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEec
Confidence 9999999999998877554 689999999999999999999999999999999999999 677899999999998875
Q ss_pred CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
. ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.+..+++..+......++ +.++++++
T Consensus 156 ~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 229 (316)
T d1fota_ 156 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVK 229 (316)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred c--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 3 3456789999999999875 599999999999999999999999999999999999998876654 36899999
Q ss_pred HHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 373 DFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 373 ~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+||.+||..||.+|+ |++++|+||||++.
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 999999999999996 99999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=467.21 Aligned_cols=261 Identities=34% Similarity=0.599 Sum_probs=222.5
Q ss_pred ccccceeecc-eeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 131 EVTSRLEVGE-EVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 131 ~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
.+.++|++.. .||+|+||.||+|+++. +|+.||||++.+. ..+.+|+.++.++.+|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 3457899865 69999999999999765 7899999999643 3567899998766579999999999986
Q ss_pred ----CCeEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 ----LDNVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 ----~~~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
++.+|||||||+||+|.++|.++. ..+++.+++.|+.||+.||+|||++||+||||||+|||++..+..+.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence 467999999999999999997653 469999999999999999999999999999999999999876667889999
Q ss_pred ecccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHH----HhcCCCC
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAV----LKADPSF 359 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i----~~~~~~~ 359 (492)
|||+|+...........+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.........+ ......+
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 9999998877777778899999999999875 5999999999999999999999999877655544433 3344445
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 360 DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 360 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
+...|..+|+++++||.+||+.||++|||+.|+|+||||++..
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 5555667999999999999999999999999999999998654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.8e-59 Score=463.42 Aligned_cols=254 Identities=30% Similarity=0.537 Sum_probs=227.8
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+++|+.+ +|||||+++++|.+.+.+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccc
Confidence 689999999999999999999765 7899999999654332223456788999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++|||||.||+|.+.+... +.+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 117 ~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred ccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecc
Confidence 9999999999999988765 689999999999999999999999999999999999999 667799999999999875
Q ss_pred CCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011154 294 PDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAK 372 (492)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 372 (492)
. .....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+...++..+......++ ..+++++.
T Consensus 193 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 266 (350)
T d1rdqe_ 193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLK 266 (350)
T ss_dssp S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHH
T ss_pred c--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHH
Confidence 3 3456789999999998865 599999999999999999999999999999999999988876654 36899999
Q ss_pred HHHHHccccCcCCCC-----CHHHHhcCcccccc
Q 011154 373 DFVKLLLNKDPRKRM-----TAAQALSHPWIRNY 401 (492)
Q Consensus 373 ~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~ 401 (492)
+||++||+.||.+|+ |++++++||||++.
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 999999999999995 99999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=455.43 Aligned_cols=256 Identities=31% Similarity=0.529 Sum_probs=225.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHH-HccCCCCccEEEEEEEeCCe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILR-ALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~-~l~~hpniv~l~~~~~~~~~ 212 (492)
++|++++.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+.++. .+ +|||||+++++|++++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCc
Confidence 579999999999999999999775 78999999997543222223456677888776 46 69999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|||||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++++||+|||+|+..
T Consensus 78 ~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred eeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhc
Confidence 99999999999999988765 679999999999999999999999999999999999999 67789999999999876
Q ss_pred CCCC-CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSD 370 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 370 (492)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+.+..+++..+....+.++. .+|++
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~ 229 (320)
T d1xjda_ 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKE 229 (320)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHH
Confidence 5433 3455789999999998864 6999999999999999999999999999999999999887766543 68999
Q ss_pred HHHHHHHccccCcCCCCCHH-HHhcCcccccc
Q 011154 371 AKDFVKLLLNKDPRKRMTAA-QALSHPWIRNY 401 (492)
Q Consensus 371 ~~~li~~~L~~dP~~Rps~~-e~l~hp~~~~~ 401 (492)
+++||.+||+.||.+|||+. ++++||||++.
T Consensus 230 ~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 99999999999999999995 89999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.9e-58 Score=459.22 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=216.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHH---HHHHHHccCCCCccEEEEEEEeC
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRRE---VKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E---v~~l~~l~~hpniv~l~~~~~~~ 210 (492)
++|++.+.||+|+||.||+|+++. +|+.||||++.+...........+.+| +.+++.+ +|||||+++++|++.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS
T ss_pred HhCeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEEC
Confidence 679999999999999999999765 789999999965433222222334444 5566666 599999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
+.+|||||||+||+|.+++.+. ..+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLAC 155 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCE
T ss_pred CEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceee
Confidence 9999999999999999988765 689999999999999999999999999999999999999 677899999999998
Q ss_pred ccCCCCCccccccCcccccccccc-C-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLH-R-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
.+... .....+||+.|||||++. + .|+.++|||||||++|+|+||+.||.+........ +...........+..+|
T Consensus 156 ~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s 233 (364)
T d1omwa3 156 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFS 233 (364)
T ss_dssp ECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSC
T ss_pred ecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCC
Confidence 77643 445678999999999885 3 48999999999999999999999998765544332 22233333334456799
Q ss_pred HHHHHHHHHccccCcCCCCC-----HHHHhcCcccccc
Q 011154 369 SDAKDFVKLLLNKDPRKRMT-----AAQALSHPWIRNY 401 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps-----~~e~l~hp~~~~~ 401 (492)
+++++||.+||++||++||| ++|+++||||++.
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999999999999999 7999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=445.50 Aligned_cols=256 Identities=29% Similarity=0.420 Sum_probs=212.4
Q ss_pred ecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCH--HHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 138 VGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTA--IAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 138 ~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~--~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
..+.||+|+||+||+|+++. +|+.||||+++....... ...+.+.+|+.+|+.++ |||||+++++|.+++++||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~i 77 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISL 77 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEE
T ss_pred cceEeccCcCeEEEEEEECC---CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceee
Confidence 45789999999999999765 789999999976543221 12345889999999995 9999999999999999999
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~ 295 (492)
|||||.|+++.. +......+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 78 vmE~~~~~~~~~-~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 78 VFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EEECCSEEHHHH-HTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSC
T ss_pred hhhhhcchHHhh-hhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCC
Confidence 999998876554 44555679999999999999999999999999999999999999 67789999999999876544
Q ss_pred C-CccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC---------
Q 011154 296 E-RLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS--------- 363 (492)
Q Consensus 296 ~-~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 363 (492)
. .....+||+.|+|||++. ..|+.++|||||||++|+|+||..||.+.+..+.+..|...........
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 3 345678999999999875 3489999999999999999999999999999888887765422221111
Q ss_pred ---------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 364 ---------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 364 ---------------~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
++.+++++++||.+||+.||++|||+.|+|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 23578999999999999999999999999999999865
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=439.21 Aligned_cols=260 Identities=30% Similarity=0.477 Sum_probs=216.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+++. +|+.||||+++..... ....+.+.+|+++|+++. |||||+++++|.+.+++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTET-EGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCC-CCcEEEeccccccccce
Confidence 689999999999999999999765 7899999999655422 223467889999999994 99999999999999999
Q ss_pred EEEEeecCCCchHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 214 YIVMELCEGGELLDRIL-SRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~-~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
|+|||||.++ +.+.+. .....+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+..
T Consensus 77 ~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHH
T ss_pred eEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceec
Confidence 9999999765 444443 445679999999999999999999999999999999999999 66779999999999887
Q ss_pred CCCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCC------
Q 011154 293 RPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGS------ 363 (492)
Q Consensus 293 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 363 (492)
.... .....+||+.|+|||++.. .++.++||||+||++|+|++|+.||.+.+..+.+..+...........
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 5433 4456689999999997653 368899999999999999999999998888777766654332222221
Q ss_pred -------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 364 -------------------WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 364 -------------------~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
++.+|.++++||++||+.||++|||+.|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 235688999999999999999999999999999998764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-57 Score=436.95 Aligned_cols=253 Identities=31% Similarity=0.550 Sum_probs=212.3
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHH---HHHHHHHHHHHHHHcc-CCCCccEEEEEE
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAI---AVEDVRREVKILRALS-GHSNLVKFYDAF 207 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~---~~~~~~~Ev~~l~~l~-~hpniv~l~~~~ 207 (492)
+.++|++++.||+|+||.||+|+++. +|+.||||++.+....... ....+.+|+.+|+++. .|||||+++++|
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 35789999999999999999999765 7899999999764433211 1123568999999995 389999999999
Q ss_pred EeCCeEEEEEeecCC-CchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEec
Q 011154 208 EDLDNVYIVMELCEG-GELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDF 286 (492)
Q Consensus 208 ~~~~~~~lv~E~~~g-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~Df 286 (492)
++.+.+|+||||+.+ +++.+.+..+ +.+++.+++.++.||+.||.|||++|||||||||+|||++. +.+.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DF 155 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDF 155 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECcc
Confidence 999999999999986 5666666554 68999999999999999999999999999999999999952 3468999999
Q ss_pred ccccccCCCCCccccccCccccccccccC-C-CCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 287 GLSDFVRPDERLNDIVGSAYYVAPEVLHR-S-YGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 287 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
|+|+.... ....+.+||+.|+|||++.+ . ++.++|||||||++|+|+||+.||.+. ..+......+.
T Consensus 156 G~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~---- 224 (273)
T d1xwsa_ 156 GSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR---- 224 (273)
T ss_dssp TTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----
T ss_pred ccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----
Confidence 99987643 34556789999999998863 3 467799999999999999999999653 23445544443
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
..+|+++++||.+||..||++|||++|+|+||||++.
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 3689999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-56 Score=434.06 Aligned_cols=262 Identities=28% Similarity=0.455 Sum_probs=223.0
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
..+.++|++.+.||+|+||.||+|+++. +|+.||||++.+....+......+.+|+++|+.+. |||||++++++.+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~ 78 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEA 78 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeee
Confidence 3467899999999999999999999765 78999999998877666777778999999999994 9999999999987
Q ss_pred CC----eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 210 LD----NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 210 ~~----~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
.+ .+|||||||+||+|.+++... +.+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.++|+|
T Consensus 79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d 154 (277)
T d1o6ya_ 79 ETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMD 154 (277)
T ss_dssp ECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECC
T ss_pred ccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeeh
Confidence 54 389999999999999887655 689999999999999999999999999999999999999 5667899999
Q ss_pred cccccccCCCC----CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC
Q 011154 286 FGLSDFVRPDE----RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 360 (492)
Q Consensus 286 fGla~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 360 (492)
||++....... .....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+..+.+..+....+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence 99987654332 3445689999999999875 599999999999999999999999999998888888888887777
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q 011154 361 DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIR 399 (492)
Q Consensus 361 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 399 (492)
...++.+|+++++||.+||+.||.+||+..+.|.|+|++
T Consensus 235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 777788999999999999999999999555556677765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=438.51 Aligned_cols=265 Identities=29% Similarity=0.397 Sum_probs=219.5
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc--CCCCccEEEEEEEe-
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS--GHSNLVKFYDAFED- 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~--~hpniv~l~~~~~~- 209 (492)
.++|++.+.||+|+||+||+|++... +++.||||++........ ....+.+|+.+|+.|. +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--CCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 47899999999999999999987542 467899999865432211 1223567888877763 59999999999863
Q ss_pred ----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 210 ----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 210 ----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
...++++||||.+|.+..........+++..++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecc
Confidence 357899999999987665555555679999999999999999999999999999999999999 6677999999
Q ss_pred cccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC----
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---- 360 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~---- 360 (492)
||+++...........+||+.|||||++. ..|+.++||||+||++|||++|+.||.+.+..+.+..+........
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 99998876666667889999999999875 5699999999999999999999999999988888777754321111
Q ss_pred -------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccccc
Q 011154 361 -------------------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNN 403 (492)
Q Consensus 361 -------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 403 (492)
...+..+++++++||.+||+.||++|||+.|+|+||||++..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 1123467899999999999999999999999999999997643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-56 Score=433.00 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=209.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++........||||.+.... .....+.+.+|+++|++|+ |||||+++++|.+.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence 478999999999999999999987644445579999986543 3445677999999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||+||+|.+++....+.+++.++..|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 999999999999999888776789999999999999999999999999999999999999 67789999999999887
Q ss_pred CCCCCc------cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011154 293 RPDERL------NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSW 364 (492)
Q Consensus 293 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (492)
...... ....||+.|||||++. +.|+.++|||||||++|||+| |..||.+....++...+...... ...
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL---PPP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 544322 2245789999999876 569999999999999999998 89999999998888888765322 223
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 365 PSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 365 ~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..+++++.+||.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4789999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-56 Score=428.12 Aligned_cols=251 Identities=23% Similarity=0.386 Sum_probs=208.1
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++++.||+|+||.||+|+++ ..||||++....... ...+.+.+|+.+|++++ |||||++++++. .+.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccE
Confidence 478999999999999999999753 359999997654433 35678999999999995 999999999875 467
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
++||||||+||+|.+++......+++.++..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeec
Confidence 899999999999999998776789999999999999999999999999999999999999 66789999999999876
Q ss_pred CCCC---CccccccCcccccccccc----CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCC--CCC
Q 011154 293 RPDE---RLNDIVGSAYYVAPEVLH----RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--DGS 363 (492)
Q Consensus 293 ~~~~---~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--~~~ 363 (492)
.... ......||+.|||||++. +.|+.++|||||||++|||+||+.||.+.........+.......+ ...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 5332 335678999999999885 2488999999999999999999999988776555544443332221 233
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 364 WPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 364 ~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
...+++++++||.+||..||++|||+.|++++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45789999999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=422.04 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=205.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|+++ +++.||||++.+.... .+++.+|+++|++++ |||||+++++|.+++.+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcC-CCCcccccceeccCCce
Confidence 57999999999999999999875 4568999999765432 356899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|+|||||++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+|+...
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------
T ss_pred EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheecc
Confidence 99999999999999988777789999999999999999999999999999999999999 667899999999998775
Q ss_pred CCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 294 PDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 294 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
.... .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||......+++..+..+..... ...+++
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~ 229 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 229 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCH
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCH
Confidence 4432 23467999999999887 469999999999999999999 5666777777778888877543322 236789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++.+||.+||+.||++|||++|+++|
T Consensus 230 ~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 230 HVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-55 Score=423.52 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=216.9
Q ss_pred ccceeecce-eccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEE-VGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~-lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.++|.+.+. ||+|+||.||+|.++.. .++..||||+++... .....+.+.+|+++|++|+ |||||++++++.+ +
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~-~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-E 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecC-CCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-C
Confidence 357888884 99999999999987642 256789999996543 3445678999999999995 9999999999975 5
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
.+|||||||+||+|.+++......+++.++..++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKA 158 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhc
Confidence 6899999999999999887666789999999999999999999999999999999999999 5567899999999998
Q ss_pred cCCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 292 VRPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 292 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
+..... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+....++...+..+... ...+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~ 235 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP 235 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCT
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 765432 23457899999999886 569999999999999999998 99999998888888888765432 2234
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHH---hcCcccc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQA---LSHPWIR 399 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~---l~hp~~~ 399 (492)
.+++++.+||.+||..||++|||+.++ |+|+|+.
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 789999999999999999999999888 5667764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-54 Score=422.88 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=211.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++. +|+.||||+++.+... .+++.+|+.+|++|+ |||||+++++|.+.+.
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTME----VEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 87 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTTCSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCccch----HHHHHHHHHHHHhCC-CCCEecCCccEeeCCe
Confidence 4689999999999999999999875 7889999999765432 457899999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+|||||||++|+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceee
Confidence 99999999999999998754 3579999999999999999999999999999999999999 6677999999999998
Q ss_pred cCCCCCc--cccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCC-CChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDERL--NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
....... ....||+.|+|||++. +.|+.++|||||||++|||++|..||+. .....+...+... .. ......+
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~--~~~~~~~ 241 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR--MERPEGC 241 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CC--CCCCTTC
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CC--CCCCccc
Confidence 7544332 3356899999999875 6799999999999999999997766654 4445555554443 22 2233578
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++++++||.+||+.||++|||+.|+++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.6e-55 Score=424.20 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=213.8
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.++||+|+||.||+|+++ +|+.||||++...... ....+.+.+|+.+|++++ |||||+++++|.+++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKED-EGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCce
Confidence 68999999999999999999864 5789999999765432 223467889999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
|++|||+.++. ...+....+.+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|....
T Consensus 76 ~i~~e~~~~~~-~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 76 VLVFEHLDQDL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151 (286)
T ss_dssp EEEEECCSEEH-HHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHC
T ss_pred eEEEEeehhhh-HHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecc
Confidence 99999997755 44555656789999999999999999999999999999999999999 667899999999998875
Q ss_pred CCC-CccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCC--------
Q 011154 294 PDE-RLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDG-------- 362 (492)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-------- 362 (492)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+..........
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 433 3445679999999998753 47899999999999999999999999888877777665422221111
Q ss_pred -----------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 363 -----------------SWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 363 -----------------~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
..+.++++++|||++||+.||++|||+.|+|+||||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 12457889999999999999999999999999999984
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=414.94 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=219.2
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++++.||+|+||.||+|+++ +++.||||++++.... .+++.+|++++++++ |||||+++++|.+++.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcC-CCceeeEEEEEeeCCce
Confidence 57899999999999999999974 5678999999876543 356899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++|||||++|+|.+++......+++..+..++.||++||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCS
T ss_pred EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheecc
Confidence 99999999999999988777789999999999999999999999999999999999999 677899999999998765
Q ss_pred CCCCc--cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011154 294 PDERL--NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSS 369 (492)
Q Consensus 294 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 369 (492)
..... ....||+.|+|||++. ..|+.++|||||||++|||+| |+.||.+.+..++...+..+..... ...+++
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~ 228 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASE 228 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCH
T ss_pred CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccH
Confidence 44332 3467999999999876 569999999999999999998 8999999999999888887543322 246889
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 370 DAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 370 ~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++.+||.+||+.||++|||++++++|
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=419.54 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=206.9
Q ss_pred ceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEEEEee
Q 011154 140 EEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYIVMEL 219 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~lv~E~ 219 (492)
++||+|+||.||+|.++.. ..++.||||+++.... +....+.+.+|+++|++|+ |||||+++++|++ +.+||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccC-CcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEc
Confidence 4699999999999987642 3678999999965543 3344567999999999995 9999999999975 567899999
Q ss_pred cCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCCCCc-
Q 011154 220 CEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPDERL- 298 (492)
Q Consensus 220 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~~~~- 298 (492)
|++|+|.+++... ..+++.++..|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+......
T Consensus 89 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 89 AELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEE
T ss_pred CCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccc
Confidence 9999999987654 679999999999999999999999999999999999999 56678999999999877544322
Q ss_pred ---cccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011154 299 ---NDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLSSDAKD 373 (492)
Q Consensus 299 ---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 373 (492)
....||+.|||||++. +.|+.++|||||||++|||+| |..||.+.+..++...+.++.... ....+++++.+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~~ 241 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYD 241 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHH
Confidence 2457999999999875 568999999999999999998 899999988888888887654321 22468999999
Q ss_pred HHHHccccCcCCCCCHHHH---hcCccc
Q 011154 374 FVKLLLNKDPRKRMTAAQA---LSHPWI 398 (492)
Q Consensus 374 li~~~L~~dP~~Rps~~e~---l~hp~~ 398 (492)
||.+||+.||++|||++++ |+|+|+
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999998 456554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=429.29 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=214.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCc--cccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEH--KDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++++.||+|+||.||+|+++.... ....||||++..... ......+.+|+.+|.++.+|||||+++++|.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3789999999999999999999875332 345799999865432 233456889999999996699999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCC
Q 011154 211 DNVYIVMELCEGGELLDRILSRC----------------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPE 268 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~----------------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~ 268 (492)
+.+|+|||||+||+|.++|..+. ..+++.+++.|+.||+.||.|||++|||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999997643 24899999999999999999999999999999999
Q ss_pred ceEeecCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCC
Q 011154 269 NFLYTSKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWAR 343 (492)
Q Consensus 269 NILl~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~ 343 (492)
|||+ +.++.+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+.
T Consensus 194 Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred cccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999 5677999999999987654443 23567899999999875 679999999999999999997 89999887
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 344 TESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.....+..+......++ ....+++++++||.+||+.||++|||++||++|
T Consensus 271 ~~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77666666666554433 234689999999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=419.05 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=212.6
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++.+.||+|+||.||+|+++ +++.||||++...... .+.+.+|+++|++++ |||||++++++.+ +.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCC-CCCEeEEEeeecc-CC
Confidence 468999999999999999999875 4678999999765432 356899999999995 9999999998754 66
Q ss_pred EEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+|+|||||++|+|.+++.... ..+++.++..|+.||+.||.|||++||+||||||+|||| ++++.+||+|||+|+.
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARL 158 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEE
Confidence 799999999999998775432 369999999999999999999999999999999999999 6778999999999998
Q ss_pred cCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcC-CCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
+..... .....||+.|||||++. +.|+.++|||||||++|||+|| .+||......+++..+..+..... ...+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~ 235 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNC 235 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTC
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---cccC
Confidence 764432 34567999999999886 5699999999999999999995 555666667777777766543222 2468
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc--Ccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS--HPWIR 399 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~ 399 (492)
++++.+||.+||+.||++|||+.++++ |+||.
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999999999999998 77775
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=417.18 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=208.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++++.||+|+||.||+|++......+..||||.+.... .....+.+.+|+++|++++ |||||++++++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence 478999999999999999999987655567789999985433 4455677999999999995 999999999996 567
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+|+|||||++|+|.+++......+++.++..++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence 899999999999999888777789999999999999999999999999999999999999 55668999999999876
Q ss_pred CCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 293 RPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 293 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
..... .....||+.|+|||++. +.|+.++|||||||++|||+| |..||.+....+++..+..+... ..++.++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~ 235 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence 54332 34567899999999886 569999999999999999998 89999999999998888775432 3346799
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+++++||.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-55 Score=431.29 Aligned_cols=265 Identities=28% Similarity=0.463 Sum_probs=221.6
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC-CHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT-TAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
++|++++.||+|+||+||+|+...+..+|+.||||++.+.... .....+.+.+|+++|+++.+||||+++++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 7799999999999999999998776678999999999654321 112234578899999999756999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
+++|||||.||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhh
Confidence 99999999999999988665 678999999999999999999999999999999999999 66779999999999876
Q ss_pred CCCC--CccccccCccccccccccC---CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 293 RPDE--RLNDIVGSAYYVAPEVLHR---SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 293 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
.... ......||+.|+|||.+.+ .++.++|||||||+||+|++|..||.+....+....+.+............+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 4332 2345789999999998753 3788999999999999999999999877665554444443322222333478
Q ss_pred CHHHHHHHHHccccCcCCCC-----CHHHHhcCccccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRM-----TAAQALSHPWIRNYN 402 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~ 402 (492)
|+++.+||.+||++||.+|| |++|+|+||||++.+
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 99999999999999999999 589999999998753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=427.41 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=212.3
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC---
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL--- 210 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~--- 210 (492)
-+|+..++||+|+||+||+|+++. +|+.||||++.+.... ..+|+.+|++|+ |||||+++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~-h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSSS-------CCHHHHHHHHCC-CTTBCCEEEEEEEC--C
T ss_pred CCcEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccchH-------HHHHHHHHHhcC-CCCCCcEEEEEEecCcc
Confidence 369999999999999999999775 7899999999765432 247999999994 99999999998643
Q ss_pred ---CeEEEEEeecCCCchHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 ---DNVYIVMELCEGGELLDRIL---SRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ---~~~~lv~E~~~ggsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.++|||||||++|. .+.+. .....+++.+++.++.||+.||+|||++|||||||||+|||++. +...+||+
T Consensus 89 ~~~~~~~lv~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~ 165 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 165 (350)
T ss_dssp CSCCEEEEEEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEEC
T ss_pred CCceEEEEEEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEe
Confidence 35899999998754 33332 23457999999999999999999999999999999999999942 23479999
Q ss_pred ecccccccCCCCCccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-----
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP----- 357 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~----- 357 (492)
|||+++.+.......+.+||+.|+|||++. ..|+.++||||+||++|||++|..||...+..+.+..+.+...
T Consensus 166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 999999887777777889999999999764 3589999999999999999999999998888777666643210
Q ss_pred ------------CCC--------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 ------------SFD--------DGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ------------~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.+. ....+.+++++.+||.+||..||++|||+.|+|+||||++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 111 112345789999999999999999999999999999998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-53 Score=423.55 Aligned_cols=254 Identities=26% Similarity=0.512 Sum_probs=212.2
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC--
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL-- 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~-- 210 (492)
.++|+++++||+|+||+||+|+++. +|+.||||++++.. .+.+.+|+.+|+.+.+||||++++++|...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 4789999999999999999999765 78999999996542 356889999999997799999999999854
Q ss_pred CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 211 DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
..+++|||||.+|+|.... +.+++.+++.++.||+.||.|||++|||||||||+|||++. ++..+||+|||+|+
T Consensus 105 ~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAE 178 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCE
T ss_pred CceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccce
Confidence 5699999999999987642 57999999999999999999999999999999999999953 34479999999999
Q ss_pred ccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChh-HHHHHHHh-------------
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLK------------- 354 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~-~~~~~i~~------------- 354 (492)
...........+||+.|+|||++.+ .|+.++||||+||++|+|++|..||...... .....+..
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 8887777778899999999998753 4899999999999999999999999765432 22222111
Q ss_pred cCCC--------------------CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 355 ADPS--------------------FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 355 ~~~~--------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
.... +....+..++++++|||++||+.||++|||++|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0000 1111223578999999999999999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=429.02 Aligned_cols=259 Identities=28% Similarity=0.510 Sum_probs=212.4
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
++.++|++.+.||+|+||.||+|+++. +|+.||||++.+... .....+.+.+|+++|+.|+ |||||+++++|...
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD 89 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccC
Confidence 467899999999999999999999765 789999999976543 4455677899999999995 99999999999865
Q ss_pred C------eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 211 D------NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 211 ~------~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
+ .+|+||||| +++|...+ ++ +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~-~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~ 163 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLM-KH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKIL 163 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHH-HH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEEC
T ss_pred ccccccceEEEEEecc-cccHHHHH-Hh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccc
Confidence 4 579999999 55666554 33 579999999999999999999999999999999999999 677899999
Q ss_pred ecccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-----
Q 011154 285 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP----- 357 (492)
Q Consensus 285 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~----- 357 (492)
|||+|+... ......+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+....+..+.....
T Consensus 164 Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 164 DFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp CCTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 999998764 34466789999999998753 478999999999999999999999988877666555443221
Q ss_pred ------------------CCCC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 358 ------------------SFDD----GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 358 ------------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
.... .....+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 1111 12346789999999999999999999999999999998753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=422.21 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=213.9
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe---
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED--- 209 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~--- 209 (492)
.++|++.++||+|+||+||+|+++. +|+.||||++.+..... .....+.+|+++|++|+ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKAS 83 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhc-CCCccceEeeeecccc
Confidence 3799999999999999999999765 78999999997654332 23456789999999995 9999999999855
Q ss_pred -----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 -----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 -----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.+.+|+|||||.++.+ ..+......+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~-~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~ 159 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLA 159 (318)
T ss_dssp -------CEEEEEECCCEEHH-HHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEEC
T ss_pred cccccCceEEEEEeccCCCcc-chhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEee
Confidence 4568999999987654 4454555789999999999999999999999999999999999999 667899999
Q ss_pred ecccccccCCCC-----CccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC
Q 011154 285 DFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 357 (492)
Q Consensus 285 DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~ 357 (492)
|||+++.+.... .....+||+.|+|||++. ..|+.++||||+||++|+|++|+.||.+.........+.....
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998765332 233468999999999875 3589999999999999999999999999888888777766554
Q ss_pred CCCCCCCCC----------------------------CCHHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q 011154 358 SFDDGSWPS----------------------------LSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRN 400 (492)
Q Consensus 358 ~~~~~~~~~----------------------------~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 400 (492)
.+....+.. .+++++|||.+||..||++|||+.|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 444333222 3678899999999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-54 Score=414.99 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=210.4
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.+.||+|+||.||+|++.........||||++.+.........+.+.+|+.+|++| +|||||+++++|.+ +.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cch
Confidence 6799999999999999999998765555678999999877666666678899999999999 49999999999976 567
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++|||||++|+|.+++..+.+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhcc
Confidence 89999999999999998887789999999999999999999999999999999999999 455689999999999875
Q ss_pred CCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 294 PDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 294 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
.... .....||..|+|||++. ..++.++|||||||++|||+| |..||.+.+..++...+.+....++ .+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Ccccc
Confidence 4432 23456888999999886 458899999999999999998 8999999999999988887655443 34578
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
++++++||.+||..||++|||+.++++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=424.29 Aligned_cols=261 Identities=30% Similarity=0.497 Sum_probs=212.0
Q ss_pred cccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe
Q 011154 130 KEVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED 209 (492)
Q Consensus 130 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~ 209 (492)
-++.++|++.+.||+|+||+||+|+++. +|+.||||++.+.. .....+.+.+|+.+|+.|+ ||||+++++++..
T Consensus 4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRA 77 (345)
T ss_dssp CCCCTTEEEEEECC---CCCEEEEEETT---TCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECC
T ss_pred cCcCCCeEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEee
Confidence 3567899999999999999999998765 78999999997543 3445667899999999995 9999999999976
Q ss_pred CC-----eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEE
Q 011154 210 LD-----NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAI 284 (492)
Q Consensus 210 ~~-----~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~ 284 (492)
.. .+|++ +|+.||+|.+++.. ..+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+
T Consensus 78 ~~~~~~~~~~l~-~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~ 151 (345)
T d1pmea_ 78 PTIEQMKDVYLV-THLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKIC 151 (345)
T ss_dssp SSTTTCCCEEEE-EECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEEC
T ss_pred ccccccceEEEE-EeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEc
Confidence 53 34555 55668999998865 479999999999999999999999999999999999999 667799999
Q ss_pred ecccccccCCCC----CccccccCcccccccccc--CCCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCC
Q 011154 285 DFGLSDFVRPDE----RLNDIVGSAYYVAPEVLH--RSYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 358 (492)
Q Consensus 285 DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~ 358 (492)
|||+|+...... .....+||+.|+|||++. ..|+.++||||+||++|+|++|+.||.+....+...........
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~ 231 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence 999998764332 235568999999999875 34788999999999999999999999887765555443321111
Q ss_pred C-----------------------CC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 359 F-----------------------DD----GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 359 ~-----------------------~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
. .. ..++.+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 1 00 12356889999999999999999999999999999999653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-53 Score=411.17 Aligned_cols=259 Identities=27% Similarity=0.486 Sum_probs=217.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
++|++.++||+|+||+||+|+++. +|+.||||+++.... .....+.+.+|+.+|+.++ |||||+++++|.+.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccce
Confidence 589999999999999999999765 789999999976543 3335677899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccC
Q 011154 214 YIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVR 293 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~ 293 (492)
++|+|++.|++|...+ ...+.+++.+++.++.|++.||+|||++|||||||||+|||+ +.+..+||+|||.|+...
T Consensus 77 ~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred eEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhccc
Confidence 9999999988877655 455789999999999999999999999999999999999999 566789999999998876
Q ss_pred CCCC-ccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCC-CCChhHHHHHHHhcCCCCCC--------
Q 011154 294 PDER-LNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDD-------- 361 (492)
Q Consensus 294 ~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~-------- 361 (492)
.... .....+++.|+|||++.+ .++.++||||+||++|+|++|..||. +.+..+.+..+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 4443 344568899999998754 37899999999999999999999864 44555555555432221111
Q ss_pred -----------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 362 -----------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 362 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
...+.+++++.+||.+||+.||++|||++|+|+||||+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 1224578899999999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=407.53 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=206.5
Q ss_pred ccceeecceeccccceEEEEEEEecCC-ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE-HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
.+.|++.+.||+|+||.||+|.++.+. .....||||++.... ......++.+|+++|++|+ |||||++++++.+.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCC
Confidence 357999999999999999999987532 223579999996543 3344567899999999995 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++|||||.+|++.+.+....+.+++.++..++.||+.||.|||+++|+||||||+|||| +.++.+||+|||+|+.
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhc
Confidence 9999999999999999888877889999999999999999999999999999999999999 6778999999999987
Q ss_pred cCCCCC----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcC-CCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011154 292 VRPDER----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDDGSWP 365 (492)
Q Consensus 292 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (492)
+..... .....||+.|||||++. +.|+.++|||||||++|||++| .+||......+++..+..+... ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---~~~~ 236 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTPM 236 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC---CCch
Confidence 654332 23356899999999886 4699999999999999999995 4555666667777777654322 2234
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 366 SLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 366 ~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.++.++.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 68899999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-53 Score=408.66 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=208.8
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++++.||+|+||.||+|+++. ++.||||+++..... .+.+.+|+.+|++++ |||||+++++|. ++.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~-h~nIv~~~g~~~-~~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLR-HEKLVQLYAVVS-EEP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEEC-SSS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----CCEEEEEEECcccCC----HHHHHHHHHHHHhcc-cCCEeEEEEEEe-cCC
Confidence 3689999999999999999998753 457999999755432 356899999999995 999999999985 466
Q ss_pred EEEEEeecCCCchHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 213 VYIVMELCEGGELLDRILSR-CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
+|+|||||++|+|.+.+... .+.+++.++..++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 162 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhh
Confidence 89999999999999887643 3569999999999999999999999999999999999999 6677999999999987
Q ss_pred cCCCCC--ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCC-CCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 292 VRPDER--LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 292 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
+..... .....||+.|+|||++. +.++.++|||||||++|||+||..| |.+....+++..+..+... .....+
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---~~~~~~ 239 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPEC 239 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTS
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---CCCccc
Confidence 754432 33467999999999875 5699999999999999999996555 5556666677777664322 234578
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhc--Cccccccccc
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALS--HPWIRNYNNV 404 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~~~~~~ 404 (492)
++++++||.+||+.||++|||+.++++ ++||......
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 999999999999999999999999988 8888765433
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=411.98 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=203.6
Q ss_pred ccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++++.||+|+||.||+|++... ..+++.||||++.... .....+.+.+|+.++.++.+|+|||.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 37899999999999999999998753 2357899999996543 3344567888999999887799999999998764
Q ss_pred -CeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeec
Q 011154 211 -DNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTS 274 (492)
Q Consensus 211 -~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~ 274 (492)
+.+++|||||++|+|.+++..+. ..+++.++..++.||+.||.|||++|||||||||+|||+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl-- 167 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 167 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence 46899999999999999997542 348999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcC-CCCCCCCChhHHH
Q 011154 275 KDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCG-SRPFWARTESGIF 349 (492)
Q Consensus 275 ~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg-~~pf~~~~~~~~~ 349 (492)
+.++.+||+|||+|+....... ....+||+.|||||++. +.|+.++|||||||++|||+|| ..||.+....+.+
T Consensus 168 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp -CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred -CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 6677999999999987654332 34568999999999876 5699999999999999999986 5678766555544
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 350 RAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 350 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
..+......+. ....+++++++||.+||+.||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44444333322 234689999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=412.89 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=210.4
Q ss_pred cceeecceeccccceEEEEEEEecCC-ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGE-HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
++|++.+.||+|+||.||+|.+..+. .....||||.+.... .....+.+.+|+++|++|+ |||||+++++|.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-C
Confidence 46999999999999999999986521 123468999886543 2234567999999999995 99999999999864 5
Q ss_pred EEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccccc
Q 011154 213 VYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFV 292 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~ 292 (492)
.++++|||.+|+|.+.+......+++..+..++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceec
Confidence 678899999999999998887889999999999999999999999999999999999999 56678999999999987
Q ss_pred CCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011154 293 RPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSL 367 (492)
Q Consensus 293 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (492)
..... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+.+..++...+..+.... ..+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---CCTTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCccc
Confidence 54433 23457899999999875 569999999999999999998 899998888888887777654322 22468
Q ss_pred CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 368 SSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 368 s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
++++.+||.+||..||.+|||+.|+++|
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=420.05 Aligned_cols=260 Identities=28% Similarity=0.489 Sum_probs=215.2
Q ss_pred ccccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 131 EVTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 131 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
++.++|++.+.||+|+||+||+|+++. +|+.||||++.+... .....+.+.+|+++|+.|. |||||+++++|...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA 89 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeec
Confidence 456899999999999999999998765 789999999976543 3445567889999999995 99999999999643
Q ss_pred -----CeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 211 -----DNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 211 -----~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
...++||+||.||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~d 164 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILD 164 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC
T ss_pred cccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccc
Confidence 345666778889999987743 579999999999999999999999999999999999999 6678999999
Q ss_pred cccccccCCCCCccccccCccccccccccC--CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCCCCCC--
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDD-- 361 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-- 361 (492)
||++.... ....+..||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.........
T Consensus 165 fg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 165 FGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp C----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 99997653 34456789999999997653 4788999999999999999999999988887777666543322211
Q ss_pred -------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCccccccc
Q 011154 362 -------------------------GSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYN 402 (492)
Q Consensus 362 -------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 402 (492)
..+..+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 01246899999999999999999999999999999999764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=412.16 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=212.0
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCe
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDN 212 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~ 212 (492)
.++|++++.||+|+||.||+|+++.+. ....||||.+.... .....+.+.+|+++|.++.+|||||+++++|.+.+.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCC-eEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 378999999999999999999987621 22357888875433 223455789999999999569999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhh---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCC
Q 011154 213 VYIVMELCEGGELLDRILSR---------------CGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDE 277 (492)
Q Consensus 213 ~~lv~E~~~ggsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~ 277 (492)
+|+|||||+||+|.++|..+ ...+++.++..++.||+.||.|||+++||||||||+|||+ +.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cC
Confidence 99999999999999998643 3579999999999999999999999999999999999999 66
Q ss_pred CCcEEEEecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCC-CCCCCCChhHHHHHHHhc
Q 011154 278 SSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGS-RPFWARTESGIFRAVLKA 355 (492)
Q Consensus 278 ~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~-~pf~~~~~~~~~~~i~~~ 355 (492)
++.+||+|||+|+............||..|+|||.+. +.|+.++|||||||++|||++|. .||.+.+..++...+..+
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 7799999999998776555555678999999999885 56999999999999999999965 578888888888877664
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 356 DPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 356 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
.. ...+..+++++++||.+||+.||++|||+.|+++|
T Consensus 243 ~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 32 22345789999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-52 Score=406.49 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=216.9
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
+++|++.+.||+|+||.||+|+++. +..+++.||||++.... .....+++.+|+++|++++ ||||++++++|.+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVG 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeeccC
Confidence 5789999999999999999999874 23467899999996543 3445677999999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 011154 211 DNVYIVMELCEGGELLDRILSRC-----------------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKP 267 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp 267 (492)
+..++|||||++|+|.+++.... ..+++.++..|+.||+.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 99999999999999999886432 2489999999999999999999999999999999
Q ss_pred CceEeecCCCCCcEEEEecccccccCCCC---CccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCC-CCCCC
Q 011154 268 ENFLYTSKDESSQLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGS-RPFWA 342 (492)
Q Consensus 268 ~NILl~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~-~pf~~ 342 (492)
+|||+ +.++.+||+|||+|+.+.... ......||+.|+|||++. ..|+.++|||||||++|||++|. .||.+
T Consensus 169 ~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 169 RNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999 667899999999998764433 223567999999999876 46999999999999999999985 68999
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 343 RTESGIFRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 343 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
....++...+..+... .....+++++.+||.+||+.||++|||+.||++
T Consensus 246 ~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999998888776532 223478999999999999999999999999865
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=418.30 Aligned_cols=258 Identities=28% Similarity=0.474 Sum_probs=202.5
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe--
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-- 209 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-- 209 (492)
+.++|++.+.||+|+||+||+|+++. +|+.||||++.+... .......+.+|+.+|++++ |||||+++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 89 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccc
Confidence 44789999999999999999999765 789999999977654 3445567899999999995 9999999999964
Q ss_pred ----CCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEe
Q 011154 210 ----LDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAID 285 (492)
Q Consensus 210 ----~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~D 285 (492)
.+.+|+|||||.++ +++.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|
T Consensus 90 ~~~~~~~~~iv~Ey~~~~-l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~d 162 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 162 (355)
T ss_dssp STTTCCEEEEEEECCSEE-HHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECC
T ss_pred ccccCceeEEEEeccchH-HHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeec
Confidence 46899999999764 55544 3579999999999999999999999999999999999999 6677899999
Q ss_pred cccccccCCCCCccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHHhcCC-------
Q 011154 286 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------- 357 (492)
Q Consensus 286 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~~~~~------- 357 (492)
||+++...........+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 163 f~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp CCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 999988877777778899999999998864 589999999999999999999999988877666555432211
Q ss_pred ---------------CCCCCCC----------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCcccccc
Q 011154 358 ---------------SFDDGSW----------------PSLSSDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNY 401 (492)
Q Consensus 358 ---------------~~~~~~~----------------~~~s~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 401 (492)
......+ ...++++++||++||..||++|||++|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 1111100 1235689999999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=404.06 Aligned_cols=254 Identities=22% Similarity=0.382 Sum_probs=213.2
Q ss_pred ccceeecceeccccceEEEEEEEecCC----ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEE
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGE----HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFE 208 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~ 208 (492)
.++|++++.||+|+||.||+|++.... .++..||||++++.. ......++.+|+..+.++.+|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 479999999999999999999876432 245689999997644 34456778999999999966999999999999
Q ss_pred eCCeEEEEEeecCCCchHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 209 DLDNVYIVMELCEGGELLDRILSRC---------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 209 ~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
+++.+++|||||++|+|.++|..+. ..+++.+++.++.||+.||+|||+++||||||||+|||+
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl- 168 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 168 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee-
Confidence 9999999999999999999997553 358999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+.++.+||+|||+++....... .....||+.|+|||++. +.|+.++|||||||++|||+| |..||.+.....+
T Consensus 169 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 169 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp --CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred --cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 6778999999999987754332 34467999999999875 679999999999999999998 7999988888888
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+..+..+.. + .....+++++++||.+||+.||++|||+.|+++
T Consensus 247 ~~~i~~~~~-~--~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTCC-C--CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCC-C--CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 877766432 2 223468999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=396.06 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=201.4
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe-CC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-LD 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-~~ 211 (492)
.++|++++.||+|+||.||+|+++ |..||||+++++. ..+.+.+|+++|++++ |||||+++++|.+ .+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 74 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-----CeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCC
Confidence 367999999999999999999863 5689999996543 2356889999999995 9999999999854 46
Q ss_pred eEEEEEeecCCCchHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRC-GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.+|+|||||++|+|.+++.++. ..+++..+..|+.||+.||.|||+.+||||||||+|||+ +.++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccce
Confidence 6899999999999999987653 359999999999999999999999999999999999999 677899999999998
Q ss_pred ccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 291 FVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
..... .....+|..|+|||++. +.++.++|||||||++|||+| |+.||......++...+.++... .....++
T Consensus 152 ~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~ 226 (262)
T d1byga_ 152 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCP 226 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCC
T ss_pred ecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCC
Confidence 76433 34457899999999875 679999999999999999998 78889888888888887654322 1224688
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+++++||.+||..||.+|||+.+++++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999999873
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=401.08 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=215.2
Q ss_pred ccceeecceeccccceEEEEEEEec--CCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKK--GEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++++.||+|+||.||+|+++. +..+++.||||+++... .......+.+|+.+++++.+|||||+++++|.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4799999999999999999999864 23467899999997654 3344567899999999997799999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEee
Q 011154 211 DNVYIVMELCEGGELLDRILSRC-----------------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYT 273 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~-----------------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~ 273 (492)
+.+|+|||||++|+|.+++.... ..+++.++..++.||+.||+|||++|||||||||+|||+
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~- 178 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence 99999999999999999987542 258999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhc-CCCCCCCCChhHH
Q 011154 274 SKDESSQLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLC-GSRPFWARTESGI 348 (492)
Q Consensus 274 ~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~llt-g~~pf~~~~~~~~ 348 (492)
+..+.+||+|||+++....... ....+||+.|+|||++. +.++.++|||||||++|||+| |.+||......+.
T Consensus 179 --~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred --cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 5667999999999998764432 23468999999999876 568999999999999999999 5666666666566
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 349 FRAVLKADPSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
+..+......... ...++.++.+||.+||+.||++|||++||++
T Consensus 257 ~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5555544433322 2468899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-51 Score=400.98 Aligned_cols=272 Identities=20% Similarity=0.240 Sum_probs=214.8
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.++|++++.||+|+||.||+|+++. +|+.||||++...... +.+.+|+++++.+.+|++|+.+.+++.+.+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 45789999999999999999999765 6889999998765432 246789999999975666777777888899
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDF 291 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~ 291 (492)
..++||||| +|+|.+.+....+.+++.++..++.||+.||+|||++|||||||||+|||++..+.+..+||+|||+|+.
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999999999 5577777777677899999999999999999999999999999999999997666777899999999988
Q ss_pred cCCCC--------CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChhHHHHHHH---hcCC-C
Q 011154 292 VRPDE--------RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL---KADP-S 358 (492)
Q Consensus 292 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~~~~~~i~---~~~~-~ 358 (492)
+.... .....+||+.|||||++.+ .|+.++|||||||++|||+||..||...........+. .... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 75433 2245689999999998875 59999999999999999999999997765543332221 1110 1
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCHH---HHhcCcccccccccCCCccHHH
Q 011154 359 FDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAA---QALSHPWIRNYNNVKVPLDISI 412 (492)
Q Consensus 359 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~---e~l~hp~~~~~~~~~~~~~~~~ 412 (492)
.....++.+++++.+||.+||..||++||++. ++|+|+|.+.......+.+...
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~ 292 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 292 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchh
Confidence 11112346899999999999999999999986 5578888765444444555443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=396.93 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=206.3
Q ss_pred eecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEe-CCeEEE
Q 011154 137 EVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFED-LDNVYI 215 (492)
Q Consensus 137 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~-~~~~~l 215 (492)
.+.++||+|+||.||+|++..+..+...||||++++. ......+++.+|+++|++|+ |||||++++++.+ ++.+++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEE
Confidence 4468899999999999998765444567999999643 34556678999999999995 9999999999876 568999
Q ss_pred EEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcEEEEecccccccCCC
Q 011154 216 VMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQLKAIDFGLSDFVRPD 295 (492)
Q Consensus 216 v~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~~~~~~ 295 (492)
|||||++|+|.+++......+++.++..++.||+.||.|||+.+|+||||||+|||+ ++++.+||+|||+++.+...
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccc
Confidence 999999999999988777788999999999999999999999999999999999999 67789999999999876544
Q ss_pred CC-----ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCC-hhHHHHHHHhcCCCCCCCCCCCCC
Q 011154 296 ER-----LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDDGSWPSLS 368 (492)
Q Consensus 296 ~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s 368 (492)
.. .....||+.|+|||++. +.++.++|||||||++|||+||..||.... ..++...+..+..... ...++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~~ 260 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCP 260 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTTCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---cccCc
Confidence 32 22357899999999875 679999999999999999999888876543 3345555555543222 23678
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
+++.+||.+||+.||++|||+.|+++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=395.82 Aligned_cols=253 Identities=19% Similarity=0.307 Sum_probs=217.0
Q ss_pred ccceeecceeccccceEEEEEEEecC--CccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeC
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKG--EHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDL 210 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~ 210 (492)
.++|++++.||+|+||.||+|.++.. ..+++.||||++++.. .......+.+|+++++++. |||||+++++|..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecC
Confidence 47899999999999999999988632 2356889999997543 4445567899999999995 99999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCcE
Q 011154 211 DNVYIVMELCEGGELLDRILSRC---------GKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQL 281 (492)
Q Consensus 211 ~~~~lv~E~~~ggsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~~ 281 (492)
+..++|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.+.++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 99999999999999999886432 347999999999999999999999999999999999999 778899
Q ss_pred EEEecccccccCCCCC---ccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcC-CCCCCCCChhHHHHHHHhcC
Q 011154 282 KAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKAD 356 (492)
Q Consensus 282 kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg-~~pf~~~~~~~~~~~i~~~~ 356 (492)
||+|||+|+.+..... .....||+.|+|||.+. +.++.++|||||||++|||+|| ..||.+.+..+++..+..+.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999987654332 23457899999999876 5688899999999999999998 57888888888888887755
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 357 PSFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 357 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
... ....+++.+.+||.+||+.||++|||+.++++
T Consensus 253 ~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 322 22468899999999999999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-48 Score=380.36 Aligned_cols=254 Identities=20% Similarity=0.284 Sum_probs=208.3
Q ss_pred cccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC
Q 011154 132 VTSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD 211 (492)
Q Consensus 132 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~ 211 (492)
+.++|++++.||+|+||.||+|++.. +|+.||||+++..... ..+.+|+++++.|.+|+||+.+++++.+..
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCCceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 46799999999999999999999765 7899999998665432 246789999999987799999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCC--CCCcEEEEecccc
Q 011154 212 NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKD--ESSQLKAIDFGLS 289 (492)
Q Consensus 212 ~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~--~~~~~kl~DfGla 289 (492)
..++||||| +|+|.+.+......+++.++..++.|++.||+|||++|||||||||+|||++... ..+.+||+|||+|
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 999999999 6799998877767899999999999999999999999999999999999996432 3568999999999
Q ss_pred cccCCCC--------CccccccCccccccccccC-CCCCccchHHHHHHHHHHhcCCCCCCCCChh---HHHHHHHhcCC
Q 011154 290 DFVRPDE--------RLNDIVGSAYYVAPEVLHR-SYGTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADP 357 (492)
Q Consensus 290 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlGvil~~lltg~~pf~~~~~~---~~~~~i~~~~~ 357 (492)
+.+.... .....+||+.|||||++.+ .++.++|||||||++|+|+||..||.+.... .....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 8764322 2345689999999998865 5999999999999999999999999764432 23333322211
Q ss_pred -CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 011154 358 -SFDDGSWPSLSSDAKDFVKLLLNKDPRKRMTAAQALS 394 (492)
Q Consensus 358 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e~l~ 394 (492)
.......+.+++++.+|+..|+..+|++||+.+.+.+
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1111122468899999999999999999999776543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=379.65 Aligned_cols=248 Identities=20% Similarity=0.274 Sum_probs=189.6
Q ss_pred ccceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCC-
Q 011154 133 TSRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLD- 211 (492)
Q Consensus 133 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~- 211 (492)
..+|.+.+.||+|+||.||+|++ +|+.||||++.... ........|+..+..+ +|||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccc----hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCC
Confidence 46789999999999999999985 56899999985432 1112233455555677 4999999999998754
Q ss_pred ---eEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCcccCCCCCceEeecCCCCCc
Q 011154 212 ---NVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHL--------HGVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 212 ---~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~--------~~ivHrDlkp~NILl~~~~~~~~ 280 (492)
.+|+|||||++|+|.+++.+. .+++.++..++.|++.||.|||+ +|||||||||+|||| +.++.
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~ 146 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSC
T ss_pred cceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCC
Confidence 689999999999999998653 79999999999999999999997 589999999999999 67789
Q ss_pred EEEEecccccccCCCCC-----ccccccCccccccccccCC-------CCCccchHHHHHHHHHHhcCCCCCCCCC----
Q 011154 281 LKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-------YGTEADVWSIGVIAYILLCGSRPFWART---- 344 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DvwSlGvil~~lltg~~pf~~~~---- 344 (492)
+||+|||+++....... ....+||+.|||||++.+. ++.++|||||||++|||+||..||....
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 99999999987754432 2356899999999998643 5668999999999999999988773211
Q ss_pred -----------hhHHHHHHHhcCCCCCC-CCC--CCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 011154 345 -----------ESGIFRAVLKADPSFDD-GSW--PSLSSDAKDFVKLLLNKDPRKRMTAAQALSH 395 (492)
Q Consensus 345 -----------~~~~~~~i~~~~~~~~~-~~~--~~~s~~~~~li~~~L~~dP~~Rps~~e~l~h 395 (492)
...+...+......... ..+ ......+.+|+.+||..||++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12222222221111110 111 1122458899999999999999999999773
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-45 Score=369.32 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=197.0
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHcc----------CCCCccEE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALS----------GHSNLVKF 203 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~----------~hpniv~l 203 (492)
++|+++++||+|+||+||+|+.+. +|+.||||++.+.. ...+.+.+|+++|+.+. +|+||+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 469999999999999999999765 78999999996542 33456788999998874 26889999
Q ss_pred EEEEEe--CCeEEEEEeecCCCchHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEeecCCCC
Q 011154 204 YDAFED--LDNVYIVMELCEGGELLDRIL--SRCGKYSEDEAKAVLVQILNVVAFCHL-HGVVHRDLKPENFLYTSKDES 278 (492)
Q Consensus 204 ~~~~~~--~~~~~lv~E~~~ggsL~~~l~--~~~~~~~~~~~~~i~~qi~~~l~ylH~-~~ivHrDlkp~NILl~~~~~~ 278 (492)
++++.. ....+++|+++.++....... .....+++..++.++.||+.||.|||+ .||+||||||+|||+..++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 998864 467777888776655443333 334579999999999999999999998 899999999999999653322
Q ss_pred ---CcEEEEecccccccCCCCCccccccCcccccccccc-CCCCCccchHHHHHHHHHHhcCCCCCCCCChh------HH
Q 011154 279 ---SQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYGTEADVWSIGVIAYILLCGSRPFWARTES------GI 348 (492)
Q Consensus 279 ---~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlGvil~~lltg~~pf~~~~~~------~~ 348 (492)
..+||+|||.|.... ......+||+.|+|||++. ..|+.++||||+||++++|++|+.||...... ..
T Consensus 166 ~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cccceeeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 259999999998654 3345678999999999875 56999999999999999999999999654321 11
Q ss_pred HHHHHhcCC------------------------CC--------------CCCCCCCCCHHHHHHHHHccccCcCCCCCHH
Q 011154 349 FRAVLKADP------------------------SF--------------DDGSWPSLSSDAKDFVKLLLNKDPRKRMTAA 390 (492)
Q Consensus 349 ~~~i~~~~~------------------------~~--------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 390 (492)
......... .. ....+...+++++|||.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111110000 00 0001123467899999999999999999999
Q ss_pred HHhcCcccccc
Q 011154 391 QALSHPWIRNY 401 (492)
Q Consensus 391 e~l~hp~~~~~ 401 (492)
|+|+||||++.
T Consensus 324 e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 324 GLVNHPWLKDT 334 (362)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhcCcccCCC
Confidence 99999999964
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=7.5e-27 Score=211.79 Aligned_cols=166 Identities=25% Similarity=0.256 Sum_probs=123.0
Q ss_pred eeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCC---------------CHHHHHHHHHHHHHHHHccCCCCc
Q 011154 136 LEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMT---------------TAIAVEDVRREVKILRALSGHSNL 200 (492)
Q Consensus 136 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~---------------~~~~~~~~~~Ev~~l~~l~~hpni 200 (492)
+.++++||+|+||.||+|+.. +|+.||||++...... .........+|+..+.++. |.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAV 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSS
T ss_pred chhCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCc
Confidence 468899999999999999763 5789999987532111 0112234567899999995 9999
Q ss_pred cEEEEEEEeCCeEEEEEeecCCCchHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEeecCCCCCc
Q 011154 201 VKFYDAFEDLDNVYIVMELCEGGELLDRILSRCGKYSEDEAKAVLVQILNVVAFCHLHGVVHRDLKPENFLYTSKDESSQ 280 (492)
Q Consensus 201 v~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ylH~~~ivHrDlkp~NILl~~~~~~~~ 280 (492)
+..+++.. .++||||++++.+. .+++..+..++.||+.+|.|||++||+||||||+|||++. ..
T Consensus 77 ~~~~~~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~----~~ 140 (191)
T d1zara2 77 PKVYAWEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE----EG 140 (191)
T ss_dssp CCEEEEET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET----TE
T ss_pred ceEEEecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC----CC
Confidence 99886532 27999999886542 3566677889999999999999999999999999999952 35
Q ss_pred EEEEecccccccCCCCCccccccCccccc------cccccCCCCCccchHHHHHH
Q 011154 281 LKAIDFGLSDFVRPDERLNDIVGSAYYVA------PEVLHRSYGTEADVWSIGVI 329 (492)
Q Consensus 281 ~kl~DfGla~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DvwSlGvi 329 (492)
++|+|||+|......... .|.. .+.+.+.|+.++|+||+.--
T Consensus 141 ~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp EEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred EEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 999999999776433211 1221 12344678999999997643
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.87 E-value=1.2e-09 Score=81.79 Aligned_cols=57 Identities=28% Similarity=0.379 Sum_probs=53.4
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+++.+++++|..||.|++|+|+.+||+.+|+.+|. .+++.+|.+|++.+|.|
T Consensus 2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~t~~e~~~~~~~~D~~ 58 (77)
T d1f54a_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDVD 58 (77)
T ss_dssp CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHTTCCS
T ss_pred CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 4678889999999999999999999999999999999998 69999999999999975
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.84 E-value=2.1e-09 Score=81.27 Aligned_cols=61 Identities=16% Similarity=0.250 Sum_probs=55.0
Q ss_pred HhhhcccchhhHHHHHHHHhhhCCCC-CcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 431 KALSKTLTVDERFYLKEQFALLEPNK-NGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 431 ~~l~~~l~~~e~~~l~~~F~~~D~~~-~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+.....++.++...++++|..||.|+ ||+|+..||+.+|+.+|. .+++++|++||+++|.|
T Consensus 3 k~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~-~~t~~el~~~i~~~D~d 64 (82)
T d1wrka1 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDED 64 (82)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTC-CCCHHHHHHHHHTTCTT
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 34456788899999999999999995 899999999999999998 69999999999999975
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.78 E-value=1.1e-09 Score=84.01 Aligned_cols=61 Identities=30% Similarity=0.453 Sum_probs=56.3
Q ss_pred HhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 431 KALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 431 ~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..|+..++.+++..++++|..||.|++|.|+.+||+.+|+++|. .+++++|++|++.+|.|
T Consensus 11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~s~~e~~~l~~~~D~d 71 (87)
T d1s6ja_ 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADID 71 (87)
T ss_dssp HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTS-SCCHHHHHHHHHHHCTT
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCC
Confidence 45677888888889999999999999999999999999999998 69999999999999975
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.78 E-value=3.8e-09 Score=79.68 Aligned_cols=56 Identities=14% Similarity=0.208 Sum_probs=52.1
Q ss_pred ccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 436 TLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.|+.+++..++++|..||.|++|.|+.+||+.+|+.+|. .+++.++.+|++.+|.|
T Consensus 7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~s~~e~~~~~~~~D~d 62 (81)
T d1avsa_ 7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDED 62 (81)
T ss_dssp HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 357788889999999999999999999999999999998 69999999999999975
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=98.74 E-value=4.4e-09 Score=77.62 Aligned_cols=56 Identities=23% Similarity=0.366 Sum_probs=52.3
Q ss_pred ccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 436 TLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+|+.+++.+++++|..||.|++|+|+.+||+.+|..+|. .++++++.+|++.+|.|
T Consensus 1 qLs~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~s~~~~~~~~~~~D~d 56 (73)
T d2pq3a1 1 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDAD 56 (73)
T ss_dssp CCCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred CcCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 367788999999999999999999999999999999998 69999999999999975
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.67 E-value=1.3e-08 Score=72.22 Aligned_cols=48 Identities=10% Similarity=0.279 Sum_probs=45.6
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+++++|+.||+|++|+|+.+||+.+|+.+|. .+++.+|..|++.+|.|
T Consensus 2 el~~aF~~fD~~~~G~I~~~el~~~l~~~g~-~~~~~ei~~l~~~~D~d 49 (61)
T d2fcea1 2 DFVKAFQVFDKESTGKVSVGDLRYMLTGLGE-KLTDAEVDELLKGVEVD 49 (61)
T ss_dssp HHHHHHHHHCTTCCSCEEHHHHHHHHHHTTC-CCCHHHHHHHHTTCCCC
T ss_pred hHHHHHHHHCCCCCCeEeHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCC
Confidence 5899999999999999999999999999998 69999999999999975
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=98.65 E-value=1.2e-08 Score=76.75 Aligned_cols=53 Identities=15% Similarity=0.179 Sum_probs=48.7
Q ss_pred chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 438 TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 438 ~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+.+++..++++|+.+|.|+||+|+.+||+.+|+.+| .+++.+|.+||+.+|.|
T Consensus 1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg--~~~~~ei~~~~~~~D~d 53 (81)
T d2opoa1 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG--SVTPDEVRRMMAEIDTD 53 (81)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT--TCCHHHHHHHHHHHCTT
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh--cCCHHHHHHHHHHhCCC
Confidence 357788999999999999999999999999999998 37999999999999975
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.63 E-value=1.9e-08 Score=72.19 Aligned_cols=49 Identities=14% Similarity=0.353 Sum_probs=46.0
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+.++++|+.||+|++|+|+.+||+.+++.+|. .+++.++.+|++.+|.|
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~-~~~~~e~~~l~~~~D~d 51 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGE-KLTDEEVDEMIREADID 51 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHTTCTT
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHcCCC
Confidence 35899999999999999999999999999998 69999999999999975
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.59 E-value=2.2e-08 Score=74.13 Aligned_cols=50 Identities=26% Similarity=0.380 Sum_probs=46.6
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+++++|+.||.|++|+|+.+||+.+|+.+|. .++++++++||+.+|.|
T Consensus 8 eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~-~~~~~e~~~~~~~~D~d 57 (75)
T d1jc2a_ 8 EEELANCFRIFDKNADGFIDIEELGEILRATGE-HVIEEDIEDLMKDSDKN 57 (75)
T ss_dssp HHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSS-CCCHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCC-CccHHHHHHHHHHhCCC
Confidence 346899999999999999999999999999998 69999999999999975
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.59 E-value=1.2e-08 Score=61.38 Aligned_cols=31 Identities=19% Similarity=0.414 Sum_probs=28.7
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
.+++++|+.||+|+||+|+..||+.+|+.+|
T Consensus 3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG 33 (33)
T d2hf5a1 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG 33 (33)
T ss_dssp HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence 4789999999999999999999999998775
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.58 E-value=1.2e-08 Score=73.98 Aligned_cols=50 Identities=16% Similarity=0.395 Sum_probs=46.4
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.+++++|..||.|++|+|+.+||+.+|+.+|...++++++++||+.+|.|
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d 51 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADED 51 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCC
Confidence 35899999999999999999999999999997668999999999999976
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=98.55 E-value=2.6e-08 Score=74.91 Aligned_cols=50 Identities=24% Similarity=0.436 Sum_probs=46.6
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+|+++|..||.|++|+|+.+||+.+|+.+|. .+++.+|++||+.+|.|
T Consensus 14 ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~ev~~~~~~~D~d 63 (81)
T d1fi5a_ 14 EEELSDLFRMFDKNADGYIDLEELKIMLQATGE-TITEDDIEELMKDGDKN 63 (81)
T ss_dssp HHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSS-CCCHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCC-CCCHHHHHHHHHHHCCC
Confidence 357999999999999999999999999999998 69999999999999975
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=1.4e-07 Score=87.17 Aligned_cols=87 Identities=13% Similarity=0.055 Sum_probs=61.5
Q ss_pred cceeecceeccccceEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeE
Q 011154 134 SRLEVGEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNV 213 (492)
Q Consensus 134 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~ 213 (492)
+.|+..+..+-++.+.||++.. ++..++||+........ ...+.+|+.+++.|..+--+.+++.++++++..
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~-----~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC-----SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe-----CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4566655544444568888752 45668889875433222 224678999999887665678899999999999
Q ss_pred EEEEeecCCCchHHH
Q 011154 214 YIVMELCEGGELLDR 228 (492)
Q Consensus 214 ~lv~E~~~ggsL~~~ 228 (492)
++||++++|.++.+.
T Consensus 86 ~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 86 NLLMSEADGVLCSEE 100 (263)
T ss_dssp EEEEECCSSEEHHHH
T ss_pred EEEEEeccccccccc
Confidence 999999999776543
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.52 E-value=5.1e-08 Score=72.50 Aligned_cols=52 Identities=19% Similarity=0.415 Sum_probs=47.7
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+...+++++|..+|.|++|+|+.+||+.+|+.+|. .+++.++.+|++.+|.|
T Consensus 6 d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~e~~~~~~~~D~d 57 (77)
T d1oqpa_ 6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGE-NLTEEELQEMIAEADRN 57 (77)
T ss_dssp SHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Confidence 34567999999999999999999999999999998 69999999999999875
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.44 E-value=9e-08 Score=69.03 Aligned_cols=47 Identities=17% Similarity=0.299 Sum_probs=44.6
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+|++|+.+|.|++|+|+.+||+.+|+.+|. .++++++++|++.+|.|
T Consensus 3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~-~~~~~~i~~~~~~~D~d 49 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSP-YFTQEDIVKFFEEIDVD 49 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHHHHHTCT-TSCHHHHHHHHHHHCCS
T ss_pred HHHHHHHHCCCCcCcCcHHHHHHHHHHhcc-ccchHHHHHHHHHhCCC
Confidence 689999999999999999999999999998 69999999999999975
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=98.30 E-value=3.5e-07 Score=72.68 Aligned_cols=50 Identities=28% Similarity=0.398 Sum_probs=44.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh---ccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN---ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~---g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|+.||.|++|+|+.+||+.+|+.+ |. .+++++|++||+.+|.|
T Consensus 40 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~-~~~~~e~~~~~~~~D~d 92 (109)
T d5pala_ 40 DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGR-DLNDTETKALLAAGDSD 92 (109)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCC-CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccC-cCCHHHHHHHHHHhCCC
Confidence 3578999999999999999999999999876 43 68999999999999975
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=9.3e-07 Score=66.44 Aligned_cols=51 Identities=10% Similarity=0.183 Sum_probs=46.9
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++++|..+|.|++|.|+.+||+.+|..+|. .++++++..|++.+|.|
T Consensus 18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~-~l~~~e~~~l~~~~d~~ 68 (83)
T d1wlza1 18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQ-ILTDEQFDRLWNEMPVN 68 (83)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTC-CCCHHHHHHHHTTSCBC
T ss_pred HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCC-CCChhHHHHHhhccccC
Confidence 3456899999999999999999999999999998 69999999999999864
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.14 E-value=6.4e-07 Score=71.10 Aligned_cols=50 Identities=20% Similarity=0.280 Sum_probs=44.5
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhh---ccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKN---ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~---g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|+.+|.|++|+|+.+||+.+|+.+ |. .+++++|++||+.+|.|
T Consensus 40 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~-~ls~~ev~~~~~~~D~d 92 (109)
T d1pvaa_ 40 ANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGR-DLTDAETKAFLKAADKD 92 (109)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCC-CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCC-CCCHHHHHHHHHHHCCC
Confidence 3468899999999999999999999999877 44 68999999999999975
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.10 E-value=1.7e-06 Score=49.47 Aligned_cols=32 Identities=22% Similarity=0.417 Sum_probs=28.3
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
..+|.++|+.||+|.||+|+.+||...|+..|
T Consensus 3 EeELae~FRifDkNaDGyiD~eEl~~ilr~tG 34 (34)
T d1ctda_ 3 EEELANAFRIFDKNADGYIDIEELGEILRATG 34 (34)
T ss_dssp HHHHHHHHHTTCCSSSSCBCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHccCCcccccHHHHHHHHHhcC
Confidence 35689999999999999999999999997653
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.09 E-value=1.2e-06 Score=73.07 Aligned_cols=50 Identities=12% Similarity=0.189 Sum_probs=45.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|+.||.|++|+|+.+||+.+|+.+|. .++++|+++|++.+|.|
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~-~lt~~e~~~l~~~~d~~ 124 (142)
T d1wdcb_ 75 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGD-NFNKDEMRMTFKEAPVE 124 (142)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSS-CCCHHHHHHHHHHCCEE
T ss_pred hhhHHHhhhhhcccCCCcccHHHHHHHHHHccc-cCCHHHHHHHHHHhCCC
Confidence 456899999999999999999999999999987 69999999999998853
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.07 E-value=2.2e-06 Score=67.69 Aligned_cols=53 Identities=21% Similarity=0.298 Sum_probs=46.5
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc--ccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT--DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~--~~~~~~ei~~~i~~~D~~ 492 (492)
....+++++|+.+|.|++|+|+.+||+.+|+.++. ..++++++.+||+.+|.|
T Consensus 37 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~d 91 (107)
T d2pvba_ 37 KSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKD 91 (107)
T ss_dssp SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTT
T ss_pred CCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCCC
Confidence 34567999999999999999999999999988753 268999999999999875
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.06 E-value=2.5e-06 Score=71.06 Aligned_cols=54 Identities=20% Similarity=0.414 Sum_probs=49.4
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
|+.+++.+++++|..+|.|++|.|+.+||+.+|+.+|. .+++.++.+++++.|.
T Consensus 1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~~~~el~~~~~~~~~ 54 (142)
T d1wdcb_ 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGR-APDDKELTAMLKEAPG 54 (142)
T ss_dssp CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSS-CCCHHHHHHHHTTSSS
T ss_pred CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhc-CCCHHHHHHHHHhccC
Confidence 46788999999999999999999999999999999998 6999999999987653
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.05 E-value=1.1e-06 Score=69.60 Aligned_cols=53 Identities=19% Similarity=0.306 Sum_probs=46.1
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc--ccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT--DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~--~~~~~~ei~~~i~~~D~~ 492 (492)
.....++++|+.||.|++|+|+.+||+.+|..++. ..++++++++|++.+|.|
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d 92 (108)
T d1rroa_ 38 MSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADND 92 (108)
T ss_dssp SCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCS
T ss_pred CCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCC
Confidence 34557899999999999999999999999988742 258899999999999975
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=98.02 E-value=2.4e-06 Score=67.69 Aligned_cols=52 Identities=19% Similarity=0.300 Sum_probs=45.4
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc--ccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT--DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~--~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.+|.|++|+|+.+||+.+|..++. ..+++.++++|++.+|.|
T Consensus 39 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D~d 92 (109)
T d1rwya_ 39 SADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKD 92 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTT
T ss_pred CHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhCCC
Confidence 3456889999999999999999999999998753 358899999999999975
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.01 E-value=5.6e-06 Score=81.16 Aligned_cols=82 Identities=18% Similarity=0.237 Sum_probs=50.1
Q ss_pred cceeccccceEEEEEEEecCCccccEEEEEEccCC----CCCCHHHHHHHHHHHHHHHHccCC--CCccEEEEEEEeCCe
Q 011154 139 GEEVGRGHFGYTCTARYKKGEHKDQKVAIKVIPKS----KMTTAIAVEDVRREVKILRALSGH--SNLVKFYDAFEDLDN 212 (492)
Q Consensus 139 ~~~lG~G~fg~V~~~~~~~~~~~~~~vavK~i~~~----~~~~~~~~~~~~~Ev~~l~~l~~h--pniv~l~~~~~~~~~ 212 (492)
.+.||.|....||++.... .++.|+||.-... ...-....++...|...|+.+..+ ..+.+++.+ +.+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~---~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCC---CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC
Confidence 3468999999999987443 5678999964321 000001223456788888877544 345566644 4556
Q ss_pred EEEEEeecCCCch
Q 011154 213 VYIVMELCEGGEL 225 (492)
Q Consensus 213 ~~lv~E~~~ggsL 225 (492)
.++|||++.+..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 6899999987654
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.00 E-value=2.9e-06 Score=70.47 Aligned_cols=51 Identities=14% Similarity=0.240 Sum_probs=46.8
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++++|+.+|.|++|+|+.+||+.+|+.+|. .++++|+++|++.+|.|
T Consensus 74 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~-~lt~~e~~~l~~~~d~~ 124 (140)
T d1ggwa_ 74 DPEEFVKGFQVFDKDATGMIGVGELRYVLTSLGE-KLSNEEMDELLKGVPVK 124 (140)
T ss_dssp CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHS-CSCHHHHHHHHHHTTCS
T ss_pred HHHHHHHHHHHHhccCCCcchHHHHHHHHHHcCC-CCCHHHHHHHHHhhCCC
Confidence 3456899999999999999999999999999997 69999999999999864
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.00 E-value=3.6e-06 Score=64.82 Aligned_cols=53 Identities=11% Similarity=0.258 Sum_probs=47.8
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.++..+++++|..+|+|++|.|+.+|++.+|++.+ ++++++.+|++.+|.|
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~---l~~~~l~~i~~~~D~d 56 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG---LPSTLLAHIWSLCDTK 56 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT---CCHHHHHHHHHHHCTT
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC---CCHHHHHHHHHHhCCC
Confidence 5677888899999999999999999999999998864 6789999999999975
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.95 E-value=4.4e-06 Score=63.91 Aligned_cols=53 Identities=26% Similarity=0.331 Sum_probs=48.2
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.+|..++++.|..+|.|++|.|+.+|++.+|++.+ ++++++..|++.+|.|
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~---l~~~~l~~i~~~~D~d 55 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK---LPILELSHIWELSDFD 55 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS---SCHHHHHHHHHHHCTT
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc---CCHHHHHHHHHHhCCC
Confidence 5677888999999999999999999999999999864 6789999999999986
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.93 E-value=4.4e-06 Score=69.69 Aligned_cols=56 Identities=29% Similarity=0.412 Sum_probs=50.9
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
..|+.++..+++++|+.+|.|++|+|+.+||+.+|...|. .+++.++..++...+.
T Consensus 2 ~~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~-~~~~~~~~~~~~~~~~ 57 (146)
T d1lkja_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDV 57 (146)
T ss_dssp CCCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCS
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCC-CCCHHHHHHHHHHhcc
Confidence 4678899999999999999999999999999999999987 6999999999887664
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=97.93 E-value=5.1e-06 Score=69.17 Aligned_cols=56 Identities=25% Similarity=0.374 Sum_probs=51.4
Q ss_pred ccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 436 TLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+|+.++..+|+++|..+|.|++|.|+.+||+.+|...|. .+++.++..+++.+|.|
T Consensus 2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~ 57 (146)
T d1exra_ 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDAD 57 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTT
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCC-CCCHHHHHHHHHhcCCC
Confidence 567888999999999999999999999999999999987 69999999999998864
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.92 E-value=6e-06 Score=69.64 Aligned_cols=59 Identities=14% Similarity=0.227 Sum_probs=52.7
Q ss_pred hhcccchhhHHHHHHHHhhhCCCC-CcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNK-NGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~-~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....|+.++..+++++|..||.|+ ||.|+.+||+.+|+.+|. .+++.++.+++..++.+
T Consensus 4 ~~~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~-~~~~~~~~~~~~~~~~~ 63 (156)
T d1dtla_ 4 AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDED 63 (156)
T ss_dssp GGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred HHHHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCC-CCCHHHHHHHHHHhhcc
Confidence 445778889999999999999995 899999999999999998 69999999999888753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=1.2e-05 Score=73.37 Aligned_cols=75 Identities=11% Similarity=0.113 Sum_probs=52.1
Q ss_pred eeccccc-eEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCC-CCccEEEEEEEeCCeEEEEEe
Q 011154 141 EVGRGHF-GYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGH-SNLVKFYDAFEDLDNVYIVME 218 (492)
Q Consensus 141 ~lG~G~f-g~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~h-pniv~l~~~~~~~~~~~lv~E 218 (492)
.+..|.. +.||++... .+..+++|....... ..+..|...|+.|..+ -.+.+++.+..+++..++||+
T Consensus 17 ~~~~G~s~~~v~r~~~~----~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEECT----TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred EcCCcccCCeEEEEEeC----CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence 3444543 578887632 456688898754432 2366788888877643 236778888888889999999
Q ss_pred ecCCCch
Q 011154 219 LCEGGEL 225 (492)
Q Consensus 219 ~~~ggsL 225 (492)
+++|.++
T Consensus 87 ~i~G~~~ 93 (255)
T d1nd4a_ 87 EVPGQDL 93 (255)
T ss_dssp CCSSEET
T ss_pred eeecccc
Confidence 9988655
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.89 E-value=4.5e-06 Score=70.91 Aligned_cols=57 Identities=14% Similarity=0.202 Sum_probs=51.6
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.++..+|+++|..+|.|++|+|+.+||+.+|...+. .+++.++..++..+|.+
T Consensus 12 ~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~-~~~~~~~~~~~~~~d~~ 68 (162)
T d1topa_ 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDED 68 (162)
T ss_dssp HHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCC-chhHHHHHhhhheeccC
Confidence 3467788889999999999999999999999999999887 69999999999999864
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=97.87 E-value=5.4e-06 Score=69.74 Aligned_cols=49 Identities=14% Similarity=0.238 Sum_probs=45.3
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
...++++|+.||.|++|+|+.+||+.+|+.+|. .++++|+++|++.+|.
T Consensus 81 ~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~-~ls~~e~~~l~~~~d~ 129 (152)
T d1wdcc_ 81 FADYMEAFKTFDREGQGFISGAELRHVLTALGE-RLSDEDVDEIIKLTDL 129 (152)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSS-CCCHHHHHHHHHHHTC
T ss_pred HHhhhhhhhccccccCccchHHHHHHHHHHcCC-CCCHHHHHHHHHHhcc
Confidence 456899999999999999999999999999997 6999999999998874
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=8.1e-06 Score=69.69 Aligned_cols=49 Identities=8% Similarity=0.180 Sum_probs=45.5
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++++|+.+|.|++|+|+.+||+.+|..+|. .+++.+++.|++.+|.|
T Consensus 70 ~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~-~l~~~~~~~l~~~~d~~ 118 (165)
T d1k94a_ 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGY-RLSPQTLTTIVKRYSKN 118 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCBT
T ss_pred chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhh-cCCHHHHHHHHHHcCCC
Confidence 46789999999999999999999999999998 69999999999998865
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.80 E-value=6.4e-06 Score=68.56 Aligned_cols=49 Identities=14% Similarity=0.189 Sum_probs=44.4
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
..++|++|..||.|++|.|+.+||+.+|+.+|. .++..++.+++..+|.
T Consensus 3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~-~~~~~e~~~~~~~~~~ 51 (145)
T d2mysc_ 3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQ-NPTNAEINKILGNPSK 51 (145)
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhh-cchhhhhHHHHHHHhh
Confidence 456899999999999999999999999999998 6999999999987653
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.80 E-value=6.1e-06 Score=60.65 Aligned_cols=50 Identities=16% Similarity=0.224 Sum_probs=41.6
Q ss_pred HHHHHHHHhhhCCC--CCcccchHHHHHHHHhhcccccc--HHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPN--KNGCIAFENIKTVLMKNATDAMK--ESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~--~~G~Is~~el~~~l~~~g~~~~~--~~ei~~~i~~~D~~ 492 (492)
..+++++|+.||.+ ++|+|+.+||+.+|+.+|. .++ +.+|++|++.+|.|
T Consensus 4 ~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~-~~~~~~~ei~~~~~~~D~d 57 (76)
T d1qx2a_ 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGP-SLLKGMSTLDEMIEEVDKN 57 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGG-GSCTTSCSHHHHHHHHCTT
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCC-cCCCCHHHHHHHHHHhhcC
Confidence 35689999999654 4799999999999999987 354 45899999999976
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.76 E-value=1.2e-05 Score=67.00 Aligned_cols=49 Identities=10% Similarity=0.247 Sum_probs=45.9
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++++|+.+|.+++|+|+.+||+.+|..+|. .+++++|++|++.+|.|
T Consensus 81 ~~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~-~l~~~ei~~l~~~~D~d 129 (146)
T d1m45a_ 81 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGE-KLTDAEVDELLKGVEVD 129 (146)
T ss_dssp HHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTT-CCCHHHHHHHHTTCCCC
T ss_pred HHHHHHHHhhccccccccchhhhhhhhcccCC-cchHHHHHHHHHHhCCC
Confidence 46899999999999999999999999999997 69999999999999875
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.76 E-value=1.2e-05 Score=66.95 Aligned_cols=50 Identities=16% Similarity=0.239 Sum_probs=46.1
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|+.||.+++|+|+.++|+.+|+.+|. .++++|+++|++.+|.|
T Consensus 76 ~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~-~ls~~e~~~~~~~~d~d 125 (145)
T d2mysb_ 76 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGG-RFTPEEIKNMWAAFPPD 125 (145)
T ss_pred HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCC
Confidence 456899999999999999999999999999997 79999999999998875
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.75 E-value=1.1e-05 Score=66.52 Aligned_cols=54 Identities=19% Similarity=0.335 Sum_probs=48.6
Q ss_pred chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 438 TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 438 ~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+.++..+|+++|..+|.|++|+|+.+||+.++...|. .+++.++..++..+|.+
T Consensus 1 t~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~ 54 (141)
T d2obha1 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGF-EPKKEEIKKMISEIDKE 54 (141)
T ss_dssp CHHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHTTT
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCC-chhHHHHHHHHHhhccC
Confidence 3567789999999999999999999999999999987 69999999999988753
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.74 E-value=8.2e-06 Score=68.77 Aligned_cols=51 Identities=24% Similarity=0.429 Sum_probs=45.0
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.+|.|++|+|+.+||+.++..+|. .++++++++||+.+|.|
T Consensus 89 ~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~-~ls~~e~~~i~~~~D~d 139 (156)
T d1dtla_ 89 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGE-TITEDDIEELMKDGDKN 139 (156)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC---CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCC-CCCHHHHHHHHHHhCCC
Confidence 3456899999999999999999999999999987 79999999999999875
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.74 E-value=2e-05 Score=65.55 Aligned_cols=48 Identities=23% Similarity=0.397 Sum_probs=44.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
...++++|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.+|
T Consensus 82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~d 129 (146)
T d1lkja_ 82 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGE-KLTDAEVDDMLREVS 129 (146)
T ss_dssp HHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTC-SCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-cccHHHHHHHHHhcc
Confidence 456899999999999999999999999999998 699999999999987
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.67 E-value=1.8e-05 Score=60.79 Aligned_cols=52 Identities=17% Similarity=0.234 Sum_probs=46.4
Q ss_pred cchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 437 LTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
++.+|..++++.|..+| |+||+|+.+|++.+|++.| +.++++..|++.+|.|
T Consensus 4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g---l~~~~L~~Iw~~~D~~ 55 (95)
T d2jxca1 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK---LPVDILGRVWELSDID 55 (95)
T ss_dssp SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS---CCHHHHHHHHHHHCTT
T ss_pred CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC---CCHHHHHHHHHHhcCC
Confidence 56788889999999999 8999999999999998765 5688999999999975
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=97.66 E-value=1.4e-05 Score=67.04 Aligned_cols=51 Identities=18% Similarity=0.182 Sum_probs=45.0
Q ss_pred cchhhHHHHHHHHhhhCC--CCCcccchHHHHHHHHhhccccccHHHHHHHHhc
Q 011154 437 LTVDERFYLKEQFALLEP--NKNGCIAFENIKTVLMKNATDAMKESRISDLLAP 488 (492)
Q Consensus 437 l~~~e~~~l~~~F~~~D~--~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~ 488 (492)
|+.+|+.+++++|..||. |++|+|+.+||+.+|+.+|. .++++++..|+..
T Consensus 1 Ls~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~-~~t~~e~~~~~~~ 53 (152)
T d1wdcc_ 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGI-NPRNEDVFAVGGT 53 (152)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTC-CCCHHHHHHTTCC
T ss_pred CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhcc-CccHhhhhhhhhh
Confidence 466788899999999994 89999999999999999998 6999999887643
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.62 E-value=3.2e-05 Score=64.09 Aligned_cols=47 Identities=17% Similarity=0.260 Sum_probs=43.0
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhc
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAP 488 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~ 488 (492)
....++++|+.+|.|++|+|+.+||+.+|..+|. .++++++++|++.
T Consensus 79 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~e~~~l~~~ 125 (145)
T d2mysc_ 79 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGE-KMTEEEVEELMKG 125 (145)
T ss_pred hHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCC-CCCHHHHHHHHhh
Confidence 3456899999999999999999999999999997 7999999999975
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=97.59 E-value=5.5e-05 Score=65.34 Aligned_cols=51 Identities=14% Similarity=0.208 Sum_probs=46.5
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.+|.|++|+|+.+||+.+|..+|. .+++++++.|++.+|.|
T Consensus 103 ~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~-~~~~~~~~~lf~~~D~d 153 (187)
T d1uhka1 103 IRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGI-IQSSEDCEETFRVCDID 153 (187)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTS-CCSHHHHHHHHHHSCCC
T ss_pred HHHHHHHHHHHHccCCCcccchHHHHHHHHHhCC-CccHHHHHHHHHHhCCC
Confidence 3456889999999999999999999999999987 69999999999999975
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=97.59 E-value=3.9e-05 Score=63.54 Aligned_cols=51 Identities=16% Similarity=0.315 Sum_probs=46.7
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....++.+|+.+|.|++|.|+.+||+.++..+|. .++++++++|++.+|.|
T Consensus 80 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~i~~~~D~d 130 (146)
T d1exra_ 80 SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGE-KLTDDEVDEMIREADID 130 (146)
T ss_dssp HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSS
T ss_pred hHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhh-cCCHHHHHHHHHHhCCC
Confidence 3457899999999999999999999999999987 69999999999999875
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.57 E-value=1.5e-05 Score=65.69 Aligned_cols=46 Identities=17% Similarity=0.286 Sum_probs=42.7
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
+++++|..||.|++|.|+.+||+.+|+.+|. .+++.++..++..++
T Consensus 1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~-~~t~~e~~~~~~~~~ 46 (139)
T d1w7jb1 1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQ-NPTNAEVLKVLGNPK 46 (139)
T ss_dssp CHHHHHHHHCCSSSSEEESTTHHHHHHHTTC-CCCHHHHHHHTTCCC
T ss_pred CHHHHHHHHhCCCCCeECHHHHHHHHHHhcc-CCCHHHHHHHHHHHh
Confidence 3799999999999999999999999999998 699999999998765
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.57 E-value=2.1e-05 Score=65.02 Aligned_cols=48 Identities=17% Similarity=0.210 Sum_probs=43.4
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
..+|++|..||.|++|.|+.+||+.+|+.+|. .+++++|..+....+.
T Consensus 5 ~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~-~~t~~ei~~~~~~~~~ 52 (140)
T d1ggwa_ 5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQ-NPTLAEITEIESTLPA 52 (140)
T ss_dssp TTTHHHHHHTCSSSSSEECHHHHHHHHHHTSC-CCCHHHHHHHHTTSCS
T ss_pred HHHHHHHHHHCCCCCCeECHHHHHHHHHHHHh-hhHHHhhhhhhccccc
Confidence 46799999999999999999999999999998 6999999999876653
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=97.57 E-value=1.7e-05 Score=68.74 Aligned_cols=51 Identities=18% Similarity=0.240 Sum_probs=46.5
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+.++|+++|..+|.|++|.|+.+||+.+|+.+|. .+++.++..|++.+|.|
T Consensus 16 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~-~~s~~~~~~l~~~~d~d 66 (182)
T d1y1xa_ 16 DNQELMEWFRAVDTDGSGAISVPELNAALSSAGV-PFSLATTEKLLHMYDKN 66 (182)
T ss_dssp TTSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTB-CCCHHHHHHHHHHHCTT
T ss_pred cHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcc-cCchhhhhhhhcccccc
Confidence 3457999999999999999999999999999987 79999999999998864
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.56 E-value=5.6e-05 Score=63.79 Aligned_cols=50 Identities=26% Similarity=0.395 Sum_probs=45.6
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++++|+.+|.|++|+|+.+||+.+|...+. ..++++++.||+.+|.|
T Consensus 95 ~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~-~~~~~~~~~l~~~~D~d 144 (162)
T d1topa_ 95 EEELANCFRIFDKNADGFIDIEELGEILRATGE-HVTEEDIEDLMKDSDKN 144 (162)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTC-CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCC-CCCHHHHHHHHHHhCCC
Confidence 345788999999999999999999999999987 68999999999999875
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.53 E-value=4.9e-05 Score=63.00 Aligned_cols=53 Identities=15% Similarity=0.303 Sum_probs=45.3
Q ss_pred chhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 438 TVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 438 ~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
+.+++.+++++|..+|.|++|.|+.+||+.+|+.+|....+++++..+++..+
T Consensus 2 ~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~ 54 (145)
T d2mysb_ 2 DETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEAS 54 (145)
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHHHHHHHHHhcc
Confidence 45778899999999999999999999999999999865577777777776544
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=97.50 E-value=7.2e-05 Score=64.76 Aligned_cols=49 Identities=10% Similarity=0.101 Sum_probs=41.3
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+..+|..+|.|++|+|+.+|++.++..+|. .++++++..|++.+|.|
T Consensus 107 ~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~-~~~~~~~~~lf~~~D~d 155 (189)
T d1qv0a_ 107 EWGDAVFDIFDKDGSGTITLDEWKAYGKISGI-SPSQEDCEATFRHCDLD 155 (189)
T ss_dssp HHHHHHHHHTC----CEECHHHHHHHHHHHSS-CCCHHHHHHHHHHSCCC
T ss_pred HHHHHHHHHHccCCCCcccchhhHHHHHhcCC-CCCHHHHHHHHHHhCCC
Confidence 45678999999999999999999999999997 69999999999999975
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.48 E-value=4e-05 Score=62.90 Aligned_cols=47 Identities=21% Similarity=0.266 Sum_probs=41.3
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhc
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAP 488 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~ 488 (492)
....++++|+.+|.|++|+|+.+||+.+|..+|. .+++++++.|++.
T Consensus 75 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~e~~~l~~~ 121 (139)
T d1w7jb1 75 TYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGE-KMTEEEVETVLAG 121 (139)
T ss_dssp ---CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSS-CCCHHHHHHHHTT
T ss_pred HHHHHHHhhhhccCCCCCeEeHHHHHHHHHHhCC-CCCHHHHHHHHhh
Confidence 3456789999999999999999999999999987 6999999999975
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=97.48 E-value=6.1e-05 Score=57.40 Aligned_cols=51 Identities=10% Similarity=0.061 Sum_probs=43.5
Q ss_pred HHHHHHHHhhh-CCCCC-cccchHHHHHHHHhhcc----ccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALL-EPNKN-GCIAFENIKTVLMKNAT----DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~-D~~~~-G~Is~~el~~~l~~~g~----~~~~~~ei~~~i~~~D~~ 492 (492)
+..|.++|..+ |.||+ |+|+.+||+.+|.+.+. ...+++++.+||+.+|.|
T Consensus 8 i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d 64 (93)
T d1zfsa1 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDEN 64 (93)
T ss_dssp HHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCC
Confidence 46789999988 88875 99999999999988753 246799999999999986
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.39 E-value=0.0001 Score=60.40 Aligned_cols=50 Identities=18% Similarity=0.395 Sum_probs=46.4
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.+++|+|+..+|+.++..+|. .+++.++.++++.+|.|
T Consensus 78 ~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~-~l~~~e~~~l~~~~D~d 127 (141)
T d2obha1 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGE-NLTDEELQEMIDEADRD 127 (141)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHhcccCCCCccHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCC
Confidence 456899999999999999999999999999987 69999999999999975
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.38 E-value=2.4e-05 Score=65.02 Aligned_cols=45 Identities=18% Similarity=0.299 Sum_probs=40.4
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhccc
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSD 490 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D 490 (492)
+|++|..+|.|++|+|+.+||+.+|+.+|. .++++++.+++...+
T Consensus 4 ~k~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~s~~ei~~l~~~~~ 48 (146)
T d1m45a_ 4 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGY-NPTNQLVQDIINADS 48 (146)
T ss_dssp CTTCHHHHCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHC--
T ss_pred HHHHHHHHcCCCcCCCCHHHHHHHHHHcCC-chhHHHHhhhhcccc
Confidence 688999999999999999999999999998 699999999997544
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=97.33 E-value=7e-05 Score=57.60 Aligned_cols=53 Identities=6% Similarity=0.063 Sum_probs=42.1
Q ss_pred hhHHHHHHHHhhh-CCCCC-cccchHHHHHHHHhhcc-ccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALL-EPNKN-GCIAFENIKTVLMKNAT-DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~-D~~~~-G~Is~~el~~~l~~~g~-~~~~~~ei~~~i~~~D~~ 492 (492)
..+..+..+|..| |.||+ |+|+..||+.+|.+.+. ...++.+|++||+.+|.|
T Consensus 11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d 66 (98)
T d1yuta1 11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVN 66 (98)
T ss_dssp HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCC
Confidence 3456788999887 78875 99999999999988643 235667799999999976
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=97.32 E-value=8e-05 Score=60.34 Aligned_cols=46 Identities=17% Similarity=0.343 Sum_probs=39.3
Q ss_pred HHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 446 KEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 446 ~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++|..+|.|+||.|+.+||+.++..++. ..++++++.+++.+|.|
T Consensus 3 e~~F~~~D~d~dG~is~~E~~~~l~~~~~-~~~~~~~~~~~~~~D~~ 48 (134)
T d1jfja_ 3 EALFKEIDVNGDGAVSYEEVKAFVSKKRA-IKNEQLLQLIFKSIDAD 48 (134)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHTTCC-SSHHHHHHHHHHHHCSS
T ss_pred HHHHHHHcCCCcCCCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhhhc
Confidence 56899999999999999999999988887 58888899998888864
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.31 E-value=9e-05 Score=57.13 Aligned_cols=49 Identities=14% Similarity=0.202 Sum_probs=39.6
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhcc---------------ccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNAT---------------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~---------------~~~~~~ei~~~i~~~D~~ 492 (492)
.++..|..+|.|+||+|+.+||+.+|++++. ....+..++.+++.+|.|
T Consensus 17 ~~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d 80 (99)
T d1snla_ 17 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTN 80 (99)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSS
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCC
Confidence 4789999999999999999999999986542 012345688899999976
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.31 E-value=2.3e-05 Score=61.82 Aligned_cols=54 Identities=24% Similarity=0.308 Sum_probs=45.0
Q ss_pred ccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 436 TLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 436 ~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++.++..+++++|+.+|+|++|+|+.+|++.+|++.| +.++++..|++.+|.|
T Consensus 15 ~lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~---L~~~~L~~Iw~l~D~d 68 (110)
T d1iq3a_ 15 RITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK---LSIPELSYIWELSDAD 68 (110)
T ss_dssp CCSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS---CSSCCHHHHHHHHCSS
T ss_pred ccCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc---cchHHHHHHHHHhccC
Confidence 35667788889999999999999999999999997754 5677888999888865
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=97.29 E-value=6.6e-05 Score=57.02 Aligned_cols=51 Identities=10% Similarity=0.177 Sum_probs=42.4
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc----ccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT----DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~----~~~~~~ei~~~i~~~D~~ 492 (492)
.+..++.+|..+|.| +|+|+.+||+.+|..... ...++..+++||+.+|.|
T Consensus 7 ~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n 61 (92)
T d1a4pa_ 7 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQC 61 (92)
T ss_dssp HHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCC
Confidence 456789999999987 899999999999987432 134678899999999986
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=97.25 E-value=0.00021 Score=54.21 Aligned_cols=52 Identities=12% Similarity=0.127 Sum_probs=42.6
Q ss_pred hHHHHHHHHhhh-CCCCCc-ccchHHHHHHHHhhc----cccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALL-EPNKNG-CIAFENIKTVLMKNA----TDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~-D~~~~G-~Is~~el~~~l~~~g----~~~~~~~ei~~~i~~~D~~ 492 (492)
.+..+.++|..+ |.|++| +|+.+||+++|++.+ ....++.++++||+.+|.|
T Consensus 7 ~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n 64 (93)
T d3c1va1 7 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSN 64 (93)
T ss_dssp HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCC
Confidence 356789999998 677765 699999999998742 2357899999999999986
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=97.23 E-value=3.3e-05 Score=56.80 Aligned_cols=52 Identities=15% Similarity=0.128 Sum_probs=41.3
Q ss_pred hHHHHHHHHhhhCC-C-CCcccchHHHHHHHHhhcc-ccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEP-N-KNGCIAFENIKTVLMKNAT-DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~-~-~~G~Is~~el~~~l~~~g~-~~~~~~ei~~~i~~~D~~ 492 (492)
....|+.+|..||. + ++|+|+.+||+.+|+.... ..+++.++++||+.+|.|
T Consensus 5 ~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d 59 (78)
T d1cb1a_ 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKN 59 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCC
T ss_pred hHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCC
Confidence 45678999999964 4 4589999999999988732 245677899999999986
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.22 E-value=8.5e-05 Score=64.07 Aligned_cols=53 Identities=11% Similarity=0.253 Sum_probs=46.3
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.+..+|.++|..+|.|++|+|+.+||+.+|+.++....+++++..+++.+|.|
T Consensus 16 ~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d 68 (181)
T d1hqva_ 16 PDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRE 68 (181)
T ss_dssp SCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCS
T ss_pred ccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccc
Confidence 34567999999999999999999999999988876567899999999988764
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=97.19 E-value=0.0002 Score=61.67 Aligned_cols=49 Identities=14% Similarity=0.302 Sum_probs=44.2
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++++|..+|.+++|.|+.+||+.+|..+|. .+++++++.|++.+|.|
T Consensus 84 ~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~-~ls~~e~~~i~~~~d~~ 132 (182)
T d1y1xa_ 84 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGY-QVSEQTFQALMRKFDRQ 132 (182)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSC-CCCHHHHHHHHHHHCTT
T ss_pred cccccchhccccccchhhhhHHHHHHHHHhCC-chhHHHHHHHHhhcccC
Confidence 45788899999999999999999999999987 69999999999999875
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=97.13 E-value=0.00015 Score=68.08 Aligned_cols=57 Identities=21% Similarity=0.324 Sum_probs=50.8
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.++...++++|..+|.|++|.|+.+||+.+|..+|. .++++++..|++.+|.|
T Consensus 114 ~~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~ 170 (321)
T d1ij5a_ 114 PMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYAD-TIPEGPLKKLFVMVEND 170 (321)
T ss_dssp CCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHT-TSCSSHHHHHHHHHHHC
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCC-cccHHHHHHHHHHHhhc
Confidence 3456677888999999999999999999999999999987 69999999999988754
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=97.09 E-value=0.00016 Score=54.16 Aligned_cols=49 Identities=8% Similarity=-0.024 Sum_probs=30.9
Q ss_pred HHHHHHHhhh-CCCCCccc-chHHHHHHHHh-hccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALL-EPNKNGCI-AFENIKTVLMK-NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~-D~~~~G~I-s~~el~~~l~~-~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+..+|..+ |+||+|.+ +.+||+.+|.. ++. .+++.+|++||+++|.|
T Consensus 10 ~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~-~~~~~~v~~i~~~~D~n 61 (87)
T d1xk4a1 10 NSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQ-YIRKKGADVWFKELDIN 61 (87)
T ss_dssp HHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCH-HHHTTCHHHHHHHHCTT
T ss_pred HHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCC-ccchHHHHHHHHHhCCC
Confidence 4456666666 66666643 66777777654 343 46666677777777664
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=97.06 E-value=0.00019 Score=53.87 Aligned_cols=50 Identities=14% Similarity=0.187 Sum_probs=35.9
Q ss_pred HHHHHHHHhhh-CCCCCc-ccchHHHHHHHHh---hccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALL-EPNKNG-CIAFENIKTVLMK---NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~-D~~~~G-~Is~~el~~~l~~---~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+..+.++|..+ |+|||| .|+..||+.++.. ++. ..++.+|++||+++|.|
T Consensus 8 i~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~-~~~~~~~~~~~~~lD~d 62 (89)
T d1k8ua_ 8 IGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGS-KLQDAEIARLMEDLDRN 62 (89)
T ss_dssp HHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGG-GTTSHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhc-cCCHHHHHHHHHHhcCC
Confidence 45567777776 777777 5888888888776 444 46677788888877764
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=97.05 E-value=0.00026 Score=59.88 Aligned_cols=48 Identities=15% Similarity=0.170 Sum_probs=43.0
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|+||.|+.+||+.++..+| +++++++.|++.+|.|
T Consensus 101 ~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~---~~~~~~~~~f~~~D~d 148 (176)
T d1nyaa_ 101 GPVVKGIVGMCDKNADGQINADEFAAWLTALG---MSKAEAAEAFNQVDTN 148 (176)
T ss_dssp HHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT---CCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHccCCChhhhHHHHHHHHHhcC---CcHHHHHHHHHHHCCC
Confidence 45678999999999999999999999998775 6789999999999975
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.03 E-value=0.00019 Score=61.97 Aligned_cols=51 Identities=18% Similarity=0.231 Sum_probs=41.1
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc-----------ccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT-----------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~-----------~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|+||.|+.+|++.++..+.. +...++.++.+++.+|.|
T Consensus 95 ~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d 156 (187)
T d1g8ia_ 95 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKN 156 (187)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSS
T ss_pred hhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCCC
Confidence 346889999999999999999999999875421 134467899999999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.01 E-value=0.0011 Score=62.35 Aligned_cols=68 Identities=9% Similarity=0.110 Sum_probs=43.5
Q ss_pred eEEEEEEEecCCccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCC-CccEEE-----EEEEeCCeEEEEEeecC
Q 011154 148 GYTCTARYKKGEHKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHS-NLVKFY-----DAFEDLDNVYIVMELCE 221 (492)
Q Consensus 148 g~V~~~~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hp-niv~l~-----~~~~~~~~~~lv~E~~~ 221 (492)
-.||++... +|..|++|+....... .+++..|+..|..|..+. -++..+ ..++..+..+.+++++.
T Consensus 36 N~vy~v~~~----dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQDE----DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECCT----TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEcC----CCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 478888643 6788999998654322 345778988888885221 111111 12345677899999998
Q ss_pred CC
Q 011154 222 GG 223 (492)
Q Consensus 222 gg 223 (492)
|.
T Consensus 108 G~ 109 (325)
T d1zyla1 108 GR 109 (325)
T ss_dssp CE
T ss_pred Cc
Confidence 74
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.00 E-value=0.00085 Score=65.05 Aligned_cols=77 Identities=19% Similarity=0.154 Sum_probs=51.4
Q ss_pred ceeccccceEEEEEEEecCC----ccccEEEEEEccCCCCCCHHHHHHHHHHHHHHHHccCCCCccEEEEEEEeCCeEEE
Q 011154 140 EEVGRGHFGYTCTARYKKGE----HKDQKVAIKVIPKSKMTTAIAVEDVRREVKILRALSGHSNLVKFYDAFEDLDNVYI 215 (492)
Q Consensus 140 ~~lG~G~fg~V~~~~~~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ev~~l~~l~~hpniv~l~~~~~~~~~~~l 215 (492)
+.|+-|--=.+|++...... ...+.|.+++.-.. .. .....+|..+++.|..+.-..++++++.+ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 46766666699998875432 13456777776421 12 12456899999999766555688887753 68
Q ss_pred EEeecCCCch
Q 011154 216 VMELCEGGEL 225 (492)
Q Consensus 216 v~E~~~ggsL 225 (492)
|+||++|..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987544
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.98 E-value=0.00035 Score=59.83 Aligned_cols=121 Identities=15% Similarity=0.159 Sum_probs=70.2
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHhcCcccccccccCCCccHHHHHHHHHHhhhhh--h-HHHHHHhhhcccchhhHHHH
Q 011154 369 SDAKDFVKLLLNKDPRKRMTAAQALSHPWIRNYNNVKVPLDISILKLMKAYMQSSS--L-RRAALKALSKTLTVDERFYL 445 (492)
Q Consensus 369 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~--l-~~a~l~~l~~~l~~~e~~~l 445 (492)
.+++.+.+.....+++...+..+..+. +........ ....+.+.+..+..... + -...+..+...........+
T Consensus 21 ~ei~~l~~~F~~~~~~g~i~~~ef~~~--l~~~~~~~~-~~~~~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~~~ 97 (181)
T d1bjfa_ 21 HEIQEWYKGFLRDCPSGHLSMEEFKKI--YGNFFPYGD-ASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKL 97 (181)
T ss_dssp HHHHHHHHHHHHHSTTSEEEHHHHHHH--HTTTSSSSC-CHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHH
T ss_pred HHHHHHHHHHHhhCCCCCcCHHHHHHH--HHHhCCCCC-HHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHHHH
Confidence 345555555566677777777776542 221110000 01111223333322221 1 12233333322223344568
Q ss_pred HHHHhhhCCCCCcccchHHHHHHHHhhcc-----------ccccHHHHHHHHhcccCC
Q 011154 446 KEQFALLEPNKNGCIAFENIKTVLMKNAT-----------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 446 ~~~F~~~D~~~~G~Is~~el~~~l~~~g~-----------~~~~~~ei~~~i~~~D~~ 492 (492)
+.+|+.+|.|++|+|+.+|++.++..... ..+.+..++.||+.+|.|
T Consensus 98 ~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d 155 (181)
T d1bjfa_ 98 KWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTN 155 (181)
T ss_dssp HHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTT
T ss_pred HHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCC
Confidence 89999999999999999999999986521 246778999999999975
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=96.93 E-value=0.00056 Score=59.13 Aligned_cols=46 Identities=9% Similarity=0.069 Sum_probs=39.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhc
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAP 488 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~ 488 (492)
...++.+|+.+|+|++|.|+..||+.+|..+|. .++++.++.|+..
T Consensus 92 ~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~-~~~~~~~~~l~~~ 137 (188)
T d1qxpa2 92 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGF-KLPCQLHQVIVAR 137 (188)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTE-ECCHHHHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCEECHHHHHHHHHHhhh-cCCHHHHHHHHHH
Confidence 356789999999999999999999999999997 5888777777665
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.92 E-value=0.00049 Score=58.49 Aligned_cols=48 Identities=6% Similarity=0.196 Sum_probs=43.8
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.++.+|+.+|.|++|+|+.+|++.+|..+|. .++++++..|++.+|.+
T Consensus 78 ~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~-~ls~~~~~~l~~~~d~~ 125 (172)
T d1juoa_ 78 GWRQHFISFDTDRSGTVDPQELQKALTTMGF-RLSPQAVNSIAKRYSTN 125 (172)
T ss_dssp HHHHHHHTTCTTCCSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHTCSS
T ss_pred hhhHHHHHhCcCCCCcCCHHHHHHHHHHHHH-hhhHHHHHHHHHHHHhc
Confidence 4678899999999999999999999999987 69999999999998864
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=96.92 E-value=0.0004 Score=52.51 Aligned_cols=53 Identities=11% Similarity=0.109 Sum_probs=43.5
Q ss_pred hhHHHHHHHHhhh-CCCCCc-ccchHHHHHHHHhhcc----ccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALL-EPNKNG-CIAFENIKTVLMKNAT----DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~-D~~~~G-~Is~~el~~~l~~~g~----~~~~~~ei~~~i~~~D~~ 492 (492)
..+..+..+|..+ |++|+| .|+.+||+.+|++... ...++.++++||+++|.|
T Consensus 6 ~~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n 64 (93)
T d1ksoa_ 6 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTN 64 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCC
Confidence 3456788999987 999999 5999999999987532 235789999999999975
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.90 E-value=0.00044 Score=53.07 Aligned_cols=46 Identities=11% Similarity=0.174 Sum_probs=40.0
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.+++.|+.+|.|++|+|+.+|++.++++.| +++.++.+|++.+|.|
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~---L~~~~L~~i~~~~D~d 57 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSG---LPDLILGKIWDLADTD 57 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTSS---SCHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcC---CcHHHHHHHHHHHcCC
Confidence 467889999999999999999999998754 6788999999999875
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.89 E-value=0.00022 Score=60.21 Aligned_cols=54 Identities=15% Similarity=0.251 Sum_probs=37.8
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccC
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDG 491 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~ 491 (492)
|...++.+|..+|+++|..+|.|++|+|+.+||+.++..... ..++++++.+|.
T Consensus 6 ~~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~~~-----~~~~~l~~~~d~ 59 (165)
T d1auib_ 6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQN-----PLVQRVIDIFDT 59 (165)
T ss_dssp CCCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHHTC-----TTHHHHHHHHCT
T ss_pred HcCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhccCC-----HHHHHHHHHHcc
Confidence 456677788888888888888888888888888776543321 234556665554
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.78 E-value=0.00081 Score=57.59 Aligned_cols=49 Identities=14% Similarity=0.121 Sum_probs=43.4
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|+.+|.+++|.|+.+||+.+|...+. .+++++++++++.+|.+
T Consensus 86 ~~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~-~l~~e~~~~~~~~~d~~ 134 (181)
T d1hqva_ 86 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGY-RLSDQFHDILIRKFDRQ 134 (181)
T ss_dssp HHHHHHHHHHCTTCCSSBCHHHHHHHHHHHTB-CCCHHHHHHHHHHHCSS
T ss_pred cccccccccccccccchhhhHHHHHHHHHcCC-cchhHHHHHHHHHhCCC
Confidence 35788999999999999999999999999887 69999999999988753
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=96.78 E-value=0.00022 Score=61.05 Aligned_cols=49 Identities=6% Similarity=0.054 Sum_probs=42.8
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....+..+|+.+|.|++|+|+.+||+.+|..+| +++++++.|++.+|.|
T Consensus 103 ~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~---l~~~~~~~~f~~~D~d 151 (185)
T d2sasa_ 103 CQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ---LQCADVPAVYNVITDG 151 (185)
T ss_dssp HHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC---CCCSSHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHccCCCccCCHHHHHHHHHHcC---CCHHHHHHHHHHcCCC
Confidence 345688999999999999999999999998765 5678999999999875
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=96.75 E-value=0.00074 Score=57.12 Aligned_cols=48 Identities=10% Similarity=0.042 Sum_probs=42.1
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|..+|.|+||.|+.+|++.+++.++ +++++++.+++.+|.|
T Consensus 93 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~---~~~~~~~~~f~~~D~d 140 (174)
T d2scpa_ 93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG---LDKTMAPASFDAIDTN 140 (174)
T ss_dssp HTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT---CCGGGHHHHHHHHCTT
T ss_pred HHHHHHHHHHHCCCccccCCHHHHHHHHHHHh---hhhHHHHHHHhhcCCC
Confidence 44578899999999999999999999998775 4677899999999976
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=96.64 E-value=0.00032 Score=54.00 Aligned_cols=52 Identities=12% Similarity=0.155 Sum_probs=40.8
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccc------cccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATD------AMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~------~~~~~ei~~~i~~~D~~ 492 (492)
..+..+.++|..++ +++|.|+..||+++|+..+.. ..++.+|++||+.+|.|
T Consensus 7 ~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n 64 (100)
T d1psra_ 7 RSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKN 64 (100)
T ss_dssp HHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTT
T ss_pred HHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCC
Confidence 44566777888886 789999999999999986532 23456799999999986
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.58 E-value=0.00086 Score=57.43 Aligned_cols=51 Identities=16% Similarity=0.231 Sum_probs=38.3
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhc----cccccHHH----HHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNA----TDAMKESR----ISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g----~~~~~~~e----i~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|+|+.+||+.++..+- ...+++++ ++.+++.+|.|
T Consensus 94 ~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d 152 (180)
T d1xo5a_ 94 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDID 152 (180)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTT
T ss_pred HHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCC
Confidence 45688999999999999999999999998761 11345544 45577777764
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=96.50 E-value=0.0011 Score=57.09 Aligned_cols=49 Identities=4% Similarity=0.045 Sum_probs=39.1
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|+|++|+|+.+||+.+|..+|. .+++..++ ++...|.|
T Consensus 90 ~~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~-~~~~~~~~-~~~~~d~d 138 (186)
T d1df0a1 90 IQKYQKIYREIDVDRSGTMNSYEMRKALEEAGF-KLPCQLHQ-VIVARFAD 138 (186)
T ss_dssp HHHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTE-ECCHHHHH-HHHHHHCC
T ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHHHHHh-cccHHHHH-HHHHHHcC
Confidence 356789999999999999999999999999987 57766554 44456654
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.44 E-value=0.0069 Score=50.50 Aligned_cols=53 Identities=17% Similarity=0.214 Sum_probs=42.7
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccc----cccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATD----AMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~----~~~~~ei~~~i~~~D~~ 492 (492)
.....++.+|+.+|.|++|.|+.+||+.+++..... ...+..+..+++.+|.|
T Consensus 82 ~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~ 138 (165)
T d1auib_ 82 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKD 138 (165)
T ss_dssp CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTT
T ss_pred hhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCC
Confidence 455678999999999999999999999999775322 34566788888888875
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=96.38 E-value=0.0027 Score=47.03 Aligned_cols=52 Identities=12% Similarity=0.091 Sum_probs=41.1
Q ss_pred hHHHHHHHHhhh-CCCCCc-ccchHHHHHHHHhhcc----ccccHHHHHHHHhcccCC
Q 011154 441 ERFYLKEQFALL-EPNKNG-CIAFENIKTVLMKNAT----DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 441 e~~~l~~~F~~~-D~~~~G-~Is~~el~~~l~~~g~----~~~~~~ei~~~i~~~D~~ 492 (492)
.+..+.++|..+ +.+|++ +|+.+||+++|++... ...++..|++||+++|.|
T Consensus 6 ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n 63 (87)
T d1e8aa_ 6 HLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDAN 63 (87)
T ss_dssp HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCC
Confidence 356688999988 566665 6999999999987321 245689999999999986
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=96.38 E-value=0.0016 Score=56.10 Aligned_cols=50 Identities=24% Similarity=0.345 Sum_probs=41.1
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhcc-----------ccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNAT-----------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~-----------~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|+.+|.|++|.|+.+|+..++..... +...+..++++++.+|.|
T Consensus 99 e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d 159 (190)
T d1fpwa_ 99 EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKN 159 (190)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCC
Confidence 46789999999999999999999999976532 123367899999999875
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=96.26 E-value=0.0015 Score=52.35 Aligned_cols=48 Identities=17% Similarity=0.394 Sum_probs=39.6
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+....++.+|+.+|.|++|+|+.+|++.++..++. .++.++|+.+|.|
T Consensus 72 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~~~~~~~-----~~~~~~~~~~D~d 119 (134)
T d1jfja_ 72 DDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGI-----EKVAEQVMKADAN 119 (134)
T ss_dssp HHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTTTTC-----HHHHHHHHHHHCS
T ss_pred cccccccccccccccccCCcccHHHHHHHHHhcCc-----HHHHHHHHHHCCC
Confidence 34456789999999999999999999999977654 4788888888765
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=96.04 E-value=0.00084 Score=57.54 Aligned_cols=47 Identities=17% Similarity=0.315 Sum_probs=39.9
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|..+|.+++|+|+..+|+.+++.+| ++++++++|++.+|.|
T Consensus 82 e~l~~aF~~~D~d~~G~i~~~el~~~l~~~g---l~~~ev~~~f~~~D~d 128 (182)
T d1s6ia_ 82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG---LDDIHIDDMIKEIDQD 128 (182)
T ss_dssp CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT---CCTTHHHHHHHHHCSS
T ss_pred HHHHHHHHHHhhcCCCccchhhhhhhhhhcC---ccHHHHHHHHHHhhcC
Confidence 3578889999999999999999999988765 6788899999998875
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=95.95 E-value=0.002 Score=59.96 Aligned_cols=50 Identities=16% Similarity=0.221 Sum_probs=44.5
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+..+|..+|.|++|+|+.+||+.+|..+|...+++.++..|++.+|.|
T Consensus 253 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d 302 (321)
T d1ij5a_ 253 LVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVD 302 (321)
T ss_dssp HHHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTT
T ss_pred hHHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCCC
Confidence 34567899999999999999999999999987558899999999999875
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=95.94 E-value=0.0034 Score=53.01 Aligned_cols=45 Identities=9% Similarity=0.147 Sum_probs=34.3
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAP 488 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~ 488 (492)
..++.+|+.+|.|++|.|+..||+.+|...|. .+++++++.+++.
T Consensus 77 ~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~-~~~~~~~~~~~~~ 121 (173)
T d1alva_ 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGF-HLNEHLYSMIIRR 121 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTC-CCCHHHHHHHHHH
T ss_pred hHHHHHHHHhccCCCCeecHHHHHHHHHHHHH-hhHHHHHHHhhcc
Confidence 34677888888888888888888888888876 5777777766643
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=95.58 E-value=0.0059 Score=51.99 Aligned_cols=50 Identities=18% Similarity=0.173 Sum_probs=38.7
Q ss_pred hhhHHHHHHHHhhhCCCCCcccchHHHHHHH-----HhhccccccHHHHHHHHhcc
Q 011154 439 VDERFYLKEQFALLEPNKNGCIAFENIKTVL-----MKNATDAMKESRISDLLAPS 489 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l-----~~~g~~~~~~~ei~~~i~~~ 489 (492)
.+.+..++++|..+|.|+||.|+.+||..++ +.+|. ..++.++..++.++
T Consensus 10 ~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~ 64 (189)
T d1qv0a_ 10 PRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEA-TPEQTKRHQVCVEA 64 (189)
T ss_dssp HHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTC-CHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCC-CchhHHHHHHHHHH
Confidence 4566789999999999999999999998754 44555 46677776666554
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.51 E-value=0.0078 Score=51.91 Aligned_cols=50 Identities=16% Similarity=0.166 Sum_probs=39.6
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhcc-------------ccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNAT-------------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~-------------~~~~~~ei~~~i~~~D~~ 492 (492)
..++.+|+.+|.|++|.|+.+|+..++..+.. ....+..++.|++.+|.|
T Consensus 99 ~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d 161 (201)
T d1omra_ 99 QKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKK 161 (201)
T ss_dssp GSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCC
Confidence 35789999999999999999999999876532 112355678899999875
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=95.51 E-value=0.0073 Score=42.12 Aligned_cols=39 Identities=18% Similarity=0.251 Sum_probs=30.4
Q ss_pred HhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhh
Q 011154 431 KALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKN 472 (492)
Q Consensus 431 ~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~ 472 (492)
..+...++.+ ++++.|..+|.|+||.|+++|+..+|.++
T Consensus 28 ~~lg~~~~~~---~i~~~~~~~D~d~dg~I~~~EF~~~m~~~ 66 (67)
T d1tiza_ 28 LAFSPYFTQE---DIVKFFEEIDVDGNGELNADEFTSCIEKM 66 (67)
T ss_dssp HHTCTTSCHH---HHHHHHHHHCCSSSSEECHHHHHHHHHTC
T ss_pred HHhccccchH---HHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 3344444433 47889999999999999999999998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.43 E-value=0.029 Score=51.70 Aligned_cols=30 Identities=30% Similarity=0.424 Sum_probs=24.6
Q ss_pred cCCcccCCCCCceEeecCCCCCcEEEEeccccc
Q 011154 258 HGVVHRDLKPENFLYTSKDESSQLKAIDFGLSD 290 (492)
Q Consensus 258 ~~ivHrDlkp~NILl~~~~~~~~~kl~DfGla~ 290 (492)
.|+||+|+.++||++ +.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~---~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFF---LGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhc---ccccceeEecccccc
Confidence 369999999999999 444456899999874
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=95.31 E-value=0.0047 Score=52.80 Aligned_cols=49 Identities=14% Similarity=0.100 Sum_probs=41.7
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccc-------cccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATD-------AMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~-------~~~~~ei~~~i~~~D~~ 492 (492)
..+|+.|..+| |+||.|+.+||+.+|..+|.. .++.+++..|++.+|.|
T Consensus 18 ~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d 73 (186)
T d1df0a1 18 DGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDED 73 (186)
T ss_dssp HHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCC
Confidence 45899999998 999999999999999887652 24678899999998875
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.12 E-value=0.021 Score=48.46 Aligned_cols=49 Identities=16% Similarity=0.150 Sum_probs=39.3
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..+...|..+|.|+||.|++.|+..++..+.. ...++.+..+++-+|.|
T Consensus 58 ~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~-~~~~~~~~~~F~~~D~d 106 (189)
T d1jbaa_ 58 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLR-GTLEHKLKWTFKIYDKD 106 (189)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSS-CCCTHHHHHHHHHHCSS
T ss_pred HHHHHHHHHhccCCCCeEeehhHHHHHHhhcc-cchHHHHHHHHhhhccC
Confidence 34678899999999999999999998887754 46677888888877764
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=95.05 E-value=0.0089 Score=50.62 Aligned_cols=49 Identities=14% Similarity=0.081 Sum_probs=36.0
Q ss_pred hhhHHHHHHHHhhhCCCCCcccchHHHHHHHHh-----hccccccHHHHHHHHhc
Q 011154 439 VDERFYLKEQFALLEPNKNGCIAFENIKTVLMK-----NATDAMKESRISDLLAP 488 (492)
Q Consensus 439 ~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~ 488 (492)
......++++|..+|.|+||+|+.+||+.++.. +|. ..++.++..++.+
T Consensus 8 p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 61 (187)
T d1uhka1 8 PRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGA-TPEQAKRHKDAVE 61 (187)
T ss_dssp HHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCC-CHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhcc-CccHHHHHHHHHH
Confidence 344678999999999999999999999877654 343 3455555555443
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.04 E-value=0.015 Score=49.97 Aligned_cols=48 Identities=15% Similarity=0.252 Sum_probs=39.1
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.+...|..+|.|++|.|+..|+..++..+.. ...++++..+++.+|.|
T Consensus 64 ~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~-~~~~~~l~~~F~~~D~d 111 (201)
T d1omra_ 64 YAQHVFRSFDANSDGTLDFKEYVIALHMTSA-GKTNQKLEWAFSLYDVD 111 (201)
T ss_dssp HHHHHHHTTTSCSSSEEEHHHHHHHHHHHHS-SCGGGSHHHHHHHHCTT
T ss_pred HHHHHHHHhccCCCCeEeehhHHHHHHhhcc-cchHHHHHHHHHHHccC
Confidence 4567899999999999999999998887755 46677888888888764
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=94.93 E-value=0.0099 Score=50.42 Aligned_cols=49 Identities=16% Similarity=0.289 Sum_probs=36.9
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhh----ccccccHHH----HHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKN----ATDAMKESR----ISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~----g~~~~~~~e----i~~~i~~~D~~ 492 (492)
..++.+|+.+|.|++|.|+.+|++.++... +. .+++++ ++.+++.+|.|
T Consensus 91 ~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~if~~~D~d 147 (183)
T d2zfda1 91 DKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGM-NLKDTVIEDIIDKTFEEADTK 147 (183)
T ss_dssp HHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTC-CCCHHHHHHHHHHHHHHHCSS
T ss_pred HHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhc-ccchHHHHHHHHHHHHHhCCC
Confidence 457889999999999999999999987643 32 345554 45567777764
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.88 E-value=0.012 Score=50.21 Aligned_cols=52 Identities=10% Similarity=0.128 Sum_probs=42.5
Q ss_pred hhHHHHHHHHhhhCCC-CCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 440 DERFYLKEQFALLEPN-KNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~-~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
-+..++++.|+.|..+ ++|+|+.+||+++|...+. ..+...++.|++.+|.|
T Consensus 18 ~~~~ei~~~~~~F~~~~~~G~i~~~Ef~~~l~~~~~-~~~~~~~~~lf~~~D~d 70 (189)
T d1jbaa_ 18 ADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDN-EEATQYVEAMFRAFDTN 70 (189)
T ss_dssp HHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSS-STTHHHHHHHHHHHCCS
T ss_pred cCHHHHHHHHHHhcccCCCCeeeHHHHHHHHHHcCC-CccHHHHHHHHHHhccC
Confidence 3445677777777655 5999999999999988876 57889999999999875
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.82 E-value=0.012 Score=49.50 Aligned_cols=51 Identities=18% Similarity=0.215 Sum_probs=38.0
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc-----------ccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT-----------DAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~-----------~~~~~~ei~~~i~~~D~~ 492 (492)
...++.+|+.+|.|++|.|+.+|+...+..+.. ....+..++.|++.+|.|
T Consensus 86 ~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d 147 (178)
T d1s6ca_ 86 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKN 147 (178)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCC
Confidence 346788999999999999999999988765421 012255677899988865
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=94.66 E-value=0.013 Score=49.94 Aligned_cols=48 Identities=25% Similarity=0.356 Sum_probs=42.3
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....+|..+|.|++|.|+++|+..++..++. ...++++..+++.+|.|
T Consensus 64 ~~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~-~~~~e~~~~~F~~~D~d 111 (190)
T d1fpwa_ 64 FANHLFTVFDKDNNGFIHFEEFITVLSTTSR-GTLEEKLSWAFELYDLN 111 (190)
T ss_dssp HHHHHHHTCCSSCSSEECHHHHHHHHHHHSC-CCSTHHHHHHHHHHCSS
T ss_pred HHHHHHHHhCcCCCCcccHHHHHHHHHHHcc-CchHHHHHHHHHHhccC
Confidence 3467899999999999999999999998875 57789999999999875
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=94.39 E-value=0.014 Score=43.58 Aligned_cols=32 Identities=16% Similarity=0.213 Sum_probs=28.6
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
...+++.|..+|.|+||.|+++||..++.++.
T Consensus 51 ~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l~ 82 (93)
T d3c1va1 51 EAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA 82 (93)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Confidence 45688999999999999999999999998764
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.09 E-value=0.015 Score=49.01 Aligned_cols=47 Identities=17% Similarity=0.195 Sum_probs=38.5
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....|..+|.+++|.|+.+|+..++...-. ...++.+..+++.+|.|
T Consensus 61 ~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~-~~~~~~~~~~f~~~D~d 107 (181)
T d1bjfa_ 61 AEHVFRTFDANGDGTIDFREFIIALSVTSR-GKLEQKLKWAFSMYDLD 107 (181)
T ss_dssp HHHHHHHHCSSCSSEEEHHHHHHHHHHHTS-SCHHHHHHHHHHHHCTT
T ss_pred HHHHHHhcCCCCCCcEeHHHHHHHHHHHhh-hchHHHHHHHHHHhccC
Confidence 467899999999999999999998877654 46678888888888764
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=94.08 E-value=0.012 Score=41.09 Aligned_cols=29 Identities=17% Similarity=0.271 Sum_probs=25.8
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
.++...|+.+|.|+||.|+++|+..+|.+
T Consensus 39 ~e~~~~~~~~D~d~dG~i~~~EF~~~m~r 67 (68)
T d1c7va_ 39 AEVEEAMKEADEDGNGVIDIPEFMDLIKK 67 (68)
T ss_dssp HHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 45778899999999999999999998865
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=94.05 E-value=0.023 Score=42.33 Aligned_cols=33 Identities=12% Similarity=0.196 Sum_probs=28.9
Q ss_pred HHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc
Q 011154 442 RFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT 474 (492)
Q Consensus 442 ~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~ 474 (492)
...+++.|+.+|.|+||.|+++|+..++.++..
T Consensus 51 ~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~~ 83 (93)
T d1zfsa1 51 ADAVDKIMKELDENGDGEVDFQEFVVLVAALTV 83 (93)
T ss_dssp HHHHHHHHHHHTTTCCSEECSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHH
Confidence 356788999999999999999999999987753
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=94.03 E-value=0.02 Score=42.70 Aligned_cols=32 Identities=9% Similarity=0.254 Sum_probs=28.1
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhcc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNAT 474 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~ 474 (492)
..+.+.|..+|.|+||.|+++|+..++..+..
T Consensus 49 ~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~~ 80 (92)
T d1a4pa_ 49 LAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTI 80 (92)
T ss_dssp THHHHHHHHHCTTSSSCBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHH
Confidence 45788999999999999999999999877653
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=93.84 E-value=0.029 Score=40.00 Aligned_cols=29 Identities=24% Similarity=0.390 Sum_probs=26.4
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKN 472 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~ 472 (492)
++.+.|..+|.|+||.|+++||..++.++
T Consensus 46 ei~~~~~~~D~d~dG~I~f~EF~~~m~~~ 74 (76)
T d1qx2a_ 46 TLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp SHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHHhhcCCCCcCcHHHHHHHHHHH
Confidence 47889999999999999999999998765
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=93.78 E-value=0.026 Score=47.65 Aligned_cols=49 Identities=20% Similarity=0.272 Sum_probs=39.3
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
.....|..+|.|++|.|++.|+-.++..+......++.+..+++.+|.|
T Consensus 55 ~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d 103 (183)
T d2zfda1 55 FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLK 103 (183)
T ss_dssp HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccC
Confidence 4578899999999999999999988876543334577788899988875
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=93.49 E-value=0.046 Score=38.89 Aligned_cols=29 Identities=21% Similarity=0.241 Sum_probs=26.2
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKN 472 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~ 472 (492)
++.+.|+.+|.|++|.|+.+|+..+|++.
T Consensus 46 e~~~~~~~~D~d~~G~I~~~EF~~~m~k~ 74 (77)
T d1oqpa_ 46 ELQEMIAEADRNDDNEIDEDEFIRIMKKT 74 (77)
T ss_dssp HHHHHHHHHCCSSSSEECHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHHHHHcc
Confidence 46788999999999999999999999764
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.36 E-value=0.013 Score=49.25 Aligned_cols=48 Identities=10% Similarity=0.243 Sum_probs=28.5
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhccc---------cccHHHHHHHHhcccC
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNATD---------AMKESRISDLLAPSDG 491 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~---------~~~~~ei~~~i~~~D~ 491 (492)
++..+|..+|.|++|+|+.+||+..|.....+ ..+.+.+.++|+.++.
T Consensus 79 ei~~~F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~ 135 (170)
T d2zkmx1 79 EIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEP 135 (170)
T ss_dssp HHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCC
T ss_pred HHHHHHHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHcc
Confidence 47789999999999999999999999876543 2467788888888765
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=93.31 E-value=0.054 Score=38.99 Aligned_cols=30 Identities=17% Similarity=0.378 Sum_probs=26.7
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
++.+.|..+|.|+||.|+++|+..+++...
T Consensus 42 ei~~~~~~~D~d~~G~I~~~EF~~~~~~~~ 71 (81)
T d2opoa1 42 EVRRMMAEIDTDGDGFISFDEFTDFARANR 71 (81)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHHCT
T ss_pred HHHHHHHHhCCCCCCeEeHHHHHHHHHHCc
Confidence 478899999999999999999999887653
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=93.29 E-value=0.055 Score=39.12 Aligned_cols=39 Identities=15% Similarity=0.361 Sum_probs=30.2
Q ss_pred HHhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 430 LKALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 430 l~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
+..+...++. .++++.|+.+|.|+||.|+++||..+|.+
T Consensus 42 l~~lg~~~t~---~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 42 MRMLGQNPTP---EELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHTTCCCCH---HHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHcCCCCCH---HHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 3445555543 34788899999999999999999998864
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=93.07 E-value=0.0041 Score=53.41 Aligned_cols=54 Identities=15% Similarity=0.164 Sum_probs=31.7
Q ss_pred chhhH-HHHHHHHhhhCCCCCcccchHHHHHHHHhhccc-------cccHHHHHHHHhcccCC
Q 011154 438 TVDER-FYLKEQFALLEPNKNGCIAFENIKTVLMKNATD-------AMKESRISDLLAPSDGF 492 (492)
Q Consensus 438 ~~~e~-~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~-------~~~~~ei~~~i~~~D~~ 492 (492)
+.++. ..+++.|..+| ++||.|+..||+.+|...+.. ....+.++.||..+|.|
T Consensus 14 s~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d 75 (188)
T d1qxpa2 14 SEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRD 75 (188)
T ss_dssp -------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC-
T ss_pred CHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCC
Confidence 34444 35899999999 568999999999998765532 24567899999999875
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.98 E-value=0.03 Score=42.20 Aligned_cols=29 Identities=7% Similarity=0.133 Sum_probs=26.0
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
..+..+|..+|.|+||.|+++|+..++++
T Consensus 68 ~~v~~~~~~~D~d~DG~Is~~EF~~~~~~ 96 (99)
T d1snla_ 68 RMREHVMKNVDTNQDRLVTLEEFLASTQR 96 (99)
T ss_dssp HHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 35688999999999999999999999865
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.72 E-value=0.06 Score=38.11 Aligned_cols=38 Identities=13% Similarity=0.286 Sum_probs=29.7
Q ss_pred HhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 431 KALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 431 ~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
..+...++.+ ++.+.|..+|.|++|.|+++||..+|+.
T Consensus 36 ~~lg~~~~~~---e~~~~~~~~D~d~dg~I~~~EF~~~m~~ 73 (75)
T d1jc2a_ 36 RATGEHVIEE---DIEDLMKDSDKNNDGRIDFDEFLKMMEG 73 (75)
T ss_dssp HHSSSCCCHH---HHHHHHHHHCSSSCSEECHHHHHHHHHT
T ss_pred HhcCCCccHH---HHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 3344555543 4678899999999999999999998864
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=92.68 E-value=0.046 Score=40.65 Aligned_cols=33 Identities=15% Similarity=0.157 Sum_probs=28.8
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
....+.+.++.+|.|+||.|+++|+..++.++.
T Consensus 50 ~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l~ 82 (93)
T d1ksoa_ 50 RECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC 82 (93)
T ss_dssp CHHHHHHHHHHHHHTTTCEECHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 345689999999999999999999999987764
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.53 E-value=0.072 Score=38.30 Aligned_cols=38 Identities=18% Similarity=0.375 Sum_probs=29.8
Q ss_pred HhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 431 KALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 431 ~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
..+...++.. ++.+.|..+|.|+||.|+++||..+|.+
T Consensus 41 ~~~g~~~s~~---e~~~~~~~~D~d~~g~I~~~eF~~~m~~ 78 (81)
T d1avsa_ 41 RMLGQNPTKE---ELDAIIEEVDEDGSGTIDFEEFLVMMVR 78 (81)
T ss_dssp HHTTCCCCHH---HHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred HHcCCCCCHH---HHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 4445555543 4678899999999999999999998864
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=92.49 E-value=0.069 Score=44.54 Aligned_cols=47 Identities=15% Similarity=0.146 Sum_probs=39.5
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....|..+|.|++|.|+.+|+..++..+.. ...++.+..+++.+|.|
T Consensus 53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~-~~~~~~~~~~f~~~D~~ 99 (178)
T d1s6ca_ 53 AHYLFNAFDTTQTGSVKFEDFVTALSILLR-GTVHEKLRWTFNLYDIN 99 (178)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHHhc-cchHHHHHHHHHhhccC
Confidence 467899999999999999999999976654 56788898888888764
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=92.44 E-value=0.084 Score=38.59 Aligned_cols=33 Identities=15% Similarity=0.333 Sum_probs=28.6
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
....+.+.|+.+|.|+||.|+++|+-..+.++.
T Consensus 49 ~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l~ 81 (87)
T d1e8aa_ 49 DKAVIDEIFQGLDANQDEQVDFQEFISLVAIAL 81 (87)
T ss_dssp SHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHHH
Confidence 345689999999999999999999999887654
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.32 E-value=0.13 Score=43.26 Aligned_cols=47 Identities=17% Similarity=0.186 Sum_probs=39.7
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
....|..+|.|+||.|++.|+..++..+.. ...++.+..+++.+|.|
T Consensus 62 ~~~if~~~d~~~dg~I~~~EF~~~l~~~~~-~~~~e~l~~~F~~~D~d 108 (187)
T d1g8ia_ 62 ATFVFNVFDENKDGRIEFSEFIQALSVTSR-GTLDEKLRWAFKLYDLD 108 (187)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTT
T ss_pred HHHHHHHhCcCCCCCCcHHHHHHHHHHhcc-CchhhhHHHHHHHHhcC
Confidence 356899999999999999999999987654 45678899999998865
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=92.18 E-value=0.058 Score=36.97 Aligned_cols=36 Identities=17% Similarity=0.256 Sum_probs=27.5
Q ss_pred HhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHH
Q 011154 431 KALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVL 469 (492)
Q Consensus 431 ~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l 469 (492)
..+...++. .++++.|..+|.|+||.|+++|+..+|
T Consensus 30 ~~lg~~~~~---~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 30 TNLGEKLTD---EEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHTTCCCCH---HHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHhCCCCCH---HHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 344444443 347888999999999999999998764
|
| >d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=92.17 E-value=0.17 Score=33.73 Aligned_cols=54 Identities=11% Similarity=0.201 Sum_probs=47.0
Q ss_pred cccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcc
Q 011154 435 KTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPS 489 (492)
Q Consensus 435 ~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~ 489 (492)
..+..++..+....|..||.|....-...+--..|.++|. ..+..|-+.|++++
T Consensus 6 ralgpeekdecmkifdifdrnaeniapvsdtmdmltklgq-tytkreteaimkea 59 (86)
T d1j7qa_ 6 RALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQ-TYTKRETEAIMKEA 59 (86)
T ss_dssp CCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSC-CCSHHHHHHHHHHH
T ss_pred cccCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhh-HHhHHHHHHHHHHh
Confidence 3455678888999999999999999999999999999997 68899999998875
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=92.07 E-value=0.088 Score=36.92 Aligned_cols=38 Identities=21% Similarity=0.381 Sum_probs=29.2
Q ss_pred HhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 431 KALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 431 ~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
..+...++. ..+.+.|+.+|.|++|.|+++|+..+|.+
T Consensus 35 ~~~g~~~s~---~~~~~~~~~~D~d~~g~I~f~eF~~~m~~ 72 (73)
T d2pq3a1 35 RSLGQNPTE---AELQDMINEVDADGNGTIDFPEFLTMMAR 72 (73)
T ss_dssp HHTTCCCCH---HHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHhCCCCCH---HHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 334444443 34788999999999999999999988753
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=91.88 E-value=0.16 Score=37.25 Aligned_cols=51 Identities=8% Similarity=0.117 Sum_probs=38.4
Q ss_pred HHHHHHHHhhh-CCCCC-cccchHHHHHHHHhh----ccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALL-EPNKN-GCIAFENIKTVLMKN----ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~-D~~~~-G~Is~~el~~~l~~~----g~~~~~~~ei~~~i~~~D~~ 492 (492)
+..+..+|..+ ..+|+ +.++..||+.+|.+- .....+...++++++.+|.|
T Consensus 8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n 64 (90)
T d3cr5x1 8 VVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSD 64 (90)
T ss_dssp HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCC
Confidence 45678889888 45665 579999999999871 12234567799999999986
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=91.73 E-value=0.061 Score=38.73 Aligned_cols=38 Identities=21% Similarity=0.315 Sum_probs=29.0
Q ss_pred HhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 431 KALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 431 ~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
..+...++.+ ++.+.|..+|.|+||.|+++||...|+.
T Consensus 42 ~~~g~~~~~~---ev~~~~~~~D~d~dg~I~~~EF~~~m~~ 79 (81)
T d1fi5a_ 42 QATGETITED---DIEELMKDGDKNNDGRIDYDEFLEFMKG 79 (81)
T ss_dssp HTSSSCCCHH---HHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred HhcCCCCCHH---HHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence 3344444433 4678899999999999999999998853
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=91.65 E-value=0.05 Score=41.67 Aligned_cols=28 Identities=11% Similarity=0.158 Sum_probs=25.0
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHH
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLM 470 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~ 470 (492)
.++++.|+.+|.|+||.|+.+|+..+|+
T Consensus 80 ~~~~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (108)
T d1rroa_ 80 SETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp HHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence 4578899999999999999999999875
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=91.19 E-value=0.098 Score=38.20 Aligned_cols=32 Identities=19% Similarity=0.281 Sum_probs=28.1
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhcc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNAT 474 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~ 474 (492)
..+.+.++.+|.|+||.|+++||-.++.++..
T Consensus 49 ~~v~~i~~~~D~n~DG~IdF~EF~~l~~~la~ 80 (87)
T d1xk4a1 49 KGADVWFKELDINTDGAVNFQEFLILVIKMGV 80 (87)
T ss_dssp TCHHHHHHHHCTTCSSSBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHH
Confidence 35788899999999999999999999987754
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=90.85 E-value=0.099 Score=37.03 Aligned_cols=37 Identities=11% Similarity=0.197 Sum_probs=29.0
Q ss_pred HhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHHH
Q 011154 431 KALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVLM 470 (492)
Q Consensus 431 ~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~ 470 (492)
..+...++. .++.+.|..+|.|++|.|+++||..+|.
T Consensus 37 ~~~g~~~t~---~e~~~~~~~~D~~~~g~I~~~eF~~~m~ 73 (77)
T d1f54a_ 37 RSLGLSPSE---AEVNDLMNEIDVDGNHQIEFSEFLALMS 73 (77)
T ss_dssp HHHTCCCCH---HHHHHHHHTTCCSSCCEEEHHHHHHHHT
T ss_pred HHhCCCCCH---HHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 344445543 3478899999999999999999998874
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=90.63 E-value=0.11 Score=39.71 Aligned_cols=28 Identities=21% Similarity=0.262 Sum_probs=25.0
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
++...|+.+|.|+||.|+++|+.++|++
T Consensus 81 e~~~~~~~~D~d~dG~i~~~EF~~~m~~ 108 (109)
T d1rwya_ 81 ETKTLMAAGDKDGDGKIGVEEFSTLVAE 108 (109)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 4678899999999999999999998864
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=90.42 E-value=0.059 Score=38.51 Aligned_cols=30 Identities=27% Similarity=0.492 Sum_probs=26.5
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
.+.+.|..+|.|+||.|+++||..++.++.
T Consensus 48 ~v~~~~~~~D~d~dG~Idf~EF~~l~~~la 77 (78)
T d1cb1a_ 48 TLDDLFQELDKNGDGEVSFEEFQVLVKKIS 77 (78)
T ss_dssp CSSHHHHHTCCCSSSSEEHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCcCcHHHHHHHHHHHh
Confidence 467889999999999999999999987764
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=90.41 E-value=0.1 Score=39.90 Aligned_cols=28 Identities=14% Similarity=0.267 Sum_probs=24.8
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
++.+.|+.+|.|+||.|+++|+..+|.+
T Consensus 81 ev~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d1pvaa_ 81 ETKAFLKAADKDGDGKIGIDEFETLVHE 108 (109)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred HHHHHHHHHCCCCcCcEeHHHHHHHHHh
Confidence 4678899999999999999999998864
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=90.21 E-value=0.12 Score=39.32 Aligned_cols=28 Identities=14% Similarity=0.166 Sum_probs=25.1
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHH
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLM 470 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~ 470 (492)
..+++.|+.+|.|+||.|+++|+..+|+
T Consensus 79 ~~~~~l~~~~D~d~dG~I~~~EF~~~m~ 106 (107)
T d2pvba_ 79 AETKAFLADGDKDGDGMIGVDEFAAMIK 106 (107)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 4578889999999999999999998875
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=89.85 E-value=0.18 Score=37.36 Aligned_cols=50 Identities=10% Similarity=-0.034 Sum_probs=38.0
Q ss_pred HHHHHHHHhhh-CCCCC-cccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALL-EPNKN-GCIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~-D~~~~-G~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+..+-.+|..+ ..+|+ +.++..||+.+|.+ ++. .-.+..|++||+.+|.|
T Consensus 8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~-~~d~~~vd~im~~LD~n 64 (95)
T d1qlsa_ 8 IESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQN-QKDPGVLDRMMKKLDLD 64 (95)
T ss_dssp HHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHH-CCCTHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcC-CCCHHHHHHHHHHhcCC
Confidence 44567788777 44565 67999999999976 433 34567899999999986
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.40 E-value=0.18 Score=42.11 Aligned_cols=48 Identities=10% Similarity=0.057 Sum_probs=38.4
Q ss_pred HHHHHhhhCCC-CCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPN-KNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~-~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
...+|+.||.| ++|.|+++|+..+|..+....-.++.+..+++-+|.|
T Consensus 59 ~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d 107 (180)
T d1xo5a_ 59 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFD 107 (180)
T ss_dssp HHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTT
T ss_pred HHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCC
Confidence 46689999987 7999999999999976643235577898889888865
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=89.39 E-value=0.13 Score=39.23 Aligned_cols=28 Identities=14% Similarity=0.228 Sum_probs=25.1
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
++.+.|+.+|.|+||.|+.+|+..+|.+
T Consensus 81 e~~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d5pala_ 81 ETKALLAAGDSDHDGKIGADEFAKMVAQ 108 (109)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence 4778899999999999999999998864
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=89.38 E-value=0.072 Score=40.10 Aligned_cols=32 Identities=28% Similarity=0.364 Sum_probs=27.9
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhcc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNAT 474 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~ 474 (492)
..+.+.|+.+|.|+||.|+++|+..++.+++.
T Consensus 52 ~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~~ 83 (100)
T d1psra_ 52 NYLADVFEKKDKNEDKKIDFSEFLSLLGDIAT 83 (100)
T ss_dssp CGGGTHHHHHCTTCSSCBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHH
Confidence 45678899999999999999999999987753
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.32 E-value=0.31 Score=40.06 Aligned_cols=43 Identities=14% Similarity=0.160 Sum_probs=32.6
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++..+..+|.|++|.|+++|+..++..+ .++.++++.+|.|
T Consensus 40 ~~~~~li~~~D~~~~G~i~~~EF~~l~~~~-------~~~~~~F~~fD~d 82 (165)
T d1k94a_ 40 ETCRIMIAMLDRDHTGKMGFNAFKELWAAL-------NAWKENFMTVDQD 82 (165)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH-------HHHHHHHHHHCTT
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHhhcc-------chhHHHHHHhCCC
Confidence 456788899999999999999998876543 3456666666653
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=88.79 E-value=0.19 Score=37.45 Aligned_cols=32 Identities=19% Similarity=0.210 Sum_probs=28.0
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhcc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNAT 474 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~ 474 (492)
..+.+.|..+|.|+||.|+++||..++.++..
T Consensus 54 ~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l~~ 85 (98)
T d1yuta1 54 GSLDEKMKSLDVNQDSELKFNEYWRLIGELAK 85 (98)
T ss_dssp SCHHHHHHHHCTTCCSCBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCCHHHHHHHHHHHHH
Confidence 35789999999999999999999999977654
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=88.73 E-value=0.083 Score=38.57 Aligned_cols=36 Identities=17% Similarity=0.278 Sum_probs=27.1
Q ss_pred HhhhcccchhhHHHHHHHHhhhCCCCCcccchHHHHHHH
Q 011154 431 KALSKTLTVDERFYLKEQFALLEPNKNGCIAFENIKTVL 469 (492)
Q Consensus 431 ~~l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~~~l 469 (492)
..+...++.+ ++++.|+.+|.|++|.|+++||..++
T Consensus 50 ~~lg~~~s~~---e~~~l~~~~D~d~~g~I~~~EFl~am 85 (87)
T d1s6ja_ 50 KRVGSELMES---EIKDLMDAADIDKSGTIDYGEFIAAT 85 (87)
T ss_dssp HTTTSSCCHH---HHHHHHHHHCTTCSSEECHHHHTTCC
T ss_pred HHcCCCCCHH---HHHHHHHHcCCCCCCeEeHHHHHHHH
Confidence 3344444433 47889999999999999999997654
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.69 E-value=0.11 Score=38.67 Aligned_cols=27 Identities=11% Similarity=0.242 Sum_probs=24.5
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHH
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLM 470 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~ 470 (492)
.+.+.|..+|.|+||.|+++||..+|.
T Consensus 45 ~l~~i~~~~D~d~dG~l~~~EF~~am~ 71 (95)
T d1c07a_ 45 LLAHIWSLCDTKDCGKLSKDQFALAFH 71 (95)
T ss_dssp HHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 578899999999999999999998874
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=88.51 E-value=0.31 Score=35.64 Aligned_cols=35 Identities=14% Similarity=0.244 Sum_probs=29.4
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT 474 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~ 474 (492)
.+...+.+.|+.+|.|+||.|+++|+-.++..+..
T Consensus 49 ~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~la~ 83 (90)
T d3cr5x1 49 KEQEVVDKVMETLDSDGDGECDFQEFMAFVAMITT 83 (90)
T ss_dssp CSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHHH
Confidence 34456889999999999999999999998877643
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=88.10 E-value=0.17 Score=36.99 Aligned_cols=31 Identities=23% Similarity=0.184 Sum_probs=27.8
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
..+.+.++.+|.|+||.|+++|+-.++.++.
T Consensus 50 ~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~la 80 (89)
T d1k8ua_ 50 AEIARLMEDLDRNKDQEVNFQEYVTFLGALA 80 (89)
T ss_dssp HHHHHHHHHHHHTTTCEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCcHHHHHHHHHHHH
Confidence 5688999999999999999999999987764
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=88.07 E-value=0.17 Score=37.14 Aligned_cols=29 Identities=14% Similarity=0.318 Sum_probs=25.1
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
..+++.+..+|.|++|.|+++||..++.-
T Consensus 43 ~~l~~i~~~~D~d~dG~l~~~EF~~a~~l 71 (92)
T d1fi6a_ 43 LELSHIWELSDFDKDGALTLDEFCAAFHL 71 (92)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeecHHHHHHHHHH
Confidence 35888999999999999999999877643
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=87.73 E-value=0.19 Score=37.50 Aligned_cols=29 Identities=14% Similarity=0.208 Sum_probs=25.9
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKN 472 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~ 472 (492)
.+.++|++.|.|++|.|+.+||..+|.-.
T Consensus 46 ~L~~i~~~~D~d~dG~L~~~EF~~am~Li 74 (99)
T d1qjta_ 46 ILGKIWDLADTDGKGVLSKQEFFVALRLV 74 (99)
T ss_dssp HHHHHHHHHCCSSSSSCCSHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCccCHHHHHHHHHHH
Confidence 57899999999999999999999988643
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=87.64 E-value=0.26 Score=40.62 Aligned_cols=41 Identities=15% Similarity=0.178 Sum_probs=30.9
Q ss_pred HHHHHhhhCCCCCcccchHHHHHHHHhhccccccHHHHHHHHhcccCC
Q 011154 445 LKEQFALLEPNKNGCIAFENIKTVLMKNATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 445 l~~~F~~~D~~~~G~Is~~el~~~l~~~g~~~~~~~ei~~~i~~~D~~ 492 (492)
..++|..+|.|++|.|+++|+..++..+ .++.++++.+|.|
T Consensus 114 ~~~~~~~~d~d~~G~i~~~EF~~~~~~~-------~~~~~~f~~~D~d 154 (173)
T d1alva_ 114 LYSMIIRRYSDEGGNMDFDNFISCLVRL-------DAMFRAFKSLDKD 154 (173)
T ss_dssp HHHHHHHHHTCSSSCBCHHHHHHHHHHH-------HHHHHHHHHHSSS
T ss_pred HHHHhhccccCCCCeEeHHHHHHHHHHH-------HHHHHHHHHhCCC
Confidence 3456667778999999999999988654 3566777777764
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=86.37 E-value=0.26 Score=36.42 Aligned_cols=34 Identities=15% Similarity=0.217 Sum_probs=28.9
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT 474 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~ 474 (492)
+...+.+.|+.+|.|+||.|+++|+-.++..+..
T Consensus 50 d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~la~ 83 (95)
T d1qlsa_ 50 DPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLAI 83 (95)
T ss_dssp CTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHH
Confidence 3456889999999999999999999988876643
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.81 E-value=0.43 Score=33.97 Aligned_cols=26 Identities=8% Similarity=0.243 Sum_probs=23.3
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHH
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVL 469 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l 469 (492)
++...|..+|.|++|.|+..|+...+
T Consensus 57 e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 57 QFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp HHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHhhccccCCCCcEeHHHHHHHh
Confidence 46788999999999999999998775
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.52 E-value=0.34 Score=35.72 Aligned_cols=28 Identities=11% Similarity=0.279 Sum_probs=24.8
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
.|++.+...|.|++|+|+.+||..++.-
T Consensus 44 ~L~~Iw~~~D~~~dG~l~~~EF~~a~~L 71 (95)
T d2jxca1 44 ILGRVWELSDIDHDGMLDRDEFAVAMFL 71 (95)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCeEcHHHHHHHHHH
Confidence 5889999999999999999999877653
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=84.36 E-value=0.52 Score=34.62 Aligned_cols=35 Identities=9% Similarity=0.179 Sum_probs=28.0
Q ss_pred hhHHHHHHHHhhhCCCCCcccchHHHHHHHHhhcc
Q 011154 440 DERFYLKEQFALLEPNKNGCIAFENIKTVLMKNAT 474 (492)
Q Consensus 440 ~e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g~ 474 (492)
.+...+.+.++.+|.|+||.|+++|+-..+.++..
T Consensus 49 ~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~la~ 83 (94)
T d1j55a_ 49 KDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAITS 83 (94)
T ss_dssp ---CHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHHH
Confidence 33456889999999999999999999998876643
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=84.36 E-value=1 Score=32.16 Aligned_cols=31 Identities=13% Similarity=0.283 Sum_probs=26.6
Q ss_pred hHHHHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 441 ERFYLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 441 e~~~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
+...+.+.|..+|.|+||.|+++|+-..+-+
T Consensus 52 d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~ 82 (83)
T d1xk4c1 52 NEKVIEHIMEDLDTNADKQLSFEEFIMLMAR 82 (83)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence 4456889999999999999999999887743
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=84.25 E-value=0.57 Score=34.41 Aligned_cols=50 Identities=12% Similarity=0.152 Sum_probs=35.0
Q ss_pred HHHHHHHHhhhC-CCCC-cccchHHHHHHHHh-----hccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLE-PNKN-GCIAFENIKTVLMK-----NATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D-~~~~-G~Is~~el~~~l~~-----~g~~~~~~~ei~~~i~~~D~~ 492 (492)
+..+..+|..+. .+|+ +.++..||+..|.+ ++. ..+...|++|++.+|.|
T Consensus 8 i~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~-~~d~~~vd~~m~~LD~n 64 (94)
T d1j55a_ 8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQS-GKDKDAVDKLLKDLDAN 64 (94)
T ss_dssp HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC-------CHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcC-CCCHHHHHHHHHHhcCC
Confidence 445778888874 4444 58999999999986 332 34466799999999986
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=84.13 E-value=0.33 Score=39.72 Aligned_cols=29 Identities=14% Similarity=0.255 Sum_probs=26.2
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKN 472 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~ 472 (492)
.+..+|..+|.|+||.|+++|+..++...
T Consensus 129 ~~~~~f~~~D~d~dG~Is~~Ef~~~~~~f 157 (174)
T d2scpa_ 129 MAPASFDAIDTNNDGLLSLEEFVIAGSDF 157 (174)
T ss_dssp GHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCcEeHHHHHHHHHHH
Confidence 46788999999999999999999998765
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=83.62 E-value=0.49 Score=31.48 Aligned_cols=31 Identities=26% Similarity=0.311 Sum_probs=23.9
Q ss_pred hhcccchhhHHHHHHHHhhhCCCCCcccchHHHH
Q 011154 433 LSKTLTVDERFYLKEQFALLEPNKNGCIAFENIK 466 (492)
Q Consensus 433 l~~~l~~~e~~~l~~~F~~~D~~~~G~Is~~el~ 466 (492)
+...++. .++...|+.+|.|++|.|+.+|+-
T Consensus 30 ~g~~~~~---~ei~~l~~~~D~d~dg~I~~~eFl 60 (61)
T d2fcea1 30 LGEKLTD---AEVDELLKGVEVDSNGEIDYKKFI 60 (61)
T ss_dssp TTCCCCH---HHHHHHHTTCCCCTTSEECHHHHH
T ss_pred cCCCCCH---HHHHHHHHHcCCCCCCcEeHHHhc
Confidence 4444443 346788999999999999999985
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=83.55 E-value=0.32 Score=39.57 Aligned_cols=31 Identities=19% Similarity=0.282 Sum_probs=27.3
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHhhc
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMKNA 473 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~~g 473 (492)
.+++++|..+|.|+||.|+.+|+..+++...
T Consensus 136 ~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~~ 166 (176)
T d1nyaa_ 136 AEAAEAFNQVDTNGNGELSLDELLTAVRDFH 166 (176)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHSCCS
T ss_pred HHHHHHHHHHCCCCCCcEeHHHHHHHHHHHh
Confidence 4578899999999999999999999997653
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=82.96 E-value=1.5 Score=31.15 Aligned_cols=51 Identities=12% Similarity=0.078 Sum_probs=36.1
Q ss_pred HHHHHHHHhhhC-CCCC-cccchHHHHHHHHh-h----ccccccHHHHHHHHhcccCC
Q 011154 442 RFYLKEQFALLE-PNKN-GCIAFENIKTVLMK-N----ATDAMKESRISDLLAPSDGF 492 (492)
Q Consensus 442 ~~~l~~~F~~~D-~~~~-G~Is~~el~~~l~~-~----g~~~~~~~ei~~~i~~~D~~ 492 (492)
+..+..+|..+. .+|+ +.++..||+..|.+ + ....-.+.-|+.+++.+|.|
T Consensus 9 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n 66 (83)
T d1xk4c1 9 IETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTN 66 (83)
T ss_dssp HHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCC
Confidence 345677888884 3443 68999999999986 2 21112455689999999986
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.60 E-value=0.44 Score=36.18 Aligned_cols=28 Identities=11% Similarity=0.208 Sum_probs=24.7
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
.|.+.+.+.|.|++|+|+.+||..+|.-
T Consensus 57 ~L~~Iw~l~D~d~dG~l~~~EF~~am~L 84 (110)
T d1iq3a_ 57 ELSYIWELSDADCDGALTLPEFCAAFHL 84 (110)
T ss_dssp CHHHHHHHHCSSSCSEEEHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCeECHHHHHHHHHH
Confidence 3788999999999999999999987753
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.71 E-value=1.2 Score=36.32 Aligned_cols=29 Identities=14% Similarity=0.275 Sum_probs=24.8
Q ss_pred HHHHHHHhhhCCCCCcccchHHHHHHHHh
Q 011154 443 FYLKEQFALLEPNKNGCIAFENIKTVLMK 471 (492)
Q Consensus 443 ~~l~~~F~~~D~~~~G~Is~~el~~~l~~ 471 (492)
..++..+..+|.|++|.|+++|+..++..
T Consensus 47 ~~v~~l~~~~D~d~~G~I~f~EF~~~~~~ 75 (172)
T d1juoa_ 47 ETCRLMVSMLDRDMSGTMGFNEFKELWAV 75 (172)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCceehHHHHHHHHh
Confidence 45678899999999999999999887743
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=80.02 E-value=0.41 Score=39.41 Aligned_cols=29 Identities=3% Similarity=0.110 Sum_probs=26.2
Q ss_pred HHHHHHhhhCCCCCcccchHHHHHHHHhh
Q 011154 444 YLKEQFALLEPNKNGCIAFENIKTVLMKN 472 (492)
Q Consensus 444 ~l~~~F~~~D~~~~G~Is~~el~~~l~~~ 472 (492)
.++..|..+|.|+||.|+.+|+..++...
T Consensus 140 ~~~~~f~~~D~d~dG~i~~~EF~~~~~~f 168 (185)
T d2sasa_ 140 DVPAVYNVITDGGKVTFDLNRYKELYYRL 168 (185)
T ss_dssp SHHHHHHHHHTTTTSCCSHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCcHHHHHHHHHHH
Confidence 46889999999999999999999999764
|